PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Xu, Y; Davidson, L; Alt, FW; Baltimore, D				Xu, Y; Davidson, L; Alt, FW; Baltimore, D			Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement	IMMUNITY			English	Article							IMMUNOGLOBULIN GENE REARRANGEMENTS; PRE-B-CELLS; ALLELIC EXCLUSION; V(D)J RECOMBINATION; PROTEIN-BINDING; HEAVY; EXPRESSION; MU; TRANSCRIPTION; LINE	Roles of the kappa intronic enhancer (iE kappa) and its asssociated matrix attachment region (MAR) during B cell development were examined using mutant embryonic stem (ES) cell lines in which the entire region on both chromosomes was replaced with either a recombined LoxP site (E kappa ND) or the PGK-neomycin resistance (PGK-neo(r)) gene (E kappa NI). B cells derived from E kappa ND ES cells had greatly impaired V kappa J kappa rearrangement, normal levels of kappa expression, and kappa:lambda ratios of 1:1 instead of the usual 10:1. Furthermore, lambda-producing hybridomas derived from E kappa ND cells displayed little kappa rearrangement. Thus, the MAR and iE kappa are quantitatively significant for kappa rearrangement but not necessary. In addition, little V kappa J kappa rearrangement could be detected in B cells derived from E kappa NI ES cells, demonstrating that an inserted PGK-neo(r) gene dominantly suppresses V kappa J kappa rearrangement.	CHILDRENS HOSP,HOWARD HUGHES MED INST,DEPT GENET & PEDIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,CTR BLOOD RES,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Xu, Y (corresponding author), MIT,DEPT BIOL,77 MASSACHUSETTS AVE,CAMBRIDGE,MA 02139, USA.			Xu, Yang/0000-0001-5574-921X	NIAID NIH HHS [AI-20047] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, R37AI020047] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALONSO A, 1985, J IMMUNOL, V135, P614; ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; ALT FW, 1980, CELL, V21, P1, DOI 10.1016/0092-8674(80)90109-9; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BLACKWELL TK, 1989, J BIOL CHEM, V264, P10327; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; ENGLER P, 1991, CELL, V65, P939, DOI 10.1016/0092-8674(91)90546-B; Ferradini L, 1996, SCIENCE, V271, P1416, DOI 10.1126/science.271.5254.1416; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; KAMPS WA, 1982, J IMMUNOL, V129, P526; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KLUG CA, 1994, GENE DEV, V8, P678, DOI 10.1101/gad.8.6.678; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KORSMEYER SJ, 1981, P NATL ACAD SCI-BIOL, V78, P7096, DOI 10.1073/pnas.78.11.7096; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LASKO M, 1992, P NATL ACAD SCI USA, V89, P6232; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LEVITT D, 1980, CELL, V19, P617, DOI 10.1016/S0092-8674(80)80038-9; LEWIS S, 1982, CELL, V30, P807, DOI 10.1016/0092-8674(82)90285-9; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; MANSOUR SL, 1988, NATURE, V336, P248; MANZ J, 1988, J EXP MED, V168, P1963; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; MULLER B, 1990, EUR J IMMUNOL, V20, P1409, DOI 10.1002/eji.1830200631; MULLER B, 1988, J EXP MED, V168, P2131, DOI 10.1084/jem.168.6.2131; NADEL B, 1990, EMBO J, V9, P435, DOI 10.1002/j.1460-2075.1990.tb08128.x; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; PERRY RP, 1981, P NATL ACAD SCI-BIOL, V78, P247, DOI 10.1073/pnas.78.1.247; QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SHIMIZU T, 1991, J EXP MED, V173, P1065, DOI 10.1084/jem.173.5.1065; SIDEN E, 1981, P NATL ACAD SCI-BIOL, V78, P1823, DOI 10.1073/pnas.78.3.1823; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WEAVER D, 1987, P NATL ACAD SCI USA, V84, P1516, DOI 10.1073/pnas.84.6.1516; Xu Y, 1996, P NATL ACAD SCI USA, V93, P2169, DOI 10.1073/pnas.93.5.2169; ZHOU R, 1995, NATURE, V374, P470; ZOU YR, 1994, CURR BIOL, V4, P1099, DOI 10.1016/S0960-9822(00)00248-7	54	146	160	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1996	4	4					377	385		10.1016/S1074-7613(00)80251-4	http://dx.doi.org/10.1016/S1074-7613(00)80251-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UH522	8612132	Bronze			2022-12-18	WOS:A1996UH52200006
J	Sanderson, F; Thomas, C; Neefjes, J; Trowsdale, J				Sanderson, F; Thomas, C; Neefjes, J; Trowsdale, J			Association between HLA-DM and HLA-DR in vivo	IMMUNITY			English	Article							MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN-PROCESSING MUTANT; INVARIANT CHAIN PEPTIDES; ALPHA-CHAIN; CELL LINE; MOLECULES; TRANSPORT; COMPARTMENTS; TRIMERS	The exchange of HLA class II-associated invariant chain peptides (CLIP) for cognate peptide is catalyzed by HLA-DM under acidic conditions in vitro by an unknown mechanism. Here, we show an association between HLA-DM and HLA-DR in vivo by coprecipitation of the two heterodimers. The association is favored at low pH and in the nonionic detergent digitonin. Most DM-DR complexes are isolated from dense subcellular fractions. Recovery of HLA-DM by the conformation-dependent DR3 monoclonal antibody 16.23 suggests an association with HLA-DR heterodimers beyond the stage at which CLIP is released. The additional N-linked glycan on mutant DR3 molecules isolated from the 10.24.6 cell line, which interferes with DM-enhanced CLIP release from DR3 in vitro, also affects the DM-DR interaction.	NETHERLANDS CANC INST,1066 CX AMSTERDAM,NETHERLANDS	Netherlands Cancer Institute	Sanderson, F (corresponding author), IMPERIAL CANC RES FUND,HUMAN IMMUNOGENET LAB,44 LINCOLNS INN FIELD,LONDON WC2A 3PX,ENGLAND.		Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211				ADAMS TE, 1983, IMMUNOLOGY, V50, P613; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; KELLY AP, 1991, NATURE, V353, P371; KOPPELMAN B, 1990, J IMMUNOL, V145, P2730; LAMB CA, 1992, J IMMUNOL, V148, P3478; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; MELLINS E, 1991, J EXP MED, V174, P1607, DOI 10.1084/jem.174.6.1607; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PETERSON M, 1990, NATURE, V345, P172, DOI 10.1038/345172a0; PIOUS D, 1985, J EXP MED, V162, P1193, DOI 10.1084/jem.162.4.1193; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; QUARANTA V, 1984, J IMMUNOL, V132, P1900; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROCHE PA, 1992, EMBO J, V11, P2841, DOI 10.1002/j.1460-2075.1992.tb05351.x; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STAM NJ, 1986, J IMMUNOL, V137, P2299; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; WRAIGHT CJ, 1990, J BIOL CHEM, V265, P5787	42	146	146	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1996	4	1					87	96		10.1016/S1074-7613(00)80301-5	http://dx.doi.org/10.1016/S1074-7613(00)80301-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TT319	8574855	Bronze			2022-12-18	WOS:A1996TT31900009
J	ZHOU, H; GLIMCHER, LH				ZHOU, H; GLIMCHER, LH			HUMAN MHC CLASS-II GENE-TRANSCRIPTION DIRECTED BY THE CARBOXYL-TERMINUS OF CIITA, ONE OF THE DEFECTIVE GENES IN TYPE-II MHC COMBINED IMMUNE-DEFICIENCY	IMMUNITY			English	Article							BARE LYMPHOCYTE SYNDROME; B-CELL LINES; TRANS-ACTING FACTORS; COMBINED IMMUNODEFICIENCY; FUNCTIONAL-ANALYSIS; DRA PROMOTER; HLA-DR; EXPRESSION; SEQUENCES; CLONING	Type II major histocompatibility complex combined immune deficiency (type II MHC CID or bare lymphocyte syndrome) is a congenital immunodeficiency disease characterized by absent MHC class II expression. Four distinct complementation groups have been identified. Recently, the defective gene in group II type II MHC CID has been isolated and termed CIITA. Here, we demonstrate that CIITA is an MHC class II gene-specific transcription activator. The transcription activation function is provided by the N-terminal acidic domain (amino acids 26-137), which is experimentally exchangeable with a heterologous viral transcription-activating domain. The specificity of CIITA for three major MHC class II genes, DR, Do and DP, is mediated by its remaining C-terminal residues (amino acids 317-1130). The transactivation of multiple cis elements, especially S and X2, of the DR alpha proximal promoter in group II CID eel Is is CIITA dependent. Since CIITA overexpression in normal cells did not increase class II expression, we propose that initiation of CIITA expression serves as the on-off switch, while availability of downstream interactor(s) limits transcription.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	ZHOU, H (corresponding author), HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,665 HUNTINGTON AVE,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32412] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; BURATOWSKI S, 1993, SCIENCE, V255, P1130; CALMAN AF, 1988, P NATL ACAD SCI USA, V85, P8830, DOI 10.1073/pnas.85.23.8830; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; CHANG CH, 1994, J EXP MED, V11, P765; CRESS A, 1991, GENE, V103, P235, DOI 10.1016/0378-1119(91)90278-J; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEPREVAL C, 1985, NATURE, V318, P291, DOI 10.1038/318291a0; DEPREVAL C, 1988, NEW ENGL J MED, V318, P1295, DOI 10.1056/NEJM198805193182003; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; FREEDMAN AS, 1987, J IMMUNOL, V139, P3260; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; HUME CR, 1989, HUM IMMUNOL, V26, P288, DOI 10.1016/0198-8859(89)90007-4; HUME CR, 1989, HUM IMMUNOL, V25, P1, DOI 10.1016/0198-8859(89)90065-7; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; KARA CJ, 1993, IMMUNOGENETICS, V37, P227; KARA CJ, 1993, EMBO J, V12, P187, DOI 10.1002/j.1460-2075.1993.tb05644.x; KEEGAN L, 1988, SCIENCE, V231, P699; KOCH W, 1988, J EXP MED, V167, P1781, DOI 10.1084/jem.167.6.1781; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; MOSES H, 1992, J IMMUNOL, V148, P3643; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; ONO SJ, 1991, J EXP MED, V173, P629, DOI 10.1084/jem.173.3.629; OTTEN G, 1994, CURR PROT IMMUNOL, V1; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PELLETT PE, 1985, P NATL ACAD SCI USA, V82, P5870, DOI 10.1073/pnas.82.17.5870; REITH W, 1989, P NATL ACAD SCI USA, V86, P4200, DOI 10.1073/pnas.86.11.4200; REYNOLDS A, 1994, CURR PROT MOL BIOL, V2; RIJKERS GT, 1987, J CLIN IMMUNOL, V7, P98, DOI 10.1007/BF00916003; RILEY JL, 1993, J IMMUNOL, V151, P6942; SEIDL C, 1992, J IMMUNOL, V148, P1576; SHEEN J, 1989, CURR PROT MOL BIOL, V1; SHERMAN PA, 1987, P NATL ACAD SCI USA, V84, P4254, DOI 10.1073/pnas.84.12.4254; SLOAN JH, 1988, P NATL ACAD SCI USA, V85, P8186, DOI 10.1073/pnas.85.21.8186; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P107; STIMAC E, 1991, J IMMUNOL, V146, P4398; TOURAINE JL, 1992, BONE MARROW TRANSPL, V9, P54; TSANG SY, 1990, MOL CELL BIOL, V10, P711, DOI 10.1128/MCB.10.2.711; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; VILEN BJ, 1991, MOL CELL BIOL, V11, P2406, DOI 10.1128/MCB.11.5.2406; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1	46	146	151	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1995	2	5					545	553		10.1016/1074-7613(95)90034-9	http://dx.doi.org/10.1016/1074-7613(95)90034-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7749985	Bronze			2022-12-18	WOS:A1995QZ43000011
J	Tordesillas, L; Berin, MC; Sampson, HA				Tordesillas, Leticia; Berin, M. Cecilia; Sampson, Hugh A.			Immunology of Food Allergy	IMMUNITY			English	Review							PEANUT ORAL IMMUNOTHERAPY; THYMIC STROMAL LYMPHOPOIETIN; REGULATORY T-CELLS; PLATELET-ACTIVATING-FACTOR; HUMANIZED MOUSE MODEL; COWS MILK ALLERGY; FC-GAMMA-RIIB; DENDRITIC CELL; MAST-CELL; B-CELLS	Many consider food allergy as the "second wave'' of the allergy epidemic following the "first wave'' of respiratory allergy, i.e., asthma and allergic rhinitis, plaguing westernized countries, with up to 8% of young children and 2%-3% of adults in the United States now affected by hypersensitivity reactions to various foods. In the past decade, there have been great strides in our understanding of the underlying immunopathogenesis of these disorders, which have led to improved diagnostic techniques, management strategies, and therapeutic approaches. Here we will review the most recent understanding of basicmechanisms underlying IgE-mediated food allergies and novel therapeutic approaches under investigation for both the prevention and treatment of IgE-mediated food allergies.	[Tordesillas, Leticia; Berin, M. Cecilia; Sampson, Hugh A.] Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, New York, NY 10034 USA	Icahn School of Medicine at Mount Sinai	Sampson, HA (corresponding author), Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, New York, NY 10034 USA.	hugh.sampson@mssm.edu		berin, cecilia/0000-0002-9051-9249				ABERNATHYCARVER KJ, 1995, J CLIN INVEST, V95, P913, DOI 10.1172/JCI117743; Apostolovic D, 2016, SCI REP-UK, V6, DOI 10.1038/srep29249; Arias K, 2009, J ALLERGY CLIN IMMUN, V124, P307, DOI 10.1016/j.jaci.2009.03.012; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487; Bedoret D, 2012, MUCOSAL IMMUNOL, V5, P267, DOI 10.1038/mi.2012.5; Bellach J, 2017, J ALLERGY CLIN IMMUN, V139, P1591, DOI 10.1016/j.jaci.2016.06.045; Beyer K, 2015, ALLERGY, V70, P90, DOI 10.1111/all.12530; Blazquez AB, 2008, J IMMUNOL, V180, P4441, DOI 10.4049/jimmunol.180.7.4441; Bolhaar STHP, 2005, CLIN EXP ALLERGY, V35, P1638, DOI 10.1111/j.1365-2222.2005.02390.x; Boyano-Martinez T, 2009, J ALLERGY CLIN IMMUN, V123, P883, DOI 10.1016/j.jaci.2008.12.1125; Brightbill HD, 2010, J CLIN INVEST, V120, P2218, DOI 10.1172/JCI40141; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P1329, DOI 10.1016/j.jaci.2014.06.032; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P867, DOI 10.1016/j.jaci.2014.08.011; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Bryce PJ, 2016, J ALLERGY CLIN IMMUN, V138, P769, DOI 10.1016/j.jaci.2016.01.049; Bunyavanich S, 2016, J ALLERGY CLIN IMMUN, V138, P1122, DOI 10.1016/j.jaci.2016.03.041; Burton OT, 2017, J ALLERGY CLIN IMMUN, V139, P314, DOI 10.1016/j.jaci.2016.04.034; Burton OT, 2014, J ALLERGY CLIN IMMUN, V134, P1310, DOI 10.1016/j.jaci.2014.05.042; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Caubet JC, 2013, J ALLERGY CLIN IMMUN, V131, P222, DOI 10.1016/j.jaci.2012.06.049; Chan SMH, 2012, ALLERGY, V67, P336, DOI 10.1111/j.1398-9995.2011.02765.x; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Dioszeghy V., 2016, CELL MOL IMMUNOL; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Eggel A, 2014, J ALLERGY CLIN IMMUN, V133, P1709, DOI 10.1016/j.jaci.2014.02.005; Egger M, 2010, CURR ALLERGY ASTHM R, V10, P326, DOI 10.1007/s11882-010-0128-9; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Finkelman FD, 2016, J ALLERGY CLIN IMMUN, V137, P1674, DOI 10.1016/j.jaci.2016.02.015; Flinterman AE, 2008, J ALLERGY CLIN IMMUN, V121, P737, DOI 10.1016/j.jaci.2007.11.039; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Foster Barbara, 2011, Clin Mol Allergy, V9, P7, DOI 10.1186/1476-7961-9-7; Fox AT, 2009, J ALLERGY CLIN IMMUN, V123, P417, DOI 10.1016/j.jaci.2008.12.014; Francis A, 2017, CLIN EXP ALLERGY, V47, P361, DOI 10.1111/cea.12868; Frischmeyer-Guerrerio PA, 2011, CLIN EXP ALLERGY, V41, P61, DOI 10.1111/j.1365-2222.2010.03606.x; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Fukutomi Y, 2014, ALLERGY, V69, P1405, DOI 10.1111/all.12481; Galand C, 2016, J ALLERGY CLIN IMMUN, V138, P1356, DOI 10.1016/j.jaci.2016.03.056; Ganeshan K, 2009, J ALLERGY CLIN IMMUN, V123, P231, DOI 10.1016/j.jaci.2008.10.011; Ganeshan K, 2012, J IMMUNOL, V188, P594, DOI 10.4049/jimmunol.1102389; Gorelik M, 2015, J ALLERGY CLIN IMMUN, V135, P1283, DOI 10.1016/j.jaci.2014.11.010; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Han HW, 2014, J CLIN INVEST, V124, P5442, DOI 10.1172/JCI77798; Harris JM, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0347-2; Haselden BM, 1999, J EXP MED, V189, P1885, DOI 10.1084/jem.189.12.1885; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hoh RA, 2016, J ALLERGY CLIN IMMUN, V137, P157, DOI 10.1016/j.jaci.2015.05.029; Hong XM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7304; Hua X, 2016, EBIOMEDICINE, V3, P172, DOI 10.1016/j.ebiom.2015.11.038; Jaervinen KM, 2007, ALLERGY, V62, P758, DOI 10.1111/j.1398-9995.2007.01332.x; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Jarvinen KM, 2002, J ALLERGY CLIN IMMUN, V110, P293, DOI 10.1067/mai.2002.126080; Jimenez-Saiz R., 2017, J ALLERGY CLIN IMMUN; Jin HL, 2009, J CLIN INVEST, V119, P47, DOI 10.1172/JCI32310; Jonsson F, 2011, J CLIN INVEST, V121, P1484, DOI 10.1172/JCI45232; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Jones SM, 2016, J ALLERGY CLIN IMMUN, V137, P1117, DOI 10.1016/j.jaci.2015.12.1316; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Khodoun MV, 2011, P NATL ACAD SCI USA, V108, P12413, DOI 10.1073/pnas.1105695108; Kim B, 2012, NATURE, V491, P613, DOI 10.1038/nature11546; Kim JS, 2011, J ALLERGY CLIN IMMUN, V128, P125, DOI 10.1016/j.jaci.2011.04.036; Kosoy R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163831; Kulis M, 2012, J ALLERGY CLIN IMMUN, V129, P1159, DOI 10.1016/j.jaci.2011.11.045; Kulis M, 2013, MOL NUTR FOOD RES, V57, P906, DOI 10.1002/mnfr.201200410; Kulis M, 2012, J ALLERGY CLIN IMMUN, V130, P716, DOI 10.1016/j.jaci.2012.05.044; Kull I, 2006, ALLERGY, V61, P1009, DOI 10.1111/j.1398-9995.2006.01115.x; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Lee JB, 2016, J ALLERGY CLIN IMMUN, V137, P1216, DOI 10.1016/j.jaci.2015.09.019; Leonard SA, 2012, J ALLERGY CLIN IMMUN, V130, P473, DOI 10.1016/j.jaci.2012.06.006; Li XM, 2003, J ALLERGY CLIN IMMUN, V112, P159, DOI 10.1067/mai.2003.1622; Lieberman JA, 2013, J ALLER CL IMM-PRACT, V1, P75, DOI 10.1016/j.jaip.2012.11.002; Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14; Liu Y, 2013, J ALLERGY CLIN IMMUN, V131, P213, DOI 10.1016/j.jaci.2012.10.018; MacGinnitie AJ, 2017, J ALLERGY CLIN IMMUN, V139, P873, DOI 10.1016/j.jaci.2016.08.010; Maldonado RA, 2015, P NATL ACAD SCI USA, V112, pE156, DOI 10.1073/pnas.1408686111; Martin PE, 2015, CLIN EXP ALLERGY, V45, P255, DOI 10.1111/cea.12406; Martino DJ, 2017, CLIN EXP ALLERGY, V47, P217, DOI 10.1111/cea.12863; Masthoff LJN, 2013, J ALLERGY CLIN IMMUN, V132, P393, DOI 10.1016/j.jaci.2013.02.024; Mondoulet L, 2015, J ALLERGY CLIN IMMUN, V135, P1546, DOI 10.1016/j.jaci.2014.11.028; Monti G, 1996, DERMATOLOGY, V193, P83, DOI 10.1159/000246218; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Moutsoglou DM, 2016, CLIN EXP ALLERGY, V46, P640, DOI 10.1111/cea.12715; Nadeau KC, 2011, J ALLERGY CLIN IMMUN, V127, P1622, DOI 10.1016/j.jaci.2011.04.009; National Academies of Sciences Engineering and Medicine (U. S.), 2016, FIND PATH SAF FOOD A; Natsume O, 2017, LANCET, V389, P276, DOI 10.1016/S0140-6736(16)31418-0; Nicolaou N, 2011, J ALLERGY CLIN IMMUN, V127, P684, DOI 10.1016/j.jaci.2010.12.012; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Osterfeld H, 2010, J ALLERGY CLIN IMMUN, V125, P469, DOI 10.1016/j.jaci.2009.09.054; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Pali-Scholl I, 2013, EUR J PHARM BIOPHARM, V85, P656, DOI 10.1016/j.ejpb.2013.03.003; Palmer DJ, 2017, J ALLERGY CLIN IMMUN, V139, P1600, DOI 10.1016/j.jaci.2016.06.052; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Patil SP, 2011, J ALLERGY CLIN IMMUN, V128, P1259, DOI 10.1016/j.jaci.2011.06.015; Patil SU, 2015, J ALLERGY CLIN IMMUN, V136, P125, DOI 10.1016/j.jaci.2015.03.026; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; PINCKARD RN, 1977, J IMMUNOL, V119, P2185; Platzer B, 2015, MUCOSAL IMMUNOL, V8, P516, DOI 10.1038/mi.2014.85; Poole JA, 2006, PEDIATRICS, V117, P2175, DOI 10.1542/peds.2005-1803; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Qamar N, 2015, CLIN EXP ALLERGY, V45, P1663, DOI 10.1111/cea.12570; Reber LL, 2013, J ALLERGY CLIN IMMUN, V132, P881, DOI 10.1016/j.jaci.2013.06.008; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P801, DOI 10.1016/j.jaci.2016.02.030; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; Roman BS, 2009, INT ARCH ALLERGY IMM, V149, P111, DOI 10.1159/000189193; Roulias A, 2014, ALLERGY, V69, P208, DOI 10.1111/all.12306; Ryan JF, 2016, P NATL ACAD SCI USA, V113, pE1286, DOI 10.1073/pnas.1520180113; Sampson HA, 2014, J ALLERGY CLIN IMMUN, V134, P1016, DOI 10.1016/j.jaci.2014.05.013; Sastre J, 2010, CLIN EXP ALLERGY, V40, P1442, DOI 10.1111/j.1365-2222.2010.03585.x; Savage JH, 2012, J ALLERGY CLIN IMMUN, V130, P1123, DOI 10.1016/j.jaci.2012.05.039; Savvatianos S, 2015, J ALLERGY CLIN IMMUN, V136, P192, DOI 10.1016/j.jaci.2015.03.037; Schroeder JT, 2010, J ALLERGY CLIN IMMUN, V125, P896, DOI 10.1016/j.jaci.2009.10.021; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Sicherer SH, 2000, J ALLERGY CLIN IMMUN, V106, P53, DOI [10.1067/mai.2000.108105, 10.1067/mai.2000.110158]; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Smarr CB, 2011, J IMMUNOL, V187, P5090, DOI 10.4049/jimmunol.1100608; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song Y, 2010, J ALLERGY CLIN IMMUN, V126, P1208, DOI 10.1016/j.jaci.2010.09.013; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Srivastava KD, 2016, J ALLERGY CLIN IMMUN, V138, P536, DOI 10.1016/j.jaci.2016.01.047; Srivastava KD, 2009, J ALLERGY CLIN IMMUN, V123, P443, DOI 10.1016/j.jaci.2008.12.1107; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stone SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101409; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Sun JF, 2007, J IMMUNOL, V179, P6696, DOI 10.4049/jimmunol.179.10.6696; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Tan J, 2016, CELL REP, V15, P2809, DOI 10.1016/j.celrep.2016.05.047; Tang MLK, 2015, J ALLERGY CLIN IMMUN, V135, P737, DOI 10.1016/j.jaci.2014.11.034; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010; Tordesillas L, 2017, J ALLERGY CLIN IMMUN, V139, P189, DOI 10.1016/j.jaci.2016.03.057; Tordesillas L, 2016, J ALLERGY CLIN IMMUN, V138, P1741, DOI 10.1016/j.jaci.2016.06.048; Tordesillas L, 2014, J CLIN INVEST, V124, P4965, DOI 10.1172/JCI75660; Tordesillas L, 2011, MOL IMMUNOL, V49, P504, DOI 10.1016/j.molimm.2011.09.020; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Vadas P, 2013, J ALLERGY CLIN IMMUN, V131, P144, DOI 10.1016/j.jaci.2012.08.016; Valenta R, 2016, J ALLERGY CLIN IMMUN, V137, P351, DOI 10.1016/j.jaci.2015.12.1299; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111; Venkataraman D, 2014, J ALLERGY CLIN IMMUN, V134, P876, DOI 10.1016/j.jaci.2014.07.033; Vickery BP, 2013, J ALLERGY CLIN IMMUN, V131, P128, DOI 10.1016/j.jaci.2012.10.048; Wai CYY, 2016, CLIN EXP ALLERGY, V46, P491, DOI 10.1111/cea.12684; Wang J, 2015, J ALLERGY CLIN IMMUN, V136, P962, DOI 10.1016/j.jaci.2015.04.029; Wang J, 2010, J ALLERGY CLIN IMMUN, V125, P695, DOI 10.1016/j.jaci.2009.12.017; Wang MQ, 2010, J ALLERGY CLIN IMMUN, V126, P306, DOI 10.1016/j.jaci.2010.05.017; Wang S, 2015, IMMUNITY, V43, P289, DOI 10.1016/j.immuni.2015.06.014; Wesemann DR, 2016, IMMUNITY, V44, P728, DOI 10.1016/j.immuni.2016.02.002; Wood RA, 2013, ALLERGY, V68, P803, DOI 10.1111/all.12158; Wood R. A., 2016, J ALLERGY CLIN IMMUN, V137; Wright BL, 2016, ALLERGY, V71, P1552, DOI 10.1111/all.12895; Yamaki K, 2012, ALLERGY, V67, P1259, DOI 10.1111/all.12000; Yamaki K, 2012, ALLERGY, V67, P114, DOI 10.1111/j.1398-9995.2011.02717.x; Yang N, 2014, ANN ALLERG ASTHMA IM, V113, P556, DOI 10.1016/j.anai.2014.07.021; Yin YZ, 2017, J ALLERGY CLIN IMMUN, V139, P1701, DOI 10.1016/j.jaci.2016.10.029; Zuidmeer-Jongejan L, 2015, INT ARCH ALLERGY IMM, V166, P41, DOI 10.1159/000371657	167	145	158	9	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					32	50		10.1016/j.immuni.2017.07.004	http://dx.doi.org/10.1016/j.immuni.2017.07.004			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723552	Bronze			2022-12-18	WOS:000405712800008
J	Procaccini, C; Carbone, F; Di Silvestre, D; Brambilla, F; De Rosa, V; Galgani, M; Faicchia, D; Marone, G; Tramontano, D; Corona, M; Alviggi, C; Porcellini, A; La Cava, A; Mauri, P; Matarese, G				Procaccini, Claudio; Carbone, Fortunata; Di Silvestre, Dario; Brambilla, Francesca; De Rosa, Veronica; Galgani, Mario; Faicchia, Deriggio; Marone, Gianni; Tramontano, Donatella; Corona, Marco; Alviggi, Carlo; Porcellini, Antonio; La Cava, Antonio; Mauri, Pierluigi; Matarese, Giuseppe			The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements	IMMUNITY			English	Article							INTERLEUKIN-2 PRODUCTION; DENDRITIC CELLS; MTOR KINASE; ACTIVATION; EXPRESSION; TOLERANCE; FOXP3; LYMPHOCYTES; GLYCOLYSIS; SUBSETS	Human CD4(+)CD25(hi)Foxp3(+)CD127(-) Treg and CD4(+)CD25(-)Foxp3(-) Tconv cell functions are governed by their metabolic requirements. Here we report a comprehensive comparative analysis between ex vivo human Treg and Tconv cells that comprises analyses of the proteomic networks in subcellular compartments. We identified a dominant proteomic signature at the metabolic level that primarily impacted the highly-tuned balance between glucose and fatty-acid oxidation in the two cell types. Ex vivo Treg cells were highly glycolytic while Tconv cells used predominantly fatty-acid oxidation (FAO). When cultured in vitro, Treg cells engaged both glycolysis and FAO to proliferate, while Tconv cell proliferation mainly relied on glucose metabolism. Our unbiased proteomic analysis provides a molecular picture of the impact of metabolism on ex vivo human Treg versus Tconv cell functions that might be relevant for therapeutic manipulations of these cells.	[Procaccini, Claudio; Carbone, Fortunata; De Rosa, Veronica; Galgani, Mario; Matarese, Giuseppe] CNR, IEOS, Lab Immunol, I-80131 Naples, Italy; [Di Silvestre, Dario; Brambilla, Francesca; Mauri, Pierluigi] CNR, ITB, I-20090 Milan, Italy; [De Rosa, Veronica] IRCCS Fdn Santa Lucia, Unita NeuroImmunol, I-00143 Rome, Italy; [Faicchia, Deriggio; Marone, Gianni] Univ Naples Federico II, Dipartimento Sci Med Traslaz, I-80131 Naples, Italy; [Faicchia, Deriggio; Marone, Gianni] Univ Naples Federico II, Ctr Interdipartimentale Ric Sci Immunol Base Clin, I-80131 Naples, Italy; [Tramontano, Donatella; Matarese, Giuseppe] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [Corona, Marco] Consiglio Nazl Ric IGB CNR, Ist Genet & Biofis A Buzzati Traverso, I-80131 Naples, Italy; [Alviggi, Carlo] Univ Naples Federico II, Dipartimento Neurosci & Sci Riprod & Odontostomat, I-80131 Naples, Italy; [Porcellini, Antonio] Univ Naples Federico II, Dipartimento Biol, Complesso Univ Monte St Angelo, I-80126 Naples, Italy; [La Cava, Antonio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Mauri, Pierluigi] Scuola Super Sant Anna, Ist Sci Vita, I-56127 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); IRCCS Santa Lucia; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Naples Federico II; University of Naples Federico II; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Scuola Superiore Sant'Anna	Matarese, G (corresponding author), CNR, IEOS, Lab Immunol, I-80131 Naples, Italy.	giuseppe.matarese@unina.it	Procaccini, Claudio/AAB-3696-2019; Mauri, Pietro Luigi/AAC-3095-2019; Matarese, Giuseppe/AAO-4077-2021; Carbone, Fortunata/K-3176-2016; di silvestre, dario/AAB-5037-2022; /AAG-9576-2020; Alviggi, Carlo/B-9096-2011; Galgani, Mario/AAC-3298-2022; Porcellini, Antonio/E-1900-2011; Porcellini, Antonio/AAC-6097-2019; Tramontano, Donatella/AAS-1740-2020	Mauri, Pietro Luigi/0000-0003-4364-0393; Matarese, Giuseppe/0000-0001-9429-0616; Carbone, Fortunata/0000-0003-4299-6515; di silvestre, dario/0000-0002-7143-6229; /0000-0002-8839-0933; Porcellini, Antonio/0000-0001-6882-9518; Brambilla, Francesca/0000-0002-9532-175X; Alviggi, Carlo/0000-0001-9116-020X; MARONE, Gianni/0000-0002-9849-4701; Tramontano, Donatella/0000-0002-9308-034X; corona, marco/0000-0002-3727-6444	European Union IDEAS Programme European Research Council Starting Grant "menTORingTregs" [310496]; Fondazione Italiana Sclerosi Multipla (FISM) [2012/R/11, 2014/R/21]; EFSD/JDRF/Lilly Programme; Ministero della Salute grant [GR-2010-2315414]; Fondo per gli Investimenti della Ricerca di Base (FIRB) [RBFR12I3UB_004]; Juvenile Diabetes Research Foundation (JDRF) [1-PNF-2015-115-5-B]; National Institutes of Health [AI109677]; Italian Ministry of Economy and Finance; Italian Ministry of University and Research [01 02388, 01 01426]; Fondazione Cariplo [2009-2532]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109677] Funding Source: NIH RePORTER	European Union IDEAS Programme European Research Council Starting Grant "menTORingTregs"; Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); EFSD/JDRF/Lilly Programme; Ministero della Salute grant(Ministry of Health, Italy); Fondo per gli Investimenti della Ricerca di Base (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Economy and Finance; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	G. Matarese is supported by grants from the European Union IDEAS Programme European Research Council Starting Grant "menTORingTregs" n. 310496, the Fondazione Italiana Sclerosi Multipla (FISM) n. 2012/R/11, and the EFSD/JDRF/Lilly Programme 2015. V.D.R. is supported by the Ministero della Salute grant n. GR-2010-2315414, Fondo per gli Investimenti della Ricerca di Base (FIRB) grant n. RBFR12I3UB_004 and the Fondazione Italiana Sclerosi Multipla (FISM) n. 2014/R/21. M.G. is supported by grant from Juvenile Diabetes Research Foundation (JDRF) n. 1-PNF-2015-115-5-B. A.L.C. is partly supported by the National Institutes of Health grant AI109677. P.M. is supported by the Italian Ministry of Economy and Finance to the CNR for the Project "FaReBio di Qualita," by Italian Ministry of University and Research for the PON projects (01 02388 and 01 01426); by Fondazione Cariplo (2009-2532). The authors wish to thank Maria Rosaria Montagna and Vincenzo Gigantino for technical support and all members of the Laboratory of Immunology at IEOS-CNR for assistance and support. This work is dedicated to the memory of E. Papa and S. Zappacosta.	Bellemore SM, 2014, CLIN EXP IMMUNOL, V177, P732, DOI 10.1111/cei.12370; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Brambilla F, 2012, BLOOD, V119, P1844, DOI 10.1182/blood-2011-07-365510; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Carbone F, 2014, NAT MED, V20, P69, DOI 10.1038/nm.3411; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Khazaie K, 2006, SEMIN CANCER BIOL, V16, P124, DOI 10.1016/j.semcancer.2005.11.006; Kohrt HE, 2010, EUR J IMMUNOL, V40, P1862, DOI 10.1002/eji.201040394; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Luo CT, 2013, TRENDS IMMUNOL, V34, P531, DOI 10.1016/j.it.2013.08.003; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Maciolek JA, 2014, CURR OPIN IMMUNOL, V27, P60, DOI 10.1016/j.coi.2014.01.006; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mauri P, 2005, FASEB J, V19, P1125, DOI 10.1096/fj.04-3000fje; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Min WP, 2003, J IMMUNOL, V170, P1304, DOI 10.4049/jimmunol.170.3.1304; Nilsson J, 2012, CURR OPIN LIPIDOL, V23, P422, DOI 10.1097/MOL.0b013e328356ec7c; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Procaccini C, 2012, CELL MOL LIFE SCI, V69, P3975, DOI 10.1007/s00018-012-1058-6; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schmidl C, 2014, BLOOD, V123, pE68, DOI 10.1182/blood-2013-02-486944; Tandon P, 2011, P NATL ACAD SCI USA, V108, P2361, DOI 10.1073/pnas.1013629108; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wilhelm AJ, 2010, J BIOL CHEM, V285, P36158, DOI 10.1074/jbc.M110.134130; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778	39	145	147	4	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					406	421		10.1016/j.immuni.2016.01.028	http://dx.doi.org/10.1016/j.immuni.2016.01.028			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885861	Green Published, hybrid			2022-12-18	WOS:000370294000021
J	Yamano, T; Nedjic, J; Hinterberger, M; Steinert, M; Koser, S; Pinto, S; Gerdes, N; Lutgens, E; Ishimaru, N; Busslinger, M; Brors, B; Kyewski, B; Klein, L				Yamano, Tomoyoshi; Nedjic, Jelena; Hinterberger, Maria; Steinert, Madlen; Koser, Sandra; Pinto, Sheena; Gerdes, Norbert; Lutgens, Esther; Ishimaru, Naozumi; Busslinger, Meinrad; Brors, Benedikt; Kyewski, Bruno; Klein, Ludger			Thymic B Cells Are Licensed to Present Self Antigens for Central T Cell Tolerance Induction	IMMUNITY			English	Article							PROMISCUOUS GENE-EXPRESSION; EPITHELIAL-CELLS; DENDRITIC CELLS; NEGATIVE SELECTION; CLONAL DELETION; AIRE; THYMOCYTES; AUTOIMMUNITY; REPERTOIRE; MECHANISMS	Thymic antigen-presenting cells (APCs) such as dendritic cells and medullary thymic epithelial cells (mTECs) use distinct strategies of self-antigen expression and presentation to mediate central tolerance. The thymus also harbors B cells; whether they also display unique tolerogenic features and how they genealogically relate to peripheral B cells is unclear. Here, we found that Aire is expressed in thymic but not peripheral B cells. Aire expression in thymic B cells coincided with major histocompatibility class II (MHCII) and CD80 upregulation and immunoglobulin class-switching. These features were recapitulated upon immigration of naive peripheral B cells into the thymus, whereby this intrathymic licensing required CD40 signaling in the context of cognate interactions with autoreactive CD4+ thymocytes. Moreover, a licensing-dependent neo-antigen selectively upregulated in immigrating B cells mediated negative selection through direct presentation. Thus, autoreactivity within the nascent T cell repertoire fuels a feed forward loop that endows thymic B cells with tolerogenic features.	[Yamano, Tomoyoshi; Nedjic, Jelena; Hinterberger, Maria; Steinert, Madlen; Klein, Ludger] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Koser, Sandra; Brors, Benedikt] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Pinto, Sheena; Kyewski, Bruno] German Canc Res Ctr, Div Dev Immunol, D-69120 Heidelberg, Germany; [Gerdes, Norbert; Lutgens, Esther] Univ Munich, Inst Cardiovasc Prevent, D-80336 Munich, Germany; [Lutgens, Esther] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708504, Japan; [Busslinger, Meinrad] AFFiRiS AG, Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; University of Amsterdam; Academic Medical Center Amsterdam; Tokushima University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Klein, L (corresponding author), Univ Munich, Inst Immunol, Goethestr 31, D-80336 Munich, Germany.	ludger.klein@med.lmu.de	Gerdes, Norbert/E-2787-2010; Busslinger, Meinrad J./J-1249-2016; Brors, Benedikt/E-5620-2013; Klein, Ludger/G-8785-2011	Gerdes, Norbert/0000-0002-4546-7208; Busslinger, Meinrad J./0000-0002-9111-9351; Brors, Benedikt/0000-0001-5940-3101; Steinert, Madlen/0000-0002-2294-1042; Klein, Ludger/0000-0003-2054-071X	Deutsche Forschungsgemeinschaft (IRTG) [KL 1228/5-1, SFB 1054]; Japan Society for the Promotion of Science (JSPS) postdoctoral fellowship; DFG grant [LK 1228/6-1]; Marie Curie postdoctoral fellowship from European Union; European Research Council (ERC-AdG)	Deutsche Forschungsgemeinschaft (IRTG)(German Research Foundation (DFG)); Japan Society for the Promotion of Science (JSPS) postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); DFG grant(German Research Foundation (DFG)); Marie Curie postdoctoral fellowship from European Union; European Research Council (ERC-AdG)(European Research Council (ERC))	This work was supported by the Deutsche Forschungsgemeinschaft (KL 1228/5-1 to L.K. and SFB 1054, project part IRTG to L.K. and M.H., SFB 1054, project part B09 to E.L.). T.Y. was supported by a Japan Society for the Promotion of Science (JSPS) postdoctoral fellowship and DFG grant LK 1228/6-1. J.N. is supported by a Marie Curie postdoctoral fellowship from the European Union. B.K. was supported by the European Research Council (ERC-2012-AdG). We thank S. Kirsch, C. Federle, and S. Hoeflinger for expert technical assistance, H. Tagoh for help with work on Pax5 reporter mice, and H. von Boehmer and M. Matsumoto for comments on the manuscript.	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Atibalentja DF, 2009, J IMMUNOL, V183, P7909, DOI 10.4049/jimmunol.0902632; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; BROOKS A, 1991, P NATL ACAD SCI USA, V88, P3290, DOI 10.1073/pnas.88.8.3290; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Fujihara C, 2014, J IMMUNOL, V193, P5534, DOI 10.4049/jimmunol.1401655; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gardner JM, 2013, IMMUNITY, V39, P560, DOI 10.1016/j.immuni.2013.08.005; Gardner JM, 2009, CURR OPIN IMMUNOL, V21, P582, DOI 10.1016/j.coi.2009.08.007; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Guerder S, 2012, CURR OPIN IMMUNOL, V24, P99, DOI 10.1016/j.coi.2012.01.008; Hadeiba H, 2012, IMMUNITY, V36, P438, DOI 10.1016/j.immuni.2012.01.017; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kleindienst P, 2000, BLOOD, V95, P2610; Laan M, 2009, J IMMUNOL, V183, P7682, DOI 10.4049/jimmunol.0804133; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Perera J, 2013, P NATL ACAD SCI USA, V110, P17011, DOI 10.1073/pnas.1313001110; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Takahama Y, 2012, CURR OPIN IMMUNOL, V24, P92, DOI 10.1016/j.coi.2012.01.006; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Volkmann A, 1997, J IMMUNOL, V158, P693; Walters SN, 2014, J IMMUNOL, V193, P170, DOI 10.4049/jimmunol.1302519; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; White AL, 2008, ANTIGONISH REV, P38; White AJ, 2014, J IMMUNOL, V192, P2659, DOI 10.4049/jimmunol.1303057; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; Yuseff MI, 2013, NAT REV IMMUNOL, V13, P475, DOI 10.1038/nri3469	50	145	147	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1048	1061		10.1016/j.immuni.2015.05.013	http://dx.doi.org/10.1016/j.immuni.2015.05.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26070482	Bronze			2022-12-18	WOS:000356362800011
J	Stone, EL; Pepper, M; Katayama, CD; Kerdiles, YM; Lai, CY; Emslie, E; Lin, YC; Yang, E; Goldrath, AW; Li, MO; Cantrell, DA; Hedrick, SM				Stone, Erica L.; Pepper, Marion; Katayama, Carol D.; Kerdiles, Yann M.; Lai, Chen-Yen; Emslie, Elizabeth; Lin, Yin C.; Yang, Edward; Goldrath, Ananda W.; Li, Ming O.; Cantrell, Doreen A.; Hedrick, Stephen M.			ICOS Coreceptor Signaling Inactivates the Transcription Factor FOXO1 to Promote Tfh Cell Differentiation	IMMUNITY			English	Article							FOLLICULAR HELPER-CELL; T-CELLS; L-SELECTIN; B-CELLS; EXPRESSION; BCL6; MEMORY; NAIVE; ROLES; GENE	T follicular helper (Tfh) cells are essential in the induction of high-affinity, class-switched antibodies. The differentiation of Tfh cells is a multi-step process that depends upon the co-receptor ICOS and the activation of phosphoinositide-3 kinase leading to the expression of key Tfh cell genes. We report that ICOS signaling inactivates the transcription factor FOXO1, and a Foxo1 genetic deletion allowed for generation of Tfh cells with reduced dependence on ICOS ligand. Conversely, enforced nuclear localization of FOXO1 inhibited Tfh cell development even though ICOS was overexpressed. FOXO1 regulated Tfh cell differentiation through a broad program of gene expression exemplified by its negative regulation of Bcl6. Final differentiation to germinal center Tfh cells (GC-Tfh) was instead FOXO1 dependent as the Foxo1(-/-) GC-Tfh cell population was substantially reduced. We propose that ICOS signaling transiently inactivates FOXO1 to initiate a Tfh cell contingency that is completed in a FOXO1-dependent manner.	[Stone, Erica L.; Katayama, Carol D.; Kerdiles, Yann M.; Lai, Chen-Yen; Hedrick, Stephen M.] Univ Calif San Diego, Sch Med, Dept Cell & Mol Med, La Jolla, CA 92093 USA; [Pepper, Marion] Univ Washington, Dept Immunol, Seattle, WA 98109 USA; [Emslie, Elizabeth; Cantrell, Doreen A.] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland; [Lin, Yin C.; Yang, Edward; Goldrath, Ananda W.; Hedrick, Stephen M.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Dundee; University of California System; University of California San Diego; Memorial Sloan Kettering Cancer Center	Hedrick, SM (corresponding author), Univ Calif San Diego, Sch Med, Dept Cell & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	shedrick@ucsd.edu	kerdiles, yann/U-2190-2018; Hedrick, Stephen M/E-9171-2010	kerdiles, yann/0000-0002-8605-1073; Hedrick, Stephen/0000-0002-6345-8751; li, ming/0000-0002-1383-0535; Lin, Yin/0000-0003-4925-5453	(K12) Institutional Research and Academic Career Development Award NIGMS; K01 award [1K01DK095008]; NIH [RO1AI073885, RO1AI067545]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067545, R01AI073885, R01AI103440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095008] Funding Source: NIH RePORTER	(K12) Institutional Research and Academic Career Development Award NIGMS; K01 award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We appreciate advice on retroviral transductions provided by J. Scott-Browne (LIAI) and K. Omilusik (UCSD). We thank Shane Crotty (LIAI) for critically reviewing an early version of this manuscript and providing Icosl<SUP>-/-</SUP> mice. We thank J. Yang, Y.S. Choi, T. Escobar (LIAI), and B.M. Wellisch (UCSD) for technical assistance. We thank Y. Altman (SBMRI) for technical expertise on the Amnis ImageStream X MkII at the Sanford-Burnham Institute. We thank BD Biosciences for the anti-BCL6 (clone 2G8). E.L.S. was supported by an (K12) Institutional Research and Academic Career Development Award NIGMS (L. Brunton, Director) and a K01 award 1K01DK095008. This work was supported by NIH grants RO1AI073885 (S.M.H.) and RO1AI067545 (A.W.G.).	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Choi YS, 2013, CURR OPIN IMMUNOL, V25, P366, DOI 10.1016/j.coi.2013.04.003; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Franko JL, 2009, J LEUKOCYTE BIOL, V85, P526, DOI 10.1189/jlb.0808505; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pellicano F, 2011, J EXP MED, V208, P2155, DOI 10.1084/jem.20112087; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Qi H, 2014, CURR OPIN IMMUNOL, V28, P34, DOI 10.1016/j.coi.2014.01.016; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Rolf J, 2010, J IMMUNOL, V184, P6563, DOI 10.4049/jimmunol.1000202; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Seo YB, 2014, J VIROL, V88, P8998, DOI 10.1128/JVI.00534-14; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Walker SR, 2013, MOL CELL BIOL, V33, P2879, DOI 10.1128/MCB.01620-12; Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183	52	145	148	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					239	251		10.1016/j.immuni.2015.01.017	http://dx.doi.org/10.1016/j.immuni.2015.01.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692700	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000349916400009
J	Wang, Y; Godec, J; Ben-Aissa, K; Cui, KR; Zhao, KJ; Pucsek, AB; Lee, YK; Weaver, CT; Yagi, R; Lazarevic, V				Wang, Yan; Godec, Jernej; Ben-Aissa, Khadija; Cui, Kairong; Zhao, Keji; Pucsek, Alexandra B.; Lee, Yun Kyung; Weaver, Casey T.; Yagi, Ryoji; Lazarevic, Vanja			The Transcription Factors T-bet and Runx Are Required for the Ontogeny of Pathogenic Interferon-gamma-Producing T Helper 17 Cells	IMMUNITY			English	Article							IFNG GENE-EXPRESSION; HUMAN TH17 CELLS; ROR-GAMMA; T(H)17 CELLS; LINEAGE; DIFFERENTIATION; PLASTICITY; CYTOKINE; FOXP3; ENCEPHALOMYELITIS	T helper 17 (Th17) cells can give rise to interleukin-17A (IL-17A)- and interferon (IFN)-gamma-double-producing cells that are implicated in development of autoimmune diseases. However, the molecular mechanisms that govern generation of IFN-gamma-producing Th17 cells are unclear. We found that coexpression of the Th1 and Th17 cell master transcription factors, T-bet and retinoid-related orphan receptor gamma-t (ROR gamma t), respectively, did not generate Th cells with robust IL-17 and IFN-gamma expression. Instead, development of IFN-gamma-producing Th17 cells required T-bet and Runx1 or Runx3. IL-12-stimulated Th17 cells upregulated Runx1, which bound to the Ifng locus in a T-bet-dependent manner. Reciprocally, T-bet or Runx1 deficiency or inhibition of Runx transcriptional activity impaired the development of IFN-gamma-producing Th17 cells during experimental autoimmune encephalomyelitis, which correlated with substantially ameliorated disease course. Thus, our studies identify a critical role for T-bet and Runx transcription factors in the generation of pathogenic IFN-gamma-producing Th17 cells.	[Wang, Yan; Ben-Aissa, Khadija; Lazarevic, Vanja] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Godec, Jernej] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Godec, Jernej] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Pucsek, Alexandra B.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA; [Lee, Yun Kyung; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Yagi, Ryoji] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba 2608670, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Chiba University	Lazarevic, V (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	lazarevicv@mail.nih.gov		Weaver, Casey/0000-0002-2180-1793; Lazarevic, Vanja/0000-0002-5783-7130	NATIONAL CANCER INSTITUTE [P30CA013148, ZIABC011431, ZICBC009255] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA BC011431-02] Funding Source: Medline; NCI NIH HHS [P30 CA013148] Funding Source: Medline; NIAMS NIH HHS [P30 AR048311] Funding Source: Medline; NIDDK NIH HHS [P01 DK071176] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Balasubramani A, 2010, IMMUNITY, V33, P35, DOI 10.1016/j.immuni.2010.07.004; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cohen CJ, 2011, J IMMUNOL, V187, P5615, DOI 10.4049/jimmunol.1101058; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Mikhail FM, 2006, J CELL PHYSIOL, V207, P582, DOI 10.1002/jcp.20538; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Waldburger KE, 1996, AM J PATHOL, V148, P375; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	39	145	148	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					355	366		10.1016/j.immuni.2014.01.002	http://dx.doi.org/10.1016/j.immuni.2014.01.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24530058	Bronze, Green Accepted			2022-12-18	WOS:000333422300009
J	Vogel, KU; Edelmann, SL; Jeltsch, KM; Bertossi, A; Heger, K; Heinz, GA; Zoller, J; Warth, SC; Hoefig, KP; Lohs, C; Neff, F; Kremmer, E; Schick, J; Repsilber, D; Geerlof, A; Blum, H; Wurst, W; Heikenwalder, M; Schmidt-Supprian, M; Heissmeyer, V				Vogel, Katharina U.; Edelmann, Stephanie L.; Jeltsch, Katharina M.; Bertossi, Arianna; Heger, Klaus; Heinz, Gitta A.; Zoeller, Jessica; Warth, Sebastian C.; Hoefig, Kai P.; Lohs, Claudia; Neff, Frauke; Kremmer, Elisabeth; Schick, Joel; Repsilber, Dirk; Geerlof, Arie; Blum, Helmut; Wurst, Wolfgang; Heikenwaelder, Mathias; Schmidt-Supprian, Marc; Heissmeyer, Vigo			Roquin Paralogs 1 and 2 Redundantly Repress the Icos and Ox40 Costimulator mRNAs and Control Follicular Helper T Cell Differentiation	IMMUNITY			English	Article							TRANSCRIPTION FACTOR IRF4; B-CELLS; EXPRESSION; AUTOIMMUNITY; LEADS; BCL6; ACCUMULATION; GENERATION; REGULATORS; FAMILY	The Roquin-1 protein binds to messenger RNAs (mRNAs) and regulates gene expression posttranscriptionally. A single point mutation in Roquin-1, but not gene ablation, increases follicular helper T (Tfh) cell numbers and causes lupus-like autoimmune disease in mice. In T cells, we did not identify a unique role for the much lower expressed paralog Roquin-2. However, combined ablation of both genes induced accumulation of T cells with an effector and follicular helper phenotype. We showed that Roquin-1 and Roquin-2 proteins redundantly repressed the mRNA of inducible costimulator (Icos) and identified the Ox40 costimulatory receptor as another shared mRNA target. Combined acute deletion increased Ox40 signaling, as well as Irf4 expression, and imposed Tfh differentiation on CD4(+) T cells. These data imply that both proteins maintain tolerance by preventing inappropriate T cell activation and Tfh cell differentiation, and that Roquin-2 compensates in the absence of Roquin-1, but not in the presence of its mutated form.	[Vogel, Katharina U.; Edelmann, Stephanie L.; Jeltsch, Katharina M.; Heinz, Gitta A.; Warth, Sebastian C.; Hoefig, Kai P.; Lohs, Claudia; Kremmer, Elisabeth; Heissmeyer, Vigo] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Bertossi, Arianna; Heger, Klaus; Schmidt-Supprian, Marc] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Zoeller, Jessica; Heikenwaelder, Mathias] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-81675 Munich, Germany; [Neff, Frauke] Helmholtz Zentrum Munchen, Inst Pathol, D-85764 Neuherberg, Germany; [Schick, Joel; Wurst, Wolfgang] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany; [Geerlof, Arie] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Repsilber, Dirk] Leibniz Inst Farm Anim Biol, D-18196 Dummerstorf, Germany; [Blum, Helmut] Univ Munich, Gene Ctr, Lab Funct Genome Anal, D-81377 Munich, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Tech Univ Munich, Lehrstuhl Entwicklungsgenet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, D-80336 Munich, Germany; [Heissmeyer, Vigo] Univ Munich, Inst Immunol, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Forschungsinstitut fur Nutztierbiologie (FBN); University of Munich; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Schmidt-Supprian, M (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	supprian@biochem.mpg.de; vigo.heissmeyer@helmholtz-muenchen.de	Heikenwalder, Mathias/AAA-2269-2020; Schmidt-Supprian, Marc/F-5893-2011; Schick, Joel/ABA-3728-2021; Hoefig, Kai/AAV-2169-2021	Schmidt-Supprian, Marc/0000-0002-8543-6166; Schick, Joel/0000-0002-8623-4910; Hoefig, Kai/0000-0002-0701-454X; Heissmeyer, Vigo/0000-0002-2263-8545; Heinz, Gitta Anne/0000-0002-9330-3689; Wurst, Wolfgang/0000-0003-4422-7410	ERC; Thyssen foundation; DFG; European Commission (EU) EU-COMMTOOLS [HEALTH-F4-2010-261492]; Boehringer Ingelheim;  [SFB1054(TP-A03)]	ERC(European Research Council (ERC)European Commission); Thyssen foundation; DFG(German Research Foundation (DFG)); European Commission (EU) EU-COMMTOOLS; Boehringer Ingelheim(Boehringer Ingelheim); 	We would like to thank C. Wolf for expert technical assistance, C. Vahl for help with cell sorting, and R. Kroczek (Robert Koch Institute, Berlin, Germany) for Icos<SUP>-/-</SUP> mice. The PBS57-loaded CD1d tetramer was obtained through the National Institutes of Health Tetramer Facility. This work was supported by an ERC grant to V. H., the SFB1054 (TP-A03 to V. H.), a grant from the Thyssen foundation to V. H. and M. S.-S., a DFG Emmy Noether grant to M. S.-S., and by a grant of the FP7 program of the European Commission (EU) EU-COMMTOOLS (HEALTH-F4-2010-261492) to W. W. G. A. H and K. H. were supported by fellowships from Boehringer Ingelheim.	Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Athanasopoulos V, 2010, FEBS J, V277, P2109, DOI 10.1111/j.1742-4658.2010.07628.x; Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; Chang PP, 2012, J IMMUNOL, V189, P701, DOI 10.4049/jimmunol.1102432; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Fanzo JC, 2006, J CLIN INVEST, V116, P703, DOI 10.1172/JCI24096; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Hu YL, 2009, J IMMUNOL, V182, P1421, DOI 10.4049/jimmunol.182.3.1421; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Mestas J, 2005, INT IMMUNOL, V17, P737, DOI 10.1093/intimm/dxh255; Murata K, 2002, J IMMUNOL, V169, P4628, DOI 10.4049/jimmunol.169.8.4628; Murray SE, 2011, J CLIN INVEST, V121, P4775, DOI 10.1172/JCI44943; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; Siess DC, 2000, J BIOL CHEM, V275, P33655, DOI 10.1074/jbc.M004461200; Simpson TR, 2010, CURR OPIN IMMUNOL, V22, P326, DOI 10.1016/j.coi.2010.01.001; So T, 2011, J IMMUNOL, V186, P3547, DOI 10.4049/jimmunol.1003156; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Weinberg AD, 2010, ADV EXP MED BIOL, V684, P57; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	45	145	156	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					655	668		10.1016/j.immuni.2012.12.004	http://dx.doi.org/10.1016/j.immuni.2012.12.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23583643	Bronze			2022-12-18	WOS:000330942100009
J	Sere, K; Baek, JH; Ober-Blobaum, J; Muller-Newen, G; Tacke, F; Yokota, Y; Zenke, M; Hieronymus, T				Sere, Kristin; Baek, Jea-Hyun; Ober-Bloebaum, Julia; Mueller-Newen, Gerhard; Tacke, Frank; Yokota, Yoshifumi; Zenke, Martin; Hieronymus, Thomas			Two Distinct Types of Langerhans Cells Populate the Skin during Steady State and Inflammation	IMMUNITY			English	Article							LANGERIN(+) DENDRITIC CELLS; BONE-MARROW; IN-VIVO; AUTOCRINE/PARACRINE TGF-BETA-1; MICE; ID2; PROGENITORS; IDENTIFICATION; HOMEOSTASIS; PRECURSORS	Langerhans cells (LCs), the dendritic cells (DCs) in skin epidermis, possess an exceptional life cycle and developmental origin. Here we identified two types of LCs, short-term and long-term LCs, which transiently or stably reconstitute the LC compartment, respectively. Short-term LCs developed from Gr-1(hi) monocytes under inflammatory conditions and occurred independently of the transcription factor Id2. Long-term LCs arose from bone marrow in steady state and were critically dependent on Id2. Surface marker and gene expression analysis positioned short-term LCs close to Gr-1(hi) monocytes, which is indicative of their monocytic origin. We also show that LC reconstitution after UV light exposure occurs in two waves: an initial fast and transient wave of Gr-1(hi) monocyte-derived short-term LCs is followed by a second wave of steady-state precursor-derived long-term LCs. Our data demonstrate the presence of two types of LCs that develop through different pathways in inflammation and steady state.	[Sere, Kristin; Baek, Jea-Hyun; Ober-Bloebaum, Julia; Zenke, Martin; Hieronymus, Thomas] Rhein Westfal TH Aachen, Fac Med, Dept Cell Biol, Inst Biomed Engn, D-52074 Aachen, Germany; [Sere, Kristin; Baek, Jea-Hyun; Ober-Bloebaum, Julia; Zenke, Martin; Hieronymus, Thomas] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany; [Mueller-Newen, Gerhard] Rhein Westfal TH Aachen, Fac Med, Inst Biochem & Mol Biol, D-52074 Aachen, Germany; [Tacke, Frank] Rhein Westfal TH Aachen, Fac Med, Med Clin 3, D-52074 Aachen, Germany; [Yokota, Yoshifumi] Univ Fukui, Fac Med Sci, Dept Biochem & Bioinformat Sci, Div Mol Genet, Fukui 9101193, Japan	RWTH Aachen University; Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; University of Fukui	Zenke, M (corresponding author), Rhein Westfal TH Aachen, Fac Med, Dept Cell Biol, Inst Biomed Engn, D-52074 Aachen, Germany.	martin.zenke@rwth-aachen.de; thomas.hieronymus@rwth-aachen.de	Baek, Jea Hyun/G-6429-2017; Hieronymus, Thomas/AAU-1995-2020; Baek, Jea Hyun/J-2752-2019; Tacke, Frank/ABF-2212-2020	Baek, Jea Hyun/0000-0003-4439-5545; Hieronymus, Thomas/0000-0002-7879-6518; Baek, Jea Hyun/0000-0003-4439-5545; 	BMBF; Deutsche Forschungsgemeinschaft (DFG) [1109 Ze 432/2-3, SFB542/B10, DFG Ta 434/2-1]; Interdisciplinary Center for Clinical Research IZKF Aachen; Immunohistochemisty and Confocal Laser Scanning Microscopy Facility of the IZKF, Faculty of Medicine, RWTH Aachen University; Faculty of Medicine, RWTH Aachen University; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER	BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research IZKF Aachen; Immunohistochemisty and Confocal Laser Scanning Microscopy Facility of the IZKF, Faculty of Medicine, RWTH Aachen University; Faculty of Medicine, RWTH Aachen University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank B. Elbers, S. Lueneberger, C. Becker, and S. Mitzka for technical support. We also thank Q. Lin for assistance with bioinformatic data analysis and P. Felker for discussion and critical reading of the manuscript. Part of this work was supported by grants from the BMBF, Deutsche Forschungsgemeinschaft (DFG Priority Program 1109 Ze 432/2-3, SFB542/B10, DFG Ta 434/2-1), and by funds from the Interdisciplinary Center for Clinical Research IZKF Aachen to F.T., T.H., and M.Z., and by the Immunohistochemisty and Confocal Laser Scanning Microscopy Facility, a core facility of the IZKF within the Faculty of Medicine, RWTH Aachen University. T.H. received a grant from the START program of the Faculty of Medicine, RWTH Aachen University.	Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Bobr A, 2012, P NATL ACAD SCI USA, V109, P10492, DOI 10.1073/pnas.1119178109; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Chang-Rodriguez S, 2005, J LEUKOCYTE BIOL, V77, P352, DOI 10.1189/jlb.1004584; Chorro L, 2010, TRENDS IMMUNOL, V31, P438, DOI 10.1016/j.it.2010.09.003; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Heinz LX, 2006, BLOOD, V107, P1445, DOI 10.1182/blood-2005-04-1721; Hieronymus T, 2005, J IMMUNOL, V174, P2552, DOI 10.4049/jimmunol.174.5.2552; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Ju XS, 2007, EUR J IMMUNOL, V37, P1174, DOI 10.1002/eji.200636504; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kissenpfennig A, 2006, TRENDS IMMUNOL, V27, P132, DOI 10.1016/j.it.2006.01.003; Kusunoki T, 2003, J ALLERGY CLIN IMMUN, V111, P136, DOI 10.1067/mai.2003.29; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mende I, 2006, BLOOD, V107, P1383, DOI 10.1182/blood-2005-05-1878; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; R Development Core Team, 2012, R LANG ENV STAT COMP; Romani N, 2003, APMIS, V111, P725, DOI 10.1034/j.1600-0463.2003.11107805.x; Schuster C, 2009, J EXP MED, V206, P169, DOI 10.1084/jem.20081747; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Takahara K, 2002, INT IMMUNOL, V14, P433, DOI 10.1093/intimm/14.5.433; Tripp CH, 2004, J INVEST DERMATOL, V122, P670, DOI 10.1111/j.0022-202X.2004.22337.x; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	47	145	151	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 16	2012	37	5					905	916		10.1016/j.immuni.2012.07.019	http://dx.doi.org/10.1016/j.immuni.2012.07.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23159228	Bronze			2022-12-18	WOS:000311460000016
J	Natoli, G				Natoli, Gioacchino			Maintaining Cell Identity through Global Control of Genomic Organization	IMMUNITY			English	Review							EMBRYONIC STEM-CELLS; TRANSCRIPTION START SITES; TISSUE-SPECIFIC ENHANCERS; CIS-REGULATORY ELEMENTS; GENE-EXPRESSION; T-CELLS; CHROMATIN MODIFICATIONS; WIDE ANALYSIS; HISTONE MODIFICATIONS; DNA METHYLATION	Cell differentiation entails early lineage choices leading to the activation, and the subsequent maintenance, of the gene expression program characteristic of each cell type. Alternative lineage choices involve the activation of different regulatory and coding regions of the genome, a process instructed by lineage-determining transcription factors, and at least in part mediated by the deposition of chromatin marks that modify functionality and accessibility of the underlying genome. According to classic epigenetics, subsequent maintenance of chromatin marks across mitoses and in spite of environmental perturbations occurs largely through autonomous and unsupervised mechanisms. However, paradigmatic genetic and biochemical studies in immune system and hematopoietic cells strongly point to the concept that both induction and maintenance of the differentiated state require constant supervision by lineage-determining transcription factors, which may act to globally organize the genome in both the one- and the three-dimensional space.	European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Natoli, G (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	gioacchino.natoli@ifom-ieo-campus.it	Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020; cheng, yong/I-4270-2012	Natoli, Gioacchino/0000-0003-0711-2411	Italian Association for Research on Cancer (A.I.R.C.); European Community	Italian Association for Research on Cancer (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission)	I am indebted to all the colleagues who provided many insightful and careful comments on this review: M. Busslinger, S. Casola, C. Cheng, D. di Bernardo, T. Graf, M. Karin, V. Orlando, S.T. Smale, G. Testa, and the members of my laboratory. D. di Bernardo (TIGEM) suggested the analogy with CPUs. Research activity in my laboratory is supported by the Italian Association for Research on Cancer (A.I.R.C.) and the European Community FP6 (Marie-Curie Excellence Grant Trans-Tar) and FP7 programs (Model-In consortium).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gargiulo G, 2009, DEV CELL, V16, P466, DOI 10.1016/j.devcel.2009.02.002; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hume DA, 2008, J IMMUNOL, V180, P6733, DOI 10.4049/jimmunol.180.10.6733; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kawaji H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r118; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lichtinger M, 2007, J BIOL CHEM, V282, P26874, DOI 10.1074/jbc.M703856200; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Riggs A. D., 1996, EPIGENETIC MECH GENE, P29; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; VISVADER JE, 1992, EMBO J, V11, P4557, DOI 10.1002/j.1460-2075.1992.tb05557.x; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yaneva M, 2006, J IMMUNOL, V176, P6906, DOI 10.4049/jimmunol.176.11.6906; Yoon H, 2010, J IMMUNOL, V184, P5018, DOI 10.4049/jimmunol.1000079; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	88	145	147	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					12	24		10.1016/j.immuni.2010.07.006	http://dx.doi.org/10.1016/j.immuni.2010.07.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20643336	Bronze			2022-12-18	WOS:000280418100006
J	Mucida, D; Pino-Lagos, K; Kim, G; Nowak, E; Benson, MJ; Kronenberg, M; Noelle, RJ; Cheroutre, H				Mucida, Daniel; Pino-Lagos, Karina; Kim, Gisen; Nowak, Elizabeth; Benson, Micah J.; Kronenberg, Mitchell; Noelle, Randolph J.; Cheroutre, Hilde			Retinoic Acid Can Directly Promote TGF-beta-Mediated Foxp3(+) Treg Cell Conversion of Naive T Cells	IMMUNITY			English	Letter							DIFFERENTIATION; EXPRESSION		[Pino-Lagos, Karina; Nowak, Elizabeth; Benson, Micah J.; Noelle, Randolph J.] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; [Pino-Lagos, Karina; Nowak, Elizabeth; Benson, Micah J.; Noelle, Randolph J.] Norris Cotton Canc Ctr, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; [Mucida, Daniel; Kim, Gisen; Kronenberg, Mitchell; Cheroutre, Hilde] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	Dartmouth College; Norris Cotton Cancer Center; La Jolla Institute for Immunology	Noelle, RJ (corresponding author), Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.	randolph.j.noelle@dartmouth.edu; hilde@liai.org	Kronenberg, Mitchell/AAT-6078-2021; Pino-Lagos, Karina/H-7581-2013; Pino-Lagos, Karina/C-9583-2017	Pino-Lagos, Karina/0000-0002-4070-6169; Pino-Lagos, Karina/0000-0002-4070-6169; Mucida, Daniel/0000-0002-0000-0452	Medical Research Council [G0600698B] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050265] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050265-09, R01 AI050265] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277	7	145	151	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 17	2009	30	4					471	472		10.1016/j.immuni.2009.03.008	http://dx.doi.org/10.1016/j.immuni.2009.03.008			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19371709	Green Accepted, Bronze			2022-12-18	WOS:000265319000001
J	Anderson, SJ; Lauritsen, JPH; Hartman, MG; Foushee, AMD; Lefebvre, JM; Shinton, SA; Gerhardt, B; Hardy, RR; Oravecz, T; Wiest, DL				Anderson, Stephen J.; Lauritsen, Jens Peter Hoist; Hartman, Matthew G.; Foushee, Ann Marie DiGeorge; Lefebvre, Juliette M.; Shinton, Susan A.; Gerhardt, Brenda; Hardy, Richard R.; Oravecz, Tamas; Wiest, David L.			Ablation of ribosomal protein L22 selectively impairs alpha beta T cell development by activation of a p53-dependent checkpoint	IMMUNITY			English	Article							CHAIN GENE REARRANGEMENT; DNA-DAMAGE; PRE-TCR; IN-VIVO; ENDOPLASMIC-RETICULUM; THYMIDYLATE SYNTHASE; LINEAGE COMMITMENT; ALLELIC EXCLUSION; RECEPTOR; P53	The alpha beta and gamma delta T lineages are thought to arise from a common precursor; however, the regulation of separation and development of these lineages is not fully understood. We report here that development of alpha beta and gamma delta precursors was differentially affected by elimination of ribosomal protein L22 (Rpl22), which is ubiquitously expressed but not essential for translation. Rpl22 deficiency selectively arrested development of alpha beta-lineage T cells at the beta-selection checkpoint by inducing their death. The death was caused by induction of p53 expression, because p53 deficiency blocked death and restored development of Rpl22-deficient thymocytes. Importantly, Rpl22 deficiency led to selective upregulation of p53 in alpha beta-lineage thymocytes, at least in part by increasing p53 synthesis. Taken together, these data indicate that RpI22 deficiency activated a p53-dependent checkpoint that produced a remarkably selective block in alpha beta T cell development but spared gamma delta-lineage cells, suggesting that some ribosomal proteins may perform cell-type-specific or stage-specific functions.	Fox Chase Canc Ctr, Div Basic Sci, Immunobiol Working Grp, Philadelphia, PA 19111 USA; Lexicon Genet Inc, Div Immunol & Hematol, The Woodlands, TX 77381 USA; Lexicon Genet Inc, Div Express Anal & Cloning, The Woodlands, TX 77381 USA	Fox Chase Cancer Center; Lexicon Pharmaceuticals; Lexicon Pharmaceuticals	Wiest, DL (corresponding author), Fox Chase Canc Ctr, Div Basic Sci, Immunobiol Working Grp, 333 Cottman Ave, Philadelphia, PA 19111 USA.	dl-wiest@fccc.edu		Wiest, David/0000-0002-0792-3188	NATIONAL CANCER INSTITUTE [R01CA100144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER; NCI NIH HHS [CA100144, P01CA06927] Funding Source: Medline; NIAID NIH HHS [AI073920] Funding Source: Medline; NIDDK NIH HHS [P30 DK50306] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; Asmal M, 2003, IMMUNITY, V19, P535, DOI 10.1016/S1074-7613(03)00268-1; Babbe H, 2007, MOL CELL BIOL, V27, P1947, DOI 10.1128/MCB.01402-06; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Carleton M, 1999, J IMMUNOL, V163, P2576; Chang SN, 2000, FEBS LETT, V484, P22, DOI 10.1016/S0014-5793(00)02118-9; Chu E, 1999, MOL CELL BIOL, V19, P1582; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DOBBELSTEIN M, 1995, J VIROL, V69, P8027, DOI 10.1128/JVI.69.12.8027-8034.1995; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; Eyquem S, 2004, P NATL ACAD SCI USA, V101, P15712, DOI 10.1073/pnas.0405546101; FADOK VA, 1992, J IMMUNOL, V148, P2207; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fitzgerald, 2003, MODEL ORGANISMS DRUG, P251; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hayes SM, 2003, IMMUNOL REV, V191, P28, DOI 10.1034/j.1600-065X.2003.00011.x; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Ju JF, 1999, P NATL ACAD SCI USA, V96, P3769, DOI 10.1073/pnas.96.7.3769; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; KEARSE KP, 1994, EMBO J, V13, P4504, DOI 10.1002/j.1460-2075.1994.tb06772.x; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; LAVERGNE JP, 1987, FEBS LETT, V216, P83, DOI 10.1016/0014-5793(87)80761-5; Le SY, 2000, MOL BIOL CELL, V11, P999, DOI 10.1091/mbc.11.3.999; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lefebvre JM, 2005, J IMMUNOL, V174, P6184, DOI 10.4049/jimmunol.174.10.6184; Leopardi R, 1997, J VIROL, V71, P1133, DOI 10.1128/JVI.71.2.1133-1139.1997; MacDonald HR, 1998, IMMUNOL REV, V165, P87, DOI 10.1111/j.1600-065X.1998.tb01232.x; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Okazuka K, 2005, BIOCHEM BIOPH RES CO, V328, P545, DOI 10.1016/j.bbrc.2005.01.013; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Schito ML, 2006, J IMMUNOL, V176, P4818, DOI 10.4049/jimmunol.176.8.4818; Schlegel RA, 2000, ANN NY ACAD SCI, V926, P217; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; SCHREIBER KL, 1994, INT IMMUNOL, V6, P101, DOI 10.1093/intimm/6.1.101; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; SILVER J, 1989, J VIROL, V63, P1924, DOI 10.1128/JVI.63.5.1924-1928.1989; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; TOCZYSKI DP, 1994, P NATL ACAD SCI USA, V91, P3463, DOI 10.1073/pnas.91.8.3463; TOCZYSKI DPW, 1991, EMBO J, V10, P459, DOI 10.1002/j.1460-2075.1991.tb07968.x; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wilson A, 1999, INT IMMUNOL, V11, P1641, DOI 10.1093/intimm/11.10.1641; Wood J, 2001, J VIROL, V75, P1348, DOI 10.1128/JVI.75.3.1348-1358.2001; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	59	145	149	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					759	772		10.1016/j.immuni.2007.04.012	http://dx.doi.org/10.1016/j.immuni.2007.04.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17555992	Bronze			2022-12-18	WOS:000247646900012
J	Sansonetti, PJ; Di Santo, JP				Sansonetti, Philippe J.; Di Santo, James P.			Debugging how bacteria manipulate the immune response	IMMUNITY			English	Review							T-CELL PROLIFERATION; SHIGELLA-FLEXNERI; YERSINIA EFFECTOR; DENDRITIC CELLS; IFN-GAMMA; CASPASE-1 ACTIVATION; KINASE ACTIVATION; ANTHRAX TOXINS; III SECRETION; NK CELLS	Beyond the innate response that is elicited when tissues are infected, bacterial pathogens have evolved strategies to subvert the immune response and "recalibrate" it both qualitatively and quantitatively, thereby achieving a balance consistent with the survival of both the microbe and its infected host, a compromise that is likely the result of a long process of coevolution between pathogens and their hosts. By collaboratively studying the mechanisms employed, microbiologists and immunologists are fostering development of a renewed approach of infectious diseases that is expected to provide useful new concepts and applications for their control. In addition, the molecular strategies developed by bacteria to dampen immune mechanisms result from such strong and prolonged selective pressure for survival that they may point to original mechanisms and targets to conceive novel immunomodulatory, anti-inflammatory, and anti-infectious molecules.	Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France; Inst Pasteur, Unite INSERM 786, F-75724 Paris 15, France; Inst Pasteur, Unite Cytokines & Dev Lymphoide, F-75724 Paris 15, France; Inst Pasteur, Unite INSERM 668, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sansonetti, PJ (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, 28 Rue Dr Roux, F-75724 Paris 15, France.	psanson@pasteur.fr	Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862				Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; Byrne P, 2004, EUR J IMMUNOL, V34, P2579, DOI 10.1002/eji.200425092; Carrero JA, 2006, J EXP MED, V203, P933, DOI 10.1084/jem.20060045; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Carrero JA, 2004, J IMMUNOL, V172, P4866, DOI 10.4049/jimmunol.172.8.4866; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Collier-Hyams LS, 2005, J IMMUNOL, V175, P4194, DOI 10.4049/jimmunol.175.7.4194; Colonna M, 2003, J INFECT DIS, V187, pS397, DOI 10.1086/374754; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; CRABBE PA, 1970, LAB INVEST, V22, P448; Crawford MA, 2006, J IMMUNOL, V176, P7557, DOI 10.4049/jimmunol.176.12.7557; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goodyear CS, 2004, P NATL ACAD SCI USA, V101, P11392, DOI 10.1073/pnas.0404382101; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Kelly D, 2005, MOL IMMUNOL, V42, P895, DOI 10.1016/j.molimm.2004.12.003; KELLY D, 2003, NAT IMMUNOL, V5, P14; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Llewelyn M, 2002, LANCET INFECT DIS, V2, P156, DOI 10.1016/S1473-3099(02)00222-0; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; LUSSOW AR, 1994, EUR J IMMUNOL, V24, P445, DOI 10.1002/eji.1830240227; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Overheim KA, 2005, INFECT IMMUN, V73, P5152, DOI 10.1128/IAI.73.8.5152-5159.2005; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; PERDOMO JJ, 1994, J CLIN INVEST, V93, P633, DOI 10.1172/JCI117015; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Petrovska L, 2004, CELL MICROBIOL, V6, P1071, DOI 10.1111/j.1462-5822.2004.00419.x; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Ruckdeschel K, 1997, J BIOL CHEM, V272, P15920, DOI 10.1074/jbc.272.25.15920; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; SANSONETTI PJ, 1995, J CLIN INVEST, V96, P884, DOI 10.1172/JCI118135; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Shanahan F, 2002, BEST PRACT RES CL GA, V16, P915, DOI 10.1053/bega.2002.0342; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Siciliano NA, 2006, J IMMUNOL, V177, P7131, DOI 10.4049/jimmunol.177.10.7131; Sing A, 2002, J EXP MED, V196, P1017, DOI 10.1084/jem.20020908; Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381; Tato CM, 2006, NATURE, V441, P166, DOI 10.1038/441166a; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; Tran AX, 2005, J ENDOTOXIN RES, V11, P161, DOI 10.1179/096805105X37349; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; WEINSTEIN PD, 1991, J IMMUNOL, V147, P4126; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	122	145	150	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2007	26	2					149	161		10.1016/j.immuni.2007.02.004	http://dx.doi.org/10.1016/j.immuni.2007.02.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17307704	Bronze			2022-12-18	WOS:000244628600007
J	Iwasaki, H; Mizuno, S; Wells, RA; Cantor, AB; Watanabe, S; Akashi, K				Iwasaki, H; Mizuno, S; Wells, RA; Cantor, AB; Watanabe, S; Akashi, K			GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages	IMMUNITY			English	Article							T-CELL DEVELOPMENT; TRANSCRIPTION FACTOR GATA-1; ZINC-FINGER PROTEIN; HEMATOPOIETIC PROGENITORS; GENE-EXPRESSION; B-LYMPHOPOIESIS; TRANSGENIC MICE; DIFFERENTIATION; PU.1; COMMITMENT	GATA-1 is an essential transcription factor for megakaryocyte and erythrocyte (MegE) development. Here we show that hematopoietic progenitors can be reprogrammed by the instructive action of GATA-1. Enforced expression of GATA-1 in hematopoietic stem cells led to loss of self-renewal activity and the exclusive generation of MegE lineages. Strikingly, ectopic GATA-1 reprogrammed common lymphoid progenitors as well as granulocyte/monocyte (GM) progenitors to differentiate into MegE lineages, while inhibiting normal lymphoid or GM differentiation. GATA-1 upregulated critical MegE-related transcription factors such as FOG-1 and GATA-2 in lymphoid and GM progenitors, and their MegE development did not require "permissive" erythropoietin signals. Furthermore, GATA-1 induced apoptosis of proB and myelomonocytic cells, which could not be prevented by enforced permissive Bcl-2 or myeloid cytokine signals. Thus, GATA-1 specifically instructs MegE commitment while excluding other fate outcomes in stem and progenitor cells, suggesting that regulation of GATA-1 is critical in maintaining multilineage homeostasis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Ontario Canc Inst, Dept Cell & Mol Biol, Toronto, ON M4X 1K9, Canada; Harvard Univ, Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat, Boston, MA 02115 USA; Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Tokyo, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Tokyo	Akashi, K (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	koichi_akashi@dfci.harvard.edu	Wilson, Matthew H/K-3193-2013	Cantor, Alan/0000-0002-5136-028X	NCI NIH HHS [CA072009] Funding Source: Medline; NIDDK NIH HHS [DK050654, DK061320] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA072009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050654, R01DK061320] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; BOYD AW, 1982, NATURE, V297, P691, DOI 10.1038/297691a0; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Chen D, 2001, EXP HEMATOL, V29, P971, DOI 10.1016/S0301-472X(01)00670-1; Delassus S, 1999, BLOOD, V94, P1495, DOI 10.1182/blood.V94.5.1495.417a08_1495_1503; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hirasawa R, 2002, J EXP MED, V195, P1379, DOI 10.1084/jem.20020170; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; LINDEMAN GJ, 1994, IMMUNITY, V1, P517, DOI 10.1016/1074-7613(94)90094-9; Liu R, 2000, ONCOGENE, V19, P571, DOI 10.1038/sj.onc.1203364; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Nakauchi H, 1999, ANN NY ACAD SCI, V872, P57, DOI 10.1111/j.1749-6632.1999.tb08453.x; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nerlov C, 1998, GENE DEV, V12, P2413, DOI 10.1101/gad.12.15.2413; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; NISHIJIMA I, 1995, MOL BIOL CELL, V6, P497, DOI 10.1091/mbc.6.5.497; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Okuno Y, 2002, P NATL ACAD SCI USA, V99, P6246, DOI 10.1073/pnas.092027799; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rothenberg EV, 2002, IMMUNOL REV, V187, P96, DOI 10.1034/j.1600-065X.2002.18709.x; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; Seshasayee D, 1998, MOL CELL BIOL, V18, P3278, DOI 10.1128/MCB.18.6.3278; Slayton WB, 2001, ANN NY ACAD SCI, V938, P157; SLAYTON WB, 2001, ANN NY ACAD SCI, V938, P165; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Tsai FY, 1998, DEV BIOL, V196, P218, DOI 10.1006/dbio.1997.8842; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; VISVADER JE, 1992, EMBO J, V11, P4557, DOI 10.1002/j.1460-2075.1992.tb05557.x; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yamada T, 1998, EXP CELL RES, V245, P186, DOI 10.1006/excr.1998.4251; Yamaguchi Y, 1998, BLOOD, V91, P450, DOI 10.1182/blood.V91.2.450.450_450_457; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1998, J EXP MED, V188, P1173, DOI 10.1084/jem.188.6.1173; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	60	145	150	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2003	19	3					451	462		10.1016/S1074-7613(03)00242-5	http://dx.doi.org/10.1016/S1074-7613(03)00242-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499119	Bronze			2022-12-18	WOS:000185499800015
J	Tsitsikov, EN; Laouini, D; Dunn, IF; Sannikova, TY; Davidson, L; Alt, FW; Geha, RS				Tsitsikov, EN; Laouini, D; Dunn, IF; Sannikova, TY; Davidson, L; Alt, FW; Geha, RS			TRAF1 is a negative regulator of TNF signaling: Enhanced TNF signaling in TRAF1-deficient mice	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; HUMAN-IMMUNODEFICIENCY-VIRUS; FACTOR RECEPTOR SUPERFAMILY; PROGRAMMED CELL-DEATH; T-CELLS; DEFECTIVE INTERLEUKIN-1; COSTIMULATORY MOLECULE; TARGETED DISRUPTION; INDUCED APOPTOSIS	TNF receptor-associated factor 1 (TRAF1) is a unique TRAF protein because it lacks a RING finger domain and is predominantly expressed in activated lymphocytes. To elucidate the function of TRAF1, we generated TRAF1-deficient mice. TRAF1(-/-) mice are viable and have normal lymphocyte development. TRAF1(-/-) T cells exhibit stronger than wild-type (WT) T cell proliferation to anti-CD3 mAb, which persisted in the presence of IL-2 or anti-CD28 antibodies. Activated TRAF1(-/-) T cells, but not TRAF1(+/+) T cells, responded to TNF by proliferation and activation of the NF-kappaB and AP-1 signaling pathways. This TNF effect was mediated by TNFR2 (p75) but not by TNFR1 (p55). Furthermore, skin from TRAF1(-/-) mice was hypersensitive to TNF-induced necrosis. These findings suggest that TRAF1 is a negative regulator of TNF signaling.	Harvard Univ, Sch Med, Div Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Tsitsikov, EN (corresponding author), Harvard Univ, Sch Med, Div Immunol, Boston, MA 02115 USA.		Laouini, Dhafer/Q-6535-2019	Laouini, Dhafer/0000-0003-1222-4880	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035714, R29AI042031] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-35714, AI-42031] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aggarwal S, 1999, J IMMUNOL, V162, P2154; Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Amar Salomon, 1995, Journal of Inflammation, V47, P180; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; COPE AP, 1995, IMMUNOLOGY, V84, P21; Dunn IF, 1999, MOL IMMUNOL, V36, P611, DOI 10.1016/S0161-5890(99)00075-9; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Gramaglia I, 2000, EUR J IMMUNOL, V30, P392, DOI 10.1002/1521-4141(200002)30:2<392::AID-IMMU392>3.0.CO;2-H; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; HINTZEN RQ, 1995, J IMMUNOL, V154, P2612; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156; Hurtado JC, 1997, J IMMUNOL, V158, P2600; HURTADO JC, 1995, J IMMUNOL, V155, P3360; Irmler M, 2000, FEBS LETT, V468, P129, DOI 10.1016/S0014-5793(00)01206-0; Jang IK, 1998, BIOCHEM BIOPH RES CO, V242, P613, DOI 10.1006/bbrc.1997.8016; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; Kwon BS, 1999, J BIOL CHEM, V274, P6056, DOI 10.1074/jbc.274.10.6056; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LEO E, 2000, J BIOL CHEM, V29, P29; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Maxwell JR, 2000, J IMMUNOL, V164, P107, DOI 10.4049/jimmunol.164.1.107; Miethke T, 1996, EUR J IMMUNOL, V26, P1459, DOI 10.1002/eji.1830260709; MIXTER PF, 1994, J AUTOIMMUN, V7, P697, DOI 10.1006/jaut.1994.1055; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; PAPIERNIK M, 1995, EUR J IMMUNOL, V25, P1517, DOI 10.1002/eji.1830250607; Pippig SD, 1999, J IMMUNOL, V163, P6520; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SADLACK B, 1994, EUR J IMMUNOL, V24, P281, DOI 10.1002/eji.1830240144; Saoulli K, 1998, J EXP MED, V187, P1849, DOI 10.1084/jem.187.11.1849; SCHEURICH P, 1987, J IMMUNOL, V138, P1786; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; SHARPE AH, 1995, CURR OPIN IMMUNOL, V7, P389, DOI 10.1016/0952-7915(95)80115-4; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; Shiels H, 2000, AM J PATHOL, V157, P679, DOI 10.1016/S0002-9440(10)64578-6; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Speiser DE, 1997, J EXP MED, V185, P1777, DOI 10.1084/jem.185.10.1777; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; Takahashi C, 1999, J IMMUNOL, V162, P5037; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P1390, DOI 10.1073/pnas.94.4.1390; WAHL C, 1993, EUR J IMMUNOL, V23, P1197, DOI 10.1002/eji.1830230536; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yamamoto T., 1998, B NATL RES I AQUACUL, V27, P27; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zapata JM, 2000, J IMMUNOL, V165, P5084, DOI 10.4049/jimmunol.165.9.5084; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	63	145	153	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2001	15	4					647	657		10.1016/S1074-7613(01)00207-2	http://dx.doi.org/10.1016/S1074-7613(01)00207-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672546	Bronze			2022-12-18	WOS:000171757800015
J	Tavian, M; Robin, C; Coulombel, L; Peault, B				Tavian, M; Robin, C; Coulombel, L; Peault, B			The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: Mapping multipotent hematopoietic cell fate in intraembryonic mesoderm	IMMUNITY			English	Article							HUMAN CORD-BLOOD; NATURAL-KILLER-CELLS; IN-VITRO; PROGENITOR CELLS; MOUSE EMBRYO; BONE-MARROW; ENDOTHELIAL-CELLS; FETAL THYMUS; T-CELLS; B-CELLS	We have traced emerging hematopoietic cells along human early ontogeny by culturing embryonic tissue rudiments in the presence of stromal cells that promote myeloid and B cell differentiation, and by assaying T cell potential in the NOD-SCID mouse thymus. Hematogenous potential was present inside the embryo as early as day 19 of development in the absence of detectable CD34(+) hematopoietic cells, and spanned both lymphoid and myeloid lineages from day 24 in the splanchnopleural mesoderm and derived aorta where CD34(+) progenitors appear at day 27. By contrast, hematopoietic cells arising in the third week yolk sac, as well as their progeny at later stages, were restricted to myelopoiesis and therefore are unlikely to contribute to definitive hematopoiesis in man.	Hop Paul Brousse, INSERM, U506, F-94807 Villejuif, France; Inst Gustave Roussy, INSERM, U362, F-94805 Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Tavian, M (corresponding author), Hop Paul Brousse, INSERM, U506, F-94807 Villejuif, France.	tavian@infobiogen.fr	Tavian, Manuela/S-3201-2019; Tavian, Manuela/E-4210-2018	Tavian, Manuela/0000-0003-4746-3240; Tavian, Manuela/0000-0003-4746-3240				Akashi K, 2000, CURR OPIN IMMUNOL, V12, P144, DOI 10.1016/S0952-7915(99)00064-3; Berardi AC, 1997, BLOOD, V89, P3554, DOI 10.1182/blood.V89.10.3554.3554_3554_3564; Blom B, 1997, J IMMUNOL, V158, P3571; Bloom W, 1940, AM J ANAT, V67, P21, DOI 10.1002/aja.1000670103; Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO;2-7; Choi K, 1998, DEVELOPMENT, V125, P725; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Dieterlen-Lievre F., 1994, Poultry Science Reviews, V5, P273; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Garcia-Porrero JA, 1998, DEV COMP IMMUNOL, V22, P303, DOI 10.1016/S0145-305X(98)00006-8; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; HUANG H, 1994, EXP HEMATOL, V22, P19; HUYHN A, 1995, BLOOD, V86, P4474, DOI 10.1182/blood.V86.12.4474.bloodjournal86124474; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Labastie MC, 1998, BLOOD, V92, P3624, DOI 10.1182/blood.V92.10.3624.422k17_3624_3635; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; LIU CP, 1991, DEVELOPMENT, V113, P1315; Marquez C, 1998, BLOOD, V91, P2760, DOI 10.1182/blood.V91.8.2760.2760_2760_2771; Marshall CJ, 2000, BLOOD, V96, P1591, DOI 10.1182/blood.V96.4.1591.h8001591_1591_1593; Medvinsky AL, 1998, DEV COMP IMMUNOL, V22, P289, DOI 10.1016/S0145-305X(98)00007-X; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; North T, 1999, DEVELOPMENT, V126, P2563; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; PALACIOS R, 1993, P NATL ACAD SCI USA, V90, P6581, DOI 10.1073/pnas.90.14.6581; Palis J, 1999, DEVELOPMENT, V126, P5073; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; PEAULT B, 1994, EUR J IMMUNOL, V24, P781, DOI 10.1002/eji.1830240345; Pende D, 1997, EUR J IMMUNOL, V27, P1875, DOI 10.1002/eji.1830270809; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Robin C, 1999, BRIT J HAEMATOL, V104, P809, DOI 10.1046/j.1365-2141.1999.01266.x; Robin C, 1999, J EXP MED, V189, P1601, DOI 10.1084/jem.189.10.1601; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; SANCHEZ MJ, 1994, J EXP MED, V180, P569, DOI 10.1084/jem.180.2.569; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Tavian M, 1999, DEVELOPMENT, V126, P793; TYAN ML, 1968, J IMMUNOL, V101, P446; VANDENBUNDER B, 1989, DEVELOPMENT, V107, P265; Watt SM, 2000, BLOOD, V95, P3113; WEISSMANN I, 1978, COLD SPRING HARB SYM, V5, P33; Wood HB, 1997, BLOOD, V90, P2300	47	145	147	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2001	15	3			SI		487	495		10.1016/S1074-7613(01)00193-5	http://dx.doi.org/10.1016/S1074-7613(01)00193-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567638	Green Published, Bronze			2022-12-18	WOS:000171211800015
J	Monroe, RJ; Seidl, KJ; Gaertner, F; Han, SH; Chen, F; Sekiguchi, J; Wang, JY; Ferrini, R; Davidson, L; Kelsoe, G; Alt, FW				Monroe, RJ; Seidl, KJ; Gaertner, F; Han, SH; Chen, F; Sekiguchi, J; Wang, JY; Ferrini, R; Davidson, L; Kelsoe, G; Alt, FW			RAG2 : GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues	IMMUNITY			English	Article							HEAT-STABLE ANTIGEN(HI); B-CELL DIFFERENTIATION; V(D)J RECOMBINATION; GENE-EXPRESSION; BONE-MARROW; DEVELOPMENTAL REGULATION; LYMPHOCYTES-B; T-CELLS; RECEPTOR; REARRANGEMENT	We generated mice in which a functional RAG2:GFP fusion gene is knocked in to the endogenous RAG2 locus. In bone marrow and thymus, RAG2:GFP expression occurs in appropriate stages of developing B and T cells as well as in immature bone marrow IgM(+) B cells. RAGS:GFP also is expressed in IgD(+) B cells following cross-linking of IgM on immature IgM(+)IgD(+) B cells generated in vitro. RAG2:GFP expression is undetectable in most immature splenic B cells; however, in young RAG2:GFP mice, there are substantial numbers of splenic RAG2:GFP(+) cells that mostly resemble pre-B cells. The tatter population decreases in size with age but reappears following immunization of older RAG2:GFP mice. We discuss the implications of these findings for current models of receptor assembly and diversification.	Childrens Hosp, Howard Hughes Med Inst, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Duke University	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Ctr Blood Res, 300 Longwood Ave, Boston, MA 02115 USA.	alt@rascal.med.harvard.edu		Sekiguchi, JoAnn/0000-0002-7178-4258	NIAID NIH HHS [AI24335, AI20047] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024335, R01AI020047, R37AI020047] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLMAN DM, 1992, J IMMUNOL, V149, P2533; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; FULOP GM, 1983, CELL IMMUNOL, V75, P80, DOI 10.1016/0008-8749(83)90307-6; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; GUYGRAND D, 1992, EUR J IMMUNOL, V22, P505, DOI 10.1002/eji.1830220232; Han S, 1997, Semin Immunol, V9, P255, DOI 10.1006/smim.1997.0081; Han SH, 1996, SCIENCE, V274, P2094, DOI 10.1126/science.274.5295.2094; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hertz M, 1998, NATURE, V394, P292, DOI 10.1038/28419; Hikida M, 1998, J EXP MED, V188, P365, DOI 10.1084/jem.188.2.365; Hikida M, 1996, SCIENCE, V274, P2092, DOI 10.1126/science.274.5295.2092; HIKIDA M, 1998, J EXP MED, V188; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Ismaili J, 1996, EUR J IMMUNOL, V26, P731, DOI 10.1002/eji.1830260402; Kelsoe G, 1999, CURR OPIN IMMUNOL, V11, P70, DOI 10.1016/S0952-7915(99)80013-2; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; MA A, 1992, EMBO J, V11, P2727, DOI 10.1002/j.1460-2075.1992.tb05338.x; McMahan CJ, 1998, IMMUNITY, V9, P637, DOI 10.1016/S1074-7613(00)80661-5; Meffre E, 1998, J EXP MED, V188, P765, DOI 10.1084/jem.188.4.765; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Melchers F, 1999, FUNDAMENTAL IMMUNOLO, V4th, P183; Papavasiliou F, 1997, SCIENCE, V278, P298, DOI 10.1126/science.278.5336.298; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; Radic MZ, 1996, IMMUNITY, V5, P505, DOI 10.1016/S1074-7613(00)80266-6; Rodewald HR, 1998, ADV IMMUNOL, V69, P1, DOI 10.1016/S0065-2776(08)60606-9; ROLINK A, 1993, BLOOD, V81, P2290; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; Smider V, 1997, Semin Immunol, V9, P189, DOI 10.1006/smim.1997.0070; TATSUMI Y, 1993, J IMMUNOL, V151, P3030; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Willerford DM, 1996, CURR OPIN GENET DEV, V6, P603, DOI 10.1016/S0959-437X(96)80090-6; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Young F, 1997, IMMUNITY, V6, P23, DOI 10.1016/S1074-7613(00)80239-3	49	145	150	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1999	11	2					201	212		10.1016/S1074-7613(00)80095-3	http://dx.doi.org/10.1016/S1074-7613(00)80095-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485655	Bronze			2022-12-18	WOS:000082383400009
J	Oxenius, A; Zinkernagel, RM; Hengartner, H				Oxenius, A; Zinkernagel, RM; Hengartner, H			Comparison of activation versus induction of unresponsiveness of virus-specific CD4(+) and CD8(+) T cells upon acute versus persistent viral infection	IMMUNITY			English	Article							DEHYDROGENASE-ELEVATING VIRUS; VESICULAR STOMATITIS-VIRUS; ANTIBODY-RESPONSES; HEPATITIS-B; TOLERANCE INDUCTION; HIV-1 INFECTION; IN-VIVO; MICE; ANTIGEN; LYMPHOCYTES	The functional status of CD4(+) T cells during establishment of persistent infection with the noncytopathic lymphocytic choriomeningitis virus was assessed and compared to that of cytotoxic CD8(+) T cells. Functionality of virus-specific CD4(+) T cells was measured by proliferative responses, cytokine secretion, cognate help, and IFN gamma-mediated protection against challenge infection with recombinant vaccinia virus. Functional CD4(+) T cells were induced early after infection and remained measurable up to 6 weeks but then were rendered unresponsive. In contrast, CD8(+) T cells were functionally inactivated within 10-15 days; Importantly, functional inactivation of virus-specific CD4(+) T cells during persistent viral infection seemed to be critical for the survival of the host.	Univ Zurich, Inst Expt Immunol, Dept Pathol, CH-8091 Zurich, Switzerland	University of Zurich	Oxenius, A (corresponding author), Univ Zurich, Inst Expt Immunol, Dept Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	aoxenius@pathol.unizh.ch	Oxenius, Annette/G-7794-2015					AHMED R, 1988, J VIROL, V62, P2102, DOI 10.1128/JVI.62.6.2102-2106.1988; BACHMANN MF, 1994, EUR J IMMUNOL, V24, P2966, DOI 10.1002/eji.1830241207; BATTEGAY M, 1993, J IMMUNOL, V151, P5408; BINDER D, 1991, J IMMUNOL, V146, P4301; BORROW P, 1991, J EXP MED, V174, P203, DOI 10.1084/jem.174.1.203; CARMICHAEL A, 1993, J EXP MED, V177, P249, DOI 10.1084/jem.177.2.249; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; FERRARI C, 1990, J IMMUNOL, V145, P3442; FORSTER I, 1995, IMMUNITY, V2, P573, DOI 10.1016/1074-7613(95)90002-0; FREER G, 1995, EUR J IMMUNOL, V25, P1410, DOI 10.1002/eji.1830250541; GUPTA SC, 1986, P NATL ACAD SCI USA, V83, P2604, DOI 10.1073/pnas.83.8.2604; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; JORDAN MC, 1978, PERSISTENT VIRUSES, P805; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KUNDIG TM, 1993, J VIROL, V67, P3680; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; LEIST TP, 1987, J IMMUNOL, V138, P2278; MATSUURA Y, 1987, J GEN VIROL, V68, P1233, DOI 10.1099/0022-1317-68-5-1233; MISHELL BB, 1980, SELECTED METHODS CEL, P347; MOSKOPHIDIS D, 1993, EUR J IMMUNOL, V23, P3306, DOI 10.1002/eji.1830231237; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; OXENIUS A, 1998, IN PRESS EUR J IMMUN; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; PLAGEMANN PGW, 1992, ADV VIRUS RES, V41, P99, DOI 10.1016/S0065-3527(08)60036-6; Rehermann B, 1996, J VIROL, V70, P7092, DOI 10.1128/JVI.70.10.7092-7102.1996; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; SHEARER GM, 1991, AIDS, V5, P245, DOI 10.1097/00002030-199103000-00001; STEVENS JG, 1971, SCIENCE, V173, P843, DOI 10.1126/science.173.3999.843; vandenBroek MF, 1997, J IMMUNOL, V159, P1585; VIEIRA P, 1990, INT IMMUNOL, V2, P487, DOI 10.1093/intimm/2.6.487; WHITTON JL, 1988, J VIROL, V62, P687, DOI 10.1128/JVI.62.3.687-695.1988; Zajac AJ, 1996, P NATL ACAD SCI USA, V93, P14730, DOI 10.1073/pnas.93.25.14730; ZINKERNAGEL RM, 1994, IMMUNOL TODAY, V15, P262, DOI 10.1016/0167-5699(94)90005-1	38	145	146	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1998	9	4					449	457		10.1016/S1074-7613(00)80628-7	http://dx.doi.org/10.1016/S1074-7613(00)80628-7			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806631	Bronze			2022-12-18	WOS:000076680700003
J	Kehrl, JH				Kehrl, JH			Heterotrimeric G protein signaling: Roles in immune function and fine-tuning by RGS proteins	IMMUNITY			English	Review							PLATELET-ACTIVATING-FACTOR; T-LYMPHOCYTE ACTIVATION; B-CELL DIFFERENTIATION; MAP KINASE ACTIVATION; BETA-GAMMA-SUBUNITS; NF-KAPPA-B; ALPHA-SUBUNITS; TYROSINE KINASES; INTRACELLULAR CALCIUM; REGULATE ACTIVATION		NIAID, Cell Mol Biol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kehrl, JH (corresponding author), NIAID, Cell Mol Biol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jkehrl@atlas.niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X				AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; Apasov SG, 1997, J IMMUNOL, V158, P5095; Bacon KB, 1996, J EXP MED, V184, P873, DOI 10.1084/jem.184.3.873; Baixeras E, 1996, SCAND J IMMUNOL, V43, P406, DOI 10.1046/j.1365-3083.1996.d01-63.x; Baltensperger H, 1997, J BIOL CHEM, V272, P10151; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Berridge MJ, 1997, CRIT REV IMMUNOL, V17, P155, DOI 10.1615/CritRevImmunol.v17.i2.30; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bohm SK, 1997, BIOCHEM J, V322, P1; Boss V, 1996, J BIOL CHEM, V271, P10429, DOI 10.1074/jbc.271.18.10429; Broder CC, 1997, J LEUKOCYTE BIOL, V62, P20, DOI 10.1002/jlb.62.1.20; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; CARRACEDO J, 1995, EUR J IMMUNOL, V25, P3094, DOI 10.1002/eji.1830251116; CARROLL RC, 1995, CURR BIOL, V5, P536, DOI 10.1016/S0960-9822(95)00106-0; Chatterjee TK, 1997, J BIOL CHEM, V272, P15481, DOI 10.1074/jbc.272.24.15481; Chen CK, 1996, P NATL ACAD SCI USA, V93, P12885, DOI 10.1073/pnas.93.23.12885; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Dhanasekaran N, 1996, CELL SIGNAL, V8, P235, DOI 10.1016/0898-6568(96)00048-4; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; DOBNER T, 1992, EUR J IMMUNOL, V22, P2795, DOI 10.1002/eji.1830221107; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; DRUEY KM, 1997, IN PRESS P NATL ACAD; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; Fedyk ER, 1996, CLIN IMMUNOL IMMUNOP, V81, P101, DOI 10.1006/clin.1996.0165; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; FRANKLIN RA, 1995, BIOCHEM BIOPH RES CO, V209, P1111, DOI 10.1006/bbrc.1995.1612; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; GILMAN AG, 1995, BIOSCIENCE REP, V15, P65, DOI 10.1007/BF01200143; GOETZL EJ, 1995, INT ARCH ALLERGY IMM, V107, P202, DOI 10.1159/000236977; Grant KR, 1997, IMMUNOLOGY, V90, P564, DOI 10.1046/j.1365-2567.1997.00196.x; Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; HONDA Z, 1995, J BIOL CHEM, V270, P4840, DOI 10.1074/jbc.270.9.4840; HONG JX, 1993, J IMMUNOL, V150, P3895; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; HUANG RQ, 1995, CELL IMMUNOL, V162, P49, DOI 10.1006/cimm.1995.1050; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; KABOURIDIS PS, 1995, MOL CELL BIOCHEM, V144, P45, DOI 10.1007/BF00926739; Kanzaki M, 1997, J BIOL CHEM, V272, P14733, DOI 10.1074/jbc.272.23.14733; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Kavelaars A, 1994, Immunomethods, V5, P41, DOI 10.1006/immu.1994.1036; Kitamura K, 1996, J BIOL CHEM, V271, P7412, DOI 10.1074/jbc.271.13.7412; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Koelle MR, 1997, CURR OPIN CELL BIOL, V9, P143, DOI 10.1016/S0955-0674(97)80055-5; Kranenburg O, 1997, EMBO J, V16, P3097, DOI 10.1093/emboj/16.11.3097; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; Kuang YN, 1996, J BIOL CHEM, V271, P3975; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; KURUVILLA A, 1994, J IMMUNOL, V153, P5433; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; LANGHANSRAJASEKARAN SA, 1995, P NATL ACAD SCI USA, V92, P8601, DOI 10.1073/pnas.92.19.8601; Liu WW, 1996, P NATL ACAD SCI USA, V93, P8258, DOI 10.1073/pnas.93.16.8258; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; MAPARA MY, 1995, BLOOD, V85, P1836, DOI 10.1182/blood.V85.7.1836.bloodjournal8571836; MAZER B, 1991, J IMMUNOL, V146, P1914; Miller BA, 1996, J CLIN INVEST, V98, P1728, DOI 10.1172/JCI118971; MOORE MW, 1995, SCIENCE, V269, P1591, DOI 10.1126/science.269.5230.1591; Murphy Philip M., 1996, Cytokine and Growth Factor Reviews, V7, P47, DOI 10.1016/1359-6101(96)00009-3; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Neill JD, 1997, ENDOCRINOLOGY, V138, P843, DOI 10.1210/en.138.2.843; Offermanns S, 1996, CANCER SURV, V27, P177; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Ohtsuka T, 1996, BBA-MOL CELL RES, V1310, P223, DOI 10.1016/0167-4889(95)00172-7; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; PALIOGIANNI F, 1993, J EXP MED, V178, P1813, DOI 10.1084/jem.178.5.1813; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; QIAN NX, 1994, J BIOL CHEM, V269, P17417; RAMIREZ R, 1994, J EXP MED, V180, P1147, DOI 10.1084/jem.180.3.1147; ROPER RL, 1994, CELL IMMUNOL, V154, P296, DOI 10.1006/cimm.1994.1079; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; Sanders VM, 1995, ADV NEUROIMMUNOL, V5, P283, DOI 10.1016/0960-5428(95)00019-X; SCHERER LJ, 1994, THYMUS, V23, P231; Sengupta TK, 1996, P NATL ACAD SCI USA, V93, P9499, DOI 10.1073/pnas.93.18.9499; SMITH CS, 1994, CELL IMMUNOL, V155, P292, DOI 10.1006/cimm.1994.1123; Snow BE, 1997, BIOCHEM BIOPH RES CO, V233, P770, DOI 10.1006/bbrc.1997.6537; Solomon KR, 1996, P NATL ACAD SCI USA, V93, P6053, DOI 10.1073/pnas.93.12.6053; SPANGRUDE GJ, 1984, J IMMUNOL, V132, P354; SPICHER K, 1994, BIOCHEM BIOPH RES CO, V198, P906, DOI 10.1006/bbrc.1994.1129; Spiegel AM, 1997, HORM RES, V47, P89, DOI 10.1159/000185441; Stanners J, 1995, J BIOL CHEM, V270, P30635, DOI 10.1074/jbc.270.51.30635; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Tamir A, 1996, J IMMUNOL, V157, P1514; Taub DD, 1996, J IMMUNOL, V156, P2095; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; Umemori H, 1997, SCIENCE, V276, P1878, DOI 10.1126/science.276.5320.1878; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; Wan Y, 1997, J BIOL CHEM, V272, P17209, DOI 10.1074/jbc.272.27.17209; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; XU Y, 1995, J CELL PHYSIOL, V163, P441, DOI 10.1002/jcp.1041630303; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924	113	145	148	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1998	8	1					1	10		10.1016/S1074-7613(00)80453-7	http://dx.doi.org/10.1016/S1074-7613(00)80453-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462506	Bronze			2022-12-18	WOS:000071765700001
J	Carson, RT; Vignali, KM; Woodland, DL; Vignali, DAA				Carson, RT; Vignali, KM; Woodland, DL; Vignali, DAA			T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage	IMMUNITY			English	Article							3-DIMENSIONAL STRUCTURE; SINGLE PEPTIDES; MOLECULE I-A(K); VIRAL PEPTIDES; COMPLEX; ANTIGEN; IDENTIFICATION; EPITOPE; LIGANDS; PROTEIN	Naturally processed MHC class II-bound peptides possess ragged NH2 and COOH termini. It is not known whether these peptide flanking residues (PFRs), which lie outside the MHC anchor residues, are recognized by the TCR or influence immunogenicity. Here we analyzed T cell responses to the COOH-terminal PFR of the H-2A(k) immunodominant epitope of hen egg lysozyme (HEL) 52-61. Surprisingly, the majority of T cells were completely dependent on, and specific for, the COOH-terminal PFR of the immunogen. In addition, there were striking correlations between TCR V beta usage and PFR dependence. We hypothesize that the V alpha CDR1 region recognizes NH2-terminal PFRs, while the V beta CDR1 region recognizes COOH-terminal PFRs. Last, peptides containing PFRs were considerably more immunogenic and mediated a greater recall response to the HEL protein. These results demonstrate that PFRs, which are a unique characteristic of peptides bound to MHC class II molecules, can have a profound effect on TCR recognition and T cell function. These data may have important implications for peptide-based immunotherapy and vaccine development.	ST JUDE CHILDRENS RES HOSP, DEPT IMMUNOL, MEMPHIS, TN 38101 USA; UNIV TENNESSEE, MED CTR, DEPT PATHOL, MEMPHIS, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center					NATIONAL CANCER INSTITUTE [R29CA056570, P30CA021765, R01CA056570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI039480, R01AI039480] Funding Source: NIH RePORTER; NCI NIH HHS [CA-56570, 5 P30 CA21765-17] Funding Source: Medline; NIAID NIH HHS [AI-39480] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN PM, 1984, P NATL ACAD SCI-BIOL, V81, P2489, DOI 10.1073/pnas.81.8.2489; ALLEN PM, 1987, NATURE, V327, P713, DOI 10.1038/327713a0; ALLEN PM, 1985, J IMMUNOL, V135, P368; Arden Bernhard, 1995, Immunogenetics, V42, P501; BERZOFSKY JA, 1995, ANN NY ACAD SCI, V754, P161, DOI 10.1111/j.1749-6632.1995.tb44449.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CHIEN YH, 1993, IMMUNOL TODAY, V14, P597, DOI 10.1016/0167-5699(93)90199-U; COLE GA, 1994, INT IMMUNOL, V6, P1767, DOI 10.1093/intimm/6.11.1767; DALY K, 1995, J IMMUNOL, V155, P27; DECKHUT AM, 1993, J IMMUNOL, V151, P2658; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; LATRON F, 1992, SCIENCE, V257, P964, DOI 10.1126/science.1380181; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MORENO J, 1991, J IMMUNOL, V147, P3306; Muller CP, 1996, INT IMMUNOL, V8, P445, DOI 10.1093/intimm/8.4.445; Nardin EH, 1995, ADV IMMUNOL, V60, P105, DOI 10.1016/S0065-2776(08)60585-4; Nelson CA, 1996, J IMMUNOL, V157, P755; NELSON CA, 1993, P NATL ACAD SCI USA, V90, P1227, DOI 10.1073/pnas.90.4.1227; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; ParraLopez CA, 1997, J IMMUNOL, V158, P2670; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; ROTZSCHKE O, 1991, IMMUNOL TODAY, V12, P447, DOI 10.1016/0167-5699(91)90018-O; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SMILEK DE, 1991, P NATL ACAD SCI USA, V88, P9633, DOI 10.1073/pnas.88.21.9633; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; SUN R, 1995, IMMUNITY, V3, P573, DOI 10.1016/1074-7613(95)90128-0; TOMONARI K, 1989, EUR J IMMUNOL, V19, P1131, DOI 10.1002/eji.1830190625; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; URBAN RG, 1993, NATURALLY PROCESSED, P197; Vidal K, 1996, J EXP MED, V183, P1311, DOI 10.1084/jem.183.4.1311; VIGNALI DAA, 1992, J EXP MED, V175, P925, DOI 10.1084/jem.175.4.925; VIGNALI DAA, 1993, EUR J IMMUNOL, V23, P1602, DOI 10.1002/eji.1830230731; VIGNALI DAA, 1994, J EXP MED, V179, P1945, DOI 10.1084/jem.179.6.1945; Vignali DAA, 1996, J EXP MED, V183, P2097, DOI 10.1084/jem.183.5.2097; VIGNALI DAA, 1994, IMMUNOLOGIST, V2, P93; Viner NJ, 1996, J IMMUNOL, V156, P2365; WOODLAND DL, 1993, J EXP MED, V177, P433, DOI 10.1084/jem.177.2.433	56	145	148	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP	1997	7	3					387	399		10.1016/S1074-7613(00)80360-X	http://dx.doi.org/10.1016/S1074-7613(00)80360-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324359	Bronze			2022-12-18	WOS:A1997XY83000008
J	Lederer, K; Castano, D; Atria, DG; Oguin, TH; Wang, S; Manzoni, TB; Muramatsu, H; Hogan, MJ; Amanat, F; Cherubin, P; Lundgreen, KA; Tam, YK; Fan, SHY; Eisenlohr, LC; Maillard, I; Weissman, D; Bates, P; Krammer, F; Sempowski, GD; Pardi, N; Locci, M				Lederer, Katlyn; Castano, Diana; Atria, Daniela Gomez; Oguin, Thomas H.; Wang, Sidney; Manzoni, Tomaz B.; Muramatsu, Hiromi; Hogan, Michael J.; Amanat, Fatima; Cherubin, Patrick; Lundgreen, Kendall A.; Tam, Ying K.; Fan, Steven H. Y.; Eisenlohr, Laurence C.; Maillard, Ivan; Weissman, Drew; Bates, Paul; Krammer, Florian; Sempowski, Gregory D.; Pardi, Norbert; Locci, Michela			SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation	IMMUNITY			English	Article							MEMORY TFH CELLS; B-CELLS; PROTECTION; EXPRESSION; MF59	The deployment of effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to eradicate the coronavirus disease 2019 (COVID-19) pandemic. Many licensed vaccines confer protection by inducing long-lived plasma cells (LLPCs) and memory B cells (MBCs), cell types canonically generated during germinal center (GC) reactions. Here, we directly compared two vaccine platforms-mRNA vaccines and a recombinant protein formulated with an MF59-like adjuvant-looking for their abilities to quantitatively and qualitatively shape SARS-CoV-2-specific primary GC responses over time. We demonstrated that a single immunization with SARS-CoV-2 mRNA, but not with the recombinant protein vaccine, elicited potent SARS-CoV-2-specific GC B and T follicular helper (Tfh) cell responses as well as LLPCs and MBCs. Importantly, GC responses strongly correlated with neutralizing antibody production. mRNA vaccines more efficiently induced key regulators of the Tfh cell program and influenced the functional properties of Tfh cells. Overall, this study identifies SARS-CoV-2 mRNA vaccines as strong candidates for promoting robust GC-derived immune responses.	[Lederer, Katlyn; Castano, Diana; Wang, Sidney; Manzoni, Tomaz B.; Cherubin, Patrick; Lundgreen, Kendall A.; Bates, Paul; Locci, Michela] Univ Penn, Ctr Res Coronavirus & Other Emerging Pathogens, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Castano, Diana] Univ Antioquia, Fac Med, Inst Invest Med, Grp Inmunol Celular & Inmunogenet, Medellin 050010, Colombia; [Atria, Daniela Gomez; Maillard, Ivan] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Div Hematol Oncol,Dept Med, Philadelphia, PA 19104 USA; [Oguin, Thomas H.; Sempowski, Gregory D.] Duke Univ, Duke Human Vaccine Inst, Sch Med, Durham, NC 27710 USA; [Muramatsu, Hiromi; Weissman, Drew; Pardi, Norbert] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Hogan, Michael J.; Eisenlohr, Laurence C.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Protect Immun, Philadelphia, PA 19104 USA; [Amanat, Fatima; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Amanat, Fatima] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Tam, Ying K.; Fan, Steven H. Y.] Acuitas Therapeut, Vancouver, BC V6T 1Z3, Canada; [Eisenlohr, Laurence C.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Sempowski, Gregory D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	University of Pennsylvania; Pennsylvania Medicine; Universidad de Antioquia; University of Pennsylvania; Pennsylvania Medicine; Duke University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Duke University	Locci, M (corresponding author), Univ Penn, Ctr Res Coronavirus & Other Emerging Pathogens, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	michela.locci@pennmedicine.upenn.edu	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X; Castano, Diana/0000-0002-5697-5603; Oguin, Thomas/0000-0001-8959-4025; Cherubin, Patrick/0000-0002-3567-836X; Manzoni, Tomaz/0000-0001-6380-5103; Sempowski, Gregory/0000-0003-0391-6594	NIH NIAID [R01 AI123738, R01 AI091627, 1R01AI146101]; NIH [T32AI007324, R21AI129531, R21AI142638]; Peer Reviewed Medical Research Program award [PR182551]; Cancer Research Institute; NIH NIAD [UC6AI058607]	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peer Reviewed Medical Research Program award; Cancer Research Institute; NIH NIAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH NIAID grant R01 AI123738 to M.L. and R01 AI091627 to I.M. N.P. was supported by NIH NIAID 1R01AI146101. T.B.M was supported by NIH T32AI007324. P.B. was supported by a Peer Reviewed Medical Research Program award PR182551 and NIH R21AI129531 and R21AI142638. M.J.H. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute. Live SARS-CoV-2 microneutralization assays were performed in the Virology Unit of the Duke Regional Biocontainment Laboratory, which received partial support for construction from the NIH NIAD (UC6AI058607; G.D.S). Graphical abstract was created with BioRender.com. We thank the Cell and Developmental Biology Microcopy core at the University of Pennsylvania for their assistance with microscopy imaging. We thank Dr. Florin Tuluc and Jennifer Murray of the CHOP Flow Cytometry core facility and Dr. Derek D. Jones of the Penn Cytomics and Cell Sorting Resource Laboratory at the University of Pennsylvania for technical assistance. We thank Dr. E. John Wherry and Dr. Shane Crotty for providing valuable scientific feedback on the manuscript.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Corbett Kizzmekia S, 2020, bioRxiv, DOI [10.1038/s41586-020-2622-0, 10.1101/2020.06.11.145920]; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Freyn AW, 2020, MOL THER, V28, P1569, DOI 10.1016/j.ymthe.2020.04.018; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Havenar-Daughton C, 2017, IMMUNOL REV, V275, P49, DOI 10.1111/imr.12512; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; Laczko D, 2020, IMMUNITY, V53, P724, DOI 10.1016/j.immuni.2020.07.019; Liang F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2094; Lindgren G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01539; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Lofano G, 2015, J IMMUNOL, V195, P1617, DOI 10.4049/jimmunol.1402604; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Mulligan MJ, 2020, PHASE 1 2 STUDY DESC, DOI [10.1038/s41586-020-2639-4, 10.1101/2020.06.30.20142570]; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Hagan DT, 2007, EXPERT REV VACCINES, V6, P699, DOI 10.1586/14760584.6.5.699; Orenstein WA, 2017, P NATL ACAD SCI USA, V114, P4031, DOI 10.1073/pnas.1704507114; Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Sahin U, 2020, NATURE, V586, P594, DOI 10.1038/s41586-020-2814-7; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Sempowski GD, 2020, CELL, V181, P1458, DOI 10.1016/j.cell.2020.05.041; Smith TRF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16505-0; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Tam HH, 2016, P NATL ACAD SCI USA, V113, pE6639, DOI 10.1073/pnas.1606050113; The World Health Organization, 2020, DRAFT LANDSC COVID 1; Victora GD, 2015, CELL, V163, P545, DOI 10.1016/j.cell.2015.10.004; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Walsh Edward E, 2020, medRxiv, DOI 10.1101/2020.08.17.20176651; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhan T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09898-0; Zhang NN, 2020, CELL, V182, P1271, DOI 10.1016/j.cell.2020.07.024	62	144	146	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1281	+		10.1016/j.immuni.2020.11.009	http://dx.doi.org/10.1016/j.immuni.2020.11.009			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33296685	Green Published, Bronze			2022-12-18	WOS:000599363300016
J	Guilliams, M; Thierry, GR; Bonnardel, J; Bajenoff, M				Guilliams, Martin; Thierry, Guilhem R.; Bonnardel, Johnny; Bajenoff, Marc			Establishment and Maintenance of the Macrophage Niche	IMMUNITY			English	Review							COLONY-STIMULATING FACTOR; MEMORY T-CELLS; TISSUE-RESIDENT MACROPHAGES; RECEPTOR-DEFICIENT MICE; FACTOR-I; LANGERHANS CELLS; GROWTH-FACTOR; GM-CSF; TESTICULAR MACROPHAGES; ALVEOLAR MACROPHAGES	Self-maintaining resident macrophages populate all mammalian organs. In addition to their role as immune sentinels, macrophages perform day-to-day functions essential to tissue homeostasis. The homeostatic functions of macrophages are regulated by so-called tissular "niches'' that control the size of the macrophage population and imprint their tissue-specific identity. Here, we review the mechanisms underlying self-maintenance of distinct macrophage populations and outline the organizing principles of the macrophage niche. We examine recent studies that uncovered mutually beneficial cell-cell circuits established between macrophages and their niche and propose a modular view of tissues that integrates the resident macrophage as an essential component of each individual module. Manipulating macrophage niche cells to control the function of resident macrophages in vivo might have therapeutic value in various disease settings.	[Guilliams, Martin; Bonnardel, Johnny] VIB, Lab Myeloid Cell Ontogeny & Funct Specializat, Ctr Inflammat Res, Ghent, Belgium; [Guilliams, Martin; Bonnardel, Johnny] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Thierry, Guilhem R.; Bajenoff, Marc] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France	Flanders Institute for Biotechnology (VIB); Ghent University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Guilliams, M; Bonnardel, J (corresponding author), VIB, Lab Myeloid Cell Ontogeny & Funct Specializat, Ctr Inflammat Res, Ghent, Belgium.; Guilliams, M; Bonnardel, J (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.; Thierry, GR; Bajenoff, M (corresponding author), Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.	martin.guilliams@ugent.vib.be; thierry@ciml.univ-mrs.fr; johnny.bonnardel@ugent.vib.be; bajenoff@ciml.univ-mrs.fr	Guilliams, Martin/N-7803-2013	Guilliams, Martin/0000-0003-3525-7570; Bonnardel, Johnny/0000-0003-2359-3438				A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Abboud SL, 2003, J HISTOCHEM CYTOCHEM, V51, P941, DOI 10.1177/002215540305100709; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Amano H, 1998, J BONE MINER RES, V13, P846, DOI 10.1359/jbmr.1998.13.5.846; [Anonymous], 2018, J HEPATOL, V69, P1197, DOI 10.1016/j.jhep.2018.02.013; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Avetisyan M, 2018, P NATL ACAD SCI USA, V115, P4696, DOI 10.1073/pnas.1802490115; Baccala R, 2005, J IMMUNOL, V174, P4606, DOI 10.4049/jimmunol.174.8.4606; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bajpai G, 2018, NAT MED, V24, P1234, DOI 10.1038/s41591-018-0059-x; Baranska A, 2018, J EXP MED, V215, P1115, DOI 10.1084/jem.20171608; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; BARTOCCI A, 1987, P NATL ACAD SCI USA, V84, P6179, DOI 10.1073/pnas.84.17.6179; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; BERGH A, 1993, J ENDOCRINOL, V136, P407, DOI 10.1677/joe.0.1360407; Berry MR, 2017, CELL, V170, P860, DOI 10.1016/j.cell.2017.07.022; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Bittmann I, 2001, AM J CLIN PATHOL, V115, P525; Bittmann I, 2003, VIRCHOWS ARCH, V443, P541, DOI 10.1007/s00428-003-0861-8; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; BLEVINS G, 1995, J NEUROSCI RES, V40, P535, DOI 10.1002/jnr.490400412; Bolon B, 2008, TOXICOL PATHOL, V36, P265, DOI 10.1177/0192623307312693; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Buck A, 2001, MECH DEVELOP, V104, P143, DOI 10.1016/S0925-4773(01)00364-1; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; BURGESS AW, 1977, J BIOL CHEM, V252, P1998; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Byrne A.J., 2020, J EXP MED, V217; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Calderon B, 2015, J EXP MED, V212, P1497, DOI 10.1084/jem.20150496; Camara A, 2019, IMMUNITY, V50, P1467, DOI 10.1016/j.immuni.2019.05.008; Capucha T, 2018, J EXP MED, V215, P481, DOI 10.1084/jem.20171508; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chakrabarti R, 2018, SCIENCE, V360, P1421, DOI 10.1126/science.aan4153; Chen X, 2018, CONNECT TISSUE RES, V59, P99, DOI 10.1080/03008207.2017.1290085; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Clark RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010641; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; Cohen PE, 1997, MOL ENDOCRINOL, V11, P1636, DOI 10.1210/me.11.11.1636; Cohen PE, 1996, BIOL REPROD, V55, P310, DOI 10.1095/biolreprod55.2.310; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Cui GW, 2014, P NATL ACAD SCI USA, V111, P1915, DOI 10.1073/pnas.1318281111; Dai XM, 2004, BLOOD, V103, P1114, DOI 10.1182/blood-2003-08-2739; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; De Creus A, 2002, J IMMUNOL, V168, P6486, DOI 10.4049/jimmunol.168.12.6486; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; ELFORD PR, 1987, CALCIFIED TISSUE INT, V41, P151, DOI 10.1007/BF02563795; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Ferrer IR, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax8704; French JD, 2005, P NATL ACAD SCI USA, V102, P14741, DOI 10.1073/pnas.0507520102; Fuller K, 2000, J CELL SCI, V113, P2445; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gow DJ, 2014, MOL THER, V22, P1580, DOI 10.1038/mt.2014.112; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Gyorki DE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2353; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Harrison SJ, 2012, DIS MODEL MECH, V5, P351, DOI 10.1242/dmm.002873; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Himes SR, 2001, J LEUKOCYTE BIOL, V70, P812; Hodson LJ, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109561; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; HOFSTETTER W, 1995, BONE, V17, P145, DOI 10.1016/S8756-3282(95)00163-8; Horiuchi K, 2007, J IMMUNOL, V179, P6715, DOI 10.4049/jimmunol.179.10.6715; HOROWITZ MC, 1989, CONNECT TISSUE RES, V20, P159, DOI 10.3109/03008208909023884; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Huffman JA, 1996, J CLIN INVEST, V97, P649, DOI 10.1172/JCI118461; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Hume DA, 2019, TRENDS IMMUNOL, V40, P98, DOI 10.1016/j.it.2018.11.007; Hutson JC, 1996, J ANDROL, V17, P502; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Hwang SJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3693; Ivanov S, 2019, EUR J IMMUNOL, V49, P2012, DOI 10.1002/eji.201948164; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kana V, 2019, J EXP MED, V216, P2265, DOI 10.1084/jem.20182037; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kim KW, 2016, J EXP MED, V213, P1951, DOI 10.1084/jem.20160486; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Komuczki J, 2019, IMMUNITY, V50, P1289, DOI 10.1016/j.immuni.2019.04.006; Kondo Y, 2009, J NEUROSCI RES, V87, P2686, DOI 10.1002/jnr.22096; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Lai SM, 2018, CELL REP, V25, P3099, DOI 10.1016/j.celrep.2018.11.059; Lambrecht B, 2014, J EXP MED, V211, P2136, DOI 10.1084/jem.21111insight1; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Lin WY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02019; Lukyanenko YO, 2001, BIOL REPROD, V64, P790, DOI 10.1095/biolreprod64.3.790; Lund H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07295-7; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; MARKS SC, 1982, AM J ANAT, V163, P157, DOI 10.1002/aja.1001630205; MARKS SC, 1976, J HERED, V67, P11, DOI 10.1093/oxfordjournals.jhered.a108657; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Matsuoka K, 2014, J BONE MINER RES, V29, P1522, DOI 10.1002/jbmr.2187; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Michaelson MD, 1996, DEVELOPMENT, V122, P2661; Mikkelsen HB, 1999, CELL TISSUE RES, V295, P485, DOI 10.1007/s004410051254; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Mondor I, 2019, IMMUNITY, V50, P1453, DOI 10.1016/j.immuni.2019.04.002; Moriguchi T, 2006, MOL CELL BIOL, V26, P5715, DOI 10.1128/MCB.00001-06; Muller PA, 2014, CELL, V158, P1210, DOI 10.1016/j.cell.2014.08.002; Nandi S, 2006, BLOOD, V107, P786, DOI 10.1182/blood-2005-05-1822; Nayak DK, 2016, AM J TRANSPLANT, V16, P2300, DOI 10.1111/ajt.13819; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nishinakamura R, 1996, J EXP MED, V183, P2657, DOI 10.1084/jem.183.6.2657; NOSSAL GJV, 1984, AM J ANAT, V170, P253, DOI 10.1002/aja.1001700304; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Outtz HH, 2011, BLOOD, V118, P3436, DOI 10.1182/blood-2010-12-327015; Pixley F.J., 2012, INT J CELL BIOL, V2012; Pollard JW, 1997, BIOL REPROD, V56, P1290, DOI 10.1095/biolreprod56.5.1290; POLLARD JW, 1994, P NATL ACAD SCI USA, V91, P9312, DOI 10.1073/pnas.91.20.9312; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Pridans C, 2018, J IMMUNOL, V201, P2683, DOI 10.4049/jimmunol.1701783; Pridans C, 2018, AM J PHYSIOL-GASTR L, V314, pG388, DOI 10.1152/ajpgi.00343.2017; Ranson T, 2003, P NATL ACAD SCI USA, V100, P2663, DOI 10.1073/pnas.0535482100; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Rho J, 2002, DNA CELL BIOL, V21, P541, DOI 10.1089/104454902320308915; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schluns KS, 2004, BLOOD, V103, P988, DOI 10.1182/blood-2003-08-2814; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schridde A, 2017, MUCOSAL IMMUNOL, V10, P1387, DOI 10.1038/mi.2016.142; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Sheih A, 2017, MUCOSAL IMMUNOL, V10, P705, DOI 10.1038/mi.2016.90; Shelburne CP, 2011, ADV EXP MED BIOL, V716, P162, DOI 10.1007/978-1-4419-9533-9_10; Shemer A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07548-5; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Shi JY, 2018, METHODS MOL BIOL, V1784, P263, DOI 10.1007/978-1-4939-7837-3_24; Sierro F, 2017, IMMUNITY, V47, P374, DOI 10.1016/j.immuni.2017.07.018; Sinder BP, 2015, J BONE MINER RES, V30, P2140, DOI 10.1002/jbmr.2735; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; Steinbach K, 2016, J EXP MED, V213, P1571, DOI 10.1084/jem.20151916; Stewart TA, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00250; Stramer B, 2010, J CELL BIOL, V189, P681, DOI 10.1083/jcb.200912134; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Tian Y, 2013, J INTERF CYTOK RES, V33, P398, DOI 10.1089/jir.2012.0122; Trapnell BC, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0066-3; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Van Nguyen A, 2002, DEV BIOL, V247, P11, DOI 10.1006/dbio.2002.0669; WANG JM, 1988, J IMMUNOL, V141, P575; Wang YM, 2016, EUR J IMMUNOL, V46, P552, DOI 10.1002/eji.201545917; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wang ZP, 2017, J ALLERGY CLIN IMMUN, V139, P1205, DOI 10.1016/j.jaci.2016.09.019; Webb SE, 1996, J CELL SCI, V109, P793; Wei S, 2005, IMMUNOBIOLOGY, V210, P109, DOI 10.1016/j.imbio.2005.05.005; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yao GQ, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.22; Yasmin N, 2013, J EXP MED, V210, P2597, DOI 10.1084/jem.20130275; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yoshida M, 2001, AM J PHYSIOL-LUNG C, V280, pL379, DOI 10.1152/ajplung.2001.280.3.L379; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	195	144	148	7	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					434	451		10.1016/j.immuni.2020.02.015	http://dx.doi.org/10.1016/j.immuni.2020.02.015			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187515	Bronze			2022-12-18	WOS:000520600200007
J	Kometani, K; Nakagawa, R; Shinnakasu, R; Kaji, T; Rybouchkin, A; Moriyama, S; Furukawa, K; Koseki, H; Takemori, T; Kurosaki, T				Kometani, Kohei; Nakagawa, Rinako; Shinnakasu, Ryo; Kaji, Tomohiro; Rybouchkin, Andrei; Moriyama, Saya; Furukawa, Koji; Koseki, Haruhiko; Takemori, Toshitada; Kurosaki, Tomohiro			Repression of the Transcription Factor Bach2 Contributes to Predisposition of IgG1 Memory B Cells toward Plasma Cell Differentiation	IMMUNITY			English	Article							MURINE MEMORY; ANTIGEN; EXPRESSION; PATHWAY; MATURATION; IDENTITY; AFFINITY; PROMOTES; SURVIVAL; BLIMP-1	Memory B cells are essential for generating rapid and robust secondary antibody responses. It has been thought that the unique cytoplasmic domain of IgG causes the prompt activation of antigen-experienced IgG memory B cells. To assess this model, we have generated a mouse containing IgG1 B cells that have never encountered antigen. We found that, upon challenge, antigen-experienced IgG1 memory B cells rapidly differentiated into plasma cells, whereas nonexperienced IgG1 B cells did not, suggesting the importance of the stimulation history. In addition, our results suggest that repression of the Bach2 transcription factor, which results from antigen experience, contributes to predisposition of IgG1 memory B cells to differentiate into plasma cells.	[Kometani, Kohei; Shinnakasu, Ryo; Moriyama, Saya; Kurosaki, Tomohiro] RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan; [Kaji, Tomohiro; Takemori, Toshitada] RIKEN, Res Ctr Allergy & Immunol, Lab Immunol Memory, Yokohama, Kanagawa 2300045, Japan; [Rybouchkin, Andrei] RIKEN, Res Ctr Allergy & Immunol, Res Unit Lymphocyte Cloning, Yokohama, Kanagawa 2300045, Japan; [Koseki, Haruhiko] RIKEN, Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa 2300045, Japan; [Nakagawa, Rinako; Moriyama, Saya; Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka 5650871, Japan; [Nakagawa, Rinako; Moriyama, Saya; Kurosaki, Tomohiro] Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan; [Furukawa, Koji] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan	RIKEN; RIKEN; RIKEN; RIKEN; Osaka University; Osaka University; National Institute of Advanced Industrial Science & Technology (AIST)	Kurosaki, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan.	kurosaki@ifrec.osaka-u.ac.jp	Furukawa, Koji/L-6909-2018; Kurosaki, Tomohiro/D-1306-2009; Koseki, Haruhiko/I-3825-2014; Rybouchkin, Andrei/T-5673-2019; Takemori, Toshitada/A-5909-2016	Furukawa, Koji/0000-0002-5701-2497; Kurosaki, Tomohiro/0000-0002-6352-304X; Koseki, Haruhiko/0000-0001-8424-5854; Kometani, Kohei/0000-0003-4281-4371	Ministry of Education, Culture, Sports, Science, and Technology in Japan; Japan Science and Technology (CREST); RIKEN Special Postdoctoral Researchers Program	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology (CREST); RIKEN Special Postdoctoral Researchers Program	We thank J. Yang for NIP monomer-Dylight649, A. Muto and K. Igarashi for Bach2 antibody, Y. Harada and L. Yun-Cai for Foxo1-CA cDNA, K. Rajewsky and S. Casola for C gamma 1-cre mice, A. Waisman for iDTR mice, M. Nussenzweig for B1-8<SUP>hi</SUP> mice, E. Hobeika and M. Reth for Cd79a-cre mice, M. Tochigi for technical assistance, Y. Aiba, T. Okada, H. Jumaa, and M. Reth for discussions, and P. Burrows for critical reading. This work was supported by grant-in-Aid to T. Kurosaki and K. K. from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and by a grant to T. Kurosaki from Japan Science and Technology (CREST). T. Kurosaki is also supported as a FRIAS fellow. This work was also supported by RIKEN Special Postdoctoral Researchers Program to K.K.	ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Arpin C, 1997, J EXP MED, V186, P931, DOI 10.1084/jem.186.6.931; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Benson MJ, 2009, J EXP MED, V206, P2013, DOI 10.1084/jem.20090667; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Chan TD, 2010, IMMUNOL REV, V237, P90, DOI 10.1111/j.1600-065X.2010.00942.x; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Good KL, 2007, P NATL ACAD SCI USA, V104, P13420, DOI 10.1073/pnas.0703872104; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Igarashi K, 2007, J BIOCHEM, V141, P783, DOI 10.1093/jb/mvm106; IMANISHI T, 1973, EUR J IMMUNOL, V3, P323, DOI 10.1002/eji.1830030602; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Robichaud GA, 2004, J BIOL CHEM, V279, P49956, DOI 10.1074/jbc.M407171200; Sasaki S, 2000, ONCOGENE, V19, P3739, DOI 10.1038/sj.onc.1203716; Shapiro-Shelef M, 2004, CURR OPIN IMMUNOL, V16, P226, DOI 10.1016/j.coi.2004.02.001; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963	49	144	146	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					136	147		10.1016/j.immuni.2013.06.011	http://dx.doi.org/10.1016/j.immuni.2013.06.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23850379	Bronze			2022-12-18	WOS:000330948300014
J	Sheridan, BS; Romagnoli, PA; Pham, QM; Fu, HH; Alonzo, F; Schubert, WD; Freitag, NE; Lefrancois, L				Sheridan, Brian S.; Romagnoli, Pablo A.; Quynh-Mai Pham; Fu, Han-Hsuan; Alonzo, Francis, III; Schubert, Wolf-Dieter; Freitag, Nancy E.; Lefrancois, Leo			gamma delta T Cells Exhibit Multifunctional and Protective Memory in Intestinal Tissues	IMMUNITY			English	Article							LISTERIA-MONOCYTOGENES; INTERFERON-GAMMA; IFN-GAMMA; IN-VIVO; IMMUNE-RESPONSES; INNATE IMMUNITY; E-CADHERIN; RECEPTOR; LYMPHOCYTES; IL-17	The study of T cell memory and the target of vaccine design have focused onmemory subsumed by T cells bearing the alpha beta T cell receptor. Alternatively, gamma delta T cells are thought to provide rapid immunity, particularly at mucosal borders. Here, we have shown that a distinct subset of mucosal gamma delta T cells mounts an immune response to oral Listeria monocytogenes (Lm) infection and leads to the development of multifunctional memory T cells capable of simultaneously producing interferon-gamma and interleukin-17A in the murine intestinal mucosa. Challenge infection with oral Lm, but not oral Salmonella or intravenous Lm, induced rapid expansion of memory gamma delta T cells, suggesting contextual specificity to the priming pathogen. Importantly, memory gamma delta T cells were able to provide enhanced protection against infection. These findings illustrate that gamma delta T cells play a role with hallmarks of adaptive immunity in the intestinal mucosa.	[Sheridan, Brian S.; Romagnoli, Pablo A.; Quynh-Mai Pham; Fu, Han-Hsuan; Lefrancois, Leo] Univ Connecticut, Ctr Hlth, Dept Immunol, Ctr Integrated Immunol & Vaccine Res, Farmington, CT 06030 USA; [Alonzo, Francis, III; Freitag, Nancy E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Schubert, Wolf-Dieter] Univ Western Cape, Dept Biotechnol, ZA-7537 Bellville, South Africa	University of Connecticut; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of the Western Cape	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Ctr Integrated Immunol & Vaccine Res, Farmington, CT 06030 USA.	llefranc@neuron.uchc.edu	Schubert, Wolf-Dieter/A-5617-2009; Romagnoli, Pablo Alberto/AAF-4719-2019	Schubert, Wolf-Dieter/0000-0003-4998-519X; Romagnoli, Pablo Alberto/0000-0002-6328-9070	National Institutes of Health [AI095544, AI076457, AI041816]; Crohn's and Colitis Foundation of America [2813]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095544, R01AI041816, R29AI041816, R56AI041816, R01AI041576, R01AI076457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the UCHC Flow Cytometry Core for expert assistance in cell sorting, the NIAID Tetramer Core Facility for providing LLO<INF>91</INF> H-2K<SUP>d</SUP> tetramers, S.J. McSorley (University of California, Davis) for providing Salmonella, and I. Prinz (Hannover Medical School) for providing TCR delta H2B eGFP reporter mice. Funding for this study was provided through support by National Institutes of Health grants AI095544 (to L. L.), AI076457 (to L. L.), and AI041816 (to N.E.F.) and by "Visualizing orally-induced T cell responses in the intestinal mucosa" reference number 2813 from the Crohn's and Colitis Foundation of America (to B. S. S.). B. S. S, P. A. R., Q. M. P., and H. H. F. performed all experiments. F. A. and N.E.F. generated Lm InlA<SUP>M</SUP> in the 10403s strain. W. D. S. designed and provided Lm InlA<SUP>M</SUP> in the EGDe strain. W. D. S. and N.E.F. contributed to the overall study design. B. S. S. and L. L. designed the experiments, analyzed and interpreted the data, and wrote the manuscript.	Abromson-Leeman S, 2009, J NEUROIMMUNOL, V215, P10, DOI 10.1016/j.jneuroim.2009.07.007; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Begley M, 2004, FEBS LETT, V561, P99, DOI 10.1016/S0014-5793(04)00131-0; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Cornish RM, 2006, J BACTERIOL, V188, P1444, DOI 10.1128/JB.188.4.1444-1450.2006; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Dejima T, 2011, INFECT IMMUN, V79, P4503, DOI 10.1128/IAI.05799-11; Do JS, 2012, IMMUNOL CELL BIOL, V90, P396, DOI 10.1038/icb.2011.50; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; FU YX, 1994, J IMMUNOL, V153, P3101; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hamada S, 2008, IMMUNOLOGY, V125, P170, DOI 10.1111/j.1365-2567.2008.02841.x; HARA T, 1992, J CLIN INVEST, V90, P204, DOI 10.1172/JCI115837; HARTY JT, 1992, P NATL ACAD SCI USA, V89, P11612, DOI 10.1073/pnas.89.23.11612; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hsieh B, 1996, J IMMUNOL, V156, P232; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jones-Carson J, 2007, INFECT IMMUN, V75, P2708, DOI 10.1128/IAI.01905-06; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Klonowski KD, 2006, J IMMUNOL, V177, P6738, DOI 10.4049/jimmunol.177.10.6738; Koenecke C, 2009, EUR J IMMUNOL, V39, P372, DOI 10.1002/eji.200838741; Korn T, 2012, ANN NY ACAD SCI, V1247, P34, DOI 10.1111/j.1749-6632.2011.06355.x; LADEL CH, 1994, J IMMUNOL, V153, P3116; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Pang DJ, 2012, IMMUNOLOGY, V136, P283, DOI 10.1111/j.1365-2567.2012.03582.x; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; Poggi A, 2009, CURR MED CHEM, V16, P4743, DOI 10.2174/092986709789878238; Puan KJ, 2007, INT IMMUNOL, V19, P657, DOI 10.1093/intimm/dxm031; Rhodes KA, 2008, EUR J IMMUNOL, V38, P2274, DOI 10.1002/eji.200838354; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Roark CL, 2004, J LEUKOCYTE BIOL, V75, P68, DOI 10.1189/jlb.0703326; Ryan-Payseur B, 2012, J IMMUNOL, V189, P1285, DOI 10.4049/jimmunol.1200641; Shao LY, 2009, J VIROL, V83, P11959, DOI 10.1128/JVI.00689-09; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Sheridan Brian S, 2012, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s99; Sprent J, 2002, CURR BIOL, V12, pR174, DOI 10.1016/S0960-9822(02)00735-2; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; TAKAGAKI Y, 1989, NATURE, V339, P712, DOI 10.1038/339712a0; Tam S, 2012, MICROBES INFECT, V14, P1133, DOI 10.1016/j.micinf.2012.05.008; TRIPP CS, 1994, J IMMUNOL, V152, P1883; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	65	144	147	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					184	195		10.1016/j.immuni.2013.06.015	http://dx.doi.org/10.1016/j.immuni.2013.06.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890071	Green Accepted, Bronze			2022-12-18	WOS:000330948300018
J	Fukui, R; Saitoh, SI; Kanno, A; Onji, M; Shibata, T; Ito, A; Onji, M; Matsumoto, M; Akira, S; Yoshida, N; Miyake, K				Fukui, Ryutaro; Saitoh, Shin-Ichiroh; Kanno, Atsuo; Onji, Masahiro; Shibata, Takuma; Ito, Akihiko; Onji, Morikazu; Matsumoto, Mitsuru; Akira, Shizuo; Yoshida, Nobuaki; Miyake, Kensuke			Unc93B1 Restricts Systemic Lethal Inflammation by Orchestrating Toll-like Receptor 7 and 9 Trafficking	IMMUNITY			English	Article							DENDRITIC CELLS; B-CELLS; LUPUS-ERYTHEMATOSUS; ANTIMICROBIAL PEPTIDE; AUTOIMMUNE-DISEASES; BLOOD-COAGULATION; BACTERIAL-DNA; MURINE LUPUS; I INTERFERON; CPG MOTIFS	Toll-like receptor-7 (TLR7) and 9, innate immune sensors for microbial RNA or DNA, have been implicated in autoimmunity. Upon activation, TLR7 and 9 are transported from the endoplasmic reticulum (ER) to endolysosomes for nucleic acid sensing by an ER-resident protein, Unc93B1. Little is known, however, about a role for sensor transportation in controlling autoimmunity. TLR9 competes with TLR7 for Unc93B1-dependent trafficking and predominates over TLR7. TLR9 skewing is actively maintained by Unc93B1 and reversed to TLR7 if Unc93B1 loses preferential binding via a D34A mutation. We here demonstrate that mice harboring a D34A mutation showed TLR7-dependent, systemic lethal inflammation. CD4(+) T cells showed marked differentiation toward T helper 1 (Th1) or Th17 cell subsets. B cell depletion abolished T cell differentiation and systemic inflammation. Thus, Unc93B1 controls homeostatic TLR7 activation by balancing TLR9 to TLR7 trafficking.	[Fukui, Ryutaro; Saitoh, Shin-Ichiroh; Kanno, Atsuo; Onji, Masahiro; Shibata, Takuma; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Div Infect Genet, Dept Microbiol & Immunol,Minato Ku, Tokyo 1088639, Japan; [Shibata, Takuma; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Lab Innate Immun, Minato Ku, Tokyo 1088639, Japan; [Yoshida, Nobuaki] Univ Tokyo, Inst Med Sci, Lab Dev Genet, Ctr Expt Med & Syst Biol,Minato Ku, Tokyo 1088639, Japan; [Ito, Akihiko] Kinki Univ, Dept Pathol, Fac Med, Osaka 5898511, Japan; [Onji, Morikazu] Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Matsuyama, Ehime 7910295, Japan; [Matsumoto, Mitsuru] Univ Tokushima, Div Mol Immunol, Inst Enzyme Res, Tokushima 7708504, Japan; [Akira, Shizuo] World Premier Int Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Kindai University (Kinki University); Ehime University; Tokushima University; Osaka University	Miyake, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Infect Genet, Dept Microbiol & Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kmiyake@ims.u-tokyo.ac.jp	Shibata, Takuma/M-8196-2019; Akira, Shizuo/C-3134-2009		Japanese-Korean Cooperative Programme on Basic Medical Research; Joint Medical Science Research Center for the Advancement of Basic and Applied Medical Science; Implementation of State-of-the-Art Medical Therapy; Takeda Science Foundation.; Grants-in-Aid for Scientific Research [22500286, 22790454] Funding Source: KAKEN	Japanese-Korean Cooperative Programme on Basic Medical Research; Joint Medical Science Research Center for the Advancement of Basic and Applied Medical Science; Implementation of State-of-the-Art Medical Therapy; Takeda Science Foundation.(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to F. Alt and J. Miyazaki for providing mice and ES cells, to P.W. Kincade for critically reviewing the manuscript, and to T. Kitamura, T. Kaisho, and S. Takaki for their advice. We also thank K.B. Kimura for technical help for histological analyses. This work was supported (in part) by Japanese-Korean Cooperative Programme on Basic Medical Research; Grant-in-Aid for Scientific Research (B, C); Grant-in-Aid for Exploratory Research; Grant-in-Aid for Young Scientists (B and Start-up); Grant-in-Aid for Scientific Research on Innovative Areas; Joint Medical Science Research Center for the Advancement of Basic and Applied Medical Science and the Implementation of State-of-the-Art Medical Therapy; and Takeda Science Foundation.	Abe M, 2007, CLIN GASTROENTEROL H, V5, P255, DOI 10.1016/j.cgh.2006.10.011; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chan OTM, 1999, J IMMUNOL, V163, P3592; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Deng GM, 1999, NAT MED, V5, P702, DOI 10.1038/9554; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dorner T, 2009, NAT REV RHEUMATOL, V5, P433, DOI 10.1038/nrrheum.2009.141; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Janka GE, 2007, BLOOD REV, V21, P245, DOI 10.1016/j.blre.2007.05.001; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kerr R, 2003, J THROMB HAEMOST, V1, P754, DOI 10.1046/j.1538-7836.2003.00194.x; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kuwata K, 2006, SHOCK, V25, P344, DOI 10.1097/01.shk.0000209520.82377.41; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Mochida S, 1999, HEPATOLOGY, V29, P1532, DOI 10.1002/hep.510290533; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Ronaghy A, 2002, J IMMUNOL, V168, P51, DOI 10.4049/jimmunol.168.1.51; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Tsukamoto Y, 2009, MOL IMMUNOL, V46, P1278, DOI 10.1016/j.molimm.2008.11.022; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; WOOLF GM, 1994, DIGEST DIS SCI, V39, P1351, DOI 10.1007/BF02093804; Yu CF, 2010, J IMMUNOL, V184, P1159, DOI 10.4049/jimmunol.0901706; Yu P, 2006, INT IMMUNOL, V18, P1211, DOI 10.1093/intimm/dxl067	50	144	147	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 22	2011	35	1					69	81		10.1016/j.immuni.2011.05.010	http://dx.doi.org/10.1016/j.immuni.2011.05.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21683627	Bronze			2022-12-18	WOS:000293107300011
J	Cucak, H; Yrlid, U; Reizis, B; Kalinke, U; Johansson-Lindbom, B				Cucak, Helena; Yrlid, Ulf; Reizis, Boris; Kalinke, Ulrich; Johansson-Lindbom, Bengt			Type I Interferon Signaling in Dendritic Cells Stimulates the Development of Lymph-Node-Resident T Follicular Helper Cells	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CXC CHEMOKINE RECEPTOR-5; B-CELL; IMMUNE-RESPONSE; ANTIBODY-RESPONSES; IFN; GENERATION; ALPHA/BETA; INTERLEUKIN-21; AUTOIMMUNITY	T follicular helper (Tfh) cells represent a recently defined CD4(+) T cell subset characterized by the expression of the chemokine receptor CXCR5 and an enhanced ability to support B cells to mount antibody responses. Here, we demonstrate that lymph-node-resident CXCR5(+) Tfh cells and gut-homing integrin alpha(4)beta(7)-expressing T helper cells are generate as separate subsets in the gut-draining mesenteric lymph nodes. Type I interferon signaling in dendritic cells and in nonhematopoietic cells selectively stimulates Tfh cell development in response to antigen in conjunction with Toll-like receptor (TLR)3 or TLR4 agonists. Consistent with this, the ability of dendritic cells to produce the cytokine IL-6, required for in vivo Tfh differentiation, and antibody affinity maturation are both reduced in absence of type I interferon signaling. Thus, our results identify type I interferon as a natural adjuvant that selectively supports the generation of lymph node resident Tfh cells.	[Cucak, Helena; Johansson-Lindbom, Bengt] Lund Univ, Immunol Sect, S-22184 Lund, Sweden; [Yrlid, Ulf] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Mucosal Immunobiol & Vaccine Ctr MIVAC, S-40530 Gothenburg, Sweden; [Yrlid, Ulf] Swedish Fdn Strateg Res, S-40530 Gothenburg, Sweden; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; [Kalinke, Ulrich] Ctr Expt & Clin Infect Res, TWINCORE, D-30625 Hannover, Germany; [Kalinke, Ulrich] Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany	Lund University; University of Gothenburg; Swedish Foundation for Strategic Research; Columbia University; Paul Ehrlich Institute	Johansson-Lindbom, B (corresponding author), Lund Univ, Immunol Sect, BMC D14, S-22184 Lund, Sweden.	bengt.johansson_lindbom@med.lu.se	yrlid, ulf/AAR-4416-2020	Reizis, Boris/0000-0003-1140-7853; Kalinke, Ulrich/0000-0003-0503-9564	Swedish Medical Research Council; Royal Physiographic Society; Crafoord Foundation; Ake Wiberg; Osterlunds	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Royal Physiographic Society; Crafoord Foundation; Ake Wiberg; Osterlunds	The authors wish to thank J. Demengeot (Instituto Gulbenkian de Ciencia, Portugal) for kindly providing Ifnar1<SUP>-/-</SUP> mice and O. Pabst (Hannover Medical School, Germany) for the kind gift of CXCR5 mAb. We also would like to thank A. Mowat (University of Glasgow, UK), F. Ivars (Lund University, Sweden), and W.W. Agace (Lund University) for their valuable input during the preparation of this manuscript. B.J.-L. and U.Y. are Assistant Professors with the Swedish Medical Research Council. This work was supported by grants to B.J.-L. from the Swedish Medical Research Council, the Royal Physiographic Society, the Crafoord Foundation, Ake Wiberg, and Osterlunds.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Belardelli F, 1996, IMMUNOL TODAY, V17, P369, DOI 10.1016/0167-5699(96)10027-X; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Braun D, 2003, J AUTOIMMUN, V20, P15, DOI 10.1016/S0896-8411(02)00109-9; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fejer G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000208; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Lefrancois L, 1999, J EXP MED, V189, P1631, DOI 10.1084/jem.189.10.1631; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Zhou ZP, 2005, EUR J IMMUNOL, V35, P1918, DOI 10.1002/eji.200525971; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06; Zhu JG, 2007, J IMMUNOL, V178, P3505, DOI 10.4049/jimmunol.178.6.3505	58	144	146	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					491	501		10.1016/j.immuni.2009.07.005	http://dx.doi.org/10.1016/j.immuni.2009.07.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19733096	Bronze			2022-12-18	WOS:000270525900016
J	Fields, PE; Lee, GR; Kim, ST; Bartsevich, VV; Flavell, RA				Fields, PE; Lee, GR; Kim, ST; Bartsevich, VV; Flavell, RA			Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region	IMMUNITY			English	Article							BETA-GLOBIN LOCUS; I-HYPERSENSITIVE SITES; T-CELL DIFFERENTIATION; HISTONE ACETYLATION; GENE-EXPRESSION; TRANSGENIC MICE; COORDINATE REGULATOR; IL-4 GENE; TRANSCRIPTION; ELEMENT	We recently identified a 3' region of the rad50 gene possessing strong enhancer activity as well as activity consistent with function as a locus control region (LCR) for the flanking Th2 cytokine genes. In this study, we identify several functional elements within this region by examining chromatin changes as well as activity in transgenic mice. We find within this region four DNase I hypersensitive clusters, three of which are highly conserved and predominantly expressed in Th2 cells. Histone acetylation of this region is elevated in Th2 cells. Further, one of the hypersensitive sites (RHS7) is rapidly demethylated in Th2, but not Th1, cells. In transgenic mice, these hypersensitive sites impart strong, The-specific enhancer activity as well as copy number-dependent expression of the reporter gene, recapitulating LCR function. We postulate that these sites function alone or in combination with other regulatory elements to coordinate gene expression in the Th2 cytokine locus.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Sangamo Biosci Inc, Richmond, CA 94804 USA	Yale University; Howard Hughes Medical Institute; Yale University; Sangamo Therapeutics, Inc.	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Fields, Patrick E/G-4878-2012	Fields, Patrick/0000-0002-6797-4139				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; AIZAWA A, 1995, NUCLEIC ACIDS RES, V23, P2236, DOI 10.1093/nar/23.12.2236; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; Cousins DJ, 2002, J IMMUNOL, V169, P2498, DOI 10.4049/jimmunol.169.5.2498; CURTIN PT, 1989, P NATL ACAD SCI USA, V86, P7082, DOI 10.1073/pnas.86.18.7082; Elefant F, 2000, EMBO J, V19, P6814, DOI 10.1093/emboj/19.24.6814; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; FRASER P, 1990, NUCLEIC ACIDS RES, V18, P3503, DOI 10.1093/nar/18.12.3503; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Jackson JD, 1996, J BIOL CHEM, V271, P11871, DOI 10.1074/jbc.271.20.11871; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Lee CC, 2003, PHOTOCH PHOTOBIO SCI, V2, P145, DOI 10.1039/b207598a; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; LI QL, 1994, BLOOD, V84, P1399; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Molete JM, 2001, MOL CELL BIOL, V21, P2969, DOI 10.1128/MCB.21.9.2969-2980.2001; Ortiz BD, 1999, MOL CELL BIOL, V19, P1901; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; Santoso B, 2000, J BIOL CHEM, V275, P1952, DOI 10.1074/jbc.275.3.1952; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Schubeler D, 2000, GENE DEV, V14, P940; Schubeler D, 2001, P NATL ACAD SCI USA, V98, P11432, DOI 10.1073/pnas.201394698; Simon I, 2001, EMBO J, V20, P6150, DOI 10.1093/emboj/20.21.6150; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Su YH, 2000, J BIOL CHEM, V275, P7902, DOI 10.1074/jbc.275.11.7902; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; WAALWIJK C, 1978, NUCLEIC ACIDS RES, V5, P3231, DOI 10.1093/nar/5.9.3231; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200	37	144	148	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					865	876		10.1016/j.immuni.2004.10.015	http://dx.doi.org/10.1016/j.immuni.2004.10.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589174	Bronze			2022-12-18	WOS:000225901600013
J	Malherbe, L; Hausl, C; Teyton, L; McHeyzer-Williams, MG				Malherbe, L; Hausl, C; Teyton, L; McHeyzer-Williams, MG			Clonal selection of helper T cells is determined by an affinity threshold with no further skewing of TCR binding properties	IMMUNITY			English	Article							RESPONSES IN-VIVO; POSITIVE SELECTION; RECEPTOR REPERTOIRE; ANTIGEN RECEPTOR; IMMUNE-RESPONSE; TRANSGENIC MICE; CHAIN; DIFFERENTIATION; RESPONSIVENESS; SPECIFICITY	Helper T cell responses that focus the TCR repertoire of responding clones provide experimental access to the mechanisms of clonal selection in vivo. Using TCRP chain animals, we directly evaluate the extent of TCRalpha CDR3 diversity and the pMHCII binding attributes of individual antigen-specific Th cells. Here, we demonstrate that dominant clonotypes, as defined by TCR junctional sequence similarities, are surprisingly diverse at the level of pMHCII binding properties, before and after antigen exposure. During an immune response, we can detect and quantify the selective loss of antigen-specific clonotypes that express lower-affinity TCR. This affinity threshold selection is followed by the unbiased propagation of preferred clonotypes regardless of TCR-pMHCII half-lives or affinity. Thus, an affinity threshold mechanism discriminates Th clones with TCR of best fit and propagates clonal diversity without promoting autoreactivity.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	McHeyzer-Williams, MG (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu		Baumgartner, Christina/0000-0002-6872-6209	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040215, R01AI047231] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40215, AI47231] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Baldwin KK, 1999, J EXP MED, V189, P13, DOI 10.1084/jem.189.1.13; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; Bikah G, 2000, NAT IMMUNOL, V1, P402, DOI 10.1038/80841; Bitmansour AD, 2001, J IMMUNOL, V167, P1151, DOI 10.4049/jimmunol.167.3.1151; Bousso P, 1999, J EXP MED, V189, P1591, DOI 10.1084/jem.189.10.1591; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Chen ZW, 2001, J IMMUNOL, V166, P4525, DOI 10.4049/jimmunol.166.7.4525; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; HEDRICK SM, 1988, SCIENCE, V239, P1541, DOI 10.1126/science.2832942; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Liu CP, 1997, J EXP MED, V186, P1441, DOI 10.1084/jem.186.9.1441; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Malherbe L, 2000, IMMUNITY, V13, P771, DOI 10.1016/S1074-7613(00)00075-3; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; McHeyzer-Williams L, 2002, ADV EXP MED BIOL, V512, P11; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; McHeyzer-Williams MG, 2000, IMMUNOL RES, V22, P223, DOI 10.1385/IR:22:2-3:223; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; Panus JF, 2000, J EXP MED, V192, P1301, DOI 10.1084/jem.192.9.1301; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Savage PA, 2001, IMMUNITY, V14, P243, DOI 10.1016/S1074-7613(01)00106-6; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Stratmann T, 2000, J IMMUNOL, V165, P3214, DOI 10.4049/jimmunol.165.6.3214; WINOTO A, 1986, NATURE, V324, P679, DOI 10.1038/324679a0	43	144	146	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2004	21	5					669	679		10.1016/j.immuni.2004.09.008	http://dx.doi.org/10.1016/j.immuni.2004.09.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539153	Bronze			2022-12-18	WOS:000225365000008
J	Salmi, M; Yegutkin, GG; Lehvonen, R; Koskinen, K; Salminen, T; Jalkanen, S				Salmi, M; Yegutkin, GG; Lehvonen, R; Koskinen, K; Salminen, T; Jalkanen, S			A cell surface amine oxidase directly controls lymphocyte migration	IMMUNITY			English	Article							VASCULAR ADHESION PROTEIN-1; HUMAN ENDOTHELIAL-CELLS; SMOOTH-MUSCLE CELLS; HYDROGEN-PEROXIDE; LYSYL OXIDASE; IN-VIVO; VAP-1; SELECTIN; INFLAMMATION; CHEMOKINES	Lymphocytes leave the blood using a sequential adhesion cascade. Vascular adhesion molecule-1 (VAP-1) is a surface-expressed endothelial glycoprotein, which belongs to a distinct subgroup of monoamine oxidases. We show here that catalytic activity of VAP-1 on primary endothelial cells directly regulates lymphocyte rolling under defined laminar shear. VAP-1 seems to bind to a primary amino group presented on the lymphocyte surface and oxidatively deaminate it in a reaction, which results in the formation of a transient covalent bond between the two cell types. Instead, soluble reaction products (aldehydes and hydrogen peroxide) are not needed for the VAP-1-dependent rolling. Enzymatic regulation of lymphocyte adhesion to endothelium provides a previously unrecognized rapid way of controlling the extravasation process.	Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; Natl Publ Hlth Inst, Dept Turku, FIN-20520 Turku, Finland; Abo Akad Univ, Dept Biochem & Pharm, FIN-20520 Turku, Finland	University of Turku; Finland National Institute for Health & Welfare; Abo Akademi University	Salmi, M (corresponding author), Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland.		Salminen, Tiina A./AAM-5443-2021; Yegutkin, Gennady G./K-3815-2014; Salminen, Tiina A/G-7492-2019	Salminen, Tiina A./0000-0002-4135-8020; Yegutkin, Gennady G./0000-0001-6684-7982; Salminen, Tiina A/0000-0002-4135-8020				BERGERET B, 1957, NATURE, V180, P1127, DOI 10.1038/1801127b0; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; BRADLEY JR, 1993, AM J PATHOL, V142, P1598; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; HARTMANN C, 1993, BIOCHEMISTRY-US, V32, P2234, DOI 10.1021/bi00060a015; Jaakkola K, 1999, AM J PATHOL, V155, P1953, DOI 10.1016/S0002-9440(10)65514-9; Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Johnston B, 1996, AM J PHYSIOL-HEART C, V271, pH614, DOI 10.1152/ajpheart.1996.271.2.H614; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KLINMAN JP, 1994, ANNU REV BIOCHEM, V63, P299, DOI 10.1146/annurev.bi.63.070194.001503; KRAULIS PJ, 1991, SCIENCE, V254, P581, DOI 10.1126/science.1658931; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Kurkijarvi R, 1998, J IMMUNOL, V161, P1549; LAWRENCE MB, 1994, IMMUNITY, V1, P137, DOI 10.1016/1074-7613(94)90107-4; Li WD, 2000, J CELL BIOCHEM, V78, P550, DOI 10.1002/1097-4644(20000915)78:4<550::AID-JCB4>3.3.CO;2-#; Lyles GA, 1996, INT J BIOCHEM CELL B, V28, P259, DOI 10.1016/1357-2725(95)00130-1; McIntire W. S., 1993, COPPER CONTAINING AM, P97; Melchers F, 1999, CELL, V99, P351, DOI 10.1016/S0092-8674(00)81521-4; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PATEL KD, 1991, J CELL BIOL, V112, P749, DOI 10.1083/jcb.112.4.749; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Saccani A, 2000, P NATL ACAD SCI USA, V97, P2761, DOI 10.1073/pnas.97.6.2761; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salmi M, 2000, CIRC RES, V86, P1245, DOI 10.1161/01.RES.86.12.1245; Salmi M, 1997, ADV IMMUNOL, V64, P139, DOI 10.1016/S0065-2776(08)60889-5; SALMI M, 1995, EUR J IMMUNOL, V25, P2803, DOI 10.1002/eji.1830251014; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Salmi M, 1996, J EXP MED, V183, P569, DOI 10.1084/jem.183.2.569; Salmi M, 1997, J EXP MED, V186, P589, DOI 10.1084/jem.186.4.589; Salminen TA, 1998, PROTEIN ENG, V11, P1195, DOI 10.1093/protein/11.12.1195; Schmidtke DW, 2000, J CELL BIOL, V149, P719, DOI 10.1083/jcb.149.3.719; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Wilmot CM, 1999, SCIENCE, V286, P1724, DOI 10.1126/science.286.5445.1724; Yu PH, 1998, ATHEROSCLEROSIS, V140, P357, DOI 10.1016/S0021-9150(98)00142-7; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	42	144	155	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2001	14	3					265	276		10.1016/S1074-7613(01)00108-X	http://dx.doi.org/10.1016/S1074-7613(01)00108-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290336	Bronze			2022-12-18	WOS:000167959500006
J	Tomasello, E; Desmoulins, PO; Chemin, K; Guia, S; Cremer, H; Ortaldo, J; Love, P; Kaiserlian, D; Vivier, E				Tomasello, E; Desmoulins, PO; Chemin, K; Guia, S; Cremer, H; Ortaldo, J; Love, P; Kaiserlian, D; Vivier, E			Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; ACTIVATING RECEPTORS; SIGNAL-TRANSDUCTION; CUTTING EDGE; IN-VIVO; COMPLEX; CYTOTOXICITY; LY-49D; DAP12; ZETA	KARAP/DAP12 is a transmembrane polypeptide with an intracytoplasmic immunoreceptor tyrosine-based activation motif (ITAM). KARAP/DAP12 is associated with several activating cell surface receptors in hematopoietic cells. Here, we report that knockin mice bearing a nonfunctional KARAP/DAP12 ITAM present altered innate immune responses. Although in these mice NK cells are present and their repertoire of inhibitory MHC class I receptors is intact, the NK cell spectrum of natural cytotoxicity toward tumor cell targets is restricted. KARAP/DAP12 loss-of-function mutant mice also exhibit a dramatic accumulation of dendritic cells in muco-cutaneous epithelia, associated with an impaired hapten-specific contact sensitivity. Thus, despite its homology with CD3 zeta and FcR gamma, KARAP/DAP12 plays a specific role in innate immunity, emphasizing the nonredundancy of these ITAM-bearing polypeptides in hematopoietic cells.	INSERM, U404, Lyon 07, France; CNRS Marseille Luminy, INSERM, Ctr Immunol, F-13288 Marseille 09, France; Lab Genet & Physiol Dev, Marseille 09, France; NCI, Expt Immunol Lab, DBS, FCRDC, Frederick, MD 21702 USA; NICHD, Sect Cellular & Dev Biol, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA; Inst Univ France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Institut Universitaire de France	Kaiserlian, D (corresponding author), INSERM, U404, Lyon 07, France.		KAISERLIAN, Dominique/G-3325-2013; Vivier, Eric/F-8939-2010	KAISERLIAN, Dominique/0000-0001-6252-4916; Vivier, Eric/0000-0001-7022-8287; Tomasello, Elena/0000-0002-6839-5219; Cremer, Harold/0000-0002-8673-5176				Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Brumbaugh KM, 1997, J EXP MED, V186, P1965, DOI 10.1084/jem.186.12.1965; Campbell KS, 1998, EUR J IMMUNOL, V28, P599, DOI 10.1002/(SICI)1521-4141(199802)28:02<599::AID-IMMU599>3.3.CO;2-6; Chang CW, 1999, J IMMUNOL, V163, P4651; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Colucci F, 1999, J IMMUNOL, V163, P1769; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Desvignes C, 1998, CLIN EXP IMMUNOL, V113, P386; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Held W, 1997, J EXP MED, V185, P2079, DOI 10.1084/jem.185.12.2079; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; Love PE, 2000, IMMUNITY, V12, P591, DOI 10.1016/S1074-7613(00)80210-1; Makrigiannis AP, 1999, J IMMUNOL, V163, P4931; Mason LH, 1998, J IMMUNOL, V160, P4148; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; MULLER G, 1995, J IMMUNOL, V155, P4661; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Olcese L, 1997, J IMMUNOL, V158, P5083; Ortaldo JR, 1999, J IMMUNOL, V163, P5269; OSHEA JJ, 1992, J IMMUNOL, V148, P2497; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Shores EW, 1998, J EXP MED, V187, P1093, DOI 10.1084/jem.187.7.1093; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Smith KM, 1998, J IMMUNOL, V161, P7; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tomasello E, 2000, EUR J IMMUNOL, V30, P2147, DOI 10.1002/1521-4141(2000)30:8<2147::AID-IMMU2147>3.0.CO;2-1; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; VIVIER E, 1991, J IMMUNOL, V146, P206; VIVIER E, 1991, EUR J IMMUNOL, V21, P1077, DOI 10.1002/eji.1830210434; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	50	144	156	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2000	13	3					355	364		10.1016/S1074-7613(00)00035-2	http://dx.doi.org/10.1016/S1074-7613(00)00035-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021533	Bronze			2022-12-18	WOS:000089616400008
J	Franzoso, G; Carlson, L; SchartonKersten, T; Shores, EW; Epstein, S; Grinberg, A; Tran, T; Shacter, E; Leonardi, A; Anver, M; Love, P; Sher, A; Siebenlist, U				Franzoso, G; Carlson, L; SchartonKersten, T; Shores, EW; Epstein, S; Grinberg, A; Tran, T; Shacter, E; Leonardi, A; Anver, M; Love, P; Sher, A; Siebenlist, U			Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions	IMMUNITY			English	Article							NF-KAPPA-B; CANDIDATE PROTOONCOGENE BCL-3; PERIPHERAL LYMPHOID ORGANS; LYN-DEFICIENT MICE; TARGETED DISRUPTION; NEONATAL LETHALITY; AUTOIMMUNE-DISEASE; TOXOPLASMA-GONDII; PRECURSOR P105; DNA-BINDING	Chromosomal translocations of bcl-3 are associated with chronic B cell lymphocytic leukemias. Previously, we have shown that Bcl-3, a distinct member of the I kappa B family, may function as a positive regulator of NF-kappa B activity, although its physiologic roles remained unknown. To uncover these roles, we generated Bcl-3-deficient mice. Mutant mice, but not their littermate controls, succumb to T. gondii owing to failure to mount a protective T helper 1 immune response. Bcl-3-deficient mice are also impaired in germinal center reactions and T-dependent antibody responses to influenza virus. The results reveal critical roles for Bcl-3 in antigen-specific priming of T and B cells. Altered microarchitecture of secondary lymphoid organs in mutant mice, including partial loss of B cells, may underlie the immunologic defects. The implied role of Bcl-3 in maintaining B cells in wild-type mice may related to its oncogenic potential.	NIAID,IMMUNOREGULAT LAB,NIH,BETHESDA,MD 20892; NIAID,PARASIT DIS LAB,NIH,BETHESDA,MD 20892; NICHHD,MOL GENET LAB,NIH,BETHESDA,MD 20892; US FDA,CTR BIOL EVALUAT & RES,DIV CELLULAR & GENE THERAPIES,BETHESDA,MD 20892; SCI APPLICAT INT CORP,PATHOL HISTOTECHNOL LAB,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); US Food & Drug Administration (FDA); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			leonardi, antonio/A-2887-2009; Franzoso, Guido/GRR-8628-2022	leonardi, antonio/0000-0001-8636-9623; Franzoso, Guido/0000-0002-0778-988X; Epstein, Suzanne/0000-0002-6311-6890				Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; BIRON CA, 1995, CURR OPIN IMMUNOL, V7, P485, DOI 10.1016/0952-7915(95)80093-X; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Campbell KA, 1996, IMMUNITY, V4, P283, DOI 10.1016/S1074-7613(00)80436-7; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CHANG CC, 1995, MOL CELL BIOL, V15, P5180; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Ferguson SE, 1996, J IMMUNOL, V156, P4576; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; FUJITA T, 1993, GENE DEV, V7, P1654; GAZZINELLI RT, 1993, INFECT AGENT DIS, V2, P139; Gerondakis S, 1996, P NATL ACAD SCI USA, V93, P3405, DOI 10.1073/pnas.93.8.3405; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; Grouard G, 1995, CURR TOP MICROBIOL, V201, P105; HAKIM FT, 1991, J IMMUNOL, V147, P2310; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; INOUE J, 1993, ONCOGENE, V8, P2067; JAMES SL, 1995, MICROBIOL REV, V59, P533, DOI 10.1128/MMBR.59.4.533-547.1995; Kamanaka M, 1996, IMMUNITY, V4, P275, DOI 10.1016/S1074-7613(00)80435-5; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Kelsoe G, 1995, ADV IMMUNOL, V60, P267, DOI 10.1016/S0065-2776(08)60587-8; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Klement JF, 1996, MOL CELL BIOL, V16, P2341; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KoscoVilbois MH, 1995, CURR TOP MICROBIOL, V201, P69; LANE P, 1994, J EXP MED, V179, P819, DOI 10.1084/jem.179.3.819; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; LeHir M, 1996, J EXP MED, V183, P2367, DOI 10.1084/jem.183.5.2367; Liu YJ, 1996, J EXP MED, V184, P1207, DOI 10.1084/jem.184.4.1207; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Michaelson JS, 1996, J IMMUNOL, V156, P2828; NAUMANN M, 1993, EMBO J, V12, P213, DOI 10.1002/j.1460-2075.1993.tb05647.x; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SHORES EW, 1994, SCIENCE, V266, P1047, DOI 10.1126/science.7526464; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Snapper CM, 1996, J IMMUNOL, V156, P183; Soong L, 1996, IMMUNITY, V4, P263, DOI 10.1016/S1074-7613(00)80434-3; TEW JG, 1993, ADV EXP MED BIOL, V329, P461; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANVLIET E, 1986, J HISTOCHEM CYTOCHEM, V34, P883, DOI 10.1177/34.7.3519751; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; VIEIRA LQ, 1994, IMMUNOL LETT, V40, P157, DOI 10.1016/0165-2478(94)90187-2; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	69	144	148	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					479	490		10.1016/S1074-7613(00)80291-5	http://dx.doi.org/10.1016/S1074-7613(00)80291-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133427	Bronze			2022-12-18	WOS:A1997XC61900013
J	vonHerrath, MG; Guerder, S; Lewicki, H; Flavell, RA; Oldstone, MBA				vonHerrath, MG; Guerder, S; Lewicki, H; Flavell, RA; Oldstone, MBA			Coexpression of B7-1 and viral (''self'') transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; DROSOPHILA-MELANOGASTER CELLS; CLASS-I; T-CELLS; INDUCTION; INFECTION; MICE; PROLIFERATION; MELLITUS; DISEASE	We evaluated the role of the costimulatory molecule B7-1 in overcoming peripheral ignorance in transgenic mice, which expressed the glycoprotein (GP) or nucleoprotein (NP) of lymphocytic choriomeningitis virus (LCMV) as the self-antigen in pancreatic beta cells. The viral transgenes or B7-1 alone did not induce autoimmune diabetes (IDDM). However, in bigenic mice expressing B7-1 and LCMV-GP, anti-self (viral) cytotoxic T lymphocytes (CTL) were activated without viral infection and spontaneous IDDM occurred. In contrast, bigenic RIP-B7-1 x RIP-NP mice with thymic expression of the self (viral-NP) antigen deleted the majority of their autoreactive CTL and did not develop spontaneous IDDM. However, these mice developed fast-onset IDDM 14 days after LCMV infection, whereas single-transgenic RIP-NP littermates developed IDDM only within 4-5 months. Rapid IDDM was associated with increased numbers of anti-self CTL and a predominance of IFN gamma produced by islet-infiltrating lymphocytes, whereas single transgenic RIP-NP littermates with slow-onset IDDM displayed less anti-self CTL and more IL-4- and IL-10-producing T lymphocytes in pancreatic infiltrates.	YALE UNIV, SCH MED, HOWARD HUGHES MED INST, IMMUNOBIOL SECT, NEW HAVEN, CT 06520 USA	Howard Hughes Medical Institute; Yale University	vonHerrath, MG (corresponding author), Scripps Res Inst, DEPT NEUROPHARMACOL, DIV VIROL, VIROL IMMUNBIOL LAB, LA JOLLA, CA 92037 USA.		Guerder, sylvie/L-6548-2014		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK043078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004342] Funding Source: NIH RePORTER; NIA NIH HHS [AGO4342] Funding Source: Medline; NIDDK NIH HHS [5-P01-DK43078, DK 49836] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISON JP, 1994, CURR OPIN IMMUNOL, V6, P414, DOI 10.1016/0952-7915(94)90120-1; BOGEN SA, 1993, J IMMUNOL, V150, P4197; BOUSSIOTIS VA, 1994, CURR OPIN IMMUNOL, V6, P797, DOI 10.1016/0952-7915(94)90087-6; CHEN CY, 1994, IMMUNITY, V1, P147, DOI 10.1016/1074-7613(94)90108-2; CHIODETTI L, 1992, J IMMUNOL, V149, P901; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; GAJEWSKI TF, 1995, J IMMUNOL, V154, P5637; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; GUERDER S, 1994, IMMUNITY, V1, P155; GUERDER S, 1994, P NATL ACAD SCI USA, V91, P5138, DOI 10.1073/pnas.91.11.5138; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARDING FA, 1993, J EXP MED, V177, P1791, DOI 10.1084/jem.177.6.1791; HARLAN DM, 1995, CLIN IMMUNOL IMMUNOP, V75, P99, DOI 10.1006/clin.1995.1058; HARLAN DM, 1994, P NATL ACAD SCI USA, V91, P3137, DOI 10.1073/pnas.91.8.3137; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; JOLY E, 1991, IMMUNOGENETICS, V34, P62, DOI 10.1007/BF00212315; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KASAIAN MT, 1990, J IMMUNOL, V144, P299; KASAIAN MT, 1991, J IMMUNOL, V146, P1955; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LEE MS, 1995, J CLIN INVEST, V95, P486, DOI 10.1172/JCI117689; LEE MS, 1994, J CLIN INVEST, V93, P1332, DOI 10.1172/JCI117092; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; LEWICKI H, 1992, J NEUROIMMUNOL, V41, P15, DOI 10.1016/0165-5728(92)90190-V; MANIATIS T, 1990, MOL CLONING; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MILLER JFAP, 1994, CURR OPIN IMMUNOL, V6, P892, DOI 10.1016/0952-7915(94)90010-8; MODLIN RL, 1993, CURR OPIN IMMUNOL, V5, P511, DOI 10.1016/0952-7915(93)90031-M; NICKOLOFF BJ, 1994, IMMUNOL TODAY, V15, P464, DOI 10.1016/0167-5699(94)90190-2; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OHASHI PS, 1993, J IMMUNOL, V150, P5185; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; SAGERSTROM CG, 1993, P NATL ACAD SCI USA, V90, P8987, DOI 10.1073/pnas.90.19.8987; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; SIGURDSSON E, 1990, CURR TOP MICROBIOL, V164, P143; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; VONHERRATH MG, 1994, J EXP MED, V180, P1901, DOI 10.1084/jem.180.5.1901; VONHERRATH MG, 1995, J CLIN INVEST, V95, P477, DOI 10.1172/JCI117688; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; WHITTON JL, 1988, VIROLOGY, V162, P321, DOI 10.1016/0042-6822(88)90471-0; WHITTON JL, 1990, SEMIN VIROL, V1, P257	45	144	145	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1995	3	6					727	738		10.1016/1074-7613(95)90062-4	http://dx.doi.org/10.1016/1074-7613(95)90062-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777718	Bronze			2022-12-18	WOS:A1995TM02300007
J	Ise, W; Fujii, K; Shiroguchi, K; Ito, A; Kometani, K; Takeda, K; Kawakami, E; Yamashita, K; Suzuki, K; Okada, T; Kurosaki, T				Ise, Wataru; Fujii, Kentaro; Shiroguchi, Katsuyuki; Ito, Ayako; Kometani, Kohei; Takeda, Kiyoshi; Kawakami, Eiryo; Yamashita, Kazuo; Suzuki, Kazuhiro; Okada, Takaharu; Kurosaki, Tomohiro			T Follicular Helper Cell-Germinal Center B Cell Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate	IMMUNITY			English	Article							MEMORY B; TRANSCRIPTION FACTORS; AFFINITY MATURATION; GENE-REGULATION; DIFFERENTIATION; SELECTION; BCL6; IRF4; PROLIFERATION; EXPRESSION	Higher- or lower-affinity germinal center (GC) B cells are directed either to plasma cell or GC recycling, respectively; however, how commitment to the plasma cell fate takes place is unclear. We found that a population of light zone (LZ) GC cells, Bcl6(lo)CD69(hi) expressing a transcription factor IRF4 and higher-affinity B cell receptors (BCRs) or Bcl6(hi)CD69(hi) with lower-affinity BCRs, favored the plasma cell or recycling GC cell fate, respectively. Mechanistically, CD40 acted as a dose-dependent regulator for Bcl6(lo)CD69(hi) cell formation. Furthermore, we found that expression of intercellular adhesion molecule 1 (ICAM-1) and signaling lymphocytic activation molecule (SLAM) in Bcl6(lo)CD69(hi) cells was higher than in Bcl6(hi)CD69(hi) cells, thereby affording more stable T follicular helper (Tfh)-GC B cell contacts. These data support a model whereby commitment to the plasma cell begins in the GC and suggest that stability of Tfh-GC B cell contacts is key for plasma cell-prone GC cell formation.	[Ise, Wataru; Fujii, Kentaro; Ito, Ayako; Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka 5650871, Japan; [Takeda, Kiyoshi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Microbiol & Immunol, Osaka 5650871, Japan; [Suzuki, Kazuhiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immune Response Dynam, Osaka 5650871, Japan; [Shiroguchi, Katsuyuki] RIKEN Ctr Biosyst Dynam Res BDR, Lab Predict Cell Syst Dynam, Osaka 5650874, Japan; [Yamashita, Kazuo] KOTAI Biotechnol Inc, Osaka 5650871, Japan; [Shiroguchi, Katsuyuki] RIKEN Ctr Integrat Med Sci IMS, Lab Immunogenet, Yokohama, Kanagawa 2300045, Japan; [Kometani, Kohei; Kurosaki, Tomohiro] RIKEN Ctr Integrat Med Sci IMS, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan; [Kawakami, Eiryo] RIKEN Ctr Integrat Med Sci IMS, Med Sci Innovat Hub Program, Yokohama, Kanagawa 2300045, Japan; [Okada, Takaharu] RIKEN Ctr Integrat Med Sci IMS, Lab Tissue Dynam, Yokohama, Kanagawa 2300045, Japan; [Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Osaka 5650871, Japan; [Shiroguchi, Katsuyuki; Okada, Takaharu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama 3320012, Japan; [Okada, Takaharu] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 2300045, Japan	Osaka University; Osaka University; Osaka University; RIKEN; RIKEN; RIKEN; RIKEN; RIKEN; Osaka University; Japan Science & Technology Agency (JST); Yokohama City University	Kurosaki, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka 5650871, Japan.; Kurosaki, T (corresponding author), RIKEN Ctr Integrat Med Sci IMS, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan.	kurosaki@ifrec.osaka-u.ac.jp		Kometani, Kohei/0000-0003-4281-4371; Suzuki, Kazuhiro/0000-0002-9081-538X; Takeda, Kiyoshi/0000-0002-1778-6332	Ministry of Education, Culture, Sports, Science and Technology in Japan [17K08883, 26221306, 21229007]; Japan Science Technology Agency [CREST J098501018, JST/PRESTO JPMJPR15F3]; SENSHIN Medical Research Foundation	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Technology Agency(Japan Science & Technology Agency (JST)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	We thank M.C. Nussenzweig (The Rockefeller University) for B1-8 hi mice, G.D. Victora (The Rockefeller University) and A. Kallies (University of Melbourne) for gene sets for the gene set enrichment analysis, K. Fukuhara (RIKEN) for help in performing digital RNA-seq, and T. Egawa (Washington University in St. Louis) for critical reading of the manuscript. This work was supported by the Ministry of Education, Culture, Sports, Science and Technology in Japan (17K08883 to W.I.; 26221306 and 21229007 to T. K.), the Japan Science Technology Agency (CREST J098501018 to T.K.; JST/PRESTO JPMJPR15F3 to K.S.), and the SENSHIN Medical Research Foundation (W.I.).	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Barnett BE, 2012, SCIENCE, V335, P342, DOI 10.1126/science.1213495; Barwick BG, 2016, NAT IMMUNOL, V17, P1216, DOI 10.1038/ni.3519; Burbach BJ, 2007, IMMUNOL REV, V218, P65, DOI 10.1111/j.1600-065X.2007.00527.x; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; De Silva NS, 2016, P NATL ACAD SCI USA, V113, P9063, DOI 10.1073/pnas.1602728113; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Erickson LD, 2002, J CLIN INVEST, V109, P613, DOI 10.1172/JCI200214110; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gloury R, 2016, J EXP MED, V213, P1095, DOI 10.1084/jem.20152003; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Huang CX, 2015, SCI CHINA LIFE SCI, V58, P1226, DOI 10.1007/s11427-015-4919-z; Huang CX, 2014, CELL REP, V8, P1497, DOI 10.1016/j.celrep.2014.07.059; Inoue T, 2017, J EXP MED, V214, P1181, DOI 10.1084/jem.20161263; Ise W, 2014, P NATL ACAD SCI USA, V111, P11792, DOI 10.1073/pnas.1404671111; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kishi Y, 2010, J IMMUNOL, V185, P211, DOI 10.4049/jimmunol.0901694; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Liao WH, 2017, J IMMUNOL, V198, P3846, DOI 10.4049/jimmunol.1601852; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Nahar R, 2011, BLOOD, V118, P4174, DOI 10.1182/blood-2011-01-331181; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shinnakasu R, 2017, CURR OPIN IMMUNOL, V45, P126, DOI 10.1016/j.coi.2017.03.003; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Suan D, 2017, CURR OPIN IMMUNOL, V45, P97, DOI 10.1016/j.coi.2017.03.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda K, 1998, J IMMUNOL, V161, P4652; Tenno M, 2017, J EXP MED, V214, P2933, DOI 10.1084/jem.20170729; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032	50	143	147	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					702	+		10.1016/j.immuni.2018.03.027	http://dx.doi.org/10.1016/j.immuni.2018.03.027			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669250	Bronze			2022-12-18	WOS:000430198900017
J	Teichmann, LL; Ols, ML; Kashgarian, M; Reizis, B; Kaplan, DH; Shlomchik, MJ				Teichmann, Lino L.; Ols, Michelle L.; Kashgarian, Michael; Reizis, Boris; Kaplan, Daniel H.; Shlomchik, Mark J.			Dendritic Cells in Lupus Are Not Required for Activation of T and B Cells but Promote Their Expansion, Resulting in Tissue Damage	IMMUNITY			English	Article							AUTOANTIBODY PRODUCTION; INTERFERON-GAMMA; IFN-GAMMA; ERYTHEMATOSUS; RESPONSES; DISEASE; HOMEOSTASIS; REVEALS; MICE; PREVENTION	Dendritic cells (DCs) initiate and control the adaptive immune response against infections. However, their contributions to the anti-self adaptive immune response in autoimmune disorders like systemic lupus erythematosus are uncertain. By constitutively deleting DCs in MRL.Fas(Ipr) mice, we show that they have complex roles in murine lupus. The net effect of DC deletion was to ameliorate disease. DCs were crucial for the expansion and differentiation of T cells but, surprisingly, not required for their initial activation. Correspondingly, kidney interstitial infiltrates developed in the absence of DCs, but failed to progress. DC deletion concomitantly decreased inflammatory and regulatory T cell numbers. Unexpectedly, plasmablast numbers and autoantibody concentrations depended on DCs, in contrast to total serum immunoglobulin concentrations, suggesting an effect of DCs on extrafollicular humoral responses. These findings reveal that DCs operate in unanticipated ways in murine lupus and validate them as a potential therapeutic target in autoimmunity.	[Teichmann, Lino L.; Ols, Michelle L.; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06519 USA; [Kashgarian, Michael] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06519 USA; [Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Kaplan, Daniel H.] Univ Minnesota, Ctr Immunol, Dept Dermatol, Minneapolis, MN 55455 USA	Yale University; Yale University; Yale University; Columbia University; University of Minnesota System; University of Minnesota Twin Cities	Shlomchik, MJ (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06519 USA.	mark.shlomchik@yale.edu	Shlomchik, Mark J./AAN-6189-2020; Kaplan, Daniel H/N-2779-2013; Teichmann, Lino/GQA-4636-2022	Shlomchik, Mark J./0000-0002-2152-0959; Kaplan, Daniel H/0000-0002-7851-7320; Teichmann, Lino/0000-0001-9489-7282; Reizis, Boris/0000-0003-1140-7853	National Institutes of Health [R01-AR044077]; Deutsche Forschungsgemeinschaft; Lupus Research Institute; Yale Skin Diseases Research Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056632, R01AR044077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lupus Research Institute; Yale Skin Diseases Research Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Martinez-Barbera for the generous gift of the Rosa26-eGFP-DTA mice. We thank Yale Animal Resources Center for outstanding animal husbandry. Supported by National Institutes of Health grant R01-AR044077 (M.J.S.), Deutsche Forschungsgemeinschaft (fellowship to L.L.T.), and the Lupus Research Institute and the Yale Skin Diseases Research Center (D.H.K.).	Ahuja A, 2007, J IMMUNOL, V179, P3351, DOI 10.4049/jimmunol.179.5.3351; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bar-On L, 2010, IMMUNOL REV, V234, P76, DOI 10.1111/j.0105-2896.2009.00875.x; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chan OTM, 1999, J IMMUNOL, V163, P3592; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Cheung YH, 2009, SEMIN IMMUNOL, V21, P372, DOI 10.1016/j.smim.2009.10.005; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; Dorner T, 2009, NAT REV RHEUMATOL, V5, P433, DOI 10.1038/nrrheum.2009.141; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hebel K, 2006, EUR J IMMUNOL, V36, P2912, DOI 10.1002/eji.200636356; Horwitz DA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2511; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Igyarto BZ, 2009, J IMMUNOL, V183, P5085, DOI 10.4049/jimmunol.0901884; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; JABS DA, 1992, CELL IMMUNOL, V141, P496, DOI 10.1016/0008-8749(92)90166-M; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; Jonsdottir T, 2008, ANN RHEUM DIS, V67, P330, DOI 10.1136/ard.2007.079095; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Looney RJ, 2010, DRUGS, V70, P529, DOI 10.2165/11535420-000000000-00000; LOSMAN MJ, 1993, INT IMMUNOL, V5, P513, DOI 10.1093/intimm/5.5.513; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mehal WZ, 1998, J IMMUNOL, V161, P1686; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; PRUDHOMME GJ, 1995, MOL IMMUNOL, V32, P495, DOI 10.1016/0161-5890(95)00024-9; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; Schwarting A, 1998, J IMMUNOL, V161, P494; Seo SJ, 2002, IMMUNITY, V16, P535, DOI 10.1016/S1074-7613(02)00298-4; SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Treml JF, 2009, CELL BIOCHEM BIOPHYS, V53, P1, DOI 10.1007/s12013-008-9036-1; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Walsh M, 2007, KIDNEY INT, V72, P676, DOI 10.1038/sj.ki.5002395; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Zhu JK, 2005, J CLIN INVEST, V115, P1869, DOI 10.1172/JCI23049	56	143	149	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 22	2010	33	6					967	978		10.1016/j.immuni.2010.11.025	http://dx.doi.org/10.1016/j.immuni.2010.11.025			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21167752	Green Accepted, Bronze			2022-12-18	WOS:000286293900016
J	Sawa, Y; Arima, Y; Ogura, H; Kitabayashi, C; Jiang, JJ; Fukushima, T; Kamimura, D; Hirano, T; Murakami, M				Sawa, Yukihisa; Arima, Yasunobu; Ogura, Hideki; Kitabayashi, Chika; Jiang, Jing-Jing; Fukushima, Toru; Kamimura, Daisuke; Hirano, Toshio; Murakami, Masaaki			Hepatic Interleukin-7 Expression Regulates T Cell Responses	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; TRANSGENIC MICE; IN-VIVO; AUTOIMMUNE ARTHRITIS; IL-7; INTERFERONS; PROLIFERATION; HOMEOSTASIS; INDUCTION; ALPHA	Systemic cytokine activity in response to Toll-like receptor (TLR) signaling induces the expression of various proteins in the liver after infections. Here we show that Interleukin-7 (IL-7), the production of which was thought to occur at a constant rate in vivo, was a hepatically expressed protein that directly controled T cell responses. Depletion of IL-7 expression in the liver abrogated several TLR-mediated T cell events, including enhanced CD4(+) T cell and CD8(+) T cell survival, augmented CD8(+) T cell cytotoxic activity, and the development of experimental autoimmune encephalitis, a Th17 cell-mediated autoimmune disease. Thus, T cell responses are regulated by hepatocyte-derived IL-7, which is expressed in response to TLR signaling in vivo. We suggested that TLR-induced IL-7 expression in the liver, which is an acute-phase response, may be a good diagnostic and therapeutic target for efficient vaccine developments and for conditions characterized by TLR-mediated T cell dysregulation, including autoimmune diseases.	[Sawa, Yukihisa; Arima, Yasunobu; Ogura, Hideki; Kitabayashi, Chika; Jiang, Jing-Jing; Fukushima, Toru; Kamimura, Daisuke; Hirano, Toshio; Murakami, Masaaki] Osaka Univ, Lab Dev Immunol, Osaka 5650871, Japan; [Sawa, Yukihisa; Arima, Yasunobu; Ogura, Hideki; Kitabayashi, Chika; Jiang, Jing-Jing; Fukushima, Toru; Kamimura, Daisuke; Hirano, Toshio; Murakami, Masaaki] Osaka Univ, CREST Program, Japan Sci & Technol Agcy, Grad Sch Frontier Biosci,Grad Sch Med, Osaka 5650871, Japan; [Sawa, Yukihisa; Arima, Yasunobu; Ogura, Hideki; Kitabayashi, Chika; Jiang, Jing-Jing; Fukushima, Toru; Kamimura, Daisuke; Hirano, Toshio] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Hirano, Toshio] RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Yokohama, Kanagawa 2300045, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University; RIKEN	Murakami, M (corresponding author), Osaka Univ, Lab Dev Immunol, Osaka 5650871, Japan.	murakami@molonc.med.osaka-u.ac.jp	Hirano, Toshio/C-8194-2009	Kamimura, Daisuke/0000-0003-1022-4430; Ogura, Hideki/0000-0002-2116-0340; Sawa, Yukihisa/0000-0003-1090-492X; , Masaaki/0000-0001-7159-7279	KAKENHI; Japan Science and Technology Agency; Yoshitomi Foundation; Uehara Foundation; Osaka Foundation for the Promotion of Clinical Immunology	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Yoshitomi Foundation; Uehara Foundation(Uehara Memorial Foundation); Osaka Foundation for the Promotion of Clinical Immunology	We thank K. Ikuta (Kyoto University) for providing the IL-7-expressing L929 cells. We also thank C. Surh (Scripps Research Institute) for the sera from IL-7-deficient mice. We thank M. Bevan (University of Washington) for providing L. monocytogenes expressing OVA, PE-conjugated D b GP33 tetramer, and H-2K b OVA tetramer, and T. Ohteki (Akita University) for the LCMV Armstrong virus strain. We appreciate the excellent technical assistance provided by R. Sato, and thank R. Masuda for her excellent secretarial assistance. This work was supported by KAKENHI (C.K., H.O., D.K., T.F., T.H., and M.M.), the CREST Program of the Japan Science and Technology Agency (T.H. and M.M.), the Yoshitomi Foundation (M.M.), the Uehara Foundation (M.M. and T.H.), and the Osaka Foundation for the Promotion of Clinical Immunology (M.M. and T.H.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; ARIIZUMI K, 1995, J IMMUNOL, V154, P6031; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Fey Georg H., 1994, P113; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kamimura D, 2006, J IMMUNOL, V177, P306, DOI 10.4049/jimmunol.177.1.306; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; Sawa S, 2006, J EXP MED, V203, P1459, DOI 10.1084/jem.20052187; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Sun SQ, 1998, J EXP MED, V188, P2335, DOI 10.1084/jem.188.12.2335; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tang JH, 1997, J IMMUNOL, V159, P117; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Treschow AP, 2005, ARTHRITIS RHEUM-US, V52, P3739, DOI 10.1002/art.21496; Uehira M, 1998, J INVEST DERMATOL, V110, P740, DOI 10.1046/j.1523-1747.1998.00179.x; Watanabe M, 1998, J EXP MED, V187, P389, DOI 10.1084/jem.187.3.389; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	36	143	145	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					447	457		10.1016/j.immuni.2009.01.007	http://dx.doi.org/10.1016/j.immuni.2009.01.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19285437	Bronze			2022-12-18	WOS:000264405500016
J	Williams, MA; Ravkov, EV; Bevan, MJ				Williams, Matthew A.; Ravkov, Eugene V.; Bevan, Michael J.			Rapid culling of the CD4(+) T cell repertoire in the transition from effector to memory	IMMUNITY			English	Article							CXC CHEMOKINE RECEPTOR-5; LISTERIA-MONOCYTOGENES; SECONDARY EXPANSION; IMMUNE-RESPONSES; B-LYMPHOCYTES; CUTTING EDGE; CD8(+); DIFFERENTIATION; ACTIVATION; EXPRESSION	Requirements for CD4(+) T cell memory differentiation were analyzed with adoptively transferred SMARTA T cell receptor (TCR) transgenic cells specific for a lymphocytic choriomeningitis virus (LCMV) epitope. LCMV-induced effector and memory differentiation of SMARTA cells mimicked the endogenous CD4(+) T cell response. In contrast, infection with a recombinant Listeria expressing the LCMV epitope, although resulting initially in massive SMARTA expansion, led to loss of effector function and rapid cell death characterized by high expression of the apoptosis regulator Bim. Defective memory differentiation was seen after stimulation of naive but not memory SMARTA cells, was independent of precursor frequency, and correlated with a lower TCR avidity compared to endogenous responders. In addition, long-lived endogenous CD4(+) memory T cells skewed to a higher functional avidity over time. These results support a model in which CD4+ T cell memory differentiation and longevity depend on the strength of the TCR signal during the primary response.	[Williams, Matthew A.; Ravkov, Eugene V.] Univ Utah, Dept Pathol, Salt Lake City, UT 84121 USA; [Bevan, Michael J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Bevan, Michael J.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Williams, MA (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84121 USA.	matthew.williams@path.utah.edu; mbevan@u.washington.edu		Williams, Matthew/0000-0002-4721-4482	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [K22 AI071112-01, R01 AI019335, R01 AI019335-28, K22 AI071112] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI071112, R01AI019335] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Blair DA, 2007, P NATL ACAD SCI USA, V104, P15045, DOI 10.1073/pnas.0703767104; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chen J, 2006, J IMMUNOL, V176, P2711, DOI 10.4049/jimmunol.176.5.2711; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Christian SL, 2003, J BIOL CHEM, V278, P41756, DOI 10.1074/jbc.M303180200; Foulds KE, 2006, J IMMUNOL, V176, P3037, DOI 10.4049/jimmunol.176.5.3037; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jia SJ, 2007, DEV DYNAM, V236, P913, DOI 10.1002/dvdy.21092; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kester HA, 1999, J BIOL CHEM, V274, P27439, DOI 10.1074/jbc.274.39.27439; Klonowski KD, 2006, J IMMUNOL, V177, P4247, DOI 10.4049/jimmunol.177.7.4247; Kroger CJ, 2007, J IMMUNOL, V179, P748, DOI 10.4049/jimmunol.179.2.748; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Liang H, 2005, ONCOGENE, V24, P2625, DOI 10.1038/sj.onc.1208167; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Mamura M, 2000, BIOCHEM BIOPH RES CO, V268, P124, DOI 10.1006/bbrc.2000.2086; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Metcalfe SM, 2005, FEBS LETT, V579, P609, DOI 10.1016/j.febslet.2004.12.027; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Onami TM, 2002, J IMMUNOL, V168, P6022, DOI 10.4049/jimmunol.168.12.6022; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; PRIC M, 2007, CURR OPIN IMMUNOL, V19, P315; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Qiang YW, 2004, FRONT BIOSCI-LANDMRK, V9, P1000, DOI 10.2741/1309; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Scott KL, 2005, GENE, V359, P119, DOI 10.1016/j.gene.2005.06.014; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2006, J IMMUNOL, V177, P4458, DOI 10.4049/jimmunol.177.7.4458; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Vietor I, 2007, DIFFERENTIATION, V75, P891, DOI 10.1111/j.1432-0436.2007.00205.x; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Way SS, 2007, J IMMUNOL, V178, P4498, DOI 10.4049/jimmunol.178.7.4498; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Whitmire JK, 2006, J IMMUNOL, V176, P3028, DOI 10.4049/jimmunol.176.5.3028; Williams MA, 2004, J IMMUNOL, V173, P6694, DOI 10.4049/jimmunol.173.11.6694; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Wojciechowski S, 2006, EUR J IMMUNOL, V36, P1694, DOI 10.1002/eji.200635897; Yamagishi N, 2006, EXP CELL RES, V312, P3215, DOI 10.1016/j.yexcr.2006.06.007; Zhang J, 2004, J BIOL CHEM, V279, P17819, DOI 10.1074/jbc.M310737200	70	143	147	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2008	28	4					533	545		10.1016/j.immuni.2008.02.014	http://dx.doi.org/10.1016/j.immuni.2008.02.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18356084	Bronze, Green Accepted			2022-12-18	WOS:000254939400014
J	Zucchelli, S; Holler, P; Yamagata, T; Roy, M; Benoist, C; Mathis, D				Zucchelli, S; Holler, P; Yamagata, T; Roy, M; Benoist, C; Mathis, D			Defective central tolerance induction in NOD mice: Genomics and genetics	IMMUNITY			English	Article							STEROID-RECEPTOR NUR77; REGULATORY T-CELLS; NEGATIVE SELECTION; ADAPTER PROTEIN; PEPTIDE LIGANDS; APOPTOSIS; THYMOCYTES; IDENTIFICATION; TRANSCRIPTION; EXPRESSION	The genetic determinism of type-1 diabetes in NOD mice likely involves complementary defects in central T cell tolerance induction and peripheral immunoregulation. To study the contribution of the NOD genetic background to central tolerance, we followed the behavior of BDC2.5 clonotype thymocytes in fetal thymic organ cultures (FTOC). The NOD genetic background encodes a quantitative deficiency in the ability to delete these self-reactive thymocytes and to divert them to the CD8 alpha alpha lineage. In genetic analyses, comparing NOD and B6.H2(g7) FTOCs, the NOD defect incorporated the influence of several loci (notably ones on chr1 and 3). Microarray analyses assessing FTOCs from the same two strains argued that the NOD abnormality reflects the combined effects of turning down the gene expression program that provokes apoptosis and turning on a new program promoting cell survival. Intersection of the data from the two approaches points to a small set of attractive candidate genes.	Harvard Univ, Sch Med,Sect Immunol & Immunogenet, Brigham & Womens Hosp, Dept Med,Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.	Benoist, C (corresponding author), Harvard Univ, Sch Med,Sect Immunol & Immunogenet, Brigham & Womens Hosp, Dept Med,Joslin Diabet Ctr, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu		Zucchelli, Silvia/0000-0003-4556-2990				Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; BERGMAN B, 1994, DIABETES, V43, P197, DOI 10.2337/diabetes.43.2.197; Blank C, 2003, J IMMUNOL, V171, P4574, DOI 10.4049/jimmunol.171.9.4574; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; CALNAN BJ, 1995, IMMUNITY, V3, P273; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; Dao T, 2001, J IMMUNOL, V166, P3090, DOI 10.4049/jimmunol.166.5.3090; DeRyckere D, 2003, J IMMUNOL, V171, P802, DOI 10.4049/jimmunol.171.2.802; Drappa J, 2003, J EXP MED, V198, P809, DOI 10.1084/jem.20021358; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Gonzalez A, 1997, IMMUNITY, V7, P873, DOI 10.1016/S1074-7613(00)80405-7; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; Kanagawa O, 2002, J IMMUNOL, V168, P6159, DOI 10.4049/jimmunol.168.12.6159; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Lesage S, 2002, J EXP MED, V196, P1175, DOI 10.1084/jem.20020735; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; Lyons PA, 2001, DIABETES, V50, P2633, DOI 10.2337/diabetes.50.11.2633; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; Nepom GT, 1998, DIABETES, V47, P1177, DOI 10.2337/diabetes.47.8.1177; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Pugliese A, 2002, DIABETES-METAB RES, V18, P13, DOI 10.1002/dmrr.261; Rajagopal K, 1999, J EXP MED, V190, P1657, DOI 10.1084/jem.190.11.1657; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; REED MI, 2004, CELL, V116, P527; Schmitz I, 2003, INT IMMUNOL, V15, P1237, DOI 10.1093/intimm/dxg125; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; Villunger A, 2003, NAT IMMUNOL, V4, P717, DOI 10.1038/ni0803-717; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Yamashiro H, 2002, INT IMMUNOL, V14, P857, DOI 10.1093/intimm/dxf061; Zhang HFM, 2003, J BIOL CHEM, V278, P33011, DOI 10.1074/jbc.M305352200; ZHANG ZL, 1994, AUTOIMMUNITY, V17, P41, DOI 10.3109/08916939409014657; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	48	143	147	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					385	396		10.1016/j.immuni.2005.01.015	http://dx.doi.org/10.1016/j.immuni.2005.01.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780994	Bronze			2022-12-18	WOS:000228105700012
J	MacLennan, ICM; Vinuesa, CG				MacLennan, ICM; Vinuesa, CG			Dendritic cells, BAFF, and APRIL: Innate players in adaptive antibody responses	IMMUNITY			English	Article							B-CELL; MARGINAL ZONE; IN-VIVO; KAPPA-B; DIFFERENTIATION; ANTIGEN; MOUSE; LYMPHOCYTE; MATURATION; RECEPTOR	The first antibody produced in bacterial or viral infection results from B cell growth as plasmablasts. Dendritic cell-derived TNF-family ligands APRIL and/or BAFF plasmablast survival and differentiation to plasma cells. Expression of these ligands by dendritic cells is promoted by innate immune signals that can convert subliminal B cell activation to a productive response. While this may be lifesaving in the face of infection, it can predispose to autoantibody production.	Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia	University of Birmingham; Australian National University; John Curtin School of Medical Research	MacLennan, ICM (corresponding author), Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England.	i.c.m.maclennan@bham.ac.uk	Vinuesa, Carola G/B-1108-2010	Vinuesa, Carola G/0000-0001-9799-0298				Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; Do RKG, 2002, CYTOKINE GROWTH F R, V13, P19, DOI 10.1016/S1359-6101(01)00025-9; Fayette J, 1998, SCAND J IMMUNOL, V48, P563; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; GulbransonJudge A, 1996, EUR J IMMUNOL, V26, P1830, DOI 10.1002/eji.1830260825; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Luther SA, 1997, J EXP MED, V185, P551, DOI 10.1084/jem.185.3.551; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Mock BA, 1996, GENOMICS, V37, P24, DOI 10.1006/geno.1996.0516; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rolink AG, 2002, CURR OPIN IMMUNOL, V14, P266, DOI 10.1016/S0952-7915(02)00332-1; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Stein JV, 2002, J CLIN INVEST, V109, P1587, DOI 10.1172/JCI200215034; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Tourigny MR, 2002, IMMUNITY, V17, P179, DOI 10.1016/S1074-7613(02)00364-3; Vinuesa CG, 2001, EUR J IMMUNOL, V31, P1340, DOI 10.1002/1521-4141(200105)31:5<1340::AID-IMMU1340>3.0.CO;2-H; VINUESA CG, 1999, EUR J IMMUNOL, V29, P1314; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wykes M, 1998, J IMMUNOL, V161, P1313; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	36	143	150	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2002	17	3					235	238		10.1016/S1074-7613(02)00398-9	http://dx.doi.org/10.1016/S1074-7613(02)00398-9			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354377	Bronze			2022-12-18	WOS:000178163100001
J	Hemmerich, S; Bistrup, A; Singer, MS; van Zante, A; Lee, JK; Tsay, D; Peters, M; Carminati, JL; Brennan, TJ; Carver-Moore, K; Leviten, M; Fuentes, ME; Ruddle, NH; Rosen, SD				Hemmerich, S; Bistrup, A; Singer, MS; van Zante, A; Lee, JK; Tsay, D; Peters, M; Carminati, JL; Brennan, TJ; Carver-Moore, K; Leviten, M; Fuentes, ME; Ruddle, NH; Rosen, SD			Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes	IMMUNITY			English	Article							HIGH-ENDOTHELIAL VENULES; SIALYL-LEWIS-X; ALLOGRAFT-REJECTION; MOLECULAR-CLONING; DEFICIENT MICE; CAPPING GROUP; P-SELECTIN; MIGRATION; ADHESION; GLYCAM-1	Lymphocytes home to lymph nodes, using L-selectin to bind specific ligands on high endothelial venules (HEV). In vitro studies implicate GIcNAc-6-sulfate as an essential posttranslational modification for ligand activity. Here, we show that genetic deletion of HEC-GIcNAc6ST, a sulfotransferase that is highly restricted to HEV, results in the loss of the binding of recombinant L-selectin to the luminal aspect of HEV, elimination of lymphocyte binding in vitro, and markedly reduced in vivo homing. Reactivity with MECA 79, an adhesion-blocking mAb that stains HEV in lymph nodes and vessels in chronic inflammatory sites, is also lost from the luminal aspects of HEV. These results establish a critical role for HEC-GIcNAc6ST in lymphocyte trafficking and suggest it as an important therapeutic target.	Roche Biosci, Dept Resp Dis, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anat, Program Immunol, San Francisco, CA 94143 USA; Roche Biosci, Dept Core Sci, Palo Alto, CA 94304 USA; Deltagen Inc, Menlo Pk, CA 94025 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Immunobiol Sect, New Haven, CT 06520 USA	Roche Holding; University of California System; University of California San Francisco; Roche Holding; Yale University	Rosen, SD (corresponding author), Roche Biosci, Dept Resp Dis, 3401 Hillview Ave, Palo Alto, CA 94304 USA.		Fuentes, Maria/HGA-8617-2022	Rosen, Steven/0000-0002-6245-701X	NCI NIH HHS [CA16885] Funding Source: Medline; NIAID NIH HHS [AI 44453] Funding Source: Medline; NIGMS NIH HHS [GM57411] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA016885, R56CA016885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057411] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Bruehl RE, 2000, J BIOL CHEM, V275, P32642, DOI 10.1074/jbc.M001703200; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; Glantz SA., 1987, PRIMER BIOSTATISTICS; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; HAMANN A, 1991, EUR J IMMUNOL, V21, P2925, DOI 10.1002/eji.1830211205; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; HEMMERICH S, 1994, BIOCHEMISTRY-US, V33, P4820, DOI 10.1021/bi00182a010; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Hemmerich S, 2000, GLYCOBIOLOGY, V10, P849, DOI 10.1093/glycob/10.9.849; Hickey MJ, 2000, J IMMUNOL, V165, P7164, DOI 10.4049/jimmunol.165.12.7164; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; IMAI Y, 1993, NATURE, V361, P555; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kimura N, 1999, P NATL ACAD SCI USA, V96, P4530, DOI 10.1073/pnas.96.8.4530; Kirveskari J, 2000, J AM SOC NEPHROL, V11, P2358, DOI 10.1681/ASN.V11122358; Koenig A, 1997, GLYCOBIOLOGY, V7, P79, DOI 10.1093/glycob/7.1.79; Kunkel EJ, 1998, J IMMUNOL, V161, P2449; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MEBIUS RE, 1993, J IMMUNOL, V151, P3252; MICHIE SA, 1995, AM J PATHOL, V147, P412; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; PAAVONEN T, 1992, AM J PATHOL, V141, P1259; ROSEN SD, 1985, SCIENCE, V228, P1005, DOI 10.1126/science.4001928; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; ROSEN SD, 1989, J IMMUNOL, V142, P1895; SCUDDER PR, 1994, GLYCOBIOLOGY, V4, P929, DOI 10.1093/glycob/4.6.929; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935; Toppila S, 1999, AM J PATHOL, V155, P1303, DOI 10.1016/S0002-9440(10)65232-7; Toppila S, 2000, AM J RESP CELL MOL, V23, P492, DOI 10.1165/ajrcmb.23.4.4113; Tu L, 1999, J EXP MED, V189, P241, DOI 10.1084/jem.189.2.241; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Wagner N, 1998, EUR J IMMUNOL, V28, P3832, DOI 10.1002/(SICI)1521-4141(199811)28:11<3832::AID-IMMU3832>3.0.CO;2-J; WATSON SR, 1990, J CELL BIOL, V110, P2221, DOI 10.1083/jcb.110.6.2221; Xu JC, 1996, J EXP MED, V183, P589, DOI 10.1084/jem.183.2.589; Zakrzewicz A, 1997, BLOOD, V89, P3228, DOI 10.1182/blood.V89.9.3228	46	143	148	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2001	15	2					237	247		10.1016/S1074-7613(01)00188-1	http://dx.doi.org/10.1016/S1074-7613(01)00188-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520459	Bronze			2022-12-18	WOS:000170717200006
J	Li, XC; Strom, TB; Turka, LA; Wells, AD				Li, XC; Strom, TB; Turka, LA; Wells, AD			T cell death and transplantation tolerance	IMMUNITY			English	Review							RECEPTOR-GAMMA-CHAIN; TERM ALLOGRAFT SURVIVAL; DENDRITIC CELLS; CLONAL EXPANSION; IL-4 EXPRESSION; BONE-MARROW; INDUCTION; APOPTOSIS; LYMPHOCYTES; TH2		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Pennsylvania	Strom, TB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.			Li, Xian Chang/0000-0002-5981-2762				Anderson CC, 2001, NAT MED, V7, P80, DOI 10.1038/83393; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bushell A, 1999, J IMMUNOL, V162, P1359; Dai ZH, 1999, J IMMUNOL, V163, P3131; Dai ZH, 1998, J IMMUNOL, V161, P1659; Davies JD, 1996, J IMMUNOL, V157, P529; Gallichan WS, 1999, J IMMUNOL, V163, P1696; Gandy KL, 1999, IMMUNITY, V11, P579, DOI 10.1016/S1074-7613(00)80133-8; Gao YK, 1998, J EXP MED, V188, P887, DOI 10.1084/jem.188.5.887; George JF, 1998, NAT MED, V4, P333, DOI 10.1038/nm0398-333; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; IIDSTAD S T, 1984, Nature (London), V307, P168; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2572, DOI 10.1002/eji.1830250925; Konieczny BT, 1998, J IMMUNOL, V160, P2059; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; Li XC, 1998, J IMMUNOL, V161, P2241; Li XC, 2001, NAT MED, V7, P114, DOI 10.1038/83253; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; Malvey EN, 1998, IMMUNOL REV, V165, P301, DOI 10.1111/j.1600-065X.1998.tb01247.x; Malvey EN, 1998, J IMMUNOL, V161, P2168; Mueller R, 1997, J IMMUNOL, V159, P1599; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; NOSSAL GJV, 1989, FUNDAMENTALS IMMUNOL, P572; Piccotti JR, 1997, TRANSPLANTATION, V63, P619, DOI 10.1097/00007890-199703150-00001; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Reich-Zeliger S, 2000, IMMUNITY, V13, P507, DOI 10.1016/S1074-7613(00)00050-9; SAYEGH MH, 1995, J EXP MED, V181, P1869, DOI 10.1084/jem.181.5.1869; SCHNEIDER TM, 1986, TRANSPLANTATION, V42, P191, DOI 10.1097/00007890-198608000-00017; SCULLY R, 1994, EUR J IMMUNOL, V24, P2383, DOI 10.1002/eji.1830241019; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; STROM TB, 1992, IMMUNOL REV, V129, P131, DOI 10.1111/j.1600-065X.1992.tb01422.x; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Tran HM, 1997, J IMMUNOL, V159, P2232; Van Parijs L, 1998, SCIENCE, V280, P243; Vendetti S, 2000, J IMMUNOL, V165, P1175, DOI 10.4049/jimmunol.165.3.1175; Waldmann H, 1998, ANNU REV IMMUNOL, V16, P619, DOI 10.1146/annurev.immunol.16.1.619; Wekerle T, 1998, J EXP MED, V187, P2037, DOI 10.1084/jem.187.12.2037; WEKERLE T, 2001, IN PRESS J IMMUNOL; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; WELLS AD, 2001, IN PRESS CURR OP ORG; Wise MP, 1998, J IMMUNOL, V161, P5813; YIN DP, 1995, J IMMUNOL, V154, P6339; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	49	143	153	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					407	416		10.1016/S1074-7613(01)00121-2	http://dx.doi.org/10.1016/S1074-7613(01)00121-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336686	Bronze			2022-12-18	WOS:000168246700008
J	Traver, D; Akashi, K; Weissman, IL; Lagasse, E				Traver, D; Akashi, K; Weissman, IL; Lagasse, E			Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOGENOUS LEUKEMIA; TUMOR SUPPRESSOR GENES; LONG-TERM REMISSION; FAS ANTIGEN; CHROMOSOMAL TRANSLOCATIONS; (CD95)-MEDIATED APOPTOSIS; TRANSGENIC MICE; T-LYMPHOCYTES; B-CELLS	Fas-deficient (Fas(lpr/lpr)) mice constitutively expressing Bcl-2 in myeloid cells by the hMRP8 promoter often develop a fatal disease analogous to human acute myeloblastic leukemia (AML-M2). Hematopoietic cells from leukemic Fas(lpr/lpr)hMRP8bcl-2 animals form clonogenic blast colonies in vitro and can transfer disease to wild-type mice. In vitro ligation of Fas on Fas(+/+) hMRP8bcl-2 marrow cells depletes approximately 50% of myeloid progenitor activity, demonstrating that Bcl-2 can only partially block Fas-mediated death signals in myelomonocytic progenitors. In addition, Fas(lpr/lpr) marrow contains greatly increased numbers of myeloid colony-forming cells as compared to Fas(+/+) controls. Taken together, these data suggest that pas has a novel role in the regulation of myelopoiesis and that Fas may act as a tumor suppressor to control leukemogenic transformation in myeloid progenitor cells.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Traver, D (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	dtraver@leland.stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NIAID NIH HHS [5T32 AI-07290] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aguila HL, 1996, BLOOD, V87, P1225, DOI 10.1182/blood.V87.4.1225.bloodjournal8741225; AKASHI K, 1991, BLOOD, V78, P197; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; BAKHSHI A, 1985, CELL, V14, P899; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; BENSI L, 1995, HAEMATOLOGICA, V80, P98; Bouscary D, 1997, LEUKEMIA, V11, P839, DOI 10.1038/sj.leu.2400654; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; COLLINS SJ, 1987, BLOOD, V70, P1233; CORY S, 1994, PHILOS T R SOC B, V345, P289, DOI 10.1098/rstb.1994.0108; DANIEL PT, 1994, J IMMUNOL, V152, P5624; DELIA D, 1992, BLOOD, V79, P1291, DOI 10.1182/blood.V79.5.1291.bloodjournal7951291; Dirks W, 1997, BRIT J HAEMATOL, V96, P584, DOI 10.1046/j.1365-2141.1997.d01-2048.x; ERICKSON P, 1992, BLOOD, V80, P1825; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; ITOH N, 1993, J IMMUNOL, V151, P621; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Klampfer L, 1996, P NATL ACAD SCI USA, V93, P14059, DOI 10.1073/pnas.93.24.14059; KOMADA Y, 1995, BLOOD, V86, P3848, DOI 10.1182/blood.V86.10.3848.bloodjournal86103848; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Min YH, 1996, BRIT J HAEMATOL, V93, P928; Miyamoto T, 1996, BLOOD, V87, P4789, DOI 10.1182/blood.V87.11.4789.bloodjournal87114789; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NUCIFORA G, 1993, BLOOD, V82, P712; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Peng SL, 1996, J EXP MED, V184, P1149, DOI 10.1084/jem.184.3.1149; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RABBITTS TH, 1991, CELL, V67, P641, DOI 10.1016/0092-8674(91)90057-6; ROBERTSON MJ, 1995, LEUKEMIA LYMPHOMA, V17, P51, DOI 10.3109/10428199509051703; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; SAWYERS CL, 1991, CELL, V64, P337, DOI 10.1016/0092-8674(91)90643-D; SCHIFFER C, 1997, CANC MED, P2617; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WU AM, 1967, J CELL PHYSIOL, V69, P177, DOI 10.1002/jcp.1040690208; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303	52	143	153	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1998	9	1					47	57		10.1016/S1074-7613(00)80587-7	http://dx.doi.org/10.1016/S1074-7613(00)80587-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697835	Bronze			2022-12-18	WOS:000075066600005
J	HOGQUIST, KA; JAMESON, SC; BEVAN, MJ				HOGQUIST, KA; JAMESON, SC; BEVAN, MJ			STRONG AGONIST LIGANDS FOR THE T-CELL RECEPTOR DO NOT MEDIATE POSITIVE SELECTION OF FUNCTIONAL CD8(+) T-CELLS	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; INVITRO CLONAL DELETION; IMMATURE THYMOCYTES; CD4+8+ THYMOCYTES; TRANSGENIC MICE; EXPRESSION; TOLERANCE; INDUCTION; PEPTIDE; SPECIFICITY	Positive selection of functional CD8(+) T cells expressing an MHC class I-restricted T cell receptor can be induced in fetal thymus organ culture by class I-binding peptides related to the antigenic peptide ligand. Peptides that act as antagonist or weak agonist/antagonist ligands for mature T cells work efficiently in this regard, In the present study, we have investigated whether low concentrations of the original agonist peptide, or variants that still have a strong agonist activity can also mediate positive selection. The antigenic peptide did not induce positive selection at any concentration tested. A strong agonist variant was capable of stimulating the differentiation of TCR(hi) CD8(+) cells, giving the appearance of phenotypic positive selection. However, these cells lacked biological function, since they could not proliferate in response to antigen. The most efficient positive selection resulted with ligands that did not activate mature T cells or stimulate negative selection.	UNIV WASHINGTON,HOWARD HUGHES MED INST,DEPT IMMUNOL,SEATTLE,WA 98195	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle			Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Hogquist, Kristin/0000-0001-9963-5687	NIAID NIH HHS [AI-29802] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129802, R01AI029802] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; AUPHAN N, 1992, INT IMMUNOL, V4, P1419, DOI 10.1093/intimm/4.12.1419; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; BLOK R, 1992, INT IMMUNOL, V4, P455, DOI 10.1093/intimm/4.4.455; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; IWABUCHI K, 1992, P NATL ACAD SCI USA, V89, P9000, DOI 10.1073/pnas.89.19.9000; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JANEWAY CA, 1993, CURR BIOL, V2, P591; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; LO D, 1986, IMMUNOL RES, V5, P221, DOI 10.1007/BF02919203; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PIRCHER H, 1993, EUR J IMMUNOL, V23, P669, DOI 10.1002/eji.1830230315; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; SCHUMACHER TNM, 1994, IMMUNITY, V1, P721, DOI 10.1016/S1074-7613(94)80013-8; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; SPAIN LM, 1992, J EXP MED, V176, P213, DOI 10.1084/jem.176.1.213; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701	26	143	144	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					79	86		10.1016/1074-7613(95)90160-4	http://dx.doi.org/10.1016/1074-7613(95)90160-4			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621079	Bronze			2022-12-18	WOS:A1995RK86800009
J	Girbl, T; Lenn, T; Perez, L; Rolas, L; Barkaway, A; Thiriot, A; del Fresno, C; Lynam, E; Hub, E; Thelen, M; Graham, G; Alon, R; Sancho, D; von Andrian, UH; Voisin, MB; Rot, A; Nourshargh, S				Girbl, Tamara; Lenn, Tchern; Perez, Lorena; Rolas, Loic; Barkaway, Anna; Thiriot, Aude; del Fresno, Carlos; Lynam, Eleanor; Hub, Elin; Thelen, Marcus; Graham, Gerard; Alon, Ronen; Sancho, David; von Andrian, Ulrich H.; Voisin, Mathieu-Benoit; Rot, Antal; Nourshargh, Sussan			Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis	IMMUNITY			English	Article							TRANSENDOTHELIAL MIGRATION; VENULAR WALLS; CELLS; EXPRESSION; ADHESION; SITES; MICE; PROTEIN; MIP-2; KC	Neutrophils require directional cues to navigate through the complex structure of venular walls and into inflamed tissues. Here we applied confocal intravital microscopy to analyze neutrophil emigration in cytokine-stimulated mouse cremaster muscles. We identified differential and non-redundant roles for the chemokines CXCL1 and CXCL2, governed by their distinct cellular sources. CXCL1 was produced mainly by TNF-stimulated endothelial cells (ECs) and pericytes and supported luminal and sub-EC neutrophil crawling. Conversely, neutrophils were the main producers of CXCL2, and this chemokine was critical for correct breaching of endothelial junctions. This pro-migratory activity of CXCL2 depended on the atypical chemokine receptor 1 (ACKR1), which is enriched within endothelial junctions. Transmigrating neutrophils promoted a self-guided migration response through EC junctions, creating a junctional chemokine "depot'' in the form of ACKR1-presented CXCL2 that enabled efficient unidirectional luminal-to-abluminal migration. Thus, CXCL1 and CXCL2 act in a sequential manner to guide neutrophils through venular walls as governed by their distinct cellular sources.	[Girbl, Tamara; Lenn, Tchern; Perez, Lorena; Rolas, Loic; Barkaway, Anna; Lynam, Eleanor; Hub, Elin; Voisin, Mathieu-Benoit; Rot, Antal; Nourshargh, Sussan] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Microvasc Res, London EC1M 6BQ, England; [Rot, Antal; Nourshargh, Sussan] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Inflammat & Therapeut Innovat, London EC1M 6BQ, England; [Thiriot, Aude; von Andrian, Ulrich H.] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Thiriot, Aude; von Andrian, Ulrich H.] Harvard Med Sch, HMS Ctr Immune Imaging, Boston, MA 02115 USA; [del Fresno, Carlos; Sancho, David] CNIC, Immunobiol Lab, Madrid 28029, Spain; [Thelen, Marcus] Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Graham, Gerard] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel; [Rot, Antal] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, D-80336 Munich, Germany	University of London; Queen Mary University London; University of London; Queen Mary University London; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universita della Svizzera Italiana; University of Glasgow; Weizmann Institute of Science; University of Munich	Nourshargh, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Microvasc Res, London EC1M 6BQ, England.; Nourshargh, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Inflammat & Therapeut Innovat, London EC1M 6BQ, England.	s.nourshargh@qmul.ac.uk	Rolas, Loic/AAA-6717-2022; Del Fresno Sánchez, CArlos/AAY-1525-2021; ALON, RONEN/GRX-6987-2022; Sancho, David/D-3433-2009; Del Fresno, Carlos/ABD-7766-2020	Sancho, David/0000-0003-2890-3984; Del Fresno, Carlos/0000-0003-1771-7254; Lenn, Yueng Tchern/0000-0002-5827-4616; Rolas, Loic/0000-0001-7617-0768; Perez-Gutierrez, Lorena/0000-0001-8135-4975; Nourshargh, Sussan/0000-0001-5677-1806; , Mathieu-Benoit/0000-0003-3001-0894; Lynam, Eleanor/0000-0001-5501-5101; Rot, Antal/0000-0002-9730-6166; Alon, Ronen/0000-0001-9161-6369; Girbl, Tamara/0000-0001-7632-478X; Barkaway, Anna/0000-0003-4366-0378	NIH [AI029564, CA156330, DK094779, CA10068, U19AI109965]; Japanese vaccine research fellowship (Japan Foundation for Pediatric Research); MRC [MR/M019764/1, G0901113] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese vaccine research fellowship (Japan Foundation for Pediatric Research); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Flow Cytometry Core Facility at University of North Carolina at Chapel Hill for providing core and technical support. This work was supported by NIH grants AI029564, CA156330, DK094779, and CA10068 (the last to the National Multiple Sclerosis Society) to J.P.-Y.T. and U19AI109965 to J.P.-Y.T. and J.K.W. T.U. was supported by the Japanese vaccine research fellowship (Japan Foundation for Pediatric Research). We thank Dr. Shumpei Yokota and Dr. Shuichi Ito for editing the manuscript and Dr. Vijay Kuchroo for generously providing the 2D2 transgenic strain.	Armstrong DA, 2004, J LEUKOCYTE BIOL, V75, P641, DOI 10.1189/jlb.0803370; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Colom B, 2015, IMMUNITY, V42, P1075, DOI 10.1016/j.immuni.2015.05.010; Dawson TC, 2000, BLOOD, V96, P1681, DOI 10.1182/blood.V96.5.1681.h8001681a_1681_1684; del Fresno C, 2018, SCIENCE, V362, P351, DOI 10.1126/science.aan8423; Duchene J, 2017, NAT IMMUNOL, V18, P753, DOI 10.1038/ni.3763; Faust N, 2000, BLOOD, V96, P719; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Kienle K, 2016, IMMUNOL REV, V273, P76, DOI 10.1111/imr.12458; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lefort CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00157; Li JL, 2016, J INVEST DERMATOL, V136, P416, DOI 10.1038/JID.2015.410; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Minten C, 2014, BRAIN, V137, P1454, DOI 10.1093/brain/awu045; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Novitzky-Basso I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00266; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Proudfoot AEI, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10030070; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Reglero-Real N, 2016, ARTERIOSCL THROM VAS, V36, P2048, DOI 10.1161/ATVBAHA.116.307610; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Stadtmann A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00263; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Tecchio C, 2016, SEMIN IMMUNOL, V28, P119, DOI 10.1016/j.smim.2016.04.003; Thiriot A, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0381-7; Vaahtomeri K, 2017, CELL REP, V19, P902, DOI 10.1016/j.celrep.2017.04.027; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Zhang XW, 2001, BRIT J PHARMACOL, V133, P413, DOI 10.1038/sj.bjp.0704087; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	39	142	143	5	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1062	+		10.1016/j.immuni.2018.09.018	http://dx.doi.org/10.1016/j.immuni.2018.09.018			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30446388	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000453556500012
J	Kim, MH; Taparowsky, EJ; Kim, CH				Kim, Myung H.; Taparowsky, Elizabeth J.; Kim, Chang H.			Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA3; INTESTINAL EPITHELIAL-CELLS; CHEMOKINE RECEPTOR 9; ROR-GAMMA-T; EXPRESSION; BET; INFLAMMATION; TRAFFICKING; THYMOCYTES; INTEGRINS	Distinct groups of innate lymphoid cells (ILCs) such as ILC1, ILC2, and ILC3 populate the intestine, but how these ILCs develop tissue tropism for this organ is unclear. We report that prior to migration to the intestine ILCs first undergo a "switch'' in their expression of homing receptors from lymphoid to gut homing receptors. This process is regulated by mucosal dendritic cells and the gut-specific tissue factor retinoic acid (RA). This change in homing receptors is required for long-term population and effector function of ILCs in the intestine. Only ILC1 and ILC3, but not ILC2, undergo the RA-dependent homing receptor switch in gut-associated lymphoid tissues. In contrast, ILC2 acquire gut homing receptors in a largely RA-independent manner during their development in the bone marrow and can migrate directly to the intestine. Thus, distinct programs regulate the migration of ILC subsets to the intestine for regulation of innate immunity.	[Kim, Myung H.; Kim, Chang H.] Purdue Univ, Purdue Vet Med, Dept Comparat Pathobiol, Lab Immunol & Hematopoiesis, W Lafayette, IN 47907 USA; [Taparowsky, Elizabeth J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Taparowsky, Elizabeth J.; Kim, Chang H.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Kim, Chang H.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kim, CH (corresponding author), Purdue Univ, Purdue Vet Med, Dept Comparat Pathobiol, Lab Immunol & Hematopoiesis, W Lafayette, IN 47907 USA.	chkim@purdue.edu	Kim, Chang/ABG-8200-2020	Kim, Chang/0000-0003-4618-9139	NIH [R01AI074745, R01DK076616, 1R01AI080769, 1S10RR028293, R21 AI105620]; National Multiple Sclerosis Society; NCI [P30 CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105620, R01AI080769, R01AI074745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank S. Hashimoto-Hill, J. Park, L. Friesen, H. Kim, and Y. Son (Purdue) for their input and assistance. This study was supported, in part, from grants from NIH (R01AI074745, R01DK076616, 1R01AI080769, and 1S10RR028293) and National Multiple Sclerosis Society to C.H.K., NIH R21 AI105620 to E.J.T. and C.H.K., and by NCI P30 CA023168.	Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kang SG, 2011, MUCOSAL IMMUNOL, V4, P66, DOI 10.1038/mi.2010.42; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kang SG, 2009, GASTROENTEROLOGY, V137, P1391, DOI 10.1053/j.gastro.2009.06.063; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Morris MA, 2004, CURR MOL MED, V4, P431, DOI 10.2174/1566524043360609; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Walzer T, 2011, TRENDS IMMUNOL, V32, P486, DOI 10.1016/j.it.2011.05.002; Wang CW, 2010, J IMMUNOL, V184, P5519, DOI 10.4049/jimmunol.0903942; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	50	142	147	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					107	119		10.1016/j.immuni.2015.06.009	http://dx.doi.org/10.1016/j.immuni.2015.06.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26141583	Bronze, Green Accepted			2022-12-18	WOS:000360101100014
J	Endo, Y; Hirahara, K; Iinuma, T; Shinoda, K; Tumes, DJ; Asou, HK; Matsugae, N; Obata-Ninomiya, K; Yamamoto, H; Motohashi, S; Oboki, K; Nakae, S; Saito, H; Okamoto, Y; Nakayama, T				Endo, Yusuke; Hirahara, Kiyoshi; Iinuma, Tomohisa; Shinoda, Kenta; Tumes, Damon J.; Asou, Hikari K.; Matsugae, Nao; Obata-Ninomiya, Kazushige; Yamamoto, Heizaburo; Motohashi, Shinichiro; Oboki, Keisuke; Nakae, Susumu; Saito, Hirohisa; Okamoto, Yoshitaka; Nakayama, Toshinori			The Interleukin-33-p38 Kinase Axis Confers Memory T Helper 2 Cell Pathogenicity in the Airway	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; T-CELLS; FAMILY-MEMBERS; TH2; IL-33; ASTHMA; CYTOKINE; P38; TRANSCRIPTION; INFLAMMATION	Memory CD4(+) T helper (Th) cells provide long-term protection against pathogens and are essential for the development of vaccines; however, some antigen-specific memory Th cells also drive immunerelated pathology, including asthma. The mechanisms regulating the pathogenicity of memory Th cells remain poorly understood. We found that interleukin-33 (IL-33)-ST2 signals selectively licensed memory Th2 cells to induce allergic airway inflammation via production of IL-5 and that the p38 MAP kinase pathway was a central downstream target of IL-33-ST2 in memory Th2 cells. In addition, we found that IL-33 induced upregulation of IL-5 by memory CD4(+) T cells isolated from nasal polyps of patients with eosinophilic chronic rhinosinusitis. Thus, IL-33ST2-p38 signaling appears to directly instruct pathogenic memory Th2 cells to produce IL-5 and induce eosinophilic inflammation.	[Endo, Yusuke; Shinoda, Kenta; Tumes, Damon J.; Asou, Hikari K.; Matsugae, Nao; Obata-Ninomiya, Kazushige; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, Chiba 2608670, Japan; [Hirahara, Kiyoshi; Yamamoto, Heizaburo] Chiba Univ, Grad Sch Med, Dept Adv Allergol Airway, Chuo Ku, Chiba 2608670, Japan; [Iinuma, Tomohisa; Yamamoto, Heizaburo; Okamoto, Yoshitaka] Chiba Univ, Grad Sch Med, Dept Otorhinolaryngol, Chuo Ku, Chiba 2608670, Japan; [Motohashi, Shinichiro] Chiba Univ, Grad Sch Med, Dept Med Immunol, Chuo Ku, Chiba 2608670, Japan; [Nakae, Susumu] Univ Tokyo, Ctr Expt Med & Syst Biol, Lab Syst Biol, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Oboki, Keisuke; Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, Tokyo 1578535, Japan; [Nakayama, Toshinori] Japan Sci & Technol Agcy, CREST, Chuo Ku, Chiba 2608670, Japan	Chiba University; Chiba University; Chiba University; Chiba University; University of Tokyo; National Center for Child Health & Development - Japan; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tnakayama@faculty.chiba-u.jp	Nakayama, Toshinori/E-1067-2017; Oboki, Keisuke/AAR-1813-2020; Tumes, Damon J/B-9917-2009; Hirahara, Kiyoshi/E-2460-2017	Nakayama, Toshinori/0000-0002-1434-2007; Tumes, Damon J/0000-0001-5709-857X; Hirahara, Kiyoshi/0000-0002-9128-9449; Saito, Hirohisa/0000-0002-6630-8337; Iinuma, Tomohisa/0000-0002-9940-5520; K Asou, Hikari/0000-0002-2701-5953; Obata-Ninomiya, Kazushige/0000-0002-0984-6518	Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment); Ministry of Education, Culture, Sports, Science, and Technology of Japan [26221305, 21390147, 24592083, 24790461, 25860352, 25893032]; Ministry of Health, Labor, and Welfare; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; Princes Takamatsu Cancer Research Fund; Takeda Science Foundation; Japanese Society for the Promotion of Science postdoctoral fellowship [2109747]; Grants-in-Aid for Scientific Research [24591475, 26870172, 25893032, 26221305] Funding Source: KAKEN	Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Princes Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society for the Promotion of Science postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Kaoru Sugaya, Miki Kato, and Toshihiro Ito for their excellent technical assistance. This work was supported by the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment) and by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grants-in-Aid for Scientific Research [S] 26221305, (B) 21390147, and (C) 24592083; Grants-in-Aid for Young Scientists (B) 24790461 and 25860352; Research Activity start-up 25893032), the Ministry of Health, Labor, and Welfare, the Astellas Foundation for Research on Metabolic Disorders, the Uehara Memorial Foundation, the Kanae Foundation for the Promotion of Medical Science, the Princes Takamatsu Cancer Research Fund, and the Takeda Science Foundation. D.J.T. was supported by a Japanese Society for the Promotion of Science postdoctoral fellowship (2109747).	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Endo Y, 2014, TRENDS IMMUNOL, V35, P69, DOI 10.1016/j.it.2013.11.003; Endo Y, 2011, IMMUNITY, V35, P733, DOI 10.1016/j.immuni.2011.08.017; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gevaert P, 2006, J ALLERGY CLIN IMMUN, V118, P1133, DOI 10.1016/j.jaci.2006.05.031; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Mori A, 1999, J IMMUNOL, V163, P4763; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nakayama T, 2008, CURR OPIN IMMUNOL, V20, P265, DOI 10.1016/j.coi.2008.03.011; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Northrup DL, 2011, IMMUNITY, V34, P830, DOI 10.1016/j.immuni.2011.06.002; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Scanlon ST, 2012, CURR OPIN IMMUNOL, V24, P707, DOI 10.1016/j.coi.2012.08.009; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Upadhyaya B, 2011, J IMMUNOL, V187, P3111, DOI 10.4049/jimmunol.1101283; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Wang J, 2006, INT IMMUNOL, V18, P313, DOI 10.1093/intimm/dxh370; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Yamamoto H, 2007, ALLERGY, V62, P1451, DOI 10.1111/j.1398-9995.2007.01464.x; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	44	142	150	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					294	308		10.1016/j.immuni.2015.01.016	http://dx.doi.org/10.1016/j.immuni.2015.01.016			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692703	Bronze			2022-12-18	WOS:000349916400013
J	Kastenmuller, W; Brandes, M; Wang, Z; Herz, J; Egen, JG; Germain, RN				Kastenmueller, Wolfgang; Brandes, Marlene; Wang, Ze; Herz, Jasmin; Egen, Jackson G.; Germain, Ronald N.			Peripheral Prepositioning and Local CXCL9 Chemokine-Mediated Guidance Orchestrate Rapid Memory CD8(+) T Cell Responses in the Lymph Node	IMMUNITY			English	Article							CLASSICAL DENDRITIC CELLS; ANTIGEN-PRESENTING CELL; RECALL RESPONSES; COGNATE ANTIGEN; RECEPTOR CXCR3; EFFECTOR; INNATE; ACTIVATION; EXPRESSION; INFECTION	After an infection, the immune system generates long-lived memory lymphocytes whose increased frequency and altered state of differentiation enhance host defense against reinfection. Recently, the spatial distribution of memory cells was found to contribute to their protective function. Effector memory CD8(+) T cells reside in peripheral tissue sites of initial pathogen encounter, in apparent anticipation of reinfection. Here we show that within lymph nodes (LNs), memory CD8(+) T cells were concentrated near peripheral entry portals of lymph-borne pathogens, promoting rapid engagement of infected sentinel macrophages. A feed-forward CXCL9-dependent circuit provided additional chemotactic cues that further increase local memory cell density. Memory CD8(+) T cells also produced effector responses to local cytokine triggers, but their dynamic behavior differed from that seen after antigen recognition. These data reveal the distinct localization and dynamic behavior of naive versus memory T cells within LNs and how these differences contribute to host defense.	[Kastenmueller, Wolfgang; Brandes, Marlene; Wang, Ze; Egen, Jackson G.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Herz, Jasmin] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD 20892 USA; [Egen, Jackson G.] Genentech Res & Early Dev, Dept Immunol, San Francisco, CA 94080 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Roche Holding; Genentech	Kastenmuller, W (corresponding author), Univ Bonn, Inst Mol Med, D-53105 Bonn, Germany.	wkastenm@uni-bonn.de; rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Egen, Jackson/0000-0003-2053-0837	Intramural Research Program, NIAID, NIH; DFG [KA 3091/1-1, HE 6068/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000758, ZIAAI000545] Funding Source: NIH RePORTER	Intramural Research Program, NIAID, NIH; DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank J. Farber and A. Luster for providing critical reagents, M. Gerner for help with imaging analysis, and G. Gasteiger, T. Lammermann, and N. van Panhuys for critically reading the manuscript. We are especially grateful to A. Luster and U. von Andrian for generously sharing unpublished data while this study was in progress or in revision. MVA NP-S-GFP was kindly provided by I. Drexler. This research was supported by the Intramural Research Program, NIAID, NIH, by DFG, KA 3091/1-1 to W. K., and HE 6068/1-1 to J.H.	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Henrickson SE, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.112pt2; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Huang WJ, 2012, J IMMUNOL, V188, P6247, DOI 10.4049/jimmunol.1103706; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; Nanno M, 2007, IMMUNOL REV, V215, P103, DOI 10.1111/j.1600-065X.2006.00474.x; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Xia LM, 2009, VIROLOGY, V385, P335, DOI 10.1016/j.virol.2008.11.042; Yang JP, 2006, P NATL ACAD SCI USA, V103, P147, DOI 10.1073/pnas.0509054103; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	58	142	143	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					502	513		10.1016/j.immuni.2012.11.012	http://dx.doi.org/10.1016/j.immuni.2012.11.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23352234	Green Accepted, Bronze			2022-12-18	WOS:000330941500015
J	Schweighoffer, E; Vanes, L; Nys, J; Cantrell, D; McCleary, S; Smithers, N; Tybulewicz, VLJ				Schweighoffer, Edina; Vanes, Lesley; Nys, Josquin; Cantrell, Doreen; McCleary, Scott; Smithers, Nicholas; Tybulewicz, Victor L. J.			The BAFF Receptor Transduces Survival Signals by Co-opting the B Cell Receptor Signaling Pathway	IMMUNITY			English	Article							SYK TYROSINE KINASE; ACTIVATING FACTOR; AUTOIMMUNE-DISEASE; MICE LACKING; FAMILY; ANTIGEN; AKT; MATURATION; TACI; BCMA	Follicular B cell survival requires signaling from BAFFR, a receptor for BAFF and the B cell antigen receptor (BCR). This "tonic'' BCR survival signal is distinct from that induced by antigen binding and may be ligand-independent. We show that inducible inactivation of the Syk tyrosine kinase, a key signal transducer from the BCR following antigen binding, resulted in the death of most follicular B cells because Syk-deficient cells were unable to survive in response to BAFF. Genetic rescue studies demonstrated that Syk transduces BAFFR survival signals via ERK and PI3 kinase. Surprisingly, BAFFR signaling directly induced phosphorylation of both Syk and the BCR-associated Ig alpha signaling subunit, and this Syk phosphorylation required the BCR. We conclude that the BCR and Ig alpha may be required for B cell survival because they function as adaptor proteins in a BAFFR signaling pathway leading to activation of Syk, demonstrating previously unrecognized crosstalk between the two receptors.	[Schweighoffer, Edina; Vanes, Lesley; Nys, Josquin; Tybulewicz, Victor L. J.] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England; [Cantrell, Doreen] Univ Dundee, Dundee DD1 4HN, Scotland; [McCleary, Scott; Smithers, Nicholas] GlaxoSmithKline, Immunoinflammat Therapy Area Unit, Stevenage SG1 2NY, Herts, England	MRC National Institute for Medical Research; University of Dundee; GlaxoSmithKline	Tybulewicz, VLJ (corresponding author), Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England.	vtybule@nimr.mrc.ac.uk		Cantrell, Doreen/0000-0001-7525-3350; Tybulewicz, Victor/0000-0003-2439-0798	MRC programme [U117527252]; MRC [MC_U117527252] Funding Source: UKRI; Medical Research Council [MC_U117527252] Funding Source: researchfish	MRC programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Reth, K. Rajewsky, D. Alessi, H. Spits, P. Krimpenfort, T. Hagenbeek, and J. Trapman for mice, M. Cancro, O. Williams, and C. Marshall for retroviral vectors, the Biological Services Division and Procedural Services Section of NIMR for animal husbandry and technical support, UCL Genomics for microarray analysis, and S. Ley, B. Seddon, P. Tolar, and K. Rajewsky for useful discussions. E. S., J.N., L. V., and V. L. J. T. were funded by the MRC programme number U117527252. S. M. and N.S. are employees of GSK.	Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Craxton A, 2005, J EXP MED, V202, P1363, DOI 10.1084/jem.20051283; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Keren Z, 2011, BLOOD, V117, P3104, DOI 10.1182/blood-2010-09-307983; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Liao GX, 2003, ONCOGENE, V22, P4868, DOI 10.1038/sj.onc.1206761; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Otipoby KL, 2008, P NATL ACAD SCI USA, V105, P12435, DOI 10.1073/pnas.0805460105; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Smith SH, 2003, J IMMUNOL, V170, P5820, DOI 10.4049/jimmunol.170.12.5820; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	32	142	147	3	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					475	488		10.1016/j.immuni.2012.11.015	http://dx.doi.org/10.1016/j.immuni.2012.11.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23453634	Green Published, hybrid			2022-12-18	WOS:000330941500013
J	Yi, TS; Wang, XM; Kelly, LM; An, JP; Xu, Y; Sailer, AW; Gustafsson, JA; Russell, DW; Cyster, JG				Yi, Tangsheng; Wang, Xiaoming; Kelly, Lisa M.; An, Jinping; Xu, Ying; Sailer, Andreas W.; Gustafsson, Jan-Ake; Russell, David W.; Cyster, Jason G.			Oxysterol Gradient Generation by Lymphoid Stromal Cells Guides Activated B Cell Movement during Humoral Responses	IMMUNITY			English	Article							DENDRITIC CELLS; MARGINAL ZONE; MACROPHAGES; MIGRATION; CHOLESTEROL; GENE; EXPRESSION; FOLLICLES; MICE	7 alpha,25-dihydroxycholesterol (7 alpha,25-OHC) is a ligand for the G protein-coupled receptor EBI2; however, the cellular sources of this oxysterol are undefined. 7 alpha,25-OHC is synthesized from cholesterol by the stepwise actions of two enzymes, CH25H and CYP7B1, and is metabolized to a 3-oxo derivative by HSD3B7. We showed that all three enzymes control EBI2 ligand concentration in lymphoid tissues. Lymphoid stromal cells were the main CH25H- and CYP7B1-expressing cells required for positioning of B cells, and they also mediated 7 alpha,25-OHC inactivation. CH25H and CYP7B1 were abundant at the follicle perimeter, whereas CH25H expression by follicular dendritic cells was repressed. CYP7B1, CH25H, and HSD3B7 deficiencies each resulted in defective T cell-dependent plasma cell responses. These findings establish that CYP7B1 and HSD3B7, as well as CH25H, have essential roles in controlling oxysterol production in lymphoid tissues, and they suggest that differential enzyme expression in stromal cell subsets establishes 7 alpha,25-OHC gradients required for B cell responses.	[Yi, Tangsheng; Wang, Xiaoming; Kelly, Lisa M.; An, Jinping; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Yi, Tangsheng; Wang, Xiaoming; Kelly, Lisa M.; An, Jinping; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Sailer, Andreas W.] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Russell, David W.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Novartis; University of Houston System; University of Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	kelly, Lisa/GWU-9804-2022; Wang, Xiaoming/E-9029-2015; Sailer, Andreas/M-9913-2016	Russell, David/0000-0002-0277-403X; Wang, Xiaoming/0000-0003-0679-9768; Sailer, Andreas/0000-0002-9015-7946	National Institutes of Health [AI40098, HL20948]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040098, R01AI040098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Brink for providing HEL<SUP>2x</SUP>, M. Tanaka for CD169<SUP>DTR</SUP> mice, R. Lathe for making Cyp7b1<SUP>+/-</SUP> mice available, and M. Barnes and A. Reboldi for comments on the manuscript. T.Y. is an Irvington Institute Postdoctoral Fellow at the Cancer Research Institute, and J.G.C. in an Investigator at the Howard Hughes Medical Institute. This work was supported by National Institutes of Health grants AI40098 and HL20948. A.W.S is a current employee of Novartis and holds stock and stock options in the Novartis company.	Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Benned-Jensen T, 2011, J BIOL CHEM, V286, P29292, DOI 10.1074/jbc.M110.196345; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Cyster JG, 2000, IMMUNOL REV, V176, P181; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Gatto D, 2011, J IMMUNOL, V187, P4621, DOI 10.4049/jimmunol.1101542; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Omoto Y, 2005, P NATL ACAD SCI USA, V102, P2814, DOI 10.1073/pnas.0500198102; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rose K, 2001, J BIOL CHEM, V276, P23937, DOI 10.1074/jbc.M011564200; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Schwarz M, 2000, J CLIN INVEST, V106, P1175, DOI 10.1172/JCI10902; Shea HC, 2007, P NATL ACAD SCI USA, V104, P11526, DOI 10.1073/pnas.0705089104; Stiles AR, 2009, J BIOL CHEM, V284, P28485, DOI 10.1074/jbc.R109.042168; Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Zou T, 2011, INFECT IMMUN, V79, P1526, DOI 10.1128/IAI.01195-10	37	142	145	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 21	2012	37	3					535	548		10.1016/j.immuni.2012.06.015	http://dx.doi.org/10.1016/j.immuni.2012.06.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22999953	Green Accepted, Bronze			2022-12-18	WOS:000309199000017
J	Turtle, CJ; Swanson, HM; Fujii, N; Estey, EH; Riddell, SR				Turtle, Cameron J.; Swanson, Hillary M.; Fujii, Nobuharu; Estey, Elihu H.; Riddell, Stanley R.			A Distinct Subset of Self-Renewing Human Memory CD8(+) T Cells Survives Cytotoxic Chemotherapy	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; MULTIDRUG-RESISTANCE; B-CELLS; MOLECULAR SIGNATURE; VIRAL-INFECTION; DENDRITIC CELLS; P-GLYCOPROTEIN; HUMAN NKR-P1A; CUTTING EDGE; DRUG EFFLUX	The mechanisms that maintain human T cell memory during normal and perturbed homeostasis are not fully understood. The repeated induction of profound lymphocytopenia in patients undergoing multiple cycles of cytotoxic chemotherapy infrequently results in severe infections with viruses controlled by memory T cells, suggesting that some memory T cells survive chemotherapy and restore immunity. Here, we identified a distinct subpopulation of memory CD8(+) T cells with the ability to rapidly efflux and survive exposure to chemotherapy drugs in vitro and in vivo. T cells with high efflux capacity shared expression of molecules with hematopoietic stem cells, were quiescent in nonlymphocytopenic individuals, and were induced to proliferate in patients rendered lymphocytopenic after chemotherapy. Effluxing T cells differentiated into noneffluxing subsets in response to antigen stimulation and inflammatory signals, thereby contributing to repopulation of memory cells after chemotherapy.	[Turtle, Cameron J.; Swanson, Hillary M.; Fujii, Nobuharu; Estey, Elihu H.; Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Program Immunol, Div Clin Res, Seattle, WA 98109 USA; [Turtle, Cameron J.; Estey, Elihu H.; Riddell, Stanley R.] Univ Washington, Dept Med, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Turtle, CJ (corresponding author), Fred Hutchinson Canc Res Ctr, Program Immunol, Div Clin Res, Seattle, WA 98109 USA.	cturtle@fhcrc.org			Thomsen Family; Komen for the Cure; Avon Foundation; FHCRC BCRP; NIH [CA18029, CA114536, AI53193]; NATIONAL CANCER INSTITUTE [P01CA018029, R01CA114536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053193] Funding Source: NIH RePORTER	Thomsen Family; Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Avon Foundation; FHCRC BCRP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge the assistance of C. Chaney, S. Crouch, and K. Gardner in acquiring samples and thank the patients and blood donors. We also acknowledge funding from the Thomsen Family, Komen for the Cure, the Avon Foundation, FHCRC BCRP, and NIH grants CA18029, CA114536, and AI53193.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; BERMAN E, 1991, BLOOD, V77, P1666; Burger H, 2003, CLIN CANCER RES, V9, P827; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Haring JS, 2009, INFECT IMMUN, V77, P1894, DOI 10.1128/IAI.01315-08; Holmes S, 2005, P NATL ACAD SCI USA, V102, P5519, DOI 10.1073/pnas.0501437102; Huarte E, 2008, BLOOD, V112, P1259, DOI 10.1182/blood-2007-12-130773; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Luo YP, 2005, CANCER RES, V65, P3419, DOI 10.1158/0008-5472.CAN-04-3120; Mackall CL, 1997, BLOOD, V89, P3700, DOI 10.1182/blood.V89.10.3700.3700_3700_3707; Manley TJ, 2004, BLOOD, V104, P1075, DOI 10.1182/blood-2003-06-1937; Messaoudi I, 2006, J IMMUNOL, V177, P2784, DOI 10.4049/jimmunol.177.5.2784; MEYN RE, 1980, J NATL CANCER I, V64, P1215; Minderman H, 1996, CYTOMETRY, V25, P14, DOI 10.1002/(SICI)1097-0320(19960901)25:1<14::AID-CYTO2>3.0.CO;2-E; Mizutani T, 2008, CURR DRUG METAB, V9, P167, DOI 10.2174/138920008783571756; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SIMMONS PJ, 1994, EXP HEMATOL, V22, P157; Smets F, 2002, TRANSPLANTATION, V73, P1603, DOI 10.1097/00007890-200205270-00014; Sung L, 2009, CANCER-AM CANCER SOC, V115, P1100, DOI 10.1002/cncr.24107; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Walter RB, 2004, BLOOD, V103, P4276, DOI 10.1182/blood-2003-11-3825; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326	41	142	146	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 20	2009	31	5					834	844		10.1016/j.immuni.2009.09.015	http://dx.doi.org/10.1016/j.immuni.2009.09.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19879163	Green Accepted, Bronze			2022-12-18	WOS:000272097900017
J	Cao, EH; Zang, XX; Ramagopal, UA; Mukhopadhaya, A; Fedorov, A; Fedorov, E; Zencheck, WD; Lary, JW; Cole, JL; Deng, HT; Xiao, H; DiLorenzo, TP; Allison, JP; Nathenson, SG; Almo, HC				Cao, Erhu; Zang, Xingxing; Ramagopal, Udupi A.; Mukhopadhaya, Arunika; Fedorov, Alexander; Fedorov, Elena; Zencheck, Wendy D.; Lary, Jeffrey W.; Cole, James L.; Deng, Haiteng; Xiao, Hui; DiLorenzo, Teresa P.; Allison, James P.; Nathenson, Stanley G.; Almo, Haiteng C.			T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface	IMMUNITY			English	Article							TIM GENE FAMILY; PERIPHERAL TOLERANCE; RESPONSES; ACTIVATION; AUTOIMMUNE; IMMUNITY; DOMAIN; IG; EXPRESSION; MECHANISM	The T cell immunoglobulin mucin (Tim) family of receptors regulates effector CD4(+) T cell functions and is implicated in autoimmune and allergic diseases. Tim-3 induces immunological tolerance, and engagement of the Tim-3 immunoglobulin variable (IgV) domain by galectin-9 is important for appropriate termination of T helper 1-immune responses. The 2 angstrom crystal structure of the Tim-3 IgV domain demonstrated that four cysteines, which are invariant within the Tim family, form two noncanonical disulfide bonds, resulting in a surface not present in other immunoglobulin superfamily members. Biochemical and biophysical studies demonstrated that this unique structural feature mediates a previously unidentified galectin-9-independent binding process and suggested that this structural feature is conserved within the entire Tim family. The current work provided a graphic example of the relationship between sequence, structure, and function and suggested that the interplay between multiple Tim-3-binding activities contributes to the regulated assembly of signaling complexes required for effective Th1-mediated immunity.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Program Immunol, New York, NY 10021 USA; Univ Connecticut, Natl Analyt Ultracentrifugat Facil, Biotechnol Bioserv Ctr Unit 3149, Storrs, CT 06269 USA; Rockefeller Univ, Proteom Resource Ctr, New York, NY 10021 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Connecticut; Rockefeller University	Nathenson, SG (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.	nathenso@aecom.yu.edu; almo@aecom.yu.edu	cao, erhu/A-7204-2011; Cole, James/G-2586-2011	Deng, Haiteng/0000-0001-9496-1280; Zang, Xingxing/0000-0001-5380-1942; Allison, James/0000-0001-8980-5697; Mukhopadhaya, Arunika/0000-0003-2121-7885	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352, S10RR019891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI007289, R37AI007289, R56AI007289] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR019352, S10 RR019891] Funding Source: Medline; NIAID NIH HHS [AI07289] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Chakravarti S, 2005, J EXP MED, V202, P437, DOI 10.1084/jem.20050308; de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frisancho-Kiss S, 2006, J IMMUNOL, V176, P6411, DOI 10.4049/jimmunol.176.11.6411; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Halaby DM, 1998, J MOL EVOL, V46, P389, DOI 10.1007/PL00006318; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; KRICKELBEIN JE, 2006, J IMMUNOL, V177, P4966; Kuchroo VK, 2006, ADV IMMUNOL, V91, P227, DOI 10.1016/S0065-2776(06)91006-2; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Meyers JH, 2005, TRENDS MOL MED, V11, P362, DOI 10.1016/j.molmed.2005.06.008; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Proba K, 1997, J MOL BIOL, V265, P161, DOI 10.1006/jmbi.1996.0726; Rennert PD, 2006, J IMMUNOL, V177, P4311, DOI 10.4049/jimmunol.177.7.4311; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2; Zhang XW, 2002, PROTEIN EXPRES PURIF, V25, P105, DOI 10.1006/prep.2002.1616; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	32	142	163	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2007	26	3					311	321		10.1016/j.immuni.2007.01.016	http://dx.doi.org/10.1016/j.immuni.2007.01.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17363302	Bronze			2022-12-18	WOS:000245228100008
J	Enzler, T; Bonizzi, G; Silverman, GJ; Otero, DC; Widhopf, GF; Anzelon-Mills, A; Rickert, RC; Karin, M				Enzler, Thomas; Bonizzi, Giuseppina; Silverman, Gregg J.; Otero, Dennis C.; Widhopf, George F.; Anzelon-Mills, Amy; Rickert, Robert C.; Karin, Michael			Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease	IMMUNITY			English	Article							IKK-ALPHA; AUTOANTIBODY PRODUCTION; IMMUNE-RESPONSES; LYMPHOCYTE-B; ACTIVATION; BAFF; MICE; SURVIVAL; BETA; EXPRESSION	Expression of B cell-activating factor (BAFF), a critical B cell survival factor, is elevated in autoimmune and lymphoproliferative disorders. Mice overproducing BAFF develop systemic lupus erythematosus (SLE)-like disease and exhibit B cell activation of classical and alternative NF-kappa B-signaling pathways. We used a genetic approach and found that both NF-kappa B-signaling pathways contributed to disease development but act through distinct mechanisms. Whereas BAFF enhanced long-term B cell survival primarily through the alternative, but not the classical, NF-kappa B pathway, it promoted immunoglobulin class switching and generation of pathogenic antibodies through the classical pathway. Activation of the alternative NF-kappa B pathway resulted in integrin upregulation, thereby retaining autoreactive B cells in the splenic marginal zone, a compartment that contributes to their survival. Thus, both classical and alternative NF-kappa B signaling are important for development of lupus-like disease associated with BAFF overproduction. The same mechanisms may be involved in the pathogenesis of human SLE.	Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Rheumat Dis Core Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Div Hematol Oncol, La Jolla, CA 92093 USA; Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Bonizzi, Giuseppina/AAD-9042-2022	Silverman, Gregg/0000-0001-9480-9457; Enzler, Thomas/0000-0002-8775-1493				Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Balow JE, 2005, LUPUS, V14, P25, DOI 10.1191/0961203305lu2055oa; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goodyear CS, 2004, J IMMUNOL, V172, P2870, DOI 10.4049/jimmunol.172.5.2870; Gu H, 2004, B CELL PROTOCOLS; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kenter AL, 2004, J EXP MED, V199, P617, DOI 10.1084/jem.20031935; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lesage S, 2001, J EXP MED, V194, pF31, DOI 10.1084/jem.194.5.F31; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lopes-Carvalho T, 2005, CURR OPIN IMMUNOL, V17, P244, DOI 10.1016/j.coi.2005.04.009; Lopes-Carvalho T, 2004, IMMUNOL REV, V197, P192, DOI 10.1111/j.0105-2896.2004.0112.x; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2004, CURR OPIN PHARMACOL, V4, P347, DOI 10.1016/j.coph.2004.02.009; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; McHeyzer-Williams MG, 2003, CURR OPIN IMMUNOL, V15, P354, DOI 10.1016/S0952-7915(03)00046-3; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Oxenius A, 1996, J EXP MED, V183, P2209, DOI 10.1084/jem.183.5.2209; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Perez Omar D, 2004, Methods Mol Biol, V263, P67; REEVES JP, 1991, CURRENT PROTOCOLS IM, DOI UNSP 1.10.11-11.10.11; Roark JH, 1998, J IMMUNOL, V160, P3121; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Won WJ, 2002, J IMMUNOL, V168, P5605, DOI 10.4049/jimmunol.168.11.5605; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251	56	142	146	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2006	25	3					403	415		10.1016/j.immuni.2006.07.010	http://dx.doi.org/10.1016/j.immuni.2006.07.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16973390	Bronze			2022-12-18	WOS:000240862200010
J	Yokoyama, WM; Kim, S				Yokoyama, WM; Kim, S			How do natural killer cells find self to achieve tolerance?	IMMUNITY			English	Review							CLASS-I MOLECULES; DEFICIENT HEMATOPOIETIC-CELLS; INTERFERON-GAMMA PRODUCTION; ACTIVATING NKG2D RECEPTOR; BARE LYMPHOCYTE SYNDROME; MARROW GRAFT-REJECTION; NK CELLS; INHIBITORY RECEPTORS; BONE-MARROW; T-CELLS	Natural killer (NK) cells provide innate defense against tumors and infections by virtue of potent capacities to immediately kill cellular targets and produce cytokines. These effector functions may potentially damage normal self-tissues unless they are kept in check by tolerance mechanisms that need clarification. Here, we discuss recent studies indicating that the NK cells acquire functional competence directly through engagement of their MHC-specific receptors by self-MHC. Ironically, these receptors were first identified in terms of recognizing target cell MHC class 1 molecules and inhibiting NK cells in effector responses. Other studies of NK cell tolerance are also discussed. Although these studies begin to clarify the means by which NK cell tolerance is achieved, much more investigation is needed because NK cell tolerance is relevant to clinical observations in patients with infections and cancer.	Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.	yokoyama@im.wustl.edu						Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; BANCROFT GJ, 1993, CURR OPIN IMMUNOL, V5, P503, DOI 10.1016/0952-7915(93)90030-V; BENNETT M, 1987, ADV IMMUNOL, V41, P333, DOI 10.1016/S0065-2776(08)60034-6; Bennett M, 1995, Semin Immunol, V7, P121, DOI 10.1006/smim.1995.0016; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Castells MC, 2001, NAT IMMUNOL, V2, P436, DOI 10.1038/87749; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Colonna M, 1997, IMMUNOL REV, V155, P127, DOI 10.1111/j.1600-065X.1997.tb00945.x; COLONNA M, 1995, SCIENCE, V268, P367; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; CUDKOWICZ G, 1964, SCIENCE, V144, P1339, DOI 10.1126/science.144.3624.1339; Davies SM, 2002, BLOOD, V100, P3825, DOI 10.1182/blood-2002-04-1197; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2003, CURR OPIN IMMUNOL, V15, P37, DOI 10.1016/S0952-7915(02)00007-9; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Dorfman JR, 1996, EUR J IMMUNOL, V26, P151, DOI 10.1002/eji.1830260123; Dorfman JR, 1998, J EXP MED, V187, P609, DOI 10.1084/jem.187.4.609; Dorfman JR, 1997, J IMMUNOL, V159, P5219; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; French AR, 2004, ARTHRITIS RES THER, V6, P8, DOI 10.1186/ar1034; Furukawa H, 1999, HUM IMMUNOL, V60, P32, DOI 10.1016/S0198-8859(98)00097-4; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; HACKETT J, 1986, J IMMUNOL, V136, P3124; HERBERMAN RB, 1982, NK CELLS OTHER NATUR; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; Hsu KC, 2005, BLOOD, V105, P4878, DOI 10.1182/blood-2004-12-4825; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; KARLHOFER FM, 1994, J IMMUNOL, V153, P2407; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; LANIER LL, 1986, J IMMUNOL, V137, P2735; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LJUNGGREN HG, 1994, P NATL ACAD SCI USA, V91, P6520, DOI 10.1073/pnas.91.14.6520; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Lowin-Kropf B, 2000, J IMMUNOL, V165, P1314, DOI 10.4049/jimmunol.165.3.1314; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; Marti F, 1998, P NATL ACAD SCI USA, V95, P11810, DOI 10.1073/pnas.95.20.11810; Martin MP, 2005, CURR OPIN IMMUNOL, V17, P510, DOI 10.1016/j.coi.2005.07.012; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Moretta L, 2000, IMMUNOL TODAY, V21, P420, DOI 10.1016/S0167-5699(00)01673-X; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; OLSSON MY, 1995, P NATL ACAD SCI USA, V92, P1649, DOI 10.1073/pnas.92.5.1649; OlssonAlheim MY, 1997, J IMMUNOL, V159, P3189; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Parham P, 2003, NAT REV IMMUNOL, V3, P108, DOI 10.1038/nri999; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Salcedo M, 1997, J IMMUNOL, V158, P3174; Sentman C L, 1995, Semin Immunol, V7, P109, DOI 10.1006/smim.1995.0015; SHULTZ LD, 1988, CURR TOP MICROBIOL, V137, P216; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; TAY CH, 1995, J IMMUNOL, V154, P780; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Vitale M, 2002, BLOOD, V99, P1723, DOI 10.1182/blood.V99.5.1723; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438; Wang LL, 2000, J IMMUNOL, V164, P5215, DOI 10.4049/jimmunol.164.10.5215; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wu MF, 1997, J IMMUNOL, V158, P1628; Yokoyama W. M., 1999, FUNDAMENTAL IMMUNOLO, P575; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; YU YYL, 1992, ANNU REV IMMUNOL, V10, P189, DOI 10.1146/annurev.iy.10.040192.001201; Yusa S, 2003, J IMMUNOL, V170, P4539, DOI 10.4049/jimmunol.170.9.4539; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zimmer J, 1998, J EXP MED, V187, P117, DOI 10.1084/jem.187.1.117	92	142	150	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2006	24	3					249	257		10.1016/j.immuni.2006.03.006	http://dx.doi.org/10.1016/j.immuni.2006.03.006			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546094	Bronze			2022-12-18	WOS:000236504500006
J	Tanaka, T; Soriano, MA; Grusby, MJ				Tanaka, T; Soriano, MA; Grusby, MJ			SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling	IMMUNITY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PROTEASOME; RESPONSES; PHOSPHORYLATION; IDENTIFICATION; DEGRADATION; METHYLATION; ACTIVATION; DOMAINS; ALPHA	STAT proteins are a family of latent cytoplasmic transcription factors that are activated by tyrosine phosphorylation in response to a variety of cytokines, growth factors, and hormones. Once activated, STAT proteins translocate into the nucleus and help coordinate gene transcription. One striking feature of STAT signaling is its rapid and transient activation and deactivation cycle, although the molecular mechanisms responsible for this remain poorly understood. Here, we report on a nuclear protein that contains both PDZ and LIM domains and that interacts with activated STAT4 molecules. We show that SLIM is an ubiquitin E3 ligase that acts on STAT proteins to cause their proteosome-mediated degradation and enhance their dephosphorylation. Overexpression of SLIM leads to impaired STAT1 and STAT4 activity due to reduced STAT protein levels, while SLIM-deficiency results in increased STAT expression and thus enhanced IFN gamma production by Th1 cells. These studies suggest that SLIM is a novel ubiquitin E3 ligase whose targets include STAT proteins.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Grusby, MJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	mgrusby@hsph.harvard.edu	Tanaka, Takashi/O-8254-2015					Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Chen WG, 2004, J IMMUNOL, V172, P6744, DOI 10.4049/jimmunol.172.11.6744; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Hanson EM, 2003, J BIOL CHEM, V278, P3903, DOI 10.1074/jbc.M211747200; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(01)00269-0; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang DM, 2000, EMBO J, V19, P392, DOI 10.1093/emboj/19.3.392; Wang KS, 2001, BLOOD, V97, P3860, DOI 10.1182/blood.V97.12.3860; XU X, 1996, SCIENCE, V272, P794	27	142	147	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					729	736		10.1016/j.immuni.2005.04.008	http://dx.doi.org/10.1016/j.immuni.2005.04.008			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963787	Bronze			2022-12-18	WOS:000230180300010
J	Han, SB; Moratz, C; Huang, NN; Kelsall, B; Cho, H; Shi, CS; Schwartz, O; Kehrl, JH				Han, SB; Moratz, C; Huang, NN; Kelsall, B; Cho, H; Shi, CS; Schwartz, O; Kehrl, JH			Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles	IMMUNITY			English	Article							SPHINGOSINE 1-PHOSPHATE; DENDRITIC CELLS; VASCULAR ADDRESSIN; T-LYMPHOCYTE; L-SELECTIN; EXPRESSION; RECEPTOR; CHEMOTAXIS; MIGRATION; TRAFFICKING	Signaling by G protein-coupled receptors coupled to G alpha(i) assists in triggering lymphocyte movement into and out of lymph nodes. Here, we show that modulating the signaling output from these receptors dramatically alters B cell trafficking. Intravital microscopy of adoptively transferred B cells from wild-type and Rgs1(-/-) mice revealed that Rgs1(-/-) B cells stick better to lymph node high endothelial venules, home better to lymph nodes, and move more rapidly within lymph node follicles than do wild-type B cells. In contrast, B cells from Gnai2(-/-) mice enter lymph nodes poorly and move more slowly than do wild-type B cells. The Gnai2(-/-) mice often lack multiple peripheral lymph nodes, and their B cells respond poorly to chemokines, indicating that G alpha(i1) and G alpha(i3) poorly compensate for the loss of G alpha(i2). These results demonstrate opposing roles for Rgs1 and Gnai2 in B cell trafficking into and within lymph nodes.	NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; NIAID, Res Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kehrl, JH (corresponding author), NIAID, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019; Schwartz, Olivier/AAZ-3765-2021	Schwartz, Olivier/0000-0002-0729-1475; Cho, Hyeseon/0000-0001-7512-1980; Kehrl, John/0000-0002-6526-159X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000738, ZIAAI000809, Z01AI000738, Z01AI000809] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; BERG EL, 1991, J CELL BIOL, V114, P343, DOI 10.1083/jcb.114.2.343; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Cho H, 2003, BIOCHEM J, V371, P973, DOI 10.1042/BJ20021769; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; Dalwadi H, 2003, J IMMUNOL, V170, P1707, DOI 10.4049/jimmunol.170.4.1707; Dorsam G, 2003, J IMMUNOL, V171, P3500, DOI 10.4049/jimmunol.171.7.3500; FRIEDL P, 1995, J IMMUNOL, V154, P4973; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Huang TT, 2003, INT IMMUNOL, V15, P1359, DOI 10.1093/intimm/dxg135; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Moratz C, 2000, J IMMUNOL, V164, P1829, DOI 10.4049/jimmunol.164.4.1829; Moratz C, 2004, METHOD ENZYMOL, V389, P15; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Ohman L, 2002, GUT, V51, P392, DOI 10.1136/gut.51.3.392; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Wei SH, 2003, IMMUNOL REV, V195, P136, DOI 10.1034/j.1600-065X.2003.00076.x; Wettschureck N, 2004, PHARMACOL THERAPEUT, V101, P75, DOI 10.1016/j.pharmthera.2003.10.005; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916	45	142	147	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					343	354		10.1016/j.immuni.2005.01.017	http://dx.doi.org/10.1016/j.immuni.2005.01.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780991	Bronze			2022-12-18	WOS:000228105700009
J	Goping, IS; Barry, M; Liston, P; Sawchuk, T; Constantinescu, G; Michalak, KM; Shostak, I; Roberts, DL; Hunter, AM; Korneluk, R; Bleackley, RC				Goping, IS; Barry, M; Liston, P; Sawchuk, T; Constantinescu, G; Michalak, KM; Shostak, I; Roberts, DL; Hunter, AM; Korneluk, R; Bleackley, RC			Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition	IMMUNITY			English	Article							CYTOCHROME-C RELEASE; STRUCTURAL BASIS; CELL-DEATH; SERINE-PROTEASE; MITOCHONDRIAL RELEASE; DNA FRAGMENTATION; RAPID INDUCTION; DIRECT CLEAVAGE; XIAP; IAP	Cytotoxic lymphocytes employ Granzyme B as a potent initiator of apoptosis to cleave and activate effector caspases. Unexpectedly, cells transfected with Bcl-2 were resistant to granzyme B-induced killing, suggesting that a mitochondrial pathway was critical. Utilizing cells expressing a dominant-negative caspase 9, the current study demonstrated that caspase activation via the apoptosome was not required. Indeed, cleavage of caspase 3 to p20 still occurred in Bcl-2-transfectants but processing to p17 was blocked. This blockade was recapitulated by the Inhibitor-of-Apoptosis-Protein XIAP and relieved by Smac/DIABLO. Thus granzyme B mediates direct cleavage of caspase 3 and also activates mitochondrial disruption, resulting in the release of proapoptotic proteins that suppress caspase inhibition. Engagement of both pathways is critical for granzyme-induced killing.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada	University of Alberta; University of Ottawa; Children's Hospital of Eastern Ontario	Bleackley, RC (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	chris.bleackley@ualberta.ca		Roberts, Darren/0000-0001-7175-7754; Constantinescu, Gabriela/0000-0001-7709-6547				Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Atkinson EA, 1998, J BIOL CHEM, V273, P21261, DOI 10.1074/jbc.273.33.21261; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Caputo A, 1999, PROTEINS, V35, P415, DOI 10.1002/(SICI)1097-0134(19990601)35:4<415::AID-PROT5>3.0.CO;2-7; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Darmon AJ, 1996, J BIOL CHEM, V271, P21709, DOI 10.1074/jbc.271.36.21709; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Heibein JA, 1999, J IMMUNOL, V163, P4683; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Holcik M, 2001, NAT REV MOL CELL BIO, V2, P550, DOI 10.1038/35080103; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Li J, 1998, ENDOCRINOLOGY, V139, P1321, DOI 10.1210/en.139.3.1321; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li SC, 2002, J BIOL CHEM, V277, P26912, DOI 10.1074/jbc.M200726200; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; Pinkoski MJ, 2001, J BIOL CHEM, V276, P12060, DOI 10.1074/jbc.M009038200; Quan LT, 1996, P NATL ACAD SCI USA, V93, P1972, DOI 10.1073/pnas.93.5.1972; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(01)00274-4; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sharif-Askari E, 2001, EMBO J, V20, P3101, DOI 10.1093/emboj/20.12.3101; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Sutton VR, 1997, J IMMUNOL, V158, P5783; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Trapani JA, 2001, GENOME BIOL, V2; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	66	142	149	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					355	365		10.1016/S1074-7613(03)00032-3	http://dx.doi.org/10.1016/S1074-7613(03)00032-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648453	Bronze			2022-12-18	WOS:000181713700006
J	Rengarajan, J; Mittelstadt, PR; Mages, HW; Gerth, AJ; Kroczek, RA; Ashwell, JD; Glimcher, LH				Rengarajan, J; Mittelstadt, PR; Mages, HW; Gerth, AJ; Kroczek, RA; Ashwell, JD; Glimcher, LH			Sequential involvement of NFAT and EGR transcription factors in fast regulation	IMMUNITY			English	Article							T-CELL ACTIVATION; CYCLOSPORINE-A; NUCLEAR FACTOR; LIGAND EXPRESSION; IMMUNE-RESPONSE; FAMILY MEMBERS; MICE LACKING; IL-4 GENE; PROMOTER; ELEMENT	The critical function of NFAT proteins in maintaining lymphoid homeostasis was revealed in mice lacking both NFATp and NFAT4 (DKO). DKO mice exhibit increased lymphoproliferation, decreased activation-induced cell death, and impaired induction of Fast. The transcription factors Egr2 and Egr3 are potent activators of Fast expression. Here we find that Egr2 and Egr3 are NFAT target genes. Activation of Fast occurs via the NFAT-dependent induction of Egr3, as demonstrated by the ability of exogenously provided NFATp to restore Egr-dependent Fast promoter activity in DKO lymph node cells. Further, Egr3 expression is enriched in Th1 cells, suggesting a molecular basis for the known preferential expression of Fast in the Th1 versus Th2 subset.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA; Robert Koch Inst, D-13353 Berlin, Germany; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Robert Koch Institute; Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.				DIVISION OF BASIC SCIENCES - NCI [Z01BC009290] Funding Source: NIH RePORTER; NIAID NIH HHS [AI98005] Funding Source: Medline; NIA NIH HHS [AG37833] Funding Source: Medline	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CHOI MSK, 1994, IMMUNITY, V1, P179, DOI 10.1016/1074-7613(94)90096-5; CRABTREE G, 1989, SCIENCE, V249, P355; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; KUBO M, 1994, INT IMMUNOL, V6, P179, DOI 10.1093/intimm/6.2.179; Latinis KM, 1997, J IMMUNOL, V158, P4602; Li-Weber M, 1998, EUR J IMMUNOL, V28, P2373, DOI 10.1002/(SICI)1521-4141(199808)28:08<2373::AID-IMMU2373>3.0.CO;2-T; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; MACH B, 1994, IMMUNOL REV, V138, P207, DOI 10.1111/j.1600-065X.1994.tb00853.x; Mages HW, 1998, MOL CELL BIOL, V18, P7157, DOI 10.1128/MCB.18.12.7157; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Mittelstadt PR, 1999, J BIOL CHEM, V274, P3222, DOI 10.1074/jbc.274.5.3222; Nonchev S, 1996, P NATL ACAD SCI USA, V93, P9339, DOI 10.1073/pnas.93.18.9339; Norian LA, 1998, J IMMUNOL, V161, P1078; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Ouyang W, 1999, P NATL ACAD SCI USA, V96, P3888, DOI 10.1073/pnas.96.7.3888; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; RANGNEKAR VM, 1990, NUCLEIC ACIDS RES, V18, P2749, DOI 10.1093/nar/18.9.2749; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; ROONEY JW, 1995, IMMUNITY, V2, P545; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SUDA T, 1995, J IMMUNOL, V154, P3806; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Timmerman LA, 1997, J IMMUNOL, V159, P2735; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Varadhachary AS, 1997, P NATL ACAD SCI USA, V94, P5778, DOI 10.1073/pnas.94.11.5778; VENKATARAMAN L, 1994, IMMUNITY, V1, P189, DOI 10.1016/1074-7613(94)90097-3; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Xiao S, 1999, EUR J IMMUNOL, V29, P3456, DOI 10.1002/(SICI)1521-4141(199911)29:11<3456::AID-IMMU3456>3.3.CO;2-2; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1	51	142	146	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2000	12	3					293	300		10.1016/S1074-7613(00)80182-X	http://dx.doi.org/10.1016/S1074-7613(00)80182-X			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755616	Bronze			2022-12-18	WOS:000086292100007
J	Dadaglio, G; Nelson, CA; Deck, MB; Petzold, SJ; Unanue, ER				Dadaglio, G; Nelson, CA; Deck, MB; Petzold, SJ; Unanue, ER			Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody	IMMUNITY			English	Article							CLASS-II MOLECULE; ANTIGEN-PRESENTING CELL; T-CELL; RESTRICTED PRESENTATION; SEROLOGIC EPITOPES; CONTACT RESIDUES; IDENTIFICATION; AK; DETERMINANT; EXPRESSION	Here we describe generation of Aw3.18, a monoclonal antibody that recognizes peptide residues 48-62 of hen egg lysozyme (HEL) bound to the MHC class II molecule I-A(k). Epitope mapping revealed that Aw3.18 detects a change in the solvent-exposed surface of this peptide-MHC complex upon substitution of the peptide side chain at position P1. Furthermore, Aw3.18 blocked recognition by some, but not all, of the HEL 48-62-reactive T cell hybridomas tested, suggesting a heterogeneity in the T cell response toward this complex. Finally, using Aw3.18, it was possible to determine the fraction of I-A(k) molecules loaded with 48-62 peptide after culture of an antigen-presenting cell in medium containing HEL.			Dadaglio, G (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PATHOL,CTR IMMUNOL,ST LOUIS,MO 63110, USA.		Dadaglio, Gilles/Y-7036-2019	Dadaglio, Gilles/0000-0003-3848-0823				ALLEN PM, 1984, P NATL ACAD SCI-BIOL, V81, P2489, DOI 10.1073/pnas.81.8.2489; ALLEN PM, 1987, NATURE, V327, P713, DOI 10.1038/327713a0; BECK BN, 1986, J IMMUNOL, V136, P2953; BROOKS A, 1991, P NATL ACAD SCI USA, V88, P3290, DOI 10.1073/pnas.88.8.3290; BROOKS AG, 1993, J IMMUNOL, V150, P3690; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BUERSTEDDE JM, 1988, J EXP MED, V167, P473, DOI 10.1084/jem.167.2.473; Eastman S, 1996, EUR J IMMUNOL, V26, P385, DOI 10.1002/eji.1830260218; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GLIMCHER LH, 1985, J IMMUNOL, V135, P3542; HAMMERLING G, 1979, IMMUNOGENETICS, V14, P433; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; IGNATOWICZ L, 1995, J IMMUNOL, V154, P3852; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; LAMBERT LE, 1989, J IMMUNOL, V143, P802; MURPHY DB, 1992, J IMMUNOL, V148, P3483; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Nelson CA, 1996, J IMMUNOL, V157, P755; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; Nelson CA, 1996, IMMUNOL REV, V151, P81, DOI 10.1111/j.1600-065X.1996.tb00704.x; Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115; ParraLopez CA, 1997, J IMMUNOL, V158, P2670; PECCOUD J, 1990, EMBO J, V9, P4215, DOI 10.1002/j.1460-2075.1990.tb07869.x; PIERRES M, 1981, IMMUNOGENETICS, V14, P481, DOI 10.1007/BF00350120; REAY PA, 1994, J IMMUNOL, V152, P3946; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; ROSLONIEC EF, 1993, MOL IMMUNOL, V30, P491, DOI 10.1016/0161-5890(93)90117-T; SANDERSON S, 1995, P NATL ACAD SCI USA, V92, P7217, DOI 10.1073/pnas.92.16.7217; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Viner NJ, 1996, J IMMUNOL, V156, P2365; WADE WF, 1989, P NATL ACAD SCI USA, V86, P6297, DOI 10.1073/pnas.86.16.6297; WEI BY, 1994, INT IMMUNOL, V6, P297, DOI 10.1093/intimm/6.2.297	38	142	152	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1997	6	6					727	738		10.1016/S1074-7613(00)80448-3	http://dx.doi.org/10.1016/S1074-7613(00)80448-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208845	Bronze			2022-12-18	WOS:A1997XG57900008
J	GIRARD, JP; SPRINGER, TA				GIRARD, JP; SPRINGER, TA			CLONING FROM PURIFIED HIGH ENDOTHELIAL VENULE CELLS OF HEVIN, A CLOSE RELATIVE OF THE ANTIADHESIVE EXTRACELLULAR-MATRIX PROTEIN SPARC	IMMUNITY			English	Article							NODE VASCULAR ADDRESSIN; LYMPH-NODE; L-SELECTIN; RECIRCULATING LYMPHOCYTES; BINDING; EXPRESSION; MIGRATION; SEQUENCE; TISSUES; MACROPHAGES	High endothelial venules (HEV) in lymphoid tissues support high levels of lymphocyte extravasion from the blood. We purified high endothelial cells from human tonsils by immunomagnetic selection with MECA-79 MAb to construct an HEV cDNA library. Differential screening of this library using cDNA probes from HEV (plus) or flat-walled vessel (minus) endothelial cells allowed us to characterize a novel human cDNA expressed to high levels in HEV. The cDNA encodes a secreted acidic calcium-binding glycoprotein of 664 aa residues, designated hevin, exhibiting 62% identify with the antiadhesive extracellular matrix protein SPARC, over a region of 232 aa spanning more than four fifths of the SPARC coding sequence. The primary structure and sequence of hevin are similar to SPARC-like proteins from rat and quail, called SC1 or QR1. Hevin could contribute to the induction or maintenance of features of the HEV endothelium that facilitate lymphocyte migration.	HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School	GIRARD, JP (corresponding author), HARVARD UNIV, SCH MED, CTR BLOOD RES, BOSTON, MA 02115 USA.		GIRARD, Jean-Philippe/F-5229-2010	GIRARD, Jean-Philippe/0000-0002-9154-1691	NATIONAL CANCER INSTITUTE [R01CA031788] Funding Source: NIH RePORTER; NCI NIH HHS [CA-31788] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGER A, 1988, EUR J IMMUNOL, V18, P1265, DOI 10.1002/eji.1830180818; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson A O, 1993, Semin Immunol, V5, P271, DOI 10.1006/smim.1993.1031; ANDERSON ND, 1976, IMMUNOLOGY, V31, P455; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BERG EL, 1991, J CELL BIOL, V114, P343, DOI 10.1083/jcb.114.2.343; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; CAHILL RNP, 1976, J EXP MED, V143, P870, DOI 10.1084/jem.143.4.870; CHIN YH, 1992, J IMMUNOL, V148, P1106; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOWBENKO D, 1993, J CLIN INVEST, V92, P952, DOI 10.1172/JCI116671; FINA L, 1990, BLOOD, V75, P2417; FREEMONT AJ, 1983, J ANAT, V136, P349; FREEMONT AJ, 1988, J PATHOL, V155, P225, DOI 10.1002/path.1711550308; GIRARD JP, 1994, IN PRESS LEUKOCYTE T, V5; GOLDBLUM SE, 1994, P NATL ACAD SCI USA, V91, P3448, DOI 10.1073/pnas.91.8.3448; GUERMAH M, 1991, P NATL ACAD SCI USA, V88, P4503, DOI 10.1073/pnas.88.10.4503; HARLOW E, 1988, ANTIBODIES LABORATOR; HENDRIKS HR, 1983, EUR J IMMUNOL, V13, P663, DOI 10.1002/eji.1830130811; HOLLAND PWH, 1987, J CELL BIOL, V105, P473, DOI 10.1083/jcb.105.1.473; JOHNSTON IG, 1990, NEURON, V4, P165, DOI 10.1016/0896-6273(90)90452-L; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANE TF, 1990, J CELL BIOL, V111, P3065, DOI 10.1083/jcb.111.6.3065; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; MEBIUS RE, 1991, IMMUNOBIOLOGY, V182, P277, DOI 10.1016/S0171-2985(11)80663-7; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; MENDIS DB, 1994, BRAIN RES, V633, P197, DOI 10.1016/0006-8993(94)91540-7; MICHIE SA, 1993, AM J PATHOL, V143, P1688; MURPHYULLRICH JE, 1991, J CELL BIOL, V115, P1127, DOI 10.1083/jcb.115.4.1127; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561; ROT A, 1992, IMMUNOL TODAY, V13, P291, DOI 10.1016/0167-5699(92)90039-A; SAGE EH, 1991, J BIOL CHEM, V266, P14831; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400; Sambrook J., 1989, MOL CLONING LAB MANU; SCHOEFL GI, 1972, J EXP MED, V136, P568, DOI 10.1084/jem.136.3.568; SMITH ME, 1983, IMMUNOLOGY, V49, P83; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; VILLARREAL XC, 1989, BIOCHEMISTRY-US, V28, P6483, DOI 10.1021/bi00441a049; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; YEDNOCK TA, 1989, ADV IMMUNOL, V44, P313, DOI 10.1016/S0065-2776(08)60645-8; YOST JC, 1993, J BIOL CHEM, V268, P25790	51	142	145	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1995	2	1					113	123		10.1016/1074-7613(95)90083-7	http://dx.doi.org/10.1016/1074-7613(95)90083-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QC593	7600298	Bronze			2022-12-18	WOS:A1995QC59300010
J	Lee, JH; Elly, C; Park, Y; Liu, YC				Lee, Jee H.; Elly, Chris; Park, Yoon; Liu, Yun-Cai			E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1 alpha to Maintain Regulatory T Cell Stability and Suppressive Capacity	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; IFN-GAMMA PRODUCTION; HIF-1-ALPHA; ENTEROPATHY; HOMEOSTASIS; EXPRESSION; HIF1-ALPHA; ABUNDANCE; RESPONSES; PROGRAMS	Foxp3(+) regulatory T (Treg) cells play a critical role in immune homeostasis; however, the mechanisms to maintain their function remain unclear. Here, we report that the E3 ubiquitin ligase VHL is essential for Treg cell function. Mice with Foxp3-restricted VHL deletion displayed massive inflammation associated with excessive Treg cell interferon-gamma (IFN-gamma) production. VHL-deficient Treg cells failed to prevent colitis induction, but converted into Th1-like effector T cells. VHL intrinsically orchestrated such conversion under both steady and inflammatory conditions followed by Foxp3 downregulation, which was reversed by IFN-gamma deficiency. Augmented hypoxia-inducible factor 1 alpha (HIF-1 alpha)-induced glycolytic reprogramming was required for IFN-gamma production. Furthermore, HIF-1 alpha bound directly to the Ifng promoter. HIF-1 alpha knockdown or knockout could reverse the increased IFN-gamma by VHL-deficient Treg cells and restore their suppressive function in vivo. These findings indicate that regulation of HIF-1 alpha pathway by VHL is crucial to maintain the stability and suppressive function of Foxp3(+) T cells.	[Lee, Jee H.; Elly, Chris; Park, Yoon; Liu, Yun-Cai] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Liu, YC (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA.	yuncail@liai.org		LIU, YUN-CAI/0000-0002-0996-7109	NIH from NIAID [RO1AI62969, RO1AI78272, PO1AI089624]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062969, R01AI078272, P01AI089624] Funding Source: NIH RePORTER	NIH from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Rudensky for providing the Foxp3-cre mice, and H.-s. Jin, J. Lopez, and other members in the laboratory for technical help and advice. This work is supported by NIH grants (RO1AI62969, RO1AI78272, and PO1AI089624) from NIAID.	Acosta-Iborra B, 2009, J IMMUNOL, V182, P3155, DOI 10.4049/jimmunol.0801710; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Buckley DL, 2012, J AM CHEM SOC, V134, P4465, DOI 10.1021/ja209924v; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Carraro F, 2007, J CELL PHYSIOL, V211, P439, DOI 10.1002/jcp.20951; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Koenecke C, 2012, J IMMUNOL, V189, P2890, DOI 10.4049/jimmunol.1200413; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Sueoka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057833; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zou J, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-3	40	141	151	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1062	1074		10.1016/j.immuni.2015.05.016	http://dx.doi.org/10.1016/j.immuni.2015.05.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084024	Green Accepted, Bronze			2022-12-18	WOS:000356362800012
J	Escobar, TM; Kanellopoulou, C; Kugler, DG; Kilaru, G; Nguyen, CK; Nagarajan, V; Bhairavabhotla, RK; Northrup, D; Zahr, R; Burr, P; Liu, XH; Zhao, KJ; Sher, A; Jankovic, D; Zhu, JF; Muljo, SA				Escobar, Thelma M.; Kanellopoulou, Chrysi; Kugler, David G.; Kilaru, Gokhul; Nguyen, Cuong K.; Nagarajan, Vijayaraj; Bhairavabhotla, Ravikiran K.; Northrup, Daniel; Zahr, Rami; Burr, Patrick; Liu, Xiuhuai; Zhao, Keji; Sher, Alan; Jankovic, Dragana; Zhu, Jinfang; Muljo, Stefan A.			miR-155 Activates Cytokine Gene Expression in Th17 Cells by Regulating the DNA-Binding Protein Jarid2 to Relieve Polycomb-Mediated Repression	IMMUNITY			English	Article							T-CELLS; T(H)17 CELLS; STEM-CELLS; TGF-BETA; DIFFERENTIATION; TARGET; MICRORNA-155; PRC2; MICE; INFLAMMATION	Specification of the T helper 17 (Th17) cell lineage requires a well-defined set of transcription factors, but how these integrate with posttranscriptional and epigenetic programs to regulate gene expression is poorly understood. Here we found defective Th17 cell cytokine expression in miR-155-deficient CD4(+) T cells in vitro and in vivo. Mir155 was bound by Th17 cell transcription factors and was highly expressed during Th17 cell differentiation. miR-155-deficient Th17 and T regulatory (Treg) cells expressed increased amounts of Jarid2, a DNA-binding protein that recruits the Polycomb Repressive Complex 2 (PRC2) to chromatin. PRC2 binding to chromatin and H3K27 histone methylation was increased in miR-155-deficient cells, coinciding with failure to express Il22, Il10, Il9, and Atf3. Defects in Th17 cell cytokine expression and Treg cell homeostasis in the absence of Mir155 could be partially suppressed by Jarid2 deletion. Thus, miR-155 contributes to Th17 cell function by suppressing the inhibitory effects of Jarid2.	[Escobar, Thelma M.; Kanellopoulou, Chrysi; Kilaru, Gokhul; Nguyen, Cuong K.; Bhairavabhotla, Ravikiran K.; Zahr, Rami; Burr, Patrick; Liu, Xiuhuai; Zhu, Jinfang; Muljo, Stefan A.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Kugler, David G.; Sher, Alan; Jankovic, Dragana] NIAID, Lab Parasit Dis, NIH, Bethesda, MD 20892 USA; [Nagarajan, Vijayaraj] NIAID, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA; [Northrup, Daniel; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Muljo, SA (corresponding author), NIAID, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	stefan.muljo@nih.gov	Zhu, Jinfang/B-7574-2012; Nguyen, Cuong/D-7567-2013; Muljo, Stefan A/F-5671-2015; Nguyen, Cuong/GYU-8270-2022; Nguyen, Cuong Kieu/Q-8306-2019	Zhu, Jinfang/0000-0002-0117-4745; Nguyen, Cuong/0000-0002-1741-669X; Muljo, Stefan A/0000-0003-1013-446X; Bhairavabhotla, Ravikiran/0000-0003-3026-8166; Escobar, Thelma/0000-0001-5352-3903; Northrup, Daniel/0000-0002-2665-2686; Kugler, David/0000-0002-2936-1649	Intramural Research Program of the NIAID, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579, ZIAAI001169, ZIAAI001131] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W.E. Paul for his generou support and advice throughout; Y.S. Chang and T. Hai (Ohio State University) for providing Atf3-deficient mice; B.J. Abraham for help with ChIP-seq analyses; E. Shevach for facilitating human T cell studies; B. Kelsall for BM chimera protocol; L. Barron, J. Hu-Li, and S. Sharma for technical advice and assistance; J. Edwards for cell sorting; the Biowulf Linux cluster (http://biowulf.nih.gov/) and NIAID Office of Cyber Infrastructure and Computational Biology for providing high performance computing; the NIH Tetramer Core Facility at Emory University for MHC tetramers; W. Ouyang (Genentech) for IL-22 antibody; and B. Brady, M. Crank, R. Germain, W. Leonard, A. Oler, J. O'Shea, and anonymous reviewers for constructive criticisms of the manuscript. T.M.E. was in the NIH-Johns Hopkins University Graduate Partnership Program and received valuable guidance from K. Beemon and S. Gottesman. This work was supported by the Intramural Research Program of the NIAID, NIH.	Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bluml S, 2011, ARTHRITIS RHEUM-US, V63, P1281, DOI 10.1002/art.30281; Bolisetty MT, 2009, J VIROL, V83, P12009, DOI 10.1128/JVI.01182-09; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Escobar T, 2013, INVEST OPHTH VIS SCI, V54, P4017, DOI 10.1167/iovs.13-11937; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li XZ, 2011, MOL CELL BIOL, V31, P351, DOI 10.1128/MCB.00259-10; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	58	141	153	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					865	879		10.1016/j.immuni.2014.03.014	http://dx.doi.org/10.1016/j.immuni.2014.03.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24856900	Green Accepted, Bronze			2022-12-18	WOS:000341440200010
J	Griseri, T; McKenzie, BS; Schiering, C; Powrie, F				Griseri, Thibault; McKenzie, Brent S.; Schiering, Chris; Powrie, Fiona			Dysregulated Hematopoietic Stem and Progenitor Cell Activity Promotes Interleukin-23-Driven Chronic Intestinal Inflammation	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; T-CELLS; IFN-GAMMA; DISEASE; INNATE; IDENTIFICATION; PROLIFERATION; EXPRESSION; RECEPTORS; BLOOD	In interleukin-23 (IL-23)-dependent colitis, there is excessive accumulation of short-lived neutrophils and inflammatory monocytes in the intestine. It is unknown whether this reflects changes in mature cell populations or whether the IL-23-driven colitogenic T cell program regulates upstream hematopoietic stem and progenitor cells (HSPC). Here we have shown dysregulation of hematopoiesis in colitis mediated by inflammatory cytokines. First, there was an interferon-gamma-dependent accumulation of proliferating hematopoietic stem cells in the bone marrow and spleen. Second, there was a strong skew toward granulocyte-monocyte progenitor (GMP) production at the expense of erythroid and lymphoid progenitors. Extramedullary hematopoiesis was also evident, and granulocyte macrophage-colony stimulating factor (GM-CSF) blockade reduced the accumulation of splenic and colonic GMPs, resulting in amelioration of colitis. Importantly, transfer of GMPs exacerbated colitis. These data identify HSPCs as a major target of the IL-23-driven inflammatory axis suggesting therapeutic strategies for the treatment of inflammatory bowel disease.	[Griseri, Thibault; Schiering, Chris; Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Translat Gastroenterol Unit,Expt Med Div, Oxford OX3 9DU, England; [McKenzie, Brent S.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, CSL Ltd, Res Dept, Parkville, Vic 3010, Australia; [Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; CSL; University of Melbourne; University of Oxford	Powrie, F (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Translat Gastroenterol Unit,Expt Med Div, Oxford OX3 9DU, England.	fiona.powrie@path.ox.ac.uk		Schiering, Chris/0000-0001-7902-6024	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank H. Ferry and N. Rust for assistance with cell sorting, R. Stillion for histology, and the staff of our animal facility. We thank Claire Pearson for technical assistance. This work was supported by grants from the Wellcome Trust to T. Griseri, C. Schiering (Four-Year PhD Programme), and F. Powrie (Senior Investigator Award). Brent McKenzie is employed by CSL Ltd. We thank Daniel Cua (Merck Research Laboratories, Palo Alto, USA) for the provision of the C57BL/6.ll23r<SUP>-/-</SUP> mice.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Bhattacharya D, 2009, J EXP MED, V206, P2837, DOI 10.1084/jem.20090778; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chen C, 2010, J CLIN INVEST, V120, P4091, DOI 10.1172/JCI43873; Chin AC, 2006, ANN NY ACAD SCI, V1072, P276, DOI 10.1196/annals.1326.018; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Erdman SE, 2009, P NATL ACAD SCI USA, V106, P1027, DOI 10.1073/pnas.0812347106; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Griseri T, 2010, J EXP MED, V207, P699, DOI 10.1084/jem.20091618; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kang YJ, 2007, STEM CELLS, V25, P1814, DOI 10.1634/stemcells.2007-0002; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura A, 2009, BLOOD, V114, P4721, DOI 10.1182/blood-2009-04-216390; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lee JH, 2009, J IMMUNOL, V183, P6377, DOI 10.4049/jimmunol.0901268; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Morita Y, 2011, EXP HEMATOL, V39, P351, DOI 10.1016/j.exphem.2010.12.008; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Souza HS, 1999, GUT, V45, P856, DOI 10.1136/gut.45.6.856; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480	41	141	141	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					1116	1129		10.1016/j.immuni.2012.08.025	http://dx.doi.org/10.1016/j.immuni.2012.08.025			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23200826	Green Published, hybrid			2022-12-18	WOS:000312575000018
J	Im, JS; Arora, P; Bricard, G; Molano, A; Venkataswamy, MM; Baine, I; Jerud, ES; Goldberg, MF; Baena, A; Yu, KOA; Ndonye, RM; Howell, AR; Yuan, WM; Cresswell, P; Chang, YT; Illarionov, PA; Besra, GS; Porcelli, SA				Im, Jin S.; Arora, Pooja; Bricard, Gabriel; Molano, Alberto; Venkataswamy, Manjunatha M.; Baine, Ian; Jerud, Elliot S.; Goldberg, Michael F.; Baena, Andres; Yu, Karl O. A.; Ndonye, Rachel M.; Howell, Amy R.; Yuan, Weiming; Cresswell, Peter; Chang, Young-tae; Illarionov, Petr A.; Besra, Gurdyal S.; Porcelli, Steven A.			Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation	IMMUNITY			English	Article							HUMAN CD1D MOLECULES; LIGAND ALPHA-GALACTOSYLCERAMIDE; II-PEPTIDE COMPLEXES; NKT CELLS; PLASMA-MEMBRANE; DENDRITIC CELLS; LIPID RAFTS; IN-VIVO; RECOGNITION; PROTEINS	CID1d-restricted natural killer T cells (NKT cells) possess a wide range of effector and regulatory activities that are related to their ability to secrete both T helper 1 (Th1) cell- and Th2 cell-type cytokines. We analyzed presentation of NKT cell activating a galactosylceramide (alpha GalCer) analogs that give predominantly Th2 cell-type cytokine responses to determine how ligand structure controls the outcome of NKT cell activation. Using a monoclonal antibody specific for alpha GalCer-CD1d complexes to visualize and quantitate glycolipid presentation, we found that Th2 cell-type cytokine-biasing ligands were characterized by rapid and direct loading of cell-surface CD1d proteins. Complexes formed by association of these Th2 cell-type cytokine-biasing alpha GalCer analogs with CD1d showed a distinctive exclusion from ganglioside-enriched, detergent-resistant plasma membrane microdomains of antigen-presenting cells. These findings help to explain how subtle alterations in glycolipid ligand structure can control the balance of proinflammatory and anti-inflammatory activities of NKT cells.	[Im, Jin S.; Arora, Pooja; Bricard, Gabriel; Molano, Alberto; Venkataswamy, Manjunatha M.; Baine, Ian; Jerud, Elliot S.; Goldberg, Michael F.; Baena, Andres; Yu, Karl O. A.; Porcelli, Steven A.] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Porcelli, Steven A.] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Ndonye, Rachel M.; Howell, Amy R.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Yuan, Weiming; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Yuan, Weiming; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Chang, Young-tae] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Chang, Young-tae] Natl Univ Singapore, Inst Life Sci, NUS MedChem Program, Singapore 117543, Singapore; [Illarionov, Petr A.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Connecticut; Yale University; Howard Hughes Medical Institute; Yale University; National University of Singapore; National University of Singapore; University of Birmingham	Porcelli, SA (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	porcelli@aecom.yu.edu	Yu, Karl/ABC-4547-2020; Chang, Young-Tae/B-2780-2010	Chang, Young-Tae/0000-0002-1927-3688; Baena, Andres/0000-0003-1309-1020; arora, pooja/0000-0002-4037-7406; Besra, Gurdyal/0000-0002-5605-0395; Baine, Ian/0000-0002-0419-0054; Howell, Amy/0000-0003-1958-6411	NIH [AI45889, AI057519, 5T32CA009173]; Medical Research Council; Wellcome Trust [084923/B/08/7]; Royal Society Wolfson Research Merit Award; James Bardrick Research Chair; Albert Einstein College of Medicine; Howard Hughes Medical Institute Training Fellowship; NCI [CA13330]; Einstein Center for AIDS Research [AI51519]; MRC [G0400421] Funding Source: UKRI; Medical Research Council [G0400421] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009173, P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519, R01AI057519, R01AI045889] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society Wolfson Research Merit Award(Royal Society of London); James Bardrick Research Chair; Albert Einstein College of Medicine; Howard Hughes Medical Institute Training Fellowship(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein Center for AIDS Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI45889 (S.A.P.) and AI057519 (A.R.H.). G.S.B. is a former Lister Institute-Jenner Research Fellow and received support from the Medical Research Council (U.K.), the Wellcome Trust (084923/B/08/7), a Royal Society Wolfson Research Merit Award, and the James Bardrick Research Chair. K.O.A.Y. was supported by the Medical Scientist Training Program of the Albert Einstein College of Medicine, E.S.J. received a Howard Hughes Medical Institute Training Fellowship, and M.G. was supported by NIH Training Grant 5T32CA009173. The authors acknowledge technical support from the Einstein Analytical Imaging and Flow Cytometry Core Laboratories supported by the NCI funded Einstein Cancer Center (CA13330) and the Einstein Center for AIDS Research (AI51519). S.A.P. is a paid consultant for Vaccinex, Inc. (Rochester, NY).	Behar SM, 2007, CURR TOP MICROBIOL, V314, P215; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bezbradica JS, 2005, J IMMUNOL, V174, P4696, DOI 10.4049/jimmunol.174.8.4696; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Buatois V, 2003, J IMMUNOL, V171, P5812, DOI 10.4049/jimmunol.171.11.5812; Chang YJ, 2007, P NATL ACAD SCI USA, V104, P10299, DOI 10.1073/pnas.0703824104; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Denkberg G, 2008, EUR J IMMUNOL, V38, P829, DOI 10.1002/eji.200737518; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Forestier C, 2007, J IMMUNOL, V178, P1415, DOI 10.4049/jimmunol.178.3.1415; Fujii SI, 2006, P NATL ACAD SCI USA, V103, P11252, DOI 10.1073/pnas.0604812103; Fujio M, 2006, J AM CHEM SOC, V128, P9022, DOI 10.1021/ja062740z; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Goff RD, 2004, J AM CHEM SOC, V126, P13602, DOI 10.1021/ja045385q; Gombos I, 2004, IMMUNOL LETT, V92, P117, DOI 10.1016/j.imlet.2003.11.022; Gombos I, 2004, CYTOM PART A, V61A, P117, DOI 10.1002/cyto.a.20080; Im JS, 2006, J IMMUNOL, V177, P5226, DOI 10.4049/jimmunol.177.8.5226; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Jiang X, 2007, AM J TRANSPLANT, V7, P1482, DOI 10.1111/j.1600-6143.2007.01827.x; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Lang GA, 2004, IMMUNOLOGY, V112, P386, DOI 10.1111/j.1365-2567.2004.01896.x; Li Q, 2007, J COMB CHEM, V9, P1084, DOI 10.1021/cc070057i; Mach N, 2000, CANCER RES, V60, P3239; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Miyake Sachiko, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P315, DOI 10.2174/1568008054863772; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Ndonye RM, 2005, J ORG CHEM, V70, P10260, DOI 10.1021/jo051147h; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Park YK, 2005, BIOCHEM BIOPH RES CO, V327, P1143, DOI 10.1016/j.bbrc.2004.12.121; Peng W, 2007, MOL MEMBR BIOL, V24, P475, DOI 10.1080/09687680701359408; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Sagiv Y, 2006, J IMMUNOL, V177, P26, DOI 10.4049/jimmunol.177.1.26; Sakuishi K, 2007, J IMMUNOL, V179, P3452, DOI 10.4049/jimmunol.179.6.3452; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Schrantz N, 2007, J EXP MED, V204, P841, DOI 10.1084/jem.20061562; Stanic AK, 2003, J IMMUNOL, V171, P4539, DOI 10.4049/jimmunol.171.9.4539; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Yu KOA, 2005, IMMUNOL LETT, V100, P42, DOI 10.1016/j.imlet.2005.06.010; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	45	141	143	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					888	898		10.1016/j.immuni.2009.03.022	http://dx.doi.org/10.1016/j.immuni.2009.03.022			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19538930	Green Published, hybrid			2022-12-18	WOS:000267270700015
J	Demotte, N; Stroobant, V; Courtoy, PJ; Van Der Smissen, P; Colau, D; Luescher, IF; Hivroz, C; Nicaise, J; Squifflet, JL; Mourad, M; Godelaine, D; Boon, T; van der Bruggen, P				Demotte, Nathalie; Stroobant, Vincent; Courtoy, Pierre J.; Van Der Smissen, Patrick; Colau, Didier; Luescher, Immanuel F.; Hivroz, Claire; Nicaise, Julie; Squifflet, Jean-Luc; Mourad, Michel; Godelaine, Danile; Boon, Thierry; van der Bruggen, Pierre			Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes	IMMUNITY			English	Article							MELANOMA PATIENTS; IMMUNOLOGICAL SYNAPSE; ANTIGEN RECOGNITION; TETRAMER BINDING; ACTIVATION; GALECTIN-3; PEPTIDE; MOLECULES; RESPONSES; COMPLEX	For several days after antigenic stimulation, human cytolytic T lymphocyte (CTL) clones exhibit a decrease in their effector activity and in their binding to human leukocyte antigen (HLA)-peptide tetramers. We observed that, when in this state, CTLs lose the colocalization of the T cell receptor (TCR) and CD8. Effector function and TCR-CD8 colocalization were restored with galectin disaccharide ligands, suggesting that the binding of TCR to galectin plays a role in the distancing of TCR from CD8. These findings appear to be applicable in vivo, as TCR was observed to be distant from CD8 on human tumor-infiltrating lymphocytes, which were anergic. These lymphocytes recovered effector functions and TCR-CD8 colocalization after ex vivo treatment with galectin disaccharide ligands. The separation of TCR and CD8 molecules could be one major mechanism of anergy in tumors and other chronic stimulation conditions.	[Demotte, Nathalie; Stroobant, Vincent; Colau, Didier; Nicaise, Julie; Godelaine, Danile; Boon, Thierry; van der Bruggen, Pierre] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Demotte, Nathalie; Stroobant, Vincent; Colau, Didier; Nicaise, Julie; Godelaine, Danile; Boon, Thierry; van der Bruggen, Pierre] Catholic Univ Louvain, Inst Cell Pathol, Cell Genet Unit, B-1200 Brussels, Belgium; [Courtoy, Pierre J.; Van Der Smissen, Patrick] Catholic Univ Louvain, Inst Cell Pathol, Cell Biol Unit, B-1200 Brussels, Belgium; [Luescher, Immanuel F.] Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [Hivroz, Claire] Inst Curie, INSERM, U653, F-75005 Paris, France; [Squifflet, Jean-Luc] Catholic Univ Louvain, Clin Univ St Luc, Dept Gynaecol, B-1200 Brussels, Belgium; [Mourad, Michel] Catholic Univ Louvain, Clin Univ St Luc, Dept Transplant Surg, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	van der Bruggen, P (corresponding author), Ludwig Inst Canc Res, B-1200 Brussels, Belgium.	pierre.vanderbruggen@bru.licr.org	Hivroz, Claire/H-2711-2014	Hivroz, Claire/0000-0002-6794-2890				Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; Blohm U, 2002, J IMMUNOL, V169, P5522, DOI 10.4049/jimmunol.169.10.5522; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Coulie PG, 2001, P NATL ACAD SCI USA, V98, P10290, DOI 10.1073/pnas.161260098; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; De Mattia F, 1999, J IMMUNOL, V163, P5929; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2002, EUR J IMMUNOL, V32, P1688, DOI 10.1002/1521-4141(200206)32:6<1688::AID-IMMU1688>3.0.CO;2-9; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; Doucey MA, 2001, EUR J IMMUNOL, V31, P1561, DOI 10.1002/1521-4141(200105)31:5&lt;1561::AID-IMMU1561&gt;3.0.CO;2-W; Drake DR, 2005, J IMMUNOL, V175, P1507, DOI 10.4049/jimmunol.175.3.1507; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Foti M, 2002, P NATL ACAD SCI USA, V99, P2008, DOI 10.1073/pnas.042689099; Germeau C, 2005, J EXP MED, V201, P241, DOI 10.1084/jem.20041379; Godelaine D, 2003, J IMMUNOL, V171, P4893, DOI 10.4049/jimmunol.171.9.4893; GOSS PE, 1994, CANCER RES, V54, P1450; Goss PE, 1997, CLIN CANCER RES, V3, P1077; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; IOANNIDES CG, 1991, J IMMUNOL, V146, P1700; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Joo HG, 2001, J LEUKOCYTE BIOL, V69, P555; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kao C, 2005, INT IMMUNOL, V17, P1607, DOI 10.1093/intimm/dxh340; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee PUY, 2003, MOL IMMUNOL, V39, P687, DOI 10.1016/S0161-5890(02)00259-6; Lim GEK, 1998, EUR J IMMUNOL, V28, P745, DOI 10.1002/(SICI)1521-4141(199802)28:02<745::AID-IMMU745>3.0.CO;2-6; Lin RS, 1998, J BIOL CHEM, V273, P32878, DOI 10.1074/jbc.273.49.32878; Lonchay C, 2004, P NATL ACAD SCI USA, V101, P14631, DOI 10.1073/pnas.0405743101; Lurquin C, 2005, J EXP MED, V201, P249, DOI 10.1084/jem.20041378; Majstoravich S, 2004, BLOOD, V104, P1396, DOI 10.1182/blood-2004-02-0437; Miro F, 2006, J IMMUNOL, V177, P3625, DOI 10.4049/jimmunol.177.6.3625; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; Pecht I, 2005, FEBS LETT, V579, P3336, DOI 10.1016/j.febslet.2005.04.025; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; SUZUKI S, 1992, EUR J IMMUNOL, V22, P2475, DOI 10.1002/eji.1830221002; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Vereecken P, 2006, CLIN EXP DERMATOL, V31, P105, DOI 10.1111/j.1365-2230.2005.01992.x; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yannelli JR, 1996, INT J CANCER, V65, P413, DOI 10.1002/(SICI)1097-0215(19960208)65:4<413::AID-IJC3>3.0.CO;2-#; Zorn E, 1999, EUR J IMMUNOL, V29, P602, DOI 10.1002/(SICI)1521-4141(199902)29:02<602::AID-IMMU602>3.0.CO;2-Y	58	141	149	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2008	28	3					414	424		10.1016/j.immuni.2008.01.011	http://dx.doi.org/10.1016/j.immuni.2008.01.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18342010	Bronze			2022-12-18	WOS:000254142500018
J	Hall, AB; Gakidis, MAM; Glogauer, M; Wilsbacher, JL; Gao, S; Swat, W; Brugge, JS				Hall, AB; Gakidis, MAM; Glogauer, M; Wilsbacher, JL; Gao, S; Swat, W; Brugge, JS			Requirements for Vav guanine nucleotide exchange factors and Rho GTPases in Fc gamma R- and complement-mediated phagocytosis	IMMUNITY			English	Article							SIGNAL-TRANSDUCTION; FAMILY PROTEINS; MACROPHAGES; RECEPTOR; ACTIVATION; CDC42; NEUTROPHILS; RAC1; SYK; IDENTIFICATION	Vav guanine nucleotide exchange factors (GEFs) have been implicated in cell adhesion by integrin and immune response receptors through the regulation of Rho GTPases. Here, we examine the role of Vav and Rho GTPases in phagocytosis by using primary murine macrophages. The genetic deletion of Rac1 and Rac2 prevents phagocytosis mediated by integrin and Fc gamma receptors (Fc gamma R), whereas the genetic deletion of Vav1 and Vav3 only prevents integrin-mediated phagocytosis through the complement receptor alpha(M)beta(2). In addition, a Rac1/2 or Vav1/3 deficiency blocks Arp2/3 recruitment and actin polymerization at the complement-induced phagosome, indicating that these proteins regulate early steps in phagocytosis. Moreover, constitutively active Rac is able to rescue actin polymerization and complement-mediated phagocytosis in Vav-deficient macrophages. These studies indicate that Rac is critical for complement- and Fc gamma R-mediated phagocytosis. In contrast, Vav is specifically required for complement-mediated phagocytosis, suggesting that Rac is regulated by GEFs other than Vav downstream of the Fc gamma R.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Toronto, Fac Dent, Toronto, ON M5S 1A8, Canada; Washington Univ, Sch Med, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; University of Toronto; Washington University (WUSTL)	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu	Glogauer, Michael/D-2504-2011	Glogauer, Michael/0000-0002-6248-5977	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL059561] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; BROWN EJ, 1987, J IMMUNOL, V139, P3777; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Hackam DJ, 1997, J EXP MED, V186, P955, DOI 10.1084/jem.186.6.955; HAZEKI K, 1994, FEBS LETT, V342, P29, DOI 10.1016/0014-5793(94)80578-4; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	31	141	143	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2006	24	3					305	316		10.1016/j.immuni.2006.02.005	http://dx.doi.org/10.1016/j.immuni.2006.02.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546099	Bronze			2022-12-18	WOS:000236504500011
J	Hansen, DS; Siomos, MA; Buckingham, L; Scalzo, AA; Schofield, L				Hansen, DS; Siomos, MA; Buckingham, L; Scalzo, AA; Schofield, L			Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex	IMMUNITY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; T-CELLS; INTERFERON-GAMMA; MONOCLONAL-ANTIBODY; CUTTING EDGE; CRUCIAL ROLE; MICE; ACTIVATION; ALPHA; MOUSE	NKT cells are specialized cells coexpressing NK and T cell receptors. Upon activation they rapidly produce high levels of interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) and are therefore postulated to influence T(H)1/T(H)2 immune responses. The precise role of the CD1/NKT cell pathway in immune response to infection remains unclear. We show here that CD1d-restricted NKT cells from distinct genetic backgrounds differentially influence TH1/TH2 polarization, proinflammatory cytokine levels, pathogenesis, and fatality in the P. berghei ANKA/rodent model of cerebral malaria. The functional properties of CD1d-restricted NKT cells vary according to expression of loci of the natural killer complex (NKC) located on mouse chromosome 6, which is shown here to be a significant genetic determinant of murine malarial fatalities.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Western Australia, Dept Microbiol, Nedlands, WA 6907, Australia	Walter & Eliza Hall Institute; University of Western Australia	Hansen, DS (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	hansen@wehi.edu.au			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045548] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-45548] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARASE H, 1992, P NATL ACAD SCI USA, V89, P6506, DOI 10.1073/pnas.89.14.6506; Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391; Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Boubou MI, 1999, INT IMMUNOL, V11, P1553, DOI 10.1093/intimm/11.9.1553; Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; DEKOSSODO S, 1993, J IMMUNOL, V151, P4811; Denkers EY, 1996, J EXP MED, V184, P131, DOI 10.1084/jem.184.1.131; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Emoto M, 1995, EUR J IMMUNOL, V25, P3321, DOI 10.1002/eji.1830251218; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Godfrey DI, 1997, J AUTOIMMUN, V10, P279, DOI 10.1006/jaut.1997.0129; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; GRAU GE, 1986, J IMMUNOL, V137, P2348; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; Hirunpetcharat C, 1998, P NATL ACAD SCI USA, V95, P1715, DOI 10.1073/pnas.95.4.1715; Ishikawa H, 2000, INT IMMUNOL, V12, P1267, DOI 10.1093/intimm/12.9.1267; Jennings VM, 1997, INFECT IMMUN, V65, P4883, DOI 10.1128/IAI.65.11.4883-4887.1997; KARLHOFER FM, 1991, J IMMUNOL, V146, P3662; Kawakami K, 2001, J IMMUNOL, V167, P6525, DOI 10.4049/jimmunol.167.11.6525; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Langhorne J, 1989, Int Immunol, V1, P416, DOI 10.1093/intimm/1.4.416; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Lucas R, 1997, EUR J IMMUNOL, V27, P1719, DOI 10.1002/eji.1830270719; Mason LH, 2000, J IMMUNOL, V164, P603, DOI 10.4049/jimmunol.164.2.603; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Molano A, 2000, J IMMUNOL, V164, P5005, DOI 10.4049/jimmunol.164.10.5005; Naiki Y, 1999, J IMMUNOL, V163, P2057; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Rudin W, 1997, AM J PATHOL, V150, P257; Rudin W, 1997, EUR J IMMUNOL, V27, P810, DOI 10.1002/eji.1830270403; Scalzo AA, 1999, IMMUNOGENETICS, V49, P238, DOI 10.1007/s002510050486; SCALZO AA, 1995, IMMUNOGENETICS, V41, P148, DOI 10.1007/BF00182328; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; SCOTT P, 1989, IMMUNOL REV, V112, P161, DOI 10.1111/j.1600-065X.1989.tb00557.x; Shi FD, 2001, P NATL ACAD SCI USA, V98, P6777, DOI 10.1073/pnas.121169698; Singh N, 1999, J IMMUNOL, V163, P2373; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Sonoda KH, 1999, J EXP MED, V190, P1215, DOI 10.1084/jem.190.9.1215; TAYLORROBINSON AW, 1993, SCIENCE, V260, P1931, DOI 10.1126/science.8100366; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; *WHO, 1992, WORLD HLTH STAT Q, V45, P257; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; WUNDERLICH F, 1988, INFECT IMMUN, V56, P2400, DOI 10.1128/IAI.56.9.2400-2406.1988; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285	54	141	143	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					391	402		10.1016/S1074-7613(03)00052-9	http://dx.doi.org/10.1016/S1074-7613(03)00052-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648456	Bronze			2022-12-18	WOS:000181713700009
J	Lu, BF; Yu, H; Chow, CW; Li, BY; Zheng, WP; Davis, RJ; Flavell, RA				Lu, BF; Yu, H; Chow, CW; Li, BY; Zheng, WP; Davis, RJ; Flavell, RA			GADD45 gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector T(H)1 cells	IMMUNITY			English	Article							TERMINAL KINASE; GENE FAMILY; T-CELLS; PROTEIN; EXPRESSION; DIFFERENTIATION; MYD118; TH1; INTERACTS; GROWTH	The p38 and JNK stress-activated MAPK signal transduction pathways are activated by T cell receptor (TCR) signaling and are required for IFN-gamma production by T(H)1 effector cells. Here, we show that the expression of GADD45 gamma is induced during T cell activation and that the level of expression is higher in TH1 cells than in T(H)2 cells. T(H)1 cells from GADD45 gamma (-1-) mice are severely compromised in their abilities to activate p38 and JNK in response to TCR signaling, produce much less IFN-gamma upon restimulation, and are deficient in activation-induced cell death (AICD). Additionally, GADD45 gamma deficiencies caused reduced contact hypersensitivity in mice. Thus, GADD45 gamma mediates activation of the p38 and JNK pathways and effector function of T(H)1 cells.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Yale University; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 310 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu			NIAID NIH HHS [1 P01 AI36529] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI036529] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABDOLLAHI A, 1991, ONCOGENE, V6, P165; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; BEADLING C, 1993, P NATL ACAD SCI USA, V90, P2719, DOI 10.1073/pnas.90.7.2719; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Diehl NL, 2000, J EXP MED, V191, P321, DOI 10.1084/jem.191.2.321; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; EISEN HN, 1952, J EXP MED, V95, P473, DOI 10.1084/jem.95.5.473; Fan W, 1999, ONCOGENE, V18, P6573, DOI 10.1038/sj.onc.1203054; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; KEARSEY JM, 1995, ONCOGENE, V11, P1675; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Lu BF, 1998, P NATL ACAD SCI USA, V95, P8233, DOI 10.1073/pnas.95.14.8233; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Nakayama K, 1999, J BIOL CHEM, V274, P24766, DOI 10.1074/jbc.274.35.24766; Rincon M, 2000, IMMUNOL CELL BIOL, V78, P166, DOI 10.1046/j.1440-1711.2000.00900.x; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Shaulian E, 1999, J BIOL CHEM, V274, P29595, DOI 10.1074/jbc.274.42.29595; SIMON JC, 1990, J IMMUNOL, V145, P2087; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Vairapandi M, 1996, ONCOGENE, V12, P2579; Wang XT, 1999, J BIOL CHEM, V274, P29599, DOI 10.1074/jbc.274.42.29599; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang W, 1999, ONCOGENE, V18, P4899, DOI 10.1038/sj.onc.1202885; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	35	141	149	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					583	590		10.1016/S1074-7613(01)00141-8	http://dx.doi.org/10.1016/S1074-7613(01)00141-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371360	Bronze			2022-12-18	WOS:000168880900010
J	Hanon, E; Stinchcombe, JC; Saito, M; Asquith, BE; Taylor, GP; Tanaka, Y; Weber, JN; Griffiths, GM; Bangham, CRM				Hanon, E; Stinchcombe, JC; Saito, M; Asquith, BE; Taylor, GP; Tanaka, Y; Weber, JN; Griffiths, GM; Bangham, CRM			Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I	IMMUNITY			English	Article							TROPICAL SPASTIC PARAPARESIS; LEUKEMIA-LYMPHOMA VIRUS; HTLV-I; CYTOTOXIC LYMPHOCYTES; DENDRITIC CELLS; TAX PROTEIN; MYELOPATHY; EXPRESSION; DESTRUCTION; COMPLEXES	Infection and gene expression by the human T lymphotropic virus type I (HTLV-I) in vivo have been thought to be confined to CD4(+) T lymphocytes. We show here that, in natural HTLV-I infection, a significant proportion of CD8(+) T lymphocytes are infected by HTLV-I. Interestingly, HTLV-I-specific but not Epstein-Barr virus-specific CD8(+) T lymphocytes were shown to be infected. Furthermore, HTLV-I protein expression in naturally infected CD8(+) T lymphocytes renders them susceptible to fratricide mediated by autologous HTLVI-specific CD8+ T lymphocytes. Fratricide among virus-specific CTLs could impair the immune control of HTLV-I and possibly other lymphotropic viruses.	Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Immunol, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Genito Urinary Med & Commun Dis, London W2 1PG, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Ryukyus, Fac Med, Okinawa Asia Res Ctr Med Sci, Dept Immunol & Infect Dis, Nishihara, Okinawa 9030215, Japan	Imperial College London; Imperial College London; University of Oxford; University of the Ryukyus	Bangham, CRM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Immunol, St Marys Campus,Norfolk Pl, London W2 1PG, England.			Griffiths, Gillian/0000-0003-0434-5842; stinchcombe, jane/0000-0003-1459-9299; Bangham, Charles/0000-0003-2624-3599; Asquith, Becca/0000-0002-5911-3160				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barchet W, 2000, EUR J IMMUNOL, V30, P1356, DOI 10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K; BERKE G, 1994, ANNU REV IMMUNOL, V12, P735, DOI 10.1146/annurev.immunol.12.1.735; Bex F, 1998, METHODS, V16, P83, DOI 10.1006/meth.1998.0646; Bieganowska K, 1999, J IMMUNOL, V162, P1765; CHO IM, 1995, AM J TROP MED HYG, V53, P412, DOI 10.4269/ajtmh.1995.53.412; DEVECCHIS L, 1985, LEUKEMIA RES, V9, P349, DOI 10.1016/0145-2126(85)90056-6; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GESSAIN A, 1990, J GEN VIROL, V71, P333, DOI 10.1099/0022-1317-71-2-333; Hanon E, 2000, BLOOD, V95, P1386, DOI 10.1182/blood.V95.4.1386.004k22_1386_1392; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; INATSUKI A, 1991, BRIT J HAEMATOL, V77, P311, DOI 10.1111/j.1365-2141.1991.tb08576.x; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; Jeffery KJM, 1999, P NATL ACAD SCI USA, V96, P3848, DOI 10.1073/pnas.96.7.3848; KANNAGI M, 1992, J VIROL, V66, P2928, DOI 10.1128/JVI.66.5.2928-2933.1992; Kataoka T, 1996, J IMMUNOL, V156, P3678; KOYANAGI Y, 1993, VIROLOGY, V196, P25, DOI 10.1006/viro.1993.1451; KRICHBAUMSTENGER K, 1987, BLOOD, V70, P1303; LEE B, 1989, TOHOKU J EXP MED, V157, P1, DOI 10.1620/tjem.157.1; MACATONIA SE, 1992, AIDS RES HUM RETROV, V8, P1699, DOI 10.1089/aid.1992.8.1699; Makino M, 1999, J VIROL, V73, P4575, DOI 10.1128/JVI.73.6.4575-4581.1999; Mattis AE, 1997, J IMMUNOL METHODS, V204, P135, DOI 10.1016/S0022-1759(97)00047-1; MERL S, 1984, BLOOD, V64, P967; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; NIEWIESK S, 1994, J VIROL, V68, P6778, DOI 10.1128/JVI.68.10.6778-6781.1994; PARKER CE, 1992, VIROLOGY, V188, P628, DOI 10.1016/0042-6822(92)90517-S; PARKER CE, 1994, J VIROL, V68, P2860, DOI 10.1128/JVI.68.5.2860-2868.1994; POPOVIC M, 1984, SCIENCE, V226, P459, DOI 10.1126/science.6093248; POPOVIC M, 1983, SCIENCE, V219, P856, DOI 10.1126/science.6600519; RADOSEVIC K, 1990, J IMMUNOL METHODS, V135, P81, DOI 10.1016/0022-1759(90)90259-X; Raftery MJ, 1999, J EXP MED, V190, P1103, DOI 10.1084/jem.190.8.1103; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; SOMMERFELT MA, 1988, SCIENCE, V242, P1557, DOI 10.1126/science.3201246; SU MWC, 1993, J IMMUNOL, V151, P658; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; WALDEN PR, 1990, P NATL ACAD SCI USA, V87, P9015, DOI 10.1073/pnas.87.22.9015; YARCHOAN R, 1986, J CLIN INVEST, V77, P1466, DOI 10.1172/JCI112459; Zinkernagel RM, 1999, IMMUNOL REV, V168, P305, DOI 10.1111/j.1600-065X.1999.tb01300.x	38	141	145	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2000	13	5					657	664		10.1016/S1074-7613(00)00065-0	http://dx.doi.org/10.1016/S1074-7613(00)00065-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114378	Bronze			2022-12-18	WOS:000165598500008
J	Lyons, PA; Hancock, WW; Denny, P; Lord, CJ; Hill, NJ; Armitage, N; Siegmund, T; Todd, JA; Phillips, MS; Hess, JF; Chen, SL; Fischer, PA; Peterson, LB; Wicker, LS				Lyons, PA; Hancock, WW; Denny, P; Lord, CJ; Hill, NJ; Armitage, N; Siegmund, T; Todd, JA; Phillips, MS; Hess, JF; Chen, SL; Fischer, PA; Peterson, LB; Wicker, LS			The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; CD4(+) T-CELLS; AUTOIMMUNE-DISEASE; CONGENIC STRAINS; ORAL INSULIN; IFN-GAMMA; IN-VIVO; MOUSE; EXPRESSION; SUSCEPTIBILITY	Previous analyses of NOD mice have shown that some genes control the development of both insulitis and diabetes, while other loci influence diabetes without reducing insulitis. Evidence for the existence of a gene only influencing diabetes, ldd9 on mouse chromosome 4, is provided here by the development of a novel congenic mouse strain, NOD.B10ldd9. NOD.B10ldd9 mice display profound resistance to diabetes even though nearly all develop insulitis. Subcongenic analysis has demonstrated that alleles of at least three B10 genes, ldd9.1, ldd9.2, and ldd9.3 are required to produce ldd9-mediated diabetes resistance. Candidate genes with amino acid differences between the NOD and B10 strains have been localized to the 5.6 cM ldd9.2 interval (Tnfr2, Cd30) and to the 2.0 cM ldd9.3 interval (Cd137).	Merck Res Labs, Dept Immunol & Rheumatol, Rahway, NJ 07065 USA; Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA; New England Deaconess Hosp, Sandoz Ctr Immunobiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Cambridge, Wellcome Trust Ctr Mol Mech, Cambridge CB2 2XY, England; Merck Res Labs, Dept Human Genet, W Point, PA 19486 USA; New England Deaconess Hosp, Dept Pathol, Boston, MA 02215 USA	Merck & Company; Merck & Company; Novartis; Sandoz; Harvard University; Harvard Medical School; University of Cambridge; Merck & Company	Wicker, LS (corresponding author), Merck Res Labs, Dept Immunol & Rheumatol, Rahway, NJ 07065 USA.		Lord, Christopher J/B-3295-2012; Todd, John A/A-3542-2010; Lord, Christopher/AAX-7130-2021; Wicker, Linda S/F-7384-2010	Lord, Christopher J/0000-0002-3226-0515; Todd, John A/0000-0003-2740-8148; Denny, Paul/0000-0003-4659-6893; Hill, Natasha/0000-0001-7224-8185				Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; Bach FH, 1997, NAT MED, V3, P196, DOI 10.1038/nm0297-196; Brodnicki TC, 2000, IMMUNOGENETICS, V51, P37, DOI 10.1007/s002510050006; CHEN SL, 1994, J AUTOIMMUN, V7, P635, DOI 10.1006/jaut.1994.1048; Denny P, 1997, DIABETES, V46, P695, DOI 10.2337/diabetes.46.4.695; DRAKE CG, 1994, P NATL ACAD SCI USA, V91, P4062, DOI 10.1073/pnas.91.9.4062; Encinas JA, 1996, J IMMUNOL, V157, P2186; Encinas JA, 1999, NAT GENET, V21, P158, DOI 10.1038/5941; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; HANCOCK WW, 1995, AM J PATHOL, V147, P1193; Hutchings PR, 1999, CELL IMMUNOL, V192, P113, DOI 10.1006/cimm.1998.1446; KNIGHT JG, 1981, J CLIN LAB IMMUNOL, V5, P165; Kurts C, 1999, NATURE, V398, P341, DOI 10.1038/18692; LORD CJ, 1995, MAMM GENOME, V6, P563, DOI 10.1007/BF00352359; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; LYONS PA, 1999, GENETICS AUTOIMMUNIT, P208; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; MCCLIVE PJ, 1994, IMMUNOGENETICS, V39, P286, DOI 10.1007/BF00188793; Melanitou E, 1998, GENOME RES, V8, P608, DOI 10.1101/gr.8.6.608; Metzker ML, 1998, BIOTECHNIQUES, V25, P446; Mittler RS, 1999, J EXP MED, V190, P1535, DOI 10.1084/jem.190.10.1535; MORAHAN G, 1994, P NATL ACAD SCI USA, V91, P5898, DOI 10.1073/pnas.91.13.5898; MOTTRAM PL, 1995, TRANSPLANTATION, V59, P559; Mueller R, 1996, J EXP MED, V184, P1093, DOI 10.1084/jem.184.3.1093; Nakamura T, 1997, J IMMUNOL, V158, P2648; Nakamura T, 1997, J IMMUNOL, V158, P2090; Ploix C, 1998, DIABETES, V47, P39, DOI 10.2337/diabetes.47.1.39; Podolin PL, 1998, MAMM GENOME, V9, P283, DOI 10.1007/s003359900749; Podolin PL, 1997, J IMMUNOL, V159, P1835; POWELL EE, 1994, MAMM GENOME, V5, P726, DOI 10.1007/BF00426081; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; Rasooly L, 1996, CLIN IMMUNOL IMMUNOP, V81, P287, DOI 10.1006/clin.1996.0191; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; RODRIGUES NR, 1994, MAMM GENOME, V5, P167, DOI 10.1007/BF00352349; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; Serreze DV, 1997, J IMMUNOL, V158, P3978; Serreze DV, 1998, J IMMUNOL, V160, P1472; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; SIEGMUND T, 2000, IN PRESS DIABETES; Silveira PA, 1999, J IMMUNOL, V162, P5106; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; WICKER LS, 1994, J EXP MED, V180, P1705, DOI 10.1084/jem.180.5.1705; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wong B, 1997, CURR OPIN IMMUNOL, V9, P358, DOI 10.1016/S0952-7915(97)80082-9; Yui MA, 1996, MAMM GENOME, V7, P331, DOI 10.1007/s003359900097	48	141	146	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2000	13	1					107	115		10.1016/S1074-7613(00)00012-1	http://dx.doi.org/10.1016/S1074-7613(00)00012-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933399	Bronze			2022-12-18	WOS:000088463600011
J	Nagarajan, UM; Louis-Plence, P; DeSandro, A; Nilsen, R; Bushey, A; Boss, JM				Nagarajan, UM; Louis-Plence, P; DeSandro, A; Nilsen, R; Bushey, A; Boss, JM			RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency	IMMUNITY			English	Article							X-BOX REGION; DNA-BINDING PROTEINS; REGULATORY FACTOR; CELL-LINES; TRANSCRIPTIONAL ACTIVATOR; TRANSACTIVATOR CIITA; COOPERATIVE BINDING; COMPLEX-FORMATION; WILD-TYPE; EXPRESSION	The bare lymphocyte syndrome (BLS) is characterized by the absence of MHC class II transcription and humoral- and cellular-mediated immune responses to foreign antigens. Three of the four BLS genetic complementation groups have defects in the activity of the MHC class II transcription factor RFX. We have purified the RFX complex and sequenced its three subunits. The sequence of the smallest subunit describes a novel gene, termed RFX-B. RFX-B complements the predominant BLS complementation group (group B) and was found to be mutant in cell lines from this BLS group. The protein has no known DNA-binding domain but does contain three ankyrin repeats that are likely to be important in protein-protein interactions.	Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Boss, JM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	boss@microbio.emory.edu	Louis-Plence, Pascale/H-1553-2015; Long, Alyssa/AAN-8497-2020	Louis-Plence, Pascale/0000-0001-7701-5241; Long, Alyssa/0000-0002-4467-4213	NIAID NIH HHS [AI34000] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI034000, R01AI034000] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ausubel F.M., 1987, CURRENT PROTOCOLS MO; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; DEPREVAL C, 1985, NATURE, V318, P291, DOI 10.1038/318291a0; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; Elhasid R, 1996, BLOOD REV, V10, P242, DOI 10.1016/S0268-960X(96)90008-9; EPSTEIN MA, 1966, J NATL CANCER I, V37, P547; Ewaskow SP, 1998, BIOCHEMISTRY-US, V37, P4437, DOI 10.1021/bi972652e; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; Gobin SJP, 1998, IMMUNITY, V9, P531, DOI 10.1016/S1074-7613(00)80636-6; GORDON HM, 1992, J IMMUNOL, V148, P4021; Griscelli C, 1989, Immunodefic Rev, V1, P135; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P6269, DOI 10.1093/nar/19.22.6269; HASEGAWA SL, 1993, J IMMUNOL, V150, P1781; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; LISOWSKAGROSPIERRE B, 1994, HUM MOL GENET, V3, P953, DOI 10.1093/hmg/3.6.953; LouisPlence P, 1997, J IMMUNOL, V159, P3899; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MACH B, 1994, IMMUNOL REV, V138, P207, DOI 10.1111/j.1600-065X.1994.tb00853.x; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Martin BK, 1997, IMMUNITY, V6, P591, DOI 10.1016/S1074-7613(00)80347-7; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORENO CS, 1995, J IMMUNOL, V155, P4313; Moreno CS, 1997, J IMMUNOL, V158, P5841; Ping DS, 1996, IMMUNITY, V4, P455, DOI 10.1016/S1074-7613(00)80412-4; REITH W, 1994, J BIOL CHEM, V269, P20020; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; RILEY JL, 1993, J IMMUNOL, V151, P6942; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; SANCHEZ CH, 1992, MOL CELL BIOL, V12, P4076, DOI 10.1128/MCB.12.9.4076; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; SEIDL C, 1992, J IMMUNOL, V148, P1576; SLOAN JH, 1988, P NATL ACAD SCI USA, V85, P8186, DOI 10.1073/pnas.85.21.8186; SLOAN JH, 1992, J IMMUNOL, V148, P2591; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; STIMAC E, 1991, J IMMUNOL, V146, P4398; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Westerheide SD, 1997, J IMMUNOL, V158, P4812; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9	52	141	146	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1999	10	2					153	162		10.1016/S1074-7613(00)80016-3	http://dx.doi.org/10.1016/S1074-7613(00)80016-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072068	Bronze			2022-12-18	WOS:000078972200003
J	CHOI, MSK; BRINES, RD; HOLMAN, MJ; KLAUS, GGB				CHOI, MSK; BRINES, RD; HOLMAN, MJ; KLAUS, GGB			INDUCTION OF NF-AT IN NORMAL B-LYMPHOCYTES BY ANTIIMMUNOGLOBULIN OR CD40 LIGAND IN CONJUNCTION WITH IL4	IMMUNITY			English	Article							ACTIVATED T-CELLS; FACTOR-ALPHA GENE; CYCLOSPORINE-A; NUCLEAR FACTOR; INTERLEUKIN-2 ENHANCER; KAPPA-B; TRANSCRIPTION; CALCINEURIN; PROMOTER; BINDING	We show here that ligation of surface immunoglobulin or CD40 receptors in conjunction with interleukin-4 induces the nuclear factor of activated T cells (NF-AT) in normal murine B cells, which is inhibited by cyclosporin (CsA). Lipopolysaccharide, which activates B cells by a Ca2+-independent, CsA-resistant pathway, does not induce NF-AT. The NF-AT complex in T cells and B cells appears to be identical, comprising both Fos and Jun proteins and the 120 kDa cytosolic component of NF-AT (NF-AT(p)). Our transfection experiments using a trimerized NF-AT site linked to the minimal IL-2 promotor driving luciferase activity demonstrate that NF-AT is functional in A20 B-lymphoma cells. These results therefore suggest that the induction of NF-AT forms part of the B cell response to both cross-linking antigens and T cell-generated signals.			CHOI, MSK (corresponding author), NATL INST MED RES,CELLULAR IMMUNOL LAB,MILL HILL,LONDON NW7 1AA,ENGLAND.							ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; BRABLETZ T, 1991, NUCLEIC ACIDS RES, V19, P61, DOI 10.1093/nar/19.1.61; BRINES RD, 1993, INT IMMUNOL, V5, P1445, DOI 10.1093/intimm/5.11.1445; CASTIGLI E, 1993, J IMMUNOL, V150, P3284; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GABRIELSEN OS, 1989, NUCLEIC ACIDS RES, V17, P6253, DOI 10.1093/nar/17.15.6253; GOLDFELD AE, 1992, P NATL ACAD SCI USA, V89, P12198, DOI 10.1073/pnas.89.24.12198; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; HAWRYLOWICZ CM, 1984, EUR J IMMUNOL, V14, P244, DOI 10.1002/eji.1830140308; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1993, J IMMUNOL, V151, P837; JULIUS MH, 1984, EUR J IMMUNOL, V14, P753, DOI 10.1002/eji.1830140816; JUSTEMENT LB, 1989, J IMMUNOL, V143, P881; KAKIUCHI T, 1991, CELL IMMUNOL, V138, P207, DOI 10.1016/0008-8749(91)90145-2; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KIM KJ, 1979, J IMMUNOL, V122, P549; KLAUS GGB, 1988, TRANSPLANTATION, V46, pS11; LALMANACHGIRARD AC, 1993, J EXP MED, V177, P1215, DOI 10.1084/jem.177.4.1215; LANE P, 1993, J EXP MED, V177, P1209, DOI 10.1084/jem.177.4.1209; LASKOV R, 1990, J IMMUNOL, V144, P3424; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; LIU JL, 1991, J IMMUNOL, V146, P1685; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; OGARRA A, 1990, INT IMMUNOL, V2, P821, DOI 10.1093/intimm/2.9.821; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; PAUL WE, 1991, BLOOD, V77, P1859; RANDAK C, 1990, EMBO J, V9, P2529, DOI 10.1002/j.1460-2075.1990.tb07433.x; RHOADES KL, 1992, J BIOL CHEM, V267, P22102; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; STOCKINGER B, 1992, EUR J IMMUNOL, V22, P1271, DOI 10.1002/eji.1830220523; SUNG SSJ, 1988, J EXP MED, V168, P1539, DOI 10.1084/jem.168.5.1539; TAIRA S, 1987, J IMMUNOL, V139, P2957; TODD MD, 1993, J EXP MED, V177, P1663, DOI 10.1084/jem.177.6.1663; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; YASEEN NR, 1993, J BIOL CHEM, V268, P14285	49	141	143	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1994	1	3					179	187		10.1016/1074-7613(94)90096-5	http://dx.doi.org/10.1016/1074-7613(94)90096-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK165	7889406				2022-12-18	WOS:A1994PK16500002
J	Park, B; Buti, L; Lee, S; Matsuwaki, T; Spooner, E; Brinkmann, MM; Nishihara, M; Ploegh, HL				Park, Boyoun; Buti, Ludovico; Lee, Sungwook; Matsuwaki, Takashi; Spooner, Eric; Brinkmann, Melanie M.; Nishihara, Masugi; Ploegh, Hidde L.			Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling	IMMUNITY			English	Article							SUBCELLULAR-LOCALIZATION; IMMUNE-RESPONSE; HOST-DEFENSE; CPG-DNA; MICE; INFLAMMATION; RECOGNITION; PROGRANULIN; GROWTH; ACTIVATION	Toll-like receptor (TLR) signaling plays a critical role in innate and adaptive immune responses and must be tightly controlled. TLR4 uses LPS binding protein, MD-2, and CD14 as accessories to respond to LPS. We therefore investigated the presence of an analagous soluble cofactor that might assist in the recruitment of CpG oligonucleotides (CpG-ODNs) to TLR9. We report the identification of granulin as an essential secreted cofactor that potentiates TLR9-driven responses to CpG-ODNs. Granulin, an unusual cysteine-rich protein, bound to CpG-ODNs and interacted with TLR9. Macrophages from granulin-deficient mice showed not only impaired delivery of CpG-ODNs to endolysosomal compartments, but also decreased interaction of TLR9 with CpG-ODNs. As a consequence, granulin-deficient macrophages showed reduced responses to stimulation with CpG-ODNs, a trait corrected by provision of exogenous granulin. Thus, we propose that granulin contributes to innate immunity as a critical soluble cofactor for TLR9 signaling.	[Park, Boyoun; Lee, Sungwook] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul 120749, South Korea; [Buti, Ludovico; Spooner, Eric; Brinkmann, Melanie M.; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Boston, MA 02115 USA; [Buti, Ludovico] Novartis Vaccines & Diagnost, Res Ctr, I-53100 Siena, Italy; [Matsuwaki, Takashi; Nishihara, Masugi] Univ Tokyo, Dept Vet Physiol, Tokyo 1138657, Japan	Yonsei University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Novartis; University of Tokyo	Park, B (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul 120749, South Korea.	bypark@yonsei.ac.kr; ploegh@wi.mit.edu	Lee, Sungwook/K-3697-2013		Ministry of Education, Science and Technology [2010-0009203]; Korean Government [KRF-2007-357-000086]; Yonsei University; Landon Clay fellowship; NIH and Novartis; Novartis; Charles A. King Trust, Bank of America; Grants-in-Aid for Scientific Research [20248030] Funding Source: KAKEN	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Government(Korean Government); Yonsei University; Landon Clay fellowship; NIH and Novartis; Novartis(Novartis); Charles A. King Trust, Bank of America; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A.M. Avalos and C.C. Lee for critical reading of the manuscript and S.-J. Ha (Yonsei University, Seoul, South Korea) for the generous gifts of the following antibodies: anti-MHC class I antigen, anti-MHC class II antigen, anti-CD40, anti-CD80, and anti-CD86 for FAGS analysis. This study was supported by grants from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0009203), Korea research foundation grant funded by the Korean Government (KRF-2007-357-000086), the Yonsei University Research Fund of 2010, and a Landon Clay fellowship (to B.P.), NIH and Novartis (to H.L.P.), Novartis (to L.B.), the Yonsei University Research Fund of 2010 (to S.L.), and the Charles A. King Trust, Bank of America, Co- \Trustee (to M.M.B.).	Ahren IL, 2001, J INFECT DIS, V184, P926, DOI 10.1086/323398; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gray RC, 2007, J LEUKOCYTE BIOL, V81, P1075, DOI 10.1189/jlb.1006606; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Park B, 2003, J IMMUNOL, V170, P961, DOI 10.4049/jimmunol.170.2.961; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	34	140	148	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					505	513		10.1016/j.immuni.2011.01.018	http://dx.doi.org/10.1016/j.immuni.2011.01.018			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21497117	Bronze, Green Published			2022-12-18	WOS:000290367300010
J	Thieu, VT; Yu, Q; Chang, HC; Yeh, N; Nguyen, ET; Sehra, S; Kaplan, MH				Thieu, Vivian T.; Yu, Qing; Chang, Hua-Chen; Yeh, Norman; Nguyen, Evelyn T.; Sehra, Sarita; Kaplan, Mark H.			Signal Transducer and Activator of Transcription 4 Is Required for the Transcription Factor T-bet to Promote T Helper 1 Cell-Fate Determination	IMMUNITY			English	Article							ENCODING INTERFERON-GAMMA; HISTONE ACETYLATION; CUTTING EDGE; LINEAGE COMMITMENT; IL-12 RESPONSES; DYNAMIC CHANGES; TH1 CELLS; STAT4; DIFFERENTIATION; EXPRESSION	Transcriptional regulatory networks direct the development of specialized cell types. The transcription factors signal tranducer and activator of transcription 4 (Stat4) and T-bet are required for the interleukin-12 (IL-12)-stimulated development of T helper 1 (Th1) cells, although the hierarchy of activity by these actors has not been clearly defined. In this report, we show that these factors did not function in a linear pathway and that each factor played a unique role in programming chromatin architecture for Th1 gene expression, with subsets of genes depending on Stat4, T-bet, or both for expression in Th1 cells. T-bet was not able to transactivate expression of Stat4-dependent genes in the absence of endogenous Stat4 expression. Thus, T-bet requires Stat4 to achieve complete IL-12-dependent Th1 cell-fate determination. These data provide a basis for understanding how transiently activated and lineage-specific transcription factors cooperate in promoting cellular differentiation.	[Thieu, Vivian T.; Yu, Qing; Chang, Hua-Chen; Nguyen, Evelyn T.; Sehra, Sarita; Kaplan, Mark H.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Thieu, Vivian T.; Yu, Qing; Chang, Hua-Chen; Yeh, Norman; Nguyen, Evelyn T.; Sehra, Sarita; Kaplan, Mark H.] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Yeh, Norman; Kaplan, Mark H.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kaplan, MH (corresponding author), Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	mkaplan2@iupui.edu		Kaplan, Mark/0000-0002-2923-8245	U.S. Public Health Service Awards from the National Institutes of Health [A145515, A157459]; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045515, R01AI057459, R56AI045515] Funding Source: NIH RePORTER	U.S. Public Health Service Awards from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. Public Health Service Awards A145515 and A157459 (to M.H.K.) from the National Institutes of Health. We thank G.S. Kansas, C.H. Chang, R.N. Laribee, and A. Finnegan for careful review of this manuscript, R. Kapur for help with the retroviral-transduction system, and G.S. Kansas for supplying the T-bet retrovirus.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Furuta S, 2008, J IMMUNOL, V180, P6656, DOI 10.4049/jimmunol.180.10.6656; Hoey T, 2003, EMBO J, V22, P4237, DOI 10.1093/emboj/cdg393; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Kaplan MH, 2005, IMMUNOL RES, V31, P231, DOI 10.1385/IR:31:3:231; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lawless VA, 2000, J IMMUNOL, V165, P6803, DOI 10.4049/jimmunol.165.12.6803; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Lewis MD, 2007, MOL CELL BIOL, V27, P8510, DOI 10.1128/MCB.01615-07; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Martins GA, 2005, J IMMUNOL, V175, P5981, DOI 10.4049/jimmunol.175.9.5981; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; O'Sullivan A, 2004, J BIOL CHEM, V279, P7339, DOI 10.1074/jbc.M309979200; Pesu M, 2006, BLOOD, V108, P983, DOI 10.1182/blood-2005-09-3824; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Tong YK, 2005, P NATL ACAD SCI USA, V102, P2034, DOI 10.1073/pnas.0409510102; Underhill GH, 2005, BLOOD, V106, P3867, DOI 10.1182/blood-2005-03-0984; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; White SJ, 2001, J IMMUNOL, V167, P628, DOI 10.4049/jimmunol.167.2.628; Yang Y, 2007, BLOOD, V110, P2494, DOI 10.1182/blood-2006-11-058271; Yu Q, 2008, J IMMUNOL, V181, P3346, DOI 10.4049/jimmunol.181.5.3346; Yu Q, 2007, EMBO J, V26, P2052, DOI 10.1038/sj.emboj.7601653; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066; Zhang YK, 2001, J EXP MED, V194, P165, DOI 10.1084/jem.194.2.165	49	140	142	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					679	690		10.1016/j.immuni.2008.08.017	http://dx.doi.org/10.1016/j.immuni.2008.08.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	18993086	Green Accepted, Bronze			2022-12-18	WOS:000261036000007
J	Taborda, CP; Casadevall, A				Taborda, CP; Casadevall, A			CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans	IMMUNITY			English	Article							CAPSULAR POLYSACCHARIDE; MONOCLONAL-ANTIBODIES; SEROTYPE-A; IMMUNOGLOBULIN; MACROPHAGES; RECEPTOR; INFECTION; IMMUNITY; BINDING; SERUM	IgM and IgA to the Cryptococcus neoformans capsular glucuronoxylomannan (GXM) promote complement-independent phagocytosis by macrophages with efficiency comparable to that of IgG1. IgM- and IgA-mediated phagocytosis of C. neoformans was proportional to CR3 expression, inhibited by Abs to CR3 (CD11b/ CD18) and CR4 (CD11c/CD18), and dramatically reduced with macrophages of CD18-deficient mice. IgM and IgA promoted ingestion of yeast cells by CHO cells expressing CR3 and CR4. In contrast, IgG1-mediated phagocytosis was only partially inhibited by Abs to CR3 and CR4. Phagocytosis by IgM and IgA but not IgG1 was inhibited by soluble GXM,which binds CD18. Involvement of CR in antibody-mediated complement-independent phagocytosis indicates a new link between innate and adaptive immune systems.	Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA.	casadeva@aecom.yu.edu	Taborda, Carlos Pelleschi/AAH-7031-2020; Taborda, Carlos P/K-1660-2016	Taborda, Carlos P/0000-0001-9928-9809	NHLBI NIH HHS [HL-59842] Funding Source: Medline; NIAID NIH HHS [AI3342, AI33774] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033774] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BIANCO C, 1975, J EXP MED, V141, P1278, DOI 10.1084/jem.141.6.1278; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Casadevall A., 1998, CRYPTOCOCCUS NEOFORM, DOI [10.1128/9781555818241, DOI 10.1128/9781555818241]; CHERNIAK R, 1982, CARBOHYD RES, V103, P239, DOI 10.1016/S0008-6215(00)80686-2; Cleare W, 1999, MED MYCOL, V37, P235, DOI 10.1046/j.1365-280X.1999.00226.x; Cleare W, 1998, CLIN DIAGN LAB IMMUN, V5, P125, DOI 10.1128/CDLI.5.2.125-129.1998; CZOP JK, 1985, J IMMUNOL, V135, P3388; DESHAW M, 1995, CLIN EXP IMMUNOL, V99, P425, DOI 10.1111/j.1365-2249.1995.tb05568.x; Dong F, 1998, J BIOL CHEM, V273, P6533, DOI 10.1074/jbc.273.11.6533; Dong ZM, 1997, INFECT IMMUN, V65, P557, DOI 10.1128/IAI.65.2.557-563.1997; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Feldmesser M, 2000, INFECT IMMUN, V68, P3642, DOI 10.1128/IAI.68.6.3642-3650.2000; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; Feldmesser M, 2002, INFECT IMMUN, V70, P1571, DOI 10.1128/IAI.70.3.1571-1580.2002; Fleuridor R, 1999, J INFECT DIS, V180, P1526, DOI 10.1086/315102; Forsyth CB, 1998, J IMMUNOL, V161, P6198; Fries BC, 2001, J CLIN INVEST, V108, P1639, DOI 10.1172/JCI13407; Grunwald U, 1996, J IMMUNOL, V157, P4119; HETLAND G, 1987, ACTA PATH MICRO IM C, V95, P15; Kozel T R, 1993, Arch Med Res, V24, P211; KOZEL TR, 1982, J IMMUNOL, V129, P1675; KOZEL TR, 1977, INFECT IMMUN, V18, P701, DOI 10.1128/IAI.18.3.701-707.1977; LAMANTIA L, 1986, J NEUROL, V233, P362; Levitz SM, 1997, INFECT IMMUN, V65, P931, DOI 10.1128/IAI.65.3.931-935.1997; MacGill TC, 2000, J IMMUNOL, V164, P4835, DOI 10.4049/jimmunol.164.9.4835; MACHER AM, 1978, J IMMUNOL, V120, P1686; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; MEDGYESI GA, 1984, IMMUNOBIOLOGY, V167, P293, DOI 10.1016/S0171-2985(84)80001-7; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; MUKHERJEE J, 1992, INFECT IMMUN, V60, P4534, DOI 10.1128/IAI.60.11.4534-4541.1992; MUKHERJEE J, 1995, J IMMUNOL METHODS, V184, P139, DOI 10.1016/0022-1759(95)00097-T; Mukherjee S, 1996, J INFECT DIS, V173, P1222, DOI 10.1093/infdis/173.5.1222; MUKHERJEE S, 1995, INFECT IMMUN, V63, P573, DOI 10.1128/IAI.63.2.573-579.1995; NEWMAN SL, 1990, J CLIN INVEST, V85, P223, DOI 10.1172/JCI114416; Nosanchuk JD, 1997, INFECT IMMUN, V65, P1836, DOI 10.1128/IAI.65.5.1836-1841.1997; Nussbaum G, 1997, J EXP MED, V185, P685, DOI 10.1084/jem.185.4.685; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; RALPH P, 1975, J IMMUNOL, V114, P898; Ramisse F, 1996, J INFECT DIS, V173, P1123, DOI 10.1093/infdis/173.5.1123; SEDLACEK HH, 1983, KLIN WOCHENSCHR, V61, P723, DOI 10.1007/BF01497399; Shibuya A, 2000, NAT IMMUNOL, V1, P441, DOI 10.1038/80886; Taborda CP, 2001, J IMMUNOL, V166, P2100, DOI 10.4049/jimmunol.166.3.2100; UHER F, 1981, IMMUNOLOGY, V42, P419	43	140	144	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2002	16	6					791	802		10.1016/S1074-7613(02)00328-X	http://dx.doi.org/10.1016/S1074-7613(02)00328-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121661	Bronze			2022-12-18	WOS:000176534000005
J	Michel, F; Attal-Bonnefoy, G; Mangino, G; Mise-Omata, S; Acuto, O				Michel, F; Attal-Bonnefoy, G; Mangino, G; Mise-Omata, S; Acuto, O			CD28 as a molecular amplifier extending TCR ligation and signaling capabilities	IMMUNITY			English	Article							T-CELL ACTIVATION; PROTEIN-TYROSINE KINASE; ANTIGEN-RECEPTOR; PHOSPHOLIPASE C-GAMMA-1; PHOSPHATIDYLINOSITOL 3-KINASE; CD28-DEFICIENT MICE; CD3 STIMULATION; COSTIMULATION; PHOSPHORYLATION; ITK	Evidence has gathered that CD28 costimulation facilitates T cell activation by potentiating TOR intrinsic-signaling. However, the underlying molecular mechanism is largely unknown. Here we show that, by enhancing T cell/APO close contacts, CD28 facilitates TOR signal transduction. Moreover, the signal supplied by CD28 does not lead to increased Zap-70 and Lat phosphorylation, but amplifies PLC-gamma1 activation and Call response. We provide evidence that the PTK Itk controls the latter function. Our data suggest that CD28 binding to B7 contributes to setting the level of TCR-induced phosphorylated Lat for recruiting signaling complexes, whereas the CD28 signal boosts multiple pathways by facilitating PLC gamma1 activation. These results should provide a conceptual framework for understanding quantitative and qualitative aspects of CD28-mediated costimulation.	Inst Pasteur, Dept Immunol, Mol Immunol Unit, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Acuto, O (corresponding author), Inst Pasteur, Dept Immunol, Mol Immunol Unit, F-75724 Paris, France.		Mangino, Giorgio/C-7310-2009	Mangino, Giorgio/0000-0002-8950-9780; Michel, Frederique/0000-0002-3524-2232				AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; Bachmann MF, 1999, J EXP MED, V190, P1383, DOI 10.1084/jem.190.10.1383; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; Carey KD, 2000, MOL CELL BIOL, V20, P8409, DOI 10.1128/MCB.20.22.8409-8419.2000; Ching KA, 1999, J IMMUNOL, V163, P6006; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Green JM, 2000, J IMMUNOL, V164, P3591, DOI 10.4049/jimmunol.164.7.3591; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harada Y, 2001, J IMMUNOL, V166, P3797, DOI 10.4049/jimmunol.166.6.3797; HAUSS P, 1995, EUR J IMMUNOL, V25, P2285, DOI 10.1002/eji.1830250826; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lewis CM, 2001, CURR OPIN IMMUNOL, V13, P317, DOI 10.1016/S0952-7915(00)00221-1; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Manickasingham SP, 1998, J IMMUNOL, V161, P3827; Michel F, 2000, J IMMUNOL, V165, P3820, DOI 10.4049/jimmunol.165.7.3820; Michel F, 1998, J BIOL CHEM, V273, P31932, DOI 10.1074/jbc.273.48.31932; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Pages F, 1996, J BIOL CHEM, V271, P9403, DOI 10.1074/jbc.271.16.9403; PARK DJ, 1991, P NATL ACAD SCI USA, V88, P5453, DOI 10.1073/pnas.88.12.5453; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; Rudd CE, 1996, IMMUNITY, V4, P527, DOI 10.1016/S1074-7613(00)80479-3; Saito K, 1998, J IMMUNOL, V160, P4225; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schneider H, 2000, J BIOL CHEM, V275, P3835, DOI 10.1074/jbc.275.6.3835; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Stoica B, 1998, J IMMUNOL, V160, P1059; Tsuchida M, 1999, J BIOL CHEM, V274, P6735, DOI 10.1074/jbc.274.10.6735; Tuosto L, 1998, EUR J IMMUNOL, V28, P2131, DOI 10.1002/(SICI)1521-4141(199807)28:07<2131::AID-IMMU2131>3.0.CO;2-Q; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Ward SG, 1996, BIOCHEM J, V318, P361, DOI 10.1042/bj3180361; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yamanashi Y, 2000, GENE DEV, V14, P11; Yang WC, 2001, J IMMUNOL, V166, P387, DOI 10.4049/jimmunol.166.1.387; Yang WC, 1999, J BIOL CHEM, V274, P607, DOI 10.1074/jbc.274.2.607; Zaru R, 2001, EUR J IMMUNOL, V31, P2438, DOI 10.1002/1521-4141(200108)31:8<2438::AID-IMMU2438>3.0.CO;2-P; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200	57	140	150	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2001	15	6					935	945		10.1016/S1074-7613(01)00244-8	http://dx.doi.org/10.1016/S1074-7613(01)00244-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754815	Green Published, Bronze			2022-12-18	WOS:000172961400008
J	Speir, JA; Garcia, KC; Brunmark, A; Degano, M; Peterson, PA; Teyton, L; Wilson, IA				Speir, JA; Garcia, KC; Brunmark, A; Degano, M; Peterson, PA; Teyton, L; Wilson, IA			Structural basis of 2C TCR allorecognition of H-2L(d) peptide complexes	IMMUNITY			English	Article							T-CELL RECEPTOR; DROSOPHILA-MELANOGASTER CELLS; SELF-PEPTIDE; HISTOCOMPATIBILITY ANTIGEN; MHC/PEPTIDE COMPLEXES; POSITIVE SELECTION; LYMPHOCYTE CLONE; MOLECULAR-BASIS; PROTEIN; BINDING	MHC class I H-2L(d) complexed with peptide QL9 (or p2Ca) is a high-affinity alloantigen for the 2C TCR. We used the crystal structure of H-2L(d) with a mixture of bound peptides at 3.1 Angstrom to construct a model of the allogeneic 2C-L-d/QL9 complex for comparison with the syngeneic 2C-K-b/dEV8 structure. A prominent ridge on the floor of the L-d peptide-binding groove, not present in K-b, creates a C-terminal bulge in L-d peptides that greatly increases interactions with the 2C beta-chain. Furthermore, weak electrostatic complementarity between Asp77 on the alpha(1) helix of K-b and 2C is enhanced in the allogeneic complex by closer proximity of QL9 peptide residue AspP8 to the 2C HV4 loop.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; RW Johnson Pharmaceut Res Inst, San Diego, CA 92121 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Johnson & Johnson; Johnson & Johnson USA	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.		Degano, Massimo/K-4669-2018	Degano, Massimo/0000-0002-0787-1883	NCI NIH HHS [CA-58896] Funding Source: Medline; NIAID NIH HHS [AI42266, AI42267] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R21AI142267, R37AI042266, R01AI042267] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Arden Bernhard, 1995, Immunogenetics, V42, P501; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; BECK JC, 1986, J IMMUNOL, V137, P916; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; Brock R, 1996, P NATL ACAD SCI USA, V93, P13108, DOI 10.1073/pnas.93.23.13108; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CONNOLLY JM, 1994, P NATL ACAD SCI USA, V91, P11482, DOI 10.1073/pnas.91.24.11482; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; Dodson E, 1996, ACTA CRYSTALLOGR D, V52, P228, DOI 10.1107/S0907444995010638; DUTZ JP, 1994, MOL IMMUNOL, V31, P967, DOI 10.1016/0161-5890(94)90091-4; Eisen HN, 1996, ADV PROTEIN CHEM, V49, P1, DOI 10.1016/S0065-3233(08)60487-8; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GERMAIN RN, 1990, NATURE, V344, P19, DOI 10.1038/344019a0; Gillanders WE, 1997, INT IMMUNOL, V9, P81, DOI 10.1093/intimm/9.1.81; HARRISON SC, 1968, J APPL CRYSTALLOGR, V1, P84, DOI 10.1107/S0021889868005054; HASKINS K, 1984, ANNU REV IMMUNOL, V2, P51, DOI 10.1146/annurev.iy.02.040184.000411; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Klein J., 1986, NATURAL HIST MAJOR H; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Minor W., 1993, XDISPLAYF PROGRAM; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; PULLEN JK, 1989, J IMMUNOL, V143, P1674; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Schlueter CJ, 1996, J MOL BIOL, V256, P859, DOI 10.1006/jmbi.1996.0132; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; Schreiber G, 1997, J MOL BIOL, V270, P111, DOI 10.1006/jmbi.1997.1080; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; SMITH TJ, 1995, J MOL GRAPHICS, V13, P122, DOI 10.1016/0263-7855(94)00019-O; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Tallquist MD, 1998, J IMMUNOL, V160, P802; TALLQUIST MD, 1995, J IMMUNOL, V155, P2419; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; TJOA BA, 1994, MOL IMMUNOL, V31, P705, DOI 10.1016/0161-5890(94)90144-9; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; Udaka K, 1996, J IMMUNOL, V157, P670; VELLIEUX FMD, 1993, DEMON PROGRAM SUITE; WUKOVITZ SW, 1995, NAT STRUCT BIOL, V2, P1062, DOI 10.1038/nsb1295-1062; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	78	140	141	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1998	8	5					553	562		10.1016/S1074-7613(00)80560-9	http://dx.doi.org/10.1016/S1074-7613(00)80560-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620676	Bronze			2022-12-18	WOS:000073885400003
J	Kong, FK; Chen, CLH; Cooper, MD				Kong, FK; Chen, CLH; Cooper, MD			Thymic function can be accurately monitored by the level of recent T cell emigrants in the circulation	IMMUNITY			English	Article							INTRAEPITHELIAL LYMPHOCYTES; INTESTINAL EPITHELIUM; V(D)J RECOMBINATION; RECEPTOR; CHICKEN; SELECTION; ANTIGEN; IDENTIFICATION; ONTOGENY; ANTIBODY	Expression of the avian chT1 thymocyte antigen persists on a subpopulation of peripheral T cells enriched in the DNA deletion circles created by alpha beta and gamma delta TCR gene rearrangements. The chT1(+) cells are evenly distributed among all of the peripheral T lymphocyte compartments. The levels of chT1(+) T cells in the periphery gradually decline in parallel with age-related thymic involution, and these cells disappear following early thymectomy. Experiments in which variable numbers of the 14 thymic robes are removed in young chicks indicate a direct correlation between the levels of circulating chT1(+) cells and residual thymic mass. Measurement of recent thymic emigrants in the periphery thus provides an accurate indication of thymic function.	Univ Alabama Birmingham, Div Dev & Clin Immunol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham	Cooper, MD (corresponding author), Univ Alabama Birmingham, Div Dev & Clin Immunol, Birmingham, AL 35294 USA.	max.cooper@ccc.uab.edu			NIAID NIH HHS [AI39561] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039561, R21AI039561] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARSTILA TP, 1993, EUR J IMMUNOL, V23, P2034, DOI 10.1002/eji.1830230848; Bogue M, 1996, CURR OPIN IMMUNOL, V8, P175, DOI 10.1016/S0952-7915(96)80055-0; Bucy R P, 1991, Semin Immunol, V3, P109; BUCY RP, 1990, J IMMUNOL, V144, P1161; BUCY RP, 1988, J IMMUNOL, V141, P2200; CHAN MM, 1988, J IMMUNOL, V140, P2133; CHAR D, 1990, J IMMUNOL, V145, P3547; CHEN CH, 1988, EUR J IMMUNOL, V18, P539, DOI 10.1002/eji.1830180408; CHEN CH, 1989, P NATL ACAD SCI USA, V86, P2351, DOI 10.1073/pnas.86.7.2351; CHEN CLH, 1984, EUR J IMMUNOL, V14, P385, DOI 10.1002/eji.1830140502; CHEN CLH, 1986, J EXP MED, V164, P375, DOI 10.1084/jem.164.1.375; Chretien I, 1996, EUR J IMMUNOL, V26, P780, DOI 10.1002/eji.1830260409; CIHAK J, 1991, P NATL ACAD SCI USA, V88, P10951, DOI 10.1073/pnas.88.23.10951; COLTEY M, 1989, J EXP MED, V170, P543, DOI 10.1084/jem.170.2.543; COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; COOPER MD, 1991, ADV IMMUNOL, V50, P87; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Dieterlen-Lievre F., 1994, Poultry Science Reviews, V5, P273; DUNON D, 1993, EUR J IMMUNOL, V23, P2545, DOI 10.1002/eji.1830231025; DUNON D, 1993, J EXP MED, V177, P257, DOI 10.1084/jem.177.2.257; DuPasquier L, 1996, RES IMMUNOL, V147, P261, DOI 10.1016/0923-2494(96)87229-4; DUPASQUIER L, 1996, 77 BAS I IMM; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; FUJIMOTO S, 1987, NATURE, V327, P242, DOI 10.1038/327242a0; GUYGRAND D, 1994, J EXP MED, V180, P673, DOI 10.1084/jem.180.2.673; Hanrahan CF, 1997, J IMMUNOL, V159, P4287; HOUSSAINT E, 1991, J EXP MED, V174, P397, DOI 10.1084/jem.174.2.397; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KASAHARA Y, 1993, EUR J IMMUNOL, V23, P2230, DOI 10.1002/eji.1830230927; Katevuo K., 1997, Developmental and Comparative Immunology, V21, P240, DOI 10.1016/S0145-305X(97)88777-0; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; LAHTI JM, 1991, P NATL ACAD SCI USA, V88, P10956, DOI 10.1073/pnas.88.23.10956; LEFRANCOIS L, 1995, IMMUNOL TODAY, V16, P16, DOI 10.1016/0167-5699(95)80065-4; LEFRANCOIS L, 1990, CELL, V63, P333, DOI 10.1016/0092-8674(90)90166-C; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LIN TS, 1995, IMMUNOL CELL BIOL, V73, P469, DOI 10.1038/icb.1995.73; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; MCCORMACK WT, 1989, CELL, V56, P785, DOI 10.1016/0092-8674(89)90683-1; NAGATA S, 1985, EUR J IMMUNOL, V15, P837, DOI 10.1002/eji.1830150818; OKAZAKI K, 1987, CELL, V49, P477, DOI 10.1016/0092-8674(87)90450-8; PICKEL JM, 1993, INT IMMUNOL, V5, P919, DOI 10.1093/intimm/5.8.919; POUSSIER P, 1994, ANNU REV IMMUNOL, V12, P521, DOI 10.1146/annurev.immunol.12.1.521; RATCLIFFE MJH, 1993, VET IMMUNOL IMMUNOP, V38, P375, DOI 10.1016/0165-2427(93)90095-L; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; SCOLLAY R, 1984, IMMUNOL REV, V82, P79, DOI 10.1111/j.1600-065X.1984.tb01118.x; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Six A, 1996, P NATL ACAD SCI USA, V93, P15329, DOI 10.1073/pnas.93.26.15329; SOWDER JT, 1988, J EXP MED, V167, P315, DOI 10.1084/jem.167.2.315; TJOELKER LW, 1990, P NATL ACAD SCI USA, V87, P7856, DOI 10.1073/pnas.87.20.7856; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TREGASKES CA, 1995, J IMMUNOL, V154, P4485; WOLFE HR, 1962, ANAT REC, V142, P485, DOI 10.1002/ar.1091420406	55	140	157	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1998	8	1					97	104		10.1016/S1074-7613(00)80462-8	http://dx.doi.org/10.1016/S1074-7613(00)80462-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462515	Bronze			2022-12-18	WOS:000071765700010
J	Khan, G; Miyashita, EM; Yang, B; Babcock, GJ; ThorleyLawson, DA				Khan, G; Miyashita, EM; Yang, B; Babcock, GJ; ThorleyLawson, DA			Is EBV persistence in vivo a model for B cell homeostasis?	IMMUNITY			English	Article							EPSTEIN-BARR-VIRUS; POLYMERASE CHAIN-REACTION; BURKITT-LYMPHOMA CELLS; LATENT GENE-EXPRESSION; LYMPHOCYTES; DNA; BLOOD; INHIBITION; ANTIGEN	We have measured the absolute numbers of EBV-infected B cells in the peripheral blood of healthy persistently infected individuals. Single measurements on a panel of 15 healthy individuals demonstrate that the frequency varies over a wide range from 1-50 per 10(6) B cells. Repeat measurements over 1-3.5 years on several individuals whose frequencies varied over a 10-fold range showed that the variation does not represent the fluctuation in the frequency that can occur within an individual; rather, the frequencies are specific to the individual. The frequency within an individual measured over time is stable and contributes less than 10% to the variance seen in the whole population. These measurements suggest that the level of EBV-infected B cells is tightly regulated and we propose that the same homeostatic mechanisms that regulate the levels of normal B cells also regulate B cells latently infected with EBV.			Khan, G (corresponding author), TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111, USA.		Khan, Gulfaraz/AAC-2859-2022	Khan, Gulfaraz/0000-0001-6836-1783	NCI NIH HHS [CA 65883, CA 31893] Funding Source: Medline; NIAID NIH HHS [AI 18757] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA031893, R37CA031893, R01CA065883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018757] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMBINDER RF, 1990, MOL CELL PROBE, V4, P397, DOI 10.1016/0890-8508(90)90030-4; AZUMA M, 1992, J EXP MED, V175, P353, DOI 10.1084/jem.175.2.353; CHEN F, 1995, J VIROL, V69, P3752, DOI 10.1128/JVI.69.6.3752-3758.1995; COEN DM, 1990, CURRENT PROTOCALS MO; Decker LL, 1996, J VIROL, V70, P3286, DOI 10.1128/JVI.70.5.3286-3289.1996; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; HURLEY EA, 1988, J EXP MED, V168, P2059, DOI 10.1084/jem.168.6.2059; Kieff E, 1996, VIROLOGY, P2343; LAM KMC, 1991, LANCET, V337, P876, DOI 10.1016/0140-6736(91)90203-2; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Masucci Maria G., 1994, Trends in Microbiology, V2, P125, DOI 10.1016/0966-842X(94)90599-1; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MIYASHITA EM, 1995, CELL, V80, P593, DOI 10.1016/0092-8674(95)90513-8; QU LR, 1992, J VIROL, V66, P3715, DOI 10.1128/JVI.66.6.3715-3724.1992; RICKINSON AB, 1985, BRIT MED BULL, V41, P75, DOI 10.1093/oxfordjournals.bmb.a072030; Rickinson AB, 1996, VIROLOGY, P2397; ROWE M, 1987, EMBO J, V6, P2743, DOI 10.1002/j.1460-2075.1987.tb02568.x; SAITO I, 1989, J EXP MED, V169, P2191, DOI 10.1084/jem.169.6.2191; SUGDEN B, 1979, J VIROL, V31, P590, DOI 10.1128/JVI.31.3.590-595.1979; SUMMERS WC, 1976, J VIROL, V18, P151, DOI 10.1128/JVI.18.1.151-155.1976; TELENTI A, 1990, J CLIN MICROBIOL, V28, P2187, DOI 10.1128/JCM.28.10.2187-2190.1990; ThorleyLawson DA, 1996, TRENDS MICROBIOL, V4, P204, DOI 10.1016/S0966-842X(96)90020-7; TIERNEY RJ, 1994, J VIROL, V68, P7374, DOI 10.1128/JVI.68.11.7374-7385.1994; WAGNER HJ, 1992, J CLIN MICROBIOL, V30, P2826, DOI 10.1128/JCM.30.11.2826-2829.1992; Winer BJ., 1971, STAT PRINCIPLES EXPT, V2nd ed; WYATT RT, 1992, J EXP MED, V175, P1575, DOI 10.1084/jem.175.6.1575; YAO QY, 1989, INT J CANCER, V43, P67, DOI 10.1002/ijc.2910430115; YAO QY, 1991, INT J CANCER, V48, P253, DOI 10.1002/ijc.2910480217; YAO QY, 1985, INT J CANCER, V35, P43, DOI 10.1002/ijc.2910350108; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0	30	140	143	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1996	5	2					173	179		10.1016/S1074-7613(00)80493-8	http://dx.doi.org/10.1016/S1074-7613(00)80493-8			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VE589	8769480	Bronze			2022-12-18	WOS:A1996VE58900007
J	Ryan, JJ; McReynolds, LJ; Keegan, A; Wang, LH; Garfein, E; Rothman, P; Nelms, K; Paul, WE				Ryan, JJ; McReynolds, LJ; Keegan, A; Wang, LH; Garfein, E; Rothman, P; Nelms, K; Paul, WE			Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor	IMMUNITY			English	Article							STIMULATORY FACTOR-I; MAST-CELL LINES; HUMAN INTERLEUKIN-4 RECEPTOR; FC-EPSILON; T-CELL; SUPERFAMILY; DEFINES; IRS-1	IL-4 causes hematopoietic cells to proliferate and express a series of genes, including CD23. We examined whether IL-4-mediated growth, as measured by 4PS phosphorylation, and gene induction were similarly controlled. Studies of M12.4.1 cells expressing human IL-4R truncation mutants indicated that the region between amino acids 557-657 is necessary for full gene expression, which correlated with State DNA binding activity. This region was not required for 4PS phosphorylation. Tyrosine-to-phenylalanine mutations in the interval between amino acids 557-657 revealed that as long as one tyrosine remained unmutated, CD23 was fully induced. When all three tyrosines were mutated, the receptor was unable to induce CD23. The results indicate that growth regulation and gene expression are principally controlled by distinct regions of IL-4R.	AMER RED CROSS,JEROME H HOLLAND LAB,ROCKVILLE,MD 20855; CUNY MT SINAI SCH MED,DEPT MICROBIOL,NEW YORK,NY 10029; COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT MICROBIOL,NEW YORK,NY 10032	American Red Cross; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University	Ryan, JJ (corresponding author), NIAID,IMMUNOL LAB,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033540] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI33540] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BROWN MA, 1987, CELL, V50, P809, DOI 10.1016/0092-8674(87)90339-4; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; CONRAD DH, 1987, J IMMUNOL, V139, P2290; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEWAALMALEFYT R, 1993, RES IMMUNOL, V144, P629; GALIZZI JP, 1990, INT IMMUNOL, V2, P669, DOI 10.1093/intimm/2.7.669; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; Isfort RJ, 1990, GROWTH FACTORS, V2, P213, DOI 10.3109/08977199009071507; IZUHARA K, 1993, RES IMMUNOL, V144, P584, DOI 10.1016/S0923-2494(05)80007-0; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; LOWENTHAL JW, 1988, J IMMUNOL, V140, P456; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MORIA AO, 1988, MOL CELL BIOL, V8, P2214; MOSMANN TR, 1986, P NATL ACAD SCI USA, V83, P5654, DOI 10.1073/pnas.83.15.5654; NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149; OHARA J, 1987, NATURE, V325, P537, DOI 10.1038/325537a0; PARK LS, 1987, P NATL ACAD SCI USA, V84, P1669, DOI 10.1073/pnas.84.6.1669; PERNIS A, 1995, P NATL ACAD SCI USA, V92, P7971, DOI 10.1073/pnas.92.17.7971; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SCHINDLER C, 1994, EMBO J, V13, P1350, DOI 10.1002/j.1460-2075.1994.tb06388.x; SEDER RA, 1991, INT ARCH ALLER A IMM, V94, P137, DOI 10.1159/000235345; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; WANG HY, 1995, IMMUNITY, V4; WANG LM, 1992, EMBO J, V11, P4899, DOI 10.1002/j.1460-2075.1992.tb05596.x; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; YIN TG, 1994, J BIOL CHEM, V269, P26614; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3	34	140	147	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1996	4	2					123	132		10.1016/S1074-7613(00)80677-9	http://dx.doi.org/10.1016/S1074-7613(00)80677-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TX225	8624803	Bronze			2022-12-18	WOS:A1996TX22500003
J	ROZDZIAL, MM; MALISSEN, B; FINKEL, TH				ROZDZIAL, MM; MALISSEN, B; FINKEL, TH			TYROSINE-PHOSPHORYLATED T-CELL RECEPTOR ZETA-CHAIN ASSOCIATES WITH THE ACTIN CYTOSKELETON UPON ACTIVATION OF MATURE T-LYMPHOCYTES	IMMUNITY			English	Article							FOCAL ADHESION KINASE; ANTIGEN-RECEPTOR; SIGNAL TRANSDUCTION; MONOCLONAL-ANTIBODY; PHOSPHOLIPASE-C; PROTEIN; COMPLEX; MOTIF; IDENTIFICATION; REORGANIZATION	The multichain T cell antigen receptor (TCR) is composed of an antigen binding (alpha/beta) domain and associated signal-transducing complexes, the CD3 (gamma, delta, and epsilon) and the zeta chains, The zeta chain (TCR zeta) plays a key role in signal transduction. We show here that TCR ligation induces association of tyrosine-phosphorylated TCR zeta with the detergent-insoluble cell fraction. The microfilament poison, cytochalasin D, disrupts this association and enhances the coprecipitation of actin with TCR zeta after receptor ligation. This microfilament association is specific to TCR-associated polypeptides containing at least one intact immunoreceptor tyrosine-based activation motif (ITAM), Mapping studies using transfectants and chimeric TCR zeta chain constructs suggest that the third ITAM is necessary and sufficient for association, if the distal tyrosine is intact. This cytoskeletal association is directly correlated with IL-2 production, and ligation of TCR on immature thymocytes does not induce TCR zeta-cytoskeleton association. These data thus provide direct evidence of a developmentally regulated activation-dependent interaction between a lymphocyte antigen receptor and the actin cytoskeleton.	CNRS MARSEILLE LUMINY,INSERM,CTR IMMUNOL,F-13288 MARSEILLE 9,FRANCE; UNIV COLORADO,HLTH SCI CTR,DEPT IMMUNOL & BIOCHEM,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT BIOPHYS,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT GENET,DENVER,CO 80262	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	ROZDZIAL, MM (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,DIV BASIC SCI,DENVER,CO 80206, USA.		Malissen, Bernard/AAK-4659-2020	Malissen, Bernard/0000-0003-1340-9342	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030575, P01AI029903] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-30575A, AI-29903A] Funding Source: Medline; PHS HHS [T-32A100048] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMIGORENA S, 1992, NATURE, V358, P337, DOI 10.1038/358337a0; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BARSAGI D, 1993, CELL, V74, P83, DOI 10.1016/0092-8674(93)90296-3; BEAUFILS P, 1993, EMBO J, V12, P5105, DOI 10.1002/j.1460-2075.1993.tb06205.x; BRAUN J, 1982, J IMMUNOL, V128, P1198; BU JJ, 1995, 9TH INT C IMM, P2639; CHAN AC, 1992, CURR OPIN IMMUNOL, V4, P246, DOI 10.1016/0952-7915(92)90072-M; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; DEBELL KE, 1992, J IMMUNOL, V149, P2271; EXLEY M, 1994, J BIOL CHEM, V269, P15140; FINKEL TH, 1991, IMMUNOL TODAY, V12, P79, DOI 10.1016/0167-5699(91)90162-M; FINKEL TH, 1987, NATURE, V330, P6144; GEPPERT TD, 1991, J IMMUNOL, V146, P3298; GILLIS S, 1978, J IMMUNOL, V120, P2027; GOLDSCHMIDTCLER.PJ, 1991, SCIENCE, V25, P1231; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HOWARD PK, 1993, SCIENCE, V259, P241, DOI 10.1126/science.7678470; HSI ED, 1989, J BIOL CHEM, V264, P10836; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; JOCKUSCH BM, 1993, METHOD CELL BIOL, V37, P343, DOI 10.1016/S0091-679X(08)60257-5; JUNGBLUTH A, 1994, J CELL SCI, V107, P117; KANNER SB, 1994, J CELL BIOCH S D, V18, P403; KOYASU S, 1994, P NATL ACAD SCI USA, V91, P6693, DOI 10.1073/pnas.91.14.6693; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEE JK, 1988, CELL, V55, P807, DOI 10.1016/0092-8674(88)90136-5; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MANESS PF, 1982, CELL, V30, P253, DOI 10.1016/0092-8674(82)90031-9; MELAMED I, 1991, J IMMUNOL, V147, P1139; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; OMANN GM, 1987, PHYSIOL REV, V67, P285, DOI 10.1152/physrev.1987.67.1.285; OSMAN N, 1995, J BIOL CHEM, V270, P13981, DOI 10.1074/jbc.270.23.13981; PARDI R, 1992, J CELL BIOL, V116, P1211, DOI 10.1083/jcb.116.5.1211; PARSEY MV, 1993, J IMMUNOL, V151, P1881; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C; ROEHM N, 1984, CELL, V38, P577, DOI 10.1016/0092-8674(84)90512-9; ROZDZIAL MM, 1994, J IMMUNOL, V153, P1563; ROZDZIAL MM, 1986, CELL, V47, P1061, DOI 10.1016/0092-8674(86)90821-4; ROZDZIAL MM, 1986, J CELL BIOL, V103, P2755, DOI 10.1083/jcb.103.6.2755; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; WALLING EA, 1988, ARCH BIOCHEM BIOPHYS, V264, P321, DOI 10.1016/0003-9861(88)90600-5; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1987, J IMMUNOL, V139, P3245; WHITE J, 1989, J IMMUNOL, V143, P1822; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P	53	140	141	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					623	633		10.1016/1074-7613(95)90133-7	http://dx.doi.org/10.1016/1074-7613(95)90133-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584152	Bronze			2022-12-18	WOS:A1995TG28100010
J	Riffelmacher, T; Clarke, A; Richter, FC; Stranks, A; Pandey, S; Danielli, S; Hublitz, P; Yu, ZR; Johnson, E; Schwerd, T; McCullagh, J; Uhlig, H; Jacobsen, SEW; Simon, AK				Riffelmacher, Thomas; Clarke, Alexander; Richter, Felix C.; Stranks, Amanda; Pandey, Sumeet; Danielli, Sara; Hublitz, Philip; Yu, Zhanru; Johnson, Errin; Schwerd, Tobias; McCullagh, James; Uhlig, Holm; Jacobsen, Sten Eirik W.; Simon, Anna Katharina			Autophagy-Dependent Generation of Free Fatty Acids Is Critical for Normal Neutrophil Differentiation	IMMUNITY			English	Article							LIPID-METABOLISM; CELL FUNCTION; MICE; MEMORY; LIPASE; HOMEOSTASIS; ACTIVATION; INHIBITORS; LIPOLYSIS; LEUKEMIA	Neutrophils are critical and short-lived mediators of innate immunity that require constant replenishment. Their differentiation in the bone marrow requires extensive cytoplasmic and nuclear remodeling, but the processes governing these energy-consuming changes are unknown. While previous studies show that autophagy is required for differentiation of other blood cell lineages, its function during granulopoiesis has remained elusive. Here, we have shown that metabolism and autophagy are developmentally programmed and essential for neutrophil differentiation in vivo. Atg7-deficient neutrophil precursors had increased glycolytic activity but impaired mitochondrial respiration, decreased ATP production, and accumulated lipid droplets. Inhibiting autophagy-mediated lipid degradation or fatty acid oxidation alonewas sufficient to cause defective differentiation, while administration of fatty acids or pyruvate for mitochondrial respiration rescued differentiation in autophagy-deficient neutrophil precursors. Together, we show that autophagy-mediated lipolysis provides free fatty acids to support a mitochondrial respiration pathway essential to neutrophil differentiation.	[Riffelmacher, Thomas; Clarke, Alexander; Richter, Felix C.; Simon, Anna Katharina] Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England; [Riffelmacher, Thomas; Stranks, Amanda; Danielli, Sara; Simon, Anna Katharina] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRCHuman Immunol Unit, Oxford OX3 9DS, England; [Hublitz, Philip; Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Hematol Unit, Oxford OX3 9DS, England; [Yu, Zhanru] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford OX3 7FZ, England; [Johnson, Errin] Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England; [Pandey, Sumeet; Schwerd, Tobias; Uhlig, Holm] Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Expt Med, Oxford OX3 9DU, England; [McCullagh, James] Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England; [Jacobsen, Sten Eirik W.] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med Huddinge, Stockholm, Sweden; [Jacobsen, Sten Eirik W.] Karolinska Inst, Wallenberg Inst Regenerat Med, Dept Cell & Mol Biol, Stockholm, Sweden; [Jacobsen, Sten Eirik W.] Karolinska Univ Hosp, Stockholm, Sweden	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Simon, AK (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England.; Simon, AK (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRCHuman Immunol Unit, Oxford OX3 9DS, England.	katja.simon@ndm.ox.ac.uk	McCullagh, James/AAD-2669-2022; Riffelmacher, Thomas/P-1853-2019; Jacobsen, Sten Eirik W/D-3974-2018; Hublitz, Philip/AAM-5159-2020	McCullagh, James/0000-0003-4733-1205; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Clarke, Alex/0000-0003-2846-7860; Simon, Anna Katharina/0000-0002-4077-7995; Danielli, Sara/0000-0003-4608-5751; Richter, Felix Clemens/0000-0002-3415-3449; Uhlig, Holm/0000-0002-6111-7355; Riffelmacher, Thomas/0000-0002-0372-5272; Hublitz, Philip/0000-0001-8810-3247	Medical Research Council; Wellcome Trust [103830/Z/14/Z]; MRC [MC_UU_12009/5]; ERC [AdG 670930]; MRC [MC_UU_00016/5, G0501838, G0801073] Funding Source: UKRI; Medical Research Council [MC_UU_00016/5, G0501838, G0801073, MC_UU_12009/5] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Prof. Ivo Touw, Dr. Mizushima, and Dr. Komatsu for providing mice, Dr. Christoph Thiele and Dr. Erdinc Sezgin for help with microscopy, Hanlin Zhang, Sandrine Obba, and Mariolina Salio for help with experiments, and Petter Woll for help with establishing and analyzing the Fluidigm experiments. Flow cytometry work was performed with the help of Craigh Waugh and Jonathan Webber from the WIMM and Kennedy Institute Flow Facilities, respectively. We would like to thank Marcia Curtinha and the Histology Facility at the Kennedy Institute for Wright-Giemsa stainings. David Ferguson helped with electron microscopy. This work was supported by grants from the Medical Research Council (PhD prize scholarship for T.R.), the Wellcome Trust (Investigator award grant number 103830/Z/14/Z to A.K.S.), and the MRC Molecular Haematology Unit core award (MC_UU_12009/5 to S.E.W.J.). Li-cor Odyssey imager funded by ERC AdG 670930.	Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Auberger P, 2017, BLOOD, V129, P547, DOI 10.1182/blood-2016-07-692707; Bardoel BW, 2014, CELL HOST MICROBE, V15, P526, DOI 10.1016/j.chom.2014.04.011; Bhattacharya A, 2015, CELL REP, V12, P1731, DOI 10.1016/j.celrep.2015.08.019; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Bugl S, 2012, ANN NY ACAD SCI, V1266, P171, DOI 10.1111/j.1749-6632.2012.06607.x; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; Evangelisti C, 2015, BBA-MOL CELL RES, V1853, P14, DOI 10.1016/j.bbamcr.2014.09.023; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Guo JY, 2016, GENE DEV, V30, P1704, DOI 10.1101/gad.283416.116; HADVARY P, 1991, J BIOL CHEM, V266, P2021; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HARRISON EH, 1990, J LIPID RES, V31, P2187; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Iida S, 2008, GENES CELLS, V13, P313, DOI 10.1111/j.1365-2443.2008.01173.x; Jacquel A, 2012, BLOOD, V119, P4527, DOI 10.1182/blood-2011-11-392167; Jiang YJ, 2016, INT J HEMATOL, V103, P607, DOI 10.1007/s12185-016-1958-6; Kabat AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12444; Kaushik S, 2016, AUTOPHAGY, V12, P432, DOI 10.1080/15548627.2015.1124226; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; KRUSZYNSKA YT, 1987, BIOCHEM PHARMACOL, V36, P3917, DOI 10.1016/0006-2952(87)90458-8; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Latif AL, 2016, CELL, V167, P45, DOI 10.1016/j.cell.2016.08.051; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/nchembio.1359, 10.1038/NCHEMBIO.1359]; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Mortensen M, 2011, AUTOPHAGY, V7, P1069, DOI 10.4161/auto.7.9.15886; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; O'Sullivan TE, 2015, IMMUNITY, V43, P331, DOI 10.1016/j.immuni.2015.07.012; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Puleston DJ, 2014, ELIFE, V3, DOI 10.7554/eLife.03706; Qu P, 2010, AM J PATHOL, V176, P2394, DOI 10.2353/ajpath.2010.091063; Riffelmacher T, 2017, FEBS J, V284, P1008, DOI 10.1111/febs.13962; Rodrigues HG, 2010, LIPIDS, V45, P809, DOI 10.1007/s11745-010-3461-9; Rozman S, 2015, CELL DEATH DIFFER, V22, P445, DOI 10.1038/cdd.2014.169; Salio M, 2014, P NATL ACAD SCI USA, V111, pE5678, DOI 10.1073/pnas.1413935112; Satake S, 2012, J IMMUNOL, V189, P4546, DOI 10.4049/jimmunol.1103007; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; VALTIERI M, 1987, J IMMUNOL, V138, P3829; Watson AS, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.8; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Wolfler A, 2010, BLOOD, V116, P4116, DOI 10.1182/blood-2010-03-275404; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang Y, 2012, BLOOD, V119, P2895, DOI 10.1182/blood-2011-08-372383	56	139	146	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					466	+		10.1016/j.immuni.2017.08.005	http://dx.doi.org/10.1016/j.immuni.2017.08.005			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28916263	Green Published, hybrid			2022-12-18	WOS:000411128200012
J	Alvarez-Diaz, S; Dillon, CP; Lalaoui, N; Tanzer, MC; Rodriguez, DA; Lin, A; Lebois, M; Hakem, R; Josefsson, EC; O'Reilly, LA; Silke, J; Alexander, WS; Green, DR; Strasser, A				Alvarez-Diaz, Silvia; Dillon, Christopher P.; Lalaoui, Najoua; Tanzer, Maria C.; Rodriguez, Diego A.; Lin, Ann; Lebois, Marion; Hakem, Razq; Josefsson, Emma C.; O'Reilly, Lorraine A.; Silke, John; Alexander, Warren S.; Green, Douglas R.; Strasser, Andreas			The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis	IMMUNITY			English	Article							MIXED LINEAGE KINASE; NLRP3 INFLAMMASOME ACTIVATION; DOMAIN-LIKE PROTEIN; CELL-DEATH; LYMPHOPROLIFERATIVE SYNDROME; PROGRAMMED NECROSIS; CASPASE-8; TNF; NECROPTOSIS; CYTOKINE	The kinases RIPK1 and RIPK3 and the pseudo-kinase MLKL have been identified as key regulators of the necroptotic cell death pathway, although a role for MLKL within the whole animal has not yet been established. Here, we have shown that MLKL deficiency rescued the embryonic lethality caused by loss of Caspase-8 or FADD. Casp8(-/-)Mlkl(-/-) and Fadd(-/-) Mlkl(-/-) mice were viable and fertile but rapidly developed severe lymphadenopathy, systemic autoimmune disease, and thrombocytopenia. Thesemorbidities occurred more rapidly and with increased severity in Casp8(-/-)Mlkl(-/-) and Fadd(-/-) Mlkl(-/-) mice compared to Casp8(-/-) Ripk3(-/-)or Fadd(-/-) Ripk3(-/-) mice,respectively. These results demonstrate that MLKL is an essential effector of aberrant necroptosis in embryos caused by loss of Caspase-8 or FADD. Furthermore, they suggest that RIPK3 and/or MLKL may exert functions independently of necroptosis. It appears that non-necroptotic functions of RIPK3 contribute to the lymphadenopathy, autoimmunity, and excess cytokine production that occur when FADD or Caspase-8-mediated apoptosis is abrogated.	[Alvarez-Diaz, Silvia; Lalaoui, Najoua; Tanzer, Maria C.; Lin, Ann; Lebois, Marion; Josefsson, Emma C.; O'Reilly, Lorraine A.; Silke, John; Alexander, Warren S.; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Alvarez-Diaz, Silvia; Lalaoui, Najoua; Tanzer, Maria C.; Josefsson, Emma C.; O'Reilly, Lorraine A.; Silke, John; Alexander, Warren S.; Strasser, Andreas] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Dillon, Christopher P.; Rodriguez, Diego A.; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Hakem, Razq] Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Hakem, Razq] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	Walter & Eliza Hall Institute; University of Melbourne; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Alexander, WS; Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; Alexander, WS; Strasser, A (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia.; Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	alexandw@wehi.edu.au; douglas.green@stjude.org; strasser@wehi.edu.au	Silke, John/B-7622-2008; Josefsson, Emma/CAF-4970-2022; Strasser, Andreas/C-7581-2013; Green, Douglas R/N-8083-2018; Lalaoui, Najoua/C-1410-2014; Alvarez-Diaz, Silvia/P-4948-2018	Silke, John/0000-0002-7611-5774; Strasser, Andreas/0000-0002-5020-4891; Green, Douglas R/0000-0002-7332-1417; Lalaoui, Najoua/0000-0002-0165-3324; Alvarez-Diaz, Silvia/0000-0002-8897-1893; Rodriguez, Diego/0000-0003-4771-0221; Hakem, Razqallah/0000-0001-5948-7931; Josefsson, Emma/0000-0001-6478-5204	Spanish Ministry of Education Postdoctoral Fellowship; Victorian International Research Scholarship; National Health and Medical Research Council (NHMRC) [1016647, 1058344, 1079250, 1047672, 1025594, 1057905, 1046984]; Australian Cancer Research Fund; U.S. NIH; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA169291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044828, R01AI044828] Funding Source: NIH RePORTER	Spanish Ministry of Education Postdoctoral Fellowship(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Victorian International Research Scholarship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Fund; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Lochland and C. Hall for genotyping, J.G. Zhang for FASL, M. Yang for technical assistance, and S. Hedrick (UC) for Casp8<SUP>-/-</SUP> mice. S.A.-D. was supported by a Spanish Ministry of Education Postdoctoral Fellowship. M.C.T. was supported by a Victorian International Research Scholarship. This work was funded by grants and fellowships from the National Health and Medical Research Council (NHMRC) (1016647, 1058344, 1079250, 1047672, 1025594, 1057905, and 1046984), the Australian Cancer Research Fund, the U.S. NIH, and the American Lebanese Syrian Associated Charities. This work made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS (361646).	Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cook WD, 2014, CELL DEATH DIFFER, V21, P1600, DOI 10.1038/cdd.2014.70; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Josefsson EC, 2012, METHODS MOL BIOL, V788, P59, DOI 10.1007/978-1-61779-307-3_5; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kearney CJ, 2013, J BIOL CHEM, V288, P4878, DOI 10.1074/jbc.M112.422410; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oliveira JB, 2010, BLOOD, V116, pE35, DOI 10.1182/blood-2010-04-280347; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pattison JM, 1996, J HEART LUNG TRANSPL, V15, P1194; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Powell N, 1996, EUR RESPIR J, V9, P2454, DOI 10.1183/09031936.96.09122454; RATHANASWAMI P, 1993, J BIOL CHEM, V268, P5834; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Su LJ, 2014, STRUCTURE, V22, P1489, DOI 10.1016/j.str.2014.07.014; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tanzer MC, 2015, BIOCHEM J, V471, P255, DOI 10.1042/BJ20150678; Teachey DT, 2005, BLOOD, V105, P2443, DOI 10.1182/blood-2004-09-3542; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; WATANABE D, 1995, EMBO J, V14, P12, DOI 10.1002/j.1460-2075.1995.tb06970.x; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wong WWL, 2014, BLOOD, V123, P2562, DOI 10.1182/blood-2013-06-510743; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	62	139	140	4	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					513	526		10.1016/j.immuni.2016.07.016	http://dx.doi.org/10.1016/j.immuni.2016.07.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27523270	Bronze, Green Accepted			2022-12-18	WOS:000388454300010
J	Akhter, A; Caution, K; Abu Khweek, A; Tazi, M; Abdulrahman, BA; Abdelaziz, DHA; Voss, OH; Doseff, AI; Hassan, H; Azad, AK; Schlesinger, LS; Wewers, MD; Gavrilin, MA; Amer, AO				Akhter, Anwari; Caution, Kyle; Abu Khweek, Arwa; Tazi, Mia; Abdulrahman, Basant A.; Abdelaziz, Dalia H. A.; Voss, Oliver H.; Doseff, Andrea I.; Hassan, Hoda; Azad, Abul K.; Schlesinger, Larry S.; Wewers, Mark D.; Gavrilin, Mikhail A.; Amer, Amal O.			Caspase-11 Promotes the Fusion of Phagosomes Harboring Pathogenic Bacteria with Lysosomes by Modulating Actin Polymerization	IMMUNITY			English	Article							LEGIONELLA-PNEUMOPHILA; INFECTION; INFLAMMASOME; ACTIVATION; ASC; APOPTOSIS; PYRIN; IDENTIFICATION; REPLICATION; MACROPHAGES	Inflammasomes are rnultiprotein complexes that include members of the NLR (nucleotide-binding domain leucine-rich repeat containing) family and caspase-1. Once bacterial molecules are sensed within the macrophage, the inflammasome is assembled, mediating the activation of caspase-1. Caspase-11 mediates caspase-1 activation in response to lipopolysaccharide and bacterial toxins, and yet its role during bacterial infection is unknown. Here, we demonstrated that caspase-11 was dispensable for caspase-1 activation in response to Legionella, Salmonella, Francisella, and Listeria. We also determined that active mouse caspase-11 was required for restriction of L. pneumophila infection. Similarly, human caspase-4 and caspase-5, homologs of mouse caspase-11, cooperated to restrict L. pneumophila infection in human macrophages. Caspase-11 promoted the fusion of the L. pneumophila vacuole with lysosomes by modulating actin polymerization through cofilin. However, caspase-11 was dispensable for the fusion of lysosomes with phagosomes containing nonpathogenic bacteria, uncovering a fundamental difference in the trafficking of phagosomes according to their cargo.	[Akhter, Anwari; Caution, Kyle; Abu Khweek, Arwa; Tazi, Mia; Abdulrahman, Basant A.; Abdelaziz, Dalia H. A.; Hassan, Hoda; Azad, Abul K.; Schlesinger, Larry S.; Amer, Amal O.] Ohio State Univ, Dept Microbial Infect & Immun, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Akhter, Anwari; Caution, Kyle; Abu Khweek, Arwa; Tazi, Mia; Abdulrahman, Basant A.; Abdelaziz, Dalia H. A.; Voss, Oliver H.; Doseff, Andrea I.; Hassan, Hoda; Schlesinger, Larry S.; Wewers, Mark D.; Gavrilin, Mikhail A.; Amer, Amal O.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Akhter, Anwari; Caution, Kyle; Abu Khweek, Arwa; Tazi, Mia; Abdulrahman, Basant A.; Abdelaziz, Dalia H. A.; Voss, Oliver H.; Doseff, Andrea I.; Hassan, Hoda; Azad, Abul K.; Schlesinger, Larry S.; Wewers, Mark D.; Gavrilin, Mikhail A.; Amer, Amal O.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Voss, Oliver H.; Doseff, Andrea I.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Amer, AO (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Ctr Microbial Interface Biol, Columbus, OH 43210 USA.	amal.amer@osumc.edu	Doseff, Andrea/E-2991-2011; Wewers, Mark/AAB-6202-2021	Abdulrahman, Basant/0000-0002-4970-6835; Gavrilin, Mikhail/0000-0003-2003-768X	Egyptian Bureau of Education; NIH [R01HL094586, RO1HL094586, R21AI083871]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083871] Funding Source: NIH RePORTER	Egyptian Bureau of Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Yuan at Harvard Medical School for providing the breeding pairs for the caspase-11-deficient (Casp4<SUP>-/-</SUP>) mice used in these studies. We are grateful to C. Newland for help with in vivo experiments. We thank T. Eubank for supplying the graphical abstract. D.H.A.A. and B.A.A. are supported by a doctoral fellowship from the Egyptian Bureau of Education. Work in A.O.A.'s laboratory is supported by grants R01HL094586, RO1HL094586 (minority supplement), and R21AI083871 from the NIH.	Abdelaziz DH, 2011, J BIOL CHEM, V286, P3203, DOI 10.1074/jbc.M110.197681; Abdelaziz DHA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00018; Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; BRIELAND J, 1994, AM J PATHOL, V145, P1537; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Choi JR, 2009, FEBS LETT, V583, P3016, DOI 10.1016/j.febslet.2009.08.014; Coers J, 2000, MOL MICROBIOL, V38, P719, DOI 10.1046/j.1365-2958.2000.02176.x; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; Fahy RJ, 1999, J IMMUNOL, V163, P1755; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Guerin I, 2000, INFECT IMMUN, V68, P2655, DOI 10.1128/IAI.68.5.2655-2662.2000; Hall MW, 2007, PEDIATR RES, V62, P597, DOI 10.1203/PDR.0b013e3181559774; HORWITZ MA, 1981, J EXP MED, V153, P398, DOI 10.1084/jem.153.2.398; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Jahraus A, 2001, MOL BIOL CELL, V12, P155, DOI 10.1091/mbc.12.1.155; Kang SJ, 2002, CELL DEATH DIFFER, V9, P1115, DOI 10.1038/sj.cdd.4401087; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kjeken R, 2004, MOL BIOL CELL, V15, P345, DOI 10.1091/mbc.e03-05-0334; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Marion S, 2011, TRAFFIC, V12, P421, DOI 10.1111/j.1600-0854.2011.01158.x; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meresse S, 2001, CELL MICROBIOL, V3, P567, DOI 10.1046/j.1462-5822.2001.00141.x; Mueller NJ, 2002, INFECT IMMUN, V70, P2657, DOI 10.1128/IAI.70.5.2657-2664.2002; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Salvesen GS, 2011, CELL, V147, DOI 10.1016/j.cell.2011.09.030; Santic M, 2007, INFECT IMMUN, V75, P2903, DOI 10.1128/IAI.00147-07; Shoma S, 2008, INFECT IMMUN, V76, P1547, DOI 10.1128/IAI.01269-07; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; Srinivasula SM, 1999, CANCER RES, V59, P999; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Stennicke HR, 1998, BBA-PROTEIN STRUCT M, V1387, P17, DOI 10.1016/S0167-4838(98)00133-2; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; Stockinger W, 2006, MOL BIOL CELL, V17, P1697, DOI 10.1091/mbc.E05-12-1140; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; Sutterwala FS, 2009, CLIN IMMUNOL, V130, P2, DOI 10.1016/j.clim.2008.08.011; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Vogel JP, 1999, CURR OPIN MICROBIOL, V2, P30, DOI 10.1016/S1369-5274(99)80005-8; Waite AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006147; Waite AL, 2009, EXP BIOL MED, V234, P40, DOI 10.3181/0806-RM-184; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; YAMAMOTO Y, 1988, INFECT IMMUN, V56, P370, DOI 10.1128/IAI.56.2.370-375.1988; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	57	139	143	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 27	2012	37	1					35	47		10.1016/j.immuni.2012.05.001	http://dx.doi.org/10.1016/j.immuni.2012.05.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22658523	Green Accepted, Bronze			2022-12-18	WOS:000307133200008
J	Meresse, B; Malamut, G; Cerf-Bensussan, N				Meresse, Bertrand; Malamut, Georgia; Cerf-Bensussan, Nadine			Celiac Disease: An Immunological Jigsaw	IMMUNITY			English	Review							REGULATORY T-CELLS; INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; NATURAL-KILLER; DERMATITIS-HERPETIFORMIS; TISSUE TRANSGLUTAMINASE; TRANSFERRIN RECEPTOR; DEAMIDATED GLIADIN; REFRACTORY SPRUE; MULTIPLE COMMON; DENDRITIC CELLS	Celiac disease (CD) is a chronic enteropathy induced by dietary gluten in genetically predisposed people. The keystone of CD pathogenesis is an adaptive immune response orchestrated by the interplay between gluten and MHC class II HLA-DQ2 and DQ8 molecules. Yet, other factors that impair immunoregulatory mechanisms and/or activate the large population of intestinal intraepithelial lymphocytes (IEL) are indispensable for driving tissue damage. Herein, we summarize our current understanding of the mechanisms and consequences of the undesirable immune response initiated by gluten peptides. We show that CD is a model disease to decipher the role of MHC class II molecules in human immunopathology, to analyze the mechanisms that link tolerance to food proteins and autoimmunity, and to investigate how chronic activation of IEL can lead to T cell lymphomagenesis.	[Meresse, Bertrand; Malamut, Georgia; Cerf-Bensussan, Nadine] INSERM, U989, F-75015 Paris, France; [Meresse, Bertrand; Malamut, Georgia; Cerf-Bensussan, Nadine] Univ Paris 05, Paris Sorbonne Ctr, Inst IMAGINE, F-75015 Paris, France; [Malamut, Georgia] Hop Europeen Georges Pompidou, AP HP, Dept Gastroenterol, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Meresse, B (corresponding author), INSERM, U989, F-75015 Paris, France.	bertrand.meresse@inserm.fr; nadine.cerf-bensussan@inserm.fr	Meresse, Bertrand/N-6325-2017; Cerf-Bensussan, nadine/H-9505-2017	Meresse, Bertrand/0000-0002-8978-8636; Cerf-Bensussan, nadine/0000-0003-0665-1245; Malamut, Georgia/0000-0003-4030-3025	INSERM; Ligue Contre le Cancer; Fondation Pour la Recherche Medicale; Agence Nationale pour la Recherche; Association pour la Recherche contre le Cancer; Association francaise des Patients Intolerants au Gluten; Fondation Princesse Grace	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Contre le Cancer(Ligue nationale contre le cancer); Fondation Pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association francaise des Patients Intolerants au Gluten; Fondation Princesse Grace	The authors acknowledge funding from INSERM, Ligue Contre le Cancer, Fondation Pour la Recherche Medicale, Agence Nationale pour la Recherche, Association pour la Recherche contre le Cancer, Association francaise des Patients Intolerants au Gluten, and Fondation Princesse Grace. They thank all members of INSERM U989 for sharing work and helpful discussions and J.C. Weill for critical review of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Aggarwal S, 2012, THER ADV GASTROENTER, V5, P37, DOI 10.1177/1756283X11417038; Ahmed MB, 2009, J IMMUNOL, V182, P6763, DOI 10.4049/jimmunol.0801792; Benahmed M, 2007, GASTROENTEROLOGY, V132, P994, DOI 10.1053/j.gastro.2006.12.025; Bergseng E, 2005, J BIOL CHEM, V280, P21791, DOI 10.1074/jbc.M501558200; Bernardo D, 2008, CLIN EXP IMMUNOL, V154, P64, DOI 10.1111/j.1365-2249.2008.03743.x; Bevan S, 1999, J MED GENET, V36, P687; Biswas PS, 2010, IMMUNOL REV, V233, P79, DOI 10.1111/j.0105-2896.2009.00864.x; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Bodd M, 2012, GASTROENTEROLOGY, V142, P552, DOI 10.1053/j.gastro.2011.11.021; Bourliere M, 2001, LANCET, V357, P803, DOI 10.1016/S0140-6736(05)71230-7; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; COLOMBEL JF, 1990, GUT, V31, P1345, DOI 10.1136/gut.31.12.1345; Colpitts SL, 2012, J IMMUNOL, V188, P2483, DOI 10.4049/jimmunol.1103609; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Cosnes J, 2008, CLIN GASTROENTEROL H, V6, P753, DOI 10.1016/j.cgh.2007.12.022; Coulon S, 2011, NAT MED, V17, P1456, DOI 10.1038/nm.2462; Dafik L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030642; de Kauwe AL, 2009, J IMMUNOL, V182, P7440, DOI 10.4049/jimmunol.0900233; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Devalliere J, 2011, BIOCHEM PHARMACOL, V82, P1391, DOI 10.1016/j.bcp.2011.06.023; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Di Sabatino A, 2007, GASTROENTEROLOGY, V133, P1175, DOI 10.1053/j.gastro.2007.08.018; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Du Pre MF, 2011, GASTROENTEROLOGY, V141, P610, DOI 10.1053/j.gastro.2011.04.048; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Elfstrom P, 2011, JNCI-J NATL CANCER I, V103, P436, DOI 10.1093/jnci/djq564; Fallang LE, 2009, NAT IMMUNOL, V10, P1096, DOI 10.1038/ni.1780; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Henderson KN, 2007, ACTA CRYSTALLOGR F, V63, P1021, DOI 10.1107/S1744309107051408; Hmida NB, 2012, AM J GASTROENTEROL, V107, P604, DOI 10.1038/ajg.2011.397; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ivarsson A, 2005, BEST PRACT RES CL GA, V19, P425, DOI 10.1016/j.bpg.2005.02.005; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Klock C., 2012, SEMIN IMMUNOPATHOL; Kooy-Winkelaar Y, 2011, J IMMUNOL, V187, P5123, DOI 10.4049/jimmunol.1101179; Koskinen O, 2008, J PEDIATR GASTR NUTR, V47, P436, DOI 10.1097/MPG.0b013e31817b6dec; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lebreton C., 2012, GASTROENTER IN PRESS; Lionetti E, 2011, INT REV IMMUNOL, V30, P219, DOI 10.3109/08830185.2011.602443; Ludvigsson JF, 2012, GUT; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Malamut G, 2010, J CLIN INVEST, V120, P2131, DOI 10.1172/JCI41344; Malamut G, 2009, GASTROENTEROLOGY, V136, P81, DOI 10.1053/j.gastro.2008.09.069; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Marietta E, 2004, J CLIN INVEST, V114, P1090, DOI 10.1172/JCI200421055; Markiewicz MA, 2012, IMMUNITY, V36, P132, DOI 10.1016/j.immuni.2011.11.014; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Mazzarella G, 2008, GASTROENTEROLOGY, V134, P1017, DOI 10.1053/j.gastro.2008.01.008; McGuire HM, 2011, IMMUNITY, V34, P602, DOI 10.1016/j.immuni.2011.01.021; Mention J.-J., 2004, P 10 S COEL DIS PAR, P119; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Meresse B, 2009, SEMIN IMMUNOL, V21, P121, DOI 10.1016/j.smim.2009.01.002; Moura IC, 2001, J EXP MED, V194, P417, DOI 10.1084/jem.194.4.417; Nistal E, 2012, INFLAMM BOWEL DIS, V18, P649, DOI 10.1002/ibd.21830; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Oberhuber G, 1996, AM J PATHOL, V148, P1351; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Ohta N, 2002, J IMMUNOL, V169, P460, DOI 10.4049/jimmunol.169.1.460; Oikarinen M, 2012, DIABETES, V61, P687, DOI 10.2337/db11-1157; Olaussen RW, 2002, SCAND J IMMUNOL, V56, P652, DOI 10.1046/j.1365-3083.2002.01195.x; Ou GW, 2009, AM J GASTROENTEROL, V104, P3058, DOI 10.1038/ajg.2009.524; Plot L, 2009, AUTOIMMUN REV, V8, P316, DOI 10.1016/j.autrev.2008.10.001; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; Ramanathan S, 2011, J IMMUNOL, V186, P5131, DOI 10.4049/jimmunol.1001221; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Sandberg-Bennich S, 2002, ACTA PAEDIATR, V91, P30, DOI 10.1080/080352502753457905; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; SEAH PP, 1971, LANCET, V2, P681; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sollid LM, 2011, J INTERN MED, V269, P604, DOI 10.1111/j.1365-2796.2011.02376.x; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; SPENCER J, 1988, AM J PATHOL, V132, P1; Sperandeo MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021281; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Szperl AM, 2011, CLIN GENET, V80, P138, DOI 10.1111/j.1399-0004.2011.01714.x; Tjon JML, 2008, BLOOD, V112, P5103, DOI 10.1182/blood-2008-04-150748; Tollefsen S, 2012, J BIOL CHEM, V287, P13611, DOI 10.1074/jbc.M111.320374; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; VAN DE KAMER J H, 1953, Acta Paediatr, V42, P223, DOI 10.1111/j.1651-2227.1953.tb05586.x; van Lummel M, 2012, J BIOL CHEM, V287, P9514, DOI 10.1074/jbc.M111.313940; Wang CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026235; Wang N, 2011, MOL MED, V17, P1383, DOI 10.2119/molmed.2011.00195; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yi JS, 2010, MICROBES INFECT, V12, P1111, DOI 10.1016/j.micinf.2010.08.008; Zanzi D, 2011, AM J GASTROENTEROL, V106, P1308, DOI 10.1038/ajg.2011.80; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004; Zone JJ, 2011, J IMMUNOL, V186, P4474, DOI 10.4049/jimmunol.1003273	106	139	141	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 29	2012	36	6					907	919		10.1016/j.immuni.2012.06.006	http://dx.doi.org/10.1016/j.immuni.2012.06.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22749351	Bronze			2022-12-18	WOS:000306097100010
J	Decker, T; di Magliano, MP; McManus, S; Sun, Q; Bonifer, C; Tagoh, H; Busslinger, M				Decker, Thorsten; di Magliano, Marina Pasca; McManus, Shane; Sun, Qiong; Bonifer, Constanze; Tagoh, Hiromi; Busslinger, Meinrad			Stepwise Activation of Enhancer and Promoter Regions of the B Cell Commitment Gene Pax5 in Early Lymphopoiesis	IMMUNITY			English	Article							TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; DNA-BINDING; CHROMATIN; PROTEINS; EBF; DIFFERENTIATION; STAT5; PU.1; BSAP	Pax5 is an essential regulator of B cell identity and function. Here, we used transgenesis and deletion mapping to identify a potent enhancer in intron 5 of the Pax5 locus. This enhancer in combination with the promoter region was sufficient to recapitulate the B lymphoid expression of Pax5. The enhancer was silenced by DNA methylation in embryonic stem cells, but became activated in multipotent hematopoietic progenitors. It contained functional binding sites for the transcription factors PU.1, IRF4, IRF8, and NF-kappa B, suggesting that these regulators contribute to sequential enhancer activation in hematopoietic progenitors and during B cell development. In contrast, the promoter region was repressed by Polycomb group proteins in non-B cells and was activated only at the onset of pro-B cell development through induction of chromatin remodeling by the transcription factor EBF1. These experiments demonstrate a stepwise activation of Pax5 in early lymphopoiesis; and provide mechanistic insights into the process of B cell commitment.	[Decker, Thorsten; di Magliano, Marina Pasca; McManus, Shane; Sun, Qiong; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Bonifer, Constanze; Tagoh, Hiromi] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Sect Expt Haematol, Leeds LS9 7TF, W Yorkshire, England	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Saint James's University Hospital; University of Leeds	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@imp.ac.at	Tagoh, Hiromi/B-2954-2009; Busslinger, Meinrad J./J-1249-2016	Tagoh, Hiromi/0000-0001-9905-6992; Busslinger, Meinrad J./0000-0002-9111-9351; Bonifer, Constanze/0000-0002-4267-0825; Pasca di Magliano, Marina/0000-0001-9632-9035	Boehringer Ingelheim; Austrian Industrial Research Promotion Fund; Austrian GEN-AU initiative; Leukaemia Research, UK	Boehringer Ingelheim(Boehringer Ingelheim); Austrian Industrial Research Promotion Fund; Austrian GEN-AU initiative; Leukaemia Research, UK	We thank R. Grosschedl for generously providing Ebf1<SUP>+/-</SUP> mice, K. Kwon for E2A-deficient progenitor cells, G.A. Busslinger for generating the EBF1 antibody, and G. Stengl for FACS sorting. This research was supported by Boehringer Ingelheim (M.B.), the Austrian Industrial Research Promotion Fund (M.B.), the Austrian GEN-AU initiative (M.B.), and grants from Leukaemia Research, UK (C.B.).	ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Fuxa M, 2007, J IMMUNOL, V178, P8221, DOI 10.4049/jimmunol.178.12.8221-a; Goetz CA, 2005, J IMMUNOL, V174, P7753, DOI 10.4049/jimmunol.174.12.7753; HAGMAN J, 1991, EMBO J, V10, P3409, DOI 10.1002/j.1460-2075.1991.tb04905.x; Hirokawa S, 2003, EUR J IMMUNOL, V33, P1824, DOI 10.1002/eji.200323974; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nebral K, 2009, LEUKEMIA, V23, P134, DOI 10.1038/leu.2008.306; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Pfeffer PL, 2000, DEVELOPMENT, V127, P1017; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Sen R, 2006, IMMUNITY, V25, P871, DOI 10.1016/j.immuni.2006.12.003; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Tagoh H, 2006, METH MOL B, V325, P285; TRAVIS A, 1993, MOL CELL BIOL, V13, P3392, DOI 10.1128/MCB.13.6.3392; Walter K, 2008, BLOOD, V112, P1673, DOI 10.1182/blood-2008-02-142786; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zhao F, 2003, MOL CELL BIOL, V23, P3837, DOI 10.1128/MCB.23.11.3837-3846.2003	36	139	143	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					508	520		10.1016/j.immuni.2009.01.012	http://dx.doi.org/10.1016/j.immuni.2009.01.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19345119	Bronze			2022-12-18	WOS:000265319000008
J	Allenspach, EJ; Lemos, MP; Porrett, PM; Turka, LA; Laufer, TM				Allenspach, Eric J.; Lemos, Maria P.; Porrett, Paige M.; Turka, Laurence A.; Laufer, Terri M.			Migratory and Lymphoid-Resident Dendritic Cells Cooperate to Efficiently Prime Naive CD4 T cells	IMMUNITY			English	Article							LANGERHANS CELLS; IN-VIVO; EPICUTANEOUS IMMUNIZATION; ANTIGEN; RESPONSES; SKIN; IDENTIFICATION; POPULATION; SUBTYPES; THYMUS	To initiate an adaptive immune response, rare antigen-specific naive CD4(+) T cells must interact with equally rare dendritic cells (DCs) bearing cognate peptide-major histocompatibility complex (MHC) complexes. Lymph nodes (LNs) draining the site of antigen entry are populated by lymphoid-resident DCs as well as DCs that have immigrated from tissues, although the requirement for each population in initiating the T cell response remains unclear. Here, we show that antigen processing and presentation by both lymphoid-resident and migratory DCs was required for clonal selection and expansion of CD4(+) T cells after subcutaneous immunization. Early antigen presentation by lymphoid-resident DCs initiated activation and trapping of antigen-specific T cells in the draining LN, without sufficing for clonal expansion. Migratory DCs, however, interacted with the CD4(+) T cells retained in the LN to induce proliferation. Therefore, distinct D subsets cooperate to alert and trap the appropriate cell and then license its expansion and differentiation.	[Allenspach, Eric J.; Lemos, Maria P.; Turka, Laurence A.; Laufer, Terri M.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Allenspach, Eric J.; Lemos, Maria P.; Porrett, Paige M.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Porrett, Paige M.] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Laufer, TM (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	tlaufer@mail.med.upenn.edu	Eckhardt, Erik/G-1567-2010; Porrett, Paige/AAU-8992-2020	Allenspach, Eric/0000-0001-7346-5835	National Institutes of Health; University of Pennsylvania Department of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI063009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Department of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank S.L. Reiner, T. Kambayashi, R.M. Anthony, and G.F. Wu for critical reading of the manuscript. This work was funded by grants to T.M.L. and L.A.T. from the National Institutes of Health and to T.M.L. from the University of Pennsylvania Department of Medicine. E.J.A. designed and did the experiments, analyzed data, and wrote the manuscript; M.P.L made initial observations; P.M.P. and L.A.T. provided technical assistance with skin grafts (data not shown) and contributed to the writing of the manuscript; and T.M.L. designed and supervised research and wrote the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Bynoe MS, 2003, IMMUNITY, V19, P317, DOI 10.1016/S1074-7613(03)00239-5; CAHILL RNP, 1976, J EXP MED, V143, P870, DOI 10.1084/jem.143.4.870; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Garg S, 2003, NAT IMMUNOL, V4, P907, DOI 10.1038/ni962; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817; Lemos MP, 2003, J IMMUNOL, V171, P5077, DOI 10.4049/jimmunol.171.10.5077; Mach N, 2000, CANCER RES, V60, P3239; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Ortner U, 1996, J IMMUNOL METHODS, V193, P71, DOI 10.1016/0022-1759(96)00058-0; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Ravindran R, 2007, P NATL ACAD SCI USA, V104, P12075, DOI 10.1073/pnas.0701363104; Sakoda Y, 2007, BLOOD, V109, P1756, DOI 10.1182/blood-2006-08-042853; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Shklovskaya E, 2008, J IMMUNOL, V181, P418, DOI 10.4049/jimmunol.181.1.418; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Smith A, 2000, IMMUNITY, V13, P783, DOI 10.1016/S1074-7613(00)00076-5; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; SPRENT J, 1976, J EXP MED, V144, P617, DOI 10.1084/jem.144.3.617; Stenger S, 2002, CURR OPIN IMMUNOL, V14, P452, DOI 10.1016/S0952-7915(02)00355-2; Stoitzner P, 2008, J IMMUNOL, V180, P1991, DOI 10.4049/jimmunol.180.3.1991; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Vremec D, 1997, J IMMUNOL, V159, P565; Wang LC, 2008, J IMMUNOL, V180, P4722, DOI 10.4049/jimmunol.180.7.4722; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	50	139	143	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2008	29	5					795	806		10.1016/j.immuni.2008.08.013	http://dx.doi.org/10.1016/j.immuni.2008.08.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	18951047	Green Accepted, Bronze			2022-12-18	WOS:000261036000016
J	Maroof, A; Beattie, L; Zubairi, S; Svensson, M; Stager, S; Kaye, PM				Maroof, Asher; Beattie, Lynette; Zubairi, Soombul; Svensson, Mattias; Stager, Simona; Kaye, Paul M.			Posttranscriptional regulation of Il10 gene expression allows natural killer cells to express immunoregulatory function	IMMUNITY			English	Article							HUMAN NK CELLS; DENDRITIC CELLS; LEISHMANIA-DONOVANI; T-CELL; VISCERAL LEISHMANIASIS; IL-10 PRODUCTION; ACTIVATION; COMBINATION; INFECTION; RESPONSES	Natural killer (NK) cells play a well-recognized role in early pathogen containment and in shaping acquired cell-mediated immunity. However, indirect evidence in humans and experimental models has suggested that NK cells also play negative regulatory roles during chronic disease. To formally test this hypothesis, we employed a well-defined experimental model of visceral leishmaniasis. Our data demonstrated that NKp46(+)CD49b(+)CD3(-) NK cells were recruited to the spleen and into hepatic granulomas, where they inhibited host protective immunity in an interleukin-10 (IL-10)-dependent manner. Although IL-10 mRNA could be detected in activated NK cells 24 hr after infection, the inhibitory function of NK cells was only acquired later during infection, coincident with increased IL-10 mRNA stability and an enhanced capacity to secrete IL-10 protein. Our data support a growing body of literature that implicates NK cells as negative regulators of cell-mediated immunity and suggest that NK cells, like CD4(+) T helper 1 cells, may acquire immunoregulatory functions as a consequence of extensive activation.	[Maroof, Asher; Beattie, Lynette; Zubairi, Soombul; Svensson, Mattias; Stager, Simona; Kaye, Paul M.] Univ York, Hull York Med Sch, Immunol & Infect Unit, York YO10 5YW, N Yorkshire, England; [Maroof, Asher; Beattie, Lynette; Zubairi, Soombul; Svensson, Mattias; Stager, Simona; Kaye, Paul M.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of Hull; University of York - UK; University of York - UK	Kaye, PM (corresponding author), Univ York, Hull York Med Sch, Immunol & Infect Unit, Wentworth Way, York YO10 5YW, N Yorkshire, England.	pmk2@york.ac.uk		Svensson, Mattias/0000-0003-1695-7934; Beattie, Lynette/0000-0002-5794-7233; Kaye, Paul/0000-0002-8796-4755	Wellcome Trust; U.K. Medical Research Council; MRC [G0400786] Funding Source: UKRI; Medical Research Council [G0400786] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the staff of the LSHTM and University of York Biological Services Facilities for animal husbandry, staff of the Biology Department Technology Facility for assistance with flow cytometry and imaging, J. Langhorne, A. O'Garra, and D. Kioussis for generously providing mice, and M. Coles and M. Kullberg for critical review of the manuscript. This work was supported by grants from The Wellcome Trust and the U.K. Medical Research Council.	Aidinis V, 2008, NUCLEIC ACIDS RES, V36, pD1048, DOI 10.1093/nar/gkm838; Alli RS, 2004, FEBS LETT, V559, P71, DOI 10.1016/S0014-5793(04)00026-2; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Andrews DM, 2001, J IMMUNOL, V166, P1796, DOI 10.4049/jimmunol.166.3.1796; Ato M, 2002, NAT IMMUNOL, V3, P1185, DOI 10.1038/ni861; BANCROFT GJ, 1993, CURR OPIN IMMUNOL, V5, P503, DOI 10.1016/0952-7915(93)90030-V; Barber MA, 2007, J IMMUNOL, V178, P6140, DOI 10.4049/jimmunol.178.10.6140; Baxter AG, 2002, AUTOIMMUNITY, V35, P1, DOI 10.1080/08916930290005864; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Bodas M, 2006, J IMMUNOL, V177, P4636, DOI 10.4049/jimmunol.177.7.4636; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; Caminschi I, 2007, J EXP MED, V204, P2579, DOI 10.1084/jem.20071351; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chakir H, 2001, CELL IMMUNOL, V212, P71, DOI 10.1006/cimm.2001.1844; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; Deniz G, 2008, J IMMUNOL, V180, P850, DOI 10.4049/jimmunol.180.2.850; Diefenbach A, 2003, CURR OPIN IMMUNOL, V15, P37, DOI 10.1016/S0952-7915(02)00007-9; Dokun AO, 2001, J IMMUNOL, V167, P5286, DOI 10.4049/jimmunol.167.9.5286; DUNN PL, 1991, J INFECT DIS, V164, P869, DOI 10.1093/infdis/164.5.869; Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2; Engwerda CR, 1998, EUR J IMMUNOL, V28, P669, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;669::AID-IMMU669&gt;3.0.CO;2-N; Farag SS, 2002, BLOOD, V100, P1935, DOI 10.1182/blood-2002-02-0350; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Flodstrom M, 2002, SCAND J IMMUNOL, V55, P432, DOI 10.1046/j.1365-3083.2002.01084.x; French AR, 2004, ARTHRITIS RES THER, V6, P8, DOI 10.1186/ar1034; Grant LR, 2008, GENES IMMUN, V9, P316, DOI 10.1038/gene.2008.20; Homann D, 2002, IMMUNITY, V16, P403, DOI 10.1016/S1074-7613(02)00290-X; Horwitz DA, 1997, IMMUNOL TODAY, V18, P538, DOI 10.1016/S0167-5699(97)01149-3; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kaye PM, 2004, IMMUNOL REV, V201, P239, DOI 10.1111/j.0105-2896.2004.00188.x; Lauwerys BR, 2000, J IMMUNOL, V165, P1847, DOI 10.4049/jimmunol.165.4.1847; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mehrotra PT, 1998, J IMMUNOL, V160, P2637; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Moretta L, 2002, MICROBES INFECT, V4, P1539, DOI 10.1016/S1286-4579(02)00037-0; Murphy ML, 2001, EUR J IMMUNOL, V31, P2848, DOI 10.1002/1521-4141(2001010)31:10&lt;2848::AID-IMMU2848&gt;3.0.CO;2-T; Murray HW, 2002, INFECT IMMUN, V70, P6284, DOI 10.1128/IAI.70.11.6284-6293.2002; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Powell MJ, 2000, J IMMUNOL, V165, P292, DOI 10.4049/jimmunol.165.1.292; RAHAL MD, 1991, CELL IMMUNOL, V134, P111, DOI 10.1016/0008-8749(91)90335-9; Sartori Alexandrina, 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P215, DOI 10.1590/S0036-46651999000400002; Schleicher U, 2007, J EXP MED, V204, P893, DOI 10.1084/jem.20061293; Sharma S, 1999, J IMMUNOL, V163, P5020; Shi FD, 2000, NAT IMMUNOL, V1, P245, DOI 10.1038/79792; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; Smelt SC, 1997, J IMMUNOL, V158, P3813; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Stager S, 2006, EUR J IMMUNOL, V36, P1764, DOI 10.1002/eji.200635937; Su HC, 2001, EUR J IMMUNOL, V31, P3048, DOI 10.1002/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vigano P, 2001, MOL HUM REPROD, V7, P971, DOI 10.1093/molehr/7.10.971; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Woelbing F, 2006, J EXP MED, V203, P177, DOI 10.1084/jem.20052288; Woolard MD, 2005, INFECT IMMUN, V73, P6742, DOI 10.1128/IAI.73.10.6742-6751.2005; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677	64	139	145	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2008	29	2					295	305		10.1016/j.immuni.2008.06.012	http://dx.doi.org/10.1016/j.immuni.2008.06.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18701085	Green Accepted, Bronze			2022-12-18	WOS:000258610800017
J	Tailor, P; Tamura, T; Kong, HJ; Kubota, T; Kubota, M; Borghi, P; Gabriele, L; Ozato, K				Tailor, Prafullakurnar; Tamura, Tomohiko; Kong, Hee Jeong; Kubota, Toru; Kubota, Mayumi; Borghi, Paola; Gabriele, Lucia; Ozato, Keiko			The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8	IMMUNITY			English	Article							SEQUENCE BINDING-PROTEIN; TRANSCRIPTION FACTORS; RIG-I; ANTIVIRAL RESPONSE; VIRAL-INFECTION; A GENES; ALPHA; ICSBP/IRF-8; ACTIVATION; CHROMATIN	Dendritic cells (DCs) produce type I interferons (IFNs) in greater amounts than other cells, but the mechanisms remain elusive. Here we studied the role of a transcription factor, IRF8, in DC induction of type I IFNs. Upon newcastle disease virus (NDV) infection, bone marrow-derived plasmacytoid and conventional DCs induced IFN transcripts, exhibiting two-phase kinetics. The second, amplifying phase represented an IFN feedback response that accounted for much of IFN protein production. Induction of second phase transcription required IRF8. Mouse cytomegalovirus (MCMV) and Toll-like receptor-mediated IFN induction in DCs also required IRF8. Chromatin immunoprecipitation analysis showed that IRF7, IRF8, and RNA polymerase 11 were recruited to the IFN promoters upon stimulation. Moreover, sustained RNA polymerase II recruitment to the promoters critically depended on IRF8. Together, these data indicate that IRF8 magnifies the second phase of IFN transcription in DCs by prolonging binding of basic transcription machinery to the IFN promoters, thereby playing a role in innate immunity.	NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; Ist Super Sanita, Virol Lab, I-00161 Rome, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Istituto Superiore di Sanita (ISS)	Ozato, K (corresponding author), NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA.	ozatok@nih.gov	Gabriele, Lucia/J-8335-2016	Gabriele, Lucia/0000-0002-1483-866X	Intramural NIH HHS [Z01 HD001310-21] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001310] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Civas A, 2006, J BIOL CHEM, V281, P4856, DOI 10.1074/jbc.M506812200; Civas A, 2002, BIOCHIMIE, V84, P643, DOI 10.1016/S0300-9084(02)01431-1; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; DAMELL JE, 2003, RECENT PROG HORM RES, V424, P324; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kulesza CA, 2006, P NATL ACAD SCI USA, V103, P18302, DOI 10.1073/pnas.0608718103; Kuwata T, 2002, MOL CELL BIOL, V22, P7439, DOI 10.1128/MCB.22.21.7439-7448.2002; Laricchia-Robbio L, 2005, P NATL ACAD SCI USA, V102, P14368, DOI 10.1073/pnas.0504014102; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Sharf R, 1997, J BIOL CHEM, V272, P9785; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Tailor P, 2006, CELL RES, V16, P134, DOI 10.1038/sj.cr.7310018; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Yang HM, 2003, J BIOL CHEM, V278, P15495, DOI 10.1074/jbc.M212940200; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	50	139	143	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					228	239		10.1016/j.immuni.2007.06.009	http://dx.doi.org/10.1016/j.immuni.2007.06.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17702615	Green Accepted, Bronze			2022-12-18	WOS:000249056300010
J	Thomas, MD; Kremer, CS; Ravichandran, KS; Rajewsky, K; Bender, TP				Thomas, MD; Kremer, CS; Ravichandran, KS; Rajewsky, K; Bender, TP			c-Myb is critical for B cell development and maintenance of follicular B cells	IMMUNITY			English	Article							MARGINAL-ZONE; IN-VIVO; CUTTING EDGE; EXPRESSION; RECEPTOR; MATURE; GENE; BAFF; PROLIFERATION; LYMPHOCYTES	The c-Myb transcription factor is crucial during definitive hematopoiesis. However, the embryonic lethality of Myb traditional null mutations has precluded analysis of c-Myb function in lymphocytes. Using tissue-specific inactivation at the Myb locus, we demonstrate that loss of Myb causes a partial block during B cell development at the pro-B to pre-B cell transition, resulting in greatly decreased output of new B cells from the bone marrow. Furthermore, we demonstrate that Myb is not essential for the proliferation of splenic B cells, but that loss of c-Myb function prevents normal B cell homeostasis due to decreased splenic B cell survival. Decreased survival is accompanied by hyporesponsiveness to the B cell survival factor BLyS (also termed BAFF), decreased expression of the BLyS receptor 3 (BR3), and altered regulation of PKC delta nuclear accumulation. Thus, c-Myb is important during multiple stages of B-lymphopoiesis.	Univ Virginia, Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	University of Virginia; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Bender, TP (corresponding author), Univ Virginia, Hlth Syst, Dept Microbiol, POB 800734, Charlottesville, VA 22908 USA.	tpb3e@virginia.edu		Rajewsky, Klaus/0000-0002-6633-6370	FIC NIH HHS [F06 TW002297] Funding Source: Medline; NCI NIH HHS [CA 85842] Funding Source: Medline; NIAID NIH HHS [AI 59294, AI 43425, R01 AI059294] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F06TW002297] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA085842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043425, R01AI059294] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agenes F, 1997, EUR J IMMUNOL, V27, P1801, DOI 10.1002/eji.1830270731; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; BENDER TP, 1987, J IMMUNOL, V139, P3822; Cabatingan MS, 2002, J IMMUNOL, V169, P6795, DOI 10.4049/jimmunol.169.12.6795; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; CATRON KM, 1992, J IMMUNOL, V148, P934; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; Gaudin E, 2004, IMMUNOL REV, V197, P102, DOI 10.1111/j.0105-2896.2004.0095.x; GOLAY J, 1992, J IMMUNOL, V149, P300; Gorelik L, 2004, J IMMUNOL, V172, P762, DOI 10.4049/jimmunol.172.2.762; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HernandezMunain C, 1996, J EXP MED, V183, P289, DOI 10.1084/jem.183.1.289; ILLERA VA, 1993, J IMMUNOL, V151, P2965; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lee YJ, 2001, J IMMUNOL, V167, P82, DOI 10.4049/jimmunol.167.1.82; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; LOFFERT D, 1994, IMMUNOL REV, V137, P135, DOI 10.1111/j.1600-065X.1994.tb00662.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; MORROW MA, 1992, GENE DEV, V6, P61, DOI 10.1101/gad.6.1.61; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; OPSTELTEN D, 1983, J IMMUNOL, V131, P2635; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Reichlin A, 2004, J EXP MED, V199, P855, DOI 10.1084/jem.20031140; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Smith SH, 2003, J IMMUNOL, V170, P5820, DOI 10.4049/jimmunol.170.12.5820; Taylor D, 1996, GENE DEV, V10, P2732, DOI 10.1101/gad.10.21.2732; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; Trescol-Biemont MC, 2004, BIOCHIMIE, V86, P287, DOI 10.1016/j.biochi.2004.04.001; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101	47	139	144	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2005	23	3					275	286		10.1016/j.immuni.2005.08.005	http://dx.doi.org/10.1016/j.immuni.2005.08.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169500	Bronze			2022-12-18	WOS:000232382500006
J	Yang, FC; Kapur, R; King, AJ; Tao, W; Kim, C; Borneo, J; Breese, R; Marshall, M; Dinauer, MC; Williams, DA				Yang, FC; Kapur, R; King, AJ; Tao, W; Kim, C; Borneo, J; Breese, R; Marshall, M; Dinauer, MC; Williams, DA			Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells	IMMUNITY			English	Article							PROTEIN-KINASE; RHO-FAMILY; PHOSPHATIDYLINOSITOL 3-KINASE; HEMATOPOIETIC-CELLS; HUMAN NEUTROPHILS; MAP KINASE; SIGNAL-TRANSDUCTION; CYCLE PROGRESSION; MESSENGER-RNA; GENE-TRANSFER	Mast cells generated from Rac2-deficient (-/-) mice demonstrated defective actin-based functions, including adhesion, migration, and degranulation. Rac2(-/-) mast cells generated lower numbers and less mast cell colonies in response to growth factors and were deficient in vivo. Rac2(-/-) mast cells demonstrated a significant reduction in growth factor-induced survival, which correlated with the lack of activation of Akt and significant changes in the expression of the Bcl-2 family members BAD and Bcl-X-L, in spite of a 3-fold induction of Rac1 protein. These results suggest that Rac2 plays a unique role in multiple cellular functions and describe an essential role for Rac2 in growth factor-dependent survival and expression of BAD/Bcl-X-L.	Indiana Univ, Herman B Wells Ctr Pediat Res, Sch Med, Dept Pediat,Sect Hematol Oncol, Indianapolis, IN 46202 USA; Indiana Univ, Walther Oncol Ctr, Sch Med, Dept Med,Div Hematol Oncol, Indianapolis, IN 46202 USA; Lilly Res Labs, Indianapolis, IN 46285 USA; Indiana Univ, Sch Med, Howard Hughes Med Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Eli Lilly; Howard Hughes Medical Institute; Indiana University System; Indiana University-Purdue University Indianapolis	Williams, DA (corresponding author), Indiana Univ, Herman B Wells Ctr Pediat Res, Sch Med, Dept Pediat,Sect Hematol Oncol, Indianapolis, IN 46202 USA.	dwilliam@iupui.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048605] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL-45635] Funding Source: Medline; NIDDK NIH HHS [R01 DK48605] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Burridge K, 1999, SCIENCE, V283, P2028, DOI 10.1126/science.283.5410.2028; COLEMAN JW, 1991, EUR J IMMUNOL, V21, P2559, DOI 10.1002/eji.1830211037; COLEMAN JW, 1993, J IMMUNOL, V150, P556; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; DASTYCH J, 1991, IMMUNOLOGY, V73, P478; DASTYCH J, 1994, J IMMUNOL, V152, P213; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dibbert B, 1998, BLOOD, V92, P778, DOI 10.1182/blood.V92.3.778.415k38_778_783; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; DIEKMANN D, 1995, EMBO J, V14, P5297, DOI 10.1002/j.1460-2075.1995.tb00214.x; FELTS K, 1999, STRATEGIES NEWSLETTE, V12, P74; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Galli SJ, 1996, NATURE, V381, P21, DOI 10.1038/381021a0; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hsu C, 1996, IMMUNOL LETT, V52, P129, DOI 10.1016/0165-2478(96)02599-0; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Kuribara R, 1999, MOL CELL BIOL, V19, P2754; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Leberer E, 1997, CURR OPIN GENET DEV, V7, P59, DOI 10.1016/S0959-437X(97)80110-4; LI B, 2000, IN PRESS SCIENCE; Lores P, 1997, ONCOGENE, V15, P601, DOI 10.1038/sj.onc.1201378; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MEININGER CJ, 1992, BLOOD, V79, P958; Mok CL, 1999, J EXP MED, V189, P575, DOI 10.1084/jem.189.3.575; MOLL J, 1991, ONCOGENE, V6, P863; NAKAHATA T, 1982, J CELL PHYSIOL, V111, P239, DOI 10.1002/jcp.1041110304; Nishida K, 1999, ONCOGENE, V18, P407, DOI 10.1038/sj.onc.1202301; NOBES CD, 1995, J CELL SCI, V108, P225; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Oritani K, 1999, BLOOD, V93, P1346, DOI 10.1182/blood.V93.4.1346.404k15_1346_1354; OSullivan AJ, 1996, MOL BIOL CELL, V7, P397, DOI 10.1091/mbc.7.3.397; Pollok KE, 1998, J VIROL, V72, P4882, DOI 10.1128/JVI.72.6.4882-4892.1998; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; SHIRSAT NV, 1990, ONCOGENE, V5, P769; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; VOJTEK AB, 1995, CELL, V82, P527, DOI 10.1016/0092-8674(95)90023-3; Vosseller K, 1997, MOL BIOL CELL, V8, P909, DOI 10.1091/mbc.8.5.909; WADDELL TK, 1995, J BIOL CHEM, V270, P15403, DOI 10.1074/jbc.270.25.15403; Weinmann P, 1999, BLOOD, V93, P3106; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WILIAMS DA, 2000, IN PRESS BLOOD; Yang L, 1996, MOL CELL BIOL, V16, P3300; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	71	139	141	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2000	12	5					557	568		10.1016/S1074-7613(00)80207-1	http://dx.doi.org/10.1016/S1074-7613(00)80207-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843388	Bronze			2022-12-18	WOS:000087356400011
J	Lucas, B; Stefanova, I; Yasutomo, K; Dautigny, N; Germain, RN				Lucas, B; Stefanova, I; Yasutomo, K; Dautigny, N; Germain, RN			Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; INTERCELLULAR-ADHESION MOLECULE-1; RECEPTOR TRANSGENIC MICE; POSITIVE SELECTION; NEGATIVE SELECTION; ANTIGEN RECEPTOR; ANTAGONIST LIGANDS; THYMOCYTE SELECTION; CD4+8+ THYMOCYTES; CLONAL DELETION	CD4(+)CD8(+) thymocyte differentiation requires TCR signaling induced by self-peptide/MHC ligands. Nevertheless, the resulting mature T cells are not activated by these self-complexes, whereas foreign ligands can be potent stimuli. Here, we show that the signaling properties of TCR change during thymocyte maturation, differentially affecting responses to related peptide/MHC molecule complexes and contributing to this discrimination. Weak agonists for CD4(+)CD8(+) thymocytes lose potency during development, accompanied by a change in TCR-associated phosphorylation from an agonist to a partial agonist/antagonist pattern. in contrast, sensitivity to strong agonists is maintained, along with full signaling. This yields a mature T cell pool highly responsive to foreign antigen while possessing a wide margin of safety against activation by self-ligands.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Inst Necker, INSERM, U345, F-75730 Paris 15, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Yasutomo, Koji/0000-0003-0411-2037; LUCAS, Bruno/0000-0002-0322-3977	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000757] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; Amsen D, 1996, INT IMMUNOL, V8, P1927, DOI 10.1093/intimm/8.12.1927; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1994, J IMMUNOL, V152, P4758; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; Combadiere B, 1998, J EXP MED, V187, P349, DOI 10.1084/jem.187.3.349; Criado G, 1996, EUR J IMMUNOL, V26, P1228, DOI 10.1002/eji.1830260607; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; DING L, 1993, J IMMUNOL, V151, P1224; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; FINK PJ, 1978, J EXP MED, V148, P776; Girao C, 1997, J IMMUNOL, V159, P4205; Grossman Z, 1996, P NATL ACAD SCI USA, V93, P14747, DOI 10.1073/pnas.93.25.14747; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kishimoto H, 1996, J EXP MED, V184, P531, DOI 10.1084/jem.184.2.531; KISIELOW P, 1995, J EXP MED, V181, P1975, DOI 10.1084/jem.181.6.1975; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LaFace DM, 1997, J IMMUNOL, V158, P2057; Lesage S, 1997, J IMMUNOL, V159, P2078; LUCAS B, 1994, J IMMUNOL, V153, P53; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MACDONALD HR, 1988, NATURE, V336, P471, DOI 10.1038/336471a0; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MANNIE MD, 1995, J IMMUNOL, V154, P2642; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; PAGE DM, 1994, P NATL ACAD SCI USA, V91, P4057, DOI 10.1073/pnas.91.9.4057; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Schmitt S, 1997, EUR J IMMUNOL, V27, P2139, DOI 10.1002/eji.1830270904; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SIU G, 1989, J IMMUNOL, V143, P3813; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Smyth LA, 1998, P NATL ACAD SCI USA, V95, P8193, DOI 10.1073/pnas.95.14.8193; Sousa CRE, 1996, J EXP MED, V184, P149, DOI 10.1084/jem.184.1.149; SPAIN LM, 1994, J IMMUNOL, V152, P1709; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; VASQUEZ NJ, 1994, IMMUNITY, V1, P45, DOI 10.1016/1074-7613(94)90008-6; Vidal K, 1996, J EXP MED, V183, P1311, DOI 10.1084/jem.183.4.1311; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; Wiest DL, 1997, IMMUNITY, V6, P663, DOI 10.1016/S1074-7613(00)80442-2; WILKINSON RW, 1995, J IMMUNOL, V155, P5234; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; ZIEGLER SF, 1994, J IMMUNOL, V152, P1228	77	139	139	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1999	10	3					367	376		10.1016/S1074-7613(00)80036-9	http://dx.doi.org/10.1016/S1074-7613(00)80036-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204492	Bronze			2022-12-18	WOS:000079455700009
J	Loffert, D; Ehlich, A; Muller, W; Rajewsky, K				Loffert, D; Ehlich, A; Muller, W; Rajewsky, K			Surrogate light chain expression is required to establish immunoglobulin heavy chain allelic exclusion during early B cell development	IMMUNITY			English	Article							D-MU PROTEIN; PRE-B; GENE REARRANGEMENT; VARIABLE REGION; JUNCTIONAL SEQUENCES; ANTIBODY DIVERSITY; TRANSGENIC MICE; V-GENE; MOUSE; SURFACE	Allelic exclusion at the IgH locus was examined in B lineage cells of wild-type mice and mice unable to express the surrogate light chain molecule lambda 5 using a single-cell PCR approach. By analyzing B precursor cells containing two V(H)D(H)J(H) rearrangements, we found that in wild-type animals, cells are allelically excluded as soon as mu chains are expressed. Furthermore, we provide evidence that in cells expressing D mu proteins V-H-->D(H)J(H) rearrangement is inhibited. In contrast, in the absence of lambda 5 protein, B precursor cells were allelically ''included,'' indicating that allelic exclusion at the IgH locus requires expression of the pre-B cell receptor either containing a mu chain or a D mu chain. However, although mu chain double-producing B precursor cells are generated in lambda 5-deficient mice, such cells were not detected among surface immunoglobulin positive B cells.			Loffert, D (corresponding author), UNIV COLOGNE, INST GENET, WEYERTAL 121, D-50931 COLOGNE, GERMANY.		Muller, Werner/B-9044-2008	Muller, Werner/0000-0002-1297-9725; Rajewsky, Klaus/0000-0002-6633-6370				ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; BAUER SR, 1993, TRANSGENE, V1, P33; BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; EHLICH A, 1995, CURR OPIN IMMUNOL, V7, P281, DOI 10.1016/0952-7915(95)80016-6; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; HAASNER D, 1994, INT IMMUNOL, V6, P21, DOI 10.1093/intimm/6.1.21; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014; IGLESIAS A, 1991, EMBO J, V10, P2147, DOI 10.1002/j.1460-2075.1991.tb07749.x; IMANISHIKARI T, 1993, J IMMUNOL, V150, P3327; KAARTINEN M, 1985, IMMUNOL TODAY, V6, P324, DOI 10.1016/0167-5699(85)90127-6; Kabat EA, 1991, SEQUENCES PROTEINS I; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOHLER G, 1980, P NATL ACAD SCI-BIOL, V77, P2197, DOI 10.1073/pnas.77.4.2197; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; LAM KP, 1993, INT IMMUNOL, V5, P1011, DOI 10.1093/intimm/5.9.1011; LANGMAN RE, 1987, MOL IMMUNOL, V24, P675, DOI 10.1016/0161-5890(87)90050-2; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0; LEPTIN M, 1984, EUR J IMMUNOL, V14, P534, DOI 10.1002/eji.1830140610; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; LIN WC, 1995, IMMUNOL TODAY, V16, P279, DOI 10.1016/0167-5699(95)80182-0; LOFFERT D, 1994, IMMUNOL REV, V137, P135, DOI 10.1111/j.1600-065X.1994.tb00662.x; MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363; MEEK K, 1990, SCIENCE, V250, P820, DOI 10.1126/science.2237433; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; NISHIKAWA SI, 1986, IMMUNOGENETICS, P1392; NISHIMOTO N, 1991, P NATL ACAD SCI USA, V88, P6284, DOI 10.1073/pnas.88.14.6284; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; OANCEA A, 1992, NATURE, V359, P371, DOI 10.1038/359371a0; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; RAJEWSKY K, 1992, CURR OPIN IMMUNOL, V4, P171, DOI 10.1016/0952-7915(92)90008-3; RAJEWSKY K, 1992, NATURE, V359, P371, DOI 10.1038/359371b0; RAJEWSKY K, 1993, CURR OPIN IMMUNOL, V359, P371; REICHMANFRIED M, 1993, INT IMMUNOL, V5, P303, DOI 10.1093/intimm/5.3.303; RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0; RETH MG, 1985, NATURE, V317, P353, DOI 10.1038/317353a0; ROES J, 1995, J IMMUNOL METHODS, V183, P231, DOI 10.1016/0022-1759(95)00059-J; ROLINK A, 1991, CELL, V66, P1081, DOI 10.1016/0092-8674(91)90032-T; RUSCONI S, 1985, NATURE, V314, P330, DOI 10.1038/314330a0; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHUPPEL R, 1987, EUR J IMMUNOL, V17, P739, DOI 10.1002/eji.1830170527; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; SPRINGER T, 1978, EUR J IMMUNOL, V8, P539, DOI 10.1002/eji.1830080802; TAKEMORI T, 1990, EMBO J, V9, P2493, DOI 10.1002/j.1460-2075.1990.tb07428.x; TAKI S, 1993, SCIENCE, V262, P1268, DOI 10.1126/science.8235657; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUBATA T, 1991, EUR J IMMUNOL, V21, P1359, DOI 10.1002/eji.1830210605; TSUBATA T, 1992, INT IMMUNOL, V4, P637, DOI 10.1093/intimm/4.6.637; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; WABL M, 1992, NATURE, V359, P370, DOI 10.1038/359370c0; WALFIELD A, 1981, NUCLEIC ACIDS RES, V9, P1101, DOI 10.1093/nar/9.5.1101; WEAVER D, 1985, CELL, V42, P117, DOI 10.1016/S0092-8674(85)80107-0; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	77	139	139	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1996	4	2					133	144		10.1016/S1074-7613(00)80678-0	http://dx.doi.org/10.1016/S1074-7613(00)80678-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TX225	8624804	Bronze			2022-12-18	WOS:A1996TX22500004
J	BUHLMANN, JE; FOY, TM; ARUFFO, A; CRASSI, KM; LEDBETTER, JA; GREEN, WR; XU, JC; SHULTZ, LD; ROOPESIAN, D; FLAVELL, RA; FAST, L; NOELLE, RJ; DURIE, FH				BUHLMANN, JE; FOY, TM; ARUFFO, A; CRASSI, KM; LEDBETTER, JA; GREEN, WR; XU, JC; SHULTZ, LD; ROOPESIAN, D; FLAVELL, RA; FAST, L; NOELLE, RJ; DURIE, FH			IN THE ABSENCE OF A CD40 SIGNAL, B-CELLS ARE TOLEROGENIC	IMMUNITY			English	Article							VIVO CD40-GP39 INTERACTIONS; DEPENDENT HUMORAL IMMUNITY; T-CELLS; ACTIVATION; INDUCTION; ANTIGEN; LIGAND; ANTIBODY; PROTEIN; CULTURE	When B cells are deprived of signaling through CD40, they exhibit the ability to induce T cell tolerance. The in vivo administration of anti-gp39 and allogeneic B cells diminished the ability of mice to mount an allogeneic response. Tolerance induction was specific for the haplotype expressed on the allogeneic B cells. Selective allospecific unresponsiveness was induced in the CD8 and CD4 compartments by the administration of anti-gp39 and class II-deficient B cells or class I-deficient B cells, respectively. As predicted by studies with anti-gp39 treatment, diminished allospecific responsiveness was induced by the administration of B cells to mice genetically deficient in gp39. Taken together, these data are consistent with the premise that deprivation of CD40 signaling engenders B cells with enhanced tolerogenicity. These studies provide insights into the tolerogenic capacity of resting B cells and outlines a practical approach to exploit this function.	DARTMOUTH COLL SCH MED,BIOCHEM GRAD PROGRAM,LEBANON,NH 03756; BRISTOL MYERS SQUIBB CO,PHARMACEUT RES INST,SEATTLE,WA 98121; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT IMMUNOBIOL,NEW HAVEN,CT 06520; JACKSON LAB,BAR HARBOR,ME 04609; RHODE ISL HOSP,DIV CLIN HEMATOL,PROVIDENCE,RI 02903	Dartmouth College; Bristol-Myers Squibb; Howard Hughes Medical Institute; Yale University; Jackson Laboratory; Lifespan Health Rhode Island; Rhode Island Hospital	BUHLMANN, JE (corresponding author), DARTMOUTH COLL SCH MED,DEPT MICROBIOL,LEBANON,NH 03756, USA.				NATIONAL CANCER INSTITUTE [R01CA036860, R01CA020408] Funding Source: NIH RePORTER; NCI NIH HHS [CA20408, CA36860] Funding Source: Medline; PHS HHS [A126296] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BOLLING SF, 1994, J SURG RES, V57, P60, DOI 10.1006/jsre.1994.1110; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DEFRANCO AL, 1982, J EXP MED, V155, P1523, DOI 10.1084/jem.155.5.1523; DURIE FH, 1994, J CLIN INVEST, V94, P1333, DOI 10.1172/JCI117453; EYNON EE, 1992, J EXP MED, V175, P131, DOI 10.1084/jem.175.1.131; Finkelman F D, 1992, Semin Immunol, V4, P247; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; FUCHS EJ, 1992, SCIENCE, P1159; GILBERT KM, 1994, J EXP MED, V179, P249, DOI 10.1084/jem.179.1.249; GREEN WR, 1979, J EXP MED, V150, P51, DOI 10.1084/jem.150.1.51; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HORI S, 1989, J IMMUNOL, V175, P1447; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; KENNEDY MK, 1994, EUR J IMMUNOL, V24, P116, DOI 10.1002/eji.1830240118; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOULOVA L, 1991, J EXP MED, V173, P759, DOI 10.1084/jem.173.3.759; KREIGER JI, 1985, J IMMUNOL, V135, P2937; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LIU Y, 1992, EUR J IMMUNOL, V22, P2855, DOI 10.1002/eji.1830221115; MARSHAKROTHSTEI.A, 1979, J IMMUNOL, V122, P2491; MIZOUCHI T, 1989, J IMMUNOL, V142, P270; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; NOWINSKI RC, 1977, VIROLOGY, V81, P363, DOI 10.1016/0042-6822(77)90152-0; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; ROY M, 1994, IN PRESS EUR J IMMUN; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SCHWARTZ RH, 1992, CELL, V57, P1073; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	33	139	145	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1995	2	6					645	653						9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7540943				2022-12-18	WOS:A1995RE53800010
J	Bernardes, JP; Mishra, N; Tran, F; Bahmer, T; Best, L; Blase, JI; Bordoni, D; Franzenburg, J; Geisen, U; Josephs-Spaulding, J; Kohler, P; Kunstner, A; Rosati, E; Aschenbrenner, AC; Bacher, P; Baran, N; Boysen, T; Brandt, B; Bruse, N; Dorr, J; Drager, A; Elke, G; Ellinghaus, D; Fischer, J; Forster, M; Franke, A; Franzenburg, S; Frey, N; Friedrichs, A; Fuss, J; Gluck, A; Hamm, J; Hinrichsen, F; Hoeppner, MP; Imm, S; Junker, R; Kaiser, S; Kan, YH; Knoll, R; Lange, C; Laue, G; Lier, C; Lindner, M; Marinos, G; Markewitz, R; Nattermann, J; Noth, R; Pickkers, P; Rabe, KF; Renz, A; Rocken, C; Rupp, J; Schaffarzyk, A; Scheffold, A; Schulte-Schrepping, J; Schunk, D; Skowasch, D; Ulas, T; Wandinger, KP; Wittig, M; Zimmermann, J; Busch, H; Hoyer, BF; Kaleta, C; Heyckendorf, J; Kox, M; Rybniker, J; Schreiber, S; Schultze, JL; Rosenstiel, P				Bernardes, Joana P.; Mishra, Neha; Tran, Florian; Bahmer, Thomas; Best, Lena; Blase, Johanna, I; Bordoni, Dora; Franzenburg, Jeanette; Geisen, Ulf; Josephs-Spaulding, Jonathan; Koehler, Philipp; Kuenstner, Axel; Rosati, Elisa; Aschenbrenner, Anna C.; Bacher, Petra; Baran, Nathan; Boysen, Teide; Brandt, Burkhard; Bruse, Niklas; Doerr, Jonathan; Draeger, Andreas; Elke, Gunnar; Ellinghaus, David; Fischer, Julia; Forster, Michael; Franke, Andre; Franzenburg, Soeren; Frey, Norbert; Friedrichs, Anette; Fuss, Janina; Glueck, Andreas; Hamm, Jacob; Hinrichsen, Finn; Hoeppner, Marc P.; Imm, Simon; Junker, Ralf; Kaiser, Sina; Kan, Ying H.; Knoll, Rainer; Lange, Christoph; Laue, Georg; Lier, Clemens; Lindner, Matthias; Marinos, Georgios; Markewitz, Robert; Nattermann, Jacob; Noth, Rainer; Pickkers, Peter; Rabe, Klaus F.; Renz, Alina; Roecken, Christoph; Rupp, Jan; Schaffarzyk, Annika; Scheffold, Alexander; Schulte-Schrepping, Jonas; Schunk, Domagoj; Skowasch, Dirk; Ulas, Thomas; Wandinger, Klaus-Peter; Wittig, Michael; Zimmermann, Johannes; Busch, Hauke; Hoyer, Bimba F.; Kaleta, Christoph; Heyckendorf, Jan; Kox, Matthijs; Rybniker, Jan; Schreiber, Stefan; Schultze, Joachim L.; Rosenstiel, Philip		HCA Lung Biol Network; Deutsch COVID-19 Omics Initiative	Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19	IMMUNITY			English	Article							HEMATOPOIETIC STEM; INNATE IMMUNITY; HYPOXIA; DATABASE; DIFFERENTIATION; RECONSTRUCTION; INHIBITION; METABOLISM; EXPRESSION; PLATELETS	Temporal resolution of cellular features associated with a severe COVID-19 disease trajectory is needed for understanding skewed immune responses and defining predictors of outcome. Here, we performed a longitudinal multi-omics study using a two-center cohort of 14 patients. We analyzed the bulk transcriptome, bulk DNA methylome, and single-cell transcriptome (>358,000 cells, including BCR profiles) of peripheral blood samples harvested from up to 5 time points. Validation was performed in two independent cohorts of COVID-19 patients. Severe COVID-19 was characterized by an increase of proliferating, metabolically hyperactive plasmablasts. Coinciding with critical illness, we also identified an expansion of interferon-activated circulating megakaryocytes and increased erythropoiesis with features of hypoxic signaling. Megakaryocyte- and erythroid-cell-derived co-expression modules were predictive of fatal disease outcome. The study demonstrates broad cellular effects of SARS-CoV-2 infection beyond adaptive immune cells and provides an entry point toward developing biomarkers and targeted treatments of patients with COVID-19.	[Bernardes, Joana P.; Mishra, Neha; Tran, Florian; Blase, Johanna, I; Bordoni, Dora; Franzenburg, Jeanette; Rosati, Elisa; Bacher, Petra; Baran, Nathan; Boysen, Teide; Ellinghaus, David; Forster, Michael; Franke, Andre; Franzenburg, Soeren; Fuss, Janina; Hamm, Jacob; Hinrichsen, Finn; Hoeppner, Marc P.; Imm, Simon; Kan, Ying H.; Laue, Georg; Wittig, Michael; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Bernardes, Joana P.; Mishra, Neha; Tran, Florian; Best, Lena; Blase, Johanna, I; Bordoni, Dora; Franzenburg, Jeanette; Josephs-Spaulding, Jonathan; Rosati, Elisa; Bacher, Petra; Baran, Nathan; Boysen, Teide; Ellinghaus, David; Forster, Michael; Franke, Andre; Franzenburg, Soeren; Fuss, Janina; Hamm, Jacob; Hinrichsen, Finn; Hoeppner, Marc P.; Imm, Simon; Kan, Ying H.; Laue, Georg; Marinos, Georgios; Wittig, Michael; Zimmermann, Johannes; Kaleta, Christoph; Schreiber, Stefan; Rosenstiel, Philip] Univ Med Ctr Schleswig Holstein, D-24105 Kiel, Germany; [Tran, Florian; Bahmer, Thomas; Friedrichs, Anette; Glueck, Andreas; Noth, Rainer; Rabe, Klaus F.; Schreiber, Stefan] Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, D-24105 Kiel, Germany; [Best, Lena; Josephs-Spaulding, Jonathan; Marinos, Georgios; Zimmermann, Johannes; Kaleta, Christoph] Univ Kiel, Inst Expt Med, D-24105 Kiel, Germany; [Franzenburg, Jeanette; Brandt, Burkhard; Junker, Ralf; Lier, Clemens; Markewitz, Robert; Wandinger, Klaus-Peter] Univ Med Ctr Schleswig Holstein, Inst Clin Chem, D-24105 Kiel, Germany; [Franzenburg, Jeanette; Brandt, Burkhard; Junker, Ralf; Lier, Clemens; Markewitz, Robert; Wandinger, Klaus-Peter] Univ Med Ctr Schleswig Holstein, Inst Clin Chem, D-23562 Lubeck, Germany; [Geisen, Ulf; Doerr, Jonathan; Kaiser, Sina; Schaffarzyk, Annika; Hoyer, Bimba F.] Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, Sect Rheumatol, D-24105 Kiel, Germany; [Koehler, Philipp; Fischer, Julia; Rybniker, Jan] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Koehler, Philipp; Fischer, Julia; Rybniker, Jan] Univ Hosp Cologne, D-50931 Cologne, Germany; [Koehler, Philipp; Fischer, Julia; Rybniker, Jan] German Ctr Infect Res, Partner Site Bonn Cologne, D-50931 Cologne, Germany; [Koehler, Philipp; Fischer, Julia; Rybniker, Jan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Kuenstner, Axel; Fischer, Julia; Rybniker, Jan] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany; [Koehler, Philipp] Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Busch, Hauke] Univ Lubeck, Lubeck Inst Expt Dermatol, D-23562 Lubeck, Germany; [Aschenbrenner, Anna C.; Schulte-Schrepping, Jonas; Ulas, Thomas; Kox, Matthijs; Schultze, Joachim L.] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, D-53115 Bonn, Germany; [Bacher, Petra; Scheffold, Alexander] Univ Med Ctr Schleswig Holstein, Inst Immunol, D-24105 Kiel, Germany; [Aschenbrenner, Anna C.; Bruse, Niklas; Pickkers, Peter] Radboud Univ Nijmegen, Dept Intens Care Med, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Aschenbrenner, Anna C.; Bruse, Niklas; Pickkers, Peter] Radboud Univ Nijmegen, Radboud Ctr Infect Dis RCI, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Draeger, Andreas; Renz, Alina] Univ Tubingen, Inst Bioinformat & Med Informat IBMI, Dept Comp Sci, D-72076 Tubingen, Germany; [Draeger, Andreas; Renz, Alina] German Ctr Infect Res DZIF, Partner Site Tubingen, D-72076 Tubingen, Germany; [Elke, Gunnar; Lindner, Matthias] Univ Med Ctr Schleswig Holstein, Dept Anaesthesiol & Intens Care Med, D-24105 Kiel, Germany; [Frey, Norbert; Heyckendorf, Jan] Univ Med Ctr Schleswig Holstein, Dept Internal Med 3, D-24105 Kiel, Germany; [Lange, Christoph] Res Ctr Borstel, Div Clin Infect Dis, D-23845 Borstel, Germany; [Lange, Christoph] TTU TB, German Ctr Infect Res DZIF, D-23845 Borstel, Germany; [Nattermann, Jacob] Univ Bonn, Dept Internal Med 1, D-53217 Bonn, Germany; [Nattermann, Jacob] Univ Bonn, German Ctr Infect Res DZIF, D-53217 Bonn, Germany; [Rabe, Klaus F.] German Ctr Lung Res, Airway Res Ctr North, LungenClin Grosshansdorf, D-22927 Grosshansdorf, Germany; [Roecken, Christoph] Univ Med Ctr Schleswig Holstein, Dept Pathol, D-24105 Kiel, Germany; [Rupp, Jan] Univ Lubeck, Dept Infect Dis & Microbiol, D-23562 Lubeck, Germany; [Schunk, Domagoj] Univ Med Ctr Schleswig Holstein, Dept Emergency Med, D-24105 Kiel, Germany; [Skowasch, Dirk] Univ Hosp Bonn, Dept Internal Med 2, Sect Pneumol, D-53127 Bonn, Germany; [Aschenbrenner, Anna C.; Knoll, Rainer; Schulte-Schrepping, Jonas; Ulas, Thomas; Schultze, Joachim L.] German Ctr Neurodegenerat Dis DZNE, Syst Med, D-53127 Bonn, Germany; [Aschenbrenner, Anna C.; Knoll, Rainer; Ulas, Thomas; Schultze, Joachim L.] DZNE, German Ctr Neurodegenerat Dis DZNE, PRECISE Platform Genom & Epigen, D-53127 Bonn, Germany; [Aschenbrenner, Anna C.; Knoll, Rainer; Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, D-53127 Bonn, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Cologne; University of Cologne; German Center for Infection Research; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Lubeck; University of Bonn; University of Kiel; Schleswig Holstein University Hospital; Radboud University Nijmegen; Radboud University Nijmegen; Eberhard Karls University of Tubingen; German Center for Infection Research; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Forschungszentrum Borstel; German Center for Infection Research; University of Bonn; German Center for Infection Research; University of Bonn; Grosshansdorf Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Rosenstiel, P (corresponding author), Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany.; Rosenstiel, P (corresponding author), Univ Med Ctr Schleswig Holstein, D-24105 Kiel, Germany.	p.rosenstiel@mucosa.de	Scheffold, Alexander/S-2090-2016; Rosati, Elisa/J-6784-2019; Dräger, Andreas/F-5620-2015; Schultze, Joachim L./ABA-8176-2020; Markewitz, Robert/AAB-2074-2022; Fischer, Julia/AAC-6111-2022; Mishra, Neha/HDN-8013-2022; Diefenbach, Andreas/T-2589-2018; Zaragosi, Laure-Emmanuelle/P-9887-2016; Rupp, Jan/C-8794-2011; Ludwig, Kerstin U/H-7828-2019; Franke, Andre/B-2151-2010; Tran, Florian/AHA-4179-2022; Bruse, Niklas/Q-3733-2018; Schulte, Eva C./AAT-2410-2021; Röcken, Christoph/A-9239-2010; B, Niklas/GQH-7080-2022; Fischer, Julia/AGD-1069-2022; Geisen, Ulf/AAL-6012-2021; Koehler, Philipp/J-7985-2019; Rabe, Klaus F./AAW-6296-2021; Frey, Norbert/M-7749-2019; Keller, Andreas/ABB-6412-2021; Bacher, Petra/AAF-1565-2021; Vogel, Jörg/D-5574-2011; Nunes da Rocha, Ulisses/AAE-5158-2021; Busch, Hauke/R-6452-2016; Vehreschild, Jorg Janne/G-6764-2013; Bartholomaus, Alexander/AAR-1277-2021	Scheffold, Alexander/0000-0002-0626-343X; Rosati, Elisa/0000-0002-2635-6422; Dräger, Andreas/0000-0002-1240-5553; Schultze, Joachim L./0000-0003-2812-9853; Markewitz, Robert/0000-0003-1676-1085; Fischer, Julia/0000-0001-6138-7454; Diefenbach, Andreas/0000-0002-9176-9530; Zaragosi, Laure-Emmanuelle/0000-0001-6747-7928; Rupp, Jan/0000-0001-8722-1233; Ludwig, Kerstin U/0000-0002-8541-2519; Franke, Andre/0000-0003-1530-5811; Tran, Florian/0000-0002-3735-9872; Bruse, Niklas/0000-0001-5146-5295; Röcken, Christoph/0000-0002-6989-8002; B, Niklas/0000-0001-5146-5295; Fischer, Julia/0000-0001-6138-7454; Geisen, Ulf/0000-0002-6583-460X; Koehler, Philipp/0000-0002-7386-7495; Rabe, Klaus F./0000-0002-7020-1401; Frey, Norbert/0000-0001-7611-378X; Keller, Andreas/0000-0002-5361-0895; Bacher, Petra/0000-0003-4264-6451; Vogel, Jörg/0000-0003-2220-1404; Nunes da Rocha, Ulisses/0000-0001-6972-6692; Stegle, Oliver/0000-0002-8818-7193; Hamm, Jacob/0000-0003-4960-6858; Fuss, Janina/0000-0002-7631-9355; Forster, Michael/0000-0001-9927-5124; Aschenbrenner, Anna/0000-0002-9429-5457; Frick, Julia-Stefanie/0000-0002-7662-7956; Busch, Hauke/0000-0003-4763-4521; Rajewsky, Nikolaus/0000-0002-4785-4332; Vehreschild, Jorg Janne/0000-0002-5446-7170; Angelov, Angel/0000-0002-9228-0817; Josephs-Spaulding, Jonathan/0000-0001-9828-0685; Mishra, Neha/0000-0002-7436-1066; Forstner, Konrad U./0000-0002-1481-2996; Bartholomaus, Alexander/0000-0003-0970-7304; Nawijn, Martijn/0000-0003-3372-6521; Marz, Manja/0000-0003-4783-8823; Ellinghaus, David/0000-0002-4332-6110; Best, Lena/0000-0003-2772-153X; Makarewicz, Oliwia/0000-0002-4404-1862; Ralser, Markus/0000-0001-9535-7413; Zimmermann, Johannes/0000-0002-5041-1954; MARINOS, GEORGIOS/0000-0002-6443-7696; Kan, Ying Hei/0000-0003-1235-2364; Renz, Alina/0000-0003-3851-9978; Tata, Purushothama Rao/0000-0003-4837-0337	German Research Foundation (DFG) [07495230, ExC 2167, CRC1182 C2]; IMI2 Project [3TR]; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany (sparse2big); EU projects SYSCID [733100]; DZIF, Germany [TTU 04.816, 04.817]; Hector Foundation [M89]; DFG [ExC 2167, EXC 2124-390838134, CRC 1182]; German Center for Infection Research (DZIF) [8020708703];  [INST 37/1049-1];  [INST 216/981-1];  [INST 257/605-1];  [INST 269/768-1];  [INST 217/988-1];  [INST 217/577-1];  [EXC2151/1 (390873048)];  [SFB TR57];  [SPP1937]	German Research Foundation (DFG)(German Research Foundation (DFG)); IMI2 Project; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany (sparse2big); EU projects SYSCID; DZIF, Germany; Hector Foundation; DFG(German Research Foundation (DFG)); German Center for Infection Research (DZIF); ; ; ; ; ; ; ; ; 	We thank K. Greve, M. Rohm, M. Hansen, S. Kock, D. Oelsner, S. Baumgarten, M. Reffelmann, M. Schlapkohl, N. Braun, T. Wesse, M. Basso, Y. Dolschanskaya, X. Yi, C. Lancken, and M. Vollstedt for perfect technical assistance. This work was supported by the German Research Foundation (DFG) CCGA Nr. 07495230, a COVID-response grant of the state SH, ExC 2167 Precision Medicine in Chronic Inflammation (RTF-VI), the research group miTARGET and the CRC1182 C2 project to P.R.; the IMI2 Project 3TR to P.R. and S.S.; INST 37/1049-1, INST 216/981-1, INST 257/605-1, INST 269/768-1, INST 217/988-1, INST 217/577-1, and EXC2151/1 (390873048) to J.L.S.; SFB TR57 and SPP1937 to J.N.; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany (sparse2big) to J.L.S.; EU projects SYSCID (733100) to P.R. and J.L.S.; the DZIF, Germany (TTU 04.816 and 04.817) to J.N.; and the Hector Foundation) (M89) to J.N. A.D. acknowledges support by the DFG (EXC 2124-390838134 Controlling Microbes to Fight Infections) and the German Center for Infection Research (DZIF grant N~ 8020708703). C.K. acknowledges support by the DFG through EXC 2167, RTF-VIII, and the CRC 1182. This publication is part of the Human Cell Atlas (www.humancellatlas.org/publications).We are indebted to the patients, their families, and the hospital staff for support, without whom this study would not have been possible.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Bashford-Rogers RJM, 2019, NATURE, V574, P122, DOI 10.1038/s41586-019-1595-3; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Brunk E, 2018, NAT BIOTECHNOL, V36, P272, DOI 10.1038/nbt.4072; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campbell RA, 2019, BLOOD, V133, P2013, DOI 10.1182/blood-2018-09-873984; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Corcoran LM, 2016, IMMUNITY, V45, P3, DOI 10.1016/j.immuni.2016.07.003; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; De Biasi S, 2020, EUR J IMMUNOL, V50, P1283, DOI 10.1002/eji.202048838; de la Pena HC, 2000, ARCH MED RES, V31, P546, DOI 10.1016/S0188-4409(00)00238-1; De Voeght A., 2020, THROMBOTIC MICROVASC, V9, DOI 10.1101/2020.10.07.20208603.; Deshpande C, 2020, ANN INTERN MED, V173, P394, DOI 10.7326/M20-3255; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Fischer DS, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky675; Garcia-Alonso L, 2019, GENOME RES, V29, P1363, DOI 10.1101/gr.240663.118; Gebauer J, 2016, CELL SYST, V2, P312, DOI 10.1016/j.cels.2016.04.017; Gelius-Dietrich G, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-125; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Glass DR, 2020, IMMUNITY, V53, P217, DOI 10.1016/j.immuni.2020.06.013; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hasler R, 2012, GENOME RES, V22, P2130, DOI 10.1101/gr.138347.112; Heirendt L, 2019, NAT PROTOC, V14, P639, DOI 10.1038/s41596-018-0098-2; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hoepel W., 2020, IMMUNOLOGY, DOI [10.1101/2020.07.13.190140, DOI 10.1101/2020.07.13.190140]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jiang HP, 1997, ONCOGENE, V14, P473, DOI 10.1038/sj.onc.1200858; Joshi CJ, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007764; Kalapos Miklos Peter, 2008, Drug Metabolism and Drug Interactions, V23, P69; Kanerva K, 2008, BIOCHEM J, V409, P187, DOI 10.1042/BJ20071004; Kaser A, 2000, J IMMUNOL, V165, P2474, DOI 10.4049/jimmunol.165.5.2474; Kim J, 2014, J IMMUNOL, V193, P3792, DOI 10.4049/jimmunol.1400176; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Lam WY, 2016, IMMUNITY, V45, P60, DOI 10.1016/j.immuni.2016.06.011; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Leppkes M, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102925; Liao SC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03175-z; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022; Liu A, 2019, NPJ SYST BIOL APPL, V5, DOI 10.1038/s41540-019-0118-z; LOEFFLER M, 1984, BLUT, V49, P427, DOI 10.1007/BF00320485; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lorente-Sorolla C, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0674-2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Manne BK, 2020, BLOOD, V136, P1317, DOI 10.1182/blood.2020007214; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Meyerholz DK, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102865; Middleton EA, 2020, BLOOD, V136, P1169, DOI 10.1182/blood.2020007008; Muller F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1664-9; Myhre PL, 2020, CIRCULATION, V142, P2128, DOI 10.1161/CIRCULATIONAHA.120.050360; Nayak M.K., 2019, BLOOD, DOI DOI 10.1182/BLOOD-2019-129027; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Noronha A, 2019, NUCLEIC ACIDS RES, V47, pD614, DOI 10.1093/nar/gky992; Ong EZY, 2020, CELL HOST MICROBE, V27, P879, DOI 10.1016/j.chom.2020.03.021; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pacheco MP, 2018, METHODS MOL BIOL, V1716, P101, DOI 10.1007/978-1-4939-7528-0_4; Pan WH, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0534-5; Peacock T.P., 2021, MEDRXIV, DOI [10.1101/2021.01.12.426407v1, DOI 10.1093/CID/CIAA344, 10.1101/2021.05.28.446163]; PESCHLE C, 1977, BRIT J HAEMATOL, V37, P345, DOI 10.1111/j.1365-2141.1977.tb01005.x; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Rapkiewicz AV, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100434; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sander J, 2017, BIOINFORMATICS, V33, P757, DOI 10.1093/bioinformatics/btw665; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Serebrovskaya TV, 2011, HIGH ALT MED BIOL, V12, P243, DOI 10.1089/ham.2010.1086; Sheffield NC, 2016, BIOINFORMATICS, V32, P587, DOI 10.1093/bioinformatics/btv612; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stephens DS, 2020, JAMA-J AM MED ASSOC, V324, P1279, DOI 10.1001/jama.2020.16656; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Swainston N, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1051-4; Vijay R, 2020, NAT IMMUNOL, V21, P790, DOI 10.1038/s41590-020-0678-5; Vlassis N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003424; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Yang WT, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01793; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269; Zhang FL, 2012, J CELL MOL MED, V16, P1889, DOI 10.1111/j.1582-4934.2011.01484.x; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zur H, 2010, BIOINFORMATICS, V26, P3140, DOI 10.1093/bioinformatics/btq602	98	138	138	7	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1296	+		10.1016/j.immuni.2020.11.017	http://dx.doi.org/10.1016/j.immuni.2020.11.017			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33296687	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000599363300017
J	Vaeth, M; Maus, M; Klein-Hessling, S; Freinkman, E; Yang, J; Eckstein, M; Cameron, S; Turvey, SE; Serfling, E; Berberich-Siebelt, F; Possemato, R; Feske, S				Vaeth, Martin; Maus, Mate; Klein-Hessling, Stefan; Freinkman, Elizaveta; Yang, Jun; Eckstein, Miriam; Cameron, Scott; Turvey, Stuart E.; Serfling, Edgar; Berberich-Siebelt, Friederike; Possemato, Richard; Feske, Stefan			Store-Operated Ca2+ Entry Controls Clonal Expansion of T Cells through Metabolic Reprogramming	IMMUNITY			English	Article							TRANSCRIPTION FACTOR; NUCLEAR FACTOR; ACTIVATION; STIM1; NFAT; IMMUNODEFICIENCY; MUTATION; IMMUNITY; ORAI1; AUTOIMMUNITY	Store-operated Ca2+ entry (SOCE) is the main Ca2+ influx pathway in lymphocytes and is essential for T cell function and adaptive immunity. SOCE is mediated by Ca2+ release-activated Ca2+ (CRAC) channels that are activated by stromal interaction molecule (STIM) 1 and STIM2. SOCE regulates many Ca2+-dependent signaling molecules, including calcineurin, and inhibition of SOCE or calcineurin impairs antigen-dependent T cell proliferation. We here report that SOCE and calcineurin regulate cell cycle entry of quiescent T cells by controlling glycolysis and oxidative phosphorylation. SOCE directs the metabolic reprogramming of naive T cells by regulating the expression of glucose transporters, glycolytic enzymes, and metabolic regulators through the activation of nuclear factor of activated T cells (NFAT) and the PI3K-AKT kinase-mTOR nutrientsensing pathway. We propose that SOCE controls a critical "metabolic checkpoint'' at which T cells assess adequate nutrient supply to support clonal expansion and adaptive immune responses.	[Vaeth, Martin; Maus, Mate; Possemato, Richard; Feske, Stefan] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Klein-Hessling, Stefan; Serfling, Edgar; Berberich-Siebelt, Friederike] Julius Maximilians Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany; [Freinkman, Elizaveta] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Eckstein, Miriam] NYU, Coll Dent, New York, NY 10010 USA; [Cameron, Scott; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Div Allergy & Clin Immunol, Vancouver, BC V6H 3N1, Canada	New York University; University of Wurzburg; Massachusetts Institute of Technology (MIT); Whitehead Institute; New York University; University of British Columbia	Feske, S (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	feskes01@nyumc.org	Turvey, Stuart/HGV-1191-2022; Feske, stefan/ABB-3554-2021; Serfling, Edgar/X-7212-2019; Maus, Mate/AAA-6055-2020	Feske, stefan/0000-0001-5431-8178; Maus, Mate/0000-0002-2128-2479; Possemato, Richard/0000-0002-2401-0030; Vaeth, Martin/0000-0001-8974-7052; Cameron, Scott/0000-0002-7045-1240; Turvey, Stuart/0000-0003-1599-1065	NIH SIG grant [1S10OD016304-01]; NIH grant [AI097302]; Department of Defense grant [W81XWH-15-1-0337]; Deutsche Forschungsgemeinschaft (DFG) [TRR52, SE 469/22-1]; DFG postdoctoral fellowship [VA 882/1-1]; Wilhelm Sander Foundation [2010.095.1-3]; Alex Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097302] Funding Source: NIH RePORTER	NIH SIG grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense grant(United States Department of Defense); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG postdoctoral fellowship(German Research Foundation (DFG)); Wilhelm Sander Foundation; Alex Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Schwartzberg (National Institutes of Health [NIH]) and J. Wherry (University of Pennsylvania) for sharing caNFATc1 and GLUT1 plasmids. The sgRNA delivery vector was a kind gift of M. Aichinger and J. Zuber (Vienna Biocenter). caNfatc1<SUP>KI</SUP> mice were provided by V. Ellenrieder (University of Gottingen). This work utilized the Seahorse XFe24 purchased with funding by NIH SIG grant 1S10OD016304-01. This work was funded by NIH grant AI097302 (to S.F.), Department of Defense grant W81XWH-15-1-0337 (to E.F.), Deutsche Forschungsgemeinschaft (DFG) grants TRR52 and SE 469/22-1 (to E.S.), DFG postdoctoral fellowship VA 882/1-1 (to M. V.), a Wilhelm Sander Foundation grant (2010.095.1-3 to S. K.-H. and E. S.), and a Young Investigator Award from the Alex Lemonade Stand Foundation (to M. M.). S. F. is a cofounder of Calcimedica.	Akashi K, 1998, IMMUNOL REV, V165, P13, DOI 10.1111/j.1600-065X.1998.tb01226.x; Azzi JR, 2013, J IMMUNOL, V191, P5785, DOI 10.4049/jimmunol.1390055; Baumgart S, 2014, CANCER DISCOV, V4, P688, DOI 10.1158/2159-8290.CD-13-0593; Bevington SL, 2016, EMBO J, V35, P515, DOI 10.15252/embj.201592534; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chen YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24253; Cho JH, 2013, J IMMUNOL, V191, P5559, DOI 10.4049/jimmunol.1302293; Desvignes L, 2015, J CLIN INVEST, V125, P2347, DOI 10.1172/JCI80273; Dutta D, 2017, NAT IMMUNOL, V18, P196, DOI 10.1038/ni.3640; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Frischbutter S, 2011, EUR J IMMUNOL, V41, P2349, DOI 10.1002/eji.201041052; Fuchs S, 2012, J IMMUNOL, V188, P1523, DOI 10.4049/jimmunol.1102507; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Klein-Hessling S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00612-6; Koga T, 2014, J CLIN INVEST, V124, P2234, DOI 10.1172/JCI73411; Lacruz RS, 2015, ANN NY ACAD SCI, V1356, P45, DOI 10.1111/nyas.12938; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li RJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19360; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Mak TW, 2017, IMMUNITY, V46, P675, DOI 10.1016/j.immuni.2017.03.019; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Maus M, 2017, CELL METAB, V25, P698, DOI 10.1016/j.cmet.2016.12.021; Mognol GP, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.97; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Patra AK, 2013, NAT IMMUNOL, V14, P127, DOI 10.1038/ni.2507; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schaballie H, 2015, J ALLERGY CLIN IMMUN, V136, P816, DOI 10.1016/j.jaci.2015.03.009; Shaw PJ, 2014, J CLIN INVEST, V124, P4549, DOI 10.1172/JCI76602; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Vaeth M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14714; Vaeth M, 2016, IMMUNITY, V44, P1350, DOI 10.1016/j.immuni.2016.04.013; Vaeth M, 2014, J EXP MED, V211, P545, DOI 10.1084/jem.20130604; Vaeth M, 2012, P NATL ACAD SCI USA, V109, P16258, DOI 10.1073/pnas.1203870109; Vaeth M, 2011, P NATL ACAD SCI USA, V108, P2480, DOI 10.1073/pnas.1009463108; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021	48	138	138	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					664	+		10.1016/j.immuni.2017.09.003	http://dx.doi.org/10.1016/j.immuni.2017.09.003			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29030115	Green Accepted, Bronze			2022-12-18	WOS:000413091600012
J	Lee, JH; Andrabi, R; Su, CY; Yasmeen, A; Julien, JP; Kong, L; Wu, NC; McBride, R; Sok, D; Pauthner, M; Cottrell, CA; Nieusma, T; Blattner, C; Paulson, JC; Klasse, PJ; Wilson, IA; Burton, DR; Ward, AB				Lee, Jeong Hyun; Andrabi, Raiees; Su, Ching-Yao; Yasmeen, Anila; Julien, Jean-Philippe; Kong, Leopold; Wu, Nicholas C.; McBride, Ryan; Sok, Devin; Pauthner, Matthias; Cottrell, Christopher A.; Nieusma, Travis; Blattner, Claudia; Paulson, James C.; Klasse, Per Johan; Wilson, Ian A.; Burton, Dennis R.; Ward, Andrew B.			A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic beta-Hairpin Structure	IMMUNITY			English	Article							PROTEIN; RECOGNITION; VALIDATION; REFINEMENT; QUATERNARY; FEATURES; BINDING; REVEAL; REGION; DOMAIN	Broadly neutralizing antibodies (bnAbs) to HIV delineate vaccine targets and are prophylactic and therapeutic agents. Some of the most potent bnAbs target a quaternary epitope at the apex of the surface HIV envelope (Env) trimer. Using cryo-electron microscopy, we solved the atomic structure of an apex bnAb, PGT145, in complex with Env. We showed that the long anionic HCDR3 of PGT145 penetrated between glycans at the trimer 3-fold axis, to contact peptide residues from all three Env protomers, and thus explains its highly trimer-specific nature. Somatic hypermutation in the other CDRs of PGT145 were crucially involved in stabilizing the structure of the HCDR3, similar to bovine antibodies, to aid in recognition of a cluster of conserved basic residues hypothesized to facilitate trimer disassembly during viral entry. Overall, the findings exemplify the creative solutions that the human immune system can evolve to recognize a conserved motif buried under a canopy of glycans.	[Lee, Jeong Hyun; Julien, Jean-Philippe; Kong, Leopold; Wu, Nicholas C.; Cottrell, Christopher A.; Nieusma, Travis; Blattner, Claudia; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Lee, Jeong Hyun; Andrabi, Raiees; Julien, Jean-Philippe; Sok, Devin; Pauthner, Matthias; Cottrell, Christopher A.; Blattner, Claudia; Wilson, Ian A.; Burton, Dennis R.; Ward, Andrew B.] Scripps Res Inst, Neutralizing Antibody Ctr & Collaborat AIDS Vacci, Int AIDS Vaccine Initiat, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Andrabi, Raiees; Su, Ching-Yao; Sok, Devin; Pauthner, Matthias; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Yasmeen, Anila; Klasse, Per Johan] Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Julien, Jean-Philippe] Univ Toronto, Program Mol Struct & Funct, Hosp Sick Children, Res Inst, Toronto, ON M5S 1A8, Canada; [Julien, Jean-Philippe] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Julien, Jean-Philippe] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol & Chem Physiol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Boston, MA 02139 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Cornell University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Scripps Research Institute; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Ward, AB (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Burton, DR; Ward, AB (corresponding author), Scripps Res Inst, Neutralizing Antibody Ctr & Collaborat AIDS Vacci, Int AIDS Vaccine Initiat, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Ragon Inst MGH MIT & Harvard, Boston, MA 02139 USA.	burton@scripps.edu; andrew@scripps.edu	Paulson, James/AAG-3565-2019; Ward, Andrew/ABD-7728-2021; Wu, Nicholas/H-3822-2015; Ward, Andrew B/F-9203-2014; Klasse, P.J./AEX-0142-2022; McBride, Ryan/E-6812-2011; Cottrell, Christopher A/P-3514-2015	Ward, Andrew/0000-0001-7153-3769; Wu, Nicholas/0000-0002-9078-6697; Ward, Andrew B/0000-0001-7153-3769; Klasse, P.J./0000-0001-8222-278X; Cottrell, Christopher A/0000-0002-3364-3083; Julien, Jean-Philippe/0000-0001-7602-3995; Pauthner, Matthias G./0000-0001-9212-4307; Lee, Jeong Hyun/0000-0001-7371-845X; Kong, Leopold/0000-0001-7456-1773	California HIV/AIDS Research Program Dissertation Award [D12-SRI-353]; Scripps CHAVI-ID [UM1 AI100663]; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation CAVD [OPP1115782, OPP1084519]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science [DE-AC02-06CH11357];  [P01 AI110657]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI110657, UM1AI100663, R01AI113867] Funding Source: NIH RePORTER	California HIV/AIDS Research Program Dissertation Award; Scripps CHAVI-ID; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation CAVD; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the California HIV/AIDS Research Program Dissertation Award D12-SRI-353 (to J.H.L.), the Scripps CHAVI-ID (UM1 AI100663), P01 AI110657, International AIDS Vaccine Initiative, and the Bill and Melinda Gates Foundation CAVD (OPP1115782 and OPP1084519). GM/CA@APS has been funded in whole or in part with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. This is manuscript number 29440 from the Scripps Research Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Barad BA, 2015, NAT METHODS, V12, P943, DOI [10.1038/nmeth.3541, 10.1038/NMETH.3541]; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng C, 2016, J VIROL, V90, P2740, DOI 10.1128/JVI.02380-15; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Lee JH, 2015, STRUCTURE, V23, P1943, DOI 10.1016/j.str.2015.07.020; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Rusert P, 2016, NAT MED, V22, P1260, DOI 10.1038/nm.4187; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scharf L, 2016, ELIFE, V5, DOI 10.7554/eLife.13783; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Yacoob C, 2016, CELL REP, V17, P1560, DOI 10.1016/j.celrep.2016.10.017; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41	51	138	140	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					690	702		10.1016/j.immuni.2017.03.017	http://dx.doi.org/10.1016/j.immuni.2017.03.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423342	Green Published, hybrid			2022-12-18	WOS:000399451100020
J	Di Niro, R; Lee, SJ; Vander Heiden, JA; Elsner, RA; Trivedi, N; Bannock, JM; Gupta, NT; Kleinstein, SH; Vigneault, F; Gilbert, TJ; Meffre, E; McSorley, SJ; Shlomchik, MJ				Di Niro, Roberto; Lee, Seung-Joo; Vander Heiden, Jason A.; Elsner, Rebecca A.; Trivedi, Nikita; Bannock, Jason M.; Gupta, Namita T.; Kleinstein, Steven H.; Vigneault, Francois; Gilbert, Tamara J.; Meffre, Eric; McSorley, Stephen J.; Shlomchik, Mark J.			Salmonella Infection Drives Promiscuous B Cell Activation Followed by Extrafollicular Affinity Maturation	IMMUNITY			English	Article							CLASS SWITCH RECOMBINATION; INFLUENZA-VIRUS INFECTION; MEMORY B; GERMINAL-CENTERS; TYPHIMURIUM INFECTION; RHEUMATOID-ARTHRITIS; PROTECTIVE IMMUNITY; ANTIBODY-RESPONSE; PLASMA-CELLS; HYPERMUTATION	The B cell response to Salmonella typhimurium (STm) occurs massively at extrafollicular sites, without notable germinal centers (GCs). Little is known in terms of its specificity. To expand the knowledge of antigen targets, we screened plasmablast (PB)-derived monoclonal antibodies (mAbs) for Salmonella specificity, using ELISA, flow cytometry, and antigen microarray. Only a small fraction (0.5%-2%) of the response appeared to be Salmonella-specific. Yet, infection of mice with limited B cell receptor (BCR) repertoires impaired the response, suggesting that BCR specificity was important. We showed, using laser microdissection, that somatic hypermutation (SHM) occurred efficiently at extrafollicular sites leading to affinity maturation that in turn led to detectable STm Ag-binding. These results suggest a revised vision of how clonal selection and affinity maturation operate in response to Salmonella. Clonal selection initially is promiscuous, activating cells with virtually undetectable affinity, yet SHM and selection occur during the extrafollicular response yielding higher affinity, detectable antibodies.	[Di Niro, Roberto; Elsner, Rebecca A.; Trivedi, Nikita; Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; [Di Niro, Roberto; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Di Niro, Roberto; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Lee, Seung-Joo; McSorley, Stephen J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Vander Heiden, Jason A.; Gupta, Namita T.; Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Bannock, Jason M.; Kleinstein, Steven H.; Meffre, Eric] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Vigneault, Francois; Gilbert, Tamara J.] AbVitro Inc, Boston, MA 02210 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Yale University; University of California System; University of California Davis; Yale University; Yale University; Yale University	Shlomchik, MJ (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA.	mshlomch@pitt.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Gupta, Namita/0000-0002-4517-1546; McSorley, Stephen/0000-0002-6363-3222	NIH [R01-AI104739, R01-AI043603, R01-AR044077, R01-AI073722]; NIH from the National Library of Medicine [T15-LM07056]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073722, R01AI105018, R01AI043603, P01AI056172, R01AI104739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044077] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	S.H.K. was supported by NIH Grant R01-AI104739. J.A.V.H. and N.T.G. were supported by NIH Grant T15-LM07056 from the National Library of Medicine. This work was funded by NIH grants R01-AI043603, R01-AR044077, and R01-AI073722.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; Bobat S, 2011, EUR J IMMUNOL, V41, P1606, DOI 10.1002/eji.201041089; CALDERON I, 1986, INFECT IMMUN, V52, P209; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Guan YJ, 2009, P NATL ACAD SCI USA, V106, P3952, DOI 10.1073/pnas.0813392106; Hastey CJ, 2012, J IMMUNOL, V188, P5612, DOI 10.4049/jimmunol.1103735; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kim HJ, 1999, J IMMUNOL, V162, P3053; Kleinstein SH, 2003, J IMMUNOL, V171, P4639, DOI 10.4049/jimmunol.171.9.4639; KOGA T, 1985, INFECT IMMUN, V47, P638, DOI 10.1128/IAI.47.3.638-647.1985; Kong W, 2012, P NATL ACAD SCI USA, V109, P19414, DOI 10.1073/pnas.1217554109; Lee SJ, 2012, P NATL ACAD SCI USA, V109, P4998, DOI 10.1073/pnas.1111413109; Marshall JL, 2011, EUR J IMMUNOL, V41, P3506, DOI 10.1002/eji.201141762; McGregor AC, 2013, CURR OPIN INFECT DIS, V26, P254, DOI 10.1097/QCO.0b013e32835fb829; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nanton MR, 2012, J IMMUNOL, V189, P5503, DOI 10.4049/jimmunol.1201413; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; ORTIZ V, 1989, J CLIN MICROBIOL, V27, P1640, DOI 10.1128/JCM.27.7.1640-1645.1989; Racine R, 2010, J IMMUNOL, V184, P5085, DOI 10.4049/jimmunol.0902710; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Scheel T, 2011, ARTHRITIS RHEUM-US, V63, P63, DOI 10.1002/art.27767; Schroder AE, 1996, P NATL ACAD SCI USA, V93, P221, DOI 10.1073/pnas.93.1.221; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/nmeth.2960, 10.1038/NMETH.2960]; SINGH SP, 1992, J BACTERIOL, V174, P1965, DOI 10.1128/jb.174.6.1965-1973.1992; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924	42	138	139	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					120	131		10.1016/j.immuni.2015.06.013	http://dx.doi.org/10.1016/j.immuni.2015.06.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26187411	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000360101100015
J	Oftedal, BE; Hellesen, A; Erichsen, MM; Bratland, E; Vardi, A; Perheentupa, J; Kemp, EH; Fiskerstrand, T; Viken, MK; Weetman, AP; Fleishman, SJ; Banka, S; Newman, WG; Sewell, WAC; Sozaeva, LS; Zayats, T; Haugarvoll, K; Orlova, EM; Haavik, J; Johansson, S; Knappskog, PM; Lovas, K; Wolff, ASB; Abramson, J; Husebye, ES				Oftedal, Bergithe E.; Hellesen, Alexander; Erichsen, Martina M.; Bratland, Eirik; Vardi, Ayelet; Perheentupa, Jaakko; Kemp, E. Helen; Fiskerstrand, Torunn; Viken, Marte K.; Weetman, Anthony P.; Fleishman, Sarel J.; Banka, Siddharth; Newman, William G.; Sewell, W. A. C.; Sozaeva, Leila S.; Zayats, Tetyana; Haugarvoll, Kristoffer; Orlova, Elizaveta M.; Haavik, Jan; Johansson, Stefan; Knappskog, Per M.; Lovas, Kristian; Wolff, Anette S. B.; Abramson, Jakub; Husebye, Eystein S.			Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases	IMMUNITY			English	Article							CANDIDIASIS-ECTODERMAL DYSTROPHY; AMINO-ACID DECARBOXYLASE; PHD FINGER; INTERFERON-OMEGA; GENE; AUTOANTIBODIES; BINDING; PROTEIN; TOLERANCE; LOCALIZATION	The autoimmune regulator (AIRE) gene is crucial for establishing central immunological tolerance and preventing autoimmunity. Mutations in AIRE cause a rare autosomal-recessive disease, autoimmune polyendocrine syndrome type 1 (APS-1), distinguished by multi-organ autoimmunity. We have identified multiple cases and families with mono-allelic mutations in the first plant homeodomain (PHD1) zinc finger of AIRE that followed dominant inheritance, typically characterized by later onset, milder phenotypes, and reduced penetrance compared to classical APS-1. These missense PHD1 mutations suppressed gene expression driven by wild-type AIRE in a dominant-negative manner, unlike CARD or truncated AIRE mutants that lacked such dominant capacity. Exome array analysis revealed that the PHD1 dominant mutants were found with relatively high frequency (>0.0008) in mixed populations. Our results provide insight into the molecular action of AIRE and demonstrate that disease-causing mutations in the AIRE locus are more common than previously appreciated and cause more variable autoimmune phenotypes.	[Oftedal, Bergithe E.; Hellesen, Alexander; Bratland, Eirik; Fiskerstrand, Torunn; Johansson, Stefan; Knappskog, Per M.; Lovas, Kristian; Wolff, Anette S. B.; Husebye, Eystein S.] Univ Bergen, Dept Clin Sci, N-5021 Bergen, Norway; [Hellesen, Alexander; Erichsen, Martina M.; Lovas, Kristian; Husebye, Eystein S.] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Vardi, Ayelet; Abramson, Jakub] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Perheentupa, Jaakko] Univ Helsinki, Hosp Children & Adolescents, SF-00100 Helsinki, Finland; [Kemp, E. Helen; Weetman, Anthony P.] Univ Sheffield, Sch Med, Dept Human Metab, Sheffield S10 2RX, S Yorkshire, England; [Fiskerstrand, Torunn; Johansson, Stefan; Knappskog, Per M.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Viken, Marte K.] Oslo Univ Hosp, Dept Immunol, N-0316 Oslo, Norway; [Viken, Marte K.] Univ Oslo, N-0316 Oslo, Norway; [Fleishman, Sarel J.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Banka, Siddharth; Newman, William G.] Univ Manchester, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Banka, Siddharth; Newman, William G.] Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Sewell, W. A. C.] Scunthorpe Gen Hosp, Path Links Immunol, Scunthorpe DN15 7BH, England; [Sozaeva, Leila S.; Orlova, Elizaveta M.] Inst Pediat Endocrinol, Endocrinol Res Ctr, Moscow 117036, Russia; [Zayats, Tetyana; Haavik, Jan] Univ Bergen, Dept Biomed, KG Jebsen Ctr Neuropsychiat Disorders, N-5021 Bergen, Norway; [Haugarvoll, Kristoffer] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Weizmann Institute of Science; University of Helsinki; University of Sheffield; University of Bergen; Haukeland University Hospital; University of Oslo; University of Oslo; Weizmann Institute of Science; University of Manchester; University of Manchester; Russian Academy of Medical Sciences; Endocrinology Research Centre; University of Bergen; University of Bergen; Haukeland University Hospital	Husebye, ES (corresponding author), Univ Bergen, Dept Clin Sci, N-5021 Bergen, Norway.	eystein.husebye@k2.uib.no	Johansson, Stefan/C-4394-2011; Wolff, Anette/AAN-5981-2020; Oftedal, Bergithe Eikeland/I-7217-2019; Haugarvoll, Kristoffer/L-1486-2015; Haavik, Jan/ABE-1535-2020; Haugarvoll, Kristoffer/AAB-5860-2019; Haavik, Jan/AAI-3974-2020	Johansson, Stefan/0000-0002-2298-7008; Oftedal, Bergithe Eikeland/0000-0003-4248-7737; Haugarvoll, Kristoffer/0000-0001-9381-1109; Haugarvoll, Kristoffer/0000-0001-9381-1109; Haavik, Jan/0000-0001-7865-2808; Newman, William/0000-0002-6382-4678; Bratland, Eirik/0000-0002-8359-9818; Viken, Marte Kathrine/0000-0002-3917-9269; Fleishman, Sarel/0000-0003-3177-7560; Banka, Siddharth/0000-0002-8527-2210; Wolff, Anette Susanne Boe/0000-0002-8485-2248	Regional Health Authorities of Western Norway; Norwegian Research Council; Novo Nordisk Foundation; Israel Science Foundation; Sy Syms Foundation; Bergen Medical Research Foundation; Nils Norman's Traveling Fund in Endocrinology; Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; Novo Nordisk Fonden [NNF15OC0016108, NNF14OC0011005] Funding Source: researchfish	Regional Health Authorities of Western Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Israel Science Foundation(Israel Science Foundation); Sy Syms Foundation; Bergen Medical Research Foundation; Nils Norman's Traveling Fund in Endocrinology; Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from The Regional Health Authorities of Western Norway, The Norwegian Research Council, Novo Nordisk Foundation, The Israel Science Foundation (J.A., S.J.F.), Sy Syms Foundation (J.A.), Bergen Medical Research Foundation (A.S.B.W.), and Nils Norman's Traveling Fund in Endocrinology (A.H.). B.E.O. and E.S.H. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Technical help from Hajirah Muneer, Elin Theodorsen, and Elisabeth Halvorsen is greatly acknowledged. We thank the patients and physicians of The National Registry of Organ-specific Autoimmune Diseases (Drs. Anne-Grethe Myhre, Johan Svartberg, Kristian Fougner, Anders Jorgensen, Tore Julsrud Berg, Kari Lima, Bjarne Mella, Bjorn Nedrebo, and Siri Carlsen) for collection of clinical information. We would like to thank Dr. Vinod Devalia, Princess of Wales Hospital, and Professor Mark Pritchard, University of Liverpool, for collecting pernicious anemia samples. Professor Christophe Benoist, Harvard Medical School, is thanked for generously providing human thymic 4D6 cells. The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies that produced and provided exome variant calls: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010).	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Buzi F, 2003, J CLIN ENDOCR METAB, V88, P3146, DOI 10.1210/jc.2002-021495; Cervato S, 2010, CLIN ENDOCRINOL, V73, P630, DOI 10.1111/j.1365-2265.2010.03862.x; Cetani F, 2001, J CLIN ENDOCR METAB, V86, P4747, DOI 10.1210/jc.86.10.4747; Chakravarty S, 2009, STRUCTURE, V17, P670, DOI 10.1016/j.str.2009.02.017; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Erichsen MM, 2009, J CLIN ENDOCR METAB, V94, P4882, DOI 10.1210/jc.2009-1368; Ferguson BJ, 2008, J BIOL CHEM, V283, P1723, DOI 10.1074/jbc.M707211200; Ferrera F, 2007, CLIN IMMUNOL, V122, P13, DOI 10.1016/j.clim.2006.09.013; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Hedstrand H, 2000, BIOCHEM BIOPH RES CO, V267, P456, DOI 10.1006/bbrc.1999.1945; Husebye ES, 1997, J CLIN ENDOCR METAB, V82, P147, DOI 10.1210/jc.82.1.147; Husebye ES, 2010, IMMUNITY, V32, P479, DOI 10.1016/j.immuni.2010.03.016; Jin Y, 2007, PIGM CELL RES, V20, P402, DOI 10.1111/j.1600-0749.2007.00398.x; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Koh AS, 2010, P NATL ACAD SCI USA, V107, P13016, DOI 10.1073/pnas.1004436107; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Kumar PG, 2001, J BIOL CHEM, V276, P41357, DOI 10.1074/jbc.M104898200; Lahner E, 2010, DIGEST LIVER DIS, V42, P854, DOI 10.1016/j.dld.2010.04.011; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Myhre AG, 2004, EUR J PEDIATR, V163, P604, DOI 10.1007/s00431-004-1516-8; Oftedal BE, 2008, CLIN IMMUNOL, V129, P163, DOI 10.1016/j.clim.2008.07.002; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Pforr J, 2006, TISSUE ANTIGENS, V68, P58, DOI 10.1111/j.1399-0039.2006.00598.x; Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Price S, 2014, BLOOD, V123, P1989, DOI 10.1182/blood-2013-10-535393; Soderbergh A, 2000, J CLIN ENDOCR METAB, V85, P460, DOI 10.1210/jc.85.1.460; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Stolarski B, 2006, CLIN GENET, V70, P348, DOI 10.1111/j.1399-0004.2006.00690.x; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Taniguchi RT, 2011, IMMUNOL CELL BIOL, V89, P40, DOI 10.1038/icb.2010.132; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Torok HP, 2004, EUR J IMMUNOGENET, V31, P83, DOI 10.1111/j.1365-2370.2004.00449.x; Turunen JA, 2006, IMMUNOGENETICS, V58, P331, DOI 10.1007/s00251-006-0088-3; Vaidya B, 2000, J CLIN ENDOCR METAB, V85, P688, DOI 10.1210/jc.85.2.688; Vogel A, 2001, HEPATOLOGY, V33, P1047, DOI 10.1053/jhep.2001.24031; Wolff ASB, 2008, GENES IMMUN, V9, P130, DOI 10.1038/sj.gene.6364457	44	138	142	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1185	1196		10.1016/j.immuni.2015.04.021	http://dx.doi.org/10.1016/j.immuni.2015.04.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084028	Green Accepted, Bronze			2022-12-18	WOS:000356362800021
J	Onai, N; Kurabayashi, K; Hosoi-Amaike, M; Toyama-Sorimachi, N; Matsushima, K; Inaba, K; Ohteki, T				Onai, Nobuyuki; Kurabayashi, Kazutaka; Hosoi-Amaike, Mayuka; Toyama-Sorimachi, Noriko; Matsushima, Kouji; Inaba, Kayo; Ohteki, Toshiaki			A Clonogenic Progenitor with Prominent Plasmacytoid Dendritic Cell Developmental Potential	IMMUNITY			English	Article							INTERFERON-PRODUCING CELLS; TRANSCRIPTION FACTOR E2-2; I INTERFERON; FLT3 LIGAND; REPORTER GENE; CUTTING EDGE; STEADY-STATE; LYMPH-NODES; PRECURSORS; MACROPHAGES	Macrophage and dendritic cell (DC) progenitors (MDPs) and common DC progenitors (CDPs) are bone marrow (BM) progenitors with DC differentiation potential. However, both MDPs and CDPs give rise to large numbers of conventional DCs (cDCs) and few plasmacytoid DCs (pDCs), implying that more dedicated pDC progenitors remain to be identified. Here we have described DC progenitors with a prominent pDC differentiation potential. Although both MDPs and CDPs express the macrophage colony stimulating factor (M-CSF) receptor (M-CSFR), the progenitors were confined to a M-CSFR- fraction, identified as Lin(-)c-Kit(int/lo)Flt3(+)M-CSFR-, and expressed high amounts of E2-2 (also known as Tcf4) an essential transcription factor for pDC development. Importantly, they appeared to be directly derived from either CDPs or lymphoid-primed multi-potent progenitors (LMPPs). Collectively, our findings provide insight into DC differentiation pathways and may lead to progenitor-based therapeutic applications for infection and autoimmune disease.	[Onai, Nobuyuki; Kurabayashi, Kazutaka; Hosoi-Amaike, Mayuka; Ohteki, Toshiaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo 1138510, Japan; [Onai, Nobuyuki; Matsushima, Kouji; Inaba, Kayo; Ohteki, Toshiaki] Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy, Tokyo 1020081, Japan; [Toyama-Sorimachi, Noriko] Natl Ctr Global Hlth & Med, Res Inst, Dept Mol Immunol & Inflammat, Tokyo 1628655, Japan; [Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo 1130033, Japan; [Inaba, Kayo] Kyoto Univ, Grad Sch Biostudies, Div Syst Life Sci, Lab Immunobiol,Dept Anim Dev & Physiol, Kyoto 6068501, Japan	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); National Center for Global Health & Medicine - Japan; University of Tokyo; Kyoto University	Ohteki, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo 1138510, Japan.	ohteki.bre@mri.tmd.ac.jp		Onai, Nobuyuki/0000-0003-2246-4917	Sumitomo Foundation; Uehara Memorial Foundation; NOVARTIS foundation; Takeda Science Foundation; Ministry of Education, Science, Sports and Culture of Japan; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST)	Sumitomo Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS foundation(Novartis); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	We thank H. Kamioka for secretarial support and N. Sakaguchi (Kumamoto University) for the B6.Rag1<SUP>gfp/+</SUP> mice. This work was supported by the Sumitomo Foundation (N.O.), the Uehara Memorial Foundation (N.O.), the NOVARTIS foundation (N.O.), the Takeda Science Foundation (N.O., T.O.), a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture of Japan (T.O.), and Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST) (T.O.).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chen W, 2004, BLOOD, V103, P2547, DOI 10.1182/blood-2003-09-3058; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kushida T, 2001, BLOOD, V97, P3292, DOI 10.1182/blood.V97.10.3292; Kuwata N, 1999, J IMMUNOL, V163, P6355; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Ovchinnikov DA, 2010, J LEUKOCYTE BIOL, V87, P815, DOI 10.1189/jlb.0809557; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlitzer A, 2012, BLOOD, V119, P6063, DOI 10.1182/blood-2012-03-418400; Schlitzer A, 2011, BLOOD, V117, P6562, DOI 10.1182/blood-2010-12-326678; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Toyama-Sorimachi N, 2004, P NATL ACAD SCI USA, V101, P1016, DOI 10.1073/pnas.0305400101; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Watowich SS, 2010, IMMUNOL REV, V238, P76, DOI 10.1111/j.1600-065X.2010.00949.x; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	55	138	139	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					943	957		10.1016/j.immuni.2013.04.006	http://dx.doi.org/10.1016/j.immuni.2013.04.006			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23623382	Bronze			2022-12-18	WOS:000330942500013
J	Chen, QZ; Yang, W; Gupta, S; Biswas, P; Smith, P; Bhagat, G; Pernis, AB				Chen, Qinzhong; Yang, Wen; Gupta, Sanjay; Biswas, Partha; Smith, Paula; Bhagat, Govind; Pernis, Alessandra B.			IRF-4-Binding Protein Inhibits Interleukin-17 and Interleukin-21 Production by Controlling the Activity of IRF-4 Transcription Factor	IMMUNITY			English	Article							ROR-GAMMA-T; RHEUMATOID-ARTHRITIS; MOLECULAR-CLONING; T-H-17 CELLS; MOUSE MODEL; IL-21; EXPRESSION; GENE; TH17; DIFFERENTIATION	The T helper 17(Th17) cell lineage is important in inflammatory and autoimmune responses, via its ability to produce interleukin-17 (IL-17) and IL-21. Given the potentially deleterious effects of Th17 cells, their generation needs to be strictly controlled. IRF-4 is a transcription factor that has recently emerged as a key regulator of Th17 cell differentiation. Here, we showed that mice deficient in a previously isolated protein, IBP (IRF-4-binding protein), rapidly developed rheumatoid arthritis-like joint disease and large-vessel vasculitis. The pathology was associated with an enhanced responsiveness of T cells to low levels of stimulation and with the inappropriate synthesis of IL-17 and IL-21. IBP sequestered IRF-4 and prevented it from targeting the transcriptional regulatory regions of the genes that encode IL-17 and IL-21. Thus, IBP appears to be important in preventing T cell-mediated autoimmunity by ensuring that the production of IL-17 and IL-21 does not occur in response to self-antigens.	[Chen, Qinzhong; Yang, Wen; Gupta, Sanjay; Biswas, Partha; Pernis, Alessandra B.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Smith, Paula; Bhagat, Govind] Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Pernis, AB (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	abp1@columbia.edu	Bhagat, Govind/AAE-9493-2021	Bhagat, Govind/0000-0001-6250-048X	National Institutes of Health [R01 HL-62215]; Lupus Research Institute; Alliance for Lupus Research; National Multiple Sclerosis Society; American Heart Association; SLE Lupus Foundation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; Alliance for Lupus Research; National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Heart Association(American Heart Association); SLE Lupus Foundation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank C. Schindler, H. Gu, and S. Greenberg for their critical reading of the manuscript and discussions. The authors also thank G. Cattoretti for help with immunohistochemical staining. The research was supported by National Institutes of Health grants R01 HL-62215, the Lupus Research Institute, the Alliance for Lupus Research, a Pilot Award from the National Multiple Sclerosis Society, and an American Heart Association Grant-in-Aid to A.P. Support to Q.C. has been provided by an SLE Lupus Foundation Fellowship.	Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Azam M, 1997, IMMUNITY, V6, P691, DOI 10.1016/S1074-7613(00)80445-8; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brand DD, 2004, METH MOLEC MED, V102, P295; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Fanzo JC, 2006, J CLIN INVEST, V116, P703, DOI 10.1172/JCI24096; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; GUPTA S, 2003, J BIOL CHEM, V278, P43451; Habu K, 1999, J IMMUNOL, V162, P2956; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Lubberts E, 2005, J IMMUNOL, V175, P3360, DOI 10.4049/jimmunol.175.5.3360; Mamane Y, 2002, J INTERF CYTOK RES, V22, P135, DOI 10.1089/107999002753452746; Masat L, 2000, P NATL ACAD SCI USA, V97, P2180, DOI 10.1073/pnas.040374497; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Mehta DS, 2004, IMMUNOL REV, V202, P84, DOI 10.1111/j.0105-2896.2004.00201.x; Mehta DS, 2005, P NATL ACAD SCI USA, V102, P2016, DOI 10.1073/pnas.0409512102; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sawalha AH, 2008, ANN RHEUM DIS, V67, P458, DOI 10.1136/ard.2007.075424; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; So T, 2006, P NATL ACAD SCI USA, V103, P3740, DOI 10.1073/pnas.0600205103; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Stamp LK, 2004, IMMUNOL CELL BIOL, V82, P1, DOI 10.1111/j.1440-1711.2004.01212.x; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Toh ML, 2007, CURR OPIN RHEUMATOL, V19, P284, DOI 10.1097/BOR.0b013e32805e87e0; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	55	138	144	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					899	911		10.1016/j.immuni.2008.10.011	http://dx.doi.org/10.1016/j.immuni.2008.10.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19062315	Green Accepted, Bronze			2022-12-18	WOS:000262012400010
J	Sato, T; Ohno, S; Hayashi, T; Sato, C; Kohu, K; Satake, M; Habu, S				Sato, T; Ohno, S; Hayashi, T; Sato, C; Kohu, K; Satake, M; Habu, S			Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes	IMMUNITY			English	Article							T-CELL DEVELOPMENT; SINGLE-POSITIVE LINEAGE; CORE-BINDING-FACTOR; TRANSCRIPTION FACTOR; GENE-EXPRESSION; TRANSGENIC MICE; LYMPHOCYTE DEVELOPMENT; REGULATORY SEQUENCES; AML1; DIFFERENTIATION	To understand how CD8 expression is regulated during the transition process from CD4(+)8(+) (CD4 and CD8 double positive, DP) to CD4(-)8(+) (CD8 single positive, CD8SP) cells in the thymus, the involvement of Runx proteins in the alteration of chromatin configuration was investigated. Using the chromatin immunoprecipitation assay, we first demonstrated that Runx proteins bind to the stage-specific CD8 enhancer, as well as the CD4 silencer, in CD8SP thymocytes. Among Runx family members, Runx3 expression was initiated in DID thymocytes receiving a positive selection signal and increased in concert with differentiation to the CD8SP stage. Furthermore, reactivation of the CD8 gene, as well as CD4 silencing, was suppressed in positively selected thymocytes of Runx dominant-negative transgenic mice. These results suggest that Flunx proteins, especially Runx3, are involved in lineage specification of CD8 T cells and provide important information for understanding the mechanism for the mutually exclusive expression of coreceptors in mature thymocytes.	Tokai Univ, Sch Med, Dept Immunol, Isehara, Kanagawa 2591193, Japan; Tokai Univ, Sch Med, Dept Glycotechnol, Isehara, Kanagawa 2591193, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tokai University; Tokai University; Tohoku University	Habu, S (corresponding author), Tokai Univ, Sch Med, Dept Immunol, Isehara, Kanagawa 2591193, Japan.	sonoko@is.icc.u-tokai.ac.jp						Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Banan M, 1997, J BIOL CHEM, V272, P18440, DOI 10.1074/jbc.272.29.18440; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Chakraborty S, 2003, ONCOGENE, V22, P5229, DOI 10.1038/sj.onc.1206600; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Downing JR, 2003, CURR OPIN GENET DEV, V13, P48, DOI 10.1016/S0959-437X(02)00018-7; Ehlers M, 2003, J IMMUNOL, V171, P3594, DOI 10.4049/jimmunol.171.7.3594; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Garefalaki A, 2002, IMMUNITY, V16, P635, DOI 10.1016/S1074-7613(02)00308-4; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hayashi K, 2000, J IMMUNOL, V165, P6816, DOI 10.4049/jimmunol.165.12.6816; Hayashi K, 2001, J IMMUNOL, V167, P4957, DOI 10.4049/jimmunol.167.9.4957; Hedrick SM, 2002, IMMUNITY, V16, P619, DOI 10.1016/S1074-7613(02)00316-3; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hostert A, 1997, J IMMUNOL, V158, P4270; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kohu K, 2005, J IMMUNOL, V174, P2627, DOI 10.4049/jimmunol.174.5.2627; LANDRY DB, 1993, J EXP MED, V178, P941, DOI 10.1084/jem.178.3.941; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Ohoka Y, 1997, J IMMUNOL, V158, P5707; Sato T, 2003, IMMUNOL LETT, V89, P39, DOI 10.1016/S0165-2478(03)00103-2; SATO T, 1994, EUR J IMMUNOL, V24, P1512, DOI 10.1002/eji.1830240708; Sato T, 2001, CELL IMMUNOL, V211, P71, DOI 10.1006/cimm.2001.1823; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schmedt C, 2001, J EXP MED, V193, P815, DOI 10.1084/jem.193.7.815; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Suzuki T, 2004, TAIWAN J MATH, V8, P1; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Telfer JC, 2004, J IMMUNOL, V172, P4359, DOI 10.4049/jimmunol.172.7.4359; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	46	138	141	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					317	328		10.1016/j.immuni.2005.01.012	http://dx.doi.org/10.1016/j.immuni.2005.01.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780989	Bronze			2022-12-18	WOS:000228105700007
J	Maynard, J; Petersson, K; Wilson, DH; Adams, EJ; Blondelle, SE; Boulanger, MJ; Wilson, DB; Garcia, KC				Maynard, J; Petersson, K; Wilson, DH; Adams, EJ; Blondelle, SE; Boulanger, MJ; Wilson, DB; Garcia, KC			Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: Insights into MHC bias and antigen specificity	IMMUNITY			English	Article							CROSS-REACTIVITY; TRANSGENIC MICE; SELF-PEPTIDE; TCR BINDING; RECOGNITION; PROTEIN; LIGANDS; EPITOPE; ENCEPHALOMYELITIS; IDENTIFICATION	T cell receptor crossreactivity with different peptide ligands and biased recognition of MHC are coupled features of antigen recognition that are necessary for the T cell's diverse functional repertoire. In the crystal structure between an autoreactive, EAE T cell clone 172.10 and myelin basic protein (1-11) presented by class 11 MHC I-A(u), recognition of the MHC is dominated by the Vbeta domain of the TCR, which interacts with the MHC alpha chain in a manner suggestive of a germline-encoded TCR/MHC "anchor point." Strikingly, there are few specific contacts between the TCR CDR3 loops and the MBP peptide. We also find that over 1,000,000 different peptides derived from combinatorial libraries can activate 172.10, yet the TCR strongly prefers the native MBP contact residues. We suggest that while TCR scanning of pMHC may be degenerate due to the TCR germline bias for MHC, recognition of structurally distinct agonist peptides is not indicative of TCR promiscuity, but rather highly specific alternative solutions to TCR engagement.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA	Stanford University; Stanford University; Torrey Pines Institute for Molecular Studies, California	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Lindkvist, Karin/0000-0002-5209-3160	NATIONAL CANCER INSTITUTE [P01CA078040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048540, F32AI055245, R37AI022519, R21AI022519, R01AI022519, R56AI048540] Funding Source: NIH RePORTER; NCI NIH HHS [CA-78040] Funding Source: Medline; NHLBI NIH HHS [HL077325] Funding Source: Medline; NIAID NIH HHS [AI-48540, F32 AI055245, AI-22519] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Anderton SM, 1998, J IMMUNOL, V161, P3357; Anderton SM, 2001, J EXP MED, V193, P1, DOI 10.1084/jem.193.1.1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bankovich AJ, 2003, IMMUNITY, V18, P7, DOI 10.1016/S1074-7613(02)00517-4; Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; BHARDWAJ V, 1993, J IMMUNOL, V151, P5000; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Daniel C, 1998, IMMUNITY, V8, P543, DOI 10.1016/S1074-7613(00)80559-2; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DeLano W. L, 2002, PYMOL MOL GENETICS G; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; Fugger L, 1996, MOL MED, V2, P181, DOI 10.1007/BF03401615; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; GAUTAM AM, 1994, P NATL ACAD SCI USA, V91, P767, DOI 10.1073/pnas.91.2.767; Gautam AM, 1998, J IMMUNOL, V161, P60; GERMAIN RN, 1990, NATURE, V344, P19, DOI 10.1038/344019a0; Goverman J, 1999, IMMUNOL REV, V169, P147, DOI 10.1111/j.1600-065X.1999.tb01313.x; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Grogan JL, 1999, J IMMUNOL, V163, P3764; HAGERTY DT, 1995, J IMMUNOL, V155, P2993; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Hemmer B, 1998, J IMMUNOL, V160, P3631; Hemmer B, 1998, IMMUNOL TODAY, V19, P163, DOI 10.1016/S0167-5699(97)01217-6; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Holler PD, 2004, MOL IMMUNOL, V40, P1027, DOI 10.1016/j.molimm.2003.11.013; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Ignatowicz L, 1997, IMMUNITY, V7, P179, DOI 10.1016/S1074-7613(00)80521-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Loftus C, 1999, J IMMUNOL, V162, P6451; Loftus DJ, 1997, J IMMUNOL, V158, P3651; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MASON K, 1995, BIOCHEMISTRY-US, V34, P14874, DOI 10.1021/bi00045a031; MATEU MG, 1995, VIRUS RES, V38, P1, DOI 10.1016/0168-1702(95)00048-U; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; PINILLA C, 1994, BIOCHEM J, V301, P847, DOI 10.1042/bj3010847; Pinilla C, 1999, CURR OPIN IMMUNOL, V11, P193, DOI 10.1016/S0952-7915(99)80033-8; Radu CG, 1998, J IMMUNOL, V160, P5915; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Shih FF, 2004, MOL IMMUNOL, V40, P1041, DOI 10.1016/j.molimm.2003.11.008; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wilson DB, 1999, J IMMUNOL, V163, P6424; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; WRAITH DC, 1992, J IMMUNOL, V149, P3765; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wucherpfennig KW, 2004, MOL IMMUNOL, V40, P1009, DOI 10.1016/j.molimm.2003.11.003; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; ZAMVIL SS, 1987, J IMMUNOL, V139, P1075	75	138	145	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2005	22	1					81	92		10.1016/j.immuni.2004.11.015	http://dx.doi.org/10.1016/j.immuni.2004.11.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664161	Bronze			2022-12-18	WOS:000226682900009
J	Fleming, HE; Paige, CJ				Fleming, HE; Paige, CJ			Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway	IMMUNITY			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; STIMULATING FACTOR PPBSF; MARROW STROMAL CELLS; BONE-MARROW; DEVELOPMENTAL PROGRESSION; LYMPHOCYTE DEVELOPMENT; ALLELIC EXCLUSION; DISTINCT SIGNALS; BCL-2 EXPRESSION; JANUS KINASE	B lymphocyte development is regulated at multiple checkpoints, mediated by signals originating both inside and outside the cell. Two signaling pathways known to be essential in this process are interleukin-7 (IL-7) and the pre-B cell receptor (pBCR). We have shown previously that these signaling pathways intersect functionally. Specifically, response to low concentrations of IL-7 requires pBCR expression. In this report, we identify the ERK/MAP kinase pathway as a key regulatory component of this response. We propose a molecular mechanism for the selective expansion of pBCR(+) precursors and for the culling of inappropriately rearranged pro-B cells.	Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Univ Hlth Network,Dept Immunol, Toronto, ON, Canada; Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Univ Hlth Network,Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Fleming, HE (corresponding author), Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Univ Hlth Network,Dept Immunol, Toronto, ON, Canada.	heatherf@oci.utoronto.ca						ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Benbernou N, 2000, J BIOL CHEM, V275, P7060, DOI 10.1074/jbc.275.10.7060; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Borghesi LA, 1999, BLOOD, V93, P140, DOI 10.1182/blood.V93.1.140.401k40_140_148; Caldwell RG, 2000, J VIROL, V74, P1101, DOI 10.1128/JVI.74.3.1101-1113.2000; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Ceredig R, 1999, EUR J IMMUNOL, V29, P2797, DOI 10.1002/(SICI)1521-4141(199909)29:09<2797::AID-IMMU2797>3.3.CO;2-#; CLARKE D, 1995, CYTOKINE, V7, P325, DOI 10.1006/cyto.1995.0041; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Cronin FE, 1998, J IMMUNOL, V161, P252; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; CUMANO A, 1990, EUR J IMMUNOL, V20, P2183, DOI 10.1002/eji.1830201006; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; GIMBLE JM, 1989, BLOOD, V74, P303; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; Iritani BM, 1999, IMMUNITY, V10, P713, DOI 10.1016/S1074-7613(00)80070-9; KINCADE PW, 1989, ANNU REV IMMUNOL, V7, P111, DOI 10.1146/annurev.iy.07.040189.000551; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; Kurosaki T, 2000, CURR OPIN IMMUNOL, V12, P276, DOI 10.1016/S0952-7915(00)00087-X; Lai LJ, 1998, J IMMUNOL, V160, P2280; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; Maki K, 2000, J EXP MED, V191, P1333, DOI 10.1084/jem.191.8.1333; Maraskovsky E, 1998, INT IMMUNOL, V10, P1367, DOI 10.1093/intimm/10.9.1367; Marshall AJ, 1998, J IMMUNOL, V161, P6038; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; McKenna SD, 1998, J IMMUNOL, V160, P2272; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Merchant M, 2000, J VIROL, V74, P9115, DOI 10.1128/JVI.74.19.9115-9124.2000; Mertsching E, 1996, EUR J IMMUNOL, V26, P28, DOI 10.1002/eji.1830260105; Michie AM, 1999, J EXP MED, V190, P1647, DOI 10.1084/jem.190.11.1647; Nagaoka H, 2000, J EXP MED, V192, P171, DOI 10.1084/jem.192.2.171; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; OSMOND DG, 1994, IMMUNOL REV, V142, P209, DOI 10.1111/j.1600-065X.1994.tb00891.x; Paget WJ, 1999, SOZ PRAVENTIV MED, V44, P1, DOI 10.1007/BF01624804; Ray RJ, 1998, J IMMUNOL, V160, P5886; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; Shaw AC, 1999, J EXP MED, V189, P123, DOI 10.1084/jem.189.1.123; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Stephan RP, 1998, BLOOD, V91, P75, DOI 10.1182/blood.V91.1.75.75_75_88; Stoddart A, 2001, EUR J IMMUNOL, V31, P1160, DOI 10.1002/1521-4141(200104)31:4<1160::AID-IMMU1160>3.0.CO;2-T; Sutherland CL, 1996, J IMMUNOL, V157, P3381; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; Vairo G, 1996, ONCOGENE, V13, P1511; Valenzona HO, 1998, CYTOKINE, V10, P404, DOI 10.1006/cyto.1997.0312; Valenzona HO, 1996, EXP HEMATOL, V24, P1521; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wei CJ, 2000, J IMMUNOL, V164, P1961, DOI 10.4049/jimmunol.164.4.1961; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; Young F, 1997, IMMUNITY, V6, P23, DOI 10.1016/S1074-7613(00)80239-3; ZENG YX, 1994, FEBS LETT, V353, P289, DOI 10.1016/0014-5793(94)01065-X	61	138	143	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2001	15	4					521	531		10.1016/S1074-7613(01)00216-3	http://dx.doi.org/10.1016/S1074-7613(01)00216-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672535	Bronze			2022-12-18	WOS:000171757800004
J	Harder, KW; Parsons, LM; Armes, J; Evans, N; Kountouri, N; Clark, R; Quilici, C; Grail, D; Hodgson, GS; Dunn, AR; Hibbs, ML				Harder, KW; Parsons, LM; Armes, J; Evans, N; Kountouri, N; Clark, R; Quilici, C; Grail, D; Hodgson, GS; Dunn, AR; Hibbs, ML			Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role of Lyn in the myeloid lineage	IMMUNITY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; MOTH-EATEN; DEFICIENT MICE; TARGETED DISRUPTION; AUTOIMMUNE-DISEASE; NEGATIVE REGULATOR; MAMMARY-TUMORS; B-CELLS; KINASE; RECEPTOR	To investigate the role of the Lyn kinase in establishing signaling thresholds in hematopoietic cells, a gain-of-function mutation analogous to the Src Y527F-activating mutation was introduced into the Lyn gene. Intriguingly, although Lyn is widely expressed within the hematopoietic system, these mice displayed no propensity toward hematological malignancy. By contrast, analysis of aging cohorts of both loss- and gain-of-function Lyn mutant mice revealed that Lyn(-/-) mice develop splenomegaly, increased numbers of myeloid progenitors, and monocyte/macrophage (MO) tumors' Biochemical analysis of cells from these mutants revealed that Lyn is essential in establishing ITIM-dependent inhibitory signaling and for activation of specific protein tyrosine phosphatases within myeloid cells. Loss of such inhibitory signaling may predispose mice lacking this putative protooncogene to tumorigenesis.	Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, Melbourne, Vic 3050, Australia; Univ Melbourne, Victorian Breast Canc Res Consortium, Parkville, Vic 3050, Australia; Royal Hosp Women, Carlton, Vic 3052, Australia	Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Melbourne	Hibbs, ML (corresponding author), Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, Melbourne, Vic 3050, Australia.	margaret.hibbs@ludwig.edu.au	Armes, Jane/D-6396-2012; Hibbs, Margaret L/D-7013-2011	Armes, Jane/0000-0002-2215-0347; Hibbs, Margaret L/0000-0002-3751-6751; Parsons, Linda/0000-0002-7738-8280				ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; Baker M, 2000, EMBO J, V19, P4644, DOI 10.1093/emboj/19.17.4644; Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855; Berg KL, 1998, ONCOGENE, V17, P2535, DOI 10.1038/sj.onc.1202203; BIGNON JS, 1994, CLIN IMMUNOL IMMUNOP, V73, P168, DOI 10.1006/clin.1994.1185; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; Chan VWF, 1998, CURR BIOL, V8, P545, DOI 10.1016/S0960-9822(98)70223-4; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; Jiao HY, 1997, EXP HEMATOL, V25, P592; KATAGIRI T, 1995, J BIOL CHEM, V270, P27987; Katagiri T, 1999, J IMMUNOL, V163, P1321; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Malek SN, 1998, P NATL ACAD SCI USA, V95, P7351, DOI 10.1073/pnas.95.13.7351; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Ramsby ML, 1999, METH MOL B, V112, P53; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; Satterthwaite AB, 1998, J EXP MED, V188, P833, DOI 10.1084/jem.188.5.833; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Smith BP, 1998, EXP APPL ACAROL, V22, P187, DOI 10.1023/A:1006010230247; Somani AK, 2001, J BIOL CHEM, V276, P1938, DOI 10.1074/jbc.M006820200; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Takeshita H, 1998, INT IMMUNOL, V10, P435, DOI 10.1093/intimm/10.4.435; Timms JF, 1999, CURR BIOL, V9, P927, DOI 10.1016/S0960-9822(99)80401-1; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; VANZANT G, 1989, EXP HEMATOL, V17, P81; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; WEBSTER MA, 1995, P NATL ACAD SCI USA, V92, P7849, DOI 10.1073/pnas.92.17.7849; Weissenberger J, 1997, ONCOGENE, V14, P2005, DOI 10.1038/sj.onc.1201168; Yang WT, 1998, EXP HEMATOL, V26, P1126; Yoshida K, 1999, J BIOL CHEM, V274, P34663, DOI 10.1074/jbc.274.49.34663	57	138	147	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2001	15	4					603	615		10.1016/S1074-7613(01)00208-4	http://dx.doi.org/10.1016/S1074-7613(01)00208-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672542	Bronze			2022-12-18	WOS:000171757800011
J	Van Parijs, L; Refaeli, Y; Abbas, AK; Baltimore, D				Van Parijs, L; Refaeli, Y; Abbas, AK; Baltimore, D			RETRACTED: Autoimmunity as a consequence of retrovirus-mediated expression of c-FLIP in lymphocytes (Retracted article. See vol. 30, pg. 612, 2009)	IMMUNITY			English	Article; Retracted Publication							T-CELL ACTIVATION; FAS-LIGAND; B-CELLS; LYMPHOPROLIFERATIVE SYNDROME; DEATH RECEPTORS; TRANSGENIC MICE; APOPTOSIS; DISEASE; MUTATIONS; PROTEIN	The induction of apoptosis by death receptors serves to regulate immune responses by eliminating unwanted and harmful cells. Mature lymphocytes express FLICE inhibitory proteins (FLIPs) that block death receptor-induced cell death. Here, we show that both B and T cells downregulate c-FLIP upon activation in vitro. Retrovirus-mediated expression of c-FLIP blocks Pas-induced apoptosis of activated lymphocytes but does not affect cell death resulting from cytokine withdrawal. In vivo, c-FLIP expression results in defective superantigen-mediated elimination of T cells, the accumulation of activated B cells, the production of autoantibodies, and the development of autoimmune disease. No effect was seen on negative selection of thyomocytes. These results suggest that activation-dependent downregulation of c-FLIP renders mature lymphocytes sensitive to death receptor-mediated apoptosis and is required to maintain self-tolerance.	CALTECH, Dept Biol, Pasadena, CA 91125 USA; Harvard Univ, Sch Med, Dept Pathol, Div Immunol, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	California Institute of Technology; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Baltimore, D (corresponding author), CALTECH, Dept Biol, Pasadena, CA 91125 USA.	baltimo@cco.caltech.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042100] Funding Source: NIH RePORTER; NCI NIH HHS [CA54162] Funding Source: Medline; NIAID NIH HHS [AI42100] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fukuyama H, 1998, J IMMUNOL, V160, P3805; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Itoh N, 1997, J EXP MED, V186, P613, DOI 10.1084/jem.186.4.613; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kabra NH, 1999, J IMMUNOL, V162, P2766; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kataoka T, 1998, J IMMUNOL, V161, P3936; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Roman CAJ, 1997, IMMUNITY, V7, P13, DOI 10.1016/S1074-7613(00)80506-3; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; Sabelko KA, 1997, J IMMUNOL, V159, P3096; SETHNA MP, 1994, IMMUNITY, V1, P415, DOI 10.1016/1074-7613(94)90072-8; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Van Parijs L, 1998, SCIENCE, V280, P243; Waldner H, 1997, J IMMUNOL, V159, P3100; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; WANG JKM, 2000, IN PRESS EUR J IMMUN; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	42	138	141	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					763	770		10.1016/S1074-7613(00)80150-8	http://dx.doi.org/10.1016/S1074-7613(00)80150-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626898	Bronze			2022-12-18	WOS:000084612900012
J	TENNER, AJ; ROBINSON, SL; EZEKOWITZ, RAB				TENNER, AJ; ROBINSON, SL; EZEKOWITZ, RAB			MANNOSE-BINDING PROTEIN (MBP) ENHANCES MONONUCLEAR PHAGOCYTE FUNCTION VIA A RECEPTOR THAT CONTAINS THE 126,000 M(R) COMPONENT OF THE C1Q RECEPTOR	IMMUNITY			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; PULMONARY SURFACTANT APOPROTEIN; PERIPHERAL-BLOOD MONOCYTES; 1ST COMPLEMENT COMPONENT; ACUTE-PHASE REACTANT; COLLAGEN-LIKE REGION; MEDIATED PHAGOCYTOSIS; SUBCOMPONENT CLQ; POLYMORPHONUCLEAR LEUKOCYTES; MOLECULAR CHARACTERIZATION	Mannose-binding protein (MBP), Clq, the recognition component of the classical complement pathway, and pulmonary surfactant protein A (SP-A) are members of a family of molecules containing a collagen-like sequence contiguous with a noncollagen-like sequence, and usually having the properties of a lectin. Clq and SP-A have been shown to enhance monocyte FcR- and CR1-mediated phagocytosis, suggesting that the common structural features of the collagen-like domains may provide a basis for this immunologically important function. Results presented here demonstrate that MBP also enhanced FcR-mediated phagocytosis by both monocytes and macrophages, and stimulated CR1-mediated phagocytosis in human culture-derived macrophages and in phorbol ester-activated monocytes. Furthermore, a monoclonal antibody that recognizes a 126,000 M(r) cell surface protein and inhibits Clq-enhanced phagocytosis, inhibited the MBP-mediated enhancement of phagocytosis. Thus, the receptors that mediate the enhancement of phagocytosis by MBP and Clq share at least one critical functional component, the 126,000 M(r) ClqRp.	AMER RED CROSS,JEROME H HOLLAND LAB,ROCKVILLE,MD 20855; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DANA FARBER CANC INST,DEPT PEDIAT,DIV HEMATOL ONCOL,BOSTON,MA 02115	American Red Cross; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	TENNER, AJ (corresponding author), UNIV CALIF IRVINE,DEPT MOLEC BIOL & BIOCHEM,IRVINE,CA 92717, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027168] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-27168] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOBAK DA, 1988, EUR J IMMUNOL, V18, P2001, DOI 10.1002/eji.1830181220; BOBAK DA, 1986, J IMMUNOL, V136, P4604; BOBAK DA, 1987, J IMMUNOL, V138, P1150; BOHNSACK JF, 1985, J EXP MED, V161, P912, DOI 10.1084/jem.161.5.912; BORDIN S, 1990, J IMMUNOL, V145, P2520; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; BROWN EJ, 1988, J EXP MED, V167, P777, DOI 10.1084/jem.167.3.777; BROWN EJ, 1986, J LEUKOCYTE BIOL, V39, P579, DOI 10.1002/jlb.39.5.579; BRUNSWICK M, 1989, J IMMUNOL, V143, P1414; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; DRICKAMER K, 1987, KIDNEY INT, V32, pS167; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; EZEKOWITZ RAB, 1988, J EXP MED, V167, P1034, DOI 10.1084/jem.167.3.1034; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; FARRIES TC, 1990, IMMUNOL TODAY, V11, P78, DOI 10.1016/0167-5699(90)90031-4; FRIISCHRISTIANS.P, 1990, SCAND J IMMUNOL, V31, P453; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; GHEBREHIWET B, 1992, J LEUKOCYTE BIOL, V51, P546, DOI 10.1002/jlb.51.6.546; GOODMAN EB, 1992, J IMMUNOL, V148, P3920; GRESHAM HD, 1988, J CLIN INVEST, V82, P1192, DOI 10.1172/JCI113716; GRESHAM HD, 1986, J IMMUNOL, V137, P868; GRESHAM HD, 1989, J CELL BIOL, V108, P1935, DOI 10.1083/jcb.108.5.1935; GUAN E, 1991, J BIOL CHEM, V266, P20345; GUAN E, 1994, J IMMUNOL, V152, P4005; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; JOMORI T, 1991, J BIOL CHEM, V266, P13318; KRIEGER M, 1992, TRENDS BIOCHEM SCI, V17, P141, DOI 10.1016/0968-0004(92)90322-Z; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Lachmann P J, 1967, Adv Immunol, V6, P479, DOI 10.1016/S0065-2776(08)60527-1; LEE YM, 1991, J BIOL CHEM, V266, P2715; LEVITZ SM, 1993, INFECT IMMUN, V61, P4891, DOI 10.1128/IAI.61.11.4891-4893.1993; Lionetti F. J., 1980, METHODS CELL SEPARAT; MALHOTRA R, 1988, BIOCHEM SOC T, V16, P735, DOI 10.1042/bst0160735; MALHOTRA R, 1993, IMMUNOLOGY, V78, P341; MALHOTRA R, 1992, EUR J IMMUNOL, V22, P1437, DOI 10.1002/eji.1830220616; MALHOTRA R, 1990, J EXP MED, V172, P955, DOI 10.1084/jem.172.3.955; PEERSCHKE EIB, 1988, J IMMUNOL, V141, P3505; PEERSCHKE EIB, 1990, J IMMUNOL, V145, P2984; POMMIER CG, 1984, J EXP MED, V159, P137, DOI 10.1084/jem.159.1.137; POMMIER CG, 1983, J EXP MED, V157, P1844, DOI 10.1084/jem.157.6.1844; REID KBM, 1976, BIOCHEM J, V155, P5, DOI 10.1042/bj1550005; REID KBM, 1972, BIOCHEM J, V130, P749, DOI 10.1042/bj1300749; SAMPSON LL, 1991, J IMMUNOL, V146, P1005; SASTRY K, 1993, CURR OPIN IMMUNOL, V5, P59, DOI 10.1016/0952-7915(93)90082-4; SASTRY K, 1991, J IMMUNOL, V147, P692; SHIMIZU H, 1992, J BIOL CHEM, V267, P1853; SIEGEL RC, 1983, MOL IMMUNOL, V20, P53, DOI 10.1016/0161-5890(83)90105-0; SOELL M, 1995, J IMMUNOL, V154, P851; SORVILLO JM, 1986, J IMMUNOL, V136, P1023; SUPER M, 1992, NAT GENET, V2, P50, DOI 10.1038/ng0992-50; TAKAHASHI H, 1985, J BIOL CHEM, V260, P2228; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TAYLOR ME, 1989, BIOCHEM J, V262, P763, DOI 10.1042/bj2620763; TENNER AJ, 1980, J IMMUNOL, V125, P1658; TENNER AJ, 1981, J IMMUNOL, V127, P648; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; TENNER AJ, 1982, J IMMUNOL, V128, P2547; THIEL S, 1989, FEBS LETT, V250, P78, DOI 10.1016/0014-5793(89)80689-1; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; VOSS T, 1988, J MOL BIOL, V201, P219, DOI 10.1016/0022-2836(88)90448-2; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WENER MH, 1989, ARTHRITIS RHEUM, V32, P544, DOI 10.1002/anr.1780320506; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0; WRIGHT JR, 1987, J BIOL CHEM, V262, P2888; WRIGHT SD, 1982, J EXP MED, V156, P1149, DOI 10.1084/jem.156.4.1149; YOUNG KR, 1991, J IMMUNOL, V146, P3356	68	138	143	0	5	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1995	3	4					485	493		10.1016/1074-7613(95)90177-9	http://dx.doi.org/10.1016/1074-7613(95)90177-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584139	Bronze			2022-12-18	WOS:A1995TB60800009
J	Wang, YT; Ning, XH; Gao, PF; Wu, SX; Sha, MY; Lv, MZ; Zhou, X; Gao, JY; Fang, R; Meng, GX; Su, XD; Jiang, ZF				Wang, Yutao; Ning, Xiaohan; Gao, Pengfei; Wu, Shuxian; Sha, Mengyin; Lv, Mengze; Zhou, Xiang; Gao, Juyi; Fang, Run; Meng, Guangxun; Su, Xiaodong; Jiang, Zhengfan			Inflammasome Activation Triggers Caspase-1-Mediated Cleavage of cGAS to Regulate Responses to DNA Virus Infection	IMMUNITY			English	Article							NF-KAPPA-B; CYCLIC GMP-AMP; DOUBLE-STRANDED-RNA; I INTERFERON; RIG-I; ADAPTER PROTEIN; CYTOSOLIC DNA; HOST-DEFENSE; CELL-DEATH; INNATE	Viral infection triggers host innate immune responses that result in the production of various cytokines including type I interferons (IFN), activation of inflammasomes, and programmed cell death of the infected cells. Tight control of inflammatory cytokine production is crucial for the triggering of an effective immune response that can resolve the infection without causing host pathology. In examining the inflammatory response of Asc(-/-) and Casp1(-/-) macrophages, we found that deficiency in these molecules resulted in increased IFN production upon DNA virus infection, but not RNA virus challenge. Investigation of the underlying mechanism revealed that upon canonical and non-canonical inflammasome activation, caspase- 1 interacted with cyclic GMP-AMP (cGAMP) synthase (cGAS), cleaving it and dampening cGASSTING- mediated IFN production. Deficiency in inflammasome signaling enhanced host resistance to DNA virus in vitro and in vivo, and this regulatory role extended to other inflammatory caspases. Thus, inflammasome activation dampens cGAS-dependent signaling, suggesting cross-regulation between intracellular DNA-sensing pathways.	[Wang, Yutao; Ning, Xiaohan; Gao, Pengfei; Sha, Mengyin; Lv, Mengze; Zhou, Xiang; Gao, Juyi; Fang, Run; Su, Xiaodong; Jiang, Zhengfan] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Wang, Yutao; Ning, Xiaohan; Gao, Pengfei; Sha, Mengyin; Lv, Mengze; Zhou, Xiang; Gao, Juyi; Fang, Run; Jiang, Zhengfan] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Sch Life Sci, Beijing 100871, Peoples R China; [Wang, Yutao; Ning, Xiaohan; Gao, Pengfei; Sha, Mengyin; Lv, Mengze; Zhou, Xiang; Gao, Juyi; Fang, Run; Jiang, Zhengfan] Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Wu, Shuxian; Meng, Guangxun] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Jiang, ZF (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Jiang, ZF (corresponding author), Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Sch Life Sci, Beijing 100871, Peoples R China.; Jiang, ZF (corresponding author), Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	jiangzf@pku.edu.cn	Lyu, Mengze/GXV-3779-2022	Lyu, Mengze/0000-0002-8509-7969	Chinese Ministry of Science and Technology [2014CB542600, 2015CC040097]; China Natural Science Foundation [31230023, 91129000, 81621001]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	We thank Drs. Vishva Dixit for gene-deficient mice, Katherine Fitzgerald for immortalized macrophages, Zhijian J. Chen for human cGAS expression vector, and Feng Shao for caspase-4/11 prokaryotic expression vectors and iBMM-Gsdmd<SUP>-/-</SUP> cells. We also thank Min Fang (Institute of microbiology Chinese Academy of Sciences, Beijing) for Vaccinia virus (Western Reserve strain). This work was supported by grants from the Chinese Ministry of Science and Technology (2014CB542600, 2015CC040097), and the China Natural Science Foundation (31230023, 91129000, and 81621001).	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Billiau A, 2006, ANTIVIR RES, V71, P108, DOI 10.1016/j.antiviral.2006.03.006; Chen G. Y., 2016, REGULATION GUT MICRO; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Corrales L, 2016, J IMMUNOL, V196, P3191, DOI 10.4049/jimmunol.1502538; Crow MK, 2014, CURR OPIN RHEUMATOL, V26, P467, DOI 10.1097/BOR.0000000000000087; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gao J, 2015, CELL RES, V25, P539, DOI 10.1038/cr.2015.40; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jabir MS, 2014, CELL HOST MICROBE, V15, P214, DOI 10.1016/j.chom.2014.01.010; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kotter I, 2004, SEMIN ARTHRITIS RHEU, V33, P320, DOI 10.1053/S0049-0172(03)00167-7; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lei GW, 2013, CELL RES, V23, P965, DOI 10.1038/cr.2013.49; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Man SM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw028; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; McIlwain David R, 2015, Cold Spring Harb Perspect Biol, V7, DOI 10.1101/cshperspect.a026716; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nallar SC, 2014, J INTERF CYTOK RES, V34, P559, DOI 10.1089/jir.2014.0021; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan TY, 2013, J GEN VIROL, V94, P2215, DOI 10.1099/vir.0.055277-0; Tweezer-Zaks N, 2008, J RHEUMATOL, V35, P1362; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; van Kempen TS, 2015, NAT REV RHEUMATOL, V11, P483, DOI 10.1038/nrrheum.2015.60; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	61	137	150	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					393	404		10.1016/j.immuni.2017.02.011	http://dx.doi.org/10.1016/j.immuni.2017.02.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28314590	Bronze			2022-12-18	WOS:000396818100012
J	Palm, NW; Rosenstein, RK; Yu, S; Schenten, DD; Florsheim, E; Medzhitov, R				Palm, Noah W.; Rosenstein, Rachel K.; Yu, Shuang; Schenten, Dominik D.; Florsheim, Esther; Medzhitov, Ruslan			Bee Venom Phospholipase A2 Induces a Primary Type 2 Response that Is Dependent on the Receptor ST2 and Confers Protective Immunity	IMMUNITY			English	Article							MAST-CELLS; CYTOKINE; ALLERGEN; MECHANISMS; RESISTANCE; INITIATION; PROTEASES; STINGS; IL-33; SNAKE	Venoms consist of toxic components that are delivered to their victims via bites or stings. Venoms also represent a major class of allergens in humans. Phospholipase A2 (PLA2) is a conserved component of venoms from multiple species and is the major allergen in bee venom. Here we examined how bee venom PLA2 is sensed by the innate immune system and induces a type 2 immune response in mice. We found that bee venom PLA2 induced a T helper type 2 (Th2) cell-type response and group 2 innate lymphoid cell activation via the enzymatic cleavage of membrane phospholipids and release of interleukin-33. Furthermore, we showed that the IgE response to PLA2 could protect mice from future challenge with a near-lethal dose of PLA2. These data suggest that the innate immune system can detect the activity of a conserved component of venoms and induce a protective immune response against a venom toxin.	[Palm, Noah W.; Rosenstein, Rachel K.; Yu, Shuang; Schenten, Dominik D.; Florsheim, Esther; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu	Florsheim, Esther Borges/G-5260-2015	Florsheim, Esther Borges/0000-0002-5889-7442; Palm, Noah/0000-0001-7262-9455	National Institutes of Health [RO1 AI08977, 5RO1 AI055502, R37 AI046688]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055502, R37AI046688, R01AI089771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank members of the Medzhitov laboratory for helpful discussions, C. Annicelli and S. Cronin for animal care and technical help, O. Colegio for helpful comments on the manuscript, and Andrew McKenzie, Mark Shlomchik, Janusz Kabarowski, and Vishva Dixit for making available the St2<SUP>-/-</SUP>, MyD88<SUP>-/-</SUP>; BALB/c, Gpr132<SUP>-/-</SUP>, Ripk3<SUP>-/-</SUP> mice, respectively. This study was supported by grants from the National Institutes of Health (RO1 AI08977, 5RO1 AI055502, and R37 AI046688) and the Howard Hughes Medical Institute.	Akahoshi M, 2011, J CLIN INVEST, V121, P4180, DOI 10.1172/JCI46139; Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bircher AJ, 2005, DERMATOLOGY, V210, P119, DOI 10.1159/000082567; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Chippaux JP, 1998, TOXICON, V36, P823, DOI 10.1016/S0041-0101(97)00160-8; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Donnelly S, 2006, CHEM IMMUNOL ALLERGY, V90, P45, DOI 10.1159/000088880; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HIGGINBOTHAM RD, 1971, J IMMUNOL, V106, P233; HIGGINBOTHAM RD, 1965, J IMMUNOL, V95, P867; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Liew FY, 2012, ANN RHEUM DIS, V71, P101, DOI 10.1136/annrheumdis-2011-200589; Madero MF, 2009, INT ARCH ALLERGY IMM, V150, P307, DOI 10.1159/000222684; Mesquita RD, 2008, INFECT IMMUN, V76, P5543, DOI 10.1128/IAI.00683-08; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; MOHAMMED AH, 1961, NATURE, V189, P837, DOI 10.1038/189837b0; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Muller UR, 2010, CHEM IMMUNOL ALLERGY, V95, P141, DOI 10.1159/000315948; Oliphant CJ, 2011, IMMUNOLOGY, V134, P378, DOI 10.1111/j.1365-2567.2011.03499.x; Ownby CL, 1997, TOXICON, V35, P67, DOI 10.1016/S0041-0101(96)00078-5; Ozdemir C, 2011, CLIN EXP ALLERGY, V41, P1226, DOI 10.1111/j.1365-2222.2011.03812.x; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Scalfone LK, 2013, INFECT IMMUN, V81, P1354, DOI 10.1128/IAI.01307-12; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; SOBOTKA AK, 1976, J ALLERGY CLIN IMMUN, V57, P29, DOI 10.1016/0091-6749(76)90076-2; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Walker JA, 2013, CURR OPIN IMMUNOL, V25, P148, DOI 10.1016/j.coi.2013.02.010; Wills-Karp M, 2010, MUCOSAL IMMUNOL, V3, P104, DOI 10.1038/mi.2009.138; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	42	137	139	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					976	985		10.1016/j.immuni.2013.10.006	http://dx.doi.org/10.1016/j.immuni.2013.10.006			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24210353	Green Accepted, Bronze			2022-12-18	WOS:000330950600018
J	Wang, YY; Shaked, I; Stanford, SM; Zhou, WB; Curtsinger, JM; Mikulski, Z; Shaheen, ZR; Cheng, GH; Sawatzke, K; Campbell, AM; Auger, JL; Bilgic, H; Shoyama, FM; Schmeling, DO; Balfour, HH; Hasegawa, K; Chan, AC; Corbett, JA; Binstadt, BA; Mescher, MF; Ley, K; Bottini, N; Peterson, EJ				Wang, Yaya; Shaked, Iftach; Stanford, Stephanie M.; Zhou, Wenbo; Curtsinger, Julie M.; Mikulski, Zbigniew; Shaheen, Zachary R.; Cheng, Genhong; Sawatzke, Kristy; Campbell, Amanda M.; Auger, Jennifer L.; Bilgic, Hatice; Shoyama, Fernanda M.; Schmeling, David O.; Balfour, Henry H., Jr.; Hasegawa, Kiminori; Chan, Andrew C.; Corbett, John A.; Binstadt, Bryce A.; Mescher, Matthew F.; Ley, Klaus; Bottini, Nunzio; Peterson, Erik J.			The Autoimmunity-Associated Gene PTPN22 Potentiates Toll-like Receptor-Driven, Type 1 Interferon-Dependent Immunity	IMMUNITY			English	Article							NF-KAPPA-B; PROTEIN-TYROSINE PHOSPHATASES; TUMOR-NECROSIS-FACTOR; T-CELLS; I INTERFERONS; CHORIOMENINGITIS VIRUS; INFLAMMATORY ARTHRITIS; HOST-DEFENSE; MURINE LUPUS; ACTIVATION	Immune cells sense microbial products through Toll-like receptors (TLR), which trigger host defense responses including type 1 interferons (IFNs) secretion. A coding polymorphism in the protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene is a susceptibility allele for human autoimmune and infectious disease. We report that Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells. Ptpn22 promoted host antiviral responses and was critical for TLR agonist-induced, type 1 IFN-dependent suppression of inflammation in colitis and arthritis. PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination. The disease-associated PTPN22W variant failed to promote TRAF3 ubiquitination, type 1 IFN upregulation, and type 1 IFN-dependent suppression of arthritis. The findings establish a candidate innate immune mechanism of action for a human autoimmunity "risk" gene in the regulation of host defense and inflammation.	[Wang, Yaya; Zhou, Wenbo; Sawatzke, Kristy; Bilgic, Hatice; Shoyama, Fernanda M.; Peterson, Erik J.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Wang, Yaya; Zhou, Wenbo; Curtsinger, Julie M.; Sawatzke, Kristy; Auger, Jennifer L.; Bilgic, Hatice; Shoyama, Fernanda M.; Binstadt, Bryce A.; Mescher, Matthew F.; Peterson, Erik J.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Schmeling, David O.; Balfour, Henry H., Jr.] Univ Minnesota, Minneapolis, MN 55455 USA; [Auger, Jennifer L.; Binstadt, Bryce A.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Shaked, Iftach; Mikulski, Zbigniew; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Stanford, Stephanie M.; Campbell, Amanda M.; Bottini, Nunzio] La Jolla Inst Allergy & Immunol, Div Cellular Biol, La Jolla, CA 92037 USA; [Shaheen, Zachary R.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Hasegawa, Kiminori] Kin Ikyo Chuo Hosp, Div Rheumatol, Higashi Ku, Sapporo, Hokkaido 0070870, Japan; [Chan, Andrew C.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; La Jolla Institute for Immunology; La Jolla Institute for Immunology; Medical College of Wisconsin; University of California System; University of California Los Angeles; Roche Holding; Genentech	Bottini, N (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	nunzio@liai.org; peter899@umn.edu	Shaked, Iftach/AAS-9961-2020; Binstadt, Bryce/N-1305-2013; Wang, Yaya/G-7587-2012; Shaked, Iftach/GNM-9959-2022; Peterson, Erik/M-9365-2013; Mikulski, Zbigniew/AAB-4447-2020; Ingegnoli, Francesca/B-6226-2017	Binstadt, Bryce/0000-0003-3127-3856; Mikulski, Zbigniew/0000-0002-1918-9216; Ingegnoli, Francesca/0000-0002-6727-1273	National Institutes of Health (NIH) [R01AR057781, R01AI070544]; American College of Rheumatology Within Our Reach Campaign; American Diabetes Association; Alliance for Lupus Research; Lupus Foundation of Minnesota; International Center for Antiviral Research and Epidemiology, UMN; Juvenile Diabetes Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069120, R01AI056154, R01AI047868, R01AI070544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020, R01AR057781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222, F30DK102363] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology Within Our Reach Campaign; American Diabetes Association(American Diabetes Association); Alliance for Lupus Research; Lupus Foundation of Minnesota; International Center for Antiviral Research and Epidemiology, UMN; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Koretzky (University of Pennsylvania) for critical reading of the manuscript, the S. Fahrenkrug laboratory and Mouse Genetics Laboratory (University of Minnesota, UMN) for assistance with generation of transgenic mice, and Z. Zhang (Indiana University) for providing PTPN22 inhibitors. The D. Masopust (UMN) and M. von Herrath (LIAI) laboratories assisted with viral infection protocols. M. Jenkins (UMN) provided reagents. J. Gonzalez-Navajas (LIAI) provided technical assistance with ubiquitination assays. S. DuCloux-Potter provided secretarial assistance. This work was supported by grants from the National Institutes of Health (NIH) R01AR057781, the American College of Rheumatology Within Our Reach Campaign, the American Diabetes Association, the Alliance for Lupus Research, and Lupus Foundation of Minnesota (to E. J. P.), the International Center for Antiviral Research and Epidemiology, UMN (to H. H. B.), and NIH R01AI070544 (to N.B.). S. M. S was supported by a postdoctoral fellowship from the Juvenile Diabetes Research Foundation. A. C. C. is an employee of Genentech. This is the publication # 1622 from the La Jolla Institute for Allergy and Immunology.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arimura Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000966; Boettler T, 2011, EXPERT REV CLIN IMMU, V7, P45, DOI 10.1586/ECI.10.91; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Chapman SJ, 2006, NAT GENET, V38, P499, DOI 10.1038/ng0506-499; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Corr M, 2009, ANN RHEUM DIS, V68, P257, DOI 10.1136/ard.2008.095356; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Flodstrom M, 2002, NAT IMMUNOL, V3, P373, DOI 10.1038/ni771; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hron JD, 2004, J IMMUNOL, V173, P2134, DOI 10.4049/jimmunol.173.3.2134; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Jung A, 2008, J VIROL, V82, P196, DOI 10.1128/JVI.01640-07; Kalliolias GD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2881; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; Niewold TB, 2011, J INTERF CYTOK RES, V31, P887, DOI 10.1089/jir.2011.0071; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rother KI, 2009, DIABETES CARE, V32, P1250, DOI 10.2337/dc08-2029; Sanford M, 2011, DRUGS, V71, P1865, DOI 10.2165/11207540-000000000-00000; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Sobel DO, 1998, DIABETES, V47, P1867, DOI 10.2337/diabetes.47.12.1867; Stanford SM, 2011, J MED CHEM, V54, P1640, DOI 10.1021/jm101202j; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553; Yarilina A, 2007, J IMMUNOL, V178, P2204, DOI 10.4049/jimmunol.178.4.2204; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	48	137	141	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					111	122		10.1016/j.immuni.2013.06.013	http://dx.doi.org/10.1016/j.immuni.2013.06.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23871208	Bronze, Green Accepted			2022-12-18	WOS:000330948300012
J	Kawashima, T; Kosaka, A; Yan, HM; Guo, ZJ; Uchiyama, R; Fukui, R; Kaneko, D; Kumagai, Y; You, DJ; Carreras, J; Uematsu, S; Jang, MH; Takeuchi, O; Kaisho, T; Akira, S; Miyake, K; Tsutsui, H; Saito, T; Nishimura, I; Tsuji, NM				Kawashima, Tadaomi; Kosaka, Akemi; Yan, Huimin; Guo, Zijin; Uchiyama, Ryosuke; Fukui, Ryutaro; Kaneko, Daisuke; Kumagai, Yutaro; You, Dong-Ju; Carreras, Joaquim; Uematsu, Satoshi; Jang, Myoung Ho; Takeuchi, Osamu; Kaisho, Tsuneyasu; Akira, Shizuo; Miyake, Kensuke; Tsutsui, Hiroko; Saito, Takashi; Nishimura, Ikuko; Tsuji, Noriko M.			Double-Stranded RNA of Intestinal Commensal but Not Pathogenic Bacteria Triggers Production of Protective Interferon-beta	IMMUNITY			English	Article							TOLL-LIKE RECEPTOR-3; INNATE IMMUNE RECOGNITION; I INTERFERON; DENDRITIC CELLS; MESSENGER-RNA; T-CELLS; LACTOBACILLUS; ANTIGEN; COLONIZATION; INDUCTION	The small intestine harbors a substantial number of commensal bacteria and is sporadically invaded by pathogens, but the response to these microorganisms is fundamentally different. We identified a discriminatory sensor by using Toll-like receptor 3 (TLR3). Double-stranded RNA (dsRNA) of one major commensal species, lactic acid bacteria (LAB), triggered interferon-beta (IFN-beta) production, which protected mice from experimental colitis. The LABinduced IFN-beta response was diminished by dsRNA digestion and treatment with endosomal inhibitors. Pathogenic bacteria contained less dsRNA and induced much less IFN-beta than LAB, and dsRNA was not involved in pathogen-induced IFN-beta induction. These results identify TLR3 as a sensor to small intestinal commensal bacteria and suggest that dsRNA in commensal bacteria contributes to anti-inflammatory and protective immune responses.	[Kawashima, Tadaomi; Kosaka, Akemi; Yan, Huimin; Carreras, Joaquim; Tsuji, Noriko M.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Kawashima, Tadaomi; Kaneko, Daisuke; Nishimura, Ikuko] Kikkoman Foods Inc, Div Res & Dev, Noda, Chiba 2780037, Japan; [Yan, Huimin] Fifth Hosp Shijiazhuang, Shijiazhuang 050021, Hebei, Peoples R China; [Guo, Zijin; Tsuji, Noriko M.] RIKEN, Res Ctr Allergy & Immunol, Lab Mucosal Immune Tolerance, Yokohama, Kanagawa 2300045, Japan; [Kaisho, Tsuneyasu] RIKEN, Res Ctr Allergy & Immunol, Lab Host Def, Yokohama, Kanagawa 2300045, Japan; [Saito, Takashi] RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Yokohama, Kanagawa 2300045, Japan; [Uchiyama, Ryosuke; Tsutsui, Hiroko] Hyogo Coll Med, Dept Microbiol, Nishinomiya, Hyogo 6638501, Japan; [Fukui, Ryutaro; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccine, Div Infect Genet, Shiroganedai, Tokyo 1088639, Japan; [Uematsu, Satoshi] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccine, Div Innate Immune Regulat, Shiroganedai, Tokyo 1088639, Japan; [Kumagai, Yutaro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan; [You, Dong-Ju; Jang, Myoung Ho] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Gastrointestinal Immunol, Suita, Osaka 5650871, Japan; [Kaisho, Tsuneyasu] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Saito, Takashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Cell Signaling, Suita, Osaka 5650871, Japan; [Jang, Myoung Ho] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Sakyo Ku, Kyoto 6068507, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Kikkoman Corporation; RIKEN; RIKEN; RIKEN; Hyogo College of Medicine; University of Tokyo; University of Tokyo; Osaka University; Osaka University; Osaka University; Osaka University; Pohang University of Science & Technology (POSTECH); Kyoto University	Tsuji, NM (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan.	nm-tsuji@aist.go.jp	Tsuji, Noriko M/M-2591-2018; Saito, Takashi/C-9684-2009; Jang, Myoung Ho/D-1714-2009; Kumagai, Yutaro/L-7732-2018; Takeuchi, Osamu/AAG-9359-2019	Saito, Takashi/0000-0001-9495-3547; Jang, Myoung Ho/0000-0001-8909-4725; Kumagai, Yutaro/0000-0002-5039-3979; Takeuchi, Osamu/0000-0002-1260-6232; Tsutsui, Hiroko/0000-0001-7928-4875; Kaneko, Daisuke/0000-0001-7730-0595; Carreras, Joaquim/0000-0002-6129-8299	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Kikkoman Co.; Ministry of Education, Culture, Sports, Science and Technology of Japan	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Kikkoman Co.; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank B. Beutler for providing Unc93b1<SUP>3d</SUP> mutant mice. We thank N. Yamaguchi, T. Kawai, and R. Medzhitov for scientific discussion. We also thank A. Matsuyama, A. Obata, K. Matsushima, and Y. Fujita for their helpful advice and M. Adachi, Y. Sawasaki, K. Nagamura, and N. Takano for their technical assistance. J.C. is a fellow from the Japanese Society for the Promotion of Science. This work was partially supported by a grant from the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Kikkoman Co., and a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Asong J, 2009, J BIOL CHEM, V284, P8634, DOI 10.1074/jbc.M806633200; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Corr SC, 2007, FEMS IMMUNOL MED MIC, V50, P380, DOI 10.1111/j.1574-695X.2007.00264.x; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Hao WL, 2004, METH MOL B, V268, P491; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Hotta C, 2006, IMMUNOLOGY, V117, P97, DOI 10.1111/j.1365-2567.2005.02270.x; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kawashima T, 2011, INT IMMUNOPHARMACOL, V11, P2017, DOI 10.1016/j.intimp.2011.08.013; Kosaka A, 2012, INT IMMUNOPHARMACOL, V14, P729, DOI 10.1016/j.intimp.2012.10.007; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lande R, 2008, J NEUROPATH EXP NEUR, V67, P388, DOI 10.1097/NEN.0b013e31816fc975; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Obermeier F, 2005, GASTROENTEROLOGY, V129, P913, DOI 10.1053/j.gastro.2005.06.061; Obuchi M, 2003, J VIROL, V77, P8843, DOI 10.1128/JVI.77.16.8843-8856.2003; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Schwarzer M, 2011, ALLERGY, V66, P368, DOI 10.1111/j.1398-9995.2010.02488.x; Shida K, 2006, J DAIRY SCI, V89, P3306, DOI 10.3168/jds.S0022-0302(06)72367-0; Shida K, 2008, TRENDS IMMUNOL, V29, P565, DOI 10.1016/j.it.2008.07.011; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Vijay-Kumar M, 2007, INFLAMM BOWEL DIS, V13, P856, DOI 10.1002/ibd.20142; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; Williams NT, 2010, AM J HEALTH-SYST PH, V67, P449, DOI 10.2146/ajhp090168; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	47	137	142	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1187	1197		10.1016/j.immuni.2013.02.024	http://dx.doi.org/10.1016/j.immuni.2013.02.024			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23791646	Bronze			2022-12-18	WOS:000330947500014
J	Yao, WG; Zhang, YL; Jabeen, R; Nguyen, ET; Wilkes, DS; Tepper, RS; Kaplan, MH; Zhou, BH				Yao, Weiguo; Zhang, Yanlu; Jabeen, Rukhsana; Nguyen, Evelyn T.; Wilkes, David S.; Tepper, Robert S.; Kaplan, Mark H.; Zhou, Baohua			Interleukin-9 Is Required for Allergic Airway Inflammation Mediated by the Cytokine TSLP	IMMUNITY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CD4(+) T-CELLS; HUMAN EPITHELIAL-CELLS; TGF-BETA; TH2 DIFFERENTIATION; ATOPIC-DERMATITIS; IL-9 EXPRESSION; DENDRITIC CELLS; ASTHMA MODEL; MAST-CELLS	Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine important for the initiation and development of T helper (Th2) cell-mediated allergic inflammation. In this study, we identified a positive association between interleukin-9 (IL-9) and TSLP concentration in the serum of infants with atopic dermatitis. In primary cell cultures, the addition of TSLP led to an increase in IL-9 production from human and mouse Th9 cells, and induced an increase in signal transducer and activator of transcription 5 (STAT5) activation and binding to the Il9 promoter. In vivo, use of an adoptive transfer model demonstrated that TSLP promoted IL-9-dependent, Th9 cell-induced allergic inflammation by acting directly on T cells. Moreover, transgenic expression of TSLP in the lung stimulated IL-9 production in vivo, and anti-IL-9 treatment attenuated TSLP-induced airway inflammation. Together, our results demonstrate that TSLP promotes Th9 cell differentiation and function and define a requirement for IL-9 in TSLP-induced allergic inflammation.	[Yao, Weiguo; Zhang, Yanlu; Jabeen, Rukhsana; Nguyen, Evelyn T.; Tepper, Robert S.; Kaplan, Mark H.; Zhou, Baohua] Indiana Univ, Sch Med, Dept Pediat, HB Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Wilkes, David S.; Kaplan, Mark H.; Zhou, Baohua] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Wilkes, David S.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Zhang, Yanlu] Zhejiang Univ, Inst Biotechnol, Hangzhou 310029, Zhejiang, Peoples R China	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Zhejiang University	Kaplan, MH (corresponding author), Indiana Univ, Sch Med, Dept Pediat, HB Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	mkaplan2@iupui.edu; zhoub@iupui.edu		, Yanlu/0000-0001-7622-3495	National Institutes of Health [R01 AI057459, R01 AI085046]; HB Wells Center from the Riley Children's Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085046, R01AI057459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HB Wells Center from the Riley Children's Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01 AI057459 to M. H. K. and R01 AI085046 to B.Z. Support provided by the HB Wells Center was in part from the Riley Children's Foundation.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Erpenbeck VJ, 2003, J ALLERGY CLIN IMMUN, V111, P1319, DOI 10.1067/mai.2003.1485; Fontenot D, 2009, P NATL ACAD SCI USA, V106, P16776, DOI 10.1073/pnas.0907347106; Fung MM, 2005, ONCOGENE, V24, P4624, DOI 10.1038/sj.onc.1208507; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Headley MB, 2009, J IMMUNOL, V182, P1641, DOI 10.4049/jimmunol.182.3.1641; HOUSSIAU FA, 1995, J IMMUNOL, V154, P2624; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jabeen R, 2012, CURR OPIN IMMUNOL, V24, P303, DOI 10.1016/j.coi.2012.02.001; Jones CP, 2012, J ALLERGY CLIN IMMUN, V129, P1000, DOI 10.1016/j.jaci.2011.12.965; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Kung TT, 2001, AM J RESP CELL MOL, V25, P600, DOI 10.1165/ajrcmb.25.5.4533; Lei LY, 2011, J IMMUNOL, V186, P2254, DOI 10.4049/jimmunol.1002503; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Rochman Y, 2010, P NATL ACAD SCI USA, V107, P19455, DOI 10.1073/pnas.1008271107; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Semlali A, 2010, J ALLERGY CLIN IMMUN, V125, P844, DOI 10.1016/j.jaci.2010.01.044; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Stritesky GL, 2011, TRANSCR-AUSTIN, V2, P179, DOI 10.4161/trns.2.4.16614; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Temann UA, 2007, INT IMMUNOL, V19, P1, DOI 10.1093/intimm/dxl117; Tepper RS, 2008, J ALLERGY CLIN IMMUN, V122, P760, DOI 10.1016/j.jaci.2008.07.022; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Yao WG, 2011, J ALLERGY CLIN IMMUN, V128, P1357, DOI 10.1016/j.jaci.2011.06.019; Yao WG, 2010, J ALLERGY CLIN IMMUN, V126, P483, DOI 10.1016/j.jaci.2010.06.028; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ying S, 2002, CLIN EXP ALLERGY, V32, P866, DOI 10.1046/j.1365-2222.2002.01376.x; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Yu Q, 2007, EMBO J, V26, P2052, DOI 10.1038/sj.emboj.7601653; Zhang YL, 2012, IMMUNOL RES, V52, P211, DOI 10.1007/s12026-012-8264-z; Zhou BH, 2008, J IMMUNOL, V181, P6557, DOI 10.4049/jimmunol.181.9.6557; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	53	137	142	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					360	372		10.1016/j.immuni.2013.01.007	http://dx.doi.org/10.1016/j.immuni.2013.01.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23376058	Bronze, Green Accepted			2022-12-18	WOS:000330940800017
J	Zheng, Y; Humphry, M; Maguire, JJ; Bennett, MR; Clarke, MCH				Zheng, Yue; Humphry, Melanie; Maguire, Janet J.; Bennett, Martin R.; Clarke, Murray C. H.			Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1 alpha, Controlling Necrosis-Induced Sterile Inflammation	IMMUNITY			English	Article							CELL-DEATH; DYING CELLS; DENDRITIC CELLS; MICE DEFICIENT; IL-1-ALPHA; PROTEIN; EXPRESSION; IL-1-BETA; RELEASE; IDENTIFICATION	Necrosis can induce profound inflammation or be clinically silent. However, the mechanisms underlying such tissue specificity are unknown. Interleukin-1 alpha (IL-1 alpha) is a key danger signal released upon necrosis that exerts effects on both innate and adaptive immunity and is considered to be constitutively active. In contrast, we have shown that necrosis-induced IL-1 alpha activity is tightly controlled in a cell type-specific manner. Most cell types examined expressed a cytosolic IL-1 receptor 2 (IL-1R2) whose binding to pro-IL-1 alpha inhibited its cytokine activity. In cell types exhibiting a silent necrotic phenotype, IL-1R2 remained associated with pro-IL-1 alpha. Cell types possessing inflammatory necrotic phenotypes either lacked IL-1R2 or had activated caspase-1 before necrosis, which degraded and dissociated IL-1R2 from pro-IL-1 alpha. Full IL-1 alpha activity required cleavage by calpain after necrosis, which increased its affinity for IL-1 receptor 1. Thus, we report a cell type-dependent process that fundamentally governs IL-1 alpha activity postnecrosis and the mechanism allowing conditional release of this blockade.	[Zheng, Yue; Humphry, Melanie; Bennett, Martin R.; Clarke, Murray C. H.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Cardiovasc Med, Cambridge CB2 0QQ, England; [Maguire, Janet J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Clin Pharmacol Unit, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Clarke, MCH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Cardiovasc Med, Cambridge CB2 0QQ, England.	mchc2@cam.ac.uk	Maguire, Janet J/Z-2180-2019	Maguire, Janet J/0000-0002-9254-7040; Clarke, Murray/0000-0002-8215-8885; Bennett, Martin/0000-0002-2565-1825	British Heart Foundation [FS/09/005/26845, PG/06/024/20354, RG 04/001]; NIHR Cambridge BRC; British Heart Foundation [FS/13/3/30038, RG/08/009/25841] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); NIHR Cambridge BRC; British Heart Foundation(British Heart Foundation)	We gratefully acknowledge monocyte donations from E. Chilvers' laboratory and J. Skepper for help with confocal. This study was supported by British Heart Foundation Grants FS/09/005/26845 (M. C. H. C.), PG/06/024/20354, and RG 04/001 (M. R. B.), and NIHR Cambridge BRC.	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; BECK G, 1986, P NATL ACAD SCI USA, V83, P7429, DOI 10.1073/pnas.83.19.7429; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chi HH, 2004, CIRCULATION, V110, P1678, DOI 10.1161/01.CIR.0000142085.39015.31; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Davis MJ, 2006, PLOS GENET, V2, P554, DOI 10.1371/journal.pgen.0020046; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Kamari Y, 2007, ATHEROSCLEROSIS, V195, P31, DOI 10.1016/j.atherosclerosis.2006.11.026; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-8; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liu CL, 1996, J BIOL CHEM, V271, P20965, DOI 10.1074/jbc.271.34.20965; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Orlando S, 1997, J BIOL CHEM, V272, P31764, DOI 10.1074/jbc.272.50.31764; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Rao DA, 2008, J EXP MED, V205, P3145, DOI 10.1084/jem.20081661; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Ruckert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012243; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tokunaga H, 2010, APPL MICROBIOL BIOT, V86, P649, DOI 10.1007/s00253-009-2325-9; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4	52	137	159	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					285	295		10.1016/j.immuni.2013.01.008	http://dx.doi.org/10.1016/j.immuni.2013.01.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23395675	Green Published, hybrid			2022-12-18	WOS:000330940800011
J	Laurence, A; Amarnath, S; Mariotti, J; Kim, YC; Foley, J; Eckhaus, M; O'Shea, JJ; Fowler, DH				Laurence, Arian; Amarnath, Shoba; Mariotti, Jacopo; Kim, Yong Chan; Foley, Jason; Eckhaus, Michael; O'Shea, John J.; Fowler, Daniel H.			STAT3 Transcription Factor Promotes Instability of nTreg Cells and Limits Generation of iTreg Cells during Acute Murine Graft-versus-Host Disease	IMMUNITY			English	Article							REGULATORY T-CELLS; BONE-MARROW-TRANSPLANTATION; TGF-BETA; IN-VIVO; FOXP3 EXPRESSION; TH17 CELLS; HELPER-CELLS; DIFFERENTIATION; PROGRAM; T(H)17	Acute graft-versus-host disease (GvHD) is a major cause of mortality in allogeneic bone marrow transplantation (BMT), for which administration of FoxP3(+) regulatory T (Treg) cells has been proposed as a therapy. However, the phenotypic stability of Treg cells is controversial, and STAT3-dependent cytokines can inhibit FoxP3 expression. We assessed whether the elimination of STAT3 in T cells could limit the severity of GvHD. We found STAT3 limited FoxP3(+) Treg cell numbers following allogeneic BMT by two pathways: instability of natural Treg (nTreg) cells and inhibition of induced Treg (iTreg) cell polarization from naive CD4(+) T cells. Deletion of STAT3 within only the nTreg cell population was not sufficient to protect against lethal GvHD. In contrast, transfer of STAT3-deficient naive CD4(+) T cells increased FoxP3(+) Treg cells post-BMT and prevented lethality, suggesting that the consequence of STAT3 signaling may be greater for iTreg rather than nTreg cells during GvHD.	[Laurence, Arian; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Amarnath, Shoba; Mariotti, Jacopo; Foley, Jason; Fowler, Daniel H.] NCI, Expt Transplantat & Immunol Branch, Bethesda, MD 20892 USA; [Kim, Yong Chan] NIAID, Immunol Lab, Bethesda, MD 20892 USA; [Eckhaus, Michael] NIH, Natl Ctr Res Resources, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA	Laurence, A (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA.	laurencea@mail.nih.gov	amarnath, shoba/AAP-4391-2020; Laurence, Arian/A-8770-2009; mariotti, jacopo/AAQ-8057-2021	Laurence, Arian/0000-0003-0942-8292; mariotti, jacopo/0000-0001-6528-9296	National Institute of Arthritis and Musculoskeletal and Skin Diseases; Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE [ZIASC010288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIAAR041167] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center for Cancer Research, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Simone, J. Lay, and W.G. Telford for flow cytometry support; P. Muranski and N.P. Restifo for providing mice. This work was supported by the Intramural Research programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Center for Cancer Research, NCI.	Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; ATKINSON K, 1992, MED J AUSTRALIA, V157, P408, DOI 10.5694/j.1326-5377.1992.tb137254.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bucher C, 2009, BLOOD, V114, P5375, DOI 10.1182/blood-2009-05-221135; Carlson MJ, 2009, BLOOD, V113, P1365, DOI 10.1182/blood-2008-06-162420; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Das R, 2009, BLOOD, V113, P2352, DOI 10.1182/blood-2008-08-175448; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; June CH, 2006, SEMIN IMMUNOL, V18, P78, DOI 10.1016/j.smim.2006.01.006; Kappel LW, 2009, BLOOD, V113, P945, DOI 10.1182/blood-2008-08-172155; KERNAN NA, 1993, NEW ENGL J MED, V328, P593, DOI 10.1056/NEJM199303043280901; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Lu SX, 2008, BLOOD, V112, P5254, DOI 10.1182/blood-2008-03-147322; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; Nikolic B, 2000, J CLIN INVEST, V105, P1289, DOI 10.1172/JCI7894; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; VALLERA DA, 1994, TRANSPLANTATION, V57, P249, DOI 10.1097/00007890-199401001-00017; Vogtenhuber C, 2010, BLOOD, V116, P466, DOI 10.1182/blood-2009-11-252825; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Yi TS, 2009, BLOOD, V114, P3101, DOI 10.1182/blood-2009-05-219402; You S, 2007, P NATL ACAD SCI USA, V104, P6335, DOI 10.1073/pnas.0701171104; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	48	137	145	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 24	2012	37	2					209	222		10.1016/j.immuni.2012.05.027	http://dx.doi.org/10.1016/j.immuni.2012.05.027			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22921119	Green Accepted, Bronze			2022-12-18	WOS:000308261800007
J	Sharma, MD; Hou, DY; Baban, B; Koni, PA; He, YK; Chandler, PR; Blazar, BR; Mellor, AL; Munn, DH				Sharma, Madhav D.; Hou, De-Yan; Baban, Babak; Koni, Pandelakis A.; He, Yukai; Chandler, Phillip R.; Blazar, Bruce R.; Mellor, Andrew L.; Munn, David H.			Reprogrammed Foxp3(+) Regulatory T Cells Provide Essential Help to Support Cross-presentation and CD8(+) T Cell Priming in Naive Mice	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; INDUCTION; SUPPRESSION; IMMUNITY; ANTIGEN; TREGS	Foxp3(+) regulatory T (Treg) cells can undergo reprogramming into a phenotype expressing proinflammatory cytokines. However, the biologic significance of this conversion remains unclear. We show that large numbers of Treg cells undergo rapid reprogramming into activated T helper cells after vaccination with antigen plus Toll-like receptor 9 (TLR-9) ligand. Helper activity from converted Treg cells proved essential during initial priming of CD8(+) T cells to a new cross-presented antigen. Help from Treg cells was dependent on CD40L, and (unlike help from conventional non-Treg CD4(+) cells) did not require preactivation or prior exposure to antigen. In hosts with established tumors, Treg cell reprogramming was suppressed by tumor-induced indoleamine 2,3-dioxygenase (IDO) and vaccination failed because of lack of help. Treg cell reprogramming, vaccine efficacy, and antitumor CD8(+) T cell responses were restored by pharmacologic inhibition of IDO. Reprogrammed Treg cells can thus participate as previously unrecognized drivers of certain early CD8(+) T cell responses.	[Sharma, Madhav D.; Hou, De-Yan; Munn, David H.] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Sharma, Madhav D.; Hou, De-Yan; Koni, Pandelakis A.; He, Yukai; Chandler, Phillip R.; Mellor, Andrew L.; Munn, David H.] Med Coll Georgia, Immunotherapy Ctr, Augusta, GA 30912 USA; [Baban, Babak] Med Coll Georgia, Sch Dent, Augusta, GA 30912 USA; [Koni, Pandelakis A.; He, Yukai; Chandler, Phillip R.; Mellor, Andrew L.] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Blazar, Bruce R.] Univ Minnesota, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Munn, DH (corresponding author), Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA.	dmunn@mail.mcg.edu		Koni, Pandelakis/0000-0002-0892-4764; Munn, David/0000-0002-7711-2858	NIH [CA103320, CA096651, CA112431, HD41187, AI063402]; NewLink Genetics, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041187] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA096651, R01CA103320, P01CA142106, R01CA112431] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063402, U01AI083005] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NewLink Genetics, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Sharma, J. Gregory, and J. Wilson for expert technical assistance; J. Pikhala for cell sorting; W. King for GFP-YFP analysis by FACS; A. Rudensky for providing Foxp3<SUP>GFP</SUP> mice; D. Ron for providing Eif2ak4<SUP>-/-</SUP> mice; and S. Akira for the use of Myd88<SUP>-/-</SUP> mice. Supported by NIH grants CA103320, CA096651, and CA112431 (to D.H.M.) and HD41187 and AI063402 (to A.L.M.). D.H.M., A.L.M., and M.D.S. have intellectual property interests in the therapeutic use of IDO and IDO inhibitors. D.H.M. and A.L.M. receive consulting income and research support from NewLink Genetics, Inc., which holds a license to develop the technology for clinical trials.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Cohn M, 2009, CELL IMMUNOL, V254, P91, DOI 10.1016/j.cellimm.2008.10.005; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Oizumi S, 2008, J IMMUNOTHER, V31, P394, DOI 10.1097/CJI.0b013e31816bc74d; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	29	137	140	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 22	2010	33	6					942	954		10.1016/j.immuni.2010.11.022	http://dx.doi.org/10.1016/j.immuni.2010.11.022			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21145762	Green Accepted, Bronze			2022-12-18	WOS:000286293900014
J	Xu, LL; Kitani, A; Stuelten, C; McGrady, G; Fuss, I; Strober, W				Xu, Lili; Kitani, Atsushi; Stuelten, Christina; McGrady, George; Fuss, Ivan; Strober, Warren			Positive and Negative Transcriptional Regulation of the Foxp3 Gene is Mediated by Access and Binding of the Smad3 Protein to Enhancer I	IMMUNITY			English	Article							T-CELLS; RETINOIC-ACID; TH17 CELLS; INDUCTION; EXPRESSION; DRIVEN	The molecular mechanisms underlying retinoic acid (RA) augmentation of T cell receptor (TCR) and transforming growth factor-beta (TGF-beta)-induced Foxp3 transcription and inhibition of the latter by cytokines such as IL-27 were here shown to be related processes involving modifications of baseline (TGF-beta-induced) phosphorylated Smad3 (pSmad3) binding to a conserved enhancer region (enhancer l). RA augmentation involved the binding of retinoic acid receptor (RAR) and retinoid X receptor (RXR) to a dominant site in enhancer I and a subordinate site in the promoter. This led to increased histone acetylation in the region of the Smad3 binding site and increased binding of pSmad3. Cytokine (IL-27) inhibition involved binding of pStat3 to a gene silencer in a second conserved enhancer region (enhancer II) downstream from enhancer I; this led to loss of pSmad3 binding to enhancer I. Thus, control of accessibility and binding of pSmad3 provides a common framework for positive and negative regulation of TGF-beta-induced Foxp3 transcription.	[Xu, Lili; Fuss, Ivan; Strober, Warren] NIAID, Mucosal Immun Sect, Lab Host Defenses, Natl Inst Hlth, Bethesda, MD 20892 USA; [Kitani, Atsushi] NCI, Cell & Canc Biol Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; [McGrady, George] Natl Inst Dent & Craniofacial Res, Oral Infect & Immun Branch, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Strober, W (corresponding author), NIAID, Mucosal Immun Sect, Lab Host Defenses, Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	wstrober@niaid.nih.gov		Stuelten, Christina/0000-0002-2850-5399	NIAID; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000354, ZIAAI000432, ZIAAI000872] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.J. O'Shea (Molecular Immunology and Inflammation Branch, NIAMS/NIH) for kindly providing us Stat3<SUP>fl/fl</SUP> and Stat3<SUP>fl/fl</SUP>;; MMTV-Cre mice and Socs3<SUP>fl/fl</SUP> and Socs3<SUP>fl/fl</SUP>; MMTV-Cre mice. We thank S. Wahl (Oral Infection and Immunity Branch, NIDCR/NIH) for Smad3-deficient mice. We thank M. Oukka (Harvard Medical School) for kindly providing us Foxp3-IRES-GFP gene-targeted mice. We thank M. Tone (University of Pennsylvania) for EL4 clone LAF cells. This research was supported by the Intramural Research Program of NIAID and NIH.	Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Kretschmer Karsten, 2008, V94, P8, DOI 10.1159/000154846; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Schneiders D, 2005, CARDIOVASC RES, V67, P87, DOI 10.1016/j.cardiores.2005.02.021; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	24	137	147	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					313	325		10.1016/j.immuni.2010.09.001	http://dx.doi.org/10.1016/j.immuni.2010.09.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20870174	Green Accepted, Bronze			2022-12-18	WOS:000282798500007
J	Maynard, CL; Weaver, CT				Maynard, Craig L.; Weaver, Casey T.			Intestinal Effector T Cells in Health and Disease	IMMUNITY			English	Review							INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL COLITIS; IFN-GAMMA; TGF-BETA; INTERLEUKIN-10-DEFICIENT MICE; DENDRITIC CELLS; CROHNS-DISEASE; CUTTING EDGE; HELPER-CELLS; MURINE MODEL	Crohn's disease and ulcerative colitis are the two major forms of chronic relapsing inflammatory disorders of the human intestines collectively referred to as inflammatory bowel disease (IBD). Though a complex set of autoinflammatory disorders that can be precipitated by diverse genetic and environmental factors, a feature that appears common to IBD pathogenesis is a dysregulated effector T cell response to the commensal microbiota. Due to the heightened effector T cell activity in IBD, developmental and functional pathways that give rise to these cells are potential targets for therapeutic intervention. In this review, we highlight recent advances in our understanding of effector T cell biology in the context of intestinal immune regulation and speculate on their potential clinical significance.	[Maynard, Craig L.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Maynard, CL (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	clmaynard@uab.edu; cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793	LAB Mucosal HIV and Immunobiology Center; NIH [AI35783, AI57956, DK071176]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057956, R21AI035783, R01AI035783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176, R24DK064400] Funding Source: NIH RePORTER	LAB Mucosal HIV and Immunobiology Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank members of the Weaver laboratory for helpful comments and discussions and Gloria Gaskins for administrative assistance. We offer our apologies to colleagues whose work could not be adequately discussed or cited due to space limitations. This work was supported by the LAB Mucosal HIV and Immunobiology Center and grants from the NIH (AI35783, AI57956 and DK071176, to C.T.W.) and the Crohn's and Colitis Foundation of America (to C.L.M. and C.T.W.).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Artis D, 2005, J IMMUNOL, V174, P7154, DOI 10.4049/jimmunol.174.11.7154; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Beltran CJ, 2009, EUR CYTOKINE NETW, V20, P94, DOI [10.1684/ecn.2009.0142, 10.1684/ecn.2009.0151]; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ito H, 1997, J AUTOIMMUN, V10, P455, DOI 10.1016/S0896-8411(97)90152-9; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 2001, INFECT IMMUN, V69, P4232, DOI 10.1128/IAI.69.7.4232-4241.2001; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Matsumoto S, 1998, GUT, V43, P71, DOI 10.1136/gut.43.1.71; Matsuoka K, 2004, GUT, V53, P1303, DOI 10.1136/gut.2003.024190; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mizoguchi A, 1996, J EXP MED, V183, P847, DOI 10.1084/jem.183.3.847; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mudter J, 2008, J CLIN INVEST, V118, P2415, DOI 10.1172/JCI33227; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; NIESSNER M, 1995, CLIN EXP IMMUNOL, V101, P428; Nishiyori A, 2009, EUR J PHARMACOL, V615, P241, DOI 10.1016/j.ejphar.2009.05.002; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; O'Garra A, 1998, CURR BIOL, V8, pR646, DOI 10.1016/S0960-9822(07)00413-7; Okazawa A, 2002, AM J GASTROENTEROL, V97, P3108, DOI 10.1111/j.1572-0241.2002.07107.x; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ramalingam TR, 2009, J IMMUNOL, V182, P6452, DOI 10.4049/jimmunol.0900181; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Shih David Q, 2008, Curr Gastroenterol Rep, V10, P568, DOI 10.1007/s11894-008-0104-x; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; SUNDBERG JP, 1994, GASTROENTEROLOGY, V107, P1726, DOI 10.1016/0016-5085(94)90813-3; TAGUCHI T, 1990, J IMMUNOL, V145, P68; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Troy AE, 2009, J IMMUNOL, V183, P2037, DOI 10.4049/jimmunol.0802918; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Weigmann B, 2008, J EXP MED, V205, P2099, DOI 10.1084/jem.20072484; Wirtz S, 1999, J IMMUNOL, V162, P1884; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	117	137	141	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					389	400		10.1016/j.immuni.2009.08.012	http://dx.doi.org/10.1016/j.immuni.2009.08.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766082	Bronze, Green Accepted			2022-12-18	WOS:000270525900005
J	Liu, DF; Bryceson, YT; Meckel, T; Vasiliver-Shamis, G; Dustin, ML; Long, EO				Liu, Dongfang; Bryceson, Yenan T.; Meckel, Tobias; Vasiliver-Shamis, Gaia; Dustin, Michael L.; Long, Eric O.			Integrin-Dependent Organization and Bidirectional Vesicular Traffic at Cytotoxic Immune Synapses	IMMUNITY			English	Article							CELL IMMUNOLOGICAL SYNAPSE; T-CELLS; RING JUNCTION; NK CELLS; ACTIVATION; RECEPTORS; COSTIMULATION; POLARIZATION; RECOGNITION; CONTRIBUTES	Cytotoxic lymphocytes kill target cells by releasing the content of secretory lysosomes at the immune synapse. To understand the dynamics and control of cytotoxic immune synapses, we imaged human primary, live natural killer cells on lipid bilayers carrying ligands of activation receptors. Formation of an organized synapse was dependent on the presence of the beta 2 integrin ligand ICAM-1. Ligands of coactivation receptors 2B4 and NKG2D segregated into central and peripheral regions, respectively. Lysosomal protein LAMP-1 that was exocytosed during degranulation accumulated in a large and spatially stable cluster, which overlapped with a site of membrane internalization. Lysosomal compartments reached the plasma membrane at focal points adjacent to centrally accumulated LAMP-1. Imaging of fixed cells revealed that perforin-containing granules were juxtaposed to an intracellular compartment where exocytosed LAMP-1 was retrieved. Thus, cytotoxic immune synapses include a central region of bidirectional vesicular traffic, which is controlled by integrin signaling.	[Liu, Dongfang; Bryceson, Yenan T.; Meckel, Tobias; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Bryceson, Yenan T.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden; [Vasiliver-Shamis, Gaia; Dustin, Michael L.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Vasiliver-Shamis, Gaia; Dustin, Michael L.] Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Karolinska Institutet; Karolinska University Hospital; New York University	Long, EO (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	elong@nih.gov	Liu, Dongfang/C-9618-2011; Meckel, Tobias/F-4372-2010; Long, Eric O/G-5475-2011; Dustin, Michael/AAM-4611-2020; Bryceson, Yenan T/D-2121-2018	Meckel, Tobias/0000-0003-0759-2072; Long, Eric O/0000-0002-7793-3728; Bryceson, Yenan T/0000-0002-7783-9934; Liu, Dongfang/0000-0002-7295-8088; Dustin, Michael/0000-0003-4983-6389	National Institutes of Health; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Starr, A. Beal, Y. Sykulev, M. March, S. Radaev, J. Brzostowski, and P. Tolar for advice and help. This work has been supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases.	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Beal AM, 2008, J IMMUNOL, V181, P4815, DOI 10.4049/jimmunol.181.7.4815; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; BURKHARDT JK, 1993, J CELL SCI, V104, P151; COUSIN MA, 2008, CURRENT PROTOCOLS NE, pCH2; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin Michael L, 2007, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1813s76; Giurisato E, 2007, MOL CELL BIOL, V27, P8583, DOI 10.1128/MCB.01477-07; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu DF, 2005, P NATL ACAD SCI USA, V102, P123, DOI 10.1073/pnas.0405737102; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Roda-Navarro P, 2004, J IMMUNOL, V173, P3640, DOI 10.4049/jimmunol.173.6.3640; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Wulfing C, 2003, P NATL ACAD SCI USA, V100, P7767, DOI 10.1073/pnas.1336920100; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011	27	137	137	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					99	109		10.1016/j.immuni.2009.05.009	http://dx.doi.org/10.1016/j.immuni.2009.05.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19592272	Bronze, Green Accepted			2022-12-18	WOS:000268219900015
J	Sanjabi, S; Mosaheb, MM; Flavell, RA				Sanjabi, Shomyseh; Mosaheb, Munir M.; Flavell, Richard A.			Opposing Effects of TGF-beta and IL-15 Cytokines Control the Number of Short-Lived Effector CD8(+) T Cells	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSE; RECEPTOR-ALPHA; MEMORY; EXPRESSION; CONTRACTION; DIFFERENTIATION; INTERLEUKIN-2; INFLAMMATION	An effective immune response against infectious agents involves massive expansion of CD8(+) T cells. Once the infection is cleared, the majority of these effector cells die through unknown mechanisms. How is expansion controlled to maximize pathogen clearance and minimize immunopathology? We found, after Listeria infection, plasma transforming growth factor beta (TGF-beta) titers increased concomitant with the expansion of effector CD8(+) T cells. Blocking TGF-beta signaling did not affect effector function of CD8(+) T cells. However, TGF-beta controlled effector cell number by lowering Bcl-2 amounts and selectively promoting the apoptosis of short-lived effector cells. TGF-beta-mediated apoptosis of this effector subpopulation occurred during clonal expansion and contraction, whereas interleukin-15 (IL-15) promoted their survival only during contraction. We demonstrate that the number of effector CD8(+) T cells is tightly controlled by multiple extrinsic signals throughout effector differentiation; this plasticity should be exploited during vaccine design and immunotherapy against tumors and autoimmune diseases.	[Sanjabi, Shomyseh; Mosaheb, Munir M.; Flavell, Richard A.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu			NIH [CA121974, DK051665]; JDRF [32-2008-352]; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051665] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Li, T. Willinger, E. Eynon, and S. Kaech for critically reading the manuscript and for helpful discussion; T. Hand for performing AKT phosphorylation experiment, R. Webber for help with breeding the CD1 I c-DNR mice; T. Taylor for cell sorting; and F. Manzo for help in submitting the manuscript. R.A.F is an investigator of the Howard Hughes Medical Institute. This work is supported by a postdoctoral fellowship grant from Cancer Research Institute (S.S.), with additional support from NIH grants CA121974 and DK051665(R.A.F.) and JDRF grant 32-2008-352 (R.A.F.). The authors declare that they have no competing financial interests.	Ahmadzadeh M, 2005, J IMMUNOL, V174, P5215, DOI 10.4049/jimmunol.174.9.5215; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; D'Souza WN, 2004, EUR J IMMUNOL, V34, P2977, DOI 10.1002/eji.200425485; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; D'Souza WN, 2002, J IMMUNOL, V168, P5566, DOI 10.4049/jimmunol.168.11.5566; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hand TW, 2009, IMMUNOL RES, V45, P46, DOI 10.1007/s12026-008-8027-z; Haring JS, 2008, J IMMUNOL, V180, P2855, DOI 10.4049/jimmunol.180.5.2855; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hildeman D, 2007, CURR OPIN IMMUNOL, V19, P516, DOI 10.1016/j.coi.2007.05.005; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Ingulli Elizabeth, 2007, Methods Mol Biol, V380, P365; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Morris JC, 2006, P NATL ACAD SCI USA, V103, P401, DOI 10.1073/pnas.0509575103; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Rubinstein MP, 2008, BLOOD, V112, P3704, DOI 10.1182/blood-2008-06-160945; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sillett HK, 2001, IMMUNOLOGY, V102, P310, DOI 10.1046/j.1365-2567.2001.01185.x; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Trapani JA, 2005, CANCER CELL, V8, P349, DOI 10.1016/j.ccr.2005.10.018; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Wojciechowski S, 2006, EUR J IMMUNOL, V36, P1694, DOI 10.1002/eji.200635897; Wolfraim LA, 2004, J IMMUNOL, V173, P3093, DOI 10.4049/jimmunol.173.5.3093; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Yajima T, 2006, J IMMUNOL, V176, P507, DOI 10.4049/jimmunol.176.1.507	56	137	139	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					131	144		10.1016/j.immuni.2009.04.020	http://dx.doi.org/10.1016/j.immuni.2009.04.020			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19604492	Green Accepted, Bronze			2022-12-18	WOS:000268219900018
J	Bertocci, B; De Smet, A; Weill, JC; Reynaud, CA				Bertocci, Barbara; De Smet, Annie; Weill, Jean-Claude; Reynaud, Claude-Agnes			Nonoverlapping functions of DNA polymerases Mu, lambda, and terminal deoxynucleotidyltransferase during immunoglobulin V(D)J recombination in vivo	IMMUNITY			English	Article							DEPENDENT PROTEIN-KINASE; N-REGIONS; LIGASE-IV; X FAMILY; POL-MU; DEFICIENT; GENE; EXPRESSION; MICE; DISTINCT	DNA polymerases mu (pol mu), lambda (pol lambda), and terminal deoxynucleotidyltransferase (TdT) are enzymes of the pol X family that share homology in sequence and functional domain organization. We showed previously that pol mu participates in light chain but surprisingly not heavy chain gene rearrangement. We show here that immunoglobulin heavy chain junctions from pol lambda-deficient animals have shorter length with normal N-additions, thus indicating that pol lambda is recruited during heavy chain rearrangement at a step that precedes the action of TdT. In contrast to previous in vitro studies, analysis of animals with combined inactivation of these enzymes revealed no overlapping or compensatory activities for V(D)J recombination between pol mu, pol lambda, and TdT. This complex usage of polymerases with distinct catalytic specificities may correspond to the specific function that the third hypervariable region assumes for each immunoglobulin chain, with pol lambda maintaining a large heavy chain junctional heterogeneity and pol mu ensuring a restricted light chain junctional variability.	INSERM, U783, F-75730 Paris 15, France; Univ Paris 05, Fac Med, F-75730 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Weill, JC (corresponding author), INSERM, U783, Site Necker Enfants Malades,156 Rue Vaugirad, F-75730 Paris 15, France.	weill@necker.fr; reynaud@necker.fr	Bertocci, Barbara/L-9115-2018					Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Bertocci B, 2002, J IMMUNOL, V168, P3702, DOI 10.4049/jimmunol.168.8.3702; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; DOYEN N, 1993, NUCLEIC ACIDS RES, V21, P1187, DOI 10.1093/nar/21.5.1187; Doyen N, 2004, J IMMUNOL, V172, P6764, DOI 10.4049/jimmunol.172.11.6764; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Garcia-Diaz M, 2006, CELL, V124, P331, DOI [10.1016/j.cell.2005.10.039, 10.1016/j.cel.2005.10.039]; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Kobayashi Y, 2002, MOL CELL BIOL, V22, P2769, DOI 10.1128/MCB.22.8.2769-2776.2002; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; McElhinny SAN, 2004, IMMUNOL REV, V200, P156, DOI 10.1111/j.0105-2896.2004.00160.x; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Ramadan K, 2004, NAT REV MOL CELL BIO, V5, P1038, DOI 10.1038/nrm1530; Repasky JAE, 2004, J IMMUNOL, V172, P5478, DOI 10.4049/jimmunol.172.9.5478; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Rubio MA, 2002, J BIOL CHEM, V277, P28609, DOI 10.1074/jbc.M203747200; TACCIOLI GE, 1993, SCIENCE, V173, P4009; Thai TH, 2005, ADV IMMUNOL, V86, P113, DOI 10.1016/S0065-2776(04)86003-6; Thai TH, 2004, J IMMUNOL, V173, P4009, DOI 10.4049/jimmunol.173.6.4009; Thai TH, 2002, NAT IMMUNOL, V3, P457, DOI 10.1038/ni788; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TOMLINSON IM, 1995, EMBO J, V14, P4628, DOI 10.1002/j.1460-2075.1995.tb00142.x; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zariwala M, 2004, AM J RESP CELL MOL, V30, P428, DOI 10.1165/rcmb.2003-0338RC	49	137	138	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2006	25	1					31	41		10.1016/j.immuni.2006.04.013	http://dx.doi.org/10.1016/j.immuni.2006.04.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860755	Green Submitted, Bronze			2022-12-18	WOS:000239713000008
J	Smith, DE; Hanna, R; Friend, D; Moore, H; Chen, H; Farese, AM; MacVittie, TJ; Virca, GD; Sims, JE				Smith, DE; Hanna, R; Friend, D; Moore, H; Chen, H; Farese, AM; MacVittie, TJ; Virca, GD; Sims, JE			The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type IIIL-1 receptor to inhibit IL-1 action	IMMUNITY			English	Article							INTERLEUKIN-1 RECEPTOR; MOLECULAR-CLONING; ELEVATED LEVELS; II RECEPTOR; ANTAGONIST; EXPRESSION; ARTHRITIS; INTERACTS; MECHANISM; LIGAND	Regulation of the activity of the proinflammatory cytokine IL-1 is complex, involving transcriptional and translational control, precursor processing, a receptor antagonist (IL-1ra), and a decoy receptor. Here we report that the soluble form of the IL-1 receptor accessory protein (AcP) increases the affinity of binding of human IL-1alpha and IL-1beta to the soluble human type 11 IL-1 receptor by approximately 100-fold, while leaving unaltered the low binding affinity of IL-1ra. Soluble AcP is present in normal human serum at an average concentration greater than 300 ng/ml. These findings suggest that the soluble form of IL-1 R AcP contributes to the antagonism of IL-1 action by the type 11 decoy receptor, adding another layer of complexity to the regulation of IL-1 action.	Amgen Corp, Seattle, WA 98101 USA; Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Sims, JE (corresponding author), Amgen Corp, 51 Univ St, Seattle, WA 98101 USA.			Sims, John/0000-0002-5667-9185				BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; BURGER D, 1995, J CLIN INVEST, V96, P38, DOI 10.1172/JCI118045; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Dayer JM, 2001, CURR OPIN RHEUMATOL, V13, P170, DOI 10.1097/00002281-200105000-00004; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; EASTGATE JA, 1988, LANCET, V2, P706; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; GIRI JG, 1994, J IMMUNOL, V153, P5802; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; Jensen LE, 2000, J IMMUNOL, V164, P5277, DOI 10.4049/jimmunol.164.10.5277; Jouvenne P, 1998, ARTHRITIS RHEUM, V41, P1083, DOI 10.1002/1529-0131(199806)41:6<1083::AID-ART15>3.0.CO;2-9; Lang D, 1998, J IMMUNOL, V161, P6871; Malinowsky D, 1998, FEBS LETT, V429, P299, DOI 10.1016/S0014-5793(98)00467-0; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Mullberg J, 1997, FEBS LETT, V401, P235, DOI 10.1016/S0014-5793(96)01480-9; Orlando S, 1997, J BIOL CHEM, V272, P31764, DOI 10.1074/jbc.272.50.31764; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Smith DE, 2002, J BIOL CHEM, V277, P47619, DOI 10.1074/jbc.M206636200; Totsuka K, 1998, INT ARCH ALLERGY IMM, V116, P40, DOI 10.1159/000023923; VILLINGER F, 1995, J IMMUNOL, V155, P3946	24	137	149	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2003	18	1					87	96		10.1016/S1074-7613(02)00514-9	http://dx.doi.org/10.1016/S1074-7613(02)00514-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530978	Bronze			2022-12-18	WOS:000180860600009
J	Sugita, M; Cao, XC; Watts, GFM; Rogers, RA; Bonifacino, JS; Brenner, MB				Sugita, M; Cao, XC; Watts, GFM; Rogers, RA; Bonifacino, JS; Brenner, MB			Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells	IMMUNITY			English	Article							MHC CLASS-II; HERMANSKY-PUDLAK-SYNDROME; BACTERIAL LIPID ANTIGENS; T-CELLS; CYTOPLASMIC TAIL; INVARIANT CHAIN; LIPOGLYCAN ANTIGENS; DENDRITIC CELLS; SORTING SIGNALS; INTRACELLULAR-TRANSPORT	Endocytosed microbial antigens are primarily delivered to lysosomal compartments where antigen binding to MHC and CD1 molecules occurs in an acidic and proteolytically active environment. Signal-dependent delivery to lysosomes has been suggested for these antigen-presenting molecules, but molecular interactions with vesicular coat proteins and adaptors that direct their lysosomal sorting are poorly understood. Here CD1b but not other CD1 isoforms bound the AP-3 adaptor protein complex. In AP-3-deficient cells derived from patients with Hermansky-Pudlak syndrome type 2 (HPS-2), CD1b failed to efficiently gain access to lysosomes, resulting in a profound defect in antigen presentation. Since MHC class 11 traffics normally in AP-3-deficient cells, defects in CD1b antigen presentation may account for recurrent bacterial infections in HPS-2 patients.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Lymphocyte Biol Sect,Div Rheumatol Immunol & Alle, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Brenner, MB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Lymphocyte Biol Sect,Div Rheumatol Immunol & Alle, Boston, MA 02115 USA.			Sugita, Masahiko/0000-0001-5511-1304; Bonifacino, Juan S./0000-0002-5673-6370; Watts, Gerald/0000-0003-2276-1524	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beckman EM, 1996, J IMMUNOL, V157, P2795; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BEHAR SM, 1995, J EXP MED, V182, P2007, DOI 10.1084/jem.182.6.2007; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; Caplan S, 2000, IMMUNOL LETT, V72, P113, DOI 10.1016/S0165-2478(00)00176-0; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; KANG SJ, 2002, IN PRESS EMBO J, V21; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; OLIVE D, 1984, IMMUNOGENETICS, V20, P253, DOI 10.1007/BF00364207; Park SH, 2000, NATURE, V406, P788, DOI 10.1038/35021233; Pena-Cruz V, 2001, J IMMUNOL METHODS, V255, P83, DOI 10.1016/S0022-1759(01)00432-X; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; PETERS PJ, 1995, J EXP MED, V182, P325, DOI 10.1084/jem.182.2.325; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 1998, TRENDS MICROBIOL, V6, P454, DOI 10.1016/S0966-842X(98)01352-3; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Rosat JP, 1999, J IMMUNOL, V162, P366; Schaible UE, 2000, SEMIN IMMUNOL, V12, P527, DOI 10.1006/smim.2000.0272; Sevilla LM, 2001, CELL IMMUNOL, V210, P143, DOI 10.1006/cimm.2001.1817; Shotelersuk V, 2000, AM J MED, V108, P423, DOI 10.1016/S0002-9343(99)00436-2; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; SUGITA M, 1994, J EXP MED, V180, P2163, DOI 10.1084/jem.180.6.2163; Sugita M, 2000, TRAFFIC, V1, P295, DOI 10.1034/j.1600-0854.2000.010401.x; Sugita M, 2000, P NATL ACAD SCI USA, V97, P8445, DOI 10.1073/pnas.150236797; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1997, J IMMUNOL, V159, P2358; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Vowels JJ, 1998, EMBO J, V17, P2482, DOI 10.1093/emboj/17.9.2482; White S, 1998, J BIOL CHEM, V273, P14355, DOI 10.1074/jbc.273.23.14355; Yang W, 2000, J CELL SCI, V113, P4077	64	137	143	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2002	16	5					697	706		10.1016/S1074-7613(02)00311-4	http://dx.doi.org/10.1016/S1074-7613(02)00311-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049721	Bronze			2022-12-18	WOS:000175820400008
J	Laczko, D; Hogan, MJ; Toulmin, SA; Hicks, P; Lederer, K; Gaudette, BT; Castano, D; Amanat, F; Muramatsu, H; Oguin, TH; Ojha, A; Zhang, LZ; Mu, ZK; Parks, R; Manzoni, TB; Roper, B; Strohmeier, S; Tombacz, I; Arwood, L; Nachbagauer, R; Kariko, K; Greenhouse, J; Pessaint, L; Porto, M; Putman-Taylor, T; Strasbaugh, A; Campbell, TA; Lin, PJC; Tam, YK; Sempowski, GD; Farzan, M; Choe, H; Saunders, KO; Haynes, BF; Andersen, H; Eisenlohr, LC; Weissman, D; Krammer, F; Bates, P; Allman, D; Locci, M; Pardi, N				Laczko, Dorottya; Hogan, Michael J.; Toulmin, Sushila A.; Hicks, Philip; Lederer, Katlyn; Gaudette, Brian T.; Castano, Diana; Amanat, Fatima; Muramatsu, Hiromi; Oguin, Thomas H., III; Ojha, Amrita; Zhang, Lizhou; Mu, Zekun; Parks, Robert; Manzoni, Tomaz B.; Roper, Brianne; Strohmeier, Shirin; Tombacz, Istvan; Arwood, Leslee; Nachbagauer, Raffael; Kariko, Katalin; Greenhouse, Jack; Pessaint, Laurent; Porto, Maciel; Putman-Taylor, Tammy; Strasbaugh, Amanda; Campbell, Tracey-Ann; Lin, Paulo J. C.; Tam, Ying K.; Sempowski, Gregory D.; Farzan, Michael; Choe, Hyeryun; Saunders, Kevin O.; Haynes, Barton F.; Andersen, Hanne; Eisenlohr, Laurence C.; Weissman, Drew; Krammer, Florian; Bates, Paul; Allman, David; Locci, Michela; Pardi, Norbert			A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice	IMMUNITY			English	Article							LIPID NANOPARTICLES; CELLS; PROTECTION; INFECTION; MEMORY	SARS-CoV-2 infection has emerged as a serious global pandemic. Because of the high transmissibility of the virus and the high rate of morbidity and mortality associated with COVID-19, developing effective and safe vaccines is a top research priority. Here, we provide a detailed evaluation of the immunogenicity of lipid nanoparticle-encapsulated, nucleoside-modified mRNA (mRNA-LNP) vaccines encoding the full-length SARS-CoV-2 spike protein or the spike receptor binding domain in mice. We demonstrate that a single dose of these vaccines induces strong type 1 CD4(+) and CD8(+) T cell responses, as well as long-lived plasma and memory B cell responses. Additionally, we detect robust and sustained neutralizing antibody responses and the antibodies elicited by nucleoside-modified mRNA vaccines do not show antibody-dependent enhancement of infection in vitro. Our findings suggest that the nucleoside-modified mRNA-LNP vaccine platform can induce robust immune responses and is a promising candidate to combat COVID-19.	[Laczko, Dorottya; Muramatsu, Hiromi; Tombacz, Istvan; Kariko, Katalin; Weissman, Drew; Pardi, Norbert] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Hogan, Michael J.; Toulmin, Sushila A.; Eisenlohr, Laurence C.] Univ Penn, Childrens Hosp, Div Protect Immun, Philadelphia, PA 19104 USA; [Hicks, Philip; Lederer, Katlyn; Castano, Diana; Manzoni, Tomaz B.; Roper, Brianne; Bates, Paul; Locci, Michela] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hicks, Philip] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Gaudette, Brian T.; Eisenlohr, Laurence C.; Allman, David] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Castano, Diana] Univ Antioquia, Fac Med, Inst Invest Med, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia; [Amanat, Fatima; Strohmeier, Shirin; Nachbagauer, Raffael; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Amanat, Fatima] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Oguin, Thomas H., III; Mu, Zekun; Parks, Robert; Arwood, Leslee; Sempowski, Gregory D.; Saunders, Kevin O.; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [Ojha, Amrita; Zhang, Lizhou; Farzan, Michael; Choe, Hyeryun] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL USA; [Kariko, Katalin] BioNTech RNA Pharmaceut, Mainz, Germany; [Greenhouse, Jack; Pessaint, Laurent; Porto, Maciel; Putman-Taylor, Tammy; Strasbaugh, Amanda; Campbell, Tracey-Ann; Andersen, Hanne] BIOQUAL Inc, Rockville, MD USA; [Lin, Paulo J. C.; Tam, Ying K.] Acuitas Therapeut, Vancouver, BC, Canada; [Sempowski, Gregory D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Universidad de Antioquia; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Duke University; Scripps Research Institute; BioNTech SE; BIOQUAL Inc.; Duke University	Pardi, N (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	pnorbert@pennmedicine.upenn.edu	Krammer, Florian/H-3237-2019; Zhang, Lizhou/AAI-1145-2021; Nachbagauer, Raffael/H-7798-2019; Mu, Zekun/GOG-8854-2022	Krammer, Florian/0000-0003-4121-776X; Zhang, Lizhou/0000-0002-2637-9712; Nachbagauer, Raffael/0000-0001-5568-5420; Mu, Zekun/0000-0003-4093-8346; Oguin, Thomas/0000-0001-8959-4025; Roper, Brianne/0000-0003-0034-173X; Lederer, Katlyn/0000-0003-2713-6664; Tombacz, Istvan/0000-0001-6683-7223; Manzoni, Tomaz/0000-0001-6380-5103; Sempowski, Gregory/0000-0003-0391-6594; Castano, Diana/0000-0002-5697-5603; Toulmin, Sushila/0000-0003-1743-1619; Hogan, Michael/0000-0002-6244-2993; Elyard, Hanne/0000-0003-1103-9608	National Institute of Allergy and Infectious Diseases [1R01AI146101, R01AI123738]; National Institute of Allergy and Infectious Diseases Collaborative Influenza Vaccine Innovation Centers (CIVIC) [75N93019C00051]; NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400008C]; NIH [T32AI055400, R21AI129531, R21AI142638]; Peer Reviewed Medical Research Program [PR182551]; NIAID [AI142596, AI124429]; State of North Carolina from the CARES Act Funds; Cancer Research Institute; National Heart, Lung, And Blood Institute [F30HL145907]; BioNTech;  [NIH R01 AI129868]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases Collaborative Influenza Vaccine Innovation Centers (CIVIC); NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peer Reviewed Medical Research Program; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); State of North Carolina from the CARES Act Funds; Cancer Research Institute; National Heart, Lung, And Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BioNTech; 	We thank Lisa Mistretta and Dalia Benetiene for helping with animal procedures (Bioqual). We thank Florin Tuluc and Jennifer Murray of the CHOP Flow Cytometry core facility for technical assistance. We thank Alec W. Freyn, Allen Zheng, Katarzyna Janowska, and Priyamvada Acharya for providing SARSCoV-2 reagents used in the study. The graphical abstract was created with BioRender. N.P. was supported by the National Institute of Allergy and Infectious Diseases (1R01AI146101). M.L. was supported by the National Institute of Allergy and Infectious Diseases (R01AI123738). Work in the Krammer laboratory was supported by the National Institute of Allergy and Infectious Diseases Collaborative Influenza Vaccine Innovation Centers (CIVIC; 75N93019C00051), the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS; HHSN272201400008C), institutional funding, and philanthropic donations. M.F. and H.C. were supported by an administrative supplement to NIH R01 AI129868 for coronavirus research. P.H. and T.B.M were supported by NIH (T32AI055400 and R21AI129531, respectively). P.B. was supported by a Peer Reviewed Medical Research Program (PR182551) and grants from the NIH (R21AI129531 and R21AI142638). B.F.H. was supported by NIAID (AI142596) and by a contract from the State of North Carolina from the CARES Act Funds. D.W. was supported by grants from the NIAID (AI142596 and AI124429) and BioNTech. M.J. H. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute. S.A.T was supported by the National Heart, Lung, And Blood Institute (F30HL145907).	Feldman RA, 2019, VACCINE, V37, P3326, DOI 10.1016/j.vaccine.2019.04.074; Alameh Mohamad-Gabriel, 2020, Curr Top Microbiol Immunol, DOI 10.1007/82_2020_202; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; Awasthi S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw7083; Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035; Baiersdorfer M, 2019, MOL THER-NUCL ACIDS, V15, P26, DOI 10.1016/j.omtn.2019.02.018; Bao L., 2020, NATURE, V2020, P7, DOI DOI 10.1016/S0140-6736(20)30183-5; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020; Espeseth AS, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0163-z; Freyn AW, 2020, MOL THER, V28, P1569, DOI 10.1016/j.ymthe.2020.04.018; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Lindgren G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01539; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Meyer M, 2018, J INFECT DIS, V217, P451, DOI 10.1093/infdis/jix592; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Mulligan M.J., 2020, PHASE 1 2 STUDY DESC, DOI [10.1101/2020.06.30, DOI 10.1101/2020.06.30]; Pardi N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05482-0; Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Roth C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01424; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Shim BS, 2019, MBIO, V10, DOI 10.1128/mBio.00758-19; Smatti MK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02991; Smith TRF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16505-0; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; Weissman Drew, 2013, Methods Mol Biol, V969, P43, DOI 10.1007/978-1-62703-260-5_3; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhang LZ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120700; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006	42	136	137	9	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					724	+		10.1016/j.immuni.2020.07.019	http://dx.doi.org/10.1016/j.immuni.2020.07.019			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	32783919	Bronze, Green Published			2022-12-18	WOS:000581062800007
J	Leonard, WJ; Lin, JX; O'Shea, JJ				Leonard, Warren J.; Lin, Jian-Xin; O'Shea, John J.			The gamma(c) Family of Cytokines: Basic Biology to Therapeutic Ramifications	IMMUNITY			English	Review							SEVERE COMBINED IMMUNODEFICIENCY; REGULATORY T-CELLS; HUMAN INTERLEUKIN-2 RECEPTOR; LOW-DOSE INTERLEUKIN-2; INNATE LYMPHOID-CELLS; BETA-CHAIN GENE; IL-2 RECEPTOR; DNA-BINDING; TRANSCRIPTION FACTOR; NATURAL-KILLER	The common cytokine receptor gamma chain, gamma(c), is a component of the receptors for interleukin-2 (IL-2), IL-4, IL-7, IL-9, IL-15, and IL-21. Mutation of the gem encoding gamma(c) results in X-linked severe combined immunodeficiency in humans, and ( )gamma(c) family cytokines collectively regulate development, proliferation, survival, and differentiation of immune cells. Here, we review the basic biology of these cytokines, highlighting mechanisms of signaling and gene regulation that have provided insights for immunodeficiency, autoimmunity, allergic diseases, and cancer. Moreover, we discuss how studies of this family stimulated the development of JAK3 inhibitors and present an overview of current strategies targeting these pathways in the clinic, including novel antibodies, antagonists, and partial agonists. The diverse roles of these cytokines on a range immune cells have important therapeutic implicatio s.	[Leonard, Warren J.; Lin, Jian-Xin] NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Leonard, Warren J.; Lin, Jian-Xin] NHLBI, Immunol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Leonard, WJ; Lin, JX (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.; Leonard, WJ; Lin, JX (corresponding author), NHLBI, Immunol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.; O'Shea, JJ (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	leonardw@nhlbi.nih.gov; linjx@nhlbi.nih.gov; osheaj@arb.niams.nih.gov	Leonard, Warren/AAA-1397-2022; Leonard, Warren J/ABD-9251-2020		Division of Intramural Research, NHLBI; Division of Intramural Research, NIAMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005408, ZIAHL005409, ZIAHL005402, ZIAHL005401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041106, ZIAAR041167, ZIAAR041159] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of Intramural Research, NIAMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	W.J.L. and J.X.L. are supported by the Division of Intramural Research, NHLBI. J.O'S. is supported by the Division of Intramural Research, NIAMS. Since this is a special anniversary issue of Immunity honoring cytokines, in this chapter on "ye" family cytokines, we wish to specifically acknowledge Dr. Kazuo Sugamura and Toshikazu Takeshita in his group at Tohoku University for their original identification and cloning of the IL-2 receptor y chain as the third component of the IL-2 receptor. We also wish to acknowledge Dr. Masayuki Noguchi, then in the Leonard lab and now a professor at Hokkaido University, Sapporo, Japan, who was the first author on the paper identifying IL2RG mutations as the genetic basis of XSCID, in which the sharing of IL-2Ry among multiple cytokines was predicted, and on the paper to coin the term, common cytokine receptor y chain, ye, as cited herein. We also would like to thank Thomas A. Waldmann, NCI, and the late William E. Paul for many years of valuable discussions about y, family cytokines.	Abadie V, 2014, IMMUNOL REV, V260, P221, DOI 10.1111/imr.12191; Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Attridge K, 2012, BLOOD, V119, P4656, DOI 10.1182/blood-2011-10-388546; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BAZAN JF, 1990, CELL, V61, P753, DOI 10.1016/0092-8674(90)90182-E; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; Berkowitz JL, 2014, CLIN IMMUNOL, V155, P176, DOI 10.1016/j.clim.2014.09.012; Bi EG, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9741; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Burrack KS, 2018, IMMUNITY, V48, P760, DOI 10.1016/j.immuni.2018.03.012; Buttrick TS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19315-z; Carrascosa LC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15366; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; Casimiro-Garcia A, 2018, J MED CHEM, V61, P10665, DOI 10.1021/acs.jmedchem.8b01308; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chisolm DA, 2017, IMMUNITY, V47, P251, DOI 10.1016/j.immuni.2017.07.015; Clarke EL, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0580-z; COHEN S, 1974, CELL IMMUNOL, V12, P150, DOI 10.1016/0008-8749(74)90066-5; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Coquet JM, 2015, IMMUNITY, V43, P318, DOI 10.1016/j.immuni.2015.07.015; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Crompton JG, 2014, IMMUNOL REV, V257, P264, DOI 10.1111/imr.12135; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Desbois M, 2016, J IMMUNOL, V197, P168, DOI 10.4049/jimmunol.1600019; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; DJEU JY, 1993, J IMMUNOL, V150, P960; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; DUGAS B, 1993, EUR J IMMUNOL, V23, P1687, DOI 10.1002/eji.1830230743; DUKOVICH M, 1987, NATURE, V327, P518, DOI 10.1038/327518a0; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fischer A, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.61; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Franchimont D, 2002, J IMMUNOL, V168, P2212, DOI 10.4049/jimmunol.168.5.2212; Genovese MC, 2017, ARTHRITIS RHEUMATOL, V69, P932, DOI 10.1002/art.40054; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Giliani S, 2005, IMMUNOL REV, V203, P110, DOI 10.1111/j.0105-2896.2005.00234.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GNARRA JR, 1990, P NATL ACAD SCI USA, V87, P3440, DOI 10.1073/pnas.87.9.3440; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Huang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132802; HULTNER L, 1990, EUR J IMMUNOL, V20, P1413, DOI 10.1002/eji.1830200632; Hurton LV, 2016, P NATL ACAD SCI USA, V113, pE7788, DOI 10.1073/pnas.1610544113; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Impellizzieri D., 2019, J ALLERGY CLIN IMMUN; ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kagoya Y, 2018, NAT MED, V24, P352, DOI 10.1038/nm.4478; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; KASHIMA N, 1985, NATURE, V313, P402, DOI 10.1038/313402a0; Katerndahl CDS, 2017, NAT IMMUNOL, V18, P694, DOI 10.1038/ni.3716; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Klose CSN, 2014, IMMUNITY, V41, P230, DOI 10.1016/j.immuni.2014.06.018; Koh B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07202-0; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Leonard WJ, 1996, ANNU REV MED, V47, P229; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; LEONARD WJ, 1985, SCIENCE, V228, P1547, DOI 10.1126/science.3925551; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Li P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02738; Li P, 2017, P NATL ACAD SCI USA, V114, P12111, DOI 10.1073/pnas.1714019114; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liao W, 2014, P NATL ACAD SCI USA, V111, P3508, DOI 10.1073/pnas.1301138111; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lin JX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01477-5; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Lo M, 1999, BLOOD, V94, P3027, DOI 10.1182/blood.V94.9.3027.421k11_3027_3036; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lorenzen I, 2006, J BIOL CHEM, V281, P6642, DOI 10.1074/jbc.M513118200; LOWENTHAL JW, 1987, J EXP MED, V166, P1156, DOI 10.1084/jem.166.4.1156; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Marnik EA, 2017, CELL REP, V21, P208, DOI 10.1016/j.celrep.2017.09.036; Martin CE, 2017, IMMUNITY, V47, P171, DOI 10.1016/j.immuni.2017.07.005; Massoud AH, 2016, NAT MED, V22, P1013, DOI 10.1038/nm.4147; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mease P, 2018, LANCET, V392, P2367, DOI 10.1016/S0140-6736(18)32483-8; Mehta DS, 2003, J IMMUNOL, V170, P4111, DOI 10.4049/jimmunol.170.8.4111; Mikami N, 2013, J IMMUNOL, V190, P4046, DOI 10.4049/jimmunol.1203102; Miloux B, 1997, FEBS LETT, V401, P163, DOI 10.1016/S0014-5793(96)01462-7; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Mitra S, 2015, IMMUNITY, V42, P826, DOI 10.1016/j.immuni.2015.04.018; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Moutuou MM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01237; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Nakayama T, 2017, ANNU REV IMMUNOL, V35, P53, DOI 10.1146/annurev-immunol-051116-052350; Nalleweg N, 2015, GUT, V64, P743, DOI 10.1136/gutjnl-2013-305947; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Novy P, 2011, J IMMUNOL, V186, P2729, DOI 10.4049/jimmunol.1003009; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Shea JJ, 2019, NAT REV RHEUMATOL, V15, P74, DOI 10.1038/s41584-018-0155-9; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Owen DL, 2019, NAT IMMUNOL, V20, P195, DOI 10.1038/s41590-018-0289-6; Owen DL, 2018, J IMMUNOL, V200, P3926, DOI 10.4049/jimmunol.1800097; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Ozaki K, 2000, P NATL ACAD SCI USA, V97, P11439, DOI 10.1073/pnas.200360997; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Paul WE, 2015, CYTOKINE, V75, P3, DOI 10.1016/j.cyto.2015.01.038; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Poholek AC, 2016, SCI IMMUNOLOGY, V1, P5, DOI DOI 10.1126/SCIIMMUN0L.AAF8612; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Rabe KF, 2018, NEW ENGL J MED, V378, P2475, DOI 10.1056/NEJMoa1804093; Recher M, 2011, BLOOD, V118, P6824, DOI 10.1182/blood-2011-06-362533; Redmond AK, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1290-2; Richard AC, 2015, J IMMUNOL, V194, P3567, DOI 10.4049/jimmunol.1401220; Richmond JM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam7710; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Robinette ML, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14601; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Roediger B, 2015, J ALLERGY CLIN IMMUN, V136, P1653, DOI 10.1016/j.jaci.2015.03.043; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Rosenzwajg M, 2019, ANN RHEUM DIS, V78, P209, DOI 10.1136/annrheumdis-2018-214229; Ross SH, 2018, ANNU REV IMMUNOL, V36, P411, DOI 10.1146/annurev-immunol-042617-053352; Ross SH, 2016, IMMUNITY, V45, P685, DOI 10.1016/j.immuni.2016.07.022; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; Russo A, 2018, BLOOD, V131, P247, DOI 10.1182/blood-2017-05-780668; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; SADLACK B, 1994, EUR J IMMUNOL, V24, P281, DOI 10.1002/eji.1830240144; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SAITO Y, 1991, J BIOL CHEM, V266, P22186; Sands BE, 2018, J CROHNS COLITIS, V12, P1158, DOI 10.1093/ecco-jcc/jjy085; Santegoets SJAM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-37; SCHMITT E, 1989, EUR J IMMUNOL, V19, P2167, DOI 10.1002/eji.1830191130; Schwartz DM, 2019, IMMUNITY, V50, P106, DOI 10.1016/j.immuni.2018.12.014; Secombes CJ, 2016, FISH SHELLFISH IMMUN, V53, P1, DOI 10.1016/j.fsi.2016.03.035; Sharabi A, 2018, NAT REV DRUG DISCOV; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; Shimba A, 2018, IMMUNITY, V48, P286, DOI 10.1016/j.immuni.2018.01.004; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Smith GA, 2016, NAT CHEM BIOL, V12, P373, DOI [10.1038/NCHEMBIO.2056, 10.1038/nchembio.2056]; Sockolosky JT, 2018, SCIENCE, V359, P1037, DOI 10.1126/science.aar3246; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Soussi-Gounni A, 2001, J ALLERGY CLIN IMMUN, V107, P575, DOI 10.1067/mai.2001.114238; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TAKESHITA T, 1990, INT IMMUNOL, V2, P477, DOI 10.1093/intimm/2.5.477; TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; Thorarensen A, 2017, J MED CHEM, V60, P1971, DOI 10.1021/acs.jmedchem.6b01694; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Trotta E, 2018, NAT MED, V24, P1005, DOI 10.1038/s41591-018-0070-2; TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; van der Heijde D, 2018, LANCET, V392, P2378, DOI 10.1016/S0140-6736(18)32463-2; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; Villarino A, 2016, ELIFE, V5, DOI 10.7554/eLife.08384; Villarino AV, 2017, J EXP MED, V214, P2999, DOI 10.1084/jem.20150907; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726; Vogelaar CF, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2304; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; von Spee-Mayer C, 2016, ANN RHEUM DIS, V75, P1407, DOI 10.1136/annrheumdis-2015-207776; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Waldmann TA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028472; Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]; Wan CK, 2015, P NATL ACAD SCI USA, V112, P9394, DOI 10.1073/pnas.1511711112; Wan CK, 2013, IMMUNITY, V38, P514, DOI 10.1016/j.immuni.2013.02.011; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Ward NC, 2018, J IMMUNOL, V201, P2579, DOI 10.4049/jimmunol.1800907; West Erin E, 2012, Drug Discov Today Dis Mech, V9, DOI 10.1016/j.ddmec.2012.09.003; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Woytschak J, 2016, IMMUNITY, V45, P172, DOI 10.1016/j.immuni.2016.06.025; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Xiao M, 2017, BLOOD, V129, P3196, DOI 10.1182/blood-2016-11-749838; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Xu Y, 2014, BLOOD, V123, P3750, DOI 10.1182/blood-2014-01-552174; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	259	136	143	6	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					832	850		10.1016/j.immuni.2019.03.028	http://dx.doi.org/10.1016/j.immuni.2019.03.028			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995502	Bronze			2022-12-18	WOS:000464660800006
J	Halle, S; Keyser, KA; Stahl, FR; Busche, A; Marquardt, A; Zheng, X; Galla, M; Heissmeyer, V; Heller, K; Boelter, J; Wagner, K; Bischoff, Y; Martens, R; Braun, A; Werth, K; Uvarovskii, A; Kempf, H; Meyer-Hermann, M; Arens, R; Kremer, M; Sutter, G; Messerle, M; Forster, R				Halle, Stephan; Keyser, Kirsten Anja; Stahl, Felix Rolf; Busche, Andreas; Marquardt, Anja; Zheng, Xiang; Galla, Melanie; Heissmeyer, Vigo; Heller, Katrin; Boelter, Jasmin; Wagner, Karen; Bischoff, Yvonne; Martens, Rieke; Braun, Asolina; Werth, Kathrin; Uvarovskii, Alexey; Kempf, Harald; Meyer-Hermann, Michael; Arens, Ramon; Kremer, Melanie; Sutter, Gerd; Messerle, Martin; Foerster, Reinhold			In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity	IMMUNITY			English	Article							MEMORY; VIRUS; SECRETION; TARGETS	According to in vitro assays, T cells are thought to kill rapidly and efficiently, but the efficacy and dynamics of cytotoxic T lymphocyte (CTL)-mediated killing of virus-infected cells in vivo remains elusive. We used two-photon microscopy to quantify CTL-mediated killing in mice infected with herpesviruses or poxviruses. On average, one CTL killed 2-16 virus-infected cells per day as determined by real-time imaging and by mathematical modeling. In contrast, upon virus-induced MHC class I downmodulation, CTLs failed to destroy their targets. During killing, CTLs remained migratory and formed motile kinapses rather than static synapses with targets. Viruses encoding the calcium sensor GCaMP6s revealed strong heterogeneity in individual CTL functional capacity. Furthermore, the probability of death of infected cells increased for those contacted by more than two CTLs, indicative of CTL cooperation. Thus, direct visualization of CTLs during killing of virus-infected cells reveals crucial parameters of CD8(+) T cell immunity.	[Halle, Stephan; Stahl, Felix Rolf; Zheng, Xiang; Heller, Katrin; Boelter, Jasmin; Bischoff, Yvonne; Martens, Rieke; Braun, Asolina; Werth, Kathrin; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Keyser, Kirsten Anja; Busche, Andreas; Marquardt, Anja; Wagner, Karen; Messerle, Martin] Hannover Med Sch, Inst Virol, D-30625 Hannover, Germany; [Galla, Melanie] Hannover Med Sch, Inst Expt Hematol, D-30625 Hannover, Germany; [Heissmeyer, Vigo] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Heissmeyer, Vigo] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Uvarovskii, Alexey; Kempf, Harald; Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol, D-38124 Braunschweig, Germany; [Uvarovskii, Alexey; Kempf, Harald; Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Braunschweig Integrated Ctr Syst Biol, D-38124 Braunschweig, Germany; [Meyer-Hermann, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38124 Braunschweig, Germany; [Arens, Ramon] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Kremer, Melanie; Sutter, Gerd] Univ Munich, Inst Infect Dis & Zoonoses, D-80539 Munich, Germany; [Stahl, Felix Rolf] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, D-20246 Hamburg, Germany; [Busche, Andreas] Burgwedel Biotech GmbH, Merck Anim Hlth, D-30938 Burgwedel, Germany; [Marquardt, Anja] Octapharma Prod Gesell Deutschland mbH, D-31832 Springe, Germany; [Braun, Asolina] Univ Melbourne, Inst Microbiol & Immunol, Melbourne, Vic 3010, Australia	Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Octapharma; University of Melbourne	Halle, S; Forster, R (corresponding author), Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany.	halle.stephan@mh-hannover.de; foerster.reinhold@mh-hannover.de	Förster, Reinhold/D-6770-2011; Arens, Ramon/V-4010-2018; Stahl, Felix/O-8715-2019	Arens, Ramon/0000-0001-5058-4110; Stahl, Felix/0000-0002-7443-8967; Braun, Asolina/0000-0002-2646-5362; Messerle, Martin/0000-0002-1227-3933; Sutter, Gerd/0000-0001-6143-082X; Forster, Reinhold/0000-0001-6190-7923; Halle, Stephan/0000-0002-7624-7005; Heissmeyer, Vigo/0000-0002-2263-8545	DFG [SFB 900-B1]; ERC advanced grant [322645-LYMPHATICS-HOMING]; Niedersachsen Research Network on Neuroinfectiology, N-RENNT; Lichtenberg stipend; Boehringer-Ingelheim stipend; German Federal Ministry of Education and Research (BMBF); Human Frontier Science Program	DFG(German Research Foundation (DFG)); ERC advanced grant(European Research Council (ERC)); Niedersachsen Research Network on Neuroinfectiology, N-RENNT; Lichtenberg stipend; Boehringer-Ingelheim stipend; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Human Frontier Science Program(Human Frontier Science Program)	This study was supported by DFG grant SFB 900-B1 to R.F. and M.M., ERC advanced grant 322645-LYMPHATICS-HOMING to R.F, the Niedersachsen Research Network on Neuroinfectiology, N-RENNT to R.F., a Lichtenberg stipend to F.R.S., and a Boehringer-Ingelheim stipend to A. Braun. A.U. and M.M.-H. were supported by the German Federal Ministry of Education and Research (BMBF) within the Measures for the Establishment of Systems Medicine (eMed) project Systems Immunology and Image Mining in Translational Biomarker (SYSIMIT). H.K. and M.M.-H. were supported by the Human Frontier Science Program. We thank Mathias Herberg for excellent animal handling and Immo Prinz, Andreas Krueger, and Olga Kristina Halle for reading and commenting on the manuscript. We would like to acknowledge the expert assistance of the Cell Sorting Core Facility of Hannover Medical School.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cockburn IA, 2013, P NATL ACAD SCI USA, V110, P9090, DOI 10.1073/pnas.1303858110; Deguine J, 2013, IMMUNOL REV, V251, P154, DOI 10.1111/imr.12015; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Elemans M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003534; Elemans M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002381; Ganusov VV, 2008, J VIROL, V82, P11749, DOI 10.1128/JVI.01128-08; Garcia V, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004178; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; Gold MC, 2004, J IMMUNOL, V172, P6944, DOI 10.4049/jimmunol.172.11.6944; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Hickman HD, 2013, CELL HOST MICROBE, V13, P155, DOI 10.1016/j.chom.2013.01.004; Hogan T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003805; Jenkins MR, 2008, J IMMUNOL, V181, P3818, DOI 10.4049/jimmunol.181.6.3818; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Kremer Melanie, 2012, Methods Mol Biol, V890, P59, DOI 10.1007/978-1-61779-876-4_4; Krmpotic A, 1999, J EXP MED, V190, P1285, DOI 10.1084/jem.190.9.1285; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Lopez JA, 2012, TRENDS IMMUNOL, V33, P406, DOI 10.1016/j.it.2012.04.001; Marangoni F, 2013, IMMUNITY, V38, P237, DOI 10.1016/j.immuni.2012.09.012; Marchingo JM, 2014, SCIENCE, V346, P1123, DOI 10.1126/science.1260044; Marquardt A, 2011, J GEN VIROL, V92, P1279, DOI 10.1099/vir.0.029827-0; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Plotkin SA, 2013, CLIN INFECT DIS, V56, P1458, DOI 10.1093/cid/cit048; Regoes RR, 2007, IMMUNOL CELL BIOL, V85, P274, DOI 10.1038/sj.icb.7100053; Ritter AT, 2015, IMMUNITY, V42, P864, DOI 10.1016/j.immuni.2015.04.013; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Varadarajan N, 2011, J CLIN INVEST, V121, P4322, DOI 10.1172/JCI58653; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103; Yewdell JW, 2010, CURR OPIN IMMUNOL, V22, P402, DOI 10.1016/j.coi.2010.04.002; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Ziegler H, 1997, IMMUNITY, V6, P57, DOI 10.1016/S1074-7613(00)80242-3	41	136	137	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					233	245		10.1016/j.immuni.2016.01.010	http://dx.doi.org/10.1016/j.immuni.2016.01.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26872694	Green Submitted, hybrid, Green Published			2022-12-18	WOS:000370294000008
J	Kolev, M; Dimeloe, S; Le Friec, G; Navarini, A; Arbore, G; Povoleri, GA; Fischer, M; Belle, R; Loeliger, J; Develioglu, L; Bantug, GR; Watson, J; Couzi, L; Afzali, B; Lavender, P; Hess, C; Kemper, C				Kolev, Martin; Dimeloe, Sarah; Le Friec, Gaelle; Navarini, Alexander; Arbore, Giuseppina; Povoleri, Giovanni A.; Fischer, Marco; Belle, Reka; Loeliger, Jordan; Develioglu, Leyla; Bantug, Glenn R.; Watson, Julie; Couzi, Lionel; Afzali, Behdad; Lavender, Paul; Hess, Christoph; Kemper, Claudia			Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses	IMMUNITY			English	Article							HEMOLYTIC-UREMIC SYNDROME; COFACTOR PROTEIN CD46; T-CELLS; EFFECTOR FUNCTION; MAMMALIAN TARGET; GLUCOSE-UPTAKE; GLYCOLYTIC SWITCH; AMINO-ACIDS; ACTIVATION; EXPRESSION	Expansion and acquisition of Th1 cell effector function requires metabolic reprogramming; however, the signals instructing these adaptations remain poorly defined. Here we found that in activated human T cells, autocrine stimulation of the complement receptor CD46, and specifically its intracellular domain CYT-1, was required for induction of the amino acid (AA) transporter LAT1 and enhanced expression of the glucose transporter GLUT1. Furthermore, CD46 activation simultaneously drove expression of LAMTOR5, which mediated assembly of the AA-sensing Ragulator-Rag-mTORC1 complex and increased glycolysis and oxidative phosphorylation (OXPHOS), required for cytokine production. T cells from CD46-deficient patients, characterized by defective Th1 cell induction, failed to upregulate the molecular components of this metabolic program as well as glycolysis and OXPHOS, but IFN-gamma production could be reinstated by retrovirus-mediated CD46-CYT-1 expression. These data establish a critical link between the complement system and immunometabolic adaptations driving human CD4(+) T cell effector function.	[Kolev, Martin; Le Friec, Gaelle; Arbore, Giuseppina; Povoleri, Giovanni A.; Afzali, Behdad; Kemper, Claudia] Guys Hosp, Kings Coll London, MRC Ctr Transplantat, Div Transplant Immunol & Mucosal Biol, London SE1 9RT, England; [Dimeloe, Sarah; Fischer, Marco; Belle, Reka; Loeliger, Jordan; Develioglu, Leyla; Bantug, Glenn R.; Hess, Christoph] Univ Basel, Dept Biomed Immunobiol, CH-4031 Basel, Switzerland; [Navarini, Alexander] Univ Zurich Hosp, Dept Dermatol, Zurich, Switzerland; [Povoleri, Giovanni A.; Afzali, Behdad] Guys Hosp, Biomed Res Ctr, Kings Hlth Partners, London SE1 9RT, England; [Watson, Julie; Lavender, Paul] Guys Hosp, Kings Coll London, MRC & Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England; [Couzi, Lionel] Hosp Pellegrin, CNRS, CHU Bordeaux, Nephrol Transplantat,UMR 1564, F-33076 Bordeaux, France; [Afzali, Behdad] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Basel; University of Zurich; University Zurich Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); CHU Bordeaux; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Hess, C (corresponding author), Univ Basel, Dept Biomed Immunobiol, 20 Hebelstr, CH-4031 Basel, Switzerland.	chess@uhbs.ch; claudia.kemper@kcl.ac.uk	Arbore, Giuseppina/AAN-1899-2020; kolev, mihail/D-1476-2015; Afzali, Behdad/H-8565-2013; Navarini, Alexander/C-5504-2014	Arbore, Giuseppina/0000-0002-8318-7557; kolev, mihail/0000-0002-5226-4759; Afzali, Behdad/0000-0003-2968-1156; Fischer, Marco/0000-0002-2704-7912; Kemper, Claudia/0000-0003-4196-1417; Povoleri, Giovanni/0000-0003-0342-651X; Watson, Julie/0000-0003-1487-2443; Navarini, Alexander/0000-0001-7059-632X; Lavender, Paul/0000-0001-8710-0263; Kolev, Martin/0000-0002-7208-3875; Bantug, Glenn Robert/0000-0003-2253-6028; Le Friec, Gaelle/0000-0002-2051-3829; Dimeloe, Sarah/0000-0002-4598-6518	MRC [G1002165, MR/J006742/1]; EU; Wellcome Trust; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust, and King's College London; Roche; Gebert Ruf Foundation [GRS-058/14]; Swiss National Science Foundation [310030-153059, 323530-139181]; Medical Research Council [G1000758, G1002165, MR/J006742/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust, and King's College London; Roche(Roche Holding); Gebert Ruf Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the donors and the patients for their support, Margaret So (University of Arizona) for the anti-CD46 CYT-1 and CYT-2 antibodies and Erez Dror (University of Basel) for help with nutrient uptake studies. This work was supported by the MRC grants G1002165 (C.K.) and MR/J006742/1, an EU-funded Innovative Medicines Initiative BTCURE (C.K.), a Wellcome Trust Investigator Award (C.K), a Wellcome Trust Intermediate Research Fellowship (B.A.), the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust, and King's College London. S.D. was supported by the Roche Postdoctoral Fellowship Program, C.H. by the Gebert Ruf Foundation (GRS-058/14), and both C.H. and M.F. by the Swiss National Science Foundation (310030-153059 and 323530-139181, respectively).	Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bhaskar PT, 2009, MOL CELL BIOL, V29, P5136, DOI 10.1128/MCB.01946-08; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Cattaneo R, 2004, J VIROL, V78, P4385, DOI 10.1128/JVI.78.9.4385-4388.2004; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Choileain SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016287; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Couzi L, 2008, AM J KIDNEY DIS, V52, pE5, DOI 10.1053/j.ajkd.2008.02.359; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fremeaux-Bacchi V, 2006, J AM SOC NEPHROL, V17, P2017, DOI 10.1681/ASN.2005101051; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Groenewoud MJ, 2013, BIOCHEM SOC T, V41, P951, DOI 10.1042/BST20130037; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Hayashi K, 2013, J IMMUNOL, V191, P4080, DOI 10.4049/jimmunol.1300923; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kemper C, 2001, CLIN EXP IMMUNOL, V124, P180, DOI 10.1046/j.1365-2249.2001.01458.x; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Le Friec G, 2012, NAT IMMUNOL, V13, P1213, DOI 10.1038/ni.2454; Le Friec G, 2009, ARCH IMMUNOL THER EX, V57, P393, DOI 10.1007/s00005-009-0047-4; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liszewski MK, 1996, J IMMUNOL, V156, P4415; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Maekawa Y, 2015, NAT MED, V21, P55, DOI 10.1038/nm.3758; Marinari B, 2004, P NATL ACAD SCI USA, V101, P6098, DOI 10.1073/pnas.0308688101; Matheny RW, 2009, BIOCHEM BIOPH RES CO, V390, P252, DOI 10.1016/j.bbrc.2009.09.100; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Rathmell JC, 2012, IMMUNOL REV, V249, P5, DOI 10.1111/j.1600-065X.2012.01158.x; Roos S, 2009, AM J PHYSIOL-CELL PH, V296, pC142, DOI 10.1152/ajpcell.00330.2008; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163	56	136	143	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1033	1047		10.1016/j.immuni.2015.05.024	http://dx.doi.org/10.1016/j.immuni.2015.05.024			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084023	hybrid, Green Published			2022-12-18	WOS:000356362800010
J	Russ, BE; Olshanksy, M; Smallwood, HS; Li, J; Denton, AE; Prier, JE; Stock, AT; Croom, HA; Cullen, JG; Nguyen, MLT; Rowe, S; Olson, MR; Finkelstein, DB; Kelso, A; Thomas, PG; Speed, TP; Rao, S; Turner, SJ				Russ, Brendan E.; Olshanksy, Moshe; Smallwood, Heather S.; Li, Jasmine; Denton, Alice E.; Prier, Julia E.; Stock, Angus T.; Croom, Hayley A.; Cullen, Jolie G.; Nguyen, Michelle L. T.; Rowe, Stephanie; Olson, Matthew R.; Finkelstein, David B.; Kelso, Anne; Thomas, Paul G.; Speed, Terry P.; Rao, Sudha; Turner, Stephen J.			Distinct Epigenetic Signatures Delineate Transcriptional Programs during Virus-Specific CD8(+) T Cell Differentiation	IMMUNITY			English	Article							EXPRESSION; EFFECTOR; NAIVE; GRANZYME; ANTIGEN; GENES; HIERARCHIES; LANDSCAPES; PROFILES; PERFORIN	The molecular mechanisms that regulate the rapid transcriptional changes that occur during cytotoxic T lymphocyte (CTL) proliferation and differentiation in response to infection are poorly understood. We have utilized ChIP-seq to assess histone H3 methylation dynamics within naive, effector, and memory virus-specific T cells isolated directly ex vivo after influenza A virus infection. Our results show that within naive T cells, codeposition of the permissive H3K4me3 and repressive H3K27me3 modifications is a signature of gene loci associated with gene transcription, replication, and cellular differentiation. Upon differentiation into effector and/or memory CTLs, the majority of these gene loci lose repressive H3K27me3 while retaining the permissive H3K4me3 modification. In contrast, immune-related effector gene promoters within naive T cells lacked the permissive H3K4me3 modification, with acquisition of this modification occurring upon differentiation into effector/memory CTLs. Thus, coordinate transcriptional regulation of CTL genes with related functions is achieved via distinct epigenetic mechanisms.	[Russ, Brendan E.; Li, Jasmine; Denton, Alice E.; Prier, Julia E.; Stock, Angus T.; Croom, Hayley A.; Cullen, Jolie G.; Nguyen, Michelle L. T.; Rowe, Stephanie; Olson, Matthew R.; Kelso, Anne; Turner, Stephen J.] Univ Melbourne, Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Olshanksy, Moshe; Speed, Terry P.] Walter & Eliza Hall Inst Med Res, Dept Bioinformat, Parkville, Vic 3010, Australia; [Smallwood, Heather S.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Finkelstein, David B.] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Kelso, Anne] Univ Melbourne, Doherty Inst, WHO Collaborating Ctr Reference & Res Influenza, Parkville, Vic 3010, Australia; [Rao, Sudha] Univ Canberra, Dept Mol & Cellular Biol, Canberra, ACT 2000, Australia	University of Melbourne; Walter & Eliza Hall Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Melbourne; World Health Organization; University of Canberra	Turner, SJ (corresponding author), Univ Melbourne, Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	sjturn@unimelb.edu.au	Thomas, Paul G./H-1063-2018; Rao, Sudha/AAW-5192-2020; Turner, Stephen/GXM-4654-2022	Thomas, Paul G./0000-0001-7955-0256; Rao, Sudha/0000-0001-9547-947X; McQuilten, Hayley/0000-0002-7089-5300; Denton, Alice/0000-0002-4580-3443; Turner, Stephen/0000-0002-1002-0000; Prier, Julia/0000-0002-2653-6300; Kelso, Anne/0000-0002-3166-3267; Russ, Brendan/0000-0001-6862-5283; Smallwood, Heather/0000-0001-5711-5771	National Health and Medical Research Council of Australia [5671222, APP1003131]; NIH [AI107625, AI077714]; Australian Research Council Future Fellowship; Australian Government Department of Health and Ageing; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI077714, R01AI107625] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council Future Fellowship(Australian Research Council); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank Drs. Nicole La Gruta and Peter Doherty for discussion and helpful suggestions. We would also like to thank members of the Australian Genome Research Facility, Parkville, Victoria, for helpful suggestions. This work was supported by grants from the National Health and Medical Research Council of Australia (Program Grant #5671222 awarded to S.J.T. and A. K. and Project grant #APP1003131 awarded to S.J.T. and S.R.) and NIH grants AI107625 and AI077714 (awarded to P.G.T.). S.J.T. is supported by an Australian Research Council Future Fellowship; The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing.	Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Araki Y, 2008, J IMMUNOL, V180, P8102, DOI 10.4049/jimmunol.180.12.8102; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brehm MA, 2005, J IMMUNOL, V175, P5043, DOI 10.4049/jimmunol.175.8.5043; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Denton AE, 2011, P NATL ACAD SCI USA, V108, P15306, DOI 10.1073/pnas.1112520108; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jenkins MR, 2007, J IMMUNOL, V179, P64, DOI 10.4049/jimmunol.179.1.64; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Juelich T, 2009, J IMMUNOL, V183, P7063, DOI 10.4049/jimmunol.0901522; Jung YL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku178; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Moffat JM, 2009, EUR J IMMUNOL, V39, P1203, DOI 10.1002/eji.200839183; Nayar R, 2012, P NATL ACAD SCI USA, V109, pE2794, DOI 10.1073/pnas.1205742109; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zediak VP, 2011, J IMMUNOL, V186, P2705, DOI 10.4049/jimmunol.1003741; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	42	136	137	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					853	865		10.1016/j.immuni.2014.11.001	http://dx.doi.org/10.1016/j.immuni.2014.11.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517617	Green Accepted, Bronze			2022-12-18	WOS:000345504900020
J	Kang, SJ; Liang, HE; Reizis, B; Locksley, RM				Kang, Suk-Jo; Liang, Hong-Erh; Reizis, Boris; Locksley, Richard M.			Regulation of Hierarchical Clustering and Activation of Innate Immune Cells by Dendritic Cells	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; LISTERIA-MONOCYTOGENES INFECTION; CD8(+) T-CELLS; MURINE CYTOMEGALOVIRUS; BACTERIAL-INFECTION; IFN-GAMMA; NK CELLS; INFLAMMATORY MONOCYTES; INTERFERON-PRODUCTION; MONOCLONAL-ANTIBODY	An early granulomatous response, characterized by collections of white blood cells at foci surrounding pathogens, occurs after infection by many intracellular organisms, including Listeria, but how these clusters become organized and for what purpose remain poorly understood. Here, we showed that dendritic cell (DC) activation by Listeria nucleated rapid Clustering of innate cells, including granulocytes, natural killer (NK) cells, and monocytes, to sites of bacteria propagation where interleukin-12 was expressed in the spleen. Clustered NK cells expressed interferon-gamma (IFN-gamma), which was necessary for the activation and maturation of colocalized monocytes to tumor necrosis factor- and inducible nitric oxide synthase-producing DCs (TipDCs). NK cell clustering was necessary for IFN-gamma production and required pertussis-toxin-sensitive recruitment, in part mediated by the chemokine receptor CCR5, and MyD88 adaptor-mediated signaling. Thus, spatial organization of the immune response by DCs between 6 and 24 hr ensures functional activation of innate cells, which restricts pathogens before adaptive immunity is fully activated.	[Kang, Suk-Jo; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; [Kang, Suk-Jo; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol Immunol, San Francisco, CA 94143 USA; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Columbia University	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu	Kang, Suk-Jo/C-1796-2011	Reizis, Boris/0000-0003-1140-7853	National Institutes of Health [A1026918, A1078869, A1067804]; Howard Hughes Medical Institute and the Sandler Asthma Basic Research Center at UCSF; Cancer Research Institute Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, P01AI078869, R21AI067804, R01AI030663, R37AI026918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute and the Sandler Asthma Basic Research Center at UCSF; Cancer Research Institute Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank 1. Charo (UCSF), G. Cheng (UCLA), A. DeFranco (UCSF), V. Dixt (Genentech), A. Luster (Harvard), M. Matloubian (UCSF), and D. Portnoy (UC Berkeley), who generously provided mice. We thank J. Leber (UC Berkeley), S. Mariathasan (Genentech), N. Meyer-Morse (UC Berkeley), and C-L. Tsou (UCSF) for help with animals; N. Flores, C. McArthur, and Z. Wang for technical assistance; and L. Lanier and W. Seaman for critical reading of the manuscript. This work was supported by the National Institutes of Health A1026918 (R.M.L.), A1078869 (R.M.L.), A1067804 (B.R.) and the Howard Hughes Medical Institute and the Sandler Asthma Basic Research Center at UCSF (R.M.L.). S.-J.K. was supported by a Cancer Research Institute Postdoctoral Fellowship.	Aichele P, 2003, J IMMUNOL, V171, P1148, DOI 10.4049/jimmunol.171.3.1148; Andrews DM, 2001, J IMMUNOL, V166, P1796, DOI 10.4049/jimmunol.166.3.1796; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Berg RE, 2005, J IMMUNOL, V175, P1751, DOI 10.4049/jimmunol.175.3.1751; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; Dokun AO, 2001, J IMMUNOL, V167, P5286, DOI 10.4049/jimmunol.167.9.5286; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; LIU W, 1995, CELL IMMUNOL, V163, P260, DOI 10.1006/cimm.1995.1125; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Ludwig IS, 2006, CURR OPIN PHARMACOL, V6, P408, DOI 10.1016/j.coph.2006.03.009; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Muraille E, 2005, EUR J IMMUNOL, V35, P1463, DOI 10.1002/eji.200526024; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Newman KC, 2007, NAT REV IMMUNOL, V7, P279, DOI 10.1038/nri2057; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; POSTON RM, 1992, J IMMUNOL, V149, P3040; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tay CH, 1999, J IMMUNOL, V162, P718; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Zhong MX, 2004, INFECT IMMUN, V72, P1057, DOI 10.1128/IAI.72.2.1057-1064.2004	58	136	136	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					819	833		10.1016/j.immuni.2008.09.017	http://dx.doi.org/10.1016/j.immuni.2008.09.017			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	19006696	Green Accepted, Bronze			2022-12-18	WOS:000261036000018
J	Van Laethem, F; Sarafova, SD; Park, JH; Tai, X; Pobezinsky, L; Guinter, TI; Adoro, S; Adams, A; Sharrow, SO; Feigenbaum, L; Singer, A				Van Laethem, Frangois; Sarafova, Sophia D.; Park, Jung-Hyun; Tai, Xuguang; Pobezinsky, Leonid; Guinter, Terry I.; Adoro, Stanley; Adams, Anthony; Sharrow, Susan O.; Feigenbaum, Lionel; Singer, Alfred			Deletion of CD4 and CD8 coreceptors permits generation of alpha beta T cells that recognize antigens independently of the MHC	IMMUNITY			English	Article							PROTEIN-KINASE P56LCK; IMMUNOLOGICAL SYNAPSE; NEGATIVE SELECTION; LINEAGE COMMITMENT; POSITIVE SELECTION; CYCLE PROGRESSION; RECEPTOR COMPLEX; REGULATES CD4; ACTIVATION; EXPRESSION	The thymus generates major histocompatibility complex (MHC)-restricted alpha beta T cells that only recognize antigenic ligands in association with MHC or MHC-like molecules. We hypothesized that MHC specificity might be imposed on a broader alpha beta TCR repertoire during thymic selection by CD4 and CD8 coreceptors; that bind and effectively sequester the tyrosine kinase Lck, thereby preventing T cell receptor (TCR) signaling by non-MHC ligands that do not engage either coreceptor. This hypothesis predicts that, in coreceptor-deficient mice, alpha beta thymocytes would be signaled by non-MHC ligands to differentiate into alpha beta T cells lacking MHC specificity. We now report that MHC-independent alpha beta T cells were indeed generated in mice deficient in both coreceptors as well as MHC ("quad-deficient" mice) and that such mice contained a diverse alpha beta T cell repertoire whose MHC independence was confirmed at the clonal level. We conclude that CD4 and CD8 coreceptors impose MHC specificity on a broader alpha beta TCR repertoire during thymic selection by preventing thymocytes from being signaled by non-MHC ligands.	NCI, Natl Inst Hlth, Expt Immunol Branch, Bethesda, MD 20892 USA; NCI, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Singer, A (corresponding author), Davidson Coll, Dept Biol, Davidson, NC 28035 USA.	singera@nih.gov	Park, Jung Hyun/B-5712-2015	Park, Jung Hyun/0000-0002-9547-9055	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bhandoola A, 1999, IMMUNITY, V10, P301, DOI 10.1016/S1074-7613(00)80030-8; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Chien YH, 2007, IMMUNOL REV, V215, P46, DOI 10.1111/j.1600-065X.2006.00470.x; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; EMMRICH F, 1986, P NATL ACAD SCI USA, V83, P8298, DOI 10.1073/pnas.83.21.8298; GORMAN SD, 1988, J IMMUNOL, V140, P3646; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; MARTH JD, 1986, P NATL ACAD SCI USA, V83, P7400, DOI 10.1073/pnas.83.19.7400; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; PAIGE LA, 1993, J BIOL CHEM, V268, P8669; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SUSSMAN JJ, 1988, J IMMUNOL, V140, P2520; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; Vidal K, 1996, J EXP MED, V183, P1311, DOI 10.1084/jem.183.4.1311; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZIJILSTRA M, 1990, NATURE, V344, P742	40	136	137	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV	2007	27	5					735	750		10.1016/j.immuni.2007.10.007	http://dx.doi.org/10.1016/j.immuni.2007.10.007			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18023370	Bronze			2022-12-18	WOS:000251269000008
J	Ehrlich, LIR; Ebert, PJR; Krummel, MF; Weiss, A; Davis, MM				Ehrlich, LIR; Ebert, PJR; Krummel, MF; Weiss, A; Davis, MM			Dynamics of p56lck translocation to the T cell immunological synapse following agonist and antagonist stimulation	IMMUNITY			English	Article							RECEPTOR SIGNAL-TRANSDUCTION; TYROSINE PROTEIN-KINASE; CROSS-LINKING; MICE LACKING; ACTIVATION; LCK; TCR; ANTIGEN; CD4; PHOSPHORYLATION	To study the spatio/temporal recruitment of lck during immunological synapse formation, we utilize highspeed time-lapse microscopy to visualize green fluorescent protein (GFP) fusions of lck and CD3zeta following agonist or altered peptide ligand (APL) stimulation. The dynamics of lck and CD3zeta recruitment are comparable; however, lck becomes excluded to the periphery of mature synapses, while most CD3zeta is centrally localized, suggesting a limited time frame within which lck can efficiently phosphorylate CD3zeta molecules during synapse maturation. Exposure of T cells to specific APLs affects the efficiency of conjugate formation and lck accumulation. Most surprisingly, we find an intracellular pool of lck associated with recycling endosomes that translocates to mature synapses within 10 min of calcium flux. This bolus of lck may contribute to intermediate-late signal transduction.	Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.			Davis, Mark/0000-0001-6868-657X				ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; ANDERSON P, 1987, J IMMUNOL, V139, P678; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; DESTGROTH BF, 1993, MOL MECH IMMUNOLOGIC, P123; Dittel BN, 1997, J IMMUNOL, V158, P4065; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; ENNS CA, 1981, P NATL ACAD SCI-BIOL, V78, P4222, DOI 10.1073/pnas.78.7.4222; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Huang J, 2000, EUR J IMMUNOL, V30, P50, DOI 10.1002/1521-4141(200001)30:1<50::AID-IMMU50>3.3.CO;2-9; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1987, J EXP MED, V165, P1565, DOI 10.1084/jem.165.6.1565; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lewis LA, 1997, J IMMUNOL, V159, P2292; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; Luton F, 1997, J IMMUNOL, V158, P3140; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; RUDD CE, 1991, ADV EXP MED BIOL, V292, P85; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1	50	136	142	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					809	822		10.1016/S1074-7613(02)00481-8	http://dx.doi.org/10.1016/S1074-7613(02)00481-8			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479826	Bronze			2022-12-18	WOS:000179985500012
J	Cascalho, M; Platt, JL				Cascalho, M; Platt, JL			The immunological barrier to xenotransplantation	IMMUNITY			English	Review							ACUTE VASCULAR REJECTION; ALPHA-GALACTOSYL EPITOPES; AORTIC ENDOTHELIAL-CELLS; NATURAL-KILLER-CELLS; DISCORDANT XENOGRAFTS; CARDIAC XENOGRAFTS; INNATE IMMUNITY; MIXED CHIMERISM; GRAFT-REJECTION; T-CELLS		Mayo Clin & Mayo Fdn, Dept Surg, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Pediat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Platt, JL (corresponding author), Mayo Clin & Mayo Fdn, Dept Surg, 200 1St St Sw, Rochester, MN 55905 USA.		Platt, Jeffrey/AHB-0480-2022	Platt, Jeffrey/0000-0002-4915-0419; Cascalho, Marilia/0000-0002-2695-3921				AlMohanna F, 1997, AM J PATHOL, V151, P111; ALTER BJ, 1990, J EXP MED, V171, P333, DOI 10.1084/jem.171.1.333; Artrip JH, 1999, J BIOL CHEM, V274, P10717, DOI 10.1074/jbc.274.16.10717; ATKINSON J P, 1991, Clinical and Experimental Immunology, V86, P27; Auchincloss H, 1998, ANNU REV IMMUNOL, V16, P433, DOI 10.1146/annurev.immunol.16.1.433; Bach FH, 1997, NAT MED, V3, P196, DOI 10.1038/nm0297-196; Bach FH, 1996, IMMUNOL TODAY, V17, P379, DOI 10.1016/0167-5699(96)10024-4; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Bracy JL, 1998, SCIENCE, V281, P1845, DOI 10.1126/science.281.5384.1845; BRAUER RB, 1993, J IMMUNOL, V151, P7240; Bustos M, 1997, TRANSPL P, V29, P886, DOI 10.1016/S0041-1345(96)00194-7; BUSTOS M, 2001, IN PRESS TRANSPLANTA; Cozzi E, 2000, TRANSPLANTATION, V70, P15; Diamond LE, 1996, TRANSPLANTATION, V61, P1241, DOI 10.1097/00007890-199604270-00021; Dorling A, 1996, EUR J IMMUNOL, V26, P1378, DOI 10.1002/eji.1830260630; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; GALILI U, 1988, J BIOL CHEM, V263, P17755; GALILI U, 1993, IMMUNOL TODAY, V14, P480, DOI 10.1016/0167-5699(93)90261-I; GELLER RL, 1993, TRANSPLANTATION, V55, P168, DOI 10.1097/00007890-199301000-00031; GOOD AH, 1992, TRANSPL P, V24, P559; GRITSCH HA, 1994, TRANSPLANTATION, V57, P906, DOI 10.1097/00007890-199403270-00024; Gunsalus JR, 1997, NAT MED, V3, P48, DOI 10.1038/nm0197-48; Hancock WW, 1998, NAT MED, V4, P1392, DOI 10.1038/3982; Holzknecht ZE, 2000, NAT MED, V6, P497, DOI 10.1038/74963; HOLZKNECHT ZE, 1995, J IMMUNOL, V154, P4565; Holzknecht ZE, 2001, AM J PATHOL, V158, P627, DOI 10.1016/S0002-9440(10)64004-7; HUMPHREYS T, 1994, IMMUNOL TODAY, V15, P316, DOI 10.1016/0167-5699(94)90079-5; Ierino FL, 1998, TRANSPLANTATION, V66, P1439, DOI 10.1097/00007890-199812150-00006; Inverardi L, 1997, TRANSPLANTATION, V63, P1318, DOI 10.1097/00007890-199705150-00021; INVERARDI L, 1992, J IMMUNOL, V149, P1416; Jurd KM, 1996, BLOOD COAGUL FIBRIN, V7, P336, DOI 10.1097/00001721-199604000-00008; Lawson JH, 1996, TRANSPLANTATION, V62, P303, DOI 10.1097/00007890-199608150-00001; Lin SS, 1998, J CLIN INVEST, V101, P1745, DOI 10.1172/JCI2134; Lin SS, 2000, TRANSPLANTATION, V70, P1667, DOI 10.1097/00007890-200012270-00002; Lin Y, 1998, J IMMUNOL, V160, P369; Lin Y, 1999, J IMMUNOL, V163, P2850; LINDAHL KF, 1976, J EXP MED, V144, P305, DOI 10.1084/jem.144.2.305; MCCURRY KR, 1995, NAT MED, V1, P423, DOI 10.1038/nm0595-423; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MOSES RD, 1992, TRANSPLANTATION, V53, P203, DOI 10.1097/00007890-199201000-00039; Muller WEG, 1999, TRANSPLANTATION, V68, P1215; MURRAY A, 1994, CH NEUR COMP SER, V2, P1; Nagayasu T, 2000, TRANSPLANTATION, V69, P475, DOI 10.1097/00007890-200002270-00003; Ohdan H, 1999, J CLIN INVEST, V104, P281, DOI 10.1172/JCI6656; Palmetshofer A, 1998, TRANSPLANTATION, V65, P844, DOI 10.1097/00007890-199803270-00013; Parker W, 1996, IMMUNOL TODAY, V17, P373, DOI 10.1016/0167-5699(96)10028-1; PIERSON RN, 1989, J EXP MED, V170, P991, DOI 10.1084/jem.170.3.991; Platt JL, 1998, XENOTRANSPLANTATION, V5, P169, DOI 10.1111/j.1399-3089.1998.tb00024.x; PLATT JL, 1990, IMMUNOL TODAY, V11, P450, DOI 10.1016/0167-5699(90)90174-8; Platt JL, 1998, NATURE, V392, P11; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Pratt JR, 1996, AM J PATHOL, V149, P2055; READ MA, 1994, J EXP MED, V179, P503, DOI 10.1084/jem.179.2.503; ROLLINS SA, 1994, TRANSPLANTATION, V57, P1709, DOI 10.1097/00007890-199406270-00004; Saadi S, 2000, CIRCULATION, V101, P1867, DOI 10.1161/01.CIR.101.15.1867; SAADI S, 1995, J EXP MED, V181, P21, DOI 10.1084/jem.181.1.21; SAADI S, 1995, J EXP MED, V182, P1807, DOI 10.1084/jem.182.6.1807; Sachs David H., 1995, Xenotransplantation, V2, P234, DOI 10.1111/j.1399-3089.1995.tb00101.x; SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391; SIBLEY DR, 1985, NATURE, V317, P124, DOI 10.1038/317124a0; Smyth MJ, 1999, TRANSPLANTATION, V68, P840, DOI 10.1097/00007890-199909270-00017; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; Yang YG, 1998, J EXP MED, V187, P1335, DOI 10.1084/jem.187.8.1335; YUZAWA Y, 1995, AM J PATHOL, V146, P1260	64	136	144	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					437	446		10.1016/S1074-7613(01)00124-8	http://dx.doi.org/10.1016/S1074-7613(01)00124-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336689	Bronze			2022-12-18	WOS:000168246700011
J	Baur, AS; Sass, G; Laffert, B; Willbold, D; ChengMayer, C; Peterlin, BM				Baur, AS; Sass, G; Laffert, B; Willbold, D; ChengMayer, C; Peterlin, BM			The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; ACCESSORY PROTEINS; ANTIGEN RECEPTOR; DOWN-REGULATION; SURFACE CD4; IN-VITRO; HIV; REPLICATION; LYMPHOCYTES	The Nef protein of human and primate lentiviruses is a key factor in HIV/SIV pathogenesis. Here we report that Nef associates with two different kinases, forming a multiprotein complex at the far N-terminus of the viral protein. One of the kinases was identified as Lck, whereas the second protein was found to be a serine kinase that phosphorylated Nef and Lck in vitro and could be discriminated from the serine kinase identified previously. The Nef-associated kinase complex (NAKC) was demonstrated in COS cells, in HIV-infected cells, and in vitro using recombinant Lck and Nef proteins. Deletion of a short amphipathic alpha-helix in the N-terminus, which was found to be conserved in all Nef proteins, inhibited association of the NAKC and significantly reduced virion infectivity.	UNIV BAYREUTH,LEHRSTUHL STRUKTUR & CHEM BIOPOLYMERE,D-95440 BAYREUTH,GERMANY; AARON DIAMOND AIDS RES CTR,NEW YORK,NY 10016; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	University of Bayreuth; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Baur, AS (corresponding author), UNIV ERLANGEN NURNBERG,INST KLIN & MOL VIROL,D-91054 ERLANGEN,GERMANY.		Willbold, Dieter/A-6280-2013	Willbold, Dieter/0000-0002-0065-7366				AIKEN C, 1994, CELL, V76, P83; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; BAUR AS, 1996, 1996 I HUM VIR ANN M; BODEUS M, 1995, J GEN VIROL, V76, P1337, DOI 10.1099/0022-1317-76-6-1337; Bukrinskaya AG, 1996, P NATL ACAD SCI USA, V93, P367, DOI 10.1073/pnas.93.1.367; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; CULLEN BR, 1995, AIDS SA, V9, P19; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; DU ZJ, 1995, CELL, V82, P665, DOI 10.1016/0092-8674(95)90038-1; FREUND J, 1994, EUR J BIOCHEM, V223, P589, DOI 10.1111/j.1432-1033.1994.tb19029.x; FREUND J, 1994, EUR J BIOCHEM, V221, P811, DOI 10.1111/j.1432-1033.1994.tb18795.x; GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; GARCIA JV, 1993, J VIROL, V67, P1511, DOI 10.1128/JVI.67.3.1511-1516.1993; GOLDSMITH MA, 1995, J VIROL, V69, P4112, DOI 10.1128/JVI.69.7.4112-4121.1995; GREENWAY A, 1995, J VIROL, V69, P1842, DOI 10.1128/JVI.69.3.1842-1850.1995; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lu XB, 1996, CURR BIOL, V6, P1677, DOI 10.1016/S0960-9822(02)70792-6; LURIA S, 1991, P NATL ACAD SCI USA, V88, P5326, DOI 10.1073/pnas.88.12.5326; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; NIEDERMAN TMJ, 1992, J VIROL, V66, P6213, DOI 10.1128/JVI.66.10.6213-6219.1992; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SAWAI ET, 1995, J BIOL CHEM, V270, P15307, DOI 10.1074/jbc.270.25.15307; SAWAI ET, 1994, P NATL ACAD SCI USA, V91, P1539, DOI 10.1073/pnas.91.4.1539; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SUBBRAMANIAN RA, 1994, J VIROL, V68, P6831, DOI 10.1128/JVI.68.11.6831-6835.1994; TRONO D, 1995, CELL, V82, P189, DOI 10.1016/0092-8674(95)90306-2; ZAZOPOULOS E, 1993, VIROLOGY, V194, P20, DOI 10.1006/viro.1993.1230	36	136	140	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					283	291		10.1016/S1074-7613(00)80331-3	http://dx.doi.org/10.1016/S1074-7613(00)80331-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075929	Bronze			2022-12-18	WOS:A1997XC61800008
J	Sylvestre, DL; Ravetch, JV				Sylvestre, DL; Ravetch, JV			A dominant role for mast cell Fc receptors in the Arthus reaction	IMMUNITY			English	Article							HETEROGENEITY; MOUSE; MICE	Antibody-antigen complexes are central to the inflammatory response and are implicated in the development of such diverse diseases as systemic lupus erythematosis, rheumatoid arthritis, immune glomerulonephritis, and vasculitis. We recently demonstrated that experimental immune complex-mediated injury in mice, as modeled by the cutaneous Arthus reaction, requires receptors for the Fc portion of the antibody and is unaffected by deficiencies in complement components. However, the responsible cell type(s) and Fc receptor(s) were not known. We now demonstrate by differential reconstitution in vivo that Fc gamma RIII on mast cells is necessary for this inflammatory response. We propose a general model of antibody-mediated diseases as an immunopathologic spectrum whose specific manifestations are determined by the Fc receptor and cell type engaged.			Sylvestre, DL (corresponding author), MEM SLOAN KETTERING CANC CTR,DIV MOL BIOL,1275 YORK AVE,NEW YORK,NY 10021, USA.		Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041				Arthus M, 1903, CR SOC BIOL, V55, P817; ESPOSITOFARESE ME, 1995, J IMMUNOL, V155, P1725; GALLI SJ, 1990, LAB INVEST, V62, P5; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; SYLVESTRE DL, 1996, IN PRESS J EXP MED; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; WALKER M, 1985, P SOC EXP BIOL MED, V180, P323; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; ZHANG Y, 1991, J CLIN INVEST, V88, P841, DOI 10.1172/JCI115385	12	136	173	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1996	5	4					387	390		10.1016/S1074-7613(00)80264-2	http://dx.doi.org/10.1016/S1074-7613(00)80264-2			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VP444	8885871	Bronze			2022-12-18	WOS:A1996VP44400010
J	Han, SJ; Zaretsky, AG; Andrade-Oliveira, V; Collins, N; Dzutsev, A; Shaik, J; da Fonseca, DM; Harrison, OJ; Tamoutounour, S; Byrd, AL; Smelkinson, M; Bouladoux, N; Bliska, JB; Brenchley, JM; Brodsky, IE; Belkaid, Y				Han, Seong-Ji; Zaretsky, Arielle Glatman; Andrade-Oliveira, Vinicius; Collins, Nicholas; Dzutsev, Amiran; Shaik, Jahangheer; da Fonseca, Denise Morais; Harrison, Oliver J.; Tamoutounour, Samira; Byrd, Allyson L.; Smelkinson, Margery; Bouladoux, Nicolas; Bliska, James B.; Brenchley, Jason M.; Brodsky, Igor E.; Belkaid, Yasmine			White Adipose Tissue Is a Reservoir for Memory T Cells and Promotes Protective Memory Responses to Infection	IMMUNITY			English	Article							METABOLIC HOMEOSTASIS; IMMUNE-RESPONSE; DENDRITIC CELLS; FAT; CYTOKINES; LOCALIZATION; INFLAMMATION; PERMEABILITY; MIGRATION; SUPPORT	White adipose tissue bridges body organs and plays a fundamental role in host metabolism. To what extent adipose tissue also contributes to immune surveillance and long-term protective defense remains largely unknown. Here, we have shown that at steady state, white adipose tissue contained abundantmemory lymphocyte populations. After infection, white adipose tissue accumulated large numbers of pathogen-specific memory T cells, including tissue-resident cells. Memory T cells in white adipose tissue expressed a distinct metabolic profile, and white adipose tissue from previously infected mice was sufficient to protect uninfected mice from lethal pathogen challenge. Induction of recall responses within white adipose tissue was associated with the collapse of lipid metabolism in favor of antimicrobial responses. Our results suggest that white adipose tissue represents a memory T cell reservoir that provides potent and rapid effector memory responses, positioning this compartment as a potential major contributor to immunological memory.	[Han, Seong-Ji; Zaretsky, Arielle Glatman; Andrade-Oliveira, Vinicius; Collins, Nicholas; Shaik, Jahangheer; da Fonseca, Denise Morais; Harrison, Oliver J.; Tamoutounour, Samira; Byrd, Allyson L.; Bouladoux, Nicolas; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Dzutsev, Amiran] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Byrd, Allyson L.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Byrd, Allyson L.] Boston Univ, Dept Bioinformat, Boston, MA 02215 USA; [Smelkinson, Margery] NIAID, Biol Imaging, Res Technol Branch, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Bouladoux, Nicolas; Belkaid, Yasmine] NIAID, Microbiome Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Bliska, James B.] SUNY Stony Brook, Dept Mol Genet & Microbiol, 238 Ctr Mol Med, Stony Brook, NY 11794 USA; [Brenchley, Jason M.] NIAID, Barrier Immun Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Brodsky, Igor E.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [da Fonseca, Denise Morais] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Universidade de Sao Paulo	Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Belkaid, Y (corresponding author), NIAID, Microbiome Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Brenchley, Jason/AAC-5085-2019; Fonseca, Denise/E-7419-2012; de Andrade Oliveira, Vinicius/S-1176-2019	Fonseca, Denise/0000-0001-8310-0186; de Andrade Oliveira, Vinicius/0000-0002-0426-1828; Brenchley, Jason/0000-0001-8357-2984; Smelkinson, Margery/0000-0001-7777-5574; Harrison, Oliver/0000-0003-1515-9586	National Institute of Allergy and Infectious Diseases (NIAID) Division of Intramural Research [1ZIAAI001132]; National Institutes of Health [R01AI099222, AI103062]; Helen Hay Whitney Foundation; Pew Charitable Trusts; EMBO; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103062, ZIAAI001029, ZIAAI001132, ZICAI001051, R01AI099222, ZICAI001233] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) Division of Intramural Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Pew Charitable Trusts; EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) Division of Intramural Research grant 1ZIAAI001132, National Institutes of Health grants R01AI099222 (J.B.B.) and AI103062 (I.E.B.), the Helen Hay Whitney Foundation (A.G.Z), the PEW Latin American Fellowship from the Pew Charitable Trusts (V.A.-O.), and an EMBO Long-Term Fellowship (S.T.). We thank the NIAID animal facility; the NIAID Flow Cytometry facility; O. Schwartz and the NIAID Biological Imaging facility; the NIH Tetramer Core Facility; and K. Beacht, J. Legrand, N. Bubunenko, D. Sun, R. Winkler-Pickett, S.Q. Lee-Lin, and J. Davis for technical assistance. We thank the members of the Belkaid laboratory for critical reading of the manuscript and helpful discussions.	Aldrich MB, 2013, CYTOKINE, V64, P362, DOI 10.1016/j.cyto.2013.05.015; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Azeez OI, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-71; Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Bergman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000573; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; Cohen SB, 2015, PARASITE IMMUNOL, V37, P108, DOI 10.1111/pim.12164; Collins N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11514; Couturier J, 2015, AIDS, V29, P667, DOI 10.1097/QAD.0000000000000599; Cromer WE, 2014, ANGIOGENESIS, V17, P395, DOI 10.1007/s10456-013-9393-2; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; Damouche A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005153; DiSpirito JR, 2015, SEMIN IMMUNOL, V27, P315, DOI 10.1016/j.smim.2015.10.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gericke M, 2015, AM J PHYSIOL-ENDOC M, V308, pE1023, DOI 10.1152/ajpendo.00075.2015; Jackson-Jones LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12651; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jones DD, 2015, INFECT IMMUN, V83, P2139, DOI 10.1128/IAI.00295-15; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lugli E, 2013, J CLIN INVEST, V123, P594, DOI 10.1172/JCI66327; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Ferreira AVM, 2011, MICROBES INFECT, V13, P1002, DOI 10.1016/j.micinf.2011.06.002; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/NMETH.1938, 10.1038/nmeth.1938]; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Odegaard JI, 2015, CURR OPIN IMMUNOL, V36, P67, DOI 10.1016/j.coi.2015.07.003; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pichyangkul S, 2015, J IMMUNOL, V195, P4378, DOI 10.4049/jimmunol.1501702; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Rajan SS, 2016, IMMUNOLOGY, V149, P353, DOI 10.1111/imm.12653; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Scallan JP, 2013, J PHYSIOL-LONDON, V591, P5071, DOI 10.1113/jphysiol.2013.260042; Scallan JP, 2010, J PHYSIOL-LONDON, V588, P243, DOI 10.1113/jphysiol.2009.179622; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Teixeira L, 2015, IMMUNOLOGY, V145, P242, DOI 10.1111/imm.12440; Trindade S, 2016, CELL HOST MICROBE, V19, P837, DOI 10.1016/j.chom.2016.05.002; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972; Zhang Y, 2014, INFECT IMMUN, V82, P3033, DOI 10.1128/IAI.01687-14; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	72	135	138	3	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1154	+		10.1016/j.immuni.2017.11.009	http://dx.doi.org/10.1016/j.immuni.2017.11.009			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29221731	Green Accepted, Bronze			2022-12-18	WOS:000418486500018
J	Xu, MM; Pu, Y; Han, DL; Shi, YY; Cao, XZ; Liang, H; Chen, X; Li, XD; Deng, LF; Chen, ZJ; Weichselbaum, RR; Fu, YX				Xu, Meng Michelle; Pu, Yang; Han, Dali; Shi, Yaoyao; Cao, Xuezhi; Liang, Hua; Chen, Xiang; Li, Xiao-Dong; Deng, Liufu; Chen, Zhijian J.; Weichselbaum, Ralph R.; Fu, Yang-Xin			Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein alpha Signaling	IMMUNITY			English	Article							GMP-AMP SYNTHASE; INNATE IMMUNE RECOGNITION; HEMATOPOIETIC STEM-CELLS; CONTROLS PHAGOSOMAL PH; NON-HODGKIN-LYMPHOMA; IMMUNOGENIC TUMORS; MEDIATED PHAGOCYTOSIS; THERAPEUTIC TARGET; NADPH OXIDASE; SIRP-ALPHA	Inhibition of cytosolic DNA sensing represents a strategy that tumor cells use for immune evasion, but the underlying mechanisms are unclear. Here we have shown that CD47-signal regulatory protein alpha (SIRP alpha) axis dictates the fate of ingested DNA in DCs for immune evasion. Although macrophages were more potent in uptaking tumor DNA, increase of DNA sensing by blocking the interaction of SIRP alpha with CD47 preferentially occurred in dendritic cells (DCs) but not in macrophages. Mechanistically, CD47 blockade enabled the activation of NADPH oxidase NOX2 in DCs, which in turn inhibited phagosomal acidification and reduced the degradation of tumor mitochondrial DNA (mtDNA) in DCs. mtDNA was recognized by cyclic-GMP-AMP synthase (cGAS) in the DC cytosol, contributing to type I interferon (IFN) production and antitumor adaptive immunity. Thus, our findings have demonstrated how tumor cells inhibit innate sensing in DCs and suggested that the CD47-SIRP alpha axis is critical for DC-driven antitumor immunity.	[Xu, Meng Michelle; Pu, Yang; Fu, Yang-Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75235 USA; [Han, Dali; Liang, Hua; Li, Xiao-Dong] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Cao, Xuezhi; Deng, Liufu; Weichselbaum, Ralph R.] Univ Texas SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Chicago; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fu, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75235 USA.	yang-xin.fu@utsouthwestern.edu	Han, Dali/I-4145-2016; Deng, Liufu/AAG-7244-2021; Chen, Zhijian/C-6039-2012	Deng, Liufu/0000-0002-1164-6777; Chen, Zhijian/0000-0002-8475-8251; Cao, Xuezhi/0000-0002-3602-4560; Li, Xiao-Dong/0000-0002-4349-6996	U.S. National Cancer Institute [CA141975]; Cancer Prevention and Research Institute of Texas [RR150072]; Ludwig Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA134563, R01CA141975] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas; Ludwig Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Amy Huser and Daryl Harmon for excellent editing. This work was in part supported by the U.S. National Cancer Institute grant CA141975 and the Cancer Prevention and Research Institute of Texas (RR150072) to Y.-X.F. and also in part by Ludwig Foundation for Cancer Research to R.R.W.	Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338; Blaauboer SM, 2015, ELIFE, V4, DOI 10.7554/eLife.06670; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Chamilos G, 2012, BLOOD, V120, P3699, DOI 10.1182/blood-2012-01-401364; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chao MP, 2011, BLOOD, V118, P4890, DOI 10.1182/blood-2011-02-338020; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Danielsen JMR, 2007, BRIT J HAEMATOL, V138, P756, DOI 10.1111/j.1365-2141.2007.06729.x; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Ding YY, 2016, NAT IMMUNOL, V17, P1167, DOI 10.1038/ni.3535; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jin L, 2013, J IMMUNOL, V190, P2835, DOI 10.4049/jimmunol.1201788; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Peitsch Manuel C., 1994, Trends in Cell Biology, V4, P37, DOI 10.1016/0962-8924(94)90002-7; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Shen YJ, 2015, CELL REP, V11, P460, DOI 10.1016/j.celrep.2015.03.041; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Sockolosky JT, 2016, P NATL ACAD SCI USA, V113, pE2646, DOI 10.1073/pnas.1604268113; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Weiskopf K, 2016, J CLIN INVEST, V126, P2610, DOI 10.1172/JCI81603; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xu MM, 2017, ONCOGENE, V36, P585, DOI 10.1038/onc.2016.231; Zhang ZY, 2015, IMMUNITY, V43, P1137, DOI 10.1016/j.immuni.2015.10.018	53	135	141	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					363	+		10.1016/j.immuni.2017.07.016	http://dx.doi.org/10.1016/j.immuni.2017.07.016			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28801234	Green Accepted, Bronze			2022-12-18	WOS:000407788300020
J	St Leger, AJ; Desai, JV; Drummond, RA; Kugadas, A; Almaghrabi, F; Silver, P; Raychaudhuri, K; Gadjeva, M; Iwakura, Y; Lionakis, MS; Caspi, RR				St Leger, Anthony J.; Desai, Jigar V.; Drummond, Rebecca A.; Kugadas, Abirami; Almaghrabi, Fatimah; Silver, Phyllis; Raychaudhuri, Kumarkrishna; Gadjeva, Mihaela; Iwakura, Yoichiro; Lionakis, Michail S.; Caspi, Rachel R.			An Ocular Commensal Protects against Corneal Infection by Driving an Interleukin-17 Response from Mucosal gamma delta T Cells	IMMUNITY			English	Article							LYMPHOID-TISSUE; CANDIDA-ALBICANS; MICROBIOME; DISEASE; SKIN; INFLAMMATION; RESISTANCE; DIVERSITY; KERATITIS; BACTERIA	Mucosal sites such as the intestine, oral cavity, nasopharynx, and vagina all have associated commensal flora. The surface of the eye is also a mucosal site, but proof of a living, resident ocular microbiome remains elusive. Here, we used a mouse model of ocular surface disease to reveal that commensals were present in the ocular mucosa and had functional immunological consequences. We isolated one such candidate commensal, Corynebacterium mastitidis, and showed that this organism elicited a commensal-specific interleukin-17 response from gamma delta T cells in the ocular mucosa that was central to local immunity. The commensal-specific response drove neutrophil recruitment and the release of antimicrobials into the tears and protected the eye from pathogenic Candida albicans or Pseudomonas aeruginosa infection. Our findings provide direct evidence that a resident commensal microbiome exists on the ocular surface and identify the cellular mechanisms underlying its effects on ocular immune homeostasis and host defense.	[St Leger, Anthony J.; Almaghrabi, Fatimah; Silver, Phyllis; Raychaudhuri, Kumarkrishna; Caspi, Rachel R.] NEI, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Desai, Jigar V.; Drummond, Rebecca A.; Lionakis, Michail S.] NIAID, Fungal Pathogenesis Unit, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kugadas, Abirami; Gadjeva, Mihaela] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA USA; [Iwakura, Yoichiro] Tokyo Univ Sci, Inst Med Sci, Ctr Expt Anim Models, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tokyo University of Science	Caspi, RR (corresponding author), NEI, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	caspir@mail.nih.gov	Desai, Jigar V/I-3109-2019; Raychaudhuri, Kumarkrishna/AAB-4589-2021; Drummond, Rebecca/I-3155-2019; Lionakis, Michail/J-8840-2017	Raychaudhuri, Kumarkrishna/0000-0001-5198-8651; Drummond, Rebecca/0000-0001-5424-7074; Lionakis, Michail/0000-0003-4994-9500; St. Leger, Anthony/0000-0002-2547-200X; Caspi, Rachel/0000-0002-7140-7671; Desai, Jigar/0000-0002-8823-0796	NIH [NEI EY000184, K99EY025761, R01EY022054]; NIAID [AI001175]; Prevention of Blindness Society of Metropolitan Washington; American Association of Immunology Fellowship Award; NATIONAL EYE INSTITUTE [R01EY022054, R00EY025761, ZICEY000457, ZIAEY000184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Prevention of Blindness Society of Metropolitan Washington; American Association of Immunology Fellowship Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank The NEI Flow Cytometry Core for assistance in cell sorting and analysis and Dr. Marco Colonna for sharing Tcrb<SUP>-/-</SUP>Tcrd<SUP>-/-</SUP> mice maintained in his colony. This work was supported by NIH Intramural funding, projects number NEI EY000184 (R.R.C.) and NIAID AI001175 (M.S.L.). This work was also supported by grants K99EY025761 (A.J.S.) and R01EY022054 (M.G.) from NIH as well as grants from the Prevention of Blindness Society of Metropolitan Washington (A.J.S.) and the American Association of Immunology Fellowship Award (M.G.).	Agnifili L, 2014, INVEST OPHTH VIS SCI, V55, P5254, DOI 10.1167/iovs.14-14365; Bernard KA, 2016, INT J SYST EVOL MICR, V66, P2803, DOI 10.1099/ijsem.0.001059; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Cortes LM, 2008, INVEST OPHTH VIS SCI, V49, P1946, DOI 10.1167/iovs.07-0868; de Paiva CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23561; DENT AL, 1990, NATURE, V343, P714, DOI 10.1038/343714a0; Dias C, 2013, SCI WORLD J, DOI 10.1155/2013/163582; Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939; Eguchi H, 2008, J CLIN MICROBIOL, V46, P527, DOI 10.1128/JCM.01741-07; Fan D, 2015, NAT MED, V21, P808, DOI 10.1038/nm.3871; Ferrer J, 2000, INT J GYNECOL OBSTET, V71, pS21, DOI 10.1016/S0020-7292(00)00350-7; Gadjeva M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000826; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Graham Joanna E, 2007, Invest Ophthalmol Vis Sci, V48, P5616; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Knop E, 2005, J ANAT, V206, P271, DOI 10.1111/j.1469-7580.2005.00394.x; Knop N, 2000, INVEST OPHTH VIS SCI, V41, P1270; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Kugadas A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005855; Lakhundi S, 2017, MICROB PATHOGENESIS, V104, P97, DOI 10.1016/j.micpath.2016.12.013; Lashof AMLO, 2011, CLIN INFECT DIS, V53, P262, DOI 10.1093/cid/cir355; Lee SH, 2012, INVEST OPHTH VIS SCI, V53, P5585, DOI 10.1167/iovs.12-9922; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nivenius E, 2015, ACTA OPHTHALMOL, V93, P579, DOI 10.1111/aos.12708; PRESTON MJ, 1995, INFECT IMMUN, V63, P3497, DOI 10.1128/IAI.63.9.3497-3501.1995; Ramirez-Valle F, 2015, P NATL ACAD SCI USA, V112, P8046, DOI 10.1073/pnas.1508990112; ROMANO A, 1976, OPHTHALMOLOGICA, V172, P282, DOI 10.1159/000307726; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Shin H, 2016, MBIO, V7, DOI 10.1128/mBio.00198-16; Siebelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082355; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; Thomas PA, 2013, CLIN MICROBIOL INFEC, V19, P210, DOI 10.1111/1469-0691.12126; Tong L, 2014, OCUL SURF, V12, P23, DOI 10.1016/j.jtos.2013.10.001; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Welch JLM, 2016, P NATL ACAD SCI USA, V113, pE791, DOI 10.1073/pnas.1522149113; Willcox MDP, 2013, EXP EYE RES, V117, P99, DOI 10.1016/j.exer.2013.06.003; Willger SD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-40; Zaidi T, 2014, INFECT IMMUN, V82, P3483, DOI 10.1128/IAI.01951-14; Zaidi TS, 2012, INFECT IMMUN, V80, P3706, DOI 10.1128/IAI.00249-12; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035700, 10.1371/journal.pone.0035991]; Zhou Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0099-x	46	135	135	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					148	+		10.1016/j.immuni.2017.06.014	http://dx.doi.org/10.1016/j.immuni.2017.06.014			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28709803	Green Accepted, Bronze			2022-12-18	WOS:000405712800016
J	Duffy, D; Rouilly, V; Libri, V; Hasan, M; Beitz, B; David, M; Urrutia, A; Bisiaux, A; LaBrie, ST; Dubois, A; Boneca, IG; Delval, C; Thomas, S; Rogge, L; Schmolz, M; Quintana-Murci, L; Albert, ML				Duffy, Darragh; Rouilly, Vincent; Libri, Valentina; Hasan, Milena; Beitz, Benoit; David, Mikael; Urrutia, Alejandra; Bisiaux, Aurelie; LaBrie, Samuel T.; Dubois, Annick; Boneca, Ivo G.; Delval, Cecile; Thomas, Stephanie; Rogge, Lars; Schmolz, Manfred; Quintana-Murci, Lluis; Albert, Matthew L.		Milieu Interieur Consortium	Functional Analysis via Standardized Whole-Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli	IMMUNITY			English	Article							TNF-ALPHA PRODUCTION; HELICOBACTER-PYLORI; GENE-EXPRESSION; DIFFERENTIAL ROLES; PERIPHERAL-BLOOD; RIG-I; STAPHYLOCOCCUS-EPIDERMIDIS; BIOLOGICAL-ACTIVITIES; IFN-GAMMA; RECOGNITION	Standardization of immunophenotyping procedures has become a high priority. We have developed a suite of whole-blood, syringe-based assay systems that can be used to reproducibly assess induced innate or adaptive immune responses. By eliminating preanalytical errors associated with immune monitoring, we have defined the protein signatures induced by (1) medically relevant bacteria, fungi, and viruses; (2) agonists specific for defined host sensors; (3) clinically employed cytokines; and (4) activators of T cell immunity. Our results provide an initial assessment of healthy donor reference values for induced cytokines and chemokines and we report the failure to release interleukin-1 alpha as a common immunological phenotype. The observed naturally occurring variation of the immune response may help to explain differential susceptibility to disease or response to therapeutic intervention. The implementation of a general solution for assessment of functional immune responses will help support harmonization of clinical studies and data sharing.	[Duffy, Darragh; Rouilly, Vincent; Libri, Valentina; Hasan, Milena; Beitz, Benoit; David, Mikael; Urrutia, Alejandra; Thomas, Stephanie; Rogge, Lars; Albert, Matthew L.] Inst Pasteur, Ctr Human Immunol, F-75015 Paris, France; [Duffy, Darragh; Urrutia, Alejandra; Bisiaux, Aurelie; Thomas, Stephanie; Albert, Matthew L.] INSERM, U818, F-75015 Paris, France; [Duffy, Darragh; Urrutia, Alejandra; Bisiaux, Aurelie; Thomas, Stephanie; Albert, Matthew L.] Inst Pasteur, Dept Immunol, Lab Dendrit Cell Immunobiol, F-75015 Paris, France; [Rouilly, Vincent] Inst Pasteur, Ctr Bioinformat, F-75015 Paris, France; [LaBrie, Samuel T.] Myriad Rules Based Med Inc, Austin, TX 78759 USA; [Dubois, Annick; Delval, Cecile] Inst Pasteur, Ctr Integrat Clin Res, F-75015 Paris, France; [Boneca, Ivo G.] Inst Pasteur, Dept Microbiol, Lab Biol & Genet Bacterial Cell Wall, F-75015 Paris, France; [Boneca, Ivo G.] INSERM, Equipe Avenir, F-75015 Paris, France; [Rogge, Lars] Inst Pasteur, Dept Immunol, Immunoregulat Lab, F-75015 Paris, France; [Schmolz, Manfred] Myriad Rules Based Med Inc, D-72770 Reutlingen, Germany; [Quintana-Murci, Lluis] Inst Pasteur, Dept Genomes & Genet, Lab Human Evolutionary Genet, F-75015 Paris, France; [Quintana-Murci, Lluis] CNRS, URA3012, F-75015 Paris, France; [Albert, Matthew L.] INSERM, UMS20, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Quintana-Murci, L (corresponding author), Inst Pasteur, Ctr Human Immunol, F-75015 Paris, France.	quintana@pasteur.fr; albertm@pasteur.fr	Rogge, Lars/GYJ-6142-2022; Hasan, Milena/AAO-6610-2021; Boneca, Ivo G/H-1677-2014; Pellegrini, Sandra -/G-5546-2015; Quintana-Murci, Lluis/AAB-7468-2022; Demangel, Caroline/H-9570-2014; BOUSSO, Philippe/M-6547-2014; Pellegrini, Sandra/Y-6351-2019; Albert, Matthew L/C-9782-2009; Abel, Laurent/H-8888-2017; , Milieu Interieur Consortium/J-8100-2017; tartour, eric/O-7957-2017	Hasan, Milena/0000-0002-0879-7099; Boneca, Ivo G/0000-0001-8122-509X; Pellegrini, Sandra -/0000-0001-5837-7589; Demangel, Caroline/0000-0001-7848-586X; BOUSSO, Philippe/0000-0002-6362-561X; Pellegrini, Sandra/0000-0001-5837-7589; Abel, Laurent/0000-0001-7016-6493; Alcover, Andres/0000-0002-9507-3450; Rogge, Lars/0000-0003-1262-9204; Bisiaux, Aurelie/0000-0002-2447-3393; Urrutia, Alejandra/0000-0002-1691-4531; , Milieu Interieur Consortium/0000-0002-8830-277X; tartour, eric/0000-0002-7323-468X; Libri, Valentina/0000-0002-2080-1089; Quintana-Murci, Lluis/0000-0003-2429-6320; Shorte, Spencer/0000-0002-2125-8663; Eberl, Gerard/0000-0002-1119-5638	French government's Invest in the Future Program [10-LABX-69-01]	French government's Invest in the Future Program	This work benefited from support of the French government's Invest in the Future Program, managed by the Agence Nationale de la Recherche (ANR, reference 10-LABX-69-01). We also acknowledge A. Pugsley for his support in obtaining funding and the logistical aspects of initiating the project.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Bekeredjian-Ding I, 2006, J IMMUNOL, V176, P7438, DOI 10.4049/jimmunol.176.12.7438; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Borriello SP, 2003, CLIN INFECT DIS, V36, P775, DOI 10.1086/368080; Braga-Neto UM, 2006, PLOS COMPUT BIOL, V2, P651, DOI 10.1371/journal.pcbi.0020081; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; CEUPPENS JL, 1985, J IMMUNOL, V134, P1498; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chen JW, 2010, J IMMUNOL METHODS, V357, P33, DOI 10.1016/j.jim.2010.03.006; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; DEGROOTE D, 1992, CYTOKINE, V4, P239, DOI 10.1016/1043-4666(92)90062-V; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DIGEL W, 1983, J INTERFERON RES, V3, P65, DOI 10.1089/jir.1983.3.65; Dinarello CA, 2012, BLOOD, V120, P2538, DOI 10.1182/blood-2012-08-445254; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; ESKOLA J, 1975, IMMUNOL COMMUN, V4, P297, DOI 10.3109/08820137509055781; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; Folds James D., 2003, Journal of Allergy and Clinical Immunology, V111, pS702; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Godaly G, 2005, CELL MICROBIOL, V7, P591, DOI 10.1111/j.1462-5822.2004.00489.x; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ida JA, 2006, J IMMUNOL METHODS, V310, P86, DOI 10.1016/j.jim.2005.12.008; Jozefowski S, 2011, MICROB PATHOGENESIS, V50, P350, DOI 10.1016/j.micpath.2011.03.001; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai K, 2013, CANCER SCI, V104, P22, DOI 10.1111/cas.12075; KIRCHNER H, 1982, J IMMUNOL METHODS, V48, P213, DOI 10.1016/0022-1759(82)90195-8; KOLB WP, 1968, P NATL ACAD SCI USA, V61, P1250, DOI 10.1073/pnas.61.4.1250; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krishna S, 2012, CURR OPIN MICROBIOL, V15, P28, DOI 10.1016/j.mib.2011.11.003; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579; Lee SK, 2003, MICROBES INFECT, V5, P1345, DOI 10.1016/j.micinf.2003.09.018; Liu-Bryan R, 2005, J IMMUNOL, V174, P5016, DOI 10.4049/jimmunol.174.8.5016; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Means TK, 1999, J IMMUNOL, V163, P3920; Miettinen M, 2008, J LEUKOCYTE BIOL, V84, P1092, DOI 10.1189/jlb.1206737; NERAD JL, 1992, J LEUKOCYTE BIOL, V52, P687, DOI 10.1002/jlb.52.6.687; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; NORRBY E, 1992, VET MICROBIOL, V33, P275, DOI 10.1016/0378-1135(92)90055-X; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Romano M, 2012, EXPERT OPIN BIOL TH, V12, P1601, DOI 10.1517/14712598.2012.721768; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schmolz M, 2004, EXP GERONTOL, V39, P667, DOI 10.1016/j.exger.2003.09.029; Shibata K, 1997, FEMS IMMUNOL MED MIC, V19, P275, DOI 10.1016/S0928-8244(97)00093-X; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stuyt RJL, 2003, CYTOKINE, V21, P65, DOI 10.1016/S1043-4666(02)00501-X; Stuyt RJL, 2001, INFECT IMMUN, V69, P5025, DOI 10.1128/IAI.69.8.5025-5030.2001; Sun X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074595; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; TAX WJM, 1983, NATURE, V304, P445, DOI 10.1038/304445a0; Torri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009404; VILJANEN MK, 1990, LANCET, V336, P831, DOI 10.1016/0140-6736(90)92337-H; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhao Y, 2007, J MED MICROBIOL, V56, P154, DOI 10.1099/jmm.0.46882-0; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	84	135	139	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					436	450		10.1016/j.immuni.2014.03.002	http://dx.doi.org/10.1016/j.immuni.2014.03.002			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24656047	Bronze			2022-12-18	WOS:000333422300016
J	van Loosdregt, J; Fleskens, V; Tiemessen, MM; Mokry, M; van Boxtel, R; Meerding, J; Pals, CEGM; Kurek, D; Baert, MRM; Delemarre, EM; Grone, A; Koerkamp, MJAG; Sijts, AJAM; Nieuwenhuis, EES; Maurice, MM; van Es, JH; ten Berge, D; Holstege, FC; Staal, FJT; Zaiss, DMW; Prakken, BJ; Coffer, PJ				van Loosdregt, Jorg; Fleskens, Veerle; Tiemessen, Machteld M.; Mokry, Michal; van Boxtel, Ruben; Meerding, Jenny; Pals, Cornelieke E. G. M.; Kurek, Dorota; Baert, Miranda R. M.; Delemarre, Eveline M.; Groene, Andrea; Koerkamp, Marianne J. A. Groot; Sijts, Alice J. A. M.; Nieuwenhuis, Edward E. S.; Maurice, Madelon M.; van Es, Johan H.; ten Berge, Derk; Holstege, Frank C.; Staal, Frank J. T.; Zaiss, Dietmar M. W.; Prakken, Berent J.; Coffer, Paul J.			Canonical Wnt Signaling Negatively Modulates Regulatory T Cell Function	IMMUNITY			English	Article							BETA-CATENIN; STEM-CELLS; FOXP3 OCCUPANCY; LITHIUM-THERAPY; DIFFERENTIATION; STABILIZATION; ENTEROPATHY; ACTIVATION; EXPRESSION; ARTHRITIS	Foxp3 is crucial for both the development and function of regulatory T (Treg) cells; however, the posttranslational mechanisms regulating Foxp3 transcriptional output remain poorly defined. Here, we demonstrate that T cell factor 1 (TCF1) and Foxp3 associates in Treg cells and that active Wnt signaling disrupts Foxp3 transcriptional activity. A global chromatin immunoprecipitation sequencing comparison in Treg cells revealed considerable overlap between Foxp3 and Wnt target genes. The activation of Wnt signaling reduced Treg-mediated suppression both in vitro and in vivo, whereas disruption of Wnt signaling in Treg cells enhanced their suppressive capacity. The activation of effector T cells increased Wnt3a production, and Wnt3a levels were found to be greatly increased in mononuclear cells isolated from synovial fluid versus peripheral blood of arthritis patients. We propose a model in which Wnt produced under inflammatory conditions represses Treg cell function, allowing a productive immune response, but, if uncontrolled, could lead to the development of autoimmunity.	[van Loosdregt, Jorg; Fleskens, Veerle; Pals, Cornelieke E. G. M.; Coffer, Paul J.] Wilhelmina Childrens Hosp, Dept Immunol, Utrecht, Netherlands; [van Loosdregt, Jorg; Meerding, Jenny; Delemarre, Eveline M.; Prakken, Berent J.; Coffer, Paul J.] Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, Utrecht, Netherlands; [van Loosdregt, Jorg; Fleskens, Veerle; van Boxtel, Ruben; Pals, Cornelieke E. G. M.; Maurice, Madelon M.; Coffer, Paul J.] Wilhelmina Childrens Hosp, Dept Cell Biol, Utrecht, Netherlands; [Mokry, Michal; Nieuwenhuis, Edward E. S.] Wilhelmina Childrens Hosp, Dept Pediat Gastroenterol, Utrecht, Netherlands; [Meerding, Jenny; Delemarre, Eveline M.; Prakken, Berent J.] Wilhelmina Childrens Hosp, Dept Pediat Immunol, Utrecht, Netherlands; [Holstege, Frank C.] Univ Med Ctr Utrecht, NL-3584 EA Utrecht, Netherlands; [van Es, Johan H.] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [van Es, Johan H.] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Tiemessen, Machteld M.; Baert, Miranda R. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; [Kurek, Dorota; ten Berge, Derk] Erasmus Stem Cell Inst, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Groene, Andrea] Fac Vet Med Utrecht, Dept Pathobiol, NL-3508 TD Utrecht, Netherlands; [Sijts, Alice J. A. M.; Zaiss, Dietmar M. W.] Fac Vet Med Utrecht, Dept Immunol & Infect Dis, NL-3508 TD Utrecht, Netherlands	Wilhelmina Kinderziekenhuis; Wilhelmina Kinderziekenhuis; Wilhelmina Kinderziekenhuis; Wilhelmina Kinderziekenhuis; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University	Coffer, PJ (corresponding author), Wilhelmina Childrens Hosp, Dept Immunol, Utrecht, Netherlands.	p.j.coffer@umcutrecht.nl	Coffer, Paul/AAF-7970-2020; van+Es, Johan/ABD-5411-2021; Holstege, Frank/AAM-9944-2021; Mokry, Michal/AAN-3809-2021; Berge, Derk ten/C-1967-2012	Mokry, Michal/0000-0002-5298-4852; van Loosdregt, Jorg/0000-0003-1411-3754; van Boxtel, Ruben/0000-0003-1285-2836; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Maurice, Madelon/0000-0001-6885-5361; Sijts, Alice/0000-0003-3815-4788; Kurek, Dorota/0000-0002-7168-8944; Zaiss, Dietmar M.W./0000-0003-3596-7062	Dutch Rheumatism Foundation (Reumafonds); American Institute for Cancer Research (AICR); VENI-ZonMW; Center for Translational Molecular Medicine; TOP grant from the Netherlands Organisation for Health Research and Development; KiKA; AICR; Dutch Cancer Society [2006-3508]; Utrecht University (High Potential Programme); European Research Council [242958]	Dutch Rheumatism Foundation (Reumafonds); American Institute for Cancer Research (AICR); VENI-ZonMW; Center for Translational Molecular Medicine; TOP grant from the Netherlands Organisation for Health Research and Development; KiKA; AICR; Dutch Cancer Society(KWF Kankerbestrijding); Utrecht University (High Potential Programme); European Research Council(European Research Council (ERC)European Commission)	The authors thank M. Klein for technical assistance and S. Sakaguchi, B. Burgering, M. van de Wetering, and A. Banham for providing us with plasmids. V.F. was supported by a grant from the Dutch Rheumatism Foundation (Reumafonds). M.M.T. was supported by the American Institute for Cancer Research (AICR) and VENI-ZonMW. R.v.B. was supported by the Center for Translational Molecular Medicine. F.J.T.S. was supported by a TOP grant from the Netherlands Organisation for Health Research and Development, KiKA, and the AICR. M.M.M. was supported by Dutch Cancer Society (2006-3508), Utrecht University (High Potential Programme), and the European Research Council (starting grant 242958).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Beekman JM, 2012, ONCOGENE, V31, P2668, DOI 10.1038/onc.2011.445; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; CALABRESE JR, 1985, AM J PSYCHIAT, V142, P1318; Chan HHL, 2000, J AFFECT DISORDERS, V57, P107, DOI 10.1016/S0165-0327(99)00064-6; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Giant TT, 2004, METH MOLEC MED, V102, P313; Guo ZY, 2007, BLOOD, V109, P5463, DOI 10.1182/blood-2006-11-059071; Han GM, 2009, CELL IMMUNOL, V258, P188, DOI 10.1016/j.cellimm.2009.05.003; HASSMAN RA, 1985, CLIN EXP IMMUNOL, V61, P49; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Roord STA, 2008, BLOOD, V111, P5233, DOI 10.1182/blood-2007-12-128488; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; SARANTIDIS D, 1983, BRIT J PSYCHIAT, V143, P42, DOI 10.1192/bjp.143.1.42; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; STERN JB, 1986, SCIENCE, V233, P203, DOI 10.1126/science.3523754; THOMPSON CJ, 1986, POSTGRAD MED J, V62, P295, DOI 10.1136/pgmj.62.726.295; Tiemessen MM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001430; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wehrens EJ, 2011, BLOOD, V118, P3538, DOI 10.1182/blood-2010-12-328187; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yan KX, 2010, BRIT J DERMATOL, V163, P48, DOI 10.1111/j.1365-2133.2010.09742.x; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	48	135	138	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					298	310		10.1016/j.immuni.2013.07.019	http://dx.doi.org/10.1016/j.immuni.2013.07.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23954131	Bronze, Green Published			2022-12-18	WOS:000330948800012
J	Lei, CQ; Zhong, B; Zhang, Y; Zhang, J; Wang, SA; Shu, HB				Lei, Cao-Qi; Zhong, Bo; Zhang, Yu; Zhang, Jing; Wang, Shuai; Shu, Hong-Bing			Glycogen Synthase Kinase 3 beta Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1	IMMUNITY			English	Article							NF-KAPPA-B; ADAPTER PROTEIN; I INTERFERON; BETA-CATENIN; VIRUS; INDUCTION; PATHWAY; RECOGNITION; RECEPTORS; PHOSPHORYLATION	Viral infection activates transcription factors IRF3 and NF-kappa B, which collaborate to induce type I interferons (IFNs). Here, we identified glycogen synthase kinase 3 beta (GSK3 beta) as an important regulator for virus-triggered IRF3 and NF-kappa B activation, IFN-beta induction, and cellular antiviral response. Overexpression of GSK3 beta potentiated virus-induced activation of IRF3 and transcription of the IFNB1 gene, whereas reduced expression or deletion of GSK3 beta impaired virus-induced IRF3 and NF-kappa B activation, transcription of the IFNB1 gene, as well as cellular antiviral response. GSK3 beta physically associated with the kinase TBK1 in a viral infection-dependent manner. GSK3 beta promoted TBK1 self-association and autophosphorylation at Ser172, which is critical for virus-induced IRF3 activation and IFN-beta induction. The effect of GSK3 beta on virus-induced signaling is independent of its kinase activity. Our findings suggest that GSK3 beta plays important roles in virus-triggered IRF3 activation by promoting TBK1 activation and provide new insights to the molecular mechanisms of cellular antiviral response.	[Lei, Cao-Qi; Zhong, Bo; Zhang, Yu; Zhang, Jing; Wang, Shuai; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn	Wang, Shuai/Y-6634-2019	Wang, Shuai/0000-0002-5432-4970	Chinese 973 program [2006CB504301, 2010CB911802]; National Natural Science Foundation of China [30630019, 30921001]; Chinese Science and Technology Key Project [2008ZX10002-014]	Chinese 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Science and Technology Key Project	We thank J. Woodgett, J. Hiscott, R. Lin, K. Fitzgerald, and Z. Huang for reagents and W.-W. Luo, R. Chen, and Y. Ran for technique assistance. This work was supported by grants from the Chinese 973 program (#2006CB504301 and #2010CB911802), the National Natural Science Foundation of China (#30630019 and #30921001), and the Chinese Science and Technology Key Project (2008ZX10002-014).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rathinam VAK, 2010, NAT IMMUNOL, V11, P466, DOI 10.1038/ni0610-466; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Wang HZ, 2008, J IMMUNOL, V181, P6797, DOI 10.4049/jimmunol.181.10.6797; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zhou FF, 2008, J BIOL CHEM, V283, P14506, DOI 10.1074/jbc.M706136200	31	135	140	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 22	2010	33	6					878	889		10.1016/j.immuni.2010.11.021	http://dx.doi.org/10.1016/j.immuni.2010.11.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21145761	Bronze			2022-12-18	WOS:000286293900009
J	Koch, M; Camp, S; Collen, T; Avila, D; Salomonsen, J; Wallny, HJ; van Hateren, A; Hunt, L; Jacob, JP; Johnston, F; Marston, DA; Shaw, I; Dunbar, PR; Cerundolo, V; Jones, EY; Kaufman, J				Koch, Michael; Camp, Simon; Collen, Trevor; Avila, David; Salomonsen, Jan; Wallny, Hans-Joachim; van Hateren, Andrew; Hunt, Lawrence; Jacob, Jansen P.; Johnston, Fiona; Marston, Denise A.; Shaw, Iain; Dunbar, P. Rod; Cerundolo, Vincenzo; Jones, E. Yvonne; Kaufman, Jim			Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MEDIATED IMMUNE-RESPONSES; CYTOTOXIC T-LYMPHOCYTES; MAREKS-DISEASE VIRUS; CRYSTAL-STRUCTURE; COMPARATIVE GENOMICS; GENE ORGANIZATION; VIRAL PEPTIDES; B LOCUS; K-D	Little is known about the structure of major histocompatibility complex (MHC) molecules outside of mammals. Only one class I molecule in the chicken MHC is highly expressed, leading to strong genetic associations with infectious pathogens. Here, we report two structures of the MHC class I molecule BF2*2101 from the B21 haplotype, which is known to confer resistance to Marek's disease caused by an oncogenic herpesvirus. The binding groove has an unusually large central cavity, which confers substantial conformational flexibility to the crucial residue Arg9, allowing remodeling of key peptide-binding sites. The coupled variation of anchor residues from the peptide, utilizing a charge-transfer system unprecedented in MHC molecules, allows peptides with conspicuously different sequences to be bound. This promiscuous binding extends our understanding of ways in which MHC class I molecules can present peptides to the immune system and might explain the resistance of the B21 haplotype to Marek's disease.	[Koch, Michael; Jones, E. Yvonne] Canc Res UK Receptor Struct Res Grp, Oxford OX3 7BN, England; [Camp, Simon; Collen, Trevor; van Hateren, Andrew; Hunt, Lawrence; Jacob, Jansen P.; Johnston, Fiona; Marston, Denise A.; Shaw, Iain; Kaufman, Jim] Inst Anim Hlth, Compton RG20 7NN, Berks, England; [Avila, David; Salomonsen, Jan; Wallny, Hans-Joachim; Kaufman, Jim] Basel Inst Immunol, CH-4005 Basel, Switzerland; [Dunbar, P. Rod; Cerundolo, Vincenzo] Univ Oxford, Weatherall Inst Mol Med, Tumor Immunol Unit, Oxford OX3 9DS, England; [Kaufman, Jim] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Kaufman, Jim] Dept Vet Med, Cambridge CB3 0ES, England	Cancer Research UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford; University of Cambridge	Jones, EY (corresponding author), Canc Res UK Receptor Struct Res Grp, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk; jfk31@cam.ac.uk	Marston, Denise A/D-7993-2011; Jones, Yvonne/N-8111-2019; Jones, Yvonne/J-2293-2016; Dunbar, Rod/C-2570-2012	Marston, Denise A/0000-0001-9215-088X; Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Dunbar, Rod/0000-0001-9626-2600; Kaufman, Jim/0000-0002-7216-8422; Cerundolo, Vincenzo/0000-0003-0040-3793; van Hateren, Andy/0000-0002-3915-0239	MRC [MC_U137884181, G0501975, G9900061] Funding Source: UKRI; Medical Research Council [G0501975, G9900061, MC_U137884181] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Apostolopoulos Vasso, 2004, Expert Rev Vaccines, V3, P151, DOI 10.1586/14760584.3.2.151; BACON LD, 1987, POULTRY SCI, V66, P802, DOI 10.3382/ps.0660802; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrow A, 1999, ACTA VIROL, V43, P90; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Comellas-Bigler M, 2002, STRUCTURE, V10, P865, DOI 10.1016/S0969-2126(02)00772-4; Dunbar PR, 1998, CURR BIOL, V8, P413, DOI 10.1016/S0960-9822(98)70161-7; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Flajnik MF, 1999, J IMMUNOL, V163, P3826; FLAJNIK MF, 1993, EMBO J, V12, P4385, DOI 10.1002/j.1460-2075.1993.tb06123.x; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; FLOCCO MW, 1995, J MOL BIOL, V254, P96, DOI 10.1006/jmbi.1995.0602; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Gaddum RM, 1996, IMMUNOGENETICS, V43, P238, DOI 10.1007/BF00587307; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia-Camacho L, 2003, VET IMMUNOL IMMUNOP, V95, P145, DOI 10.1016/S0165-2427(03)00140-5; GUILLEMOT F, 1988, EMBO J, V7, P2775, DOI 10.1002/j.1460-2075.1988.tb03132.x; HANSEN MP, 1967, POULTRY SCI, V46, P1268; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Hunt HD, 1998, IMMUNOGENETICS, V47, P456, DOI 10.1007/s002510050383; HUTT FB, 1947, SCIENCE, V106, P379, DOI 10.1126/science.106.2756.379; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; KAUFMAN J, 1992, J IMMUNOL, V148, P1532; Kaufman J, 1999, IMMUNOL REV, V167, P101, DOI 10.1111/j.1600-065X.1999.tb01385.x; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Kaufman J, 1999, IMMUNOGENETICS, V50, P228, DOI 10.1007/s002510050597; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lima-Rosa CAV, 2004, ANIM GENET, V35, P278, DOI 10.1111/j.1365-2052.2004.01160.x; Livant EJ, 2004, ANIM GENET, V35, P18, DOI 10.1111/j.1365-2052.2003.01078.x; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Markowski-Grimsrud CJ, 2003, IMMUNOLOGY, V109, P283, DOI 10.1046/j.1365-2567.2003.01643.x; Mata M, 1998, J IMMUNOL, V161, P2985; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Moon DA, 2005, J IMMUNOL, V175, P6702, DOI 10.4049/jimmunol.175.10.6702; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okamura K, 1997, IMMUNITY, V7, P777, DOI 10.1016/S1074-7613(00)80396-9; Omar AR, 1997, IMMUNOLOGY, V90, P579, DOI 10.1046/j.1365-2567.1997.00211.x; Omar AR, 1996, VIROLOGY, V222, P87, DOI 10.1006/viro.1996.0400; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLACHY J, 1992, CRIT REV IMMUNOL, V12, P47; Probst-Kepper M, 2004, J IMMUNOL, V173, P5610, DOI 10.4049/jimmunol.173.9.5610; Quesnel A, 1996, FEBS LETT, V387, P42, DOI 10.1016/0014-5793(96)00446-2; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; Rudolph MG, 2001, IMMUNITY, V14, P231, DOI 10.1016/S1074-7613(01)00105-4; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Shiina T, 1999, IMMUNOGENETICS, V49, P456, DOI 10.1007/s002510050519; Shiina T, 2007, J IMMUNOL, V178, P7162, DOI 10.4049/jimmunol.178.11.7162; SIMONSEN M, 1982, IMMUNOGENETICS, V16, P513, DOI 10.1007/BF00372021; Smith KJ, 1996, IMMUNITY, V4, P215, DOI 10.1016/S1074-7613(00)80430-6; Speir JA, 2001, IMMUNITY, V14, P81, DOI 10.1016/S1074-7613(01)00091-7; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; Walter TS, 2003, J APPL CRYSTALLOGR, V36, P308, DOI 10.1107/S0021889803001997; WATTS S, 1989, IMMUNOGENETICS, V30, P390, DOI 10.1007/BF02425281; Wilson I A, 1993, Semin Immunol, V5, P75, DOI 10.1006/smim.1993.1011; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	72	135	142	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					885	899		10.1016/j.immuni.2007.11.007	http://dx.doi.org/10.1016/j.immuni.2007.11.007			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18083574	Bronze			2022-12-18	WOS:000251907300009
J	Beaudoin, L; Laloux, V; Novak, J; Lucas, B; Lehuen, A				Beaudoin, L; Laloux, V; Novak, J; Lucas, B; Lehuen, A			NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells	IMMUNITY			English	Article							ALPHA-GALACTOSYLCERAMIDE; IN-VIVO; MEDIATED CYTOTOXICITY; MICE; TOLERANCE; COMPLEX; LYMPHOCYTES; THYMOCYTES; ACTIVATION; PREVENTS	To determine the precise regulatory effect of NKT cells on CD4(+) T cells involved in autoimmune diabetes, we developed an in vivo model in which transferred naive transgenic T cells are stimulated by their antigen in the presence or absence of NKT cells or in the presence of another conventional transgenic alphabeta T cell. The presence of NKT cells did not block the initial activation and expansion of the CD4+ T cells but did inhibit their IL-2 and IFN-gamma production and later proliferation, resulting in an anergic phenotype. These CD4+ T cells did not induce significant insulitis and were unable to destroy the beta cells. Thus, NKT cells prevent alphabeta CD4 T cell differentiation into effector cells.	Hop Cochin St Vincent Paul, INSERM, U561, F-75014 Paris, France; Hop Necker Enfants Malad, INSERM, U25, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, U345, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lehuen, A (corresponding author), Hop Cochin St Vincent Paul, INSERM, U561, F-75014 Paris, France.	lehuen@cochin.inserm.fr		LUCAS, Bruno/0000-0002-0322-3977; Novak, Jan/0000-0003-1241-1635; Lehuen, Agnes/0000-0002-0450-3321				BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bansal-Pakala P, 2001, NAT MED, V7, P907, DOI 10.1038/90942; Baxter AG, 1997, DIABETES, V46, P572, DOI 10.2337/diabetes.46.4.572; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G; Carnaud C, 2001, J IMMUNOL, V166, P2404, DOI 10.4049/jimmunol.166.4.2404; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Denkers EY, 1996, J EXP MED, V184, P131, DOI 10.1084/jem.184.1.131; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; Hayakawa Y, 2001, EUR J IMMUNOL, V31, P1720, DOI 10.1002/1521-4141(200106)31:6<1720::AID-IMMU1720>3.3.CO;2-L; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Laloux V, 2001, J IMMUNOL, V166, P3749, DOI 10.4049/jimmunol.166.6.3749; Laloux W, 2002, J IMMUNOL, V168, P3251, DOI 10.4049/jimmunol.168.7.3251; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Luhder F, 2000, P NATL ACAD SCI USA, V97, P12204, DOI 10.1073/pnas.200348397; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mars LT, 2002, J IMMUNOL, V168, P6007, DOI 10.4049/jimmunol.168.12.6007; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; PENIT C, 1993, CYTOMETRY, V14, P757, DOI 10.1002/cyto.990140708; Pied S, 2000, J IMMUNOL, V164, P1463, DOI 10.4049/jimmunol.164.3.1463; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Singh N, 1999, J IMMUNOL, V163, P2373; Tamada K, 1996, IMMUNOLOGY, V89, P627, DOI 10.1046/j.1365-2567.1996.d01-771.x; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Tanchot C, 2001, J IMMUNOL, V167, P2030, DOI 10.4049/jimmunol.167.4.2030; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; TONY HP, 1985, J EXP MED, V161, P223, DOI 10.1084/jem.161.1.223; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wilson P, 1998, REV INT STUD, V24, P1, DOI 10.1017/S0260210598000011; Zeng DF, 1999, J EXP MED, V189, P1073, DOI 10.1084/jem.189.7.1073	46	135	152	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2002	17	6					725	736		10.1016/S1074-7613(02)00473-9	http://dx.doi.org/10.1016/S1074-7613(02)00473-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479819	Bronze			2022-12-18	WOS:000179985500005
J	Waskow, C; Paul, S; Haller, C; Gassmann, M; Rodewald, HR				Waskow, C; Paul, S; Haller, C; Gassmann, M; Rodewald, HR			Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis	IMMUNITY			English	Article							STEM-CELL FACTOR; MURINE BONE-MARROW; MOUSE; EXPRESSION; MICE; GENE; DIFFERENTIATION; INTERLEUKIN-2; EXPANSION; IMMATURE	Mice lacking the receptor tyrosine kinase c-Kit (c-Kit(W/W)) have hematopoietic defects causing perinatal death. We have identified a viable c-Kit(W/W) mouse, termed the "Vickid" mouse. Around birth, c-Kit plays a redundant role in T and no role in B cell development. Here, we show an age-dependent, progressive decline of pro-T and pro-B cells accompanied by loss of common lymphoid progenitors in the bone marrow in adult mice lacking c-Kit. Adult c-Kit(W/W) hematopoietic stem cells can engraft in host bone marrow but fail to radioprotect, form spleen colonies, or establish sustained lymphopoiesis. These defects in adult T and B cell development are also evident in a second viable c-Kit(W/W) strain, rescued by overexpression of erythropoietin.	Univ Ulm, Dept Immunol, D-89070 Ulm, Germany; Basel Inst Immunol, CH-4005 Basel, Switzerland; Univ Zurich, Inst Vet Physiol, CH-8057 Zurich, Switzerland	Ulm University; University of Zurich	Rodewald, HR (corresponding author), Univ Ulm, Dept Immunol, D-89070 Ulm, Germany.	claudia.waskow@medizin.uni-ulm.de; hans-reimer.rodewald@medizin.uni-ulm.de	Waskow, Claudia/F-8146-2010	Waskow, Claudia/0000-0003-3261-0922; Gassmann, Max/0000-0003-2750-8878				Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; FLEISCHMAN RA, 1979, P NATL ACAD SCI USA, V76, P5736, DOI 10.1073/pnas.76.11.5736; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAYASHI SI, 1991, NUCLEIC ACIDS RES, V19, P1267, DOI 10.1093/nar/19.6.1267; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kondo M, 2001, CURR OPIN GENET DEV, V11, P520, DOI 10.1016/S0959-437X(00)00227-6; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Matsuoka S, 2001, BLOOD, V97, P419, DOI 10.1182/blood.V97.2.419; MCCULLOCH EA, 1964, SCIENCE, V144, P844, DOI 10.1126/science.144.3620.844; Moritz DR, 1998, J IMMUNOL, V161, P4866; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Payne KJ, 1999, BLOOD, V94, P713, DOI 10.1182/blood.V94.2.713.414k15_713_723; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Rodewald HR, 1998, ADV IMMUNOL, V69, P1, DOI 10.1016/S0065-2776(08)60606-9; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; Rodewald HR, 1996, ONCOGENE, V12, P397; ROLINK A, 1991, EUR J IMMUNOL, V21, P2609, DOI 10.1002/eji.1830211044; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Ruschitzka FT, 2000, P NATL ACAD SCI USA, V97, P11609, DOI 10.1073/pnas.97.21.11609; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; RUSSELL ELIZABETH S., 1966, P351; RUSSELL ELIZABETH S., 1959, JOUR HEREDITY, V50, P19; SONODA T, 1982, J CELL PHYSIOL, V112, P136, DOI 10.1002/jcp.1041120120; Staal FJT, 2001, STEM CELLS, V19, P165, DOI 10.1634/stemcells.19-3-165; Takeda S, 1997, BLOOD, V89, P518, DOI 10.1182/blood.V89.2.518; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7	39	135	141	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2002	17	3					277	288		10.1016/S1074-7613(02)00386-2	http://dx.doi.org/10.1016/S1074-7613(02)00386-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354381	Bronze			2022-12-18	WOS:000178163100005
J	Lloyd, CM; Marsland, BJ				Lloyd, Clare M.; Marsland, Benjamin J.			Lung Homeostasis: Influence of Age, Microbes, and the Immune System	IMMUNITY			English	Review							INNATE LYMPHOID-CELLS; CHAIN FATTY-ACIDS; PLASMACYTOID DENDRITIC CELLS; REGULATORY T-CELLS; MHC CLASS-I; AIRWAY INFLAMMATION; EARLY-LIFE; ALLERGIC-ASTHMA; GUT MICROBIOTA; ANTIBIOTIC EXPOSURE	Pulmonary immune homeostasis is maintained by a network of tissue-resident cells that continually monitor the external environment, and in health, instruct tolerance to innocuous inhaled particles while ensuring that efficient and rapid immune responses can be mounted against invading pathogens. Here we review the multiple pathways that underlie effective lung immunity in health, and discuss how these may be affected by external environmental factors and contribute to chronic inflammation during disease. In this context, we examine the current understanding of the impact of the microbiota in immune development and function and in the setting of the threshold for immune responses that maintains the balance between tolerance and chronic inflammation in the lung. We propose that host interactions with microbes are critical for establishing the immune landscape of the lungs.	[Lloyd, Clare M.] Imperial Coll London, Natl Heart & Lung Inst, Inflammat Repair & Dev Sect, London SW7 2AZ, England; [Marsland, Benjamin J.] Univ Lausanne, Ctr Hosp Univ Vaudoise, Fac Biol & Med, Serv Pneumol, CH-1011 Lausanne, Switzerland	Imperial College London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Lloyd, CM (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Inflammat Repair & Dev Sect, London SW7 2AZ, England.; Marsland, BJ (corresponding author), Univ Lausanne, Ctr Hosp Univ Vaudoise, Fac Biol & Med, Serv Pneumol, CH-1011 Lausanne, Switzerland.	c.lloyd@imperial.ac.uk; benjamin.marsland@chuv.ch		Lloyd, Clare/0000-0001-8977-6726	Welcome Trust [107059/Z/15/Z]; Medical Research Council [G1000758, G1000758B] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish	Welcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	C.M.L. is supported by a Welcome Trust Senior Fellowship (grant 107059/Z/15/Z).	Acciani TH, 2013, CLIN EXP ALLERGY, V43, P1406, DOI 10.1111/cea.12200; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Baraldo S, 2012, J ALLERGY CLIN IMMUN, V130, P1307, DOI 10.1016/j.jaci.2012.08.005; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bernasconi E, 2016, AM J RESP CRIT CARE, V194, P1252, DOI 10.1164/rccm.201512-2424OC; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; BINDER HJ, 1989, GASTROENTEROLOGY, V96, P989, DOI 10.1016/0016-5085(89)91614-4; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Brix S, 2015, J ALLERGY CLIN IMMUN, V135, P277, DOI 10.1016/j.jaci.2014.09.036; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Chen RC, 2016, J ALLERGY CLIN IMMUN, V137, pAB178, DOI 10.1016/j.jaci.2015.12.716; Chen ZH, 2015, J THORAC DIS, V7, P46, DOI 10.3978/j.issn.2072-1439.2014.12.20; Cho JL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1370; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Cotran R., 1999, ROBBINS COTRAN PATHO, P718; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; de Lafaille MAC, 2010, CURR OPIN IMMUNOL, V22, P616, DOI 10.1016/j.coi.2010.08.014; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edwards MR, 2013, MUCOSAL IMMUNOL, V6, P797, DOI 10.1038/mi.2012.118; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Gagliardi L, 2011, AM J EPIDEMIOL, V173, P1343, DOI 10.1093/aje/kwr082; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hagner S, 2013, ALLERGY, V68, P322, DOI 10.1111/all.12094; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Han CZ, 2016, NATURE, V539, P570, DOI 10.1038/nature20141; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Ho AWS, 2011, J IMMUNOL, V187, P6011, DOI 10.4049/jimmunol.1100987; Holt PG, 1999, NAT MED, V5, P1127, DOI 10.1038/13447; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Iwasaki A, 2017, NAT REV IMMUNOL, V17, P7, DOI 10.1038/nri.2016.117; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; Lahn M, 2002, P NATL ACAD SCI USA, V99, P8850, DOI 10.1073/pnas.132519299; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; Marsland BJ, 2004, P NATL ACAD SCI USA, V101, P6116, DOI 10.1073/pnas.0401582101; Martin-Gayo E, 2010, BLOOD, V115, P5366, DOI 10.1182/blood-2009-10-248260; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Medoff BD, 2009, J IMMUNOL, V182, P623, DOI 10.4049/jimmunol.182.1.623; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; Molyneaux PL, 2013, AM J RESP CRIT CARE, V188, P1224, DOI 10.1164/rccm.201302-0341OC; Morita H, 2015, IMMUNITY, V43, P175, DOI 10.1016/j.immuni.2015.06.021; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Murdoch JR, 2014, CLIN EXP ALLERGY, V44, P1386, DOI 10.1111/cea.12395; Nagakumar P, 2016, J ALLERGY CLIN IMMUN, V137, P624, DOI 10.1016/j.jaci.2015.06.038; Nanno M, 2007, IMMUNOL REV, V215, P103, DOI 10.1111/j.1600-065X.2006.00474.x; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nembrini C, 2011, THORAX, V66, P755, DOI 10.1136/thx.2010.152512; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Neyt K, 2013, IMMUNOL REV, V255, P57, DOI 10.1111/imr.12100; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Pearson C, 2016, ELIFE, V5, DOI 10.7554/eLife.10066; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Radicioni G, 2016, MUCOSAL IMMUNOL, V9, P1442, DOI 10.1038/mi.2016.27; Radulovic S., 2008, J ALLERGY CLIN IMMUN, V121; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Remot A., 2017, ISME J; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Roduit C, 2009, THORAX, V64, P107, DOI 10.1136/thx.2008.100875; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Segal LN, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.31, 10.1038/NMICROBIOL.2016.31]; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Shenoy MK, 2017, AM J RESP CRIT CARE, V195, P104, DOI [10.1164/rccm.201603-0523OC, 10.1164/rccm.201603-0523oc]; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smith SG, 2016, J ALLERGY CLIN IMMUN, V137, P75, DOI 10.1016/j.jaci.2015.05.037; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Surette Michael G, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS61, DOI 10.1513/AnnalsATS.201306-159MG; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Sykes A, 2014, THORAX, V69, P240, DOI 10.1136/thoraxjnl-2012-202909; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tai A, 2014, J ALLERGY CLIN IMMUN, V133, P1572, DOI 10.1016/j.jaci.2013.12.1033; Thannickal VJ, 2015, AM J RESP CRIT CARE, V191, P261, DOI 10.1164/rccm.201410-1876PP; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Verheijden KAT, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0171-0; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Vos AP, 2007, INT IMMUNOPHARMACOL, V7, P1582, DOI 10.1016/j.intimp.2007.07.024; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Willemsen LEM, 2003, GUT, V52, P1442, DOI 10.1136/gut.52.10.1442; Wojno EDT, 2016, J EXP MED, V213, P2229, DOI 10.1084/jem.20160525; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Wu XD, 2016, J EXP MED, V213, P2553, DOI 10.1084/jem.20160600; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Yadava K, 2016, AM J RESP CRIT CARE, V193, P975, DOI 10.1164/rccm.201504-0779OC; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	138	134	141	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					549	561		10.1016/j.immuni.2017.04.005	http://dx.doi.org/10.1016/j.immuni.2017.04.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423336	Bronze			2022-12-18	WOS:000399451100009
J	Gomes, AC; Hara, T; Lim, VY; Herndler-Brandstetter, D; Nevius, E; Sugiyama, T; Tani-ichi, S; Schlenner, S; Richie, E; Rodewald, HR; Flavell, RA; Nagasawa, T; Ikuta, K; Pereira, JP				Gomes, Ana Cordeiro; Hara, Takahiro; Lim, Vivian Y.; Herndler-Brandstetter, Dietmar; Nevius, Erin; Sugiyama, Tatsuki; Tani-ichi, Shizue; Schlenner, Susan; Richie, Ellen; Rodewald, Hans-Reimer; Flavell, Richard A.; Nagasawa, Takashi; Ikuta, Koichi; Pereira, Joao Pedro			Hematopoietic Stem Cell Niches Produce Lineage-Instructive Signals to Control Multipotent Progenitor Differentiation	IMMUNITY			English	Article							EARLY LYMPHOID PROGENITORS; CHEMOKINE RECEPTOR CXCR4; BONE-MARROW NICHE; B-LYMPHOPOIESIS; STEM/PROGENITOR CELLS; CRE RECOMBINASE; ADULT MICE; MAINTENANCE; EXPRESSION; MAINTAIN	Hematopoietic stem cells (HSCs) self-renew in bone marrow niches formed by mesenchymal progenitors and endothelial cells expressing the chemokine CXCL12, but whether a separate niche instructs multipotent progenitor (MPP) differentiation remains unclear. We show that MPPs resided in HSC niches, where they encountered lineage-instructive differentiation signals. Conditional deletion of the chemokine receptor CXCR4 in MPPs reduced differentiation into common lymphoid progenitors (CLPs), which decreased lymphopoiesis. CXCR4 was required for CLP positioning near Interleukin-7(+) (IL-7) cells and for optimal IL-7 receptor signaling. IL-7(+) cells expressed CXCL12 and the cytokine SCF, were mesenchymal progenitors capable of differentiation into osteoblasts and adipocytes, and comprised a minor subset of sinusoidal endothelial cells. Conditional Il7 deletion in mesenchymal progenitors reduced B-lineage committed CLPs, while conditional Cxcl12 or Scf deletion from IL-7(+) cells reduced HSC and MPP numbers. Thus, HSC maintenance and multilineage differentiation are distinct cell lineage decisions that are both controlled by HSC niches.	[Gomes, Ana Cordeiro; Lim, Vivian Y.; Herndler-Brandstetter, Dietmar; Nevius, Erin; Flavell, Richard A.; Pereira, Joao Pedro] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Gomes, Ana Cordeiro] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099002 Oporto, Portugal; [Hara, Takahiro; Tani-ichi, Shizue; Ikuta, Koichi] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Biol Protect, Kyoto 6068507, Japan; [Sugiyama, Tatsuki; Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto 6068507, Japan; [Sugiyama, Tatsuki; Nagasawa, Takashi] Osaka Univ, Grad Sch Frontier Biosci, Lab Stem Cell Biol & Dev Immunol, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan; [Sugiyama, Tatsuki; Nagasawa, Takashi] Osaka Univ, Grad Sch Med, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan; [Schlenner, Susan] VIB, Autoimmune Genet Lab, B-3000 Leuven, Belgium; [Schlenner, Susan] Univ Leuven, Dept Microbiol & Immunol, B-3000 Leuven, Belgium; [Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Richie, Ellen] Univ Texas MD Anderson Canc Ctr, Div Sci Pk Res, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Universidade do Porto; Kyoto University; Kyoto University; Osaka University; Osaka University; Flanders Institute for Biotechnology (VIB); KU Leuven; Helmholtz Association; German Cancer Research Center (DKFZ); University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute	Pereira, JP (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.; Hara, T (corresponding author), Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Biol Protect, Kyoto 6068507, Japan.	thara@virus.kyoto-u.ac.jp; joao.pereira@yale.edu	Gomes, Ana Cordeiro/AAX-6181-2020; Schlenner, Susan/P-7905-2017	Gomes, Ana Cordeiro/0000-0001-5305-8538; Schlenner, Susan/0000-0002-8553-3388; Sugiyama, Tatsuki/0000-0002-9349-0824; Ikuta, Koichi/0000-0003-1319-1021; Nagasawa, Takashi/0000-0002-1085-0960; Pereira, Joao/0000-0002-5694-4938; Lim, Vivian/0000-0002-2851-4391; Richie, Ellen/0000-0003-0786-973X; Hara, Takahiro/0000-0002-3845-8434; Tani-ichi, Shizue/0000-0003-2388-776X	FCT [SFRH/BD/73782/2010]; A*STAR, Singapore; NIH [1F32AR063574-01A1, R56AI098996, RO1AI113040]; Austrian Science Fund [J3220-B19]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460589, 25111504, 15H01153, 24790468, 26860322]; Fujiwara Memorial Foundation; BioLegend/Tomy Digital Biology; Shimizu Foundation for Immunology and Neuroscience; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113040, R56AI098996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR063574, P30AR053495] Funding Source: NIH RePORTER	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fujiwara Memorial Foundation; BioLegend/Tomy Digital Biology; Shimizu Foundation for Immunology and Neuroscience; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Peter Cresswell, Michael McCune, and Susan Kaech for mice and equipment. A.C.G. was funded by FCT (SFRH/BD/73782/2010); V.Y.L. was supported by A*STAR, Singapore. E.N. was sponsored by NIH (1F32AR063574-01A1). D.H.-B. was supported by the Austrian Science Fund (J3220-B19). This work was supported by the NIH (R56AI098996 and RO1AI113040), by the Ministry of Education, Culture, Sports, Science, and Technology of Japan ([C] 25460589, 25111504 and 15H01153 to K.I.; [B] 24790468 and 26860322 to T.H.), by Fujiwara Memorial Foundation, by BioLegend/Tomy Digital Biology, and by the Shimizu Foundation for Immunology and Neuroscience.	Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Beck TC, 2014, J EXP MED, V211, P2567, DOI 10.1084/jem.20140457; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; BRYON PA, 1979, PATHOL BIOL, V27, P209; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Gazit R, 2014, J EXP MED, V211, P1314, DOI 10.1084/jem.20130428; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; McDermott DH, 2015, CELL, V160, P686, DOI 10.1016/j.cell.2015.01.014; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miller CN, 2013, INT IMMUNOL, V25, P471, DOI 10.1093/intimm/dxt012; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Noda M, 2011, BLOOD, V117, P451, DOI 10.1182/blood-2010-04-277897; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Parrish YK, 2009, J IMMUNOL, V182, P4255, DOI 10.4049/jimmunol.0800489; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Terashima A, 2016, IMMUNITY, V44, P1434, DOI 10.1016/j.immuni.2016.05.012; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yu VWC, 2016, STEM CELL REP, V7, P220, DOI 10.1016/j.stemcr.2016.06.009; Zaretsky AG, 2014, J IMMUNOL, V192, P27, DOI 10.4049/jimmunol.1302061; Zhang J., 2016, J BONE MINER RES; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	52	134	139	3	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1219	1231		10.1016/j.immuni.2016.11.004	http://dx.doi.org/10.1016/j.immuni.2016.11.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	27913094	Bronze, Green Accepted			2022-12-18	WOS:000392918100009
J	Song, XY; Dai, D; He, X; Zhu, S; Yao, YK; Gao, HC; Wang, JJ; Qu, FF; Qiu, J; Wang, HL; Li, XX; Shen, N; Qian, YC				Song, Xinyang; Dai, Dai; He, Xiao; Zhu, Shu; Yao, Yikun; Gao, Hanchao; Wang, Jingjing; Qu, Fangfang; Qiu, Ju; Wang, Honglin; Li, Xiaoxia; Shen, Nan; Qian, Youcun			Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage	IMMUNITY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; GUT MICROBIOTA; COMMENSAL BACTERIA; ADAPTER PROTEIN; MESSENGER-RNA; RECEPTOR; BARRIER; KINASE; CELLS; BETA	The intestinal epithelial barrier plays a critical role in the mucosal immunity. However, it remains largely unknown how the epithelial barrier is maintained after damage. Here we show that growth factor FGF2 synergized with interleukin-17 (IL-17) to induce genes for repairing of damaged epithelium. FGF2 or IL-17 deficiency resulted in impaired epithelial proliferation, increased pro-inflammatory microbiota outgrowth, and consequently worse pathology in a DSS-induced colitis model. The dysregulated microbiota in the model induced transforming growth factor beta 1 (TGF beta 1) expression, which in turn induced FGF2 expression mainly in regulatory T cells. Act1, an essential adaptor in IL-17 signaling, suppressed FGF2-induced ERK activation through binding to adaptor molecule GRB2 to interfere with its association with guanine nucleotide exchange factor SOS1. Act1 preferentially bound to IL-17 receptor complex, releasing its suppressive effect on FGF2 signaling. Thus, microbiota-driven FGF2 and IL-17 cooperate to repair the damaged intestinal epithelium through Act1-mediated direct signaling cross-talk.	[Song, Xinyang; Dai, Dai; Zhu, Shu; Yao, Yikun; Gao, Hanchao; Wang, Jingjing; Qu, Fangfang; Qiu, Ju; Shen, Nan; Qian, Youcun] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Shanghai Ins, Shanghai 200031, Peoples R China; [He, Xiao; Shen, Nan; Qian, Youcun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Shanghai Inst Rheumatol, Shanghai 200001, Peoples R China; [Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200025, Peoples R China; [Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA; [Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200032, Peoples R China; [Shen, Nan] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH 45229 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Cleveland Clinic Foundation; Shanghai Jiao Tong University; Cincinnati Children's Hospital Medical Center	Shen, N (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Shanghai Ins, Shanghai 200031, Peoples R China.	nanshensibs@gmail.com; ycqian@sibs.ac.cn	Yao, Yikun/AAH-9197-2021; Shen, Nan/AGK-6807-2022; WANG, Honglin/AAJ-2708-2020; Qiu, Ju/AAW-7301-2021; wang, jing/GRS-7509-2022; Song, Xinyang/AAL-7495-2021; Gao, Hanchao/AGW-6043-2022; WANG, JINGYI/GSJ-1241-2022; Zhu, Shu/P-6163-2018	WANG, Honglin/0000-0001-6302-6927; Zhu, Shu/0000-0002-8163-0869; Song, Xinyang/0000-0002-3422-6927; Yao, Yikun/0000-0002-8890-2409; Shen, Nan/0000-0002-5875-4417	National Natural Science Foundation of China [81430036, 81230075, 91429307, 31329002, 91329301, 31300710, 81421001]; 973 Program [2013CB944904, 2014CB541902]; Science and Technology Commission of Shanghai Municipality [13JC1408900]; Collaborative Innovation Center of Systems Biomedicine; Chinese Academy of Sciences [KJZD-EW-L01-3]; State Key Laboratory of Oncogenes and Related Genes [91-14-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Collaborative Innovation Center of Systems Biomedicine; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Oncogenes and Related Genes	This work was supported by grants from the National Natural Science Foundation of China (81430036, 81230075, 91429307, 31329002, 91329301, 31300710, and 81421001), the 973 Program (2013CB944904 and 2014CB541902), the Science and Technology Commission of Shanghai Municipality (13JC1408900), Collaborative Innovation Center of Systems Biomedicine, the Chinese Academy of Sciences (KJZD-EW-L01-3), and the State Key Laboratory of Oncogenes and Related Genes (No. 91-14-05).	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bousvaros A, 1997, DIGEST DIS SCI, V42, P378, DOI 10.1023/A:1018882322566; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Matsuura M, 2005, GASTROENTEROLOGY, V128, P975, DOI 10.1053/j.gastro.2005.01.006; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qu FF, 2012, MOL CELL BIOL, V32, P3925, DOI 10.1128/MCB.00268-12; Shi PQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001653; Smith PM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00111; Song XY, 2014, IMMUNITY, V40, P140, DOI 10.1016/j.immuni.2013.11.018; Song XY, 2013, CYTOKINE, V62, P175, DOI 10.1016/j.cyto.2013.03.014; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Thorn M, 2000, SCAND J GASTROENTERO, V35, P408; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; TSANG M, 2004, SCI STKE; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	47	134	137	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					488	501		10.1016/j.immuni.2015.06.024	http://dx.doi.org/10.1016/j.immuni.2015.06.024			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE9NY	26320657	Bronze			2022-12-18	WOS:000370965900002
J	Yu, CI; Becker, C; Wang, YY; Marches, F; Helft, J; Leboeuf, M; Anguiano, E; Pourpe, S; Goller, K; Pascual, V; Banchereau, J; Merad, M; Palucka, K				Yu, Chun I.; Becker, Christian; Wang, Yuanyuan; Marches, Florentina; Helft, Julie; Leboeuf, Marylene; Anguiano, Esperanza; Pourpe, Stephane; Goller, Kristina; Pascual, Virginia; Banchereau, Jacques; Merad, Miriam; Palucka, Karolina			Human CD1c(+) Dendritic Cells Drive the Differentiation of CD103(+) CD8(+) Mucosal Effector T Cells via the Cytokine TGF-beta	IMMUNITY			English	Article							HUMAN LANGERHANS CELLS; INTEGRIN ALPHA(E)(CD103)BETA(7); CROSS-PRESENTATION; SUBSETS; EXPRESSION; TISSUE; BLOOD; TUMOR; INFECTION; RESPONSES	In comparison to murine dendritic cells (DCs), less is known about the function of human DCs in tissues. Here, we analyzed, by using lung tissues from humans and humanized mice, the role of human CD1c(+) and CD141(+) DCs in determining the type of CD8(+) T cell immunity generated to live-attenuated influenza virus (LAIV) vaccine. We found that both lung DC subsets acquired influenza antigens in vivo and expanded specific cytotoxic CD8(+) T cells in vitro. However, lung-tissue-resident CD1c(+) DCs, but not CD141(+) DCs, were able to drive CD103 expression on CD8(+) T cells and promoted CD8(+) T cell accumulation in lung epithelia in vitro and in vivo. CD1c(+) DCs induction of CD103 expression was dependent on membrane-bound cytokine TGF-beta 1. Thus, CD1c(+) and CD141(+) DCs generate CD8(+) T cells with different properties, and CD1c(+) DCs specialize in the regulation of mucosal CD8(+) T cells.	[Yu, Chun I.; Wang, Yuanyuan; Marches, Florentina; Anguiano, Esperanza; Pourpe, Stephane; Goller, Kristina; Pascual, Virginia; Banchereau, Jacques; Palucka, Karolina] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Becker, Christian] Mt Sinai Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA; [Becker, Christian; Helft, Julie; Leboeuf, Marylene; Merad, Miriam; Palucka, Karolina] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Becker, Christian; Helft, Julie; Leboeuf, Marylene; Merad, Miriam; Palucka, Karolina] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Wang, Yuanyuan] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA	Baylor Scott & White Health; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Baylor University	Merad, M (corresponding author), Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA.	miriam.merad@mssm.edu; karolinp@baylorhealth.edu	Pourpe, Stephane/K-8976-2015; Helft, Julie/ABE-6179-2020; Pascual, Virginia/ABD-3099-2020; Yu, Chun I/AAL-5882-2020; Lv, Yuanjie/AER-0767-2022	Helft, Julie/0000-0002-2733-1972; Yu, Chun I/0000-0002-4304-2177; 	Lucille A. Fennessy Pulmonary Research Fund; Vivian Richenthal Institute for Pulmonary and Critical Care Research; National Institutes of Health (NIH) [T32AI007623-10, 5T32CA078207-12, U19AI057234, U19AI089987, R01HL086899, R01AI095611, UO1AI095611]; NATIONAL CANCER INSTITUTE [T32CA078207] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234, T32AI007623, U19AI089987, U01AI095611] Funding Source: NIH RePORTER	Lucille A. Fennessy Pulmonary Research Fund; Vivian Richenthal Institute for Pulmonary and Critical Care Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank our patients and healthy volunteers; C. Chin, T. Weiser, D. Krellenstein, A. Kaufman, and R. Flores (Cardiothoracic Surgery); T. Harkin (Department of Medicine); and J. Gil, M. Beasley, and the entire staff (Department of Pathology), MSSM; J. Fay, the Clinical Core, the Apheresis Core, the Flow Cytometry Core, the Imaging Core, the Genomic Core, and the Animal Facility team at BIIR. C. B. thanks M. Padilla and the late A. S. Teirstein of MSSM. This work was supported by the Lucille A. Fennessy Pulmonary Research Fund, the Vivian Richenthal Institute for Pulmonary and Critical Care Research, and National Institutes of Health (NIH) training grants to C. B. (T32AI007623-10 and 5T32CA078207-12) and the NIH grants to K. P. (U19AI057234, U19AI089987, and UO1AI095611) and to M. M. (R01HL086899, R01AI095611, and UO1AI095611).	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2012, BLOOD, V119, P5742, DOI 10.1182/blood-2011-08-371245; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Dubois B, 1998, J IMMUNOL, V161, P2223; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Glader PS, 2005, LUNG, V183, P123, DOI 10.1007/s00408-004-2528-x; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; Morelli AE, 2005, J IMMUNOL, V175, P7905, DOI 10.4049/jimmunol.175.12.7905; NESTLE FO, 1993, J IMMUNOL, V151, P6535; ODOHERTY U, 1993, J EXP MED, V178, P1067, DOI 10.1084/jem.178.3.1067; Palucka AK, 2003, BLOOD, V102, P3302, DOI 10.1182/blood-2003-02-0384; PARKER CM, 1992, P NATL ACAD SCI USA, V89, P1924, DOI 10.1073/pnas.89.5.1924; Piet B, 2011, J CLIN INVEST, V121, P2254, DOI 10.1172/JCI44675; Rihs S, 1996, AM J RESP CELL MOL, V15, P600, DOI 10.1165/ajrcmb.15.5.8918367; Romano E, 2012, BLOOD, V119, P5182, DOI 10.1182/blood-2011-09-382200; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Schon MP, 1999, J IMMUNOL, V162, P6641; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; SILVERSTEIN RL, 1992, J BIOL CHEM, V267, P16607; Smyth LJC, 2007, CLIN EXP IMMUNOL, V149, P162, DOI 10.1111/j.1365-2249.2007.03385.x; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; van der Aar AMG, 2011, J IMMUNOL, V187, P3488, DOI 10.4049/jimmunol.1101105; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; Wang X, 2010, MOL BIOL REP, V37, P1649, DOI 10.1007/s11033-009-9579-2; Wang X, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-36; Yehualaeshet T, 2000, AM J RESP CELL MOL, V23, P204, DOI 10.1165/ajrcmb.23.2.4089; Yu CI, 2008, BLOOD, V112, P3671, DOI 10.1182/blood-2008-05-157016; Yu Q, 2000, GENE DEV, V14, P163; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282; Zhan YF, 2011, EUR J IMMUNOL, V41, P2585, DOI 10.1002/eji.201141540	60	134	135	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					818	830		10.1016/j.immuni.2013.03.004	http://dx.doi.org/10.1016/j.immuni.2013.03.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23562160	Green Accepted, Bronze			2022-12-18	WOS:000330942100022
J	Oyoshi, MK; He, R; Li, YT; Mondal, S; Yoon, J; Afshar, R; Chen, M; Lee, DM; Luo, HBR; Luster, AD; Cho, JS; Miller, LS; Larson, A; Murphy, GF; Geha, RS				Oyoshi, Michiko K.; He, Rui; Li, Yitang; Mondal, Subhanjan; Yoon, Juhan; Afshar, Roshi; Chen, Mei; Lee, David M.; Luo, Hongbo R.; Luster, Andrew D.; Cho, John S.; Miller, Lloyd S.; Larson, Allison; Murphy, George F.; Geha, Raif S.			Leukotriene B4-Driven Neutrophil Recruitment to the Skin Is Essential for Allergic Skin Inflammation	IMMUNITY			English	Article							INFL AMMATORY ARTHRITIS; T-CELL RECRUITMENT; ATOPIC-DERMATITIS; AIRWAY HYPERRESPONSIVENESS; A(4) HYDROLASE; RECEPTOR BLT1; MURINE MODEL; B-4; MICE; 5-LIPOXYGENASE	Scratching triggers skin flares in atopic dermatitis. We demonstrate that scratching of human skin and tape stripping of mouse skin cause neutrophil influx. In mice, this influx was largely dependent on the generation of leukotriene B4 (LTB4) by neutrophils and their expression of the LTB4 receptor BLT1. Allergic skin inflammation in response to epicutaneous (EC) application of ovalbumin to tape-stripped skin was severely impaired in Ltb4r1(-/-) mice and required expression of BLT1 on both T cells and non-T cells. Cotransfer of wild-type (WT) neutrophils, but not neutrophils deficient in BLT1 or the LTB4-synthesizing enzyme LTA4H, restored the ability of WT CD4(+) effector T cells to transfer allergic skin inflammation to Ltb4r1(-/-) recipients. Pharmacologic blockade of LTB4 synthesis inhibited allergic skin inflammation elicited by cutaneous antigen challenge in previously EC-sensitized mice. Our results demonstrate that a neutrophil-T cell axis reliant on LTB4-BLT1 interaction is required for allergic skin inflammation.	[Oyoshi, Michiko K.; He, Rui; Yoon, Juhan; Geha, Raif S.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Li, Yitang; Mondal, Subhanjan; Luo, Hongbo R.] Boston Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Afshar, Roshi; Luster, Andrew D.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Chen, Mei; Lee, David M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Larson, Allison; Murphy, George F.] Brigham & Womens Hosp, Dermatopathol Program, Boston, MA 02115 USA; [Cho, John S.; Miller, Lloyd S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Oyoshi, Michiko K.; He, Rui; Li, Yitang; Mondal, Subhanjan; Yoon, Juhan; Afshar, Roshi; Chen, Mei; Lee, David M.; Luo, Hongbo R.; Luster, Andrew D.; Larson, Allison; Murphy, George F.; Geha, Raif S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Oyoshi, Michiko K.; He, Rui; Li, Yitang; Mondal, Subhanjan; Yoon, Juhan; Afshar, Roshi; Chen, Mei; Lee, David M.; Luo, Hongbo R.; Luster, Andrew D.; Larson, Allison; Murphy, George F.; Geha, Raif S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Oyoshi, Michiko K.; He, Rui; Li, Yitang; Mondal, Subhanjan; Yoon, Juhan; Afshar, Roshi; Chen, Mei; Lee, David M.; Luo, Hongbo R.; Luster, Andrew D.; Larson, Allison; Murphy, George F.; Geha, Raif S.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Oyoshi, MK (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	michiko.oyoshi@childrens.harvard.edu; raif.geha@childrens.harvard.edu	He, Rui/P-7302-2019; Luster, Andrew/ABE-6504-2020; Larson, Allison/N-4263-2015	He, Rui/0000-0001-5288-9786; Luster, Andrew/0000-0001-9679-7912; Larson, Allison/0000-0001-8534-7078; Miller, Lloyd/0000-0002-8332-2210	Atopic Dermatitis Research Network National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN272201000020C]; U.S. Public Health Service [AR-047417, AI 065858-03, HL-085100, AI-076471, HL-092020, GM-076084]; American Cancer Society [AI-050892, AI-040618, R01 AI078910, T32 AR058921, R24 CA92865]; Boston Children's Hospital Faculty Career Development Fellowship; NATIONAL CANCER INSTITUTE [R24CA092865] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095489, R01HL085100, R01HL092020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076471, R01AI040618, P01AI065858, R01AI078910, R37AI040618, R01AI050892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047417, T32AR058921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076084] Funding Source: NIH RePORTER	Atopic Dermatitis Research Network National Institutes of Health/National Institute of Allergy and Infectious Diseases; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Cancer Society(American Cancer Society); Boston Children's Hospital Faculty Career Development Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Atopic Dermatitis Research Network National Institutes of Health/National Institute of Allergy and Infectious Diseases contract HHSN272201000020C (R.S.G.); U.S. Public Health Service grants AR-047417 (R.S.G.), AI 065858-03 (D.M.L.) HL-085100, AI-076471, and HL-092020, GM-076084; a Research Scholar Grant from the American Cancer Society (H.R.L.); and AI-050892 and AI-040618 (A.D.L.), R01 AI078910 (L.S.M.), T32 AR058921 (J.S.C.), R24 CA92865 (UCLA Small Animal Imaging Resource Program); and the Boston Children's Hospital Faculty Career Development Fellowship (M.K.O.). D.M.L. is currently an employee of Novartis Pharma AG and owns stock and/or options >$10,000 and has ownership and consulting income >$10,000 from Synovex. M.C. is currently an employee of Pfizer. We thank M.J. Massaad and H.C. Oettgen for reading the manuscript. We also thank J. Beaupre for her technical assistance.	Alenius H, 2002, J ALLERGY CLIN IMMUN, V109, P106, DOI 10.1067/mai.2002.120553; Byrum RS, 1999, J IMMUNOL, V163, P6810; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; DEJONG EMGJ, 1992, CLIN EXP DERMATOL, V17, P413; Faust N, 2000, BLOOD, V96, P719; Fleischer AB, 2010, J DRUGS DERMATOL, V9, P488; FOGH K, 1989, J ALLERGY CLIN IMMUN, V83, P450, DOI 10.1016/0091-6749(89)90132-2; Friedrich EB, 2003, ARTERIOSCL THROM VAS, V23, P1761, DOI 10.1161/01.ATV.0000092941.77774.3C; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Guiducci C, 2010, J EXP MED, V207, P2931, DOI 10.1084/jem.20101048; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; HILGER RA, 1991, IMMUNOLOGY, V74, P689; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Kim DK, 2007, EUR J PHARMACOL, V554, P30, DOI 10.1016/j.ejphar.2006.09.057; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Koro O, 1999, J ALLERGY CLIN IMMUN, V103, P663, DOI 10.1016/S0091-6749(99)70240-X; LEIFERMAN KM, 1994, J ALLERGY CLIN IMMUN, V94, P1310, DOI 10.1016/0091-6749(94)90347-6; Miyahara N, 2005, J IMMUNOL, V174, P4979, DOI 10.4049/jimmunol.174.8.4979; Nosbaum A, 2010, EUR J DERMATOL, V20, P563, DOI 10.1684/ejd.2010.1014; Ohnishi Hiroshi, 2008, Allergol Int, V57, P291, DOI 10.2332/allergolint.08-RAI-0019; OkanoMitani H, 1996, ARCH DERMATOL RES, V288, P168, DOI 10.1007/BF02505219; Patcha V, 2004, EXP CELL RES, V300, P308, DOI 10.1016/j.yexcr.2004.07.015; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; RUZICKA T, 1986, J INVEST DERMATOL, V86, P105, DOI 10.1111/1523-1747.ep12284061; Sicherer SH, 2007, J ALLERGY CLIN IMMUN, V119, P1462, DOI 10.1016/j.jaci.2007.02.013; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; THORSEN S, 1990, ALLERGY, V45, P457, DOI 10.1111/j.1398-9995.1990.tb01097.x; WENZEL SE, 1995, AM J RESP CRIT CARE, V152, P897, DOI 10.1164/ajrccm.152.3.7663802; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	39	134	138	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 19	2012	37	4					747	758		10.1016/j.immuni.2012.06.018	http://dx.doi.org/10.1016/j.immuni.2012.06.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23063331	Green Accepted, Bronze			2022-12-18	WOS:000310185400018
J	Sette, A; Moutaftsi, M; Moyron-Quiroz, J; McCausland, MM; Davies, DH; Johnston, RJ; Peters, L; Benhnia, MREI; Hoffmann, J; Su, HP; Singh, K; Garboczi, DN; Head, S; Grey, H; Felgner, PL; Crotty, S				Sette, Alessandro; Moutaftsi, Magdalini; Moyron-Quiroz, Juan; McCausland, Megan M.; Davies, D. Huw; Johnston, Robert J.; Peters, Ljoem; Benhnia, Mohammed Rafii-El-Idrissi; Hoffmann, Julia; Su, Hua-Poo; Singh, Kavita; Garboczi, David N.; Head, Steven; Grey, Howard; Felgner, Philip L.; Crotty, Shane			Selective CD4(+) T cell help for antibody responses to a large viral pathogen: Deterministic linkage of specificities	IMMUNITY			English	Article							HUMORAL IMMUNE-RESPONSE; VACCINIA VIRUS; B-CELLS; SUBCAPSULAR SINUS; PROTECT MICE; LYMPH-NODES; ANTIGEN; INFECTION; ENVELOPE; TARGET	Antibody responses are critical components of protective immune responses to many pathogens, but parameters determining which proteins are targeted remain unclear. Vaccination with individual MHC-II-restricted vaccinia virus (VACV, smallpox vaccine) epitopes revealed that CD4(+) T cell help to B cells was surprisingly nontransferable to other virion protein specificities. Many VACV CD4(+) T cell responses identified in an unbiased screen targeted antibody virion protein targets, consistent with deterministic linkage between specificities. We tested the deterministic linkage model by efficiently predicting new vaccinia MHC II epitopes (830% improved efficiency). Finally, we showed CD4(+) T cell help was limiting for neutralizing antibody development and protective immunity in vivo. In contrast to the standard model, these data indicate individual proteins are the unit of B cell-T cell recognition for a large virus. Therefore, MHC restriction is a key selective event for the antiviral antibody response and is probably important for vaccine development to large pathogens.	[Sette, Alessandro; Moutaftsi, Magdalini; Moyron-Quiroz, Juan; McCausland, Megan M.; Johnston, Robert J.; Peters, Ljoem; Benhnia, Mohammed Rafii-El-Idrissi; Grey, Howard; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Davies, D. Huw; Felgner, Philip L.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92697 USA; [Hoffmann, Julia; Head, Steven] Scripps Res Inst, DNA Array Core Facil, La Jolla, CA 92037 USA; [Hoffmann, Julia; Head, Steven] Scripps Res Inst, Consortium Funct Glyc, La Jolla, CA 92037 USA; [Su, Hua-Poo; Singh, Kavita; Garboczi, David N.] NIAAA, Struct Biol Sect, Immunogenet Lab, Natl Inst Hlth, Rockville, MD 20852 USA	La Jolla Institute for Immunology; University of California System; University of California Irvine; Scripps Research Institute; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	shane@liai.org	Sette, Alessandro/AFO-8916-2022; Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019; benhnia, mohammed rafii el idrissi/F-3019-2015	Crotty, Shane/0000-0002-6484-6262; benhnia, mohammed rafii el idrissi/0000-0001-7405-9476; Su, Hua-Poo/0000-0003-3808-7837	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [R01 AI063107-02, U01 AI077953, R01 AI063107-03, U01 AI077953-01, R01 AI063107-01A1, R01 AI063107-04, R01 AI063107] Funding Source: Medline; PHS HHS [HHSN266200400024] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000956, R01AI063107, U01AI077953, ZICAI001051] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; BRIODY BA, 1959, BACTERIOL REV, V23, P61, DOI 10.1128/MMBR.23.2.61-95.1959; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chen ZC, 2006, P NATL ACAD SCI USA, V103, P1882, DOI 10.1073/pnas.0510598103; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102; Davies DH, 2005, J VIROL, V79, P11724, DOI 10.1128/JVI.79.18.11724-11733.2005; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; DEMKOWICZ WE, 1992, J VIROL, V66, P386, DOI 10.1128/JVI.66.1.386-398.1992; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; FENNER F, 1988, SMALLPOX ITS ERADLCA; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Galmiche MC, 1999, VIROLOGY, V254, P71, DOI 10.1006/viro.1998.9516; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hollinger F.B., 2001, FIELDS VIROLOGY, P2971; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; Janeway C., 2005, IMMUNOBIOLOGY; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Knipe D.M., 2001, FIELDS VIROLOGY; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; LAKE P, 1976, COLD SPRING HARB SYM, V41, P589, DOI 10.1101/SQB.1977.041.01.068; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lodish H., 2003, MOL CELL BIOL; Lustig S, 2005, J VIROL, V79, P13454, DOI 10.1128/JVI.79.21.13454-13462.2005; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; MILICH DR, 1987, NATURE, V329, P547, DOI 10.1038/329547a0; MOSS B, 2001, FUNDAMENTAL VIROLOGY; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Newman FK, 2003, J CLIN MICROBIOL, V41, P3154, DOI 10.1128/JCM.41.7.3154-3157.2003; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; PAPPUOLI R, 2002, SCIENCE, V297, P937; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Resch W, 2007, VIROLOGY, V358, P233, DOI 10.1016/j.virol.2006.08.025; Roos N, 1996, EMBO J, V15, P2343, DOI 10.1002/j.1460-2075.1996.tb00590.x; RUSSELL SM, 1979, NATURE, V280, P147, DOI 10.1038/280147a0; SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114; SETTE A, 1993, J IMMUNOL, V151, P3163; Su HP, 2005, P NATL ACAD SCI USA, V102, P4240, DOI 10.1073/pnas.0501103102; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; Wykes M, 1998, J IMMUNOL, V161, P1313; Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265	55	134	137	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2008	28	6					847	858		10.1016/j.immuni.2008.04.018	http://dx.doi.org/10.1016/j.immuni.2008.04.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549802	Green Accepted, Bronze			2022-12-18	WOS:000256760200015
J	Catron, DM; Itano, AA; Pape, KA; Mueller, DL; Jenkins, MK				Catron, DM; Itano, AA; Pape, KA; Mueller, DL; Jenkins, MK			Visualizing the first 50 Hr of the primary immune response to a soluble antigen	IMMUNITY			English	Review							CD4(+) T-CELLS; LYMPH-NODE CORTEX; DENDRITIC CELLS; IN-VIVO; B-CELLS; PROLIFERATIVE CAPACITY; CLONAL EXPANSION; CD8(+); MOUSE; REPERTOIRE	Recently, static and dynamic imaging methods have produced the first glimpses of the interactions between antigen-specific T cells and peptide-MHC-bearing antigen-presenting cells in the lymph nodes. Using data from these experiments, we produced a numerically, spatially, and temporally scaled simulation of the first 50 hr of the primary T cell-dependent immune response. The simulation highlights how lymph node structure facilitates antigen presentation to rare, naive, antigen-specific CD4+ T cells.	Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Med, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Catron, DM (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA.	catro001@umn.edu	Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; Mueller, Daniel/0000-0003-1621-0419; Itano, Andrea/0000-0002-4766-6876				Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bajenoff M, 2002, J IMMUNOL, V168, P1723, DOI 10.4049/jimmunol.168.4.1723; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; FORD WL, 1969, SEMIN HEMATOL, V6, P67; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Germain RN, 2004, CURR OPIN IMMUNOL, V16, P120, DOI 10.1016/j.coi.2003.11.001; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HAYAKAWA M, 1988, ARCH HISTOL CYTOL, V51, P233, DOI 10.1679/aohc.51.233; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lee WT, 2002, J IMMUNOL, V168, P1682, DOI 10.4049/jimmunol.168.4.1682; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Manickasingham S, 2000, J IMMUNOL, V165, P5027, DOI 10.4049/jimmunol.165.9.5027; McHeyzer-Williams MG, 2000, IMMUNOL RES, V22, P223, DOI 10.1385/IR:22:2-3:223; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miga AJ, 2001, EUR J IMMUNOL, V31, P959, DOI 10.1002/1521-4141(200103)31:3<959::AID-IMMU959>3.0.CO;2-A; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Muller G, 2003, IMMUNOL REV, V195, P117, DOI 10.1034/j.1600-065X.2003.00073.x; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Schrum AG, 2002, J EXP MED, V196, P793, DOI 10.1084/jem.20020158; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407	40	134	137	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2004	21	3					341	347		10.1016/j.immuni.2004.08.007	http://dx.doi.org/10.1016/j.immuni.2004.08.007			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357945	Bronze			2022-12-18	WOS:000224034900005
J	Hugues, S; Mougneau, E; Ferlin, W; Jeske, D; Hofman, P; Homann, D; Beaudoin, L; Schrike, C; Von Herrath, M; Lehuen, A; Glaichenhaus, N				Hugues, S; Mougneau, E; Ferlin, W; Jeske, D; Hofman, P; Homann, D; Beaudoin, L; Schrike, C; Von Herrath, M; Lehuen, A; Glaichenhaus, N			Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells	IMMUNITY			English	Article							RESTRICTED CROSS-PRESENTATION; CD4(+) T-CELLS; DENDRITIC CELLS; NOD MICE; MOUSE; MODEL; STREPTOZOTOCIN; DEATH; DESTRUCTION; INDUCTION	Crosspresentation of self-antigens by antigen-presenting cells is critical for the induction of peripheral tolerance. As apoptosis facilitates the entry of antigens into the cross presentation pathway, we sought to prevent the development of autoimmune diabetes by inducing pancreatic beta cell apoptosis before disease onset. Accordingly, young nonobese diabetic (NOD) mice injected with a single low dose of streptozotocin (SZ), a drug cytotoxic for beta cells, exhibited impaired T cell responses to islet antigens and were protected from spontaneous diabetes. Furthermore, beta cell apoptosis was necessary for protection since SZ did not protect RIP-CrmA transgenic NOD mice in which beta cells expressed the caspase inhibitor CrmA. Our results support a model in which apoptosis of pancreatic beta cells induces the development of regulatory cells leading to the tolerization of self-reactive T cells and protection from diabetes.	Hop Necker Enfants Malad, INSERM, U25, F-75743 Paris 15, France; Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France; Univ Nice, Fac Med, F-06000 Nice, France; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; La Jolla Institute for Immunology	Lehuen, A (corresponding author), Hop Necker Enfants Malad, INSERM, U25, 161 Rue de Sevres, F-75743 Paris 15, France.		Hofman, Paul/P-7654-2018	Hofman, Paul/0000-0003-0431-9353; hugues, stephanie/0000-0002-1031-5909; Homann, Dirk/0000-0002-7622-5754; Lehuen, Agnes/0000-0002-0450-3321				Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Albers R, 1998, EUR J IMMUNOL, V28, P1233, DOI 10.1002/(SICI)1521-4141(199804)28:04<1233::AID-IMMU1233>3.0.CO;2-G; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Austyn JM, 1999, NAT MED, V5, P1232, DOI 10.1038/15182; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Forster I, 1996, EUR J IMMUNOL, V26, P3194, DOI 10.1002/eji.1830261253; FORSTER I, 1995, IMMUNITY, V2, P573, DOI 10.1016/1074-7613(95)90002-0; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KLINKHAMMER C, 1989, IMMUNOBIOLOGY, V180, P1; Kolb H, 1993, DIABETES REV, V1, P116; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Laloux V, 2001, J IMMUNOL, V166, P3749, DOI 10.4049/jimmunol.166.6.3749; LARGER E, 1995, J EXP MED, V181, P1635, DOI 10.1084/jem.181.5.1635; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MILLER J, 1993, IMMUNOL REV, V133, P132; OBrien BA, 1996, J PATHOL, V178, P176; OBrien BA, 1997, DIABETES, V46, P750, DOI 10.2337/diabetes.46.5.750; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Soderstrom I, 1996, SCAND J IMMUNOL, V43, P525, DOI 10.1046/j.1365-3083.1996.d01-70.x; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; Thomas HE, 1999, J IMMUNOL, V163, P1562; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; VANDEWINKEL M, 1982, BIOCHEM BIOPH RES CO, V107, P525, DOI 10.1016/0006-291X(82)91523-6; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5	49	134	139	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2002	16	2					169	181		10.1016/S1074-7613(02)00273-X	http://dx.doi.org/10.1016/S1074-7613(02)00273-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869679	Bronze			2022-12-18	WOS:000174039600002
J	Outram, SV; Varas, A; Pepicelli, CV; Crompton, T				Outram, SV; Varas, A; Pepicelli, CV; Crompton, T			Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte	IMMUNITY			English	Article							T-CELL RECEPTOR; SONIC-HEDGEHOG; V(D)J RECOMBINATION; MICE; GENE; EXPRESSION; INDUCTION; POLARITY; PROTEIN; DROSOPHILA	The hedgehog (Hh) signaling pathway is involved in the development of many tissues. Here we show that sonic hedgehog (Shh) is involved in thymocyte development. Our data suggest that termination of Hh signaling is necessary for differentiation from CD4(-)CD8(-) double-negative (DN) to CD4(+)CD8(+) double-positive (DP) thymocyte. Shh is produced by the thymic stroma, and Patched and Smoothened (Smo), the transmembrane receptors for Shh, are expressed in DN thymocytes. A neutralizing monoclonal antibody against Shh increases differentiation of DN to DP thymocytes, and Shh protein arrests thymocyte differentiation at the CD25(+) DN stage, after T cell receptor beta (TCR beta) gene rearrangement. We show that one consequence of pre-TCR signaling is downregulation of Smo, allowing DN thymocytes to proliferate and differentiate.	Univ London Imperial Coll Sci Technol & Med, Dept Biol, London SW7 2AZ, England; Ontogeny Inc, Skin Grp, Cambridge, MA 02138 USA	Imperial College London	Crompton, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	t.crompton@ic.ac.uk	Varas, Alberto/B-8292-2015	Varas, Alberto/0000-0001-8329-6457; Crompton, Tessa/0000-0002-8973-4021				Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; ANDJELIC S, 1993, EUR J IMMUNOL, V23, P2109, DOI 10.1002/eji.1830230910; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Crompton T, 1997, EUR J IMMUNOL, V27, P100, DOI 10.1002/eji.1830270115; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; Goodrich LV, 1999, DEV BIOL, V211, P323, DOI 10.1006/dbio.1999.9311; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Haks MC, 1999, SEMIN IMMUNOL, V11, P23, DOI 10.1006/smim.1998.0153; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Jenkinson E J, 1990, Semin Immunol, V2, P51; Kang J, 1997, Semin Immunol, V9, P171, DOI 10.1006/smim.1997.0069; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; LIN WC, 1995, IMMUNOL TODAY, V16, P279, DOI 10.1016/0167-5699(95)80182-0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7	32	134	148	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2000	13	2					187	197		10.1016/S1074-7613(00)00019-4	http://dx.doi.org/10.1016/S1074-7613(00)00019-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981962	Bronze			2022-12-18	WOS:000089132100004
J	Shamshiev, A; Donda, A; Prigozy, TI; Mori, L; Chigorno, V; Benedict, CA; Kappos, L; Sonnino, S; Kronenberg, M; De Libero, G				Shamshiev, A; Donda, A; Prigozy, TI; Mori, L; Chigorno, V; Benedict, CA; Kappos, L; Sonnino, S; Kronenberg, M; De Libero, G			The alpha beta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides	IMMUNITY			English	Article							ANTIGEN-PRESENTING MOLECULES; TITER RETROVIRAL VECTORS; LIPOGLYCAN ANTIGENS; CRYSTAL-STRUCTURE; MOUSE CD1; CYTOPLASMIC TAIL; LIPID ANTIGENS; RECOGNITION; GANGLIOSIDES; GM1	The structural basis for the T cell recognition of lipoglycans remains to be elucidated. We have described autoreactive T cells responsive to GM1 ganglioside presented by CD1b. We show that glycosphingolipids bind to CD1b on the cell surface at neutral pH and are recognized without internalization or processing. Furthermore, soluble GM1-CD1b complexes stimulate specific T cells. Oligosaccharide groups containing five or more sugars are required to build a minimal epitope for TCR recognition. This suggests a mechanism for T cell recognition of glycosphingolipids in which much of the CD1b-bound ligand is exposed. Binding to CD1b is a highly reversible process and other ceramide-containing glycosphingolipids displace GM1. These nonantigenic compounds act as blockers and may prevent harmful autoreactivity in vivo.	Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; Univ Milan, Study Ctr Funct Biochem Brain Lipids, Dept Med Chem & Biochem LITA Segrate, Sch Med, I-20090 Segrate, Italy	University of Basel; University of Basel; La Jolla Institute for Immunology; University of Milan	De Libero, G (corresponding author), Univ Basel Hosp, Dept Res, Hebelstr 20, CH-4031 Basel, Switzerland.		Sonnino, Sandro/R-4154-2017	Sonnino, Sandro/0000-0001-8180-5908	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040617] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40617] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACQUOTTI D, 1994, EUR J BIOCHEM, V225, P271, DOI 10.1111/j.1432-1033.1994.00271.x; Albert LJ, 1999, NEW ENGL J MED, V341, P2068, DOI 10.1056/NEJM199912303412707; Beckman EM, 1996, J IMMUNOL, V157, P2795; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Brossay L, 1997, J IMMUNOL, V159, P1216; Burdin N, 1999, CURR OPIN IMMUNOL, V11, P326, DOI 10.1016/S0952-7915(99)80052-1; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Glithero A, 1999, IMMUNITY, V10, P63, DOI 10.1016/S1074-7613(00)80007-2; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; LI SC, 1984, J BIOL CHEM, V259, P5409; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prendergast MM, 1998, INFECT IMMUN, V66, P3649, DOI 10.1128/IAI.66.8.3649-3655.1998; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Rosat JP, 1999, J IMMUNOL, V162, P366; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; SONNINO S, 1994, CHEM PHYS LIPIDS, V71, P21, DOI 10.1016/0009-3084(94)02304-2; SONNINO S, 1985, J LIPID RES, V26, P248; SONNINO S, 1990, CHEM PHYS LIPIDS, V56, P49, DOI 10.1016/0009-3084(90)90087-8; SONNINO S, 1988, CHEM PHYS LIPIDS, V46, P181, DOI 10.1016/0009-3084(88)90020-5; Sonnino S, 1996, GLYCOBIOLOGY, V6, P479, DOI 10.1093/glycob/6.5.479-e; Speir JA, 1999, IMMUNITY, V10, P51, DOI 10.1016/S1074-7613(00)80006-0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Tangri S, 1998, P NATL ACAD SCI USA, V95, P14314, DOI 10.1073/pnas.95.24.14314; WIEGANDT H, 1970, EUR J BIOCHEM, V15, P287, DOI 10.1111/j.1432-1033.1970.tb01006.x; Yamaguchi Y, 1996, ONCOL RES, V8, P399; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	39	134	137	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2000	13	2					255	264		10.1016/S1074-7613(00)00025-X	http://dx.doi.org/10.1016/S1074-7613(00)00025-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981968	Bronze			2022-12-18	WOS:000089132100010
J	Gandy, KL; Domen, J; Aguila, H; Weissman, IL				Gandy, KL; Domen, J; Aguila, H; Weissman, IL			CD8(+)TCR(+) and CD8(+)TCR(-) cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; MONOCLONAL-ANTIBODY OKT3; VERSUS-HOST DISEASE; T-CELL; GRAFT-REJECTION; HYBRID RESISTANCE; TRANSGENIC MICE; LYMPH-NODES; GRANZYME-A; MURINE NK	Although purified hematopoietic stem cells (HSC) are sufficient to engraft irradiated allogeneic recipients, bone marrow (BM) contains other cells that facilitate engraftment. Here, several candidate facilitators were tested by cotransplantation with HSC. Both TCR+ and TCR(-)CD8 alpha(+) BM subpopulations have facilitative potential. CD8(+)TCR(+) cells are typical T lymphocytes. CD8(+)TCR(-) facilitators are CD3(-), not CD3(+), have a granular morphology, and are CD8 beta(-) and CD11c(+); they share phenotypic characteristics with CD8 alpha alpha lymphoid dendritic cells and veto cells. We also demonstrate that lytic function is not necessary for facilitation and that the CD8 alpha molecule is either important for facilitation or in the development of facilitators.	Stanford Univ, Med Ctr, Dept Pathol & Dev Biol, Stanford, CA 94305 USA	Stanford University	Gandy, KL (corresponding author), Duke Univ, Med Ctr, Dept Surg, Box 31193, Durham, NC 27710 USA.	gandy001@mc.duke.edu			NCI NIH HHS [CA49605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguila HL, 1996, BLOOD, V87, P1225, DOI 10.1182/blood.V87.4.1225.bloodjournal8741225; AGUILA HL, 1995, P NATL ACAD SCI USA, V92, P10192, DOI 10.1073/pnas.92.22.10192; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Asiedu C, 1999, TRANSPLANTATION, V67, P372, DOI 10.1097/00007890-199902150-00006; Baker M B, 1995, Biol Blood Marrow Transplant, V1, P69; BENNETT M, 1987, TRANSPLANT P, V19, P5; BLAZAR BR, 1991, J IMMUNOL, V147, P1492; CAI ZL, 1994, J EXP MED, V179, P2005, DOI 10.1084/jem.179.6.2005; DAVENPORT C, 1995, J IMMUNOL, V154, P2568; DEEG HJ, 1979, BLOOD, V53, P552; DENNERT G, 1985, J IMMUNOL, V135, P3729; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Drobyski WR, 1997, BLOOD, V89, P1100, DOI 10.1182/blood.V89.3.1100; FILIPOVICH AH, 1982, LANCET, V1, P1266; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Gandy KL, 1998, TRANSPLANTATION, V65, P295, DOI 10.1097/00007890-199802150-00001; GERSHENFELD HK, 1986, SCIENCE, V232, P854, DOI 10.1126/science.2422755; Graubert TA, 1996, BLOOD, V87, P1232, DOI 10.1182/blood.V87.4.1232.bloodjournal8741232; HEEG K, 1990, J EXP MED, V172, P719, DOI 10.1084/jem.172.3.719; HERSHBERGER RJ, 1992, J BIOL CHEM, V267, P25488; HIRUMA K, 1992, BLOOD, V79, P3050; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; ILDSTAD ST, 1986, J IMMUNOL, V136, P28; KAUFMAN CL, 1994, BLOOD, V84, P2436; KORNGOLD R, 1978, J EXP MED, V148, P1687; Kumar V, 1997, CURR OPIN IMMUNOL, V9, P52, DOI 10.1016/S0952-7915(97)80158-6; LAPIDOT T, 1992, BLOOD, V80, P2406; Lee LA, 1996, TRANSPLANTATION, V61, P125, DOI 10.1097/00007890-199601150-00024; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Martin PJ, 1999, BLOOD, V94, P2192, DOI 10.1182/blood.V94.7.2192.419a38_2192_2199; MARTIN PJ, 1993, J EXP MED, V178, P703, DOI 10.1084/jem.178.2.703; Martin PJ, 1998, BLOOD, V92, P2177, DOI 10.1182/blood.V92.6.2177.418k02_2177_2181; Martin PJ, 1990, GRAFT VERSUS HOST DI, P371; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MURPHY WJ, 1992, J IMMUNOL, V148, P2953; MURPHY WJ, 1987, J EXP MED, V166, P1499, DOI 10.1084/jem.166.5.1499; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; PALATHUMPAT V, 1995, TRANSPLANTATION, V60, P355, DOI 10.1097/00007890-199508270-00010; PRENTICE HG, 1982, LANCET, V1, P700; RINKEVICH B, 1992, DEV COMP IMMUNOL, V16, P275, DOI 10.1016/0145-305X(92)90002-T; RODT H, 1974, EUR J IMMUNOL, V4, P25, DOI 10.1002/eji.1830040107; ROSEN C, 1989, SEMIN DERMATOL, V8, P149; RUDD CE, 1991, ADV EXP MED BIOL, V292, P85; RUDD CE, 1990, IMMUNOL TODAY, V11, P400, DOI 10.1016/0167-5699(90)90159-7; SCHWARTZ E, 1987, J IMMUNOL, V138, P460; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STORB R, 1968, TRANSPLANTATION, V6, P587, DOI 10.1097/00007890-196807000-00011; SYKES M, 1988, J IMMUNOL, V141, P2282; THOMAS JM, 1994, CLIN TRANSPLANT, V8, P195; TIBERGHIEN P, 1990, BLOOD, V76, P1419; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; Vremec D, 1997, J IMMUNOL, V159, P565; Wang BY, 1997, P NATL ACAD SCI USA, V94, P14632, DOI 10.1073/pnas.94.26.14632; Ware CF, 1996, J CELL BIOCHEM, V60, P47, DOI 10.1002/(SICI)1097-4644(19960101)60:1<47::AID-JCB8>3.3.CO;2-H; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903	58	134	140	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1999	11	5					579	590		10.1016/S1074-7613(00)80133-8	http://dx.doi.org/10.1016/S1074-7613(00)80133-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591183	Bronze			2022-12-18	WOS:000083952200010
J	Bruno, L; Fehling, HJ; vonBoehmer, H				Bruno, L; Fehling, HJ; vonBoehmer, H			The alpha beta T cell receptor can replace the gamma delta receptor in the development of gamma delta lineage cells	IMMUNITY			English	Article							TRANSGENIC MICE; SELECTION; REARRANGEMENTS; GENE; EXPRESSION; THYMOCYTES; DELETION	In peripheral lymphoid tissues of TCR transgenic mice that express the nominal antigen (HY peptide plus H-2D(b) MHC) recognized by the transgenic TCR, there exist unusual CD4(-)CD8(-) and CD4(-)CD8(low) cells bearing the transgenic TCR. Here we show that, unlike TCR alpha beta T cells that are generated in the absence of nominal antigen, these unusual cells do not express endogenous TCR alpha genes, have maintained the TCR delta locus on both chromosomes, and can coexpress TCR alpha beta and TCR gamma delta chains on the cell surface. The latter is also true for CD4(-)CD8(-), HSA(+) TCR alpha beta(+) thymocytes in male and female TCR transgenic mice. The number of TCR alpha beta and TCR gamma delta coexpressing cells is increased in pre-TCR-deficient mice. The data indicate that the TCR alpha beta can replace the TCR gamma delta in the development of gamma delta lineage cells and that the pre-TCR interferes with the generation of gamma delta-expressing cells.	INSERM 373,INST NECKER,F-75730 PARIS 15,FRANCE; BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite								ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DiSanto JP, 1996, J EXP MED, V183, P1111, DOI 10.1084/jem.183.3.1111; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; DYALINAS DP, 1983, J IMMUNOL, V131, P2445; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; KANG J, 1995, EUR J IMMUNOL, V25, P2706, DOI 10.1002/eji.1830250946; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; NAKAJIMA PB, 1995, IMMUNITY, V3, P609, DOI 10.1016/1074-7613(95)90132-9; Owen MJ, 1996, CURR OPIN IMMUNOL, V8, P191, DOI 10.1016/S0952-7915(96)80057-4; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Teh H S, 1990, Dev Immunol, V1, P1, DOI 10.1155/1990/18208; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; VONBOEHMER H, 1988, P NATL ACAD SCI USA, V85, P9729, DOI 10.1073/pnas.85.24.9729; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; VONBOEHMER H, 1991, J EXP MED, V174, P1001, DOI 10.1084/jem.174.5.1001	27	134	136	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1996	5	4					343	352		10.1016/S1074-7613(00)80260-5	http://dx.doi.org/10.1016/S1074-7613(00)80260-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VP444	8885867	Bronze			2022-12-18	WOS:A1996VP44400006
J	Bosteels, C; Neyt, K; Vanheerswynghels, M; van Helden, MJ; Sichien, D; Debeuf, N; De Prijck, S; Bosteels, V; Vandamme, N; Martens, L; Saeys, Y; Louagie, E; Lesage, M; Williams, DL; Tang, SC; Mayer, JU; Ronchese, F; Scott, CL; Hammad, H; Guilliams, M; Lambrecht, BN				Bosteels, Cedric; Neyt, Katrijn; Vanheerswynghels, Manon; van Helden, Mary J.; Sichien, Dorine; Debeuf, Nincy; De Prijck, Sofie; Bosteels, Victor; Vandamme, Niels; Martens, Liesbet; Saeys, Yvan; Louagie, Els; Lesage, Manon; Williams, David L.; Tang, Shiau-Choot; Mayer, Johannes U.; Ronchese, Franca; Scott, Charlotte L.; Hammad, Hamida; Guilliams, Martin; Lambrecht, Bart N.			Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection	IMMUNITY			English	Article							CD103(+) DENDRITIC CELLS; FC-GAMMA RECEPTORS; INFLUENZA-VIRUS; ALUM ADJUVANT; CROSS-PRESENTATION; PNEUMONIA VIRUS; ANTIGEN UPTAKE; LYMPH-NODES; BONE-MARROW; IN-VIVO	The phenotypic and functional dichotomy between IRF8(+) type 1 and IRF4(+) type 2 conventional dendritic cells (cDC1s and cDC2s, respectively) is well accepted; it is unknown how robust this dichotomy is under inflammatory conditions, when additionally monocyte-derived cells (MCs) become competent antigen-presenting cells (APCs). Using single-cell technologies in models of respiratory viral infection, we found that lung cDC2s acquired expression of the Fc receptor CD64 shared with MCs and of IRF8 shared with cDC1s. These inflammatory cDC2s (inf-cDC2s) were superior in inducing CD4(+) T helper (Th) cell polarization while simultaneously presenting antigen to CD8(+) T cells. When carefully separated from inf-cDC2s, MCs lacked APC function. Inf-cDC2s matured in response to cell-intrinsic Toll-like receptor and type 1 interferon receptor signaling, upregulated an IRF8-dependent maturation module, and acquired antigens via convalescent serum and Fc receptors. Because hybrid inf-cDC2s are easily confused with monocyte-derived cells, their existence could explain why APC functions have been attributed to MCs.	[Bosteels, Cedric; Neyt, Katrijn; Vanheerswynghels, Manon; van Helden, Mary J.; Sichien, Dorine; Debeuf, Nincy; De Prijck, Sofie; Scott, Charlotte L.; Hammad, Hamida; Guilliams, Martin; Lambrecht, Bart N.] VIB UGent Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium; [Bosteels, Cedric; Neyt, Katrijn; Vanheerswynghels, Manon; van Helden, Mary J.; Sichien, Dorine; Debeuf, Nincy; De Prijck, Sofie; Bosteels, Victor; Hammad, Hamida; Lambrecht, Bart N.] Univ Ghent, Dept Internal Med & Pediat, B-9000 Ghent, Belgium; [Bosteels, Victor] VIB UGent Ctr Inflammat Res, Lab ER Stress & Inflammat, B-9052 Ghent, Belgium; [Vandamme, Niels; Martens, Liesbet; Saeys, Yvan] VIB UGent Ctr Inflammat Res, Data Min & Modeling Biomed Grp, B-9052 Ghent, Belgium; [Martens, Liesbet; Scott, Charlotte L.; Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Louagie, Els; Lesage, Manon] Argenx BV, B-9052 Ghent, Belgium; [Williams, David L.] East Tennessee State Univ, Quillen Coll Med, Dept Surg, Johnson City, TN USA; [Williams, David L.] East Tennessee State Univ, Quillen Coll Med, Ctr Excellence Inflammat Infect Dis & Immun, Johnson City, TN USA; [Tang, Shiau-Choot; Mayer, Johannes U.; Ronchese, Franca] Malaghan Inst Med Res, Wellington 6012, New Zealand; [Hammad, Hamida; Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, NL-3015 GJ Rotterdam, Netherlands; [Vandamme, Niels; Saeys, Yvan] Univ Ghent, Dept Appl Math Comp Sci & Stat, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; East Tennessee State University; East Tennessee State University; Malaghan Institute; Victoria University Wellington; Erasmus University Rotterdam; Erasmus MC; Ghent University	Guilliams, M; Lambrecht, BN (corresponding author), VIB UGent Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium.; Lambrecht, BN (corresponding author), Univ Ghent, Dept Internal Med & Pediat, B-9000 Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium.; Lambrecht, BN (corresponding author), Erasmus MC, Dept Pulm Med, NL-3015 GJ Rotterdam, Netherlands.	martin.guilliams@ugent.vib.be; bart.lambrecht@ugent.be	Guilliams, Martin/N-7803-2013; Lambrecht, Bart N/K-2484-2014; Saeys, Yvan/C-1311-2009	Guilliams, Martin/0000-0003-3525-7570; Lambrecht, Bart N/0000-0003-4376-6834; Saeys, Yvan/0000-0002-0415-1506; Mayer, Johannes U/0000-0001-6225-7803; Sichien, Dorine/0000-0002-7298-3005; Bosteels, Victor/0000-0001-8838-021X; Bosteels, Cedric/0000-0003-3230-0879; Martens, Liesbet/0000-0001-9180-7456	European Research Council (ERC); Ghent University; Excellence of Science (EOS) research grant; Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO); GOA from Ghent University; ERC consolidator grant; FWO; ERC; Flanders Innovation & Entrepreneurship (VLAIO); Health Research Council of New Zealand Independent Research Organisation grant; Health Research Council of NZ project grant	European Research Council (ERC)(European Research Council (ERC)European Commission); Ghent University(Ghent University); Excellence of Science (EOS) research grant; Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); GOA from Ghent University; ERC consolidator grant(European Research Council (ERC)); FWO(FWO); ERC(European Research Council (ERC)European Commission); Flanders Innovation & Entrepreneurship (VLAIO); Health Research Council of New Zealand Independent Research Organisation grant; Health Research Council of NZ project grant	We thank the technicians of the Hammad, Lambrecht, and Guilliams lab and the VIB Nucleomics and Flow cores. B.N.L. is supported by a European Research Council (ERC) advanced grant, a concerted research initiative grant (GOA) from Ghent University, and an Excellence of Science (EOS) research grant. M.G. is supported by Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO), a GOA from Ghent University, and an ERC consolidator grant. Y.S. is supported by the FWO and is a Marylou Ingram Scholar. C.L.S. is supported by the FWO and an ERC starting grant. C.B., K.N., N.D., and V.B. are supported by grants from FWO. D.S., M.L., and E.L. are supported by Flanders Innovation & Entrepreneurship (VLAIO). This research was further funded by a Health Research Council of New Zealand Independent Research Organisation grant (to the Malaghan Institute) and a Health Research Council of NZ project grant (to F.R.).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Ainsua-Enrich E, 2019, MUCOSAL IMMUNOL, V12, P1025, DOI 10.1038/s41385-019-0173-1; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bagadia P, 2019, NAT IMMUNOL, V20, P1174, DOI 10.1038/s41590-019-0449-3; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Baptista AP, 2019, IMMUNITY, V50, P1188, DOI 10.1016/j.immuni.2019.04.001; Bosteels C., 2018, CURR PROTOC IMMUNOL, V120; Bosteels C, 2020, MOL IMMUNOL, V121, P38, DOI 10.1016/j.molimm.2020.02.021; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Cabeza-Cabrerizo M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw1941; Camberis M, 2013, J IMMUNOL METHODS, V394, P62, DOI 10.1016/j.jim.2013.05.004; Casadevall A, 2020, J CLIN INVEST, V130, P1545, DOI 10.1172/JCI138003; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Connor LM, 2017, J EXP MED, V214, P125, DOI 10.1084/jem.20160470; Connor LM, 2014, J IMMUNOL, V193, P2709, DOI 10.4049/jimmunol.1400374; Cook PM, 1998, J GEN VIROL, V79, P2411, DOI 10.1099/0022-1317-79-10-2411; De Koker S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06236-6; Deckers J, 2017, J ALLERGY CLIN IMMUN, V140, P1364, DOI 10.1016/j.jaci.2016.12.970; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Desch AN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5674; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Everts B, 2016, J EXP MED, V213, P35, DOI 10.1084/jem.20150235; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Grine L, 2015, J IMMUNOL, V194, P5094, DOI 10.4049/jimmunol.1403015; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hadebe S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134219; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hintzen G, 2006, J IMMUNOL, V177, P7346, DOI 10.4049/jimmunol.177.10.7346; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Ivanov S, 2016, J CLIN INVEST, V126, P1581, DOI 10.1172/JCI84518; Jaiswal H, 2013, J IMMUNOL, V191, P5993, DOI 10.4049/jimmunol.1203541; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kirkling ME, 2018, CELL REP, V23, P3658, DOI 10.1016/j.celrep.2018.05.068; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kool M, 2012, J MED MICROBIOL, V61, P927, DOI 10.1099/jmm.0.038943-0; Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597; Krishnaswamy JK, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9169; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Larson SR, 2016, CELL DEATH DIFFER, V23, P997, DOI 10.1038/cdd.2016.24; Lehmann CHK, 2017, J EXP MED, V214, P1509, DOI 10.1084/jem.20160951; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Luda KM, 2016, IMMUNITY, V44, P860, DOI 10.1016/j.immuni.2016.02.008; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Lun Aaron T L, 2016, F1000Res, V5, P2122; Mayer JU, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15820; MEISTER A, 1986, J GEN VIROL, V67, P1633, DOI 10.1099/0022-1317-67-8-1633; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Mesnil C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053242; Min J, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.292; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naessens T, 2020, AM J RESP CRIT CARE, V202, P535, DOI 10.1164/rccm.201906-1123OC; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2013, MUCOSAL IMMUNOL, V6, P678, DOI 10.1038/mi.2012.106; Nakano H, 2017, J LEUKOCYTE BIOL, V101, P1143, DOI 10.1189/jlb.1A0616-285R; Nakano H, 2015, J IMMUNOL, V194, P3808, DOI 10.4049/jimmunol.1402195; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Neyt K, 2016, MUCOSAL IMMUNOL, V9, P999, DOI 10.1038/mi.2015.91; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Scott CL, 2015, MUCOSAL IMMUNOL, V8, P327, DOI 10.1038/mi.2014.70; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sheng JP, 2017, CELL REP, V21, P1203, DOI 10.1016/j.celrep.2017.10.024; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tanaka A, 2007, CLIN EXP ALLERGY, V37, P1083, DOI 10.1111/j.1365-2222.2006.02616.x; Tang XZ, 2019, J ALLERGY CLIN IMMUN, V143, P1643, DOI 10.1016/j.jaci.2018.11.045; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Van de Walle I, 2011, BLOOD, V117, P4449, DOI 10.1182/blood-2010-06-290049; Van der Borght K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02714; Vandersarren L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03042-y; Vanheerswynghels M, 2018, METHODS MOL BIOL, V1799, P183, DOI 10.1007/978-1-4939-7896-0_15; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Walsh KB, 2013, J VIROL, V87, P9949, DOI 10.1128/JVI.00339-13; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Wu XD, 2016, J EXP MED, V213, P2553, DOI 10.1084/jem.20160600	103	133	136	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					1039	+		10.1016/j.immuni.2020.04.005	http://dx.doi.org/10.1016/j.immuni.2020.04.005			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32392463	Green Published, Bronze			2022-12-18	WOS:000541890000017
J	Konkel, JE; Zhang, DF; Zanvit, P; Chia, C; Zangarle-Murray, T; Jin, WW; Wang, SL; Chen, WJ				Konkel, Joanne E.; Zhang, Dunfang; Zanvit, Peter; Chia, Cheryl; Zangarle-Murray, Tamsin; Jin, Wenwen; Wang, Songlin; Chen, WanJun			Transforming Growth Factor-beta Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; TGF-BETA; IN-VIVO; REG-CELLS; MEDIATED REGULATION; CD103 EXPRESSION; TH17 CELLS; INFLAMMATION; AUTOIMMUNITY; HOMEOSTASIS	Regulatory T cells (Treg cells) perform suppressive functions in disparate tissue environments and against many inflammatory insults, yet the tissue-enriched factor(s) that influence Treg cell phenotype and function remain largely unknown. We have shown a vital role for transforming growth factor-beta (TGF-beta) signals in safe-guarding specific Treg cell functions. TGF-beta signals were dispensable for steady-state Treg cell homeostasis and for Treg cell suppression of T cell proliferation and T helper-1 (Th1) cell differentiation. However, Treg cells require TGF-beta signals to appropriately dampen Th17 cells and regulate responses in the gastrointestinal tract. TGF-beta signaling maintains CD103 expression, promotes expression of the colon-specific trafficking molecule GPR15, and inhibits expression of GPR174, a receptor for lysophosphatidylserine, on Treg cells, collectively supporting the accumulation and retention of Treg cells in the colon and control of colitogenic responses. Thus, we reveal an unrecognized function for TGF-beta signaling as an upstream factor controlling Treg cell activity in specific tissue environments.	[Konkel, Joanne E.; Zhang, Dunfang; Zanvit, Peter; Chia, Cheryl; Jin, Wenwen; Chen, WanJun] NIDCR, Mucosal Immunol Sect, OPCB, NIH, Bethesda, MD 20892 USA; [Konkel, Joanne E.; Zangarle-Murray, Tamsin] Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England; [Konkel, Joanne E.; Zangarle-Murray, Tamsin] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9PT, Lancs, England; [Wang, Songlin] Capital Med Univ, Sch Basic Med Sci, Mol Lab Gene Therapy & Tooth Regenerat, Beijing 100050, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Manchester; University of Manchester; Capital Medical University	Konkel, JE; Chen, WJ (corresponding author), NIDCR, Mucosal Immunol Sect, OPCB, NIH, Bethesda, MD 20892 USA.; Konkel, JE (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England.; Konkel, JE (corresponding author), Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9PT, Lancs, England.	joanne.konkel@manchester.ac.uk; wchen@mail.nih.gov		Zhang, Dunfang/0000-0001-7545-9930	NIH, NIDCR; BBSRC [BB/M025977/1]; Manchester Collaborative Centre for Inflammation Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/M025977/1] Funding Source: researchfish	NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Manchester Collaborative Centre for Inflammation Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Intramural Research Program of the NIH, NIDCR, by the BBSRC (BB/M025977/1 to J.E.K.), and by the Manchester Collaborative Centre for Inflammation Research (to J.E.K). We thank the NIDCR flow core and Hayley Bridgeman at the University of Manchester for technical assistance.	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Barnes MJ, 2015, J EXP MED, V212, P1011, DOI 10.1084/jem.20141827; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen WJ, 2003, CYTOKINE GROWTH F R, V14, P85, DOI 10.1016/S1359-6101(03)00003-0; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Chu X, 2013, J MED GENET, V50, P479, DOI 10.1136/jmedgenet-2013-101595; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Gu AD, 2012, P NATL ACAD SCI USA, V109, P905, DOI 10.1073/pnas.1108352109; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Ishigame H, 2013, P NATL ACAD SCI USA, V110, P6961, DOI 10.1073/pnas.1304498110; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Konkel JE, 2014, P NATL ACAD SCI USA, V111, pE465, DOI 10.1073/pnas.1320319111; Konkel JE, 2011, TRENDS MOL MED, V17, P668, DOI 10.1016/j.molmed.2011.07.002; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; McPherson RC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00069; Mokrani M, 2014, J IMMUNOL, V192, P2471, DOI 10.4049/jimmunol.1302192; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Novitskiy SV, 2012, J LEUKOCYTE BIOL, V92, P641, DOI 10.1189/jlb.1211639; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schon MP, 1999, J IMMUNOL, V162, P6641; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tartar DM, 2010, J IMMUNOL, V184, P3377, DOI 10.4049/jimmunol.0903324; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Yang B.-H., 2015, MUCOSAL IMMUNOLOGY; Zhang P, 2013, BLOOD, V122, P2224, DOI 10.1182/blood-2013-05-503250; Zhao YG, 2011, CELL MOL IMMUNOL, V8, P315, DOI 10.1038/cmi.2011.11; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	53	133	138	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					660	674		10.1016/j.immuni.2017.03.015	http://dx.doi.org/10.1016/j.immuni.2017.03.015			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423340	Green Submitted, Bronze			2022-12-18	WOS:000399451100018
J	Lam, WY; Becker, AM; Kennerly, KM; Wong, R; Curtis, JD; Llufrio, EM; McCommis, KS; Fahrmann, J; Pizzato, HA; Nunley, RM; Lee, J; Wolfgang, MJ; Patti, GJ; Finck, BN; Pearce, EL; Bhattacharya, D				Lam, Wing Y.; Becker, Amy M.; Kennerly, Krista M.; Wong, Rachel; Curtis, Jonathan D.; Llufrio, Elizabeth M.; McCommis, Kyle S.; Fahrmann, Johannes; Pizzato, Hannah A.; Nunley, Ryan M.; Lee, Jieun; Wolfgang, Michael J.; Patti, Gary J.; Finck, Brian N.; Pearce, Erika L.; Bhattacharya, Deepta			Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells	IMMUNITY			English	Article							MEMORY B-CELLS; BONE-MARROW; GERMINAL-CENTERS; FATTY-ACIDS; RESPIRATORY CAPACITY; GLUCOSE-METABOLISM; IMMUNE-RESPONSE; CARRIER 2; DIFFERENTIATION; GROWTH	Durable antibody production after vaccination or infection is mediated by long-lived plasma cells (LLPCs). Pathways that specifically allow LLPCs to persist remain unknown. Through bioenergetic profiling, we found that human and mouse LLPCs could robustly engage pyruvate-dependent respiration, whereas their short-lived counterparts could not. LLPCs took up more glucose than did short-lived plasma cells (SLPCs) in vivo, and this glucose was essential for the generation of pyruvate. Glucose was primarily used to glycosylate antibodies, but glycolysis could be promoted by stimuli such as low ATP levels and the resultant pyruvate used for respiration by LLPCs. Deletion of Mpc2, which encodes an essential component of the mitochondrial pyruvate carrier, led to a progressive loss of LLPCs and of vaccine-specific antibodies in vivo. Thus, glucose uptake and mitochondrial pyruvate import prevent bioenergetic crises and allow LLPCs to persist. Immunizations that maximize these plasma cell metabolic properties might thus provide enduring antibody-mediated immunity.	[Lam, Wing Y.; Becker, Amy M.; Kennerly, Krista M.; Wong, Rachel; Curtis, Jonathan D.; Pizzato, Hannah A.; Pearce, Erika L.; Bhattacharya, Deepta] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Llufrio, Elizabeth M.; Patti, Gary J.] Washington Univ, Sch Med, Dept Chem, St Louis, MO 63110 USA; [McCommis, Kyle S.; Finck, Brian N.] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Fahrmann, Johannes] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [Nunley, Ryan M.] Washington Univ Orthoped, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Lee, Jieun; Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Dept Biol Chem, Baltimore, MD 21205 USA; [Becker, Amy M.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Curtis, Jonathan D.; Pearce, Erika L.] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Fahrmann, Johannes] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis; Barnes-Jewish Hospital; Washington University (WUSTL); Johns Hopkins University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Max Planck Society; University of Texas System; UTMD Anderson Cancer Center	Bhattacharya, D (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	deeptab@wustl.edu		Wong, Rachel/0000-0001-7837-2881; Fahrmann, Johannes/0000-0001-5088-0198; McCommis, Kyle/0000-0003-2381-1589; Finck, Brian/0000-0001-5411-3674	NIH [R01AI099108, R01AI091965, R01DK104735, R42AA021228, R01NS072241, K01DK099395, U24 DK-097154, P30CA91842, UL1TR000448]; New York Stem Cell Foundation; American Cancer Society [125091-RSG-13-252-01-LIB]; Diabetes Research Postdoctoral Training Program [T32 DK07296, DK007120]; National Science Foundation [DGE-1143954]; Biocomposites; Cardinal Health; CardioMEMS; DePUy; Johnson & Johnson Company; Integra Sciences; Medtronic; Smith Nephew; Wright Medical Technology, Inc.; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA181125] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099108, R01AI091965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007296, P30DK020579, U24DK097154, P30DK056341, T32DK007120, K01DK099395, R01DK104735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R42AA021228] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; American Cancer Society(American Cancer Society); Diabetes Research Postdoctoral Training Program; National Science Foundation(National Science Foundation (NSF)); Biocomposites; Cardinal Health; CardioMEMS; DePUy; Johnson & Johnson Company(Johnson & JohnsonJohnson & Johnson USA); Integra Sciences; Medtronic(Medtronic); Smith Nephew; Wright Medical Technology, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grants R01AI099108 (D.B.), R01AI091965 (E.L.P.), R01DK104735 (B.N.F.), R42AA021228 (B.N.F.), R01NS072241 (M.J.W.), and K01DK099395 (A.M.B.). This work was also supported by the New York Stem Cell Foundation and a Research Scholar grant from the American Cancer Society (125091-RSG-13-252-01-LIB, to D.B.). D.B. is a New York Stem Cell Foundation-Robertson Investigator. K.S.M. is a Diabetes Research Postdoctoral Training Program fellow (T32 DK07296 and DK007120). R.W. is supported by a predoctoral fellowship from the National Science Foundation (DGE-1143954). The West Coast Metabolomics Center is supported by NIH grant U24 DK-097154. RNA-seq analysis was performed by the Genome Technology Access Center at Washington University, supported by NIH grants P30CA91842 (Siteman Cancer Center) and UL1TR000448 (ICTS/CTSA). G.J.P. is a scientific advisory board member for Cambridge Isotope Laboratories. R.M.N. is a paid consultant for Biocomposites, Cardinal Health; CardioMEMS; DePUy, A Johnson & Johnson Company; Integra Sciences; Medtronic; Smith & Nephew; and Wright Medical Technology, Inc.	Ahuja A, 2008, P NATL ACAD SCI USA, V105, P4802, DOI 10.1073/pnas.0800555105; Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Chernova I, 2014, J IMMUNOL, V193, P4971, DOI 10.4049/jimmunol.1401264; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Curi TCP, 1997, AM J PHYSIOL-CELL PH, V273, pC1124, DOI 10.1152/ajpcell.1997.273.4.C1124; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Dufort FJ, 2007, J IMMUNOL, V179, P4953, DOI 10.4049/jimmunol.179.8.4953; Dufort FJ, 2014, J BIOL CHEM, V289, P7011, DOI 10.1074/jbc.M114.551051; FAGRAEUS A, 1948, J IMMUNOL, V58, P1; Garcia-Manteiga JM, 2011, J PROTEOME RES, V10, P4165, DOI 10.1021/pr200328f; GARLAND PB, 1963, NATURE, V200, P169, DOI 10.1038/200169a0; Halestrap AP, 2012, CELL METAB, V16, P141, DOI 10.1016/j.cmet.2012.07.013; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; HAN SH, 1995, J IMMUNOL, V155, P556; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; HICKMAN S, 1977, J BIOL CHEM, V252, P4402; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; Lee K, 2013, BLOOD, V122, P2369, DOI 10.1182/blood-2013-01-477505; Lehninger AL, 2013, LEHNINGER PRINCIPLES; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SCHLIERF G, 1973, J CLIN INVEST, V52, P732, DOI 10.1172/JCI107235; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Tooze RM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00460; Tung JW, 2004, CLIN IMMUNOL, V110, P277, DOI 10.1016/j.clim.2003.11.016; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Spriel AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003113; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Yoshioka K, 1996, BIOSCI BIOTECH BIOCH, V60, P1899, DOI 10.1271/bbb.60.1899; Zelle RM, 2011, APPL ENVIRON MICROB, V77, P732, DOI 10.1128/AEM.02132-10	63	133	134	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					60	73		10.1016/j.immuni.2016.06.011	http://dx.doi.org/10.1016/j.immuni.2016.06.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27396958	Green Accepted, Bronze			2022-12-18	WOS:000380749000010
J	Gallo, PM; Rapsinski, GJ; Wilson, RP; Oppong, GO; Sriram, U; Goulian, M; Buttaro, B; Caricchio, R; Gallucci, S; Tukel, C				Gallo, Paul M.; Rapsinski, Glenn J.; Wilson, R. Paul; Oppong, Gertrude O.; Sriram, Uma; Goulian, Mark; Buttaro, Bettina; Caricchio, Roberto; Gallucci, Stefania; Tuekel, Cagla			Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ENTERICA SEROTYPE TYPHIMURIUM; INDUCIBLE GENE-EXPRESSION; ESCHERICHIA-COLI; I INTERFERON; RISK-FACTORS; SALMONELLA-TYPHIMURIUM; MICROBIAL BIOFILMS; DENDRITIC CELLS; CURLI FIBERS	Research on the human microbiome has established that commensal and pathogenic bacteria can influence obesity, cancer, and autoimmunity through mechanisms mostly unknown. We found that a component of bacterial biofilms, the amyloid protein curli, irreversibly formed fibers with bacterial DNA during biofilm formation. This interaction accelerated amyloid polymerization and created potent immunogenic complexes that activated immune cells, including dendritic cells, to produce cytokines such as type I interferons, which are pathogenic in systemic lupus erythematosus (SLE). When given systemically, curli-DNA composites triggered immune activation and production of autoantibodies in lupus-prone and wild-type mice. We also found that the infection of lupus-prone mice with curli-producing bacteria triggered higher autoantibody titers compared to curli-deficient bacteria. These data provide a mechanism by which the microbiome and biofilm-producing enteric infections may contribute to the progression of SLE and point to a potential molecular target for treatment of autoimmunity.	[Gallo, Paul M.; Rapsinski, Glenn J.; Wilson, R. Paul; Oppong, Gertrude O.; Sriram, Uma; Buttaro, Bettina; Gallucci, Stefania; Tuekel, Cagla] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Gallo, Paul M.; Sriram, Uma; Gallucci, Stefania] Temple Univ, Sch Med, Lab Dendrit Cell Biol, Philadelphia, PA 19140 USA; [Caricchio, Roberto] Temple Univ, Sch Med, Dept Med, Div Rheumatol, Philadelphia, PA 19140 USA; [Goulian, Mark] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Tukel, C (corresponding author), Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA.	ctukel@temple.edu			NIH, NIAID [1R03AI107434, 1R21AI105370, RO1-AI076423]; FCCC-Temple University Nodal grant; Lupus Research Institute; Innovative Research Grant; NIH, NIAMS [RO1-AR061569]; Lupus Foundation's Goldie Simon Preceptorship Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076423, R21AI105370, R03AI107434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080279] Funding Source: NIH RePORTER	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FCCC-Temple University Nodal grant; Lupus Research Institute; Innovative Research Grant; NIH, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Lupus Foundation's Goldie Simon Preceptorship Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in C.T.'s laboratory was supported by the NIH, NIAID 1R03AI107434 and 1R21AI105370. Work in S.G.'s laboratory was supported by the NIH, NIAID RO1-AI076423, the FCCC-Temple University Nodal grant, and the Lupus Research Institute, Innovative Research Grant. R.C. was supported by NIH, NIAMS RO1-AR061569. P.M.G. was partially supported by the Lupus Foundation's Goldie Simon Preceptorship Award.	Alteri CJ, 2007, P NATL ACAD SCI USA, V104, P5145, DOI 10.1073/pnas.0602304104; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Barrera-Vargas A, 2014, J RHEUMATOL, V41, P1311, DOI 10.3899/jrheum.131261; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bian Z, 2000, J INFECT DIS, V181, P602, DOI 10.1086/315233; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Bollinger RR, 2007, GUT, V56, P1481; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Connolly JJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/798924; Costa-Reis P, 2013, CLIN IMMUNOL, V149, P442, DOI 10.1016/j.clim.2013.08.009; Crawford RW, 2008, INFECT IMMUN, V76, P5341, DOI 10.1128/IAI.00786-08; Crow MK, 2003, AUTOIMMUNITY, V36, P481, DOI 10.1080/08916930310001625952; DESAI DD, 1993, J IMMUNOL, V151, P1614; Di Domizio J, 2012, P NATL ACAD SCI USA, V109, P14550, DOI 10.1073/pnas.1206923109; Di Domizio J, 2012, J BIOL CHEM, V287, P736, DOI 10.1074/jbc.M111.238477; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Elkon KB, 2011, J INTERF CYTOK RES, V31, P803, DOI 10.1089/jir.2011.0045; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Fessler BJ, 2002, BEST PRACT RES CL RH, V16, P281, DOI 10.1053/berh.2001.0226; FOURNIE GJ, 1974, J EXP MED, V140, P1189, DOI 10.1084/jem.140.5.1189; Gallo PM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00138; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gerona JG, 2009, INT J RHEUM DIS, V12, P319, DOI 10.1111/j.1756-185X.2009.01440.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Han GM, 2003, GENES IMMUN, V4, P177, DOI 10.1038/sj.gene.6363966; HANG L, 1983, J EXP MED, V157, P874, DOI 10.1084/jem.157.3.874; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hufnagel DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003740; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Hung C, 2013, MBIO, V4, DOI 10.1128/mBio.00645-13; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jimenez JS, 2010, J ALZHEIMERS DIS, V22, P375, DOI 10.3233/JAD-2010-100189; Johnson L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-115; Jorgensen TN, 2006, GENES IMMUN, V7, P555, DOI 10.1038/sj.gene.6364329; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lim E, 2001, LUPUS, V10, P87, DOI 10.1191/096120301675973164; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Macfarlane S, 2011, ADV APPL MICROBIOL, V75, P111, DOI 10.1016/B978-0-12-387046-9.00005-0; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Morel L, 1997, J IMMUNOL, V158, P6019; Morel L, 2010, NAT REV RHEUMATOL, V6, P348, DOI 10.1038/nrrheum.2010.63; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; NAIKI H, 1991, LAB INVEST, V65, P104; Nishimori JH, 2012, INFECT IMMUN, V80, P4398, DOI 10.1128/IAI.00911-12; NISSLE A, 1957, Medizinische, V10, P82; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; PABLOS JL, 1994, BRIT J RHEUMATOL, V33, P129; Petri M, 1998, RHEUM DIS CLIN N AM, V24, P423, DOI 10.1016/S0889-857X(05)70016-8; Raffatellu M, 2005, INFECT IMMUN, V73, P3367, DOI 10.1128/IAI.73.6.3367-3374.2005; Rapsinski GJ, 2013, J BIOL CHEM, V288, P14178, DOI 10.1074/jbc.M112.447060; Romling U, 1998, J BACTERIOL, V180, P722; Schnabel J, 2010, NATURE, V464, P828, DOI 10.1038/464828a; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Shi LS, 2012, SCI WORLD J, P1, DOI 10.1100/2012/918620; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tan EM, 2012, J CLIN INVEST, V122, P3835, DOI 10.1172/JCI66510; Tsao CH, 2002, J RHEUMATOL, V29, P1214; Tukel C, 2009, CELL HOST MICROBE, V6, P45, DOI 10.1016/j.chom.2009.05.020; Tukel C, 2005, MOL MICROBIOL, V58, P289, DOI 10.1111/j.1365-2958.2005.04825.x; Tukel C, 2010, CELL MICROBIOL, V12, P1495, DOI 10.1111/j.1462-5822.2010.01485.x; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; von Rosenvinge EC, 2013, PATHOG DIS, V67, P25, DOI 10.1111/2049-632X.12020; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	81	133	138	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1171	1184		10.1016/j.immuni.2015.06.002	http://dx.doi.org/10.1016/j.immuni.2015.06.002			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084027	Green Accepted, Bronze			2022-12-18	WOS:000356362800020
J	Kashem, SW; Igyarto, BZ; Gerami-Nejad, M; Kumamoto, Y; Mohammed, J; Jarrett, E; Drummond, RA; Zurawski, SM; Zurawski, G; Berman, J; Iwasaki, A; Brown, GD; Kaplan, DH				Kashem, Sakeen W.; Igyarto, Botond Z.; Gerami-Nejad, Maryam; Kumamoto, Yosuke; Mohammed, Javed; Jarrett, Elizabeth; Drummond, Rebecca A.; Zurawski, Sandra M.; Zurawski, Gerard; Berman, Judith; Iwasaki, Akiko; Brown, Gordon D.; Kaplan, Daniel H.			Candida albicans Morphology and Dendritic Cell Subsets Determine T Helper Cell Differentiation	IMMUNITY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; CYTOKINE PRODUCTION; T(H)17 CELLS; IN-VITRO; DECTIN-1; RESPONSES; IMMUNE; IL-17; INDUCTION; GAMMA	Candida albicans is a dimorphic fungus responsible for chronic mucocutaneous and systemic infections. Mucocutaneous immunity to C. albicans requires T helper 17 (Th17) cell differentiation that is thought to depend on recognition of filamentous C. albicans. Systemic immunity is considered T cell independent. Using a murine skin infection model, we compared T helper cell responses to yeast and filamentous C. albicans. We found that only yeast induced Th17 cell responses through a mechanism that required Dectin-1-mediated expression of interleukin- 6 (IL-6) by Langerhans cells. Filamentous forms induced Th1 without Th17 cell responses due to the absence of Dectin-1 ligation. Notably, Th17 cell responses provided protection against cutaneous infection while Th1 cell responses provided protection against systemic infection. Thus, C. albicans morphology drives distinct T helper cell responses that provide tissue-specific protection. These findings provide insight into compartmentalization of Th cell responses and C. albicans pathogenesis and have critical implications for vaccine strategies.	[Kashem, Sakeen W.; Igyarto, Botond Z.; Mohammed, Javed; Jarrett, Elizabeth; Kaplan, Daniel H.] Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA; [Gerami-Nejad, Maryam; Berman, Judith] Univ Minnesota, Dept Mol & Cellular Biol, Minneapolis, MN 55455 USA; [Kumamoto, Yosuke; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Drummond, Rebecca A.; Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen AB25 2ZD, Scotland; [Zurawski, Sandra M.; Zurawski, Gerard] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Zurawski, Sandra M.; Zurawski, Gerard] ANRS Ctr Human Vaccines, INSERM, U899, Dallas, TX 75204 USA; [Berman, Judith] Tel Aviv Univ, George Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Ramat Aviv, Israel	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Yale University; University of Aberdeen; Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Tel Aviv University	Kaplan, DH (corresponding author), Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA.	dankaplan@umn.edu	Berman, Judith/AAS-5115-2021; Drummond, Rebecca/I-3155-2019; Iwasaki, Akiko/Z-1591-2019; Berman, Judith/ABA-8528-2021	Drummond, Rebecca/0000-0001-5424-7074; Iwasaki, Akiko/0000-0002-7824-9856; Berman, Judith/0000-0002-8577-0084; Igyarto, Botond/0000-0002-9770-800X; brown, gordon/0000-0002-0287-5383; Kashem, Sakeen/0000-0002-2594-2884	NIH [AR056632, AR060744]; Dermatology Foundation research award; American Skin Association research award; Al Zelickson Family endowed professorship; University of Minnesota NIH MSTP [T32 GM008244]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R01AI054359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060744, R01AR056632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation research award; American Skin Association research award; Al Zelickson Family endowed professorship; University of Minnesota NIH MSTP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Jenkins for assistance with 2W1S tetramers. B. Chicoine provided technical assistance. We thank Bruce Klein and Marcel Wuethrich for assistance with celc7a<SUP>-/-</SUP> mice. We also thank the University of Minnesota Research Animal Resources staff for expert animal care and P. Champoux and T. Martin of the Flow Cytometry Core Facility at the Center for Immunology for assistance with flow cytometry experiments. This work was supported by grants from the NIH (AR056632 and AR060744) to D.H.K., a Dermatology Foundation research award (B.Z.I.), and an American Skin Association research award (B.Z.I.). D.H.K. is also supported by the Al Zelickson Family endowed professorship. S.W.K. was supported by the University of Minnesota NIH MSTP grant T32 GM008244.	Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Bar E, 2014, IMMUNITY, V40, P117, DOI 10.1016/j.immuni.2013.12.002; Bobr A, 2012, P NATL ACAD SCI USA, V109, P10492, DOI 10.1073/pnas.1119178109; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Bonifazi P, 2009, MUCOSAL IMMUNOL, V2, P362, DOI 10.1038/mi.2009.17; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; CABIB E, 1971, J BIOL CHEM, V246, P152; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Conti HR, 2010, MICROBES INFECT, V12, P518, DOI 10.1016/j.micinf.2010.03.013; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Flamar AL, 2012, J IMMUNOL, V189, P2645, DOI 10.4049/jimmunol.1102390; FONZI WA, 1993, GENETICS, V134, P717; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Haley K, 2012, J IMMUNOL, V188, P4334, DOI 10.4049/jimmunol.1102759; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Hu W, 2011, IMMUNITY, V35, P1010, DOI 10.1016/j.immuni.2011.10.013; Huppler AR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3893; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Maccallum Donna M, 2012, Int J Microbiol, V2012, P363764, DOI 10.1155/2012/363764; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; McDonald DR, 2012, J ALLERGY CLIN IMMUN, V129, P1429, DOI 10.1016/j.jaci.2012.03.034; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; MURRAY HW, 1985, NEW ENGL J MED, V313, P1504, DOI 10.1056/NEJM198512123132403; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Sampaio EP, 2013, J ALLERGY CLIN IMMUN, V131, P1624, DOI 10.1016/j.jaci.2013.01.052; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; van de Veerdonk FL, 2010, CURR OPIN CRIT CARE, V16, P453, DOI 10.1097/MCC.0b013e32833e046e; van der Graaf CAA, 2005, INFECT IMMUN, V73, P7458, DOI 10.1128/IAI.73.11.7458-7464.2005; Van Enckevort FHJ, 1999, MED MYCOL, V37, P419, DOI 10.1046/j.1365-280X.1999.00247.x; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	55	133	137	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					356	366		10.1016/j.immuni.2015.01.008	http://dx.doi.org/10.1016/j.immuni.2015.01.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25680275	Bronze, Green Accepted			2022-12-18	WOS:000349916400018
J	Choi, J; Park, S; Biering, SB; Selleck, E; Liu, CY; Zhang, X; Fujita, N; Saitoh, T; Akira, S; Yoshimori, T; Sibley, LD; Hwang, S; Virgin, HW				Choi, Jayoung; Park, Sunmin; Biering, Scott B.; Selleck, Elizabeth; Liu, Catherine Y.; Zhang, Xin; Fujita, Naonobu; Saitoh, Tatsuya; Akira, Shizuo; Yoshimori, Tamotsu; Sibley, L. David; Hwang, Seungmin; Virgin, Herbert W.			The Parasitophorous Vacuole Membrane of Toxoplasma gondii Is Targeted for Disruption by Ubiquitin-like Conjugation Systems of Autophagy	IMMUNITY			English	Article							PROTEINS; COMPLEX; GTPASES; ATG14L; GAMMA; PHAGOCYTOSIS; MACHINERY; INFECTION; RUBICON; ATG16L1	Autophagy is a lysosomal degradation pathway that is important in cellular homeostasis. Prior work showed a key role for the autophagy related 5 (Atg5) in resistance to Toxoplasma gondii. Here we show that the cassette of autophagy proteins involved in the conjugation of microtubule-associated protein 1 light chain 3 (LC3) to phosphatidylethanolamine, including Atg7, Atg3, and the Atg12-Atg5-Atg16L1 complex play crucial roles in the control of T. gondii in vitro and in vivo. In contrast, pharmacologic modulation of the degradative autophagy pathway or genetic deletion of other essential autophagy genes had no substantial effects. Rather the conjugation system was requiredfor targeting of LC3 and interferon-gamma effectors onto the vacuolar membrane of T. gondii and its consequent disruption. These data suggest that the ubiquitin-like conjugation systems that reorganize intracellular membranes during canonical autophagy are necessary for proper targeting of immune effectors to the intracellular vacuole membranes utilized by pathogens.	[Choi, Jayoung; Hwang, Seungmin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Biering, Scott B.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Park, Sunmin; Liu, Catherine Y.; Zhang, Xin; Virgin, Herbert W.] St Louis Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Selleck, Elizabeth; Sibley, L. David] St Louis Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Fujita, Naonobu; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan	University of Chicago; University of Chicago; Saint Louis University; Saint Louis University; Osaka University; Osaka University	Hwang, S (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	shwang@bsd.uchicago.edu; virgin@wustl.edu	Fujita, Naonobu/A-1218-2010; Biering, Scott/ABE-2931-2021; Akira, Shizuo/C-3134-2009	Choi, Jayoung/0000-0003-0464-0649; Fujita, Naonobu/0000-0003-1914-8438; Biering, Scott/0000-0003-1991-629X; Hwang, Seungmin/0000-0003-0846-5462; Selleck Fiore, Elizabeth/0000-0003-0213-1250; Virgin, Herbert/0000-0001-8580-7628	CCFA [274415]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health [P30AR048335];  [U19 AI109725];  [RO1 AI054483];  [RO1 AI084887];  [RO1 AI036629]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084887, R01AI036629, U19AI109725, R01AI054483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26251020, 25670027] Funding Source: KAKEN	CCFA; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by U19 AI109725, RO1 AI054483, RO1 AI084887, and CCFA grant #274415 to H.W.V., startup funds to S.H. and RO1 AI036629 to L.D.S. We thank Virgin laboratory and Hwang laboratory members for their comments on the manuscript and D. Kreamalmeyer and M. White for managing mouse colonies. Experimental support was provided by the Speed Congenics Facility of the Rheumatic Diseases Core Center. Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, under Award Number P30AR048335.	Bestebroer J, 2013, TRAFFIC, V14, P1029, DOI 10.1111/tra.12091; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Gammoh N, 2013, NAT STRUCT MOL BIOL, V20, P144, DOI 10.1038/nsmb.2475; Haldar AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086684; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Jones JL, 2010, ZOONOSES PUBLIC HLTH, V57, P27, DOI 10.1111/j.1863-2378.2009.01277.x; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nishimura T, 2013, EMBO REP, V14, P284, DOI 10.1038/embor.2013.6; Ohshima J, 2014, J IMMUNOL, V192, P3328, DOI 10.4049/jimmunol.1302822; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Selleck EM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003320; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Van Grol J, 2013, INFECT IMMUN, V81, P2002, DOI 10.1128/IAI.01145-12; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	39	133	141	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					924	935		10.1016/j.immuni.2014.05.006	http://dx.doi.org/10.1016/j.immuni.2014.05.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24931121	Green Accepted, Bronze			2022-12-18	WOS:000341440200014
J	Glatzer, T; Killig, M; Meisig, J; Ommert, I; Luetke-Eversloh, M; Babic, M; Paclik, D; Bluthgen, N; Seidl, R; Seifarth, C; Grone, J; Lenarz, M; Stolzel, K; Fugmann, D; Porgador, A; Hauser, A; Karlas, A; Romagnani, C				Glatzer, Timor; Killig, Monica; Meisig, Johannes; Ommert, Isabelle; Luetke-Eversloh, Merlin; Babic, Marina; Paclik, Daniela; Bluethgen, Nils; Seidl, Rainer; Seifarth, Claudia; Groene, Joern; Lenarz, Minoo; Stoelzel, Katharina; Fugmann, Dominik; Porgador, Angel; Hauser, Anja; Karlas, Alexander; Romagnani, Chiara			ROR gamma t(+) Innate Lymphoid Cells Acquire a Proinflammatory Program upon Engagement of the Activating Receptor NKp44	IMMUNITY			English	Article							ROR-GAMMA-T; NK CELLS; EXPRESSION; HEMAGGLUTININS; RECOGNITION; LIGANDS; DRIVES; FAMILY; NKP30; GUT	ROR gamma t(+) innate lymphoid cells (ILCs) are crucial players of innate immune responses and represent a major source of interleukin-22 (IL-22), which has an important role in mucosal homeostasis. The signals required by ROR gamma t(+) ILCs to express IL-22 and other cytokines have been elucidated only partially. Here we showed that ROR gamma t(+) ILCs can directly sense the environment by the engagement of the activating receptor NKp44. NKp44 triggering in ROR gamma t(+) ILCs selectively activated a coordinated proinflammatory program, including tumor necrosis factor (TNF), whereas cytokine stimulation preferentially induced IL-22 expression. However, combined engagement of NKp44 and cytokine receptors resulted in a strong synergistic effect. These data support the concept that NKp44(+) ROR gamma t(+) ILCs can be activated without cytokines and are able to switch between IL-22 or TNF production, dependingon the triggering stimulus.	[Glatzer, Timor; Killig, Monica; Ommert, Isabelle; Luetke-Eversloh, Merlin; Babic, Marina; Paclik, Daniela; Hauser, Anja; Romagnani, Chiara] Deutsch Rheumaforsch Zentrum Leibniz Gemeinschaft, D-10117 Berlin, Germany; [Meisig, Johannes; Bluethgen, Nils] Charite, Inst Pathol, D-12200 Berlin, Germany; [Seifarth, Claudia; Groene, Joern] Charite, Chirurg Klin, D-12200 Berlin, Germany; [Seifarth, Claudia; Groene, Joern] Charite, Hsch Ambulanz 1, D-12200 Berlin, Germany; [Lenarz, Minoo; Stoelzel, Katharina] Charite, HNO Klin, D-12200 Berlin, Germany; [Fugmann, Dominik] Charite, Klin Allgemein Visceral & Transplantat Chirurg, D-12200 Berlin, Germany; [Meisig, Johannes; Bluethgen, Nils] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Babic, Marina] Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka RIJEKA, Croatia; [Seidl, Rainer] Unfallkrankenhaus, HNO Klin, D-12683 Berlin, Germany; [Porgador, Angel] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Karlas, Alexander] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; University of Rijeka; Ben Gurion University; Ben Gurion University; Max Planck Society	Romagnani, C (corresponding author), Deutsch Rheumaforsch Zentrum Leibniz Gemeinschaft, D-10117 Berlin, Germany.	romagnani@drfz.de	Cac, Marina Babic/ABH-3595-2020; Bluthgen, Nils/A-1711-2011; Babic Cac, Marina/AFO-1124-2022; Romagnani, Chiara/E-4708-2016; Meyer, Thomas F./J-2485-2013	Bluthgen, Nils/0000-0002-0171-7447; Romagnani, Chiara/0000-0002-5167-7463; Seifarth, Claudia/0000-0001-6102-4338; Porgador, Angel/0000-0003-1540-4449; Meyer, Thomas F./0000-0002-6120-8679; Karlas, Alexander/0000-0002-2187-2057; Hauser, Anja Erika/0000-0002-7725-9526	Deutsche Forschungsgemeinschaft (DFG) [SFB 633, SFB 650]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank Toralf Kaiser and Jenny Kirsch for cell sorting, Andreas Grutzkau for discussion about the microarrays, Heidi Schliemann for excellent technical assistance, Andrey Kruglov and Ofer Mandelboim for sharing reagents and helpful discussion, and Simon Fillatreau and Jens Geginat for critical reading of the manuscript and discussion. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB 633 and SFB 650 (to C.R.).	Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; BULL DM, 1977, J CLIN INVEST, V59, P966, DOI 10.1172/JCI108719; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Byrd A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001339; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Flajnik MF, 2012, IMMUNOGENETICS, V64, P571, DOI 10.1007/s00251-012-0616-2; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Huang YC, 2008, J LEUKOCYTE BIOL, V84, P1501, DOI 10.1189/jlb.0408255; Jost S, 2011, IMMUNOLOGY, V132, P516, DOI 10.1111/j.1365-2567.2010.03394.x; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Ryon J.J., 2001, CURRENT PROTOCOLS IM; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	31	133	137	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1223	1235		10.1016/j.immuni.2013.05.013	http://dx.doi.org/10.1016/j.immuni.2013.05.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23791642	Bronze			2022-12-18	WOS:000330947500017
J	Yang, ZY; Sullivan, BM; Allen, CDC				Yang, Zhiyong; Sullivan, Brandon M.; Allen, Christopher D. C.			Fluorescent In Vivo Detection Reveals that IgE(+) B Cells Are Restrained by an Intrinsic Cell Fate Predisposition	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELLS; FC-EPSILON-RI; AFFINITY MATURATION; NIPPOSTRONGYLUS-BRASILIENSIS; SECRETING CELLS; LYMPHOID-CELLS; PLASMA-CELLS; MEMORY; EXPRESSION; SELECTION	IgE antibodies may be protective in parasite immunity, but their aberrant production can lead to allergic disease and life-threatening anaphylaxis. Despite the importance of IgE regulation, few studies have directly examined the B cells that express IgE, because these cells are rare and difficult to detect. Here, we describe fluorescent IgE reporter mice and validate a flow cytometry procedure to allow sensitive and specific identification of IgE-expressing B cells in vivo. Similar to IgG1(+) cells, IgE(+) B cells differentiated into germinal center (GC) B cells and plasma cells (PCs) during primary immune responses to a T cell-dependent hapten-protein conjugate and the helminth Nippostrongylus brasiliensis. However, the participation of IgE(+) B cells in GCs was transient. IgE(+) B cells had an atypical propensity to upregulate the transcription factor Blimp-1 and undergo PC differentiation. Most IgE(+) PCs were short lived and showed reduced affinity maturation, revealing intrinsic mechanisms that restrict the IgE antibody response.	[Yang, Zhiyong; Allen, Christopher D. C.] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Yang, Zhiyong; Allen, Christopher D. C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Sullivan, Brandon M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Sullivan, Brandon M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Allen, CDC (corresponding author), Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA.	chris.allen@ucsf.edu		Allen, Christopher/0000-0002-1879-9047; Yang, Zhiyong/0000-0003-0589-6224	Sandler Asthma Basic Research Center; Lorraine Newman Foundation; School of Medicine at the University of California, San Francisco	Sandler Asthma Basic Research Center; Lorraine Newman Foundation; School of Medicine at the University of California, San Francisco	We thank T. Okada for generously providing Bcl6<SUP>yfp</SUP> mice and for comments on the manuscript; J.G. Cyster for cryostat and two-photon microscope use, providing mice, and comments on the manuscript; R.M. Locksley for advice and support of N. brasiliensis experiments; L.M. Kelly for advice and comments on the manuscript; J. Pereira for advice; N. Killeen and the UCSF Comprehensive Cancer Center Transgenic Core for assistance with gene targeting; and members of the Sandler Asthma Basic Research Center for helpful discussions. This work was supported by the Sandler Asthma Basic Research Center, the Lorraine Newman Foundation, and the School of Medicine at the University of California, San Francisco. Z.Y. and C.D.C.A. designed the experiments, Z.Y. did most of the experiments, C.D.C.A. did the two-photon imaging experiments, B.M.S. maintained N. brasiliensis and performed mouse infections, and Z.Y. and C.D.C.A. analyzed the data and wrote the paper.	Achatz-Straussberger G, 2008, EUR J IMMUNOL, V38, P3167, DOI 10.1002/eji.200838456; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Anand S, 1997, MOL IMMUNOL, V34, P175, DOI 10.1016/S0161-5890(96)00110-1; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dahlke I, 2006, J ALLERGY CLIN IMMUN, V117, P1477, DOI 10.1016/j.jaci.2005.12.1359; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Gould HJ, 2006, TRENDS IMMUNOL, V27, P446, DOI 10.1016/j.it.2006.08.007; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Karnowski A, 2006, EUR J IMMUNOL, V36, P1917, DOI 10.1002/eji.200535495; KATONA IM, 1983, J IMMUNOL, V130, P350; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; MAEDA K, 1992, J IMMUNOL, V148, P2340; McHeyzer-Williams L.J., 2004, METHOD MOL BIOL, P173; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; OGILVIE BM, 1968, J PARASITOL, V54, P1073, DOI 10.2307/3276966; Ota T, 2009, J IMMUNOL, V182, P8110, DOI 10.4049/jimmunol.0900300; Pelletier N, 2010, NAT IMMUNOL, V11, P1110, DOI 10.1038/ni.1954; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Sato M, 2007, J IMMUNOL, V178, P2901, DOI 10.4049/jimmunol.178.5.2901; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; STANWORTH DR, 1993, ALLERGY, V48, P67, DOI 10.1111/j.1398-9995.1993.tb00687.x; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; Tarlinton DM, 2000, IMMUNOL TODAY, V21, P436, DOI 10.1016/S0167-5699(00)01687-X; TILNEY NL, 1971, J ANAT, V109, P369; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Wang Y, 2011, SCAND J IMMUNOL, V73, P496, DOI 10.1111/j.1365-3083.2011.02525.x	50	133	135	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 25	2012	36	5					857	872		10.1016/j.immuni.2012.02.009	http://dx.doi.org/10.1016/j.immuni.2012.02.009			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22406270	Bronze			2022-12-18	WOS:000304976000018
J	Edelson, BT; Bradstreet, TR; Hildner, K; Carrero, JA; Frederick, KE; Wumesh, KC; Belizaire, R; Aoshi, T; Schreiber, RD; Miller, MJ; Murphy, TL; Unanue, ER; Murphy, KM				Edelson, Brian T.; Bradstreet, Tara R.; Hildner, Kai; Carrero, Javier A.; Frederick, Katherine E.; Wumesh, K. C.; Belizaire, Roger; Aoshi, Taiki; Schreiber, Robert D.; Miller, Mark J.; Murphy, Theresa L.; Unanue, Emil R.; Murphy, Kenneth M.			CD8 alpha(+) Dendritic Cells Are an Obligate Cellular Entry Point for Productive Infection by Listeria monocytogenes	IMMUNITY			English	Article							CD8(+) T-CELLS; IN-VIVO; SPLENECTOMIZED MICE; PROTECTIVE IMMUNITY; MONOCLONAL-ANTIBODY; MOUSE SPLEEN; RESISTANCE; ACTIVATION; SUBSET; LYMPHOCYTES	CD8 alpha(+) dendritic cells (DCs) prime cytotoxic T lymphocytes during viral infections and produce interleukin-12 in response to pathogens. Although the loss of CD8 alpha(+) DCs in Batf3(-/-) mice increases their susceptibility to several pathogens, we observed that Batf3(-/-) mice exhibited enhanced resistance to the intracellular bacterium Listeria monocytogenes. In wild-type mice, Listeria organisms, initially located in the splenic marginal zone, migrated to the periarteriolar lymphoid sheath (PALS) where they grew exponentially and induced widespread lymphocyte apoptosis. In Batf3(-/-) mice, however, Listeria organisms remain trapped in the marginal zone, failed to traffic into the PALS, and were rapidly cleared by phagocytes. In addition, Batf3(-/-) mice, which lacked the normal population of hepatic CD103(+) peripheral DCs, also showed protection from liver infection. These results suggest that Batf3-dependent CD8 alpha(+) and CD103(+) DCs provide initial cellular entry points within the reticuloendothelial system by which Listeria establishes productive infection.	[Edelson, Brian T.; Bradstreet, Tara R.; Hildner, Kai; Carrero, Javier A.; Frederick, Katherine E.; Wumesh, K. C.; Belizaire, Roger; Aoshi, Taiki; Schreiber, Robert D.; Miller, Mark J.; Murphy, Theresa L.; Unanue, Emil R.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hildner, Kai; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Schreiber, Robert D/A-1276-2013; Schreiber, Robert/Q-7550-2019	Schreiber, Robert D/0000-0001-6311-0432; Miller, Mark/0000-0001-5676-389X; Belizaire, Roger/0000-0001-8496-287X; Edelson, Brian/0000-0003-2856-7650; Schreiber, Robert/0000-0003-1590-2341	Howard Hughes Medical Institute; Burroughs Wellcome Fund Career Award for Medical Scientists; Washington University School of Medicine; German Research Foundation; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077600, R01AI062832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Washington University School of Medicine; German Research Foundation(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Howard Hughes Medical Institute (K.M.M.), the Burroughs Wellcome Fund Career Award for Medical Scientists (B.T.E.), the Jack H. Ladenson Fellowship in Experimental Clinical Pathology at Washington University School of Medicine (B.T.E.), the Emmy Noether Program of the German Research Foundation (K.H.), and the National Institutes of Health (E.R.U. and M.J.M.).	Alaniz RC, 2004, J IMMUNOL, V172, P3725, DOI 10.4049/jimmunol.172.6.3725; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Aoshi T, 2009, EUR J IMMUNOL, V39, P417, DOI 10.1002/eji.200838718; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Campisi L, 2011, EUR J IMMUNOL, V41, P1594, DOI 10.1002/eji.201041036; Carrero JA, 2006, J EXP MED, V203, P933, DOI 10.1084/jem.20060045; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dresing P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015567; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Frehel C, 2003, MICROBIOL-SGM, V149, P611, DOI 10.1099/mic.0.25986-0; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOF H, 1988, INFECTION, V16, pS141, DOI 10.1007/BF01639737; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kapadia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019376; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Merrick JC, 1997, AM J PATHOL, V151, P785; Mitchell LM, 2011, CELL IMMUNOL, V268, P79, DOI 10.1016/j.cellimm.2011.03.001; Muraille E, 2005, EUR J IMMUNOL, V35, P1463, DOI 10.1002/eji.200526024; Muraille E, 2007, CELL MICROBIOL, V9, P1445, DOI 10.1111/j.1462-5822.2007.00883.x; Naik SH, 2008, IMMUNOL CELL BIOL, V86, P439, DOI 10.1038/icb.2008.28; Narni-Mancinelli E, 2007, J EXP MED, V204, P2075, DOI 10.1084/jem.20070204; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; PIETRANGELI C, 1983, INFECT IMMUN, V39, P742, DOI 10.1128/IAI.39.2.742-749.1983; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; SKAMENE E, 1977, IMMUNOLOGY, V33, P851; Solodova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018543; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Waite JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001326	51	133	135	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 26	2011	35	2					236	248		10.1016/j.immuni.2011.06.012	http://dx.doi.org/10.1016/j.immuni.2011.06.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21867927	Green Accepted, Bronze			2022-12-18	WOS:000294387900013
J	Thompson, EC; Cobb, BS; Sabbattini, P; Meixlsperger, S; Parelho, V; Liberg, D; Taylor, B; Dillon, N; Georgopoulos, K; Jumaa, H; Smale, ST; Fisher, AG; Merkenschlager, M				Thompson, Elizabeth C.; Cobb, Bradley S.; Sabbattini, Pierangela; Meixlsperger, Sonja; Parelho, Vania; Liberg, David; Taylor, Benjamin; Dillon, Niall; Georgopoulos, Katia; Jumaa, Hassan; Smale, Stephen T.; Fisher, Amanda G.; Merkenschlager, Matthias			Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits	IMMUNITY			English	Article							TRANSCRIPTION FACTOR; GENE; FAMILY; HETEROCHROMATIN; LOCALIZATION; ACTIVATION; COMPLEXES; MECHANISM; AIOLOS	Ikaros DNA-binding proteins are critical for the development of lymphocytes and other hematopoietic lineages, but it remains unclear how they cooperate with other regulators of signaling and transcription to achieve ordered gene expression during development. Here, we show that Ikaros proteins regulate the pre-BCR component lambda 5 in a stage-specific manner. In pre-BI cells, Ikaros modulated lambda 5 expression in competition with the transcriptional activator EBF. This required Ikaros binding to the IgII1 (lambda 5) promoter and was abolished either by mutation of the Ikaros DNA-binding domain or by deletion of a single Ikaros site from the IgII1 promoter. At the transition from the pre-BI to pre-BI stage, the expression of the Ikaros family member Aiolos was upregulated and required for the efficient silencing of IgII1. Aiolos expression was controlled by pre-BCR signals via the adaptor protein SLP-65. Thus, pre-BCR signaling regulates Aiolos and the silencing of IgII1 via a developmental-stage-specific feedback loop.	Imperial Coll London, MRC, Ctr Clin Sci, Lymphocyte Dev Grp, London W12 0NN, England; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Imperial Coll London, MRC, Ctr Clin Sci, Gene Regulat & Chromatin Grp, London W12 0NN, England; Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Imperial College London; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Imperial College London; Max Planck Society; Harvard University; Massachusetts General Hospital	Merkenschlager, M (corresponding author), Imperial Coll London, MRC, Ctr Clin Sci, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	matthias.merkenschlager@csc.mrc.ac.uk		Taylor, Benjamin/0000-0001-6101-3786; Merkenschlager, Matthias/0000-0003-2889-3288	MRC [MC_U120027516, MC_U120036884] Funding Source: UKRI; Medical Research Council [MC_U120036884, MC_U120027516] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azuara V, 2003, NAT CELL BIOL, V5, P668, DOI 10.1038/ncb1006; Baxter J, 2004, EMBO J, V23, P4462, DOI 10.1038/sj.emboj.7600414; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cobb BS, 2005, CURR TOP MICROBIOL, V290, P29; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Jumaa H, 2001, EUR J IMMUNOL, V31, P2164, DOI 10.1002/1521-4141(200107)31:7<2164::AID-IMMU2164>3.0.CO;2-S; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; LAWRENCE PA, 1992, MAKING FLY, P240; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Martin MU, 1997, EUR CYTOKINE NETW, V8, P5; Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1111/j.1600-065X.2000.imr017510.x; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812; Spanopoulou E, 1995, IMMUNITY, V3, P715, DOI 10.1016/1074-7613(95)90061-6; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8	31	133	143	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2007	26	3					335	344		10.1016/j.immuni.2007.02.010	http://dx.doi.org/10.1016/j.immuni.2007.02.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17363301	Bronze			2022-12-18	WOS:000245228100010
J	Sutton, VR; Wowk, ME; Cancilla, M; Trapani, JA				Sutton, VR; Wowk, ME; Cancilla, M; Trapani, JA			Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors	IMMUNITY			English	Article							CYTOCHROME-C RELEASE; PERFORIN-DEFICIENT MICE; STRUCTURAL BASIS; CELL-DEATH; CYTOTOXIC LYMPHOCYTES; PROMOTES APOPTOSIS; DNA FRAGMENTATION; SERINE-PROTEASE; DIRECT CLEAVAGE; PORE FORMATION	Apoptosis in response to granzyme B involves activation of caspase-dependent target cell death pathways. Herein, we show that granzyme B initiates caspase processing but cannot fully process procaspase-3 in intact Jurkat T leukemia or NT2 neuronal cells. Rather, the release from mitochondria of proapoptotic mediators cytochrome c, Smac/Diablo, and HtrA2/Omi facilitates full activation of caspases that results from auto-processing. Bcl-2 overexpression in mitochondria suppresses the release of these proapoptotic molecules, resulting in cell survival despite partial procaspase processing by granzyme B. We propose that binding of inhibitor of apoptosis (IAP) proteins to partially processed procaspases inhibits cell death unless mitochondrial disruption also occurs in response to granzyme B or activated BH3-domain proteins such as truncated Bid.	Peter MacCallum Canc Inst, Canc Immunol Program, Melbourne, Vic 8006, Australia; Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Peter Maccallum Cancer Center; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Trapani, JA (corresponding author), Peter MacCallum Canc Inst, Canc Immunol Program, Locked Bag 1,A Beckett St, Melbourne, Vic 8006, Australia.	j.trapani@pmci.unimelb.edu.au		Trapani, Joseph/0000-0003-0983-1532				Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Andrade F, 1998, IMMUNITY, V8, P451, DOI 10.1016/S1074-7613(00)80550-6; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Browne KA, 1999, MOL CELL BIOL, V19, P8604; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Davis JE, 2000, CELL DEATH DIFFER, V7, P973, DOI 10.1038/sj.cdd.4400725; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ekert PG, 2001, J CELL BIOL, V152, P483, DOI 10.1083/jcb.152.3.483; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Grinberg M, 2002, J BIOL CHEM, V277, P12237, DOI 10.1074/jbc.M104893200; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Heibein JA, 1999, J IMMUNOL, V163, P4683; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Mullbacher A, 1999, P NATL ACAD SCI USA, V96, P13950, DOI 10.1073/pnas.96.24.13950; Mullbacher A, 1999, J VIROL, V73, P1665; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sarin A, 1997, IMMUNITY, V6, P209, DOI 10.1016/S1074-7613(00)80427-6; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Sharif-Askari E, 2001, EMBO J, V20, P3101, DOI 10.1093/emboj/20.12.3101; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Sutton VR, 1997, J IMMUNOL, V158, P5783; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; TRAPANI JA, 1993, BIOCHEM BIOPH RES CO, V195, P910, DOI 10.1006/bbrc.1993.2131; Trapani JA, 2000, CURR OPIN IMMUNOL, V12, P323, DOI 10.1016/S0952-7915(00)00094-7; Trapani JA, 1998, J BIOL CHEM, V273, P27934, DOI 10.1074/jbc.273.43.27934; van Loo G, 2002, CELL DEATH DIFFER, V9, P1207, DOI 10.1038/sj.cdd.4401101; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278	64	133	136	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					319	329		10.1016/S1074-7613(03)00050-5	http://dx.doi.org/10.1016/S1074-7613(03)00050-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648450	Bronze			2022-12-18	WOS:000181713700003
J	Cha, SS; Kim, MS; Choi, YH; Sung, BJ; Shin, NK; Shin, HC; Sung, YC; Oh, BH				Cha, SS; Kim, MS; Choi, YH; Sung, BJ; Shin, NK; Shin, HC; Sung, YC; Oh, BH			2.8 angstrom resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; TNF RECEPTOR SUPERFAMILY; FACTOR-ALPHA; LIGAND TRAIL; FAMILY; APOPTOSIS; DEATH; ACTIVATION; OSTEOPROTEGERIN; DOMAIN	TRAIL is a newly identified cytokine belonging to the large tumor necrosis factor (TNF) family. TRAIL is a novel molecule inducing apoptosis in a wide variety of tumor cells but not in normal cells. To help in elucidating its biological roles and designing mutants with improved therapeutic potential, we have determined the crystal structure of human TRAIL. The structure reveals that a unique frame insertion of 12-16 amino acids adopts a salient loop structure penetrating into the receptor-binding site. The loop drastically alters the common receptor-binding surface of the TNF family most likely for the specific recognition of cognate partners. A structure-based mutagenesis study demonstrates a critical role of the insertion loop in the cytotoxic activity of TRAIL.	Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea; Pohang Univ Sci & Technol, Sch Environm Engn, Pohang 790784, Kyungbuk, South Korea; Hanhyo Inst Technol, Taejon 305390, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Oh, BH (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea.	bhoh@postech.ac.kr	Oh, Byung-Ha/C-2061-2011	Cha, Sun-Shin/0000-0002-0913-8706				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BAZAN JF, 1993, CURR BIOL, V3, P603, DOI 10.1016/0960-9822(93)90009-D; BRUNGER AT, 1992, X PLOR VERSION 3 0; Cha SS, 1999, ACTA CRYSTALLOGR D, V55, P1101, DOI 10.1107/S090744499900164X; CORTI A, 1992, BIOCHEM J, V284, P905, DOI 10.1042/bj2840905; COSMAN D, 1994, STEM CELLS, V12, P440, DOI 10.1002/stem.5530120501; CREASEY AA, 1987, CANCER RES, V47, P145; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; JONE TA, 1993, VERSION 5 9; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; KAGAN BL, 1992, SCIENCE, V255, P1427, DOI 10.1126/science.1371890; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; Kayagaki N, 1999, J IMMUNOL, V162, P2639; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lotz M, 1996, J LEUKOCYTE BIOL, V60, P1; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Mongkolsapaya J, 1998, J IMMUNOL, V160, P3; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Singh MJ, 1998, EUR PHYS J D, V4, P7, DOI 10.1007/s100530050179; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; VANOSTADE X, 1994, PROTEIN ENG, V7, P5, DOI 10.1093/protein/7.1.5; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	36	133	149	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1999	11	2					253	261		10.1016/S1074-7613(00)80100-4	http://dx.doi.org/10.1016/S1074-7613(00)80100-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485660	Bronze			2022-12-18	WOS:000082383400014
J	Petrenko, O; Beavis, A; Klaine, M; Kittappa, R; Godin, I; Lemischka, IR				Petrenko, O; Beavis, A; Klaine, M; Kittappa, R; Godin, I; Lemischka, IR			The molecular characterization of the fetal stem cell marker AA4	IMMUNITY			English	Article							IN-VITRO DIFFERENTIATION; HEMATOPOIETIC PRECURSOR CELLS; YOLK-SAC; MOUSE EMBRYO; C1Q-MEDIATED ENHANCEMENT; HYALURONAN-BINDING; ENDOTHELIAL-CELLS; B-CELLS; EXPRESSION; MURINE	We have identified and characterized the stem cell antigen AA4. This molecule is a type I transmembrane protein whose overall structure suggests a role in cell adhesion. During fetal ontogeny (days 9-14 of development), AA4 is expressed in three major cell types: vascular endothelial cells, aorta-associated hematopoietic clusters, and primitive fetal liver hematopoietic progenitors. In the adult, AA4 is abundant in lung, heart, and whole bone marrow. In the adult hematopoietic compartment, aa4 transcripts are present in bone marrow CD34(-lo)Lin(-)Sca-1(+)c-Kit(+) and CD34(hi) Lin(-)Sca-1(+)c-Kit(+) stem and progenitor cell subsets. Our observations suggest that AA4 plays a role in cell-cell interactions during hematopoietic and vascular development.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; CNRS, Inst Embryol Cellulaire & Mol, F-94736 Nogent Sur Marne, France	Princeton University; Centre National de la Recherche Scientifique (CNRS)	Lemischka, IR (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ilemischka@molbio.princeton.edu	GODIN, Isabelle/K-5769-2013	GODIN, Isabelle/0000-0001-8577-8388	NATIONAL CANCER INSTITUTE [R01CA045339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042989] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 45339] Funding Source: Medline; NIDDK NIH HHS [R01 DK 42989] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bajorath J, 1998, J BIOL CHEM, V273, P338, DOI 10.1074/jbc.273.1.338; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; CARLSSON L, 1995, EUR J IMMUNOL, V25, P2308, DOI 10.1002/eji.1830250829; Choi K, 1998, DEVELOPMENT, V125, P725; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; DieterlenLievre F, 1997, INT ARCH ALLERGY IMM, V112, P3, DOI 10.1159/000237423; Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4; Elefanty AG, 1997, BLOOD, V90, P1435, DOI 10.1182/blood.V90.4.1435.1435_1435_1447; Garcia-Porrero JA, 1998, DEV COMP IMMUNOL, V22, P303, DOI 10.1016/S0145-305X(98)00006-8; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; GUAN E, 1991, J BIOL CHEM, V266, P20345; GUAN E, 1994, J IMMUNOL, V152, P4005; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; JORDAN CT, 1995, EXP HEMATOL, V23, P1011; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Klickstein LB, 1997, IMMUNITY, V7, P345, DOI 10.1016/S1074-7613(00)80356-8; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Ling V, 1997, J CELL PHYSIOL, V171, P104, DOI 10.1002/(SICI)1097-4652(199704)171:1<104::AID-JCP12>3.0.CO;2-G; Lu LS, 1996, P NATL ACAD SCI USA, V93, P14782, DOI 10.1073/pnas.93.25.14782; Marcos MAR, 1997, J IMMUNOL, V158, P2627; MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MOORE T, 1994, J IMMUNOL, V153, P4978; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nepomuceno RR, 1997, IMMUNITY, V6, P119, DOI 10.1016/S1074-7613(00)80419-7; Nepomuceno RR, 1998, J IMMUNOL, V160, P1929; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PARDANAUD L, 1987, DEVELOPMENT, V100, P339; PARDANAUD L, 1989, DEVELOPMENT, V105, P473; Potocnik AJ, 1997, P NATL ACAD SCI USA, V94, P10295, DOI 10.1073/pnas.94.19.10295; Ray RJ, 1996, EUR J IMMUNOL, V26, P1504, DOI 10.1002/eji.1830260715; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SZILVASSY SJ, 1993, BLOOD, V81, P2310; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Weisel JW, 1996, J BIOL CHEM, V271, P31485, DOI 10.1074/jbc.271.49.31485; Wood HB, 1997, BLOOD, V90, P2300; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6	51	133	142	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1999	10	6					691	700		10.1016/S1074-7613(00)80068-0	http://dx.doi.org/10.1016/S1074-7613(00)80068-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403644	Bronze			2022-12-18	WOS:000081209600007
J	Weng, NP; Hathcock, KS; Hodes, RJ				Weng, NP; Hathcock, KS; Hodes, RJ			Regulation of telomere length and telomerase in T and B cells: A mechanism for maintaining replicative potential	IMMUNITY			English	Review							LYMPHOCYTE DEVELOPMENT; HEMATOPOIETIC-CELLS; SHORTENED TELOMERES; MOUSE TELOMERASE; ANTIGEN RECEPTOR; HIV-1 INFECTION; RNA COMPONENT; ACTIVATION; PROTEIN; EXPRESSION		National Institutes Health, National Institute Aging, Baltimore, MD 21228 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hodes, RJ (corresponding author), National Institutes Health, National Institute Aging, Baltimore, MD 21228 USA.		Weng, Nan-ping/AAC-5037-2020					BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bodnar AG, 1996, EXP CELL RES, V228, P58, DOI 10.1006/excr.1996.0299; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; CHADENEAU C, 1995, ONCOGENE, V11, P893; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GUERRINI AM, 1993, HUM MOL GENET, V2, P455, DOI 10.1093/hmg/2.4.455; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrington L, 1997, GENE DEV, V11, P3109, DOI 10.1101/gad.11.23.3109; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HATHCOCK KS, 1998, IN PRESS J IMMUNOL; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HIYAMA K, 1995, J IMMUNOL, V155, P3711; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hu BT, 1997, J IMMUNOL, V159, P1068; Igarashi H, 1997, BLOOD, V89, P1299, DOI 10.1182/blood.V89.4.1299; Igarashi H, 1996, BIOCHEM BIOPH RES CO, V219, P649, DOI 10.1006/bbrc.1996.0288; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; Mandal M, 1997, J BIOL CHEM, V272, P14183, DOI 10.1074/jbc.272.22.14183; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Monteiro J, 1996, J IMMUNOL, V156, P3587; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Norrback KF, 1996, BLOOD, V88, P222; Ogoshi M, 1997, J IMMUNOL, V158, P622; Palmer LD, 1997, J EXP MED, V185, P1381, DOI 10.1084/jem.185.7.1381; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Shay Jerry W., 1996, Current Opinion in Oncology, V8, P66, DOI 10.1097/00001622-199601000-00012; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Smith S, 1997, TRENDS GENET, V13, P21, DOI 10.1016/S0168-9525(96)10052-4; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; VAZIRI H, 1993, AM J HUM GENET, V52, P661; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Weng NP, 1997, J IMMUNOL, V158, P3215; Weng NP, 1996, J EXP MED, V183, P2471, DOI 10.1084/jem.183.6.2471; Weng NP, 1997, P NATL ACAD SCI USA, V94, P10827, DOI 10.1073/pnas.94.20.10827; Weng NP, 1997, IMMUNOL REV, V160, P43, DOI 10.1111/j.1600-065X.1997.tb01026.x; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; Yashima K, 1997, J CLIN PATHOL, V50, P110, DOI 10.1136/jcp.50.2.110	59	133	140	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	1998	9	2					151	157		10.1016/S1074-7613(00)80597-X	http://dx.doi.org/10.1016/S1074-7613(00)80597-X			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729035	Bronze			2022-12-18	WOS:000075610300001
J	Azam, M; Lee, C; Strehlow, I; Schindler, C				Azam, M; Lee, C; Strehlow, I; Schindler, C			Functionally distinct isoforms of STAT5 are generated by protein processing	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTOR; CELL-LINES; SIGNAL-TRANSDUCTION; INTERFERON-ALPHA; GM-CSF; INTERLEUKIN-3; GENE; RECEPTOR	The interleukin-3 family of cytokines, which play an important role in the development of myeloid lineages, transduce signals through the JAK-STAT pathway. Previous studies demonstrate that this process entails the activation of four distinct isoforms of STAT5, where two shorter isoforms are activated in a distinct population of cells. We now demonstrate that the shorter isoforms represent carboxy-terminal truncations. Moreover, these truncations are not generated by RNA processing, but by a specific proteolytic activity. Consistent with the notion that truncated STAT5 isoforms transduce distinct signals, they fail to promote the activation of several known interleukin-3 target genes. These studies suggest that the activity of a specific protease may play a critical role in defining the biological responses transduced by STAT5.	COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PHYSIOL & CELLULAR BIOPHYS,NEW YORK,NY 10032	Columbia University; Columbia University								AZAM M, 1995, EMBO J, V14, P1402, DOI 10.1002/j.1460-2075.1995.tb07126.x; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; BOURETTE RP, 1995, CELL GROWTH DIFFER, V6, P631; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CURRAN T, 1983, MOL CELL BIOL, V3, P914, DOI 10.1128/MCB.3.5.914; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EILERS A, 1993, MOL CELL BIOL, V13, P3245, DOI 10.1128/MCB.13.6.3245; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GOODALL GJ, 1993, GROWTH FACTORS, V8, P87, DOI 10.3109/08977199309046929; Gupta S, 1996, EMBO J, V15, P1075, DOI 10.1002/j.1460-2075.1996.tb00445.x; ISFORT R, 1988, J BIOL CHEM, V263, P19203; KAZANSKY AV, 1995, MOL ENDOCRINOL, V9, P1598, DOI 10.1210/me.9.11.1598; KITAMURA T, 1994, TRENDS ENDOCRIN MET, V5, P8, DOI 10.1016/1043-2760(94)90115-5; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; MEEKER TC, 1990, MOL CELL BIOL, V10, P1680, DOI 10.1128/MCB.10.4.1680; Meinke A, 1996, MOL CELL BIOL, V16, P6937; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MIGLIACCIO G, 1989, J CELL BIOL, V109, P833, DOI 10.1083/jcb.109.2.833; Mikita T, 1996, MOL CELL BIOL, V16, P5811; MIURA O, 1991, MOL CELL BIOL, V11, P4895, DOI 10.1128/MCB.11.10.4895; MIYAJIMA A, 1993, BLOOD, V82, P1960; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; MU SX, 1995, BLOOD, V86, P4532, DOI 10.1182/blood.V86.12.4532.bloodjournal86124532; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; PALLARD C, 1995, EMBO J, V14, P2847, DOI 10.1002/j.1460-2075.1995.tb07284.x; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; RIPPERGER JA, 1995, J BIOL CHEM, V270, P29998, DOI 10.1074/jbc.270.50.29998; ROTHMAN P, 1994, IMMUNITY, V1, P457, DOI 10.1016/1074-7613(94)90088-4; SACHS L, 1993, BLOOD CELLS, V19, P709; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Wang DM, 1996, MOL CELL BIOL, V16, P6141; WONG KK, 1995, MOL CELL BIOL, V15, P6535; YAN H, 1996, EMBO J, V15, P1065; YAN RQ, 1995, NUCLEIC ACIDS RES, V23, P459, DOI 10.1093/nar/23.3.459; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x	52	133	145	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1997	6	6					691	701		10.1016/S1074-7613(00)80445-8	http://dx.doi.org/10.1016/S1074-7613(00)80445-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208842	hybrid			2022-12-18	WOS:A1997XG57900005
J	Mangasarian, A; Foti, M; Aiken, C; Chin, D; Carpentier, JL; Trono, D				Mangasarian, A; Foti, M; Aiken, C; Chin, D; Carpentier, JL; Trono, D			The HIV-1 nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4 DOWN-REGULATION; CLATHRIN-COATED VESICLES; TYROSINE KINASE P56LCK; CELL-SURFACE CD4; DI-LEUCINE MOTIF; T-CELLS; ENDOPLASMIC-RETICULUM; CYTOPLASMIC DOMAIN; ENDOCYTIC PATHWAY	The HIV Nef protein down-regulates the cell surface expression of CD4 and of MHC I at least in part through accelerated endocytosis. To investigate further the mechanism of this effect, we created chimeric integral membrane proteins comprising the extracellular and transmembrane regions of CD4 or CD8 and Nef as the cytoplasmic domain. These fusion molecules could down-modulate CD4 in trans in a dileucine-dependent manner. Furthermore, in spite of lacking receptor-derived internalization signals, the Nef-containing chimeras underwent both Golgi retention and rapid endocytosis via clathrin-coated pits. Taken together, these data suggest that Nef down-regulates CD4 and probably MHC I by physically connecting these receptors with sorting pathways in the Golgi and at the plasma membrane.	CTR MED UNIV GENEVA, DEPT MORPHOL, CH-1211 GENEVA 4, SWITZERLAND; AGOURON INST, LA JOLLA, CA 92037 USA	University of Geneva	Mangasarian, A (corresponding author), SALK INST BIOL STUDIES, INFECT DIS LAB, 10010 N TORREY PINES RD, LA JOLLA, CA 92037 USA.		Aiken, Christopher/Y-9252-2019	Foti, Michelangelo/0000-0001-7199-4135; Mangasarian, Aram/0000-0002-8087-7990				ACRES RB, 1986, J BIOL CHEM, V261, P6210; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; ANDERSON S, 1993, J VIROL, V67, P4923, DOI 10.1128/JVI.67.8.4923-4931.1993; Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Ausubel F.M., 1987, CURRENT PROTOCOLS MO; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BARRY M, 1995, J VIROL, V69, P5243, DOI 10.1128/JVI.69.9.5243-5251.1995; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; CARLIN CR, 1989, CELL, V57, P135, DOI 10.1016/0092-8674(89)90179-7; CARTER LL, 1993, J CELL BIOL, V120, P37, DOI 10.1083/jcb.120.1.37; CHAMBERS JD, 1993, J LEUKOCYTE BIOL, V53, P462, DOI 10.1002/jlb.53.4.462; CRISE B, 1990, J VIROL, V64, P5585, DOI 10.1128/JVI.64.11.5585-5593.1990; CRISE B, 1992, J VIROL, V66, P2296, DOI 10.1128/JVI.66.4.2296-2301.1992; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; FRANCHINI G, 1986, VIROLOGY, V155, P593, DOI 10.1016/0042-6822(86)90219-9; GALLAY P, 1995, CELL, V80, P379, DOI 10.1016/0092-8674(95)90488-3; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GARCIA JV, 1993, J VIROL, V67, P1511, DOI 10.1128/JVI.67.3.1511-1516.1993; GOLDSMITH MA, 1995, J VIROL, V69, P4112, DOI 10.1128/JVI.69.7.4112-4121.1995; GREENWAY A, 1995, J VIROL, V69, P1842, DOI 10.1128/JVI.69.3.1842-1850.1995; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; HARRIS MPG, 1994, J MOL BIOL, V241, P136; HOFFMAN P, 1992, J VIROL, V66, P197, DOI 10.1128/JVI.66.1.197-203.1992; HOXIE JA, 1988, J IMMUNOL, V140, P786; HOXIE JA, 1986, J IMMUNOL, V137, P1194; JABBAR MA, 1990, J VIROL, V64, P6297, DOI 10.1128/JVI.64.12.6297-6304.1990; KAMINCHIK J, 1991, J VIROL, V65, P583, DOI 10.1128/JVI.65.2.583-588.1991; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LINSTEDT AD, 1995, P NATL ACAD SCI USA, V92, P5102, DOI 10.1073/pnas.92.11.5102; Luo TC, 1996, J VIROL, V70, P1527, DOI 10.1128/JVI.70.3.1527-1534.1996; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MARIANI R, 1993, P NATL ACAD SCI USA, V90, P5549, DOI 10.1073/pnas.90.12.5549; Miceli M C, 1991, Semin Immunol, V3, P133; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; PARNES JR, 1989, ADV IMMUNOL, V44, P265, DOI 10.1016/S0065-2776(08)60644-6; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; PELCHENMATTHEWS A, 1991, J EXP MED, V173, P575, DOI 10.1084/jem.173.3.575; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; PELCHENMATTHEWS A, 1989, EMBO J, V8, P3641, DOI 10.1002/j.1460-2075.1989.tb08538.x; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; RHEE SS, 1994, J IMMUNOL, V152, P5128; ROBERTGUROFF M, 1990, J VIROL, V64, P3391, DOI 10.1128/JVI.64.7.3391-3398.1990; ROBEY E, 1990, CELL, V60, P697, DOI 10.1016/0092-8674(90)90082-P; Rossi F, 1996, VIROLOGY, V217, P397, DOI 10.1006/viro.1996.0130; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SALGHETTI S, 1995, P NATL ACAD SCI USA, V92, P349, DOI 10.1073/pnas.92.2.349; SCHWARTZ O, 1995, J VIROL, V69, P528, DOI 10.1128/JVI.69.1.528-533.1995; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SCHWARTZ O, 1993, J VIROL, V67, P3274, DOI 10.1128/JVI.67.6.3274-3280.1993; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SHIN J, 1990, EMBO J, V9, P425, DOI 10.1002/j.1460-2075.1990.tb08127.x; SHIN JY, 1991, J BIOL CHEM, V266, P10658; SLECKMAN BP, 1992, P NATL ACAD SCI USA, V89, P7566, DOI 10.1073/pnas.89.16.7566; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cellbio.9.1.129; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WHITNEY JA, 1995, CELL, V83, P703; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Zuniga-Pflucker J C, 1991, Semin Immunol, V3, P167	72	133	133	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1997	6	1					67	77		10.1016/S1074-7613(00)80243-5	http://dx.doi.org/10.1016/S1074-7613(00)80243-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB161	9052838	Bronze			2022-12-18	WOS:A1997XB16100007
J	Villey, I; Caillol, D; Selz, F; Ferrier, P; deVillartay, JP				Villey, I; Caillol, D; Selz, F; Ferrier, P; deVillartay, JP			Defect in rearrangement of the most 5' TCR-J alpha following targeted deletion of T early alpha (TEA): Implications for TCR alpha locus accessibility	IMMUNITY			English	Article							CHAIN INTRON ENHANCER; RECEPTOR-DELTA-LOCUS; REGION GENE SEGMENTS; LINE-V-ALPHA; V(D)J RECOMBINATION; CELL-DEVELOPMENT; TRANSCRIPTIONAL ENHANCER; THYMOCYTE DEVELOPMENT; ALPHA/DELTA LOCUS; TRANSGENIC MICE	To address the role of the TEA germline transcription, which initiates upstream of the TCR-J alpha s, in the regulation of TCR-J alpha locus accessibility, we created a mouse in which this region has been removed by homologous recombination. Normal development of T alpha beta cells and the expression of other TCR alpha germline transcripts in TEA(-/-) mice ruled out an exclusive role for TEA in the overall accessibility of the J alpha cluster. However, the rearrangement of the most 5' J alpha (J alpha 61 to J alpha 53) was severely impaired, indicating that TEA may control the DNA accessibility of a particular J alpha window. Moreover, the relative usage of every J alpha segment was affected. These results are consistent with TEA acting as a ''rearrangement-focusing'' element, targeting the primary waves of V alpha-J alpha recombination to the most 5' J alpha s in an ongoing TCR-J alpha rearrangement model.	HOP NECKER ENFANTS MALAD, INSERM, U429, PARIS, FRANCE; CNRS MARSEILLE LUMINY, INSERM, CTR IMMUNOL, MARSEILLE, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite			de Villartay, jean pierre/H-9353-2017	de Villartay, jean pierre/0000-0001-5987-0463				BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; BORIES JC, 1990, J EXP MED, V171, P75, DOI 10.1084/jem.171.1.75; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; BUCCHINI D, 1987, NATURE, V326, P409, DOI 10.1038/326409a0; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; DECHASSEVAL R, 1993, EUR J IMMUNOL, V23, P1294, DOI 10.1002/eji.1830230616; DEVILLARTAY JP, 1990, RES IMMUNOL, V141, P618, DOI 10.1016/0923-2494(90)90069-B; DEVILLARTAY JP, 1987, P NATL ACAD SCI USA, V84, P8608; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Ferradini L, 1996, SCIENCE, V271, P1416, DOI 10.1126/science.271.5254.1416; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; FLERING S, 1995, GENE DEV, V9, P2203; FONDELL JD, 1992, MOL CELL BIOL, V12, P1480, DOI 10.1128/MCB.12.4.1480; GOODHARDT M, 1987, P NATL ACAD SCI USA, V84, P4229, DOI 10.1073/pnas.84.12.4229; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; Hiramatsu R, 1995, CELL, V83, P1113, DOI 10.1016/0092-8674(95)90138-8; HO IC, 1989, P NATL ACAD SCI USA, V86, P6714, DOI 10.1073/pnas.86.17.6714; HOCKETT R D JR, 1989, New Biologist, V1, P266; HOCKETT RD, 1988, P NATL ACAD SCI USA, V85, P9694, DOI 10.1073/pnas.85.24.9694; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KOOP BF, 1994, NAT GENET, V7, P48, DOI 10.1038/ng0594-48; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LAUSTER R, 1993, EMBO J, V12, P4615, DOI 10.1002/j.1460-2075.1993.tb06150.x; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; LETOURNEUR F, 1989, EUR J IMMUNOL, V19, P2269, DOI 10.1002/eji.1830191214; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Livak F, 1996, MOL CELL BIOL, V16, P609; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; MALISSEN M, 1988, CELL, V55, P49, DOI 10.1016/0092-8674(88)90008-6; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Maniatis T., 1982, MOL CLONING; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MAROLLEAU JP, 1988, CELL, V55, P291, DOI 10.1016/0092-8674(88)90052-9; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NAKAJIMA PB, 1995, IMMUNITY, V3, P609, DOI 10.1016/1074-7613(95)90132-9; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OKADA A, 1994, J EXP MED, V180, P261, DOI 10.1084/jem.180.1.261; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; REDONDO JM, 1990, SCIENCE, V247, P1225, DOI 10.1126/science.2156339; REITMAN M, 1993, MOL CELL BIOL, V13, P3990, DOI 10.1128/MCB.13.7.3990; RIEUXLAUCAT F, 1993, EUR J IMMUNOL, V23, P928, DOI 10.1002/eji.1830230425; RYTKONEN M, 1994, EUR J IMMUNOL, V24, P107, DOI 10.1002/eji.1830240117; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SHIMIZU T, 1993, INT IMMUNOL, V5, P155, DOI 10.1093/intimm/5.2.155; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; THOMPSON SD, 1990, J IMMUNOL, V145, P2347; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; WEAVER DT, 1995, ADV IMMUNOL, V58, P29, DOI 10.1016/S0065-2776(08)60619-7; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4; WILSON RK, 1992, GENOMICS, V13, P1198, DOI 10.1016/0888-7543(92)90038-T; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2	76	133	133	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1996	5	4					331	342		10.1016/S1074-7613(00)80259-9	http://dx.doi.org/10.1016/S1074-7613(00)80259-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VP444	8885866	Bronze			2022-12-18	WOS:A1996VP44400005
J	CHIN, KC; MAO, C; SKINNER, C; RILEY, JL; WRIGHT, KL; MORENO, CS; STARK, GR; BOSS, JM; TING, JPY				CHIN, KC; MAO, C; SKINNER, C; RILEY, JL; WRIGHT, KL; MORENO, CS; STARK, GR; BOSS, JM; TING, JPY			MOLECULAR ANALYSIS OF G1B AND G3A IFN-GAMMA MUTANTS REVEALS THAT DEFECTS IN CIITA OR RFX RESULT IN DEFECTIVE CLASS-II MHC AND II-GENE INDUCTION	IMMUNITY			English	Article							INVARIANT CHAIN GENE; HLA-DR-ALPHA; SIGNAL-TRANSDUCTION PATHWAY; BARE LYMPHOCYTE SYNDROME; TRANS-ACTING PROTEIN; DNA-BINDING PROTEIN; X-BOX-BINDING; INTERFERON-GAMMA; INDUCED EXPRESSION; MESSENGER-RNAS	Class II major histocompatibility complex (MHC) genes and the invariant (Ii) gene are inducible by interferon-gamma (IFN gamma) but not by interferon-alpha and interferon-beta. The promoter regions of these genes contain three regulatory elements that mediate constitutive and IFN gamma-induced expressions; however, none of the DNA-binding proteins that interact with these elements are regulated by IFN gamma. Recently, a gene coding for a transactivator (CIITA) of class II MHC genes that complements a HLA-DR-negative immunodeficiency has been isolated. Using one IFN gamma mutant cell line (G3A) that is selectively defective in HLA-DR and Ii induction, four lines of evidence are presented to show that CIITA mediates the IFN gamma induction of HLA-DR and Ii genes. Analysis of another mutant line, G1B, indicates that the lack of DRA and Ii gene induction by IFN gamma is correlated with the lack of RFX DNA binding activity, thus providing the link between RFX and an IFN gamma response.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,DEPT IMMUNOL MICROBIOL,CHAPEL HILL,NC 27599; FAC MED LARIBOISIERE,INSERM,U248,PARIS,FRANCE; EMORY UNIV,DEPT IMMUNOL MICROBIOL,ATLANTA,GA 30322; CLEVELAND CLIN FDN,RES INST,CLEVELAND,OH 44195	University of North Carolina; University of North Carolina Chapel Hill; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Emory University; Cleveland Clinic Foundation	CHIN, KC (corresponding author), UNIV N CAROLINA,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599, USA.		Moreno, Carlos S/B-3863-2009	Moreno, Carlos S/0000-0002-5582-0028; Riley, James/0000-0002-1057-576X	NCI NIH HHS [CA37172] Funding Source: Medline; NIAID NIH HHS [AI29564, AI34000] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034000, R21AI034000, R56AI029564, R01AI029564] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; AMALDI I, 1989, J IMMUNOL, V142, P999; ANDERSSON G, 1990, J IMMUNOL, V145, P3456; BARR CL, 1991, J BIOL CHEM, V266, P3475; BASTA PV, 1987, J IMMUNOL, V138, P1275; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; BLANAR MA, 1988, P NATL ACAD SCI USA, V85, P4672, DOI 10.1073/pnas.85.13.4672; BOTTGER EC, 1988, IMMUNOGENETICS, V28, P215, DOI 10.1007/BF00345497; BROWN AM, 1993, J BIOL CHEM, V268, P26328; BROWN AM, 1994, MOL CELL BIOL, V14, P2926, DOI 10.1128/MCB.14.5.2926; BROWN AM, 1991, J IMMUNOL, V146, P3183; CHANG CH, 1992, IMMUNOGENETICS, V35, P378; CHELLY J, 1990, EUR J BIOCHEM, V187, P691, DOI 10.1111/j.1432-1033.1990.tb15355.x; COGSWELL JP, 1990, P NATL ACAD SCI USA, V87, P7703, DOI 10.1073/pnas.87.19.7703; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; DALE TC, 1989, P NATL ACAD SCI USA, V86, P1203, DOI 10.1073/pnas.86.4.1203; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; DEVAJYOTHI C, 1993, J BIOL CHEM, V268, P18794; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P6269, DOI 10.1093/nar/19.22.6269; HASEGAWA SL, 1993, J IMMUNOL, V150, P1781; HUME CR, 1989, HUM IMMUNOL, V26, P288, DOI 10.1016/0198-8859(89)90007-4; INABA K, 1986, J EXP MED, V163, P1030, DOI 10.1084/jem.163.4.1030; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; KARA CJ, 1993, J IMMUNOL, V150, P4934; KATO T, 1989, J INTERFERON RES, V9, P393, DOI 10.1089/jir.1989.9.393; KESSLER DS, 1990, GENE DEV, V4, P1753, DOI 10.1101/gad.4.10.1753; KOUSKOFF V, 1991, J IMMUNOL, V146, P3197; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; LING PD, 1985, J IMMUNOL, V135, P1857; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; LOH JE, 1992, EMBO J, V11, P1351, DOI 10.1002/j.1460-2075.1992.tb05180.x; MAITY SN, 1990, P NATL ACAD SCI USA, V87, P5378, DOI 10.1073/pnas.87.14.5378; MAITY SN, 1992, J BIOL CHEM, V267, P16574; MAO C, 1993, P NATL ACAD SCI USA, V90, P2880, DOI 10.1073/pnas.90.7.2880; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; PARRINGTON J, 1993, EUR J BIOCHEM, V214, P617, DOI 10.1111/j.1432-1033.1993.tb17961.x; PELLEGRINI S, 1993, TRENDS BIOCHEM SCI, V18, P338, DOI 10.1016/0968-0004(93)90070-4; PETERLIN BM, 1990, J IMMUNOL, V145, P3456; POLITIS AD, 1994, J IMMUNOL, V152, P2270; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; RILEY JL, 1993, J IMMUNOL, V151, P5942; ROBINSON MO, 1991, NUCLEIC ACIDS RES, V19, P1557, DOI 10.1093/nar/19.7.1557; ROSA F, 1983, EMBO J, V2, P1585, DOI 10.1002/j.1460-2075.1983.tb01628.x; SAMBROOK J, 1987, MOL CLONING LABORATO; SANCHEZ CH, 1992, MOL CELL BIOL, V12, P4076, DOI 10.1128/MCB.12.9.4076; SHERMAN PA, 1989, MOL CELL BIOL, V9, P50, DOI 10.1128/MCB.9.1.50; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; SLOAN JH, 1992, J IMMUNOL, V148, P2591; STARK GR, 1992, J INTERFERON RES, V12, P147, DOI 10.1089/jir.1992.12.147; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; TAKIGUCHI M, 1985, EUR J IMMUNOL, V15, P809, DOI 10.1002/eji.1830150813; TING JP, 1993, IMMUNOL RES, V12, P65, DOI 10.1007/BF02918369; VANHUIJSDUIJNEN RAMH, 1987, NUCLEIC ACIDS RES, V15, P7265, DOI 10.1093/nar/15.18.7265; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WEIS JH, 1992, TRENDS GENET, V8, P263, DOI 10.1016/0168-9525(92)90242-V; WILLIAMS BRG, 1991, EUR J BIOCHEM, V200, P1, DOI 10.1111/j.1432-1033.1991.tb21041.x; WRIGHT KL, 1992, P NATL ACAD SCI USA, V89, P7601, DOI 10.1073/pnas.89.16.7601; WRIGHT KL, 1994, EMBO J, V13, P4042, DOI 10.1002/j.1460-2075.1994.tb06721.x; YAMAMOTO H, 1994, ONCOGENE, V9, P1423; ZELEZNIKLE NJ, 1991, P NATL ACAD SCI USA, V88, P1873, DOI 10.1073/pnas.88.5.1873	69	133	133	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1994	1	8					687	697		10.1016/1074-7613(94)90039-6	http://dx.doi.org/10.1016/1074-7613(94)90039-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PT930	7600294				2022-12-18	WOS:A1994PT93000006
J	Roncarolo, MG; Gregori, S; Bacchetta, R; Battaglia, M; Gagliani, N				Roncarolo, Maria Grazia; Gregori, Silvia; Bacchetta, Rosa; Battaglia, Manuela; Gagliani, Nicola			The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases	IMMUNITY			English	Review							IMMATURE DENDRITIC CELLS; HLA CLASS-I; TR1 CELLS; TRANSCRIPTION FACTOR; INTERLEUKIN-10 PRODUCTION; HELPER TYPE-1; CUTTING EDGE; IFN-GAMMA; CD4(+); IL-10	Thirty years ago, one of the first types of CD4(+) T regulatory cells was discovered and named T regulatory type 1 (Tr1) cells. Tr1 cells represent a distinct population of T cells, which are induced in the periphery upon antigen exposure under tolerogenic conditions. They produce the immunosuppressive cytokines interleukin-10 (IL-10) and transforming growth factor-beta (TGF-beta), do not constitutively express FOXP3, and suppress the function of effector immune cells. In this review, the key studies leading to the identification and biological characterization of Tr1 cells are recapitulated. The fundamental role of Tr1 cells in regulating immune responses to pathogenic and non-pathogenic antigens, as well as their use as cell therapeutics, is summarized.	[Roncarolo, Maria Grazia; Bacchetta, Rosa] Stanford Sch Med, Dept Pediat, Div Stem Cell Transplantat & Regenerat Med, Stanford, CA 94305 USA; [Roncarolo, Maria Grazia] Stanford Sch Med, ISCBRM, Stanford, CA 94305 USA; [Gregori, Silvia] IRCCS San Raffaele Sci Inst Milan, San Raffaele Telethon Inst Gene Therapy SR TIGET, Milan, Italy; [Battaglia, Manuela] IRCCS San Raffaele Sci Inst, DRI, Milan, Italy; [Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, D-20246 Hamburg, Germany; [Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, D-20246 Hamburg, Germany; [Gagliani, Nicola] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, S-17176 Stockholm, Sweden	Stanford University; Stanford University; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet	Roncarolo, MG (corresponding author), Stanford Sch Med, Dept Pediat, Div Stem Cell Transplantat & Regenerat Med, Stanford, CA 94305 USA.; Roncarolo, MG (corresponding author), Stanford Sch Med, ISCBRM, Stanford, CA 94305 USA.	mg1@stanford.edu	; Gregori, Silvia/J-7718-2016	Battaglia, Manuela/0000-0003-4535-3152; Gregori, Silvia/0000-0002-3517-9683; Gagliani, Nicola/0000-0001-8514-1395				Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Alfen JS, 2018, J ALLERGY CLIN IMMUN, V142, P1537, DOI 10.1016/j.jaci.2017.12.984; Ali MA, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf7779; Amodio G, 2015, HAEMATOLOGICA, V100, P551, DOI 10.3324/haematol.2014.113803; Amodio G, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-14; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Andolfi G, 2012, MOL THER, V20, P1778, DOI 10.1038/mt.2012.71; Andreani Marco, 2014, Chimerism, V5, P75, DOI 10.1080/19381956.2015.1103423; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Asnagli H, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4567; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Augustin M, 2019, AIDS RES HUM RETROV, V35, P247, DOI [10.1089/aid.2018.0052, 10.1089/AID.2018.0052]; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; BACCHETTA R, 1990, J IMMUNOL, V144, P902; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; Bacchetta R, 2018, ANN NY ACAD SCI, V1417, P5, DOI 10.1111/nyas.13011; Bacchetta R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00016; Bacchetta R, 2010, HAEMATOL-HEMATOL J, V95, P2134, DOI 10.3324/haematol.2010.025825; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Bergmann C, 2008, CLIN CANCER RES, V14, P3706, DOI 10.1158/1078-0432.CCR-07-5126; Bollyky PL, 2011, P NATL ACAD SCI USA, V108, P7938, DOI 10.1073/pnas.1017360108; Brockmann L, 2017, J IMMUNOL, V198, P1130, DOI 10.4049/jimmunol.1601045; Brun V, 2009, INT IMMUNOPHARMACOL, V9, P609, DOI 10.1016/j.intimp.2009.01.032; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Charbonnier LM, 2006, J IMMUNOL, V177, P3806, DOI 10.4049/jimmunol.177.6.3806; Chen C, 2003, J IMMUNOL, V171, P733, DOI 10.4049/jimmunol.171.2.733; Chen ZM, 2003, BLOOD, V101, P5076, DOI 10.1182/blood-2002-09-2798; Chevalier MF, 2015, J INFECT DIS, V211, P769, DOI 10.1093/infdis/jiu549; Chien CH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46348; Choileain SN, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah6163; Chujo D, 2015, CLIN IMMUNOL, V161, P270, DOI 10.1016/j.clim.2015.08.014; Clemente-Casares X, 2016, NATURE, V530, P434, DOI 10.1038/nature16962; Corre B, 2013, EUR J IMMUNOL, V43, P2730, DOI 10.1002/eji.201242977; de Marquesini LGP, 2010, DIABETOLOGIA, V53, P1451, DOI 10.1007/s00125-010-1739-3; de Oca MM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005398; DEMEURE CE, 1994, J IMMUNOL, V152, P4775; Dennis KL, 2013, CURR OPIN ONCOL, V25, P637, DOI 10.1097/CCO.0000000000000006; Desreumaux P, 2012, GASTROENTEROLOGY, V143, P1207, DOI 10.1053/j.gastro.2012.07.116; Facciotti F, 2016, J ALLERGY CLIN IMMUN, V137, P318, DOI 10.1016/j.jaci.2015.06.044; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Frenkel D, 2003, J IMMUNOL, V171, P6549, DOI 10.4049/jimmunol.171.12.6549; Gagliani N, 2013, AM J TRANSPLANT, V13, P1963, DOI 10.1111/ajt.12333; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gagliani N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028434; Gagliani N, 2010, DIABETES, V59, P433, DOI 10.2337/db09-1168; Gianfrani C, 2006, J IMMUNOL, V177, P4178, DOI 10.4049/jimmunol.177.6.4178; Globinska A, 2018, ANN ALLERG ASTHMA IM, V121, P306, DOI 10.1016/j.anai.2018.06.026; Gregori S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00233; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Groux H, 1999, J IMMUNOL, V162, P1723; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Groux H, 1998, J IMMUNOL, V160, P3188; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Heinemann C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4770; Hooper KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179184; Huang WS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15871; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Iwasaki Y, 2013, EUR J IMMUNOL, V43, P1063, DOI 10.1002/eji.201242942; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Jin JO, 2013, J AUTOIMMUN, V40, P28, DOI 10.1016/j.jaut.2012.07.009; Jofra T, 2018, EUR J IMMUNOL, V48, P1389, DOI 10.1002/eji.201747316; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Karwacz K, 2017, NAT IMMUNOL, V18, P412, DOI 10.1038/ni.3683; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kim J, 2018, J INVEST DERMATOL, V138, P2669, DOI 10.1016/j.jid.2018.05.021; Koch K, 2015, AIDS RES HUM RETROV, V31, P1238, DOI [10.1089/aid.2014.0356, 10.1089/AID.2014.0356]; Kunicki MA, 2018, J IMMUNOL, V200, P336, DOI 10.4049/jimmunol.1701025; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Lino AC, 2018, IMMUNITY, V49, P120, DOI 10.1016/j.immuni.2018.06.007; Locafaro G, 2017, MOL THER, V25, P2254, DOI 10.1016/j.ymthe.2017.06.029; Lonnberg T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2192; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Magnani CF, 2011, EUR J IMMUNOL, V41, P1652, DOI 10.1002/eji.201041120; MALEFYT RD, 1991, J EXP MED, V174, P915; Mandapathil M, 2010, J BIOL CHEM, V285, P27571, DOI 10.1074/jbc.M110.127100; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Mfarrej B, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1133-8; Miroux C, 2010, EXPERT OPIN BIOL TH, V10, P1563, DOI 10.1517/14712598.2010.529125; Morris ES, 2004, BLOOD, V103, P3573, DOI 10.1182/blood-2003-08-2864; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Neumann C, 2014, J EXP MED, V211, P1807, DOI 10.1084/jem.20131548; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Pacciani V, 2010, J ALLERGY CLIN IMMUN, V125, P727, DOI 10.1016/j.jaci.2009.12.004; Passerini L, 2011, EUR J IMMUNOL, V41, P1120, DOI 10.1002/eji.201040909; Pedroza-Gonzalez A, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008355; Pellerin L., 2017, J ALLERGY CLIN IMMUN, V141-202, P213; Petrelli A, 2015, TRANSPLANTATION, V99, P1582, DOI 10.1097/TP.0000000000000751; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rahmoun M, 2006, INT ARCH ALLERGY IMM, V140, P139, DOI 10.1159/000092533; Ranjbar M, 2012, CLIN EXP NEPHROL, V16, P636, DOI 10.1007/s10157-012-0591-9; Roncarolo MG, 2014, CURR TOP MICROBIOL, V380, P39, DOI 10.1007/978-3-662-43492-5_3; RONCAROLO MG, 1988, J EXP MED, V167, P1523, DOI 10.1084/jem.167.5.1523; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Sabatos-Peyton CA, 2010, CURR OPIN IMMUNOL, V22, P609, DOI 10.1016/j.coi.2010.08.006; Said SS, 2018, MOL IMMUNOL, V96, P48, DOI 10.1016/j.molimm.2018.02.010; Sanda S, 2008, CLIN IMMUNOL, V127, P138, DOI 10.1016/j.clim.2007.12.003; SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996; Scurr M, 2014, MUCOSAL IMMUNOL, V7, P428, DOI 10.1038/mi.2013.62; Serafini G, 2009, HAEMATOL-HEMATOL J, V94, P1415, DOI 10.3324/haematol.2008.003129; Singha S, 2017, NAT NANOTECHNOL, V12, P701, DOI [10.1038/nnano.2017.56, 10.1038/NNANO.2017.56]; Smith EL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00392; Song ZC, 2018, EXP CELL RES, V367, P251, DOI 10.1016/j.yexcr.2018.04.002; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sumitomo Shuji, 2010, Nihon Rinsho Meneki Gakkai Kaishi, V33, P92; Sutavani RV, 2013, J IMMUNOL, V191, P5895, DOI 10.4049/jimmunol.1301458; Totsuka T, 2005, EUR J IMMUNOL, V35, P1773, DOI 10.1002/eji.200425109; Tousa S, 2017, P NATL ACAD SCI USA, V114, pE2891, DOI 10.1073/pnas.1616942114; Tree TIM, 2010, DIABETES, V59, P1451, DOI 10.2337/db09-0503; van den Boogaardt DEM, 2006, TRANSPLANTATION, V82, P844, DOI 10.1097/01.tp.0000229448.64363.18; Vicente R, 2016, J IMMUNOL, V196, P298, DOI 10.4049/jimmunol.1501069; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Wakkach A, 2001, J IMMUNOL, V167, P3107, DOI 10.4049/jimmunol.167.6.3107; Wang H, 2011, IMMUNOL LETT, V136, P21, DOI 10.1016/j.imlet.2010.11.007; White AM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00355; Wildbaum G, 2002, J CLIN INVEST, V110, P701, DOI 10.1172/JCI200215176; Xu L, 2013, P NATL ACAD SCI USA, V110, P16993, DOI 10.1073/pnas.1306437110; Xu YQ, 2010, J ASTHMA, V47, P367, DOI 10.3109/02770903.2010.481340; Yan H., 2017, TUMOR BIOL, V39, P1; Yao Y, 2015, J IMMUNOL, V195, P488, DOI 10.4049/jimmunol.1403225; Yu H, 2017, P NATL ACAD SCI USA, V114, P10443, DOI 10.1073/pnas.1705599114; Zeller JC, 1999, J IMMUNOL, V163, P3684; Zhang P, 2017, 12TH CHINESE CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CHINESECSCW 2017), P2, DOI 10.1145/3127404.3127405; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhu ZD, 2018, HUM IMMUNOL, V79, P564, DOI 10.1016/j.humimm.2018.05.001	141	132	133	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1004	1019		10.1016/j.immuni.2018.12.001	http://dx.doi.org/10.1016/j.immuni.2018.12.001			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566879	Bronze			2022-12-18	WOS:000453556500008
J	Halim, TYF; Rana, BMJ; Walker, JA; Kerscher, B; Knolle, MD; Jolin, HE; Serrao, EM; Haim-Vilmovsky, L; Teichmann, SA; Rodewald, HR; Botto, M; Vyse, TJ; Fallon, PG; Li, Z; Withers, DR; McKenzie, ANJ				Halim, Timotheus Y. F.; Rana, Batika M. J.; Walker, Jennifer A.; Kerscher, Bernhard; Knolle, Martin D.; Jolin, Helen E.; Serrao, Eva M.; Haim-Vilmovsky, Liora; Teichmann, Sarah A.; Rodewald, Hans-Reimer; Botto, Marina; Vyse, Timothy J.; Fallon, Padraic G.; Li, Zhi; Withers, David R.; McKenzie, Andrew N. J.			Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells	IMMUNITY			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR GATA3; ALLERGIC INFLAMMATION; LIGAND INTERACTION; GENE-EXPRESSION; MURINE MODEL; RESPONSES; ACTIVATION; ALPHA; INTERLEUKIN-33	The local regulation of type 2 immunity relies on dialog between the epithelium and the innate and adaptive immune cells. Here we found that alarm-ininduced expression of the co-stimulatory molecule OX40L on group 2 innate lymphoid cells (ILC2s) provided tissue-restricted T cell co-stimulation that was indispensable for Th2 and regulatory T (Treg) cell responses in the lung and adipose tissue. Interleukin (IL)-33 administration resulted in organ-specific surface expression of OX40L on ILC2s and the concomitant expansion of Th2 and Treg cells, which was abolished upon deletion of OX40L on ILC2s (Il7ra(Cre/+)Tnfsf4(fl/fl) mice). Moreover, Il7ra(Cre/+) Tnfsf4(fl/fl) mice failed to mount effective Th2 and Treg cell responses and corresponding adaptive type 2 pulmonary inflammation arising from Nippostrongylus brasiliensis infection or allergen exposure. Thus, the increased expression of OX40L in response to IL-33 acts as a licensing signal in the orchestration of tissue-specific adaptive type 2 immunity, without which this response fails to establish.	[Halim, Timotheus Y. F.; Rana, Batika M. J.; Walker, Jennifer A.; Kerscher, Bernhard; Knolle, Martin D.; Jolin, Helen E.; McKenzie, Andrew N. J.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Halim, Timotheus Y. F.; Serrao, Eva M.] Univ Cambridge, CRUK Cambridge Inst, Cambridge CB2 0RE, England; [Knolle, Martin D.] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England; [Haim-Vilmovsky, Liora; Teichmann, Sarah A.] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Botto, Marina] Imperial Coll London, Dept Med, London, England; [Vyse, Timothy J.] Kings Coll London, Dept Med & Mol Genet, London, England; [Fallon, Padraic G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin, Ireland; [Li, Zhi; Withers, David R.] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England; [Kerscher, Bernhard] Paul Ehrlich Inst, Div Microbiol, Langen, Germany	MRC Laboratory Molecular Biology; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Imperial College London; University of London; King's College London; Trinity College Dublin; University of Birmingham; Paul Ehrlich Institute	Halim, TYF; McKenzie, ANJ (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.; Halim, TYF (corresponding author), Univ Cambridge, CRUK Cambridge Inst, Cambridge CB2 0RE, England.	tim.halim@cruk.cam.ac.uk; anm@mrc-lmb.cam.ac.uk	Kerscher, Bernhard G R/B-1907-2015; Fallon, Padraic/Y-2711-2019; Withers, David/C-7055-2015; Halim, Timotheus/B-3117-2018	Kerscher, Bernhard G R/0000-0001-9300-7401; Fallon, Padraic/0000-0002-8401-7293; Withers, David/0000-0003-3757-7594; Vilmovsky, Liora/0000-0001-9342-749X; Halim, Timotheus/0000-0001-9773-0023; Li, Zhi/0000-0002-0583-1116	UK Medical Research Council [U105178805]; Wellcome Trust [100963/Z/13/Z, 17966/Z/2008, 204622/Z/16/Z]; EMBL; ERC; Cancer Research UK; MRC [MC_U105178805] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EMBL; ERC(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Natalio Garbi for the Itgax<SUP>Luci.DTR.Cre</SUP> mice and Peter Lane for the Tnfrsf4<SUP>-/-</SUP> mice. We thank the MRC ARES and flow cytometry facilities, Jhuma Pramanik and the Sanger RSF, and the CRUK histology and genomics core facilities. This study was supported by grants from the UK Medical Research Council (U105178805) and Wellcome Trust (100963/Z/13/Z) (A.N.J.M.); Wellcome Trust (17966/Z/2008) (T.J.V.); EMBL and ERC (L.H.-V.); and Cancer Research UK and Wellcome Trust (204622/Z/16/Z) (T.Y.F.H.).	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Chapoval S, 2010, J LEUKOCYTE BIOL, V87, P1011, DOI 10.1189/jlb.1209772; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Cortini A, 2017, ANN RHEUM DIS, V76, P2095, DOI 10.1136/annrheumdis-2017-211499; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Drake LY, 2014, ALLERGY, V69, P1300, DOI 10.1111/all.12446; Ekkens MJ, 2003, J IMMUNOL, V170, P384, DOI 10.4049/jimmunol.170.1.384; Gaspal FMC, 2005, J IMMUNOL, V174, P3891, DOI 10.4049/jimmunol.174.7.3891; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gauvreau GM, 2014, CLIN EXP ALLERGY, V44, P29, DOI 10.1111/cea.12235; Gold MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1142, DOI 10.1016/j.jaci.2014.02.033; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoshino A, 2003, EUR J IMMUNOL, V33, P861, DOI 10.1002/eji.200323455; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Jenkins SJ, 2007, J IMMUNOL, V179, P3515, DOI 10.4049/jimmunol.179.6.3515; Kim MY, 2005, J IMMUNOL, V174, P6686, DOI 10.4049/jimmunol.174.11.6686; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Linch SN, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00034; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Man K, 2017, CELL METAB, V25, P11, DOI 10.1016/j.cmet.2016.08.016; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Morita H, 2015, IMMUNITY, V43, P175, DOI 10.1016/j.immuni.2015.06.021; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Odegaard JI, 2015, CURR OPIN IMMUNOL, V36, P67, DOI 10.1016/j.coi.2015.07.003; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Siede J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161507; Steer CA, 2017, J ALLERGY CLIN IMMUN, V140, P593, DOI 10.1016/j.jaci.2016.12.984; Suto A, 2001, AM J RESP CRIT CARE, V164, P680, DOI 10.1164/ajrccm.164.4.2010170; Tahiliani V, 2017, J IMMUNOL, V198, P218, DOI 10.4049/jimmunol.1601356; Takeda I, 2004, J IMMUNOL, V172, P3580, DOI 10.4049/jimmunol.172.6.3580; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Webb GJ, 2016, CLIN REV ALLERG IMMU, V50, P312, DOI 10.1007/s12016-015-8498-3; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	57	132	135	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1195	+		10.1016/j.immuni.2018.05.003	http://dx.doi.org/10.1016/j.immuni.2018.05.003			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29907525	Green Published, hybrid			2022-12-18	WOS:000436456900018
J	Chen, CY; Lee, JB; Liu, B; Ohta, S; Wang, PY; Kartashov, AV; Mugge, L; Abonia, JP; Barski, A; Izuhara, K; Rothenberg, ME; Finkelman, FD; Hogan, SP; Wang, YH				Chen, Chun-Yu; Lee, Jee-Boong; Liu, Bo; Ohta, Shoichiro; Wang, Pin-Yi; Kartashov, Andrey V.; Mugge, Luke; Abonia, J. Pablo; Barski, Artem; Izuhara, Kenji; Rothenberg, Marc E.; Finkelman, Fred D.; Hogan, Simon P.; Wang, Yui-Hsi			Induction of Interleukin-9-Producing Mucosal Mast Cells Promotes Susceptibility to IgE-Mediated Experimental Food Allergy	IMMUNITY			English	Article							TRICHINELLA-SPIRALIS; PROTECTIVE IMMUNITY; DIFFERENTIATION; HETEROGENEITY; ANAPHYLAXIS; PROGENITORS; INFECTION; SEVERITY; RECEPTOR; LUNG	Experimental IgE-mediated food allergy depends on intestinal anaphylaxis driven by interleukin-9 (IL-9). However, the primary cellular source of IL-9 and the mechanisms underlying the susceptibility to food-induced intestinal anaphylaxis remain unclear. Herein, we have reported the identification of multifunctional IL-9-producing mucosal mast cells (MMC9s) that can secrete prodigious amounts of IL-9 and IL-13 in response to IL-33, and mast cell protease-1 (MCPt-1) in response to antigen and IgE complex crosslinking, respectively. Repeated intragastric antigen challenge induced MMC9 development that required T cells, IL-4, and STAT6 transcription factor, but not IL-9 signals. Mice ablated of MMC9 induction failed to develop intestinal mastocytosis, which resulted in decreased food allergy symptoms that could be restored by adoptively transferred MMC9s. Finally, atopic patients that developed food allergy displayed increased intestinal expression of Il9- and MC-specific transcripts. Thus, the induction of MMC9s is a pivotal step to acquire the susceptibility to IgE-mediated food allergy.	[Chen, Chun-Yu; Lee, Jee-Boong; Liu, Bo; Kartashov, Andrey V.; Mugge, Luke; Abonia, J. Pablo; Barski, Artem; Rothenberg, Marc E.; Hogan, Simon P.; Wang, Yui-Hsi] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Ohta, Shoichiro] Saga Med Sch, Dept Lab Med, Saga 8498501, Japan; [Wang, Pin-Yi] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga 8498501, Japan; [Finkelman, Fred D.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Finkelman, Fred D.] Univ Cincinnati, Coll Med, Cincinnati Vet Affairs Med Ctr, Dept Med, Cincinnati, OH 45267 USA; [Finkelman, Fred D.] Univ Cincinnati, Coll Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Saga University; Cincinnati Children's Hospital Medical Center; Saga University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati	Wang, YH (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA.	yui_hsi.wang@cchmc.org		Kartashov, Andrey/0000-0001-9102-5681; Barski, Artem/0000-0002-1861-5316; Mugge, Luke/0000-0001-7238-5665	NIH [AI090129-1, A1073553]; Digestive Health Center [P30 DK078392]; Campaign Urging Research For Eosinophilic Diseases (CURED) Foundation; Buckeye Foundation; Food Allergy Research Education Fund; VA Merit Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL098691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090129, R01AI073553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Health Center; Campaign Urging Research For Eosinophilic Diseases (CURED) Foundation; Buckeye Foundation; Food Allergy Research Education Fund; VA Merit Award(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D.A. Hidleman, C. Karp, and A. Munitz for critical reading of the manuscript and S. Hottinger for editorial assistance. This work is supported by the NIH (AI090129-1 to Y.-H.W., A1073553 to S.P.H.), the Digestive Health Center (P30 DK078392, Pilot and Feasibility Award to Y.-H.W.), Campaign Urging Research For Eosinophilic Diseases (CURED) Foundation, the Buckeye Foundation, the Food Allergy Research Education Fund to M.E.R., and VA Merit Award to F.D.F.	Ahrens R, 2012, AM J PATHOL, V180, P1535, DOI 10.1016/j.ajpath.2011.12.036; Angkasekwinai P, 2013, INFECT IMMUN, V81, P3731, DOI 10.1128/IAI.00646-13; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Arumugam M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-14; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Beaven MA, 2009, EUR J IMMUNOL, V39, P11, DOI 10.1002/eji.200838899; BENGTSSON U, 1991, INT ARCH ALLER A IMM, V95, P86, DOI 10.1159/000235459; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Caffarelli C, 1998, PEDIATR RES, V44, P485, DOI 10.1203/00006450-199810000-00004; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; DILLON SB, 1986, PARASITE IMMUNOL, V8, P503, DOI 10.1111/j.1365-3024.1986.tb00865.x; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Franco CB, 2010, CELL STEM CELL, V6, P361, DOI 10.1016/j.stem.2010.02.013; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Helm RM, 2002, CURR OPIN ALLERGY CL, V2, P541, DOI 10.1097/00130832-200212000-00011; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Li XM, 1999, J ALLERGY CLIN IMMUN, V103, P206, DOI 10.1016/S0091-6749(99)70492-6; Liu AY, 2013, J IMMUNOL, V190, P1758, DOI 10.4049/jimmunol.1202567; Mathias CB, 2011, J ALLERGY CLIN IMMUN, V127, P795, DOI 10.1016/j.jaci.2010.11.009; Miller HRP, 2002, IMMUNOLOGY, V105, P375, DOI 10.1046/j.1365-2567.2002.01375.x; Morafo V, 2003, J ALLERGY CLIN IMMUN, V111, P1122, DOI 10.1067/mai.2003.1463; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Osterfeld H, 2010, J ALLERGY CLIN IMMUN, V125, P469, DOI 10.1016/j.jaci.2009.09.054; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; RUITENBER EJ, 1976, NATURE, V264, P258, DOI 10.1038/264258a0; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Smit JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028917; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; Strait RT, 2011, J ALLERGY CLIN IMMUN, V127, P982, DOI 10.1016/j.jaci.2011.01.034; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Urban JF, 2000, J IMMUNOL, V164, P2046, DOI 10.4049/jimmunol.164.4.2046; Vickery BP, 2011, PEDIATR CLIN N AM, V58, P363, DOI 10.1016/j.pcl.2011.02.012; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133	46	132	139	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					788	802		10.1016/j.immuni.2015.08.020	http://dx.doi.org/10.1016/j.immuni.2015.08.020			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26410628	Green Accepted, Bronze			2022-12-18	WOS:000363478700020
J	Molofsky, AB; Savage, AK; Locksley, RM				Molofsky, Ari B.; Savage, Adam K.; Locksley, Richard M.			Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation	IMMUNITY			English	Review							INNATE LYMPHOID-CELLS; REGULATORY T-CELLS; THYMIC STROMAL LYMPHOPOIETIN; VISCERAL ADIPOSE-TISSUE; RECEPTOR FAMILY-MEMBER; TYPE-2 IMMUNITY; CYTOKINE IL-33; ALARMIN IL-33; ST2 PROTEIN; CD8(+) T	Interleukin-33 (IL-33) is a nuclear-associated cytokine of the IL-1 family originally described as a potent inducer of allergic type 2 immunity. IL-33 signals via the receptor ST2, which is highly expressed on group 2 innate lymphoid cells (ILC2s) and T helper 2 (Th2) cells, thus underpinning its association with helminth infection and allergic pathology. Recent studies have revealed ST2 expression on subsets of regulatory T cells, and for a role for IL-33 in tissue homeostasis and repair that suggests previously unrecognized interactions within these cellular networks. IL-33 can participate in pathologic fibrotic reactions, or, in the setting of microbial invasion, can cooperate with inflammatory cytokines to promote responses by cytotoxic NK cells, Th1 cells, and CD8(+) T cells. Here, we highlight the regulation and function of IL-33 and ST2 and review their roles in homeostasis, damage, and inflammation, suggesting a conceptual framework for future studies.	[Savage, Adam K.; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Molofsky, Ari B.; Savage, Adam K.; Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu		Molofsky, Ari/0000-0003-0764-3175; Savage, Adam/0000-0003-1913-5485	NIH [AI026918, AI030663, HL107202, K08DK101604]; UCSF Diabetes Family Fund; Sandler Asthma Basic Research Center at UCSF; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128903, P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663, R01AI026918, R37AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK101604] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Diabetes Family Fund; Sandler Asthma Basic Research Center at UCSF; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank laboratory members for critical review of the manuscript. This work was supported by AI026918, AI030663, HL107202, and K08DK101604 (A.B.M.) from the NIH, the UCSF Diabetes Family Fund (A.B.M.), the Sandler Asthma Basic Research Center at UCSF, and the Howard Hughes Medical Institute.	Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Andrade MV, 2011, EUR J IMMUNOL, V41, P760, DOI 10.1002/eji.201040718; Aupperlee MD, 2014, ENDOCRINOLOGY, V155, P2301, DOI 10.1210/en.2013-1933; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Baumann C, 2015, P NATL ACAD SCI USA, V112, P4056, DOI 10.1073/pnas.1418549112; Beamer CA, 2013, NANOTOXICOLOGY, V7, P1070, DOI 10.3109/17435390.2012.702230; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Besnard AG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004607; Bessa J, 2014, J AUTOIMMUN, V55, P33, DOI 10.1016/j.jaut.2014.02.012; Bie QL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/923135; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2014, NATURE; Brunner SM, 2011, TRANSPL INT, V24, P1027, DOI 10.1111/j.1432-2277.2011.01306.x; Bulek K, 2010, IMMUNOL CELL BIOL, V88, P257, DOI 10.1038/icb.2009.113; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Carlock CI, 2014, J IMMUNOL, V193, P161, DOI 10.4049/jimmunol.1400381; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Cheng LE, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016352; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Colbert DC, 2005, CONTEMP TOP LAB ANIM, V44, P53; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Doherty TA, 2012, AM J PHYSIOL-LUNG C, V303, pL577, DOI 10.1152/ajplung.00174.2012; Duan LH, 2012, MOL MED, V18, P753, DOI 10.2119/molmed.2011.00428; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Fabbi M, 2015, J LEUKOCYTE BIOL, V97, P665, DOI 10.1189/jlb.5RU0714-360RR; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Finlay CM, 2014, IMMUNOL REV, V259, P206, DOI 10.1111/imr.12164; Fock V, 2013, J IMMUNOL, V191, P3734, DOI 10.4049/jimmunol.1300490; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Funakoshi-Tago M, 2011, CELL SIGNAL, V23, P363, DOI 10.1016/j.cellsig.2010.10.006; Gao X, 2015, J IMMUNOL, V194, P438, DOI 10.4049/jimmunol.1401344; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Garlanda C, 2013, SEMIN IMMUNOL, V25, P408, DOI 10.1016/j.smim.2013.10.019; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-12; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Ho JE, 2013, J CLIN INVEST, V123, P4208, DOI 10.1172/JCI67119; Hong J, 2011, J BIOL CHEM, V286, P20078, DOI 10.1074/jbc.M111.219089; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Hu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096338; Hudson CA, 2008, J LEUKOCYTE BIOL, V84, P631, DOI 10.1189/jlb.1207830; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Iijima K, 2014, J IMMUNOL, V193, P1549, DOI 10.4049/jimmunol.1302984; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Jin Y, 2015, MOL CELL BIOCHEM, V402, P111, DOI 10.1007/s11010-014-2319-5; Jovanovic IP, 2014, INT J CANCER, V134, P1669, DOI 10.1002/ijc.28481; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kato A, 2015, ALLERGOL INT, V64, P121, DOI 10.1016/j.alit.2014.12.006; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Khaled WT, 2007, DEVELOPMENT, V134, P2739, DOI 10.1242/dev.003194; Kim BS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016337; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim J. Y., 2014, ONCOGENE; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P474, DOI 10.1006/bbrc.1997.6810; Kuroiwa K, 2000, HYBRIDOMA, V19, P151, DOI 10.1089/02724570050031194; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Layland LE, 2010, J IMMUNOL, V184, P713, DOI 10.4049/jimmunol.0901435; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Lefrancais E, 2012, EUR CYTOKINE NETW, V23, P120, DOI 10.1684/ecn.2012.0320; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Levescot A, 2014, CANCER RES, V74, P2669, DOI 10.1158/0008-5472.CAN-13-2797; Liang YJ, 2013, J IMMUNOL, V190, P5666, DOI 10.4049/jimmunol.1300117; Lingel A, 2009, STRUCTURE, V17, P1398, DOI 10.1016/j.str.2009.08.009; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Lunderius-Andersson C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00082; Luo Y, 2015, BRAIN RES, V1597, P86, DOI 10.1016/j.brainres.2014.12.005; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; Martinez-Gonzalez I, 2015, TRENDS IMMUNOL, V36, P189, DOI 10.1016/j.it.2015.01.005; Marvie P, 2010, J CELL MOL MED, V14, P1726, DOI 10.1111/j.1582-4934.2009.00801.x; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Matta BM, 2014, J IMMUNOL, V193, P4010, DOI 10.4049/jimmunol.1400481; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Molofsky AV, 2013, GLIA, V61, P1518, DOI 10.1002/glia.22538; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Muto T, 2014, INT IMMUNOL, V26, P539, DOI 10.1093/intimm/dxu058; Nabekura T, 2015, J IMMUNOL, V194, P5948, DOI 10.4049/jimmunol.1500424; Nakanishi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078099; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Onda H, 1999, J CEREBR BLOOD F MET, V19, P1279, DOI 10.1097/00004647-199911000-00013; Oshikawa K, 2002, CLIN EXP ALLERGY, V32, P1520, DOI 10.1046/j.1365-2745.2002.01494.x; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rankin AL, 2010, J IMMUNOL, V184, P1526, DOI 10.4049/jimmunol.0903306; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Reynolds LA, 2014, J IMMUNOL, V193, P2984, DOI 10.4049/jimmunol.1401056; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Rostan O, 2015, INFECT IMMUN, V83, P1738, DOI 10.1128/IAI.02908-14; Roussel L, 2008, EMBO REP, V9, P1006, DOI 10.1038/embor.2008.145; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Sanchez-Mas J, 2014, EUR J CLIN INVEST, V44, P643, DOI 10.1111/eci.12282; Sattler S, 2013, ARCH IMMUNOL THER EX, V61, P107, DOI 10.1007/s00005-012-0208-8; Scalfone LK, 2013, INFECT IMMUN, V81, P1354, DOI 10.1128/IAI.01307-12; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seki K, 2009, CIRC-HEART FAIL, V2, P684, DOI 10.1161/CIRCHEARTFAILURE.109.873240; Senn KA, 2000, EUR J IMMUNOL, V30, P1929, DOI 10.1002/1521-4141(200007)30:7&lt;1929::AID-IMMU1929&gt;3.0.CO;2-1; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Shimizu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058159; Smith DE, 2011, J LEUKOCYTE BIOL, V89, P383, DOI 10.1189/jlb.0810470; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Snelgrove RJ, 2014, J ALLERGY CLIN IMMUN, V134, P583, DOI 10.1016/j.jaci.2014.02.002; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sun JC, 2009, J IMMUNOL, V183, P2911, DOI 10.4049/jimmunol.0901872; Sun L, 2014, EUR J IMMUNOL, V44, P2153, DOI 10.1002/eji.201344310; Sundlisaeter E, 2012, AM J PATHOL, V181, P1099, DOI 10.1016/j.ajpath.2012.06.003; Sundnes O., 2015, J INVEST DERMATOL; Talabot-Ayer D, 2015, J IMMUNOL, V194, P750, DOI 10.4049/jimmunol.1402057; Talabot-Ayer D, 2012, J LEUKOCYTE BIOL, V91, P119, DOI 10.1189/jlb.0811425; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Villarreal DO, 2015, EXPERT REV VACCINES, V14, P489, DOI 10.1586/14760584.2015.1011135; Villarreal DO, 2014, CURR OPIN IMMUNOL, V28, P102, DOI 10.1016/j.coi.2014.03.004; Villarreal DO, 2014, CANCER RES, V74, P1789, DOI 10.1158/0008-5472.CAN-13-2729; Voehringer D, 2012, EUR J IMMUNOL, V42, P2544, DOI 10.1002/eji.201142318; von Moltke J, 2014, CURR OPIN IMMUNOL, V31, P58, DOI 10.1016/j.coi.2014.09.009; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; WERENSKIOLD AK, 1989, MOL CELL BIOL, V9, P5207, DOI 10.1128/MCB.9.11.5207; Wicher G, 2013, NEUROSCI LETT, V555, P171, DOI 10.1016/j.neulet.2013.09.046; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2015, J IMMUNOL, V194, P2140, DOI 10.4049/jimmunol.1402503; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; YANAGISAWA K, 1993, FEBS LETT, V318, P83, DOI 10.1016/0014-5793(93)81333-U; Yanagisawa K, 1997, J BIOCHEM-TOKYO, V121, P95; Yang QT, 2011, EUR J IMMUNOL, V41, P3351, DOI 10.1002/eji.201141629; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; Yin H, 2013, MOL IMMUNOL, V56, P347, DOI 10.1016/j.molimm.2013.05.225; Yu XX, 2015, DIGEST DIS SCI, V60, P1265, DOI 10.1007/s10620-014-3463-1; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zeyda M, 2013, INT J OBESITY, V37, P658, DOI 10.1038/ijo.2012.118	199	132	137	4	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1005	1019		10.1016/j.immuni.2015.06.006	http://dx.doi.org/10.1016/j.immuni.2015.06.006			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084021	Bronze, Green Accepted			2022-12-18	WOS:000356362800008
J	Coulombe, F; Jaworska, J; Verway, M; Tzelepis, F; Massoud, A; Gillard, J; Wong, G; Kobinger, G; Xing, Z; Couture, C; Joubert, P; Fritz, JH; Powell, WS; Divangahi, M				Coulombe, Francois; Jaworska, Joanna; Verway, Mark; Tzelepis, Fanny; Massoud, Amir; Gillard, Joshua; Wong, Gary; Kobinger, Gary; Xing, Zhou; Couture, Christian; Joubert, Philippe; Fritz, Joerg H.; Powell, William S.; Divangahi, Maziar			Targeted Prostaglandin E-2 Inhibition Enhances Antiviral Immunity through Induction of Type I Interferon and Apoptosis in Macrophages	IMMUNITY			English	Article							INFLUENZA-VIRUS; ALVEOLAR MACROPHAGES; BLOOD MONOCYTES; INFECTION; CELLS; NS1; CONTRIBUTES; CHEMOKINE; RESPONSES; PROTECTS	Aspirin gained tremendous popularity during the 1918 Spanish Influenza virus pandemic, 50 years prior to the demonstration of their inhibitory action on prostaglandins. Here, we show that during influenza A virus (IAV) infection, prostaglandin E-2 (PGE(2)) was upregulated, which led to the inhibition of type I interferon (IFN) production and apoptosis in macrophages, thereby causing an increase in virus replication. This inhibitory role of PGE(2) was not limited to innate immunity, because both antigen presentation and T cell mediated immunity were also suppressed. Targeted PGE(2) suppression via genetic ablation of microsomal prostaglandin E-synthase 1 (mPGES-1) or by the pharmacological inhibition of PGE(2) receptors EP2 and EP4 substantially improved survival against lethal IAV infection whereas PGE(2) administration reversed this phenotype. These data demonstrate that the mPGES-1-PGE(2) pathway is targeted by IAV to evade host type I IFN-dependent antiviral immunity. We propose that specific inhibition of PGE(2) signaling might serve as a treatment for IAV.	[Coulombe, Francois; Jaworska, Joanna; Verway, Mark; Tzelepis, Fanny; Massoud, Amir; Gillard, Joshua; Powell, William S.; Divangahi, Maziar] McGill Univ, Ctr Hlth, McGill Int TB Ctr, Dept Med,Dept Microbiol & Immunol,Dept Pathol, Montreal, PQ H2X 2P2, Canada; [Coulombe, Francois; Jaworska, Joanna; Verway, Mark; Tzelepis, Fanny; Massoud, Amir; Gillard, Joshua; Powell, William S.; Divangahi, Maziar] McGill Univ, Meakins Christie Labs, Res Inst, Montreal, PQ H2X 2P2, Canada; [Wong, Gary; Kobinger, Gary] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada; [Xing, Zhou] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON L8N 3Z5, Canada; [Xing, Zhou] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Couture, Christian; Joubert, Philippe] Univ Quebec, Ctr Hosp, Dept Pathol, Quebec City, PQ G1R 2J6, Canada; [Fritz, Joerg H.] McGill Life Sci Complex, Dept Microbiol & Immunol, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University; Public Health Agency of Canada; McMaster University; McMaster University; Laval University; University of Quebec	Divangahi, M (corresponding author), McGill Univ, Ctr Hlth, McGill Int TB Ctr, Dept Med,Dept Microbiol & Immunol,Dept Pathol, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	maziar.divangahi@mcgill.ca	Powell, William/AAE-9000-2020; Massoud, Amir Hossein/AAO-2940-2021	Joubert, Philippe/0000-0001-7784-6387; Powell, William/0000-0002-8507-4038	CIHR [MOP-106488]; CIHR New Investigator Award	CIHR(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported by the CIHR operating grant (MOP-106488) to M. D., and M. D. holds CIHR New Investigator Award. F. C. is supported by a F. Banting and C. Best CGS from CIHR. The authors would like to thank E. Fixman for helpful comments and valuable discussions.	Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; BETZ M, 1991, J IMMUNOL, V146, P108; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Carey MA, 2005, J IMMUNOL, V175, P6878, DOI 10.4049/jimmunol.175.10.6878; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Cloutier A, 2012, J INFECT DIS, V205, P621, DOI 10.1093/infdis/jir804; Dessing MC, 2007, CLIN IMMUNOL, V125, P328, DOI 10.1016/j.clim.2007.08.001; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Friesenhagen J, 2012, J LEUKOCYTE BIOL, V92, P11, DOI 10.1189/jlb.0911479; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Hou WQ, 2012, BLOOD, V119, P3128, DOI 10.1182/blood-2011-09-379479; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Joung SM, 2011, J IMMUNOL, V186, P499, DOI 10.4049/jimmunol.0903534; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Kirby AC, 2009, J IMMUNOL, V183, P1983, DOI 10.4049/jimmunol.0901089; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Lauder SN, 2011, THORAX, V66, P368, DOI 10.1136/thx.2010.150318; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Lee SMY, 2012, J LEUKOCYTE BIOL, V92, P1, DOI 10.1189/jlb.0312130; McCarthy MK, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/236345; Mok CKP, 2007, J GEN VIROL, V88, P1275, DOI 10.1099/vir.0.82423-0; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Piqueras B, 2006, BLOOD, V107, P2613, DOI 10.1182/blood-2005-07-2965; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; Schmidt LM, 2011, J IMMUNOL, V186, P2095, DOI 10.4049/jimmunol.1002414; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Trebino CE, 2005, J BIOL CHEM, V280, P16579, DOI 10.1074/jbc.M412075200; Wareing MD, 2007, J LEUKOCYTE BIOL, V81, P793, DOI 10.1189/jlb.0506299; Xing Z, 2009, J GEN VIROL, V90, P1109, DOI 10.1099/vir.0.007518-0; Xu DG, 2008, J PHARMACOL EXP THER, V326, P754, DOI 10.1124/jpet.108.138776; Zaslona Z, 2012, BLOOD, V119, P2358, DOI 10.1182/blood-2011-08-374207	45	132	133	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					554	568		10.1016/j.immuni.2014.02.013	http://dx.doi.org/10.1016/j.immuni.2014.02.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24726877	Bronze			2022-12-18	WOS:000334849400013
J	Sorbara, MT; Ellison, LK; Ramjeet, M; Travassos, LH; Jones, NL; Girardin, SE; Philpott, DJ				Sorbara, Matthew T.; Ellison, Lisa K.; Ramjeet, Mahendrasingh; Travassos, Leonardo H.; Jones, Nicola L.; Girardin, Stephen E.; Philpott, Dana J.			The Protein ATG16L1 Suppresses Inflammatory Cytokines Induced by the Intracellular Sensors Nod1 and Nod2 in an Autophagy-Independent Manner	IMMUNITY			English	Article							NF-KAPPA-B; BACTERIAL; MEMBRANE; SUSCEPTIBILITY; PEPTIDOGLYCAN; ACTIVATION; SHIGELLA; ASSOCIATION; INFECTION; DEFENSE	The peptidoglycan sensor Nod2 and the autophagy protein ATG16L1 have been linked to Crohn's disease (CD). Although Nod2 and the related sensor, Nod1, direct ATG16L1 to initiate anti-bacterial autophagy, whether ATG16L1 affects Nod-driven inflammation has not been examined. Here, we uncover an unanticipated autophagy-independent role for ATG16L1 in negatively regulating Nod-driven inflammatory responses. Knockdown of ATG16L1 expression, but not that of ATG5 or ATG9a, specifically enhanced Nod-driven cytokine production. In addition, autophagy-incompetent truncated forms of ATG16L1 regulated Nod-driven cytokine responses. Mechanistically, we demonstrated that ATG16L1 interfered with poly-ubiquitination of the Rip2 adaptor and recruitment of Rip2 into large signaling complexes. The CD-associated allele of ATG16L1 was impaired in its ability to regulate Nod-driven inflammatory responses. Overall, these results suggest that ATG16L1 is critical for Nod-dependent regulation of cytokine responses and that disruption of this Nod1- or Nod2-ATG16L1 signaling axis could contribute to the chronic inflammation associated with CD.	[Sorbara, Matthew T.; Ellison, Lisa K.; Travassos, Leonardo H.; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Ramjeet, Mahendrasingh; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Jones, Nicola L.] Univ Toronto, Cell Biol Program, Hosp Sick Children, Res Inst, Toronto, ON M5S 1A8, Canada; [Jones, Nicola L.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Philpott, DJ (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	dana.philpott@utoronto.ca	Travassos, Leonardo/G-1925-2012	Travassos, Leonardo/0000-0003-1323-3797	Canadian Institutes of Health Research (CIHR); Crohn's and Colitis Foundation of Canada; Natural Sciences and Engineering Research Council (CGS-M); Ontario Genealogical Society; CIHR (CGS-D); CIHR Strategic Training Fellowship [STP-53877]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada; Natural Sciences and Engineering Research Council (CGS-M)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Genealogical Society; CIHR (CGS-D); CIHR Strategic Training Fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (to D.J.P and S. E. G.) and the Crohn's and Colitis Foundation of Canada (to N.L.J., S. E. G., and D.J.P.). M. T. S. was supported by fellowships from the Natural Sciences and Engineering Research Council (CGS-M), the Ontario Genealogical Society, and CIHR (CGS-D) and by CIHR Strategic Training Fellowship STP-53877. We would like to thank Glaxo-Smith Kline for generously providing the Rip2 inhibitors.	Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fujita N, 2009, J BIOL CHEM, V284, P32602, DOI 10.1074/jbc.M109.037671; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Inohara N, 2000, J BIOL CHEM, V275, P27823; Ishibashi K, 2012, MOL BIOL CELL, V23, P3193, DOI 10.1091/mbc.E12-01-0010; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lee J, 2012, J BIOL CHEM, V287, P4033, DOI 10.1074/jbc.M111.280065; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Tattoli I, 2013, EMBO J, V32, P3066, DOI 10.1038/emboj.2013.234; Tattoli I, 2012, BIOL OPEN, V1, P1215, DOI 10.1242/bio.20122840; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wittkopf N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/278059; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	41	132	141	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					858	873		10.1016/j.immuni.2013.10.013	http://dx.doi.org/10.1016/j.immuni.2013.10.013			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24238340	Bronze			2022-12-18	WOS:000330950600009
J	Chen, K; McAleer, JP; Lin, Y; Paterson, DL; Zheng, MQ; Alcorn, JF; Weaver, CT; Kolls, JK				Chen, Kong; McAleer, Jeremy P.; Lin, Yuan; Paterson, David L.; Zheng, Mingquan; Alcorn, John F.; Weaver, Casey T.; Kolls, Jay K.			Th17 Cells Mediate Clade-Specific, Serotype-Independent Mucosal Immunity	IMMUNITY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HOST-DEFENSE; IL-17	The interleukin-17 (IL-17) family of cytokines phylogenetically predates the evolution of T cells in jawed vertebrates, suggesting that the ontogeny of the Th17 cell lineage must have arisen to confer an evolutionary advantage to the host over innate sources of IL-17. Utilizing a model of nnucosal immunization with the encapsulated bacteria Klebsiella pneumoniae, we found that B cells, which largely recognized polysaccharide capsular antigens, afforded protection to only the vaccine strain. In contrast, memory Th17 cells proliferated in response to conserved outer membrane proteins and conferred protection against several serotypes of K. pneumoniae, including the recently described multidrug resistant New Dehli metallolactamase strain. Notably, this heterologous, clade-specific protection was antibody independent, demonstrating the Th17 cell lineage confers a host advantage by providing heterologous mucosal immunity independent of serotype-specific antibody.	[Chen, Kong; McAleer, Jeremy P.; Lin, Yuan; Zheng, Mingquan; Kolls, Jay K.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA; [Chen, Kong; McAleer, Jeremy P.; Zheng, Mingquan; Alcorn, John F.; Kolls, Jay K.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Paterson, David L.] Univ Queensland, Mater Adults Hosp, Brisbane, Qld 4101, Australia; [Weaver, Casey T.] Univ Alabama Birmingham, Birmingham, AL 35294 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Queensland; University of Alabama System; University of Alabama Birmingham	Kolls, JK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA.	jay.kolls@chp.edu	Rivet, Catherine A/M-7978-2014; Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304; Weaver, Casey/0000-0002-2180-1793; Paterson, David/0000-0003-2079-4437	National institutes of Health [R37 HL079142]; PHS [R37 HL079142, P50HL084932, 5R01HL061271, P01 DK71176, DK6440]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL079142, R01HL061271, R21HL104601, P50HL084932, R01HL062052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176] Funding Source: NIH RePORTER	National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank C. Fisher for technical assistance with Luminex analyses and C. Porretta for assistance with flow cytometry. The authors would also like to thank A. Chan at Genentech for kindly providing the B-cell depletion antibodies. This work was supported by grant R37 HL079142 from the National institutes of Health. The authors would like to acknowledge support from the PHS grants P50HL084932, 5R01HL061271, and R37 HL079142 to J.K.K. and and P01 DK71176 and DK6440 to C.T.W. The authors would like to thank N. Ghilardi at Genentech for providing the IL-23p19<SUP>-/-</SUP> mice. K.C. and J.K.K. designed the experiments. K.C., J.P.M., and J.K.K. wrote the manuscript with input from the coauthors. Y.L. generated the IL-17 cladogram. M.Z. and J.F.A. provided reagents and read the paper. D.L.P. provided the clinical isolates of K. pneumoniae. C.T.W. provided the IL-17F-Thy1.1 reporter mice.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Fei MJ, 2011, P NATL ACAD SCI USA, V108, P5360, DOI 10.1073/pnas.1015476108; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Ho J, 2010, CURR OPIN INFECT DIS, V23, P546, DOI 10.1097/QCO.0b013e32833f0d3e; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kohler Jonathan E, 2007, Surg Infect (Larchmt), V8, P227, DOI 10.1089/sur.2006.007; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Malley R, 2010, J MOL MED, V88, P135, DOI 10.1007/s00109-009-0579-4; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Ovodov YS, 2006, BIOCHEMISTRY-MOSCOW+, V71, P937, DOI 10.1134/S000629790609001X; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Roberts S, 2008, DEV COMP IMMUNOL, V32, P1099, DOI 10.1016/j.dci.2008.02.006; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Wuthrich M, 2011, J IMMUNOL, V187, P1421, DOI 10.4049/jimmunol.1100921; Wuthrich M, 2011, J CLIN INVEST, V121, P554, DOI 10.1172/JCI43984; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	27	132	135	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 23	2011	35	6					997	1009		10.1016/j.immuni.2011.10.018	http://dx.doi.org/10.1016/j.immuni.2011.10.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195749	Bronze, Green Accepted			2022-12-18	WOS:000298777300017
J	Hatton, RD; Harrington, LE; Luther, RJ; Wakefield, T; Janowski, KM; Oliver, JR; Lallone, RL; Murphy, KM; Weaver, CT				Hatton, Robin D.; Harrington, Laurie E.; Luther, Rita J.; Wakefield, Therese; Janowski, Karen M.; Oliver, James R.; Lallone, Roger L.; Murphy, Kenneth M.; Weaver, Casey T.			A distal conserved sequence element controls Ifng gene expression by T cells and NK cells	IMMUNITY			English	Article							INTERFERON-GAMMA PRODUCTION; I-HYPERSENSITIVE SITE; TRANSCRIPTION FACTOR; CYTOKINE GENES; COORDINATE REGULATOR; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; NATURAL-KILLER; CUTTING EDGE; TH2 CELLS	Chromatin dynamics that regulate Ifng gene expression are incompletely understood. By using cross-species comparative sequence analyses, we have identified conserved noncoding sequences (CNSs) upstream of the Ifng gene, one of which, located -22 kb from the transcriptional start site, contains clustered consensus binding sequences of transcription factors that function in T cell differentiation. CNS-22 was uniquely associated with histone modifications typical of accessible chromatin in both T helper 1 (Th1) and Th2 cells and demonstrated significant and selective T-bet (T-box transcription factor expressed in T cells, Tbx21)-dependent binding and enhancer activity in Th1 cells. Deletion of CNS-22 in the context of an Ifng reporter transgene ablated T cell receptor-dependent and -independent Ifng expression in Th1 effectors and similarly blocked expression by cytotoxic T lymphocytes and natural killer cells. Thus, a single distal element may be essential for Ifng gene expression by both innate and adaptive immune effector cell lineages.	Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Brookwood Biomed, Birmingham, AL 35209 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; Washington University (WUSTL)	Hatton, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, 845 19th St S, Birmingham, AL 35294 USA.	rdzialo@path.uab.edu		Hatton, Robin/0000-0002-4797-9899; Weaver, Casey/0000-0002-2180-1793	NHLBI NIH HHS [HL07553] Funding Source: Medline; NIAID NIH HHS [AI035783] Funding Source: Medline; NIAMS NIH HHS [AR049293] Funding Source: Medline; NIDDK NIH HHS [DK64400] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI035783, R01AI035783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR049293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Gu Xun, 2005, Human Genomics, V2, P187; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; HENKEL G, 1992, J IMMUNOL, V149, P3239; Hsieh SL, 2000, MOL IMMUNOL, V37, P281, DOI 10.1016/S0161-5890(00)00052-3; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mostoslavsky R, 2003, NAT IMMUNOL, V4, P603, DOI 10.1038/ni0703-603; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Ptacek Travis, 2005, Briefings in Functional Genomics & Proteomics, V4, P178, DOI 10.1093/bfgp/4.2.178; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Santangelo S, 2002, J IMMUNOL, V169, P1893, DOI 10.4049/jimmunol.169.4.1893; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Soutto M, 2002, J IMMUNOL, V169, P6664, DOI 10.4049/jimmunol.169.12.6664; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; YOUNG HA, 1994, J IMMUNOL, V153, P3603; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855	61	132	135	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2006	25	5					717	729		10.1016/j.immuni.2006.09.007	http://dx.doi.org/10.1016/j.immuni.2006.09.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17070076	Bronze			2022-12-18	WOS:000242063100006
J	Eagar, TN; Tang, QZ; Wolfe, M; He, YP; Pear, WS; Bluestone, JA				Eagar, TN; Tang, QZ; Wolfe, M; He, YP; Pear, WS; Bluestone, JA			Notch 1 signaling regulates peripheral T cell activation	IMMUNITY			English	Article							GAMMA-SECRETASE INHIBITORS; GLYCOGEN-SYNTHASE KINASE-3; INDUCTION; ANTIGEN; DIFFERENTIATION; PROLIFERATION; LYMPHOPOIESIS; DOWNSTREAM; EXPRESSION; DROSOPHILA	Notch signaling has been identified as an important regulator of leukocyte differentiation and thymic maturation. Less is known about the role of Notch signaling in regulating mature T cells. We examined the role of Notch I in regulating peripheral T cell activity in vitro and in vivo. Coligation of Notch 1 together with TCR and CD28 resulted in a dramatic inhibition of T cell activation, proliferation, and cytokine production. This effect was dependent on presenilin activity and induced the expression of HES-1, suggestive of Notch 1 signaling. Biochemical analysis demonstrated an inhibition of AKT and GSK3beta phosphorylation following Notch I engagement while other biochemical signals such as TCR and ERK phosphorylation remained intact. Similar effects were observed in vivo in an adoptive transfer model. Therefore, Notch 1 signaling may play an important role in regulating naive T cell activation and homeostasis.	Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu		Tang, Qizhi/0000-0001-7313-3574	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK061934] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 47833] Funding Source: Medline; NIDDK NIH HHS [U19 DK61934] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; COLIGAN J, 2001, CURRENT PROTOCOLS IM; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Griffin MD, 2001, J IMMUNOL METHODS, V248, P77, DOI 10.1016/S0022-1759(00)00344-6; Hoyne GF, 1999, INT ARCH ALLERGY IMM, V118, P122, DOI 10.1159/000024046; Hoyne GF, 2000, INT IMMUNOL, V12, P177, DOI 10.1093/intimm/12.2.177; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; JENKINS MK, 1990, J IMMUNOL, V144, P16; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Robey E, 1997, CURR OPIN GENET DEV, V7, P551, DOI 10.1016/S0959-437X(97)80085-8; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; RUEL L, 1993, NATURE, V362, P557, DOI 10.1038/362557a0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Vigouroux S, 2003, J VIROL, V77, P10872, DOI 10.1128/JVI.77.20.10872-10880.2003; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wong KK, 2003, J CLIN INVEST, V112, P1741, DOI 10.1172/JCI18020	30	132	147	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					407	415		10.1016/S1074-7613(04)00081-0	http://dx.doi.org/10.1016/S1074-7613(04)00081-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084270	Bronze			2022-12-18	WOS:000221442800007
J	Salvador, JM; Hollander, MC; Nguyen, AT; Kopp, JB; Barisoni, L; Moore, JK; Ashwell, JD; Fornace, AJ				Salvador, JM; Hollander, MC; Nguyen, AT; Kopp, JB; Barisoni, L; Moore, JK; Ashwell, JD; Fornace, AJ			Mice lacking the p53-effector gene Gadd45a develop a Lupus-like syndrome	IMMUNITY			English	Article							P53-REGULATED PROTEIN GADD45; MURINE MODELS; P21; P53; EXPRESSION; ACTIVATION; INDUCTION; PATHWAY; MYD118; GROWTH	This study addresses the biological function of the p53-effector genes Gadd45a and p21 in the immune system. We find that Gadd45a is a negative regulator of T cell proliferation because, compared to wild-type cells, Gadd45a(-/-) T cells have a lower threshold of activation and proliferate to a greater extent following primary T cell receptor stimulation. Gadd45a(-/-) mice develop an autoimmune disease, similar to human systemic lupus erythematosus (SLE), characterized by high titers of anti-dsDNA, anti-ssDNA, and anti-histone autoantibodies, severe hematological disorders, autoimmune glomerulonephritis, and premature death. Here we show that the lack of both Gadd45a and p21 dramatically accelerates the development of autoimmunity observed in each individual single-gene disruption mutant, demonstrating that these genes play nonredundant roles in the immune response.	Natl Canc Inst, Ctr Canc Res, Gene Response Sect, Bethesda, MD 20892 USA; Natl Inst Diabetes & Digest & Kidney Dis, Metab Dis Branch, Kidney Dis Sect, Bethesda, MD 20892 USA; Natl Canc Inst, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fornace, AJ (corresponding author), Natl Canc Inst, Ctr Canc Res, Gene Response Sect, Bethesda, MD 20892 USA.		Kopp, Jeffrey B/O-2681-2015; Fornace, Albert J/A-7407-2008	Kopp, Jeffrey B/0000-0001-9052-186X; Fornace, Albert J/0000-0001-9695-085X; Salvador, Jesus Maria/0000-0002-1087-9675	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK043308, ZIADK043308] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABDOLLAHI A, 1991, ONCOGENE, V6, P165; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; BEADLING C, 1993, P NATL ACAD SCI USA, V90, P2719, DOI 10.1073/pnas.90.7.2719; Carrier F, 1999, MOL CELL BIOL, V19, P1673; DATTA SK, 1987, J EXP MED, V165, P1252, DOI 10.1084/jem.165.5.1252; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Fan W, 1999, ONCOGENE, V18, P6573, DOI 10.1038/sj.onc.1203054; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; HANG LM, 1984, J IMMUNOL, V132, P1809; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hoffmeyer A, 2001, MOL CELL BIOL, V21, P3137, DOI 10.1128/MCB.21.9.3137-3143.2001; Hollander MC, 2001, CANCER RES, V61, P2487; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; ISENBERG DA, 1987, ANN RHEUM DIS, V46, P448, DOI 10.1136/ard.46.6.448; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Prives C, 1999, J PATHOL, V187, P112; ROZZO SJ, 1994, J IMMUNOL, V153, P1340; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Vairapandi M, 1996, ONCOGENE, V12, P2579; Vratsanos GS, 2001, J EXP MED, V193, P329, DOI 10.1084/jem.193.3.329; WOFSY D, 1985, J EXP MED, V161, P378, DOI 10.1084/jem.161.2.378; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhao HC, 2000, EXP CELL RES, V258, P92, DOI 10.1006/excr.2000.4906	27	132	135	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2002	16	4					499	508		10.1016/S1074-7613(02)00302-3	http://dx.doi.org/10.1016/S1074-7613(02)00302-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970874	Bronze			2022-12-18	WOS:000175109600002
J	Homann, D; Jahreis, A; Wolfe, T; Hughes, A; Coon, B; van Stipdonk, MJB; Prilliman, KR; Schoenberger, SP; von Herrath, MG				Homann, D; Jahreis, A; Wolfe, T; Hughes, A; Coon, B; van Stipdonk, MJB; Prilliman, KR; Schoenberger, SP; von Herrath, MG			CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells	IMMUNITY			English	Article							HUMAN DENDRITIC CELLS; CYTOTOXIC T-LYMPHOCYTES; NATURAL-KILLER; NK CELLS; MONOCLONAL-ANTIBODY; BETA-CELLS; ANTIVIRAL IMMUNITY; VIRUS-INFECTION; CUTTING EDGE; MURINE LUPUS	Systemic treatment with antibody to CD40 ligand (aCD40L) can prevent autoimmunity and transplant rejection in several animal models and is currently under evaluation in clinical trials. While it is known that aCD40L administration inhibits expansion and effector functions of aggressive T cells, it is still unclear whether additional regulatory mechanisms are operative. Here we demonstrate that a single episode of CD40L blockade during development of the autoaggressive immune response completely prevented autoimmune disease in the RIP-LCMV mouse model for virally induced type 1 diabetes. Interestingly, protection could be transferred by a highly potent, bitypic cell population sharing phenotypic and functional properties of both natural killer (NK) and dendritic cells (DC). Furthermore, protection of prediabetic recipients was autoantigen specific and did not result in generalized immunosuppression. The origin, function, and therapeutic potential of these bitypic NK/DC regulatory cells is discussed.	La Jolla Inst Allergy & Immunol, Div Immune Regulat, San Diego, CA 92121 USA; Scripps Res Inst, Div Virol, Dept Neuropharmacol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Scripps Research Institute	von Herrath, MG (corresponding author), Scripps Res Inst, Div Virol, Dept Neuropharmacol, La Jolla, CA 92037 USA.	matthias@liai.org		Homann, Dirk/0000-0002-7622-5754	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK051091] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 51973, R01 AI 4451] Funding Source: Medline; NIDDK NIH HHS [R29 DK 51091] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Assarsson E, 2000, J IMMUNOL, V165, P3673, DOI 10.4049/jimmunol.165.7.3673; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; AZUMA M, 1993, J EXP MED, V177, P845, DOI 10.1084/jem.177.3.845; Bachmann MF, 1998, J IMMUNOL, V161, P5791; Balasa B, 1997, J IMMUNOL, V159, P4620; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Borrow P, 1998, J VIROL, V72, P7440, DOI 10.1128/JVI.72.9.7440-7449.1998; Carayanniotis G, 1997, IMMUNOLOGY, V90, P421, DOI 10.1111/j.1365-2567.1997.00421.x; CHAMBERS BJ, 1999, DENDRITIC CELLS, P257; Christen U, 2001, J IMMUNOL, V166, P7023, DOI 10.4049/jimmunol.166.12.7023; Davis JC, 2001, J RHEUMATOL, V28, P95; DOrazio JA, 1996, CLIN EXP IMMUNOL, V104, P366, DOI 10.1046/j.1365-2249.1996.08698.x; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; Eisenbarth GS, 1998, P ASSOC AM PHYSICIAN, V110, P126; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Graca L, 2000, J IMMUNOL, V165, P4783, DOI 10.4049/jimmunol.165.9.4783; Griggs ND, 1996, J EXP MED, V183, P801, DOI 10.1084/jem.183.3.801; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Holz A, 2000, J IMMUNOL, V165, P5945, DOI 10.4049/jimmunol.165.10.5945; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Homann D, 1999, IMMUNITY, V11, P463, DOI 10.1016/S1074-7613(00)80121-1; Horwitz DA, 1997, IMMUNOL TODAY, V18, P538, DOI 10.1016/S0167-5699(97)01149-3; Howard LM, 1999, J CLIN INVEST, V103, P281, DOI 10.1172/JCI5388; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Im SH, 2001, J IMMUNOL, V166, P6893, DOI 10.4049/jimmunol.166.11.6893; Josien R, 1997, J EXP MED, V186, P467, DOI 10.1084/jem.186.3.467; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kenyon NS, 1999, P NATL ACAD SCI USA, V96, P8132, DOI 10.1073/pnas.96.14.8132; King C, 2001, NAT MED, V7, P206, DOI 10.1038/84659; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; Kos FJ, 1998, IMMUNOL RES, V17, P303, DOI 10.1007/BF02786453; Kover KL, 2000, DIABETES, V49, P1666, DOI 10.2337/diabetes.49.10.1666; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Ludewig B, 2001, J IMMUNOL, V166, P3678, DOI 10.4049/jimmunol.166.6.3678; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Marquez C, 1998, BLOOD, V91, P2760, DOI 10.1182/blood.V91.8.2760.2760_2760_2771; MCFARLAND HI, 1992, J IMMUNOL, V149, P1326; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; MOHAN C, 1995, J IMMUNOL, V154, P1470; Molano RD, 2001, DIABETES, V50, P270, DOI 10.2337/diabetes.50.2.270; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Ramiya VK, 2000, NAT MED, V6, P278; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rossini AA, 1999, PHYSIOL REV, V79, P99, DOI 10.1152/physrev.1999.79.1.99; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Seewaldt S, 2000, DIABETES, V49, P1801, DOI 10.2337/diabetes.49.11.1801; Seung E, 2000, BLOOD, V95, P2175, DOI 10.1182/blood.V95.6.2175; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shaw SG, 1998, J IMMUNOL, V161, P2817; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Trinite B, 2000, J IMMUNOL, V165, P4202, DOI 10.4049/jimmunol.165.8.4202; Vidalain PO, 2001, J IMMUNOL, V167, P3765, DOI 10.4049/jimmunol.167.7.3765; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; vonHerrath MG, 1997, J EXP MED, V185, P531, DOI 10.1084/jem.185.3.531; vonHerrath MG, 1995, IMMUNITY, V3, P727, DOI 10.1016/1074-7613(95)90062-4; WELSH RM, 1991, J EXP MED, V173, P1053, DOI 10.1084/jem.173.5.1053; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9; Whitmire JK, 1999, J IMMUNOL, V163, P3194; Wilson JL, 1999, J IMMUNOL, V163, P6365	79	132	139	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2002	16	3					403	415		10.1016/S1074-7613(02)00290-X	http://dx.doi.org/10.1016/S1074-7613(02)00290-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911825	Bronze			2022-12-18	WOS:000174572800009
J	Schrama, D; Straten, PT; Fischer, WH; McLellan, AD; Brocker, EB; Reisfeld, RA; Becker, JC				Schrama, D; Straten, PT; Fischer, WH; McLellan, AD; Brocker, EB; Reisfeld, RA; Becker, JC			Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue	IMMUNITY			English	Article							T-CELL RESPONSES; GRADIENT GEL-ELECTROPHORESIS; INTERLEUKIN-2 THERAPY; LT-ALPHA; MELANOMA; BETA; INFLAMMATION; EXPRESSION; LYMPHOCYTES; RECEPTOR	A recombinant antibody-lymphotoxin-alpha fusion protein induced an adaptive immune response protecting mice from melanoma. Importantly, this fusion protein elicited the formation of a lymphoid-like tissue in the tumor microenvironment containing L-selectin(+) T cells and MHC class II+ antigen-presenting cells, as well as B and T cell aggregates. Furthermore, PNAd(+)/TCA4(+) high endothelial venules were observed within the tumor, suggesting entry channels for naive T cell infiltrates. Over the course of therapy, a marked clonal expansion of certain TCR specificities occurred among tumor-infiltrating lymphocytes that displayed reactivity against melanoma cells and the TRP-2(180-188) peptide. Consequently, naive T cells may have been recruited to as well as primed and expanded in the lymphoid-like tissue induced by the lymphotoxin-alpha fusion protein at the tumor site.	Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany; Univ Wurzburg, Dept Immunotoxicol, D-97080 Wurzburg, Germany; Danish Canc Soc, Dept Tumor Cell Biol, Div Canc Biol, DK-2100 Copenhagen, Denmark; Scripps Res Inst, La Jolla, CA 92037 USA	University of Wurzburg; University of Wurzburg; Danish Cancer Society; Scripps Research Institute	Becker, JC (corresponding author), Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany.			McLellan, Alexander/0000-0003-0761-0947; Schrama, David/0000-0002-6931-8194				Becker JC, 1996, J EXP MED, V183, P2361, DOI 10.1084/jem.183.5.2361; Bousso P, 1999, SEMIN IMMUNOL, V11, P423, DOI 10.1006/smim.1999.0200; Brouard S, 1999, HUM IMMUNOL, V60, P455, DOI 10.1016/S0198-8859(99)00020-8; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; Cuff CA, 1998, J IMMUNOL, V161, P6853; Cuff CA, 1999, J IMMUNOL, V162, P5965; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Fields P, 1996, J MOL MED-JMM, V74, P673, DOI 10.1007/s001090050071; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; GILLIES SD, 1991, HYBRIDOMA, V10, P347, DOI 10.1089/hyb.1991.10.347; HARAGUCHI M, 1994, P NATL ACAD SCI USA, V91, P10455, DOI 10.1073/pnas.91.22.10455; Keilholz U, 2000, ONCOLOGY-BASEL, V58, P89, DOI 10.1159/000012085; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Moerch U, 2000, CANCER IMMUNOL IMMUN, V49, P426, DOI 10.1007/s002620000136; Premier RR, 1998, IMMUNOLOGY, V94, P363, DOI 10.1046/j.1365-2567.1998.00522.x; Reisfeld RA, 1996, CANCER RES, V56, P1707; Reisfeld RA, 1997, MELANOMA RES, V7, pS99; RENNERT P, 1996, J EXP MED, V184, P1; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Robson SC, 1999, ANN NY ACAD SCI, V875, P261, DOI 10.1111/j.1749-6632.1999.tb08509.x; Ruddle NH, 1999, IMMUNOL RES, V19, P119, DOI 10.1007/BF02786481; Sacca R, 1998, J IMMUNOL, V160, P485; SAIMI M, 1998, J IMMUNOL, V160, P5629; Shrikant P, 1999, J IMMUNOL, V162, P2858; STACKPOLE CW, 1981, NATURE, V289, P798, DOI 10.1038/289798a0; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Straten P, 1996, J CLIN INVEST, V98, P279, DOI 10.1172/JCI118790; Straten PT, 1999, J IMMUNOL, V163, P443; Straten PT, 1998, P NATL ACAD SCI USA, V95, P8785; Straten PT, 1998, BIOTECHNIQUES, V25, P244, DOI 10.2144/98252st05; TAGUCHI T, 1990, J IMMUNOL METHODS, V128, P65, DOI 10.1016/0022-1759(90)90464-7	39	132	137	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2001	14	2					111	121		10.1016/S1074-7613(09)00094-6	http://dx.doi.org/10.1016/S1074-7613(09)00094-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404HZ	11239444				2022-12-18	WOS:000167092500002
J	Donnadieu, E; Jouvin, MH; Kinet, JP				Donnadieu, E; Jouvin, MH; Kinet, JP			A second amplifier function for the allergy-associated Fc epsilon RI-beta subunit	IMMUNITY			English	Article							HIGH-AFFINITY RECEPTOR; IMMUNOGLOBULIN-E-RECEPTOR; EPIDERMAL LANGERHANS CELLS; IGE-BINDING-SITE; T-CELL; TRANSFECTED CELLS; ALPHA-SUBUNIT; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; EOSINOPHILS	Genetics studies have identified the gene for the high-affinity IgE receptor (Fc epsilon RI) beta subunit as a candidate gene for atopy. We have shown that beta is an intrinsic signaling amplifier leading to enhanced allergic responses in vivo. Here we report that beta has a second amplification function: the amplification of Fc epsilon RI cell surface expression. This function is due to an early association of beta with alpha, resulting in improved trafficking and maturation of alpha and receptor complexes. These data provide a possible molecular explanation for the large difference in Fc epsilon RI density between beta(-)cells such as monocytes, dendritic cells, and beta(+) effector cells (mast cells, basophils). In beta(+) cells, the combined signaling and expression amplification results in an estimated 12- to 30-fold amplification of downstream events.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kinet, JP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA.	jkinet@caregroup.harvard.edu	Donnadieu, Emmanuel/P-4566-2017					ALBER G, 1991, J BIOL CHEM, V266, P22613; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; BLANK U, 1991, J BIOL CHEM, V266, P2639; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Cook JPD, 1997, BIOCHEMISTRY-US, V36, P15579, DOI 10.1021/bi9713005; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; GALLI SJ, 1995, ALLERGY, V50, P851, DOI 10.1111/j.1398-9995.1995.tb02490.x; Garman SC, 1999, ANNU REV IMMUNOL, V17, P973, DOI 10.1146/annurev.immunol.17.1.973; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; HAGAN P, 1991, NATURE, V349, P243, DOI 10.1038/349243a0; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; Hulett MD, 1999, J BIOL CHEM, V274, P13345, DOI 10.1074/jbc.274.19.13345; Jankovic D, 1997, J IMMUNOL, V159, P1868; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; KINET JP, 1988, P NATL ACAD SCI USA, V85, P6483, DOI 10.1073/pnas.85.17.6483; Kita H, 1999, J IMMUNOL, V162, P6901; KUSTER H, 1990, J BIOL CHEM, V265, P6448; KUSTER H, 1992, J BIOL CHEM, V267, P12782; LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971; LETOURNEUR F, 1991, P NATL ACAD SCI USA, V88, P8905, DOI 10.1073/pnas.88.20.8905; LETOURNEUR O, 1991, J IMMUNOL, V147, P2652; LETOURNEUR O, 1995, J BIOL CHEM, V270, P8249, DOI 10.1074/jbc.270.14.8249; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; Lin R, 1996, J VIRAL HEPATITIS, V3, P85, DOI 10.1111/j.1365-2893.1996.tb00086.x; MALLAMACI MA, 1993, J BIOL CHEM, V268, P22076; MAURER D, 1995, J IMMUNOL, V154, P6285; Maurer D, 1996, J IMMUNOL, V157, P607; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Maurer D, 1998, J IMMUNOL, V161, P2731; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; NISSIM A, 1993, J IMMUNOL, V150, P1365; OSTERHOFF B, 1994, J INVEST DERMATOL, V102, P315, DOI 10.1111/1523-1747.ep12371789; PRESTA L, 1994, J BIOL CHEM, V269, P26368; RA C, 1989, J BIOL CHEM, V264, P15323; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROBERTSON MW, 1993, J BIOL CHEM, V268, P12736; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; SCHWARZBAUM S, 1989, EUR J IMMUNOL, V19, P1015, DOI 10.1002/eji.1830190610; Seminario MC, 1999, J IMMUNOL, V162, P6893; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Sihra BS, 1997, J ALLERGY CLIN IMMUN, V99, P699, DOI 10.1016/S0091-6749(97)70033-2; Smith SJ, 2000, J ALLERGY CLIN IMMUN, V105, P309, DOI 10.1016/S0091-6749(00)90081-2; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; YOKOTA T, 1986, P NATL ACAD SCI USA, V83, P5894, DOI 10.1073/pnas.83.16.5894	49	132	136	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2000	12	5					515	523		10.1016/S1074-7613(00)80203-4	http://dx.doi.org/10.1016/S1074-7613(00)80203-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843384	Bronze			2022-12-18	WOS:000087356400007
J	Moriggl, R; Sexl, V; Piekorz, R; Topham, D; Ihle, JN				Moriggl, R; Sexl, V; Piekorz, R; Topham, D; Ihle, JN			Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells	IMMUNITY			English	Article							LYMPHOCYTE ANTIGEN RECEPTORS; MICE LACKING JAK3; INTERLEUKIN-2; RESPONSES; PROTEINS; CHAIN; IL-4; BETA	The activation and subsequent proliferation of peripheral T cells requires the engagement of the T cell and a cytokine receptor, typically the IL-2 or IL-4 receptors. Critical to understanding the regulation of peripheral T cells is the knowledge of the unique contributions of each receptor to full T cell activation and cell cycle progression. Mice deficient in Stat5a and Stat5b have demonstrated the essential role that these highly related proteins play in cell cycle progression following peripheral T cell activation. Here we demonstrate that activation of the Stat5 proteins by tyrosine phosphorylation is uniquely contributed by cytokine receptor signaling and specifically does not occur through the T cell receptor complex.	St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; Univ Tennessee, Sch Med, Dept Biochem, Memphis, TN 38063 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Ihle, JN (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA.	ihle@stjude.org	Moriggl, Richard/H-8118-2019; Sexl, Veronika/B-8657-2016	Moriggl, Richard/0000-0003-0918-9463; Sexl, Veronika/0000-0001-9363-0412				AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; KUPPER T, 1987, J IMMUNOL, V138, P4280; Lischke A, 1998, J BIOL CHEM, V273, P31222, DOI 10.1074/jbc.273.47.31222; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Welte T, 1999, SCIENCE, V283, P222, DOI 10.1126/science.283.5399.222	20	132	138	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG	1999	11	2					225	230		10.1016/S1074-7613(00)80097-7	http://dx.doi.org/10.1016/S1074-7613(00)80097-7			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485657	Bronze			2022-12-18	WOS:000082383400011
J	Bonfoco, E; Stuart, PM; Brunner, T; Lin, T; Griffith, TS; Gao, Y; Nakajima, H; Henkart, PA; Ferguson, TA; Green, DR				Bonfoco, E; Stuart, PM; Brunner, T; Lin, T; Griffith, TS; Gao, Y; Nakajima, H; Henkart, PA; Ferguson, TA; Green, DR			Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells	IMMUNITY			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; RECEPTOR TRANSGENIC MICE; APOPTOSIS IN-VIVO; CYCLOSPORINE-A; CD95 LIGAND; LYMPHOPROLIFERATIVE SYNDROME; IMMUNE PRIVILEGE; CLONAL DELETION; LYMPHOCYTES; ACTIVATION	Fas (CD95) and Fas ligand (FasL) play major roles in staphylococcal enterotoxin B (SEB)-induced peripheral deletion of V beta 8(+) T cells. We found that peripheral deletion was defective in radiation chimeras with nonfunctional tissue FasL, regardless of the FasL status of the bone marrow-derived cells. SEE induced a dramatic upregulation of FasL expression and function in nonlymphoid cells of liver and small intestine. This effect was resistant to inhibition by cyclosporin A, which also failed to inhibit peripheral deletion. In SCID animals nonlymphoid tissues did not express Fast in response to SEB unless transplanted lymphocytes were present. Thus, some immune responses induce Fast in nonlymphoid tissues, which in turn kills activated lymphocytes, leading to peripheral T cell deletion.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Washington Univ, Dept Ophthalmol, St Louis, MO 63110 USA; Univ Bern, Inst Pathol, CH-3010 Bern, Switzerland; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	La Jolla Institute for Immunology; Washington University (WUSTL); University of Bern; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Green, DR (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA.	dgreen5240@aol.com	Griffith, Thomas/ABF-8225-2020; Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735, R01GM052735] Funding Source: NIH RePORTER; NEI NIH HHS [EY06765] Funding Source: Medline; NIGMS NIH HHS [GM52735] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Allison J, 1997, P NATL ACAD SCI USA, V94, P3943, DOI 10.1073/pnas.94.8.3943; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Brunner T, 1996, INT IMMUNOL, V8, P1017, DOI 10.1093/intimm/8.7.1017; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; French LE, 1996, J CELL BIOL, V133, P335, DOI 10.1083/jcb.133.2.335; French LE, 1997, J IMMUNOL, V159, P2196; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; GONZALO JA, 1992, EUR J IMMUNOL, V22, P1007, DOI 10.1002/eji.1830220420; Gratas C, 1997, BRAIN PATHOL, V7, P863, DOI 10.1111/j.1750-3639.1997.tb00889.x; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; HUANG L, 1994, IMMUNITY, V1, P741, DOI 10.1016/S1074-7613(94)80016-2; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KLAS C, 1993, INT IMMUNOL, V5, P625, DOI 10.1093/intimm/5.6.625; Kuschnaroff LM, 1997, SCAND J IMMUNOL, V46, P459, DOI 10.1046/j.1365-3083.1997.d01-152.x; Latinis KM, 1997, J IMMUNOL, V158, P4602; Lu LN, 1997, J IMMUNOL, V158, P5676; MARTZ E, 1975, J IMMUNOL, V115, P261; MOGIL RJ, 1995, INT IMMUNOL, V7, P1451, DOI 10.1093/intimm/7.9.1451; Niehans GA, 1997, CANCER RES, V57, P1007; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Shiraki K, 1997, P NATL ACAD SCI USA, V94, P6420, DOI 10.1073/pnas.94.12.6420; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SPANGRUDE GJ, 1994, CURRENT PROTOCOLS IM, V1; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Tsutsui H, 1996, J IMMUNOL, V157, P3967; VANIER LE, 1992, J EXP MED, V176, P37, DOI 10.1084/jem.176.1.37; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	47	132	144	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					711	720		10.1016/S1074-7613(00)80668-8	http://dx.doi.org/10.1016/S1074-7613(00)80668-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846492	Bronze, Green Submitted			2022-12-18	WOS:000077298300013
J	Jackman, RM; Stenger, S; Lee, A; Moody, DB; Rogers, RA; Niazi, KR; Sugita, M; Modlin, RL; Peters, PJ; Porcelli, SA				Jackman, RM; Stenger, S; Lee, A; Moody, DB; Rogers, RA; Niazi, KR; Sugita, M; Modlin, RL; Peters, PJ; Porcelli, SA			The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens	IMMUNITY			English	Article							MHC CLASS-II; T-CELLS; INTRACELLULAR-TRANSPORT; INTERNALIZATION SIGNAL; MEMBRANE-GLYCOPROTEINS; PRESENTING MOLECULES; INVARIANT CHAIN; LYMPHOCYTES-T; HLA-DM; COMPARTMENTS	CD1b is an antigen-presenting molecule that mediates recognition of bacterial lipid and glycolipid antigens by specific T cells. We demonstrate that the nine-amino acid cytoplasmic tail of CD1b contains all of the signals required for its normal endosomal targeting, and that the single cytoplasmic tyrosine is a critical component of the targeting motif. Mutant forms of CD1b lacking the endosomal targeting motif are expressed at high levels on the cell surface but are unable to efficiently present lipid antigens acquired either exogenously or from live intracellular organisms. These results define the functional role of the CD1b targeting motif in a physiologic setting and demonstrate its importance in delivery of this antigen-presenting molecule to appropriate intracellular compartments.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Lymphocyte Biol Sect, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Univ Calif Los Angeles, Sch Med, Div Dermatol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Los Angeles, CA 90095 USA; Harvard Univ, Sch Publ Hlth, BioMed Imaging Inst, Boston, MA 02115 USA; Univ Utrecht, Sch Med, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard T.H. Chan School of Public Health; Utrecht University	Porcelli, SA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Lymphocyte Biol Sect, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA.		Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X; Sugita, Masahiko/0000-0001-5511-1304	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033009, P01HL043510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001988] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL43510, HL33009] Funding Source: Medline; NIAMS NIH HHS [AR01988] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; Beckman EM, 1996, J IMMUNOL, V157, P2795; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BEHAR SM, 1995, J EXP MED, V182, P2007, DOI 10.1084/jem.182.6.2007; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Melian A, 1996, CURR OPIN IMMUNOL, V8, P82, DOI 10.1016/S0952-7915(96)80109-9; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; NEEFJES JJ, 1992, IMMUNOL TODAY, V13, P179, DOI 10.1016/0167-5699(92)90123-O; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; OLIVE D, 1984, IMMUNOGENETICS, V20, P253, DOI 10.1007/BF00364207; PANCHOLI P, 1993, SCIENCE, V260, P984, DOI 10.1126/science.8098550; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; ROGERS RA, 1993, J CELL SCI, V106, P485; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Sugita M, 1997, J IMMUNOL, V159, P2358; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; SUGITA M, IN PRESS CLIN IMMUNO, V86; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; XU SM, 1994, J IMMUNOL, V153, P2568; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	46	132	132	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1998	8	3					341	351		10.1016/S1074-7613(00)80539-7	http://dx.doi.org/10.1016/S1074-7613(00)80539-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529151	Bronze			2022-12-18	WOS:000072705300007
J	RAGHAVAN, M; CHEN, MY; GASTINEL, LN; BJORKMAN, PJ				RAGHAVAN, M; CHEN, MY; GASTINEL, LN; BJORKMAN, PJ			INVESTIGATION OF THE INTERACTION BETWEEN THE CLASS-I MHC-RELATED FC RECEPTOR AND ITS IMMUNOGLOBULIN-G LIGAND	IMMUNITY			English	Article								The neonatal Fe receptor (FcRn) is structurally similar to class I major histocompatibility molecules. FcRn transports maternal immunoglobulin G (IgG) from ingested milk into the blood. IgG is bound at the pH of milk (pH 6.0-6.5) in the gut and released at the pH of blood (pH 7.5). We find that alteration of a histidine pair within the alpha 3 domain of FcRn and of a nearby loop (the FcRn counterpart of the class I CD8-binding loop) affects the affinity for IgG. Inhibition studies suggest the involvement of the FcRn B-2-microglobulin domain in IgG binding. Fragment B of protein A inhibits FcRn binding to IgG, localizing the binding site on Fc for FcRn to the C(H)2-C(H)3 domain interface. Three histidines present at the C(H)2-C(H)3 domain interface of Fc could be partially responsible for the pH-dependent interaction between FcRn and IgG.	CALTECH, HOWARD HUGHES MED INST, PASADENA, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	RAGHAVAN, M (corresponding author), CALTECH, DIV BIOL, 156-29, PASADENA, CA 91125 USA.							BEAVIL AJ, 1993, BIOCHEM SOC T, V21, P968, DOI 10.1042/bst0210968; Bebbington CR, 1987, DNA CLONING PRACTICA, VIII, P163; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.biochem.59.1.253; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; CARAS IW, 1987, SCIENCE, V238, P1280, DOI 10.1126/science.2446389; CONNOLLY JM, 1988, J EXP MED, V168, P325, DOI 10.1084/jem.168.1.325; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DEVOE AM, 1992, SCIENCE, V255, P199; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; HELM B, 1988, NATURE, V331, P180, DOI 10.1038/331180a0; HUBER AH, 1993, J MOL BIOL, V230, P1077, DOI 10.1006/jmbi.1993.1220; Hynes RO, 1990, FIBRONECTINS; ISRAEL EJ, 1993, IMMUNOLOGY, V79, P77; JOHNSON PM, 1979, PROTEIN TRANSMISSION, P45; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Kabat EA, 1991, SEQUENCES PROTEINS I; Koke J A, 1991, Protein Expr Purif, V2, P51, DOI 10.1016/1046-5928(91)90009-8; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MALMQVIST M, 1993, NATURE, V361, P186, DOI 10.1038/361186a0; MOSTOV KE, 1984, NATURE, V308, P37, DOI 10.1038/308037a0; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; PARHAM P, 1989, NATURE, V337, P118, DOI 10.1038/337118a0; PHLZACKERLEY RP, 1979, MOL IMMUNOL, V16, P841; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; RAGHAVAN M, 1993, BIOCHEMISTRY-US, V32, P8654, DOI 10.1021/bi00084a037; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; RODEWALD R, 1976, J CELL BIOL, V71, P666, DOI 10.1083/jcb.71.2.666; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; Sambrook J., 1989, MOL CLONING LAB MANU; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; STALLCUP KC, 1981, J IMMUNOL, V127, P923; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; WALLACE KH, 1980, BIOCHEM J, V188, P9, DOI 10.1042/bj1880009; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	50	132	155	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1994	1	4					303	315		10.1016/1074-7613(94)90082-5	http://dx.doi.org/10.1016/1074-7613(94)90082-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK166	7889418				2022-12-18	WOS:A1994PK16600008
J	Bacher, P; Rosati, E; Esser, D; Martini, GR; Saggau, C; Schiminsky, E; Dargvainiene, J; Schroder, I; Wieters, I; Khodamoradi, Y; Eberhardt, F; Vehreschild, MJGT; Neb, H; Sonntagbauer, M; Conrad, C; Tran, F; Rosenstiel, P; Markewitz, R; Wandinger, KP; Augustin, M; Rybniker, J; Kochanek, M; Leypoldt, F; Cornely, OA; Koehler, P; Franke, A; Scheffold, A				Bacher, Petra; Rosati, Elisa; Esser, Daniela; Martini, Gabriela Rios; Saggau, Carina; Schiminsky, Esther; Dargvainiene, Justina; Schroeder, Ina; Wieters, Imke; Khodamoradi, Yascha; Eberhardt, Fabian; Vehreschild, Maria J. G. T.; Neb, Holger; Sonntagbauer, Michael; Conrad, Claudio; Tran, Florian; Rosenstiel, Philip; Markewitz, Robert; Wandinger, Klaus-Peter; Augustin, Max; Rybniker, Jan; Kochanek, Matthias; Leypoldt, Frank; Cornely, Oliver A.; Koehler, Philipp; Franke, Andre; Scheffold, Alexander			Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19	IMMUNITY			English	Article							NAIVE; IMMUNITY; TECHNOLOGIES; SPECIFICITY; PROTECTION	CD4 (+) T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, we utilized SARS-CoV-2-reactive CD4(+) T cell enrichment to examine the antigen avidity and clonality of these cells, as well as the relative contribution of CCCoV cross-reactivity. SARS-CoV-2-reactive CD4(+) memory T cells were present in virtually all unexposed individuals examined, displaying low functional avidity and multiple, highly variable cross-reactivities that were not restricted to CCCoVs. SARS-CoV-2-reactive CD4 (+) T cells from COVID-1 9 patients lacked cross-reactivity to CCCoVs, irrespective of strong memory T cell responses against CCCoV in all donors analyzed. In severe but not mild COVID-19, SARS-CoV-2-specific T cells displayed low functional avidity and clonality, despite increased frequencies. Our findings identify low-avidity CD4(+) T cell responses as a hallmark of severe COVID-19 and argue against a protective role for CCCoV-reactive T cells in SARS-CoV-2 infection.	[Bacher, Petra; Martini, Gabriela Rios; Saggau, Carina; Schiminsky, Esther; Scheffold, Alexander] Christian Albrechts Univ Kiel, Inst Immunol, Kiel, Germany; [Bacher, Petra; Martini, Gabriela Rios; Saggau, Carina; Schiminsky, Esther; Scheffold, Alexander] UKSH Schleswig Holstein, Kiel, Germany; [Bacher, Petra; Rosati, Elisa; Martini, Gabriela Rios; Tran, Florian; Rosenstiel, Philip; Franke, Andre] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Esser, Daniela; Dargvainiene, Justina; Schroeder, Ina; Markewitz, Robert; Wandinger, Klaus-Peter; Leypoldt, Frank] Univ Hosp Schleswig Holstein, Inst Clin Chem, Kiel, Germany; [Wieters, Imke; Khodamoradi, Yascha; Eberhardt, Fabian; Vehreschild, Maria J. G. T.] Univ Hosp Frankfurt, Dept Internal Med, Infect Dis, Frankfurt, Germany; [Wieters, Imke; Khodamoradi, Yascha; Eberhardt, Fabian; Vehreschild, Maria J. G. T.] Goethe Univ Frankfurt, Frankfurt, Germany; [Neb, Holger; Sonntagbauer, Michael] Univ Hosp Frankfurt, Dept Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Conrad, Claudio] Hosp Preetz, Dept Internal Med, Preetz, Germany; [Tran, Florian] UKSH Kiel, Dept Internal Med 1, Kiel, Germany; [Augustin, Max; Rybniker, Jan; Kochanek, Matthias; Cornely, Oliver A.; Koehler, Philipp] Univ Cologne, Med Fac, Cologne, Germany; [Augustin, Max; Rybniker, Jan; Kochanek, Matthias; Cornely, Oliver A.; Koehler, Philipp] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Augustin, Max; Rybniker, Jan; Cornely, Oliver A.; Koehler, Philipp] Univ Cologne, Ctr Mol Med Cologne CMMC, Cologne, Germany; [Augustin, Max; Rybniker, Jan; Cornely, Oliver A.] Univ Hosp Cologne, German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany; [Leypoldt, Frank] Univ Hosp Schleswig Holstein, Dept Neurol, Kiel, Germany; [Cornely, Oliver A.] ZKS Koln, Clin Trials Ctr Cologne, Cologne, Germany; [Cornely, Oliver A.; Koehler, Philipp] Univ Hosp Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Cologne; University of Cologne; University of Cologne; German Center for Infection Research; University of Cologne; University of Kiel; Schleswig Holstein University Hospital; University of Cologne; University of Cologne	Bacher, P (corresponding author), UKSH Schleswig Holstein, Kiel, Germany.; Bacher, P (corresponding author), Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	p.bacher@ikmb.uni-kiel.de	Cornely, Oliver A./J-5095-2013; Esser, Daniela/ABB-9383-2020; Vehreschild, Maria/HGB-6948-2022; Bacher, Petra/AAF-1565-2021; Scheffold, Alexander/S-2090-2016; Koehler, Philipp/J-7985-2019; Franke, Andre/B-2151-2010; Leypoldt, Frank/ABC-3186-2021; Tran, Florian/AHA-4179-2022; Markewitz, Robert/AAB-2074-2022; Rosati, Elisa/J-6784-2019	Cornely, Oliver A./0000-0001-9599-3137; Bacher, Petra/0000-0003-4264-6451; Scheffold, Alexander/0000-0002-0626-343X; Koehler, Philipp/0000-0002-7386-7495; Franke, Andre/0000-0003-1530-5811; Tran, Florian/0000-0002-3735-9872; Markewitz, Robert/0000-0003-1676-1085; Rosati, Elisa/0000-0002-2635-6422; Leypoldt, Frank/0000-0002-8972-515X; Khodamoradi, Yascha/0000-0001-5972-0967	German Research Foundation (DFG) [EXC 2167-390884018]; DFG [433038070, 4096610003]; COVID-19 research grant from the Land Schleswig-Holstein [DIO002/CoVispecT]; BMBF Grant AnDiPath [Fkz 03ZZ0838B]; E-Rare Joint Transnational research support (ERA-Net) [LE3064/2-1]; BMBF Grant COVIM "NaFoUniMedCovid19'' [FKZ: 01KX2021]; German Ministry of Education and Research [01GM1908A]; German Federal Ministry of Research and Education; DFG under Germany's Excellence Strategy, CECAD [EXC 2030 -390661388];  [RU5042-miTarget]	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); COVID-19 research grant from the Land Schleswig-Holstein; BMBF Grant AnDiPath(Federal Ministry of Education & Research (BMBF)); E-Rare Joint Transnational research support (ERA-Net); BMBF Grant COVIM "NaFoUniMedCovid19''(Federal Ministry of Education & Research (BMBF)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Research and Education; DFG under Germany's Excellence Strategy, CECAD(German Research Foundation (DFG)); 	We thank Daniel Unterweger, Ulf Klein, and Chiara Romagnani for critical reading of the manuscript; the flow-cytometry facility Cyto Kiel, especially Esther Schiminsky and the Competence Centre for Genomic Analysis (CCGA) Kiel, Janina Fu beta, Soren Franzesnburg, Yewgenia Dolshanskaya, Catharina von der Lancken, Melanie Vollstedt, and Melanie Schlapkohl for support with cell sorting and single-cell sequencing; and the Clinical Trial Unit 2 of the University Hospital of Cologne for help with recruiting study participants and technical assistance. This research was supported by the German Research Foundation (DFG) under Germany's Excellence Strategy-EXC 2167-390884018 Precision Medicine in Chronic Inflammation to P.B., A.F., and A.S.; RU5042-miTarget to P.B. and A.F.; DFG 433038070 to P.B., A.F., and A.S.; DFG 4096610003 to E.R; by a COVID-19 research grant from the Land Schleswig-Holstein, DIO002/CoVispecT to P.B. and A.S.; the BMBF Grant AnDiPath (Fkz 03ZZ0838B) to A.S.; F.L. and D.E. were supported by the E-Rare Joint Transnational research support (ERA-Net, LE3064/2-1); and M.A. was supported by the BMBF Grant COVIM "NaFoUniMedCovid19'' (FKZ: 01KX2021). F.L. is supported by German Ministry of Education and Research (01GM1908A). O.A.C. is supported by the German Federal Ministry of Research and Education and is funded by the DFG under Germany's Excellence Strategy, CECAD, EXC 2030 -390661388.	Anft M, 2020, COVID 19 PROGRESSION, DOI 10.1101/2020.04.28.20083089; Bacher P, 2019, CELL, V176, P1340, DOI 10.1016/j.cell.2019.01.041; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Bacher P, 2015, CURR OPIN PHARMACOL, V23, P17, DOI 10.1016/j.coph.2015.04.005; Bacher P, 2013, CYTOM PART A, V83A, P692, DOI [10.1002/cyto.a.22317, 10.1002/cyto.22317]; Bacher P, 2013, J IMMUNOL, V190, P3967, DOI 10.4049/jimmunol.1202221; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campion SL, 2014, J EXP MED, V211, P1273, DOI 10.1084/jem.20130555; Chen ZY, 2020, NAT REV IMMUNOL, V20, P529, DOI 10.1038/s41577-020-0402-6; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Greiling TM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan2306; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hayward AC, 2015, AM J RESP CRIT CARE, V191, P1422, DOI 10.1164/rccm.201411-1988OC; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Koutsakos M, 2019, NAT IMMUNOL, V20, P613, DOI 10.1038/s41590-019-0320-6; Kwok WW, 2012, J IMMUNOL, V188, P2537, DOI 10.4049/jimmunol.1102190; Lanzer KG, 2018, IMMUN AGEING, V15, DOI 10.1186/s12979-018-0122-y; Lanzer KG, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-9; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Meckiff BJ, 2020, CELL, V183, P1340, DOI 10.1016/j.cell.2020.10.001; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Schulz AR, 2015, J IMMUNOL, V195, P4699, DOI 10.4049/jimmunol.1500598; Sekine T., 2020, CELL, DOI [10.1101/2020.06.29.174888, DOI 10.1016/J.CELL.2020.08.017, 10.1016/j.cell.2020.08.017]; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI [10.1038/s41564-020-00813-8, DOI 10.1038/S41564-020-00813-8, 10.1101/2020.07.09.20148429]; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Woodland DL, 2006, TRENDS IMMUNOL, V27, P303, DOI 10.1016/j.it.2006.05.002; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3	45	131	134	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1258	+		10.1016/j.immuni.2020.11.016	http://dx.doi.org/10.1016/j.immuni.2020.11.016			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33296686	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000599363300014
J	Sakai, M; Troutman, TD; Seidman, JS; Ouyang, ZY; Spann, NJ; Abe, Y; Ego, KM; Bruni, CM; Deng, ZH; Schlachetzki, JCM; Nott, A; Bennett, H; Chang, J; Vu, BT; Pasillas, MP; Link, VM; Texari, L; Heinz, S; Thompson, BM; McDonald, JG; Geissmann, F; Glass, CK				Sakai, Mashito; Troutman, Ty D.; Seidman, Jason S.; Ouyang, Zhengyu; Spann, Nathanael J.; Abe, Yohei; Ego, Kaori M.; Bruni, Cassi M.; Deng, Zihou; Schlachetzki, Johannes C. M.; Nott, Alexi; Bennett, Hunter; Chang, Jonathan; Vu, BaoChau T.; Pasillas, Martina P.; Link, Verena M.; Texari, Lorane; Heinz, Sven; Thompson, Bonne M.; McDonald, Jeffrey G.; Geissmann, Frederic; Glass, Christopher K.			Liver-Derived Signals Sequentially Reprogram Myeloid Enhancers to Initiate and Maintain Kupffer Cell Identity	IMMUNITY			English	Article							MACROPHAGE; CHOLESTEROL; METABOLISM; MECHANISM; SELECTION; PATHWAY; BINDING; NOTCH; LXR	Tissue environment plays a powerful role in establishing and maintaining the distinct phenotypes of resident macrophages, but the underlying molecular mechanisms remain poorly understood. Here, we characterized transcriptomic and epigenetic changes in repopulating liver macrophages following acute Kupffer cell depletion as a means to infer signaling pathways and transcription factors that promote Kupffer cell differentiation. We obtained evidence that combinatorial interactions of the Notch ligand DLL4 and transforming growth factor-b (TGF-beta) family ligands produced by sinusoidal endothelial cells and endogenous LXR ligands were required for the induction and maintenance of Kupffer cell identity. DLL4 regulation of the Notch transcriptional effector RBPJ activated poised enhancers to rapidly induce LXR alpha and other Kupffer cell lineage-determining factors. These factors in turn reprogrammed the repopulating liver macrophage enhancer landscape to converge on that of the original resident Kupffer cells. Collectively, these findings provide a framework for understanding how macrophage progenitor cells acquire tissue-specific phenotypes.	[Sakai, Mashito; Troutman, Ty D.; Seidman, Jason S.; Ouyang, Zhengyu; Spann, Nathanael J.; Abe, Yohei; Ego, Kaori M.; Bruni, Cassi M.; Schlachetzki, Johannes C. M.; Nott, Alexi; Bennett, Hunter; Chang, Jonathan; Vu, BaoChau T.; Pasillas, Martina P.; Link, Verena M.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Troutman, Ty D.; Texari, Lorane; Heinz, Sven; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Link, Verena M.] Ludwig Maximilian Univ Munich, Fac Biol, Div Evolutionary Biol, D-82152 Munich, Germany; [Thompson, Bonne M.; McDonald, Jeffrey G.] UT Southwestern Med Ctr, Ctr Human Nutr, Dept Mol Genet, Dallas, TX 75390 USA; [Deng, Zihou; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Munich; University of Texas System; University of Texas Southwestern Medical Center Dallas; Memorial Sloan Kettering Cancer Center	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Glass, CK (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Texari, Lorane/AAP-1238-2021; Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Troutman, Ty/0000-0001-8925-8080; Sakai, Mashito/0000-0002-4908-2727; Thompson, Bonne/0000-0001-7563-8330; Bennett, Hunter/0000-0002-8495-1545	NIH [HL20948, DK091183, GM085764, HL088093, 5T32DK007541]; Leducq Foundation, France; Manpei Suzuki Diabetes Foundation of Tokyo, Japan; Osamu Hayaishi Memorial Scholarship for Study Abroad, Japan; National Research Service Award (NRSA) [T32CA009523]; American Heart Association Fellowship [16PRE30980030]; Japan Society for the Promotion of Science Overseas Research Fellowship; Transatlantic Network Grant;  [P30 DK063491];  [T32DK007044]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093, P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, T32DK007541, R01DK091183, T32DK007044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198, P50GM085764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation, France(Leducq Foundation); Manpei Suzuki Diabetes Foundation of Tokyo, Japan; Osamu Hayaishi Memorial Scholarship for Study Abroad, Japan; National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Fellowship(American Heart Association); Japan Society for the Promotion of Science Overseas Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Transatlantic Network Grant; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by NIH grants DK091183, HL088093, and GM085764 and a Leducq Foundation, France, Transatlantic Network Grant. M.S. was supported by the Manpei Suzuki Diabetes Foundation of Tokyo, Japan, and the Osamu Hayaishi Memorial Scholarship for Study Abroad, Japan. T.D.T. was supported by P30 DK063491, T32DK007044, and National Research Service Award (NRSA) T32CA009523. J.S.S. was supported by American Heart Association Fellowship 16PRE30980030 and NIH Predoctoral Training Grant 5T32DK007541. J.G.M. is supported in part by NIH HL20948. Y.A. was supported by the Japan Society for the Promotion of Science Overseas Research Fellowship.	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; AVIGAN J, 1960, BIOCHEM BIOPH RES CO, V2, P63, DOI 10.1016/0006-291X(60)90266-7; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chu JL, 2002, J BIOL CHEM, V277, P7587, DOI 10.1074/jbc.M111044200; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Geraud C, 2017, J CLIN INVEST, V127, P1099, DOI 10.1172/JCI90086; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Halpern KB, 2018, NAT BIOTECHNOL, V36, P962, DOI 10.1038/nbt.4231; Heinz S, 2018, CELL, V174, P1522, DOI 10.1016/j.cell.2018.07.047; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Muse ED, 2018, P NATL ACAD SCI USA, V115, pE4680, DOI 10.1073/pnas.1714518115; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Prigge JR, 2013, MAMM GENOME, V24, P389, DOI 10.1007/s00335-013-9469-8; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Sakai M, 2012, NAT MED, V18, P612, DOI 10.1038/nm.2691; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sierro F, 2017, IMMUNITY, V47, P374, DOI 10.1016/j.immuni.2017.07.018; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029	49	131	131	4	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					655	+		10.1016/j.immuni.2019.09.002	http://dx.doi.org/10.1016/j.immuni.2019.09.002			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31587991	Green Accepted, Bronze			2022-12-18	WOS:000490141700012
J	Meixiong, J; Anderson, M; Limjunyawong, N; Sabbagh, MF; Hu, E; Mack, MR; Oetjen, LK; Wang, F; Kim, BS; Dong, XZ				Meixiong, James; Anderson, Michael; Limjunyawong, Nathachit; Sabbagh, Mark F.; Hu, Eric; Mack, Madison R.; Oetjen, Landon K.; Wang, Fang; Kim, Brian S.; Dong, Xinzhong			Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch	IMMUNITY			English	Article							ALLERGIC CONTACT-DERMATITIS; SUBSTANCE-P; SKIN; MRGX2; INFLAMMATION; ANTAGONISTS; PEPTIDE; IGE	Classical itch studies have focused on immunoglobulin E (IgE)-mediated mast cell activation and histamine release. Recently, members of the Mas-related G-protein-cou pled receptor (Mrgpr) family have been identified as mast cell receptors, but their role in itch is unclear. Here, we report that mast cell activation via Mrgprb2 evoked non-histaminergic itch in mice independently of the IgE-Fc epsilon RI (Fc epsilon RI)-histamine axis. Compared with IgE-Fc epsilon RI stimulation, Mrgprb2 activation of mast cells was distinct in both released substances (histamine, serotonin, and tryptase) and the pattern of activated itch-sensory neurons. Mrgprb2 deficiency decreased itch in multiple preclinical models of allergic contact dermatitis (ACD), a pruritic inflammatory skin disorder, and both mast cell number and PAMP1-20 concentrations (agonist of the human Mrgprb2 homolog, MRGPRX2) were increased in human ACD skin. These findings suggest that this pathway may represent a therapeutic target for treating ACD and mast-cell-associated itch disorders in which antihistamines are ineffective.	[Meixiong, James; Anderson, Michael; Limjunyawong, Nathachit; Sabbagh, Mark F.; Hu, Eric; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Mack, Madison R.; Oetjen, Landon K.; Wang, Fang; Kim, Brian S.] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA; [Mack, Madison R.; Oetjen, Landon K.; Wang, Fang; Kim, Brian S.] Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Dong, Xinzhong] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA.; Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.; Dong, XZ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	briankim@wustl.edu; xdong2@jhmi.edu	Limjunyawong, Nathachit/GVS-1517-2022; Kim, Brian/GZK-6649-2022	Kim, Brian/0000-0002-8100-7161; Anderson, Michael/0000-0001-8746-4681; Wang, Fang/0000-0002-3327-4177; Limjunyawong, Nathachit/0000-0002-9540-6171	NIH [R01NS054791, R01AI135186, K08AR065577, R01AR070116]; American Skin Association; Doris Duke Charitable Foundation; NHLBI [T32HL007317]; NIAID [T32AI007163]; Core A of the Penn Skin Biology and Diseases Resource-based Center [1P30AR069589-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070116, K08AR065577, P30AR069589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Skin Association; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Core A of the Penn Skin Biology and Diseases Resource-based Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Sze Yan Janelle Ho, Dr. Dustin Green, and Dr. Priyanka Pundir for helpful comments. This work was supported by NIH grants R01NS054791 and R01AI135186 (to X.D.), K08AR065577 (to B.S.K.), and R01AR070116 (to B.S.K.). B.S.K. is also supported by the American Skin Association and the Doris Duke Charitable Foundation. L.K.O. is supported by NHLBI grant T32HL007317. M.R.M. is supported by NIAID grant T32AI007163. This research was supported by Core A of the Penn Skin Biology and Diseases Resource-based Center, funded by 1P30AR069589-01 (Millar).	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; ASKENASE PW, 1983, J IMMUNOL, V131, P2687; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; deAndres B, 1997, BLOOD, V89, P3826, DOI 10.1182/blood.V89.10.3826.3826_3826_3836; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Dunford PJ, 2007, J ALLERGY CLIN IMMUN, V119, P176, DOI 10.1016/j.jaci.2006.08.034; El-Nour H, 2006, IMMUNOPHARM IMMUNOT, V28, P621, DOI 10.1080/08923970601067136; Flegel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128951; Fu K, 2014, NEUROSCI LETT, V579, P190, DOI 10.1016/j.neulet.2014.03.062; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Gimenez-Rivera VA, 2016, J IMMUNOL, V197, P4240, DOI 10.4049/jimmunol.1600236; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Harvima IT, 2010, GIORN ITAL DERMAT V, V145, P195; Kamo A, 2014, J INVEST DERMATOL, V134, P546, DOI 10.1038/jid.2013.351; Kamohara M, 2005, BIOCHEM BIOPH RES CO, V330, P1146, DOI 10.1016/j.bbrc.2005.03.088; Kapas S, 2001, J INVEST DERMATOL, V117, P353, DOI 10.1046/j.0022-202x.2001.01426.x; Kim YS, 2016, NEURON, V91, P1085, DOI 10.1016/j.neuron.2016.07.044; Kim YS, 2014, NEURON, V81, P873, DOI 10.1016/j.neuron.2013.12.011; Kleij Hanneke Pm van der, 2005, Allergy Asthma Clin Immunol, V1, P65, DOI 10.1186/1710-1492-1-2-65; Kostner L, 2017, IMMUNOL ALLERGY CLIN, V37, P141, DOI 10.1016/j.iac.2016.08.014; Kuwasako K, 1997, FEBS LETT, V414, P105, DOI 10.1016/S0014-5793(97)00971-X; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meixiong J, 2017, ANNU REV GENET, V51, P103, DOI 10.1146/annurev-genet-120116-024723; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; Morita T, 2015, NEURON, V87, P124, DOI 10.1016/j.neuron.2015.05.044; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; Nattkemper LA, 2018, J INVEST DERMATOL, V138, P1311, DOI 10.1016/j.jid.2017.12.029; Ng MFY, 2010, INT WOUND J, V7, P55, DOI 10.1111/j.1742-481X.2009.00651.x; Nothacker HP, 2005, EUR J PHARMACOL, V519, P191, DOI 10.1016/j.ejphar.2005.07.001; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; Peiser M, 2012, CELL MOL LIFE SCI, V69, P763, DOI 10.1007/s00018-011-0846-8; Reddy AT, 2012, JOVE-J VIS EXP, DOI 10.3791/3771; Robas N, 2003, J BIOL CHEM, V278, P44400, DOI 10.1074/jbc.M302456200; Scholzen TE, 2001, J IMMUNOL, V166, P1285, DOI 10.4049/jimmunol.166.2.1285; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; Shimada SG, 2006, EUR J PHARMACOL, V530, P281, DOI 10.1016/j.ejphar.2005.11.012; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Takamori A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25094-4; Usatine RP, 2010, AM FAM PHYSICIAN, V82, P249; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; van Diest SA, 2012, BBA-MOL BASIS DIS, V1822, P74, DOI 10.1016/j.bbadis.2011.03.019; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Yamaguchi T, 1999, NEUROSCI RES, V35, P77, DOI 10.1016/S0168-0102(99)00070-X; 2006, J DERMATOL, V33, P75, DOI DOI 10.1111/J.1346-8138.2006.00017.X	52	131	139	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1163	+		10.1016/j.immuni.2019.03.013	http://dx.doi.org/10.1016/j.immuni.2019.03.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31027996	Green Accepted, Bronze			2022-12-18	WOS:000468429500009
J	Gherardin, NA; Keller, AN; Woolley, RE; Le Nours, J; Ritchie, DS; Neeson, PJ; Birkinshaw, RW; Eckle, SBG; Waddington, JN; Liu, LG; Fairlie, DP; Uldrich, AP; Pellicci, DG; McCluskey, J; Godfrey, DI; Rossjohn, J				Gherardin, Nicholas A.; Keller, Andrew N.; Woolley, Rachel E.; Le Nours, Jerome; Ritchie, David S.; Neeson, Paul J.; Birkinshaw, Richard W.; Eckle, Sidonia B. G.; Waddington, John N.; Liu, Ligong; Fairlie, David P.; Uldrich, Adam P.; Pellicci, Daniel G.; McCluskey, James; Godfrey, Dale I.; Rossjohn, Jamie			Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition	IMMUNITY			English	Article							VITAMIN-B METABOLITES; MAIT CELLS; RECEPTOR HETEROGENEITY; ACTIVATION; ALPHA; MOUSE	A characteristic of mucosal-associated invariant T (MAIT) cells is the expression of TRAV1-2(+) T cell receptors (TCRs) that are activated by riboflavin metabolite- based antigens (Ag) presented by the MHC-I related molecule, MR1. Whether the MR1-restricted T cell repertoire and associated Ag responsiveness extends beyond these cells remains unclear. Here, we describe MR1 autoreactivity and folate-derivative reactivity in a discrete subset of TRAV1-2(+) MAIT cells. This recognition was attributable to CDR3 beta loop-mediated effects within a consensus TRAV1-2(+) TCR-MR1-Ag footprint. Furthermore, we have demonstrated differential folate-and riboflavin-derivative reactivity by a diverse population of "atypical'' TRAV1-2(-) MR1-restricted T cells. We have shown that TRAV1-2(-) T cells are phenotypically heterogeneous and largely distinct from TRAV1-2(+) MAIT cells. A TRAV1-2(-) TCR docks more centrally on MR1, thereby adopting a markedly different molecular footprint to the TRAV1-2(+) TCR. Accordingly, diversity within the MR1-restricted T cell repertoire leads to differing MR1-restricted Ag specificity.	[Gherardin, Nicholas A.; Eckle, Sidonia B. G.; Waddington, John N.; Uldrich, Adam P.; Pellicci, Daniel G.; McCluskey, James; Godfrey, Dale I.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Gherardin, Nicholas A.; Ritchie, David S.; Neeson, Paul J.] Peter MacCallum Canc Ctr, Canc Immunol Program, East Melbourne, Vic 3002, Australia; [Gherardin, Nicholas A.; Waddington, John N.; Uldrich, Adam P.; Pellicci, Daniel G.; Godfrey, Dale I.] Univ Melbourne, ARC Ctr Excellence Adv Mol Imaging, Parkville, Vic 3010, Australia; [Keller, Andrew N.; Woolley, Rachel E.; Le Nours, Jerome; Birkinshaw, Richard W.; Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Keller, Andrew N.; Woolley, Rachel E.; Le Nours, Jerome; Birkinshaw, Richard W.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Keller, Andrew N.; Woolley, Rachel E.; Le Nours, Jerome; Birkinshaw, Richard W.; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Ritchie, David S.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [Liu, Ligong; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Liu, Ligong; Fairlie, David P.] Univ Queensland, ARC Ctr Excellence Adv Mol Imaging, Brisbane, Qld 4072, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Monash University; Monash University; University of Melbourne; University of Queensland; University of Queensland; Cardiff University	Godfrey, DI (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	godfrey@unimelb.edu.au; jamie.rossjohn@monash.edu	Eckle, Sidonia BG/O-8146-2014; Rossjohn, Jamie/F-9032-2013; Gherardin, Nicholas/P-6853-2019; Birkinshaw, Richard/AAC-7809-2019; Uldrich, Adam/AAX-3785-2020; liu, ligong/B-1690-2010; Neeson, Paul/ABD-4686-2020; Pellicci, Daniel/AAX-8539-2020; McCluskey, James/A-1291-2007; Fairlie, David P/F-8865-2014	Eckle, Sidonia BG/0000-0003-0766-171X; Rossjohn, Jamie/0000-0002-2020-7522; Birkinshaw, Richard/0000-0003-1825-0182; liu, ligong/0000-0002-2693-1896; McCluskey, James/0000-0002-8597-815X; Fairlie, David P/0000-0002-7856-8566; Woolley, Rachel/0000-0003-3280-9405; Pellicci, Daniel/0000-0001-5305-2398; Le Nours, Jerome/0000-0002-2221-7636; Neeson, Paul/0000-0002-2729-5887; ULDRICH, ADAM/0000-0002-6350-5976; Godfrey, Dale/0000-0002-3009-5472; Gherardin, Nicholas/0000-0003-4690-2571	National Health and Medical Research Council of Australia (NHMRC) [1013667, 1063587]; Australian Research Council (ARC) [CE140100011, LE110100106]; Leukaemia Foundation of Australia Postgraduate Scholarship; ARC Future Fellowship; NHMRC ECF Fellowship [1054431]; NHMRC Australia Fellowship [AF50]; NHMRC Senior Principal Research Fellowships [1020770, 1027369]; Monash Macromolecular Crystallization Facility	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Leukaemia Foundation of Australia Postgraduate Scholarship; ARC Future Fellowship(Australian Research Council); NHMRC ECF Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Monash Macromolecular Crystallization Facility	We thank Marcin Ciula and Bronwyn Meehan for technical assistance and advice. We thank the Monash Macromolecular Crystallization Facility for support and the Australian Synchrotron staff for assistance with data collection. We thank staff from the Flow Cytometry facility at The University of Melbourne and Melbourne Brain Centre. We are grateful to Dr. Dario Vignali (St. Jude Children's research hospital) and Professor Stephen Turner (The University of Melbourne) for providing pMIG expression vector and Dr. Paul Savage (Brigham Young University) for alpha- GalCer analog PBS-44. This work was supported by the National Health and Medical Research Council of Australia ((NHMRC) 1013667 and 1063587) and the Australian Research Council (ARC; CE140100011 and LE110100106). N.A.G. is supported by a Leukaemia Foundation of Australia Postgraduate Scholarship; A.P.U. is supported by an ARC Future Fellowship; D.G.P. is supported by an NHMRC ECF Fellowship (1054431); J.R. is supported by an NHMRC Australia Fellowship (AF50); D.I.G. and D.P.F. are supported by NHMRC Senior Principal Research Fellowships (1020770, 1027369).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7, DOI 10.1016/j.coi.2013.09.007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gold MC, 2013, MUCOSAL IMMUNOL, V6, P35, DOI 10.1038/mi.2012.45; Gold MC, 2014, J EXP MED, V211, P1601, DOI 10.1084/jem.20140507; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Ussher JE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00450; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	35	131	133	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					32	45		10.1016/j.immuni.2015.12.005	http://dx.doi.org/10.1016/j.immuni.2015.12.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26795251	Bronze			2022-12-18	WOS:000368347000011
J	Bar, E; Whitney, PG; Moor, K; Sousa, CRE; LeibundGut-Landmann, S				Baer, Eva; Whitney, Paul G.; Moor, Kathrin; Reis e Sousa, Caetano; LeibundGut-Landmann, Salome			IL-17 Regulates Systemic Fungal Immunity by Controlling the Functional Competence of NK Cells	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; INNATE LYMPHOID-CELLS; T-HELPER-CELLS; TH17 CELLS; CANDIDA-ALBICANS; IFN-GAMMA; ASPERGILLUS-FUMIGATUS; HOST-DEFENSE; INFECTION; CYTOMEGALOVIRUS	Interleukin 17 (IL-17)-mediated immunity plays a key role in protection from fungal infections in mice and man. Here, we confirmed that mice deficient in the IL-17 receptor or lacking the ability to secrete IL-17 are highly susceptible to systemic candidiasis, but we found that temporary blockade of the IL-17 pathway during infection in wild-type mice did not impact fungal control. Rather, mice lacking IL-17 receptor signaling had a cell-intrinsic impairment in the development of functional NK cells, which accounted for the susceptibility of these mice to systemic fungal infection. NK cells promoted antifungal immunity by secreting GM-CSF, necessary for the fungicidal activity of neutrophils. These data reveal that NK cells are crucial for antifungal defense and indicate a role for IL-17 family cytokines in NK cell development. The IL-17-NK cell axis may impact immunity against not only fungi but also bacteria, viruses, and tumors.	[Baer, Eva; Moor, Kathrin; LeibundGut-Landmann, Salome] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Whitney, Paul G.; Reis e Sousa, Caetano] Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3LY, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Cancer Research UK	LeibundGut-Landmann, S (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	leibundgut@micro.biol.ethz.ch	Reis e Sousa, Caetano/O-1657-2014; Moor, Kathrin/K-4226-2015; Reis e Sousa, Caetano/ABD-7322-2021	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Whitney, Paul/0000-0003-3836-7601; Moor, Kathrin/0000-0002-2799-3837; LeibundGut-Landmann, Salome/0000-0002-5724-4837	National Science Foundation [PP00P3_123342]; Swiss Life Anniversary Foundation; Cancer Research UK [15689] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); Swiss Life Anniversary Foundation; Cancer Research UK(Cancer Research UK)	The authors would like to thank B. Becher, M. Greter, S. Pantelyushin, and G. de Libero for mice; the staff of the Rodent Center HCI and the Institute of Laboratory Animal Sciences for animal husbandry; S. Mandaric for help with the MCMV infection experiment; A. Zinkernagel for help with setting up the neutrophil killing experiments; and K. Trautwein-Weidner, A. Gladiator, F. Osorio, and A. Oxenius for helpful advice and discussions. This work was supported by the National Science Foundation (grant number PP00P3_123342) and the Swiss Life Anniversary Foundation.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bar E, 2012, J IMMUNOL, V188, P5636, DOI 10.4049/jimmunol.1200594; Bhatnagar N, 2010, BLOOD, V116, P1308, DOI 10.1182/blood-2010-01-264903; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bouzani M, 2011, J IMMUNOL, V187, P1369, DOI 10.4049/jimmunol.1003593; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chen K, 2011, IMMUNITY, V35, P997, DOI 10.1016/j.immuni.2011.10.018; Conti HR, 2010, MICROBES INFECT, V12, P518, DOI 10.1016/j.micinf.2010.03.013; Costantini C, 2010, INT IMMUNOL, V22, P827, DOI 10.1093/intimm/dxq434; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cypowyj S, 2012, EUR J IMMUNOL, V42, P2246, DOI 10.1002/eji.201242605; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Granucci F, 2004, J EXP MED, V200, P287, DOI 10.1084/jem.20040370; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kelly MN, 2013, J IMMUNOL, V190, P285, DOI 10.4049/jimmunol.1200861; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Loh J, 2005, J VIROL, V79, P661, DOI 10.1128/JVI.79.1.661-667.2005; MacCallum DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006420; Marr KJ, 2009, INFECT IMMUN, V77, P2436, DOI 10.1128/IAI.01232-08; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Morandi B, 2006, EUR J IMMUNOL, V36, P2394, DOI 10.1002/eji.200636290; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Schmidt S, 2011, J INFECT DIS, V203, P430, DOI 10.1093/infdis/jiq062; Sellge G, 2010, J IMMUNOL, V184, P2076, DOI 10.4049/jimmunol.0900978; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Walton SM, 2008, J IMMUNOL, V181, P1128, DOI 10.4049/jimmunol.181.2.1128; Wuthrich M, 2011, J CLIN INVEST, V121, P554, DOI 10.1172/JCI43984	50	131	139	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					117	127		10.1016/j.immuni.2013.12.002	http://dx.doi.org/10.1016/j.immuni.2013.12.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24412614	Bronze			2022-12-18	WOS:000331476900014
J	Wen, LJ; Brill-Dashoff, J; Shinton, SA; Asano, M; Hardy, RR; Hayakawa, K				Wen, LJ; Brill-Dashoff, J; Shinton, SA; Asano, M; Hardy, RR; Hayakawa, K			Evidence of marginal-zone B cell-positive selection in spleen	IMMUNITY			English	Article							ANTIGEN RECEPTOR; NEGATIVE SELECTION; T-CELLS; THY-1 GLYCOPROTEIN; TYROSINE KINASE; B-1 CELLS; EXPRESSION; MICE; FATE; SERUM	Antigen receptor-mediated signaling is critical for the development and survival of B cells. However, it has not been established whether B cell development requires a signal from self-ligand engagement at the immature stage, a process known as "positive selection." Here, using a monoclonal B cell receptor (BCR) mouse line, specific for the self-Thy-1/CD90 glycoprotein, we demonstrate that BCR crosslinking by low-dose self-antigen promotes survival of immature B cells in culture. In spleen, an increase in BCR signaling strength, induced by low-dose self-antigen, directed naive immature B cells to mature, not into the default follicular B cell fate, but instead into the marginal-zone B cell subset. These data indicate that positive selection can occur in developing B cells and that BCR signal strength is a key factor in deciding between two functionally distinct mature B cell compartments in the microenvironment of the spleen.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Hayakawa, K (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	k_hayakawa@fccc.edu						Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; BERGMAN AS, 1994, BIOCHEM J, V298, P661, DOI 10.1042/bj2980661; Cariappa A, 2002, CURR OPIN IMMUNOL, V14, P241, DOI 10.1016/S0952-7915(02)00328-X; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; CARLSSON SR, 1984, BIOCHEM J, V221, P379, DOI 10.1042/bj2210379; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; Dammers PM, 1999, EUR J IMMUNOL, V29, P1522, DOI 10.1002/(SICI)1521-4141(199905)29:05<1522::AID-IMMU1522>3.0.CO;2-0; Dammers PM, 2005, EUR J IMMUNOL, V35, P2089, DOI 10.1002/eji.200526118; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Gui M, 1999, J IMMUNOL, V163, P4796; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HARDY RR, 1982, NATURE, V297, P589, DOI 10.1038/297589a0; Hayakawa K, 2000, CURR OPIN IMMUNOL, V12, P346, DOI 10.1016/S0952-7915(00)00098-4; Hayakawa K, 2003, J EXP MED, V197, P87, DOI 10.1084/jem.20021459; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Heltemes LM, 2002, J IMMUNOL, V169, P1283, DOI 10.4049/jimmunol.169.3.1283; Hikida M, 2003, J EXP MED, V198, P581, DOI 10.1084/jem.20030280; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; King LB, 2000, IMMUNOL REV, V176, P86; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; KUMARARATNE DS, 1981, EUR J IMMUNOL, V11, P858, DOI 10.1002/eji.1830111103; KUMARARATNE DS, 1982, ADV EXP MED BIOL, V149, P83; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LOW MG, 1985, NATURE, V318, P62, DOI 10.1038/318062a0; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Moon BG, 2001, IMMUNOLOGY, V102, P289, DOI 10.1046/j.1365-2567.2001.01196.x; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13; Reth M, 2000, IMMUNOL REV, V176, P10; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; Saalbach A, 1999, CELL TISSUE RES, V298, P307, DOI 10.1007/s004419900079; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Samardzic T, 2002, EUR J IMMUNOL, V32, P561, DOI 10.1002/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; TEUTSCH M, 1995, INT IMMUNOL, V7, P381, DOI 10.1093/intimm/7.3.381; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Tomayko MM, 1998, J IMMUNOL, V160, P107; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; VITETTA ES, 1974, EUR J IMMUNOL, V4, P276, DOI 10.1002/eji.1830040409; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wen LJ, 2005, J IMMUNOL, V174, P6918, DOI 10.4049/jimmunol.174.11.6918; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	60	131	134	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2005	23	3					297	308		10.1016/j.immuni.2005.08.007	http://dx.doi.org/10.1016/j.immuni.2005.08.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169502	Bronze			2022-12-18	WOS:000232382500008
J	Coutinho-Silva, R; Stahl, L; Raymond, MN; Jungas, T; Verbeke, P; Burnstock, G; Darville, T; Ojcius, DM				Coutinho-Silva, R; Stahl, L; Raymond, MN; Jungas, T; Verbeke, P; Burnstock, G; Darville, T; Ojcius, DM			Inhibition of chlamydial infectious activity due to P2X(7)R-dependent phospholipase D activation	IMMUNITY			English	Article							VIRULENT MYCOBACTERIUM-TUBERCULOSIS; NITRIC-OXIDE SYNTHASE; HUMAN MACROPHAGES; REACTIVE ARTHRITIS; NUCLEOTIDE RECEPTOR; PROTEIN TRANSIT; DENDRITIC CELLS; ATP; TRACHOMATIS; RELEASE	Chlamydia trachomatis survives within host cells by inhibiting fusion between Chlamydia vacuoles and lysosomes. We show here that treatment of infected macrophages with ATP leads to killing of chlamydiae through ligation of the purinergic receptor, P2X(7)R. Chlamydial killing required phospholipase, D (PLD) activation, as PLD inhibition led to rescue of chlamydiae in ATP-treated macrophages. However, there was no PLD activation nor chlamydial killing in ATP-treated P2X(7)R-deficient macrophages. P2X(7)R ligation exerts its effects by promoting fusion between Chlamydia vacuoles and lysosomes. P2X(7)R stimulation also resulted in macrophage death, but fusion with lysosomes preceded macrophage death and PLD inhibition did not prevent macrophage death. These results suggest that P2X(7)R ligation leads to PLD activation, which is directly responsible for inhibition of infection.	Univ Paris 07, Inst Jacques Monod, CNRS, UMR 7592, F-75251 Paris 5, France; UCL Royal Free & Univ Coll, Sch Med, Auton Neurosci Inst, Dept Anat & Dev Biol, London NW3 2PF, England; Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; Univ Paris 11, Lab Activat Cellulaire & Transduct Signaux, UMR8619, F-91405 Orsay, France; Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; UCL Medical School; Universidade Federal do Rio de Janeiro; UDICE-French Research Universities; Universite Paris Saclay; University of Arkansas System; University of Arkansas Medical Sciences	Ojcius, DM (corresponding author), Univ Paris 07, Inst Jacques Monod, CNRS, UMR 7592, F-75251 Paris 5, France.	ojcius@ijm.jussieu.fr	Coutinho-Silva, Robson/M-4690-2013; Ojcius, David/ABE-6557-2020	Coutinho-Silva, Robson/0000-0002-7318-0204; Ojcius, David/0000-0003-1461-4495	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054624] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI054624] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBUQUERQUE C, 1993, AM J PHYSIOL, V265, pC1663, DOI 10.1152/ajpcell.1993.265.6.C1663; Auger R, 1999, J BIOL CHEM, V274, P28652, DOI 10.1074/jbc.274.40.28652; Bavoil PM, 2000, MICROBIOL-UK, V146, P2723, DOI 10.1099/00221287-146-11-2723; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Bodin P, 1998, INFLAMM RES, V47, P351, DOI 10.1007/s000110050341; BODIN P, 1995, EXPERIENTIA, V51, P256, DOI 10.1007/BF01931108; Brown FD, 1998, CURR BIOL, V8, P835, DOI 10.1016/S0960-9822(98)70326-4; Chow SC, 1997, NEUROPHARMACOLOGY, V36, P1149, DOI 10.1016/S0028-3908(97)00123-8; COUNTINHOSILVA R, 2001, AM J PHYSIOL, V280, pC81; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139, DOI 10.1152/ajpcell.1999.276.5.C1139; Denmat-Ouisse LA, 2001, J BIOL CHEM, V276, P48840, DOI 10.1074/jbc.M104276200; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Fairbairn IP, 2001, J IMMUNOL, V167, P3300, DOI 10.4049/jimmunol.167.6.3300; Gargett CE, 1996, BIOCHEM J, V313, P529, DOI 10.1042/bj3130529; Gerard HC, 1998, MED MICROBIOL IMMUN, V187, P115, DOI 10.1007/s004300050082; Gerard HC, 1998, J RHEUMATOL, V25, P734; Gerard HC, 2002, J RHEUMATOL, V29, P1827; Gerbase AC, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)90001-0; GOGOLAK FM, 1953, J INFECT DIS, V92, P254, DOI 10.1093/infdis/92.3.254; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Hackstadt T, 1999, CHLAMYDIA, P101; Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265, DOI 10.1002/jlb.64.2.265; Humphreys BD, 1996, J IMMUNOL, V157, P5627; Igietseme JU, 1998, INFECT IMMUN, V66, P1282, DOI 10.1128/IAI.66.4.1282-1286.1998; Johansen KA, 1996, INFECT IMMUN, V64, P3259, DOI 10.1128/IAI.64.8.3259-3266.1996; Khatsenko OG, 1998, BIOCHEM PHARMACOL, V55, P1835, DOI 10.1016/S0006-2952(98)00066-5; Koehler L, 1997, MICROB PATHOGENESIS, V22, P133, DOI 10.1006/mpat.1996.0103; Kusner DJ, 1996, J EXP MED, V184, P585, DOI 10.1084/jem.184.2.585; Kusner DJ, 2001, J IMMUNOL, V167, P3308, DOI 10.4049/jimmunol.167.6.3308; Kusner DJ, 2000, J IMMUNOL, V164, P379, DOI 10.4049/jimmunol.164.1.379; La Verda D, 1994, Immunol Ser, V60, P381; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mutini C, 1999, J IMMUNOL, V163, P1958; NANAGARA R, 1995, ARTHRITIS RHEUM, V38, P1410, DOI 10.1002/art.1780381008; Ojcius DM, 1998, J BIOL CHEM, V273, P7052, DOI 10.1074/jbc.273.12.7052; Ojcius DM, 1998, J IMMUNOL, V160, P1297; PEARLMAN MD, 1994, OBSTET GYNECOL SURV, V47, P448; Pedersen S, 1999, BBA-BIOMEMBRANES, V1416, P271, DOI 10.1016/S0005-2736(98)00228-4; Perfettini JL, 2003, J BIOL CHEM, V278, P9496, DOI 10.1074/jbc.M211275200; Perfettini JL, 2002, METHOD ENZYMOL, V358, P334; RAMSEY KH, 1989, INFECT IMMUN, V57, P2441, DOI 10.1128/IAI.57.8.2441-2446.1989; Rosenfeld ME, 2000, J INFECT DIS, V181, pS492, DOI 10.1086/315618; SCHACHTER H, 1988, MICROBIOLOGY CHLAMYD, P153; Schramm N, 1996, INFECT IMMUN, V64, P1208, DOI 10.1128/IAI.64.4.1208-1214.1996; Sikora A, 1999, J IMMUNOL, V163, P558; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Stober CB, 2001, J IMMUNOL, V166, P6276, DOI 10.4049/jimmunol.166.10.6276; TAYLORROBINSON D, 1992, LANCET, V340, P81, DOI 10.1016/0140-6736(92)90399-N; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; YANG SF, 1967, J BIOL CHEM, V242, P477; Zaborina O, 1999, MOL MICROBIOL, V31, P1333, DOI 10.1046/j.1365-2958.1999.01240.x; Zaborina O, 1999, INFECT IMMUN, V67, P5231, DOI 10.1128/IAI.67.10.5231-5242.1999	59	131	134	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2003	19	3					403	412		10.1016/S1074-7613(03)00235-8	http://dx.doi.org/10.1016/S1074-7613(03)00235-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499115	Bronze			2022-12-18	WOS:000185499800011
J	Mueller, YM; De Rosa, SC; Hutton, JA; Witek, J; Roederer, M; Altman, JD; Katsikis, PD				Mueller, YM; De Rosa, SC; Hutton, JA; Witek, J; Roederer, M; Altman, JD; Katsikis, PD			Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FAS LIGAND EXPRESSION; LYMPH-NODES; PERIPHERAL-BLOOD; CROSS-LINKING; UP-REGULATION; LYMPHOCYTES; DEATH; ACTIVATION; RECEPTOR	Why HIV-specific CD8(+) T cells ultimately fail to clear or control HIV infection is not known. We show here that HIV-specific CD8(+) T cells exhibit increased sensitivity to CD95/Fas-induced apoptosis. This apoptosis is 3-fold higher compared to CMV-specific CD8(+) T cells from the same patients. HIV-specific CD8+ T cells express the CD45RA(-)CD62L(-) but lack the CD45RA(+)CD62L- T cell effector memory (T-EM) phenotype. This skewing is not found in CMV- and EBV-specific CD8(+) T cells in HIV-infected individuals. CD95/Fas-induced apoptosis is much higher in the CD45RA-CD62L- T-EM cells. However, cytotoxicity and IFN gamma production by HIV-specific CD8(+) T cells is not impaired. Our data suggest that the survival and differentiation of HIV-specific CDW T cells may be compromised by CD95/Fas apoptosis induced by FasL-expressing HIV-infected cells.	Med Coll Penn & Hahnemann Univ, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA; Med Coll Penn & Hahnemann Univ, Dept Med, Philadelphia, PA 19129 USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30329 USA	Drexel University; Drexel University; National Institutes of Health (NIH) - USA; Emory University	Katsikis, PD (corresponding author), Med Coll Penn & Hahnemann Univ, Dept Microbiol & Immunol, 3300 Henry Ave, Philadelphia, PA 19129 USA.	katsikis@drexel.edu	Roederer, Mario/G-1887-2011	Mueller, Yvonne/0000-0002-4654-7509; Katsikis, Peter/0000-0001-7690-5218	NIAID NIH HHS [R01 AI46719] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005021, R01AI046719] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Baars PA, 2000, J IMMUNOL, V165, P1910, DOI 10.4049/jimmunol.165.4.1910; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; BANDA NK, 1992, J EXP MED, V176, P1099, DOI 10.1084/jem.176.4.1099; BOFILL M, 1995, AM J PATHOL, V146, P1542; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brodie SJ, 2000, J CLIN INVEST, V105, P1407, DOI 10.1172/JCI8707; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Brown SB, 1999, J IMMUNOL, V162, P480; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; ESTAQUIER J, 1995, J EXP MED, V182, P1759, DOI 10.1084/jem.182.6.1759; FADOK VA, 1992, J IMMUNOL, V148, P2207; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; GOUGEON ML, 1993, AIDS RES HUM RETROV, V9, P553, DOI 10.1089/aid.1993.9.553; Gray CM, 1999, J IMMUNOL, V162, P1780; GROUX H, 1992, J EXP MED, V175, P331, DOI 10.1084/jem.175.2.331; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Katsikis PD, 1997, INT IMMUNOL, V9, P835, DOI 10.1093/intimm/9.6.835; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; Katsikis PD, 1996, INT IMMUNOL, V8, P1311, DOI 10.1093/intimm/8.8.1311; Kiener PA, 1997, J IMMUNOL, V159, P1594; Kuroda MJ, 2000, BLOOD, V96, P1474, DOI 10.1182/blood.V96.4.1474.h8001474_1474_1479; Kuroda MJ, 1999, J VIROL, V73, P1573, DOI 10.1128/JVI.73.2.1573-1579.1999; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; MUROCACHO CA, 1995, J IMMUNOL, V154, P5555; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Pantaleo G, 1997, EUR J IMMUNOL, V27, P3166, DOI 10.1002/eji.1830271213; Perlman H, 2001, EUR J IMMUNOL, V31, P2421, DOI 10.1002/1521-4141(200108)31:8<2421::AID-IMMU2421>3.0.CO;2-W; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; Tan RS, 1999, BLOOD, V93, P1506, DOI 10.1182/blood.V93.5.1506.405a38_1506_1510; Tang MLK, 1998, J IMMUNOL, V160, P5113; Tanner JE, 1999, BLOOD, V94, P3439, DOI 10.1182/blood.V94.10.3439.422k23_3439_3447; Tateyama M, 2000, BLOOD, V96, P195, DOI 10.1182/blood.V96.1.195.013k51_195_202; Tussey L, 2000, EUR J IMMUNOL, V30, P1823, DOI 10.1002/1521-4141(200007)30:7<1823::AID-IMMU1823>3.0.CO;2-6; Vlahakis SR, 2001, J CLIN INVEST, V107, P207, DOI 10.1172/JCI11109; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7	47	131	131	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2001	15	6					871	882		10.1016/S1074-7613(01)00246-1	http://dx.doi.org/10.1016/S1074-7613(01)00246-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754810	Bronze			2022-12-18	WOS:000172961400003
J	Look, DC; Roswit, WT; Frick, AG; Gris-Alevy, Y; Dickhaus, DM; Walter, MJ; Holtzman, MJ				Look, DC; Roswit, WT; Frick, AG; Gris-Alevy, Y; Dickhaus, DM; Walter, MJ; Holtzman, MJ			Direct suppression of Stat1 function during adenoviral infection	IMMUNITY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; NUCLEAR-PROTEIN CBP; INTERFERON-GAMMA; EPITHELIAL-CELLS; TARGETED DISRUPTION; ICAM-1 EXPRESSION; GENE PROMOTER; E1A PROTEINS; DNA-BINDING; TRANSCRIPTION	The action of adenoviral E1A oncoprotein on host immune-response genes has been attributed to interaction with p300/CBP-type transcriptional coactivators in competition with endogenous transcription factors such as signal transducer and activator of transcription (STAT) proteins. However, we show that mutant forms of E1A that no longer bind p300/CBP can still interact directly with Stat1 (via E1A N-terminal and Stat1 C-terminal residues) and block IFN gamma-driven, Stat1-dependent gene activation and consequent function during early-phase infection in the natural host cell. The results provide a distinct and more specific mechanism for E1A-mediated immune suppression and an alternative model of IFN gamma-driven enhanceosome formation that may allow for other adaptors (in addition to p300/CBP) to link Stat1 to the basal transcription complex.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Holtzman, MJ (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	mholtzman@pulmonary.wustl.edu						ACKRILL AM, 1991, NUCLEIC ACIDS RES, V19, P4387, DOI 10.1093/nar/19.16.4387; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bartel PL, 1993, CELLULAR INTERACTION, P153; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, MOL CELL BIOL, V16, P3454; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; GIRDLESTONE J, 1993, P NATL ACAD SCI USA, V90, P11568, DOI 10.1073/pnas.90.24.11568; GRAHAM FL, 1991, METHODS MOL BIOL; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Guerette B, 1997, J LEUKOCYTE BIOL, V61, P533, DOI 10.1002/jlb.61.4.533; Holtzman MJ, 1998, P ASSOC AM PHYSICIAN, V110, P1; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Horvath CM, 1996, J VIROL, V70, P647, DOI 10.1128/JVI.70.1.647-650.1996; KALVAKOLANU DVR, 1991, P NATL ACAD SCI USA, V88, P7459, DOI 10.1073/pnas.88.17.7459; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Keicho N, 1997, AM J RESP CELL MOL, V16, P23, DOI 10.1165/ajrcmb.16.1.8998075; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lee JS, 1996, MOL CELL BIOL, V16, P4312; Leonard GT, 1996, VIROLOGY, V224, P25, DOI 10.1006/viro.1996.0503; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; LOOK DC, 1992, AM J PHYSIOL, V263, pL79, DOI 10.1152/ajplung.1992.263.1.L79; LOOK DC, 1994, J BIOL CHEM, V269, P8952; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Min W, 1996, J IMMUNOL, V156, P3174; MORAN E, 1994, SEMIN VIROL, V5, P327, DOI 10.1006/smvy.1994.1037; NAKAJIMA S, 1994, AM J PHYSIOL-LUNG C, V267, pL422, DOI 10.1152/ajplung.1994.267.4.L422; NAKAJIMA S, 1995, J IMMUNOL, V155, P1117; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; STEIN RW, 1990, J VIROL, V64, P4421, DOI 10.1128/JVI.64.9.4421-4427.1990; Taguchi M, 1998, J EXP MED, V187, P1927, DOI 10.1084/jem.187.12.1927; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Walter MJ, 1997, J BIOL CHEM, V272, P28582, DOI 10.1074/jbc.272.45.28582; Walter MJ, 1998, FASEB J, V12, pA1453; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; WEINTRAUB SJ, 1992, MOL CELL BIOL, V12, P512, DOI 10.1128/MCB.12.2.512; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	53	131	135	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1998	9	6					871	880		10.1016/S1074-7613(00)80652-4	http://dx.doi.org/10.1016/S1074-7613(00)80652-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881977	Bronze			2022-12-18	WOS:000077836600012
J	Dutzan, N; Abusleme, L; Bridgeman, H; Greenwell-Wild, T; Zangerle-Murray, T; Fife, ME; Bouladoux, N; Linley, H; Brenchley, L; Wemyss, K; Calderon, G; Hong, BY; Break, TJ; Bowdish, DME; Lionakis, MS; Jones, SA; Trinchieri, G; Diaz, PI; Belkaid, Y; Konkel, JE; Moutsopoulos, NM				Dutzan, Nicolas; Abusleme, Loreto; Bridgeman, Hayley; Greenwell-Wild, Teresa; Zangerle-Murray, Tamsin; Fife, Mark E.; Bouladoux, Nicolas; Linley, Holly; Brenchley, Laurie; Wemyss, Kelly; Calderon, Gloria; Hong, Bo-Young; Break, Timothy J.; Bowdish, Dawn M. E.; Lionakis, Michail S.; Jones, Simon A.; Trinchieri, Giorgio; Diaz, Patricia I.; Belkaid, Yasmine; Konkel, Joanne E.; Moutsopoulos, Niki M.			On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier	IMMUNITY			English	Article							T-HELPER-CELLS; INTESTINAL INFLAMMATION; T(H)17 CELLS; MICROBIOTA; PERIODONTITIS; IL-1-BETA; DIFFERENTIATION; IMMUNITY; DISTINCT; EXPRESSION	Immuno-surveillance networks operating at barrier sites are tuned by local tissue cues to ensure effective immunity. Site-specific commensal bacteria provide key signals ensuring host defense in the skin and gut. However, how the oral microbiome and tissue-specific signals balance immunity and regulation at the gingiva, a key oral barrier, remains minimally explored. In contrast to the skin and gut, we demonstrate that gingiva-resident T helper 17 (Th17) cells developed via a commensal colonization- independent mechanism. Accumulation of Th17 cells at the gingiva was driven in response to the physiological barrier damage that occurs during mastication. Physiological mechanical damage, via induction of interleukin 6 (IL-6) from epithelial cells, tailored effector T cell function, promoting increases in gingival Th17 cell numbers. These data highlight that diverse tissue-specific mechanisms govern education of Th17 cell responses and demonstrate that mechanical damage helps define the immune tone of this important oral barrier.	[Dutzan, Nicolas; Abusleme, Loreto; Greenwell-Wild, Teresa; Brenchley, Laurie; Calderon, Gloria; Moutsopoulos, Niki M.] NIDCR, Oral Immun & Inflammat Unit, NIH, Bethesda, MD 20892 USA; [Bridgeman, Hayley; Zangerle-Murray, Tamsin; Wemyss, Kelly; Konkel, Joanne E.] Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England; [Bridgeman, Hayley; Zangerle-Murray, Tamsin; Fife, Mark E.; Linley, Holly; Wemyss, Kelly; Konkel, Joanne E.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England; [Bouladoux, Nicolas; Belkaid, Yasmine] NIAID, Immun Barrier Sites Initiat, NIH, Bethesda, MD 20892 USA; [Bouladoux, Nicolas; Belkaid, Yasmine] NIAID, Parasit Dis Lab, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA; [Break, Timothy J.; Lionakis, Michail S.] NIAID, Fungal Pathogenesis Unit, NIH, Bethesda, MD 20892 USA; [Bowdish, Dawn M. E.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Jones, Simon A.] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, Wales; [Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hong, Bo-Young; Diaz, Patricia I.] UConn Hlth Ctr, Dept Oral Hlth & Diagnost Sci, Div Periodontol, Farmington, CT 06030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Manchester; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); McMaster University; Cardiff University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Connecticut	Moutsopoulos, NM (corresponding author), NIDCR, Oral Immun & Inflammat Unit, NIH, Bethesda, MD 20892 USA.; Konkel, JE (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England.; Konkel, JE (corresponding author), Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England.	joanne.konkel@manchester.ac.uk; nmoutsopoulos@dir.nidr.nih.gov	Hong, Bo-young/AAQ-1679-2021; Trinchieri, Giorgio/F-9369-2015; Dutzan, Nicolas/I-8838-2019; Lionakis, Michail/J-8840-2017; Moutsopoulos, Niki/A-9538-2019; Jones, Simon Arnett/Q-7017-2018	Trinchieri, Giorgio/0000-0001-5892-7464; Dutzan, Nicolas/0000-0001-8343-0214; Lionakis, Michail/0000-0003-4994-9500; Zangerle Murray, Tamsin/0000-0002-3112-1564; Jones, Simon Arnett/0000-0001-7297-9711; Hong, Bo-young/0000-0001-5055-0893; Bowdish, Dawn/0000-0001-6823-2957; Belkaid, Yasmine/0000-0001-9962-3571; Bouladoux, Nicolas/0000-0003-1593-671X; Wemyss, Kelly/0000-0003-0385-5920; Break, Timothy/0000-0001-5987-7817; Abusleme, Loreto/0000-0002-7210-1236	intramural program of NIDCR; BBSRC [BB/M025977/1]; Wellcome Trust [097820/Z/11/B, 105610/Z/14/Z]; Manchester Collaborative Centre for Inflammation Research; NATIONAL CANCER INSTITUTE [ZIABC011153, ZIABC011152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001175, ZIAAI001133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000736] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/M025977/1] Funding Source: researchfish; Kidney Research UK [RP_024_20160304] Funding Source: researchfish; Versus Arthritis [20770] Funding Source: researchfish	intramural program of NIDCR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Manchester Collaborative Centre for Inflammation Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Kidney Research UK(Kidney Research UK (KRUK)); Versus Arthritis(Versus Arthritis)	This study was funded in part from the intramural program of NIDCR (to N.M.M.), by the BBSRC (BB/M025977/1 to J.E.K.), by the Wellcome Trust (097820/Z/11/B and 105610/Z/14/Z to J.E.K.), and by the Manchester Collaborative Centre for Inflammation Research (to J.E.K). This work was also made possible through use of the University of Manchester Flow Cytometry Core Facility, the Manchester Gnotobiotic Facility (which is supported by the Wellcome Trust [097820/Z/11/B]), the NIAID and NIH Frederick Gnotobiotic facilities, the NIDCR Combined Technical Core, and the NIDCR Veterinary Resource Core. We thank Gnotobiotic Animal Facility staff, in particular V. Taylor (Manchester) and D. Trageser-Cesler and C. Acevedo (NIAID). Wethank Loretta Smith, Robin Winkler-Pickett (both NCI), and Sheila Brown (Manchester) for their help in planning experiments in the Gnotobiotic Facilities. We also thank Dr. J. Grainger for critical review of this manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dutzan N, 2016, MUCOSAL IMMUNOL, V9, P1163, DOI 10.1038/mi.2015.136; Dutzan N, 2016, JOVE-J VIS EXP, DOI 10.3791/53736; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Fukuno N, 2011, BIOCHEM BIOPH RES CO, V408, P202, DOI 10.1016/j.bbrc.2011.02.127; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hallmon W W, 1999, Ann Periodontol, V4, P102, DOI 10.1902/annals.1999.4.1.102; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kobayashi S, 2003, BIOCHEM BIOPH RES CO, V308, P306, DOI 10.1016/S0006-291X(03)01362-7; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lamont RJ, 2015, TRENDS MOL MED, V21, P172, DOI 10.1016/j.molmed.2014.11.004; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; LINDHE J, 1974, J CLIN PERIODONTOL, V1, P3, DOI 10.1111/j.1600-051X.1974.tb01234.x; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Moutsopoulos NM, 2015, J DENT RES, V94, P753, DOI 10.1177/0022034515583533; Moutsopoulos NM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007696; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Ouyang XS, 2011, CELL IMMUNOL, V266, P208, DOI 10.1016/j.cellimm.2010.10.007; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; POLSON AM, 1976, J PERIODONTAL RES, V11, P290, DOI 10.1111/j.1600-0765.1976.tb00083.x; Seo SU, 2015, IMMUNITY, V42, P744, DOI 10.1016/j.immuni.2015.03.004; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Skutek M, 2001, EUR J APPL PHYSIOL, V86, P48, DOI 10.1007/s004210100502; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2013, ANNU REV PATHOL-MECH, V8, P477, DOI 10.1146/annurev-pathol-011110-130318; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Zhang Y, 2015, IMMUNITY, V42, P309, DOI 10.1016/j.immuni.2015.01.014	47	130	130	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					133	147		10.1016/j.immuni.2016.12.010	http://dx.doi.org/10.1016/j.immuni.2016.12.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28087239	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000392918300016
J	Hu, DS; Mohanta, SK; Yin, CJ; Peng, L; Ma, Z; Srikakulapu, P; Grassia, G; MacRitchie, N; Dever, G; Gordon, P; Burton, FL; Ialenti, A; Sabir, SR; McInnes, IB; Brewer, JM; Garside, P; Weber, C; Lehmann, T; Teupser, D; Habenicht, L; Beer, M; Grabner, R; Maffia, P; Weih, F; Habenicht, AJR				Hu, Desheng; Mohanta, Sarajo K.; Yin, Changjun; Peng, Li; Ma, Zhe; Srikakulapu, Prasad; Grassia, Gianluca; MacRitchie, Neil; Dever, Gary; Gordon, Peter; Burton, Francis L.; Ialenti, Armando; Sabir, Suleman R.; McInnes, Iain B.; Brewer, James M.; Garside, Paul; Weber, Christian; Lehmann, Thomas; Teupser, Daniel; Habenicht, Livia; Beer, Michael; Grabner, Rolf; Maffia, Pasquale; Weih, Falk; Habenicht, Andreas J. R.			Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin beta Receptors	IMMUNITY			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; CENTRAL MEMORY; CD4(+); INFLAMMATION; PATHOGENESIS; RECRUITMENT; ACTIVATION; GENERATION; MONOCYTES	Tertiary lymphoid organs (TLOs) emerge during non-resolving peripheral inflammation, but their impact on disease progression remains unknown. We have found in aged Apoe(-/-) mice that artery TLOs (ATLOs) controlled highly territorialized aorta T cell responses. ATLOs promoted T cell recruitment, primed CD4(+) T cells, generated CD4(+), CD8(+), T regulatory (Treg) effector and central memory cells, converted naive CD4(+) T cells into induced Treg cells, and presented antigen by an unusual set of dendritic cells and B cells. Meanwhile, vascular smooth muscle cell lymphotoxin beta receptors (VSMC-LT beta Rs) protected against atherosclerosis by maintaining structure, cellularity, and size of ATLOs though VSMC-LT beta Rs did not affect secondary lymphoid organs: Atherosclerosis was markedly exacerbated in Apoe(-/-)Ltbr(-/-) and to a similar extent in aged Apoe(-/-)Ltbr(fl/fl)Tagln-cre mice. These data support the conclusion that the immune system employs ATLOs to organize aorta T cell homeostasis during aging and that VSMC-LT beta Rs participate in atherosclerosis protection via ATLOs.	[Hu, Desheng] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Hu, Desheng; Peng, Li; Grabner, Rolf; Weih, Falk] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Mohanta, Sarajo K.; Yin, Changjun; Ma, Zhe; Weber, Christian; Habenicht, Livia; Habenicht, Andreas J. R.] Univ Munich, Inst Cardiovasc Prevent, D-80336 Munich, Germany; [Peng, Li] Xiamen Univ, Coll Med, Dept Tradit Chinese Med, Xiamen 361102, Peoples R China; [Srikakulapu, Prasad] Univ Virginia, Cardiovasc Res Ctr CVRC, Charlottesville, VA 22908 USA; [Grassia, Gianluca; MacRitchie, Neil; Dever, Gary; Gordon, Peter; Sabir, Suleman R.; McInnes, Iain B.; Brewer, James M.; Garside, Paul; Maffia, Pasquale] Univ Glasgow, Coll Med Vet & Life Sci, Ctr Immunobiol, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Grassia, Gianluca; Ialenti, Armando; Maffia, Pasquale] Univ Naples Federico II, Dept Pharm, I-80131 Naples, Italy; [Gordon, Peter] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland; [Burton, Francis L.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Weber, Christian] Munich Heart Alliance, German Ctr Cardiovasc Res, DZHK, Munich, Germany; [Weber, Christian] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Lehmann, Thomas] Univ Jena, Jena Univ Hosp, Inst Med Stat, D-07743 Jena, Germany; [Teupser, Daniel] Univ Munich, Dept Lab Med, D-80336 Munich, Germany; [Habenicht, Livia] Tech Univ Munich, Med Klin & Poliklin 2, Klinikum Rechts Isar, D-81675 Munich, Germany; [Beer, Michael] Univ Jena, Jena Univ Hosp, Dept Informat Technol, D-07743 Jena, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Munich; Xiamen University; University of Virginia; University of Glasgow; University of Naples Federico II; University of Strathclyde; University of Glasgow; German Centre for Cardiovascular Research; Munich Heart Alliance; Maastricht University; Friedrich Schiller University of Jena; University of Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena	Habenicht, AJR (corresponding author), Univ Munich, Inst Cardiovasc Prevent, Pettenkoferstr 9, D-80336 Munich, Germany.	andreas.habenicht@med.uni-muenchen.de	Mohanta, Sarajo K/J-5441-2015; Mohanta, Sarajo/L-1355-2019; Weber, Christian/AAW-2153-2020; Habenicht, Andreas/HGA-2184-2022; Srikakulapu, Prasad/AAK-3185-2020; Grassia, Gianluca/H-7677-2019; Yin, Changjun/ABI-7117-2020; Brewer, James/A-7186-2010	Mohanta, Sarajo K/0000-0001-6144-4092; Mohanta, Sarajo/0000-0001-6144-4092; Weber, Christian/0000-0003-4610-8714; Srikakulapu, Prasad/0000-0003-3428-4518; Grassia, Gianluca/0000-0001-7846-5594; habenicht, andreas/0000-0003-2901-3027; Brewer, James/0000-0001-7933-0915; Yin, Changjun/0000-0002-1913-4477; Habenicht, Livia/0000-0002-6582-6458; Peng, Li/0000-0003-0646-8117	German Research Council [HA 1083/15-3, HA 1083/16-1, WE 2224/5-1, WE1913/11-2]; German Centre for Cardiovascular Research (MHA VD1.2) [SFB 1123/A1, SFB 1123/Z3]; European Research Council [AdG 249929]; People's Republic of China; British Heart Foundation [PG/06/083/21198, PG/12/81/29897]; Medical Research Scotland [276 FRG-L-0806]; Oliver Bird Studentship by Nuffield Foundation	German Research Council(German Research Foundation (DFG)); German Centre for Cardiovascular Research (MHA VD1.2); European Research Council(European Research Council (ERC)European Commission); People's Republic of China; British Heart Foundation(British Heart Foundation); Medical Research Scotland; Oliver Bird Studentship by Nuffield Foundation	We thank Volker Brinkmann (Department of Autoimmunity; Novartis Institutes for Biomedical Research) for a gift of FTY720 and advice regarding the need for splenectomy; Alexander Rudensky (Memorial Sloan-Kettering Cancer Center) for Foxp3 transgenic mice, and Yang-Xin Fu (Department for Pathology, University of Chicago) for Ltbr<SUP>fl/fl</SUP> mice. This work was supported by the German Research Council: HA 1083/15-3; 16-1 to A.J.R.H.; WE 2224/5-1; WE1913/11-2 to F.W.; the German Centre for Cardiovascular Research (MHA VD1.2), SFB 1123/A1 and Z3, and the European Research Council (AdG 249929) to C.W.; by a government fellowship of the People's Republic of China to Z.M.; by the British Heart Foundation to P.G. (PG/06/083/21198) and to P.M. (PG/12/81/29897); by the Medical Research Scotland (276 FRG-L-0806) to P.M.; and an Oliver Bird Studentship by the Nuffield Foundation to S.R.S.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Cao RY, 2009, ATHEROSCLEROSIS, V203, P395, DOI 10.1016/j.atherosclerosis.2008.07.045; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Lopez-Diego RS, 2008, NAT REV DRUG DISCOV, V7, P909, DOI 10.1038/nrd2358; Mackay CR, 2001, SCIENCE, V291, P2323, DOI 10.1126/science.1059984; MacRitchie N, 2012, ARTERIOSCL THROM VAS, V32, P2569, DOI 10.1161/ATVBAHA.112.251314; Maffia P, 2007, CIRCULATION, V115, pE326, DOI 10.1161/CIRCULATIONAHA.106.658492; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mikhak Z, 2013, J EXP MED, V210, P1855, DOI 10.1084/jem.20130091; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Mohanta SK, 2014, CIRC RES, V114, P1772, DOI 10.1161/CIRCRESAHA.114.301137; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schmitt MMN, 2014, CIRCULATION, V129, P66, DOI 10.1161/CIRCULATIONAHA.113.004149; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stopfer P, 2004, J IMMUNOL, V172, P7459, DOI 10.4049/jimmunol.172.12.7459; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Weber C, 2011, J CLIN INVEST, V121, P2898, DOI 10.1172/JCI44925; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Weyand CM, 2001, AM J PATHOL, V159, P787, DOI 10.1016/S0002-9440(10)61751-8; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	54	130	134	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1100	1115		10.1016/j.immuni.2015.05.015	http://dx.doi.org/10.1016/j.immuni.2015.05.015			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084025	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000356362800015
J	Chang, JT; Ciocca, ML; Kinjyo, I; Palanivel, VR; McClurkin, CE; De Jong, CS; Mooney, EC; Kim, JS; Steinel, NC; Oliaro, J; Yin, CC; Florea, BI; Overkleeft, HS; Berg, LJ; Russell, SM; Koretzky, GA; Jordan, MS; Reiner, SL				Chang, John T.; Ciocca, Maria L.; Kinjyo, Ichiko; Palanivel, Vikram R.; McClurkin, Courtney E.; De Jong, Caitlin S.; Mooney, Erin C.; Kim, Jiyeon S.; Steinel, Natalie C.; Oliaro, Jane; Yin, Catherine C.; Florea, Bogdan I.; Overkleeft, Herman S.; Berg, Leslie J.; Russell, Sarah M.; Koretzky, Gary A.; Jordan, Martha S.; Reiner, Steven L.			Asymmetric Proteasome Segregation as a Mechanism for Unequal Partitioning of the Transcription Factor T-bet during T Lymphocyte Division	IMMUNITY			English	Article							IMMUNOLOGICAL SYNAPSE; LINEAGE COMMITMENT; CELL-DIVISION; DIFFERENTIATION; KINASE; EXPRESSION; EFFECTOR; GAMMA; CD4; ITK	Polarized segregation of proteins in T cells is thought to play a role in diverse cellular functions including signal transduction, migration, and directed secretion of cytokines. Persistence of this polarization can result in asymmetric segregation of fate-determining proteins during cell division, which may enable a T cell to generate diverse progeny. Here, we provide evidence that a lineage-determining transcription factor, T-bet, underwent asymmetric organization in activated T cells preparing to divide and that it was unequally partitioned into the two daughter cells. This unequal acquisition of T-bet appeared to result from its asymmetric destruction during mitosis by virtue of concomitant asymmetric segregation of the proteasome. These results suggest a mechanism by which a cell may unequally localize cellular activities during division, thereby imparting disparity in the abundance of cell fate regulators in the daughter cells.	[Chang, John T.; Ciocca, Maria L.; Kinjyo, Ichiko; Palanivel, Vikram R.; McClurkin, Courtney E.; De Jong, Caitlin S.; Mooney, Erin C.; Kim, Jiyeon S.; Steinel, Natalie C.; Koretzky, Gary A.; Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Chang, John T.; Ciocca, Maria L.; Kinjyo, Ichiko; Palanivel, Vikram R.; McClurkin, Courtney E.; De Jong, Caitlin S.; Mooney, Erin C.; Kim, Jiyeon S.; Steinel, Natalie C.; Koretzky, Gary A.; Reiner, Steven L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Oliaro, Jane; Russell, Sarah M.] Peter MacCallum Canc Ctr, Immune Signalling Lab, Melbourne, Vic 2002, Australia; [Yin, Catherine C.; Berg, Leslie J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Florea, Bogdan I.; Overkleeft, Herman S.] Leiden Univ, NL-2333 CC Leiden, Netherlands; [Russell, Sarah M.] Swinburne Univ Technol, Fac Engn & Ind Sci, Ctr MicroPhoton, Hawthorn, Vic 3122, Australia; [Koretzky, Gary A.; Jordan, Martha S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Peter Maccallum Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; Leiden University; Leiden University - Excl LUMC; Swinburne University of Technology; University of Pennsylvania	Chang, JT (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	changj@ucsd.edu; sreiner@mail.med.upenn.edu	Steinel, Natalie C/R-3682-2018; Florea, Bogdan I./AAM-9975-2020; Koretzky, Gary/AAU-5381-2021; Russell, Sarah M/B-9341-2009	Russell, Sarah M/0000-0001-5826-9641; Steinel, Natalie/0000-0002-7585-8402; Florea, Bogdan Iulius/0000-0001-7114-2266; Chang, John/0000-0003-0873-6218; Overkleeft, Herman/0000-0001-6976-7005; Kinjyo, Ichiko/0000-0001-7051-3790; Oliaro, Jane/0000-0002-2097-6428	NIH [AI042370, AI076458, AI061699, DK080949, AGA-FDHN, T32HD007516, AI37584, AI46564, CA093615, GM053256, AR052802]; Abramson Family; NHMRC; Peter MacCallum Cancer Centre; HFSP; ARC; UCSD Digestive Diseases Research Development Center [DK80506]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA093615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055428, R01AI046564, R56AI076458, R01AI076458, R01AI061699, R01AI084987, R01AI037584, R01AI042370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, K08DK080949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053256, R37GM053256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Family; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Peter MacCallum Cancer Centre; HFSP(Human Frontier Science Program); ARC(Australian Research Council); UCSD Digestive Diseases Research Development Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Birnbaum for use of the confocal microscope; A. Stout for assistance with time-lapse microscopy; J. Burkhardt for the use of the electroporator; and E. Holzbaur, L. Boyd, I. Su, A. Banerjee, S. Gordon, M. Paley, R. May, L. Rupp, and K. Baraldi for assistance and discussion. Supported by NIH grants AI042370, AI076458, and AI061699 and the Abramson Family (S.L.R.); NIH grant DK080949 and AGA-FDHN (J.T.C.); NIH grants T32HD007516 (M.L.C.), AI37584 and AI46564 (L.J.B.), CA093615 and GM053256 (G.A.K.), and AR052802 (M.S.J.); NHMRC (J.O.); Peter MacCallum Cancer Centre, NHMRC, HFSP, and ARC (S.M.R.); and the UCSD Digestive Diseases Research Development Center Grant DK80506. J.T.C. is a Howard Hughes Medical Institute Physician-Scientist Early Career Awardee.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Azar GA, 2010, P NATL ACAD SCI USA, V107, P3675, DOI 10.1073/pnas.0905901107; Barcia C, 2006, J EXP MED, V203, P2095, DOI 10.1084/jem.20060420; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Day D, 2009, IMMUNOL CELL BIOL, V87, P154, DOI 10.1038/icb.2008.79; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Florea BI, 2010, CHEM BIOL, V17, P795, DOI 10.1016/j.chembiol.2010.05.027; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Friedman RS, 2010, J EXP MED, V207, P2733, DOI 10.1084/jem.20091201; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Martin P, 2005, P NATL ACAD SCI USA, V102, P9866, DOI 10.1073/pnas.0501202102; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; Smith-Garvin JE, 2010, BLOOD, V116, P5548, DOI 10.1182/blood-2010-06-292748; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543	47	130	134	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 22	2011	34	4					492	504		10.1016/j.immuni.2011.03.017	http://dx.doi.org/10.1016/j.immuni.2011.03.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21497118	Green Accepted, Bronze			2022-12-18	WOS:000290367300009
J	Borbulevych, OY; Piepenbrink, KH; Gloor, BE; Scott, DR; Sommese, RF; Cole, DK; Sewell, AK; Baker, BM				Borbulevych, Oleg Y.; Piepenbrink, Kurt H.; Gloor, Brian E.; Scott, Daniel R.; Sommese, Ruth F.; Cole, David K.; Sewell, Andrew K.; Baker, Brian M.			T Cell Receptor Cross-reactivity Directed by Antigen-Dependent Tuning of Peptide-MHC Molecular Flexibility	IMMUNITY			English	Article							CRYSTAL-STRUCTURES; RECOGNITION; COMPLEX; DYNAMICS; BINDING; PROTEINS; PLASTICITY; STABILITY; MOTIONS; SIGNALS	T cell-mediated immunity requires T cell receptor (TCR) cross-reactivity, the mechanisms behind which remain incompletely elucidated. The alpha beta TCR A6 recognizes both the Tax (LLFGYPVYV) and Tel1p (MLWGYLQYV) peptides presented by the human class I MHC molecule HLA-A2. Here we found that although the two ligands are ideal structural mimics, they form substantially different interfaces with A6, with conformational differences in the peptide, the TCR, and unexpectedly, the MHC molecule. The differences between the Tax and Tel1p ternary complexes could not be predicted from the free peptide-MHC structures and are inconsistent with a traditional induced-fit mechanism. Instead, the differences were attributable to peptide and MHC molecular motion present in Tel1p-HLA-A2 but absent in Tax-HLA-A2. Differential "tuning" of the dynamic properties of HLA-A2 by the Tax and Tell p peptides thus facilitates cross-recognition and impacts how structural diversity can be presented to and accommodated by receptors of the immune system.	[Borbulevych, Oleg Y.; Piepenbrink, Kurt H.; Gloor, Brian E.; Scott, Daniel R.; Sommese, Ruth F.; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Baker, Brian M.] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA; [Cole, David K.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales	University of Notre Dame; University of Notre Dame; Walther Cancer Institute; Cardiff University	Baker, BM (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 251 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.		Cole, David/C-8387-2012; Sewell, Andrew/GPT-4220-2022; Baker, Brian/B-4584-2009	Sewell, Andrew/0000-0003-3194-3135; Baker, Brian/0000-0002-0864-0964; Cole, David/0000-0003-0028-9396; Piepenbrink, Kurt/0000-0002-2527-0301	NIGMS (NIH) [R01GM06079, T32GM075762]; NSF [MCB0448298]; Notre Dame CBBI training program;  [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067079, T32GM075762] Funding Source: NIH RePORTER	NIGMS (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Notre Dame CBBI training program; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F Insaidoo for helpful discussion, A. Wojnarowicz for technical assistance, and P Kamat for use of a FluoroCube 5000U instrument. Supported by grants R01GM06079 from NIGMS (NIH) and MCB0448298 from NSF. Results shown in this report are derived from work performed at the Structural Biology Center and Lilly Research Laboratories Collaborative Access Teams (SBC-CAT and LRL-CAT) at the Advanced Photon Source, Argonne National Laboratory Argonne is operated by UChicago Argonne, LLC, for the U S Department of Energy under contract DE-AC02-06CH11357 Use of the LRL-CAT facilities at Sector 31 of the Advanced Photon Source was provided by Eli Lilly & Company, who operates the facility K H P was supported by the Notre Dame CBBI training program, funded by T32GM075762 from NIGMS (NIH)	Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; Armstrong KM, 2007, BIOPHYS J, V93, P597, DOI 10.1529/biophysj.107.104570; Binz AK, 2003, BIOCHEMISTRY-US, V42, P4954, DOI 10.1021/bi034077m; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Gagnon SJ, 2006, J MOL BIOL, V363, P228, DOI 10.1016/j.jmb.2006.08.045; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Hausmann S, 1999, J IMMUNOL, V162, P5389; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Kim MK, 1999, PROTEIN SCI, V8, P1492, DOI 10.1110/ps.8.7.1492; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Laugel B, 2005, J BIOL CHEM, V280, P1882, DOI 10.1074/jbc.M409427200; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Miller DW, 1997, PROTEIN SCI, V6, P2166; Piepenbrink KH, 2009, BIOCHEM J, V423, P353, DOI 10.1042/BJ20090732; Pohlmann T, 2004, J BIOL CHEM, V279, P28197, DOI 10.1074/jbc.C400128200; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rudolph MG, 2001, IMMUNITY, V14, P231, DOI 10.1016/S1074-7613(01)00105-4; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432	39	130	131	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					885	896		10.1016/j.immuni.2009.11.003	http://dx.doi.org/10.1016/j.immuni.2009.11.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064447	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000273616400009
J	Wilson, EH; Harris, TH; Mrass, P; John, B; Tait, ED; Wu, GF; Pepper, M; Wherry, EJ; Dzierzinski, F; Roos, D; Haydon, PG; Laufer, TM; Weninger, W; Hunter, CA				Wilson, Emma H.; Harris, Tajie H.; Mrass, Paulus; John, Beena; Tait, Elia D.; Wu, Gregory F.; Pepper, Marion; Wherry, E. John; Dzierzinski, Florence; Roos, David; Haydon, Philip G.; Laufer, Terri M.; Weninger, Wolfgang; Hunter, Christopher A.			Behavior of Parasite-Specific Effector CD8(+) T Cells in the Brain and Visualization of a Kinesis-Associated System of Reticular Fibers	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LYMPH-NODE; TOXOPLASMA-GONDII; IN-VIVO; MIGRATION; MOTILITY; INFECTION; ANTIGEN; TRAFFICKING; COLLAGEN	To understand lymphocyte behavior in the brain, we used two-photon microscopy to visualize effector CD8(+) T cells during toxoplasmic encephalitis. These cells displayed multiple behaviors with two distinct populations of cells apparent: one with a constrained pattern of migration and one with a highly migratory subset. The proportion of these populations varied over time associated with changes in antigen availability as well as T cell expression of the inhibitory receptor PD1. Unexpectedly, the movement of infiltrating cells was closely associated with an infection-induced reticular system of fibers. This observation suggests that, whereas in other tissues pre-existing scaffolds exist that guide lymphocyte migration, in the brain specialized structures are induced by inflammation that guide migration of T cells in this immune-privileged environment.	[Haydon, Philip G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Roos, David] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Dzierzinski, Florence] McGill Univ, Inst Parasitol, Montreal, PQ, Canada; [Wu, Gregory F.; Laufer, Terri M.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Mrass, Paulus; Wherry, E. John; Weninger, Wolfgang] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Wilson, Emma H.; Harris, Tajie H.; John, Beena; Tait, Elia D.; Pepper, Marion; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Tufts University; University of Pennsylvania; McGill University; University of Pennsylvania; The Wistar Institute; University of Pennsylvania	Wilson, EH (corresponding author), Univ Calif Riverside, Dept Biomed Sci, Riverside, CA 92521 USA.	emmaw@ucr.edu; chunter@vet.upenn.edu	Hunter, Christopher/H-1970-2011; Wherry, John/ABI-1280-2020	Harris, Tajie/0000-0002-1355-2109; Weninger, Wolfgang/0000-0003-3133-8699; Roos, David Siker/0000-0001-6725-4089; Tait Wojno, Elia/0000-0003-2822-296X	National Institutes of Health [A141158]; state of Pennsylvania; Max Kade Foundation, Inc.; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041158, T32AI007532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); state of Pennsylvania; Max Kade Foundation, Inc.; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank M. Izzo at Volocity and J.E. Hayden, L.G. Ng, and C. Hoeller for technical assistance and helpful discussions. C.A.H. was supported by a grant from the National Institutes of Health (A141158) and the state of Pennsylvania and is a member of the Marie Lowe and Abramson Cancer Centers. P.M. is a fellow of the Max Kade Foundation, Inc., and the recipient of a Cancer Research Institute postcloctoral fellowship. Thanks to U. von Andrian and R. Germain for discussions during this project.	Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; BARKER CF, 1977, ADV IMMUNOL, V25, P1; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Cox Guy, 2006, V319, P15; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Galea I, 2007, J EXP MED, V204, P2023, DOI 10.1084/jem.20070064; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Heck N, 2007, MOL CELL NEUROSCI, V36, P71, DOI 10.1016/j.mcn.2007.06.002; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; HUNTER CA, 1994, J INFECT DIS, V170, P1057, DOI 10.1093/infdis/170.5.1057; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Mrass P, 2006, IMMUNOL REV, V213, P195, DOI 10.1111/j.1600-065X.2006.00433.x; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P920, DOI 10.1073/pnas.0608383104; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Pepper M, 2004, INFECT IMMUN, V72, P7240, DOI 10.1128/IAI.72.12.7240-7246.2004; Reichmann G, 1999, J IMMUNOL, V163, P3354; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376; Yasui T, 2004, APPL OPTICS, V43, P2861, DOI 10.1364/AO.43.002861; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	46	130	134	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					300	311		10.1016/j.immuni.2008.12.013	http://dx.doi.org/10.1016/j.immuni.2008.12.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19167248	Bronze, Green Accepted			2022-12-18	WOS:000263710500016
J	Glusman, G; Rowen, L; Lee, I; Boysen, C; Roach, JC; Smit, AFA; Wang, K; Koop, BF; Hood, L				Glusman, G; Rowen, L; Lee, I; Boysen, C; Roach, JC; Smit, AFA; Wang, K; Koop, BF; Hood, L			Comparative genomics of the human and mouse T cell receptor loci	IMMUNITY			English	Review							CONSERVED SEQUENCE; BETA; EVOLUTION; GENE; ORGANIZATION; ALPHA; ELEMENTS; MURINE; REGION; LOCUS	The availability of the complete genomic sequences of the human and mouse T cell receptor loci opens up new opportunities for understanding T cell receptors (TCRs) and their genes. The full complement of TCR gene segments is finally known and should prove a valuable resource for supporting functional studies. A rational nomenclature system has been implemented and is widely available through IMGT and other public databases. Systematic comparisons of the genomic sequences within each locus, between loci, and across species enable precise analyses of the various diversification mechanisms and some regulatory signals. The genomic landscape of the TCR loci provides fundamental insights into TCR evolution as highly localized and tightly regulated gene families.	Inst Syst Biol, Seattle, WA 98105 USA; Paracel Inc, Pasadena, CA 91106 USA; Phenogenom Corp, Bothell, WA 98021 USA; Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada	Institute for Systems Biology (ISB); University of Victoria	Hood, L (corresponding author), Inst Syst Biol, 4225 Roosevelt Way NE, Seattle, WA 98105 USA.	lhood@systemsbiology.org	Koop, Ben F./A-8151-2008	Koop, Ben F./0000-0003-0045-5200; Glusman, Gustavo/0000-0001-8060-5955				Aderem A, 2001, NAT IMMUNOL, V2, P373, DOI 10.1038/87665; ANDERSON SJ, 1988, P NATL ACAD SCI USA, V85, P3551, DOI 10.1073/pnas.85.10.3551; [Anonymous], 1995, Immunogenetics, V42, P451; Arden Bernhard, 1995, Immunogenetics, V42, P455; Arden Bernhard, 1995, Immunogenetics, V42, P501; Clark Stephen P., 1995, Immunogenetics, V42, P531; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Finta C, 2000, GENOMICS, V63, P433, DOI 10.1006/geno.1999.6063; Finta C, 2000, GENE, V260, P13, DOI 10.1016/S0378-1119(00)00470-4; Funkhouser W, 1997, MOL PHYLOGENET EVOL, V8, P51, DOI 10.1006/mpev.1997.0406; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Glusman G, 2000, BIOINFORMATICS, V16, P482, DOI 10.1093/bioinformatics/16.5.482; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; KOOP BF, 1994, NAT GENET, V7, P48, DOI 10.1038/ng0594-48; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; Kuo CL, 1998, P NATL ACAD SCI USA, V95, P3839, DOI 10.1073/pnas.95.7.3839; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; LEFRANC MP, T CELL RECEPTOR FACT; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; RAMSDEN DA, 1994, NUCLEIC ACIDS RES, V22, P1785, DOI 10.1093/nar/22.10.1785; Rast JP, 1997, IMMUNITY, V6, P1, DOI 10.1016/S1074-7613(00)80237-X; RATANAVONGSIRI J, 1990, J IMMUNOL, V144, P1111; Richards MH, 2000, MOL BIOL EVOL, V17, P146, DOI 10.1093/oxfordjournals.molbev.a026227; ROBINSON MA, 1993, P NATL ACAD SCI USA, V90, P2433, DOI 10.1073/pnas.90.6.2433; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SEBOUN E, 1989, J EXP MED, V170, P1263, DOI 10.1084/jem.170.4.1263; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Yang LM, 1997, J IMMUNOL, V158, P2522; ZHAO TM, 1994, J EXP MED, V180, P1405, DOI 10.1084/jem.180.4.1405; Zhu C, 1996, CANCER SURV, V28, P295	36	130	140	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2001	15	3			SI		337	349		10.1016/S1074-7613(01)00200-X	http://dx.doi.org/10.1016/S1074-7613(01)00200-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567625	Bronze			2022-12-18	WOS:000171211800002
J	Cannon, JL; Labno, CM; Bosco, G; Seth, A; McGavin, MHK; Siminovitch, KA; Rosen, MK; Burkhardt, JK				Cannon, JL; Labno, CM; Bosco, G; Seth, A; McGavin, MHK; Siminovitch, KA; Rosen, MK; Burkhardt, JK			WASP recruitment to the T cell : APC contact site occurs independently of Cdc42 activation	IMMUNITY			English	Article							WISKOTT-ALDRICH-SYNDROME; SYNDROME PROTEIN WASP; ACTIN POLYMERIZATION; ARP2/3 COMPLEX; ANTIGEN-RECEPTOR; N-WASP; GOLGI-APPARATUS; CYTOSKELETAL REARRANGEMENT; SIGNAL-TRANSDUCTION; GENETIC-EVIDENCE	Cdc42 and WASP are critical regulators of actin polymerization whose function during T cell signaling is poorly understood. Using a novel reagent that specifically detects Cdc42-GTP in fixed cells, we found that activated Cdc42 localizes to the T cell:APC contact site in an antigen-dependent manner. TCR signaling alone was sufficient to induce localization of Cdc42-GTP, and functional Lck and Zap-70 kinases were required. WASP also localized to the T cell:APC contact site in an antigen-dependent manner. Surprisingly, WASP localization was independent of the Cdc42 binding domain but required the proline-rich domain. Our results indicate that localized WASP activation requires the integration of multiple signals: WASP is recruited via interaction with SH3 domain-containing proteins and is activated by Cdc42-GTP concentrated at the same site.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Immunol, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada	University of Chicago; University of Chicago; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Burkhardt, JK (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jburkhar@uchicago.edu	Siminovitch, Katherine/K-1475-2013	Cannon, Judy/0000-0003-0069-8106	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI44835] Funding Source: Medline; NIGMS NIH HHS [R01 GM56322] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Anton IM, 1998, J BIOL CHEM, V273, P20992, DOI 10.1074/jbc.273.33.20992; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; Binks M, 1998, EUR J IMMUNOL, V28, P3259; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Borroto A, 2000, EUR J IMMUNOL, V30, P3403, DOI 10.1002/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Denny MF, 1999, J BIOL CHEM, V274, P5146, DOI 10.1074/jbc.274.8.5146; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Fischer KD, 1998, SEMIN IMMUNOL, V10, P317, DOI 10.1006/smim.1998.0124; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Galandrini R, 1997, IMMUNITY, V7, P163, DOI 10.1016/S1074-7613(00)80519-1; Gallego MD, 1997, BLOOD, V90, P3089, DOI 10.1182/blood.V90.8.3089; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Henning SW, 1997, EMBO J, V16, P2397, DOI 10.1093/emboj/16.9.2397; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; KENNEY D, 1986, BLOOD, V68, P1329; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; KUPFER A, 1984, J IMMUNOL, V133, P2762; KUPFER A, 1986, J EXP MED, V163, P489, DOI 10.1084/jem.163.3.489; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; LI R, 1995, J CELL BIOL, V128, P599, DOI 10.1083/jcb.128.4.599; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Mullins RD, 1999, CURR BIOL, V9, P405, DOI 10.1016/S0960-9822(99)80187-0; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Ochs HD, 1998, SEMIN HEMATOL, V35, P332; PARSEY MV, 1993, J IMMUNOL, V151, P1881; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1995, CURR OPIN GENET DEV, V5, P24, DOI 10.1016/S0959-437X(95)90049-7; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Savoy DN, 2000, J IMMUNOL, V164, P2866, DOI 10.4049/jimmunol.164.6.2866; Sedwick CE, 1999, J IMMUNOL, V162, P1367; Sherman LS, 2000, J BIOL CHEM, V275, P30740, DOI 10.1074/jbc.M001702200; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tu H, 1999, MOL CELL BIOL, V19, P602; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x; Zuckerman LA, 1998, J IMMUNOL, V160, P3259	73	130	131	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2001	15	2					249	259		10.1016/S1074-7613(01)00178-9	http://dx.doi.org/10.1016/S1074-7613(01)00178-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520460	Bronze			2022-12-18	WOS:000170717200007
J	Youn, HD; Liu, JO				Youn, HD; Liu, JO			Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2	IMMUNITY			English	Article							TRANSCRIPTION FACTOR MEF2; ORPHAN STEROID-RECEPTOR; MADS BOX; N-COR; YEAST; COMPLEX; GENE; COREPRESSOR; ACTIVATION; PROTEINS	TCR signaling leading to thymocyte apoptosis is mediated through the expression of the Nur77 family of orphan nuclear receptors. MEF2 has been shown to be the major transcription factor responsible for calcium-dependent Nur77 transcription. Cabin1 was recently identified as a transcriptional repressor of MEF2, which can be released from MEF2 in a calcium-dependent fashion. The molecular basis of repression of MEF2 by Cabin1, however, has remained unknown. We report that Cabin1 represses MEF2 by two distinct mechanisms. Cabin1 recruits mSin3 and its associated histone deacetylases 1 and 2; Cabin1 also competes with p300 for binding to MEF2. Thus, activation of MEF2 and the consequent transcription of Nur77 are controlled by the association of MEF2 with the histone deacetylases via the calcium-dependent repressor Cabin1.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Liu, JO (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.		Youn, Hong-Duk/J-2774-2012		NIGMS NIH HHS [GM55783] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055783] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Grant PA, 1998, TRENDS CELL BIOL, V8, P193, DOI 10.1016/S0962-8924(98)01263-X; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; LEIFER D, 1993, P NATL ACAD SCI USA, V90, P1546, DOI 10.1073/pnas.90.4.1546; LIU ML, 1994, J BIOL CHEM, V269, P28514; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; MARTIN JF, 1993, P NATL ACAD SCI USA, V90, P5282, DOI 10.1073/pnas.90.11.5282; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Ornatsky OI, 1996, J BIOL CHEM, V271, P24927, DOI 10.1074/jbc.271.40.24927; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Winoto A, 1997, CURR OPIN IMMUNOL, V9, P365, DOI 10.1016/S0952-7915(97)80083-0; Wong B, 1997, CURR OPIN IMMUNOL, V9, P358, DOI 10.1016/S0952-7915(97)80082-9; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; YOUN HD, 2000, IN PRESS J BIOL CHEM; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Zhang BG, 1997, DYN CONTIN DISCRET I, V3, P89	54	130	132	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2000	13	1					85	94		10.1016/S1074-7613(00)00010-8	http://dx.doi.org/10.1016/S1074-7613(00)00010-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933397	Bronze			2022-12-18	WOS:000088463600009
J	Kawamoto, H; Ikawa, T; Ohmura, K; Fujimoto, S; Katsura, Y				Kawamoto, H; Ikawa, T; Ohmura, K; Fujimoto, S; Katsura, Y			T cell progenitors emerge earlier than B cell progenitors in the murine fetal liver	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; INTERLEUKIN-7 RECEPTOR; DENDRITIC CELLS; MYELOID-LINEAGE; CUTTING EDGE; THYMUS; GENE; DIFFERENTIATION; MOUSE	The developmental potential of individual cells in the Lin(-)c-kit(+)CD45(+)IL-7R(+) (IL-7R(+)) population from murine fetal liver was investigated using a clonal assay capable of determining the potential of a progenitor to give rise to myeloid, T, and B cells. Unipotent progenitors generating T cells (p-T) or B cells (p-B) but not other types of progenitors were found in the IL-7R(+) population. A large proportion of progenitors at day 12 of gestation are p-T, whereas the frequency of p-T dramatically decreases with gestational age. In marked contrast, p-B are very rare by day 12, but they rapidly increase thereafter. These findings strongly suggest that the commitment of multipotent progenitors to T and B cell lineages occurs independently.	Kyoto Univ, Dept Immunol, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Katsura, Y (corresponding author), Kyoto Univ, Dept Immunol, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.							ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; Aiba Y, 1997, BLOOD, V90, P3923, DOI 10.1182/blood.V90.10.3923; AKASHI K, 1993, EXP HEMATOL, V21, P743; Akashi K, 1999, INT J HEMATOL, V69, P217; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Bjorck P, 1998, J IMMUNOL, V161, P5795; BORRELLO MA, 1995, J IMMUNOL, V155, P4155; BOYD AW, 1982, NATURE, V297, P691, DOI 10.1038/297691a0; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Ema H, 1998, EUR J IMMUNOL, V28, P1563, DOI 10.1002/(SICI)1521-4141(199805)28:05<1563::AID-IMMU1563>3.0.CO;2-R; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Ikawa T, 1999, J EXP MED, V190, P1617, DOI 10.1084/jem.190.11.1617; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; KATSURA Y, 1988, EUR J IMMUNOL, V18, P889, DOI 10.1002/eji.1830180609; Kawamoto H, 1999, J IMMUNOL, V162, P2725; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; Kawamoto H, 1998, J IMMUNOL, V161, P3799; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; OGAWA M, 1993, BLOOD, V81, P2844; Ohmura K, 1999, J IMMUNOL, V163, P4788; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; Ryan DH, 1997, BLOOD, V89, P929, DOI 10.1182/blood.V89.3.929; Schmidt CA, 1996, BRIT J HAEMATOL, V92, P929, DOI 10.1046/j.1365-2141.1996.426964.x; Spain LM, 1999, J IMMUNOL, V163, P2681; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1988, J IMMUNOL, V141, P1877; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WATANABE Y, 1993, EUR J IMMUNOL, V23, P200, DOI 10.1002/eji.1830230131; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	47	130	132	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2000	12	4					441	450		10.1016/S1074-7613(00)80196-X	http://dx.doi.org/10.1016/S1074-7613(00)80196-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	309FH	10795742	Bronze			2022-12-18	WOS:000086757300009
J	Ferretti, AP; Kula, T; Wang, YF; Nguyen, DMV; Weinheimer, A; Dunlap, GS; Xu, QK; Nabilsi, N; Perullo, CR; Cristofaro, AW; Whitton, HJ; Virbasius, A; Olivier, KJ; Buckner, LR; Alistar, AT; Whitman, ED; Bertino, SA; Chattopadhyay, S; MacBeath, G				Ferretti, Andrew P.; Kula, Tomasz; Wang, Yifan; Nguyen, Dalena M., V; Weinheimer, Adam; Dunlap, Garrett S.; Xu, Qikai; Nabilsi, Nancy; Perullo, Candace R.; Cristofaro, Alexander W.; Whitton, Holly J.; Virbasius, Amy; Olivier, Kenneth J., Jr.; Buckner, Lyndsey R.; Alistar, Angela T.; Whitman, Eric D.; Bertino, Sarah A.; Chattopadhyay, Shrikanta; MacBeath, Gavin			Unbiased Screens Show CD8(+) T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein	IMMUNITY			English	Article							ACUTE RESPIRATORY SYNDROME; NEURAL-NETWORKS; RESPONSES; PROTECTION	Developing effective strategies to prevent or treat coronavirus disease 2019 (COVID-19) requires understanding the natural immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used an unbiased, genome-wide screening technology to determine the precise peptide sequences in SARS-CoV-2 that are recognized by the memory CD8(+) T cells of COVID-19 patients. In total, we identified 3-8 epitopes for each of the 6 most prevalent human leukocyte antigen (HLA) types. These epitopes were broadly shared across patients and located in regions of the virus that are not subject to mutational variation. Notably, only 3 of the 29 shared epitopes were located in the spike protein, whereas most epitopes were located in ORF1ab or the nucleocapsid protein. We also found that CD8(+) T cells generally do not cross-react with epitopes in the four seasonal coronaviruses that cause the common cold. Overall, these findings can inform development of next-generation vaccines that better recapitulate natural CD8(+) T cell immunity to SARS-CoV-2.	[Ferretti, Andrew P.; Kula, Tomasz; Wang, Yifan; Nguyen, Dalena M., V; Weinheimer, Adam; Dunlap, Garrett S.; Xu, Qikai; Nabilsi, Nancy; Perullo, Candace R.; Cristofaro, Alexander W.; Whitton, Holly J.; Virbasius, Amy; Olivier, Kenneth J., Jr.; Bertino, Sarah A.; Chattopadhyay, Shrikanta; MacBeath, Gavin] TScan Therapeut, Waltham, MA 02451 USA; [Buckner, Lyndsey R.] Ochsner Med Ctr, New Orleans, LA 70121 USA; [Alistar, Angela T.; Whitman, Eric D.] Atlantic Hlth Syst, Morristown, NJ 07960 USA; [Kula, Tomasz] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA	Ochsner Health System; Atlantic Health System; Harvard University	MacBeath, G (corresponding author), TScan Therapeut, Waltham, MA 02451 USA.	gmacbeath@tscan.com		Dunlap, Garrett/0000-0002-2627-0506; Cristofaro, Alexander/0000-0001-7905-9264; Nguyen, Dalena/0000-0003-2384-1446; Kula, Tomasz/0000-0002-6458-9833	TScan Therapeutics	TScan Therapeutics	We thank the patients and their families who participated in this study. We also thank Stephen Elledge and Kai Wucherpfennig for helpful discussions. This work was supported by TScan Therapeutics, a privately owned biotechnology company.	Albert-Vega C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02367; Altmann DM, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6160; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Gonzalez-Galarza FF, 2020, NUCLEIC ACIDS RES, V48, pD783, DOI 10.1093/nar/gkz1029; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591; Kula T, 2019, CELL, V178, P1016, DOI 10.1016/j.cell.2019.07.009; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Mulligan MJ, 2020, PHASE 1 2 STUDY DESC, DOI [10.1038/s41586-020-2639-4, 10.1101/2020.06.30.20142570]; Ng OW, 2016, VACCINE, V34, P2008, DOI 10.1016/j.vaccine.2016.02.063; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Peng H, 2006, VIROLOGY, V351, P466, DOI 10.1016/j.virol.2006.03.036; Sahin U, 2020, CONCURRENT HUMAN ANT, DOI [10.1101/2020.07.17.20140533, DOI 10.1101/2020.07.17.20140533]; Sekine T., 2020, CELL, DOI [10.1101/2020.06.29.174888, DOI 10.1016/J.CELL.2020.08.017, 10.1016/j.cell.2020.08.017]; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI [10.1038/s41564-020-00813-8, DOI 10.1038/S41564-020-00813-8, 10.1101/2020.07.09.20148429]; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Tang F, 2011, J IMMUNOL, V186, P7264, DOI 10.4049/jimmunol.0903490; Thieme C., 2020, J CLIN INVEST, DOI DOI 10.1172/JCI140965; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10	32	129	137	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					1095	+		10.1016/j.immuni.2020.10.006	http://dx.doi.org/10.1016/j.immuni.2020.10.006			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33128877	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000599348200018
J	Hong, S; Zhang, ZM; Liu, HT; Tian, MJ; Zhu, XP; Zhang, ZQ; Wang, WH; Zhou, XY; Zhang, FP; Ge, Q; Zhu, B; Tang, H; Hua, ZL; Hou, BD				Hong, Sheng; Zhang, Zhimin; Liu, Hongtao; Tian, Meijie; Zhu, Xiping; Zhang, Zhuqiang; Wang, Weihong; Zhou, Xuyu; Zhang, Fuping; Ge, Qing; Zhu, Bing; Tang, Hong; Hua, Zhaolin; Hou, Baidong			B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4(+) T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen	IMMUNITY			English	Article							ADAPTIVE IMMUNE-RESPONSES; GERMINAL CENTER; DENDRITIC CELLS; TRANSGENIC MICE; INNATE; LYMPHOCYTES; EXPRESSION; INFECTION; SELF; DIFFERENTIATION	B cells can present antigens to CD4(+) T cells, but it is thought that dendritic cells (DCs) are the primary initiators of naive CD4(+) T cell responses. Nanoparticles, including virus-like particles (VLPs), are attractive candidates as carriers for vaccines and drug delivery. Using RNA phage DO-derived VLP (Q beta-VLP) as a model antigen, we found that antigen-specific B cells were the dominant antigen-presenting cells that initiated naive CD4(+) T cell activation. B cells were sufficient to induce T follicular helper cell development in the absence of DCs. DO-specific B cells promoted CD4(+) T cell proliferation and differentiation via cognate interactions and through Toll-like receptor signaling-mediated cytokine production. Antigen-specific B cells were also involved in initiating CD4(+) T cell responses during immunization with inactivated influenza virus. These findings have implications for the rational design of nanoparticles as vaccine candidates, particularly for therapeutic vaccines that aim to break immune tolerance.	[Hong, Sheng; Zhang, Zhimin; Tian, Meijie; Wang, Weihong; Hua, Zhaolin; Hou, Baidong] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100101, Peoples R China; [Zhang, Zhimin; Zhu, Xiping; Zhou, Xuyu; Zhang, Fuping; Zhu, Bing; Hua, Zhaolin; Hou, Baidong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Liu, Hongtao; Zhou, Xuyu; Zhang, Fuping] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Zhu, Xiping; Zhang, Zhuqiang; Zhu, Bing] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Ge, Qing] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Key Lab Med Immunol,Minist Hlth,Dept Immunol, Beijing 100191, Peoples R China; [Tang, Hong] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Hua, ZL; Hou, BD (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100101, Peoples R China.; Hua, ZL; Hou, BD (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Tang, H (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.	htang@ips.ac.cn; zlhua@moon.ibp.ac.cn; baidong_hou@sun5.ibp.ac.cn	Zhang, Zhuqiang/P-7329-2019; Zhou, Xuyu/L-7422-2019	Zhang, Zhuqiang/0000-0001-6513-2854; Zhou, Xuyu/0000-0002-6626-0898; Tian, Meijie/0000-0003-0547-9447; Wang, Weihong/0000-0002-0226-9244	Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB03]; Chinese National 973 Program [2015CB554303]; National Natural Science Foundation of China [81590764, 31370888, 31470863]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	3 We thank Dr. Ping Zhu and his laboratory members for helping with examination of VLP with electron microscopy. We thank Dr. Jie Sun for providing PR8OVA influenza viruses. We thank our lab members Yifan Liu, Lin Lin, Leyang Xin, Can Liu, and Xiangfei Xie for their technique help. We thank Dr. Anthony L. DeFranco for his thorough reading of the manuscript and constructive comments. The work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences XDPB03 (to B.H.), Chinese National 973 Program 2015CB554303 (to Z.H.), and National Natural Science Foundation of China 81590764, 31370888 (to B.H.), and 31470863 (to Z.H.).	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Browne EP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002293; Chan OTM, 1999, IMMUNOL REV, V169, P107, DOI 10.1111/j.1600-065X.1999.tb01310.x; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Clark MR, 2004, CURR OPIN IMMUNOL, V16, P382, DOI 10.1016/j.coi.2004.03.007; Clingan JM, 2013, J IMMUNOL, V191, P810, DOI 10.4049/jimmunol.1300244; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; EPSTEIN MM, 1995, J EXP MED, V182, P915, DOI 10.1084/jem.182.4.915; Gomes AC, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5010006; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Hua LQ, 2013, J VIROL, V87, P11884, DOI 10.1128/JVI.01461-13; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; KOZLOVSKA TM, 1993, GENE, V137, P133, DOI 10.1016/0378-1119(93)90261-Z; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Liao WH, 2017, J IMMUNOL, V198, P3846, DOI 10.4049/jimmunol.1601852; Link A, 2012, J IMMUNOL, V188, P3724, DOI 10.4049/jimmunol.1103312; Ludwig C, 2007, CURR OPIN BIOTECH, V18, P537, DOI 10.1016/j.copbio.2007.10.013; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; McKinstry KK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6377; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; Rookhuizen DC, 2014, P NATL ACAD SCI USA, V111, pE3224, DOI 10.1073/pnas.1323985111; Serreze DV, 1998, J IMMUNOL, V161, P3912; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Tian MJ, 2018, J IMMUNOL, V200, P937, DOI 10.4049/jimmunol.1701067; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; Topham DJ, 1996, J IMMUNOL, V157, P2947; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; van Panhuys N, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00006; Walsh KB, 2012, CELL HOST MICROBE, V11, P643, DOI 10.1016/j.chom.2012.04.016; Yan J, 2006, J IMMUNOL, V177, P4481, DOI 10.4049/jimmunol.177.7.4481; Yi TS, 2015, IMMUNITY, V43, P764, DOI 10.1016/j.immuni.2015.08.021	50	129	132	8	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					695	+		10.1016/j.immuni.2018.08.012	http://dx.doi.org/10.1016/j.immuni.2018.08.012			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30291027	Bronze			2022-12-18	WOS:000447386700015
J	Bilban, M; Bach, FH; Otterbein, SL; Ifedigbo, E; d'Avila, JC; Esterbauer, H; Chin, BY; Usheva, A; Robson, SC; Wagner, O; Otterbein, LE				Bilban, Martin; Bach, Fritz H.; Otterbein, Sherrie L.; Ifedigbo, Emeka; d'Avila, Joana de Costa; Esterbauer, Harald; Yoke Chin, Beek; Usheva, Anny; Robson, Simon C.; Wagner, Oswald; Otterbein, Leo E.			Carbon monoxide orchestrates a protective response through PPAR gamma	IMMUNITY			English	Article							ACTIVATED RECEPTOR-GAMMA; PROTEIN-KINASE PATHWAY; SMOOTH-MUSCLE-CELLS; TISSUE FACTOR; LUNG INJURY; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; NITRIC-OXIDE; EGR-1; HEME	Carbon monoxide (CO) suppresses proinflammatory responses in macrophages reacting to LPS. We hypothesize that CO acts by inducing a molecule(s) that suppresses the inflammatory response to subsequent stress. Exposure of macrophages to CO alone in vitro produced a brief burst of mitochondrial-derived ROS, which led to expression of PPAR gamma. PPAR gamma expression proved essential for mediating the antiinflammatory effects of CO. Blocking the CO-mediated increase in ROS generation prevented PPAR gamma induction, and blocking PPAR gamma prevented CO's anti-inflammatory effects. In a model of acute lung injury in mice, CO blocked expression of Egr-1, a central mediator of inflammation, and decreased tissue damage; inhibition of PPAR gamma abrogated both effects. These data identify the mitochondrial oxidases as an (perhaps the) initial cellular target of CO and demonstrate that CO upregulates expression of PPAR gamma via the mitochondria, which assures that a subsequent stress stimulus will lead to a cytoprotective as opposed to a proinflammatory phenotype.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Med Univ Vienna, Dept Lab Med, Ludwig Boltzmann Inst Clin & Expt Oncol, A-1090 Vienna, Austria; Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Ludwig Boltzmann Institute; Medical University of Vienna; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Otterbein, LE (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA.	lotterbe@bidmc.harvard.edu	d'Avila, Joana/L-8970-2013; Robson, Simon C./AAA-8537-2021	d'Avila, Joana/0000-0002-2045-0813; Esterbauer, Harald/0000-0001-7343-7455	NHLBI NIH HHS [HL-58688, R01 HL057307-08, HL-071797, HL-076167, R01 HL057307] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076167, R01HL058688, R01HL071797, R01HL057307] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen F, 2003, J CELL BIOCHEM, V90, P732, DOI 10.1002/jcb.10668; Cheng S, 2004, J BIOL CHEM, V279, P22057, DOI 10.1074/jbc.M402828200; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kopp CW, 1998, THROMB HAEMOSTASIS, V79, P529; Lucerna M, 2003, J BIOL CHEM, V278, P11433, DOI 10.1074/jbc.M204937200; Morita T, 1997, J BIOL CHEM, V272, P32804, DOI 10.1074/jbc.272.52.32804; Okada M, 2002, FASEB J, V16, P1861, DOI 10.1096/fj.02-0503com; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pawlinski R, 2003, BLOOD, V101, P3940, DOI 10.1182/blood-2002-07-2303; Peyton KJ, 2002, BLOOD, V99, P4443, DOI 10.1182/blood.V99.12.4443; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Shi L, 2002, AM J PHYSIOL-CELL PH, V282, pC1205, DOI 10.1152/ajpcell.00511.2001; Simonin MA, 2002, AM J PHYSIOL-CELL PH, V282, pC125, DOI 10.1152/ajpcell.2002.282.1.C125; Song RP, 2003, AM J PATHOL, V163, P231, DOI 10.1016/S0002-9440(10)63646-2; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Theocharis S, 2004, CANCER TREAT REV, V30, P545, DOI 10.1016/j.ctrv.2004.04.004; Usheva A, 1996, P NATL ACAD SCI USA, V93, P13571, DOI 10.1073/pnas.93.24.13571; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yang XY, 2000, J BIOL CHEM, V275, P4541, DOI 10.1074/jbc.275.7.4541; Zhang XC, 2003, J BIOL CHEM, V278, P1248, DOI 10.1074/jbc.M208419200; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003	43	129	131	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2006	24	5					601	610		10.1016/j.immuni.2006.03.012	http://dx.doi.org/10.1016/j.immuni.2006.03.012			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713977	Bronze			2022-12-18	WOS:000237970100016
J	Liston, A; Lesage, S; Gray, DHD; O'Reilly, LA; Strasser, A; Fahrer, AM; Boyd, RL; Wilson, J; Baxter, AG; Gallo, EM; Crabtree, GR; Peng, KM; Wilson, SR; Goodnow, CC				Liston, A; Lesage, S; Gray, DHD; O'Reilly, LA; Strasser, A; Fahrer, AM; Boyd, RL; Wilson, J; Baxter, AG; Gallo, EM; Crabtree, GR; Peng, KM; Wilson, SR; Goodnow, CC			Generalized resistance to thymic deletion in the NOD mouse: A polygenic trait characterized by defective induction of Bim	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; ORGAN-SPECIFIC AUTOIMMUNITY; FAMILY-MEMBER BIM; CD4(+) T-CELLS; NEGATIVE SELECTION; B-CELLS; GENETIC-CONTROL; PROTEIN BIM; APOPTOSIS; SELF	The cause of common polygenic autoimmune diseases is not understood because of genetic and cellular complexity. Here, we pinpoint the action of a subset of autoimmune susceptibility loci in the NOD mouse strain linked to D1mit181, D2mit490, D7,rnit101, and D15mit229 which cause a generalized resistance to thymic deletion in vivo that applies equally to Aire-induced organ-specific gene products in the thymic medulla and to systemic antigens expressed at high levels throughout the thymus and affects CD4(+).	Australian Natl Univ, John Curtin Sch Med Res, Immunogenom Lab, Canberra, ACT 2601, Australia; Australian Natl Univ, Australian Phenom Facil, Canberra, ACT 2601, Australia; Monash Univ, Fac Med, Dept Pathol & Immunol, Melbourne, Vic 3181, Australia; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Australian Natl Univ, Canberra, ACT 2601, Australia; James Cook Univ N Queensland, Comparat Genom Ctr, Townsville, Qld 4811, Australia; Beckman Ctr, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Australian Natl Univ, John Curtin Sch Med Res, Biomol Resource Facil, Canberra, ACT 2601, Australia; Australian Natl Univ, Inst Math Sci, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Monash University; Walter & Eliza Hall Institute; Australian National University; James Cook University; Australian National University; John Curtin School of Medical Research; Australian National University	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Immunogenom Lab, Canberra, ACT 2601, Australia.	chris.goodnow@anu.edu.au	Baxter, Alan G/A-1412-2010; Fahrer, Aude M/C-9318-2009; Wilson, Stephen/C-5753-2009; Strasser, Andreas/C-7581-2013; Liston, Adrian/A-2478-2008; Goodnow, Christopher C/V-8108-2018; Liston, Adrian/G-8606-2013; Gray, Daniel HD/A-3293-2013	Baxter, Alan G/0000-0002-6960-9821; Strasser, Andreas/0000-0002-5020-4891; Goodnow, Christopher C/0000-0001-5296-6155; Liston, Adrian/0000-0002-6272-4085; Gray, Daniel HD/0000-0002-8457-8242; Fahrer, Aude/0000-0001-8556-0223; Lesage, Sylvie/0000-0002-0968-2795				ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; Akkaraju S, 1997, J EXP MED, V186, P2005, DOI 10.1084/jem.186.12.2005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bergman ML, 2003, DIABETES, V52, P1677, DOI 10.2337/diabetes.52.7.1677; Bergman ML, 2001, J AUTOIMMUN, V16, P105, DOI 10.1006/jaut.2000.0474; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Boulard O, 2002, J IMMUNOL, V168, P4192, DOI 10.4049/jimmunol.168.8.4192; Choisy-Rossi CM, 2004, J IMMUNOL, V173, P3791, DOI 10.4049/jimmunol.173.6.3791; DEGERMANN S, 1994, J IMMUNOL, V152, P3254; Esteban LM, 2003, J IMMUNOL, V171, P2873, DOI 10.4049/jimmunol.171.6.2873; Fox CJ, 2000, AM J HUM GENET, V67, P67, DOI 10.1086/302995; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Gonzalez A, 1997, IMMUNITY, V7, P873, DOI 10.1016/S1074-7613(00)80405-7; Gonzalez A, 2001, NAT IMMUNOL, V2, P1117, DOI 10.1038/ni738; Hamilton-Williams EE, 2001, P NATL ACAD SCI USA, V98, P11533, DOI 10.1073/pnas.191383798; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kamogawa J, 2002, ARTHRITIS RHEUM, V46, P1067, DOI 10.1002/art.10193; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kishimoto H, 1999, J IMMUNOL, V163, P1817; Lesage S, 2002, J EXP MED, V196, P1175, DOI 10.1084/jem.20020735; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; McDuffie M, 2000, CLIN IMMUNOL, V96, P119, DOI 10.1006/clim.2000.4893; McHugh RS, 2001, MICROBES INFECT, V3, P919, DOI 10.1016/S1286-4579(01)01453-8; PODOLIN PL, 1993, J EXP MED, V178, P793, DOI 10.1084/jem.178.3.793; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Salojin K, 1997, J EXP MED, V186, P887, DOI 10.1084/jem.186.6.887; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; SERREZE DV, 1994, CURR OPIN IMMUNOL, V6, P900, DOI 10.1016/0952-7915(94)90011-6; Serreze DV, 1998, J IMMUNOL, V160, P1472; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Villunger A, 2004, P NATL ACAD SCI USA, V101, P7052, DOI 10.1073/pnas.0305757101; Villunger A, 2003, NAT IMMUNOL, V4, P717, DOI 10.1038/ni0803-717; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Xue YT, 1997, EUR J IMMUNOL, V27, P2048, DOI 10.1002/eji.1830270832; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	45	129	129	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					817	830		10.1016/S1074-7613(04)00313-9	http://dx.doi.org/10.1016/S1074-7613(04)00313-9			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589170	Bronze			2022-12-18	WOS:000225901600009
J	Lee, YN; Nechushtan, H; Figov, N; Razin, E				Lee, YN; Nechushtan, H; Figov, N; Razin, E			The function of Lysyl-tRNA synthetase and Ap4A as signaling regulators of MITF activity in Fc epsilon RI-activated mast cells	IMMUNITY			English	Article							LOOP-HELIX PROTEIN; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; GENE-EXPRESSION; LOCUS; HINT; FHIT; INVOLVEMENT; HYDROLASES; APOPTOSIS	The involvement of microphthalmia transcription factor (MITF) in the function of mast cells, melanocytes, and osteoclasts has recently started to be investigated in depth. In a previous study, we found Hint to be associated with MITF in mast cells and showed that it suppresses MITF's transcriptional activity. Here, we have found that lysyl-tRNA synthetase (LysRS) is also associated with MITF and forms a multicomplex with MITF and Hint. We have also shown that APA an endogenous molecule consisting of two adenosine linked by four phosphate which is known to be synthesized by LysRS, is accumulated intracellularily above 700 muM in IgE-Ag-activated mast cells, binds to Hint, liberates MITF, and thus leads to the activation of MITF-dependent gene expression. This implies that LysRS plays a key role via Ap(4)A as an important signaling molecule in MITF transcriptional activity.	Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Biochem, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Oncol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Razin, E (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Biochem, POB 12272, IL-91120 Jerusalem, Israel.	ehudr@cc.huji.ac.il	nechushtan, hovav/Z-3564-2019; Lee, Yu Nee/T-2360-2017	Lee, Yu Nee/0000-0001-8648-5253				Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BERGER NA, 1976, BIOCHIM BIOPHYS ACTA, V425, P1, DOI 10.1016/0005-2787(76)90211-2; Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1997, NAT STRUCT BIOL, V4, P231, DOI 10.1038/nsb0397-231; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; BREVET A, 1982, J BIOL CHEM, V257, P4613; CARR CS, 1990, MOL CELL BIOL, V10, P4384, DOI 10.1128/MCB.10.8.4384; Cen S, 2001, J VIROL, V75, P5043, DOI 10.1128/JVI.75.11.5043-5048.2001; Hankin S, 1997, INT J BIOCHEM CELL B, V29, P317, DOI 10.1016/S1357-2725(96)00153-7; HILDERMAN RH, 1987, BIOCHEMISTRY-US, V26, P1586, DOI 10.1021/bi00380a015; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; ISOZAKI K, 1994, AM J PATHOL, V145, P827; Ito A, 1998, BLOOD, V91, P3210, DOI 10.1182/blood.V91.9.3210.3210_3210_3221; Ito A, 1999, BLOOD, V93, P1189, DOI 10.1182/blood.V93.4.1189.404k32_1189_1196; Jaiswal AS, 2001, J CELL BIOCHEM, V81, P262, DOI 10.1002/1097-4644(20010501)81:2<262::AID-JCB1041>3.0.CO;2-R; Javanbakht H, 2003, J BIOL CHEM, V278, P27644, DOI 10.1074/jbc.M301840200; Levy C, 2002, J BIOL CHEM, V277, P1962, DOI 10.1074/jbc.M109236200; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; MOORE KJ, 1995, TRENDS GENET, V11, P442, DOI 10.1016/S0168-9525(00)89143-X; Morii E, 1996, BLOOD, V88, P2488, DOI 10.1182/blood.V88.7.2488.bloodjournal8872488; Morii E, 1997, BLOOD, V90, P3057, DOI 10.1182/blood.V90.8.3057; Murphy GA, 2000, CANCER RES, V60, P2342; Nechushtan H, 1997, BLOOD, V89, P2999, DOI 10.1182/blood.V89.8.2999; Razin E, 1999, J BIOL CHEM, V274, P34272, DOI 10.1074/jbc.274.48.34272; RAZIN E, 1984, J IMMUNOL, V132, P1479; Shiba K, 1997, J BIOL CHEM, V272, P22809, DOI 10.1074/jbc.272.36.22809; Stark LA, 1998, J VIROL, V72, P3037, DOI 10.1128/JVI.72.4.3037-3044.1998; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; Tsujimura T, 1997, AM J PATHOL, V151, P1043; Tsujimura T, 1996, BLOOD, V88, P1225, DOI 10.1182/blood.V88.4.1225.bloodjournal8841225; Vartanian A, 1999, FEBS LETT, V456, P175, DOI 10.1016/S0014-5793(99)00956-4; ZHAO GQ, 1993, MOL CELL BIOL, V13, P4505, DOI 10.1128/MCB.13.8.4505	36	129	140	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2004	20	2					145	151		10.1016/S1074-7613(04)00020-2	http://dx.doi.org/10.1016/S1074-7613(04)00020-2			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975237				2022-12-18	WOS:000221442400004
J	Venturi, GM; Tu, LL; Kadono, T; Khan, AI; Fujimoto, Y; Oshel, P; Bock, CB; Miller, AS; Albrecht, RM; Kubes, P; Steeber, DA; Tedder, TF				Venturi, GM; Tu, LL; Kadono, T; Khan, AI; Fujimoto, Y; Oshel, P; Bock, CB; Miller, AS; Albrecht, RM; Kubes, P; Steeber, DA; Tedder, TF			Leukocyte migration is regulated by L-selectin endoproteolytic release	IMMUNITY			English	Article							HIGH-ENDOTHELIAL VENULES; MEMBRANE-PROXIMAL CLEAVAGE; ADHESION MOLECULE-1 LAM-1; CELL-SURFACE MOLECULE; DEFICIENT MICE; HOMING RECEPTOR; IN-VITRO; TRANSENDOTHELIAL MIGRATION; LYMPHOCYTE MIGRATION; CHEMOTACTIC FACTORS	L-selectin mediates lymphocyte migration to peripheral lymph nodes and leukocyte rolling on vascular endothelium during inflammation. One unique feature that distinguishes L-selectin from other adhesion molecules is that it is rapidly cleaved from the cell surface after cellular activation. The biological significance of L-selectin endoproteolytic release was determined by generating gene-targeted mice expressing a modified receptor that was not cleaved from the cell surface. Blocking L-selectin cleavage on antigen-stimulated lymphocytes allowed their continued migration to peripheral lymph nodes and inhibited their short-term redirection to the spleen. Blocking homeostatic L-selectin cleavage also resulted in a constitutive 2-fold increase in overall L-selectin expression by leukocytes. As a result, neutrophils entered the inflamed peritoneum in greater numbers or for a longer duration. Thus, endoproteolytic cleavage regulates both homeostatic and activation-induced changes in cell surface L-selectin density, which directs the migration patterns of activated lymphocytes and neutrophils in vivo.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Univ Calgary, Med Ctr, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA	Duke University; University of Calgary; University of Wisconsin System; University of Wisconsin Madison	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.				NATIONAL CANCER INSTITUTE [R01CA081776, R01CA054464, R55CA054464] Funding Source: NIH RePORTER; NCI NIH HHS [CA54464, CA81776] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allport JR, 1997, J IMMUNOL, V158, P4365; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Bennett TA, 1996, J IMMUNOL, V156, P3093; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Chao CC, 1997, J IMMUNOL, V159, P1686; CHEN AJ, 1995, J EXP MED, V182, P519, DOI 10.1084/jem.182.2.519; DOWBENKO DJ, 1991, GENOMICS, V9, P270, DOI 10.1016/0888-7543(91)90252-A; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; Faveeuw C, 2001, BLOOD, V98, P688, DOI 10.1182/blood.V98.3.688; Feehan C, 1996, J BIOL CHEM, V271, P7019, DOI 10.1074/jbc.271.12.7019; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GRIFFIN JD, 1990, J IMMUNOL, V145, P576; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Hafezi-Moghadam A, 1999, J EXP MED, V189, P939, DOI 10.1084/jem.189.6.939; HAMANN A, 1988, J IMMUNOL, V140, P737; Hickey MJ, 2000, J IMMUNOL, V165, P7164, DOI 10.4049/jimmunol.165.12.7164; JUNG TM, 1988, J IMMUNOL, V141, P4110; JUTILA MA, 1989, J IMMUNOL, V143, P3318; Kadono T, 2002, J IMMUNOL, V169, P4542, DOI 10.4049/jimmunol.169.8.4542; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; KAHN J, 1994, J CELL BIOL, V125, P461, DOI 10.1083/jcb.125.2.461; Kanwar S, 1997, J EXP MED, V185, P1077, DOI 10.1084/jem.185.6.1077; Kanwar S, 1999, J IMMUNOL, V162, P2709; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; LEY K, 1991, BLOOD, V77, P2553; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; MIGAKI GI, 1995, J EXP MED, V182, P549, DOI 10.1084/jem.182.2.549; ORD DC, 1990, J BIOL CHEM, V265, P7760; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Preece G, 1996, J BIOL CHEM, V271, P11634, DOI 10.1074/jbc.271.20.11634; SCHLEIFFENBAUM B, 1992, J CELL BIOL, V119, P229, DOI 10.1083/jcb.119.1.229; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SIMON SI, 1995, J IMMUNOL, V155, P1502; SMITH CW, 1991, J CLIN INVEST, V87, P609, DOI 10.1172/JCI115037; SPERTINI O, 1991, NATURE, V349, P691, DOI 10.1038/349691a0; SPERTINI O, 1991, J IMMUNOL, V147, P2565; SPERTINI O, 1991, LEUKEMIA, V5, P300; SPERTINI O, 1992, J IMMUNOL METHODS, V156, P115, DOI 10.1016/0022-1759(92)90017-N; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Steeber DA, 1996, J IMMUNOL, V157, P1096; Steeber DA, 1997, J IMMUNOL, V159, P952; Steeber DA, 1999, J IMMUNOL, V163, P2176; Steeber DA, 1998, J IMMUNOL, V161, P6638; Tang MLK, 1998, J IMMUNOL, V160, P5113; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; TEDDER TF, 1990, J IMMUNOL, V144, P532; TEDDER TF, 1991, AM J RESP CELL MOL, V5, P305, DOI 10.1165/ajrcmb/5.4.305; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Tu L, 2002, J IMMUNOL, V169, P2034, DOI 10.4049/jimmunol.169.4.2034; Walcheck B, 1996, NATURE, V380, P720, DOI 10.1038/380720a0; WALLACE DL, 1993, IMMUNOLOGY, V78, P623; Zhao L C, 2001, Dev Immunol, V8, P267, DOI 10.1155/2001/91831; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200	56	129	135	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					713	724		10.1016/S1074-7613(03)00295-4	http://dx.doi.org/10.1016/S1074-7613(03)00295-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614858	Bronze			2022-12-18	WOS:000186672200011
J	Chi, TH; Wan, MM; Lee, PP; Akashi, K; Metzger, D; Chambon, P; Wilson, CB; Crabtree, GR				Chi, TH; Wan, MM; Lee, PP; Akashi, K; Metzger, D; Chambon, P; Wilson, CB; Crabtree, GR			Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development	IMMUNITY			English	Article							T-CELL DEVELOPMENT; MAMMALIAN SWI/SNF COMPLEXES; C-MYC EXPRESSION; BETA-CATENIN; PRE-TCR; LYMPHOCYTE DEVELOPMENT; IN-VIVO; RECEPTOR; GENE; DIFFERENTIATION	T cells develop through distinct stages directed by a series of signals. We explored the roles of SWI/SNF-like BAF chromatin remodeling complexes in this process by progressive deletion of the ATPase subunit, Brg, through successive stages of early T cell development. Brg-deficient cells were blocked at each of the developmental transitions examined. Bcl-xL overexpression suppressed cell death without relieving the developmental blockades, leading to the accumulation of Brg-deleted cells that were unexpectedly cell cycle arrested. These defects resulted partly from the disruptions of pre-TCR and potentially Writ signaling pathways controlling the expression of genes such as c-Kit and c-Myc critical for continued development. Our studies indicate that BAF complexes dynamically remodel chromatin to propel sequential developmental transitions in response to external signals.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Dana Farber Canc Inst, Dept Canc Immunol, Boston, MA 02115 USA; CU Strasbourg, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, Stanford, CA 94305 USA.	crabtree@cmgm.stanford.edu		Metzger, Daniel/0000-0002-5555-046X	NCI NIH HHS [CA39612] Funding Source: Medline; NICHD NIH HHS [HD39454] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039454] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA039612, R01CA039612] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarwal S, 1999, J ALLERGY CLIN IMMUN, V103, P990, DOI 10.1016/S0091-6749(99)70168-5; Akashi K, 1998, IMMUNOL REV, V165, P13, DOI 10.1111/j.1600-065X.1998.tb01226.x; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chao DT, 1997, INT IMMUNOL, V9, P1375, DOI 10.1093/intimm/9.9.1375; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; Di Santo JP, 1998, CURR OPIN IMMUNOL, V10, P196, DOI 10.1016/S0952-7915(98)80249-5; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; GROETTRUP M, 1993, IMMUNOL TODAY, V14, P610, DOI 10.1016/0167-5699(93)90201-U; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Levens D, 1997, CURR TOP MICROBIOL, V224, P33; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; OReilly LA, 1997, INT IMMUNOL, V9, P1291, DOI 10.1093/intimm/9.9.1291; Peterson CL, 2002, CURR BIOL, V12, pR245, DOI 10.1016/S0960-9822(02)00782-0; Petrie HT, 2000, J IMMUNOL, V165, P3094, DOI 10.4049/jimmunol.165.6.3094; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Schilham MW, 1998, J IMMUNOL, V161, P3984; SHEN X, 2002, SCIENCE; SIEBENLIST U, 1986, MOL CELL BIOL, V6, P3042, DOI 10.1128/MCB.6.9.3042; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; von Boehmer H, 2000, CURR BIOL, V10, pR642, DOI 10.1016/S0960-9822(00)00665-5; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wu L, 2001, NAT IMMUNOL, V2, P823, DOI 10.1038/ni0901-823; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	53	129	131	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2003	19	2					169	182		10.1016/S1074-7613(03)00199-7	http://dx.doi.org/10.1016/S1074-7613(03)00199-7			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932351	Bronze			2022-12-18	WOS:000184929000005
J	Chong, MMW; Cornish, AL; Darwiche, R; Stanley, EG; Purton, JF; Godfrey, DI; Hilton, DJ; Starr, R; Alexander, WS; Kay, TWH				Chong, MMW; Cornish, AL; Darwiche, R; Stanley, EG; Purton, JF; Godfrey, DI; Hilton, DJ; Starr, R; Alexander, WS; Kay, TWH			Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8(+) T cell differentiation	IMMUNITY			English	Article							PANCREATIC BETA-CELLS; TUMOR-NECROSIS-FACTOR; IN-VIVO; TRANSGENIC MICE; NATURAL-KILLER; NEGATIVE REGULATION; IFN-GAMMA; MEMORY; LYMPHOCYTES; THYMOCYTES	To determine the tissue-specific functions of SOCS-1, mice were generated in which the SOCS-1 gene could be deleted in individual tissues. A reporter gene of SOCS-1 promoter activity was also inserted. Using the reporter, high SOCS-1 expression was found at the CD4(+)CD8(+) stage in thymocyte development. To investigate the function of this expression, the SOCS-1 gene was specifically deleted throughout the thymocyte/T/ NKT cell compartment. Unlike SOCS-1(-/-) mice, these mice did not develop lethal multiorgan inflammation but developed multiple lymphoid abnormalities, including enhanced differentiation of thymocytes toward CD8(+) T cells and very high percentages of peripheral CD8+ T cells with a memory phenotype (CD44(hi)CD25(lo)CD69(lo)). These phenotypes were found to correlate with hypersensitivity to the gamma-common family of cytokines.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Monash Univ, Dept Pathol & Immunol, Cent & Eastern Clin Sch, Prahran, Vic 3181, Australia	Walter & Eliza Hall Institute; Monash University	Kay, TWH (corresponding author), St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	kay@medstv.unimelb.edu.au	Chong, Mark/H-6684-2016; Stanley, Ed G/A-2985-2013; Hilton, Douglas J/C-7250-2013	Chong, Mark/0000-0002-3701-7397; Stanley, Ed G/0000-0002-6389-3665; Hilton, Douglas J/0000-0002-7698-2392; Godfrey, Dale/0000-0002-3009-5472				AIBA Y, 1993, EUR J IMMUNOL, V23, P815, DOI 10.1002/eji.1830230407; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Borger P, 1996, J IMMUNOL, V156, P1333; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chong MMW, 2001, DIABETES, V50, P2744, DOI 10.2337/diabetes.50.12.2744; Chong MMW, 2002, J BIOL CHEM, V277, P27945, DOI 10.1074/jbc.M110214200; Cornish AL, 2003, J IMMUNOL, V170, P878, DOI 10.4049/jimmunol.170.2.878; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fujimoto M, 2000, J IMMUNOL, V165, P1799, DOI 10.4049/jimmunol.165.4.1799; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; GODFREY DI, 1994, J IMMUNOL, V152, P2729; Golden-Mason L, 2001, CYTOKINE, V14, P143, DOI 10.1006/cyto.2001.0852; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; GRESSER I, 1981, AM J PATHOL, V102, P396; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Lin Jian-Xin, 1997, Cytokine and Growth Factor Reviews, V8, P313; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; McInnes IB, 1997, NAT MED, V3, P189, DOI 10.1038/nm0297-189; MERTSCHING E, 1995, INT IMMUNOL, V7, P401, DOI 10.1093/intimm/7.3.401; Moore TA, 1996, J IMMUNOL, V157, P2366; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; Sakihama T, 2000, EUR J IMMUNOL, V30, P279; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Singer A, 1999, SEMIN IMMUNOL, V11, P273, DOI 10.1006/smim.1999.0183; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Tanchot C, 2001, EUR J IMMUNOL, V31, P2256, DOI 10.1002/1521-4141(200108)31:8<2256::AID-IMMU2256>3.0.CO;2-8; Varas A, 1997, IMMUNOLOGY, V92, P457, DOI 10.1046/j.1365-2567.1997.00387.x; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519	46	129	138	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2003	18	4					475	487		10.1016/S1074-7613(03)00078-5	http://dx.doi.org/10.1016/S1074-7613(03)00078-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705851	Bronze			2022-12-18	WOS:000182353900004
J	Anderson, MK; Weiss, AH; Hernandez-Hoyos, G; Dionne, CJ; Rothenberg, EV				Anderson, MK; Weiss, AH; Hernandez-Hoyos, G; Dionne, CJ; Rothenberg, EV			Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage	IMMUNITY			English	Article							TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; LYMPHOCYTE; DIFFERENTIATION; INHIBITION; GATA-1; SPI-1; C/EBP; SPECIFICATION; REGIONS	The essential hematopoietic transcription factor PU.1 is expressed in multipotent thymic precursors but downregulated during T lineage commitment. The significance of PU.1 downregulation was tested using retroviral vectors to force hematopoietic precursors to maintain PU.1 expression during differentiation in fetal thymic organ culture. PU.1 reduced thymocyte expansion and blocked development at the pro-T cell stage. PU.1-expressing cells could be rescued by switching to conditions permissive for macrophage development; thus, the inhibition depends on both lineage and developmental stage. An intact DNA binding domain was required for these effects. PU.1 expression can downregulate pre-Talpha, Rag-1, and Rag-2 in a dose-dependent manner, and higher PU.1 levels induce Mac-1 and Id-2. Thus, downregulation of PU.1 is specifically required for progression in the T cell lineage.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	California Institute of Technology; Stowers Institute for Medical Research	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.			Rothenberg, Ellen/0000-0002-3901-347X; Anderson, Michele/0000-0002-8820-5910	NCI NIH HHS [CA90233] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090233] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson MK, 2000, CURR TOP MICROBIOL, V248, P137; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Carleton M, 1999, J IMMUNOL, V163, P2576; CHEN HM, 1995, ONCOGENE, V11, P1549; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Ikawa T, 1999, J EXP MED, V190, P1617, DOI 10.1084/jem.190.11.1617; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Lee CK, 2001, J IMMUNOL, V166, P5964, DOI 10.4049/jimmunol.166.10.5964; Lucas K, 1998, DEV COMP IMMUNOL, V22, P339, DOI 10.1016/S0145-305X(98)00012-3; Maitra S, 2000, MOL CELL BIOL, V20, P1911, DOI 10.1128/MCB.20.6.1911-1922.2000; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rothenberg EV, 1999, BIOESSAYS, V21, P726, DOI 10.1002/(SICI)1521-1878(199909)21:9<726::AID-BIES4>3.0.CO;2-S; Rothenberg EV, 2000, CURR OPIN GENET DEV, V10, P370, DOI 10.1016/S0959-437X(00)00098-8; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Spain LM, 1999, J IMMUNOL, V163, P2681; Takeuchi A, 2001, J IMMUNOL, V167, P2157, DOI 10.4049/jimmunol.167.4.2157; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Yamada T, 1997, BLOOD, V89, P1383, DOI 10.1182/blood.V89.4.1383; Yasuda Y, 1997, BLOOD, V89, P1349, DOI 10.1182/blood.V89.4.1349; Zarrin AA, 1997, J IMMUNOL, V159, P4382; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	35	129	130	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2002	16	2					285	296		10.1016/S1074-7613(02)00277-7	http://dx.doi.org/10.1016/S1074-7613(02)00277-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869688	Bronze			2022-12-18	WOS:000174039600011
J	Antoniou, AN; Blackwood, SL; Mazzeo, D; Watts, C				Antoniou, AN; Blackwood, SL; Mazzeo, D; Watts, C			Control of antigen presentation by a single protease cleavage site	IMMUNITY			English	Article							MHC CLASS-II; CATHEPSIN-S; ASPARAGINYL ENDOPEPTIDASE; DENDRITIC CELLS; LYMPHOCYTES-B; MOLECULES; PEPTIDE; DEGRADATION; TRAFFICKING; FRAGMENTS	Protein antigens require limited proteolytic processing to generate peptides for binding to class II MHC molecules, but the proteases and processing sites involved are largely unknown. Here we analyze the effect of eliminating the th ree major asparagine endopeptidase (AEP)-processing sites in the microbial antigen tetanus toxin C fragment. The mutant antigen is highly resistant to proteolysis by AEP and crude lysosomal extracts and is dramatically impaired in its ability to be processed and presented to T cells. Remarkably, processing at a single asparagine residue (1219) is obligatory for optimal presentation of many T cell epitopes in this antigen. These studies demonstrate that cleavage at a single processing site can be crucial for effective antigen presentation.	Univ Dundee, Dept Biochem, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland	University of Dundee	Watts, C (corresponding author), Univ Dundee, Dept Biochem, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland.			Antoniou, Antony/0000-0002-6536-7781; Watts, Colin/0000-0001-6183-2087				AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; Bogyo M, 1998, NATURE, V396, P625, DOI 10.1038/25238; Castellino F, 1998, J IMMUNOL, V161, P4048; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Dando PM, 1999, BIOCHEM J, V339, P743, DOI 10.1042/0264-6021:3390743; DAVIDSON HW, 1989, J CELL BIOL, V109, P85, DOI 10.1083/jcb.109.1.85; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; DAVIDSON HW, 1990, J IMMUNOL, V144, P41014; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; DONERMEYER DL, 1989, J IMMUNOL, V142, P1063; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Emsley P, 2000, J BIOL CHEM, V275, P8889, DOI 10.1074/jbc.275.12.8889; FAIRWEATHER NF, 1997, NUCLEIC ACIDS RES, V22, P377; Fineschi B, 1997, TRENDS BIOCHEM SCI, V22, P377, DOI 10.1016/S0968-0004(97)01116-X; Hewitt EW, 1997, J IMMUNOL, V159, P4693; Knight AM, 1997, EMBO J, V16, P3842, DOI 10.1093/emboj/16.13.3842; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; RODRIGUEZ GM, 1992, J IMMUNOL, V149, P2894; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; Umland TC, 1997, NAT STRUCT BIOL, V4, P788, DOI 10.1038/nsb1097-788; VANNOORT JM, 1994, EUR J IMMUNOL, V24, P2175, DOI 10.1002/eji.1830240936; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; West MA, 1999, EUR J IMMUNOL, V29, P3450, DOI 10.1002/(SICI)1521-4141(199911)29:11<3450::AID-IMMU3450>3.0.CO;2-A; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411	32	129	134	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2000	12	4					391	398		10.1016/S1074-7613(00)80191-0	http://dx.doi.org/10.1016/S1074-7613(00)80191-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	309FH	10795737	Bronze			2022-12-18	WOS:000086757300004
J	Frey, S; Bertocci, B; Delbos, F; Quint, L; Weill, JC; Reynaud, CA				Frey, S; Bertocci, B; Delbos, F; Quint, L; Weill, JC; Reynaud, CA			Mismatch repair deficiency interferes with the accumulation of mutations in chronically stimulated B cells and not with the hypermutation process	IMMUNITY			English	Article							SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; MOUSE; MICE; DNA; SEQUENCES; ANTIBODY	Primary responses to the hapten phenyloxazolone and chronic responses to environmental antigens occuring in Peyer's patches were analyzed in two different mismatch repair-deficient backgrounds. Paradoxically, whereas primary responses were found normal in MSH2- and only slightly diminished in PMS2-deficient mice, mutations in Peyer's patch B cells from both k.o. animals were reduced three times, the subset of Peyer's patch B cells with highly mutated sequences being specifically missing in the mismatch repair-deficient context. Strikingly, germinal center B cells from Peyer's patches of k.o. animals showed microsatellite instability at an unprecedented level. We thus propose that the amount of DNA damages generated prevents these cells from recycling in germinal centers and that mismatch repair deficiency is only the indirect cause of the lower mutation incidence observed.	Hop Necker Enfants Malad, INSERM, U373, F-75730 Paris 15, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Reynaud, CA (corresponding author), Hop Necker Enfants Malad, INSERM, U373, 156 Rue Vaugirad, F-75730 Paris 15, France.	reynaud@infobiogen.fr	Bertocci, Barbara/L-9115-2018					Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Fishel R, 1997, CURR OPIN GENET DEV, V7, P105, DOI 10.1016/S0959-437X(97)80117-7; GONZALEZFERNANDEZ A, 1994, EUR J IMMUNOL, V24, P2918, DOI 10.1002/eji.1830241151; Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kim N, 1998, J EXP MED, V187, P1729, DOI 10.1084/jem.187.11.1729; Kim N, 1997, J EXP MED, V186, P413, DOI 10.1084/jem.186.3.413; Kunkel T. A., 1991, Somatic hypermutation in V-regions., P159; MAKELA O, 1978, J EXP MED, V148, P1644, DOI 10.1084/jem.148.6.1644; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Prolla TA, 1998, NAT GENET, V18, P276, DOI 10.1038/ng0398-276; Reitmair AH, 1996, CANCER RES, V56, P3842; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Shen HN, 1997, MOL IMMUNOL, V34, P527, DOI 10.1016/S0161-5890(97)00064-3; Storb U, 1996, Semin Immunol, V8, P131, DOI 10.1006/smim.1996.0017; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Wagner SD, 1996, INT IMMUNOL, V8, P701, DOI 10.1093/intimm/8.5.701; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953	31	129	129	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1998	9	1					127	134		10.1016/S1074-7613(00)80594-4	http://dx.doi.org/10.1016/S1074-7613(00)80594-4			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697842	Bronze			2022-12-18	WOS:000075066600012
J	Liu, YJ; deBouteiller, O; Arpin, C; Briere, F; Galibert, L; Ho, S; MartinezValdez, H; Banchereau, J; Lebecque, S				Liu, YJ; deBouteiller, O; Arpin, C; Briere, F; Galibert, L; Ho, S; MartinezValdez, H; Banchereau, J; Lebecque, S			Normal human IgD(+)IgM(-) germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts	IMMUNITY			English	Article							IMMUNOGLOBULIN-D; IMMUNE-RESPONSE; MOLECULAR EVOLUTION; SOMATIC MUTATION; T-CELLS; ANTIGEN; MEMORY; MATURATION; MUTANTS; GENES	Somatic hypermutation in immunoglobulin variable region genes occurs within germinal centers. Here, we describe a subset of germinal center dark zone centroblasts that express only sIgD and have accumulated up to 80 mutations per heavy chain variable region (IgV(H) delta gene). Over half of the hypermutated IgV(H) delta sequences were found to be clonally related. This level of mutation is not observed in either IgV(H) gamma transcripts from the same sample or IgV(H) delta transcripts from peripheral blood, suggesting that these cells neither undergo isotype switch nor mature into circulating memory B cells. Optimal growth of these cells in vitro depends on CD40 ligand, T cell cytokines, and a fibroblast stroma, a combination possibly mimicking the dark zone microenvironment. Our hypothesis is that these cells may be sequestered within germinal centers, where their somatic mutation machinery is triggered. The isolation of these hypermutated B cells may represent a critical step for studying both the biology and biochemistry of somatic hypermutation.			Liu, YJ (corresponding author), SCHERING PLOUGH CORP,LAB IMMUNOL RES,27 CHEM PEUPLIERS,BP11,F-69571 DARDILLY,FRANCE.		Arpin, Christophe/M-3862-2014	Arpin, Christophe/0000-0003-0915-5554; lebecque, serge/0000-0003-4006-8061				BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BEREK C, 1993, CURR OPIN IMMUNOL, V5, P218, DOI 10.1016/0952-7915(93)90007-F; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; CARSETTI R, 1993, EUR J IMMUNOL, V23, P168, DOI 10.1002/eji.1830230127; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; COICO RF, 1988, IMMUNOL REV, V105, P45, DOI 10.1111/j.1600-065X.1988.tb00765.x; COICO RF, 1985, NATURE, V316, P744, DOI 10.1038/316744a0; FEUILLARD J, 1995, INT IMMUNOL, V7, P121, DOI 10.1093/intimm/7.1.121; FORSGREN A, 1979, J IMMUNOL, V122, P1468; GRAY D, 1993, ANNU REV IMMUNOL, V11, P49, DOI 10.1146/annurev.immunol.11.1.49; INSEL RA, 1994, INT IMMUNOL, V6, P1437, DOI 10.1093/intimm/6.9.1437; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; JANSON H, 1991, INFECT IMMUN, V59, P119, DOI 10.1128/IAI.59.1.119-125.1991; KLEIN U, 1994, J EXP MED, V180, P1383, DOI 10.1084/jem.180.4.1383; KLUIN PM, 1996, EUR J IMMUNOL, V25, P3504; KRAAL G, 1982, NATURE, V298, P377, DOI 10.1038/298377a0; Kroese F G, 1990, Curr Top Pathol, V84 ( Pt 1), P103; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; LIU YJ, 1994, IN VIVO IMMUNOLOGY, P289; LIU YJ, 1995, IMMUNITY, V2, P238; LIU YJ, 1996, IN PRESS HDB EXPT IM; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MAIELS N, 1995, CELL, V83, P9; MANSER T, 1985, IMMUNOL TODAY, V6, P94, DOI 10.1016/0167-5699(85)90024-6; MartinezValdez H, 1996, J EXP MED, V183, P971, DOI 10.1084/jem.183.3.971; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; NOSSAL GJV, 1992, CELL, V68, P1, DOI 10.1016/0092-8674(92)90198-L; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; RAJEWSKY K, 1989, PROGR IMMUNOLOGY, V7, P397; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; THORBECKE GJ, 1994, FASEB J, V8, P832, DOI 10.1096/fasebj.8.11.8070632; VANDERSTOEP N, 1993, J EXP MED, V177, P99, DOI 10.1084/jem.177.1.99; VITETTA ES, 1991, ANNU REV IMMUNOL, V9, P193, DOI 10.1146/annurev.iy.09.040191.001205; Weill JC, 1996, IMMUNOL TODAY, V17, P92, DOI 10.1016/0167-5699(96)80586-X; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233; WEISSMAN IL, 1994, CELL, V76, P207, DOI 10.1016/0092-8674(94)90329-8; YASUI H, 1989, EUR J IMMUNOL, V19, P1399, DOI 10.1002/eji.1830190808; YUAN D, 1985, FED PROC, V44, P2652	53	129	135	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1996	4	6					603	613		10.1016/S1074-7613(00)80486-0	http://dx.doi.org/10.1016/S1074-7613(00)80486-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UU443	8673707	Bronze			2022-12-18	WOS:A1996UU44300009
J	LECOANETHENCHOZ, S; GAUCHAT, JF; AUBRY, JP; GRABER, P; LIFE, P; PAULEUGENE, N; FERRUA, B; CORBI, AL; DUGAS, B; PLATERZYBERK, C; BONNEFOY, JY				LECOANETHENCHOZ, S; GAUCHAT, JF; AUBRY, JP; GRABER, P; LIFE, P; PAULEUGENE, N; FERRUA, B; CORBI, AL; DUGAS, B; PLATERZYBERK, C; BONNEFOY, JY			CD23 REGULATES MONOCYTE ACTIVATION THROUGH A NOVEL INTERACTION WITH THE ADHESION MOLECULES CD11B-CD18 AND CD11C-CD18	IMMUNITY			English	Article							LOW-AFFINITY RECEPTOR; LEUKOCYTE ADHESION; ALPHA-SUBUNIT; ANTIBODIES; CLONING; CELLS; IGE; GLYCOPROTEIN; EXPRESSION; GENERATION	CD23 is expressed on a variety of haemopoietic cells and displays pleiotropic activities in vitro. We report that in addition to CD21 and IgE, CD23 interacts specifically with the CD11b and CD11c, the alpha chains of the beta 2 integrin adhesion molecule complexes CD11b-CD18 and CD11c-CD18, on monocytes. Full-length recombinant CD23 incorporated into fluorescent liposomes was shown to bind to COS cells transfected with cDNA encoding either CD11b-CD18 or CD11c-CD18 but not with CD11a-CD18, The interactio n was specifically inhibited by anti-CD11b or anti-CD11c, respectively, and by anti-CD23 MAbs. The functional significance of this ligand pairing was demonstrated by triggering CD11b and CD11e on monocytes with either recombinant CD23 or anti-CD11b and anti-CD11c MAbs to cause a marked increase in nitrite-oxidative products and proinflammatory cytokines (IL-1 beta, IL-6, and TNF alpha). These CD23-mediated activities were decreased by Fab fragments of MAbs to CD11b, CD11c, and CD23. These results demonstrate that CD11b and CD11c are receptors for CD23 and that this novel ligand pairing regulates important activities of monocytes.	HOP KREMLIN BICETRE,NEUROIMMUNOL LAB,F-94320 LE KREMLIN BICETR,FRANCE; FAC MED NICE,PHARMACOL LAB,F-06107 NICE,FRANCE; HOSP PRINCESA,E-28006 MADRID,SPAIN; HOP LA PITIE SALPETRIERE,IMMUNOHEMATOL LAB,CNRS,URA 625,F-75013 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Cote d'Azur; Hospital de La Princesa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	LECOANETHENCHOZ, S (corresponding author), GLAXO INST MOLEC BIOL SA,CHEM AULX 14,CH-1228 GENEVA,SWITZERLAND.		Corbí, Angel L./ABC-8146-2020; Corbi, Angel/B-7194-2011	Corbí, Angel L./0000-0003-1980-5733; Corbi, Angel/0000-0003-1980-5733				ALTIERI DC, 1991, J IMMUNOL, V147, P1891; AUBRY JP, 1994, J IMMUNOL, V152, P5806; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; BANSAL A, 1992, CLIN EXP IMMUNOL, V89, P452; BONNEFOY JY, 1993, CURR OPIN IMMUNOL, V5, P944, DOI 10.1016/0952-7915(93)90110-E; BONNEFOY JY, 1987, J IMMUNOL, V38, P2970; CORBI AL, 1987, EMBO J, V6, P4023, DOI 10.1002/j.1460-2075.1987.tb02746.x; CORBI AL, 1988, J BIOL CHEM, V263, P12403; DELESPESSE G, 1992, IMMUNOL REV, V125, P77, DOI 10.1111/j.1600-065X.1992.tb00626.x; FERRUA B, 1988, J IMMUNOL METHODS, V114, P41, DOI 10.1016/0022-1759(88)90151-2; Fischer A, 1988, Immunodefic Rev, V1, P39; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; GORDON J, 1991, MONOGR ALLERGY, P29; GRABER P, 1992, J IMMUNOL METHODS, V149, P215, DOI 10.1016/0022-1759(92)90253-P; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; HELLEN EA, 1991, J CLIN PATHOL, V44, P293, DOI 10.1136/jcp.44.4.293; KAISERLIAN D, 1993, IMMUNOLOGY, V80, P90; KIKUTANI H, 1986, CELL, V47, P867; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; LACAL PM, 1990, BIOCHEM J, V268, P707, DOI 10.1042/bj2680707; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; MANIE S, 1993, EUR CYTOKINE NETW, V4, P51; MONCADA S, 1991, PHARMACOL REV, V43, P109; PAULEUGENE N, 1992, J IMMUNOL, V149, P3066; PLATERZYBERK C, 1995, IN PRESS NATURE MED; POCHON S, 1992, J EXP MED, V176, P389, DOI 10.1084/jem.176.2.389; PONCELET P, 1985, J IMMUNOL METHODS, V85, P65, DOI 10.1016/0022-1759(85)90274-1; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STIEF A, 1994, J IMMUNOL, V152, P3378; TREZZINI C, 1991, BRIT J HAEMATOL, V77, P16, DOI 10.1111/j.1365-2141.1991.tb07942.x; YANO N, 1992, NEPHRON, V60, P404, DOI 10.1159/000186799; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0; YUKAWA K, 1987, J IMMUNOL, V38, P2576	35	129	133	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					119	125		10.1016/1074-7613(95)90164-7	http://dx.doi.org/10.1016/1074-7613(95)90164-7			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621072	Bronze			2022-12-18	WOS:A1995RK86800013
J	WEINSTEIN, PD; ANDERSON, AO; MAGE, RG				WEINSTEIN, PD; ANDERSON, AO; MAGE, RG			RABBIT IGH SEQUENCES IN APPENDIX GERMINAL-CENTERS - VH DIVERSIFICATION BY GENE CONVERSION-LIKE AND HYPERMUTATION MECHANISMS	IMMUNITY			English	Article							CHAIN VARIABLE-REGION; HUMORAL IMMUNE-SYSTEM; B-CELL DEVELOPMENT; HEAVY-CHAIN; SOMATIC DIVERSIFICATION; ANTIBODY DIVERSITY; LYMPHOID-TISSUES; EMBRYONIC BURSA; PEYERS-PATCHES; VDJ GENES	Although the rabbit IgH locus contains approximately 100 VH genes, the majority of B cells rearrange VH1. To produce a primary repertoire containing a sufficient number of protective antibodies, rearranged VH1-DH-JH sequences may diversify within rabbit B cells in an organ that functions like a chicken bursa, sheep ileal Peyer's patch, or both. It was suggested many years ago that the rabbit appendix could be a bursal equivalent. To reexamine this possibility, we analyzed rearranged heavy chain variable region sequences in B cells from light and dark zones of appendix germinal centers from B-week old rabbits. Our findings indicate that antibody diversification occurs by gene conversion-like and somatic hypermutation mechanisms in appendix germinal centers of young rabbits.	NIAID, IMMUNOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	WEINSTEIN, PD (corresponding author), USA, MED RES INST INFECT DIS, DIV APPL RES, FT DETRICK, FREDERICK, MD 21702 USA.							ACKERMAN GA, 1959, AM J ANAT, V104, P163, DOI 10.1002/aja.1001040202; ALEKSANDERSEN M, 1990, IMMUNOLOGY, V70, P391; ALLEGRUCCI M, 1991, EUR J IMMUNOL, V21, P411, DOI 10.1002/eji.1830210224; ALLEGRUCCI M, 1990, P NATL ACAD SCI USA, V87, P5444, DOI 10.1073/pnas.87.14.5444; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; ARCHER OK, 1963, NATURE, V200, P337, DOI 10.1038/200337a0; BECKER RS, 1990, EUR J IMMUNOL, V20, P397, DOI 10.1002/eji.1830200224; BECKER RS, 1989, J IMMUNOL, V142, P1351; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; BEREK C, 1993, IMMUNOL TODAY, V14, P400, DOI 10.1016/0167-5699(93)90143-9; BERNSTEIN KE, 1982, NATURE, V300, P74, DOI 10.1038/300074a0; BERNSTEIN KE, 1983, IMMUNOGENETICS, V18, P387, DOI 10.1007/BF00372471; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; Blackwell T. K., 1988, Molecular Immunology., P1; CARLSON LM, 1990, GENE DEV, V4, P536, DOI 10.1101/gad.4.4.536; CHEN HT, 1993, J IMMUNOL, V150, P2783; CHOU CL, 1993, J IMMUNOL, V150, P5350; Cohn M, 1990, IMMUNOL REV, V115, P1; COOPER MD, 1968, INT ARCH ALLER A IMM, V33, P65, DOI 10.1159/000229975; EKINO S, 1993, EUR J IMMUNOL, V23, P772, DOI 10.1002/eji.1830230331; FRIEDMAN ML, 1994, J IMMUNOL, V152, P632; GATHINGS WE, 1981, EUR J IMMUNOL, V11, P200, DOI 10.1002/eji.1830110308; GATHINGS WE, 1982, EUR J IMMUNOL, V12, P76, DOI 10.1002/eji.1830120114; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; HARDIE DL, 1993, EUR J IMMUNOL, V23, P997, DOI 10.1002/eji.1830230502; HAYWARD AR, 1978, J EXP MED, V148, P1366; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kabat EA, 1991, SEQUENCES PROTEINS I; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; KNIGHT KL, 1992, ANNU REV IMMUNOL, V10, P593, DOI 10.1146/annurev.iy.10.040192.003113; KNIGHT KL, 1990, CELL, V60, P963, DOI 10.1016/0092-8674(90)90344-E; KONOGURA T, 1993, J VET MED SCI, V55, P59; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; LANDSVERK T, 1991, VET IMMUNOL IMMUNOP, V28, P1, DOI 10.1016/0165-2427(91)90038-E; LANGMAN RE, 1993, RES IMMUNOL, V144, P422, DOI 10.1016/0923-2494(93)80126-J; MACLENNAN ICM, 1992, IMMUNOL REV, V126, P143, DOI 10.1111/j.1600-065X.1992.tb00635.x; MAGE RG, 1993, RES IMMUNOL, V144, P476, DOI 10.1016/0923-2494(93)80143-M; MAGE RG, 1984, MOL IMMUNOL, V21, P1067, DOI 10.1016/0161-5890(84)90117-2; MAIZELS N, 1993, RES IMMUNOL, V144, P459, DOI 10.1016/0923-2494(93)80136-M; MANSIKKA A, 1990, P NATL ACAD SCI USA, V87, P9416, DOI 10.1073/pnas.87.23.9416; MCCORMACK WT, 1989, CELL, V56, P785, DOI 10.1016/0092-8674(89)90683-1; MCCORMACK WT, 1991, ANNU REV IMMUNOL, V9, P219; MCCORMACK WT, 1985, NUCLEIC ACIDS RES, V13, P7041, DOI 10.1093/nar/13.19.7041; NIEUWENHUIS P, 1974, IMMUNOLOGY, V26, P497; PARAMITHIOTIS E, 1993, EUR J IMMUNOL, V23, P96, DOI 10.1002/eji.1830230116; PARVARI R, 1990, P NATL ACAD SCI USA, V87, P3072, DOI 10.1073/pnas.87.8.3072; PINK JRL, 1985, EUR J IMMUNOL, V15, P617, DOI 10.1002/eji.1830150616; RATCLIFFE MJH, 1986, EUR J IMMUNOL, V16, P129, DOI 10.1002/eji.1830160204; RAYNAUD CA, 1989, CELL, V59, P171; REYNAUD CA, 1991, CELL, V64, P995, DOI 10.1016/0092-8674(91)90323-Q; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; REYNOLDS JD, 1983, EUR J IMMUNOL, V13, P627, DOI 10.1002/eji.1830130805; REYNOLDS JD, 1984, EUR J IMMUNOL, V14, P1, DOI 10.1002/eji.1830140102; ROUX KH, 1991, J IMMUNOL, V146, P2027; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHORT JA, 1991, J IMMUNOL, V147, P4014; STEPANKOVA R, 1980, FOLIA MICROBIOL, V25, P491, DOI 10.1007/BF02897215; SUTHERLAND DER, 1963, P SOC EXP BIOL MED, V115, P673; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; TLASKALOVAHOGENOVA H, 1980, FOLIA BIOL-PRAGUE, V26, P81; WAKSMAN BH, 1973, LAB INVEST, V28, P614; WEILL JC, 1986, P NATL ACAD SCI USA, V83, P3336, DOI 10.1073/pnas.83.10.3336; WEILL JC, 1987, SCIENCE, V238, P1094, DOI 10.1126/science.3317827; WEINSTEIN PD, 1994, IN PRESS LYMPHATIC T	67	129	130	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1994	1	8					647	659		10.1016/1074-7613(94)90036-1	http://dx.doi.org/10.1016/1074-7613(94)90036-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PT930	7600292				2022-12-18	WOS:A1994PT93000003
J	Banerjee, I; Behl, B; Mendonca, M; Shrivastava, G; Russo, AJ; Menoret, A; Ghosh, A; Vella, AT; Vanaja, SK; Sarkar, SN; Fitzgerald, KA; Rathinam, VAK				Banerjee, Ishita; Behl, Bharat; Mendonca, Morena; Shrivastava, Gaurav; Russo, Ashley J.; Menoret, Antoine; Ghosh, Arundhati; Vella, Anthony T.; Vanaja, Sivapriya Kailasan; Sarkar, Saumendra N.; Fitzgerald, Katherine A.; Rathinam, Vijay A. K.			Gasdermin D Restrains Type I Interferon Response to Cytosolic DNA by Disrupting Ionic Homeostasis	IMMUNITY			English	Article							NLRP3 INFLAMMASOME ACTIVATION; CGAS-STING PATHWAY; CYCLIC GMP-AMP; AIM2 INFLAMMASOME; HOST-DEFENSE; CELL-DEATH; PYROPTOSIS; CASPASE-11; SENSOR; GSDMD	Inflammasome-activated caspase-1 cleaves gasdermin D to unmask its pore-forming activity, the predominant consequence of which is pyroptosis. Here, we report an additional biological role for gasdermin D in limiting cytosolic DNA surveillance. Cytosolic DNA is sensed by Aim2 and cyclic GMP-AMP synthase (cGAS) leading to inflammasome and type I interferon responses, respectively. We found that gasdermin D activated by the Aim2 inflammasome suppressed cGAS-driven type I interferon response to cytosolic DNA and Francisella novicida in macrophages. Similarly, interferon-beta (IFN-beta) response to F. novicida infection was elevated in gasdermin D-deficient mice. Gasdermin D-mediated negative regulation of IFN-beta occurred in a pyroptosis-, interleukin-1 (IL-1)-, and IL-18-independent manner. Mechanistically, gasdermin D depleted intracellular potassium (K+) viamembrane pores, and this K+ efflux was necessary and sufficient to inhibit cGAS-dependent IFN-beta response. Thus, our findings have uncovered an additional interferon regulatory module involving gasdermin D and K+ efflux.	[Banerjee, Ishita; Behl, Bharat; Mendonca, Morena; Russo, Ashley J.; Menoret, Antoine; Vella, Anthony T.; Vanaja, Sivapriya Kailasan; Rathinam, Vijay A. K.] UConn Hlth Sch Med, Dept Immunol, 263 Farmington Ave, Farmington, CT 06030 USA; [Mendonca, Morena] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Shrivastava, Gaurav] IPN, CINVESTAV, Dept Mol Biomed, Mexico City, DF, Mexico; [Ghosh, Arundhati; Sarkar, Saumendra N.] Univ Pittsburgh, Canc Virol Program, Inst Canc, Pittsburgh, PA 15213 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Div Infect Dis & Immunol, Dept Med, Program Innate Immun,Med Sch, Worcester, MA 01605 USA; [Fitzgerald, Katherine A.] NTNU, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway	Universidade Federal do Rio de Janeiro; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU)	Rathinam, VAK (corresponding author), UConn Hlth Sch Med, Dept Immunol, 263 Farmington Ave, Farmington, CT 06030 USA.	rathinam@uchc.edu	Sarkar, Saumendra N/B-5038-2011; Shrivastava, Gaurav/AAC-4617-2021; Rathinam, Vijay/ABE-7544-2020; Fitzgerald, Katherine/ABE-6317-2020; BANERJEE, ISHITA/AAA-4580-2020	Sarkar, Saumendra N/0000-0002-2850-6121; Rathinam, Vijay/0000-0002-8009-3977; BANERJEE, ISHITA/0000-0002-9710-6180; Fitzgerald, Kate/0000-0003-3175-609X; SHRIVASTAVA, GAURAV/0000-0003-3229-4106	NIH [AI119015, AI083713, AI118896]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118896, R01AI119015] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. Vishva Dixit and Nobuhiko Kayagaki for Aim2<SUP>-/-</SUP>, Casp11<SUP>-/-</SUP>, and Gsdmd<SUP>-/-</SUP> mice; Dr. Feng Shao for wild-type and Gsdmd<SUP>-/-</SUP> iBMDM; Drs. Thirumaladevi Kanneganti and Jonathan Kagan for reagents; and Drs. Jan Beumer and Robert Parise for LC-MS for cGAMP. This work was supported by the NIH (AI119015 to V.A.K.R., AI083713 to K.A.F., and AI118896 to S.N.S.).	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Conos SA, 2017, P NATL ACAD SCI USA, V114, pE961, DOI 10.1073/pnas.1613305114; Corrales L, 2016, J IMMUNOL, V196, P3191, DOI 10.4049/jimmunol.1502538; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Cui Y, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006156; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gohara DW, 2016, J BIOL CHEM, V291, P20840, DOI 10.1074/jbc.R116.737833; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Gray EE, 2016, IMMUNITY, V45, P255, DOI 10.1016/j.immuni.2016.06.015; Gutierrez KD, 2017, J IMMUNOL, V198, P2156, DOI 10.4049/jimmunol.1601757; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Henry T, 2010, J IMMUNOL, V184, P3755, DOI 10.4049/jimmunol.0902065; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Parthoens E., 2018, CELL DEATH DIFFER, V26, pR568; Prindle A, 2015, NATURE, V527, P59, DOI 10.1038/nature15709; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Storek KM, 2015, J IMMUNOL, V194, P3236, DOI 10.4049/jimmunol.1402764; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Suschak JJ, 2016, J IMMUNOL, V196, P310, DOI 10.4049/jimmunol.1501836; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; Vanaja SK, 2014, P NATL ACAD SCI USA, V111, P7765, DOI 10.1073/pnas.1400075111; Wang CG, 2018, IMMUNITY, V48, P675, DOI 10.1016/j.immuni.2018.03.017; Wang YT, 2017, IMMUNITY, V46, P393, DOI 10.1016/j.immuni.2017.02.011; Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Zhu QF, 2018, CELL REP, V22, P3168, DOI 10.1016/j.celrep.2018.02.096	59	128	132	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					413	+		10.1016/j.immuni.2018.07.006	http://dx.doi.org/10.1016/j.immuni.2018.07.006			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30170814	Green Accepted, Bronze			2022-12-18	WOS:000444909600010
J	Beura, LK; Wijeyesinghe, S; Thompson, EA; Macchietto, MG; Rosato, PC; Pierson, MJ; Schenkel, JM; Mitchell, JS; Vezys, V; Fife, BT; Shen, S; Masopust, D				Beura, Lalit K.; Wijeyesinghe, Sathi; Thompson, Emily A.; Macchietto, Marissa G.; Rosato, Pamela C.; Pierson, Mark J.; Schenkel, Jason M.; Mitchell, Jason S.; Vezys, Vaiva; Fife, Brian T.; Shen, Steven; Masopust, David			T Cells in Nonlymphoid Tissues Give Rise to Lymph-Node-Resident Memory T Cells	IMMUNITY			English	Article							MOLECULAR SIGNATURE; RECALL RESPONSES; CUTTING EDGE; IN-VIVO; SKIN; DIFFERENTIATION; ORGANS; MICE; COMPARTMENTALIZATION; MAINTENANCE	Immunosurveillance of secondary lymphoid organs (SLO) is performed by central memory T cells that recirculate through blood. Resident memory T (Trm) cells remain parked in nonlymphoid tissues and often stably express CD69. We recently identified Trm cells within SLO, but the origin and phenotype of these cells remains unclear. Using parabiosis of "dirty'' mice, we found that CD69 expression is insufficient to infer stable residence of SLO Trm cells. Restimulation of nonlymphoid memory CD8(+) T cells within the skin or mucosa resulted in a substantial increase in bona fide Trm cells specifically within draining lymph nodes. SLO Trm cells derived from emigrants from nonlymphoid tissues and shared some transcriptional and phenotypic signatures associated with nonlymphoid Trm cells. These data indicate that nonlymphoid cells can give rise to SLO Trm cells and suggest vaccination strategies by which memory CD8(+) T cell immunosurveillance can be regionalized to specific lymph nodes.	[Beura, Lalit K.; Wijeyesinghe, Sathi; Thompson, Emily A.; Rosato, Pamela C.; Pierson, Mark J.; Schenkel, Jason M.; Vezys, Vaiva; Masopust, David] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA; [Beura, Lalit K.; Wijeyesinghe, Sathi; Thompson, Emily A.; Rosato, Pamela C.; Pierson, Mark J.; Schenkel, Jason M.; Mitchell, Jason S.; Vezys, Vaiva; Fife, Brian T.; Masopust, David] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Macchietto, Marissa G.; Shen, Steven] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN 55455 USA; [Mitchell, Jason S.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Fife, Brian T.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Schenkel, Jason M.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital	Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA.; Masopust, D (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA.	masopust@umn.edu	masopust, david/B-5027-2008; Vezys, Vaiva/N-3144-2013; Schenkel, Jason/AAV-8184-2020; Beura, Lalit/W-6281-2019; Fife, Brian/D-2042-2013	Schenkel, Jason/0000-0003-4641-6872; Fife, Brian/0000-0001-9826-5637; Wijeyesinghe, Sathi/0000-0002-8819-2654	National Institutes of Health [R01AI111671, R01AI084913]; Howard Hughes Medical Institute Faculty Scholars program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084913, R01AI111671, T32AI007313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Faculty Scholars program(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the Masopust laboratory for helpful discussions. The authors acknowledge the assistance of the University of Minnesota Flow Cytometry core facility, the Biosafety level 3 program, Thomas Pengo (University Imaging Center), J. Michael Stolley, and funding by National Institutes of Health grants R01AI111671 and R01AI084913 and the Howard Hughes Medical Institute Faculty Scholars program (D.M.).	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Beura LK, 2015, J LEUKOCYTE BIOL, V97, P217, DOI 10.1189/jlb.1HI0314-154R; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Collins N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11514; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Freeman BE, 2012, P NATL ACAD SCI USA, V109, P9971, DOI 10.1073/pnas.1203543109; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Li SB, 2016, J VIROL, V90, P11168, DOI 10.1128/JVI.01332-16; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Marriott CL, 2017, EUR J IMMUNOL, V47, P860, DOI 10.1002/eji.201646681; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Petrovas C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2285; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Silva KA, 2013, COMPARATIVE MED, V63, P392; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Takamura S, 2016, J EXP MED, V213, P3057, DOI 10.1084/jem.20160938; Tatovic D, 2015, J IMMUNOL, V195, P386, DOI 10.4049/jimmunol.1500364; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Thompson EA, 2016, J IMMUNOL, V196, P3054, DOI 10.4049/jimmunol.1501797; Thompson JD, 2016, STATISTICS FOR BIOINFORMATICS: METHODS FOR MULTIPLE SEQUENCE ALIGNMENT, P1; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Ugur M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5821; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Woon HG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005799; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	43	128	129	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					327	+		10.1016/j.immuni.2018.01.015	http://dx.doi.org/10.1016/j.immuni.2018.01.015			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466758	Green Accepted, Bronze			2022-12-18	WOS:000425507800017
J	Jones, RG; Pearce, EJ				Jones, Russell G.; Pearce, Edward J.			MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells	IMMUNITY			English	Review							TUBEROUS SCLEROSIS COMPLEX; CHAIN AMINO-ACIDS; HELPER T-CELLS; MAMMALIAN TARGET; DENDRITIC CELL; METABOLIC CHECKPOINT; MECHANISTIC TARGET; MACROPHAGE DIFFERENTIATION; MITOCHONDRIAL ACTIVITY; NEUTROPHIL CHEMOTAXIS	Tissue-resident immune cells must balance survival in peripheral tissues with the capacity to respond rapidly upon infection or tissue damage, and in turn couple these responses with intrinsic metabolic control and conditions in the tissue microenvironment. The serine/threonine kinase mammalian/mechanistic target of rapamycin (mTOR) is a central integrator of extracellular and intracellular growth signals and cellular metabolism and plays important roles in both innate and adaptive immune responses. This review discusses the function of mTOR signaling in the differentiation and function of tissue-resident immune cells, with focus on the role of mTOR as a metabolic sensor and its impact on metabolic regulation in innate and adaptive immune cells. We also discuss the impact of metabolic constraints in tissues on immune homeostasis and disease, and how manipulating mTOR activity with drugs such as rapamycin can modulate immunity in these contexts.	[Jones, Russell G.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Jones, Russell G.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Pearce, Edward J.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	McGill University; McGill University; Max Planck Society; University of Freiburg	Jones, RG (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.; Jones, RG (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada.; Pearce, EJ (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.; Pearce, EJ (corresponding author), Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.	russell.jones@mcgill.ca; pearceed@ie-freiburg.mpg.de	Jones, Russell/AAC-2861-2022; Jones, Russell Graham/ABD-5261-2021	Jones, Russell Graham/0000-0003-2250-4675	Canadian Institutes of Health Research (CIHR) [MOP-142259]; NIH [AI032573, CA164062, AI110481]; Max Planck Society; NATIONAL CANCER INSTITUTE [R01CA164062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032573, R01AI032573, R01AI110481] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Maya C. Poffenberger for graphical design of figures and Dr. Aga Kabat for critical reading of the manuscript. We acknowledge financial support from the Canadian Institutes of Health Research (CIHR MOP-142259 to R.G.J.), the NIH (AI032573, CA164062, and AI110481 to E.J.P.), and the Max Planck Society (E.J.P.).	Abraham RT, 1998, CURR OPIN IMMUNOL, V10, P330, DOI 10.1016/S0952-7915(98)80172-6; Adams WC, 2016, CELL REP, V17, P3142, DOI 10.1016/j.celrep.2016.11.065; Albert V, 2016, EMBO MOL MED, V8, P232, DOI 10.15252/emmm.201505610; Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Amiel E, 2014, J IMMUNOL, V193, P2821, DOI 10.4049/jimmunol.1302498; Amiel E, 2012, J IMMUNOL, V189, P2151, DOI 10.4049/jimmunol.1103741; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Barnhart BC, 2008, CANCER BIOL THER, V7, P1443; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Bjur E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003494; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Calder PC, 2006, J NUTR, V136, p288S, DOI 10.1093/jn/136.1.288S; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Cejka D, 2010, ARTHRITIS RHEUM-US, V62, P2294, DOI 10.1002/art.27504; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003; Chen FD, 2016, J IMMUNOL, V196, P4390, DOI 10.4049/jimmunol.1501541; Chen W, 2012, CANCER RES, V72, P1363, DOI 10.1158/0008-5472.CAN-11-2684; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Cunningham JT, 2014, CELL, V157, P1088, DOI 10.1016/j.cell.2014.03.052; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, MOL IMMUNOL, V46, P2694, DOI 10.1016/j.molimm.2009.05.185; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Finlay DK, 2015, BIOCHEM SOC T, V43, P758, DOI 10.1042/BST20150116; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Gogoi M, 2016, CURR OPIN MICROBIOL, V29, P43, DOI 10.1016/j.mib.2015.10.005; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hallowell RW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14208; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; He Y, 2013, MOL BIOL CELL, V24, P3369, DOI 10.1091/mbc.E13-07-0405; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Hua W, 2015, RESPIROLOGY, V20, P1055, DOI 10.1111/resp.12554; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Hukelmann JL, 2016, NAT IMMUNOL, V17, P104, DOI 10.1038/ni.3314; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Iwata TN, 2016, J IMMUNOL, V197, P2250, DOI 10.4049/jimmunol.1600492; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jellusova J, 2016, CRIT REV BIOCHEM MOL, V51, P359, DOI 10.1080/10409238.2016.1215288; Jiang HF, 2014, DIABETOLOGIA, V57, P2393, DOI 10.1007/s00125-014-3350-5; Jones DD, 2016, J CLIN INVEST, V126, P4250, DOI 10.1172/JCI86504; Kakazu E, 2007, J IMMUNOL, V179, P7137, DOI 10.4049/jimmunol.179.10.7137; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Kellersch B, 2013, BLOOD, V121, P298, DOI 10.1182/blood-2012-06-439786; Kim MS, 2008, J IMMUNOL, V180, P4586, DOI 10.4049/jimmunol.180.7.4586; Kimura T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13130; Kirsch AH, 2012, AM J PHYSIOL-RENAL, V303, pF569, DOI 10.1152/ajprenal.00180.2012; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee K, 2013, BLOOD, V122, P2369, DOI 10.1182/blood-2013-01-477505; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li K, 2017, SCI REP-UK, V7, DOI 10.1038/srep42655; Limon JJ, 2014, P NATL ACAD SCI USA, V111, pE5076, DOI 10.1073/pnas.1407104111; Linke M, 2017, NAT IMMUNOL, V18, P293, DOI 10.1038/ni.3655; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; McInturff AM, 2012, BLOOD, V120, P3118, DOI 10.1182/blood-2012-01-405993; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mercalli A, 2013, IMMUNOLOGY, V140, P179, DOI 10.1111/imm.12126; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; Nobs SP, 2015, IMMUNITY, V43, P674, DOI 10.1016/j.immuni.2015.09.006; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Ohtani M, 2012, J IMMUNOL, V188, P4736, DOI 10.4049/jimmunol.1200069; Olenchock BA, 2017, IMMUNITY, V46, P703, DOI 10.1016/j.immuni.2017.04.013; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Powell JD, 1999, J IMMUNOL, V162, P2775; Prevot N, 2015, J IMMUNOL, V194, P223, DOI 10.4049/jimmunol.1401985; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Raich-Regue D, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1146841; Raich-Regue D, 2015, J IMMUNOL, V194, P4767, DOI 10.4049/jimmunol.1402551; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Rodriguez PC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00093; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Salek-Ardakani S, 2004, J IMMUNOL, V173, P6440, DOI 10.4049/jimmunol.173.10.6440; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saric A, 2016, MOL BIOL CELL, V27, P321, DOI 10.1091/mbc.E15-05-0272; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Sato M, 2013, CELL METAB, V18, P749, DOI 10.1016/j.cmet.2013.09.014; Scheffler JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6138; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shin J, 2014, P NATL ACAD SCI USA, V111, pE776, DOI 10.1073/pnas.1315435111; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sklarz T, 2017, EUR J IMMUNOL, V47, P516, DOI 10.1002/eji.201646343; Smrz D, 2014, J IMMUNOL, V193, P5924, DOI 10.4049/jimmunol.1303495; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sowell RT, 2014, J IMMUNOL, V193, P2067, DOI 10.4049/jimmunol.1400074; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Valmori D, 2006, J IMMUNOL, V177, P944, DOI 10.4049/jimmunol.177.2.944; Van de Velde LA, 2016, J BIOL CHEM, V291, P25815, DOI 10.1074/jbc.C116.763623; van den Bosch MWM, 2014, J BIOL CHEM, V289, P22980, DOI 10.1074/jbc.M114.573089; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Wang XC, 2014, DNA CELL BIOL, V33, P198, DOI 10.1089/dna.2013.2164; Wang XM, 2016, EXP CELL RES, V344, P219, DOI 10.1016/j.yexcr.2016.04.017; Wang YY, 2013, P NATL ACAD SCI USA, V110, pE4894, DOI 10.1073/pnas.1308905110; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wei J, 2014, J IMMUNOL, V193, P4297, DOI 10.4049/jimmunol.1402042; Wei WC, 2015, J LEUKOCYTE BIOL, V97, P1071, DOI 10.1189/jlb.2A0414-206RR; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wu JH, 2014, J CLIN INVEST, V124, P1685, DOI 10.1172/JCI69780; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yang MX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12730; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang LJ, 2014, J IMMUNOL, V193, P1759, DOI 10.4049/jimmunol.1400769; Zhang SL, 2013, J IMMUNOL, V191, P1692, DOI 10.4049/jimmunol.1201767	150	128	131	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					730	742		10.1016/j.immuni.2017.04.028	http://dx.doi.org/10.1016/j.immuni.2017.04.028			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514674	Bronze, Green Accepted			2022-12-18	WOS:000401316300003
J	Lee, HM; Bautista, JL; Scott-Browne, J; Mohan, JF; Hsieh, CS				Lee, Hyang-Mi; Bautista, Jhoanne L.; Scott-Browne, James; Mohan, James F.; Hsieh, Chyi-Song			A Broad Range of Self-Reactivity Drives Thymic Regulatory T Cell Selection to Limit Responses to Self	IMMUNITY			English	Article							IN-VIVO; EPITHELIAL-CELLS; AMINO-ACIDS; ANTIGEN; PEPTIDE; FOXP3(+); SPECIFICITY; TOLERANCE; MICE; DIFFERENTIATION	The degree of T cell self-reactivity considered dangerous by the immune system, thereby requiring thymic selection processes to prevent autoimmunity, is unknown. Here, we analyzed a panel of T cell receptors (TCRs) with a broad range of reactivity to ovalbumin (OVA(323-339)) in the rat insulin promoter (RIP)-mOVA self-antigen model for their ability to trigger thymic self-tolerance mechanisms. Thymic regulatory T (Treg) cell generation in vivo was directly correlated with in vitro TCR reactivity to OVA-peptide in a broad similar to 1,000-fold range. Interestingly, higher TCR affinity was associated with a larger Treg cell developmental "niche" size, even though the amount of antigen should remain constant. The TCR-reactivity threshold to elicit thymic negative selection and peripheral T cell responses was similar to 100-fold higher than that of Treg cell differentiation. Thus, these data suggest that the broad range of self-reactivity that elicits thymic Treg cell generation is tuned to secure peripheral tolerance to self.	[Lee, Hyang-Mi; Bautista, Jhoanne L.; Hsieh, Chyi-Song] Washington Univ, Sch Med, Dept Internal Med, Div Rheumatol, St Louis, MO 63110 USA; [Scott-Browne, James] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Mohan, James F.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); National Jewish Health; Washington University (WUSTL)	Hsieh, CS (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Rheumatol, St Louis, MO 63110 USA.	chsieh@wustl.edu		Hsieh, Chyi-Song/0000-0001-5976-9250; Bautista, Jhoanne/0000-0002-8984-1361	NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079187] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Santacruz and J. Hunn for technical assistance, W. Ise, K. Murphy, B. Helmink, and B. Sleckman for reagents; W. McCoy, D. Fremont, D. Donermeyer, and P.M. Allen for technical assistance and helpful discussions; and K. Murphy, T. Egawa, P.M. Allen, E. Unanue, C.W. Lio (all Wash. U), Y. Zheng (Salk), and L.F. Lu (UCSD) for helpful discussion and critical reading of the manuscript. This work was supported by the NIH (C.-S.H.).	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; DILLON SR, 1994, J IMMUNOL, V152, P1790; Feuerer M, 2007, P NATL ACAD SCI USA, V104, P18181, DOI 10.1073/pnas.0708899104; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; McCaughtry TM, 2008, SEMIN IMMUNOPATHOL, V30, P399, DOI 10.1007/s00281-008-0137-0; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Palmer E., 2009, IMMUNITY, V9, P207; Picca CC, 2011, P NATL ACAD SCI USA, V108, P14890, DOI 10.1073/pnas.1103810108; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; Scott-Browne JP, 2011, IMMUNITY, V35, P526, DOI 10.1016/j.immuni.2011.09.005; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wirnsberger G, 2009, P NATL ACAD SCI USA, V106, P10278, DOI 10.1073/pnas.0901877106; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	35	128	128	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 21	2012	37	3					475	486		10.1016/j.immuni.2012.07.009	http://dx.doi.org/10.1016/j.immuni.2012.07.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22921379	Green Accepted, Bronze			2022-12-18	WOS:000309199000012
J	Kaufmann, SHE				Kaufmann, Stefan H. E.			Future Vaccination Strategies against Tuberculosis: Thinking outside the Box	IMMUNITY			English	Review							T-CELL RESPONSES; MYCOBACTERIUM-BOVIS BCG; CALMETTE-GUERIN VACCINE; CHRONIC VIRAL-INFECTION; HEPARIN-BINDING HEMAGGLUTININ; IMMUNE-RESPONSES; EXTRAPULMONARY DISSEMINATION; ANTIGEN PRESENTATION; DEFENSE-MECHANISM; INTERFERON-GAMMA	With almost a dozen vaccine candidates in clinical trials, tuberculosis (TB) research and development is finally reaping the first fruits of its labors Vaccine candidates in clinical trials may prevent TB disease reactivation by efficiently containing the pathogen Mycobacterium tuberculosis (Mtb) Future research should target vaccines that achieve sterile eradication of Mtb or even prevent stable infection These are ambitious goals that can be reached only by highly cooperative engagement of basic immunologists, vaccinologists, and clinical researchers or in other words, by translation from basic immunology to vaccine research and development, as well as reverse translation of insights from clinical trials back to hypothesis-driven research in the basic laboratory Here, we review current and future strategies toward the rational design of novel vaccines against TB, as well as the progress made thus far, and the hurdles that need to be overcome in the near and distant future	Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Charitepl 1, D-10117 Berlin, Germany.		Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268	NEWTBVAC [HEALTH F3 2009 241745]; Bill & Melinda Gates Foundation [37772]	NEWTBVAC; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	I thank M Grossman for outstanding editorial support I also thank D Schad for her outstanding graphic design of the figures Many thanks to W Hanekom of Capetown South Africa and C Martin of Zaragosa Spain for helpful comments I thank the many colleagues and friends with whom I have dis cussed future vaccination strategies against TB on many occasions notably members of the Tuberculosis Vaccine Initiative (TBVI) and members of the Bill & Melinda Gates Foundation Grand Challenge 6 Program Work from my own laboratory on TB vaccine development receives financial support from numerous sources notably NEWTBVAC FP7 (HEALTH F3 2009 241745) and Bill & Melinda Gates Foundation Grand Challenges in Global Health (Grant No 37772) SHEK is coinventor of the rBCG Delta UreC Hly vaccine candidate and member of the Scientific Advisory Boards of Intercell and of Vaccine Project Management (VPM)	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P193; [Anonymous], 2009, NEW PLAGUES PANDEMIC; Antas PRZ, 2008, T ROY SOC TROP MED H, V102, P628, DOI 10.1016/j.trstmh.2008.03.014; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Azzopardi P, 2009, INT J TUBERC LUNG D, V13, P1331; Bangari DS, 2006, VACCINE, V24, P849, DOI 10.1016/j.vaccine.2005.08.101; Bange FC, 1996, INFECT IMMUN, V64, P1794, DOI 10.1128/IAI.64.5.1794-1799.1996; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Calmette A., 1927, ANN I PASTEUR PARIS, V41, P201; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cosma CL, 2008, J INFECT DIS, V198, P1851, DOI 10.1086/593175; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Day TA, 2010, EUR J IMMUNOL, V40, P1663, DOI 10.1002/eji.201040299; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dlugovitzky D, 1999, SCAND J IMMUNOL, V49, P210, DOI 10.1046/j.1365-3083.1999.00492.x; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Dorhoi A, 2009, CURR OPIN IMMUNOL, V21, P367, DOI 10.1016/j.coi.2009.07.004; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gram GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006950; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Guleria I, 1996, NAT MED, V2, P334, DOI 10.1038/nm0396-334; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; GUYOT RV, 2006, AM J RESP CRIT CARE, V173, P803; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hatherill M, 2009, VACCINE, V27, P4743, DOI 10.1016/j.vaccine.2009.05.021; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; HOTEZ PJ, 2009, PLOS NEGLECT TROP D, V0003; Hutnick NA, 2009, NAT MED, V15, P876, DOI 10.1038/nm.1989; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; KAGINA MN, 2010, AM J RESP C IN PRESS, DOI DOI 10.1164/RCCM.201003.0334OC; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lin MY, 2008, BIOL CHEM, V389, P497, DOI 10.1515/BC.2008.057; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Lingnau K, 2007, EXPERT REV VACCINES, V6, P741, DOI 10.1586/14760584.6.5.741; Locht C, 2006, TUBERCULOSIS, V86, P303, DOI 10.1016/j.tube.2006.01.016; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Mansoor N, 2009, J INFECT DIS, V199, P982, DOI 10.1086/597304; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; O'Brien KL, 2009, NAT MED, V15, P873, DOI 10.1038/nm.1991; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Rouanet C, 2009, MICROBES INFECT, V11, P995, DOI 10.1016/j.micinf.2009.07.005; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russi TJ, 1997, LUNG SCI FDN, V1, P371; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Scotet E, 2008, FRONT BIOSCI-LANDMRK, V13, P6872, DOI 10.2741/3195; Shitrit D, 2006, LUNG, V184, P21, DOI 10.1007/s00408-005-2558-2; Stanley M, 2010, CURR OPIN INFECT DIS, V23, P70, DOI 10.1097/QCO.0b013e328334c0e1; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; *STOPTB PARTN WORK, 2009, STOPTB TUB VACC PIP; SUN R, 2010, Patent No. 7666656; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Toossi Zahra, 1998, Frontiers in Bioscience, V3, pE133; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Tullius MV, 2008, INFECT IMMUN, V76, P5200, DOI 10.1128/IAI.00434-08; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Walker K B, 2010, Vaccine, V28, P2259, DOI 10.1016/j.vaccine.2009.12.083; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Weir RE, 2006, CLIN EXP IMMUNOL, V146, P390, DOI 10.1111/j.1365-2249.2006.03222.x; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; WILSON ME, 1995, CLIN INFECT DIS, V20, P982, DOI 10.1093/clinids/20.4.982; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; World Health Organization, 2009, GLOB TUB CONTR EP ST; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194	113	128	140	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					567	577		10.1016/j.immuni.2010.09.015	http://dx.doi.org/10.1016/j.immuni.2010.09.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029966	Bronze			2022-12-18	WOS:000284300200012
J	Spooner, CJ; Cheng, JX; Pujadas, E; Laslo, P; Singh, H				Spooner, Chauncey J.; Cheng, Jason X.; Pujadas, Elisabet; Laslo, Peter; Singh, Harinder			A Recurrent Network Involving the Transcription Factors PU.1 and Gfi1 Orchestrates Innate and Adaptive Immune Cell Fates	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; GENE REGULATORY NETWORKS; HEMATOPOIETIC STEM-CELLS; LYMPHOCYTE DEVELOPMENT; REPRESSOR GFI1; PROGENITORS; EXPRESSION; SPECIFICATION; GROWTH; MICE	The transcription factor PU.1, encoded by the Sfpi1 gene, functions in a graded manner to regulate macrophage versus B cell generation; its higher concentration favors the macrophage fate. We demonstrated that Gfi1 reciprocally promoted B cell fate choice at the expense of myeloid progeny. Gfi1(-/-) multipotential progenitors (MPPs) were unable to constrain the expression of PU.1 because Gfi1 functioned to repress the Sfpi1 gene by displacing PU.1 from positive autoregulatory elements. Attenuating a transcriptional module composed of PU.1 and Egr suppressed the B lineage developmental defects of Gfi1(-/-) MPPs. Finally lkaros, a transcription factor required for B cell development, promoted Gfi1 and antagonized PU.1 expression in MPPs. Our results reveal that a core transcriptional regulatory network used for directing cell fate choice in the innate immune system has been co-opted by lkaros to orchestrate B lymphocyte generation. These findings have important implications for the evolution of the adaptive immune system.	[Spooner, Chauncey J.; Pujadas, Elisabet; Laslo, Peter; Singh, Harinder] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Cheng, Jason X.] Univ Chicago, Sch Med, Dept Pathol, Chicago, IL 60637 USA; [Spooner, Chauncey J.; Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, 929 E 57th St,GCIS W522, Chicago, IL 60637 USA.	hsingh@uchicago.edu	Pujadas, Elisabet/AAC-2138-2021	Pujadas, Elisabet/0000-0003-4795-7945	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [T90 DK070076] Funding Source: Medline; NIGMS NIH HHS [P50 GM081892-01A1, P50 GM081892] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Krysinska H, 2007, MOL CELL BIOL, V27, P878, DOI 10.1128/MCB.01915-06; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Stehling-Sun S, 2009, NAT IMMUNOL, V10, P289, DOI 10.1038/ni.1694; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Taillebourg E, 2002, GENESIS, V32, P112, DOI 10.1002/gene.10062; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zarebski A, 2008, IMMUNITY, V28, P370, DOI 10.1016/j.immuni.2007.12.020; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zou GM, 2005, P NATL ACAD SCI USA, V102, P13236, DOI 10.1073/pnas.0506218102	45	128	131	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 16	2009	31	4					576	586		10.1016/j.immuni.2009.07.011	http://dx.doi.org/10.1016/j.immuni.2009.07.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19818654	Green Accepted, Bronze			2022-12-18	WOS:000271403900009
J	Dai, S; Huseby, ES; Rubtsova, K; Scott-Browne, J; Crawford, F; Macdonald, WA; Marrack, P; Kappler, JW				Dai, Shaodong; Huseby, Eric S.; Rubtsova, Kira; Scott-Browne, James; Crawford, Frances; Macdonald, Whitney A.; Marrack, Philippa; Kappler, John W.			Crossreactive T cells spotlight the germline rules for alpha beta T cell-receptor interactions with MHC molecules	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE; ANTIGEN; REPERTOIRE; SELECTION; IMMUNOGLOBULIN; SPECIFICITY; INSIGHTS; DELETION; BINDING	To test whether highly crossreactive alpha beta T cell receptors (TCRs) produced during limited negative selection best illustrate evolutionarily conserved interactions between TCR and major histocompatibility complex (MHC) molecules, we solved the structures of three TCRs bound to the same MHC II peptide(IA(b)- 3K). The TCRs had similar affinities for IA(b)-3K but varied from noncrossreactive to extremely crossreactive with other peptides and MHCs. Crossreactivity correlated with a shrinking, increasingly hydrophobic TCR-ligand interface, involving fewer TCR amino acids. A few CDR1 and CDR2 amino acids dominated the most crossreactive TCR interface with MHC, including V beta 8 48Y and 54E and V alpha 4 29Y, arranged to impose the familiar diagonal orientation of TCR on MHC. These interactions contribute to MHC binding by other TCRs using related V regions, but not usually so dominantly. These data show that crossreactive TCRs can spotlight the evolutionarily conserved features of TCR-MHC interactions and that these interactions impose the diagonal docking of TCRs on MHC.	[Dai, Shaodong; Huseby, Eric S.; Rubtsova, Kira; Scott-Browne, James; Crawford, Frances; Marrack, Philippa; Kappler, John W.] Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; [Dai, Shaodong; Huseby, Eric S.; Crawford, Frances; Marrack, Philippa; Kappler, John W.] Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; [Marrack, Philippa] Univ Colorado, Dept Biochem & Mol Genet, Denver, CO 80202 USA; [Marrack, Philippa; Kappler, John W.] Hlth Sci Ctr, Aurora, CO 80045 USA; [Kappler, John W.] Univ Colorado, Program Biomol Struct, Denver, CO 80202 USA	National Jewish Health; Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver	Marrack, P (corresponding author), Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA.	marrackp@njc.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017134, R56AI018785, R37AI018785, P01AI022295, R56AI017134, R01AI018785, R01AI017134, R01AI052225] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R37 AI018785, P01 AI022295-21A16790, P01 AI022295, AI-17134, R01 AI052225, P01 AI022295-20, R01 AI018785-25A1, R01 AI018785-23, R01 AI018785-26, R56 AI018785, R01 AI052225-05, R01 AI018785, R01 AI018785-24, AI-18785, R01 AI017134, R01 AI018785-22, R56 AI017134, P01 AI022295-21A1, AI-22295] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arden Bernhard, 1995, Immunogenetics, V42, P501; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Clark Stephen P., 1995, Immunogenetics, V42, P531; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Huseby ES, 2003, P NATL ACAD SCI USA, V100, P11565, DOI 10.1073/pnas.1934636100; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Martinez-Palacios CA, 1996, AQUACULT NUTR, V2, P11, DOI 10.1111/j.1365-2095.1996.tb00003.x; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mazza C, 2007, SEMIN IMMUNOL, V19, P225, DOI 10.1016/j.smim.2007.03.003; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SILICIANO RF, 1985, J IMMUNOL, V135, P906; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	50	128	128	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2008	28	3					324	334		10.1016/j.immuni.2008.01.008	http://dx.doi.org/10.1016/j.immuni.2008.01.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18308592	Bronze, Green Accepted			2022-12-18	WOS:000254142500010
J	Park-Min, KH; Serbina, NV; Yang, WT; Ma, XJ; Krystal, G; Neel, BG; Nutt, SL; Hu, XY; Ivashkiv, LB				Park-Min, Kyung-Hyun; Serbina, Natalya V.; Yang, Wentian; Ma, Xiaojing; Krystal, Gerald; Neel, Benjamin G.; Nutt, Stephen L.; Hu, Xiaoyu; Ivashkiv, Lionel B.			Fc gamma RIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin	IMMUNITY			English	Article							AUTOIMMUNE-DISEASE; IFN-GAMMA; INFLAMMATORY MYOPATHIES; LISTERIA-MONOCYTOGENES; KAWASAKI-DISEASE; RECEPTOR; IMMUNOGLOBULIN; EXPRESSION; COMPLEXES; IGG	Intravenous immune globulin (IVIG) suppresses autoantibody-mediated inflammation by inducing and activating the inhibitory Fc receptor Fc gamma RIIb and downstream negative signaling pathways. We investigated the effects of IVIG on cellular responses to interferon-gamma (IFN-gamma), a potent macrophage activator that exacerbates inflammation. Our study showed that IVIG blocked IFN-gamma signaling and IFN-gamma-induced gene expression and suppressed IFN-gamma function in vivo during immune responses to Listeria monocytogenes and in an IFN-gamma-enhanced model of immune thrombocytopenic purpura. The mechanism of inhibition of IFN-gamma signaling was suppression of expression of the IFNGR2 subunit of the IFN-gamma receptor. The inhibitory effect of IVIG was mediated at least in part by soluble immune complexes and was dependent on Fc gamma RIII but independent of Fc gamma RIIb. These results reveal an unexpected inhibitory role for the activating Fc gamma RIII in mediating suppression of IFN-gamma signaling and suggest that inhibition of macrophage responses to IFN-gamma contributes to the anti-inflammatory properties of IVIG.	Cornell Univ, Weill Med Coll, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Dept Med, Immunol Program,Sloan Kettering Inst, New York, NY 10021 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Dept Med, Boston, MA 02215 USA; British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; Hosp Special Surg, Dept Med, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; British Columbia Cancer Agency; Walter & Eliza Hall Institute	Ivashkiv, LB (corresponding author), Cornell Univ, Weill Med Coll, Grad Program Immunol & Microbial Pathogenesis, 1300 York Ave, New York, NY 10021 USA.	ivashkivl@hss.edu	Hu, Xiaoyu/D-5403-2017; Nutt, Stephen L/C-9256-2013	Hu, Xiaoyu/0000-0002-4289-6998; Nutt, Stephen L/0000-0002-0020-6637; Krystal, Gerald/0000-0002-1961-6281				Abe J, 2005, J IMMUNOL, V174, P5837, DOI 10.4049/jimmunol.174.9.5837; Akilesh S, 2004, J CLIN INVEST, V113, P1328, DOI 10.1172/JCI200418838; Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; Balasa B, 1997, J EXP MED, V186, P385, DOI 10.1084/jem.186.3.385; Basta M, 2003, NAT MED, V9, P431, DOI 10.1038/nm836; BASTA M, 1994, J CLIN INVEST, V94, P1729, DOI 10.1172/JCI117520; Bernabei P, 2001, EUR CYTOKINE NETW, V12, P6; Braun-Moscovici Y, 2003, CURR OPIN RHEUMATOL, V15, P237, DOI 10.1097/00002281-200305000-00010; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Carella C, 2006, BLOOD, V107, P1124, DOI 10.1182/blood-2005-03-1196; Clynes R, 2005, J CLIN INVEST, V115, P25, DOI 10.1172/JCI200523994; Crow AR, 2003, BLOOD, V102, P558, DOI 10.1182/blood-2003-01-0023; Du ZM, 2005, P NATL ACAD SCI USA, V102, P10267, DOI 10.1073/pnas.0408854102; ESPARZA I, 1983, J IMMUNOL, V131, P2117; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; HAMERMAN JA, 2006, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3202006RE1; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Ichiyama T, 2005, RHEUMATOLOGY, V44, P314, DOI 10.1093/rheumatology/keh488; Illa I, 1997, AM J PATHOL, V151, P81; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; Johnston JA, 2003, NAT IMMUNOL, V4, P507, DOI 10.1038/ni0603-507; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kihara-Negishi F, 2001, ONCOGENE, V20, P6039, DOI 10.1038/sj.onc.1204756; Levy Y, 1998, NAT IMMUN, V16, P207, DOI 10.1159/000069447; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; Mina-Osorio P, 2004, TRENDS IMMUNOL, V25, P529, DOI 10.1016/j.it.2004.08.008; Musaji A, 2005, AUTOIMMUN REV, V4, P247, DOI 10.1016/j.autrev.2004.11.010; NAGARAJAN S, 1995, J BIOL CHEM, V270, P25762, DOI 10.1074/jbc.270.43.25762; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Qin HW, 2004, J IMMUNOL, V173, P6211, DOI 10.4049/jimmunol.173.10.6211; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rhee S, 1996, J BIOL CHEM, V271, P28947, DOI 10.1074/jbc.271.46.28947; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Siragam V, 2005, J CLIN INVEST, V115, P155, DOI 10.1172/JCI200522753; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Suhrbier A, 2003, TRENDS IMMUNOL, V24, P165, DOI 10.1016/S1471-4906(03)00065-6; Teeling JL, 2001, BLOOD, V98, P1095, DOI 10.1182/blood.V98.4.1095; VIRGIN HW, 1984, J IMMUNOL, V133, P104; VIRGIN HW, 1985, J IMMUNOL, V135, P3735; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	52	128	130	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2007	26	1					67	78		10.1016/j.immuni.2006.11.010	http://dx.doi.org/10.1016/j.immuni.2006.11.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17239631	Bronze			2022-12-18	WOS:000243959000010
J	Murga, M; Fernandez-Capetillo, O; Field, SJ; Moreno, B; Borlado, LR; Fujiwara, Y; Balomenos, D; Vicario, A; Carrera, AC; Orkin, SH; Greenberg, ME; Zubiaga, AM				Murga, M; Fernandez-Capetillo, O; Field, SJ; Moreno, B; Borlado, LR; Fujiwara, Y; Balomenos, D; Vicario, A; Carrera, AC; Orkin, SH; Greenberg, ME; Zubiaga, AM			Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity	IMMUNITY			English	Article							THYMIC NEGATIVE SELECTION; RECEPTOR TRANSGENIC MICE; S-PHASE ENTRY; TRANSCRIPTION FACTOR; RETINOBLASTOMA PROTEIN; CELL-PROLIFERATION; SUSCEPTIBILITY GENES; IN-VIVO; EXPRESSION; GROWTH	E2Fs are important regulators of proliferation, differentiation, and apoptosis. Here we characterize the phenotype of mice deficient in E2F2. We show that E2F2 is required for immunologic self-tolerance. E2F2(-/-) mice develop late-onset autoimmune features, characterized by widespread inflammatory infiltrates, glomerular immunocomplex deposition, and anti-nuclear antibodies. E2F2-deficient T lymphocytes exhibit enhanced TCR-stimulated proliferation and a lower activation threshold, leading to the accumulation of a population of autoreactive effector/memory T lymphocytes, which appear to be responsible for causing autoimmunity in E2F2-deficient mice. Finally, we provide support for a model to explain E2F2's unexpected role as a suppressor of T lymphocyte proliferation. Rather than functioning as a transcriptional activator, E2F2 appears to function as a transcriptional repressor of genes required for normal S phase entry, particularly E2F1.	Univ Basque Country, Fac Sci, Dept Anim Biol & Genet, E-48080 Bilbao, Spain; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Basque Inst Agr Res & Dev, NEIKER, E-48160 Derio, Spain; Univ Autonoma Madrid, Ctr Nacl Biotecnol, CSIC, Dept Immunol & Oncol, E-28049 Madrid, Spain; Childrens Hosp, Howard Hughes Med Inst, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	University of Basque Country; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Zubiaga, AM (corresponding author), Univ Basque Country, Fac Sci, Dept Anim Biol & Genet, E-48080 Bilbao, Spain.		Moreno Burgos, Bernardino/ABF-4969-2021; Fernandez-Capetillo, Oscar/H-3508-2015; zubiaga, ana/S-3457-2019; Balomenos, Dimitrios/I-3850-2015	Fernandez-Capetillo, Oscar/0000-0002-2690-6885; zubiaga, ana/0000-0002-2132-9708; Balomenos, Dimitrios/0000-0002-1252-0850; Field, Seth/0000-0002-8893-4806; Carrera, Ana/0000-0002-3999-5434	NCI NIH HHS [CA43855] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043855] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Borlado LR, 2000, FASEB J, V14, P895; Brehm A, 1999, TRENDS BIOCHEM SCI, V24, P142, DOI 10.1016/S0968-0004(99)01368-7; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Garcia I, 2000, CELL GROWTH DIFFER, V11, P91; He YW, 2000, ONCOGENE, V19, P3422, DOI 10.1038/sj.onc.1203682; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Humbert PO, 2000, GENE DEV, V14, P690; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; IVEYHOYLE M, 1993, MOL CELL BIOL, V13, P7802, DOI 10.1128/MCB.13.12.7802; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; London CA, 1999, J IMMUNOL, V162, P766; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Macleod K, 1999, CURR OPIN GENET DEV, V9, P31, DOI 10.1016/S0959-437X(99)80005-7; Muller H, 1997, MOL CELL BIOL, V17, P5508; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ohtani K, 1996, MOL CELL BIOL, V16, P6977; SARDET C, 1997, ONCOGENES TRANSCRIPT, V2, P1; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Van Parijs L, 1998, SCIENCE, V280, P243; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Vigo E, 1999, MOL CELL BIOL, V19, P6379; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WU X, 1994, P NATL ACAD SCI USA, V91, P3802; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Zhu JW, 1999, CELL GROWTH DIFFER, V10, P829; ZHU JW, 2001, IN PRESS MOL CELL BI	49	128	131	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2001	15	6					959	970		10.1016/S1074-7613(01)00254-0	http://dx.doi.org/10.1016/S1074-7613(01)00254-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754817	Bronze			2022-12-18	WOS:000172961400010
J	Balamuth, F; Leitenberg, D; Unternaehrer, J; Mellman, I; Bottomly, K				Balamuth, F; Leitenberg, D; Unternaehrer, J; Mellman, I; Bottomly, K			Distinct patterns of membrane microdomain partitioning in Th1 and Th2 cells	IMMUNITY			English	Article							CD45 TYROSINE PHOSPHATASE; LIPID RAFTS; T-CELLS; ANTIGEN-RECEPTOR; SIGNAL-TRANSDUCTION; POSITIVE SELECTION; MAP KINASE; ACTIVATION; TCR; LYMPHOCYTES	Here we show that activated Th1 and Th2 cells have distinct patterns of membrane compartmentalization into lipid rafts. TOR complex members are recruited efficiently to rafts and aggregate with rafts at the site of MHC/peptide contact in Th1 cells but not Th2 cells. TCR/raft association in Th1 cells is deficient in the absence of CD4, suggesting that CD4 aids recruitment of the TOR to rafts. We show differential utilization of rafts in Th1 and Th2 cells by cholesterol depletion studies, which alters calcium signaling in Th1 but not Th2 cells. Furthermore, Th2 cells have a decreased ability to respond to low-affinity peptide stimulation. These studies indicate that components of membrane microdomains are differentially regulated in functionally distinct CD4 T cells.	Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Bottomly, K (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.		Mellman, Ira/ABG-5896-2020	Unternaehrer-Hamm, Julia/0000-0001-5864-4704; Leitenberg, David/0000-0002-0622-9522				Boutin Y, 1997, J IMMUNOL, V159, P5802; Chung JB, 2001, J IMMUNOL, V166, P736, DOI 10.4049/jimmunol.166.2.736; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; DIANZANI U, 1990, EUR J IMMUNOL, V20, P2249, DOI 10.1002/eji.1830201014; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Ebert PJR, 2000, J IMMUNOL, V165, P5435, DOI 10.4049/jimmunol.165.10.5435; Fanger CM, 2000, J IMMUNOL, V164, P1153, DOI 10.4049/jimmunol.164.3.1153; FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29; GAJEWSKI TF, 1990, J IMMUNOL, V144, P4110; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Holowka D, 2000, J CELL SCI, V113, P1009; Ilangumaran S, 1999, MOL BIOL CELL, V10, P891, DOI 10.1091/mbc.10.4.891; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Leitenberg D, 1996, J EXP MED, V183, P249, DOI 10.1084/jem.183.1.249; Leitenberg D, 1999, IMMUNITY, V10, P701, DOI 10.1016/S1074-7613(00)80069-2; Leitenberg D, 1998, J IMMUNOL, V161, P1194; LEVIN D, 1993, J IMMUNOL, V151, P6742; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Millan J, 1999, TISSUE ANTIGENS, V53, P33, DOI 10.1034/j.1399-0039.1999.530104.x; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; Patel VP, 2001, J IMMUNOL, V166, P754, DOI 10.4049/jimmunol.166.2.754; Paz FL, 2001, EUR J IMMUNOL, V31, P777; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; Pierre P, 1996, IMMUNITY, V4, P229, DOI 10.1016/S1074-7613(00)80431-8; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; SCHRAVEN B, 1991, EUR J IMMUNOL, V21, P2469, DOI 10.1002/eji.1830211025; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SloanLancaster J, 1997, J IMMUNOL, V159, P1160; Smith JA, 1998, J IMMUNOL, V160, P4841; Sproul TW, 2000, J IMMUNOL, V165, P6020, DOI 10.4049/jimmunol.165.11.6020; TAMURA T, 1995, J IMMUNOL, V155, P4692; Thomas ML, 1999, CURR OPIN IMMUNOL, V11, P270, DOI 10.1016/S0952-7915(99)80044-2; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; VOLAREVIC S, 1990, P NATL ACAD SCI USA, V87, P7085, DOI 10.1073/pnas.87.18.7085; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	51	128	132	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					729	738		10.1016/S1074-7613(01)00223-0	http://dx.doi.org/10.1016/S1074-7613(01)00223-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728335	Bronze			2022-12-18	WOS:000172528200006
J	Denepoux, S; Razanajaona, D; Blanchard, D; Meffre, G; Capra, JD; Banchereau, J; Lebecque, S				Denepoux, S; Razanajaona, D; Blanchard, D; Meffre, G; Capra, JD; Banchereau, J; Lebecque, S			Induction of somatic mutation in a human B cell line in vitro	IMMUNITY			English	Article							IMMUNOGLOBULIN VARIABLE GENES; ANTIGEN-DRIVEN SELECTION; V-H GENES; GERMINAL-CENTERS; AFFINITY MATURATION; BURKITTS-LYMPHOMA; INTRON ENHANCER; IMMUNE-RESPONSE; SOLUBLE-ANTIGEN; CD40 ANTIGEN	Both the B cell-surface trigger(s) and the intracellular molecular mechanism(s) of somatic hypermutation in immunoglobulin (Ig) variable region genes remain unknown, partly because of the lack of a simple and reproducible in vitro model. Here, we show that upon surface immunoglobulin cross-linking followed by coculture with activated cloned T cells, the Burkitt's lymphoma cell line BL2 is induced to mutate its IgV(H) gene. Repeated activation of BL2 cells increased the frequency of mutation. The in vitro-induced mutations, which do not affect the IgM constant region, are point mutations distributed over the entire V(H)DJ(H) gene segment and do not show evidence of antigen-driven selection.	UNIV TEXAS,SW MED CTR,MOL IMMUNOL CTR,DEPT MICROBIOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Denepoux, S (corresponding author), SCHERING PLOUGH SPA,LAB IMMUNOL RES,F-69571 DARDILLY,FRANCE.			lebecque, serge/0000-0003-4006-8061	NCI NIH HHS [CA44016] Funding Source: Medline; NIAID NIH HHS [AI12127] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA044016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI012127, R37AI012127] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; BLANCHARD D, 1994, EUR J IMMUNOL, V24, P330, DOI 10.1002/eji.1830240209; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; CHAPMAN CJ, 1995, BLOOD, V85, P2176, DOI 10.1182/blood.V85.8.2176.bloodjournal8582176; COHEN JHM, 1987, JNCI-J NATL CANCER I, V78, P235; DECKER DJ, 1995, IMMUNITY, V2, P195, DOI 10.1016/S1074-7613(95)80092-1; GALIBERT L, 1995, EUR J IMMUNOL, V25, P733, DOI 10.1002/eji.1830250316; GOLDING GB, 1987, GENETICS, V115, P169; GRAY D, 1993, ANNU REV IMMUNOL, V11, P49, DOI 10.1146/annurev.immunol.11.1.49; GREEN NS, 1995, P NATL ACAD SCI USA, V92, P6304, DOI 10.1073/pnas.92.14.6304; Grouard G, 1996, NATURE, V384, P364, DOI 10.1038/384364a0; HAN SH, 1995, J IMMUNOL, V155, P556; HERMANN P, 1993, EUR J IMMUNOL, V23, P961, DOI 10.1002/eji.1830230430; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; KALLBERG E, 1993, INT IMMUNOL, V5, P573, DOI 10.1093/intimm/5.6.573; Kallberg E, 1996, SCIENCE, V271, P1285, DOI 10.1126/science.271.5253.1285; KELLY PJ, 1992, J IMMUNOL, V148, P1294; Kelsoe G, 1995, ADV IMMUNOL, V60, P267, DOI 10.1016/S0065-2776(08)60587-8; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; KLEIN U, 1995, MOL MED, V1, P495, DOI 10.1007/BF03401587; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; Liu Y.J., 1996, IMMUNOLOGIST, V4, P55; Liu YJ, 1996, INT REV CYTOL, V166, P139, DOI 10.1016/S0074-7696(08)62508-5; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1994, ADV EXP MED BIOL, V355, P289; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MACLENNAN ICM, 1994, CURR BIOL, V4, P70, DOI 10.1016/S0960-9822(00)00017-8; MACLENNAN ICM, 1986, IMMUNOL REV, V91, P61, DOI 10.1111/j.1600-065X.1986.tb01484.x; MANSER T, 1987, J IMMUNOL, V139, P234; MARKS JD, 1991, EUR J IMMUNOL, V21, P985, DOI 10.1002/eji.1830210419; MILLER RA, 1982, NEW ENGL J MED, V306, P517, DOI 10.1056/NEJM198203043060906; MILLIER C, 1995, J EXP MED, V181, P1318; MOLLER P, 1993, BLOOD, V81, P2067; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; PULENDRAN B, 1995, J IMMUNOL, V155, P1141; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; RIZZO LV, 1992, J IMMUNOL, V148, P3733; SABLITZKY F, 1985, EMBO J, V4, P345, DOI 10.1002/j.1460-2075.1985.tb03635.x; SANZ I, 1989, EMBO J, V8, P3741, DOI 10.1002/j.1460-2075.1989.tb08550.x; Schattner EJ, 1996, BLOOD, V88, P1375, DOI 10.1182/blood.V88.4.1375.bloodjournal8841375; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Smith DS, 1996, J IMMUNOL, V156, P2642; VANDERMAAREL S, 1993, J IMMUNOL, V150, P2858; WABL MR, 1989, GENOME, V31, P118, DOI 10.1139/g89-022; Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; WILLIAMS MGM, 1993, J EXP MED, V178, P295; Wu HY, 1995, EUR J IMMUNOL, V25, P3263, DOI 10.1002/eji.1830251210; WYSOCKI LJ, 1992, IMMUNOLOGY, V75, P116; YELAMOS J, 1995, NATURE, V376, P225; ZHU MH, 1995, P NATL ACAD SCI USA, V92, P2810, DOI 10.1073/pnas.92.7.2810; ZIEGNER M, 1994, EUR J IMMUNOL, V24, P2393, DOI 10.1002/eji.1830241020	59	128	134	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1997	6	1					35	46		10.1016/S1074-7613(00)80240-X	http://dx.doi.org/10.1016/S1074-7613(00)80240-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB161	9052835	Bronze			2022-12-18	WOS:A1997XB16100004
J	Morse, L; Chen, DQ; Franklin, D; Xiong, Y; ChenKiang, S				Morse, L; Chen, DQ; Franklin, D; Xiong, Y; ChenKiang, S			Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6	IMMUNITY			English	Article							INTERLEUKIN-6 TRANSGENIC MICE; DEPENDENT KINASES; TRANSCRIPTIONAL ACTIVATION; P21; PROTEIN; PROLIFERATION; PLASMACYTOMAS; EXPRESSION; RESPONSES; INVITRO	Cell cycle arrest and cell death are tightly coupled to terminal differentiation of B cells to plasma cells in vivo. This process was recapitulated in vitro by stimulation of IgG-bearing human B lymphoblastoid cells with interleukin-6 (IL-6), which led to orderly cell cycle arrest, differentiation, and apoptosis. In terminally differentiated plasmacytoid cells, phosphorylation of pRb was suppressed, correlating with the activation of the D-type cyclin-dependent kinase (CDK) inhibitors p18(INK4c) and p21(WAF1/CIP1). The expression of CDK6, however, remained unchanged. Activation of p18 by IL-6 was rapid, concomitant with marked enhancement of its association with CDK6 and cell cycle arrest. Overexpression of p18 in IgM-bearing lymphoblastoid cells, which differentiated in response to IL-6 but did not exit the cell cycle, reconstituted coupled differentiation and cell cycle arrest. Thus, CDK inhibitors, in particular p18, are likely to play a pivotal role in controlling cell cycle arrest and cell death in terminal differentiation of late-stage B cells to plasma cells via inhibition of pRb phosphorylation by CDK6.	MT SINAI SCH MED,DEPT MICROBIOL,NEW YORK,NY 10029; UNIV N CAROLINA,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599	Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill	Morse, L (corresponding author), CORNELL UNIV,COLL MED,DEPT PATHOL,1300 YORK AVE,NEW YORK,NY 10021, USA.		Morse, Leslie R/C-9442-2015; Morse, Leslie/AAU-5608-2020	Morse, Leslie R/0000-0002-7426-6341; 	NCI NIH HHS [CA-68377] Funding Source: Medline; NIAMS NIH HHS [AR-24404, F32 AR08421] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR008421] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDIERY WS, 1993, CELL, V75, P817; Franklin DS, 1996, MOL BIOL CELL, V7, P1587, DOI 10.1091/mbc.7.10.1587; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HARDY R, 1991, DEVELOPMENT, V111, P1061; HARPER JW, 1993, CELL, V75, P805; HILBERT DM, 1995, J EXP MED, V182, P243, DOI 10.1084/jem.182.1.243; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; KATO J, 1993, GENES DEV, V7; KEMPKES B, 1995, EMBO J, V14, P88, DOI 10.1002/j.1460-2075.1995.tb06978.x; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MAY LT, 1991, CYTOKINE, V3, P204, DOI 10.1016/1043-4666(91)90018-9; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; NATKUNAM Y, 1994, J IMMUNOL, V153, P3476; NEVINS JR, 1992, SCIENCE, V258, P424; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; RAYNAL MC, 1989, P NATL ACAD SCI USA, V86, P8024, DOI 10.1073/pnas.86.20.8024; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SINGH P, 1995, NATURE, V374, P562, DOI 10.1038/374562a0; SPRUCK CH, 1994, NATURE, V370, P183, DOI 10.1038/370183a0; STEINMAN RA, 1994, ONCOGENE, V9, P3389; SUEMATSU S, 1992, P NATL ACAD SCI USA, V89, P232, DOI 10.1073/pnas.89.1.232; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321	38	128	131	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1997	6	1					47	56		10.1016/S1074-7613(00)80241-1	http://dx.doi.org/10.1016/S1074-7613(00)80241-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB161	9052836	hybrid			2022-12-18	WOS:A1997XB16100005
J	LAWRENCE, MB; BAINTON, DF; SPRINGER, TA				LAWRENCE, MB; BAINTON, DF; SPRINGER, TA			NEUTROPHIL TETHERING TO AND ROLLING ON E-SELECTIN ARE SEPARABLE BY REQUIREMENT FOR L-SELECTIN	IMMUNITY			English	Article							LEUKOCYTE ADHESION MOLECULE-1; ENDOTHELIAL CELL RECOGNITION; NODE HOMING RECEPTOR; P-SELECTIN; GLYCOPROTEIN LIGAND; EVOLUTIONARY CONSERVATION; CHEMOTACTIC FACTORS; MYELOID CELLS; IN-VIVO; EXPRESSION	Neutrophil tethering and rolling in shear flow are mediated by selectins and have been thought to be two indistinguishable manifestations of a single molecular interaction between selectin and ligand. However, we report that under physiologic flow conditions, tethering to E-selectin requires a ligand distinct from the one that supports neutrophil rolling. Tethering under shear to E-selectin requires a carbohydrate ligand that is closely associated with the lectin domain of L-selectin on the neutrophil surface, as enzymatic removal of L-selectin, chemotactic factor-induced shedding of L-selectin, and L-selectin MAbs effectively block tethering. In contrast, this ligand is dispensable for the ability to roll on E-selectin, since rolling adhesions formed after static incubations were not affected by the presence or absence of L-selectin. Thus, E-selectin interactions with ligands on neutrophils persist after L-selectin shedding. These findings add an additional step for regulation of leukocyte localization in inflammatory sites.	HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143	Harvard University; Harvard Medical School; University of California System; University of California San Francisco	LAWRENCE, MB (corresponding author), CTR BLOOD RES INC,BOSTON,MA 02115, USA.				NHLBI NIH HHS [HLB-48675] Funding Source: Medline; NIDDK NIH HHS [DK 10486] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK010486] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBASSI O, 1993, J CLIN INVEST, V92, P2719, DOI 10.1172/JCI116889; ASHFORD DA, 1993, J BIOL CHEM, V268, P3260; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BERG EL, 1992, BIOCHEM BIOPH RES CO, V184, P1048, DOI 10.1016/0006-291X(92)90697-J; BERG EL, 1991, J BIOL CHEM, V266, P14869; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; BUTTRUM SM, 1993, BLOOD, V82, P1165; CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245; DORE M, 1993, BLOOD, V82, P1308; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; KANSAS GS, 1991, J CELL BIOL, V114, P351, DOI 10.1083/jcb.114.2.351; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; KISHIMOTO TK, 1991, BLOOD, V78, P805; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LARSEN GR, 1992, J BIOL CHEM, V267, P11104; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LAWRENCE MB, 1993, J IMMUNOL, V151, P6338; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEVINOVITZ A, 1993, J CELL BIOL, V121, P449, DOI 10.1083/jcb.121.2.449; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; LEY K, 1993, BLOOD, V82, P1632; LEY K, 1991, BLOOD, V77, P2553; LOBB RR, 1991, J IMMUNOL, V147, P124; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MILLER LJ, 1987, J CLIN INVEST, V80, P535, DOI 10.1172/JCI113102; MILLER LJ, 1986, J IMMUNOL, V137, P2891; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; PICKER LJ, 1990, AM J PATHOL, V136, P1053; PICKER LJ, 1991, CELL, V66, P921, DOI 10.1016/0092-8674(91)90438-5; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785; SAUNDERS KB, 1994, IN PRESS LEUKOCYTE T; SIEGELMAN MH, 1989, P NATL ACAD SCI USA, V86, P5562, DOI 10.1073/pnas.86.14.5562; SMITH CW, 1991, J CLIN INVEST, V87, P609, DOI 10.1172/JCI115037; SPERTINI O, 1991, NATURE, V349, P691, DOI 10.1038/349691a0; SPERTINI O, 1991, J IMMUNOL, V147, P2565; SPERTINI O, 1991, LEUKEMIA, V5, P300; SPERTINI O, 1991, J IMMUNOL, V147, P942; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; VONANDRIAN UH, 1993, BLOOD, V82, P182, DOI 10.1182/blood.V82.1.182.bloodjournal821182; VONANDRIAN UH, 1992, AM J PHYSIOL, V263, pH1034, DOI 10.1152/ajpheart.1992.263.4.H1034; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0	53	128	128	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1994	1	2					137	145		10.1016/1074-7613(94)90107-4	http://dx.doi.org/10.1016/1074-7613(94)90107-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK162	7534197				2022-12-18	WOS:A1994PK16200006
J	Boulenouar, S; Michelet, X; Duquette, D; Alvarez, D; Hogan, AE; Dold, C; O'Connor, D; Stutte, S; Tavakkoli, A; Winters, D; Exley, MA; O'Shea, D; Brenner, MB; von Andrian, U; Lynch, L				Boulenouar, Selma; Michelet, Xavier; Duquette, Danielle; Alvarez, David; Hogan, Andrew E.; Dold, Christina; O'Connor, Donal; Stutte, Suzanne; Tavakkoli, Ali; Winters, Desmond; Exley, Mark A.; O'Shea, Donal; Brenner, Michael B.; von Andrian, Ulrich; Lynch, Lydia			Adipose Type One Innate Lymphoid Cells Regulate Macrophage Homeostasis through Targeted Cytotoxicity	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; INVARIANT NKT CELLS; T-CELLS; TISSUE MACROPHAGES; OBESITY; DIFFERENTIATION; DIVERSITY; PROMOTE; LIVER; BET	Adipose tissue has a dynamic immune system that adapts to changes in diet and maintains homeostatic tissue remodeling. Adipose type 1 innate lymphoid cells (AT1-ILCs) promote pro-inflammatory macrophages in obesity, but little is known about their functions at steady state. Here we found that human and murine adipose tissue harbor heterogeneous populations of AT1-ILCs. Experiments using parabiotic mice fed a high-fat diet (HFD) showed differential trafficking of AT1-ILCs, particularly in response to short-and long-term HFD and diet restriction. At steady state, AT1-ILCs displayed cytotoxic activity toward adipose tissue macrophages (ATMs). Depletion of AT1-ILCs and perforin deficiency resulted in alterations in the ratio of inflammatory to anti-inflammatory ATMs, and adoptive transfer of AT1-ILCs exacerbated metabolic disorder. Diet-induced obesity impaired AT1-ILC killing ability. Our findings reveal a role for AT1-ILCs in regulating ATM homeostasis through cytotoxicity and suggest that this function is relevant in both homeostasis and metabolic disease.	[Boulenouar, Selma; Michelet, Xavier; Duquette, Danielle; Tavakkoli, Ali; Exley, Mark A.; Brenner, Michael B.; Lynch, Lydia] Brigham & Womens Hosp, Boston, MA 02115 USA; [Boulenouar, Selma; Michelet, Xavier; Alvarez, David; Stutte, Suzanne; von Andrian, Ulrich; Lynch, Lydia] Harvard Med Sch, Boston, MA 02115 USA; [Hogan, Andrew E.; O'Connor, Donal; Winters, Desmond; O'Shea, Donal] St Vincents Univ Hosp, Educ Res Ctr, Dublin 4, Ireland; [Dold, Christina; Lynch, Lydia] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University College Dublin; Saint Vincent's University Hospital; Trinity College Dublin	Lynch, L (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.; Lynch, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Lynch, L (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	llynch@bwh.harvard.edu	Lynch, Lydia/ABD-5598-2021; Dold, Christina/ABA-4237-2021; O'Connor, Donal/AAL-4941-2021	O'Shea, Donal/0000-0002-1408-5274; Hogan, Andrew/0000-0001-5875-230X; Lynch, Lydia/0000-0002-4273-4681; Exley, Mark/0000-0002-5088-1032; dold, christina/0000-0003-2314-507X	American Diabetes JF Development Award [116JDF061]; BWH Evergreen Innovation Grant; BADERC grant; ERC Stg grant [679173]; Wallonie Bruxelles International Award; NIH [5RO1AI113046]; HMS Center for Immune Imaging;  [PO1 AI112521]	American Diabetes JF Development Award; BWH Evergreen Innovation Grant; BADERC grant; ERC Stg grant; Wallonie Bruxelles International Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HMS Center for Immune Imaging; 	L.L. was supported by an American Diabetes JF Development Award (116JDF061), a BWH Evergreen Innovation Grant, a BADERC grant, and an ERC Stg grant (679173). S.B. is supported by Wallonie Bruxelles International Award. M.B.B. is supported by NIH 5RO1AI113046. U.v.A. is supported by HMS Center for Immune Imaging and PO1 AI112521.	Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Bellora F, 2010, P NATL ACAD SCI USA, V107, P21659, DOI 10.1073/pnas.1007654108; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorkstrom NK, 2016, NAT REV IMMUNOL, V16, P310, DOI 10.1038/nri.2016.34; Boulenouar S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00043; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Chung JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110108; Cortez VS, 2016, IMMUNOL LETT, V179, P19, DOI 10.1016/j.imlet.2016.07.005; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Fischer-Posovszky P, 2011, ENDOCRINOLOGY, V152, P3074, DOI 10.1210/en.2011-1031; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lapaque N, 2009, J IMMUNOL, V182, P4339, DOI 10.4049/jimmunol.0803329; Lee BC, 2016, CELL METAB, V23, P685, DOI 10.1016/j.cmet.2016.03.002; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; Michel T, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00403; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Seillet C, 2016, INT IMMUNOL, V28, P3, DOI 10.1093/intimm/dxv051; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Vosshenrich CAJ, 2005, CURR OPIN IMMUNOL, V17, P151, DOI 10.1016/j.coi.2005.01.005; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001	51	127	131	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					273	286		10.1016/j.immuni.2017.01.008	http://dx.doi.org/10.1016/j.immuni.2017.01.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228283	Bronze, Green Accepted			2022-12-18	WOS:000396410900015
J	Lu, LF; Gasteiger, G; Yu, IS; Chaudhry, A; Hsin, JP; Lu, YH; Bos, PD; Lin, LL; Zawislak, CL; Cho, SL; Sun, JC; Leslie, CS; Lin, SW; Rudensky, AY				Lu, Li-Fan; Gasteiger, Georg; Yu, I-Shing; Chaudhry, Ashutosh; Hsin, Jing-Ping; Lu, Yuheng; Bos, Paula D.; Lin, Ling-Li; Zawislak, Carolyn L.; Cho, Sunglim; Sun, Joseph C.; Leslie, Christina S.; Lin, Shu-Wha; Rudensky, Alexander Y.			A Single miRNA-mRNA Interaction Affects the Immune Response in a Context- and Cell-Type-Specific Manner	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INDUCED CYTIDINE DEAMINASE; NATURAL-KILLER-CELLS; REGULATORY T-CELLS; NEGATIVE REGULATOR; VIRAL-INFECTION; MICRORNA-155; MIR-155; ACTIVATION; DIFFERENTIATION	MicroRNA (miRNA)-dependent regulation of gene expression confers robustness to cellular phenotypes and controls responses to extracellular stimuli. Although a single miRNA can regulate expression of hundreds of target genes, it is unclear whether any of its distinct biological functions can be due to the regulation of a single target. To explore in vivo the function of a single miRNA-mRNA interaction, we mutated the 3' UTR of a major miR-155 target (SOCS1) to specifically disrupt its regulation by miR-155. We found that under physiologic conditions and during autoimmune inflammation or viral infection, some immunological functions of miR-155 were fully or largely attributable to the regulation of SOCS1, whereas others could be accounted only partially or not at all by this interaction. Our data suggest that the role of a single miRNA-mRNA interaction is dependent on cell type and biological context.	[Lu, Li-Fan; Gasteiger, Georg; Chaudhry, Ashutosh; Hsin, Jing-Ping; Bos, Paula D.; Lin, Ling-Li; Zawislak, Carolyn L.; Sun, Joseph C.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst & Immunol Program, New York, NY 10065 USA; [Lu, Li-Fan; Gasteiger, Georg; Chaudhry, Ashutosh; Hsin, Jing-Ping; Bos, Paula D.; Lin, Ling-Li; Zawislak, Carolyn L.; Sun, Joseph C.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Lu, Li-Fan; Lin, Ling-Li; Cho, Sunglim] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Lu, Li-Fan; Lin, Ling-Li; Cho, Sunglim] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Gasteiger, Georg] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Yu, I-Shing] Natl Taiwan Univ, Coll Med, Lab Anim Ctr, Taipei 100, Taiwan; [Lu, Yuheng; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 100, Taiwan; [Lin, Shu-Wha] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego; University of California System; University of California San Diego; Johannes Gutenberg University of Mainz; National Taiwan University; Memorial Sloan Kettering Cancer Center; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst & Immunol Program, New York, NY 10065 USA.	rudenska@mskcc.org		Chaudhry, Ashutosh/0000-0003-3379-5236; Lu, Li-Fan/0000-0002-9727-0036; Gasteiger, Georg/0000-0001-6986-127X; LIN, SHU-WHA/0000-0001-6748-5581	NIH [AI089935, AI103646, AI108651, AI085034, AI100874, AI034206]; Cancer Research Institute; DFG Emmy Noether programme; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103646, R00AI089935, R29AI034206, R01AI108651, R01AI100874, R37AI034206, R01AI034206, R00AI085034, K99AI089935] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; DFG Emmy Noether programme(German Research Foundation (DFG)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI089935, AI103646, AI108651 (L.-F.L.), AI085034, AI100874 (J.C.S.), and AI034206 (A.Y.R.). G.G. is supported by an Irvington Fellowship of the Cancer Research Institute and the DFG Emmy Noether programme. J.C.S. is a Searle Scholar. A.Y.R. is an investigator with the Howard Hughes Medical Institute. We thank the technical services provided by the Transgenic Mouse Model Core Facility of the National Core Facility Program for Biotechnology, National Science Council, and the Gene Knockout Mouse Core Laboratory of National Taiwan University Center of Genomic Medicine. We would also like to thank Alice Kamphorst and Rafi Ahmed for providing P14 T cells and Andrea Ventura for providing miR-19a/b retroviral plasmids.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Evel-Kabler K, 2006, J CLIN INVEST, V116, P90, DOI 10.1172/JCI26169; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lu D, 2014, J EXP MED, V211, P2183, DOI 10.1084/jem.20140338; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Simpson LJ, 2014, NAT IMMUNOL, V15, P1162, DOI 10.1038/ni.3026; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Trotta R, 2013, BLOOD, V121, P3126, DOI 10.1182/blood-2012-12-467597; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046082; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zawislak CL, 2013, P NATL ACAD SCI USA, V110, P6967, DOI 10.1073/pnas.1304410110; Zhang J, 2014, J NEUROIMMUNOL, V266, P56, DOI 10.1016/j.jneuroim.2013.09.019	37	127	130	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					52	64		10.1016/j.immuni.2015.04.022	http://dx.doi.org/10.1016/j.immuni.2015.04.022			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26163372	Bronze, Green Accepted			2022-12-18	WOS:000360101100010
J	Pisitkun, P; Ha, HL; Wang, HS; Claudio, E; Tivy, CC; Zhou, H; Mayadas, TN; Illei, GG; Siebenlist, U				Pisitkun, Prapaporn; Ha, Hye-Lin; Wang, Hongshan; Claudio, Estefania; Tivy, Caitlyn C.; Zhou, Hua; Mayadas, Tanya N.; Illei, Gabor G.; Siebenlist, Ulrich			Interleukin-17 Cytokines Are Critical in Development of Fatal Lupus Glomerulonephritis	IMMUNITY			English	Article							FC-GAMMA-RIIB; COLLAGEN-INDUCED ARTHRITIS; ADAPTER PROTEIN CIKS/ACT1; AUTOIMMUNE-DISEASE; INTERFERON-GAMMA; CLASS SWITCH; MOUSE MODEL; B-CELLS; RECEPTOR; EXPRESSION	Systemic lupus erythematosus is a potentially fatal autoimmune disease. Although interleukin-17 (IL-17) has been linked to human lupus and mouse models of this disease, it has not been addressed whether this cytokine plays a critical role in fatal lupus pathology. Here we have demonstrated that increased production of IL-17 cytokines and their signaling via the adaptor protein CIKS (a.k.a. Traf3ip2, Act1) critically contributed to lethal pathology in an FcgammaR2b-deficient mouse model of lupus. Mice lacking IL-17 and especially those lacking CIKS showed greatly improved survival and were largely protected from development of glomerulonephritis. Importantly in this model, potential effects of IL-17 cytokines on antibody production could be distinguished from critical local contributions in kidneys, including recruitment of neutrophils and monocytes. These findings provide the proof of principle that signaling by IL-17 family cytokines mediated via CIKS presents promising therapeutic targets for the treatment of systemic lupus erythematosus, especially in cases with kidney involvement.	[Pisitkun, Prapaporn; Ha, Hye-Lin; Wang, Hongshan; Claudio, Estefania; Tivy, Caitlyn C.; Siebenlist, Ulrich] NIAID, Immune Activat Sect, Immunoregulat Lab, Bethesda, MD 20892 USA; [Zhou, Hua; Illei, Gabor G.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Mayadas, Tanya N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Excellence Vasc Biol,Dept Pathol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Siebenlist, U (corresponding author), NIAID, Immune Activat Sect, Immunoregulat Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	usiebenlist@niaid.nih.gov			Intramural Research Programs of NIAID; NIDCR; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001095, ZIAAI001096] Funding Source: NIH RePORTER	Intramural Research Programs of NIAID; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Yoichiro Iwakura for providing ll17a<SUP>-/-</SUP> B6 mice, Michael Reth for providing Mb1-cre mice, Trairak Pisitkun for providing the technical support for isolation of single cell suspensions from kidneys, and Lily Koo and Steven M. Becker for help with fluorescence microscopy. We are most thankful to Rachel Caspi and Silvia Bolland for critical reading of the manuscript and suggestions and James E. Balow for discussion. We greatly appreciate the constructive inputs provided by members of the Siebenlist laboratory and we are grateful to Anthony S. Fauci for continued support. This research was supported by the Intramural Research Programs of NIAID and NIDCR, NIH.	Baerenwaldt A, 2011, P NATL ACAD SCI USA, V108, P18772, DOI 10.1073/pnas.1111810108; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Boross P, 2011, J IMMUNOL, V187, P1304, DOI 10.4049/jimmunol.1101194; Chan O, 1997, ANN NY ACAD SCI, V815, P75, DOI 10.1111/j.1749-6632.1997.tb52046.x; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gunaratne R, 2010, P NATL ACAD SCI USA, V107, P15653, DOI 10.1073/pnas.1007424107; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Kyttaris VC, 2010, J IMMUNOL, V184, P4605, DOI 10.4049/jimmunol.0903595; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Odobasic D, 2011, AM J PATHOL, V179, P1188, DOI 10.1016/j.ajpath.2011.05.039; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Paust HJ, 2012, KIDNEY INT, V82, P72, DOI 10.1038/ki.2012.101; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Pisitkun P, 2010, ARTHRITIS RHEUM-US, V62, P3334, DOI 10.1002/art.27653; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Richards HB, 2001, KIDNEY INT, V60, P2173, DOI 10.1046/j.1523-1755.2001.00045.x; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Rosenkranz AR, 1999, J CLIN INVEST, V103, P649, DOI 10.1172/JCI5183; Ruddy MJ, 2004, J LEUKOCYTE BIOL, V76, P135, DOI 10.1189/jlb.0204065; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Sato-Hayashizaki A, 2011, ARTHRITIS RHEUM-US, V63, P2930, DOI 10.1002/art.30485; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Smith KGC, 2010, NAT REV IMMUNOL, V10, P328, DOI 10.1038/nri2762; Sweet RA, 2010, AUTOIMMUNITY, V43, P607, DOI 10.3109/08916930903567500; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Valente AJ, 2012, J MOL CELL CARDIOL, V53, P113, DOI 10.1016/j.yjmcc.2012.04.009; Vielhauer V, 2005, J CLIN INVEST, V115, P1199, DOI 10.1172/JCI200523348; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	49	127	135	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					1104	1115		10.1016/j.immuni.2012.08.014	http://dx.doi.org/10.1016/j.immuni.2012.08.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23123062	Green Accepted, Bronze			2022-12-18	WOS:000312575000017
J	Park, SG; Mathur, R; Long, MX; Hosh, N; Hao, LM; Hayden, MS; Ghosh, S				Park, Sung-Gyoo; Mathur, Ramkumar; Long, Meixiao; Hosh, Namiko; Hao, Liming; Hayden, Matthew S.; Ghosh, Sankar			T Regulatory Cells Maintain Intestinal Homeostasis by Suppressing gamma delta T Cells	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; VERSUS-HOST-DISEASE; ULCERATIVE-COLITIS; MUTANT MICE; ANTIGEN RECEPTOR; CROHNS-DISEASE; T(H)17 CELLS; IN-VITRO; EXPRESSION	Immune tolerance against enteric commensal bacteria is important for preventing intestinal inflammation. Deletion of phosphoinositide-dependent protein kinase 1 (Pdk1) in T cells via Cd4-Cre induced chronic inflammation of the intestine despite the importance of PDK1 in T cell activation. Analysis of colonic intraepithelial lymphocytes of PDK1-deficient mice revealed markedly increased CD8 alpha(+) T cell receptor (TCR)gamma delta T+ cells, including an interleukin-17 (IL-17)-expressing population. TCR gamma delta(+) T cells were responsible for the inflammatory colitis as shown by the fact that deletion of Tcrd abolished spontaneous colitis in the PDK1-deficient mice. This dysregulation of intestinal TCR gamma delta(+) T cells was attributable to a reduction in the number and functional capacity of PDK1-deficient T regulatory (Treg) cells. Adoptive transfer of wild-type Treg cells abrogated the spontaneous activation and proliferation of intestinal TCR gamma delta(+) T cells observed in PDK1-deficient mice and prevented the development of colitis. Therefore, suppression of intestinal TCR gamma delta(+) T cells by Treg cells maintains enteric immune tolerance.	[Park, Sung-Gyoo; Mathur, Ramkumar; Long, Meixiao; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10032 USA; [Park, Sung-Gyoo] GIST, Sch Life Sci, Kwangju 500712, South Korea; [Park, Sung-Gyoo] GIST, Synapse Res Ctr, Kwangju 500712, South Korea; [Hosh, Namiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Hosh, Namiko] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hao, Liming] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Columbia University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Yale University; Yale University; Yale University	Ghosh, S (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10032 USA.	sg2715@columbia.edu	Hayden, Matthew/C-1263-2008; Park, Sung-Gyoo/H-8652-2019; Hoshi, Namiko/V-8370-2019; Mathur, Ramkumar/AAZ-4314-2020	Park, Sung-Gyoo/0000-0003-3702-5765; mathur, Ramkumar/0000-0002-9317-2631; Hayden, Matthew/0000-0003-1670-6430	National Institutes of Health [R01-AI59440]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059440, R01AI068977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Kasuga (Kobe University) for the PDK1 conditional knockout mice and C. Wilson (University of Washington) for Cd4-Cre mice. Supported by the National Institutes of Health (R01-AI59440).	Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; BANDEIRA A, 1990, J EXP MED, V172, P239, DOI 10.1084/jem.172.1.239; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beyersdorf N, 2005, ANN RHEUM DIS, V64, P91, DOI 10.1136/ard.2005.042564; Bhan A K, 2000, Int Rev Immunol, V19, P123, DOI 10.3109/08830180009048393; Bonneville M, 2006, NAT IMMUNOL, V7, P791, DOI 10.1038/ni0806-791; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Egan CE, 2005, J IMMUNOL, V175, P8191, DOI 10.4049/jimmunol.175.12.8191; Elson CO, 2000, GASTROENTEROLOGY, V119, P254, DOI 10.1053/gast.2000.9159; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; HAYDAY AC, 1985, CELL, V40, P259, DOI 10.1016/0092-8674(85)90140-0; Inagaki-Ohara K, 2004, J IMMUNOL, V173, P1390, DOI 10.4049/jimmunol.173.2.1390; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Maeda Y, 2005, BLOOD, V106, P749, DOI 10.1182/blood-2004-10-4087; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McVay LD, 1997, MOL MED, V3, P183, DOI 10.1007/BF03401672; MIXTER PF, 1994, INFECT IMMUN, V62, P4618, DOI 10.1128/IAI.62.10.4618-4621.1994; Mizoguchi A, 1996, J EXP MED, V183, P847, DOI 10.1084/jem.183.3.847; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nanno M, 2008, GASTROENTEROLOGY, V134, P481, DOI 10.1053/j.gastro.2007.11.056; Nanno M, 2007, IMMUNOL REV, V215, P103, DOI 10.1111/j.1600-065X.2006.00474.x; Nirula A, 2006, J EXP MED, V203, P1733, DOI 10.1084/jem.20051715; O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Oak JS, 2006, P NATL ACAD SCI USA, V103, P16882, DOI 10.1073/pnas.0607984103; Pabst C, 2007, CLIN CANCER RES, V13, P2916, DOI 10.1158/1078-0432.CCR-06-2602; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; PECHHOLD K, 1994, J IMMUNOL, V152, P4984; Pereira P, 1997, P NATL ACAD SCI USA, V94, P5761, DOI 10.1073/pnas.94.11.5761; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Saurer L, 2009, ALLERGY, V64, P505, DOI 10.1111/j.1398-9995.2009.01965.x; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shiohara T, 1996, J EXP MED, V183, P1483, DOI 10.1084/jem.183.4.1483; Simpson SJ, 1997, EUR J IMMUNOL, V27, P17, DOI 10.1002/eji.1830270104; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Takahashi M, 2006, DIGEST DIS SCI, V51, P677, DOI 10.1007/s10620-006-3191-2; Targan SR, 2005, IMMUNOL REV, V206, P296, DOI 10.1111/j.0105-2896.2005.00286.x; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Toto P, 2000, J IMMUNOL, V164, P522, DOI 10.4049/jimmunol.164.1.522; Veldhoen M, 2006, TRENDS IMMUNOL, V27, P358, DOI 10.1016/j.it.2006.06.001; VIDELA S, 1994, GUT, V35, P1090, DOI 10.1136/gut.35.8.1090; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yeung MMW, 2000, GUT, V47, P215, DOI 10.1136/gut.47.2.215	62	127	131	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					791	803		10.1016/j.immuni.2010.10.014	http://dx.doi.org/10.1016/j.immuni.2010.10.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21074460	Green Accepted, Bronze			2022-12-18	WOS:000286082600016
J	Feyerabend, TB; Terszowski, G; Tietz, A; Blum, C; Luche, H; Gossler, A; Gale, NW; Radtke, F; Fehling, HJ; Rodewald, HR				Feyerabend, Thorsten B.; Terszowski, Grzegorz; Tietz, Annette; Blum, Carmen; Luche, Herve; Gossler, Achim; Gale, Nicholas W.; Radtke, Freddy; Fehling, Hans Joerg; Rodewald, Hans-Reimer			Deletion of Notch1 Converts Pro-T Cells to Dendritic Cells and Promotes Thymic B Cells by Cell-Extrinsic and Cell-intrinsic Mechanisms	IMMUNITY			English	Article							LYMPHOCYTE DEVELOPMENT; LINEAGE DECISION; TRANSCRIPTION FACTORS; CARBOXYPEPTIDASE-A; ALPHA-BETA; IN-VIVO; PROGENITORS; FATE; GENE; PRECURSORS	Notch1 signaling is required for T cell development and has been implicated in fate decisions in the thymus. We showed that Notch1 deletion in progenitor T cells (pro-T cells) revealed their latent developmental potential toward becoming conventional and plasmacytoid dendritic cells. In addition, Notch1 deletion in pro-T cells resulted in large numbers of thymic B cells, previously explained by T-to-B cell fate conversion. Single-cell genotyping showed, however, that the majority of these thymic B cells arose from Notch1-sufficient cells by a cell-extrinsic pathway. Fate switching nevertheless exists for a subset of thymic B cells originating from Notch1 deleted pro-T cells. Chimeric mice lacking the Notch ligand delta-like 4 (DII4) in thymus epithelium revealed an essential role for DII4 in T cell development. Thus, Notch1-DII4 signaling fortifies T cell commitment by suppressing non-T cell lineage potential in pro-T cells, and normal Notch1-driven T cell development repels excessive B cells in the thymus.	[Feyerabend, Thorsten B.; Terszowski, Grzegorz; Tietz, Annette; Blum, Carmen; Luche, Herve; Fehling, Hans Joerg; Rodewald, Hans-Reimer] Univ Ulm, Inst Immunol, D-89081 Ulm, Germany; [Gossler, Achim] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; [Gale, Nicholas W.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Radtke, Freddy] Swiss Inst Expt Canc Res, Ecole Polytech Fed Lausanne, CH-1066 Epalinges, Switzerland	Ulm University; Hannover Medical School; Regeneron; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Rodewald, HR (corresponding author), Univ Ulm, Inst Immunol, D-89081 Ulm, Germany.	hans-reimer.rodewald@uni-ulm.de	Radtke, Freddy/Q-3198-2017	Radtke, Freddy/0000-0003-4315-4045; LUCHE, Herve/0000-0003-4309-8338	Deutsche Forschungsgemeinschaft [SFB 497-B5, KFO 142-P8, SFB 497-A7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Rolink for advice on B cell populations, A. Singer for insightful discussions, S. Schlenner for critical reading of the manuscript, C. Costa for expert technical assistance, and C. Tannert and the animal facility for animal husbandry. Supported by grants from the Deutsche Forschungsgemeinschaft (SFB 497-B5 and KFO 142-P8 to H.R.R. and SFB 497-A7 to H.J.F.). N.W.G. is an employee and shareholder of Regeneron Pharmaceuticals.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Benz C, 2008, J EXP MED, V205, P1187, DOI 10.1084/jem.20072168; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Bhandoola A, 2003, J IMMUNOL, V171, P5653, DOI 10.4049/jimmunol.171.11.5653; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Di Santo JP, 2000, CURR OPIN IMMUNOL, V12, P159, DOI 10.1016/S0952-7915(99)00066-7; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Dumortier A, 2005, INT J HEMATOL, V82, P277, DOI 10.1532/IJH97.05099; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Heinzel K, 2007, J IMMUNOL, V178, P858, DOI 10.4049/jimmunol.178.2.858; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Jenkinson EJ, 2006, NAT REV IMMUNOL, V6, P551, DOI 10.1038/nri1883; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Muller SM, 2005, P NATL ACAD SCI USA, V102, P10587, DOI 10.1073/pnas.0502752102; Nie L, 2008, MOL CELL BIOL, V28, P2078, DOI 10.1128/MCB.00844-07; Osborne BA, 2000, CURR OPIN IMMUNOL, V12, P301, DOI 10.1016/S0952-7915(00)00091-1; Petrie HT, 2005, J EXP MED, V202, P11, DOI 10.1084/jem.20050990; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; Robey EA, 2004, CURR OPIN IMMUNOL, V16, P360, DOI 10.1016/j.coi.2004.03.009; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; RODEWALD HR, 1995, CURR OPIN IMMUNOL, V7, P176, DOI 10.1016/0952-7915(95)80002-6; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Visan I, 2006, NAT IMMUNOL, V7, P634, DOI 10.1038/ni1345; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Xie HF, 2007, NATURE, V449, P410, DOI 10.1038/449410a; ZON LI, 1991, J BIOL CHEM, V266, P22948	61	127	129	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					67	79		10.1016/j.immuni.2008.10.016	http://dx.doi.org/10.1016/j.immuni.2008.10.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19110448	Bronze			2022-12-18	WOS:000262769900011
J	Tsuboi, N; Asano, K; Lauterbach, M; Mayadas, TN				Tsuboi, Naotake; Asano, Kenichi; Lauterbach, Michael; Mayadas, Tanya N.			Human neutrophil Fc gamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases	IMMUNITY			English	Article							IMMUNE-COMPLEXES; CRESCENTIC GLOMERULONEPHRITIS; ARTHUS REACTION; LEUKOCYTE RECRUITMENT; LUPUS NEPHRITIS; DEFICIENT MICE; T-CELLS; COMPLEMENT; MACROPHAGES; EXPRESSION	Inflammation mediated by anti body-antigen complexes contributes to autoimmune diseases. Mice deficient in the common Fc gamma-chain are protected from IgG-mediated glomerulonephritis and the reverse passive Arthus (RPA) reaction and FcR-bearing macrophages, and mast cells have been assigned primary roles in these processes. Here we demonstrate that neutrophil-selective transgenic expression of the two uniquely human neutrophil Fc gamma receptors (Fc gamma Rs), Fc gamma RIIA and Fc gamma RIIIB, in Fc gamma-chain-deficient mice restored susceptibility to progressive glomerulonephritis and the cutaneous RPA reaction. Fc gamma RIIIB and Fc gamma RIIA mediated neutrophil accumulation, whereas Fc gamma RIIA alone promoted organ injury. In a model of soluble immune complexes deposited within the vasculature, Fc gamma RIIIB was responsible for neutrophil slow rolling and adhesion whereas in the cremaster RPA, induced by both vascular and tissue soluble immune complexes, Fc gamma RIIA predominated. Thus, human Fc gamma Rs on neutrophils serve as molecular links between antibody and immunological disease, with Fc gamma RIIA promoting tissue injury and Fc gamma RIIIB and Fc gamma RIIA displaying specialized context-dependent functions in neutrophil recruitment.	[Tsuboi, Naotake; Asano, Kenichi; Lauterbach, Michael; Mayadas, Tanya N.] Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Tsuboi, Naotake; Asano, Kenichi; Lauterbach, Michael; Mayadas, Tanya N.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Mayadas, TN (corresponding author), Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, 75 Francis St, Boston, MA 02115 USA.	tmayadas@rics.bwh.harvard.edu	Tsuboi, Naotake/L-5960-2019	Tsuboi, Naotake/0000-0003-0760-845X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050800] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL065095-09, R01 HL065095] Funding Source: Medline; NIAMS NIH HHS [AR050800, R01 AR050800, R01 AR050800-04] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Bergtold A, 2006, J IMMUNOL, V177, P7287, DOI 10.4049/jimmunol.177.10.7287; CAMUSSI G, 1980, CLIN NEPHROL, V14, P280; COCHRANE CG, 1963, J EXP MED, V118, P489, DOI 10.1084/jem.118.4.489; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; CREAM J J, 1971, Clinical Allergy, V1, P235; CREAM JJ, 1971, BRIT J DERMATOL, V84, P106, DOI 10.1111/j.1365-2133.1971.tb06851.x; CROCKETTTORABI E, 1992, AM J PATHOL, V140, P613; Dean EG, 2005, KIDNEY INT, V67, P566, DOI 10.1111/j.1523-1755.2005.67113.x; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Florey OJ, 2007, BLOOD, V109, P3881, DOI 10.1182/blood-2006-08-044669; Fodor S, 2006, IMMUNOL LETT, V104, P29, DOI 10.1016/j.imlet.2005.11.001; FRIES JWU, 1988, KIDNEY INT, V34, P333, DOI 10.1038/ki.1988.186; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Hogarth PM, 2002, CURR OPIN IMMUNOL, V14, P798, DOI 10.1016/S0952-7915(02)00409-0; HOOKE DH, 1987, KIDNEY INT, V31, P964, DOI 10.1038/ki.1987.93; HUIZINGA TWJ, 1988, NATURE, V333, P667, DOI 10.1038/333667a0; Jancar S, 2005, TRENDS IMMUNOL, V26, P48, DOI 10.1016/j.it.2004.11.007; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; JONES SL, 1996, HUMAN IGG FC RECEPTO, P149; Kanamaru Y, 2007, EUR J IMMUNOL, V37, P1116, DOI 10.1002/eji.200636826; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; LAUTERBACH M, 2008, J LEUKOC BI IN PRESS; Li S, 1997, KIDNEY INT, V51, P672, DOI 10.1038/ki.1997.97; Lister KJ, 2007, MICROCIRCULATION, V14, P709, DOI 10.1080/10739680701404879; Luscinskas FW, 2007, BLOOD, V109, P3615, DOI 10.1182/blood-2007-02-072728; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; MOVAT HZ, 1963, AM J PATHOL, V42, P41; Nagarajan S, 2000, BLOOD, V95, P1069, DOI 10.1182/blood.V95.3.1069.003k14_1069_1077; Nangaku Masaomi, 2005, Clin Exp Nephrol, V9, P183, DOI 10.1007/s10157-005-0357-8; NEALE TJ, 1982, SPRINGER SEMIN IMMUN, V5, P221, DOI 10.1007/BF01892087; NIKOLICPATERSON DJ, 1994, SPRINGER SEMIN IMMUN, V16, P3; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Norman MU, 2003, AM J PATHOL, V163, P1491, DOI 10.1016/S0002-9440(10)63506-7; Norman MU, 2005, BRIT J PHARMACOL, V144, P265, DOI 10.1038/sj.bjp.0706081; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; REEVES WH, 1980, J CELL BIOL, V85, P735, DOI 10.1083/jcb.85.3.735; Rosenkranz AR, 1999, J CLIN INVEST, V103, P649, DOI 10.1172/JCI5183; Rosenkranz AR, 2000, KIDNEY INT, V58, P1055, DOI 10.1046/j.1523-1755.2000.00263.x; Sardjono CT, 2005, ARTHRITIS RHEUM-US, V52, P3220, DOI 10.1002/art.21344; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Segerer S, 2006, KIDNEY INT, V69, P1765, DOI 10.1038/sj.ki.5000337; SELVARAJ P, 1988, NATURE, V333, P565, DOI 10.1038/333565a0; Stokol T, 2004, J EXP MED, V200, P835, DOI 10.1084/jem.20040501; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Suzuki Y, 2003, J IMMUNOL, V170, P3243, DOI 10.4049/jimmunol.170.6.3243; Suzuki Y, 1998, KIDNEY INT, V54, P1166, DOI 10.1046/j.1523-1755.1998.00108.x; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Tipping PG, 2006, J AM SOC NEPHROL, V17, P1253, DOI 10.1681/ASN.2005091013; Trcka J, 2002, IMMUNITY, V16, P861, DOI 10.1016/S1074-7613(02)00327-8; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Unkeless J C, 1995, Semin Immunol, V7, P37, DOI 10.1016/1044-5323(95)90006-3; Utomo A, 2008, J IMMUNOL, V180, P6279, DOI 10.4049/jimmunol.180.9.6279; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; van der Pol WL, 1998, IMMUNOGENETICS, V48, P222, DOI 10.1007/s002510050426; van Sorge NM, 2003, TISSUE ANTIGENS, V61, P189, DOI 10.1034/j.1399-0039.2003.00037.x; VANDENHERIKOUDIJK IE, 1995, BLOOD, V86, P3302, DOI 10.1182/blood.V86.9.3302.bloodjournal8693302; Vielhauer V, 2003, NEPHRON EXP NEPHROL, V93, pE63, DOI 10.1159/000068517; Werner Erica, 2003, Sci STKE, V2003, pPL3, DOI 10.1126/stke.2003.168.pl3	64	127	131	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					833	846		10.1016/j.immuni.2008.04.013	http://dx.doi.org/10.1016/j.immuni.2008.04.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18538590	Green Accepted, Bronze			2022-12-18	WOS:000256760200014
J	Bonder, CS; Norman, MU; Swain, MG; Zbytnuik, LD; Yamanouchi, J; Santamaria, P; Ajuebor, M; Salmi, M; Jalkanen, S; Kubes, P				Bonder, CS; Norman, MU; Swain, MG; Zbytnuik, LD; Yamanouchi, J; Santamaria, P; Ajuebor, M; Salmi, M; Jalkanen, S; Kubes, P			Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: A role for alpha-4 integrin and vascular adhesion protein-1	IMMUNITY			English	Article							A-INDUCED HEPATITIS; CD4(+) T-CELLS; CONCANAVALIN-A; IN-VIVO; ENDOTHELIAL-CELL; P-SELECTIN; LEUKOCYTE RECRUITMENT; MOLECULAR-MECHANISMS; MONOCLONAL-ANTIBODY; T-HELPER-2 CELLS	The mechanisms that mediate the recruitment of Th1 and Th2 lymphocytes in vivo are poorly understood. We demonstrate that the mechanisms by which exogenously produced CD4(+) Th1 and Th2 cells roll and adhere in Con A-inflamed liver microcirculation differ dramatically: Th1 cells use alpha(4)beta(1)-integrin and Th2 cells use the vascular adhesion protein (VAP)-1. P-selectin plays no detectable role in Th1 or Th2 cell trafficking in liver microcirculation. Cellular recruitment in the liver sinusoids has previously been shown to be independent of many known adhesion molecules, leading to the suggestion that recruitment in these structures is mediated by physical trapping. While this may still be true for neutrophils, Th1 and Th2 cells use alpha(4)-integrin and VAP-1, respectively, to adhere within the liver sinusoids.	Univ Calgary, Fac Med, Immunol Res Grp, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Gastrointestinal Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; Natl Inst Publ Hlth, Turku, Finland; Univ Turku, MedCity Res Lab, Turku, Finland	University of Calgary; University of Calgary; University of Calgary; University of Turku	Kubes, P (corresponding author), Univ Calgary, Fac Med, Immunol Res Grp, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	pkubes@ucalgary.ca	Santamaria, Pere/ABF-6823-2021	Norman, Maarit/0000-0002-3032-3957; Bonder, Claudine S./0000-0001-9875-967X				ALON R, 1995, J IMMUNOL, V154, P5356; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; Bono P, 1999, AM J PATHOL, V155, P1613, DOI 10.1016/S0002-9440(10)65477-6; Borges E, 1997, J EXP MED, V185, P573, DOI 10.1084/jem.185.3.573; BUCY RP, 1995, P NATL ACAD SCI USA, V92, P7565, DOI 10.1073/pnas.92.16.7565; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Fox-Robichaud A, 2000, HEPATOLOGY, V31, P1123, DOI 10.1053/he.2000.6961; Gonzalez S, 2001, J INVEST DERMATOL, V117, P384, DOI 10.1046/j.0022-202x.2001.01420.x; Hamann A, 2000, EUR J IMMUNOL, V30, P3207, DOI 10.1002/1521-4141(200011)30:11<3207::AID-IMMU3207>3.0.CO;2-L; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; Hickey MJ, 1999, J IMMUNOL, V163, P3441; Hickey MJ, 2002, J IMMUNOL, V168, P4728, DOI 10.4049/jimmunol.168.9.4728; Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0; Jaeschke H, 1996, SHOCK, V6, P351, DOI 10.1097/00024382-199611000-00009; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; John B, 2004, J IMMUNOL, V172, P5222, DOI 10.4049/jimmunol.172.9.5222; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kretschmer U, 2004, EUR J IMMUNOL, V34, P3070, DOI 10.1002/eji.200424972; KUBES P, 1995, J CLIN INVEST, V95, P2510, DOI 10.1172/JCI117952; Kurkijarvi R, 2000, GASTROENTEROLOGY, V119, P1096, DOI 10.1053/gast.2000.18163; Lalor PF, 2002, IMMUNOL CELL BIOL, V80, P52, DOI 10.1046/j.1440-1711.2002.01062.x; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; MACCONI D, 1995, AM J PHYSIOL-CELL PH, V269, pC42, DOI 10.1152/ajpcell.1995.269.1.C42; Massaguer A, 2002, J LEUKOCYTE BIOL, V72, P262; McCuskey RS, 1996, CARDIOVASC RES, V32, P752, DOI 10.1016/S0008-6363(96)00113-7; McNab G, 1996, GASTROENTEROLOGY, V110, P522, DOI 10.1053/gast.1996.v110.pm8566600; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; Reinhardt PH, 1997, BLOOD, V89, P3837, DOI 10.1182/blood.V89.10.3837.3837_3837_3846; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Salmi M, 1997, J EXP MED, V186, P589, DOI 10.1084/jem.186.4.589; SCOAZEC JY, 1994, J HEPATOL, V20, P296, DOI 10.1016/S0168-8278(05)80072-8; STEINHOFF G, 1993, AM J PATHOL, V142, P481; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307; Xu HP, 2004, J IMMUNOL, V172, P3215, DOI 10.4049/jimmunol.172.5.3215	42	127	130	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2005	23	2					153	163		10.1016/j.immuni.2005.06.007	http://dx.doi.org/10.1016/j.immuni.2005.06.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111634	Bronze			2022-12-18	WOS:000231721700006
J	Baron, V; Bouneaud, C; Cumano, A; Lim, A; Arstila, TP; Kourilsky, P; Ferradini, L; Pannetier, C				Baron, V; Bouneaud, C; Cumano, A; Lim, A; Arstila, TP; Kourilsky, P; Ferradini, L; Pannetier, C			The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct	IMMUNITY			English	Article							PRIMARY IMMUNE-RESPONSE; IN-VIVO; L-SELECTIN; HOMING POTENTIALS; GENE SEGMENT; LYMPHOCYTES; NAIVE; ACTIVATION; DIFFERENTIATION; GENERATION	Memory T cells are divided into central and effector subsets with distinct functions and homing capabilities. We analyzed the composition and dynamics of the CD8(+) T cell repertoire of these subsets within the peripheral blood of four healthy individuals. Both subsets had largely distinct and autonomous TCRbeta repertoires. Their composition remained stable over a 9 month period, during which no cell passage between these subsets was detected despite important size variation of several clones. In one donor, four out of six TCRbeta clonotypes specific for the influenza A virus were detected in the central subset only, while the two others were shared. Altogether, these observations suggest that most effector memory T cells may not have derived from the central memory subset.	Inst Pasteur, INSERM, Unite Biol Mol Gene, F-75015 Paris, France; Inst Pasteur, CNRS, URA 1961, Unite Dev Lymphocytes, F-75015 Paris, France; Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Helsinki	Pannetier, C (corresponding author), Inst Pasteur, INSERM, Unite Biol Mol Gene, F-75015 Paris, France.			Cumano, Ana/0000-0002-4578-959X				ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Collette A, 2002, BIOINFORMATICS, V18, P329, DOI 10.1093/bioinformatics/18.2.329; DEJONG R, 1991, J IMMUNOL, V146, P2088; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Faint JM, 2001, J IMMUNOL, V167, P212, DOI 10.4049/jimmunol.167.1.212; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Hemmerich S, 2001, IMMUNITY, V15, P237, DOI 10.1016/S1074-7613(01)00188-1; Iezzi G, 2001, J EXP MED, V193, P987, DOI 10.1084/jem.193.8.987; Kantele A, 1997, J IMMUNOL, V158, P574; Kantele A, 1999, J IMMUNOL, V162, P5173; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; KOVAR H, 1991, NUCLEIC ACIDS RES, V19, P3507, DOI 10.1093/nar/19.13.3507; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Lim A, 2002, J IMMUNOL METHODS, V261, P177, DOI 10.1016/S0022-1759(02)00004-2; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Merkenschlager M, 1989, Int Immunol, V1, P450, DOI 10.1093/intimm/1.4.450; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; PANNETIER C, 1997, ANTIGEN T CELL RECEP, P287; PICKER LJ, 1993, J IMMUNOL, V150, P1105; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; QuidingJarbrink M, 1997, J CLIN INVEST, V99, P1281, DOI 10.1172/JCI119286; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2001, J CLIN INVEST, V108, P805, DOI 10.1172/JCI14005; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Tan LC, 1999, J IMMUNOL, V162, P1827; Van Parijs L, 1998, SCIENCE, V280, P243; WEI S, 1994, IMMUNOGENETICS, V40, P27, DOI 10.1007/BF00163961; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wills MR, 1999, J IMMUNOL, V162, P7080; Young JL, 1997, EUR J IMMUNOL, V27, P2383, DOI 10.1002/eji.1830270937	41	127	133	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2003	18	2					193	204		10.1016/S1074-7613(03)00020-7	http://dx.doi.org/10.1016/S1074-7613(03)00020-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594947	Bronze			2022-12-18	WOS:000181138100004
J	Schebesta, M; Pfeffer, PL; Busslinger, M				Schebesta, M; Pfeffer, PL; Busslinger, M			Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene	IMMUNITY			English	Article							B-CELL-DEVELOPMENT; TYROSINE KINASE; BONE-MARROW; ANTIGEN RECEPTOR; MICE LACKING; FETAL LIVER; BSAP PAX-5; EXPRESSION; PROLIFERATION; DOMAINS	The developmental progression from pro-B to pre-B cells is controlled by pre-B cell receptor (pre-BCR) signaling which depends on BLNK (SLP-65) for coupling the Syk kinase to its downstream effector pathways. Here we identified BLNK as a direct target of the transcription factor Pax5 (BSAP). Restoration of BLNK expression in Igmu transgenic Pax5(-/-) pro-B cells resulted in constitutive pre-BCR signaling and increased cell proliferation without inducing progression to the pre-B cell stage. Igmu(+) Pax5(-/-) pro-B cells expressing a BLNK-estrogen receptor fusion protein initiated signaling immediately upon hormone addition, which facilitated analysis of pre-BCR-induced gene expression changes. The pre-BCR was shown to execute its checkpoint function by regulating genes involved in cell proliferation, intracellular signaling, growth factor responsiveness, and V(D)J recombination.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Busslinger, Meinrad J./J-1249-2016; Pfeffer, Peter/J-7675-2017; Schebesta, Michael/B-5891-2008	Busslinger, Meinrad J./0000-0002-9111-9351; Pfeffer, Peter/0000-0001-5933-9728; 				ABRAMS CS, 1995, J BIOL CHEM, V270, P14485, DOI 10.1074/jbc.270.24.14485; Auethavekiat V, 1997, J BIOL CHEM, V272, P1786, DOI 10.1074/jbc.272.3.1786; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bonilla FA, 2000, P NATL ACAD SCI USA, V97, P1725, DOI 10.1073/pnas.040543597; Borghesi LA, 1999, BLOOD, V93, P140, DOI 10.1182/blood.V93.1.140.401k40_140_148; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Eberhard D, 1999, CANCER RES, V59, p1716S; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Gantner F, 1998, BRIT J PHARMACOL, V123, P1031, DOI 10.1038/sj.bjp.0701688; Goitsuka R, 1998, J IMMUNOL, V161, P5804; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GROSSCHEDL R, 1984, CELL, V38, P647, DOI 10.1016/0092-8674(84)90259-9; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Lin XY, 2000, MOL CELL BIOL, V20, P7259, DOI 10.1128/MCB.20.19.7259-7272.2000; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Matzaris M, 1998, J BIOL CHEM, V273, P8256, DOI 10.1074/jbc.273.14.8256; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pan LH, 1999, MOL CELL BIOL, V19, P5969; PAPAVASILIOU F, 1995, J EXP MED, V182, P1389, DOI 10.1084/jem.182.5.1389; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; ROLINK A, 1991, EUR J IMMUNOL, V21, P2609, DOI 10.1002/eji.1830211044; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; SALAMERO J, 1995, EUR J IMMUNOL, V25, P2757, DOI 10.1002/eji.1830251007; Shaffer AL, 1997, J IMMUNOL, V159, P1265; SHWAROK NW, 1997, J BIOL CHEM, V272, P28008; Thevenin C, 1998, J EXP MED, V188, P735, DOI 10.1084/jem.188.4.735; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; YAMANOUCHI PHARM CO, 1999, Patent No. 9931073; Yasuda T, 2000, J EXP MED, V191, P641, DOI 10.1084/jem.191.4.641; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	54	127	129	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2002	17	4					473	485		10.1016/S1074-7613(02)00418-1	http://dx.doi.org/10.1016/S1074-7613(02)00418-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387741	Bronze			2022-12-18	WOS:000178667100008
J	Villadangos, JA; Cardoso, M; Steptoe, RJ; van Berkel, D; Pooley, J; Carbone, FR; Shortman, K				Villadangos, JA; Cardoso, M; Steptoe, RJ; van Berkel, D; Pooley, J; Carbone, FR; Shortman, K			MHC class II expression is regulated in dendritic cells independently of invariant chain degradation	IMMUNITY			English	Article							CATHEPSIN-S; ANTIGEN PRESENTATION; SURFACE EXPRESSION; DEVELOPMENTAL REGULATION; CD8 EXPRESSION; MOUSE THYMUS; HLA-DM; MOLECULES; MATURATION; TRANSPORT	We have investigated the mechanisms that control MHC class II (MHC II) expression in immature and activated dendritic cells (DC) grown from spleen and bone marrow precursors. Degradation of the MHC II chaperone invariant chain (li), acquisition of peptide cargo by MHC II, and delivery of MHC II-peptide complexes to the cell surface proceeded similarly in both immature and activated DC. However, immature DC reendocytosed and then degraded the MHC II-peptide complexes much faster than the activated DC. MHC II expression in DC is therefore not controlled by the activity of the protease(s) that degrade Ii, but by the rate of endocytosis of peptide-loaded MHC II. Late after activation, DC downregulated MHC II synthesis both in vitro and in vivo.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne	Villadangos, JA (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.		Steptoe, Raymond/B-3843-2011; Carbone, Francis/ABF-2141-2020; Villadangos, Jose A/AAU-1404-2020	Steptoe, Raymond/0000-0002-6513-6406; Villadangos, Jose A/0000-0001-6771-8891	NIDDK NIH HHS [DK577728-01] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMIGORENA S, 1995, J EXP MED, V181, P1729, DOI 10.1084/jem.181.5.1729; Askew D, 2000, J IMMUNOL, V165, P6889, DOI 10.4049/jimmunol.165.12.6889; Bakke O, 1999, IMMUNOL REV, V172, P171, DOI 10.1111/j.1600-065X.1999.tb01365.x; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BOOG CJP, 1989, EUR J IMMUNOL, V19, P537, DOI 10.1002/eji.1830190319; Brachet V, 1997, J CELL BIOL, V137, P51, DOI 10.1083/jcb.137.1.51; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; Fong L, 2000, ANNU REV IMMUNOL, V18, P245, DOI 10.1146/annurev.immunol.18.1.245; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; KAMPGEN E, 1991, P NATL ACAD SCI USA, V88, P3014, DOI 10.1073/pnas.88.8.3014; Kropshofer H, 1999, IMMUNOL REV, V172, P267, DOI 10.1111/j.1600-065X.1999.tb01371.x; Kropshofer H, 1997, IMMUNOL TODAY, V18, P77, DOI 10.1016/S0167-5699(97)01006-2; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NELSON CA, 1993, P NATL ACAD SCI USA, V90, P1227, DOI 10.1073/pnas.90.4.1227; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; PURE E, 1990, J EXP MED, V172, P1459, DOI 10.1084/jem.172.5.1459; Rescigno M, 1998, P NATL ACAD SCI USA, V95, P5229, DOI 10.1073/pnas.95.9.5229; Rovere P, 1998, P NATL ACAD SCI USA, V95, P1067, DOI 10.1073/pnas.95.3.1067; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Thomas R, 1999, J LEUKOCYTE BIOL, V66, P286, DOI 10.1002/jlb.66.2.286; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; Villadangos JA, 2000, EMBO J, V19, P882, DOI 10.1093/emboj/19.5.882; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Vremec D, 1997, J IMMUNOL, V159, P565; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821	41	127	127	4	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2001	14	6					739	749		10.1016/S1074-7613(01)00148-0	http://dx.doi.org/10.1016/S1074-7613(01)00148-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420044	Bronze			2022-12-18	WOS:000169495100010
J	Suzuki, K; Oida, T; Hamada, H; Hitotsumatsu, O; Watanabe, M; Hibi, T; Yamamoto, H; Kubota, E; Kaminogawa, S; Ishikawa, H				Suzuki, K; Oida, T; Hamada, H; Hitotsumatsu, O; Watanabe, M; Hibi, T; Yamamoto, H; Kubota, E; Kaminogawa, S; Ishikawa, H			Gut cryptopatches: Direct evidence of extrathymic anatomical sites for intestinal T lymphopoiesis	IMMUNITY			English	Article							RECEPTOR-GAMMA CHAIN; CELL ANTIGEN RECEPTOR; HUMAN FETAL INTESTINE; INTRAEPITHELIAL LYMPHOCYTES; DENDRITIC CELLS; REGIONAL SPECIALIZATION; ACCESSIBILITY CONTROL; LYMPHOID DEVELOPMENT; GENE REARRANGEMENT; PEYERS-PATCHES	Athymic cytokine receptor gamma chain mutant mice that lack the thymus, Peyer's patches, cryptopatches (CP), and intestinal T cells were reconstituted with wildtype bone marrow cells. Bone marrow-derived TCR-intraepithelial lymphocytes (IEL) first appeared within viIlous epithelia of small intestine overlying the regenerated CP, and these TCR- IEL subsequently emerged throughout the epithelia. Thereafter, TCR+ IEL increased to a comparable number to that in athymic mice and consisted of TCR gamma delta and TCR alpha beta IEL. In gut-associated lymphoid tissues of wild-type mice, only CP harbored a targe population of c-kit(high)IL-7R(+)CD44(+)Thy-1(+/-)CD(4+/-)CD25(low/-)alpha (E)beta (-)(7)Lin(-)(Lin, lineage markers) lymphocytes that included cells expressing germline but not rearranged TCR gamma and TCR beta gene transcripts. These findings provide direct evidence that gut CP develop progenitor T cells for extrathymic IEL descendants.	Keio Univ, Sch Med, Dept Microbiol, Tokyo 1608582, Japan; Kanagawa Dent Sch, Dept Oral & Maxillofacial Surg 2, Kanagawa 2388580, Japan; Univ Tokyo, Dept Appl Biol Chem, Tokyo 1138657, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Osaka 5650871, Japan; Keio Univ, Sch Med, Dept Internal Med, Tokyo 1608582, Japan; Tokyo Med & Dent Univ, Grad Sch, Dept Gastroenterol & Hepatol, Tokyo 1138519, Japan	Keio University; Kanagawa Dental College; University of Tokyo; Osaka University; Keio University; Tokyo Medical & Dental University (TMDU)	Ishikawa, H (corresponding author), Keio Univ, Sch Med, Dept Microbiol, Tokyo 1608582, Japan.							ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; BOLL G, 1995, SCAND J IMMUNOL, V41, P103, DOI 10.1111/j.1365-3083.1995.tb03541.x; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cruz D, 1998, J EXP MED, V188, P255, DOI 10.1084/jem.188.2.255; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Fujiura Y, 1996, J IMMUNOL, V156, P2710; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GUYGRAND D, 1992, EUR J IMMUNOL, V22, P505, DOI 10.1002/eji.1830220232; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; HAARS R, 1986, J EXP MED, V164, P1, DOI 10.1084/jem.164.1.1; Hamad M, 1997, DEV COMP IMMUNOL, V21, P435, DOI 10.1016/S0145-305X(97)00018-9; Hempel WM, 1998, ADV IMMUNOL, V69, P309, DOI 10.1016/S0065-2776(08)60610-0; Howie D, 1998, J IMMUNOL, V161, P5862; Hozumi K, 1996, INT IMMUNOL, V8, P1473, DOI 10.1093/intimm/8.10.1473; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Klein JR, 1998, CHEM IMMUNOL, V71, P88; Koningsberger JC, 1997, J IMMUNOL, V159, P1775; Koyasu S, 1997, INT IMMUNOL, V9, P1475, DOI 10.1093/intimm/9.10.1475; KUBOTA E, 1981, J IMMUNOL, V127, P1498; Laky K, 1998, J IMMUNOL, V161, P707; Laky K, 2000, J EXP MED, V191, P1569, DOI 10.1084/jem.191.9.1569; LATTHE M, 1994, EUR J IMMUNOL, V24, P1703, DOI 10.1002/eji.1830240737; LEFRANCOIS L, 1994, J IMMUNOL, V153, P987; Lefrancois L, 1997, J IMMUNOL, V159, P538; LEFRANCOIS L, 1999, MUCOSAL IMMUNOLOGY, P413; LIN T, 1994, EUR J IMMUNOL, V24, P1080, DOI 10.1002/eji.1830240511; LIN T, 1993, EUR J IMMUNOL, V23, P1968, DOI 10.1002/eji.1830230836; LUNDQVIST C, 1995, INT IMMUNOL, V7, P1473, DOI 10.1093/intimm/7.9.1473; LYNCH S, 1995, EUR J IMMUNOL, V25, P1143, DOI 10.1002/eji.1830250502; MAYRHOFER G, 1999, MUCOSAL IMMUNOL UPDA, V7, P9; MAYRHOFER G, 1995, CLIN IMMUNOL IMMUNOP, V76, pS55; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; NANNO M, 1994, J IMMUNOL, V153, P2014; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Oida T, 2000, J IMMUNOL, V164, P3616, DOI 10.4049/jimmunol.164.7.3616; Page ST, 1998, P NATL ACAD SCI USA, V95, P9459, DOI 10.1073/pnas.95.16.9459; Poussier P, 1999, SEMIN IMMUNOL, V11, P293, DOI 10.1006/smim.1999.0185; POUSSIER P, 1994, ANNU REV IMMUNOL, V12, P521, DOI 10.1146/annurev.immunol.12.1.521; ROCHA B, 1994, J EXP MED, V180, P681, DOI 10.1084/jem.180.2.681; ROCHA B, 1995, CURR OPIN IMMUNOL, V7, P235, DOI 10.1016/0952-7915(95)80008-5; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; Shortman K, 1998, IMMUNOL REV, V165, P39, DOI 10.1111/j.1600-065X.1998.tb01228.x; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Suzuki S, 1998, EUR J IMMUNOL, V28, P3719, DOI 10.1002/(SICI)1521-4141(199811)28:11<3719::AID-IMMU3719>3.3.CO;2-F; TAKAGAKI Y, 1989, NATURE, V339, P712, DOI 10.1038/339712a0; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; WANG J, 1994, SCIENCE, V265, P1860, DOI 10.1126/science.8091211; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; WILSON A, 1995, INT IMMUNOL, V7, P1659, DOI 10.1093/intimm/7.10.1659; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; ZunigaPflucker JC, 1996, CURR OPIN IMMUNOL, V8, P215, DOI 10.1016/S0952-7915(96)80060-4	57	127	133	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2000	13	5					691	702		10.1016/S1074-7613(00)00068-6	http://dx.doi.org/10.1016/S1074-7613(00)00068-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114381	Bronze			2022-12-18	WOS:000165598500011
J	Avitahl, N; Winandy, S; Friedrich, C; Jones, B; Ge, YM; Georgopoulos, K				Avitahl, N; Winandy, S; Friedrich, C; Jones, B; Ge, YM; Georgopoulos, K			Ikaros sets thresholds for T cell activation and regulates chromosome propagation	IMMUNITY			English	Article							RECEPTOR SIGNAL-TRANSDUCTION; DNA-REPLICATION; KINASE INHIBITOR; PROTEIN-KINASE; RAPAMYCIN; PATHWAYS; POTENT; SITES; GENE; INTERLEUKIN-2	T cell activation involves the sustained accumulation of T cell receptor (TCR) and IL-2 receptor (IL-2R) mediated signaling events that promote cell cycle entry and progression. The Ikaros family of nuclear factors regulate this process by providing thresholds overcome by receptor signaling. T cells with reduced levels of Ikaros activity require fewer TCR engagement events for activation, exhibit a greater proliferative response to IL-2, and are less sensitive to inhibitors of TCR and IL-2R signaling. Upon T cell activation, Ikaros proteins localize in a higher-order chromatin structure where they colocalize with components of the DNA replication machinery. Proliferating T cells with reduced Ikaros activity display chromosome abnormalities. We propose that participation of Ikaros in higher-order chromatin structures controls cell cycle transitions and restricts DNA replication.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Georgopoulos, K (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	katia_georgopoulos@cbrc.mgh.harvard.ed			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038342] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI38342-03, R01 AI038342] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALMOUZNI G, 1993, GENE DEV, V7, P2033, DOI 10.1101/gad.7.10.2033; Araujo FD, 1998, MOL CELL BIOL, V18, P3475, DOI 10.1128/MCB.18.6.3475; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; BRANDEIS M, 1993, BIOESSAYS, V15, P709, DOI 10.1002/bies.950151103; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hozak Pavel, 1994, Trends in Cell Biology, V4, P48, DOI 10.1016/0962-8924(94)90009-4; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; JANEWAY CA, 1994, IMMUNITY, V1, P3, DOI 10.1016/1074-7613(94)90003-5; Jeppesen P, 1997, BIOESSAYS, V19, P67, DOI 10.1002/bies.950190111; Johnston JA, 1996, J LEUKOCYTE BIOL, V60, P441, DOI 10.1002/jlb.60.4.441; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; Kwon TK, 1997, J IMMUNOL, V158, P5642; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Migone TS, 1998, P NATL ACAD SCI USA, V95, P3845, DOI 10.1073/pnas.95.7.3845; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; POWIS G, 1994, CANCER RES, V54, P2419; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SEN S, 1989, CANCER RES, V49, P6731; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TURNER JM, 1993, INT IMMUNOL, V5, P1199, DOI 10.1093/intimm/5.10.1199; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Wingren AG, 1995, CRIT REV IMMUNOL, V15, P235, DOI 10.1615/CritRevImmunol.v15.i3-4.30	46	127	129	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1999	10	3					333	343		10.1016/S1074-7613(00)80033-3	http://dx.doi.org/10.1016/S1074-7613(00)80033-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204489	Bronze			2022-12-18	WOS:000079455700006
J	Cartwright, EK; Spicer, L; Smith, SA; Lee, D; Fast, R; Paganini, S; Lawson, BO; Nega, M; Easley, K; Schmitz, JE; Bosinger, SE; Paiardini, M; Chahroudi, A; Vanderford, TH; Estes, JD; Lifson, JD; Derdeyn, CA; Silvestri, G				Cartwright, Emily K.; Spicer, Lori; Smith, S. Abigail; Lee, David; Fast, Randy; Paganini, Sara; Lawson, Benton O.; Nega, Melon; Easley, Kirk; Schmitz, Joern E.; Bosinger, Steven E.; Paiardini, Mirko; Chahroudi, Ann; Vanderford, Thomas H.; Estes, Jacob D.; Lifson, Jeffrey D.; Derdeyn, Cynthia A.; Silvestri, Guido			CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy	IMMUNITY			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL DEPLETION; MHC CLASS-I; RHESUS MACAQUES; CYCLOSPORINE-A; HIV-INFECTION; MONOCLONAL-ANTIBODY; PLASMA VIREMIA; IMMUNE CONTROL; REPLICATION	Infection with HIV persists despite suppressive anti-retroviral therapy (ART), and treatment interruption results in rapid viral rebound. Antibody-mediated CD8(+) lymphocyte depletion in simian immunodeficiency virus (SIV)-infected rhesus macaques (RMs) shows that these cells contribute to viral control in untreated animals. However, the contribution of CD8(+) lymphocytes to maintaining viral suppression under ART remains unknown. Here, we have shown that in SIV-infected RMs treated with short-term (i.e., 8-32 week) ART, depletion of CD8(+) lymphocytes resulted in increased plasma viremia in all animals and that repopulation of CD8(+) T cells was associated with prompt reestablishment of virus control. Although the number of SIV-DNA-positive cells remained unchanged after CD8 depletion and reconstitution, the frequency of SIV-infected CD4(+) T cells before depletion positively correlated with both the peak and area under the curve of viremia after depletion. These results suggest a role for CD8(+) T cells in controlling viral production during ART, thus providing a rationale for exploring immunotherapeutic approaches in ART-treated HIV-infected individuals.	[Cartwright, Emily K.; Spicer, Lori; Smith, S. Abigail; Lee, David; Paganini, Sara; Lawson, Benton O.; Nega, Melon; Bosinger, Steven E.; Paiardini, Mirko; Chahroudi, Ann; Vanderford, Thomas H.; Derdeyn, Cynthia A.; Silvestri, Guido] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Cartwright, Emily K.; Spicer, Lori; Smith, S. Abigail; Lee, David; Paganini, Sara; Lawson, Benton O.; Nega, Melon; Bosinger, Steven E.; Paiardini, Mirko; Chahroudi, Ann; Vanderford, Thomas H.; Derdeyn, Cynthia A.; Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Fast, Randy; Estes, Jacob D.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Easley, Kirk] Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30329 USA; [Schmitz, Joern E.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Chahroudi, Ann] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Schmitz, Joern E.] Fraunhofer Inst Mol Biol & Appl Ecol IME, D-52074 Aachen, Germany	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; Rollins School Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Emory University; Fraunhofer Gesellschaft	Silvestri, G (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.; Silvestri, G (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.	gsilves@emory.edu	Easley, Kirk A/K-6910-2015; Schmitz, Joern/A-4929-2018	Easley, Kirk A/0000-0003-4419-2617; Schmitz, Joern/0000-0001-8803-0922	NIH [R01-AI90797, RR000165/OD011132, P30-AI-50409, R01 AI-58706, U19 AI-109633]; Emory CFAR; NIH National Cancer Institute [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058706, R01AI090797, U19AI109633, U19AI096187] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010976, P51OD011132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory CFAR; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Levy, D.G. Carnathan, M. Mavigner, C.S. McGary, and G. Mylvaganam for helpful discussions; B. Cervasi, K.P. Gill, and J.P. Mackel for technical support; S. Ehnert for study organization and scheduling; Yerkes National Primate Research Center (YNPRC) veterinary staff, especially S. Jean, for caring for the animals and daily ART administration; Merck (I.MTA.14.232) Gilead Sciences (I.MTA.14.230) for generously providing Raltegravir, PMPA, and FTC; and Janssen R&D Ireland (I.MTA.14.231) for providing Darunavir. We thank the Emory CFAR Virology Core for viral loads and the Emory CFAR Immunology Core for use of the MiSeq platform. This work was funded in part by NIH grants R01-AI90797 (to G. S.), RR000165/OD011132 (to the YNPRC), and P30-AI-50409, R01 AI-58706, and U19 AI-109633 (to C.D.), the Emory CFAR, and federal funds from the NIH National Cancer Institute (contract HHSN261200800001E with J.L.).	Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; BARTZ SR, 1995, P NATL ACAD SCI USA, V92, P5381, DOI 10.1073/pnas.92.12.5381; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Braaten D, 1996, J VIROL, V70, P5170, DOI 10.1128/JVI.70.8.5170-5176.1996; Burton SL, 2015, P NATL ACAD SCI USA, V112, P10780, DOI 10.1073/pnas.1509731112; Chahroudi A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003958; Chapuis AG, 2000, NAT MED, V6, P762, DOI 10.1038/77489; Chen ZW, 2000, J IMMUNOL, V164, P6474, DOI 10.4049/jimmunol.164.12.6474; Chowdhury A, 2015, J VIROL, V89, P8677, DOI 10.1128/JVI.00869-15; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Del Prete GQ, 2014, ANTIMICROB AGENTS CH, V58, P6790, DOI 10.1128/AAC.03746-14; Dornadula G, 1999, VIROLOGY, V253, P10, DOI 10.1006/viro.1998.9465; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Evans DT, 1999, IMMUNOL LETT, V66, P53, DOI 10.1016/S0165-2478(98)00151-5; Evans DT, 2000, J VIROL, V74, P7400, DOI 10.1128/JVI.74.16.7400-7410.2000; Franke EK, 1996, VIROLOGY, V222, P279, DOI 10.1006/viro.1996.0421; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Gilliam BL, 2007, AIDS, V21, P2108, DOI 10.1097/QAD.0b013e3282f02a4f; Haynes BF, 1996, SCIENCE, V271, P324, DOI 10.1126/science.271.5247.324; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; Klein MR, 1998, J GEN VIROL, V79, P2191, DOI 10.1099/0022-1317-79-9-2191; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Margolis DM, 2002, JAIDS-J ACQ IMM DEF, V31, P45, DOI 10.1097/00126334-200209010-00006; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Peris-Pertusa A, 2010, JAIDS-J ACQ IMM DEF, V55, P29, DOI 10.1097/QAI.0b013e3181e69609; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Roy J, 2002, ANTIMICROB AGENTS CH, V46, P3447, DOI 10.1128/AAC.46.11.3447-3455.2002; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Smedley J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092830; Smith SA, 2016, J VIROL, V90, P1880, DOI 10.1128/JVI.02711-15; Sokolskaja E, 2010, J VIROL, V84, P4851, DOI 10.1128/JVI.01699-09; Streblow DN, 1998, VIROLOGY, V245, P197, DOI 10.1006/viro.1998.9155; Taaffe J, 2010, J VIROL, V84, P5476, DOI 10.1128/JVI.00039-10; Van Rompay KKA, 2004, J VIROL, V78, P5324, DOI 10.1128/JVI.78.10.5324-5337.2004; Vanderford TH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002048; von Stockenstrom S, 2015, J INFECT DIS, V212, P596, DOI 10.1093/infdis/jiv092; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993	53	126	126	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					656	668		10.1016/j.immuni.2016.08.018	http://dx.doi.org/10.1016/j.immuni.2016.08.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27653601	Green Accepted, Bronze			2022-12-18	WOS:000388454300020
J	Scoville, SD; Mundy-Bosse, BL; Zhang, MH; Chen, L; Zhang, XL; Keller, KA; Hughes, T; Chen, LX; Cheng, S; Bergin, SM; Mao, HYC; McClory, S; Yu, JH; Carson, WE; Caligiuri, MA; Freud, AG				Scoville, Steven D.; Mundy-Bosse, Bethany L.; Zhang, Michael H.; Chen, Li; Zhang, Xiaoli; Keller, Karen A.; Hughes, Tiffany; Chen, Luxi; Cheng, Stephanie; Bergin, Stephen M.; Mao, Hsiaoyin C.; McClory, Susan; Yu, Jianhua; Carson, William E., III; Caligiuri, Michael A.; Freud, Aharon G.			A Progenitor Cell Expressing Transcription Factor ROR gamma t Generates All Human Innate Lymphoid Cell Subsets	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; CD56(DIM) NK CELLS; DIFFERENTIATION; CD56(BRIGHT); IL-7; INDUCTION; PROGRAM; ALPHA; FOXP3; BET	The current model of murine innate lymphoid cell (ILC) development holds that mouse ILCs are derived downstream of the common lymphoid progenitor through lineage-restricted progenitors. However, corresponding lineage-restricted progenitors in humans have yet to be discovered. Here we identified a progenitor population in human secondary lymphoid tissues (SLTs) that expressed the transcription factor ROR gamma t and was unique in its ability to generate all known ILC subsets, including natural killer (NK) cells, but not other leukocyte populations. In contrast to murine fate-mapping data, which indicate that only ILC3s express Ror gamma t, these human progenitor cells as well as human peripheral blood NK cells and all mature ILC populations expressed ROR gamma t. Thus, all human ILCs can be generated through an ROR gamma t(+) developmental pathway from a common progenitor in SLTs. These findings help establish the developmental signals and pathways involved in human ILC development.	[Scoville, Steven D.; Chen, Luxi; Bergin, Stephen M.] Ohio State Univ, Med Scientist Training Program, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Mundy-Bosse, Bethany L.; Zhang, Michael H.; Chen, Li; Hughes, Tiffany; Mao, Hsiaoyin C.; Yu, Jianhua; Caligiuri, Michael A.] Ohio State Univ, Dept Internal Med, Div Hematol & Oncol, Columbus, OH 43210 USA; [Zhang, Xiaoli] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Keller, Karen A.; Cheng, Stephanie; Freud, Aharon G.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Carson, William E., III] Ohio State Univ, Dept Surg, Div Surg Oncol, Columbus, OH 43210 USA; [Scoville, Steven D.; Mundy-Bosse, Bethany L.; Zhang, Michael H.; Chen, Li; Zhang, Xiaoli; Keller, Karen A.; Hughes, Tiffany; Chen, Luxi; Cheng, Stephanie; Bergin, Stephen M.; Mao, Hsiaoyin C.; Yu, Jianhua; Carson, William E., III; Caligiuri, Michael A.; Freud, Aharon G.] Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Scoville, Steven D.; Mundy-Bosse, Bethany L.; Zhang, Michael H.; Chen, Li; Zhang, Xiaoli; Keller, Karen A.; Hughes, Tiffany; Chen, Luxi; Cheng, Stephanie; Bergin, Stephen M.; Mao, Hsiaoyin C.; Yu, Jianhua; Carson, William E., III; Caligiuri, Michael A.; Freud, Aharon G.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA; [McClory, Susan] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Caligiuri, MA (corresponding author), Ohio State Univ, Dept Internal Med, Div Hematol & Oncol, Columbus, OH 43210 USA.; Freud, AG (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.; Caligiuri, MA; Freud, AG (corresponding author), Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH 43210 USA.; Freud, AG (corresponding author), Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA.	michael.caligiuri@osumc.edu; aharon.freud@osumc.edu		Bergin, Stephen/0000-0001-9692-5814; Zhang, Michael/0000-0001-8774-5256; McClory, Susan/0000-0002-4607-5230	NCI [CA095426, CA163205, CA16058, CA068458, F30CA196244]; Pelotonia Graduate Student Fellowship; NATIONAL CANCER INSTITUTE [R01CA185301, P01CA095426, R37CA068458, P01CA163205, F30CA196244, R01CA068458, P30CA016058] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pelotonia Graduate Student Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grants CA095426, CA163205, CA16058, CA068458 (M.A.C.), and F30CA196244 (S.D.S.) and a Pelotonia Graduate Student Fellowship. We thank Dr. James DiSanto for his review and discussion of the manuscript, the Cincinnati Children's Hospital Medical Center (CCHMC) for collecting UCB samples from normal deliveries and BM samples, the Cooperative Human Tissue Network, and the Analytic Cytometry, Genomics, and Biostatistics Shared Resources within The Ohio State University Comprehensive Cancer Center. We would also like to thank Dr. Zuniga-Pflucker (University of Toronto) for kindly providing the OP9-DL1 cell line.	Ahn YO, 2013, BLOOD, V121, P2234, DOI 10.1182/blood-2012-07-440099; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Briercheck EL, 2015, J IMMUNOL, V194, P1832, DOI 10.4049/jimmunol.1401224; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Cichocki F, 2010, METHODS MOL BIOL, V612, P15, DOI 10.1007/978-1-60761-362-6_2; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dulphy N, 2008, J IMMUNOL, V181, P2227, DOI 10.4049/jimmunol.181.3.2227; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Ghazawi FM, 2013, IMMUNOL CELL BIOL, V91, P149, DOI 10.1038/icb.2012.69; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; GUYGRAND D, 1992, EUR J IMMUNOL, V22, P505, DOI 10.1002/eji.1830220232; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hughes T, 2014, CELL REP, V8, P150, DOI 10.1016/j.celrep.2014.05.042; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; McClory S, 2012, J CLIN INVEST, V122, P1403, DOI 10.1172/JCI46125; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Ratajewski M, 2012, J IMMUNOL, V189, P3034, DOI 10.4049/jimmunol.1200519; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Scoville SD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12490; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Trotta R, 2005, BLOOD, V105, P3011, DOI 10.1182/blood-2004-10-4072; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929	53	126	129	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1140	1150		10.1016/j.immuni.2016.04.007	http://dx.doi.org/10.1016/j.immuni.2016.04.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27178467	Green Accepted, Bronze			2022-12-18	WOS:000376478500018
J	Hickman, HD; Reynoso, GV; Ngudiankama, BF; Cush, SS; Gibbs, J; Bennink, JR; Yewdell, JW				Hickman, Heather D.; Reynoso, Glennys V.; Ngudiankama, Barbara F.; Cush, Stephanie S.; Gibbs, James; Bennink, Jack R.; Yewdell, Jonathan W.			CXCR3 Chemokine Receptor Enables Local CD8(+) T Cell Migration for the Destruction of Virus-Infected Cells	IMMUNITY			English	Article							LEUKOCYTE MIGRATION; EFFECTOR; RECRUITMENT; GENERATION; MATURATION; RESPONSES; GUIDANCE; BINDING	CD8(+) T cells play a critical role in limiting peripheral virus replication, yet how they locate virus-infected cells within tissues is unknown. Here, we have examined the environmental signals that CD8(+) T cells use to localize and eliminate virus-infected skin cells. Epicutaneous vaccinia virus (VV) infection, mimicking human smallpox vaccination, greatly increased expression of the CXCR3 chemokine receptor ligands CXCL9 and CXCL10 in VV-infected skin. Despite normal T cell numbers in the skin, Cxcr3(-/-) mice exhibited dramatically impaired CD8(+)-T-cell-dependent virus clearance. Intravital microscopy revealed that Cxcr3(-/-) T cells were markedly deficient in locating, engaging, and killing virus-infected cells. Further, transfer of wild-type CD8(+) T cells restored viral clear-ance in Cxcr3(-/-) animals. These findings demonstrate a function for CXCR3 in enhancing the ability of tissue-localized CD8(+) T cells to locate virus-infected cells and thereby exert anti-viral effector functions.	[Hickman, Heather D.; Reynoso, Glennys V.; Ngudiankama, Barbara F.; Cush, Stephanie S.; Gibbs, James; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Cell Biol Sect, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Hickman, Heather D.; Reynoso, Glennys V.; Ngudiankama, Barbara F.; Cush, Stephanie S.; Gibbs, James; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Immunol Sect, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hickman, HD (corresponding author), NIAID, Cell Biol Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	hhickman@mail.nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Hickman, Heather/0000-0003-4168-4894	Intramural Research Program of the NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001212, ZIAAI001053] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank members of the Comparative Medicine Branch for excellence in animal husbandry, the NIAID flow cytometry facility (Bishop Hague and Elina Stregevsky) for cell sorting, and the NIAID Biological Imaging facility (Owen Schwartz) for assistance with microscopy. This work was supported by the Intramural Research Program of the NIAID, NIH.	Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Gordon SN, 2011, J INFECT DIS, V203, P1043, DOI 10.1093/infdis/jiq162; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hickman HD, 2013, CELL HOST MICROBE, V13, P155, DOI 10.1016/j.chom.2013.01.004; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Hickman HD, 2011, IMMUNOL REV, V239, P209, DOI 10.1111/j.1600-065X.2010.00973.x; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Huen AC, 2012, ADV WOUND CARE, V1, P244, DOI 10.1089/wound.2011.0355; Ip PP, 2010, J IMMUNOL, V184, P5705, DOI 10.4049/jimmunol.0903484; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lee BJ, 2005, J VIROL, V79, P9351, DOI 10.1128/JVI.79.14.9351-9355.2005; Lim JK, 2011, EXP CELL RES, V317, P569, DOI 10.1016/j.yexcr.2011.01.009; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Mahalingam S, 1999, J VIROL, V73, P1479, DOI 10.1128/JVI.73.2.1479-1491.1999; Mota BEF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018924; Mueller SN, 2010, CURR OPIN IMMUNOL, V22, P293, DOI 10.1016/j.coi.2009.12.009; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; ROT A, 1993, EUR J IMMUNOL, V23, P303, DOI 10.1002/eji.1830230150; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Taqueti VR, 2006, J IMMUNOL, V177, P5890, DOI 10.4049/jimmunol.177.9.5890; Thapa M, 2009, J VIROL, V83, P9486, DOI 10.1128/JVI.00854-09; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Yates CC, 2008, AM J PATHOL, V173, P643, DOI 10.2353/ajpath.2008.070990; Yates CC, 2007, AM J PATHOL, V171, P484, DOI 10.2353/ajpath.2007.061092	40	126	127	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					524	537		10.1016/j.immuni.2015.02.009	http://dx.doi.org/10.1016/j.immuni.2015.02.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25769612	Green Accepted, Bronze			2022-12-18	WOS:000351301900016
J	Bao, XF; Moseman, EA; Saito, H; Petryanik, B; Thiriot, A; Hatakeyama, S; Ito, Y; Kawashima, H; Yamaguchi, Y; Lowe, JB; von Andrian, UH; Fukuda, M				Bao, Xingfeng; Moseman, E. Ashley; Saito, Hideo; Petryanik, Bronislawa; Thiriot, Aude; Hatakeyama, Shingo; Ito, Yuki; Kawashima, Hiroto; Yamaguchi, Yu; Lowe, John B.; von Andrian, Ulrich H.; Fukuda, Minoru			Endothelial Heparan Sulfate Controls Chemokine Presentation in Recruitment of Lymphocytes and Dendritic Cells to Lymph Nodes	IMMUNITY			English	Article							L-SELECTIN; CONTACT HYPERSENSITIVITY; MICE DEFICIENT; P-SELECTIN; MIGRATION; LIGANDS; BIOSYNTHESIS; EXPRESSION; INDUCTION; BINDING	Heparan sulfate can bind several adhesion molecules involved in lymphocyte trafficking. However, the in vivo function of endothelial heparan sulfate in lymphocyte homing and stimulation of the immune response has not been elucidated. Here, we generated mutant mice deficient in the enzyme Ext1, which is required for heparan sulfate synthesis, in a Tek-dependent and inducible manner. Chemokine presentation was diminished in the mutant mice, causing the lack of appropriate integrin-mediated adhesion, and resulted in a marked decrease in lymphocyte sticking to high endothelial venules and in recruitment of resident dendritic cells through lymphatic vessels to the lymph nodes. As a consequence, mutant mice displayed a severe impairment in lymphocyte homing and a compromised contact hypersensitivity response. By contrast, lymphocyte rolling was increased because of loss of electrostatic repulsion by heparan sulfate. These results demonstrate critical roles of endothelial heparan sulfate in immune surveillance and immune response generation.	[Bao, Xingfeng; Saito, Hideo; Hatakeyama, Shingo; Ito, Yuki; Kawashima, Hiroto; Yamaguchi, Yu; Fukuda, Minoru] Sanford Burnham Med Res Inst, Glycobiol Unit, La Jolla, CA 92037 USA; [Yamaguchi, Yu] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA; [Moseman, E. Ashley; Thiriot, Aude; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Petryanik, Bronislawa; Lowe, John B.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School; Case Western Reserve University	Fukuda, M (corresponding author), Sanford Burnham Med Res Inst, Glycobiol Unit, La Jolla, CA 92037 USA.	minoru@burnham.org	von Andrian, Ulrich H/A-5775-2008; Hatakeyama, Shingo/E-9234-2013; Hatakeyama, Shingo/AAQ-2583-2020	Hatakeyama, Shingo/0000-0002-0026-4079	National Institutes of Health [PO1 CA71932]; Toyobo Biotechnology Fellowship; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072252, R01AI069259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Toyobo Biotechnology Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M.N. Fukuda and F. Ire for support and advice; S. Rosen, T. Sato, T. Kojima, and A. Nagy for 38C13 cells, Tie2-promoter plus enhancer, syndecan-4-deficient mice, and Tet-Cre mice, respectively; L. Wang, B. Charbono, Y. Altman, J. Tomlin, P. Lee, L. Haynes, and G. Chen for technical assistance; E. Lamar for critical reading of the manuscript; and A. Morse for organizing the manuscript. This work was supported by National Institutes of Health grant PO1 CA71932 to M.F., U.H.v.A., and J.B.L, NIH T32 Training Grant in Hematology (E.A.M), and Toyobo Biotechnology Fellowship (Y.I.).	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Coltart DM, 2002, J AM CHEM SOC, V124, P9833, DOI 10.1021/ja020208f; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; de Paz LL, 2007, ACS CHEM BIOL, V2, P735, DOI 10.1021/cb700159m; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Garner OB, 2008, IMMUNOLOGY, V125, P420, DOI 10.1111/j.1365-2567.2008.02856.x; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; LEY K, 1991, CIRC RES, V69, P1034, DOI 10.1161/01.RES.69.4.1034; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; M'Rini C, 2003, J EXP MED, V198, P1301, DOI 10.1084/jem.20030182; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Sangaletti S, 2005, J CELL SCI, V118, P3685, DOI 10.1242/jcs.02474; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimoda H, 2009, HISTOCHEM CELL BIOL, V131, P231, DOI 10.1007/s00418-008-0513-9; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Staite ND, 1996, BLOOD, V88, P2973, DOI 10.1182/blood.V88.8.2973.bloodjournal8882973; SUBRAMANIAM M, 1995, J EXP MED, V181, P2277, DOI 10.1084/jem.181.6.2277; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; van Zante A, 2003, J EXP MED, V198, P1289, DOI 10.1084/jem.20030057; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Yang BG, 2007, J IMMUNOL, V179, P4376, DOI 10.4049/jimmunol.179.7.4376; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	48	126	128	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					817	829		10.1016/j.immuni.2010.10.018	http://dx.doi.org/10.1016/j.immuni.2010.10.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21093315	Green Accepted, Bronze			2022-12-18	WOS:000286082600018
J	Mei, JJ; Liu, YH; Dai, N; Favara, M; Greene, T; Jeyaseelan, S; Poncz, M; Lee, JS; Worthen, GS				Mei, Junjie; Liu, Yuhong; Dai, Ning; Favara, Michael; Greene, Teshell; Jeyaseelan, Samithamby; Poncz, Mortimer; Lee, Janet S.; Worthen, G. Scott			CXCL5 Regulates Chemokine Scavenging and Pulmonary Host Defense to Bacterial Infection	IMMUNITY			English	Article							DUFFY ANTIGEN RECEPTOR; MICE LACKING; NEUTROPHIL MIGRATION; SEVERE EXACERBATIONS; IL-8 RECEPTOR; LUNG INJURY; IN-VITRO; LIPOPOLYSACCHARIDE; INFLAMMATION; CELLS	The chemokine sink hypothesis pertaining to erythrocyte Duffy Antigen Receptor for Chemokines (DARC) during inflammation has received considerable attention, but lacks direct in vivo evidence. Here we demonstrate, using mice with a targeted deletion in CXCL5, that CXCL5 bound erythrocyte DARC and impaired its chemokine scavenging in blood. CXCL5 increased the plasma concentrations of CXCL1 and CXCL2 in part through inhibiting chemokine scavenging, impairing chemokine gradients and desensitizing CXCR2, which led to decreased neutrophil influx to the lung, increased lung bacterial burden and mortality in an Escherichia coli pneumonia model. In contrast, CXCL5 exerted a predominant role in mediating neutrophil influx to the lung during inflammation after LPS inhalation. Platelets and lung resident cells were the sources of homeostatic CXCL5 in blood and inflammatory CXCL5 in the lung respectively. This study presents a paradigm whereby platelets and red cells alter chemokine scavenging and neutrophil-chemokine interaction during inflammation.	[Mei, Junjie; Liu, Yuhong; Dai, Ning; Favara, Michael; Worthen, G. Scott] Childrens Hosp Philadelphia, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA; [Greene, Teshell; Poncz, Mortimer] Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA; [Jeyaseelan, Samithamby] Louisiana State Univ, Dept Pathobiol Sci, Lab Lung Biol, Baton Rouge, LA 70803 USA; [Jeyaseelan, Samithamby] Louisiana State Univ, Ctr Expt Infect Dis Res, Baton Rouge, LA 70803 USA; [Lee, Janet S.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA 15260 USA; [Greene, Teshell; Poncz, Mortimer; Worthen, G. Scott] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania	Mei, JJ (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA.	meij@email.chop.edu; worthen@email.chop.edu		Lee, Janet/0000-0002-6812-6043	US National Institute of Health [HL068876, HL086884, HL091958]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105834, R01HL091958, R01HL086884, R01HL068876] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by US National Institute of Health (HL068876 to G.S.W, HL086884 to J.S.L and HL091958 to S.J). We thank Dr. Paula M. Oliver for help in generation of BM-reconstituted mice, and Dr.Yuhuan Wang and Dr. Lubica Rauova for help in isolation and analysis of murine platelets, and Dr. Jorg Reutershan for help in measurement of erythrocyte DARC-binding chemokines.	Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Blackwell TS, 1999, AM J RESP CRIT CARE, V159, P1644, DOI 10.1164/ajrccm.159.5.9806166; Borroni EM, 2008, IMMUNOL INVEST, V37, P483, DOI 10.1080/08820130802191318; Bozza FA, 2009, AM J RESP CELL MOL, V40, P123, DOI 10.1165/rcmb.2008-0241TR; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Call DR, 2001, AM J PATHOL, V158, P715, DOI 10.1016/S0002-9440(10)64014-X; Chen SC, 2001, J IMMUNOL, V166, P3362, DOI 10.4049/jimmunol.166.5.3362; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Dawson TC, 2000, BLOOD, V96, P1681, DOI 10.1182/blood.V96.5.1681.h8001681a_1681_1684; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; FREVERT CW, 1995, J IMMUNOL, V154, P335; Fukuma N, 2003, BIOCHEM BIOPH RES CO, V303, P137, DOI 10.1016/S0006-291X(03)00293-6; Gardner L, 2004, BIOCHEM BIOPH RES CO, V321, P306, DOI 10.1016/j.bbrc.2004.06.146; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; HOME K, 2009, INFLAMM RES, V58, P431; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Jeyaseelan S, 2005, J IMMUNOL, V175, P7484, DOI 10.4049/jimmunol.175.11.7484; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Kwon JH, 2005, AM J PHYSIOL-GASTR L, V289, pG1075, DOI 10.1152/ajpgi.00073.2005; Lee JS, 2003, J IMMUNOL, V170, P5244, DOI 10.4049/jimmunol.170.10.5244; Luo H, 2000, MOL CELL BIOL, V20, P3097, DOI 10.1128/MCB.20.9.3097-3101.2000; Mangalmurti NS, 2009, BLOOD, V113, P1158, DOI 10.1182/blood-2008-07-166264; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Prado GN, 1996, J BIOL CHEM, V271, P19186, DOI 10.1074/jbc.271.32.19186; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Qiu YS, 2007, THORAX, V62, P475, DOI 10.1136/thx.2006.066670; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Reutershan J, 2009, EUR J IMMUNOL, V39, P1597, DOI 10.1002/eji.200839089; Rossi DL, 1999, J IMMUNOL, V162, P5490; Rot A, 2009, METHOD ENZYMOL, V461, P191, DOI 10.1016/S0076-6879(09)05409-3; Sabroe I, 1997, J IMMUNOL, V158, P1361; Schmal H, 1996, J IMMUNOL, V156, P1963; Smith JB, 2002, IMMUNOGENETICS, V54, P599, DOI 10.1007/s00251-002-0501-5; Sommeijer DW, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-12; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Vanderbilt JN, 2003, AM J RESP CELL MOL, V29, P661, DOI 10.1165/rcmb.2002-0227OC; Wiekowski MT, 2001, J IMMUNOL, V167, P7102, DOI 10.4049/jimmunol.167.12.7102; Wuyts A, 1999, J IMMUNOL, V163, P6155; Zarbock A, 2007, CRIT CARE MED, V35, P2156, DOI 10.1097/01.CCM.0000280570.82885.32; Zineh I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003117	51	126	127	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					106	117		10.1016/j.immuni.2010.07.009	http://dx.doi.org/10.1016/j.immuni.2010.07.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20643340	Green Accepted, Bronze			2022-12-18	WOS:000280418100014
J	Harkiolaki, M; Holmes, SL; Svendsen, P; Gregersen, JW; Jensen, LT; McMahon, R; Friese, MA; van Boxel, G; Etzensperger, R; Tzartos, JS; Kranc, K; Sainsbury, S; Harlos, K; Mellins, ED; Palace, J; Esiri, MM; van der Merwe, PA; Jones, EY; Fugger, L				Harkiolaki, Maria; Holmes, Samantha L.; Svendsen, Pia; Gregersen, Jon W.; Jensen, Lise T.; McMahon, Roisin; Friese, Manuel A.; van Boxel, Gijs; Etzensperger, Ruth; Tzartos, John S.; Kranc, Kamil; Sainsbury, Sarah; Harlos, Karl; Mellins, Elizabeth D.; Palace, Jackie; Esiri, Margaret M.; van der Merwe, P. Anton; Jones, E. Yvonne; Fugger, Lars			T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides	IMMUNITY			English	Article							MYELIN BASIC-PROTEIN; CLASS-II MOLECULE; MULTIPLE-SCLEROSIS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; SELF-PEPTIDE; TCR BINDING; HLA-DR; RECEPTOR; MHC	Environmental factors account for 75% of the risk of developing multiple sclerosis (MS). Numerous infections have been suspected as environmental disease triggers, but none of them has consistently been incriminated, and it is unclear how so many different infections may play a role. We show that a microbial peptide, common to several major classes of bacteria, can induce MS-like disease in humanized mice by crossreacting with a T cell receptor (TCR) that also recognizes a peptide from myelin basic protein, a candidate MS autoantigen. Structural analysis demonstrates this crossreactivity is due to structural mimicry of a binding hotspot shared by self and microbial antigens, rather than to degenerate TCR recognition. Biophysical studies reveal that the autoreactive TCR binding affinity is markedly lower for the microbial (mimicry) peptide than for the autoantigenic pepticle. Thus, these data suggest a possible explanation for the difficulty in incriminating individual infections in the development of MS.	[Harkiolaki, Maria; Holmes, Samantha L.; McMahon, Roisin; van Boxel, Gijs; Sainsbury, Sarah; Harlos, Karl; Jones, E. Yvonne] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; [Holmes, Samantha L.; McMahon, Roisin; Friese, Manuel A.; Etzensperger, Ruth; Kranc, Kamil; Fugger, Lars] Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; [Svendsen, Pia; Gregersen, Jon W.; Jensen, Lise T.; Fugger, Lars] Aarhus Univ Hosp, Inst Clin, DK-8200 Aarhus N, Denmark; [Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Friese, Manuel A.; Etzensperger, Ruth; Tzartos, John S.; Palace, Jackie; Fugger, Lars] Univ Oxford, Dept Clin Neurol, John Radcliffe Hosp, Oxford OX3 9DS, England; [Esiri, Margaret M.] Univ Oxford, Dept Neuropathol, John Radcliffe Hosp, Oxford OX3 9DS, England; [van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford; Aarhus University; Stanford University; University of Oxford; University of Oxford; University of Oxford	Jones, EY (corresponding author), Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk; lars.fugger@imm.ox.ac.uk	Jones, Yvonne/J-2293-2016; Kranc, Kamil/B-3449-2009; McMahon, Roisin/A-9823-2014; Jones, Yvonne/N-8111-2019	Jones, Yvonne/0000-0002-3834-1893; McMahon, Roisin/0000-0001-5437-0355; Jones, Yvonne/0000-0002-3834-1893; Friese, Manuel A./0000-0001-6380-2420	MRC [G9722488, MC_U137881016, G9900061, G0500365] Funding Source: UKRI; Medical Research Council [G9722488, G0500365, G9900061, MC_U137881016] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Boulter JM, 2007, EUR J IMMUNOL, V37, P798, DOI 10.1002/eji.200636743; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; Correale J, 2006, NEUROLOGY, V67, P652, DOI 10.1212/01.wnl.0000233834.09743.3b; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Figueras MJ, 2005, REV MED MICROBIOL, V16, P145; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hausmann S, 1999, J IMMUNOL, V162, P338; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Marrie RA, 2004, LANCET NEUROL, V3, P709, DOI 10.1016/S1474-4422(04)00933-0; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Murray P. R., 2013, SUPERFICIAL CUTANEOU, V7th; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OKSENBERG JR, 1990, NATURE, V345, P344, DOI 10.1038/345344a0; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SIBLEY WA, 1985, LANCET, V1, P1313; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Svendsen P, 2004, J IMMUNOL, V173, P7037, DOI 10.4049/jimmunol.173.11.7037; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9	45	126	144	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					348	357		10.1016/j.immuni.2009.01.009	http://dx.doi.org/10.1016/j.immuni.2009.01.009			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19303388	Bronze			2022-12-18	WOS:000264405500008
J	McLachlan, JB; Catron, DM; Moon, JJ; Jenkins, MK				McLachlan, James B.; Catron, Drew M.; Moon, James J.; Jenkins, Marc K.			Dendritic Cell Antigen Presentation Drives Simultaneous Cytokine Production by Effector and Regulatory T Cells in Inflamed Skin	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; IFN-GAMMA PRODUCTION; IN-VIVO; INTERFERON-GAMMA; LANGERHANS CELLS; PRESENTING CELLS; LEISHMANIA-MAJOR; MICE; RECEPTOR; INTERLEUKIN-10	Effector (Teff) and regulatory (Treg) T cells produce cytokines that balance immunity and immunopathology at sites of infection. It is not known how this balance is achieved. Here, we show that Treg and Teff cells specific for the same foreign peptide: major histocompatibility complex II (pMHCII) ligand accumulated preferentially in a subcutaneous site injected with the relevant antigen plus an adjuvant. Some of the Treg cells in this site were producing IL-10 12 days after injection, whereas a similar fraction of the Teff cells were producing IFN-gamma. Acute ablation of Treg cells increased the fraction of IFN-gamma-producing Teff cells, indicating that Teff function was limited by the Treg cells. Production of cytokines by both populations was driven by pMHCII presentation by local CDIIb(hi) dermal dendritic cells. Therefore, balanced production of microbicidal and suppressive cytokines in inflamed skin is achieved by simultaneous dendritic cell antigen presentation to Teff and Treg cells.	[Jenkins, Marc K.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jenkins, MK (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Jenkins, Marc K/G-1063-2012; moon, james/F-1031-2014	Jenkins, Marc K/0000-0001-8009-7655; moon, james/0000-0001-8071-1491	National Institutes of Health [F32-A1068326]; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039614, R01AI066018, R01AI027998, F32AI068326, P01AI035296, F32AI063793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank M. Pepper for helpful advice, D. Kaplan for critical reading of the manuscript, and J. Walter, M. Priess, and J. Liboon for technical help. P. Champoux and the Flow Cytometry Core Facility at the Center for Immunology (University of Minnesota) assisted with sorting and flow-cytometry experiments. This work was supported by grants from the National Institutes of Health to M.K.J., J.J.M., and J.B.M. (F32-A1068326) and by a Cancer Research Institute fellowship to D.M.C.	Annacker O, 2003, J AUTOIMMUN, V20, P277, DOI 10.1016/S0896-8411(03)00045-3; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Blair DA, 2007, P NATL ACAD SCI USA, V104, P15045, DOI 10.1073/pnas.0703767104; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; Bryant P, 2004, CURR OPIN IMMUNOL, V16, P96, DOI 10.1016/j.coi.2003.11.011; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Foulds KE, 2006, J IMMUNOL, V176, P3037, DOI 10.4049/jimmunol.176.5.3037; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kumar RK, 2004, AM J RESP CRIT CARE, V170, P1043, DOI 10.1164/rccm.200405-681OC; Lemos MP, 2004, J EXP MED, V199, P725, DOI 10.1084/jem.20030795; Mahnke K, 2007, CELL IMMUNOL, V250, P1, DOI 10.1016/j.cellimm.2008.01.004; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; MURPHY DB, 1992, J IMMUNOL, V148, P3483; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Seery JP, 1997, J EXP MED, V186, P1451, DOI 10.1084/jem.186.9.1451; Shi HZ, 2004, J LEUKOCYTE BIOL, V76, P520, DOI 10.1189/jlb.0404228; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Timoshanko JR, 2002, J IMMUNOL, V168, P4135, DOI 10.4049/jimmunol.168.8.4135; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; Vincent-Schneider H, 2001, J CELL SCI, V114, P323; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wang B, 1997, P NATL ACAD SCI USA, V94, P13844, DOI 10.1073/pnas.94.25.13844; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Yoshimoto T, 1998, J IMMUNOL, V161, P3400	63	126	130	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					277	288		10.1016/j.immuni.2008.11.013	http://dx.doi.org/10.1016/j.immuni.2008.11.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19200757	Green Accepted, Bronze			2022-12-18	WOS:000263710500014
J	Haynes, L; Swain, SL				Haynes, Laura; Swain, Susan L.			Why aging T cells fail: Implications for vaccination	IMMUNITY			English	Editorial Material							AGE-RELATED DEFECTS; INFLUENZA; LYMPHOCYTES; REPERTOIRE; CYTOKINES; VIRUS; YOUNG	The decline in CD4(+) T cell function with aging contributes to reduced vaccine efficacy. In this commentary, we discuss the factors leading to age-related changes in T cell function and propose how they may be overcome to enhance vaccine efficacy for the elderly.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA	Trudeau Institute	Swain, SL (corresponding author), Trudeau Inst Inc, Saranac Lake, NY 12983 USA.	sswain@northnet.org			NIA NIH HHS [R01 AG021054, P01 AG021600] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG021054, P01AG021600] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Chen Q, 2005, BIOMED ENVIRON SCI, V18, P220; COOK JM, 1987, CELL IMMUNOL, V109, P89, DOI 10.1016/0008-8749(87)90294-2; Eaton SM, 2004, J EXP MED, V200, P1613, DOI 10.1084/jem.20041395; ERNST DN, 1990, J IMMUNOL, V145, P1295; Garcia GG, 1997, CELL IMMUNOL, V175, P51, DOI 10.1006/cimm.1996.1040; Hainz U, 2005, VACCINE, V23, P3232, DOI 10.1016/j.vaccine.2005.01.085; Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013; Haynes L, 2004, J IMMUNOL, V172, P5194, DOI 10.4049/jimmunol.172.9.5194; Haynes L, 2005, J EXP MED, V201, P845, DOI 10.1084/jem.20041933; Haynes L, 2003, P NATL ACAD SCI USA, V100, P15053, DOI 10.1073/pnas.2433717100; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Maletto BA, 2005, CLIN IMMUNOL, V117, P251, DOI 10.1016/j.clim.2005.08.016; Min H, 2004, J IMMUNOL, V173, P245, DOI 10.4049/jimmunol.173.1.245; MUSHER DM, 1986, J INFECT DIS, V154, P245, DOI 10.1093/infdis/154.2.245; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Song HF, 1997, IMMUNOL REV, V160, P55, DOI 10.1111/j.1600-065X.1997.tb01027.x; Swain S, 2005, SEMIN IMMUNOL, V17, P370, DOI 10.1016/j.smim.2005.05.007; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tsiagbe VK, 1996, CRIT REV IMMUNOL, V16, P381; Turner SJ, 2004, SEMIN IMMUNOL, V16, P179, DOI 10.1016/j.smim.2004.02.005; Vu T, 2002, VACCINE, V20, P1831, DOI 10.1016/S0264-410X(02)00041-5; Zheng B, 1997, IMMUNOL REV, V160, P63, DOI 10.1111/j.1600-065X.1997.tb01028.x	25	126	130	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					663	666		10.1016/j.immuni.2006.06.003	http://dx.doi.org/10.1016/j.immuni.2006.06.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782020	Green Published, Bronze			2022-12-18	WOS:000238592200002
J	Garren, H; Ruiz, PJ; Watkins, TA; Fontoura, P; Nguyen, LVT; Estline, ER; Hirschberg, DL; Steinman, L				Garren, H; Ruiz, PJ; Watkins, TA; Fontoura, P; Nguyen, LVT; Estline, ER; Hirschberg, DL; Steinman, L			Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway	IMMUNITY			English	Article							IMMUNE-RESPONSES; IFN-GAMMA; ENCEPHALOMYELITIS; VACCINES; PLASMIDS; IL-4; MICE; IMMUNIZATION; POPULATIONS; MODULATION	Using a combination of local gene delivery and tolerizing DNA vaccination, we demonstrate that codelivery of the interieukin-4 (IL-4) gene and a DNA vaccine encoding the self-peptide proteolipid protein 139-151 (PLP139-151) provides protective immunity against experimental autoimmune encephalomyelitis (EAE). We provide evidence for a mechanism whereby IL-4 expressed from the naked DNA is secreted and acts locally on autoreactive T cells via activation of STAT6 to shift their cytokine profile to T helper 2. We also show that DNA vaccines can be used to reverse established EAE by covaccination with the genes for myelin oligodendrocyte glycoprotein and IL-4. This treatment strategy combines the antigen-specific effects of DNA vaccination and the beneficial effects of local gene delivery.	Stanford Univ, Beckman Ctr Mol Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; SunVax Corp, Palo Alto, CA 94304 USA	Stanford University	Steinman, L (corresponding author), Stanford Univ, Beckman Ctr Mol Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.		Fontoura, Paulo/A-2315-2010	Steinman, Lawrence/0000-0002-2437-2250	NIAID NIH HHS [1K08AI492-01, AI07290-15] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bernard CCA, 1997, J MOL MED-JMM, V75, P77, DOI 10.1007/s001090050092; Chow YH, 1998, J IMMUNOL, V160, P1320; Chow YH, 1997, J VIROL, V71, P169, DOI 10.1128/JVI.71.1.169-178.1997; GARREN H, 2000, BIOL GENE THERAPY AU, P203; Geissler M, 1997, J IMMUNOL, V158, P1231; Ishii KJ, 1999, GENE THER, V6, P237, DOI 10.1038/sj.gt.3300799; Kim JJ, 1997, J IMMUNOL, V158, P816; Kim JJ, 1999, J INTERF CYTOK RES, V19, P77, DOI 10.1089/107999099314441; Kim JJ, 1998, EUR J IMMUNOL, V28, P1089, DOI 10.1002/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L; Larsen DL, 1998, J VIROL, V72, P1704, DOI 10.1128/JVI.72.2.1704-1708.1998; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Lobell A, 1999, J IMMUNOL, V163, P4754; Lobell A, 1998, J EXP MED, V187, P1543, DOI 10.1084/jem.187.9.1543; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; Mocci S, 1997, J IMMUNOL, V158, P1559; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; Paul WE, 1997, CIBA F SYMP, V204, P208; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Robinson H L, 1997, Semin Immunol, V9, P271, DOI 10.1006/smim.1997.0083; Ruiz PJ, 1999, J IMMUNOL, V162, P3336; STEINMAN L, 1995, CELL, V80, P7, DOI 10.1016/0092-8674(95)90443-3; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Vanderlugt CJ, 1996, CURR OPIN IMMUNOL, V8, P831, DOI 10.1016/S0952-7915(96)80012-4; Waisman A, 1996, NAT MED, V2, P899, DOI 10.1038/nm0896-899; Yoshizawa I, 1998, J NEUROIMMUNOL, V89, P73, DOI 10.1016/S0165-5728(98)00101-5; Yu M, 1996, J EXP MED, V183, P1777, DOI 10.1084/jem.183.4.1777; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	28	126	134	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2001	15	1					15	22		10.1016/S1074-7613(01)00171-6	http://dx.doi.org/10.1016/S1074-7613(01)00171-6			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485734	Bronze			2022-12-18	WOS:000170153300003
J	Koopmann, JO; Albring, J; Huter, E; Bulbuc, N; Spee, P; Neefjes, J; Hammerling, GJ; Momburg, F				Koopmann, JO; Albring, J; Huter, E; Bulbuc, N; Spee, P; Neefjes, J; Hammerling, GJ; Momburg, F			Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel	IMMUNITY			English	Article							MHC CLASS-I; HEAVY-CHAINS; DISULFIDE-ISOMERASE; BINDING-PROTEIN; ATP-BINDING; CONFORMATIONAL CHANGE; PSEUDOMONAS EXOTOXIN; DEGRADATION PATHWAY; PROCESSING TAP; TRANSPORT	Antigenic peptides are translocated by the TAP peptide transporter from the cytosol into the endoplasmic reticulum (ER) for loading onto MHC class I molecules. Peptides that fail to bind need to be removed from the ER. Here we provide evidence that peptide export utilizes the Sec61p translocon as demonstrated by blocking this channel with bacterial exotoxin. Peptide export interferes with the retrotranslocation of beta(2)-microglobulin from the ER to the cytosol, suggesting similar pathways for the disposal of proteins and oligopeptides. Peptide export requires ATP supply to the ER lumen but is independent of ATP hydrolysis.	German Canc Res Ctr, Dept Mol Immunol, D-69120 Heidelberg, Germany; Netherlands Canc Inst, Dept Tumor Biol, NL-1066 CX Amsterdam, Netherlands	Helmholtz Association; German Cancer Research Center (DKFZ); Netherlands Cancer Institute	Momburg, F (corresponding author), German Canc Res Ctr, Dept Mol Immunol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Albring, Jorn/0000-0002-5534-7250				Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; CSERMELY P, 1993, J BIOL CHEM, V268, P1901; Dierks T, 1996, EMBO J, V15, P6931, DOI 10.1002/j.1460-2075.1996.tb01085.x; EISENLOHR LC, 1992, CELL, V71, P963, DOI 10.1016/0092-8674(92)90392-P; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; GRIEM P, 1991, CELL, V65, P633, DOI 10.1016/0092-8674(91)90095-G; GUILLEN E, 1995, BIOCHEMISTRY-US, V34, P5472, DOI 10.1021/bi00016a018; Guthapfel R, 1996, J BIOL CHEM, V271, P2663, DOI 10.1074/jbc.271.5.2663; HAUSER S, 1995, EMBO J, V14, P5485, DOI 10.1002/j.1460-2075.1995.tb00235.x; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Jackson ME, 1999, J CELL SCI, V112, P467; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Lacaille VG, 1998, J BIOL CHEM, V273, P17386, DOI 10.1074/jbc.273.28.17386; Lammert E, 1997, EUR J IMMUNOL, V27, P1685, DOI 10.1002/eji.1830270714; Lammert E, 1997, EUR J IMMUNOL, V27, P923, DOI 10.1002/eji.1830270418; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; Lord JM, 1998, J CELL BIOL, V140, P733; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; Marusina K, 1997, BIOCHEMISTRY-US, V36, P856, DOI 10.1021/bi9619738; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X; MULLBACHER A, 1995, IMMUNITY, V3, P207, DOI 10.1016/1074-7613(95)90090-X; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; Nijenhuis M, 1996, J IMMUNOL, V156, P2186; OGATA M, 1990, J BIOL CHEM, V265, P20678; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Romisch K, 1997, P NATL ACAD SCI USA, V94, P6730, DOI 10.1073/pnas.94.13.6730; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Spee P, 1999, BIOCHEMISTRY-US, V38, P10559, DOI 10.1021/bi990321r; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; STAM NJ, 1986, J IMMUNOL, V137, P2299; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	63	126	130	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2000	13	1					117	127		10.1016/S1074-7613(00)00013-3	http://dx.doi.org/10.1016/S1074-7613(00)00013-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933400	Bronze			2022-12-18	WOS:000088463600012
J	Shresta, S; Graubert, TA; Thomas, DA; Raptis, SZ; Ley, TJ				Shresta, S; Graubert, TA; Thomas, DA; Raptis, SZ; Ley, TJ			Granzyme A initiates an alternative pathway for granule-mediated apoptosis	IMMUNITY			English	Article							VERSUS-HOST DISEASE; CYTOKINE RESPONSE MODIFIER; TARGET-CELL LYSIS; DNA FRAGMENTATION; CYTOTOXIC LYMPHOCYTES; NATURAL-KILLER; T-CELLS; SERINE PROTEASES; RAPID INDUCTION; DEFICIENT MICE	Granzyme (gzm) B-deficient cytotoxic lymphocytes (CTL) have a severe defect in the rapid induction of target cell apoptosis that is almost completely corrected by prolonged incubation of the CTL effecters and their targets. We show in this report that perforin-dependent, gzmB-independent cytotoxicity is caused by gzmA (or tightly linked genes). CTL deficient for gzmA and gzmB retain normal perforin function, but these CTL have a cytotoxic defect in vivo that is as severe as perforin-deficient CTL. Collectively, these results suggest that perforin provides target cell access and/or trafficking signals for the gzms, and that the gzms themselves deliver the lethal hits. The gzmA pathway appears to function independently from gzmB and may therefore provide a critical "back-up" system when gzmB is inhibited in the target cell.	Washington Univ, Sch Med, Dept Internal Med & Genet, Div Bone Marrow Transplantat & Stem Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Sch Med, Dept Internal Med & Genet, Div Bone Marrow Transplantat & Stem Cell Biol, St Louis, MO 63110 USA.			Graubert, Timothy/0000-0002-7710-1171	NCI NIH HHS [CA49712] Funding Source: Medline; NIDDK NIH HHS [DK49786] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA049712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049786] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrade F, 1998, IMMUNITY, V8, P451, DOI 10.1016/S1074-7613(00)80550-6; Beresford PJ, 1997, P NATL ACAD SCI USA, V94, P9285, DOI 10.1073/pnas.94.17.9285; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Braun MY, 1996, J EXP MED, V183, P657, DOI 10.1084/jem.183.2.657; Darmon AJ, 1996, J BIOL CHEM, V271, P21709, DOI 10.1074/jbc.271.36.21709; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; DUKE RC, 1989, J EXP MED, V170, P1451, DOI 10.1084/jem.170.4.1451; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Froelich CJ, 1998, IMMUNOL TODAY, V19, P30, DOI 10.1016/S0167-5699(97)01184-5; Graubert TA, 1996, BLOOD, V87, P1232, DOI 10.1182/blood.V87.4.1232.bloodjournal8741232; Graubert TA, 1997, J CLIN INVEST, V100, P904, DOI 10.1172/JCI119606; Hampson IN, 1997, BLOOD, V89, P108, DOI 10.1182/blood.V89.1.108.108_108_118; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; HUDIG D, 1991, J IMMUNOL, V147, P1360; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jans DA, 1996, J BIOL CHEM, V271, P30781, DOI 10.1074/jbc.271.48.30781; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; KOJIMA H, 1994, IMMUNITY, V1, P357, DOI 10.1016/1074-7613(94)90066-3; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; MASSON D, 1987, CELL, V49, P679, DOI 10.1016/0092-8674(87)90544-7; Mullbacher A, 1996, P NATL ACAD SCI USA, V93, P5783, DOI 10.1073/pnas.93.12.5783; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; PASTERNACK MS, 1985, NATURE, V314, P743, DOI 10.1038/314743a0; Pham CTN, 1998, J BIOL CHEM, V273, P1629, DOI 10.1074/jbc.273.3.1629; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Pinkoski MJ, 1998, BLOOD, V92, P1044; POE M, 1991, J BIOL CHEM, V266, P98; Quan LT, 1996, P NATL ACAD SCI USA, V93, P1972, DOI 10.1073/pnas.93.5.1972; QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; Sarin A, 1997, IMMUNITY, V6, P209, DOI 10.1016/S1074-7613(00)80427-6; SENTMAN CL, 1989, J IMMUNOL, V142, P1847; SHI L, 1996, J EXP MED, V195, P855; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; SHIVER JW, 1992, CELL, V71, P315, DOI 10.1016/0092-8674(92)90359-K; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Shresta S, 1997, J BIOL CHEM, V272, P20236, DOI 10.1074/jbc.272.32.20236; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; SIEG S, 1995, J VIROL, V69, P3538, DOI 10.1128/JVI.69.6.3538-3541.1995; Simon MM, 1997, J EXP MED, V186, P1781, DOI 10.1084/jem.186.10.1781; Smyth MJ, 1998, J VIROL, V72, P1; SPRENT J, 1986, J EXP MED, V163, P998, DOI 10.1084/jem.163.4.998; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; TEWARI M, 1995, J BIOL CHEM, V270, P22705, DOI 10.1074/jbc.270.39.22705; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; Xia ZN, 1998, BIOCHEM BIOPH RES CO, V243, P384, DOI 10.1006/bbrc.1998.8102; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	65	126	130	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1999	10	5					595	605		10.1016/S1074-7613(00)80059-X	http://dx.doi.org/10.1016/S1074-7613(00)80059-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367905	Bronze			2022-12-18	WOS:000080709400011
J	Lenz, LL; Dere, B; Bevan, MJ				Lenz, LL; Dere, B; Bevan, MJ			Identification of an H2-M3-restricted Listeria epitope: Implications for antigen presentation by M3	IMMUNITY			English	Article							CLASS-I MOLECULES; T-CELLS; ESCHERICHIA-COLI; LYMPHOCYTES-T; SPECIALIZED FUNCTIONS; MEMBRANE TOPOLOGY; PEPTIDE BINDING; MONOCYTOGENES; PROTEIN; SEQUENCE	Using expression cloning, we have identified an H2-M3-restricted epitope of the intracellular bacterial pathogen Listeria monocytogenes. Picomolar concentrations of an amino-terminal N-formylated hexapeptide, fMIGWII, targeted cells for lysis by CD8(+) cytotoxic T cells, while the nonformylated peptide was approximately 100-fold less active. The sequence of the 185 aa protein source of this epitope predicts a transmembrane protein that retains its N terminus and assumes an N-out-C-in topology. This membrane orientation offers an explanation for the protection of the epitope from deformylases present in the bacterial cell and suggests an explanation for the ability of phagocytes to present H2-M3-restricted bacterial epitopes via a vacuolar TAP-independent mechanism.			Lenz, LL (corresponding author), UNIV WASHINGTON, DEPT IMMUNOL, HOWARD HUGHES MED INST, SEATTLE, WA 98195 USA.				NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019335, R01AI019335] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32 CA009537, T32 CA009537-13, CA-09537] Funding Source: Medline; NIAID NIH HHS [R01 AI019335, R01 AI019335-19, AI-19335] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BACHMANN MF, 1995, EUR J IMMUNOL, V25, P1739, DOI 10.1002/eji.1830250637; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BLOCH KD, 1987, CURRENT PROTOCOLS MO; BROWN ML, 1992, J IMMUNOL, V148, P555; BRUNT LM, 1990, J IMMUNOL, V145, P3540; DAY PM, 1995, IMMUNITY, V2, P137, DOI 10.1016/S1074-7613(95)80014-X; DEBRUIJN MLH, 1995, EUR J IMMUNOL, V25, P1274, DOI 10.1002/eji.1830250522; DELIBERO G, 1986, J IMMUNOL, V137, P2688; FLAMM RK, 1984, INFECT IMMUN, V44, P157, DOI 10.1128/IAI.44.1.157-161.1984; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; HARTY JT, 1995, J IMMUNOL, V154, P4642; KAUFMANN SHE, 1988, J IMMUNOL, V140, P3173; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; KURLANDER RJ, 1992, SCIENCE, V257, P678, DOI 10.1126/science.1496381; LENZ LL, 1996, IN PRESS IMMUNOL REV, V151; LINDAHL KF, 1991, ANNU REV IMMUNOL, V9, P351, DOI 10.1146/annurev.iy.09.040191.002031; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; LUKACS K, 1989, J IMMUNOL, V143, P3731; MEINNEL T, 1993, BIOCHIMIE, V75, P1061, DOI 10.1016/0300-9084(93)90005-D; MICHEL E, 1992, J BACTERIOL, V174, P7098, DOI 10.1128/jb.174.22.7098-7103.1992; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Nataraj C, 1996, INT IMMUNOL, V8, P367, DOI 10.1093/intimm/8.3.367; PAMER EG, 1994, J IMMUNOL, V152, P686; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; PAMER EG, 1992, CELL, V70, P215, DOI 10.1016/0092-8674(92)90097-V; Pamer Eric G., 1993, Trends in Microbiology, V1, P35, DOI 10.1016/0966-842X(93)90023-K; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SHAWAR SM, 1991, J EXP MED, V174, P941, DOI 10.1084/jem.174.4.941; SHAWAR SM, 1990, J EXP MED, V171, P897, DOI 10.1084/jem.171.3.897; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Sijts AJAM, 1996, J IMMUNOL, V156, P685; SIMONEN M, 1993, MICROBIOL REV, V57, P109, DOI 10.1128/MMBR.57.1.109-137.1993; SMITH GP, 1994, INT IMMUNOL, V6, P1917, DOI 10.1093/intimm/6.12.1917; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; VAZQUEZBOLAND JA, 1992, INFECT IMMUN, V60, P219, DOI 10.1128/IAI.60.1.219-230.1992; VIANNEY A, 1994, J BACTERIOL, V176, P822, DOI 10.1128/jb.176.3.822-829.1994; VILLANUEVA MS, 1994, IMMUNITY, V1, P479, DOI 10.1016/1074-7613(94)90090-6; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; VYAS JM, 1995, J EXP MED, V181, P1817, DOI 10.1084/jem.181.5.1817; VYAS JM, 1992, J IMMUNOL, V149, P3605; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; WANG CR, 1991, CELL, V66, P335, DOI 10.1016/0092-8674(91)90623-7; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411; WOLFE PB, 1983, J BIOL CHEM, V258, P2073	52	126	127	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1996	5	1					63	72		10.1016/S1074-7613(00)80310-6	http://dx.doi.org/10.1016/S1074-7613(00)80310-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ454	8758895	Green Accepted, Bronze			2022-12-18	WOS:A1996UZ45400007
J	Liu, J; Zhang, XM; Chen, K; Cheng, YJ; Liu, SX; Xia, M; Chen, YL; Zhu, H; Li, ZQ; Cao, XT				Liu, Juan; Zhang, Xiaomin; Chen, Kun; Cheng, Yujie; Liu, Shuxun; Xia, Meng; Chen, Yali; Zhu, Ha; Li, Zhiqing; Cao, Xuetao			CCR7 Chemokine Receptor-Inducible Inc-Dpf3 Restrains Dendritic Cell Migration by Inhibiting HIF-1 alpha-Mediated Glycolysis	IMMUNITY			English	Article							LYMPH-NODES; T-CELL; RNA MODIFICATIONS; METHYLATION; HOMEOSTASIS; ACTIVATION; RESOLUTION; RESPONSES; IMMUNITY; HYPOXIA	CCR7 chemokine receptor stimulation induces rapid but transient dendritic cell (DC) migration toward draining lymph nodes, which is critical for the initiation of protective immunity and maintenance of immune homeostasis. The mechanisms for terminating CCR7-mediated DC migration remain incompletely understood. Here we have identified a long non-coding RNA Inc-Dpf3 whose feedback restrained CCR7-mediated DC migration. CCR7 stimulation up-regulated Inc-Dpf3 via removing N6-methyladenosine (m(6)A) modification to prevent RNA degradation. DC-specific Inc-Dpf3 deficiency increased CCR7-mediated DC migration, leading to exaggerated adaptive immune responses and inflammatory injuries. Mechanistically, CCR7 stimulation activated the HIF-1 alpha transcription factor pathway in DCs, leading to metabolic reprogramming toward glycolysis for DC migration. Inc-Dpf3 directly bound to HIF-1 alpha and suppressed HIF-1 alpha-dependent transcription of the glycolytic gene Ldha, thus inhibiting DC glycolytic metabolism and migratory capacity. We demonstrate a critical role for CCR7-inducible Inc-Dpf3 in coupling epigenetic and metabolic pathways to feedback-control DC migration and inflammatory responses.	[Liu, Juan; Zhang, Xiaomin; Cheng, Yujie; Liu, Shuxun; Zhu, Ha; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Liu, Juan; Zhang, Xiaomin; Cheng, Yujie; Liu, Shuxun; Zhu, Ha; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Chen, Kun; Xia, Meng; Li, Zhiqing; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Dept Immunol, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Chen, Kun; Xia, Meng; Li, Zhiqing; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Ctr Immunotherapy, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Chen, Yali; Cao, Xuetao] Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Cao, Xuetao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Zhejiang University; Nankai University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Dept Immunol, Inst Basic Med Sci, Beijing 100005, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Ctr Immunotherapy, Inst Basic Med Sci, Beijing 100005, Peoples R China.; Cao, XT (corresponding author), Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.; Cao, XT (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	juanliu@immunol.org; caoxt@immunol.org		xia, meng/0000-0001-5223-7390	National Natural Science Foundation of China [31622024, 81671546, 81788101, 81801577]; National Key RAMP;D Program of China [2018YFA0507401]; CAMS Innovation Fund for Medical Sciences [2016-12M-1-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RAMP;D Program of China; CAMS Innovation Fund for Medical Sciences	We thank Dr. Ming Zhang (Renji Hospital, Medical College of Shanghai Jiaotong University, China) for providing Hif1a<SUP>fl/fl</SUP> mice, Dr. Wuhan Xiao (Institute of Hydrobiology, Chinese Academy of Sciences, China) for helpful discussion, and Ms. Ting Guo and Zhongmei Li for their technical assistance. This work was supported by grants from the National Natural Science Foundation of China (31622024, 81671546, 81788101, 81801577), National Key R&D Program of China (2018YFA0507401), and CAMS Innovation Fund for Medical Sciences (2016-12M-1-003).	Ardouin L, 2016, IMMUNITY, V45, P305, DOI 10.1016/j.immuni.2016.07.019; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Baratin M, 2015, IMMUNITY, V42, P627, DOI 10.1016/j.immuni.2015.03.003; Bretou M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aak9573; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dress RJ, 2018, IMMUNOL CELL BIOL, V96, P463, DOI 10.1111/imcb.12028; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Du XR, 2018, NATURE, V558, P141, DOI 10.1038/s41586-018-0177-0; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Frittoli E, 2011, IMMUNITY, V35, P388, DOI 10.1016/j.immuni.2011.07.007; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Guak H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04804-6; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Han YP, 2015, J IMMUNOL, V195, P4126, DOI 10.4049/jimmunol.1401842; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu BY, 2017, NAT IMMUNOL, V18, P499, DOI 10.1038/ni.3712; Liu J, 2014, NAT IMMUNOL, V15, P612, DOI 10.1038/ni.2898; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Roquilly A, 2017, IMMUNITY, V47, P135, DOI 10.1016/j.immuni.2017.06.021; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Tomura M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06030; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Venter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097378; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Worbs T, 2017, NAT REV IMMUNOL, V17, P30, DOI 10.1038/nri.2016.116; Zheng QL, 2017, NAT IMMUNOL, V18, P1094, DOI 10.1038/ni.3830	53	125	135	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					600	+		10.1016/j.immuni.2019.01.021	http://dx.doi.org/10.1016/j.immuni.2019.01.021			31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30824325	Bronze			2022-12-18	WOS:000461660500012
J	Gray, SM; Amezquita, RA; Guan, TX; Kleinstein, SH; Kaech, SM				Gray, Simon M.; Amezquita, Robert A.; Guan, Tianxia; Kleinstein, Steven H.; Kaech, Susan M.			Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8(+) T Cell Terminal Differentiation and Loss of Multipotency	IMMUNITY			English	Article							H3 LYSINE 27; TRANSCRIPTION FACTOR; DNA METHYLATION; MEMORY; EZH2; BET; EXPRESSION; MAINTENANCE; RESPONSES; DIVISION	Understanding immunological memory formation depends on elucidating how multipotent memory precursor (MP) cells maintain developmental plasticity and longevity to provide long-term immunity while other effector cells develop into terminally differentiated effector (TE) cells with limited survival. Profiling active (H3K27ac) and repressed (H3K27me3) chromatin in naive, MP, and TE CD8(+) T cells during viral infection revealed increased H3K27me3 deposition at numerous pro-memory and pro-survival genes in TE relative to MP cells, indicative of fate restriction, but permissive chromatin at both pro-memory and pro-effector genes in MP cells, indicative of multipotency. Polycomb repressive complex 2 deficiency impaired clonal expansion and TE cell differentiation, but minimally impacted CD8(+) memory T cell maturation. Abundant H3K27me3 deposition at pro-memory genes occurred late during TE cell development, probably from diminished transcription factor FOXO1 expression. These results outline a temporal model for loss of memory cell potential through selective epigenetic silencing of pro-memory genes in effector T cells.	[Gray, Simon M.; Amezquita, Robert A.; Guan, Tianxia; Kleinstein, Steven H.; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06510 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Gray, SM; Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.	simon.gray@yale.edu; susan.kaech@yale.edu			Howard Hughes Medical Institute (HHMI); HHMI; NIH [R37 AI066232, F30 AI114090, 1S10OD018521]; NIH/NIGMS [T32 GM007205]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066232, F30AI114090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018521] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Kaech and Kleinstein laboratories for helpful comments and suggestions. This study was supported in part by the Howard Hughes Medical Institute (HHMI) (S.M.K.), HHMI Gilliam Fellowship (R.A.A.), the HHMI International Student Research Fellowship (T.G.), the NIH grants R37 AI066232 (S.M.K.), F30 AI114090 (S.M.G.), 1S10OD018521 (S.M. Mane), and NIH/NIGMS T32 GM007205 (S.M.G.). This work was supported by the HPC facilities operated by the Yale Center for Research Computing and the Yale Center for Genome Analysis.	Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Gerlach C, 2016, J IMMUNOL, V196; Gunawan M, 2015, NAT IMMUNOL, V16, P505, DOI 10.1038/ni.3125; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Ladle BH, 2016, P NATL ACAD SCI USA, V113, P10631, DOI 10.1073/pnas.1524490113; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lin WHW, 2015, CELL REP, V13, P2203, DOI 10.1016/j.celrep.2015.10.072; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Manna S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9152; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin HM, 2013, IMMUNITY, V39, P661, DOI 10.1016/j.immuni.2013.08.032; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001; Yang XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10643; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	41	125	125	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					596	608		10.1016/j.immuni.2017.03.012	http://dx.doi.org/10.1016/j.immuni.2017.03.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28410989	Green Accepted, Bronze			2022-12-18	WOS:000399451100013
J	Pingen, M; Bryden, SR; Pondeville, E; Schnettler, E; Kohl, A; Merits, A; Fazakerley, JK; Graham, GJ; McKimmie, CS				Pingen, Marieke; Bryden, Steven R.; Pondeville, Emilie; Schnettler, Esther; Kohl, Alain; Merits, Andres; Fazakerley, John K.; Graham, Gerard J.; McKimmie, Clive S.			Host Inflammatory Response to Mosquito Bites Enhances the Severity of Arbovirus Infection	IMMUNITY			English	Article							DENGUE VIRUS-INFECTION; SEMLIKI-FOREST-VIRUS; BONE-MARROW; IN-VIVO; MICE; SALIVA; ENCEPHALITIS; POTENTIATION; PATHOGENESIS; MACROPHAGES	Aedes aegypti mosquitoes are responsible for transmitting many medically important viruses such as those that cause Zika and dengue. The inoculation of viruses into mosquito bite sites is an important and common stage of all mosquito-borne virus infections. We show, using Semliki Forest virus and Bunyamwera virus, that these viruses use this inflammatory niche to aid their replication and dissemination in vivo. Mosquito bites were characterized by an edema that retained virus at the inoculation site and an inflammatory influx of neutrophils that coordinated a localized innate immune program that inadvertently facilitated virus infection by encouraging the entry and infection of virus-permissive myeloid cells. Neutrophil depletion and therapeutic blockade of inflammasome activity suppressed inflammation and abrogated the ability of the bite to promote infection. This study identifies facets of mosquito bite inflammation that are important determinants of the subsequent systemic course and clinical outcome of virus infection.	[Pingen, Marieke; Bryden, Steven R.; McKimmie, Clive S.] Univ Leeds, Leeds Inst Canc & Pathol, Sect Infect & Immun, Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England; [Bryden, Steven R.; Graham, Gerard J.] Univ Glasgow, Inst Infect Immunol & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Pondeville, Emilie; Schnettler, Esther; Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland; [Merits, Andres] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia; [Fazakerley, John K.] Pirbright Inst, Ash Rd, Pirbright GU24 0NF, Surrey, England	University of Leeds; University of Glasgow; University of Glasgow; University of Tartu; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	McKimmie, CS (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Sect Infect & Immun, Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England.	c.s.mckimmie@leeds.ac.uk	Schnettler, Esther/AAV-8774-2020; Pingen, Marieke/F-9990-2012; Merits, Andres/H-3125-2015; McKimmie, Clive/AAD-9509-2019	Pingen, Marieke/0000-0001-5689-9076; Merits, Andres/0000-0001-8193-0071; McKimmie, Clive/0000-0002-7694-9509; Bryden, Steven/0000-0001-5408-6047; Pondeville, Emilie/0000-0001-8545-8472; Fazakerley, John/0000-0001-7071-105X	MRC [G1001724]; BBSRC PhD studentship; Biotechnology and Biological Sciences Research Council [1511961] Funding Source: researchfish; Medical Research Council [MC_UU_12014/8, MC_UP_A550_1031, MR/M019764/1, G0901113, G1001724] Funding Source: researchfish; Wellcome Trust [099251/Z/12/Z] Funding Source: researchfish; MRC [G0901113, MC_UP_A550_1031, MC_UU_12014/8, MR/M019764/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the kind assistance of Melanie McFarlane and Stephanie Rainey for the provision of virus stocks and insect cell culture; Ryan Ritchie for help with IVIS; Margaret McFadyen and Joy Kean for culture of mosquitoes; Prof. Eileen Devaney for her detailed editing of the manuscript; and the Institute of Infection, Immunity and Inflammation Flow Cytometry Facility, all based at the University of Glasgow. This work was funded by the MRC (G1001724) and a BBSRC PhD studentship to S.R.B.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Charmoy M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000755; Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13; Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Dessens JT, 1998, J VIROL, V72, P8362, DOI 10.1128/JVI.72.10.8362-8364.1998; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332; Ferguson MC, 2015, J VIROL, V89, P7536, DOI 10.1128/JVI.03645-14; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Jabir MS, 2014, CELL HOST MICROBE, V15, P214, DOI 10.1016/j.chom.2014.01.010; King JG, 2011, J BIOL CHEM, V286, P40824, DOI 10.1074/jbc.M111.280552; Le Coupanec A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002237; Limesand KH, 2000, PARASITE IMMUNOL, V22, P461, DOI 10.1046/j.1365-3024.2000.00326.x; McCracken MK, 2014, J VIROL, V88, P1881, DOI 10.1128/JVI.01218-13; Michlmayr D, 2014, J VIROL, V88, P9553, DOI 10.1128/JVI.03421-13; Moser LA, 2016, J VIROL, V90, P292, DOI 10.1128/JVI.02280-15; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Reagan KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001935; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x; Schaeffer E, 2015, J INVEST DERMATOL, V135, P1743, DOI 10.1038/jid.2014.525; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541; Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Ulper L, 2008, J VIROL METHODS, V148, P265, DOI 10.1016/j.jviromet.2007.10.007; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062	43	125	127	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1455	1469		10.1016/j.immuni.2016.06.002	http://dx.doi.org/10.1016/j.immuni.2016.06.002			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332734	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000378341200022
J	Vlantis, K; Wullaert, A; Polykratis, A; Kondylis, V; Dannappel, M; Schwarzer, R; Welz, P; Corona, T; Walczak, H; Weih, F; Klein, U; Kelliher, M; Pasparakis, M				Vlantis, Katerina; Wullaert, Andy; Polykratis, Apostolos; Kondylis, Vangelis; Dannappel, Marius; Schwarzer, Robin; Welz, Patrick; Corona, Teresa; Walczak, Henning; Weih, Falk; Klein, Ulf; Kelliher, Michelle; Pasparakis, Manolis			NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-kappa B-Dependent and -Independent Functions	IMMUNITY			English	Article							ANHIDROTIC ECTODERMAL DYSPLASIA; NLRP3 INFLAMMASOME; IKK-BETA; HOMEOSTASIS; APOPTOSIS; ACTIVATION; EXPRESSION; CASPASE-8; MUTATION; NECROSIS	Intestinal epithelial cells (IECs) regulate gut immune homeostasis, and impaired epithelial responses are implicated in the pathogenesis of inflammatory bowel diseases (IBD). IEC-specific ablation of nuclear factor kappa B (NF-kappa B) essential modulator (NEMO) caused Paneth cell apoptosis and impaired antimicrobial factor expression in the ileum, as well as colonocyte apoptosis and microbiota-driven chronic inflammation in the colon. Combined RelA, c-Rel, and RelB deficiency in IECs caused Paneth cell apoptosis but not colitis, suggesting that NEMO prevents colon inflammation by NF-kappa B-independent functions. Inhibition of receptor-interacting protein kinase 1 (RIPK1) kinase activity or combined deficiency of Fas-associated via death domain protein (FADD) and RIPK3 prevented epithelial cell death, Paneth cell loss, and colitis development in mice with epithelial NEMO deficiency. Therefore, NEMO prevents intestinal inflammation by inhibiting RIPK1 kinase activity-mediated IEC death, suggesting that RIPK1 inhibitors could be effective in the treatment of colitis in patients with NEMO mutations and possibly in IBD.	[Vlantis, Katerina; Wullaert, Andy; Polykratis, Apostolos; Kondylis, Vangelis; Dannappel, Marius; Schwarzer, Robin; Welz, Patrick; Corona, Teresa; Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Vlantis, Katerina; Wullaert, Andy; Polykratis, Apostolos; Kondylis, Vangelis; Dannappel, Marius; Schwarzer, Robin; Welz, Patrick; Corona, Teresa; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Vlantis, Katerina; Wullaert, Andy; Polykratis, Apostolos; Kondylis, Vangelis; Dannappel, Marius; Schwarzer, Robin; Welz, Patrick; Corona, Teresa; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany; [Walczak, Henning] UCL, UCL Canc Inst, Ctr Cell Death Canc & Inflammat CCCI, 72 Huntley St, London WC1E 6D, England; [Weih, Falk] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Klein, Ulf] Columbia Univ, Dept Pathol & Cell Biol, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Klein, Ulf] Columbia Univ, Dept Microbiol & Immunol, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Kelliher, Michelle] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Wullaert, Andy] Univ Ghent VIB, Inflammat Res Ctr, Technol Pk 927, B-9052 Ghent, Belgium; [Wullaert, Andy] Univ Ghent, Dept Internal Med, Technol Pk 927, B-9052 Ghent, Belgium; [Welz, Patrick] IRB, Barcelona 08028, Spain	University of Cologne; University of Cologne; University of Cologne; University of London; University College London; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Columbia University; Columbia University; University of Massachusetts System; University of Massachusetts Worcester; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, D-50674 Cologne, Germany.; Pasparakis, M (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.; Pasparakis, M (corresponding author), Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany.	pasparakis@uni-koeln.de	Wullaert, Andy/D-2975-2018; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Corona, Teresa/AAU-8333-2021; Walczak, Henning/AAV-2214-2020; Welz, Patrick-Simon/F-3856-2016; Kondylis, Vangelis/S-6276-2019; Wullaert, Andy/R-1924-2019	Wullaert, Andy/0000-0001-5012-654X; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Corona, Teresa/0000-0002-9324-229X; Walczak, Henning/0000-0002-6312-4591; Welz, Patrick-Simon/0000-0001-8370-625X; Kondylis, Vangelis/0000-0002-6970-8731; Wullaert, Andy/0000-0001-5012-654X; Polykratis, Apostolos/0000-0001-6720-3302	ERC [323040]; DFG [SFB670, SPP1656]; European Commission [223404, 223151]; NIAID division of the NIH [RO1AI075118]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075118] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); NIAID division of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to V. Dixit and Genentech for Ripk3<SUP>-/-</SUP>, G. Kollias for Tnfr1<SUP>FL</SUP>, D. Gumucio for Villin-Cre, and S. Robine for Villin-CreER<SUP>T2</SUP> mice, and to P. Kirsch and the gnotobiotic facility at the University of Ulm for the generation of germ-free NEMO<SUP>IEC-KO</SUP> mice. We thank J. Buchholz, C. Uthoff-Hachenberg, E. Mahlberg, B. Kuhnel, B. Hulser, E. Stade, and D. Beier for technical assistance. Research reported in this publication was supported by funding from the ERC (grant agreement no. 323040), the DFG (SFB670, SPP1656), and the European Commission (grants 223404 and 223151) to M.P., and by the NIAID division of the NIH under award RO1AI075118 to M.K.	Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Eckmann L, 2008, P NATL ACAD SCI USA, V105, P15058, DOI 10.1073/pnas.0808216105; Fish JD, 2009, BONE MARROW TRANSPL, V43, P217, DOI 10.1038/bmt.2008.308; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kawai T, 2012, ALLERGOL INT, V61, P207, DOI 10.2332/allergolint.12-RAI-0446; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Mizukami T, 2012, J CLIN IMMUNOL, V32, P39, DOI 10.1007/s10875-011-9600-0; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; O'Donnell MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041238; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ouellette AJ, 2010, CURR OPIN GASTROEN, V26, P547, DOI 10.1097/MOG.0b013e32833dccde; Pai Sung-Yun, 2008, J Allergy Clin Immunol, V122, P1113, DOI 10.1016/j.jaci.2008.08.026; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Permaul P, 2009, IMMUNOL RES, V44, P89, DOI 10.1007/s12026-008-8085-2; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Seidelin JB, 2009, SCAND J GASTROENTERO, V44, P1429, DOI 10.3109/00365520903301212; Souza HSP, 2005, INT J COLORECTAL DIS, V20, P277, DOI 10.1007/s00384-004-0639-8; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Van Hauwermeiren F, 2013, J CLIN INVEST, V123, P2590, DOI 10.1172/JCI65624; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	36	125	132	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					553	567		10.1016/j.immuni.2016.02.020	http://dx.doi.org/10.1016/j.immuni.2016.02.020			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982364	Green Published, hybrid			2022-12-18	WOS:000372784200014
J	Satpathy, AT; Chang, HY				Satpathy, Ansuman T.; Chang, Howard Y.			Long Noncoding RNA in Hematopoiesis and Immunity	IMMUNITY			English	Review							DENDRITIC CELL-DIFFERENTIATION; CENTRAL-NERVOUS-SYSTEM; THEILERS-VIRUS; GENE-EXPRESSION; STEM-CELL; XIST RNA; TRANSCRIPTIONAL ACTIVITY; PERSISTENT INFECTION; MOLECULAR-BIOLOGY; BINDING PROTEINS	Dynamic gene expression during cellular differentiation is tightly coordinated by transcriptional and post-transcriptional mechanisms. An emerging theme is the central role of long noncoding RNAs (lncRNAs) in the regulation of this specificity. Recent advances demonstrate that lncRNAs are expressed in a lineage-specific manner and control the development of several cell types in the hematopoietic system. Moreover, specific lncRNAs are induced to modulate innate and adaptive immune responses. lncRNAs can function via RNA-DNA, RNA-RNA, and RNA-protein target interactions. As a result, they affect several stages of gene regulation, including chromatin modification, mRNA biogenesis, and protein signaling. We discuss recent advances, future prospects, and challenges in understanding the roles of lncRNAs in immunity and immune-mediated diseases.	[Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	howchang@stanford.edu		Satpathy, Ansuman/0000-0002-5167-537X	NIH; Scleroderma Research Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation	We thank members of the H.Y.C. lab, Xiaodi Wu, and Carlos Briseno for helpful discussions and Mervin Kaunda for artwork. This work was supported by the NIH and Scleroderma Research Foundation (H.Y.C.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. H.Y.C. is a founder of Epinomics and a scientific advisory board member of RaNA Therapeutics.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Alvarez-Dominguez JR, 2014, BLOOD, V123, P570, DOI 10.1182/blood-2013-10-530683; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Aubagnac S, 2002, J VIROL, V76, P5807, DOI 10.1128/JVI.76.11.5807-5812.2002; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Bihl F, 1999, GENETICS, V152, P385; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Brunner AL, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r75; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; BUREAU JF, 1993, NAT GENET, V5, P87, DOI 10.1038/ng0993-87; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Chu C, 2015, NAT STRUCT MOL BIOL, V22, P29, DOI 10.1038/nsmb.2921; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Collier SP, 2014, J IMMUNOL, V193, P3959, DOI 10.4049/jimmunol.1401099; Collier SP, 2012, J IMMUNOL, V189, P2084, DOI 10.4049/jimmunol.1200774; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Herquel B, 2013, NAT STRUCT MOL BIOL, V20, P339, DOI 10.1038/nsmb.2496; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Iwamoto S, 2001, AM J HEMATOL, V68, P106, DOI 10.1002/ajh.1161; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Karijolich J, 2010, RNA BIOL, V7, P192, DOI 10.4161/rna.7.2.11207; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kowalczyk MS, 2012, NATURE, V482, P310, DOI 10.1038/482310a; Krawczyk M, 2014, ELIFE, V3, DOI 10.7554/eLife.01776; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lafontaine DLJ, 2015, NAT STRUCT MOL BIOL, V22, P11, DOI 10.1038/nsmb.2939; LANIER LL, 1983, IMMUNOL REV, V74, P143, DOI 10.1111/j.1600-065X.1983.tb01088.x; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Levillayer F, 2007, GENETICS, V176, P1835, DOI 10.1534/genetics.107.073536; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Luo M, 2015, CELL STEM CELL, V16, P426, DOI 10.1016/j.stem.2015.02.002; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; MATTICK JS, 1994, CURR OPIN GENET DEV, V4, P823, DOI 10.1016/0959-437X(94)90066-3; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Meng LY, 2015, NATURE, V518, P409, DOI 10.1038/nature13975; Miller MC, 2010, LOST MANSIONS OF MISSISSIPPI, VOL II, P110; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Ouyang J, 2014, CELL HOST MICROBE, V16, P616, DOI 10.1016/j.chom.2014.10.001; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Paralkar VR, 2014, BLOOD, V123, P1927, DOI 10.1182/blood-2013-12-544494; Peschansky VJ, 2014, EPIGENETICS-US, V9, P3, DOI 10.4161/epi.27473; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Quinn JJ, 2014, NAT BIOTECHNOL, V32, P933, DOI 10.1038/nbt.2943; Raina M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00171; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tugnet Nicola, 2013, Open Rheumatol J, V7, P13, DOI 10.2174/1874312901307010013; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Vigneau S, 2003, J VIROL, V77, P5632, DOI 10.1128/JVI.77.10.5632-5638.2003; Vigneau S, 2001, GENOMICS, V78, P206, DOI 10.1006/geno.2001.6656; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Washietl S, 2014, GENOME RES, V24, P616, DOI 10.1101/gr.165035.113; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Zeng M, 2014, SCIENCE, V346, P1486, DOI 10.1126/science.346.6216.1486; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang XQ, 2014, RNA BIOL, V11, P777, DOI 10.4161/rna.28828; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	125	125	138	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					792	804		10.1016/j.immuni.2015.05.004	http://dx.doi.org/10.1016/j.immuni.2015.05.004			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992856	Bronze			2022-12-18	WOS:000354827400007
J	Suan, D; Nguyen, A; Moran, I; Bourne, K; Hermes, JR; Arshi, M; Hampton, HR; Tomura, M; Miwa, Y; Kelleher, AD; Kaplan, W; Deenick, EK; Tangye, SG; Brink, R; Chtanova, T; Phan, TG				Suan, Dan; Nguyen, Akira; Moran, Imogen; Bourne, Katherine; Hermes, Jana R.; Arshi, Mehreen; Hampton, Henry R.; Tomura, Michio; Miwa, Yoshihiro; Kelleher, Anthony D.; Kaplan, Warren; Deenick, Elissa K.; Tangye, Stuart G.; Brink, Robert; Chtanova, Tatyana; Tri Giang Phan			T Follicular Helper Cells Have Distinct Modes of Migration and Molecular Signatures in Naive and Memory Immune Responses	IMMUNITY			English	Article							SUBCAPSULAR SINUS MACROPHAGES; CXC CHEMOKINE RECEPTOR-5; CENTER B-CELL; LYMPH-NODE; GERMINAL-CENTERS; BCL6 EXPRESSION; CUTTING EDGE; DYNAMICS; ANTIGEN; LYMPHOCYTES	B helper follicular T (Tfh) cells are critical for long-term humoral immunity. However, it remains unclear how these cells are recruited and contribute to secondary immune responses. Here we show that primary Tfh cells segregate into follicular mantle (FM) and germinal center (GC) subpopulations that display distinct gene expression signatures. Restriction of the primary Tfh cell subpopulation in the GC was mediated by downregulation of chemotactic receptor EBI2. Following collapse of the GC, memory T cells persisted in the outer follicle where they scanned CD169(+) subcapsular sinus macrophages. Reactivation and intrafollicular expansion of these follicular memory T cells in the subcapsular region was followed by their extrafollicular dissemination via the lymphatic flow. These data suggest that Tfh cells integrate their antigen-experience history to focus T cell help within the GC during primary responses but act rapidly to provide systemic T cell help after re-exposure to the antigen.	[Suan, Dan; Nguyen, Akira; Moran, Imogen; Bourne, Katherine; Hermes, Jana R.; Arshi, Mehreen; Hampton, Henry R.; Kaplan, Warren; Deenick, Elissa K.; Tangye, Stuart G.; Brink, Robert; Chtanova, Tatyana; Tri Giang Phan] Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Suan, Dan; Nguyen, Akira; Moran, Imogen; Hampton, Henry R.; Kaplan, Warren; Deenick, Elissa K.; Tangye, Stuart G.; Brink, Robert; Chtanova, Tatyana; Tri Giang Phan] UNSW Australia, Fac Med, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia; [Arshi, Mehreen; Kelleher, Anthony D.] St Vincents Ctr Appl Med Res, Darlinghurst, NSW 2010, Australia; [Miwa, Yoshihiro] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Garvan Institute of Medical Research; University of New South Wales Sydney; Kyoto University	Chtanova, T (corresponding author), Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	t.chtanova@garvan.org.au; t.phan@garvan.org.au	Tangye, Stuart G/H-4023-2014; Deenick, Elissa/AAY-8998-2020; Brink, Robert/B-7910-2010; Phan, Tri/G-3937-2012	Tangye, Stuart G/0000-0002-5360-5180; Deenick, Elissa/0000-0002-9271-0004; Brink, Robert/0000-0002-9586-3655; Kelleher, Anthony/0000-0002-0009-3337; Phan, Tri/0000-0002-4909-2984; Suan, Dan/0000-0001-5996-5120; Chtanova, Tatyana/0000-0003-3419-4483	Australian Post-graduate Award; NHMRC [1004632, 1062332, 1016953]	Australian Post-graduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank T. Okada, J. Cyster, I. Grigorova, and D. Butt for helpful discussions and A. Basten and C. Sundling for comments on the manuscript. We thank P. Schwartzberg for SAP KO mice. We also thank J.-H. Cho for the primary T cell retroviral transduction protocol, N. Anders from the Small Animal Imaging Facility, R. Solomon and D. Snowden from the MLC Flow Cytometry Facility, and P. Bitter from the ACRF Facility. D.S. is supported by an NHMRC Postgraduate Scholarship, I.M. and H.R.H. by an Australian Post-graduate Award, S.G.T., A.D.K., and R.B. by Research Fellowships from the NHMRC and T. C. and T.G.P. by Career Development Fellowships from the NHMRC. This work was funded by Peter and Val Duncan, NHMRC Project Grants 1004632 (T.G.P.), 1062332 (T.C. and T.G.P.) and NHMRC Program Grant 1016953 (R.B. and S.G.T.). The contents of this article are solely the responsibility of the authors and do not reflect the views of NHMRC.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chtanova T, 2014, J BIOPHOTONICS, V7, P425, DOI 10.1002/jbio.201200175; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; HARDIE DL, 1993, EUR J IMMUNOL, V23, P997, DOI 10.1002/eji.1830230502; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Ise W, 2014, P NATL ACAD SCI USA, V111, P11792, DOI 10.1073/pnas.1404671111; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1995, IMMUNITY, V2, P239, DOI 10.1016/1074-7613(95)90048-9; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Paramithiotis E, 1997, P NATL ACAD SCI USA, V94, P208, DOI 10.1073/pnas.94.1.208; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schaerli P, 2001, J IMMUNOL, V167, P6082, DOI 10.4049/jimmunol.167.11.6082; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Weber JP, 2012, EUR J IMMUNOL, V42, P1981, DOI 10.1002/eji.201242540; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	52	125	129	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					704	718		10.1016/j.immuni.2015.03.002	http://dx.doi.org/10.1016/j.immuni.2015.03.002			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25840682	Bronze			2022-12-18	WOS:000353347500016
J	del Fresno, C; Soulat, D; Roth, S; Blazek, K; Udalova, I; Sancho, D; Ruland, J; Ardavin, C				del Fresno, Carlos; Soulat, Didier; Roth, Susanne; Blazek, Katrina; Udalova, Irina; Sancho, David; Ruland, Juergen; Ardavin, Carlos			Interferon-beta Production via Dectin-1-Syk-IRF5 Signaling in Dendritic Cells Is Crucial for Immunity to C. albicans	IMMUNITY			English	Article							LECTIN RECEPTORS; RECOGNITION; INDUCTION; CANDIDIASIS; RESPONSES; DECTIN-1; PATTERN; DELTA	Type I interferon (IFN) is crucial during infection through its antiviral properties and by coordinating the immunocompetent cells involved in antiviral or antibacterial immunity. Type I IFN (IFN-alpha and IFN-beta) is produced after virus or bacteria recognition by cytosolic receptors or membrane-bound TLR receptors following the activation of the transcription factors IRF3 or IRF7. IFN-beta production after fungal infection was recently reported, although the underlying mechanism remains controversial. Here we describe that IFN-beta production by dendritic cells (DCs) induced by Candida albicans is largely dependent on Dectin-1- and Dectin-2-mediated signaling. Dectin-1-induced IFN-beta production required the tyrosine kinase Syk and the transcription factor IRF5. Type I IFN receptor-deficient mice had a lower survival after C. albicans infection, paralleled by defective renal neutrophil infiltration. IFN-beta production by renal infiltrating leukocytes was severely reduced in C. albicans-infected mice with Syk-deficient DCs. These data indicate that Dectin-induced IFN-beta production by renal DCs is crucial for defense against C. albicans infection.	[del Fresno, Carlos; Soulat, Didier; Ardavin, Carlos] CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Madrid 28049, Spain; [Soulat, Didier] Univ Klinikum Erlangen, Mikrobiol Inst Klin Mikrobiol Immunol & Hyg, D-91054 Erlangen, Germany; [Soulat, Didier] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Roth, Susanne; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany; [Blazek, Katrina; Udalova, Irina] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, London W6 8KH, England; [Sancho, David] Ctr Nacl Invest Cardiovasc Carlos III, Madrid 28029, Spain; [Ruland, Juergen] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Lab Signaling Immune Syst, D-85764 Neuherberg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Erlangen Nuremberg; University of Erlangen Nuremberg; Technical University of Munich; University of Oxford; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Ardavin, C (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, C Darwin 3, Madrid 28049, Spain.	ardavin@cnb.csic.es	Del Fresno, Carlos/ABD-7766-2020; Sancho, David/D-3433-2009; Ruland, Jürgen/Q-6680-2018; Del Fresno, Carlos/F-2624-2016; Del Fresno Sánchez, CArlos/AAY-1525-2021; Blazek, Katrina/AAU-6194-2020	Del Fresno, Carlos/0000-0003-1771-7254; Sancho, David/0000-0003-2890-3984; Ruland, Jürgen/0000-0002-8381-3597; Del Fresno, Carlos/0000-0003-1771-7254; Blazek, Katrina/0000-0002-4439-4756; Soulat, Didier/0000-0002-3688-5846; Udalova, Irina/0000-0002-6716-2528	Spanish Ministerio de Ciencia e Innovacion [SAF 2009-11592]; Ministerio de Sanidad [RD07/0064/0027]; Fundacion Genoma Espana; Medical Research Council [MR/J001899/1] Funding Source: researchfish; MRC [MR/J001899/1] Funding Source: UKRI	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); Fundacion Genoma Espana; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Gil for C. albicans SC5314 strain and experimental advice, P. Taylor for Dectin-2 mAbs and scientific advice, G. Brown for Clec7a<SUP>-/-</SUP> bone marrow and scientific advice, G. Trinchieri for scientific advice, M. Fresno for Tlr2<SUP>-/-</SUP> bone marrow, J. Pardo for Tlr9<SUP>-/-</SUP> bone marrow, T. Decker for Irf3<SUP>-/-</SUP> or Irf7-/- bone marrow, T. Mak for Irf5<SUP>-/-</SUP> bone marrow, U. Kalinke for Ifnar1<SUP>-/-</SUP> mice, and M. Minguito and L. Gonzalez for technical assistance. This work was supported by the Spanish Ministerio de Ciencia e Innovacion (Grant SAF 2009-11592), Ministerio de Sanidad (Grant RD07/0064/0027), and Fundacion Genoma Espana (MACIA project) to C.A.	Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Biondo C, 2008, J IMMUNOL, V181, P566, DOI 10.4049/jimmunol.181.1.566; Biondo C, 2011, EUR J IMMUNOL, V41, P1969, DOI 10.1002/eji.201141490; Bourgeois C, 2011, J IMMUNOL, V186, P3104, DOI 10.4049/jimmunol.1002599; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Dejima T, 2011, INFECT IMMUN, V79, P4503, DOI 10.1128/IAI.05799-11; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gratz N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001345; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Inglis DO, 2010, INFECT IMMUN, V78, P3871, DOI 10.1128/IAI.00204-10; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; MacCallum DM, 2009, FEMS YEAST RES, V9, P1111, DOI 10.1111/j.1567-1364.2009.00576.x; Majer O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002811; Mansour MK, 2002, CURR OPIN MICROBIOL, V5, P359, DOI 10.1016/S1369-5274(02)00342-9; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Purtha WE, 2012, P NATL ACAD SCI USA, V109, pE898, DOI 10.1073/pnas.1118155109; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200	31	125	126	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1176	1186		10.1016/j.immuni.2013.05.010	http://dx.doi.org/10.1016/j.immuni.2013.05.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23770228	Bronze			2022-12-18	WOS:000330947500013
J	Yu, SY; Zhou, XY; Steinke, FC; Liu, CY; Chen, SC; Zagorodna, O; Jing, XF; Yokota, Y; Meyerholz, DK; Mullighan, CG; Knudson, CM; Zhao, DM; Xue, HH				Yu, Shuyang; Zhou, Xinyuan; Steinke, Farrah C.; Liu, Chengyu; Chen, Shann-Ching; Zagorodna, Oksana; Jing, Xuefang; Yokota, Yoshifumi; Meyerholz, David K.; Mullighan, Charles G.; Knudson, C. Michael; Zhao, Dong-Mei; Xue, Hai-Hui			The TCF-1 and LEF-1 Transcription Factors Have Cooperative and Opposing Roles in T Cell Development and Malignancy	IMMUNITY			English	Article							MOLECULAR PATHOGENESIS; NOTCH1 MUTATIONS; EXPRESSION; LEUKEMIA; TRANSFORMATION; SPECIFICATION; MODELS	The TCF-1 and LEF-1 transcription factors are known to play critical roles in normal thymocyte development. Unexpectedly, we found that TCF-1-deficient (Tcf7(-/-)) mice developed aggressive T cell malignancy, resembling human T cell acute lymphoblastic leukemia (T-ALL). LEF-1 was aberrantly up-regulated in premalignant Tcf7(-/-) early thymocytes and lymphoma cells. We further demonstrated that TCF-1 directly repressed LEF-1 expression in early thymocytes and that conditional inactivation of Lef1 greatly delayed or prevented T cell malignancy in Tcf7(-/-) mice. In human T-ALLs, an early thymic progenitor (ETP) subtype was associated with diminished TCF7 expression, and two of the ETP-ALL cases harbored TCF7 gene deletions. We also showed that TCF-1 and LEF-1 were dispensable for T cell lineage commitment but instead were required for early thymocytes to mature beyond the CD4(-)CD8(-) stage. TCF-1 thus has dual roles, i.e., acting cooperatively with LEF-1 to promote thymocyte maturation while restraining LEF-1 expression to prevent malignant transformation of developing thymocytes.	[Yu, Shuyang; Zhou, Xinyuan; Steinke, Farrah C.; Jing, Xuefang; Zhao, Dong-Mei; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Zagorodna, Oksana; Meyerholz, David K.; Knudson, C. Michael] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Zhao, Dong-Mei] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Xue, Hai-Hui] Univ Iowa, Interdisciplinary Immunol Grad Program, Carver Coll Med, Iowa City, IA 52242 USA; [Liu, Chengyu] NHLBI, Transgen Core Facil, NIH, Bethesda, MD 20892 USA; [Chen, Shann-Ching; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Yokota, Yoshifumi] Univ Fukui, Sch Med, Dept Biochem & Bioinformat Sci, Div Mol Genet, Fukui 9101193, Japan	University of Iowa; University of Iowa; University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); St Jude Children's Research Hospital; University of Fukui	Zhao, DM (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	dong-mei-zhao@uiowa.edu; hai-hui-xue@uiowa.edu	Meyerholz, David/J-8131-2019; Zhou, Xinyuan/AFS-9817-2022; Mullighan, Charles/H-3253-2011	Meyerholz, David/0000-0003-1552-3253; Mullighan, Charles/0000-0002-1871-1850; Xue, Hai-Hui/0000-0002-9163-7669; Zhou, Xinyuan/0000-0002-1374-8240; Knudson, Charles Michael/0000-0003-3964-5466	American Cancer Society [RSG-11-161-01-MPC]; NIH [HL095540, AI080966]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080966] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Clevers for permission to use the Tcf7<SUP>-/-</SUP> mice, D.L. Court and N.G. Copland (NCI) for providing all the recombineering reagents, F. McCormick (UCSF) for WT and mutant beta-catenin constructs, W.S. Pear (UPenn) for the ICN and DN-MAML constructs, D.G. Tenen (Harvard) for the self-inactivating retroviral reporter construct, and J.C. Zuniga-Pflucker (Sunnybrook Research Institute, Canada) for the OP9-DL1 cells. We thank J. Harty and A. Dupuy for critical reading of the manuscript, G. Hauser and T. Bair (DNA Facility) for performing microarray analysis and assistance with the data analysis, H. Vignes and G. Rasmussen (Flow Cytometry Facility) for cell sorting, and S. Martin for cell cycle analysis. This study is supported by grants from the American Cancer Society (RSG-11-161-01-MPC to H.-H.X.) and the NIH (HL095540 and AI080966 to H.-H.X.).	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Allman D, 2001, J EXP MED, V194, P99, DOI 10.1084/jem.194.1.99; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Bhandoola A, 2006, NAT REV IMMUNOL, V6, P117, DOI 10.1038/nri1778; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Goux D, 2005, BLOOD, V106, P1726, DOI 10.1182/blood-2005-01-0337; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Guo ZY, 2007, BLOOD, V109, P5463, DOI 10.1182/blood-2006-11-059071; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Gutierrez A, 2010, BLOOD, V115, P2845, DOI 10.1182/blood-2009-07-234377; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/ng0501-53; Hoverter NP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.139pe43; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Lin YW, 2006, BLOOD, V107, P2540, DOI 10.1182/blood-2005-07-3013; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Morrow MA, 1999, MOL IMMUNOL, V36, P491, DOI 10.1016/S0161-5890(99)00071-1; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Petropoulos K, 2008, J EXP MED, V205, P515, DOI 10.1084/jem.20071875; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Schilham MW, 1998, J IMMUNOL, V161, P3984; Spaulding C, 2007, BLOOD, V110, P2650, DOI 10.1182/blood-2007-04-084202; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xue HH, 2012, ANN NY ACAD SCI, V1247, P16, DOI 10.1111/j.1749-6632.2011.06302.x; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Yashiro-Ohtani Y, 2010, SEMIN IMMUNOL, V22, P261, DOI 10.1016/j.smim.2010.04.015; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	44	125	129	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 16	2012	37	5					813	826		10.1016/j.immuni.2012.08.009	http://dx.doi.org/10.1016/j.immuni.2012.08.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23103132	Bronze, Green Accepted			2022-12-18	WOS:000311460000009
J	Keller, AM; Schildknecht, A; Xiao, YL; van den Broek, M; Borst, J				Keller, Anna M.; Schildknecht, Anita; Xiao, Yanling; van den Broek, Maries; Borst, Jannie			Expression of Costimulatory Ligand CD70 on Steady-State Dendritic Cells Breaks CD8(+) T Cell Tolerance and Permits Effective Immunity	IMMUNITY			English	Article							CUTTING EDGE; PERIPHERAL TOLERANCE; SELF-ANTIGENS; RESPONSES; ACTIVATION; CD27; STIMULATION; INDUCTION; FAMILY; GENERATION	Steady-state dendritic cells (DCs) maintain peripheral T cell tolerance, whereas mature DCs generate immunity. CD70 is a costimulatory ligand acquired upon DC maturation. To determine its impact on T cell fate, we have generated mice that constitutively express CD70 in conventional DCs (cDCs). In these mice, naive CD4(+) and CD8(+) T cells spontaneously convert into effector cells. Administration of peptide without adjuvant, which is ordinarily tolerogenic, elicited tumor-eradicating CD8(+) T cell responses and robust CD4(+) T cell-independent memory. CD70 was also constitutively expressed in cDCs that inducibly present viral epitopes. In this case, tolerance induction was prevented as well. The antigen-presenting DCs generated protective immunity to virus infection and broke a pre-existing state of CD8(+) T cell tolerance. Thus, the sole expression of CD70 by otherwise immature cDCs sufficed to convert CD8(+) T cell tolerance into immunity, defining the importance of CD27-CD70 interactions at the interface between T cell and DC.	[Keller, Anna M.; Xiao, Yanling; Borst, Jannie] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Schildknecht, Anita; van den Broek, Maries] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland	Netherlands Cancer Institute; University of Zurich	Borst, J (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	j.borst@nki.nl	van den Broek, Maries/L-6532-2019; van den Broek, Maries/G-4128-2016	van den Broek, Maries/0000-0002-9489-3692; Borst, Jannie/0000-0002-8043-5009; Xiao, Yanling/0000-0003-1755-1709	Dutch Cancer Society [NKI 2003-2859]; European Community [MUGEN LSHG-CT-2005-005203]; Swiss National Science Foundation	Dutch Cancer Society(KWF Kankerbestrijding); European Community(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank I. Verbrugge, G. van der Horst, A. Jorritsma, and S. Middendorp for help with various experiments; F. van Diepen, A. Pfauth, J. Blitz, R. Bin Ali, and the personnel of the experimental animal facility of The Netherlands Cancer Institute (NKI) for expert technical assistance; and S. Naik and T.N.M. Schumacher for critical comments on the manuscript. M. Nolte and R.A.W. van Lier are acknowledged for providing CD19-CD70tg mice. We also thank V. Escalante and A. Ruffieux (Institute of Laboratory Animal Science, Zurich) for animal care and H. Hengartner and R. Zinkernagel (Institute of Experimental Immunology, Zurich) for support to A.S. and M.v.d.B. This work was financially supported by the Dutch Cancer Society (grant NKI 2003-2859), the European Community (MUGEN LSHG-CT-2005-005203), and the Swiss National Science Foundation.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Arens R, 2005, J IMMUNOL, V174, P5915, DOI 10.4049/jimmunol.174.10.5915; Arens R, 2004, J IMMUNOL, V173, P3901, DOI 10.4049/jimmunol.173.6.3901; Arens R, 2004, J EXP MED, V199, P1595, DOI 10.1084/jem.20031111; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bloom MB, 1997, J EXP MED, V185, P453, DOI 10.1084/jem.185.3.453; Borst J, 2005, CURR OPIN IMMUNOL, V17, P275, DOI 10.1016/j.coi.2005.04.004; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Bullock TNJ, 2005, J IMMUNOL, V174, P710, DOI 10.4049/jimmunol.174.2.710; de Witte MA, 2006, BLOOD, V108, P870, DOI 10.1182/blood-2005-08-009357; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Garcia P, 2004, J LEUKOCYTE BIOL, V76, P263, DOI 10.1189/jlb.1003508; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Keller AM, 2007, P NATL ACAD SCI USA, V104, P5989, DOI 10.1073/pnas.0700946104; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lee WW, 2007, J IMMUNOL, V179, P2609, DOI 10.4049/jimmunol.179.4.2609; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Naik S, 2003, BLOOD, V102, P601, DOI 10.1182/blood-2002-10-3186; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rowley TF, 2004, J IMMUNOL, V172, P6039, DOI 10.4049/jimmunol.172.10.6039; Sanchez PJ, 2007, J IMMUNOL, V178, P1564, DOI 10.4049/jimmunol.178.3.1564; Sawalha AH, 2007, EUR J IMMUNOL, V37, P1407, DOI 10.1002/eji.200636872; Schildknecht A, 2007, EUR J IMMUNOL, V37, P716, DOI 10.1002/eji.200636824; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Taraban VY, 2004, J IMMUNOL, V173, P6542, DOI 10.4049/jimmunol.173.11.6542; Tesselaar K, 1997, J IMMUNOL, V159, P4959; Tesselaar K, 2003, NAT IMMUNOL, V4, P49, DOI 10.1038/ni869; Tesselaar K, 2003, J IMMUNOL, V170, P33, DOI 10.4049/jimmunol.170.1.33; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Yamada A, 2005, J IMMUNOL, V174, P1357, DOI 10.4049/jimmunol.174.3.1357	50	125	130	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					934	946		10.1016/j.immuni.2008.10.009	http://dx.doi.org/10.1016/j.immuni.2008.10.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19062317	Bronze			2022-12-18	WOS:000262012400013
J	McNeill, L; Salmond, RJ; Cooper, JC; Carret, CK; Cassady-Cain, RL; Roche-Molina, M; Tandon, P; Holmes, N; Alexander, DR				McNeill, Louise; Salmond, Robert J.; Cooper, Joanne C.; Carret, Celine K.; Cassady-Cain, Robin L.; Roche-Molina, Marta; Tandon, Panna; Holmes, Nick; Alexander, Denis R.			The differential regulation of lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses	IMMUNITY			English	Article							TYROSINE PROTEIN-KINASE; B-CELL; MUTATIONAL ANALYSIS; NEGATIVE SELECTION; PHOSPHATASE; DOMAIN; ACTIVATION; ISOFORMS; P56(LCK); CD8	The molecular mechanisms whereby the CD45 tyrosine phosphatase (PTPase) regulates T cell receptor (TCR) signaling responses remain to be elucidated. To investigate this question, we have reconstituted CD45 (encoded by Ptprc)-deficient mice, which display severe defects in thymic development, with five different expression levels of transgenic CD45R0, or with mutant PTPase null or PTPase-low CD45R0. Whereas CD45 PTPase activity was absolutely required for the reconstitution of thymic development, only 3% of wild-type CD45 activity restored T cell numbers and normal cytotoxic T cell responses. Lowering the CD45 expression increased CD4 lineage commitment. Peripheral T cells with very low activity of CD45 phosphatase displayed reduced TCR signaling, whereas intermediate activity caused hyperactivation of CD4(+) and CD8(+)T cells. These results are explained by a rheostat mechanism whereby CD45 differentially regulates the negatively acting pTyr-505 and positively acting pTyr-394 p56(Ick)tyrosine kinase phosphorylation sites. We propose that high wild-type CD45 expression is necessary to dephosphorylate p56(Ick) pTyr-394, suppressing CD4 T+ cell lineage commitment and hyperactivity.	Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1PQ, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Alexander, DR (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England.	denis.alexander@bbsrc.ac.uk	Roche-Molina, Marta/G-2731-2016	Roche-Molina, Marta/0000-0002-9487-6980; O'Brien, Louise McNeill/0000-0002-8121-5374				Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Alexander DR, 2005, HANDB EXP PHARM, V167, P263; BEVERLEY PCL, 1992, BIOCHEM SOC T, V20, P184, DOI 10.1042/bst0200184; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CAMPBELL KS, 1995, EUR J IMMUNOL, V25, P2408, DOI 10.1002/eji.1830250842; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chiang GG, 2001, J BIOL CHEM, V276, P23173, DOI 10.1074/jbc.M101219200; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; D'Oro U, 1999, J IMMUNOL, V162, P1879; Denny MF, 1999, J BIOL CHEM, V274, P5146, DOI 10.1074/jbc.274.8.5146; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Doro U, 1996, MOL CELL BIOL, V16, P4996; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Grossman Z, 1996, P NATL ACAD SCI USA, V93, P14747, DOI 10.1073/pnas.93.25.14747; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HOLDORF AD, 2002, NAT IMMUNOL, V4, P4; Holmes N, 2006, IMMUNOLOGY, V117, P145, DOI 10.1111/j.1365-2567.2005.02265.x; Huntington ND, 2006, NAT IMMUNOL, V7, P190, DOI 10.1038/ni1292; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; JOHNSON P, 1992, J BIOL CHEM, V267, P8035; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Leitenberg D, 1996, J EXP MED, V183, P249, DOI 10.1084/jem.183.1.249; Lin K, 1997, INT IMMUNOL, V9, P291, DOI 10.1093/intimm/9.2.291; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; MAROUN CR, 1994, EUR J IMMUNOL, V24, P959, DOI 10.1002/eji.1830240427; McNeill L, 2004, IMMUNOL LETT, V92, P125, DOI 10.1016/j.imlet.2003.10.018; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; Ogilvy S, 2003, J IMMUNOL, V171, P1792, DOI 10.4049/jimmunol.171.4.1792; Ogilvy S, 1999, BLOOD, V94, P1855; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; RAVICHANDRAN KS, 1994, J EXP MED, V179, P727, DOI 10.1084/jem.179.2.727; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Sharp LL, 1999, J IMMUNOL, V163, P6598; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sohn SJ, 2001, J IMMUNOL, V166, P2209, DOI 10.4049/jimmunol.166.4.2209; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stone JD, 1997, J IMMUNOL, V158, P5773; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; VEILLETTE A, 1992, ONCOGENE, V7, P971; Wallace VA, 1997, J IMMUNOL, V158, P3205; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhao R, 2004, CANCER CELL, V5, P37, DOI 10.1016/S1535-6108(03)00333-7	52	125	136	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					425	437		10.1016/j.immuni.2007.07.015	http://dx.doi.org/10.1016/j.immuni.2007.07.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17719247	Green Published, Bronze			2022-12-18	WOS:000249843400010
J	Nandi, A; Estess, P; Siegelman, M				Nandi, A; Estess, P; Siegelman, M			Bimolecular complex between rolling and firm adhesion receptors required for cell arrest: CD44 association with VLA-4 in T cell extravasation	IMMUNITY			English	Article							ENDOTHELIAL HYALURONAN EXPRESSION; CYTOPLASMIC DOMAIN; IN-VIVO; L-SELECTIN; PERIPHERAL-BLOOD; BINDING; INTEGRIN; PATHWAY; PHOSPHORYLATION; LYMPHOCYTES	CD44 on activated T cells can initiate contact and mediate rolling on hyaluronan on endothelial cells. We have shown that the integrin VLA-4 is used preferentially over LFA-1 in conjunction with this rolling interaction for firm adhesion. Here, we show by coimmunoprecipitation and transfection studies that CD44 associates with VLA-4 but not LFA-1 on the plasma membrane of immune cells. Absence of the cytoplasmic portion of CD44 abrogates this coassociation and attendant firm adhesion. Moreover, in an in vivo model of lymphocyte homing, cells expressing only the truncated form of CD44 together with VLA-4 fail to traffic to an inflamed site, thereby defining a discrete biological role for the cytoplasmic domain. These studies demonstrate a molecular mechanism whereby coanchoring within a single bimolecular complex between a primary and secondary adhesion molecule regulates a cell's ability to firmly adhere, providing a fundamental alteration to the paradigm of leukocyte extravasation.	Univ Texas, SW Med Ctr, Dept Pathol, Lab Mol Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Siegelman, M (corresponding author), Univ Texas, SW Med Ctr, Dept Pathol, Lab Mol Pathol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	siegelman@pathology.swmed.edu			NHLBI NIH HHS [R01 HL56746] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056746] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; BARON JL, 1994, J CLIN INVEST, V93, P1700, DOI 10.1172/JCI117153; Barone C M, 1993, J Craniofac Surg, V4, P177, DOI 10.1097/00001665-199307000-00013; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Catalina MD, 1999, BLOOD, V93, P580, DOI 10.1182/blood.V93.2.580.402k16_580_589; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Dianzani U, 1999, INT IMMUNOL, V11, P1085, DOI 10.1093/intimm/11.7.1085; Estess P, 1999, J EXP MED, V190, P9, DOI 10.1084/jem.190.1.9; Estess P, 1998, J CLIN INVEST, V102, P1173, DOI 10.1172/JCI4235; Forlow SB, 2000, J CLIN INVEST, V106, P1457, DOI 10.1172/JCI10555; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; Ilangumaran S, 1998, BLOOD, V91, P3901; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Kadono T, 2002, J IMMUNOL, V169, P4542, DOI 10.4049/jimmunol.169.8.4542; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; LABETA MO, 1988, J IMMUNOL METHODS, V112, P133, DOI 10.1016/0022-1759(88)90043-9; LAFFON A, 1991, J CLIN INVEST, V88, P546, DOI 10.1172/JCI115338; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; Liu D, 1996, J EXP MED, V183, P1987, DOI 10.1084/jem.183.5.1987; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; MIKECZ K, 1995, NAT MED, V1, P558, DOI 10.1038/nm0695-558; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; NEAME SJ, 1992, EMBO J, V11, P4733, DOI 10.1002/j.1460-2075.1992.tb05578.x; PERSCHL A, 1995, EUR J IMMUNOL, V25, P495, DOI 10.1002/eji.1830250228; Protin U, 1999, J IMMUNOL, V163, P4917; PURE E, 1995, J EXP MED, V181, P55, DOI 10.1084/jem.181.1.55; Schmitz H, 1997, PHILOS RUNDSCH, V44, P90; Siegelman MH, 2000, J CLIN INVEST, V105, P683, DOI 10.1172/JCI8692; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; UFF CR, 1995, EUR J IMMUNOL, V25, P1883, DOI 10.1002/eji.1830250714; VANDINTHERJANSSEN ACHM, 1991, J IMMUNOL, V147, P4207; VISWESWARIAH SS, 1994, EUR J BIOCHEM, V219, P727, DOI 10.1111/j.1432-1033.1994.tb18551.x; Weiss L, 2000, P NATL ACAD SCI USA, V97, P285, DOI 10.1073/pnas.97.1.285; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	47	125	132	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					455	465		10.1016/S1074-7613(04)00077-9	http://dx.doi.org/10.1016/S1074-7613(04)00077-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084274	Bronze			2022-12-18	WOS:000221442800011
J	Elser, B; Lohoff, M; Kock, S; Giaisi, M; Kirchhoff, S; Krammer, PH; Li-Weber, M				Elser, B; Lohoff, M; Kock, S; Giaisi, M; Kirchhoff, S; Krammer, PH; Li-Weber, M			IFN-gamma represses IL-4 expression via IRF-1 and IRF-2	IMMUNITY			English	Article							INTERFERON REGULATORY FACTORS; HUMAN T-CELLS; TRANSCRIPTION FACTOR; TH2 CELLS; CYTOKINE RESPONSES; GENE-EXPRESSION; DEFICIENT MICE; NATURAL-KILLER; FACTOR-I; C-MAF	Polarization of CD4(+) T helper cells toward either a Th1 or Th2 response can significantly influence host immunity to pathogens. IL-4 and IFN-gamma are the signature cytokines of Th2 and Th1 cells, respectively. IFN-gamma was shown to assist Th1 development by promoting IL-12 and IL-12 receptor expression. So far, direct influence of Th2 cytokine expression by IFN-gamma has not been described. We show here that IFN-gamma directly suppresses IL-4 gene expression. IRF-1 and IRF-2 induced by IFN-gamma bind to three distinct IL-4 promoter sites and function as transcriptional repressors. Our data demonstrate a direct negative feedback of IFN-gamma on expression of the Th2 cytokine gene IL-4 and, thus, provide evidence for another important mechanism by which IFNgamma assists Th1 and attenuates Th2 responses.	German Canc Res Ctr, Tumorimmunol Program, D-69120 Heidelberg, Germany; Univ Marburg, Inst Med Microbiol, D-35037 Marburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Philipps University Marburg	Li-Weber, M (corresponding author), German Canc Res Ctr, Tumorimmunol Program, D-69120 Heidelberg, Germany.	m.li-weber@dkfz-heidelberg.de						Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ARTHUR RP, 1986, J EXP MED, V163, P774, DOI 10.1084/jem.163.4.774; Bluyssen Hans A. R., 1996, Cytokine and Growth Factor Reviews, V7, P11, DOI 10.1016/1359-6101(96)00005-6; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; KIRCHHOFF S, 1993, NUCLEIC ACIDS RES, V21, P2881, DOI 10.1093/nar/21.12.2881; Kirchhoff S, 2000, EUR J BIOCHEM, V267, P6753, DOI 10.1046/j.1432-1327.2000.01750.x; KLAS C, 1993, INT IMMUNOL, V5, P625, DOI 10.1093/intimm/5.6.625; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Li-Weber M, 1998, J BIOL CHEM, V273, P32460, DOI 10.1074/jbc.273.49.32460; LIWEBER M, 1994, J IMMUNOL, V153, P4122; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MIN LW, 1992, J IMMUNOL, V148, P1913; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nelson N, 1996, J IMMUNOL, V156, P3711; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; SHARF R, 1995, J BIOL CHEM, V270, P13063, DOI 10.1074/jbc.270.22.13063; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Tanaka N, 2000, SEMIN CANCER BIOL, V10, P73, DOI 10.1006/scbi.2000.0310; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; VAUGHAN PS, 1995, NATURE, V377, P362, DOI 10.1038/377362a0; Vaughan PS, 1998, J BIOL CHEM, V273, P194, DOI 10.1074/jbc.273.1.194; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	53	125	128	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2002	17	6					703	712		10.1016/S1074-7613(02)00471-5	http://dx.doi.org/10.1016/S1074-7613(02)00471-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479817	Bronze			2022-12-18	WOS:000179985500003
J	Takeshita, T; Arita, T; Higuchi, M; Asao, H; Endo, K; Kuroda, H; Tanaka, N; Murata, K; Ishii, N; Sugamura, K				Takeshita, T; Arita, T; Higuchi, M; Asao, H; Endo, K; Kuroda, H; Tanaka, N; Murata, K; Ishii, N; Sugamura, K			STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction	IMMUNITY			English	Article							RECEPTOR-GAMMA-CHAIN; PROTEIN-TYROSINE KINASE; IL-2 RECEPTOR; INTERLEUKIN-2 RECEPTOR; CYTOKINE RECEPTORS; BETA-CHAIN; FUNCTIONAL COMPONENT; ACTIVATION; PHOSPHORYLATION; IDENTIFICATION	We previously identified a putative signal transducing adaptor molecule, named STAM, that contains an Src homology 3 (SH3) domain and immunoreceptor tyrosine-based activation motif (ITAM). In this report, we demonstrate the functional significance of STAM in cytokine-mediated signal transduction. STAM is associated with Jak3 and Jak2 tyrosine kinases via its ITAM region and phosphorylated by Jak3 and Jak2 upon stimulation with IL-2 and GM-CSF, respectively. An SH3 deletion mutant of STAM confers a dominant-negative effect on DNA synthesis mediated by IL-2 and GM-CSF. Furthermore, the wild-type STAM, but not STAM mutants deleted of SH3 and ITAM, significantly enhances c-myc induction mediated by IL-2 and GM-CSF. These results strongly implicate STAM in the signaling pathways for cell growth and c-myc induction immediately downstream of the Jaks associated with the cytokine receptors.			Takeshita, T (corresponding author), TOHOKU UNIV, SCH MED, DEPT MICROBIOL, AOBA KU, 2-1 SEIRYO MACHI, SENDAI, MIYAGI 98077, JAPAN.			Ishii, Naoto/0000-0002-0549-8245				ASAO H, 1994, FEBS LETT, V351, P201, DOI 10.1016/0014-5793(94)00831-0; ASAO H, 1993, P NATL ACAD SCI USA, V90, P4127, DOI 10.1073/pnas.90.9.4127; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; Higuchi M, 1996, EUR J IMMUNOL, V26, P1322, DOI 10.1002/eji.1830260622; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; ISHIDA S, 1994, CELL GROWTH DIFFER, V5, P287; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; KAWAHARA A, 1995, P NATL ACAD SCI USA, V92, P8724, DOI 10.1073/pnas.92.19.8724; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; KIRKEN RA, 1994, J BIOL CHEM, V269, P19136; KOBAYASHI N, 1993, P NATL ACAD SCI USA, V90, P4201, DOI 10.1073/pnas.90.9.4201; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; MINAMI Y, 1995, IMMUNITY, V2, P89, DOI 10.1016/1074-7613(95)90081-0; MINAMI Y, 1993, EMBO J, V12, P759, DOI 10.1002/j.1460-2075.1993.tb05710.x; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; NEMOTO T, 1995, EUR J IMMUNOL, V25, P3001, DOI 10.1002/eji.1830251102; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; SPENCER CA, 1991, ADV CANCER RES, V56, P1; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; SUGAMURA K, 1995, ADV IMMUNOL, V59, P225, DOI 10.1016/S0065-2776(08)60632-X; TAKESHITA T, 1992, J IMMUNOL, V148, P2154; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; TANAKA N, 1994, P NATL ACAD SCI USA, V91, P7271, DOI 10.1073/pnas.91.15.7271; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; TORIGOE T, 1992, P NATL ACAD SCI USA, V89, P2674, DOI 10.1073/pnas.89.7.2674; VIGANLS ML, 1996, MOL CELL BIOL, V16, P1759; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; Watanabe S, 1996, J BIOL CHEM, V271, P12681, DOI 10.1074/jbc.271.21.12681; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0	48	125	130	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1997	6	4					449	457		10.1016/S1074-7613(00)80288-5	http://dx.doi.org/10.1016/S1074-7613(00)80288-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133424	Bronze			2022-12-18	WOS:A1997XC61900010
J	Castro, JE; Listman, JA; Jacobson, BA; Wang, YS; Lopez, PA; Ju, ST; Finn, PW; Perkins, DL				Castro, JE; Listman, JA; Jacobson, BA; Wang, YS; Lopez, PA; Ju, ST; Finn, PW; Perkins, DL			Fas modulation of apoptosis during negative selection of thymocytes	IMMUNITY			English	Article							MRL-LPR/LPR MICE; IMMATURE CD4+8+ THYMOCYTES; PROGRAMMED CELL-DEATH; TUMOR-NECROSIS-FACTOR; MATURE T-CELLS; LPR MICE; CD4(+)CD8(+) THYMOCYTES; MONOCLONAL-ANTIBODIES; CD4+CD8+ THYMOCYTES; POSITIVE SELECTION	A major mechanism maintaining immune tolerance is the deletion of potentially autoreactive thymocytes by apoptosis during development in the thymus, Previous reports suggest that apoptosis is induced by high avidity signals transduced via the T cell receptor; however, the role of signals transduced by other cell surface receptors during thymic selection remains poorly understood. Fas, a member of the TNF receptor family, has been shown to induce apoptosis in mature peripheral T cells; however, the effects of Fas on negative selection of thymocytes have not been previously detected. Using a sensitive terminal deoxynucleotidyl transferase method to detect apoptotic cells, we found that mutant Pas molecules in lpr mice decrease the sensitivity of thymocytes to T cell receptor-mediated apoptosis and that blockade of Fas-Fas ligand interactions in vivo can inhibit antigen-induced apoptosis of thymocytes in non-lpr mice. Thus, we have shown that Fas, in conjunction with antigen-specific signals, can modulate apoptosis during negative selection of thymocytes.	HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DIV PULM,BOSTON,MA 02115; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,LAB IMMUNOGENET & TRANSPLANTAT,RENAL DIV,BOSTON,MA 02115; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV RENAL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; BOSTON UNIV,MED CTR,DEPT MICROBIOL,BOSTON,MA 02118; BOSTON UNIV,MED CTR,DEPT MED,CTR ARTHRITIS,BOSTON,MA 02118; DANA FARBER CANC INST,CORE FLOW CYTOMETRY FACIL,BOSTON,MA 02115	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Boston University; Harvard University; Dana-Farber Cancer Institute	Castro, JE (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DIV PULM,BOSTON,MA 02115, USA.		Lopez, Peter/AAP-7234-2020	Lopez, Peter/0000-0002-8587-7148; Castro, M.D., Januario E./0000-0003-2785-0892	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033100] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33100] Funding Source: Medline; NIEHS NIH HHS [ES01065] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; ANDJELIC S, 1994, INT IMMUNOL, V6, P73, DOI 10.1093/intimm/6.1.73; ARASE H, 1994, J EXP MED, V180, P423, DOI 10.1084/jem.180.2.423; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; DRAPPA J, 1993, P NATL ACAD SCI USA, V90, P10340, DOI 10.1073/pnas.90.21.10340; FINE JS, 1991, J IMMUNOL, V147, P2852; Fisher GH, 1996, CELL IMMUNOL, V169, P99, DOI 10.1006/cimm.1996.0096; FOY TM, 1995, J EXP MED, V182, P1377, DOI 10.1084/jem.182.5.1377; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIESE T, 1992, J IMMUNOL, V149, P3097; GORCZYCA W, 1992, INT J ONCOL, V1, P639; HELLSTROM I, 1986, CANCER RES, V46, P3917; HERRON LR, 1993, J IMMUNOL, V151, P3450; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Killeen N, 1996, CURR TOP MICROBIOL, V205, P89; KISHIMOTO H, 1995, J EXP MED, V181, P649, DOI 10.1084/jem.181.2.649; KOTZIN BL, 1988, J EXP MED, V168, P2221, DOI 10.1084/jem.168.6.2221; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Liblau RS, 1996, P NATL ACAD SCI USA, V93, P3031, DOI 10.1073/pnas.93.7.3031; MANANI S, 1994, EUR J IMMUNOL, V24, P3119; MATSUMOTO K, 1991, J EXP MED, V173, P127, DOI 10.1084/jem.173.1.127; Mountz J D, 1994, Semin Immunol, V6, P27, DOI 10.1006/smim.1994.1005; MOUNTZ JD, 1990, J IMMUNOL, V144, P2159; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; MUSETTE P, 1994, EUR J IMMUNOL, V24, P2761, DOI 10.1002/eji.1830241128; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NISHIMURA Y, 1995, J IMMUNOL, V154, P4395; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; OGASAWARA J, 1993, NATURE, V365, P568, DOI 10.1038/365568a0; PAGE DM, 1993, J IMMUNOL, V151, P1868; Perkins DL, 1996, J IMMUNOL, V156, P4961; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; SHI YF, 1991, J IMMUNOL, V146, P3340; SIDMAN CL, 1992, EUR J IMMUNOL, V22, P499, DOI 10.1002/eji.1830220231; SINGER GG, 1994, CURR OPIN IMMUNOL, V6, P913, DOI 10.1016/0952-7915(94)90013-2; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SINGER PA, 1989, J EXP MED, V170, P1869, DOI 10.1084/jem.170.6.1869; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; SWAT W, 1991, J IMMUNOL METHODS, V137, P79, DOI 10.1016/0022-1759(91)90396-W; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; TSAI CY, 1995, SCAND J IMMUNOL, V41, P157, DOI 10.1111/j.1365-3083.1995.tb03548.x; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YONEHARA S, 1994, INT IMMUNOL, V6, P1849, DOI 10.1093/intimm/6.12.1849; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; ZHOU T, 1993, J IMMUNOL, V150, P3651	57	125	130	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1996	5	6					617	627		10.1016/S1074-7613(00)80275-7	http://dx.doi.org/10.1016/S1074-7613(00)80275-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986720	hybrid			2022-12-18	WOS:A1996WA65100011
J	AurrandLions, M; Galland, F; Bazin, H; Zakharyev, VM; Imhof, BA; Naquet, P				AurrandLions, M; Galland, F; Bazin, H; Zakharyev, VM; Imhof, BA; Naquet, P			Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing	IMMUNITY			English	Article							HIGH-ENDOTHELIAL VENULES; CELL-ADHESION MOLECULE; T-CELLS; MONOCLONAL-ANTIBODIES; EPITHELIAL-CELLS; L-SELECTIN; DISTINCT ROLES; MOUSE THYMUS; LYMPH-NODES; INTEGRINS	Migration of hematopoietic precursor cells to the thymus is shown to depend upon a novel molecule called Vanin-1 expressed by perivascular thymic stromal cells. An anti-Vanin-1 antibody blocks the binding of pro-T cells to thymic sections in vitro, the in vivo accumulation of bone marrow cells around cortical thymic vessels, and long-term thymic regeneration. Thus, it interferes with the entry, and not the differentiation, of hematopoietic precursor cells. The Vanin-1 gene codes for a GPI-anchored 70 kDa protein that shows homology only with human biotinidase. Transfection of thymic stromal cells with the Vanin-1 cDNA enhances thymocyte adhesion in vitro. These data suggest that vanin-1 regulates late adhesion steps of thymus homing under physiological, noninflammatory conditions.	CNRS,INSERM,CTR IMMUNOL,F-13288 MARSEILLE 9,FRANCE; RUSSIAN ACAD SCI,VA ENGELHARDT MOL BIOL INST,MOSCOW,RUSSIA; BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS			Aurrand-Lions, Michel/O-9953-2016	Aurrand-Lions, Michel/0000-0002-8361-3034				AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; BARTHALAY Y, 1990, EMBO J, V9, P3603, DOI 10.1002/j.1460-2075.1990.tb07571.x; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CHANG JCC, 1990, J IMMUNOL, V145, P409; COLE H, 1994, J BIOL CHEM, V269, P6566; COLTEY M, 1987, CELL DIFFER DEV, V22, P71, DOI 10.1016/0045-6039(87)90414-3; DARGEMONT C, 1989, SCIENCE, V246, P803, DOI 10.1126/science.2683083; DELISSER HM, 1994, IMMUNOL TODAY, V15, P490, DOI 10.1016/0167-5699(94)90195-3; DUNON D, 1993, BLOOD, V81, P1; Dunon D, 1993, Curr Top Microbiol Immunol, V184, P139; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GEOFFROY JS, 1989, J CELL BIOL, V109, P2463, DOI 10.1083/jcb.109.5.2463; GOELZ SE, 1990, CELL, V63, P1349, DOI 10.1016/0092-8674(90)90430-M; GOLSTEIN P, 1982, IMMUNOL REV, V68, P5, DOI 10.1111/j.1600-065X.1982.tb01058.x; HE HT, 1991, J EXP MED, V173, P515, DOI 10.1084/jem.173.2.515; HE HT, 1987, J CELL BIOL, V105, P2489, DOI 10.1083/jcb.105.6.2489; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; IMHOF BA, 1991, J CELL BIOL, V114, P1069, DOI 10.1083/jcb.114.5.1069; ISHIHARA A, 1987, P NATL ACAD SCI USA, V84, P1290, DOI 10.1073/pnas.84.5.1290; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; KAMPINGA J, 1990, J IMMUNOL, V145, P1659; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEPAULT F, 1981, NATURE, V293, P151, DOI 10.1038/293151a0; LEPESANT H, 1990, INT IMMUNOL, V2, P1021, DOI 10.1093/intimm/2.11.1021; LEPESANT H, 1995, CELL IMMUNOL, V161, P279, DOI 10.1006/cimm.1995.1037; LOW MG, 1985, NATURE, V318, P62, DOI 10.1038/318062a0; LOWE JB, 1990, CELL, V63, P475, DOI 10.1016/0092-8674(90)90444-J; MALAVASI F, 1994, IMMUNOL TODAY, V15, P95, DOI 10.1016/0167-5699(94)90148-1; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; NAQUET P, 1989, THYMUS, V13, P217; ONEILL HC, 1987, CELL IMMUNOL, V109, P222, DOI 10.1016/0008-8749(87)90306-6; PELKONEN J, 1987, J EXP MED, V166, P1245, DOI 10.1084/jem.166.5.1245; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; PIALI L, 1993, EUR J IMMUNOL, V23, P2464, DOI 10.1002/eji.1830231013; PICKER LJ, 1991, NATURE, V349, P796, DOI 10.1038/349796a0; PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561; PONT S, 1985, EUR J IMMUNOL, V15, P1222, DOI 10.1002/eji.1830151215; POWELL SK, 1991, NATURE, V353, P76, DOI 10.1038/353076a0; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; RUIZ P, 1995, EUR J IMMUNOL, V25, P2034, DOI 10.1002/eji.1830250735; SCOLLAY R, 1986, IMMUNOL REV, V91, P129, DOI 10.1111/j.1600-065X.1986.tb01487.x; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; TAKADA A, 1968, J EXP MED, V150, P445; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; TROWBRIDGE IS, 1982, IMMUNOGENETICS, V15, P299, DOI 10.1007/BF00364338; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; VANEWIJK W, 1991, ANNU REV IMMUNOL, V9, P591, DOI 10.1146/annurev.iy.09.040191.003111; VANVLIET E, 1984, CELL IMMUNOL, V87, P101, DOI 10.1016/0008-8749(84)90134-5; VIVIER I, 1991, J IMMUNOL, V147, P447; VOLLGER LW, 1987, J IMMUNOL, V138, P358; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WOLF B, 1990, METHOD ENZYMOL, V184, P103; WU L, 1993, IMMUNOL LETT, V38, P69, DOI 10.1016/0165-2478(93)90121-H; YEDNOCK TA, 1987, J CELL BIOL, V104, P725, DOI 10.1083/jcb.104.3.725	65	125	132	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1996	5	5					391	405		10.1016/S1074-7613(00)80496-3	http://dx.doi.org/10.1016/S1074-7613(00)80496-3			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VV658	8934567	Bronze			2022-12-18	WOS:A1996VV65800001
J	Sidorenko, SP; Law, CL; Klaus, SJ; Chandran, KA; Takata, M; Kurosaki, T; Clark, EA				Sidorenko, SP; Law, CL; Klaus, SJ; Chandran, KA; Takata, M; Kurosaki, T; Clark, EA			Protein kinase C mu (PKC mu) associates with the B cell antigen receptor complex and regulates lymphocyte signaling	IMMUNITY			English	Article							SURFACE-IMMUNOGLOBULIN-M; PLECKSTRIN HOMOLOGY DOMAINS; TYROSINE KINASE; MEMBRANE IMMUNOGLOBULIN; MOLECULAR-CLONING; PHOSPHOLIPASE-C; PHORBOL ESTER; SH2 DOMAINS; ACTIVATION; PHOSPHORYLATION	We have identified a Ser/Thr kinase associated with the B cell receptor (BCR) complex as protein kinase C mu (PKC mu). PKC mu activity is up-regulated after crosslinking the BCR and CD19 on B cells, and PKC mu coprecipitates with Syk and phospholipase C-gamma 1/2 (PLC gamma 1/2). In vitro phosphorylation of fusion proteins showed that both Syk and PLC gamma 1 are potential substrates of PKC mu in vivo. Analysis of mutants of the chicken B cell line DT40 deficient in either Syk, Lyn, Btk, or PLC gamma 2 revealed that BCR-induced activation of PKC mu, like activation of PLC gamma 2, requires Syk and is partially regulated by Btk, but is Lyn independent. PKC mu can down-regulate the ability of Syk to phosphorylate PLC gamma 1 in vitro. Thus, PKC mu may function in a negative feedback loop regulating BCR-initiated signaling cascades.	UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MICROBIOL,SEATTLE,WA 98195; KANSAI MED UNIV,INST HEPAT RES,DEPT MOL GENET,MORIGUCHI,OSAKA 570,JAPAN; OKAYAMA UNIV,SCH MED,DEPT MED 2,OKAYAMA 700,JAPAN	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kansai Medical University; Okayama University			Kurosaki, Tomohiro/D-1306-2009; Clark, Edward/K-3462-2012	Kurosaki, Tomohiro/0000-0002-6352-304X; Clark, Edward A/0000-0001-8061-5475; Takata, Minoru/0000-0002-4926-3675; Sidorenko, Svetlana/0000-0001-8281-8006	NIGMS NIH HHS [GM37905, GM42508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037905, P01GM042508] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOLEN JB, 1995, CURR OPIN IMMUNOL, V7, P306, DOI 10.1016/0952-7915(95)80103-0; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; CARTER RH, 1991, P NATL ACAD SCI USA, V88, P2745, DOI 10.1073/pnas.88.7.2745; CARTER RH, 1991, J IMMUNOL, V147, P3663; CHEN CLH, 1982, J IMMUNOL, V129, P2580; DEFRANCO AL, 1995, CURR OPIN CELL BIOL, V7, P163, DOI 10.1016/0955-0674(95)80024-7; Dieterich S, 1996, FEBS LETT, V381, P183, DOI 10.1016/0014-5793(96)00116-0; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; GILLILAND LK, 1992, J BIOL CHEM, V267, P13610; GOLD MR, 1992, BIOCHEM J, V287, P269, DOI 10.1042/bj2870269; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HUANG PS, 1995, FEBS LETT, V358, P287, DOI 10.1016/0014-5793(94)01453-8; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; JOHANNES FJ, 1995, EUR J BIOCHEM, V227, P303, DOI 10.1111/j.1432-1033.1995.tb20389.x; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; JUSTEMENT LB, 1994, IMMUNOL TODAY, V15, P399, DOI 10.1016/0167-5699(94)90268-2; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; LAW CL, 1993, J IMMUNOL, V151, P175; Law CL, 1996, MOL CELL BIOL, V16, P1305; LAW CL, 1994, J BIOL CHEM, V269, P12310; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; LEPRINCE C, 1992, EUR J IMMUNOL, V22, P2093, DOI 10.1002/eji.1830220820; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; NEUBERGER MS, 1993, IMMUNOL REV, V132, P147, DOI 10.1111/j.1600-065X.1993.tb00841.x; PARK DJ, 1992, J BIOL CHEM, V267, P1496; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PLEIMAN CM, 1994, IMMUNOL TODAY, V15, P393, DOI 10.1016/0167-5699(94)90267-4; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; RETH M, 1994, CURR OPIN IMMUNOL, V6, P3, DOI 10.1016/0952-7915(94)90026-4; RIJKERS GT, 1990, P NATL ACAD SCI USA, V87, P8766, DOI 10.1073/pnas.87.22.8766; ROWLEY RB, 1995, J BIOL CHEM, V270, P12659, DOI 10.1074/jbc.270.21.12659; SEEDORF K, 1995, J BIOL CHEM, V270, P18953, DOI 10.1074/jbc.270.32.18953; SIDORENKO SP, 1995, P NATL ACAD SCI USA, V92, P359, DOI 10.1073/pnas.92.2.359; SILLMAN AL, 1995, J BIOL CHEM, V270, P11806, DOI 10.1074/jbc.270.20.11806; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; VANNOESEL CJM, 1991, J IMMUNOL, V146, P3881; VANNOESEL CJM, 1990, EUR J IMMUNOL, V20, P2789, DOI 10.1002/eji.1830201238; VANNOESEL CJM, 1992, J EXP MED, V175, P1511, DOI 10.1084/jem.175.6.1511; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; YAGI S, 1994, BIOCHEM BIOPH RES CO, V200, P28, DOI 10.1006/bbrc.1994.1409; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175	53	125	127	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1996	5	4					353	363		10.1016/S1074-7613(00)80261-7	http://dx.doi.org/10.1016/S1074-7613(00)80261-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VP444	8885868	Bronze			2022-12-18	WOS:A1996VP44400007
J	PeaceBrewer, AL; Tussey, LG; Matsui, M; Li, GX; Quinn, DG; Frelinger, JA				PeaceBrewer, AL; Tussey, LG; Matsui, M; Li, GX; Quinn, DG; Frelinger, JA			A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; HLA-B ANTIGENS; ENDOPLASMIC-RETICULUM; VIRAL-ANTIGEN; LYMPHOCYTES-T; INTACT-CELLS; MHC; TRANSPORTERS; PROTEINS	Mutating the HLA-A*0201 heavy chain from threonine to lysine at position 134 (T134K) results in a molecule that presents exogenous peptide, but cannot present endogenously derived antigen. This is reflected in diminished cell surface expression and altered intracellular trafficking of T134K. The failure of T134K to present endogenous antigen can be overcome by using an ER targeting sequence, suggesting that the antigen presentation defect is restricted to TAP-dependent peptide loading. The ability of T134K to load peptide in a TAP-dependent manner is dramatically reduced compared with HLA-A*0201. By coimmunoprecipitation there is no detectable association of the T134K molecule with the TAP complex. Thus, T134K selectively affects TAP association and peptide loading, suggesting a requirement for the direct interaction of MHC class I heavy chain and the TAP complex for efficient presentation of endogenous antigen.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill	PeaceBrewer, AL (corresponding author), UNIV N CAROLINA,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27599, USA.		Quinn, David/N-3730-2019; Frelinger, Jeffrey A/F-2448-2014	Quinn, David/0000-0002-1411-0417; Frelinger, Jeffrey A/0000-0002-2503-6267	NIAID NIH HHS [AI 20288, AI 28324, AI 07273] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020288, R37AI020288] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; BAAS EJ, 1992, J EXP MED, V176, P147, DOI 10.1084/jem.176.1.147; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BIJLMAKERS MJ, 1993, CURR OPIN IMMUNOL, V5, P21, DOI 10.1016/0952-7915(93)90076-5; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; CARRENO BM, 1995, J IMMUNOL, V155, P4726; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; DEMARS R, 1985, P NATL ACAD SCI USA, V82, P8183, DOI 10.1073/pnas.82.23.8183; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HILL A, 1993, IMMUNOGENETICS, V37, P95; HOSKEN NA, 1990, SCIENCE, V248, P367, DOI 10.1126/science.2326647; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE N, 1995, IMMUNITY, V3, P591, DOI 10.1016/1074-7613(95)90130-2; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MCMICHAEL AJ, 1988, P NATL ACAD SCI USA, V85, P9194, DOI 10.1073/pnas.85.23.9194; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; MOOTS RJ, 1991, IMMUNOGENETICS, V34, P141; NEEFJES JJ, 1986, IMMUNOGENETICS, V23, P164, DOI 10.1007/BF00373817; NEEFJES JJ, 1993, J EXP MED, V178, P1971, DOI 10.1084/jem.178.6.1971; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; TUSSEY LG, 1995, IMMUNITY, V3, P65, DOI 10.1016/1074-7613(95)90159-0; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; ZWEERINK HJ, 1993, J IMMUNOL, V150, P1763	42	125	125	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1996	4	5					505	514		10.1016/S1074-7613(00)80416-1	http://dx.doi.org/10.1016/S1074-7613(00)80416-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UM678	8630735	Green Published, Bronze			2022-12-18	WOS:A1996UM67800009
J	PINCHUK, LM; POLACINO, PS; AGY, MB; KLAUS, SJ; CLARK, EA				PINCHUK, LM; POLACINO, PS; AGY, MB; KLAUS, SJ; CLARK, EA			THE ROLE OF CD40 AND CD80 ACCESSORY CELL MOLECULES IN DENDRITIC CELL-DEPENDENT HIV-1 INFECTION	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; LYMPHOCYTES-T; B-CELLS; ACTIVATION; ANTIGEN; RECEPTOR; LIGAND; PROLIFERATION; EXPRESSION	We investigated the role of blood dendritic cells (DCs) in transmission of HIV-1 from infected to uninfected CD4(+) T cells, and the accessory molecules involved. DCs promoted transmission from infected to uninfected CD4(+) cells, but DCs themselves were not infectable. DC-mediated transmission was blocked by MAb to CD4 and MHC class II, but strongly increased by MAb to CD40 on DCs or CD28 on T cells. The DC-dependent infection was inhibitable by anti-CD80 and a soluble fusion protein of the CD80 ligand, CTLA4; soluble CTLA4 immunoglobulin also blocked infection augmented by cross-linking CD40. These data suggest a linkage between CD40-CD40L and CD28-CD80 counterreceptors on DCs and T cells, and spread of HIV infection in vivo.	UNIV WASHINGTON,MED CTR,DEPT MICROBIOL,SEATTLE,WA 98195; UNIV WASHINGTON,MED CTR,DEPT IMMUNOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	PINCHUK, LM (corresponding author), UNIV WASHINGTON,MED CTR,REG PRIMATE RES CTR,SEATTLE,WA 98195, USA.		Clark, Edward/K-3462-2012	Clark, Edward A/0000-0001-8061-5475	NCRR NIH HHS [RR00166] Funding Source: Medline; NIGMS NIH HHS [GM 37905] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037905] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGY MB, 1990, VIROLOGY, V177, P251, DOI 10.1016/0042-6822(90)90478-A; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; CAMERON PU, 1992, CLIN EXP IMMUNOL, V88, P226, DOI 10.1111/j.1365-2249.1992.tb03066.x; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; CHEHIMI J, 1993, ADV EXP MED BIOL, V329, P521; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; DEIGELLD, 1993, AIDS RES HUM RETROV, V9, P465; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREUDENTHAL PS, 1990, P NATL ACAD SCI USA, V87, P7698, DOI 10.1073/pnas.87.19.7698; HAFFAR OK, 1993, P NATL ACAD SCI USA, V90, P11094, DOI 10.1073/pnas.90.23.11094; HART DNJ, 1993, IMMUNOLOGY, V79, P616; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; KNIGHT S C, 1990, International Reviews of Immunology, V6, P163, DOI 10.3109/08830189009056627; KNIGHT SC, 1993, ADV EXP MED BIOL, V329, P545; KNIGHT SC, 1993, RES VIROLOGY, V144, P75, DOI 10.1016/S0923-2516(06)80015-4; LANGHOFF E, 1991, P NATL ACAD SCI USA, V88, P7998, DOI 10.1073/pnas.88.18.7998; LANGHOFF E, 1993, J CLIN INVEST, V91, P2721, DOI 10.1172/JCI116512; LANGHOFF E, 1992, J INVEST DERMATOL, V99, P89; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; MACATONIA SE, 1992, IMMUNOLOGY, V75, P576; MACATONIA SE, 1989, J EXP MED, V169, P1255, DOI 10.1084/jem.169.4.1255; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; PATTERSON S, 1987, J GEN VIROL, V68, P1177, DOI 10.1099/0022-1317-68-4-1177; POLACINO PS, 1993, J VIROL, V67, P7008, DOI 10.1128/JVI.67.12.7008-7016.1993; RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925; SCHLOSSMAN SF, 1994, J IMMUNOL, V152, P1; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; STEINMAN RM, 1993, ADV EXP MED BIOL, V329, P1; THOMAS R, 1993, J IMMUNOL, V151, P6840; THOMAS R, 1993, J IMMUNOL, V150, P821; VANLIER RAW, 1989, IMMUNOLOGY, V68, P45; WAINHOBSON S, 1991, SCIENCE, V252, P961, DOI 10.1126/science.2035026; YOUNG JW, 1988, CELL IMMUNOL, V111, P167, DOI 10.1016/0008-8749(88)90061-5; YOUNG JW, 1992, J CLIN INVEST, V90, P229, DOI 10.1172/JCI115840	38	125	128	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1994	1	4					317	325		10.1016/1074-7613(94)90083-3	http://dx.doi.org/10.1016/1074-7613(94)90083-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK166	7534204				2022-12-18	WOS:A1994PK16600009
J	Omenetti, S; Bussi, C; Metidji, A; Iseppon, A; Lee, S; Tolaini, M; Li, Y; Kelly, G; Chakravarty, P; Shoaie, S; Gutierrez, MG; Stockinger, B				Omenetti, Sara; Bussi, Claudio; Metidji, Amina; Iseppon, Andrea; Lee, Sunjae; Tolaini, Mauro; Li, Ying; Kelly, Gavin; Chakravarty, Probir; Shoaie, Saeed; Gutierrez, Maximiliano G.; Stockinger, Brigitta			The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells	IMMUNITY			English	Article							SEGMENTED FILAMENTOUS BACTERIA; PATHOGENIC T(H)17 CELLS; LYMPHOID-TISSUES; GUT MICROBIOTA; T-CELLS; INDUCTION; MATURATION; RECEPTOR; DRIVES; FATE	T helper 17 (Th17) cells are pathogenic inmany inflammatory diseases, but also support the integrity of the intestinal barrier in a non-inflammatory manner. It is unclear what distinguishes inflammatory Th17 cells elicited by pathogens and tissue-resident homeostatic Th17 cells elicited by commensals. Here, we compared the characteristics of Th17 cells differentiating in response to commensal bacteria (SFB) to those differentiating in response to a pathogen (Citrobacter rodentium). Homeostatic Th17 cells exhibited little plasticity towards expression of inflammatory cytokines, were characterized by a metabolism typical of quiescent or memory T cells, and did not participate in inflammatory processes. In contrast, infection-induced Th17 cells showed extensive plasticity towards pro-inflammatory cytokines, disseminated widely into the periphery, and engaged aerobic glycolysis in addition to oxidative phosphorylation typical for inflammatory effector cells. These findings will help ensure that future therapies directed against inflammatory Th17 cells do not inadvertently damage the resident gut population.	[Omenetti, Sara; Bussi, Claudio; Metidji, Amina; Iseppon, Andrea; Lee, Sunjae; Tolaini, Mauro; Li, Ying; Kelly, Gavin; Chakravarty, Probir; Shoaie, Saeed; Gutierrez, Maximiliano G.; Stockinger, Brigitta] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England; [Lee, Sunjae; Shoaie, Saeed] Kings Coll London, Ctr Host Microbiome Interact, Fac Dent Oral & Craniofacial Sci, London SE1 9RT, England; [Metidji, Amina] CRAPC, Ctr Rech Sci & Tech Analyses Physicochim, Algiers, Algeria	Francis Crick Institute; University of London; King's College London; Centre de Recherche Scientifique et Technique en Analyses Physico-Chimiques	Stockinger, B (corresponding author), Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England.	brigitta.stockinger@crick.ac.uk	Kelly, Gavin/ABG-2715-2021; Bussi, Claudio/AIA-8046-2022; Lee, Sunjae/H-9815-2019	Kelly, Gavin/0000-0001-7219-560X; Bussi, Claudio/0000-0002-9396-9042; Lee, Sunjae/0000-0002-6428-5936; Omenetti, Sara/0000-0002-2443-3631; chakravarty, probir/0000-0003-1146-8824; Metidji, Amina/0000-0003-2785-7023; Shoaie, Saeed/0000-0001-5834-4533	Francis Crick Institute from Cancer Research UK [FC001092, FC001159]; UK Medical Research Council [FC001092, FC001159]; Wellcome Trust [FC001092, FC001159]; Engineering and Physical Sciences Research Council (EPSRC) [EP/S001301/1]; EPSRC [EP/S001301/1] Funding Source: UKRI	Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK FC001092 to M.G.G. and FC001159 to B.S., The UK Medical Research Council FC001092 to M.G.G., FC001159 to B.S., and the Wellcome Trust FC001092 to M.G.G. and FC001159 to B.S. S.S. and S.L. are supported by the Engineering and Physical Sciences Research Council (EPSRC) EP/S001301/1.	Ahlfors H, 2014, J IMMUNOL, V193, P4602, DOI 10.4049/jimmunol.1401244; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Auguie B., 2017, GRIDEXTRA MISCELLANE; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Caruso R, 2014, MUCOSAL IMMUNOL, V7, P1467, DOI 10.1038/mi.2014.35; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Crepin VF, 2016, NAT PROTOC, V11, P1851, DOI 10.1038/nprot.2016.100; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Endo Y, 2015, CELL REP, V12, P1042, DOI 10.1016/j.celrep.2015.07.014; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kempski J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01373; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; Kumar P, 2016, IMMUNITY, V44, P659, DOI 10.1016/j.immuni.2016.02.007; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mardinoglu A, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156487; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Murphy CT, 2012, INFECT IMMUN, V80, P2712, DOI 10.1128/IAI.06319-11; Olenchock BA, 2017, IMMUNITY, V46, P703, DOI 10.1016/j.immuni.2017.04.013; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schnupf P, 2017, CURR OPIN MICROBIOL, V35, P100, DOI 10.1016/j.mib.2017.03.004; Schnupf P, 2013, SEMIN IMMUNOL, V25, P342, DOI 10.1016/j.smim.2013.09.001; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weaver CT, 2013, ANNU REV PATHOL-MECH, V8, P477, DOI 10.1146/annurev-pathol-011110-130318; Withers DR, 2016, NAT MED, V22, P319, DOI 10.1038/nm.4046; Witten DM, 2011, ANN APPL STAT, V5, P2493, DOI 10.1214/11-AOAS493; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	64	124	126	4	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					77	+		10.1016/j.immuni.2019.05.004	http://dx.doi.org/10.1016/j.immuni.2019.05.004			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31229354	Green Published, hybrid			2022-12-18	WOS:000475561000012
J	Cronan, MR; Beerman, RW; Rosenberg, AF; Saelens, JW; Johnson, MG; Oehlers, SH; Sisk, DM; Smith, KLJ; Medvitz, NA; Miller, SE; Trinh, LA; Fraser, SE; Madden, JF; Turner, J; Stout, JE; Lee, S; Tobin, DM				Cronan, Mark R.; Beerman, Rebecca W.; Rosenberg, Allison F.; Saelens, Joseph W.; Johnson, Matthew G.; Oehlers, Stefan H.; Sisk, Dana M.; Smith, Kristen L. Jurcic; Medvitz, Neil A.; Miller, Sara E.; Trinh, Le A.; Fraser, Scott E.; Madden, John F.; Turner, Joanne; Stout, Jason E.; Lee, Sunhee; Tobin, David M.			Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes Infection	IMMUNITY			English	Article							TUBERCULOUS GRANULOMA; ADULT ZEBRAFISH; E-CADHERIN; CELLS; INFLAMMATION; EXPRESSION; PATHOGENESIS; INITIATION; ADHESION; TISSUE	Mycobacterium tuberculosis infection in humans triggers formation of granulomas, which are tightly organized immune cell aggregates that are the central structure of tuberculosis. Infected and uninfected macrophages interdigitate, assuming an altered, flattened appearance. Although pathologists have described these changes for over a century, the molecular and cellular programs underlying this transition are unclear. Here, using the zebrafish-Mycobacteriummarinummodel, we found thatmycobacterial granuloma formation is accompanied by macrophage induction of canonical epithelial molecules and structures. We identified fundamental macrophage reprogramming events that parallel E-cadherin- dependent mesenchymal-epithelial transitions. Macrophage-specific disruption of E-cadherin function resulted in disordered granuloma formation, enhanced immune cell access, decreased bacterial burden, and increased host survival, suggesting that the granuloma can also serve a bacteria-protective role. Granuloma macrophages in humans with tuberculosis were similarly transformed. Thus, during mycobacterial infection, granuloma macrophages are broadly reprogrammed by epithelial modules, and this reprogramming alters the trajectory of infection and the associated immune response.	[Cronan, Mark R.; Beerman, Rebecca W.; Rosenberg, Allison F.; Saelens, Joseph W.; Oehlers, Stefan H.; Sisk, Dana M.; Smith, Kristen L. Jurcic; Lee, Sunhee; Tobin, David M.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Johnson, Matthew G.; Stout, Jason E.] Duke Univ, Sch Med, Div Infect Dis, Durham, NC 27710 USA; [Johnson, Matthew G.; Smith, Kristen L. Jurcic; Stout, Jason E.; Lee, Sunhee] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA; [Medvitz, Neil A.; Miller, Sara E.; Madden, John F.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA; [Tobin, David M.] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA; [Trinh, Le A.; Fraser, Scott E.] Univ Southern Calif, Mol & Computat Biol & Translat Imaging Ctr, Los Angeles, CA 90089 USA; [Turner, Joanne] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Turner, Joanne] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	Duke University; Duke University; Duke University; Duke University; Duke University; University of Southern California; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Tobin, DM (corresponding author), Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.; Tobin, DM (corresponding author), Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA.	david.tobin@duke.edu	Oehlers, Stefan/L-5341-2019; Fraser, Scott/Y-3406-2019	Oehlers, Stefan/0000-0003-0260-672X; Fraser, Scott/0000-0002-5377-0223; Stout, Jason/0000-0002-6698-8176; Tobin, David/0000-0003-3465-5518; Cronan, Mark/0000-0002-3760-1649; Beerman, Rebecca/0000-0002-2057-4170	American Cancer Society Postdoctoral Fellowship [PF-13-223-01-MPC]; NIH Training Grant for Immunological Diseases [5T32AI007217-33]; Australian NHMRC Early Career Fellowship; NSF Graduate Fellowship; Duke University NIH AIDS Training Grant [5T32AI007392]; Duke Center for AIDS Research, NIH funded program [5P30 AI064518]; Searle Scholar Award; Vallee Foundation Young Investigator Award; NIH Director's New Innovator Award [1DP2-OD008614]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, R21AI111067, T32AI007392, T32AI007217] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008614] Funding Source: NIH RePORTER	American Cancer Society Postdoctoral Fellowship(American Cancer Society); NIH Training Grant for Immunological Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NSF Graduate Fellowship(National Science Foundation (NSF)); Duke University NIH AIDS Training Grant; Duke Center for AIDS Research, NIH funded program; Searle Scholar Award; Vallee Foundation Young Investigator Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Yi Feng for l-plastin antibodies; S. Abraham, J. Coers, M. Matty, and L. Ramakrishnan for helpful discussions and comments; A. Sagasti for suggesting the gene-trap lines; and W. Terrell for assistance with clinical samples. This work was funded by an American Cancer Society Postdoctoral Fellowship PF-13-223-01-MPC (M.R.C.); an NIH Training Grant for Immunological Diseases 5T32AI007217-33 (A.F.R.); an Australian NHMRC Early Career Fellowship (S.H.O.); an NSF Graduate Fellowship (J.W.S.); a Duke University NIH AIDS Training Grant (5T32AI007392) (M.G.J.); the Duke Center for AIDS Research, an NIH funded program (5P30 AI064518), and a Searle Scholar Award, a Vallee Foundation Young Investigator Award, and an NIH Director's New Innovator Award 1DP2-OD008614 (D.M.T.).	ADAMS DO, 1974, AM J PATHOL, V76, P17; ADAMS DO, 1976, AM J PATHOL, V84, P164; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cronan MR, 2015, DIS MODEL MECH, V8, P1643, DOI 10.1242/dmm.021394; Dallenga T, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw012; DANNENBE.AM, 1968, BACTERIOL REV, V32, P85, DOI 10.1128/MMBR.32.2.85-102.1968; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P533, DOI 10.1016/j.smim.2014.10.002; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Gauthier DT, 2004, DIS AQUAT ORGAN, V62, P121, DOI 10.3354/dao062121; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Marakalala MJ, 2016, NAT MED, V22, P531, DOI 10.1038/nm.4073; Martin CJ, 2016, SEMIN IMMUNOPATHOL, V38, P213, DOI 10.1007/s00281-015-0533-1; Medina E, 1998, IMMUNOLOGY, V93, P270, DOI 10.1046/j.1365-2567.1998.00419.x; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Metschnikoft E., 1888, Virchow's Archiv, Vcxiii, P63; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Nieman MT, 1999, J CELL SCI, V112, P1621; Oehlers SH, 2015, NATURE, V517, P612, DOI 10.1038/nature13967; Parikka M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002944; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Schuppel O., 1871, UNTERSUCHUNGEN LYMPH; SPECTOR WG, 1968, J PATHOL BACTERIOL, V96, P389, DOI 10.1002/path.1700960217; SPECTOR WG, 1966, J PATHOL BACTERIOL, V92, P163, DOI 10.1002/path.1700920117; SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Trinh LA, 2011, GENE DEV, V25, P2306, DOI 10.1101/gad.174037.111; Turner J, 2001, INFECT IMMUN, V69, P3264, DOI 10.1128/IAI.69.5.3264-3270.2001; Van den Bossche J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12599; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vannella KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004372; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Walton EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138949; Wanat KA, 2014, AM J DERMATOPATH, V36, P651, DOI 10.1097/DAD.0b013e31828de7e0; WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yona S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00328; Zakrzewska A, 2010, BLOOD, V116, pE1, DOI 10.1182/blood-2010-01-262873	49	124	126	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					861	876		10.1016/j.immuni.2016.09.014	http://dx.doi.org/10.1016/j.immuni.2016.09.014			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760340	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000389473200017
J	Vanden Berghe, T; Hulpiau, P; Martens, L; Vandenbroucke, RE; Van Wonterghem, E; Perry, SW; Bruggeman, I; Divert, T; Choi, SM; Vuylsteke, M; Shestopalov, VI; Libert, C; Vandenabeele, P				Vanden Berghe, Tom; Hulpiau, Paco; Martens, Liesbet; Vandenbroucke, Roosmarijn E.; Van Wonterghem, Elien; Perry, Seth W.; Bruggeman, Inge; Divert, Tatyana; Choi, Sze Men; Vuylsteke, Marnik; Shestopalov, Valery I.; Libert, Claude; Vandenabeele, Peter			Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice	IMMUNITY			English	Article							MOUSE STRAINS; INFLAMMATORY DISEASES; KNOCKOUT MOUSE; GENOME; CASPASE-11; MUTAGENESIS; ACTIVATION; PHENOTYPES; INTEGRITY; TARGETS	Targeted mutagenesis in mice is a powerful tool for functional analysis of genes. However, genetic variation between embryonic stem cells (ESCs) used for targeting (previously almost exclusively 129-derived) and recipient strains (often C57BL/6J) typically results in congenic mice in which the targeted gene is flanked by ESC-derived passenger DNA potentially containing mutations. Comparative genomic analysis of 129 and C57BL/6J mouse strains revealed indels and single nucleotide polymorphisms resulting in alternative or aberrant amino acid sequences in 1,084 genes in the 129-strain genome. Annotating these passenger mutations to the reported genetically modified congenic mice that were generated using 129-strain ESCs revealed that nearly all these mice possess multiple passenger mutations potentially influencing the phenotypic outcome. We illustrated this phenotypic interference of 129-derived passenger mutations with several case studies and developed a Me-PaMuFind-It web tool to estimate the number and possible effect of passenger mutations in transgenic mice of interest.	[Vanden Berghe, Tom; Hulpiau, Paco; Martens, Liesbet; Vandenbroucke, Roosmarijn E.; Van Wonterghem, Elien; Bruggeman, Inge; Divert, Tatyana; Choi, Sze Men; Libert, Claude; Vandenabeele, Peter] VIB, Inflammat Res Ctr, B-9000 Ghent, Belgium; [Vanden Berghe, Tom; Hulpiau, Paco; Martens, Liesbet; Vandenbroucke, Roosmarijn E.; Van Wonterghem, Elien; Bruggeman, Inge; Divert, Tatyana; Choi, Sze Men; Libert, Claude; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Perry, Seth W.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA; [Vuylsteke, Marnik] GNOMIXX Bvba, Stat Genom, B-9000 Ghent, Belgium; [Shestopalov, Valery I.] Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA; [Shestopalov, Valery I.] Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Shestopalov, Valery I.] Vavilov Inst Gen Genet, Dept Cell Biol & Anat, Moscow 119333, Russia; [Vandenabeele, Peter] Univ Ghent, Methusalem Program, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; University of Rochester; Bascom Palmer Eye Institute; University of Miami; Russian Academy of Sciences; Vavilov Institute of General Genetics; Ghent University	Vanden Berghe, T (corresponding author), VIB, Inflammat Res Ctr, B-9000 Ghent, Belgium.	tom.vandenberghe@irc.vib-ugent.be; peter.vandenabeele@irc.vib-ugent.be	Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009; Shestopalov, Valery/AAE-9838-2020; Hulpiau, Paco/C-3215-2009; Vandenbroucke, Roosmarijn E/B-9419-2009; Berghe, Tom Vanden/N-2902-2019; Vanden Berghe, Tom/C-4916-2009; Vandenbroucke, Roosmarijn/AAC-2757-2019	Vandenabeele, Peter/0000-0002-6669-8822; Hulpiau, Paco/0000-0002-6692-2150; Vandenbroucke, Roosmarijn E/0000-0002-8327-620X; Berghe, Tom Vanden/0000-0002-1633-0974; Vanden Berghe, Tom/0000-0002-1633-0974; Perry, Seth W/0000-0002-1503-6634; Martens, Liesbet/0000-0001-9180-7456; Shestopalov, Valery/0000-0002-1568-6637	Foundation against Cancer [2012-188]; Flemish Government [BOF09/01M00709]; European grant (FP6 ApopTrain) [MRTNCT-035624]; European grant (FP7 EC RTD Integrated Project, Apo-Sys) [FP7-200767]; European grant (Euregional PACT II); Belgian grants (Interuniversity Attraction Poles) [IAP 6/18, IAP 7/32]; Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11 N, FWO G.0A45.12 N, FWO G.0172.12, FWO G.0787.13N, G0C3114N, FWO KAN 31528711]; Flemish grants (Foundation against Cancer) [2012-188]; Ghent University grants (MRP, GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Methusalem grant; NIH R01 grant from USA [EY021517]; FWO; Ghent University grants; NATIONAL CANCER INSTITUTE [R21CA185216] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021517] Funding Source: NIH RePORTER	Foundation against Cancer; Flemish Government(European Commission); European grant (FP6 ApopTrain); European grant (FP7 EC RTD Integrated Project, Apo-Sys); European grant (Euregional PACT II); Belgian grants (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish grants (Research Foundation Flanders)(FWO); Flemish grants (Foundation against Cancer); Ghent University grants (MRP, GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Methusalem grant; NIH R01 grant from USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FWO(FWO); Ghent University grants(Ghent University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Wim Declercq for critical reading and feedback. We are grateful to Edward B. Brown for providing us Mmp13-null mice and to Vishva M. Dixit and Genentech for the Panx1-null mice. T.V.B. is paid by a research grant from the Foundation against Cancer (2012-188) and his research is supported by the Methusalem grant to P.V. Research in P.V.'s unit is further supported by European grants (FP6 ApopTrain, MRTNCT-035624; FP7 EC RTD Integrated Project, Apo-Sys, FP7-200767; Euregional PACT II), Belgian grants (Interuniversity Attraction Poles, IAP 6/18, IAP 7/32), Flemish grants (Research Foundation Flanders [FWO G.0875.11, FWO G.0973.11 N, FWO G.0A45.12 N, FWO G.0172.12, FWO G.0787.13N, G0C3114N, and FWO KAN 31528711] and Foundation against Cancer [2012-188]), Ghent University grants (MRP, GROUP-ID consortium), and grants from Flanders Institute for Biotechnology (VIB). P.V. holds a Methusalem grant (BOF09/01M00709) from the Flemish Government. V.I.S. holds a NIH R01 grant EY021517 from, USA. R.E.V. is a Dr. Assistant at Ghent University and researcher in the lab of C.L. and is supported by FWO and Ghent University grants.	Alizadeh A, 2004, INVEST OPHTH VIS SCI, V45, P884, DOI 10.1167/iovs.03-0677; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coulombe P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3065; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Flaherty L., 1981, CONGENIC STRAINS, V1; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gomez-Sintes R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00253; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kenneth NS, 2012, BIOCHEM J, V443, P355, DOI 10.1042/BJ20120249; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Lusis AJ, 2007, ARTERIOSCL THROM VAS, V27, P2100, DOI 10.1161/ATVBAHA.107.147918; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martins M, 2014, P NATL ACAD SCI USA, V111, P4239, DOI 10.1073/pnas.1311500111; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Murray SA, 2012, MAMM GENOME, V23, P587, DOI 10.1007/s00335-012-9430-2; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Rogers MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035237; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Sandilands A, 2004, EXP EYE RES, V78, P109, DOI 10.1016/j.exer.2003.09.001; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Spector A, 1996, EXP EYE RES, V62, P521, DOI 10.1006/exer.1996.0063; Spector A, 1998, EXP EYE RES, V67, P457, DOI 10.1006/exer.1998.0548; Su ZG, 2009, J LIPID RES, V50, P116, DOI 10.1194/jlr.M800411-JLR200; Terao M, 2009, MOL CELL BIOL, V29, P357, DOI 10.1128/MCB.01385-08; Vanden Berghe T, 2013, AM J RESP CRIT CARE, V188, P120, DOI 10.1164/rccm.201210-1775LE; Vandenbroucke RE, 2014, MUCOSAL IMMUNOL, V7, P579, DOI 10.1038/mi.2013.76; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Vandenbroucke RE, 2013, EMBO MOL MED, V5, P1000, DOI 10.1002/emmm.201202100; Vandenbroucke RE, 2012, J NEUROSCI, V32, P9805, DOI 10.1523/JNEUROSCI.0967-12.2012; Vanlaere I, 2009, CLIN MICROBIOL REV, V22, P224, DOI 10.1128/CMR.00047-08; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432	47	124	124	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					200	209		10.1016/j.immuni.2015.06.011	http://dx.doi.org/10.1016/j.immuni.2015.06.011			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26163370	Green Accepted, Bronze			2022-12-18	WOS:000360101100021
J	Schuster, IS; Wikstrom, ME; Brizard, G; Coudert, JD; Estcourt, MJ; Manzur, M; O'Reilly, LA; Smyth, MJ; Trapani, JA; Hill, GR; Andoniou, CE; Degli-Esposti, MA				Schuster, Iona S.; Wikstrom, Matthew E.; Brizard, Geraldine; Coudert, Jerome D.; Estcourt, Marie J.; Manzur, Mitali; O'Reilly, Lorraine A.; Smyth, Mark J.; Trapani, Joseph A.; Hill, Geoffrey R.; Andoniou, Christopher E.; Degli-Esposti, Mariapia A.			TRAIL(+) NK Cells Control CD4(+) T Cell Responses during Chronic Viral Infection to Limit Autoimmunity	IMMUNITY			English	Article							APOPTOSIS-INDUCING LIGAND; NATURAL-KILLER-CELLS; CYTOMEGALOVIRUS-INFECTION; FUNCTIONAL-ANALYSIS; SJOGRENS-SYNDROME; DENDRITIC CELLS; VIRUS-INFECTION; IMMUNITY; LYMPHOCYTES; AUTOANTIBODIES	Natural killer (NK) cells have been reported to control adaptive immune responses that occur in lymphoid organs at the early stages of immune challenge. The physiological purpose of such regulatory activity remains unclear, because it generally does not confera survival advantage. We found that NK cells specifically eliminated activated CD4(+) T cells in the salivary gland during chronic murine cytomegalovirus (MCMV) infection. This was dependent on TNF-related apoptosis inducing ligand (TRAIL) expression by NK cells. Although NK cell-mediated deletion of CD4(+) T cells prolonged the chronicity of infection, it also constrained viral-induced autoimmunity. In the absence of this activity, chronic infection was associated with a Sjogren's-like syndrome characterized by focal lymphocytic infiltration into the glands, production of autoantibodies, and reduced saliva and tear secretion. Thus, NK cells are an important homeostatic control that balances the efficacy of adaptive immune responses with the risk of developing autoimmunity.	[Schuster, Iona S.; Wikstrom, Matthew E.; Brizard, Geraldine; Coudert, Jerome D.; Estcourt, Marie J.; Manzur, Mitali; Andoniou, Christopher E.; Degli-Esposti, Mariapia A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Immunol & Virol Program, Nedlands, WA 6009, Australia; [Schuster, Iona S.; Wikstrom, Matthew E.; Brizard, Geraldine; Coudert, Jerome D.; Estcourt, Marie J.; Manzur, Mitali; Andoniou, Christopher E.; Degli-Esposti, Mariapia A.] Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA 6009, Australia; [O'Reilly, Lorraine A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [O'Reilly, Lorraine A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Brisbane, Qld 4006, Australia; [Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Cell Death Lab, East Melbourne, Vic 3002, Australia; [Trapani, Joseph A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Hill, Geoffrey R.] QIMR Berghofer Med Res Inst, Bone Marrow Transplantat Lab, Brisbane, Qld 4006, Australia	University of Western Australia; Lions Eye Institute; University of Western Australia; Walter & Eliza Hall Institute; University of Melbourne; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; QIMR Berghofer Medical Research Institute	Degli-Esposti, MA (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Immunol & Virol Program, Nedlands, WA 6009, Australia.	mariapia@lei.org.au	Hill, Geoffrey/O-2630-2016; Coudert, Jerome D/B-2628-2008; Smyth, Mark J/H-8709-2014; Estcourt, Marie/E-6884-2017; Degli-Esposti, Mariapia/H-9073-2014	Hill, Geoffrey/0000-0003-2994-0429; Coudert, Jerome D/0000-0001-6081-8494; Smyth, Mark J/0000-0001-7098-7240; Estcourt, Marie/0000-0001-8403-6075; Brizard-Mandin, Geraldine/0000-0003-4593-3931; Degli-Esposti, Mariapia/0000-0002-7808-5935; Andoniou, Christopher/0000-0003-0566-3180; Trapani, Joseph/0000-0003-0983-1532	NHMRC Australia; McCusker Charitable Foundation	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); McCusker Charitable Foundation	The authors thank staff at the Animal Facilities of the University of Western Australia, Peter MacCallum Cancer Centre, and QIMR for their support with animal breeding and maintenance. This work was supported by grants and fellowships from NHMRC Australia and the McCusker Charitable Foundation.	Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Andrews DM, 2001, J IMMUNOL, V166, P1796, DOI 10.4049/jimmunol.166.3.1796; BARTHOLOMAEUS WN, 1988, IMMUNOLOGY, V64, P397; Biron CA, 2012, P NATL ACAD SCI USA, V109, P1814, DOI 10.1073/pnas.1120528109; Bombardieri M, 2012, CURR PHARM BIOTECHNO, V13, P1989, DOI 10.2174/138920112802273209; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Crome SQ, 2013, TRENDS IMMUNOL, V34, P342, DOI 10.1016/j.it.2013.03.002; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; EISEN SA, 1972, IMMUNOL COMMUN, V1, P571, DOI 10.3109/08820137209022965; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Getts DR, 2013, IMMUNOL REV, V255, P197, DOI 10.1111/imr.12091; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Hoffmann O, 2007, J CLIN INVEST, V117, P2004, DOI 10.1172/JCI30356; Kyriakidis NC, 2014, J AUTOIMMUN, V51, P67, DOI 10.1016/j.jaut.2013.11.001; Lamhamedi-Cherradi SE, 2003, DIABETES, V52, P2274, DOI 10.2337/diabetes.52.9.2274; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; LAWSON CM, 1992, IMMUNOLOGY, V75, P513; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Martinez-Lostao L, 2012, BIOCHEM PHARMACOL, V83, P1475, DOI 10.1016/j.bcp.2011.12.036; Mavragani CP, 2010, AUTOIMMUN REV, V9, pA305, DOI 10.1016/j.autrev.2009.11.004; McGrath EE, 2011, J LEUKOCYTE BIOL, V90, P855, DOI 10.1189/jlb.0211062; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Ong ML, 2013, BLOOD, V122, P55, DOI 10.1182/blood-2012-12-471227; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Rabinovich BA, 2003, J IMMUNOL, V170, P3572, DOI 10.4049/jimmunol.170.7.3572; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Rusakiewicz S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005727; Scalzo AA, 1999, IMMUNOGENETICS, V49, P238, DOI 10.1007/s002510050486; Shi FD, 2006, NAT REV IMMUNOL, V6, P751, DOI 10.1038/nri1935; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Su HC, 2001, EUR J IMMUNOL, V31, P3048, DOI 10.1002/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Tessmer MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001254; van der Most RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006982; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1999, CANCER RES, V59, P2770	44	124	128	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					646	656		10.1016/j.immuni.2014.09.013	http://dx.doi.org/10.1016/j.immuni.2014.09.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367576	Bronze			2022-12-18	WOS:000345504300017
J	Ajibade, AA; Wang, QF; Cui, J; Zou, J; Xia, XJ; Wang, MJ; Tong, YZ; Hui, W; Liu, D; Su, B; Wang, HY; Wang, RF				Ajibade, Adebusola Alagbala; Wang, Qinfu; Cui, Jun; Zou, Jia; Xia, Xiaojun; Wang, Mingjun; Tong, Yanzheng; Hui, Wei; Liu, Dou; Su, Bing; Wang, Helen Y.; Wang, Rong-Fu			TAK1 Negatively Regulates NF-kappa B and p38 MAP Kinase Activation in Gr-1(+)CD11b(+) Neutrophils	IMMUNITY			English	Article							T-CELLS; RIG-I; INFLAMMATORY RESPONSES; INNATE; RECEPTOR; RECOGNITION; P38-ALPHA; HEPATOCYTES; INVOLVEMENT; INHIBITION	Stringent control of NF-kappa B and mitogen-activated protein kinase (MAPK) signaling is critical during innate immune responses. TGF-beta activated kinase-1 (TAK1) is essential for NF-kappa B activation in T and B cells but has precisely the opposite activity in myeloid cells. Specific deletion of TAK1 (Map3k7(Delta M/Delta M)) led to development of splenomegaly and lymphomegaly associated with neutrophilia. Compared with wildtype cells, TAK1-deficient neutrophils enhanced the phosphorylation of the kinases IKK, p38, and JNK and the production of interleukin-1 beta (IL-1 beta), IL-6, tumor necrosis factor-alpha (INF-alpha), and reactive oxygen species (ROS) after lipopolysaccharide (LPS) stimulation. Map3k7(Delta M/Delta M) mice were significantly more susceptible to LPS-induced septic shock and produced higher amounts of IL-1 beta, IL-6, and TNF-alpha in plasma than do wild-type mice. Specific ablation of p38 rescued the phenotype and functional properties of Map3k7(Delta M/Delta M) mice. Our findings identify a previously unrecognized role of TAK1 as a negative regulator of p38 and IKK activation in a cell type-specific manner.	[Ajibade, Adebusola Alagbala; Wang, Qinfu; Cui, Jun; Zou, Jia; Xia, Xiaojun; Wang, Mingjun; Tong, Yanzheng; Hui, Wei; Wang, Helen Y.; Wang, Rong-Fu] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Wang, Helen Y.; Wang, Rong-Fu] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Ajibade, Adebusola Alagbala; Cui, Jun; Zou, Jia; Wang, Mingjun; Tong, Yanzheng; Wang, Helen Y.; Wang, Rong-Fu] Methodist Hosp, Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA; [Liu, Dou; Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Yale University	Wang, RF (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	rwang3@tmhs.org	Wang, Qinfu/H-3517-2011	Wang, Qinfu/0000-0001-8155-8345	NCI; NIH; Cancer Research Institute; NNSFC [31000394]; NATIONAL CANCER INSTITUTE [R01CA090327, P01CA094237, R01CA101795, R01CA116408, R01CA121191] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070225] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030338] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NNSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank M. Schneider (Baylor College of Medicine) for TAK1<SUP>flox/flox</SUP> mice; Y. Wang (UCLA) and H. Jiang (Boehringer-Ingelheim) for p38<SUP>flox/flox</SUP> mice; and D. Zhang (Texas A&M University) for TAK1-deficient MEFs. This work was in part supported by grants from NCI, NIH, and Cancer Research Institute. J.C. was partially supported by NNSFC (31000394).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kang YJ, 2006, J BIOL CHEM, V281, P26225, DOI 10.1074/jbc.M606800200; Kantari Chahrazade, 2008, V15, P118, DOI 10.1159/000136335; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Lam CRI, 2011, CELL DEATH DIFFER, V18, P1120, DOI 10.1038/cdd.2010.182; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Su B, 2005, NAT IMMUNOL, V6, P541, DOI 10.1038/ni0605-541; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022	48	124	128	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 27	2012	36	1					43	54		10.1016/j.immuni.2011.12.010	http://dx.doi.org/10.1016/j.immuni.2011.12.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22226633	Green Accepted, Bronze			2022-12-18	WOS:000299766000009
J	Hashimoto-Tane, A; Yokosuka, T; Sakata-Sogawa, K; Sakuma, M; Ishihara, C; Tokunaga, M; Saito, T				Hashimoto-Tane, Akiko; Yokosuka, Tadashi; Sakata-Sogawa, Kumiko; Sakuma, Machie; Ishihara, Chitose; Tokunaga, Makio; Saito, Takashi			Dynein-Driven Transport of T Cell Receptor Microclusters Regulates Immune Synapse Formation and T Cell Activation	IMMUNITY			English	Article							IMMUNOLOGICAL SYNAPSE; CYTOPLASMIC DYNEIN; ANTIGEN RECEPTOR; INTRAFLAGELLAR TRANSPORT; COMPLEX; PROTEIN; ACTIN; COSTIMULATION; TRANSLOCATION; POLARIZATION	When T cells recognize a peptide-major histocompatibility complex on antigen-presenting cells (APCs), T cell receptor microclusters (TCR-MCs) are generated and move to the center of the T cell-APC interface to form the central supramolecular activation cluster (cSMAC). cSMAC formation depends on stimulation strength and regulates T cell activation. We demonstrate that the dynein motor complex colocalized and coimmunoprecipitated with the TCR complex and that TCR-MCs moved along microtubules (MTs) toward the center of the immune synapse in a dynein-dependent manner to form cSMAC. MTs are located in close proximity to the plasma membrane at the activation site. TCR-MC velocity and cSMAC formation were impaired by dynein or MT inhibitors or by ablation of dynein expression. T cells with impaired cSMAC formation exhibited enhanced cellular activation including protein phosphorylation and interleukin-2 production. These results indicate that cSMAC formation by TCR-MC movement depends on dynein and MTs, and the movement regulates T cell activation.	[Hashimoto-Tane, Akiko; Yokosuka, Tadashi; Sakuma, Machie; Ishihara, Chitose; Saito, Takashi] RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan; [Sakata-Sogawa, Kumiko] RIKEN Res Ctr Allergy & Immunol, Res Unit Single Mol Imaging, Kanagawa 2300045, Japan; [Sakata-Sogawa, Kumiko; Tokunaga, Makio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Yokohama, Kanagawa 2268501, Japan; [Saito, Takashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	RIKEN; RIKEN; Tokyo Institute of Technology; Osaka University	Saito, T (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan.	saito@rcai.riken.jp	Saito, Takashi/C-9684-2009	Saito, Takashi/0000-0001-9495-3547; Hashimoto-Tane, Akiko/0000-0001-8519-266X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [20114004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Igarashi and K. Shibata for help of STED microscopy, M.L. Dustin, S. Kimura, A. Kubo for discussion, T. Watanabe for technical advices, K. Ueda for EM analysis, W. Kobayashi and M. Takamatsu for technical support, and H. Yamaguchi for secretarial assistance. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (A.T., K.S.-S.,T.Y., M.T., and T.S.).	Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235; BOUCHARD P, 1981, P NATL ACAD SCI-BIOL, V78, P1033, DOI 10.1073/pnas.78.2.1033; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Eng EW, 2007, MOL BIOL CELL, V18, P2389, DOI 10.1091/mbc.e06-12-1128; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Huby RDJ, 1998, J BIOL CHEM, V273, P12024, DOI 10.1074/jbc.273.20.12024; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Martin-Cofreces NB, 2008, J CELL BIOL, V182, P951, DOI 10.1083/jcb.200801014; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nag A, 2009, BIOPHYS J, V96, P2604, DOI 10.1016/j.bpj.2009.01.019; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Quann EJ, 2009, NAT IMMUNOL, V10, P627, DOI 10.1038/ni.1734; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schnyder T, 2011, IMMUNITY, V34, P905, DOI 10.1016/j.immuni.2011.06.001; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WOLF DE, 1985, BIOCHEMISTRY-US, V24, P582, DOI 10.1021/bi00324a006; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011878; YU WQ, 1994, J NEUROSCI, V14, P2818	48	124	127	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 24	2011	34	6					919	931		10.1016/j.immuni.2011.05.012	http://dx.doi.org/10.1016/j.immuni.2011.05.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703543	Bronze			2022-12-18	WOS:000292349700012
J	Boissonnas, A; Scholer-Dahirel, A; Simon-Blancal, V; Pace, L; Valet, F; Kissenpfennig, A; Sparwasser, T; Malissen, B; Fetler, L; Amigorena, S				Boissonnas, Alexandre; Scholer-Dahirel, Alix; Simon-Blancal, Virginie; Pace, Luigia; Valet, Fabien; Kissenpfennig, Adrien; Sparwasser, Tim; Malissen, Bernard; Fetler, Luc; Amigorena, Sebastian			Foxp3(+) T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph Nodes	IMMUNITY			English	Article							CUTTING EDGE; REGULATORY CELLS; MEDIATED SUPPRESSION; GRANZYME-B; DEPLETION; CD8(+); EFFECTOR; GENERATION; DYNAMICS; CYTOTOXICITY	Regulatory T (Treg) cells limit the onset of effective antitumor immunity, through yet-ill-defined mechanisms. We showed the rejection of established oval-burnin (OVA)-expressing MCA101 tumors required both the adoptive transfer of OVA-specific CD8(+) T cell receptor transgenic T cells (OTI) and the neutralization of Foxp3(+) T cells. In tumor-draining lymph nodes, Foxp3(+) T cell neutralization induced a marked arrest in the migration of OTI T cells, increased numbers of dendritic cells (DCs), and enhanced OTI T cell priming. Using an in vitro cytotoxic assay and two-photon live microscopy after adoptive transfer of DCs, we demonstrated that Foxp3(+) T cells induced the death of DCs in tumor-draining lymph nodes, but not in the absence of tumor. DC death correlated with Foxp3(+) T cell-DC contacts, and it was tumor-antigen and perforin dependent. We conclude that Foxp3(+) T cell-dependent DC death in tumor-draining lymph nodes limits the onset of CD8(+) T cell responses.	[Fetler, Luc] CNRS, UMR 168, Lab Physicochim Curie, Inst Curie, F-75245 Paris 05, France; [Boissonnas, Alexandre; Scholer-Dahirel, Alix; Simon-Blancal, Virginie; Pace, Luigia; Amigorena, Sebastian] INSERM, U932, Inst Curie, F-75245 Paris 05, France; [Valet, Fabien] INSERM, U900, Inst Curie, F-75245 Paris 05, France; [Kissenpfennig, Adrien; Malissen, Bernard] Univ Mediterrannee, CNRS, INSERM,U631,UMR6102, Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, D-30625 Hannover, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Helmholtz-Center for Infection Research	Fetler, L (corresponding author), CNRS, UMR 168, Lab Physicochim Curie, Inst Curie, F-75245 Paris 05, France.	luc.fetler@curie.fr; sebastian.amigorena@curie.fr	Boissonnas, Alexandre/A-2801-2016; Sparwasser, Tim/AAF-7085-2019; Fetler, luc/M-9034-2018; Scholer-Dahirel, Alix/G-5858-2014; Sparwasser, Tim D/AAA-4306-2022; Malissen, Bernard/AAK-4659-2020	Boissonnas, Alexandre/0000-0002-7770-7210; Sparwasser, Tim/0000-0001-5645-902X; Amigorena, Sebastian/0000-0001-8583-8416; Malissen, Bernard/0000-0003-1340-9342; Kissenpfennig, Adrien/0000-0002-9633-3111	Association pour la Recherche contre le Cancer (ARC); Ligue contre le Cancer (LNCC); Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; La Ligue Contre le Cancer; Association de la Recherche Contre le Cancer; Institut Curie; Fondation Bettencourt-Schueller; EC [DC-Thera NoLSBH-CT-2004-512074, LSHC-CT-2006-518234, ENCITE, Health-F5-2008-201842]	Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Ligue contre le Cancer (LNCC); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Association de la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut Curie; Fondation Bettencourt-Schueller; EC(European CommissionEuropean Commission Joint Research Centre)	We would like to thank S. Krumeich and G. Sugano for experimental help, A. Trautmann, E. Donnadieu, M. Krummel, and R. Voituriez for helpful discussions, C. Thery and O. Lantz for critically reading the manuscript, and B. Salomon for providing the PC61 cell line. A.B. has been supported by Association pour la Recherche contre le Cancer (ARC) and Ligue contre le Cancer (LNCC); A.S. was a fellow of Ministere de I'Education et de la Recherche. The Foxp3-EGFP mice have been developed by the Plate-forme Technologique du Vivant IBISA. This work was supported by funding from Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; La Ligue Contre le Cancer; Association de la Recherche Contre le Cancer (ARC, Leopold Griffuel award); the Institut Curie; Fondation Bettencourt-Schueller; EC grant DC-Thera NoLSBH-CT-2004-512074 "Dendritic Cells for Novel Immunotherapies"; EC grant Cancer Immunotherapy LSHC-CT-2006-518234 "Cancer Immunology and Immunotherapy"; and EC grant ENCITE, Health-F5-2008-201842.	Appay V, 2006, J IMMUNOL, V177, P1670, DOI 10.4049/jimmunol.177.3.1670; Blankenstein T, 2005, CURR OPIN IMMUNOL, V17, P180, DOI 10.1016/j.coi.2005.01.008; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Hugues S, 2006, CURR OPIN IMMUNOL, V18, P491, DOI 10.1016/j.coi.2006.03.021; Janssens W, 2003, J IMMUNOL, V171, P4604, DOI 10.4049/jimmunol.171.9.4604; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Misra N, 2004, J IMMUNOL, V172, P4676, DOI 10.4049/jimmunol.172.8.4676; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; NORTH RJ, 1984, J EXP MED, V159, P1295, DOI 10.1084/jem.159.5.1295; Onizuka S, 1999, CANCER RES, V59, P3128; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Somasundaram R, 2002, CANCER RES, V62, P5267; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Yu G, 2006, J EXP MED, V203, P1851, DOI 10.1084/jem.20060603; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163; Zelenay S, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036-a; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502	47	124	126	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					266	278		10.1016/j.immuni.2009.11.015	http://dx.doi.org/10.1016/j.immuni.2009.11.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20137985	Bronze			2022-12-18	WOS:000275346000015
J	Chang, HC; Zhang, SM; Thieu, VT; Slee, RB; Bruns, HA; Laribee, RN; Klemsz, MJ; Kaplan, MH				Chang, HC; Zhang, SM; Thieu, VT; Slee, RB; Bruns, HA; Laribee, RN; Klemsz, MJ; Kaplan, MH			PU.1 expression delineates heterogeneity in primary Th2 cells	IMMUNITY			English	Article							TRANSCRIPTION FACTOR PU.1; T-CELL; IL-4 PRODUCTION; CYTOKINE GENES; IN-VIVO; B-CELL; DIFFERENTIATION; GATA-3; LINEAGE; STAT6	Primary T helper 2 cells are heterogeneous, expressing subsets of cytokines at varying levels. Mechanisms controlling this spectrum of phenotypes are still unclear. The ETS family transcription factor PU.1 is expressed in Th2 but not Th1 cells. Th2 cytokine production is decreased in cultures transduced with a PU.1-expressing retrovirus and increased in Th2 cells following RNAi that decreases PU.1 expression. In primary cultures, PU.1 expression is restricted to a subpopulation of Th2 cells that express CCL22 and a subset of Th2 cytokines. PUA regulates the Th2 phenotype by interfering with GATA-3 DNA binding without altering GATA-3 protein levels. Thus, the expression of PUA in subsets of Th2 cells establishes a defined cytokine profile and contributes towards establishing the spectrum of cytokine production observed in Th2 populations.	Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; Walther Canc Inst, Indianapolis, IN 46208 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Walther Cancer Institute	Kaplan, MH (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	mkaplan2@iupui.edu		Kaplan, Mark/0000-0002-2923-8245; Laribee, R. Nicholas/0000-0003-4519-4470	NIAID NIH HHS [AI45515, AI57459] Funding Source: Medline; NIDDK NIH HHS [DK007519] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045515, R01AI045515, R01AI057459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bruns HA, 2003, J IMMUNOL, V170, P3478, DOI 10.4049/jimmunol.170.7.3478; BUCY RP, 1995, P NATL ACAD SCI USA, V92, P7565, DOI 10.1073/pnas.92.16.7565; Chang HC, 2003, J BIOL CHEM, V278, P32471, DOI 10.1074/jbc.M302776200; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Dahl R, 2002, EMBO J, V21, P2220, DOI 10.1093/emboj/21.9.2220; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Farrar JD, 2001, J EXP MED, V193, P643, DOI 10.1084/jem.193.5.643; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Glimcher LH, 2000, GENE DEV, V14, P1693; Gourley T, 1999, IMMUNITY, V10, P377, DOI 10.1016/S1074-7613(00)80037-0; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Karulin AY, 2000, J IMMUNOL, V164, P1862, DOI 10.4049/jimmunol.164.4.1862; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Klemsz MJ, 1996, MOL CELL BIOL, V16, P390; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Lieberson R, 2001, J EXP MED, V194, P89, DOI 10.1084/jem.194.1.89; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; NEISEN B, 1993, SCIENCE, V261, P82; O'Sullivan A, 2004, J BIOL CHEM, V279, P7339, DOI 10.1074/jbc.M309979200; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sommer F, 1998, INT IMMUNOL, V10, P1853, DOI 10.1093/intimm/10.12.1853; Spain LM, 1999, J IMMUNOL, V163, P2681; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Zhang P, 2000, BLOOD, V96, P2641; Zhang SM, 2000, J IMMUNOL, V165, P10, DOI 10.4049/jimmunol.165.1.10; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461; Zou GM, 2003, BIOL CELL, V95, P365, DOI 10.1016/S0248-4900(03)00079-0	50	124	127	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					693	703		10.1016/j.immuni.2005.03.016	http://dx.doi.org/10.1016/j.immuni.2005.03.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963784	Bronze			2022-12-18	WOS:000230180300007
J	Qian, YC; Qin, JZ; Cui, G; Naramura, M; Snow, EC; Ware, CF; Fairchild, RL; Omori, SA; Rickert, RC; Scott, M; Kotzin, BL; Li, XX				Qian, YC; Qin, JZ; Cui, G; Naramura, M; Snow, EC; Ware, CF; Fairchild, RL; Omori, SA; Rickert, RC; Scott, M; Kotzin, BL; Li, XX			Act1, a negative regulator in CD40- and BAFF-mediated B cell survival	IMMUNITY			English	Article							NF-KAPPA-B; KINASE COMPLEX; TNF RECEPTOR; IKK-BETA; ACTIVATION; CD40; TAK1; DEFICIENT; TRAF6; MICE	TNF receptor (TNFR) superfamily members, CD40, and BAFFR play critical roles in B cell survival and differentiation. Genetic deficiency in a novel adaptor molecule, Act1, for CD40 and BAFF results in a dramatic increase in peripheral B cells, which culminates in lymphadenopathy and splenomegaly, hypergammaglobulinemia, and autoantibodies. While the B cell-specific Act1 knockout mice displayed a similar phenotype with less severity, the pathology of the Act1-deficient mice was mostly blocked in CD40-Act1 and BAFF-Act1 double knockout mice. CD40- and BAFF-mediated survival is significantly increased in Act1-deficent B cells, with stronger IkappaB phosphorylation, processing of NF-(K)B2 (p100/p52), and activation of JNK, ERK, and p38 pathways, indicating that Act1 negatively regulates CD40 and BAFF-mediated signaling events. These findings demonstrate that Act1 plays an important role in the homeostasis of B cells by attenuating CD40 and BAFFR signaling.	Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; Univ Kentucky, Med Ctr, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, UCSD Canc Ctr, La Jolla, CA 92093 USA; Biogen Inc, Cambridge Ctr 14, Cambridge, MA 02142 USA; Univ Colorado, Hlth Sci Ctr, Div Clin Immunol B164, Denver, CO 80262 USA	Cleveland Clinic Foundation; University of Kentucky; La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego; Biogen; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Li, XX (corresponding author), Cleveland Clin Fdn, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org		Naramura, Mayumi/0000-0003-3658-0767; Fitzpatrick, Sidne/0000-0002-5245-4624	NIGMS NIH HHS [GM 600020] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop GA, 2001, IMMUNOL RES, V24, P97, DOI 10.1385/IR:24:2:097; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Garceau N, 2000, J EXP MED, V191, P381, DOI 10.1084/jem.191.2.381; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grammer A C, 2000, Adv Immunol, V76, P61; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hostager BS, 1999, J IMMUNOL, V162, P6307; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; KOTZIN BL, 1984, J IMMUNOL, V133, P2554; Lei XF, 1998, J CLIN INVEST, V101, P1342, DOI 10.1172/JCI1662; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; vanKooten C, 1997, INT ARCH ALLERGY IMM, V113, P393, DOI 10.1159/000237614; Vyse TJ, 1996, J CLIN INVEST, V98, P1762, DOI 10.1172/JCI118975; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Xu LG, 2002, J IMMUNOL, V169, P6883, DOI 10.4049/jimmunol.169.12.6883; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhao ZD, 2003, J IMMUNOL, V170, P5674, DOI 10.4049/jimmunol.170.11.5674	49	124	135	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					575	587		10.1016/j.immuni.2004.09.001	http://dx.doi.org/10.1016/j.immuni.2004.09.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485634	Bronze			2022-12-18	WOS:000224744400013
J	Liang, HE; Hsu, LY; Cado, D; Cowell, LG; Kelsoe, G; Schlissel, MS				Liang, HE; Hsu, LY; Cado, D; Cowell, LG; Kelsoe, G; Schlissel, MS			The "dispensable" portion of RAG2 is necessary for efficient V-to-DJ rearrangement during B and T cell development	IMMUNITY			English	Article							RECOMBINATION SIGNAL SEQUENCES; IMMUNOGLOBULIN GENE REARRANGEMENT; V(D)J RECOMBINATION; IN-VITRO; DNA CLEAVAGE; RECEPTOR; ACTIVATION; ENHANCER; ROLES; LOCUS	Previous in vitro studies defined the minimal regions of RAG1 and RAG2 essential for V(D)J recombination. In order to characterize the role of the C-terminal "dispensable" portion of RAG2, we generated core-RAG2 knock-in mice. We found that the core-RAG2-containing recombinase complex is selectively defective in catalyzing V-to-DJ rearrangement at the IgH and TCRO loci, resulting in partial developmental blocks in B and T lymphopoiesis. Analysis of recombination intermediates showed defects at the cleavage phase of the reaction. We also observed a reduction in overall recombinase activity in core-RAG2-expressing thymocytes, leading us to suggest that the interaction of a defective recombinase with RSS sequences unique to VH and Vbeta gene segments may underlie the specific V-to-DJ rearrangement defect in core-RAG2 mice.	Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21205 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	University of California System; University of California Berkeley; Johns Hopkins University; Duke University	Schlissel, MS (corresponding author), Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040227, R37AI040227] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40227] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akamatsu Y, 1998, MOL CELL BIOL, V18, P4670, DOI 10.1128/MCB.18.8.4670; Bassing CH, 2000, NATURE, V405, P583, DOI 10.1038/35014635; CONNOR AM, 1995, J IMMUNOL, V155, P5268; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; COWELL LG, 2002, IN PRESS GENOME BIOL; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; Eastman QM, 1999, MOL CELL BIOL, V19, P3788; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hempel WM, 1998, GENE DEV, V12, P2305, DOI 10.1101/gad.12.15.2305; Hernandez-Munain C, 1999, IMMUNITY, V10, P723, DOI 10.1016/S1074-7613(00)80071-0; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; Kirch SA, 1996, EUR J IMMUNOL, V26, P886, DOI 10.1002/eji.1830260425; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; McMahan CJ, 1997, MOL CELL BIOL, V17, P4544, DOI 10.1128/MCB.17.8.4544; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Mo XM, 1999, J BIOL CHEM, V274, P7025, DOI 10.1074/jbc.274.11.7025; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; Roman CAJ, 1997, IMMUNITY, V7, P13, DOI 10.1016/S1074-7613(00)80506-3; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Schlissel MS, 2000, J EXP MED, V191, P1045, DOI 10.1084/jem.191.6.1045; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Schlissel MS, 1998, MOL CELL BIOL, V18, P2029, DOI 10.1128/MCB.18.4.2029; Sekiguchi J, 2001, MOL CELL, V8, P1383, DOI 10.1016/S1097-2765(01)00423-3; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Steen SB, 1999, MOL CELL BIOL, V19, P3010; Swanson PC, 1999, MOL CELL BIOL, V19, P3674; Swanson PC, 1998, IMMUNITY, V9, P115, DOI 10.1016/S1074-7613(00)80593-2; Tillman RE, 2002, J EXP MED, V195, P309, DOI 10.1084/jem.20011803; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Williams GS, 2001, J IMMUNOL, V167, P257, DOI 10.4049/jimmunol.167.1.257	42	124	126	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2002	17	5					639	651		10.1016/S1074-7613(02)00448-X	http://dx.doi.org/10.1016/S1074-7613(02)00448-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433370	Bronze			2022-12-18	WOS:000179335100010
J	Priatel, JJ; Teh, SJ; Dower, NA; Stone, JC; Teh, HS				Priatel, JJ; Teh, SJ; Dower, NA; Stone, JC; Teh, HS			RasGRP1 transduces low-grade TCR signals which are critical for T cell development, homeostasis, and differentiation	IMMUNITY			English	Article							IMMATURE CD4(+)CD8(+) THYMOCYTES; RECEPTOR TRANSGENIC MICE; POSITIVE SELECTION; NEGATIVE SELECTION; LINEAGE COMMITMENT; THYMIC SELECTION; ERK ACTIVATION; RAS; DELETION; PROLIFERATION	Two important Ras-guanyl nucleotide exchange factors, Sos and RaSGRP1, control Ras activation in thymocytes. However, the relative contribution of these two exchange factors to Ras/ERK activation and their resulting impact on positive and negative selection is unclear. We have produced two lines of RaSGRP1(-/-) TCR transgenic mice to determine the effect of RasGRP1 in T cell development under conditions of defined TCR signaling. Our results demonstrate that RasGRP1 is crucial for thymocytes expressing weakly selecting TCRs whereas those that express stronger selecting TCRs are more effective at utilizing RaSGRPi-independent mechanisms for ERK activation and positive selection. Analysis of RaSGRP(-/-) peripheral T cells also revealed hitherto unidentified functions of RasGRP1 in regulating T cell homeostasis and sustaining antigen-induced developmental programming.	Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Univ Alberta, Dept Pediat, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of British Columbia; University of Alberta; University of Alberta	Teh, HS (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.		Teh, Hung-Sia/A-5710-2008	Priatel, John/0000-0001-8794-6306				ABEROLAILA J, 1995, NATURE, V373, P620; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; Bommhardt U, 2000, J IMMUNOL, V164, P2326, DOI 10.4049/jimmunol.164.5.2326; CARLOW DA, 1992, J IMMUNOL, V148, P1595; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Chow S, 2001, CYTOMETRY, V46, P72, DOI 10.1002/cyto.1067; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; KELLY KA, 1993, EUR J IMMUNOL, V23, P1922, DOI 10.1002/eji.1830230829; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; Lorenzo PS, 2001, CANCER RES, V61, P943; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; Mariathasan S, 2000, EUR J IMMUNOL, V30, P1060, DOI 10.1002/(SICI)1521-4141(200004)30:4<1060::AID-IMMU1060>3.0.CO;2-2; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; Maurice MM, 2001, P NATL ACAD SCI USA, V98, P7437, DOI 10.1073/pnas.141143298; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Motyka B, 1998, J IMMUNOL, V160, P77; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Priatel JJ, 2001, J IMMUNOL, V167, P6188, DOI 10.4049/jimmunol.167.11.6188; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Roose J, 2000, NAT IMMUNOL, V1, P275, DOI 10.1038/79713; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; Udaka K, 1996, J IMMUNOL, V157, P670; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Yun TJ, 2001, NAT IMMUNOL, V2, P13, DOI 10.1038/83118	53	124	127	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2002	17	5					617	627		10.1016/S1074-7613(02)00451-X	http://dx.doi.org/10.1016/S1074-7613(02)00451-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433368	Bronze			2022-12-18	WOS:000179335100008
J	Edelson, BT; Unanue, ER				Edelson, BT; Unanue, ER			Intracellular antibody neutralizes Listeria growth	IMMUNITY			English	Article							T-CELL RESPONSE; NITRIC-OXIDE; MONOCLONAL-ANTIBODIES; REACTIVE OXYGEN; PERITONEAL-MACROPHAGES; ENDOTHELIAL-CELLS; PHOSPHOLIPASE-C; MONOCYTOGENES; INFECTION; ACTIVATION	We previously reported that treatment of mice with a neutralizing mAb against listeriolysin O (LLO), the pore-forming toxin of Listeria monocytogenes, provided resistance to this intracellular bacterium. We evaluated whether anti-LLO mAb would affect Listeria handling by macrophages, essential cells in Listeria resistance. Macrophages infected in the presence of anti-LLO mAb showed a marked reduction in intracellular Listeria growth, with a concomitant block in LLO-dependent Listeria passage from phagosome to cytosol. Anti-LLO mAb did not opsonize Listeria but, rather, acted within macrophages to neutralize LLO. Importantly, anti-LLO mAb effects on Listeria growth were independent of Fc gamma receptor expression, IFN gamma signaling, and production of nitric oxide and superoxide. These results identify a novel mechanism for antibody control of bacteria within macrophages.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Edelson, BT (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.			Edelson, Brian/0000-0003-2856-7650				Alvarez-Dominguez C, 1998, J BIOL CHEM, V273, P33901, DOI 10.1074/jbc.273.51.33901; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; BECKERMAN KP, 1993, J IMMUNOL, V150, P888; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Busch DH, 1999, IMMUNOL REV, V172, P163, DOI 10.1111/j.1600-065X.1999.tb01364.x; Casadevall A, 1998, TRENDS MICROBIOL, V6, P102, DOI 10.1016/S0966-842X(98)01208-6; CORBETT JA, 1992, DIABETES, V41, P552, DOI 10.2337/diabetes.41.4.552; DECHASTELLIER C, 1994, INFECT IMMUN, V62, P543, DOI 10.1128/IAI.62.2.543-553.1994; Edelson BT, 1999, J IMMUNOL, V163, P4087; Fehr T, 1997, J EXP MED, V185, P921, DOI 10.1084/jem.185.5.921; Fleming SD, 1997, IMMUNOL REV, V158, P69, DOI 10.1111/j.1600-065X.1997.tb00993.x; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; Gardner PR, 1996, ARCH BIOCHEM BIOPHYS, V325, P20, DOI 10.1006/abbi.1996.0003; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; GOLLINS SW, 1986, NATURE, V321, P244, DOI 10.1038/321244a0; Guzman CA, 1996, MOL MICROBIOL, V20, P119, DOI 10.1111/j.1365-2958.1996.tb02494.x; HIGGINBOTHAM JN, 1992, CLIN EXP IMMUNOL, V88, P492; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; INOUE S, 1995, INFECT IMMUN, V63, P1876, DOI 10.1128/IAI.63.5.1876-1886.1995; Kayal S, 1999, MOL MICROBIOL, V31, P1709, DOI 10.1046/j.1365-2958.1999.01305.x; LEENEN PJM, 1994, J IMMUNOL, V153, P5141; LEVINE B, 1991, SCIENCE, V254, P856, DOI 10.1126/science.1658936; MACKANESS GB, 1962, J EXP MED, V116, P381, DOI 10.1084/jem.116.3.381; MAZANEC MB, 1992, P NATL ACAD SCI USA, V89, P6901, DOI 10.1073/pnas.89.15.6901; MAZANEC MB, 1995, J VIROL, V69, P1339, DOI 10.1128/JVI.69.2.1339-1343.1995; MELLMAN IS, 1983, J CELL BIOL, V96, P887, DOI 10.1083/jcb.96.3.887; Merrick JC, 1997, AM J PATHOL, V151, P785; MIKI K, 1964, J EXP MED, V120, P93, DOI 10.1084/jem.120.1.93; NATO F, 1991, INFECT IMMUN, V59, P4641, DOI 10.1128/IAI.59.12.4641-4646.1991; Nishibori T, 1996, INFECT IMMUN, V64, P3188, DOI 10.1128/IAI.64.8.3188-3195.1996; Ohya S, 1998, INFECT IMMUN, V66, P4043; Ohya S, 1998, J MED MICROBIOL, V47, P211, DOI 10.1099/00222615-47-3-211; OSEBOLD JW, 1957, J IMMUNOL, V78, P262; Pierce MM, 1996, J MED MICROBIOL, V45, P258, DOI 10.1099/00222615-45-4-258; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Sibelius U, 1996, INFECT IMMUN, V64, P674, DOI 10.1128/IAI.64.2.674-676.1996; Sibelius U, 1999, INFECT IMMUN, V67, P1125, DOI 10.1128/IAI.67.3.1125-1130.1999; STEINMAN RM, 1972, J CELL BIOL, V55, P186, DOI 10.1083/jcb.55.1.186; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tang P, 1996, INFECT IMMUN, V64, P2359, DOI 10.1128/IAI.64.6.2359-2361.1996; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; Via LE, 1998, J CELL SCI, V111, P897; VILLANUEVA MS, 1995, J IMMUNOL, V155, P5227; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770	51	124	136	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2001	14	5					503	512		10.1016/S1074-7613(01)00139-X	http://dx.doi.org/10.1016/S1074-7613(01)00139-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371353	Bronze			2022-12-18	WOS:000168880900003
J	Fujimoto, M; Bradney, AP; Poe, JC; Steeber, DA; Tedder, TF				Fujimoto, M; Bradney, AP; Poe, JC; Steeber, DA; Tedder, TF			Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop	IMMUNITY			English	Article							LYN-DEFICIENT MICE; TYROSINE-PHOSPHATASE 1C; CELL ACTIVATION; NEGATIVE REGULATOR; IMMUNOGLOBULIN SUPERFAMILY; CD22-DEFICIENT MICE; AUTOIMMUNE-DISEASE; CA2+ MOBILIZATION; KINASE LYN; MOTH-EATEN	CD19 and CD22 are B lymphocyte cell-surface molecules that positively and negatively regulate antigen receptor signal transduction, respectively. Biochemical studies with B cells from CD19-deficient and CD22-deficient mice indicated that these two regulatory molecules influenced each other's functions: CD22 expression negatively regulated CD19 tyrosine phosphorylation, while optimal CD22 function was dependent on CD19 expression. Functional CD19 and CD22 interactions were also assessed in vivo by generating CD19/CD22 double-deficient mice. Remarkably, the CD19 mutation was dominant to the CD22 mutation in most instances. B lymphocytes from CD19/CD22-deficient and CD19-deficient mice were functionally equivalent despite the negative influence normally provided by CD22 expression. These data collectively suggest that CD19 activates the CD22/SHP1 inhibitory pathway that then acts primarily on CD19.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.			Poe, Jonathan/0000-0002-7789-1564; Fujimoto, Manabu/0000-0002-3062-4872	NATIONAL CANCER INSTITUTE [R01CA081776, R01CA054464, R55CA054464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL050985] Funding Source: NIH RePORTER; NCI NIH HHS [CA-81776, CA-54464] Funding Source: Medline; NHLBI NIH HHS [HL-50985] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Buhl AM, 1999, J IMMUNOL, V162, P4438; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; Carroll MC, 1998, SEMIN IMMUNOL, V10, P279, DOI 10.1006/smim.1998.0120; Carter RH, 1997, J IMMUNOL, V158, P3062; CHALUPNY NJ, 1993, EMBO J, V12, P2691, DOI 10.1002/j.1460-2075.1993.tb05930.x; Chan VWF, 1998, CURR BIOL, V8, P545, DOI 10.1016/S0960-9822(98)70223-4; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Cyster JG, 1997, IMMUNITY, V6, P509, DOI 10.1016/S1074-7613(00)80339-8; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DeFranco AL, 1998, SEMIN IMMUNOL, V10, P299, DOI 10.1006/smim.1998.0122; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; ENGEL P, 1993, J IMMUNOL, V150, P4719; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fujimoto M, 1999, J IMMUNOL, V162, P7088; Fujimoto M, 1998, SEMIN IMMUNOL, V10, P267, DOI 10.1006/smim.1998.9999; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hippen KL, 1997, IMMUNITY, V7, P49, DOI 10.1016/S1074-7613(00)80509-9; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; Krop I, 1996, J IMMUNOL, V157, P48; LANKESTER AC, 1995, J BIOL CHEM, V270, P20305, DOI 10.1074/jbc.270.35.20305; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; Li XL, 1997, J IMMUNOL, V158, P5649; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pani G, 1997, J EXP MED, V186, P581, DOI 10.1084/jem.186.4.581; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Sato S, 1998, SEMIN IMMUNOL, V10, P287, DOI 10.1006/smim.1998.0121; Sato S, 1997, P NATL ACAD SCI USA, V94, P13158, DOI 10.1073/pnas.94.24.13158; Sato S, 1997, J IMMUNOL, V158, P4662; Sato S, 1996, J IMMUNOL, V157, P4371; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SCHULTE RJ, 1992, SCIENCE, V258, P1001, DOI 10.1126/science.1279802; Siminovitch KA, 1998, SEMIN IMMUNOL, V10, P329, DOI 10.1006/smim.1998.0125; Smith BP, 1998, EXP APPL ACAROL, V22, P187, DOI 10.1023/A:1006010230247; Tedder TF, 1998, SEMIN IMMUNOL, V10, P259, DOI 10.1006/smim.1998.0118; TEDDER TF, 1989, J IMMUNOL, V143, P712; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; Tuscano JM, 1996, EUR J IMMUNOL, V26, P1246, DOI 10.1002/eji.1830260610; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; UCKUN FM, 1993, J BIOL CHEM, V268, P21172; WENG WK, 1994, J BIOL CHEM, V269, P32514; WILSON GL, 1991, J EXP MED, V173, P137, DOI 10.1084/jem.173.1.137; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884	58	124	124	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	1999	11	2					191	200		10.1016/S1074-7613(00)80094-1	http://dx.doi.org/10.1016/S1074-7613(00)80094-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485654	Bronze			2022-12-18	WOS:000082383400008
J	Whitehurst, CE; Chattopadhyay, S; Chen, JZ				Whitehurst, CE; Chattopadhyay, S; Chen, JZ			Control of V(D)J recombinational accessibility of the D beta 1 gene segment at the TCR beta locus by a germline promoter	IMMUNITY			English	Article							TARGETED DELETION; CELL DEVELOPMENT; ALPHA-ENHANCER; IG-KAPPA; B-CELLS; REARRANGEMENT; CHROMATIN; DNA; SEQUENCES; ELEMENTS	The germline promoter region upstream of the D beta 1 gene segment in the murine TCR beta locus was deleted to assess its role in controlling V(D)J recombination. Associated with diminished D beta 1 region germline transcription, rearrangement of the D beta 1 but not the D beta 2 gene segment was reduced 10- to 20-fold. A corresponding reduction in RAG-mediated cleavage at the D beta 1 and J beta 1 signal sequences was apparent only when purified CD4(-)CD8(-) thymocytes were analyzed because, as we demonstrate, cleavage at these gene segments also occurred in CD4(+)CD8(+) thymocytes. These findings suggest that germline promoters regulate localized accessibility of gene segments for recombination and that in CD4(+)CD8(+) thymocytes TCR beta allelic exclusion does not result from inaccessibility of D beta gene segments.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chen, JZ (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.			Whitehurst, Charles/0000-0003-3112-5458	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040146] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40146] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; Baker JE, 1998, IMMUNITY, V9, P159, DOI 10.1016/S1074-7613(00)80598-1; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; Chattopadhyay S, 1998, J IMMUNOL, V160, P1256; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Danska J S, 1997, Semin Immunol, V9, P199, DOI 10.1006/smim.1997.0072; FEENEY AJ, 1991, J EXP MED, V174, P115, DOI 10.1084/jem.174.1.115; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; GODFREY DI, 1994, J IMMUNOL, V152, P4783; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Grawunder U, 1998, CURR OPIN IMMUNOL, V10, P172, DOI 10.1016/S0952-7915(98)80246-X; Hempel WM, 1998, GENE DEV, V12, P2305, DOI 10.1101/gad.12.15.2305; Hempel WM, 1998, ADV IMMUNOL, V69, P309, DOI 10.1016/S0065-2776(08)60610-0; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; JENUWEIN T, 1993, COLD SPRING HARB SYM, V58, P97, DOI 10.1101/SQB.1993.058.01.013; LANSFORD R, 1996, MOL IMMUNOL, P1; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; Levelt CN, 1995, IMMUNITY, V3, P667, DOI 10.1016/1074-7613(95)90056-X; McMurry MT, 1997, MOL CELL BIOL, V17, P4553, DOI 10.1128/MCB.17.8.4553; OKADA A, 1994, J EXP MED, V180, P261, DOI 10.1084/jem.180.1.261; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Senoo M, 1998, INT IMMUNOL, V10, P553, DOI 10.1093/intimm/10.5.553; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; Sikes ML, 1998, J IMMUNOL, V161, P1399; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4	36	124	124	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1999	10	3					313	322		10.1016/S1074-7613(00)80031-X	http://dx.doi.org/10.1016/S1074-7613(00)80031-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204487	Bronze			2022-12-18	WOS:000079455700004
J	CRISPE, IN				CRISPE, IN			FATAL INTERACTIONS - FAS-INDUCED APOPTOSIS OF MATURE T-CELLS	IMMUNITY			English	Article							LPR/LPR MICE; LPR MICE; RECEPTOR; ANTIGEN; EXPRESSION; DELETION; SELECTION; TOLERANCE; ORIGIN; DEATH				CRISPE, IN (corresponding author), YALE UNIV,SCH MED,IMMUNOBIOL SECT,333 CEDAR ST,NEW HAVEN,CT 06520, USA.							AKBAR AN, 1993, J EXP MED, V178, P427, DOI 10.1084/jem.178.2.427; BUDD RC, 1987, J IMMUNOL, V139, P2200; Crispe I N, 1994, Semin Immunol, V6, P39, DOI 10.1006/smim.1994.1006; DAVIDSON WF, 1986, J IMMUNOL, V136, P4075; HUANG L, 1993, J IMMUNOL, V151, P1844; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KOTZIN BL, 1988, J EXP MED, V168, P2221, DOI 10.1084/jem.168.6.2221; MAMALAKI C, 1993, INT IMMUNOL, V5, P1285, DOI 10.1093/intimm/5.10.1285; MIYAWAKI T, 1992, J IMMUNOL, V149, P3753; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; OHTEKI T, 1992, J IMMUNOL, V149, P1562; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SCOTT DE, 1993, J IMMUNOL, V150, P664; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SIDMAN CL, 1992, EUR J IMMUNOL, V22, P499, DOI 10.1002/eji.1830220231; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SINGER PA, 1990, J AUTOIMMUN, V3, P123, DOI 10.1016/0896-8411(90)90136-G; SINGER PA, 1989, J EXP MED, V170, P1869, DOI 10.1084/jem.170.6.1869; SMYTH L, 1992, DEV IMMUNOL, V3, P309; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; VONBOEHMER H, 1986, IMMUNOL TODAY, V7, P333; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; ZHOU T, 1993, J IMMUNOL, V150, P3651; ZHOU T, 1991, J IMMUNOL, V147, P468	29	124	128	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					347	349						3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7533643				2022-12-18	WOS:A1994PK16800002
J	Szabo, PA; Dogra, P; Gray, JI; Wells, SB; Connors, TJ; Weisberg, SP; Krupska, I; Matsumoto, R; Poon, MML; Idzikowski, E; Morris, SE; Pasin, C; Yates, AJ; Ku, A; Chait, M; Davis-Porada, J; Guo, XV; Zhou, J; Steinle, M; Mackay, S; Saqi, A; Baldwin, MR; Sims, PA; Farber, DL				Szabo, Peter A.; Dogra, Pranay; Gray, Joshua, I; Wells, Steven B.; Connors, Thomas J.; Weisberg, Stuart P.; Krupska, Izabela; Matsumoto, Rei; Poon, Maya M. L.; Idzikowski, Emma; Morris, Sinead E.; Pasin, Chloe; Yates, Andrew J.; Ku, Amy; Chait, Michael; Davis-Porada, Julia; Guo, Xinzheng, V; Zhou, Jing; Steinle, Matthew; Mackay, Sean; Saqi, Anjali; Baldwin, Matthew R.; Sims, Peter A.; Farber, Donna L.			Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19	IMMUNITY			English	Article							MEMORY T-CELLS; INFECTION; COMPARTMENTALIZATION; MACROPHAGES; HOMEOSTASIS; OUTCOMES; SUBSETS; SEPSIS; SCORE	Immune response dynamics in coronavirus disease 2019 (COVID-19) and their severe manifestations have largely been studied in circulation. Here, we examined the relationship between immune processes in the respiratory tract and circulation through longitudinal phenotypic, transcriptomic, and cytokine profiling of paired airway and blood samples from patients with severe COVID-19 relative to heathy controls. In COVID-19 airways, T cells exhibited activated, tissue-resident, and protective profiles; higher T cell frequencies correlated with survival and younger age. Myeloid cells in COVID-19 airways featured hyperinflammatory signatures, and higher frequencies of these cells correlated withmortality and older age. In COVID-19 blood, aberrant CD163(+) monocytes predominated over conventional monocytes, and were found in corresponding airway samples and in damaged alveoli. High levels of myeloid chemoattractants in airways suggest recruitment of these cells through a CCL2-CCR2 chemokine axis. Our findings provide insights into immune processes drivingCOVID-19 lung pathology with therapeutic implications for targeting inflammation in the respiratory tract.	[Szabo, Peter A.; Dogra, Pranay; Gray, Joshua, I; Poon, Maya M. L.; Farber, Donna L.] Columbia Univ, Dept Microbiol & Immunol, Irving Med Ctr, New York, NY 10032 USA; [Wells, Steven B.; Krupska, Izabela; Sims, Peter A.] Columbia Univ, Dept Syst Biol, Irving Med Ctr, New York, NY 10032 USA; [Connors, Thomas J.; Idzikowski, Emma] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10032 USA; [Weisberg, Stuart P.; Morris, Sinead E.; Pasin, Chloe; Yates, Andrew J.; Ku, Amy; Chait, Michael; Saqi, Anjali] Columbia Univ, Dept Pathol & Cell Biol, Irving Med Ctr, New York, NY 10032 USA; [Matsumoto, Rei; Farber, Donna L.] Columbia Univ, Dept Surg, Irving Med Ctr, New York, NY 10032 USA; [Poon, Maya M. L.; Davis-Porada, Julia] Columbia Univ, Med Scientist Training Program, New York, NY 10032 USA; [Guo, Xinzheng, V] Columbia Univ, Human Immune Monitoring Core, Irving Med Ctr, New York, NY 10032 USA; [Zhou, Jing; Steinle, Matthew; Mackay, Sean] IsoPlexis Corp, Branford, CT 06405 USA; [Baldwin, Matthew R.] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY 10032 USA; [Sims, Peter A.] Columbia Univ, Dept Biochem & Mol Biophys, Irving Med Ctr, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Farber, DL (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Irving Med Ctr, New York, NY 10032 USA.; Farber, DL (corresponding author), Columbia Univ, Dept Surg, Irving Med Ctr, New York, NY 10032 USA.	df2396@cumc.columbia.edu	Guo, Xinzheng Victor/ABG-2980-2021; Baldwin, Matthew/GQY-7234-2022	Guo, Xinzheng Victor/0000-0003-0499-9870; Weisberg, Stuart/0000-0002-8698-5976; Szabo, Peter Anthony/0000-0003-1603-761X; Davis-Porada, Julia/0000-0001-9313-4590; Wells, Steven/0000-0001-5428-0683; Pasin, Chloe/0000-0001-8730-790X; Connors, Thomas/0000-0002-0199-7733; , Maya/0000-0002-7927-5853	NIH [K08 DK122130, AI128949, AI06697, K23 A1141686]; Chan Zuckerberg Initiative COVID-19 grant; CRI-Irvington Postdoctoral Fellowship; Canadian Institutes of Health Research Fellowship; NCI cancer center support grant [P30CA013696];  [AI093870];  [AI150680]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chan Zuckerberg Initiative COVID-19 grant; CRI-Irvington Postdoctoral Fellowship; Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); NCI cancer center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; 	We wish to express our gratitude to the medical ICU nurse champions Cora Garcellano, Tenzin Drukdak, Harriet Avila Raymundo, LoriWagner, and Ricky Lee, who led the efforts to obtain patient samples for the severe COVID-19 patients; to Evelyn Hernandez and Lorena Gomez for their roles as clinical coordinators; and to the nurses and clinical staff in the Pediatric Intensive Care Unit of MSCHONY. We acknowledge the dedication, commitment, and sacrifice of the other nurses, providers, and personnel who helped care for these patients during the COVID-19 crisis. We acknowledge the suffering and loss of our COVID-19 patients and of their families and our community. We gratefully acknowledge the generosity of the donor families and the exceptional efforts of LiveOnNY transplant coordinators and staff for the organ donor lungs. This work was supported by NIH grants AI128949 and AI06697 awarded to D.L.F., a Chan Zuckerberg Initiative COVID-19 grant to D.L.F. and P.A. Sims, and AI093870 and AI150680 awarded to A.J.Y. P.D. was supported by a CRI-Irvington Postdoctoral Fellowship, and P. A. Szabo was supported by a Canadian Institutes of Health Research Fellowship. T.J.C. is supported by NIH K23 A1141686, and S.P.W. is supported by NIH K08 DK122130. Research reported in this publication was performed in the Human Immune Monitoring Core, the Columbia Single Cell Analysis Core, and the Sulzberger Columbia Genome Center, which are supported by NCI cancer center support grant P30CA013696. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank Eldad Hod for the use of his laboratory for sample processing, and Carly Ziegler and Dr. Alex Shalek of MIT for sharing their merged human SARS-CoV-2 genome and transcriptome annotation.	Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Bharat A, 2016, AM J RESP CELL MOL, V54, P147, DOI 10.1165/rcmb.2015-0147LE; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Carpenter DJ, 2018, AM J TRANSPLANT, V18, P74, DOI 10.1111/ajt.14434; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Cole SL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91868; Connors TJ, 2018, J IMMUNOL, V201, P432, DOI 10.4049/jimmunol.1800396; Connors TJ, 2016, AM J RESP CELL MOL, V54, P822, DOI 10.1165/rcmb.2015-0297OC; Cummings Matthew J, 2020, Lancet, V395, P1763, DOI [10.1101/2020.04.15.20067157, 10.1016/S0140-6736(20)31189-2]; Damiani S, 2021, J PATHOL, V253, P31, DOI 10.1002/path.5549; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; De Michele S, 2020, AM J CLIN PATHOL, V154, P748, DOI 10.1093/ajcp/aqaa156; Della-Torre E, 2020, ANN RHEUM DIS, V79, P1277, DOI [10.1136/annrheumdis-2020-218122, 10.1136/annrheumdis-2020-218612]; Dogra P, 2020, CELL, V180, P749, DOI 10.1016/j.cell.2020.01.022; Farhadian Shelli, 2020, Res Sq, DOI [10.1186/s12883-020-01812-2, 10.21203/rs.3.rs-28583/v1]; Furlow B, 2020, LANCET RHEUMATOL, V2, pE592, DOI 10.1016/S2665-9913(20)30313-1; Garibaldi BT, 2021, ANN INTERN MED, V174, P33, DOI 10.7326/M20-3905; Gartrell RD, 2018, CANCER IMMUNOL RES, V6, P481, DOI 10.1158/2326-6066.CIR-17-0360; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Griffiths JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05083-x; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hassan AO, 2020, CELL, V183, P169, DOI 10.1016/j.cell.2020.08.026; Hendrix AY, 2017, PROG MOL BIOL TRANSL, V148, P1, DOI 10.1016/bs.pmbts.2017.04.004; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Jeyanathan M, 2020, NAT REV IMMUNOL, V20, P615, DOI 10.1038/s41577-020-00434-6; Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97; Kapellos TS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02035; Khemani RG, 2015, PEDIATR CRIT CARE ME, V16, pS23, DOI 10.1097/PCC.0000000000000432; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Levitin HM, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188557; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Lin KL, 2011, J IMMUNOL, V186, P508, DOI 10.4049/jimmunol.1001002; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Matics TJ, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.2352; Melsted P, 2019, MODULAR EFFICIENT PR, DOI [10.1101/673285, DOI 10.1101/673285]; Melsted P, 2019, BIOINFORMATICS, V35, P4472, DOI 10.1093/bioinformatics/btz279; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Morrell ED, 2019, AM J RESP CRIT CARE, V200, P732, DOI 10.1164/rccm.201807-1381OC; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC; Paik DH, 2021, J EXP MED, V218, DOI 10.1084/jem.20200218; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Schultze JL, 2019, IMMUNITY, V50, P288, DOI 10.1016/j.immuni.2019.01.019; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Silvin A, 2020, CELL, V182, P1401, DOI 10.1016/j.cell.2020.08.002; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Snyder ME, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav5581; Szabo PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12464-3; Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thieme CJ, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100092; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vasilevskis EE, 2016, CRIT CARE MED, V44, P138, DOI 10.1097/CCM.0000000000001375; Venet F, 2021, ANN NY ACAD SCI, V1499, P3, DOI 10.1111/nyas.14333; Veras F.P., 2020, J EXP MED, V217; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Weisberg SP, 2021, NAT IMMUNOL, V22, P25, DOI 10.1038/s41590-020-00826-9; Weisberg SP, 2019, CELL REP, V29, P3916, DOI 10.1016/j.celrep.2019.11.056; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yoo JK, 2013, J ALLERGY CLIN IMMUN, V132, P1263, DOI 10.1016/j.jaci.2013.06.006; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006	87	123	123	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					797	+		10.1016/j.immuni.2021.03.005	http://dx.doi.org/10.1016/j.immuni.2021.03.005		APR 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33765436	Green Published, Bronze			2022-12-18	WOS:000640102800018
J	Boothby, M; Rickert, RC				Boothby, Mark; Rickert, Robert C.			Metabolic Regulation of the Immune Humoral Response	IMMUNITY			English	Review							GERMINAL CENTER B; CLASS-SWITCH RECOMBINATION; T-CELL DIFFERENTIATION; EMBRYONIC STEM-CELLS; ATP-CITRATE LYASE; KINASE C-BETA; NF-KAPPA-B; MEMORY B; TRANSCRIPTION FACTORS; PLASMA-CELLS	Productive humoral responses require that naive B cells and their differentiated progeny move among distinct micro-environments. In this review, we discuss how studies are beginning to address the nature of these niches as well as the interplay between cellular signaling, metabolic programming, and adaptation to the locale. Recent work adds evidence to the expectation that B cells at distinct stages of development or functional subsets are influenced by the altered profiles of nutrients and metabolic by-products that distinguish these sites. Moreover, emerging findings reveal a cross-talk among the external milieu, signal transduction pathways, and transcription factors that direct B cell fate in the periphery.	[Boothby, Mark] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Boothby, Mark] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Boothby, Mark] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Boothby, Mark] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Boothby, Mark] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Rickert, Robert C.] Sanford Burnham Prebys Med Discovery Inst SBP, Tumor Microenvironm & Canc Immunol Program, La Jolla, CA 92037 USA; [Rickert, Robert C.] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Sanford Burnham Prebys Medical Discovery Institute	Boothby, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Boothby, M (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.; Boothby, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA.; Boothby, M (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA.; Boothby, M (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.; Rickert, RC (corresponding author), Sanford Burnham Prebys Med Discovery Inst SBP, Tumor Microenvironm & Canc Immunol Program, La Jolla, CA 92037 USA.; Rickert, RC (corresponding author), Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA.	mark.boothby@vanderbilt.edu; robert@SBPdiscovery.org			NIH [AI113292, HL106812, AI41649]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI113292, R21AI109690, R01AI041649, R01AI113292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors apologize in advance for and regret any omissions, either unintended or due to space limitations or a chosen focus on events after B cell maturation and exclusion of the complex topics involving malignant B lineage cells. We gratefully acknowledge a critical reading of drafts by A. Raybuck and J. Jellusova. Preparation of this review was supported by NIH grants AI113292 (M.B.), HL106812 (M.B.), and AI41649 (R.C.R.).	AAGAARDTILLERY KM, 1994, CELL IMMUNOL, V156, P493, DOI 10.1006/cimm.1994.1193; Abbott RK, 2016, J IMMUNOL, V197, P4014, DOI 10.4049/jimmunol.1601401; Adams WC, 2016, CELL REP, V17, P3142, DOI 10.1016/j.celrep.2016.11.065; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Arnold J, 2016, CELL DEATH DIFFER, V23, P853, DOI 10.1038/cdd.2015.149; Aronov M, 2016, J CLIN IMMUNOL, V36, pS12, DOI 10.1007/s10875-016-0246-9; Baracho GV, 2014, P NATL ACAD SCI USA, V111, P9573, DOI 10.1073/pnas.1314562111; Barnett BE, 2012, SCIENCE, V335, P342, DOI 10.1126/science.1213495; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Blair D, 2012, BIOCHEM J, V448, P165, DOI 10.1042/BJ20121225; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Calamito M, 2010, BLOOD, V115, P4043, DOI 10.1182/blood-2009-09-241638; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cantor J, 2009, NAT IMMUNOL, V10, P412, DOI 10.1038/ni.1712; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chan LN, 2017, NATURE, V542, P479, DOI 10.1038/nature21076; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chen M, 2015, J IMMUNOL, V194, P2607, DOI 10.4049/jimmunol.1403001; Chen M, 2014, NAT MED, V20, P507, DOI 10.1038/nm.3521; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Cho SH, 2011, P NATL ACAD SCI USA, V108, P15972, DOI 10.1073/pnas.1017082108; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Clarke AJ, 2015, ANN RHEUM DIS, V74, P912, DOI 10.1136/annrheumdis-2013-204343; Comb W.C., 2015, NATURE, V517, P302; Corcoran LM, 2016, CURR OPIN IMMUNOL, V39, P59, DOI 10.1016/j.coi.2015.12.008; Das F, 2016, AM J PHYSIOL-CELL PH, V310, pC583, DOI 10.1152/ajpcell.00266.2015; Davey AM, 2012, J IMMUNOL, V188, P3332, DOI 10.4049/jimmunol.1102322; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Dominguez-Sola D., 2012, NAT IMMUNOL, V13, P1083; Dufort FJ, 2007, J IMMUNOL, V179, P4953, DOI 10.4049/jimmunol.179.8.4953; Dufort FJ, 2014, J BIOL CHEM, V289, P7011, DOI 10.1074/jbc.M114.551051; Garcia-Alvarez G, 2007, BBA-MOL CELL RES, V1773, P375, DOI 10.1016/j.bbamcr.2006.09.015; Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gloury R, 2016, J EXP MED, V213, P1095, DOI 10.1084/jem.20152003; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Haniuda K, 2016, NAT IMMUNOL, V17, P1109, DOI 10.1038/ni.3508; Hawkins ED, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2796; Heinzel S, 2017, NAT IMMUNOL, V18, P96, DOI 10.1038/ni.3598; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Henley T, 2008, EUR J IMMUNOL, V38, P3543, DOI 10.1002/eji.200838618; HENRIKSSON J, 1988, AM J PHYSIOL, V255, pC543, DOI 10.1152/ajpcell.1988.255.4.C543; HENRIKSSON J, 1986, AM J PHYSIOL, V251, pC614, DOI 10.1152/ajpcell.1986.251.4.C614; Hobeika E, 2015, EMBO J, V34, P925, DOI 10.15252/embj.201489732; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jellusova J, 2017, NAT IMMUNOL, V18, P303, DOI 10.1038/ni.3664; Jellusova J, 2016, CRIT REV BIOCHEM MOL, V51, P359, DOI 10.1080/10409238.2016.1215288; Jellusova J, 2013, CELL REP, V5, P1022, DOI 10.1016/j.celrep.2013.10.022; Jones DD, 2016, J CLIN INVEST, V126, P4250, DOI 10.1172/JCI86504; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kobayashi N, 2003, BLOOD, V102, P3186, DOI 10.1182/blood-2003-02-0567; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Laffleur B, 2015, CELL REP, V10, P900, DOI 10.1016/j.celrep.2015.01.023; Lam WY, 2016, IMMUNITY, V45, P60, DOI 10.1016/j.immuni.2016.06.011; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lee IH, 2013, CURR OPIN CELL BIOL, V25, P724, DOI 10.1016/j.ceb.2013.07.002; Lee K, 2013, BLOOD, V122, P2369, DOI 10.1182/blood-2013-01-477505; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Limon JJ, 2014, P NATL ACAD SCI USA, V111, pE5076, DOI 10.1073/pnas.1407104111; Lin WHW, 2015, CELL REP, V13, P2203, DOI 10.1016/j.celrep.2015.10.072; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Luo W., 2011, CELL, V145, P732; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; MANCHESTER J, 1994, AM J PHYSIOL, V266, pE326, DOI 10.1152/ajpendo.1994.266.3.E326; Matsuda S, 2009, BLOOD, V113, P1037, DOI 10.1182/blood-2008-06-163725; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mayer A, 2008, EUR J IMMUNOL, V38, P948, DOI 10.1002/eji.200738045; Melchers F, 2015, J CLIN INVEST, V125, P2203, DOI 10.1172/JCI78083; Mendez A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004696; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Oldham WM, 2015, CELL METAB, V22, P291, DOI 10.1016/j.cmet.2015.06.021; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Pierce SK, 2013, COLD SH Q B, V78, P231, DOI 10.1101/sqb.2013.78.020206; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Recaldin T, 2016, CLIN EXP IMMUNOL, V183, P65, DOI 10.1111/cei.12702; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Sage PT, 2016, NAT IMMUNOL, V17, P1436, DOI 10.1038/ni.3578; Sajic T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02350; Salzer E, 2016, J CLIN IMMUNOL, V36, P631, DOI 10.1007/s10875-016-0323-0; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Shackelford D.B., 2008, MOL CELL, V30, P214; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; Wienands J, 2016, CURR TOP MICROBIOL, V393, P107, DOI 10.1007/82_2015_480; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Wohner M, 2016, J EXP MED, V213, P1201, DOI 10.1084/jem.20152002; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yang ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.21238; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	143	123	123	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					743	755		10.1016/j.immuni.2017.04.009	http://dx.doi.org/10.1016/j.immuni.2017.04.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514675	Green Accepted, Bronze			2022-12-18	WOS:000401316300004
J	Norata, GD; Caligiuri, G; Chavakis, T; Matarese, G; Netea, MG; Nicoletti, A; O'Neill, LAJ; Marelli-Berg, FM				Norata, Giuseppe Danilo; Caligiuri, Giuseppina; Chavakis, Triantafyllos; Matarese, Giuseppe; Netea, Mihai Gheorge; Nicoletti, Antonino; O'Neill, Luke A. J.; Marelli-Berg, Federica M.			The Cellular and Molecular Basis of Translational Immunometabolism	IMMUNITY			English	Review							ADIPOSE-TISSUE INFLAMMATION; VITAMIN-B METABOLITES; REGULATORY T-CELLS; CHAIN FATTY-ACIDS; PPAR-GAMMA; NONALCOHOLIC STEATOHEPATITIS; MESSENGER-RNA; KUPFFER CELLS; ORCHESTRATE DEVELOPMENT; ALTERNATIVE ACTIVATION	The immune response requires major changes to metabolic processes, and indeed, energy metabolism and functional activation are fully integrated in immune cells to determine their ability to divide, differentiate, and carry out effector functions. Immune cell metabolism has therefore become an attractive target area for therapeutic purposes. A neglected aspect in the translation of immunometabolism is the critical connection between systemic and cellular metabolism. Here, we discuss the importance of understanding and manipulating the integration of systemic and immune cell metabolism through in-depth analysis of immune cell phenotype and function in human metabolic diseases and, in parallel, of the effects of conventional metabolic drugs on immune cell differentiation and function. We examine how the recent identification of selective metabolic programs operating in distinct immune cell subsets and functions has the potential to deliver tools for cell- and function-specific immunometabolic targeting.	[Norata, Giuseppe Danilo] Univ Milan, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy; [Norata, Giuseppe Danilo] Bassini Hosp, Ctr Study Atherosclerosis, I-20092 Milan, Italy; [Caligiuri, Giuseppina] Hop X Bichat, INSERM, U1148, F-75018 Paris, France; [Caligiuri, Giuseppina] Univ Paris Diderot, Sorbonne Paris Cite, F-75013 Paris, France; [Caligiuri, Giuseppina] Dept Hospitalouniv FIRE, F-75018 Paris, France; [Chavakis, Triantafyllos; Nicoletti, Antonino] Tech Univ Dresden, Dept Clin Pathobiochem, D-01307 Dresden, Germany; [Chavakis, Triantafyllos; Nicoletti, Antonino] Tech Univ Dresden, Inst Clin Chem & Lab Med, D-01307 Dresden, Germany; [Matarese, Giuseppe] Univ Salerno, Dipartimento Med & Chirurg, I-84081 Salerno, Italy; [Matarese, Giuseppe] IRCCS MultiMed, I-20138 Milan, Italy; [Netea, Mihai Gheorge] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [Netea, Mihai Gheorge] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 GA Nijmegen, Netherlands; [O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Marelli-Berg, Federica M.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England	University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Technische Universitat Dresden; Technische Universitat Dresden; University of Salerno; IRCCS Multimedica; Radboud University Nijmegen; Radboud University Nijmegen; Trinity College Dublin; University of London; Queen Mary University London	Norata, GD (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy.	danilo.norata@unimi.it	Matarese, Giuseppe/AAO-4077-2021; Chavakis, Triantafyllos/ABE-8845-2020; Netea, Mihai/N-5155-2014; Nicoletti, Antonino/A-9460-2015; Norata, Giuseppe Danilo/AAC-2863-2019; Caligiuri, Giuseppina/G-4810-2015	Matarese, Giuseppe/0000-0001-9429-0616; Nicoletti, Antonino/0000-0002-2623-0897; Caligiuri, Giuseppina/0000-0003-4973-2205; O'Neill, Luke/0000-0002-4333-2748; Norata, Giuseppe Danilo/0000-0002-6081-1257	Telethon Foundation [GGP13002]; UNIMI Piano di Ricerca B; Ministero della Salute [WFR GR-2011-02346974]; ANR-France; EU FP7 program; Deutsche Forschungsgemeinschaft [CH279/5-1]; ERC (ENDHOMRET); ERC [310496]; Fondazione Italiana Sclerosi Multipla (FISM) [2012/R/11]; ERC Consolidator Grant [310372]; INSERM; Region Ile de France (CORDDIM); Fondation de la Recherche Medicale (FRM); Fondation de France (FdF); Science Foundation Ireland; British Heart Foundation [RG/14/2/30616]; Bill and Melinda Gates Foundation [OPP1043517]	Telethon Foundation(Fondazione Telethon); UNIMI Piano di Ricerca B; Ministero della Salute(Ministry of Health, Italy); ANR-France(French National Research Agency (ANR)); EU FP7 program(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC (ENDHOMRET); ERC(European Research Council (ERC)European Commission); Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); ERC Consolidator Grant(European Research Council (ERC)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Ile de France (CORDDIM)(Region Ile-de-France); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation de France (FdF)(Fondation de France); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); British Heart Foundation(British Heart Foundation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The authors are part of the European Working Group on Immunomentabolism (IMMUNOMET). G.D.N. is supported by Telethon Foundation GGP13002, UNIMI 2013 Piano di Ricerca B, and Ministero della Salute WFR GR-2011-02346974. G.C. is supported by ANR-France and the EU FP7 program. T.C. is supported by the Deutsche Forschungsgemeinschaft (CH279/5-1) and by the ERC (ENDHOMRET). G.M. is supported by an ERC Starting Grant "men-TORingTregs'' (no. 310496) and a Fondazione Italiana Sclerosi Multipla (FISM) grant (no. 2012/R/11). M.G.N. is supported by an ERC Consolidator Grant (no. 310372). A.N. is supported by INSERM, the Region Ile de France (CORDDIM), the Fondation de la Recherche Medicale (FRM), and the Fondation de France (FdF). L.A.J.O. is supported by the ERC and Science Foundation Ireland. F.M.M.-B. is supported by the British Heart Foundation (RG/14/2/30616) and the Bill and Melinda Gates Foundation (OPP1043517).	Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Ammirati E, 2012, J AM HEART ASSOC, V1, P27, DOI 10.1161/JAHA.111.000125; Ammirati E, 2010, ARTERIOSCL THROM VAS, V30, P1832, DOI 10.1161/ATVBAHA.110.206813; Aouadi M, 2014, AM J PHYSIOL-ENDOC M, V307, pE374, DOI 10.1152/ajpendo.00187.2014; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arts RJW, 2015, J LEUKOCYTE BIOL, V98, P129, DOI 10.1189/jlb.6AB0914-416R; Bernstein BW, 2003, J NEUROSCI, V23, P1; Bie JH, 2012, AM J PHYSIOL-ENDOC M, V302, pE1283, DOI 10.1152/ajpendo.00511.2011; Bieghs V, 2013, LIVER INT, V33, P1056, DOI 10.1111/liv.12170; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brooks-Worrell B, 2013, DIABETES OBES METAB, V15, P137, DOI 10.1111/dom.12167; Caballero AE, 2004, J CLIN ENDOCR METAB, V89, P3943, DOI 10.1210/jc.2004-0019; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carbone F, 2014, NAT MED, V20, P69, DOI 10.1038/nm.3411; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Catapano AL, 2014, CARDIOVASC RES, V103, P372, DOI 10.1093/cvr/cvu150; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Chatzigeorgiou A, 2012, DIABETOLOGIA, V55, P2583, DOI 10.1007/s00125-012-2607-0; Chatzigeorgiou A, 2016, HANDB EXP PHARMACOL, V233, P221, DOI 10.1007/164_2015_8; Chatzigeorgiou A, 2014, HEPATOLOGY, V60, P1196, DOI 10.1002/hep.27233; Chatzigeorgioua A, 2014, P NATL ACAD SCI USA, V111, P2686, DOI 10.1073/pnas.1400419111; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Chmelar J, 2013, THROMB HAEMOSTASIS, V109, P399, DOI 10.1160/TH12-09-0703; Cipolletta D, 2015, P NATL ACAD SCI USA, V112, P482, DOI 10.1073/pnas.1423486112; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; DANIEL JL, 1986, EUR J BIOCHEM, V156, P677, DOI 10.1111/j.1432-1033.1986.tb09631.x; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Diomede L, 2001, ARTERIOSCL THROM VAS, V21, P1327, DOI 10.1161/hq0801.094222; Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fabrizi M, 2014, DIABETES, V63, P2086, DOI 10.2337/db13-0939; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; GALLACHER SJ, 1995, DIABETIC MED, V12, P916, DOI 10.1111/j.1464-5491.1995.tb00396.x; Gillespie MA, 2015, EMBO J, V34, P1244, DOI 10.15252/embj.201489819; Haas R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002202; Han JM, 2014, J IMMUNOL, V192, P623, DOI 10.4049/jimmunol.1302181; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HELDERMAN JH, 1981, J CLIN INVEST, V67, P1636, DOI 10.1172/JCI110199; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Henson SM, 2010, ADV EXP MED BIOL, V684, P189; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu X, 2015, NAT CHEM BIOL, V11, P141, DOI [10.1038/NCHEMBIO.1714, 10.1038/nchembio.1714]; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Ichiki T, 2014, TRENDS CARDIOVAS MED, V24, P197, DOI 10.1016/j.tcm.2014.03.004; Ip BC, 2015, TRENDS ENDOCRIN MET, V26, P91, DOI 10.1016/j.tem.2014.12.001; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Johnson KM, 2005, CHEM BIOL, V12, P485, DOI 10.1016/j.chembiol.2005.02.012; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kagami S, 2009, INT IMMUNOL, V21, P679, DOI 10.1093/intimm/dxp037; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kannan Y, 2012, J BIOL CHEM, V287, P23479, DOI 10.1074/jbc.M111.320960; Kim YC, 2010, IMMUNOLOGY, V130, P484, DOI 10.1111/j.1365-2567.2010.03269.x; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lv S, 2015, CLIN EXP RHEUMATOL, V33, P69; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Mandard S, 2013, PPAR RES, V2013, DOI 10.1155/2013/613864; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; MAURO VF, 1993, CLIN PHARMACOKINET, V24, P195, DOI 10.2165/00003088-199324030-00002; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Murooka TT, 2008, BLOOD, V111, P4892, DOI 10.1182/blood-2007-11-125039; MURRAY HW, 1994, AM J MED, V97, P459, DOI 10.1016/0002-9343(94)90326-3; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Norata GD, 2012, ATHEROSCLEROSIS, V220, P11, DOI 10.1016/j.atherosclerosis.2011.06.045; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Passos JF, 2006, FREE RADICAL RES, V40, P1277, DOI 10.1080/10715760600917151; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pirillo A, 2015, HANDB EXP PHARMACOL, V224, P483, DOI 10.1007/978-3-319-09665-0_15; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Reinoso RF, 2002, METHOD FIND EXP CLIN, V24, P593; Remaley AT, 2014, CARDIOVASC RES, V103, P423, DOI 10.1093/cvr/cvu141; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sala F, 2013, INT J CARDIOL, V168, P2886, DOI 10.1016/j.ijcard.2013.03.103; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Sarchielli P, 2003, ARCH NEUROL-CHICAGO, V60, P1082, DOI 10.1001/archneur.60.8.1082; Sarikonda G, 2014, J AUTOIMMUN, V50, P77, DOI 10.1016/j.jaut.2013.12.003; Schonbeck U, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000129505.34151.23; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Singhal A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009885; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sniderman AD, 2014, J AM COLL CARDIOL, V63, P1935, DOI 10.1016/j.jacc.2014.01.060; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Stentz FB, 2003, CURR DRUG TARGETS, V4, P493, DOI 10.2174/1389450033490966; Stienstra R, 2007, J HEPATOL, V46, P869, DOI 10.1016/j.jhep.2006.11.019; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Taub DD, 2013, FASEB J, V27, P342, DOI 10.1096/fj.12-217620; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Thurnher M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005970; Tisell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061817; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Tousoulis D, 2014, J AM COLL CARDIOL, V63, P2491, DOI 10.1016/j.jacc.2014.01.054; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Viardot A, 2007, ENDOCRINOLOGY, V148, P346, DOI 10.1210/en.2006-0686; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wahl DR, 2012, IMMUNOL REV, V249, P104, DOI 10.1111/j.1600-065X.2012.01148.x; Walley KR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008782; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wendel M, 2007, INTENS CARE MED, V33, P25, DOI 10.1007/s00134-006-0433-x; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yang K, 2012, SEMIN IMMUNOL, V24, P421, DOI 10.1016/j.smim.2012.12.004; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhao GJ, 2012, MOL MED, V18, P149, DOI 10.2119/molmed.2011.00183; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zhu XW, 2012, CIRC RES, V111, P1398, DOI 10.1161/CIRCRESAHA.112.269043; Zilverschoon GRC, 2008, INT J OBESITY, V32, P1407, DOI 10.1038/ijo.2008.109	165	123	128	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					421	434		10.1016/j.immuni.2015.08.023	http://dx.doi.org/10.1016/j.immuni.2015.08.023			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26377896	Green Published, Bronze			2022-12-18	WOS:000361575300006
J	Munoz, M; Eidenschenk, C; Ota, N; Wong, K; Lohmann, U; Kuhl, AA; Wang, XT; Manzanillo, P; Li, Y; Rutz, S; Zheng, Y; Diehl, L; Kayagaki, N; van Lookeren-Campagne, M; Liesenfeld, O; Heimesaat, M; Ouyang, WJ				Munoz, Melba; Eidenschenk, Celine; Ota, Naruhisa; Wong, Kit; Lohmann, Uwe; Kuehl, Anja A.; Wang, Xiaoting; Manzanillo, Paolo; Li, Yun; Rutz, Sascha; Zheng, Yan; Diehl, Lauri; Kayagaki, Nobuhiko; van Lookeren-Campagne, Menno; Liesenfeld, Oliver; Heimesaat, Markus; Ouyang, Wenjun			Interleukin-22 Induces Interleukin-18 Expression from Epithelial Cells during Intestinal Infection	IMMUNITY			English	Article							TOXOPLASMA-GONDII; INTERFERON-GAMMA; IFN-GAMMA; T-CELLS; ORAL INFECTION; HOST-DEFENSE; TNF-ALPHA; IL-18; MICE; INFLAMMATION	T helper 1 (Th1) cell-associated immunity exacerbates ileitis induced by oral Toxoplasma gondii infection. We show here that attenuated ileitis observed in interleukin-22 (IL-22)-deficient mice was associated with reduced production of Th1-cell-promoting IL-18. IL-22 not only augmented the expression of Il18 mRNA and inactive precursor protein (proIL-18) in intestinal epithelial cells after T. gondii or Citrobacter rodentium infection, but also maintained the homeostatic amount of proIL-18 in the ileum. IL-22, however, did not induce the processing to active IL-18, suggesting a two-step regulation of IL-18 in these cells. Although IL-18 exerted pathogenic functions during ileitis triggered by T. gondii, it was required for host defense against C. rodentium. Conversely, IL-18 was required for the expression of IL-22 in innate lymphoid cells (ILCs) upon T. gondii infection. Our results define IL-18 as an IL-22 target gene in epithelial cells and describe a complex mutual regulation of both cytokines during intestinal infection.	[Munoz, Melba; Lohmann, Uwe; Liesenfeld, Oliver; Heimesaat, Markus] Charite, Inst Microbiol & Hyg, D-12203 Berlin, Germany; [Eidenschenk, Celine; Ota, Naruhisa; Wong, Kit; Wang, Xiaoting; Manzanillo, Paolo; Li, Yun; Rutz, Sascha; Zheng, Yan; van Lookeren-Campagne, Menno; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Kuehl, Anja A.] Charite, Dept Med Gastroenterol Infect Dis & Rheumatol 1, D-12203 Berlin, Germany; [Kuehl, Anja A.] Charite, Res Ctr ImmunoSci RCIS, D-12203 Berlin, Germany; [Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Kayagaki, Nobuhiko] Genentech Inc, Physiol Chem Dept, San Francisco, CA 94080 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Roche Holding; Genentech; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	ouyang@gene.com	Ouyang, Wenjun/ABA-8763-2020; Zheng, Yan/A-6993-2008	Zheng, Yan/0000-0002-7002-277X; Heimesaat, Markus/0000-0001-6399-651X; Ouyang, Wenjun/0000-0002-1811-5864; Kuhl, Anja/0000-0003-2293-5387; Munoz, Melba/0000-0003-3386-4502				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Cai GF, 2000, INFECT IMMUN, V68, P6932, DOI 10.1128/IAI.68.12.6932-6938.2000; Chikano S, 2000, GUT, V47, P779, DOI 10.1136/gut.47.6.779; Dao T, 1998, J IMMUNOL, V161, P2217; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Egan CE, 2011, MUCOSAL IMMUNOL, V4, P658, DOI 10.1038/mi.2011.31; Eidenschenk C, 2014, CURR TOP MICROBIOL, V380, P213, DOI 10.1007/978-3-662-43492-5_10; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Ewald SE, 2014, INFECT IMMUN, V82, P460, DOI 10.1128/IAI.01170-13; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; Kolinska J, 2008, J INTERF CYTOK RES, V28, P287, DOI 10.1089/jir.2006.0130; Leung BP, 2001, J IMMUNOL, V167, P2879, DOI 10.4049/jimmunol.167.5.2879; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; Vossenkamper A, 2004, EUR J IMMUNOL, V34, P3197, DOI 10.1002/eji.200424993; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	39	123	124	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					321	331		10.1016/j.immuni.2015.01.011	http://dx.doi.org/10.1016/j.immuni.2015.01.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25680273	Bronze			2022-12-18	WOS:000349916400015
J	Satoh-Takayama, N; Serafini, N; Verrier, T; Rekiki, A; Renauld, JC; Frankel, G; Di Santo, JP				Satoh-Takayama, Naoko; Serafini, Nicolas; Verrier, Thomas; Rekiki, Abdessalem; Renauld, Jean-Christophe; Frankel, Gad; Di Santo, James P.			The Chemokine Receptor CXCR6 Controls the Functional Topography of Interleukin-22 Producing Intestinal Innate Lymphoid Cells	IMMUNITY			English	Article							ROR-GAMMA-T; DENDRITIC CELLS; MONONUCLEAR PHAGOCYTES; HOST-DEFENSE; IMMUNITY; INFECTION; DRIVES; GUT; DIFFERENTIATION; HOMEOSTASIS	Interleukin-22 (IL-22) plays a critical role in mucosal defense, although the molecular mechanisms that ensure IL-22 tissue distribution remain poorly understood. We show that the CXCL16-CXCR6 chemokine-chemokine receptor axis regulated group 3 innate lymphoid cell (ILC3) diversity and function. CXCL16 was constitutively expressed by CX3CR1(+) intestinal dendritic cells (DCs) and coexpressed with IL-23 after Citrobacter rodentium infection. Intestinal ILC3s expressed CXCR6 and its ablation generated a selective loss of the NKp46(+) ILC3 subset, a depletion of intestinal IL-22, and the inability to control C. rodentium infection. CD4(+) ILC3s were unaffected by CXCR6 deficiency and remained clustered within lymphoid follicles. In contrast, the lamina propria of Cxcr6(-/-) mice was devoid of ILC3s. The loss of ILC3-dependent IL-22 epithelial stimulation reduced antimicrobial peptide expression that explained the sensitivity of Cxcr6(-/-) mice to C. rodentium. Our results delineate a critical CXCL16-CXCR6 crosstalk that coordinates the intestinal topography of IL-22 secretion required for mucosal defense.	[Satoh-Takayama, Naoko; Serafini, Nicolas; Verrier, Thomas; Rekiki, Abdessalem; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Satoh-Takayama, Naoko; Serafini, Nicolas; Verrier, Thomas; Rekiki, Abdessalem; Di Santo, James P.] Inst Pasteur, INSERM, U668, F-75724 Paris, France; [Renauld, Jean-Christophe] Catholic Univ Louvain, Expt Med Unit, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Imperial College London	Satoh-Takayama, N (corresponding author), Inst Pasteur, Innate Immun Unit, 25 Rue Docteur Roux, F-75724 Paris, France.	naoko@pasteur.fr; disanto@pasteur.fr	Di Santo, James P/M-4298-2014; SERAFINI, nicolas/S-5675-2019; Renauld, Jean-Christophe/B-7268-2012	Di Santo, James P/0000-0002-7146-1862; SERAFINI, nicolas/0000-0002-7440-4353; abdessalem, rekiki/0000-0003-0678-8110; Renauld, Jean-Christophe/0000-0003-1736-2131	Japan Society for the Promotion of Science (JSPS), Japan; Institut Pasteur; Inserm; ANR (Gut_ILC); MRC [MR/J006874/1] Funding Source: UKRI	Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR (Gut_ILC)(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank O. Mandelboim (Hebrew University, Jerusalem), F. Geissmann (Necker Hospital, Paris) and G. Eberl (Institut Pasteur) for Ncr1<SUP>gfp/+</SUP> mice, Cxcr6<SUP>gfp</SUP>/Cx3cr1<SUP>gfp</SUP> mice, and Rorc<SUP>gfp</SUP> mice, respectively. N.S.-T. was the recipient of fellowship from Japan Society for the Promotion of Science (JSPS), Japan. Supported by the Institut Pasteur, Inserm, and the ANR (Gut_ILC).	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cox JH, 2012, MUCOSAL IMMUNOL, V5, P99, DOI 10.1038/mi.2011.54; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2011, EUR J IMMUNOL, V41, P780, DOI 10.1002/eji.201040851; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tohyama M, 2007, INT IMMUNOL, V19, P1095, DOI 10.1093/intimm/dxm083; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yu YRA, 2007, INT J CANCER, V121, P316, DOI 10.1002/ijc.22660; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	52	123	126	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					776	788		10.1016/j.immuni.2014.10.007	http://dx.doi.org/10.1016/j.immuni.2014.10.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25456160	Bronze			2022-12-18	WOS:000345504900014
J	Bonilla, DL; Bhattacharya, A; Sha, YB; Xu, Y; Xiang, Q; Kan, A; Jagannath, C; Komatsu, M; Eissa, NT				Bonilla, Diana L.; Bhattacharya, Abhisek; Sha, Youbao; Xu, Yi; Xiang, Qian; Kan, Arshad; Jagannath, Chinnaswamy; Komatsu, Masaaki; Eissa, N. Tony			Autophagy Regulates Phagocytosis by Modulating the Expression of Scavenger Receptors	IMMUNITY			English	Article							SR-AI/II; MARCO; TUBERCULOSIS; DEFENSE; INNATE; PHAGOSOME; SURVIVAL; BACTERIA; IMMUNITY; BINDING	Autophagy and phagocytosis are conserved cellular functions involved in innate immunity. However, the nature of their interactions remains unclear. We evaluated the role of autophagy in regulating phagocytosis in macrophages from myeloid-specific autophagy-related gene 7-deficient (Atg7(-/-)) mice. Atg7(-/-) macrophages exhibited higher bacterial uptake when infected with Mycobacterium tuberculosis (Mtb) or with M. tuberculosis var. bovis BCG (BCG). In addition, BCG-infected Atg7(-/-) mice showed increased bacterial loads and exacerbated lung inflammatory responses. Atg7(-/-) macrophages had increased expression of two class A scavenger receptors: macrophage receptor with collagenous structure (MARCO) and macrophage scavenger receptor 1 (MSR1). The increase in scavenger receptors was caused by increased activity of the nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) transcription factor resulting from accumulated sequestosome 1 (SQSTM1 or p62) in Atg7(-/-) macrophages. These insights increase our understanding of the host-pathogen relationship and suggest that therapeutic strategies should be designed to include modulation of both phagocytosis and autophagy.	[Bonilla, Diana L.; Bhattacharya, Abhisek; Sha, Youbao; Xu, Yi; Xiang, Qian; Eissa, N. Tony] Baylor Coll Med, Dept Pulm Med, Houston, TX 77030 USA; [Bonilla, Diana L.; Bhattacharya, Abhisek; Sha, Youbao; Xu, Yi; Xiang, Qian; Eissa, N. Tony] Baylor Coll Med, Crit Care Sect, Houston, TX 77030 USA; [Kan, Arshad; Jagannath, Chinnaswamy] Univ Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Tokyo 1568506, Japan	Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; Tokyo Metropolitan Institute of Medical Science	Eissa, NT (corresponding author), Baylor Coll Med, Dept Pulm Med, Houston, TX 77030 USA.	teissa@bcm.edu	Bhattacharya, Abhisek/AAN-6511-2020; Komatsu, Masaaki/B-8321-2011; Khan, Arshad/E-6855-2015	Bhattacharya, Abhisek/0000-0002-1667-7169; Komatsu, Masaaki/0000-0001-7672-7722; Khan, Arshad/0000-0003-3655-2854	Heart Lung and Blood Institute; National Institute of Allergy and Infectious Diseases; American Heart Association; Cytometry and Cell Sorting Core at Baylor College of Medicine; National Institutes of Health [NIAID P30AI036211, NCI P30CA125123, NCR S10RR024574]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); Cytometry and Cell Sorting Core at Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank scientists who contributed reagents, as outlined in the text, and members of the N.T.E. laboratory for useful discussions. This study is supported by Heart Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, and the American Heart Association. This project was supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the National Institutes of Health (NIAID P30AI036211, NCI P30CA125123, and NCR S10RR024574) and the assistance of J.M. Sederstrom.	Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Arredouani MS, 2007, J IMMUNOL, V178, P5912, DOI 10.4049/jimmunol.178.9.5912; Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Lima JGB, 2011, BIOCHEM BIOPH RES CO, V405, P604, DOI 10.1016/j.bbrc.2011.01.076; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Court N, 2010, J IMMUNOL, V184, P7057, DOI 10.4049/jimmunol.1000164; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Inoue D, 2011, BIOCHEM BIOPH RES CO, V405, P13, DOI 10.1016/j.bbrc.2010.12.092; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jozefowski S, 2005, J IMMUNOL, V175, P8032, DOI 10.4049/jimmunol.175.12.8032; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lei JT, 2008, J LEUKOCYTE BIOL, V84, P499, DOI 10.1189/jlb.1207828; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024069; McMurray DN, 2001, TRENDS MOL MED, V7, P135, DOI 10.1016/S1471-4914(00)01901-8; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Rogers NJ, 2009, J IMMUNOL, V182, P1982, DOI 10.4049/jimmunol.0801320; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Xu Yi, 2010, Proc Am Thorac Soc, V7, P22, DOI 10.1513/pats.200909-103JS; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zhou HW, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-7	37	123	134	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					537	547		10.1016/j.immuni.2013.08.026	http://dx.doi.org/10.1016/j.immuni.2013.08.026			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24035364	Green Accepted, Bronze			2022-12-18	WOS:000330949600016
J	Sharma, MD; Huang, L; Choi, JH; Lee, EJ; Wilson, JM; Lemos, H; Pan, F; Blazar, BR; Pardoll, DM; Mellor, AL; Shi, HD; Munn, DH				Sharma, Madhav D.; Huang, Lei; Choi, Jeong-Hyeon; Lee, Eun-Joon; Wilson, James M.; Lemos, Henrique; Pan, Fan; Blazar, Bruce R.; Pardoll, Drew M.; Mellor, Andrew L.; Shi, Huidong; Munn, David H.			An Inherently Bifunctional Subset of Foxp3(+) T Helper Cells Is Controlled by the Transcription Factor Eos	IMMUNITY			English	Article							DRAINING LYMPH-NODES; PLASMACYTOID DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; IN-VIVO; CD40 LIGAND; ACTIVATION; LINEAGE; ANTIGEN; MICE; AUTOIMMUNITY	At sites of inflammation, certain regulatory T cells (Treg cells) can undergo rapid reprogramming into helper-like cells without loss of the transcription factor Foxp3. We show that reprogramming is controlled by downregulation of the transcription factor Eos (Ikzf4), an obligate corepressor for Foxp3. Reprogramming was restricted to a specific subset of "Eos-labile'' Treg cells that was present in the thymus and identifiable by characteristic surface markers and DNA methylation. Mice made deficient in this subset became impaired in their ability to provide help for presentation of new antigens to naive T cells. Downregulation of Eos required the proinflammatory cytokine interleukin-6 (IL-6), and mice lacking IL-6 had impaired development and function of the Eos-labile subset. Conversely, the immunoregulatory enzyme IDO blocked loss of Eos and prevented the Eos-labile Treg cells from reprogramming. Thus, the Foxp3(+) lineage contains a committed subset of Treg cells capable of rapid conversion into biologically important helper cells.	[Sharma, Madhav D.; Huang, Lei; Choi, Jeong-Hyeon; Lee, Eun-Joon; Wilson, James M.; Lemos, Henrique; Mellor, Andrew L.; Shi, Huidong; Munn, David H.] Georgia Regents Univ, Ctr Canc, Augusta, GA 30912 USA; [Sharma, Madhav D.; Munn, David H.] Georgia Regents Univ, Dept Pediat, Augusta, GA 30912 USA; [Huang, Lei] Georgia Regents Univ, Dept Radiol, Augusta, GA 30912 USA; [Mellor, Andrew L.] Georgia Regents Univ, Dept Med, Augusta, GA 30912 USA; [Pan, Fan; Pardoll, Drew M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Immunol & Hematopoiesis Div, Baltimore, MD 21231 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Blazar, Bruce R.] Univ Minnesota, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Johns Hopkins University; Johns Hopkins Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Munn, DH (corresponding author), Georgia Regents Univ, Ctr Canc, Augusta, GA 30912 USA.	dmunn@gru.edu	Choi, Justin/F-8792-2014; de Paula Lemos, Henrique/AAI-2698-2020	de Paula Lemos, Henrique/0000-0002-0539-3283; Munn, David/0000-0002-7711-2858; Shi, Huidong/0000-0003-1137-3390; huang, lei/0000-0002-1996-944X	National Institutes of Health [CA103320, CA096651, CA112431, HD41187, AI083005, AI063402, CA72669, HL56067, AI34495]; Immunotherapy Discovery Institute seed grant; NewLink Genetics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041187] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA142106, R01CA103320, R01CA072669, P01CA065493, R01CA096651, R01CA112431] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL056067, R01HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI083005, P01AI056299, R01AI034495, R01AI103347, R01AI063402, R01AI089830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunotherapy Discovery Institute seed grant; NewLink Genetics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Anita Sharma, Judy Gregory, Joyce Wilson, and Jeanene Pihkala for expert technical assistance. Supported by National Institutes of Health grants CA103320, CA096651, CA112431 (to D. H. M.); HD41187, AI083005, AI063402 (to A. L. M.); and CA72669, HL56067, AI34495 (to B. R. B.); and an Immunotherapy Discovery Institute seed grant (to H. S.). H. S. is a Georgia Cancer Coalition Distinguished Cancer Scientist. D. H. M., A. L. M., and B. R. B. have intellectual property interests in the therapeutic use of IDO and IDO inhibitors. D. H. M. and A. L. M. receive consulting income and research support from NewLink Genetics, which holds a license to develop the IDO technology for clinical trials.	Addey C, 2011, J IMMUNOL, V186, P4557, DOI 10.4049/jimmunol.1003797; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Hershko DD, 2004, J CELL BIOCHEM, V91, P951, DOI 10.1002/jcb.20014; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koguchi Y, 2011, J IMMUNOL, V187, P626, DOI 10.4049/jimmunol.1004083; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Martins MD, 2012, TRENDS MOL MED, V18, P454, DOI 10.1016/j.molmed.2012.06.001; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Muth S, 2012, P NATL ACAD SCI USA, V109, P9059, DOI 10.1073/pnas.1110620109; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; Wang YQ, 2010, J IMMUNOL, V185, P5983, DOI 10.4049/jimmunol.1001255; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yarilin AA, 2004, CURR MED CHEM, V11, P447, DOI 10.2174/0929867043455972; Yurchenko E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035572; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	34	123	124	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					998	1012		10.1016/j.immuni.2013.01.013	http://dx.doi.org/10.1016/j.immuni.2013.01.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23684987	Bronze, Green Accepted			2022-12-18	WOS:000330942500017
J	Cortez-Retamozo, V; Etzrodt, M; Newton, A; Ryan, R; Pucci, F; Sio, SW; Kuswanto, W; Rauch, PJ; Chudnovskiy, A; Iwamoto, Y; Kohler, R; Marinelli, B; Gorbatov, R; Wojtkiewicz, G; Panizzi, P; Mino-Kenudson, M; Forghani, R; Figueiredo, JL; Chen, JW; Xavier, R; Swirski, FK; Nahrendorf, M; Weissleder, R; Pittet, MJ				Cortez-Retamozo, Virna; Etzrodt, Martin; Newton, Andita; Ryan, Russell; Pucci, Ferdinando; Sio, Selena W.; Kuswanto, Wilson; Rauch, Philipp J.; Chudnovskiy, Aleksey; Iwamoto, Yoshiko; Kohler, Rainer; Marinelli, Brett; Gorbatov, Rostic; Wojtkiewicz, Gregory; Panizzi, Peter; Mino-Kenudson, Mari; Forghani, Reza; Figueiredo, Jose-Luiz; Chen, John W.; Xavier, Ramnik; Swirski, Filip K.; Nahrendorf, Matthias; Weissleder, Ralph; Pittet, Mikael J.			Angiotensin II Drives the Production of Tumor-Promoting Macrophages	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; MYOCARDIAL-INFARCTION; DENDRITIC CELLS; LUNG ADENOCARCINOMA; SPLENIC RESERVOIR; LYMPHOID ORGANS; MYELOID CELLS; CANCER; MONOCYTES; INFLAMMATION	Macrophages frequently infiltrate tumors and can enhance cancer growth, yet the origins of the macrophage response are not well understood. Here we address molecular mechanisms of macrophage production in a conditional mouse model of lung adenocarcinoma. We report that overproduction of the peptide hormone Angiotensin II (AngII) in tumor-bearing mice amplifies self-renewing hematopoietic stem cells (HSCs) and macrophage progenitors. The process occurred in the spleen but not the bone marrow, and was independent of hemodynamic changes. The effects of AngII required direct hormone ligation on HSCs, depended on S1P(1) signaling, and allowed the extramedullary tissue to supply new tumor-associated macrophages throughout cancer progression. Conversely, blocking AngII production prevented cancer-induced HSC and macrophage progenitor amplification and thus restrained the macrophage response at its source. These findings indicate that AngII acts upstream of a potent macrophage amplification program and that tumors can remotely exploit the hormone's pathway to stimulate cancer-promoting immunity.	[Cortez-Retamozo, Virna; Etzrodt, Martin; Newton, Andita; Pucci, Ferdinando; Sio, Selena W.; Kuswanto, Wilson; Rauch, Philipp J.; Chudnovskiy, Aleksey; Iwamoto, Yoshiko; Kohler, Rainer; Marinelli, Brett; Gorbatov, Rostic; Wojtkiewicz, Gregory; Panizzi, Peter; Forghani, Reza; Figueiredo, Jose-Luiz; Chen, John W.; Swirski, Filip K.; Nahrendorf, Matthias; Weissleder, Ralph; Pittet, Mikael J.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Xavier, Ramnik] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ryan, Russell; Mino-Kenudson, Mari] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pittet, MJ (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	mpittet@mgh.harvard.edu	Pucci, Ferdinando/AAT-8239-2020; Swirski, Filip/AAF-1340-2019; Panizzi, Peter/A-6072-2019; Etzrodt, Martin/P-3325-2015; Pittet, Mikael/ABD-6300-2021; Wojtkiewicz, Gregory/L-3660-2018	Pucci, Ferdinando/0000-0002-1300-9931; Panizzi, Peter/0000-0003-0141-8807; Etzrodt, Martin/0000-0003-1928-3904; Swirski, Filip/0000-0002-3163-9152; Ryan, Russell/0000-0001-8174-3962; Forghani, Reza/0000-0002-8572-1864; /0000-0003-0828-4143; Rauch, Philipp/0000-0001-8677-0986; Wojtkiewicz, Gregory/0000-0002-3148-8411	NIH [P50-CA86355, R01-AI084880, R56-AI084880]; MGH-Center for Systems Biology [U54-CA126515]; AACR Centennial Predoctoral Fellowship; Boehringer Ingelheim Fonds; NATIONAL CANCER INSTITUTE [U54CA126515, P50CA086355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI084880, R01AI084880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072167, R01NS070835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH-Center for Systems Biology; AACR Centennial Predoctoral Fellowship; Boehringer Ingelheim Fonds(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Jessica Truelove (MGH) for imaging and Michael Waring and Adam Chicoine (Ragon Institute, MGH) for sorting cells. This work was supported in part by NIH grants P50-CA86355, R01-AI084880, R56-AI084880, and MGH-Center for Systems Biology (to M.J.P.) and U54-CA126515 (to R. W.). M. E. is part of the International PhD program "Cancer and Immunology" at the University of Lausanne, Switzerland, and was supported by the AACR Centennial Predoctoral Fellowship and the Boehringer Ingelheim Fonds.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; [Anonymous], 2006, GASTROENTEROLOGY, V131, P343, DOI 10.1053/j.gastro.2006.06.031; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; FREEDMAN MH, 1981, AM J HEMATOL, V11, P271, DOI 10.1002/ajh.2830110307; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Huang CC, 2011, AM J CARDIOL, V107, P1028, DOI 10.1016/j.amjcard.2010.11.026; Jokubaitis VJ, 2008, BLOOD, V111, P4055, DOI 10.1182/blood-2007-05-091710; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Lin CT, 2011, FASEB J, V25, P1145, DOI 10.1096/fj.10-169433; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; McAlpine H M, 1988, Am J Med, V84, P61, DOI 10.1016/0002-9343(88)90206-9; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Tsubakimoto Y, 2009, ARTERIOSCL THROM VAS, V29, P1529, DOI 10.1161/ATVBAHA.109.187732; Ugel S, 2012, CELL REP, V2, P628, DOI 10.1016/j.celrep.2012.08.006; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wilop S, 2009, J CANCER RES CLIN, V135, P1429, DOI 10.1007/s00432-009-0587-3; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zhang BC, 2011, MED ONCOL, V28, P1447, DOI 10.1007/s12032-010-9638-5; Zhang BC, 2011, CLINICS, V66, P1879, DOI 10.1590/S1807-59322011001100006; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	51	123	130	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					296	308		10.1016/j.immuni.2012.10.015	http://dx.doi.org/10.1016/j.immuni.2012.10.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23333075	Green Accepted, Bronze			2022-12-18	WOS:000330940800012
J	Yagi, R; Junttila, IS; Wei, G; Urban, JF; Zhao, KJ; Paul, WE; Zhu, JF				Yagi, Ryoji; Junttila, Ilkka S.; Wei, Gang; Urban, Joseph F., Jr.; Zhao, Keji; Paul, William E.; Zhu, Jinfang			The Transcription Factor GATA3 Actively Represses RUNX3 Protein-Regulated Production of Interferon-gamma	IMMUNITY			English	Article							T-BET; TH1 DEVELOPMENT; CELLS; CD4; DIFFERENTIATION; EXPRESSION; RESPONSES; FATES; STAT4; REQUIREMENT	The transcription factor GATA3 is crucial for the differentiation of naive CD4(+) T cells into T helper 2 (Th2) cells. Here, we show that deletion of Gata3 allowed the appearance of interferon-gamma (IFN-gamma)-producing cells in the absence of interleukin-12 (IL-12) and IFN-gamma. Such IFN-gamma production was transcription factor T-bet independent. Another T-box-containing transcription factor Eomes, but not T-bet, was induced both in GATA3-deficient CD4(+) T cells differentiated under Th2 cell conditions and in Th2 cells with enforced Runx3 expression, contributing to IFN-gamma production. GATA3 overexpression blocked Runx3-mediated Eomes induction and IFN-gamma production, and GATA3 protein physically interacted with Runx3 protein. Furthermore, we found that Runx3 directly bound to multiple regulatory elements of the Ifng gene and that blocking Runx3 function in either Th1 or GATA3-deficient "Th2" cells results in diminished IFN-gamma production by these cells. Thus, the Runx3-mediated pathway, actively suppressed by GATA3, induces IFN-gamma production in a STAT4- and T-bet-independent manner.	[Yagi, Ryoji; Junttila, Ilkka S.; Paul, William E.; Zhu, Jinfang] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Wei, Gang; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Urban, Joseph F., Jr.] USDA, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); United States Department of Agriculture (USDA)	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.		Zhu, Jinfang/B-7574-2012; Wei, Gang/A-3291-2011	Zhu, Jinfang/0000-0002-0117-4745; Junttila, Ilkka/0000-0002-9830-0823; Urban, Joseph/0000-0002-1590-8869	Division of Intramural Research, National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N Killeen for providing dLck-Cre transgenic mice (line 3779), I Taniuchi and D R Littman for providing anti-CBF beta and Runx<SUP>fl/fl</SUP> mice, S L Reiner for providing Eomes-GFP-RV and T-bet DN-GFP-RV, R A Flavell for providing Thy1 1-RV, T Egawa for both providing Runx antibody and for helpful discussion, S Tanksley, C Eigsti, and J Edwards for cell sorting, and T Nakayama, D Jankovic, N Takemoto, and H Yamane for their helpful discussions We also thank J J O'Shea and P L Schwartzberg for critical reading of the manuscript The work is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases and the Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, USA	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Hayashi K, 2000, J IMMUNOL, V165, P6816, DOI 10.4049/jimmunol.165.12.6816; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Lawless VA, 2000, J IMMUNOL, V165, P6803, DOI 10.4049/jimmunol.165.12.6803; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yang Y, 2007, BLOOD, V110, P2494, DOI 10.1182/blood-2006-11-058271; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	43	123	125	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					507	517		10.1016/j.immuni.2010.04.004	http://dx.doi.org/10.1016/j.immuni.2010.04.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20399120	Green Accepted, Bronze			2022-12-18	WOS:000277171900010
J	Szatmari, I; Gogolak, P; Im, JS; Dezso, B; Rajnavolgyi, E; Nagy, L				Szatmari, I; Gogolak, P; Im, JS; Dezso, B; Rajnavolgyi, E; Nagy, L			Activation of PPAR gamma specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion	IMMUNITY			English	Article							KILLER T-CELLS; MACROPHAGE-GENE-EXPRESSION; COLONY-STIMULATING FACTOR; RECEPTOR-GAMMA; ALPHA-GALACTOSYLCERAMIDE; DISTINCT SUBSETS; MANNOSE RECEPTOR; PERIPHERAL-BLOOD; OXIDIZED LDL; NOD MICE	Little is known of the transcriptional events controlling the differentiation and function of dendritic cells (DC). We found that the ligand-activated transcription factor Peroxisome Proliferator Activated Receptor gamma (PPARgamma) is immediately upregulated after the induction of monocyte-derived DC differentiation. Activation of PPARgamma changed the expression pattern of cell surface receptors and enhanced the internalizing activity of DC. Unexpectedly, we found that CD1 glycoproteins, a class of molecules responsible for the presentation of self and foreign modified lipids, were coordinately regulated by PPAR-gamma activation. CD1 a levels were reduced, while CD1d expression was induced. Enhanced expression of CD1d was coupled to the selective induction of invariant natural-killer T cell (iNKT cell) proliferation in the presence of alpha-GalCer. These results suggest that PPARgamma orchestrates a transcriptional response leading to the development of a DC subtype with increased internalizing capacity, efficient lipid presentation, and the augmented potential to activate iNKT cells.	Univ Debrecen, Med & Hlth Sci Ctr, Dept Biochem & Mol Biol, Res Ctr Mol Med, H-4012 Debrecen, Hungary; Univ Debrecen, Med & Hlth Sci Ctr, Dept Immunol, Res Ctr Mol Med, H-4012 Debrecen, Hungary; Univ Debrecen, Med & Hlth Sci Ctr, Dept Pathol, Res Ctr Mol Med, H-4012 Debrecen, Hungary; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	University of Debrecen; University of Debrecen; University of Debrecen; Yeshiva University; Albert Einstein College of Medicine	Nagy, L (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Biochem & Mol Biol, Res Ctr Mol Med, Nagyerdei Krt 98, H-4012 Debrecen, Hungary.	lnagy@indi.biochem.dote.hu	Eckhardt, Erik/G-1567-2010; Nagy, Laszlo/A-3814-2008; Szatmari, Istvan/B-3152-2010; Rajnavölgyi, Éva/D-4384-2013	Nagy, Laszlo/0000-0001-6653-2155; Szatmari, Istvan/0000-0001-5260-1498; Gogolak, Peter/0000-0001-9411-9587; Dezso, Balazs/0000-0002-7871-0219				Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Augstein P, 2003, BIOCHEM BIOPH RES CO, V304, P378, DOI 10.1016/S0006-291X(03)00590-4; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Carnaud C, 2001, J IMMUNOL, V166, P2404, DOI 10.4049/jimmunol.166.4.2404; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Coste A, 2003, IMMUNITY, V19, P329, DOI 10.1016/S1074-7613(03)00229-2; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; Faveeuw C, 2000, FEBS LETT, V486, P261, DOI 10.1016/S0014-5793(00)02319-X; Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hammond KJL, 2003, CURR OPIN IMMUNOL, V15, P683, DOI 10.1016/j.coi.2003.09.014; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; KASINRERK W, 1993, J IMMUNOL, V150, P579; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kukreja A, 2002, J AUTOIMMUN, V19, P117, DOI 10.1006/jaut.2002.0609; Laman JD, 2003, TRENDS IMMUNOL, V24, P190, DOI 10.1016/S1471-4906(03)00063-2; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nencioni A, 2002, J IMMUNOL, V169, P1228, DOI 10.4049/jimmunol.169.3.1228; Perrin-Cocon L, 2001, J IMMUNOL, V167, P3785, DOI 10.4049/jimmunol.167.7.3785; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shi FD, 2001, P NATL ACAD SCI USA, V98, P6777, DOI 10.1073/pnas.121169698; Shimizu S, 2002, RESP MED, V96, P770, DOI 10.1053/rmed.2002.1345; Sieling PA, 1999, J IMMUNOL, V162, P1851; Summers KL, 2001, AM J PATHOL, V159, P285, DOI 10.1016/S0002-9440(10)61694-X; Takahashi T, 2002, J IMMUNOL, V168, P3140, DOI 10.4049/jimmunol.168.7.3140; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000	45	123	128	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					95	106		10.1016/j.immuni.2004.06.003	http://dx.doi.org/10.1016/j.immuni.2004.06.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345223	Bronze			2022-12-18	WOS:000222975500011
J	Varga, SM; Wang, XT; Welsh, RM; Braciale, TJ				Varga, SM; Wang, XT; Welsh, RM; Braciale, TJ			Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells	IMMUNITY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; BALB/C MICE; LEISHMANIA-MAJOR; CYTOKINE SECRETION; VIRAL-INFECTION; G GLYCOPROTEIN; EOSINOPHILIA; RESPONSES; REPERTOIRE; DETERMINES	Vaccination with the respiratory syncytial virus (RSV) attachment (G) protein results in immune-mediated lung injury after natural RSV infection with pathogenic features characteristic of an exaggerated Th2 response. Here we demonstrate that approximately half of the CD4(+) T cells infiltrating the lungs of G-primed mice utilize a single VP gene (V beta 14) with remarkably limited CDR3 diversity. Furthermore, elimination of these V beta 14-bearing CD4(+) T cells in vivo abolishes the type 2-like pulmonary injury. These results suggest that a novel subset of CD4(+) T cells may be crucial in the development of pathology during human RSV infection and that genetic or environmental factors prior to or at the time of G antigen exposure may affect the commitment of this discrete antigen-specific T cell subset to Th2 differentiation.	Univ Virginia, Hlth Sci Ctr, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA 22908 USA; Univ Massachusetts, Med Ctr, Program Immunol & Virol, Worcester, MA 01655 USA; Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA	University of Virginia; University of Virginia; University of Virginia; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Braciale, TJ (corresponding author), Univ Virginia, Hlth Sci Ctr, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	tjb2r@virginia.edu	Varga, Steven/C-2009-2009	Varga, Steven/0000-0001-7332-4290	NHLBI NIH HHS [HL-10446] Funding Source: Medline; NIAID NIH HHS [AI-37293, AI-17672, AI-34607] Funding Source: Medline; NIAMS NIH HHS [AR-35506] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI034607, U01AI034607, R37AI017672, R01AI017672, R01AI037293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035506] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALWAN WH, 1994, J EXP MED, V179, P81, DOI 10.1084/jem.179.1.81; BELSHE RB, 1982, J INFECT DIS, V145, P311, DOI 10.1093/infdis/145.3.311; Blander JM, 2000, J EXP MED, V191, P2065, DOI 10.1084/jem.191.12.2065; Blattman JN, 2000, J IMMUNOL, V165, P6081, DOI 10.4049/jimmunol.165.11.6081; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; CONNORS M, 1992, J VIROL, V66, P7444, DOI 10.1128/JVI.66.12.7444-7451.1992; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; FALSEY AR, 1992, J AM GERIATR SOC, V40, P115, DOI 10.1111/j.1532-5415.1992.tb01929.x; Fischer JE, 1997, J VIROL, V71, P8672, DOI 10.1128/JVI.71.11.8672-8677.1997; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; GRAHAM MB, 1994, J EXP MED, V180, P1273, DOI 10.1084/jem.180.4.1273; HARRINGTON RD, 1992, J INFECT DIS, V165, P987, DOI 10.1093/infdis/165.6.987; HEILMAN CA, 1990, J INFECT DIS, V161, P402, DOI 10.1093/infdis/161.3.402; Hussell T, 1999, CURR OPIN MICROBIOL, V2, P410, DOI 10.1016/S1369-5274(99)80072-1; JANEWAY CA, 1988, IMMUNOL REV, V101, P39, DOI 10.1111/j.1600-065X.1988.tb00732.x; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Johnson TR, 1999, J VIROL, V73, P8485, DOI 10.1128/JVI.73.10.8485-8495.1999; Julia V, 2000, J IMMUNOL, V165, P5637, DOI 10.4049/jimmunol.165.10.5637; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KATZ ME, 1982, EUR J IMMUNOL, V12, P535, DOI 10.1002/eji.1830120702; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kopf M, 1996, J EXP MED, V184, P1127, DOI 10.1084/jem.184.3.1127; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; Lin MY, 2000, MICROBES INFECT, V2, P1025, DOI 10.1016/S1286-4579(00)01257-0; Maloy KJ, 2000, J EXP MED, V191, P2159, DOI 10.1084/jem.191.12.2159; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; MlinaricGalinovic G, 1996, EUR J CLIN MICROBIOL, V15, P777, DOI 10.1007/BF01701518; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; MOSMANN TR, 1991, IMMUNOL REV, V123, P209, DOI 10.1111/j.1600-065X.1991.tb00612.x; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Neuzil KM, 1996, SEMIN VIROL, V7, P255, DOI 10.1006/smvy.1996.0032; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; REINER SL, 1993, SCIENCE, V259, P1457, DOI 10.1126/science.8451641; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; Slifka MK, 2000, J IMMUNOL, V164, P208, DOI 10.4049/jimmunol.164.1.208; Sparer TE, 1998, J EXP MED, V187, P1921, DOI 10.1084/jem.187.11.1921; Srikiatkhachorn A, 1997, J VIROL, V71, P678, DOI 10.1128/JVI.71.1.678-685.1997; Tang YW, 1997, J CLIN INVEST, V99, P2183, DOI 10.1172/JCI119391; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Varga SM, 2000, J IMMUNOL, V165, P6487, DOI 10.4049/jimmunol.165.11.6487; Walzl G, 2001, J EXP MED, V193, P785, DOI 10.1084/jem.193.7.785; Waris ME, 1996, J VIROL, V70, P2852, DOI 10.1128/JVI.70.5.2852-2860.1996; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787	53	123	123	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2001	15	4					637	646		10.1016/S1074-7613(01)00209-6	http://dx.doi.org/10.1016/S1074-7613(01)00209-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672545	Bronze			2022-12-18	WOS:000171757800014
J	Dykstra, ML; Longnecker, R; Pierce, SK				Dykstra, ML; Longnecker, R; Pierce, SK			Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR	IMMUNITY			English	Article							MEMBRANE-PROTEIN 2A; MEMORY B-CELLS; IN-VIVO; T-CELL; REGULATES REACTIVATION; LYMPHOCYTE ACTIVATION; CYTOPLASMIC DOMAINS; PERIPHERAL-BLOOD; TYROSINE KINASES; CROSS-LINKING	The B cell antigen receptor (BCR) functions to initiate signaling and to internalize antigen for processing from within Lyn kinase-enriched membrane lipid rafts. The signaling function of the BCR is blocked by Epstein-Barr Virus (EBV] latent membrane protein 2A (LMP2A), which is constitutively phosphorylated by Lyn. Here, we show that LMP2A resides in lipid rafts and excludes the BCR from entering rafts by Lyn-dependent mechanisms, thus blocking both BCR signaling and antigen transport. Mutant LMP2A that permits BCR signaling and raft translocation still blocks antigen trafficking, indicating independent control of these BCR functions. Thus, EBV coopts the lipid rafts to disarm both the signaling and antigen-processing functions of the BCR by independent mechanisms.	Northwestern Univ, Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA	Northwestern University	Pierce, SK (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	spierce@niaid.nih.gov			NCI NIH HHS [CA62234, CA73507] Funding Source: Medline; NIGMS NIH HHS [T32 GM08061] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073507, R01CA062234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000899, Z01AI000898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aluvihare VR, 1997, EMBO J, V16, P3553, DOI 10.1093/emboj/16.12.3553; Babcock GJ, 1999, J EXP MED, V190, P567, DOI 10.1084/jem.190.4.567; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Caldwell RG, 2000, J VIROL, V74, P1101, DOI 10.1128/JVI.74.3.1101-1113.2000; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; CHENG ADY, 1995, GRAVITATION COSMOLOG, V1, P1; Cheng PC, 1999, J IMMUNOL, V162, P7171; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; DEMARS R, 1983, HUM IMMUNOL, V8, P123, DOI 10.1016/0198-8859(83)90008-3; Fruehling S, 1996, J VIROL, V70, P6216, DOI 10.1128/JVI.70.9.6216-6226.1996; Fruehling S, 1998, J VIROL, V72, P7796, DOI 10.1128/JVI.72.10.7796-7806.1998; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GOLD MR, 1994, ADV IMMUNOL, V55, P221; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GRUPP SA, 1993, J BIOL CHEM, V268, P25776; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Ikeda M, 2000, VIROLOGY, V268, P178, DOI 10.1006/viro.1999.0166; JELACHICH ML, 1984, P NATL ACAD SCI-BIOL, V81, P5537, DOI 10.1073/pnas.81.17.5537; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; LAUX G, 1988, EMBO J, V7, P769, DOI 10.1002/j.1460-2075.1988.tb02874.x; LONGNECKER R, 1993, J VIROL, V67, P2006, DOI 10.1128/JVI.67.4.2006-2013.1993; Longnecker R, 1996, TRENDS MICROBIOL, V4, P38; Longnecker R, 2000, ADV CANCER RES, V79, P175, DOI 10.1016/S0065-230X(00)79006-3; MILLER CL, 1994, INFECT AGENT DIS, V3, P128; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; MILLER CL, 1993, J VIROL, V67, P3087, DOI 10.1128/JVI.67.6.3087-3094.1993; MITCHELL RN, 1995, J EXP MED, V181, P1705, DOI 10.1084/jem.181.5.1705; MITCHELL RN, 1991, J BIOL CHEM, V266, P8856; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; MIYASHITA EM, 1995, CELL, V80, P593, DOI 10.1016/0092-8674(95)90513-8; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; PLEIMAN CM, 1994, IMMUNOL TODAY, V15, P393, DOI 10.1016/0167-5699(94)90267-4; QU LR, 1992, J VIROL, V66, P3715, DOI 10.1128/JVI.66.6.3715-3724.1992; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; SAMPLE J, 1989, J VIROL, V63, P933, DOI 10.1128/JVI.63.2.933-937.1989; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SONG WX, 1995, J IMMUNOL, V155, P4255; TIERNEY RJ, 1994, J VIROL, V68, P7374, DOI 10.1128/JVI.68.11.7374-7385.1994; Wagle NM, 2000, CURR TOP MICROBIOL, V245, P101; Wagle NM, 1998, CELL IMMUNOL, V184, P1, DOI 10.1006/cimm.1998.1264; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821	50	123	130	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2001	14	1					57	67		10.1016/S1074-7613(01)00089-9	http://dx.doi.org/10.1016/S1074-7613(01)00089-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	394FQ	11163230	Bronze			2022-12-18	WOS:000166513800006
J	Chen, XP; Losman, JA; Rothman, P				Chen, XP; Losman, JA; Rothman, P			SOCS proteins, regulators of intracellular signaling	IMMUNITY			English	Article							BOX MOTIF; CYTOKINE; LIVER; MICE; SUPPRESSION; INHIBITOR; DOMAIN; BINDS		Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University; Columbia University	Chen, XP (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.							Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Morita Y, 2000, P NATL ACAD SCI USA, V97, P5405, DOI 10.1073/pnas.090084797; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	21	123	129	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2000	13	3					287	290		10.1016/S1074-7613(00)00028-5	http://dx.doi.org/10.1016/S1074-7613(00)00028-5			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021526	Bronze			2022-12-18	WOS:000089616400001
J	Miaw, SC; Choi, A; Yu, E; Kishikawa, H; Ho, IC				Miaw, SC; Choi, A; Yu, E; Kishikawa, H; Ho, IC			ROG, repressor of GATA, regulates the expression of cytokine genes	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA-3; ZINC-FINGER PROTEIN; ACUTE PROMYELOCYTIC LEUKEMIA; GERMINAL-CENTER FORMATION; CD4+ T-CELLS; DNA-BINDING; HISTONE DEACETYLASE; INTERACTION MOTIF; TH2 CELLS; DOMAIN	GATA-3 is a T cell-specific transcription factor and is essential for the development of the T cell lineage. Recently, it was shown that the expression of GATA-3 is further induced in CD4(+) helper T cells upon differentiation into type 2 but not type 1 effector cells. Here, we report the molecular cloning of a GATA-3 interacting protein, repressor of GATA (ROG). ROG is a lymphoid-specific gene and is rapidly induced in Th cells upon stimulation with anti-CD3. In in vitro assays, ROG represses the GATA-3-induced transactivation. Furthermore, overexpression of ROG in Th clones inhibits the production of Th cytokines. Taken together, our results suggest that ROG might play a critical role in regulating the differentiation and activation of Th cells.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Ho, IC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.			MIAW, SHI-CHUEN/0000-0003-1347-9367	NIAID NIH HHS [AI-45653-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045653] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; CORREALE J, 1995, J IMMUNOL, V154, P2959; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kapsenberg ML, 1996, INT ARCH ALLERGY IMM, V110, P107, DOI 10.1159/000237274; KAPSENBERG ML, 1991, IMMUNOL TODAY, V12, P392, DOI 10.1016/0167-5699(91)90137-I; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; Lai WS, 1999, MOL CELL BIOL, V19, P4311; LANDRY DB, 1993, J EXP MED, V178, P941, DOI 10.1084/jem.178.3.941; LEIDEN JM, 1993, ANNU REV IMMUNOL, V11, P539, DOI 10.1146/annurev.iy.11.040193.002543; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; RAFF JW, 1994, EMBO J, V13, P5977, DOI 10.1002/j.1460-2075.1994.tb06943.x; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Szabo SJ, 1997, CURR OPIN IMMUNOL, V9, P776, DOI 10.1016/S0952-7915(97)80177-X; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YING S, 1995, AM J RESP CELL MOL, V12, P477, DOI 10.1165/ajrcmb.12.5.7742012; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	50	123	133	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2000	12	3					323	333		10.1016/S1074-7613(00)80185-5	http://dx.doi.org/10.1016/S1074-7613(00)80185-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755619	Bronze			2022-12-18	WOS:000086292100010
J	Osborne, B; Miele, L				Osborne, B; Miele, L			Notch and the immune system	IMMUNITY			English	Review							NEOPLASTIC LESIONS; CELL DEVELOPMENT; ALPHA-BETA; RECEPTOR; GENE; EXPRESSION; PATHWAY; DOMAIN; DIFFERENTIATION; INHIBITION		Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Canc Immunol Program, Maywood, IL 60153 USA	University of Massachusetts System; University of Massachusetts Amherst; Loyola University Chicago	Osborne, B (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	osborne@vasci.umass.edu		Miele, Lucio/0000-0002-5853-7287	NCI NIH HHS [1R01 CA84065-01] Funding Source: Medline; PHS HHS [R01A47922] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084065] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bain G, 1998, SEMIN IMMUNOL, V10, P143, DOI 10.1006/smim.1998.0116; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Beatus P, 1999, DEVELOPMENT, V126, P3925; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cruts M, 1998, HUM MUTAT, V11, P183, DOI 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.3.CO;2-M; Daniel B, 1997, J GEN VIROL, V78, P1095, DOI 10.1099/0022-1317-78-5-1095; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Ferreira V, 1999, J IMMUNOL, V162, P6442; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Gray GE, 1999, AM J PATHOL, V154, P785, DOI 10.1016/S0002-9440(10)65325-4; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Jehn BM, 1999, J IMMUNOL, V162, P635; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kim HK, 1998, MOL CELL BIOL, V18, P7166, DOI 10.1128/MCB.18.12.7166; Kolenko V, 1999, J IMMUNOL, V163, P590; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Lardelli M, 1995, INT J DEV BIOL, V39, P769; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Luo B, 1997, MOL CELL BIOL, V17, P6057, DOI 10.1128/MCB.17.10.6057; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; MIELE L, 1999, IN PRESS J CELL PHYS; Milner LA, 1996, P NATL ACAD SCI USA, V93, P13014, DOI 10.1073/pnas.93.23.13014; MILNER LA, 1994, BLOOD, V83, P2057; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; QI H, 1999, SCIENCE, V93, P3302; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shelly LL, 1999, J CELL BIOCHEM, V73, P164, DOI 10.1002/(SICI)1097-4644(19990501)73:2<164::AID-JCB3>3.0.CO;2-0; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Walker L, 1999, STEM CELLS, V17, P162, DOI 10.1002/stem.170162; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Winoto A, 1997, Semin Immunol, V9, P51, DOI 10.1006/smim.1996.0053; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414; Zecchini V, 1999, CURR BIOL, V9, P460, DOI 10.1016/S0960-9822(99)80211-5	64	123	135	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1999	11	6					653	663		10.1016/S1074-7613(00)80140-5	http://dx.doi.org/10.1016/S1074-7613(00)80140-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626888	Bronze			2022-12-18	WOS:000084612900002
J	Mukouyama, YS; Hara, T; Xu, MJ; Tamura, K; Donovan, PJ; Kim, HJ; Kogo, H; Tsuji, K; Nakahata, T; Miyajima, A				Mukouyama, YS; Hara, T; Xu, MJ; Tamura, K; Donovan, PJ; Kim, HJ; Kogo, H; Tsuji, K; Nakahata, T; Miyajima, A			In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region	IMMUNITY			English	Article							LEUKEMIA-INHIBITORY FACTOR; FETAL LIVER HEMATOPOIESIS; COLONY-STIMULATING FACTOR; LOW-DENSITY LIPOPROTEIN; PRIMORDIAL GERM-CELLS; ONCOSTATIN-M; STEM-CELLS; IN-VITRO; DEFINITIVE HEMATOPOIESIS; SIGNAL TRANSDUCER	The origin of hematopoietic stem cells (HSCs) and their growth factor requirement are poorly understood. Here we describe a new in vitro culture system of the aorta-gonad-mesonephros (AGM) region, where long-term repopulating HSCs first arise. We demonstrate that oncostatin M (OSM) is expressed in the AGM and is absolutely required for the expansion of multipotential hematopoietic progenitors in vitro. In addition, OSM enhances the formation of endothelial cell clusters. Thus, OSM appears to be a key cytokine for the development of multipotential hematopoietic progenitors in the AGM, possibly acting on common precursor cells between HSCs and endothelial cells. fly using the AG M culture derived from macrophage colony-stimulating factor (M-CSF)-deficient op/op mutant embryos, we also show a pivotal role for M-CSF in fetal myelopoiesis.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 108, Japan; Tokyo Univ Pharm & Life Sci, Tokyo 19203, Japan; NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Frederick, MD 21702 USA	University of Tokyo; University of Tokyo; Tokyo University of Pharmacy & Life Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Miyajima, A (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yaoi, Tokyo 113, Japan.			Mukouyama, Yoh-suke/0000-0002-9084-4922	OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bentley DJ, 1996, NAT GENET, V13, P489, DOI 10.1038/ng0896-489; BORZILLO GV, 1990, MOL CELL BIOL, V10, P2703, DOI 10.1128/MCB.10.6.2703; BRUCE AG, 1992, J IMMUNOL, V149, P1271; CORMIER F, 1988, DEVELOPMENT, V102, P279; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; DONOVAN PJ, 1986, CELL, V44, P831, DOI 10.1016/0092-8674(86)90005-X; DZIERZAK E, 1995, TRENDS GENET, V11, P356; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Ichihara M, 1997, BLOOD, V90, P165; IMAKAWA K, 1995, ENDOCRINE, V3, P511, DOI 10.1007/BF02738826; JEFFERY E, 1993, CYTOKINE, V5, P107, DOI 10.1016/1043-4666(93)90048-A; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; KODAMA H, 1994, EXP HEMATOL, V22, P979; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; LEDER A, 1992, DEVELOPMENT, V116, P1041; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MIYAJIMA A, 1987, GENE, V58, P273, DOI 10.1016/0378-1119(87)90382-9; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; NAKAHATA T, 1982, J CELL PHYSIOL, V111, P239, DOI 10.1002/jcp.1041110304; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; Peters M, 1997, J EXP MED, V185, P755, DOI 10.1084/jem.185.4.755; PLOEMACHER RE, 1989, BLOOD, V74, P2755; RICH IN, 1995, BLOOD, V86, P463, DOI 10.1182/blood.V86.2.463.bloodjournal862463; Richards CD, 1997, J IMMUNOL, V159, P2431; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; ROSE TM, 1994, CYTOKINE, V6, P48, DOI 10.1016/1043-4666(94)90007-8; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; SUI XW, 1995, P NATL ACAD SCI USA, V92, P2859, DOI 10.1073/pnas.92.7.2859; THOMA B, 1994, J BIOL CHEM, V269, P6215; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Yoder MC, 1997, BLOOD, V89, P2176, DOI 10.1182/blood.V89.6.2176; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x	59	123	129	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1998	8	1					105	114		10.1016/S1074-7613(00)80463-X	http://dx.doi.org/10.1016/S1074-7613(00)80463-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462516	Bronze			2022-12-18	WOS:000071765700011
J	SU, X; ZHOU, T; WANG, Z; YANG, PA; JOPE, RS; MOUNTZ, JD				SU, X; ZHOU, T; WANG, Z; YANG, PA; JOPE, RS; MOUNTZ, JD			DEFECTIVE EXPRESSION OF HEMATOPOIETIC-CELL PROTEIN-TYROSINE-PHOSPHATASE (HCP) IN LYMPHOID-CELLS BLOCKS FAS-MEDIATED APOPTOSIS	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; DNA FRAGMENTATION; MONOCLONAL-ANTIBODY; VIABLE MOTHEATEN; PHORBOL ESTER; FACTOR-ALPHA; SH2 DOMAIN; MOTH-EATEN; KINASE-C; DEATH	Protein tyrosine dephosphorylation after Fas crosslinking occurred in Fas apoptosis-sensitive CEM-6 cells but not in Pas apoptosis-resistant MOLT-4 cells, and apoptosis in the CEM-6 cells could be inhibited by the protein tyrosine phosphatase inhibitor, pervanadate. The time course and level of dephosphorylation were correlated with increased hematopoietic cell protein tyrosine phosphatase (HCP) activity, but not with the activity of two other tyrosine phosphatases. The level of expression of HCP was correlated with Fas apoptosis function in eleven human and murine Fas-positive lymphoid cell lines. Expression of recombinant HCP in the MOLT-4 cell line converted this Fas apoptosis-resistant cell line to Pas apoptosis sensitive. HOP-mutant me(v)/me(v) mice exhibited increased expression of Fas but decreased Fas-mediated apoptosis function in lymphoid organs after anti-mouse Fas antibody treatment in vivo. Thus, HCP-mediated protein dephosphorylation is involved in the delivery of the Pas apoptosis signal in lymphoid cells.	UNIV ALABAMA, DEPT PSYCHIAT & BEHAV NEUROBIOL, BIRMINGHAM, AL 35294 USA; UNIV ALABAMA, VET ADM MED CTR, BIRMINGHAM, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	SU, X (corresponding author), UNIV ALABAMA, DEPT MED, DIV CLIN IMMUNOL & RHEUMATOL, 473 LYONS HARRISON RES BLDG, BIRMINGHAM STN, BIRMINGHAM, AL 35294 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042547, P01AR003555] Funding Source: NIH RePORTER; NIAID NIH HHS [U01-AI34568] Funding Source: Medline; NIAMS NIH HHS [R01-AR42547, P01-AR03555] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; ARENDS MJ, 1990, AM J PATHOL, V136, P593; BALLOU LR, 1992, IMMUNOL TODAY, V13, P339, DOI 10.1016/0167-5699(92)90167-6; BAXTER GD, 1992, J IMMUNOL, V148, P1949; BUDD RC, 1992, J IMMUNOL, V148, P1055; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361; FORBES IJ, 1992, EXP CELL RES, V198, P367, DOI 10.1016/0014-4827(92)90393-M; FRUMAN DA, 1992, EUR J IMMUNOL, V22, P2513, DOI 10.1002/eji.1830221008; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOLSTEIN P, 1991, IMMUNOL REV, V121, P29, DOI 10.1111/j.1600-065X.1991.tb00822.x; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Hayes S M, 1992, Dev Immunol, V2, P191, DOI 10.1155/1992/68954; ILLERA VA, 1993, J IMMUNOL, V151, P2965; ITOH N, 1993, J BIOL CHEM, V268, P10932; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; KIM MY, 1991, J BIOL CHEM, V266, P484; KNIGHT CRL, 1991, BIOCHIM BIOPHYS ACTA, V1096, P312, DOI 10.1016/0925-4439(91)90067-J; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OEHM A, 1992, J BIOL CHEM, V267, P10709; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281, DOI 10.1016/0165-6147(89)90029-1; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; PLUTZKY J, 1992, GENOMICS, V13, P869, DOI 10.1016/0888-7543(92)90172-O; PUMIGLIA KM, 1992, BIOCHEM J, V286, P441, DOI 10.1042/bj2860441; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SAMELSON LE, 1986, NATURE, V324, P674, DOI 10.1038/324674a0; SCHMID DS, 1986, P NATL ACAD SCI USA, V83, P1881, DOI 10.1073/pnas.83.6.1881; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; Shultz L D, 1991, Semin Immunol, V3, P397; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SHULTZ LD, 1988, CURR TOP MICROBIOL, V137, P216; SIDMAN CL, 1989, P NATL ACAD SCI USA, V86, P6279, DOI 10.1073/pnas.86.16.6279; SONG QZ, 1993, BIOCHEM BIOPH RES CO, V190, P47, DOI 10.1006/bbrc.1993.1009; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TAKANO Y, 1993, PATHOL RES PRACT, V189, P197, DOI 10.1016/S0344-0338(11)80092-0; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; UCKER DS, 1987, NATURE, V327, P62, DOI 10.1038/327062a0; Walker N I, 1988, Methods Achiev Exp Pathol, V13, P18; WALKER PR, 1993, EXP CELL RES, V207, P142, DOI 10.1006/excr.1993.1173; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816	61	123	124	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1995	2	4					353	362		10.1016/1074-7613(95)90143-4	http://dx.doi.org/10.1016/1074-7613(95)90143-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU616	7536621	Bronze			2022-12-18	WOS:A1995QU61600005
J	Werneburg, S; Jung, J; Kunjamma, RB; Ha, SK; Luciano, NJ; Willis, CM; Gao, GP; Biscola, NP; Havton, LA; Crocker, SJ; Popko, B; Reich, DS; Schafer, DP				Werneburg, Sebastian; Jung, Jonathan; Kunjamma, Rejani B.; Ha, Seung-Kwon; Luciano, Nicholas J.; Willis, Cory M.; Gao, Guangping; Biscola, Natalia P.; Havton, Leif A.; Crocker, Stephen J.; Popko, Brian; Reich, Daniel S.; Schafer, Dorothy P.			Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; MOUSE MODEL; INJURY; EXPRESSION; INSIGHTS; ACTIVATION; PATHWAY; SYSTEM	Multiple sclerosis (MS) is a demyelinating, autoimmune disease of the central nervous system. While work has focused on myelin and axon loss in MS, less is known about mechanisms underlying synaptic changes. Using postmortem human MS tissue, a preclinical nonhuman primate model of MS, and two rodent models of demyelinating disease, we investigated synapse changes in the visual system. Similar to other neurodegenerative diseases, microglial synaptic engulfment and profound synapse loss were observed. In mice, synapse loss occurred independently of local demyelination and neuronal degeneration but coincided with gliosis and increased complement component C3, but not C1q, at synapses. Viral overexpression of the complement inhibitor Crry at C3-bound synapses decreased microglial engulfment of synapses and protected visual function. These results indicate that microglia eliminate synapses through the alternative complement cascade in demyelinating disease and identify a strategy to prevent synapse loss that may be broadly applicable to other neurodegenerative diseases.	[Werneburg, Sebastian; Jung, Jonathan; Schafer, Dorothy P.] Univ Massachusetts, Brudn Neuropsychiat Res Inst, Dept Neurobiol, Med Sch, Worcester, MA 01605 USA; [Kunjamma, Rejani B.; Popko, Brian] Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Ha, Seung-Kwon; Luciano, Nicholas J.; Reich, Daniel S.] NINDS, Translat Neuroradiol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Willis, Cory M.; Crocker, Stephen J.] Univ Connecticut, Dept Neurosci, Sch Med, Farmington, CT 06032 USA; [Gao, Guangping] Univ Massachusetts, Horae Gene Therapy Ctr, Med Sch, Worcester, MA 01605 USA; [Gao, Guangping] Univ Massachusetts, Li Weibo Inst Rare Dis Res, Med Sch, Worcester, MA 01605 USA; [Gao, Guangping] Univ Massachusetts, Dept Microbiol & Physiol Syst, Med Sch, Worcester, MA 01605 USA; [Biscola, Natalia P.; Havton, Leif A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Havton, Leif A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Connecticut; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schafer, DP (corresponding author), Univ Massachusetts, Brudn Neuropsychiat Res Inst, Dept Neurobiol, Med Sch, Worcester, MA 01605 USA.	dorothy.schafer@umassmed.edu	Werneburg, Sebastian/AAX-3007-2020; Willis, Cory/AAL-1086-2020; Reich, Daniel S./E-5701-2010	Werneburg, Sebastian/0000-0002-2173-8392; Reich, Daniel S./0000-0002-2628-4334; Willis, Cory/0000-0001-7938-7276; Jung, Jonathan/0000-0002-3342-1245	Deutsche Forschungsgemeinschaft (DFG, Germany) grant [WE 6170/1-1]; Intramural Research Program of NINDS; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation;  [NIMH-RO1MH113743];  [NINDS-R01NS099334]	Deutsche Forschungsgemeinschaft (DFG, Germany) grant(German Research Foundation (DFG)); Intramural Research Program of NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; ; 	We thank Dr. Christopher C. Hemond (UMMS) for critical reading of the manuscript. Wethank Dr. Paola Perrat (UMMS) for advice on the design and production of plasmids, Shannon Becker (UMMS) and Anoushka Lotun (UMMS) for assistance with tissue preparation, and Dr. Claudio Punzo and Georgia Gunner for advice and training on optomotor testing. We further thank Prof. Dr. Matthew Rasband (Baylor College of Medicine) for sharing CASPR and bIV-spectrin specific antibodies and Prof. Oleg Butovsky for providing P2RY12 specific antibodies. This work was supported by Deutsche Forschungsgemeinschaft (DFG, Germany) grant WE 6170/1-1 (S.W.), NIMH-RO1MH113743 (D.P.S.), the Intramural Research Program of NINDS (D.S.R.), NINDS-R01NS099334 (B.P.), and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (D.P.S., D.S.R., B.P., L.A.H.).	Absinta M, 2016, NAT REV NEUROL, V12, P358, DOI 10.1038/nrneurol.2016.59; Aeinehband S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122048; Alawieh A, 2016, IMMUNOL REV, V274, P270, DOI 10.1111/imr.12470; Alawieh A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0464-8; Amato MP, 2010, NEUROL SCI, V31, P211, DOI 10.1007/s10072-010-0376-4; Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208; Atkinson C, 2006, J IMMUNOL, V177, P7266, DOI 10.4049/jimmunol.177.10.7266; Bellesi M, 2017, J NEUROSCI, V37, P5263, DOI 10.1523/JNEUROSCI.3981-16.2017; Bellizzi MJ, 2016, J NEUROSCI, V36, P1336, DOI 10.1523/JNEUROSCI.1171-15.2016; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Boos L, 2004, J IMMUNOL, V173, P4708, DOI 10.4049/jimmunol.173.7.4708; Bove RM, 2012, MULT SCLER J, V18, P1472, DOI 10.1177/1352458512438236; Bullard DC, 2005, J IMMUNOL, V175, P6327, DOI 10.4049/jimmunol.175.10.6327; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Chung WS, 2016, P NATL ACAD SCI USA, V113, P10186, DOI 10.1073/pnas.1609896113; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Ciotti JR, 2018, CURR TREAT OPTION NE, V20, DOI 10.1007/s11940-018-0496-3; Coleman P, 2004, NEUROLOGY, V63, P1155, DOI 10.1212/01.WNL.0000140626.48118.0A; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Cree BAC, 2019, ANN NEUROL, V85, P653, DOI 10.1002/ana.25463; Crocker SJ, 2006, AM J PATHOL, V169, P2104, DOI 10.2353/ajpath.2006.060626; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; Dutta R, 2011, ANN NEUROL, V69, P445, DOI 10.1002/ana.22337; Eshaghi A, 2018, BRAIN, V141, P1665, DOI 10.1093/brain/awy088; Forner S, 2017, TRENDS NEUROSCI, V40, P347, DOI 10.1016/j.tins.2017.04.002; Garber C, 2019, NAT NEUROSCI, V22, P1276, DOI 10.1038/s41593-019-0427-y; Gholipour T, 2011, NEUROLOGY, V76, P1996, DOI 10.1212/WNL.0b013e31821e559d; Gunner G, 2019, NAT NEUROSCI, V22, P1075, DOI 10.1038/s41593-019-0419-y; Henstridge CM, 2016, AGEING RES REV, V28, P72, DOI 10.1016/j.arr.2016.04.005; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hong YK, 2014, NEURON, V84, P332, DOI 10.1016/j.neuron.2014.08.059; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Hu XZ, 2012, NEUROSCI LETT, V531, P35, DOI 10.1016/j.neulet.2012.10.012; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Ingram G, 2012, MULT SCLER J, V18, P1401, DOI 10.1177/1352458512438238; Ingram G, 2009, CLIN EXP IMMUNOL, V155, P128, DOI 10.1111/j.1365-2249.2008.03830.x; Ingram G, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-53; Janova H, 2018, J CLIN INVEST, V128, P734, DOI 10.1172/JCI97032; Jurgens T, 2016, BRAIN, V139, P39, DOI 10.1093/brain/awv353; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; LAMBRIS JD, 1986, ANTICANCER RES, V6, P515; Lassmann H., 2018, COLD SPRING HARB PER, V8; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Lee NJ, 2018, BRAIN, V141, P1637, DOI 10.1093/brain/awy082; Leibovitch EC, 2018, P NATL ACAD SCI USA, V115, P11292, DOI 10.1073/pnas.1811974115; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lodygin D, 2019, NATURE, V566, P503, DOI 10.1038/s41586-019-0964-2; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Mandolesi G, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.222; Marshall KM, 2014, J EXP MED, V211, P1793, DOI 10.1084/jem.20131902; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; Michailidou I, 2017, GLIA, V65, P264, DOI 10.1002/glia.23090; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; Molina H, 2002, CELL MOL LIFE SCI, V59, P220, DOI 10.1007/s00018-002-8418-6; Morgan B, 2018, SEMIN IMMUNOPATHOL, V40, P1, DOI 10.1007/s00281-017-0664-7; Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nataf S, 2000, J IMMUNOL, V165, P5867, DOI 10.4049/jimmunol.165.10.5867; Paolicelli RC, 2017, NEURON, V95, P297, DOI 10.1016/j.neuron.2017.05.037; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Reis ES, 2019, NAT REV IMMUNOL, V19, P503, DOI 10.1038/s41577-019-0168-x; Araujo SES, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0936-0; Schafer DP, 2016, ELIFE, V5, DOI 10.7554/eLife.15224; Schafer Dorothy P, 2014, J Vis Exp, DOI 10.3791/51482; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Selkoe Dennis J., 2008, P89; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Szalai AJ, 2007, MOL IMMUNOL, V44, P3132, DOI 10.1016/j.molimm.2007.02.002; Tatomir A, 2017, IMMUNOL RES, V65, P1103, DOI 10.1007/s12026-017-8961-8; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Traka M, 2016, NAT NEUROSCI, V19, P65, DOI 10.1038/nn.4193; Traka M, 2010, BRAIN, V133, P3017, DOI 10.1093/brain/awq247; Turnberg D, 2003, MOL IMMUNOL, V40, P145, DOI 10.1016/S0161-5890(03)00110-X; Tyebji S, 2017, PROG NEUROBIOL, V153, P18, DOI 10.1016/j.pneurobio.2017.03.008; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Voet S, 2019, TRENDS MOL MED, V25, P112, DOI 10.1016/j.molmed.2018.11.005; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Watkins LM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0611-x; Weideman AM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00577; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Wolswijk G, 2003, BRAIN, V126, P1638, DOI 10.1093/brain/awg151; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zivadinov R, 2013, RADIOLOGY, V268, P831, DOI 10.1148/radiol.13122424	96	122	124	4	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					167	+		10.1016/j.immuni.2019.12.004	http://dx.doi.org/10.1016/j.immuni.2019.12.004			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31883839	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000507384600016
J	Zhao, YL; Lee, CK; Lin, CH; Gassen, RB; Xu, XZ; Huang, Z; Xiao, CC; Bonorino, C; Lu, LF; Bui, JD; Hui, EF				Zhao, Yunlong; Lee, Calvin K.; Lin, Chia-Hao; Gassen, Rodrigo B.; Xu, Xiaozheng; Huang, Zhe; Xiao, Changchun; Bonorino, Cristina; Lu, Li-Fan; Bui, Jack D.; Hui, Enfu			PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways	IMMUNITY			English	Article							IMMUNE-CHECKPOINT INHIBITOR; T-CELLS; ANTI-PD-L1 ANTIBODY; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; B7 FAMILY; SURFACE; NIVOLUMAB; BLOCKADE; BINDING	Combined immunotherapy targeting the immune checkpoint receptors cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death 1 (PD-1), or CTLA-4 and the PD-1 ligand (PD-L1) exhibits superior anti-tumor responses compared with single-agent therapy. Here, we examined the molecular basis for this synergy. Using reconstitution assays with fluorescence readouts, we found that PD-L1 and the CTLA-4 ligand CD80 heterodimerize in cis but not trans. Quantitative biochemistry and cell biology assays revealed that PD-L1:CD80 cis-heterodimerization inhibited both PD-L1:PD-1 and CD80:CTLA-4 interactions through distinct mechanisms but preserved the ability of CD80 to activate the T cell co-stimulatory receptor CD28. Furthermore, PD-L1 expression on antigen-presenting cells (APCs) prevented CTLA-4-mediated trans-endocytosis of CD80. Atezolizumab (anti-PD-L1), but not anti-PD-1, reduced cell surface expression of CD80 on APCs, and this effect was negated by co-blockade of CTLA-4 with ipilimumab (anti-CTLA-4). Thus, PD-L1 exerts an immunostimulatory effect by repressing the CTLA-4 axis; this has implications to the synergy of anti-PD-L1 and anti-CTLA-4 combination therapy.	[Zhao, Yunlong; Xu, Xiaozheng; Hui, Enfu] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Lee, Calvin K.; Bui, Jack D.] Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Lin, Chia-Hao; Lu, Li-Fan] Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA; [Gassen, Rodrigo B.] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil; [Huang, Zhe; Xiao, Changchun] Scripps Res Inst, Dept Immunol & Microbiol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Bonorino, Cristina] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [Bonorino, Cristina] Univ Fed Ciencias Saude Porto Alegre, Dept Ciencias Basicas Saude, Porto Alegre, RS, Brazil	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Pontificia Universidade Catolica Do Rio Grande Do Sul; Scripps Research Institute; University of California System; University of California San Diego; Universidade Federal de Ciencias da Saude de Porto Alegre	Hui, EF (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	enfuhui@ucsd.edu	/AAJ-4923-2021	Lu, Li-Fan/0000-0002-9727-0036	NINDS P30 Grant [NS047101]; UCSD Cancer Biology Postdoctoral Fellowship; CAPES fellowship; CNPq Productivity Fellowship; Searle Scholar Award from the Kinship Foundation; Pew Biomedical Scholar Award from the Pew Charitable Trusts; NIH [R37 CA239072, AI108651, AI140095]; Hartwell Foundation; NATIONAL CANCER INSTITUTE [R37CA239072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108651, R01AI121155] Funding Source: NIH RePORTER	NINDS P30 Grant; UCSD Cancer Biology Postdoctoral Fellowship; CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq Productivity Fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Searle Scholar Award from the Kinship Foundation; Pew Biomedical Scholar Award from the Pew Charitable Trusts; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Bennett (UCSD) and M. Niwa (UCSD) for critically reading the manuscript; J. Wilhelm (UCSD) for allowing the use of the TIRF microscope; N. Stuurman (UCSF) for technical support with TIRF microscopy; J. Sabatini and M. Bohm for help with confocal microscopy at the UCSD School of Medicine Microscopy Core, supported by NINDS P30 Grant NS047101; and Affina Biotechnologies for conducting the SPR experiments. Y.Z. is a Cancer Research Institute Irvington Postdoctoral Fellow. C.-H.L. is supported by a UCSD Cancer Biology Postdoctoral Fellowship, R.B.G. by a CAPES fellowship, and C.B. by a CNPq Productivity Fellowship. This work was supported by a Searle Scholar Award from the Kinship Foundation to E.H., a Pew Biomedical Scholar Award from the Pew Charitable Trusts to E.H, NIH grants R37 CA239072 to E.H. and AI108651 and AI140095 to L.-F.L., and a grant from the Hartwell Foundation to J.D.B.	Alegre ML, 1996, J IMMUNOL, V157, P4762; Bhatia S, 2005, P NATL ACAD SCI USA, V102, P15569, DOI 10.1073/pnas.0507257102; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Callahan MK, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00385; Chaudhri A, 2018, CANCER IMMUNOL RES, V6, P921, DOI 10.1158/2326-6066.CIR-17-0316; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Dong HD, 1999, NAT MED, V5, P1365; Dumortier H, 2005, J IMMUNOL, V175, P855, DOI 10.4049/jimmunol.175.2.855; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Edelstein A.D., 2014, J BIOL METHODS, V1, pe10; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Girard T, 2014, IMMUNOL LETT, V161, P65, DOI 10.1016/j.imlet.2014.05.002; Haile ST, 2011, J IMMUNOL, V186, P6822, DOI 10.4049/jimmunol.1003682; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hou TZ, 2015, J IMMUNOL, V194, P2148, DOI 10.4049/jimmunol.1401876; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kluger HM, 2017, CLIN CANCER RES, V23, P4270, DOI 10.1158/1078-0432.CCR-16-3146; Kong KF, 2014, NAT IMMUNOL, V15, P465, DOI 10.1038/ni.2866; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lin H, 2018, J CLIN INVEST, V128, P1708, DOI 10.1172/JCI120803; LINSLEY PS, 1995, J BIOL CHEM, V270, P15417, DOI 10.1074/jbc.270.25.15417; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Nye JA, 2008, LANGMUIR, V24, P4145, DOI 10.1021/la703788h; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Passiglia F, 2018, INT J CANCER, V142, P1277, DOI 10.1002/ijc.31136; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Qureshi OS, 2012, J BIOL CHEM, V287, P9429, DOI 10.1074/jbc.M111.304329; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Roszik J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-346; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Sugiura D., 2019, SCIENCE; Tang HD, 2018, J CLIN INVEST, V128, P580, DOI 10.1172/JCI96061; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Valk E, 2008, TRENDS IMMUNOL, V29, P272, DOI 10.1016/j.it.2008.02.011; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zappasodi R, 2018, CANCER CELL, V33, P581, DOI 10.1016/j.ccell.2018.03.005; Zhang Y, 2018, ENERGY TECHNOL-GER, V6, P1, DOI DOI 10.1016/J.SMHL.2018.03.004; Zhao YL, 2018, CELL REP, V24, P379, DOI 10.1016/j.celrep.2018.06.054; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	66	122	130	5	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					1059	+		10.1016/j.immuni.2019.11.003	http://dx.doi.org/10.1016/j.immuni.2019.11.003			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31757674	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000503162900012
J	Roberts, AW; Lee, BL; Deguine, J; John, S; Shlomchik, MJ; Barton, GM				Roberts, Allison W.; Lee, Bettina L.; Deguine, Jacques; John, Shinu; Shlomchik, Mark J.; Barton, Gregory M.			Tissue-Resident Macrophages Are Locally Programmed for Silent Clearance of Apoptotic Cells	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; NUCLEIC-ACID RECOGNITION; TRANSCRIPTION-FACTOR; IMPAIRED UPTAKE; MARGINAL ZONE; UP-REGULATION; PPAR-GAMMA; SELF-DNA; EXPRESSION; PHAGOCYTOSIS	Although apoptotic cells (ACs) contain nucleic acids that can be recognized by Toll-like receptors (TLRs), engulfment of ACs does not initiate inflammation in healthy organisms. Here we identified macrophage populations that continually engulf ACs in distinct tissues and found that these macrophages share characteristics compatible with immunologically silent clearance of ACs; such characteristics include high expression of AC recognition receptors, low expression of TLR9, and reduced TLR responsiveness to nucleic acids. Removal of the macrophages from tissues resulted in loss of many of these characteristics and the ability to generate inflammatory responses to AC-derived nucleic acids, suggesting that cues from the tissue microenvironment program macrophages for silent AC clearance. The transcription factors KLF2 and KLF4 control the expression of many genes within this AC clearance program. The coordinated expression of AC receptors with genes that limit responses to nucleic acids might ensure maintenance of homeostasis and thus represent a central feature of tissue macrophages.	[Roberts, Allison W.; Lee, Bettina L.; Deguine, Jacques; Barton, Gregory M.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [John, Shinu; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; [Lee, Bettina L.] Genentech Inc, San Francisco, CA 94080 USA; [John, Shinu] Moderna Therapeut, Cambridge, MA 02141 USA	University of California System; University of California Berkeley; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Roche Holding; Genentech	Barton, GM (corresponding author), Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	barton@berkeley.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Deguine, Jacques/0000-0001-9218-3040; Barton, Gregory/0000-0002-3793-0100	NIH [AI072429, AI105184, AI063302, AI118841, AR050256]; Lupus Research Institute; Long-Term Human Frontier Science Program Fellowship [LT-000081-2013L]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI118841, R01AI072429, R01AI105184, P01AI063302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; Long-Term Human Frontier Science Program Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jerry Lingrel for providing Lyz2cre<SUP>+/~</SUP>Klf2<SUP>fl/fl</SUP> mice. We thank K. Ching for assistance with cloning and R. Vance and members of the Barton and Vance labs for constructive discussions and critical reading of the manuscript. This work was supported by the NIH (AI072429, AI105184 and AI063302 to G.M.B. and AI118841 and AR050256 to M.J.S) and by the Lupus Research Institute (Distinguished Innovator Award to G.M.B.). J.D. was supported by a Long-Term Human Frontier Science Program Fellowship (LT-000081-2013L).	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Calvani N, 2005, J IMMUNOL, V175, P4777, DOI 10.4049/jimmunol.175.7.4777; Coch C, 2009, J LEUKOCYTE BIOL, V86, P663, DOI 10.1189/jlb.0509314; Cummings RJ, 2016, NATURE, V539, P565, DOI 10.1038/nature20138; Dini L, 2002, MICROSC RES TECHNIQ, V57, P530, DOI 10.1002/jemt.10107; Duriez M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00316; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fond AM, 2016, ADV EXP MED BIOL, V930, P25, DOI 10.1007/978-3-319-39406-0_2; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; King KL, 2000, CELL DEATH DIFFER, V7, P994, DOI 10.1038/sj.cdd.4400731; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McDonald PP, 1999, J IMMUNOL, V163, P6164; McGaha TL, 2011, BLOOD, V117, P5403, DOI 10.1182/blood-2010-11-320028; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sathanoori R, 2015, PURINERG SIGNAL, V11, P139, DOI 10.1007/s11302-014-9442-3; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sharma S, 2015, J IMMUNOL, V195, P3507, DOI 10.4049/jimmunol.1500964; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; Stamatiades EG, 2016, CELL, V166, P991, DOI 10.1016/j.cell.2016.06.058; Summers SA, 2010, J AUTOIMMUN, V35, P291, DOI 10.1016/j.jaut.2010.05.004; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Tuomisto TT, 2008, CARDIOVASC RES, V78, P175, DOI 10.1093/cvr/cvn007; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Wang Y, 2008, SCAND J IMMUNOL, V68, P297, DOI 10.1111/j.1365-3083.2008.02141.x; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Yasuda K, 2009, J IMMUNOL, V183, P3109, DOI 10.4049/jimmunol.0900399	70	122	122	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					913	+		10.1016/j.immuni.2017.10.006	http://dx.doi.org/10.1016/j.immuni.2017.10.006			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29150239	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000416483700015
J	Ho, SSW; Zhang, WYL; Tan, NYJ; Khatoo, M; Suter, MA; Tripathi, S; Cheung, FSG; Lim, WK; Tan, PH; Ngeow, J; Gasser, S				Ho, Samantha S. W.; Zhang, Wendy Y. L.; Tan, Nikki Yi Jie; Khatoo, Muznah; Suter, Manuel A.; Tripathi, Shubhita; Cheung, Florence S. G.; Lim, Weng Khong; Tan, Puay Hoon; Ngeow, Joanne; Gasser, Stephan			The DNA Structure-Specific Endonuclease MUS81 Mediates DNA Sensor STING-Dependent Host Rejection of Prostate Cancer Cells	IMMUNITY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; INNATE IMMUNE RECOGNITION; REPLICATION RESTART; INFLAMMATION; CONTRIBUTES; PATHWAYS; TARGET; FORKS	Self-DNA is present in the cytosol of many cancer cells and can promote effective immune rejection of tumor cells, but the mechanisms leading to the presence of cytosolic DNA are unknown. Here, we report that the cleavage of genomic DNA by DNA structure-specific endonuclease MUS81 and PARP-dependent DNA repair pathways leads to the accumulation of cytosolic DNA in prostate cancer cells. The number of nuclear MUS81 foci and the amount of cytosolic dsDNA increased in tandem from hyperplasia to clinical stage II prostate cancers and decreased at stage III. Cytosolic DNA generated by MUS81 stimulated DNA sensor STING-dependent type I interferon (IFN) expression and promoted phagocytic and T cell responses, resulting in type I and II IFN-mediated rejection of prostate tumor cells via mechanisms that partly depended on macrophages. Our results demonstrate that the tumor suppressor MUS81 alerts the immune system to the presence of transformed host cells.	[Ho, Samantha S. W.; Zhang, Wendy Y. L.; Tan, Nikki Yi Jie; Khatoo, Muznah; Suter, Manuel A.; Tripathi, Shubhita; Cheung, Florence S. G.; Gasser, Stephan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Immunol Programme, Singapore 117456, Singapore; [Lim, Weng Khong] Natl Canc Ctr Singapore, Lab Canc Epigenome, Div Med Sci, 11 Hosp Dr, Singapore 169610, Singapore; [Lim, Weng Khong] Duke NUS Grad Med Sch, Div Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore; [Tan, Puay Hoon] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore; [Tan, Puay Hoon; Ngeow, Joanne] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Ngeow, Joanne] Natl Canc Ctr Singapore, Div Med Oncol, 11 Hosp Dr, Singapore 169610, Singapore; [Ngeow, Joanne] Duke NUS Grad Med Sch, Oncol Acad Clin Program, 8 Coll Rd, Singapore 169857, Singapore; [Gasser, Stephan] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; Singapore General Hospital; National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore	Gasser, S (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Immunol Programme, Singapore 117456, Singapore.; Gasser, S (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore.	stgasser1@yahoo.com	Pinheiro, Maísa/E-7424-2012; Lim, Weng Khong/Q-8661-2019; Ngeow, Joanne/O-1250-2013; Joanne, Ngeow/G-9610-2019	Lim, Weng Khong/0000-0003-4391-1130; Ngeow, Joanne/0000-0003-1558-3627; Joanne, Ngeow/0000-0003-1558-3627; Gasser, Stephan/0000-0002-5616-0914	NRF grant HUJ-CREATE - Cellular and Molecular Mechanisms of Inflammation	NRF grant HUJ-CREATE - Cellular and Molecular Mechanisms of Inflammation	We would like to thank Dr. Hutchinson for technical assistance in flow cytometry. This work was supported by the NRF grant HUJ-CREATE - Cellular and Molecular Mechanisms of Inflammation. Dr. L. Robinson and Dr. N. McCarthy of Insight Editing London critically reviewed the manuscript.	Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6166; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chang AJ, 2014, NAT REV CLIN ONCOL, V11, P308, DOI 10.1038/nrclinonc.2014.68; Cote AG, 2008, MOL CELL, V31, P800, DOI 10.1016/j.molcel.2008.08.025; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Dehe PM, 2013, NAT STRUCT MOL BIOL, V20, P598, DOI 10.1038/nsmb.2550; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; GiraudPanis MJE, 1997, EMBO J, V16, P2528, DOI 10.1093/emboj/16.9.2528; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hurwitz A. A., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.im2005s45, DOI 10.1002/0471142735.IM2005S45]; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Lam AR, 2014, CANCER RES, V74, P2193, DOI 10.1158/0008-5472.CAN-13-1703; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Martini M, 2010, VACCINE, V28, P3548, DOI 10.1016/j.vaccine.2010.03.007; Mayle R, 2015, SCIENCE, V349, P742, DOI 10.1126/science.aaa8391; Mazouzi A, 2014, EXP CELL RES, V329, P85, DOI 10.1016/j.yexcr.2014.09.030; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; Miselis NR, 2008, MOL CANCER THER, V7, P788, DOI 10.1158/1535-7163.MCT-07-0579; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nishino T, 2002, ONCOGENE, V21, P9022, DOI 10.1038/sj.onc.1206135; Nowak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011311; Ohkuri T, 2014, CANCER IMMUNOL RES, V2, P1199, DOI 10.1158/2326-6066.CIR-14-0099; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Shen YJ, 2015, CELL REP, V11, P460, DOI 10.1016/j.celrep.2015.03.041; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Waitz R, 2012, CANCER RES, V72, P430, DOI 10.1158/0008-5472.CAN-11-1782; Wang YQ, 2013, NAT IMMUNOL, V14, P714, DOI 10.1038/ni.2623; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051	46	122	124	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1177	1189		10.1016/j.immuni.2016.04.010	http://dx.doi.org/10.1016/j.immuni.2016.04.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27178469	Bronze			2022-12-18	WOS:000376478500021
J	Malchow, S; Leventhal, DS; Lee, V; Nishi, S; Socci, ND; Savage, PA				Malchow, Sven; Leventhal, Daniel S.; Lee, Victoria; Nishi, Saki; Socci, Nicholas D.; Savage, Peter A.			Aire Enforces Immune Tolerance by Directing Autoreactive T Cells into the Regulatory T Cell Lineage	IMMUNITY			English	Article							SELF-ANTIGEN EXPRESSION; AUTOIMMUNE-DISEASE; SELECTION; THYMUS; POPULATION; FOXP3(+); SUBSETS; DEFECT	The promiscuous expression of tissue-restricted antigens in the thymus, driven in part by autoimmune regulator (Aire), is critical for the protection of peripheral tissues from autoimmune attack. Aire-dependent processes are thought to promote both clonal deletion and the development of Foxp3(+) regulatory T (Treg) cells, suggesting that autoimmunity associated with Aire deficiency results from two failed tolerance mechanisms. Here, examination of autoimmune lesions in Aire(-/-) mice revealed an unexpected third possibility. We found that the predominant conventional T cell clonotypes infiltrating target lesions express antigen receptors that were preferentially expressed by Foxp3(+) Treg cells in Aire(+/+) mice. Thus, Aire enforces immune tolerance by ensuring that distinct autoreactive T cell specificities differentiate into the Treg cell lineage; dysregulation of this process results in the diversion of Treg cell-biased clonotypes into pathogenic conventional T cells.	[Malchow, Sven; Leventhal, Daniel S.; Lee, Victoria; Nishi, Saki; Savage, Peter A.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core, 1275 York Ave, New York, NY 10021 USA	University of Chicago; Memorial Sloan Kettering Cancer Center	Savage, PA (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	psavage@bsd.uchicago.edu			Cancer Research Institute Investigator Award; University of Chicago Comprehensive Cancer Center; Deutsche Forschungsgemeinschaft (DFG) [MA 6154/1-1]; NIH/NCI [CA183357]; MSKCC Comprehensive Cancer Center [P30 CA008748];  [R01CA160371];  [R01AI110507]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA160371, F31CA183357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110507] Funding Source: NIH RePORTER	Cancer Research Institute Investigator Award; University of Chicago Comprehensive Cancer Center; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MSKCC Comprehensive Cancer Center; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Bendelac and R. Gottschalk for critical reading of the manuscript. This work was funded by the following sources (to P.A.S.): R01 (R01CA160371), R01 (R01AI110507), a Cancer Research Institute Investigator Award, and the University of Chicago Comprehensive Cancer Center. S.M. was supported by a Deutsche Forschungsgemeinschaft (DFG) Research Fellowship MA 6154/1-1. D.S.L. was supported by an NIH/NCI F31 predoctoral fellowship (CA183357). N.D.S. was supported by MSKCC Comprehensive Cancer Center (Support Grant #P30 CA008748).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; DeVoss JJ, 2008, J IMMUNOL, V181, P4072, DOI 10.4049/jimmunol.181.6.4072; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hou YF, 2009, J CLIN INVEST, V119, P2031, DOI 10.1172/JCI38332; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Hubert FX, 2009, J IMMUNOL, V182, P3902, DOI 10.4049/jimmunol.0802124; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kekalainen E, 2015, SCAND J IMMUNOL, V81, P298, DOI 10.1111/sji.12280; Kekalainen E, 2007, J IMMUNOL, V178, P1208, DOI 10.4049/jimmunol.178.2.1208; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Laakso SM, 2010, J AUTOIMMUN, V35, P351, DOI 10.1016/j.jaut.2010.07.008; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Magurran A.E, 1988, ECOLOGICAL DIVERSITY; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; Setiady YY, 2006, BLOOD, V107, P1056, DOI 10.1182/blood-2005-08-3088; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; Zhu ML, 2013, CANCER RES, V73, P2104, DOI 10.1158/0008-5472.CAN-12-3781	36	122	125	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1102	1113		10.1016/j.immuni.2016.02.009	http://dx.doi.org/10.1016/j.immuni.2016.02.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27130899	Green Accepted, Bronze			2022-12-18	WOS:000376478500015
J	Yu, P; Lubben, W; Slomka, H; Gebler, J; Konert, M; Cai, CC; Neubrandt, L; da Costa, OP; Paul, S; Dehnert, S; Dohne, K; Thanisch, M; Storsberg, S; Wiegand, L; Kaufmann, A; Nain, M; Quintanilla-Martinez, L; Bettio, S; Schnierle, B; Kolesnikova, L; Becker, S; Schnare, M; Bauer, S				Yu, Philipp; Luebben, Wolger; Slomka, Heike; Gebler, Janine; Konert, Madlen; Cai, Chengcong; Neubrandt, Luisa; da Costa, Olivia Prazeres; Paul, Stephanie; Dehnert, Sonja; Doehne, Karolin; Thanisch, Michael; Storsberg, Silke; Wiegand, Lisa; Kaufmann, Andreas; Nain, Marianne; Quintanilla-Martinez, Leticia; Bettio, Sabrina; Schnierle, Barbara; Kolesnikova, Larissa; Becker, Stephan; Schnare, Markus; Bauer, Stefan			Nucleic Acid-Sensing Toll-like Receptors Are Essential for the Control of Endogenous Retrovirus Viremia and ERV-Induced Tumors	IMMUNITY			English	Article							MURINE LEUKEMIA-VIRUS; CELLS; RNA; DNA; IMMUNITY; MICE; IDENTIFICATION; INTEGRATION; INDUCTION; DISCOVERY	The genome of vertebrates contains endogenous retroviruses (ERVs) that are largely nonfunctional relicts of ancestral germline infection by exogenous retroviruses. However, in some mouse strains ERVs are actively involved in disease. Here we report that nucleic acid-recognizing Toll-like receptors 3, 7, and 9 (TLR 3, TLR7, and TLR9) are essential for the control of ERVs. Loss of TLR7 function caused spontaneous retroviral viremia that coincided with the absence of ERV-specific antibodies. Importantly, additional TLR3 and TLR9 deficiency led to acute T cell lymphoblastic leukemia, underscoring a prominent role for TLR3 and TLR9 in surveillance of ERV-induced tumors. Experimental ERV infection induced a TLR3-, TLR7-, and TLR9-dependent group of "acute-phase" genes previously described in HIV and SIV infections. Our study suggests that in addition to their role in innate immunity against exogenous pathogens, nucleic acid-recognizing TLRs contribute to the immune control of activated ERVs and ERV-induced tumors.	[Yu, Philipp; Luebben, Wolger; Slomka, Heike; Gebler, Janine; Konert, Madlen; Cai, Chengcong; Neubrandt, Luisa; Paul, Stephanie; Dehnert, Sonja; Doehne, Karolin; Thanisch, Michael; Storsberg, Silke; Wiegand, Lisa; Kaufmann, Andreas; Nain, Marianne; Schnare, Markus; Bauer, Stefan] Univ Marburg, Inst Immunol, D-35043 Marburg, Germany; [Kolesnikova, Larissa; Becker, Stephan] Univ Marburg, Inst Virol, D-35043 Marburg, Germany; [da Costa, Olivia Prazeres] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-81675 Munich, Germany; [Quintanilla-Martinez, Leticia; Bettio, Sabrina] Univ Tubingen, Inst Pathol, D-72076 Tubingen, Germany; [Schnierle, Barbara] Paul Ehrlich Inst, D-63225 Langen, Germany	Philipps University Marburg; Philipps University Marburg; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Paul Ehrlich Institute	Yu, P (corresponding author), Univ Marburg, Inst Immunol, Hans Meerwein Str 2, D-35043 Marburg, Germany.	philipp.yu@staff.uni-marburg.de; stefan.bauer@staff.uni-marburg.de	Schnierle, Barbara/AAG-8108-2019	Bauer, Stefan/0000-0002-8462-1845; Yu, Philipp/0000-0003-2629-6690; Schnierle, Barbara/0000-0001-9563-4564	DFG [Yu47/2-1]; Cooperation Contract Universitatsklinikum Giessen und Marburg; Deutsche Krebshilfe; Hessian LOEWE consortium "Tumor and Inflammation";  [SFB-TR22];  [SFB-TR84];  [SFB-685]	DFG(German Research Foundation (DFG)); Cooperation Contract Universitatsklinikum Giessen und Marburg; Deutsche Krebshilfe(Deutsche Krebshilfe); Hessian LOEWE consortium "Tumor and Inflammation"; ; ; 	We are in debt to C. Kirschning, J. Denner, M.-A. Langlois, K. Yasuda, E. Latz, H. Wagner, and T. Kaishou for critical comments on the manuscript. The MuLV env-specific Ab 83A25 was provided by H. Evans and Sendai virus (Cantell strain) by H. Hochrein. Unc93b1-3d/3d mutant mice were provided by U. Kodel in a collaborative effort. We thank U. Dittmer, L. Klein, J. von Rohrscheidt, and W. Mothes for reagents, D. Busch for the PE-labeled NKG2D-Tetramer, and I. Corraliza-Generelo for help with the infection experiments. We acknowledge the expert technical assistance of C. Kloss and S. Weidner. We thank M. Fornerod for providing valuable reagents and comments. This work was supported in part by DFG grant Yu47/2-1, Cooperation Contract Universitatsklinikum Giessen und Marburg (P.Y.), Deutsche Krebshilfe (to P.Y. and S. Bauer), Hessian LOEWE consortium "Tumor and Inflammation" (S. Bauer), SFB-TR22 (S. Bauer), SFB-TR84 (S. Bauer), and SFB-685 (L.Q.-M.).	AARONSON SA, 1974, P NATL ACAD SCI USA, V71, P1957, DOI 10.1073/pnas.71.5.1957; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Balada E, 2009, REV MED VIROL, V19, P273, DOI 10.1002/rmv.622; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Basyuk E, 2003, DEV CELL, V5, P161, DOI 10.1016/S1534-5807(03)00188-6; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Breckpot K, 2010, J VIROL, V84, P5627, DOI 10.1128/JVI.00014-10; Browne EP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002293; Browne EP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000298; CHATTOPADHYAY SK, 1980, P NATL ACAD SCI-BIOL, V77, P5774, DOI 10.1073/pnas.77.10.5774; de Leval L, 2009, CRIT REV ONCOL HEMAT, V72, P125, DOI 10.1016/j.critrevonc.2009.01.002; DEHARVEN E, 1964, J EXP MED, V120, P857, DOI 10.1084/jem.120.5.857; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; FARRAR JJ, 1980, J IMMUNOL, V125, P2555; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gaulton GN, 1998, IMMUNOL RES, V17, P75, DOI 10.1007/BF02786432; HAYASHI H, 1992, J IMMUNOL, V149, P1223; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirsch I, 2010, TRENDS IMMUNOL, V31, P391, DOI 10.1016/j.it.2010.07.004; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; HUEBNER RJ, 1969, P NATL ACAD SCI USA, V64, P1087, DOI 10.1073/pnas.64.3.1087; Iannello A, 2010, J INFECT DIS, V201, P608, DOI 10.1086/650314; IHLE JN, 1974, J EXP MED, V139, P1568, DOI 10.1084/jem.139.6.1568; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Kane M, 2011, IMMUNITY, V35, P135, DOI 10.1016/j.immuni.2011.05.011; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kozak CA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-25; Kuang ZZ, 2011, J VIROL, V85, P7153, DOI 10.1128/JVI.02610-10; Lee KH, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-82; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Li MF, 1999, J VIROL, V73, P9178, DOI 10.1128/JVI.73.11.9178-9186.1999; LOWY DR, 1974, P NATL ACAD SCI USA, V71, P3555, DOI 10.1073/pnas.71.9.3555; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; NEXO BA, 1977, INFECT IMMUN, V15, P376; Pothlichet J, 2006, INT J CANCER, V119, P1869, DOI 10.1002/ijc.22066; Pothlichet J, 2006, INT J CANCER, V119, P815, DOI 10.1002/ijc.21935; RISSER R, 1983, ANNU REV GENET, V17, P85, DOI 10.1146/annurev.ge.17.120183.000505; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; ROWE WP, 1980, P NATL ACAD SCI-BIOL, V77, P4871, DOI 10.1073/pnas.77.8.4871; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; SHOEMAKER C, 1981, J VIROL, V40, P164, DOI 10.1128/JVI.40.1.164-172.1981; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; STOYE JP, 1991, J VIROL, V65, P1273, DOI 10.1128/JVI.65.3.1273-1285.1991; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Wiederin JL, 2010, J PROTEOME RES, V9, P4721, DOI 10.1021/pr1004345; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Xu SL, 2009, SEMIN CELL DEV BIOL, V20, P620, DOI 10.1016/j.semcdb.2009.03.003; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yan N, 2011, CURR OPIN IMMUNOL, V23, P21, DOI 10.1016/j.coi.2010.11.004; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Zhang JY, 2000, J VIROL, V74, P2313, DOI 10.1128/JVI.74.5.2313-2322.2000	66	122	128	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 16	2012	37	5					867	879		10.1016/j.immuni.2012.07.018	http://dx.doi.org/10.1016/j.immuni.2012.07.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23142781	Bronze			2022-12-18	WOS:000311460000013
J	Labbe, K; McIntire, CR; Doiron, K; Leblanc, PM; Saleh, M				Labbe, Katherine; McIntire, Christian R.; Doiron, Karine; Leblanc, Philippe M.; Saleh, Maya			Cellular Inhibitors of Apoptosis Proteins cIAP1 and cIAP2 Are Required for Efficient Caspase-1 Activation by the Inflammasome	IMMUNITY			English	Article							KAPPA-B ACTIVATION; X-LINKED INHIBITOR; UBIQUITIN-LIGASE; INNATE; DEGRADATION; RECOGNITION; MECHANISMS; RECEPTORS; INDUCTION; INFECTION	Pathogen and danger recognition by the inflammasome activates inflammatory caspases that mediate inflammation and cell death. The cellular inhibitor of apoptosis proteins (cIAPs) function in apoptosis and innate immunity, but their role in modulating the inflammasome and the inflammatory caspases is unknown. Here we report that the cIAPs are critical effectors of the inflammasome and are required for efficient caspase-1 activation. cIAP1, cIAP2, and the adaptor protein TRAF2 interacted with caspase-1-containing complexes and mediated the activating nondegradative K63-linked polyubiquitination of caspase-1. Deficiency in cIAP1 (encoded by Birc2) or cIAP2 (Birc3) impaired caspase-1 activation after spontaneous or agonist-induced inflammasome assembly, and Birc2(-/-) or Birc3(-/-) mice or mice administered with an IAP antagonist had a dampened response to inflammasome agonists and were resistant to peritonitis. Our results describe a role for the cIAPs in innate immunity and further demonstrate the evolutionary conservation between cell death and inflammation mechanisms.	[Labbe, Katherine; Leblanc, Philippe M.; Saleh, Maya] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 0B1, Canada; [McIntire, Christian R.; Saleh, Maya] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Doiron, Karine; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University; McGill University	Saleh, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 0B1, Canada.	maya.saleh@mcgill.ca		Saleh, Maya/0000-0003-1538-9146	Canadian Institutes for Health Research [CIHR-MOP 82801]; Burroughs Wellcome Fund; National Institutes of Health [AI-56324]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056324] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Barker (McGill University) for providing plasmids and R. Korneluk (University of Ottawa) for Birc3<SUP>-/-</SUP> mice. This work was supported by grants from the Canadian Institutes for Health Research (CIHR-MOP 82801) and the Burroughs Wellcome Fund to M.S. and the National Institutes of Health (AI-56324). M.S. is a Fonds de Recherche en Sante du Quebec Junior 2 Investigator and a McGill University William Dawson Scholar. K.L. is supported by a CIHR studentship.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang HK, 2000, J BIOL CHEM, V275, P26661; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Lopez J, 2010, CURR OPIN CELL BIOL, V22, P872, DOI 10.1016/j.ceb.2010.08.025; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McIntire CR, 2009, APOPTOSIS, V14, P522, DOI 10.1007/s10495-009-0312-3; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; O'Riordan MXD, 2008, DEV CELL, V15, P497, DOI 10.1016/j.devcel.2008.09.012; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zitvogel L, 2008, CELL DEATH DIFFER, V15, P1, DOI 10.1038/sj.cdd.4402267	47	122	125	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 23	2011	35	6					897	907		10.1016/j.immuni.2011.10.016	http://dx.doi.org/10.1016/j.immuni.2011.10.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195745	Bronze			2022-12-18	WOS:000298777300009
J	Nish, S; Medzhitov, R				Nish, Simone; Medzhitov, Ruslan			Host Defense Pathways: Role of Redundancy and Compensation in Infectious Disease Phenotypes	IMMUNITY			English	Article							PATTERN-RECOGNITION RECEPTORS; APIS-MELLIFERA; IMMUNITY; MECHANISMS; EVOLUTION; TISSUE; INNATE	Innate host defense pathways consist of microbial sensors, their signaling pathways, and the antimicrobial effector mechanisms. Several classes of host defense pathways are currently known, each comprising several pattern-recognition receptors that detect different types of pathogens. These pathways interact with one another in a variety of ways that can be categorized into cooperation, complementation, and compensation. Understanding the principles of these interactions is important for better understanding of host defense mechanisms, as well as for correct interpretation of immunodeficient phenotypes.	[Nish, Simone; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Medzhitov, Ruslan] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Howard Hughes Medical Institute	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute; National Institutes of Health [R37 AI046688, AI055502, DK071754, 055502-07S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI046688, R01AI055502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work in R.M.'s laboratory is supported by the Howard Hughes Medical Institute and grants from the National Institutes of Health (R37 AI046688, AI055502, and DK071754). S.N. is supported by the NIH 055502-07S1 Diversity Supplement.	Arkwright PD, 2002, BLOOD, V99, P2694, DOI 10.1182/blood.V99.8.2694; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lo H, 2009, LANCET INFECT DIS, V9, P418, DOI 10.1016/S1473-3099(09)70132-X; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260	21	122	123	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 27	2011	34	5					629	636		10.1016/j.immuni.2011.05.009	http://dx.doi.org/10.1016/j.immuni.2011.05.009			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21616433	Bronze, Green Accepted			2022-12-18	WOS:000291456500001
J	Li, QS; Rao, RR; Araki, K; Pollizzi, K; Odunsi, K; Powell, JD; Shrikant, PA				Li, Qingsheng; Rao, Rajesh R.; Araki, Koichi; Pollizzi, Kristen; Odunsi, Kunle; Powell, Jonathan D.; Shrikant, Protul A.			A Central Role for mTOR Kinase in Homeostatic Proliferation Induced CD8(+) T Cell Memory and Tumor Immunity	IMMUNITY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; PROTECTIVE IMMUNITY; IN-VIVO; NAIVE; SURVIVAL; IL-7; PHENOTYPE; RAPAMYCIN; EFFECTOR; BET	The cell-intrinsic mechanisms guiding naive CD8(+) T cells for clonal expansion and memory generation via homeostatic proliferation (HP) are unclear. Here, we have shown that HP of naive CD8(+) T cells requires IL-7-, but not IL-15-induced mTOR kinase activation. HP-induced mTOR enhances transcription factor T-bet for functional maturation and CD122 expression, which sensitizes for an IL-15-dependent memory transition by favoring transcription factor Eomesodermin over T-bet. Inhibition of mTOR blocks T-bet and CD122 expression but preserves memory in an IL-15-independent manner by promoting Eomesodermin expression. The ability of rapamycin to augment HP-induced memory was cell-intrinsic given that silencing mTOR in CD8(+) T cells generated identical outcomes. Strikingly, HP-induced CD8(+) T cell memory generated by IL-15-dependent or -independent mechanisms demonstrated identical tumor efficacy. These results indicate a central role for mTOR in HP-induced CD8(+) T cell responses and demonstrate the importance for CD8(+) memory in HP-induced tumor efficacy.	[Li, Qingsheng; Rao, Rajesh R.; Odunsi, Kunle; Shrikant, Protul A.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Araki, Koichi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Araki, Koichi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Pollizzi, Kristen; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Roswell Park Cancer Institute; Emory University; Emory University; Johns Hopkins University; Johns Hopkins Medicine	Shrikant, PA (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Elm & Carlton Str, Buffalo, NY 14263 USA.	protul.shrikant@roswellpark.org		Araki, Koichi/0000-0003-3478-6315	National Institutes of Health [CA104645]; Ovarian Cancer Research Fund; Alliance Foundation of Roswell Park Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA104645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; Alliance Foundation of Roswell Park Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Ahmed for providing us with mTOR RNAi retrovirus and T. Tomasi and N. Bangia for critical reading of the manuscript. This work was supported in part by National Institutes of Health (CA104645), Ovarian Cancer Research Fund, and Alliance Foundation of Roswell Park Cancer Institute (to P.A.S.).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Blazar BR, 1998, J IMMUNOL, V160, P5355; Brown VI, 2003, P NATL ACAD SCI USA, V100, P15113, DOI 10.1073/pnas.2436348100; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cheung KP, 2009, J IMMUNOL, V183, P3364, DOI 10.4049/jimmunol.0900641; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kelly J, 2003, J IMMUNOL, V170, P210, DOI 10.4049/jimmunol.170.1.210; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kieper WC, 2001, J IMMUNOL, V166, P5515, DOI 10.4049/jimmunol.166.9.5515; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Le Campion A, 2002, P NATL ACAD SCI USA, V99, P4538, DOI 10.1073/pnas.062621699; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Ma J, 2003, EUR J IMMUNOL, V33, P2123, DOI 10.1002/eji.200324034; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nelson D, 2000, J IMMUNOL, V165, P6123, DOI 10.4049/jimmunol.165.11.6123; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Phung TL, 2007, CANCER RES, V67, P5070, DOI 10.1158/0008-5472.CAN-06-3341; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Ramsey C, 2008, J IMMUNOL, V180, P5320, DOI 10.4049/jimmunol.180.8.5320; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Sandau MM, 2007, J IMMUNOL, V179, P120, DOI 10.4049/jimmunol.179.1.120; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Suzuki T, 2008, J IMMUNOL, V180, P4596, DOI 10.4049/jimmunol.180.7.4596; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; VENKITARAMAN AR, 1994, EUR J IMMUNOL, V24, P2168, DOI 10.1002/eji.1830240935; Webb LMC, 1999, IMMUNOLOGY, V98, P400, DOI 10.1046/j.1365-2567.1999.00906.x; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297	50	122	128	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 22	2011	34	4					541	553		10.1016/j.immuni.2011.04.006	http://dx.doi.org/10.1016/j.immuni.2011.04.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21511183	Bronze, Green Accepted			2022-12-18	WOS:000290367300013
J	Yokosuka, T; Kobayashi, W; Takamatsu, M; Sakata-Sogawa, K; Zeng, H; Hashimoto-Tane, A; Yagita, H; Tokunaga, M; Saito, T				Yokosuka, Tadashi; Kobayashi, Wakana; Takamatsu, Masako; Sakata-Sogawa, Kumiko; Zeng, Hu; Hashimoto-Tane, Akiko; Yagita, Hideo; Tokunaga, Makio; Saito, Takashi			Spatiotemporal Basis of CTLA-4 Costimulatory Molecule-Mediated Negative Regulation of T Cell Activation	IMMUNITY			English	Article							IMMUNOLOGICAL SYNAPSE; RECEPTOR MICROCLUSTERS; CO-STIMULATION; CD28; COMPLEX; TRANSCRIPTION; LOCALIZATION; SEGREGATION; INDUCTION; SUBUNIT	T cell activation is positively and negatively regulated by a pair of costimulatory receptors, CD28 and CTLA-4, respectively. Because these receptors share common ligands, CD80 and CD86, the expression and behavior of CTLA-4 is critical for T cell costimulation regulation. However, in vivo blocking of CD28-mediated costimulation by CTLA-4 and its mechanisms still remain elusive. Here, we demonstrate the dynamic behavior of CTLA-4 in its real-time competition with CD28 at the central-supramolecular activation cluster (cSMAC), resulting in the dislocalization of protein kinase C-theta and CARMA1 scaffolding protein. CTLA-4 translocation to the T cell receptor microclusters and the cSMAC is tightly regulated by its ectodomain size, and its accumulation at the cSMAC is required for its inhibitory function. The CTLA-4-mediated suppression was demonstrated by the in vitro anergy induction in regulatory T cells constitutively expressing CTLA-4. These results show the dynamic mechanism of CTLA-4-mediated T cell suppression at the cSMAC.	[Yokosuka, Tadashi; Kobayashi, Wakana; Takamatsu, Masako; Zeng, Hu; Saito, Takashi] RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan; [Sakata-Sogawa, Kumiko] RIKEN, Res Ctr Allergy & Immunol, Res Unit Single Mol Imaging, Kanagawa 2300045, Japan; [Tokunaga, Makio] RIKEN, Res Ctr Allergy & Immunol, Res Unit Mol Syst Immunol, Kanagawa 2300045, Japan; [Hashimoto-Tane, Akiko; Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Sakata-Sogawa, Kumiko; Tokunaga, Makio] Tokyo Inst Technol, Dept Biol Informat, Kanagawa 2268501, Japan; [Zeng, Hu; Saito, Takashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	RIKEN; RIKEN; RIKEN; Juntendo University; Tokyo Institute of Technology; Osaka University	Yokosuka, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan.	yokosuka@rcai.riken.jp; saito@rcai.riken.jp	Zeng, Hu/AAA-2706-2020; Saito, Takashi/C-9684-2009	Zeng, Hu/0000-0002-9909-7732; Saito, Takashi/0000-0001-9495-3547; Hashimoto-Tane, Akiko/0000-0001-8519-266X; Tokunaga, Makio/0000-0003-4586-8922	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [20114004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hod at RIKEN RCAI for discussions and H. Yamaguchi and S. Kato for secretarial assistance. This work was supported by a Grant-in-Aid for Priority Area Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (T.Y., K.S.S., M.T., and T.S.).	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Baroja ML, 2002, J IMMUNOL, V168, P5070, DOI 10.4049/jimmunol.168.10.5070; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chikuma S, 2003, J EXP MED, V197, P129, DOI 10.1084/jem.20021646; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Darlington PJ, 2005, J IMMUNOL, V175, P996, DOI 10.4049/jimmunol.175.2.996; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fos C, 2008, J IMMUNOL, V181, P1969, DOI 10.4049/jimmunol.181.3.1969; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; LINSLEY PS, 1995, J BIOL CHEM, V270, P15417, DOI 10.1074/jbc.270.25.15417; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Nuriya S, 1996, INT IMMUNOL, V8, P917, DOI 10.1093/intimm/8.6.917; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Pentcheva-Hoang T, 2007, P NATL ACAD SCI USA, V104, P17765, DOI 10.1073/pnas.0708767104; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; SloanLancaster J, 1997, J EXP MED, V186, P1713, DOI 10.1084/jem.186.10.1713; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yokosuka T, 2010, CURR TOP MICROBIOL, V340, P81, DOI 10.1007/978-3-642-03858-7_5; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	50	122	138	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					326	339		10.1016/j.immuni.2010.09.006	http://dx.doi.org/10.1016/j.immuni.2010.09.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20870175	Bronze			2022-12-18	WOS:000282798500008
J	Cheroutre, H; Lambolez, F				Cheroutre, Hilde; Lambolez, Florence			Doubting the TCR coreceptor function of CD8 alpha alpha	IMMUNITY			English	Review							T-CELL-RECEPTOR; MHC CLASS-I; CD8 BETA-CHAIN; COMPLEX CLASS-I; INTRAEPITHELIAL LYMPHOCYTES; NEGATIVE REGULATION; CUTTING EDGE; THYMIC DIFFERENTIATION; DEVELOPING THYMOCYTES; SIGNAL-TRANSDUCTION	"The beginning of wisdom is found in doubting; by doubting we come to question, and by seeking we may come upon the truth." - Pierre Abelard CD8 is a glycoprotein expressed on hematopoietic cells. Two isoforms of CD8, CD8 alpha beta and CD8 alpha alpha, have been identified that are distinct in their expression and function. Whereas CD8 alpha beta serves as a T cell receptor (TCR) coreceptor to enhance the functional avidity and is constitutively expressed on MHC class I-restricted T cells, CD8 alpha alpha marks T cells that are distinct from the conventional thymus-selected and MHC-restricted CD4(+) or CD8 alpha beta(+) T cells. Inconsistent with a coreceptor function, CD8 alpha alpha decreases antigen sensitivity of the TCR, and it can be transiently or permanently expressed on T cells, regardless of the MHC restriction of the TCR or the presence of conventional coreceptors. Together, these observations indicate that CD8 alpha alpha on T cells marks a differentiation stage and that it likely functions as a TCR corepressor to negatively regulate T cell activation.	[Cheroutre, Hilde; Lambolez, Florence] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	hilde@liai.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054451] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 064584] Funding Source: Medline; NIDDK NIH HHS [R01 DK 054451] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Addison EG, 2005, IMMUNOLOGY, V116, P354, DOI 10.1111/j.1365-2567.2005.02235.x; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; Attinger A, 2005, J IMMUNOL, V174, P3501, DOI 10.4049/jimmunol.174.6.3501; Barnden MJ, 1997, CELL IMMUNOL, V175, P111, DOI 10.1006/cimm.1996.1054; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Bosselut R, 2000, IMMUNITY, V12, P409, DOI 10.1016/S1074-7613(00)80193-4; Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; CARBONE AM, 1988, SCIENCE, V242, P1174, DOI 10.1126/science.2460926; CARBONE AM, 1988, J IMMUNOL, V141, P1369; Cawthon AG, 2002, J IMMUNOL, V169, P3492, DOI 10.4049/jimmunol.169.7.3492; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chandele A, 2005, J IMMUNOL, V175, P5619, DOI 10.4049/jimmunol.175.9.5619; Chang HC, 2005, IMMUNITY, V23, P661, DOI 10.1016/j.immuni.2005.11.002; Chang HC, 2006, J BIOL CHEM, V281, P28090, DOI 10.1074/jbc.M604931200; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; Choksi S, 1998, NAT MED, V4, P309, DOI 10.1038/nm0398-309; CROOKS MEC, 1994, IMMUNITY, V1, P277; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Devine L, 1999, IMMUNOL RES, V19, P201, DOI 10.1007/BF02786488; Devine L, 2000, J IMMUNOL, V164, P833, DOI 10.4049/jimmunol.164.2.833; Devine L, 2006, J IMMUNOL, V177, P3930, DOI 10.4049/jimmunol.177.6.3930; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Feik N, 2005, J IMMUNOL, V174, P1513, DOI 10.4049/jimmunol.174.3.1513; FUNGLEUNG WP, 1994, J EXP MED, V180, P959, DOI 10.1084/jem.180.3.959; Gangadharan D, 2004, CURR OPIN IMMUNOL, V16, P264, DOI 10.1016/j.coi.2004.03.015; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Gao GF, 2000, IMMUNOL TODAY, V21, P630, DOI 10.1016/S0167-5699(00)01750-3; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garefalaki A, 2002, IMMUNITY, V16, P635, DOI 10.1016/S1074-7613(02)00308-4; GIBLIN P, 1989, P NATL ACAD SCI USA, V86, P998, DOI 10.1073/pnas.86.3.998; GUYGRAND D, 1994, J EXP MED, V180, P673, DOI 10.1084/jem.180.2.673; Hamerman JA, 1997, J IMMUNOL, V159, P1240; Hansen JD, 2000, J IMMUNOL, V164, P3132, DOI 10.4049/jimmunol.164.6.3132; HERSHBERG R, 1990, P NATL ACAD SCI USA, V87, P9727, DOI 10.1073/pnas.87.24.9727; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Iouzalen N, 2001, EUR J IMMUNOL, V31, P2885, DOI 10.1002/1521-4141(2001010)31:10<2885::AID-IMMU2885>3.0.CO;2-2; Irie HY, 1998, J IMMUNOL, V161, P183; KARAKI S, 1992, J IMMUNOL, V149, P1613; Kenny E, 2004, EUR J IMMUNOL, V34, P1262, DOI 10.1002/eji.200324363; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Kerry SE, 2003, J IMMUNOL, V171, P4493, DOI 10.4049/jimmunol.171.9.4493; Kieffer LJ, 2002, J IMMUNOL, V168, P3915, DOI 10.4049/jimmunol.168.8.3915; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Konno A, 2002, BLOOD, V100, P4090, DOI 10.1182/blood-2002-04-1136; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; KWANLIM GE, 1993, INT IMMUNOL, V5, P1219, DOI 10.1093/intimm/5.10.1219; Lambolez F, 2007, IMMUNOL REV, V215, P178, DOI 10.1111/j.1600-065X.2006.00488.x; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Levelt CN, 1999, P NATL ACAD SCI USA, V96, P5628, DOI 10.1073/pnas.96.10.5628; Liu YW, 2003, IMMUNITY, V18, P205, DOI 10.1016/S1074-7613(03)00027-X; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Maile R, 2005, J IMMUNOL, V174, P619, DOI 10.4049/jimmunol.174.2.619; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; McNicol AM, 2007, EUR J IMMUNOL, V37, P1634, DOI 10.1002/eji.200636900; Merry AH, 2003, J BIOL CHEM, V278, P27119, DOI 10.1074/jbc.M213056200; MICELI MC, 1991, P NATL ACAD SCI USA, V88, P2623, DOI 10.1073/pnas.88.7.2623; Mixter PF, 1999, J IMMUNOL, V162, P5747; MOEBIUS U, 1991, EUR J IMMUNOL, V21, P1793, DOI 10.1002/eji.1830210803; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; NORMENT AM, 1989, J IMMUNOL, V142, P3312; PALIARD X, 1988, NATURE, V335, P642, DOI 10.1038/335642a0; Pang DJ, 2007, J BIOL CHEM, V282, P13884, DOI 10.1074/jbc.M701027200; REIMANN J, 1995, EUR J IMMUNOL, V25, P1580, DOI 10.1002/eji.1830250617; Renard V, 1996, J EXP MED, V184, P2439, DOI 10.1084/jem.184.6.2439; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; RUDD CE, 2002, SCI STKE, pPE18; Sewell AK, 1999, NAT MED, V5, P399, DOI 10.1038/7398; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; SROUR EF, 1990, CYTOMETRY, V11, P442, DOI 10.1002/cyto.990110316; Sun JR, 1997, J IMMUNOL, V159, P6077; Sydora BC, 1996, J IMMUNOL, V156, P4209; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; VANOERS NSC, 1993, J IMMUNOL, V151, P777; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wang RF, 2002, P NATL ACAD SCI USA, V99, P2181, DOI 10.1073/pnas.042692799; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; Williams MA, 2005, J IMMUNOL, V175, P2066, DOI 10.4049/jimmunol.175.4.2066; Witte T, 1999, CELL IMMUNOL, V191, P90, DOI 10.1006/cimm.1998.1412; Wong JS, 2003, J IMMUNOL, V171, P867, DOI 10.4049/jimmunol.171.2.867; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; WU L, 1990, INT IMMUNOL, V2, P51, DOI 10.1093/intimm/2.1.51; Yamamoto M, 1998, J IMMUNOL, V160, P2188; ZAMOYSKA R, 1988, EMBO J, V7, P2359, DOI 10.1002/j.1460-2075.1988.tb03080.x; ZAMOYSKA R, 1985, CELL, V43, P153, DOI 10.1016/0092-8674(85)90020-0; ZAMOYSKA R, 1994, IMMUNITY, V1, P243, DOI 10.1016/1074-7613(94)90075-2; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhong WM, 2005, EUR J IMMUNOL, V35, P3103, DOI 10.1002/eji.200535162; Zhu MH, 2006, IMMUNITY, V25, P757, DOI 10.1016/j.immuni.2006.08.025	101	122	124	2	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2008	28	2					149	159		10.1016/j.immuni.2008.01.005	http://dx.doi.org/10.1016/j.immuni.2008.01.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275828	Bronze			2022-12-18	WOS:000253275000006
J	Arana, E; Vehlow, A; Harwood, NE; Vigorito, E; Henderson, R; Turner, M; Tybulewicz, VLJ; Batista, FD				Arana, Eloisa; Vehlow, Anne; Harwood, Naomi E.; Vigorito, Elena; Henderson, Robert; Turner, Martin; Tybulewicz, Victor L. J.; Batista, Facundo D.			Activation of the small GTPase Rac2 via the B cell receptor regulates B cell adhesion and immunological-synapse formation	IMMUNITY			English	Article							ANTIGEN RECEPTOR; INTEGRIN ACTIVATION; DENDRITIC CELLS; IN-VIVO; SIGNAL-TRANSDUCTION; EXCHANGE FACTOR; VAV; FAMILY; MICROCLUSTERS; LOCALIZATION	The integrin leukocyte function-associated antigen-1 (LFA-1) is important in the promotion of B cell adhesion, thereby facilitating immunological synapse (IS) formation and B cell activation. Despite this significance, the associated signaling mechanisms regulating LFA-1 activation remain elusive. Here, we show that both isoforms of the small GTPase Rac expressed by primary B cells, Rac1 and Rac2, were activated rapidly downstream of Src-family kinases, guanine-nucleotide exchange factors Vav1 and Vav2, and phosphoinositide-3 kinase (PI3K) after BCR engagement. We identify Rac2, but not Rac1, as critical for B cell adhesion to intercellular adhesion molecule-1 (ICAM-1) and IS formation. Furthermore, B cells expressing constitutively active Rac2 are highly adhesive. We observe that Rac2-deficient B cells exhibit lower amounts of Rap1-GTP and severe actin polymerization defects, identifying a potential mechanism underlying their behavior. We postulate that this critical role for Rac2 in mediating B cell adhesion and IS formation might apply in all lymphocytes.	[Arana, Eloisa; Vehlow, Anne; Harwood, Naomi E.; Batista, Facundo D.] Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Lymphocyte Interact Lab, London WC2A 3PX, England; [Vigorito, Elena; Turner, Martin] Babraham Inst, Mol Immunol Programme, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England; [Henderson, Robert; Tybulewicz, Victor L. J.] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	Cancer Research UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; MRC National Institute for Medical Research	Batista, FD (corresponding author), Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	facundo.batista@cancer.org.uk	Turner, Martin/N-9976-2014	Turner, Martin/0000-0002-3801-9896; Tybulewicz, Victor/0000-0003-2439-0798	Medical Research Council [G117/424, MC_U117527252] Funding Source: Medline; MRC [G117/424, MC_U117527252] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Johmura S, 2003, IMMUNITY, V18, P777, DOI 10.1016/S1074-7613(03)00139-0; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; KOOPMAN G, 1991, J EXP MED, V173, P1297, DOI 10.1084/jem.173.6.1297; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kushnir N, 1998, J IMMUNOL, V160, P1774; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Okkenhaug K, 2002, SCIENCE, V297, P1031; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; SZAKAL AK, 1988, J IMMUNOL, V140, P341; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; Togni M, 2005, MOL CELL BIOL, V25, P8052, DOI 10.1128/MCB.25.18.8052-8063.2005; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; Wulfing C, 2000, P NATL ACAD SCI USA, V97, P10150, DOI 10.1073/pnas.97.18.10150; Wykes M, 1998, J IMMUNOL, V161, P1313; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	54	122	123	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2008	28	1					88	99		10.1016/j.immuni.2007.12.003	http://dx.doi.org/10.1016/j.immuni.2007.12.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18191593	Bronze			2022-12-18	WOS:000252627300013
J	Radaev, S; Rostro, B; Brooks, AG; Colonna, M; Sun, PD				Radaev, S; Rostro, B; Brooks, AG; Colonna, M; Sun, PD			Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3	IMMUNITY			English	Article							T-CELL-RECEPTOR; CRYSTAL-STRUCTURE; NK CELLS; COMPLEX; PEPTIDE; MOLECULES; BIND; RECOGNITION; ACTIVATION; ENGAGEMENT	wNKG2D is known to trigger the natural killer (NK) cell lysis of various tumor and virally infected cells. In the NKG2D/ULBP3 complex, the structure of ULBP3 resembles the alpha1 and alpha2 domains of classical MHC molecules without a bound peptide. The lack of alpha3 and beta 2m domains is compensated by replacing two hydrophobic patches at the underside of the class I MHC-like beta sheet floor with a group of hydrophilic and charged residues in ULBP3. NKG2D binds diagonally across the ULBP3 a helices, creating a complementary interface, an asymmetrical subunit orientation, and local conformational adjustments in the receptor. The interface is stabilized primarily by hydrogen bonds and hydrophobic interactions. Unlike the KIR receptors that recognize a conserved HLA region by a lock-and-key mechanism, NKG2D recognizes diverse ligands by an induced-fit mechanism.	NIAID, Struct Biol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Melbourne; Washington University (WUSTL)	Sun, PD (corresponding author), NIAID, Struct Biol Sect, Immunogenet Lab, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	psun@nih.gov		Colonna, Marco/0000-0001-5222-4987; Brooks, Andrew/0000-0002-4085-9683	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000697, ZIAAI000697] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Boyington JC, 2000, PROTEIN EXPRES PURIF, V18, P235, DOI 10.1006/prep.1999.1188; Boyington JC, 1999, IMMUNITY, V10, P75, DOI 10.1016/S1074-7613(00)80008-4; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peruzzi M, 1996, J IMMUNOL, V157, P3350; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yokoyama WM, 1998, CURR OPIN IMMUNOL, V10, P298, DOI 10.1016/S0952-7915(98)80168-4; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412; Zappacosta F, 1997, P NATL ACAD SCI USA, V94, P6313, DOI 10.1073/pnas.94.12.6313	51	122	132	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2001	15	6					1039	1049		10.1016/S1074-7613(01)00241-2	http://dx.doi.org/10.1016/S1074-7613(01)00241-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754823	Bronze			2022-12-18	WOS:000172961400016
J	Furukawa, K; Akasako-Furukawa, A; Shirai, H; Nakamura, H; Azuma, T				Furukawa, K; Akasako-Furukawa, A; Shirai, H; Nakamura, H; Azuma, T			Junctional amino acids determine the maturation pathway of an antibody	IMMUNITY			English	Article							SOMATIC MUTATION; GERMINAL-CENTERS; IMMUNE-RESPONSE; IMMUNOLOGICAL MEMORY; VARIABLE REGION; IN-VITRO; GENERATION; ANTI-(4-HYDROXY-3-NITROPHENYL)ACETYL; IMMUNOGLOBULIN; HYPERMUTATION	We found that two distinct antibody maturation pathways exist in the immune response of C57BL/6 mice to (4-hydroxy-3-nitrophenyl)acetyl and that the junctional amino acid introduced by a process far preceding somatic hypermutation determined the pathway of affinity maturation. Antibodies belonging to each pathway clearly separated into two separate branches of a phylogenic tree. We also constructed a three-dimensional fitness landscape for antibody evolution by introducing the association constants of the antibodies into the phylogenic tree as the third axis, allowing us to comprehend the significance of junctional diversity in the "evolvability" of antibodies. Thermodynamic analyses of the antigen-antibody interactions suggested that a high conformational versatility in the antigen-combining site allows for the enhanced evolvability of antibodies.	Sci Univ Tokyo, Res Inst Biol Sci, Noda, Chiba 2780022, Japan; Biomol Engn Res Inst, Osaka 5650874, Japan; Tanabe Seiyaku Co Ltd, Discovery Res Lab, Yodogawa Ku, Osaka 5328505, Japan	Tokyo University of Science; Mitsubishi Tanabe Pharma Corporation	Azuma, T (corresponding author), Sci Univ Tokyo, Res Inst Biol Sci, 2669 Yamazaki, Noda, Chiba 2780022, Japan.		Nakamura, Haruki/O-4028-2014; Furukawa, Koji/L-6909-2018	Furukawa, Koji/0000-0002-5701-2497	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; BEREK C, 1993, CURR OPIN IMMUNOL, V5, P218, DOI 10.1016/0952-7915(93)90007-F; BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; BROWNSTONE A, 1966, IMMUNOLOGY, V10, P465; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; FRENCH DL, 1989, SCIENCE, V244, P1152, DOI 10.1126/science.2658060; Gearhart Patricia J., 1993, P865; GEARHART PJ, 1981, NATURE, V291, P29, DOI 10.1038/291029a0; GRIFFITHS GM, 1984, NATURE, V312, P271, DOI 10.1038/312271a0; HARRIS LJ, 1992, NATURE, V360, P369, DOI 10.1038/360369a0; HATCHER N, 1972, IMMUNOCHEMISTRY, V9, P1139; IMANISHI T, 1974, J EXP MED, V140, P1498, DOI 10.1084/jem.140.6.1498; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Joyce GF, 1997, SCIENCE, V276, P1658, DOI 10.1126/science.276.5319.1658; Kabat E. A., 1991, SEQUENCES PROTEINS I; Kallberg E, 1996, SCIENCE, V271, P1285, DOI 10.1126/science.271.5253.1285; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; MACLENNAN ICM, 1992, IMMUNOL REV, V126, P143, DOI 10.1111/j.1600-065X.1992.tb00635.x; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Milstein C., 1995, IMMUNOGLOBULIN GENES, P57, DOI 10.1016/B978-012053640-5/50006-9; MIZUTANI R, 1995, J MOL BIOL, V254, P205; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; ROTHENFLUH HS, 1993, EUR J IMMUNOL, V23, P2152, DOI 10.1002/eji.1830230916; Shirai H, 1996, FEBS LETT, V399, P1, DOI 10.1016/S0014-5793(96)01252-5; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; TAKETANI M, 1995, MOL IMMUNOL, V32, P983, DOI 10.1016/0161-5890(95)00057-L; TAO W, 1990, J IMMUNOL, V145, P3216; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TONEGAWA S, 1983, NATURE, V302, P57; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WYSOCKI L, 1986, P NATL ACAD SCI USA, V83, P1847, DOI 10.1073/pnas.83.6.1847	37	122	124	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1999	11	3					329	338		10.1016/S1074-7613(00)80108-9	http://dx.doi.org/10.1016/S1074-7613(00)80108-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514011	Bronze			2022-12-18	WOS:000082918500008
J	Gonzalez, A; Katz, JD; Mattei, MG; Kikutani, H; Benoist, C; Mathis, D				Gonzalez, A; Katz, JD; Mattei, MG; Kikutani, H; Benoist, C; Mathis, D			Genetic control of diabetes progression	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; T-CELL; NOD MICE; AUTOIMMUNE-DISEASE; SUSCEPTIBILITY LOCUS; POLYGENIC CONTROL; COMPLEX TRAITS; MELLITUS; MOUSE; RECEPTOR	Autoimmune diabetes in both the human and the nonobese diabetic mouse has elaborate genetics; in the latter case, the disease is influenced by at least 15-20 loci. We anticipated that the genetics would be simpler in the BDC2.5 T cell receptor transgenic mouse model of diabetes, wherein many T cells express a particular diabetogenic specificity. Initiation of insulitis in this model was the same on the two genetic backgrounds analyzed, but the kinetics and penetrance of diabetes were strikingly different, permitting us to focus on genetic influences during a defined window of disease progression. The differences correlated with variations in five genomic intervals, certain ones of which have been previously implicated in susceptibility to autoimmune disease. This reductionist approach indeed simplified the analysis of diabetes susceptibility loci.	CNRS INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, Strasbourg, France; Fac Med Timone, INSERM, U406, F-13385 Marseille 5, France; Osaka Univ, Microbial Dis Res Inst, Div Mol Immunol, Suita, Osaka 565, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Osaka University	Benoist, C (corresponding author), CNRS INSERM, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, Strasbourg, France.		Kikutani, Hitoshi/C-9525-2009; Gonzalez, Antonio/C-4444-2008	Gonzalez, Antonio/0000-0002-2624-0606; Katz, Jonathan/0000-0002-9864-2268				ALLISON JP, 1995, SCIENCE, V270, P932, DOI 10.1126/science.270.5238.932; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BENOIST C, 1993, CURR OPIN IMMUNOL, V5, P900, DOI 10.1016/0952-7915(93)90103-Y; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; Denny P, 1997, DIABETES, V46, P695, DOI 10.2337/diabetes.46.4.695; DIETRICH W, 1992, GENETICS, V131, P423; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; FORSTER I, 1995, IMMUNITY, V2, P573, DOI 10.1016/1074-7613(95)90002-0; GARCHON HJ, 1991, NATURE, V353, P260, DOI 10.1038/353260a0; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; GREGOIRE C, 1991, P NATL ACAD SCI USA, V88, P8077, DOI 10.1073/pnas.88.18.8077; HANCOCK WW, 1995, AM J PATHOL, V147, P1193; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000; IKEGAMI H, 1995, J CLIN INVEST, V96, P1936, DOI 10.1172/JCI118239; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KONO DH, 1994, P NATL ACAD SCI USA, V91, P10168, DOI 10.1073/pnas.91.21.10168; KUBO RT, 1989, J IMMUNOL, V142, P2736; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; MEEKER ND, 1995, P NATL ACAD SCI USA, V92, P5684, DOI 10.1073/pnas.92.12.5684; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; MORAHAN G, 1994, P NATL ACAD SCI USA, V91, P5898, DOI 10.1073/pnas.91.13.5898; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Mueller R, 1995, CURR OPIN IMMUNOL, V7, P799, DOI 10.1016/0952-7915(95)80051-4; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Owerbach D, 1996, DIABETES, V45, P544, DOI 10.2337/diabetes.45.5.544; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; PANKEWYCZ OG, 1992, EUR J IMMUNOL, V22, P2017, DOI 10.1002/eji.1830220810; PHILBRICK WM, 1990, EMBO J, V9, P2485, DOI 10.1002/j.1460-2075.1990.tb07427.x; Podolin PL, 1997, J IMMUNOL, V159, P1835; PRINS JB, 1993, SCIENCE, V260, P695, DOI 10.1126/science.8480181; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; RISCH N, 1993, AM J HUM GENET, V53, P702; RODRIGUES NR, 1994, MAMM GENOME, V5, P167, DOI 10.1007/BF00352349; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TOCHINO Y, 1986, INSULITIS TYPE 1 DIA, P3; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; VERGE CF, 1995, DIABETES, V44, P1176, DOI 10.2337/diabetes.44.10.1176; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Yui MA, 1996, MAMM GENOME, V7, P331, DOI 10.1007/s003359900097	52	122	123	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					873	883		10.1016/S1074-7613(00)80405-7	http://dx.doi.org/10.1016/S1074-7613(00)80405-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430232	Bronze			2022-12-18	WOS:000071351300014
J	DOro, U; Vacchio, MS; Weissman, AM; Ashwell, JD				DOro, U; Vacchio, MS; Weissman, AM; Ashwell, JD			Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation	IMMUNITY			English	Article							DI-LEUCINE MOTIF; SIGNAL TRANSDUCTION; PROTEIN-KINASE; MONOCLONAL-ANTIBODY; MUTATIONAL ANALYSIS; DOWN-REGULATION; TCR EXPRESSION; COMPLEX; PHOSPHORYLATION; THYMOCYTES	The mechanism by which TCR expression is regulated was explored by expressing a constitutively active form of the tyrosine kinase Lck (Lck(505F)) in T cells. Expression of Lck(505F) down-regulated TCR levels, an effect that was even more pronounced in CD45(-) T cells, in which the activity of this tyrosine kinase is further enhanced. Cells expressing Lck(505F) synthesized all TCR subunits, but lysosomal degradation of assembled receptors was enhanced. TCRs were rapidly internalized and degraded after removal of a tyrosine kinase inhibitor that had permitted cell surface expression. Finally, TCR levels on thymocytes were increased by an Lck inhibitor, and activation- but not phorbol ester-induced internalization of TCRs on Jurkat cells was prevented by inhibition or loss of Lck. These studies identify a regulated nonreceptor tyrosine kinase-mediated pathway for targeting cell surface receptors for lysosomal degradation.	NCI,LAB IMMUNE CELL BIOL,NIH,BETHESDA,MD 20892; US FDA,CTR BIOL EVALUAT & RES,DIV HEMATOL PROD,IMMUNOL LAB,BETHESDA,MD 20852	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA)								AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BECKER MLB, 1989, CELL, V58, P911, DOI 10.1016/0092-8674(89)90943-4; BONIFACINO JS, 1988, P NATL ACAD SCI USA, V85, P6929, DOI 10.1073/pnas.85.18.6929; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; BONIFACINO JS, 1990, NATURE, V344, P247, DOI 10.1038/344247a0; BOYER C, 1991, EUR J IMMUNOL, V21, P1623, DOI 10.1002/eji.1830210707; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Doro U, 1996, MOL CELL BIOL, V16, P4996; ERICSSON PO, 1995, INT IMMUNOL, V7, P617, DOI 10.1093/intimm/7.4.617; Frank S J, 1990, Semin Immunol, V2, P89; GOSGROVE D, 1991, CELL, V66, P1051; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KAPPLER J, 1983, CELL, V34, P727, DOI 10.1016/0092-8674(83)90529-9; KEARSE KP, 1994, EMBO J, V13, P4504, DOI 10.1002/j.1460-2075.1994.tb06772.x; KEARSE KP, 1995, IMMUNITY, V2, P391; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; KRANGEL MS, 1987, J EXP MED, V165, P1141, DOI 10.1084/jem.165.4.1141; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; Luton F, 1997, J IMMUNOL, V158, P4162; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MCCARTHY SA, 1988, NATURE, V336, P76, DOI 10.1038/336076a0; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; PANTALEO G, 1987, J EXP MED, V166, P619, DOI 10.1084/jem.166.2.619; REINHERZ EL, 1982, CELL, V30, P735, DOI 10.1016/0092-8674(82)90278-1; ROEHM N, 1984, CELL, V38, P577, DOI 10.1016/0092-8674(84)90512-9; Salio M, 1997, EUR J IMMUNOL, V27, P1769, DOI 10.1002/eji.1830270726; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SUSSMAN JJ, 1988, J IMMUNOL, V140, P2520; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; VOLAREVIC S, 1992, J EXP MED, V176, P835, DOI 10.1084/jem.176.3.835; WANG X, 1996, SCIENCE, V272, P1935; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701	51	122	122	1	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					619	628		10.1016/S1074-7613(00)80383-0	http://dx.doi.org/10.1016/S1074-7613(00)80383-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390686	Bronze			2022-12-18	WOS:A1997YH55400005
J	Fikrig, E; Barthold, SW; Sun, W; Feng, W; Telford, SR; Flavell, RA				Fikrig, E; Barthold, SW; Sun, W; Feng, W; Telford, SR; Flavell, RA			Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity	IMMUNITY			English	Article							OUTER SURFACE-PROTEIN; LYME-DISEASE; OSPA; MICE; AGENT; INFECTION; DIAGNOSIS; ARTHRITIS; PLASMID	p35 and p37 are Borrelia burgdorferi genes encoding 35 and 37 kDa proteins. The gene products were identified by differential screening of a B. burgdorferi expression library with sera from B. burgdorferi infected-and B. burgdorferi-hyperimmunized mice. Northern blot and RT-PCR analyses confirmed that these genes were selectively expressed in vivo. ELISA, using P35 and P37, showed that infected mice (5 of 5, 100%) and patients (31 of 43, 72%) with Lyme borreliosis developed P35 or P37 antibodies. Mice developed peak IgG titers to P35 and P37 within 30 days, followed by decline. Mice given both P35 and P37 antisera were protected from challenge with 10(2) B. burgdorferi, and P35 and P37 antisera also afforded protection when administered 24 hr after spirochete challenge. The use of in vivo-expressed antigens such as P35 and P37 represents a new approach for Lyme disease serodiagnosis and for understanding the role of B. burgdorferi-specific immune responses in host immunity.	YALE UNIV,SCH MED,DEPT INTERNAL MED,RHEUMATOL SECT,NEW HAVEN,CT 06520; YALE UNIV,SCH MED,COMPARAT MED SECT,NEW HAVEN,CT 06520; YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06520; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06520; HARVARD UNIV,SCH PUBL HLTH,DEPT TROP PUBL HLTH,BOSTON,MA 02115	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Harvard University; Harvard T.H. Chan School of Public Health					NIAID NIH HHS [AI-26815, AI-30548] Funding Source: Medline; NIAMS NIH HHS [AR-40452] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026815, P01AI030548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040452] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AKINS D, 1996, MOL MICROBIOL, V18, P507; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARTHOLD S, 1997, IN PRESS CLIN INFECT; Barthold SW, 1996, LAB INVEST, V74, P57; BARTHOLD SW, 1993, INFECT IMMUN, V61, P4696, DOI 10.1128/IAI.61.11.4696-4702.1993; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; BARTHOLD SW, 1995, INFECT IMMUN, V63, P2255, DOI 10.1128/IAI.63.6.2255-2261.1995; CHAMPION CI, 1994, INFECT IMMUN, V62, P2653, DOI 10.1128/IAI.62.7.2653-2661.1994; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; FIKRIG E, 1995, J CLIN INVEST, V96, P1706, DOI 10.1172/JCI118215; FIKRIG E, 1993, INFECT IMMUN, V61, P2553, DOI 10.1128/IAI.61.6.2553-2557.1993; FIKRIG E, 1990, SCIENCE, V250, P553, DOI 10.1126/science.2237407; FIKRIG E, 1992, J INFECT DIS, V165, P1127, DOI 10.1093/infdis/165.6.1127; FINGERLE V, 1995, J CLIN MICROBIOL, V33, P1867, DOI 10.1128/JCM.33.7.1867-1869.1995; Johnson BJB, 1996, J INFECT DIS, V174, P346, DOI 10.1093/infdis/174.2.346; KALISH RA, 1995, INFECT IMMUN, V63, P2228, DOI 10.1128/IAI.63.6.2228-2235.1995; KALISH RA, 1993, INFECT IMMUN, V61, P2774, DOI 10.1128/IAI.61.7.2774-2779.1993; LAM TT, 1994, INFECT IMMUN, V62, P290, DOI 10.1128/IAI.62.1.290-298.1994; MAGNARELLI LA, 1989, RHEUM DIS CLIN N AM, V15, P735; Magnarelli LA, 1996, J CLIN MICROBIOL, V34, P237, DOI 10.1128/JCM.34.2.237-240.1996; Marconi RT, 1996, J BACTERIOL, V178, P5615, DOI 10.1128/jb.178.19.5615-5626.1996; Montgomery RR, 1996, J EXP MED, V183, P261, DOI 10.1084/jem.183.1.261; SCHUTZER SE, 1994, J CLIN INVEST, V94, P454, DOI 10.1172/JCI117346; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; SEARS JE, 1991, J IMMUNOL, V147, P1995; Stanek G, 1987, LYME BORRELIOSIS; Stevenson B, 1996, J BACTERIOL, V178, P3508, DOI 10.1128/jb.178.12.3508-3516.1996; SUK KH, 1995, P NATL ACAD SCI USA, V92, P4269, DOI 10.1073/pnas.92.10.4269; WALLICH R, 1995, INFECT IMMUN, V63, P3327, DOI 10.1128/IAI.63.9.3327-3335.1995; YSSEL H, 1991, J EXP MED, V174, P593, DOI 10.1084/jem.174.3.593	31	122	131	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					531	539		10.1016/S1074-7613(00)80341-6	http://dx.doi.org/10.1016/S1074-7613(00)80341-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175831	Bronze			2022-12-18	WOS:A1997XB81900004
J	Pelanda, R; Schaal, S; Torres, RM; Rajewsky, K				Pelanda, R; Schaal, S; Torres, RM; Rajewsky, K			A prematurely expressed Ig kappa transgene, but not a V kappa J kappa gene segment targeted into the Ig kappa locus, can rescue B cell development in lambda 5-deficient mice	IMMUNITY			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; LIGHT-CHAIN; PRE-B; BONE-MARROW; LYMPHOCYTES-B; MONOCLONAL-ANTIBODIES; DEFICIENT MICE; MEMBRANE EXON; CROSS-LINKING; LINEAGE CELLS	We generated surrogate light chain (SLC)-deficient mice carrying either a V kappa J kappa-C kappa transgene under the control of the kappa promoter and intron enhancer or a V kappa J kappa gene segment targeted into its physiological position. Efficient rescue of B cell development was seen in the former and partial rescue in the latter. This difference corresponded to a developmentally earlier onset of kappa chain expression from the conventional than from the targeted transgene. Thus, a kappa chain can substitute for SLC in development. However, mechanisms controlling gene expression in addition to gene rearrangements appear to restrict kappa chain expression largely to a cellular compartment into which mu chain-expressing B cell progenitors are selected with the help of the SLC.			Pelanda, R (corresponding author), UNIV COLOGNE, INST GENET, WEYERTAL 121, D-50931 COLOGNE, GERMANY.			Rajewsky, Klaus/0000-0002-6633-6370				ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0; BROUNS GS, 1993, EUR J IMMUNOL, V23, P1088, DOI 10.1002/eji.1830230517; COFFMAN RL, 1983, IMMUNOL REV, V69, P5, DOI 10.1111/j.1600-065X.1983.tb00446.x; DURDIK J, 1984, NATURE, V307, P749, DOI 10.1038/307749a0; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; ERNST P, 1995, IMMUNITY, V2, P427, DOI 10.1016/1074-7613(95)90024-1; Ferradini L, 1996, SCIENCE, V271, P1416, DOI 10.1126/science.271.5254.1416; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Grutzmann R., 1981, THESIS U COLOGNE COL; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hiramatsu R, 1995, CELL, V83, P1113, DOI 10.1016/0092-8674(95)90138-8; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LEWIS S, 1982, CELL, V30, P807, DOI 10.1016/0092-8674(82)90285-9; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; LOFFERT D, 1994, IMMUNOL REV, V137, P135, DOI 10.1111/j.1600-065X.1994.tb00662.x; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATSUO T, 1993, J IMMUNOL, V150, P3766; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; MISENER V, 1991, INT IMMUNOL, V3, P1129, DOI 10.1093/intimm/3.11.1129; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; OSMOND DG, 1991, CURR OPIN IMMUNOL, V3, P179, DOI 10.1016/0952-7915(91)90047-5; OZATO K, 1980, J IMMUNOL, V124, P533; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; REICHMANFRIED M, 1990, P NATL ACAD SCI USA, V87, P2730, DOI 10.1073/pnas.87.7.2730; ROES J, 1995, J IMMUNOL METHODS, V183, P231, DOI 10.1016/0022-1759(95)00059-J; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; ROLINK A, 1993, EUR J IMMUNOL, V23, P1284, DOI 10.1002/eji.1830230614; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; STORB U, 1985, NATURE, V316, P356, DOI 10.1038/316356a0; TAKEMORI T, 1990, EMBO J, V9, P2493, DOI 10.1002/j.1460-2075.1990.tb07428.x; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TSUBATA T, 1992, INT IMMUNOL, V4, P637, DOI 10.1093/intimm/4.6.637; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; VANNESS BG, 1981, CELL, V27, P593, DOI 10.1016/0092-8674(81)90401-3; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; YANCOPOULOS GD, 1986, ANNU REV IMMUNOL, V4, P339, DOI 10.1146/annurev.iy.04.040186.002011; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; ZOU YR, 1994, CURR BIOL, V4, P1099, DOI 10.1016/S0960-9822(00)00248-7; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	62	122	141	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1996	5	3					229	239		10.1016/S1074-7613(00)80318-0	http://dx.doi.org/10.1016/S1074-7613(00)80318-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VJ797	8808678	Bronze			2022-12-18	WOS:A1996VJ79700005
J	Lino, AC; Dang, VD; Lampropoulou, V; Welle, A; Joedicke, J; Pohar, J; Simon, Q; Thalmensi, J; Baures, A; Fluhler, V; Sakwa, I; Stervbo, U; Ries, S; Jouneau, L; Boudinot, P; Tsubata, T; Adachi, T; Hutloff, A; Dorner, T; Zimber-Strobl, U; de Vos, AF; Dahlke, K; Loh, G; Korniotis, S; Goosmann, C; Weill, JC; Reynaud, CA; Kaufmann, SHE; Walter, J; Fillatreau, S				Lino, Andreia C.; Van Duc Dang; Lampropoulou, Vicky; Welle, Anna; Joedicke, Jara; Pohar, Jelka; Simon, Quentin; Thalmensi, Jessie; Baures, Aurelia; Fluhler, Vinciane; Sakwa, Imme; Stervbo, Ulrik; Ries, Stefanie; Jouneau, Luc; Boudinot, Pierre; Tsubata, Takeshi; Adachi, Takahiro; Hutloff, Andreas; Doerner, Thomas; Zimber-Strobl, Ursula; de Vos, Alex F.; Dahlke, Katja; Loh, Gunnar; Korniotis, Sarantis; Goosmann, Christian; Weill, Jean-Claude; Reynaud, Claude-Agnes; Kaufmann, Stefan H. E.; Walter, Joern; Fillatreau, Simon			LAG-3 Inhibitory Receptor Expression Identifies Immunosuppressive Natural Regulatory Plasma Cells	IMMUNITY			English	Article							B-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MODEL; IL-10; DIFFERENTIATION; AUTOIMMUNITY; GENERATION; IMMUNITY	B lymphocytes can suppress immunity through interleukin (IL)-10 production in infectious, autoimmune, and malignant diseases. Here, we have identified a natural plasma cell subset that distinctively expresses the inhibitory receptor LAG-3 and mediates this function in vivo. These plasma cells also express the inhibitory receptors CD200, PD-L1, and PD-L2. They develop from various B cell subsets in a B cell receptor (BCR)-dependent manner independently of microbiota in naive mice. After challenge they upregulate IL-10 expression via a Toll-like receptor-driven mechanism within hours and without proliferating. This function is associated with a unique transcriptome and epigenome, including the lowest amount of DNA methylation at the Il10 locus compared to other B cell subsets. Their augmented accumulation in naive mutant mice with increased BCR signaling correlates with the inhibition of memory T cell formation and vaccine efficacy after challenge. These natural regulatory plasma cells may be of broad relevance for disease intervention.	[Lino, Andreia C.; Van Duc Dang; Lampropoulou, Vicky; Joedicke, Jara; Sakwa, Imme; Stervbo, Ulrik; Ries, Stefanie; Hutloff, Andreas; Doerner, Thomas; Fillatreau, Simon] Deutsch Rheuma Forschungszentrum, Charitepl 1, D-10117 Berlin, Germany; [Welle, Anna; Walter, Joern] Saarland Univ, Dept EpiGenet, Campus A2-4, D-66123 Saarbrucken, Germany; [Pohar, Jelka; Simon, Quentin; Thalmensi, Jessie; Baures, Aurelia; Fluhler, Vinciane; Korniotis, Sarantis; Weill, Jean-Claude; Reynaud, Claude-Agnes; Fillatreau, Simon] INSERM U1151 CNRS UMR 8253, Inst Necker Enfants Malad, Paris, France; [Jouneau, Luc; Boudinot, Pierre] Univ Paris Saclay, INRA, Virol & Immunol Mol, F-78352 Jouy En Josas, France; [Tsubata, Takeshi; Adachi, Takahiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo 1138510, Japan; [Doerner, Thomas] Charite Univ Med Berlin, Dept Med Rheumatol & Clin Immunol, Berlin, Germany; [Zimber-Strobl, Ursula] Helmholtz Ctr Munich, Dept Gene Vectors, Marchioninistr 25, D-81377 Munich, Germany; [de Vos, Alex F.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Dahlke, Katja; Loh, Gunnar] German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, D-14558 Nuthetal, Germany; [Goosmann, Christian; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Charitepl 1, D-10117 Berlin, Germany; [Fillatreau, Simon] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Fillatreau, Simon] Hop Necker Enfants Malad, AP HP, Paris, France	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Saarland University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Tokyo Medical & Dental University (TMDU); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Amsterdam; Academic Medical Center Amsterdam; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Fillatreau, S (corresponding author), Deutsch Rheuma Forschungszentrum, Charitepl 1, D-10117 Berlin, Germany.; Fillatreau, S (corresponding author), INSERM U1151 CNRS UMR 8253, Inst Necker Enfants Malad, Paris, France.; Fillatreau, S (corresponding author), Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France.; Fillatreau, S (corresponding author), Hop Necker Enfants Malad, AP HP, Paris, France.	simonfillatreau@googlemail.com	Lino, Andreia/GOV-5217-2022; Hutloff, Andreas/D-1781-2014; Tsubata, Takeshi/AAI-7489-2021; Zimber-Strobl, Ursula/M-4618-2014; Stervbo, Ulrik/AAV-1561-2020; Walter, Jörn/AFN-6428-2022; Jouneau, Luc/AAC-4711-2020; Simon, Quentin/AAW-8810-2020	Hutloff, Andreas/0000-0002-0572-8151; Tsubata, Takeshi/0000-0003-0760-1258; Zimber-Strobl, Ursula/0000-0002-9765-5251; Stervbo, Ulrik/0000-0002-2831-8868; Walter, Jörn/0000-0003-0563-7417; Simon, Quentin/0000-0002-2383-2809; Dang, Van Duc/0000-0002-0403-6479; Pohar, Jelka/0000-0002-7616-164X; Lino, Andreia C/0000-0002-3791-8232; boudinot, pierre/0000-0002-7490-9677; Joedicke, Jara Johanna/0000-0002-4708-3216	ERC [PREG-LAB 647696]; AXA Chair Translational Immunology; Agence Nationale de la Recherche [ANR-16-CE18-0007-01]; Chair of Excellence (Universite Sorbonne Paris Cite); Infect-ERA project ABIR [031A403]; Deutsche Forschungsgemeinschaft [TRR130, FI 1238/1-2]; JSPS KAKENHI [26293062, 17H05790]; German Ministry for Education and Research BMBF [01KU1216F]; Vietnam Ministry of Education and Training [322, 911]	ERC(European Research Council (ERC)European Commission); AXA Chair Translational Immunology(AXA Research Fund); Agence Nationale de la Recherche(French National Research Agency (ANR)); Chair of Excellence (Universite Sorbonne Paris Cite); Infect-ERA project ABIR; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); German Ministry for Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); Vietnam Ministry of Education and Training	We thank J. Kirsch, H. Schliemann, the Regine von Ramin Laboratory (DRFZ), and A.B. Koehler (Max Planck Institute of Infection Biology) for technical help, K. Rajewsky (MDC, Berlin) for VH12, K. Hayakawa (Fox Chase Cancer Center, USA) for VH11 and Vk14 antibodies, H. Wardemann (DKFZ, Heidelberg) for Ig expression plasmids, S. Nutt (WEHI, Australia) for Prdm1eGFP mice, H.J. Fehling (Ulm) for ROSA-STOP-tdRFP mice, and D. Vignali, St. Jude Children's Research Hospital, and IGBMC for Lag3<SUP>-/-</SUP> mice. S.F. lab is supported by ERC PREG-LAB 647696, AXA Chair Translational Immunology, Agence Nationale de la Recherche (ANR-16-CE18-0007-01), Chair of Excellence (Universite Sorbonne Paris Cite), and Infect-ERA project ABIR (031A403), Deutsche Forschungsgemeinschaft (TRR130, FI 1238/1-2). T.T. is supported by JSPS KAKENHI 26293062 and 17H05790 grants. J.W. was supported by the German Ministry for Education and Research BMBF through the grant 01KU1216F (DEEP). V.D.D. received a 4-year PhD fellowship from the Vietnam Ministry of Education and Training (Projects 322 and 911).	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Chen TW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-539; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Corneth OBJ, 2016, CURR TOP MICROBIOL, V393, P67, DOI 10.1007/82_2015_478; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Durek P, 2016, IMMUNITY, V45, P1148, DOI 10.1016/j.immuni.2016.10.022; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Frescas D, 2017, P NATL ACAD SCI USA, V114, pE1668, DOI 10.1073/pnas.1614661114; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hardy RR, 2004, IMMUNOL REV, V197, P60, DOI 10.1111/j.0105-2896.2004.0100.x; Iwasaki Y, 2013, EUR J IMMUNOL, V43, P1063, DOI 10.1002/eji.201242942; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Schoenhals M, 2016, CELL CYCLE, V15, P1919, DOI 10.1080/15384101.2016.1191709; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Teichmann LL, 2012, J IMMUNOL, V188, P678, DOI 10.4049/jimmunol.1102456; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Wang ZY, 2005, J IMMUNOL, V174, P2098, DOI 10.4049/jimmunol.174.4.2098; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yang M, 2012, AM J PATHOL, V180, P2375, DOI 10.1016/j.ajpath.2012.03.010; Yoshida R, 2012, BIOCHEM BIOPH RES CO, V423, P247, DOI 10.1016/j.bbrc.2012.05.097	39	121	128	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					120	+		10.1016/j.immuni.2018.06.007	http://dx.doi.org/10.1016/j.immuni.2018.06.007			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	30005826	Green Published, hybrid			2022-12-18	WOS:000438949100016
J	Oh, H; Grinberg-Bleyer, Y; Liao, W; Maloney, D; Wang, PZ; Wu, ZK; Wang, JG; Bhatt, DM; Heise, N; Schmid, RM; Hayden, MS; Klein, U; Rabadan, R; Ghosh, S				Oh, Hyunju; Grinberg-Bleyer, Yenkel; Liao, Will; Maloney, Dillon; Wang, Pingzhang; Wu, Zikai; Wang, Jiguang; Bhatt, Dev M.; Heise, Nicole; Schmid, Roland M.; Hayden, Matthew S.; Klein, Ulf; Rabadan, Raul; Ghosh, Sankar			An NF-kappa B Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and Function	IMMUNITY			English	Article							GENOMIC FEATURES; READ ALIGNMENT; C-REL; FOXP3; EXPRESSION; ENHANCER; DIFFERENTIATION	Both conventional T (Tconv) cells and regulatory T (Treg) cells are activated through ligation of the T cell receptor (TCR) complex, leading to the induction of the transcription factor NF-kappa B. In Tconv cells, NF-kappa B regulates expression of genes essential for T cell activation, proliferation, and function. However the role of NF-kappa B in Treg function remains unclear. We conditionally deleted canonical NF-kappa B members p65 and c-Rel in developing and mature Treg cells and found they have unique but partially redundant roles. c-Rel was critical for thymic Treg development while p65 was essential for mature Treg identity and maintenance of immune tolerance. Transcriptome and NF-kappa B p65 binding analyses demonstrated a lineage specific, NF-kappa B-dependent transcriptional program, enabled by enhanced chromatin accessibility. These dual roles of canonical NF-kappa B in Tconv and Treg cells highlight the functional plasticity of the NF-kappa B signaling pathway and underscores the need for more selective strategies to therapeutically target NF-kappa B.	[Oh, Hyunju; Grinberg-Bleyer, Yenkel; Bhatt, Dev M.; Hayden, Matthew S.; Klein, Ulf; Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Liao, Will; Maloney, Dillon] New York Genome Ctr, New York, NY 10013 USA; [Wang, Pingzhang; Wu, Zikai; Wang, Jiguang; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Syst Biol, New York, NY 10032 USA; [Wang, Pingzhang; Wu, Zikai; Wang, Jiguang; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA; [Heise, Nicole; Klein, Ulf] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Schmid, Roland M.] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, Munich, Germany; [Hayden, Matthew S.] Dartmouth Hitchcock Med Ctr, Dept Surg, Sect Dermatol, Lebanon, NH 03756 USA; [Klein, Ulf] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Klein, Ulf] Univ Leeds, Leeds Inst Canc & Pathol, Sect Expt Haematol, Leeds LS2 9JT, W Yorkshire, England	Columbia University; Columbia University; Columbia University; Columbia University; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Dartmouth College; Columbia University; University of Leeds	Ghosh, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA.	sg2715@cumc.columbia.edu	Rabadan, Raul/AAZ-7367-2020; Wang, Jiguang/B-2717-2012	Rabadan, Raul/0000-0001-7946-9255; Grinberg-Bleyer, Yenkel/0000-0002-3515-8305; Bhatt, Dev/0000-0003-3616-3701; Hayden, Matthew/0000-0003-1670-6430; Wang, Jiguang/0000-0002-6923-4097	Cancer Research Institute; NIH [R37-AI33443 a, R01-AI068977]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068977, R37AI033443] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Crystal Bussey for technical help and Christian Schindler for reading the manuscript. We also thank Lauren Vaughn for discussion. Y.G.-B. was supported by a postdoctoral fellowship from the Cancer Research Institute. This work was supported by grants from the NIH (R37-AI33443 and R01-AI068977) to S.G.	Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Aschermann S, 2013, P NATL ACAD SCI USA, V110, P19042, DOI 10.1073/pnas.1313547110; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grigoriadis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026851; Grinber- Bleyer Y. G., 2017, CANCER CELL, V170, P1; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Joshi SK, 2002, GENESIS, V33, P48, DOI 10.1002/gene.10089; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Love M, 2013, DIFFERENTIAL ANAL RN; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Messina N, 2016, J AUTOIMMUN, V70, P52, DOI 10.1016/j.jaut.2016.03.017; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schuster M, 2012, IMMUNITY, V37, P998, DOI 10.1016/j.immuni.2012.08.023; Setty M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004271; Soligo M, 2011, EUR J IMMUNOL, V41, P503, DOI 10.1002/eji.201040712; Tone Y, 2014, J IMMUNOL, V192, P3915, DOI 10.4049/jimmunol.1302174; Wakamatsu E, 2013, P NATL ACAD SCI USA, V110, P1023, DOI 10.1073/pnas.1220688110; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang YX, 2014, BIOINFORMATICS, V30, P2568, DOI 10.1093/bioinformatics/btu372; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772	43	121	127	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					450	+		10.1016/j.immuni.2017.08.010	http://dx.doi.org/10.1016/j.immuni.2017.08.010			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28889947	Green Accepted, Bronze			2022-12-18	WOS:000411128200011
J	Andres-Terre, M; McGuire, HM; Pouliot, Y; Bongen, E; Sweeney, TE; Tato, CM; Khatri, P				Andres-Terre, Marta; McGuire, Helen M.; Pouliot, Yannick; Bongen, Erika; Sweeney, Timothy E.; Tato, Cristina M.; Khatri, Purvesh			Integrated, Multi-cohort Analysis Identifies Conserved Transcriptional Signatures across Multiple Respiratory Viruses	IMMUNITY			English	Article							EXPRESSION PROFILES; DRUG-RESISTANCE; SYSTEMS BIOLOGY; IMMUNE-RESPONSE; INFLUENZA; REVEALS; GENE; ACTIVATION; INFECTION; CD38	Respiratory viral infections are a significant burden to healthcare worldwide. Many whole genome expression profiles have identified different respiratory viral infection signatures, but these have not translated to clinical practice. Here, we performed two integrated, multi-cohort analyses of publicly available transcriptional data of viral infections. First, we identified a common host signature across different respiratory viral infections that could distinguish (1) individuals with viral infections from healthy controls and from those with bacterial infections, and (2) symptomatic from asymptomatic subjects prior to symptom onset in challenge studies. Second, we identified an influenza-specific host response signature that (1) could distinguish influenza-infected samples from those with bacterial and other respiratory viral infections, (2) was a diagnostic and prognostic marker in influenza-pneumonia patients and influenza challenge studies, and (3) was predictive of response to influenza vaccine. Our results have applications in the diagnosis, prognosis, and identification of drug targets in viral infections.	[Andres-Terre, Marta; McGuire, Helen M.; Pouliot, Yannick; Bongen, Erika; Sweeney, Timothy E.; Tato, Cristina M.; Khatri, Purvesh] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Sweeney, Timothy E.; Khatri, Purvesh] Stanford Univ, Dept Med, Div Biomed Informat, Stanford, CA 94305 USA	Stanford University; Stanford University	Khatri, P (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.	pkhatri@stanford.edu	McGuire, Helen/L-6877-2019	McGuire, Helen/0000-0003-2047-6543; Pouliot, Yannick/0000-0002-0344-1923; Sweeney, Timothy/0000-0002-3596-1093; Tato, Cristina M./0000-0002-0614-756X; Khatri, Purvesh/0000-0002-4143-4708	"La Caixa'' Foundation; NHMRC; Stanford Child Health Research Institute Young Investigator Award (Institute for Immunity, Transplantation and Infection); Society for University Surgeons Resident Scholar award; NIAID [1U19AI109662, U19AI057229, U54I117925, U01AI089859]; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, T32AI007290, U01AI089859, U19AI109662, U54AI117925] Funding Source: NIH RePORTER	"La Caixa'' Foundation(La Caixa Foundation); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Stanford Child Health Research Institute Young Investigator Award (Institute for Immunity, Transplantation and Infection); Society for University Surgeons Resident Scholar award; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Mark M. Davis for helpful discussion. M.A.-T. is funded by "La Caixa'' Foundation. H.M.M. is funded by a NHMRC early career fellowship. T.E.S. is funded by a Stanford Child Health Research Institute Young Investigator Award (through the Institute for Immunity, Transplantation and Infection) and a Society for University Surgeons Resident Scholar award. P.K. is funded by NIAID grants 1U19AI109662, U19AI057229, U54I117925, and U01AI089859 and the Bill and Melinda Gates Foundation.	Babcock HM, 2008, INFECT CONT HOSP EP, V29, P921, DOI 10.1086/590663; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Chen R, 2014, CANCER RES, V74, P2892, DOI 10.1158/0008-5472.CAN-13-2775; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Fisher RA, 1934, STAT METHODS RES WOR, V5th; Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Herberg JA, 2013, J INFECT DIS, V208, P1664, DOI 10.1093/infdis/jit348; Hu XR, 2013, P NATL ACAD SCI USA, V110, P12792, DOI 10.1073/pnas.1302968110; Ison MG, 2010, CLEV CLIN J MED, V77, P812, DOI 10.3949/ccjm.77a.10135; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Khatri P., 2008, PROGR PATTERN RECOGN, P32; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Li CJ, 2011, J VIROL, V85, P10955, DOI 10.1128/JVI.05792-11; Li MD, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0093-y; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Locarnini S, 2007, ANTIVIR THER, V12, pH15; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Moreno-Garcia ME, 2005, J IMMUNOL, V174, P2687, DOI 10.4049/jimmunol.174.5.2687; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Parnell G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017186, 10.1371/journal.pone.0023162]; Parnell GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11477; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sutejo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033732; Sweeney TE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5993; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; WILCOXON F, 1947, BIOMETRICS, V3, P119, DOI 10.2307/3001946; Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	42	121	122	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1199	1211		10.1016/j.immuni.2015.11.003	http://dx.doi.org/10.1016/j.immuni.2015.11.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682989	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000366846600022
J	Spangler, JB; Tomala, J; Luca, VC; Jude, KM; Dong, S; Ring, AM; Votavova, P; Pepper, M; Kovar, M; Garcia, KC				Spangler, Jamie B.; Tomala, Jakub; Luca, Vincent C.; Jude, Kevin M.; Dong, Shen; Ring, Aaron M.; Votavova, Petra; Pepper, Marion; Kovar, Marek; Garcia, K. Christopher			Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms	IMMUNITY			English	Article							IN-VIVO EXPANSION; AUTOIMMUNE-DISEASE; SMALL-MOLECULE; HOT-SPOT; IL-2; COMPLEXES; RECEPTOR; IMMUNOTHERAPY; CANCER; NK	Interleukin-2 (IL-2) is a pleiotropic cytokine that regulates immune cell homeostasis and has been used to treat a range of disorders including cancer and autoimmune disease. IL-2 signals via interleukin-2 receptor-beta (IL-2R beta):IL-2R gamma heterodimers on cells expressing high (regulatory T cells, Treg) or low (effector cells) amounts of IL-2R alpha (CD25). When complexed with IL-2, certain anti-cytokine antibodies preferentially stimulate expansion of Treg (JES6-1) or effector (S4B6) cells, offering a strategy for targeted disease therapy. We found that JES6-1 sterically blocked the IL-2:IL-2R beta and IL-2:IL-2Rg interactions, but also allosterically lowered the IL-2:IL-2R alpha affinity through a "triggered exchange'' mechanism favoring IL-2R alpha hi Treg cells, creating a positive feedback loop for IL-2R alpha hi cell activation. Conversely, S4B6 sterically blocked the IL-2:IL-2R alpha interaction, while also conformationally stabilizing the IL-2:IL-2R beta interaction, thus stimulating all IL-2-responsive immune cells, particularly IL-2R beta hi effector cells. These insights provide a molecular blueprint for engineering selectively potentiating therapeutic antibodies.	[Spangler, Jamie B.; Luca, Vincent C.; Jude, Kevin M.; Dong, Shen; Ring, Aaron M.; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Spangler, Jamie B.; Luca, Vincent C.; Jude, Kevin M.; Dong, Shen; Ring, Aaron M.; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Spangler, Jamie B.; Luca, Vincent C.; Jude, Kevin M.; Dong, Shen; Ring, Aaron M.; Garcia, K. Christopher] Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA; [Tomala, Jakub; Votavova, Petra; Kovar, Marek] Acad Sci Czech Republic, Inst Microbiol, Lab Tumor Immunol, CR-14220 Prague 4, Krc, Czech Republic; [Pepper, Marion] Univ Washington, Dept Immunol, Seattle, WA 98109 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Washington; University of Washington Seattle	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Kovar, Marek/H-7793-2014; Dong, Shen/ABC-2875-2020; Tomala, Jakub/J-6042-2014	Tomala, Jakub/0000-0002-6315-2832; Jude, Kevin/0000-0002-3675-5136; dong, Shen/0000-0001-8839-7046; Ring, Aaron/0000-0003-3699-2446; Spangler, Jamie/0000-0001-8187-3732	US NIH [R01 AI51321, R01 AI108626]; US NIH (National Research Service Award) [NIH-F30DK094541]; Mathers Fund; Ludwig Foundation; Czech Science Foundation [13-12885S]; Institute of Microbiology of the Academy of Sciences of the Czech Republic the Institutional Research Concept [RVO 61388971]; Project BIOCEV of the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; Leukemia & Lymphoma Society; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051321, R01AI108626, R01AI051321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094541] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH (National Research Service Award); Mathers Fund; Ludwig Foundation; Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Microbiology of the Academy of Sciences of the Czech Republic the Institutional Research Concept; Project BIOCEV of the European Regional Development Fund; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the K.C.G. and M.K. laboratories for helpful advice and discussions, Miloslav Kverka for help with the mouse DSS colitis model, and A. Velasco, D. Waghray, and S. Fischer for technical assistance. We thank Onur Boyman and Carsten Krieg for providing the JES6-1 hybridoma cell line and for helpful discussions. This work was supported by the US NIH (R01 AI51321 to K.C.G., R01 AI108626 to M.P., and National Research Service Award NIH-F30DK094541 to A.M.R.), the Mathers Fund, the Ludwig Foundation, the Czech Science Foundation (Grant 13-12885S to M.K.), the Institute of Microbiology of the Academy of Sciences of the Czech Republic the Institutional Research Concept (grant RVO 61388971 to M.K.), and Project BIOCEV of the European Regional Development Fund (grant CZ. 1.05/1.1.00/02.0109 to M.K.). K.C.G. is an investigator of the Howard Hughes Medical Institute, J.B.S. is the recipient of a Leukemia & Lymphoma Society Career Development Program fellowship, and V.C.L. is the recipient of a Cancer Research Institute Irvington postdoctoral fellowship. M.K. is listed as a co-inventor on the patent entitled "Methods for improving immune function and methods for prevention or treatment of disease in a mammalian subject,'' which was filed on February 16, 2007, and now bears International Application Number PCT/US2007/0623631.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Boyman O, 2006, EXPERT OPIN BIOL TH, V6, P1323, DOI 10.1517/14712598.6.12.1323; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Castro I, 2012, J IMMUNOL, V189, P4321, DOI 10.4049/jimmunol.1202067; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Jin GH, 2008, INT IMMUNOL, V20, P783, DOI 10.1093/intimm/dxn036; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Park YH, 2010, CLIN IMMUNOL, V135, P43, DOI 10.1016/j.clim.2009.11.011; Rao BM, 2004, MOL PHARMACOL, V66, P864, DOI 10.1124/mol.66.4.864; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Rojas G, 2014, MABS-AUSTIN, V6, P273, DOI 10.4161/mabs.27224; Rojas G, 2013, IMMUNOBIOLOGY, V218, P105, DOI 10.1016/j.imbio.2012.02.009; Rosenberg SA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003634; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Thanos CD, 2003, J AM CHEM SOC, V125, P15280, DOI 10.1021/ja0382617; Thanos CD, 2006, P NATL ACAD SCI USA, V103, P15422, DOI 10.1073/pnas.0607058103; Tomala J, 2009, J IMMUNOL, V183, P4904, DOI 10.4049/jimmunol.0900284; Verdeil G, 2008, P NATL ACAD SCI USA, V105, P16683, DOI 10.1073/pnas.0805054105; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	37	121	131	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					815	825		10.1016/j.immuni.2015.04.015	http://dx.doi.org/10.1016/j.immuni.2015.04.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992858	Bronze, Green Accepted			2022-12-18	WOS:000354827400009
J	Duffy, D; Perrin, H; Abadie, V; Benhabiles, N; Boissonnas, A; Liard, C; Descours, B; Reboulleau, D; Bonduelle, O; Verrier, B; Van Rooijen, N; Combadiere, C; Combadiere, B				Duffy, Darragh; Perrin, Helene; Abadie, Valerie; Benhabiles, Nora; Boissonnas, Alexandre; Liard, Christelle; Descours, Benjamin; Reboulleau, Damien; Bonduelle, Olivia; Verrier, Bernard; Van Rooijen, Nico; Combadiere, Christophe; Combadiere, Behazine			Neutrophils Transport Antigen from the Dermis to the Bone Marrow, Initiating a Source of Memory CD8(+) T Cells	IMMUNITY			English	Article							IN-VIVO; CHEMOKINE RECEPTOR; DENDRITIC CELLS; LYMPH-NODES; LEISHMANIA-MAJOR; IMMUNE-RESPONSE; MICE LACKING; SITE; LYMPHOCYTES; INFECTION	The bone marrow (BM) has been identified as a possible organ for T cell priming, yet the fundamental mechanisms of a polyclonal immune response in the BM remain unknown. We found that after intradermal injection of modified vaccinia Ankara virus, unexpected sources of newly primed polyclonal virus-specific CD8(+), but not CD4(+), T cells were localized in the BM and the draining lymph nodes (dLNs) prior to blood circulation. We identified neutrophils as the virus-carrier cells from the dermis to the BM. In both neutrophil-depleted and Ccr1(-/-) mice, virus-specific BM CD8(+) responses were lost. Myeloid antigen-presenting cells were required for BM CD8(+) T cell priming. A systems biology analysis of dLN and BM virus-specific CD8(+) T cells revealed distinct transcriptional and multifunctional profiles for cells primed in each organ. We provide direct evidence for how antigen is transported to the BM, providing a source of virus-specific memory CD8(+) T cells.	[Duffy, Darragh; Perrin, Helene; Abadie, Valerie; Boissonnas, Alexandre; Liard, Christelle; Descours, Benjamin; Reboulleau, Damien; Bonduelle, Olivia; Combadiere, Christophe; Combadiere, Behazine] INSERM, UMR S 945, F-75013 Paris 13, France; [Duffy, Darragh; Perrin, Helene; Abadie, Valerie; Boissonnas, Alexandre; Liard, Christelle; Descours, Benjamin; Reboulleau, Damien; Bonduelle, Olivia; Combadiere, Christophe; Combadiere, Behazine] Univ Paris 06, Lab Immun & Infect, F-75013 Paris 13, France; [Benhabiles, Nora] CEA Saclay DRT LIST DCSI LOAD, CEA List, F-91191 Gif Sur Yvette, France; [Verrier, Bernard] Univ Lyon 1, Ctr Natl Rech Sci, Inst Biol & Chim Prot, F-69367 Lyon 07, France; [Van Rooijen, Nico] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; [Combadiere, Christophe; Combadiere, Behazine] Hop La Pitie Salpetriere, AP HP, F-75013 Paris 13, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Combadiere, B (corresponding author), INSERM, UMR S 945, 91 Bld Hop, F-75013 Paris 13, France.	behazine.combadiere@upmc.fr	Combadiere, Behazine/S-8054-2019; Boissonnas, Alexandre/A-2801-2016; Combadiere, Behazine/G-3881-2013; Van Rooijen, Nico/Z-1578-2019; Combadiere, Christophe/I-5639-2013; verrier, bernard/J-4094-2017	Combadiere, Behazine/0000-0002-2353-4406; Boissonnas, Alexandre/0000-0002-7770-7210; Combadiere, Christophe/0000-0002-1755-4531; verrier, bernard/0000-0002-8478-7095	Fondation pour la recherche Medicale; European commission [241904]; ANRS (Agence Nationale de Recherche sur le Sida); INSERM (Institut national de la sante et de la recherche medicale)	Fondation pour la recherche Medicale(Fondation pour la Recherche Medicale); European commission(European CommissionEuropean Commission Joint Research Centre); ANRS (Agence Nationale de Recherche sur le Sida)(ANRSFrench National Research Agency (ANR)); INSERM (Institut national de la sante et de la recherche medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	The work was funded by Fondation pour la recherche Medicale and European commission FP7 CUTHIVAC program (Grant Agreement 241904). D.D. was the recipient of ANRS (Agence Nationale de Recherche sur le Sida) and INSERM (Institut national de la sante et de la recherche medicale) postdoctoral grants. B.C. and C.C. are recipients of a contract "Interface" from INSERM-Assistance Publique-Hopitaux de Paris. The authors would like to thank M. Nguyen of Imagopole - Plate-Forme de Cytometrie, Pasteur Institute for help with Imagestream analysis and Dormeur Investment Service Ltd. for funding of equipment used in this project.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Abadie V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008159; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; BENNER R, 1974, CELL IMMUNOL, V13, P95, DOI 10.1016/0008-8749(74)90230-5; Blease K, 2000, J IMMUNOL, V165, P1564, DOI 10.4049/jimmunol.165.3.1564; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Chiba K, 1999, TRANSPLANT P, V31, P1230, DOI 10.1016/S0041-1345(98)01975-7; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Desmedt M, 1998, J IMMUNOL, V160, P5300; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Di Rosa F, 2003, IMMUNOLOGY, V108, P296, DOI 10.1046/j.1365-2567.2003.01593.x; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; HUNT SV, 1987, LYMPHOCYTES PRACTICA, P1; Jochim RC, 2009, TRENDS PARASITOL, V25, P145, DOI 10.1016/j.pt.2009.01.001; Khan IA, 2001, J IMMUNOL, V166, P1930, DOI 10.4049/jimmunol.166.3.1930; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; Lehmann MH, 2009, J VIROL, V83, P2540, DOI 10.1128/JVI.01884-08; Liard C, 2012, J INVEST DERMATOL, V132, P615, DOI 10.1038/jid.2011.346; Mahe B, 2009, J INVEST DERMATOL, V129, P1156, DOI 10.1038/jid.2008.356; Maletto BA, 2006, BLOOD, V108, P3094, DOI 10.1182/blood-2006-04-016659; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Parretta E, 2005, J IMMUNOL, V174, P7654, DOI 10.4049/jimmunol.174.12.7654; Parretta E, 2008, J IMMUNOL, V180, P7230, DOI 10.4049/jimmunol.180.11.7230; Rodriguez-Sosa M, 2003, IMMUNOL CELL BIOL, V81, P114, DOI 10.1046/j.0818-9641.2002.01132.x; Segura E, 2009, CURR OPIN IMMUNOL, V21, P105, DOI 10.1016/j.coi.2009.03.011; Slifka MK, 1997, BLOOD, V90, P2103, DOI 10.1182/blood.V90.5.2103; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Su SB, 1996, J LEUKOCYTE BIOL, V60, P658, DOI 10.1002/jlb.60.5.658; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Tripp RA, 1997, J IMMUNOL, V158, P3716; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062	43	121	123	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 16	2012	37	5					917	929		10.1016/j.immuni.2012.07.015	http://dx.doi.org/10.1016/j.immuni.2012.07.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23142782	Bronze			2022-12-18	WOS:000311460000017
J	Lin, JX; Li, P; Liu, DL; Jin, HT; He, JP; Rasheed, MAU; Rochman, Y; Wang, L; Cui, KR; Liu, CY; Kelsall, BL; Ahmed, R; Leonard, WJ				Lin, Jian-Xin; Li, Peng; Liu, Delong; Jin, Hyun Tak; He, Jianping; Rasheed, Mohammed Ata Ur; Rochman, Yrina; Wang, Lu; Cui, Kairong; Liu, Chengyu; Kelsall, Brian L.; Ahmed, Rafi; Leonard, Warren J.			Critical Role of STAT5 Transcription Factor Tetramerization for Cytokine Responses and Normal Immune Function	IMMUNITY			English	Article							T-CELLS; IL-2 RECEPTOR; DNA-BINDING; GENE-EXPRESSION; PROMOTER; DIMERS; ALPHA; DIFFERENTIATION; PROLIFERATION; SEQUENCE	Cytokine-activated STAT proteins dimerize and bind to high-affinity motifs, and N-terminal domain-mediated oligomerization of dimers allows tetramer formation and binding to low-affinity tandem motifs, but the functions of dimers versus tetramers are unknown. We generated Stat5a-Stat5b double knockin (DKI) N-domain mutant mice in which STAT5 proteins form dimers but not tetramers, identified cytokine-regulated genes whose expression required STAT5 tetramers, and defined dimer versus tetramer consensus motifs. Whereas Stat5-deficient mice exhibited perinatal lethality, DKI mice were viable; thus, STAT5 dimers were sufficient for survival. Nevertheless, STAT5 DKI mice had fewer CD4(+)CD25(+) T cells, NK cells, and CD8(+) T cells, with impaired cytokine-induced and homeostatic proliferation of CD8(+) T cells. Moreover, DKI CD8(+) T cell proliferation after viral infection was diminished and DKI Treg cells did not efficiently control colitis. Thus, tetramerization of STAT5 is critical for cytokine responses and normal immune function, establishing a critical role for STAT5 tetramerization in vivo.	[Lin, Jian-Xin; Li, Peng; Rochman, Yrina; Wang, Lu; Cui, Kairong; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Liu, Delong] Ctr Informat Technol, Math & Stat Comp Lab, Bethesda, MD 20892 USA; [Jin, Hyun Tak; Rasheed, Mohammed Ata Ur; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [He, Jianping; Kelsall, Brian L.] NIAID, Mucosal Immun Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA.	wjl@helix.nih.gov	Leonard, Warren/AAA-1397-2022; Rasheed, Mohammed/N-2749-2013		Division of Intramural Research, NHLBI, NIH, Bethesda, MD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005401, ZIAHL005402, ZICHL005907, ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000833] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI, NIH, Bethesda, MD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Raghavachari (NHLBI) for Affymetrix Chip assay, R. Spolski (NHLBI), R.H. Schwartz, K.-T. Jeang (NIAID), K. Zhao (NHLBI), and P.J. Munson (CIT) for critical comments, P.J. Munson (CIT) for his input in Affymetrix analysis, J. Chen (Hematology Branch), R. Spolski, W. Liao, and C. Robinson for experimental help, other members in the Leonard lab for suggestions, and C. Robinson for maintaining the mouse colony. We thank C. Wu, S. Adhya, and S. Simmons for valuable discussions. This work was supported in part by the Division of Intramural Research, NHLBI, NIH, Bethesda, MD.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; COPELAND NG, 1995, GENOMICS, V29, P225, DOI 10.1006/geno.1995.1235; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Hou ZY, 2003, MOL ENDOCRINOL, V17, P1910, DOI 10.1210/me.2003-0045; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Jenkins D, 1997, J CLIN PATHOL, V50, P93, DOI 10.1136/jcp.50.2.93; John S, 1999, MOL CELL BIOL, V19, P1910; John S, 1996, EMBO J, V15, P5627, DOI 10.1002/j.1460-2075.1996.tb00947.x; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kelly JA, 2003, J EXP MED, V198, P79, DOI 10.1084/jem.20021548; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Meyer WKH, 1997, J BIOL CHEM, V272, P31821, DOI 10.1074/jbc.272.50.31821; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; MUNSON P, 2001, GENELOGIC WORKSH LOW; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Ota N, 2004, NAT IMMUNOL, V5, P208, DOI 10.1038/ni1032; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Verdier F, 1998, MOL CELL BIOL, V18, P5852, DOI 10.1128/MCB.18.10.5852; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yamamoto K, 2002, BIOCHEM BIOPH RES CO, V297, P1245, DOI 10.1016/S0006-291X(02)02378-1; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	43	121	130	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 20	2012	36	4					586	599		10.1016/j.immuni.2012.02.017	http://dx.doi.org/10.1016/j.immuni.2012.02.017			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22520852	Bronze, Green Accepted			2022-12-18	WOS:000303223900011
J	Kumar, R; Ferez, M; Swamy, M; Arechaga, I; Rejas, MT; Valpuesta, JM; Schamel, WWA; Alarcon, B; van Santen, HM				Kumar, Rashmi; Ferez, Maria; Swamy, Mahima; Arechaga, Ignacio; Teresa Rejas, Maria; Valpuesta, Jose M.; Schamel, Wolfgang W. A.; Alarcon, Balbino; van Santen, Hisse M.			Increased Sensitivity of Antigen-Experienced T Cells through the Enrichment of Oligomeric T Cell Receptor Complexes	IMMUNITY			English	Article							LIPID RAFTS; SIGNAL-TRANSDUCTION; TETRAMER BINDING; MEMORY CELLS; TCR; ACTIVATION; NAIVE; CD8; KINETICS; MULTIVALENT	Although memory T cells respond more vigorously to stimulation and they are more sensitive to low doses of antigen than naive T cells, the molecular basis of this increased sensitivity remains unclear. We have previously shown that the T cell receptor (TCR) exists as different-sized oligomers on the surface of resting T cells and that large oligomers are preferentially activated in response to low antigen doses. Through biochemistry and electron microscopy, we now showed that previously stimulated and memory T cells have more and larger TCR oligomers at the cell surface than their naive counterparts. Reconstitution of cells and mice with a point mutant of the CD3 zeta subunit, which impairs TCR oligomer formation, demonstrated that the increased size of TCR oligomers was directly responsible for the increased sensitivity of antigen-experienced T cells. Thus, we propose that an "avidity maturation" mechanism underlies T cell antigenic memory.	[Kumar, Rashmi; Ferez, Maria; Alarcon, Balbino; van Santen, Hisse M.] Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Dept Biol Celular & Inmunol, E-28049 Madrid, Spain; [Teresa Rejas, Maria] Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Serv Microscopia Elect, E-28049 Madrid, Spain; [Swamy, Mahima; Schamel, Wolfgang W. A.] Univ Freiburg, Ctr Chron Immunodeficiency, Fac Biol, BIOSS Ctr Biol Signalling Studies, D-79108 Freiburg, Germany; [Swamy, Mahima; Schamel, Wolfgang W. A.] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Arechaga, Ignacio; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Freiburg; Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alarcon, B (corresponding author), Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Dept Biol Celular & Inmunol, E-28049 Madrid, Spain.	balarcon@cbm.uam.es; hvansanten@cbm.uam.es	Valpuesta, José M/T-1977-2017; Valpuesta, Jose M/AAA-6002-2019; Alarcon, Balbino/N-9648-2016; van Santen, Hisse Martien/E-8103-2013; Swamy, Mahima/J-7046-2019; Arechaga, Ignacio/K-2198-2014	Valpuesta, José M/0000-0001-7468-8053; Alarcon, Balbino/0000-0001-7820-1070; van Santen, Hisse Martien/0000-0003-0769-4511; Swamy, Mahima/0000-0003-3977-3425; Arechaga, Ignacio/0000-0002-1342-9370	CICYT [SAF2006-01391, SAF2010-14912]; EU; Ministerio de Ciencia e Innovacion [BFU2006-04031, BFU2009-08009, BES-2007-15570]; Deutsche Forschungsgemeinschaft [SFB620]; Ministerio de Educacion y Ciencia	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); EU(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministerio de Educacion y Ciencia(Spanish Government)	We thank E. Palmer for the generous supply of the K<SUP>b</SUP>-OVA tetramers, G. Sutter and A. Schwantes for the MVA-OVA virus, C. Prieto and T. Gomez for maintenance of the animal colony, and M. Nieto and M. Sefton for critical reading of the manuscript. This work was supported by grants SAF2006-01391 and SAF2010-14912 from the CICYT to B.A., FP7/2007-2013 (Sybilla) from the EU to B.A. and W.W.A.S and BFU2006-04031 and BFU2009-08009 from the Ministerio de Ciencia e Innovacion to H.M.v.S. W.W.A.S. was supported by the Deutsche Forschungsgemeinschaft through the Emmy Noether program, the excellence cluster bioss and the SFB620. M.F. is a recipient of a FPI predoctoral fellowship (ref BES-2007-15570) from the Ministerio de Ciencia e Innovacion. H.M.v.S. was supported by a Ramon y Cajal fellowship from the Ministerio de Educacion y Ciencia during the initial stages of this project.	Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Arechaga I, 2010, INT IMMUNOL, V22, P897, DOI 10.1093/intimm/dxq443; ASKONAS BA, 1982, IMMUNOLOGY, V45, P79; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; BUDD RC, 1987, J IMMUNOL, V138, P3120; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Choudhuri K, 2010, FEBS LETT, V584, P4823, DOI 10.1016/j.febslet.2010.10.015; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; CROFT M, 1994, J IMMUNOL, V152, P2675; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; DASILVA PP, 1984, J CELL BIOL, V99, P1156, DOI 10.1083/jcb.99.3.1156; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Drake DR, 2001, J IMMUNOL, V166, P7009, DOI 10.4049/jimmunol.166.12.7009; El-Gogo S, 2007, VACCINE, V25, P3934, DOI 10.1016/j.vaccine.2007.02.054; Ericsson PO, 1996, J IMMUNOL, V156, P2045; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Jose ES, 1998, EUR J IMMUNOL, V28, P12; Kersh EN, 2003, J IMMUNOL, V170, P5455, DOI 10.4049/jimmunol.170.11.5455; Kimachi K, 1997, EUR J IMMUNOL, V27, P3310, DOI 10.1002/eji.1830271230; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; LEE WT, 1991, CELL IMMUNOL, V132, P215, DOI 10.1016/0008-8749(91)90020-C; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Martinez-Martin N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000402; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; RONCHESE F, 1987, NATURE, V329, P254, DOI 10.1038/329254a0; Schamel WWA, 2006, TRENDS IMMUNOL, V27, P176, DOI 10.1016/j.it.2006.02.005; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; SWAMY M, 2006, SCI STKE, pP14; Swamy M, 2007, J IMMUNOL METHODS, V324, P74, DOI 10.1016/j.jim.2007.05.003; Tani-ichi S, 2005, INT IMMUNOL, V17, P749, DOI 10.1093/intimm/dxh257; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Torres J, 2002, J MOL BIOL, V316, P375, DOI 10.1006/jmbi.2001.5268; Uhlin M, 2003, SCAND J IMMUNOL, V57, P99, DOI 10.1046/j.1365-3083.2003.01188.x; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Yokosuka T, 2010, CURR TOP MICROBIOL, V340, P81, DOI 10.1007/978-3-642-03858-7_5; Zarnitsyna VI, 2007, P NATL ACAD SCI USA, V104, P18037, DOI 10.1073/pnas.0704811104; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	58	121	126	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 23	2011	35	3					375	387		10.1016/j.immuni.2011.08.010	http://dx.doi.org/10.1016/j.immuni.2011.08.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21903423	Bronze			2022-12-18	WOS:000295748100009
J	Dustin, ML				Dustin, Michael L.			The Cellular Context of T Cell Signaling	IMMUNITY			English	Review							IMMUNOLOGICAL SYNAPSE FORMATION; PRESENTING B-CELLS; KINASE-C-THETA; FC-EPSILON-RI; ACTIN CYTOSKELETON; ANTIGEN RECEPTOR; DENDRITIC CELLS; INTEGRIN ACTIVATION; LYMPHOCYTE FUNCTION; IMMUNE-SYNAPSE	Classical alpha beta T cells protect the host by monitoring intracellular and extracellular proteins in a two-step process. The first step is protein degradation and combination with a major histocompatibility complex (MHC) molecule, leading to surface expression of this amalgam (antigen processing). The second step is the interaction of the T cell receptor with the MHC-peptide complex, leading to signaling in the T cells (antigen recognition). The context for this interaction is a T cell-antigen presenting cell junction, known as an immunological synapse if symmetric and stable and as a kinapse if asymmetric and mobile. The physiological recognition of a ligand takes place most efficiently in the F-actin-rich lamellipodium and is F-actin dependent in stages of formation and triggering and myosin II dependent for signal amplification. This review discusses how these concepts emerged from early studies on adhesion, signaling, and cell biology of T cells.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Dustin, ML (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 550 1st Ave, New York, NY 10016 USA.	michael.dustin@med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389	NIH [AI43542]; Nanomedicine Development Center [PN2 EY016586]; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542, R01AI043542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nanomedicine Development Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I thank Kaushik Choudhuri and David Fooksman for valuable discussions. This work was supported by NIH grant AI43542 and grant PN2 EY016586, related to a Nanomedicine Development Center.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; BAETZ K, 1995, J IMMUNOL, V154, P6122; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; Beal AM, 2008, J IMMUNOL, V181, P4815, DOI 10.4049/jimmunol.181.7.4815; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; DUSTIN ML, 1986, J IMMUNOL, V137, P245; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Germain RN, 1997, CURR BIOL, V7, pR640, DOI 10.1016/S0960-9822(06)00323-X; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; ILANI T, 2009, NAT IMMUNOL IN PRESS; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; KAIZUKA Y, 2009, J CELL BIOL IN PRESS; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; KUPFER A, 1986, P NATL ACAD SCI USA, V83, P6080, DOI 10.1073/pnas.83.16.6080; KUPFER A, 1989, J EXP MED, V170, P1697, DOI 10.1084/jem.170.5.1697; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; NORCROSS MA, 1984, ANN INST PASTEUR IMM, VD135, P113, DOI 10.1016/S0769-2625(84)81105-8; Oddos S, 2008, BIOPHYS J, V95, pL66, DOI 10.1529/biophysj.108.143198; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; SCHMIDT RE, 1988, J IMMUNOL, V140, P991; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SHIMIZU Y, 1990, IMMUNOL REV, V114, P109, DOI 10.1111/j.1600-065X.1990.tb00563.x; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolar P, 2008, IMMUNOL REV, V221, P64, DOI 10.1111/j.1600-065X.2008.00583.x; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tseng SY, 2008, J IMMUNOL, V181, P4852, DOI 10.4049/jimmunol.181.7.4852; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; WHITE J, 1983, J IMMUNOL, V130, P1033; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	120	121	124	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 17	2009	30	4					482	492		10.1016/j.immuni.2009.03.010	http://dx.doi.org/10.1016/j.immuni.2009.03.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19371714	Bronze, Green Accepted			2022-12-18	WOS:000265319000006
J	Henderson, KN; Tye-Din, JA; Reid, HH; Chen, Z; Borg, NA; Beissbarth, T; Tatham, A; Mannering, SI; Purcell, AW; Dudek, NL; van Heel, DA; McCluskey, J; Rossjohn, J; Anderson, RP				Henderson, Kate N.; Tye-Din, Jason A.; Reid, Hugh H.; Chen, Zhenjun; Borg, Natalie A.; Beissbarth, Tim; Tatham, Arthur; Mannering, Stuart I.; Purcell, Anthony W.; Dudek, Nadine L.; van Heel, David A.; McCluskey, James; Rossjohn, Jamie; Anderson, Robert P.			A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease	IMMUNITY			English	Article							T-CELL EPITOPE; EUROPEAN GENETICS CLUSTER; SEQUENCE-SPECIFIC PRIMERS; TISSUE TRANSGLUTAMINASE; CRYSTAL-STRUCTURE; MODIFIED PEPTIDE; CEREAL TOXICITY; GLIADIN; GLUTEN; DEAMIDATION	The risk of celiac disease is strongly associated with human leukocyte antigen (HLA) DQ2 and to a lesser extent with HLA DQ8. Although the pathogenesis of HLA-DQ2-mediated celiac disease is established, the underlying basis for HLA-DQ8-mediated celiac disease remains unclear. We showed that T helper 1 (Th1) responses in HLA-DQ8-associated celiac pathology were indeed HLA DQ8 restricted and that multiple, mostly deamidated peptides derived from protease-sensitive sites of gliadin were recognized. This pattern of reactivity contrasted with the more absolute deamidation dependence and relative protease resistance of the dominant gliadin peptide in DQ2-mediated disease. We provided a structural basis for the selection of HLA-DQ8-restricted, deamidated gliadin peptides. The data established that the molecular mechanisms underlying HLA-DQ8-mediated celiac disease differed markedly from the HLA-DQ2-mediated form of the disease. Accordingly, nondietary therapeutic interventions in celiac disease might need to be tailored to the genotype of the individual.	Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia; Walter & Eliza Hall Inst Med Res, Autoimmun & Transplantat Div, Parkville, Vic 3050, Australia; Royal Melbourne Hosp, Dept Gastroenterol, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Walter & Eliza Hall Inst Med Res, Genet & Bioinformat Div, Parkville, Vic 3050, Australia; Univ Wales Inst, Sch Appl Sci, Cardiff CF5 2YB, Wales; Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; Barts & London Queen Marys Sch Med & Dent, London E1 2AD, England	Monash University; Walter & Eliza Hall Institute; Royal Melbourne Hospital; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; University of London; Queen Mary University London	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia.	jamie.rossjohn@med.monash.edu.au; banderson@wehi.edu.au	Tye-Din, Jason A./A-6109-2019; Purcell, Anthony/AAH-1942-2019; Beissbarth, Tim/B-3129-2013; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007	Tye-Din, Jason A./0000-0001-7687-9654; Purcell, Anthony/0000-0003-0532-8331; Beissbarth, Tim/0000-0001-6509-2143; Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Anderson, Robert/0000-0002-0764-7267; van Heel, David/0000-0002-0637-2265; Borg, Natalie/0000-0002-8677-9056; Tatham, Arthur/0000-0001-5080-5585	Wellcome Trust [gr068094ma] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Anderson RP, 2005, GUT, V54, P1217, DOI 10.1136/gut.2004.059998; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Beissbarth T, 2005, BIOINFORMATICS, V21, pI29, DOI 10.1093/bioinformatics/bti1013; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Mannering SI, 2005, J IMMUNOL METHODS, V298, P83, DOI 10.1016/j.jim.2005.01.001; Mannering SI, 2003, VACCINE, V21, P3638, DOI 10.1016/S0264-410X(03)00402-X; Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Moustakas AK, 2000, INT IMMUNOL, V12, P1157, DOI 10.1093/intimm/12.8.1157; Mullighan CG, 1997, TISSUE ANTIGENS, V50, P688, DOI 10.1111/j.1399-0039.1997.tb02936.x; OLERUP O, 1993, TISSUE ANTIGENS, V41, P119, DOI 10.1111/j.1399-0039.1993.tb01991.x; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Qiao SW, 2005, J IMMUNOL, V174, P1657, DOI 10.4049/jimmunol.174.3.1657; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; Shan L, 2005, J PROTEOME RES, V4, P1732, DOI 10.1021/pr050173t; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Straumfors A, 1998, SCAND J IMMUNOL, V47, P561; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Vader LW, 2003, GASTROENTEROLOGY, V125, P1105, DOI 10.1016/S0016-5085(03)01204-6; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, J IMMUNOL, V161, P1585; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; van de Wal Y, 1999, EUR J IMMUNOL, V29, P3133, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3133::AID-IMMU3133&gt;3.0.CO;2-G; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119	36	121	127	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2007	27	1					23	34		10.1016/j.immuni.2007.05.015	http://dx.doi.org/10.1016/j.immuni.2007.05.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17629515	Bronze			2022-12-18	WOS:000248398100006
J	Yu, P; Constien, R; Dear, N; Katan, M; Hanke, P; Bunney, TD; Kunder, S; Quintanilla-Martinez, L; Huffstadt, U; Schroder, A; Jones, NP; Peters, T; Fuchs, H; de Angelis, MH; Nehls, M; Grosse, J; Wabnitz, P; Meyer, TPH; Yasuda, K; Schiemann, M; Schneider-Fresenius, C; Jagla, W; Russ, A; Popp, A; Josephs, M; Marquardt, A; Laufs, J; Schmittwolf, C; Wagner, H; Pfeffer, K; Mudde, GC				Yu, P; Constien, R; Dear, N; Katan, M; Hanke, P; Bunney, TD; Kunder, S; Quintanilla-Martinez, L; Huffstadt, U; Schroder, A; Jones, NP; Peters, T; Fuchs, H; de Angelis, MH; Nehls, M; Grosse, J; Wabnitz, P; Meyer, TPH; Yasuda, K; Schiemann, M; Schneider-Fresenius, C; Jagla, W; Russ, A; Popp, A; Josephs, M; Marquardt, A; Laufs, J; Schmittwolf, C; Wagner, H; Pfeffer, K; Mudde, GC			Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-CELL DEVELOPMENT; C-GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE; GENOME-WIDE; RECEPTOR; C-GAMMA-2; ACTIVATION; DISEASE; MICE	The identification of specific genetic loci that contribute to inflammatory and autoimmune diseases has proved difficult due to the contribution of multiple interacting genes, the inherent genetic heterogeneity present in human populations, and a lack of new mouse mutants. By using N-ethyl-N-nitrosourea (ENU) mutagenesis to discover new immune regulators, we identified a point mutation in the murine phospholipase Cg2 (Plcg2) gene that leads to severe spontaneous inflammation and autoimmunity. The disease is composed of an autoimmune component mediated by autoantibody immune complexes and B and T cell independent inflammation. The underlying mechanism is a gain-of-function mutation in Plcg2, which leads to hyperreactive external calcium entry in B cells and expansion of innate inflammatory cells. This mutant identifies Plcg2 as a key regulator in an autoimmune and inflammatory disease mediated by B cells and non-B, non-T haematopoietic cells and emphasizes that by distinct genetic modulation, a single point mutation can lead to a complex immunological phenotype.	Ingenium Pharmaceut AG, D-82152 Munich, Germany; Tech Univ Munich, Clin Rechts Isar, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; Inst Canc Res, Chester Beatty Labs, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England; GSF Natl Res Ctr Environm & Hlth, Inst Pathol, D-85764 Neuherberg, Germany; GSF Natl Res Ctr Environm & Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; MRC, Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England; Tech Univ Munich, GSF Natl Res Ctr Environm, Clin Cooperat Grp Vaccinol, D-81675 Munich, Germany; Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England	Technical University of Munich; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; MRC Harwell; Technical University of Munich; University of Oxford	Yu, P (corresponding author), Ingenium Pharmaceut AG, Fraunhoferstr 13, D-82152 Munich, Germany.	philipp.yu@lrz.tum.de	de Angelis, Martin Hrabe/F-5531-2012; Fuchs, Helmut/M-7347-2014	de Angelis, Martin Hrabe/0000-0002-7898-2353; Fuchs, Helmut/0000-0002-5143-2677; Yu, Philipp/0000-0003-2629-6690; Yasuda, Kei/0000-0002-6791-4531; Schroder, Andreas/0000-0002-3568-1358; Bunney, Tom/0000-0002-0281-8813; Pfeffer, Klaus/0000-0002-5652-6330				Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Coggeshall KM, 2002, MOL IMMUNOL, V39, P521, DOI 10.1016/S0161-5890(02)00209-2; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; EMORI Y, 1989, J BIOL CHEM, V264, P21885; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Flaswinkel H, 2000, MAMM GENOME, V11, P526, DOI 10.1007/s003350010100; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; Hiller G, 2002, CELL SIGNAL, V14, P169, DOI 10.1016/S0898-6568(01)00252-2; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Hurley JH, 1997, CURR OPIN STRUC BIOL, V7, P557, DOI 10.1016/S0959-440X(97)80122-4; Khoury SJ, 2004, IMMUNITY, V20, P529, DOI 10.1016/S1074-7613(04)00116-5; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kurosaki T, 2000, IMMUNOL REV, V176, P19; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Marshall AJ, 2000, IMMUNOL REV, V176, P30; Martin F, 2004, IMMUNITY, V20, P517, DOI 10.1016/S1074-7613(04)00112-8; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monroe JG, 2004, CURR OPIN IMMUNOL, V16, P288, DOI 10.1016/j.coi.2004.03.010; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Oliver AM, 1999, J IMMUNOL, V162, P7198; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Putney JW, 2002, NAT CELL BIOL, V4, pE280, DOI 10.1038/ncb1202-e280; Putney JW, 2001, J CELL SCI, V114, P2223; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Roberton CA, 2000, EXP NEPHROL, V8, P194; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Taylor CW, 1998, TRENDS PHARMACOL SCI, V19, P370, DOI 10.1016/S0165-6147(98)01243-7; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Vinuesa CG, 2004, IMMUNITY, V20, P669, DOI 10.1016/j.immuni.2004.05.012; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wen RR, 2002, J IMMUNOL, V169, P6743, DOI 10.4049/jimmunol.169.12.6743; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Wollheim FA, 2003, SCAND J RHEUMATOL, V32, P196, DOI 10.1080/03009740310002597; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Yu CCK, 1996, J EXP MED, V183, P371, DOI 10.1084/jem.183.2.371; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998	56	121	124	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2005	22	4					451	465		10.1016/j.immuni.2005.01.018	http://dx.doi.org/10.1016/j.immuni.2005.01.018			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845450	Bronze			2022-12-18	WOS:000228909600007
J	Kuball, J; Schmitz, FW; Voss, RH; Ferreira, EA; Engel, R; Guillaume, P; Strand, S; Romero, P; Huber, C; Sherman, LA; Theobald, M				Kuball, J; Schmitz, FW; Voss, RH; Ferreira, EA; Engel, R; Guillaume, P; Strand, S; Romero, P; Huber, C; Sherman, LA; Theobald, M			Cooperation of human tumor-reactive CD4(+) and CD8(+) T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR	IMMUNITY			English	Article							WILD-TYPE; QUANTITATIVE-ANALYSIS; IN-VIVO; RECEPTOR; P53; LYMPHOCYTES; MHC; HELPER; IMMUNOTHERAPY; ERADICATION	Efficient immune attack of malignant disease requires the concerted action of both CD8(+) CTL and CD4(+) Th cells. We used human leukocyte antigen (HLA)-A*0201 (A2.1) transgenic mice, in which the mouse CD8 molecule cannot efficiently interact with the alpha3 domain of A2.1, to generate a high-affinity, CD38-independent T cell receptor (TCR) specific for a commonly expressed, tumor-associated cytotoxic T lymphocyte (CTL) epitope derived from the human p53 tumor suppressor protein. Retroviral expression of this CD8-independent, p53-specific TCR into human T cells imparted the CD8(+) T lymphocytes with broad tumor-specific CTL activity and turned CD4(+) T cells into potent tumor-reactive, p53A2.1-specific Th cells. Both T cell subsets were cooperative and interacted synergistically with dendritic cell intermediates and tumor targets. The intentional redirection of both CD4(+) Th cells and CD8(+) CTL by the same high-affinity, CD8-independent, tumor-specific TCR could provide the basis for novel broad-spectrum cancer immunotherapeutics.	Johannes Gutenberg Univ Mainz, Dept Hematol & Oncol, D-55101 Mainz, Germany; Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; Johannes Gutenberg Univ Mainz, Dept Gastroenterol, D-55101 Mainz, Germany; Hop Orthoped, Lausanne Branch, Ludwig Inst Canc Res, CH-1005 Lausanne, Switzerland; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Johannes Gutenberg University of Mainz; Ludwig Institute for Cancer Research; Johannes Gutenberg University of Mainz; Ludwig Institute for Cancer Research; Scripps Research Institute	Theobald, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept Hematol & Oncol, D-55101 Mainz, Germany.	theobald@3-med.klinik.uni-mainz.de	Romero, Pedro/S-6015-2017	Romero, Pedro/0000-0002-9688-2882; Sherman, Linda/0000-0001-6422-7069				Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Berger C, 2004, BLOOD, V103, P1261, DOI 10.1182/blood-2003-08-2908; Berger C, 2001, J VIROL, V75, P799, DOI 10.1128/JVI.75.2.799-808.2001; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Card KF, 2004, CANCER IMMUNOL IMMUN, V53, P345, DOI 10.1007/s00262-003-0450-3; Cawthon AG, 2002, J IMMUNOL, V169, P3492, DOI 10.4049/jimmunol.169.7.3492; Chamoto K, 2004, CANCER RES, V64, P386, DOI 10.1158/0008-5472.CAN-03-2596; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Freedman DA, 1999, CANCER RES, V59, P1; GILL RG, 1989, J IMMUNOL, V143, P4009; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; Heemskerk MHM, 2003, BLOOD, V102, P3530, DOI 10.1182/blood-2003-05-1524; Ho WY, 2002, J CLIN INVEST, V110, P1415, DOI 10.1172/JCI200217214; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Holmberg K, 2003, J IMMUNOL, V171, P2427, DOI 10.4049/jimmunol.171.5.2427; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kessels HWHC, 2000, P NATL ACAD SCI USA, V97, P14578, DOI 10.1073/pnas.97.26.14578; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Kuball J, 2002, GENE THER, V9, P833, DOI 10.1038/sj.gt.3301709; Kuckelkorn U, 2002, EUR J IMMUNOL, V32, P1368, DOI 10.1002/1521-4141(200205)32:5<1368::AID-IMMU1368>3.0.CO;2-Z; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lotz C, 2004, INT J CANCER, V108, P571, DOI 10.1002/ijc.11602; Luznik L, 2001, BLOOD, V98, P3456, DOI 10.1182/blood.V98.12.3456; Melief CJM, 2000, ADV IMMUNOL, V75, P235, DOI 10.1016/S0065-2776(00)75006-1; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Pittet MJ, 2003, J IMMUNOL, V171, P1844, DOI 10.4049/jimmunol.171.4.1844; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; Roszkowski JJ, 2003, J IMMUNOL, V170, P2582, DOI 10.4049/jimmunol.170.5.2582; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SHERMAN LA, 1992, SCIENCE, V258, P815, DOI 10.1126/science.1439792; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; STAUSS HJ, 1998, IMMUNOL TODAY, V20, P193; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Theobald M, 1995, P NATL ACAD SCI USA, V92, P11993, DOI 10.1073/pnas.92.26.11993; Theobald M, 1997, J EXP MED, V185, P833, DOI 10.1084/jem.185.5.833; Theobald M, 1998, J EXP MED, V188, P1017, DOI 10.1084/jem.188.6.1017; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Vierboom MPM, 2000, CANCER RES, V60, P5508; Vierboom MPM, 1997, J EXP MED, V186, P695, DOI 10.1084/jem.186.5.695; Wroblewski VJ, 2003, BIOCHEM PHARMACOL, V65, P657, DOI 10.1016/S0006-2952(02)01612-X; Zwaveling S, 2002, CANCER RES, V62, P6187	53	121	130	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2005	22	1					117	129		10.1016/j.immuni.2004.12.005	http://dx.doi.org/10.1016/j.immuni.2004.12.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664164	Bronze			2022-12-18	WOS:000226682900012
J	Carpino, N; Turner, S; Mekala, D; Takahashi, Y; Zang, HS; Geiger, TL; Doherty, P; Ihle, JN				Carpino, N; Turner, S; Mekala, D; Takahashi, Y; Zang, HS; Geiger, TL; Doherty, P; Ihle, JN			Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2	IMMUNITY			English	Article							T-CELL-ACTIVATION; NEGATIVE REGULATION; ADAPTER PROTEINS; ANTIGEN RECEPTOR; CBL-B; AUTOIMMUNE ENCEPHALOMYELITIS; TYROSINE KINASES; IMMUNE-SYSTEM; SELECTION; TRANSDUCTION	T cells play a central role in the recognition and elimination of foreign pathogens. Signals through the T cell receptor (TCR) control the extent and duration of the T cell response. To ensure that T cells are not inappropriately activated, signaling pathways downstream of the TCR are subject to multiple levels of positive and negative regulation. Herein, we describe two related proteins, Sts-1 and Sts-2, that negatively regulate TCR signaling. T cells from mice lacking Sts-1 and Sts-2 are hyperresponsive to TCR stimulation. The phenotype is accompanied by increased Zap-70 phosphorylation and activation, including its ubiquitinylated forms. Additionally, hyperactivation of signaling proteins downstream of the TCR, a marked increase in cytokine production by Sts1/2(-/-) T cells, and increased susceptibility to autoimmunity in a mouse model of multiple sclerosis is observed. Therefore, Sts-1 and Sts-2 are critical regulators of the signaling pathways that regulate T cell activation.	St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Ihle, JN (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.ihle@stjude.org	Turner, Stephen/GXM-4654-2022; Geiger, Terrence/M-4516-2018; Doherty, Peter Charles/C-4185-2013	Geiger, Terrence/0000-0001-8290-5732; Doherty, Peter Charles/0000-0002-5028-3489; Turner, Stephen/0000-0002-1002-0000	NATIONAL CANCER INSTITUTE [F32CA083269, P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042932] Funding Source: NIH RePORTER; NCI NIH HHS [5-F32-CA83269, CA21765] Funding Source: Medline; NHLBI NIH HHS [P01 HL53749] Funding Source: Medline; NIDDK NIH HHS [R01 DK 42932] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Elder ME, 1998, SEMIN HEMATOL, V35, P310; Finco TS, 1999, COLD SPRING HARB SYM, V64, P265, DOI 10.1101/sqb.1999.64.265; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Germain RN, 2001, J BIOL CHEM, V276, P35223, DOI 10.1074/jbc.R100025200; HOFFMAN K, 1996, TRENDS BIOCHEM SCI, V21, P172; Holloway AF, 2002, MOL IMMUNOL, V38, P567, DOI 10.1016/S0161-5890(01)00094-3; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Leitenberg D, 2001, SEMIN IMMUNOL, V13, P129, DOI 10.1006/smim.2000.0304; Liu YC, 2002, TRENDS IMMUNOL, V23, P140, DOI 10.1016/S1471-4906(01)02157-3; MILLS S, 1998, CHI TRIB        0110, P1; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Ohashi PS, 2002, NAT REV IMMUNOL, V2, P427, DOI 10.1038/nri822; Ohashi PS, 2002, CURR OPIN IMMUNOL, V14, P744, DOI 10.1016/S0952-7915(02)00406-5; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551; Tomlinson MG, 2000, IMMUNOL TODAY, V21, P584, DOI 10.1016/S0167-5699(00)01716-3; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Willenborg DO, 2003, ADV EXP MED BIOL, V520, P96; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	36	121	124	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2004	20	1					37	46		10.1016/S1074-7613(03)00351-0	http://dx.doi.org/10.1016/S1074-7613(03)00351-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738763	Bronze			2022-12-18	WOS:000221442200005
J	Schweighoffer, E; Vanes, L; Mathiot, A; Nakamura, T; Tybulewicz, VLJ				Schweighoffer, E; Vanes, L; Mathiot, A; Nakamura, T; Tybulewicz, VLJ			Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; IMMUNOGLOBULIN GENE REARRANGEMENT; LIGHT-CHAIN EXPRESSION; HEAVY-CHAIN; DEFICIENT MICE; TARGETED DISRUPTION; MEMBRANE EXON; RECEPTOR; SYK; DIFFERENTIATION	ZAP-70, a member of the Syk family of tyrosine kinases, has been reported to be expressed exclusively in T and NK cells. We show here that it is expressed throughout B cell development and that it plays a role in the transition of pro-B to pre-B cells in the bone marrow, a checkpoint controlled by signals from the pre-B cell receptor (pre-BCR), which monitors for successful rearrangement of immunoglobulin heavy chain genes. Whereas mice deficient in Syk show a partial block at this step, mice mutant in both Syk and ZAP-70 show a complete block at the pro-B cell stage and a failure of heavy chain allelic exclusion, hallmarks of defective pre-BCR signaling.	Natl Inst Med Res, London NW7 1AA, England; Univ Tokyo, Inst Med Sci, Dept Infect Dis & Appl Immunol, Tokyo 108, Japan	MRC National Institute for Medical Research; University of Tokyo	Tybulewicz, VLJ (corresponding author), Natl Inst Med Res, Mill Hill,The Ridgeway, London NW7 1AA, England.			Tybulewicz, Victor/0000-0003-2439-0798				CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Chen L, 1997, J I ENERGY, V70, P2; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Cornall RJ, 2000, P NATL ACAD SCI USA, V97, P1713, DOI 10.1073/pnas.97.4.1713; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; Gong Q, 1997, IMMUNITY, V7, P369, DOI 10.1016/S1074-7613(00)80358-1; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Iritani BM, 1999, IMMUNITY, V10, P713, DOI 10.1016/S1074-7613(00)80070-9; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KONG GH, 1995, IMMUNITY, V2, P485, DOI 10.1016/1074-7613(95)90029-2; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; Martensson IL, 2002, SEMIN IMMUNOL, V14, P335, DOI 10.1016/S1044-5323(02)00066-0; MINAMI Y, 1995, IMMUNITY, V2, P89, DOI 10.1016/1074-7613(95)90081-0; Mundt C, 2001, J EXP MED, V193, P435, DOI 10.1084/jem.193.4.435; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13; Rolink AG, 2001, CURR OPIN IMMUNOL, V13, P202, DOI 10.1016/S0952-7915(00)00205-3; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; ten Boekel E, 1998, IMMUNITY, V8, P199; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	39	121	130	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2003	18	4					523	533		10.1016/S1074-7613(03)00082-7	http://dx.doi.org/10.1016/S1074-7613(03)00082-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705855	Bronze			2022-12-18	WOS:000182353900008
J	Surh, CD; Lee, DS; FungLeung, WP; Karlsson, L; Sprent, J				Surh, CD; Lee, DS; FungLeung, WP; Karlsson, L; Sprent, J			Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4(+) T cells	IMMUNITY			English	Article							RECEPTOR TRANSGENIC MICE; EARLY CELLULAR EVENTS; VS-HOST REACTION; POSITIVE SELECTION; CLASS-II; RECIRCULATING LYMPHOCYTES; ANTIGEN PRESENTATION; NEGATIVE SELECTION; THYMOCYTES; TOLERANCE	The influence of individual peptides in thymic selection was examined in H2-M- mice, in which positive selection is directed to a single peptide, class Ii-associated invariant chain peptide (CLIP) bound to H2-A(b). Two sensitive in vivo approaches showed that 70%-80% of CD4(+) T cells undergoing positive selection to CLIP+H2-A(b) have self-reactivity to the various peptides expressed on wild-type H2-M+ antigen-presenting cells. When these self-reactive T cells were depleted, the residual CD4(+) cells displayed a polyclonal repertoire in terms of alloreactivity, responses to foreign protein antigens, and V beta usage. Nevertheless, studies with two T cell receptor transgenic lines suggested that the repertoire of CD4(+) cells induced by CLIP was less diverse than the repertoire of CD4(+) cells in normal mice. Generation of a fully diverse T cell repertoire thus requires positive selection against multiple peptides.	RW JOHNSON PHARMACEUT RES INST, SAN DIEGO, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA	Surh, CD (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.		Lee, Dong-Sup/J-2777-2012	Fung-Leung, Wai-Ping/0000-0001-7013-8855	NATIONAL CANCER INSTITUTE [R01CA038355, P01CA025803, R37CA038355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038385] Funding Source: NIH RePORTER; NCI NIH HHS [CA25803, CA38355] Funding Source: Medline; NIAID NIH HHS [AI38385] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ATKINS RC, 1975, J EXP MED, V141, P664, DOI 10.1084/jem.141.3.664; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BYRNE JA, 1988, J IMMUNOL, V141, P3249; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; FORD WL, 1975, J EXP MED, V141, P681, DOI 10.1084/jem.141.3.681; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GAO EK, 1990, J EXP MED, V171, P1101, DOI 10.1084/jem.171.4.1101; GAO EK, 1989, J EXP MED, V170, P1947, DOI 10.1084/jem.170.6.1947; HOGQUIST KA, 1994, CURR OPIN IMMUNOL, V6, P273, DOI 10.1016/0952-7915(94)90101-5; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAUFER TM, 1996, NATURE, V383, P81; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISHIMOTO H, 1995, J EXP MED, V181, P649, DOI 10.1084/jem.181.2.649; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KOSAKA H, 1992, J EXP MED, V176, P1291, DOI 10.1084/jem.176.5.1291; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; Pawlowski TJ, 1996, EUR J IMMUNOL, V26, P851, DOI 10.1002/eji.1830260419; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; ROWLEY DA, 1972, J EXP MED, V136, P499, DOI 10.1084/jem.136.3.499; SCHUMACHER TNM, 1994, IMMUNITY, V1, P721, DOI 10.1016/S1074-7613(94)80013-8; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Shimizu T, 1997, EUR J IMMUNOL, V27, P500, DOI 10.1002/eji.1830270222; SPRENT J, 1994, J EXP MED, V180, P307, DOI 10.1084/jem.180.1.307; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; SPRENT J, 1973, CELL IMMUNOL, V7, P10, DOI 10.1016/0008-8749(73)90180-9; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; SPRENT J, 1985, J EXP MED, V162, P2068, DOI 10.1084/jem.162.6.2068; SPRENT J, 1976, J EXP MED, V143, P585, DOI 10.1084/jem.143.3.585; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WEBB SR, 1990, J EXP MED, V171, P953, DOI 10.1084/jem.171.3.953; WILSON DB, 1968, J EXP MED, V128, P1157, DOI 10.1084/jem.128.5.1157; YOKOYAMA WM, 1988, J IMMUNOL, V141, P369	47	121	121	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					209	219		10.1016/S1074-7613(00)80524-5	http://dx.doi.org/10.1016/S1074-7613(00)80524-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285406	Bronze			2022-12-18	WOS:A1997XT49200005
J	Bogue, MA; Wang, CY; Zhu, CM; Roth, DB				Bogue, MA; Wang, CY; Zhu, CM; Roth, DB			V(D)J recombination in Ku86-deficient mice: Distinct effects on coding, signal, and hybrid joint formation	IMMUNITY			English	Article							STRAND BREAK REPAIR; DEPENDENT PROTEIN-KINASE; TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; BROKEN DNA-MOLECULES; MOUSE THYMOCYTES; JUNCTIONAL DIVERSITY; NUCLEOTIDE INSERTION; MAMMALIAN-CELLS; HIGH-FREQUENCY; KU PROTEIN	Ku, a heterodimer of 70 and 86 kDa subunits, plays a critical but poorly understood role in V(D)J recombination. Although Ku86-deficient mice are defective in coding and signal joint formation, rare recombination products have been detected by PCR. Here, we report nucleotide sequences of 99 junctions from Ku86-deficient mice. Over 90% of the coding joints, but not signal or hybrid joints, exhibit short sequence homologies, indicating that homology is required to join coding ends in the absence of Ku86. Our results suggest that Ku86 may normally have distinct functions in the formation of these different types of junctions. Furthermore, Ku86(-/-) joints are unexpectedly devoid of N-region diversity, suggesting a novel role for Ku in the addition of N nucleotides by terminal deoxynucleotidyl transferase.	BAYLOR COLL MED,DEPT MICROBIOL & IMMUNOL,HOUSTON,TX 77030	Baylor College of Medicine					NIAID NIH HHS [T32-AI07495] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007495] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Araki R, 1996, INT IMMUNOL, V8, P1045, DOI 10.1093/intimm/8.7.1045; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BOGUE M, 1992, P NATL ACAD SCI USA, V89, P11011, DOI 10.1073/pnas.89.22.11011; Bogue M, 1996, CURR OPIN IMMUNOL, V8, P175, DOI 10.1016/S0952-7915(96)80055-0; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Candeias S, 1996, J EXP MED, V184, P1919, DOI 10.1084/jem.184.5.1919; CARROLL AM, 1993, MOL CELL BIOL, V13, P3632, DOI 10.1128/MCB.13.6.3632; CARROLL AM, 1993, J IMMUNOL, V150, P2222; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; COLEMAN M S, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P237; Danska JS, 1996, MOL CELL BIOL, V16, P5507; EASTMAN OM, 1996, NATURE, V380, P85; Feeney A J, 1994, Semin Immunol, V6, P155, DOI 10.1006/smim.1994.1021; FEENEY AJ, 1992, J IMMUNOL, V149, P222; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; FISH SM, 1994, MOL CELL BIOL, V14, P4455, DOI 10.1128/MCB.14.7.4455; GERSTEIN RM, 1993, NATURE, V363, P625, DOI 10.1038/363625a0; GETTS RC, 1994, J BIOL CHEM, V269, P15981; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Han JO, 1997, MOL CELL BIOL, V17, P2226, DOI 10.1128/MCB.17.4.2226; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; KIENKER LJ, 1991, J EXP MED, V174, P769, DOI 10.1084/jem.174.4.769; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; LEWIS SM, 1988, CELL, V55, P1099, DOI 10.1016/0092-8674(88)90254-1; LEWIS SM, 1991, EMBO J, V10, P3631, DOI 10.1002/j.1460-2075.1991.tb04929.x; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LEWIS SM, 1994, P NATL ACAD SCI USA, V91, P1332, DOI 10.1073/pnas.91.4.1332; LI GC, 1995, P NATL ACAD SCI USA, V92, P4512, DOI 10.1073/pnas.92.10.4512; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Liang F, 1996, J BIOL CHEM, V271, P14405, DOI 10.1074/jbc.271.24.14405; LIEBER MR, 1988, P NATL ACAD SCI USA, V85, P8588, DOI 10.1073/pnas.85.22.8588; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; LIEBER MR, 1992, CELL, V70, P873, DOI 10.1016/0092-8674(92)90237-7; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MEIER JT, 1993, MOL CELL BIOL, V13, P1078, DOI 10.1128/MCB.13.2.1078; MIMORI T, 1986, J BIOL CHEM, V261, P375; Mizuta R, 1996, INT IMMUNOL, V8, P1467, DOI 10.1093/intimm/8.9.1467; MOROZOV VE, 1994, J BIOL CHEM, V269, P16684; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; PENNYCOOK JL, 1993, J EXP MED, V178, P1007, DOI 10.1084/jem.178.3.1007; PERGOLA F, 1993, MOL CELL BIOL, V13, P3464, DOI 10.1128/MCB.13.6.3464; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; ROTH DB, 1989, MOL CELL BIOL, V9, P3049, DOI 10.1128/MCB.9.7.3049; ROTH DB, 1992, CELL, V69, P41, DOI 10.1016/0092-8674(92)90117-U; ROTH DB, 1995, CURR BIOL, V5, P496, DOI 10.1016/S0960-9822(95)00101-1; ROTH DB, 1985, MOL CELL BIOL, V5, P2599, DOI 10.1128/MCB.5.10.2599; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SCHULER W, 1991, EUR J IMMUNOL, V21, P589, DOI 10.1002/eji.1830210309; SOLLBACH AE, 1995, MOL CELL BIOL, V15, P671; Steen SB, 1996, GENES CELLS, V1, P543; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; TILLINGHAST JP, 1989, J IMMUNOL, V143, P2378; VanDyk LF, 1996, J IMMUNOL, V157, P4005; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; ZHANG Y, 1995, IMMUNITY, V3, P439, DOI 10.1016/1074-7613(95)90173-6; ZHU CM, 1995, IMMUNITY, V2, P101, DOI 10.1016/1074-7613(95)90082-9; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	74	121	122	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					37	47		10.1016/S1074-7613(00)80508-7	http://dx.doi.org/10.1016/S1074-7613(00)80508-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252118	Bronze			2022-12-18	WOS:A1997XN69300004
J	DANIELS, BF; NAKAMURA, MC; ROSEN, SD; YOKOYAMA, WM; SEAMAN, WE				DANIELS, BF; NAKAMURA, MC; ROSEN, SD; YOKOYAMA, WM; SEAMAN, WE			LY-49A, A RECEPTOR FOR H-2D(D), HAS A FUNCTIONAL CARBOHYDRATE-RECOGNITION DOMAIN	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; LOW AFFINITY RECEPTOR; HAMSTER OVARY CELLS; LINKED OLIGOSACCHARIDES; MEMBRANE-PROTEINS; HOMING RECEPTOR; HLA-C; RESISTANCE; BINDING; GLYCOSYLATION	Ly-49A(+) murine natural killer (NK) cells cannot lyse target cells that express H-2D(d). We demonstrate a functional requirement for carbohydrate recognition by Ly-49A. Treatment of H-2D(d+) target cells with tunicamycin prevents their binding to Ly-49A(+) cells and renders them susceptible to lysis by Ly-49A(+) NK cells. Fucoidan, a sulfated polysaccharide, binds to Ly-49A in a calcium-dependent manner, and this binding is inhibited by monosaccharides, particularly sulfated hexoses. The inactivation of Ly-49A(+) NK cells by H-2D(d+) target cells is reversed in the presence of glucose 6-SO4. These results indicate that Ly-49A has a functional carbohydrate recognition domain and that target expression of carbohydrates alters their susceptibility to natural killing.	UNIV CALIF SAN FRANCISCO, DEPT IMMUNOL MICROBIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA; DEPT VET AFFAIRS HOSP, SAN FRANCISCO, CA 94121 USA; MT SINAI MED CTR, HOWARD HUGHES MED INST, DEPT MED, NEW YORK, NY 10029 USA; MT SINAI MED CTR, HOWARD HUGHES MED INST, DEPT MICROBIOL, NEW YORK, NY 10029 USA; MT SINAI MED CTR, BROOKDALE CTR MOLEC BIOL, NEW YORK, NY 10029 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	DANIELS, BF (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA.		Nakamura, Mary/ABI-2887-2020	Nakamura, Mary/0000-0001-8127-9426	NCI NIH HHS [CA46812] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046812] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHRENS PB, 1987, J BIOL CHEM, V262, P7575; AHRENS PB, 1988, BIOCHIMIE, V70, P1619, DOI 10.1016/0300-9084(88)90297-0; ASHFORD DA, 1993, J BIOL CHEM, V268, P3260; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BEZOUSKA K, 1994, J BIOL CHEM, V269, P16945; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; CONRAD DH, 1990, ANNU REV IMMUNOL, V8, P623, DOI 10.1146/annurev.immunol.8.1.623; CORR M, 1993, J EXP MED, V178, P1877, DOI 10.1084/jem.178.6.1877; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GLABE CG, 1983, ANAL BIOCHEM, V130, P287, DOI 10.1016/0003-2697(83)90590-0; GOOCHEE CF, 1990, BIO-TECHNOL, V8, P421, DOI 10.1038/nbt0590-421; GOOCHEE CF, 1991, BIO-TECHNOL, V9, P1347, DOI 10.1038/nbt1291-1347; HAHN TJ, 1992, J BIOL CHEM, V267, P23982; IMAI Y, 1990, J CELL BIOL, V111, P1225, DOI 10.1083/jcb.111.3.1225; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1992, T ASSOC AM PHYSICIAN, V105, P72; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MURAMATSU T, 1993, GLYCOBIOLOGY, V3, P294; PATANKAR MS, 1993, J BIOL CHEM, V268, P21770; PIONTEK GE, 1985, J IMMUNOL, V135, P4281; POCHON S, 1992, J EXP MED, V176, P389, DOI 10.1084/jem.176.2.389; POHAJDAK B, 1986, J NATL CANCER I, V76, P257; PULLEN JK, 1992, J IMMUNOL, V148, P953; QUILLET A, 1988, J IMMUNOL, V141, P17; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; RYAN JC, 1991, J IMMUNOL, V147, P3244; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; SIEGELMAN MH, 1990, CELL, V61, P611, DOI 10.1016/0092-8674(90)90473-R; SMITH HRC, 1994, J IMMUNOL, V153, P1068; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; STORKUS WJ, 1989, J IMMUNOL, V143, P3853; STORKUS WJ, 1991, P NATL ACAD SCI USA, V88, P5989, DOI 10.1073/pnas.88.14.5989; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; VOSHOL H, 1993, GLYCOBIOLOGY, V3, P69, DOI 10.1093/glycob/3.1.69; Wagtmann Nicolai, 1994, Natural Immunity, V13, P195; WONG S, 1991, J IMMUNOL, V147, P1417; YEDNOCK TA, 1987, J CELL BIOL, V104, P713, DOI 10.1083/jcb.104.3.713; YEDNOCK TA, 1987, J CELL BIOL, V104, P725, DOI 10.1083/jcb.104.3.725; YOKOYAMA WM, 1989, J IMMUNOL, V143, P1379; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; YUEN CT, 1992, BIOCHEMISTRY-US, V31, P9126, DOI 10.1021/bi00153a003	46	121	123	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1994	1	9					785	792		10.1016/S1074-7613(94)80020-0	http://dx.doi.org/10.1016/S1074-7613(94)80020-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX648	7895167				2022-12-18	WOS:A1994PX64800008
J	Schneider, C; Lee, J; Koga, S; Ricardo-Gonzalez, RR; Nussbaum, JC; Smith, LK; Villeda, SA; Liang, HE; Locksley, RM				Schneider, Christoph; Lee, Jinwoo; Koga, Satoshi; Ricardo-Gonzalez, Roberto R.; Nussbaum, Jesse C.; Smith, Lucas K.; Villeda, Saul A.; Liang, Hong-Erh; Locksley, Richard M.			Tissue-Resident Group 2 Innate Lymphoid Cells Differentiate by Layered Ontogeny and In Situ Perinatal Priming	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; TYPE-2 IMMUNITY; T-CELLS; ACTIVATION; PROGENITOR; LINEAGE; MAINTENANCE; PLASTICITY; PATHWAYS; PROTEIN	The perinatal period is a critical window for distribution of innate tissue-resident immune cells within developing organs. Despite epidemiologic evidence implicating the early-life environment in the risk for allergy, temporally controlled lineage tracing of group 2 innate lymphoid cells (ILC2s) during this period remains unstudied. Using complementary fate-mapping approaches and reporters for ILC2 activation, we show that ILC2s appeared in multiple organs during late gestation like tissue macro-phages, but, unlike the latter, a majority of peripheral ILC2 pools were generated de novo during the postnatal window. This period was accompanied by systemic ILC2 priming and acquisition of tissue-specific transcriptomes. Although perinatal ILC2s were variably replaced across tissues with age, the dramatic increases in tissue ILC2s following helminth infection were mediated through local expansion independent of de novo generation by bone marrow hematopoiesis. We provide comprehensive temporally controlled fate mapping of an innate lymphocyte subset with notable nuances as compared to tissue macrophage ontogeny.	[Schneider, Christoph; Lee, Jinwoo; Koga, Satoshi; Nussbaum, Jesse C.; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ricardo-Gonzalez, Roberto R.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Smith, Lucas K.; Villeda, Saul A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Nussbaum, Jesse C.] Merck Res Labs, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Merck & Company	Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	richard.locksley@ucsf.edu	Lee, Jinwoo/AAA-9510-2020	Lee, Jinwoo/0000-0003-2991-4183; Schneider, Christoph/0000-0002-0452-2960; Ricardo-Gonzalez, Roberto/0000-0002-6135-4035	NIH [R01AI026918, R01HL128903, P01HL107202, F30AI122702, T32GM007618]; Howard Hughes Medical Institute; Australian NHMRC [APP1143020]; Sandler Asthma Basic Research Center at UCSF; Swiss National Science Foundation [P2EZP3_162266, P300PA_171591]; Dermatology Foundation; A.P. Giannini Foundation; Robert Wood Johnson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, R01HL128903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, T32AI007334, F30AI122702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sandler Asthma Basic Research Center at UCSF; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Dermatology Foundation; A.P. Giannini Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Wang, M. Ji, and M. Consengco for technical expertise; members of the Locksley laboratory for discussions; M. Ansel and L. Lanier for manuscript comments; A.Y. Rudensky for providing the tdTomato-T2A-CreERT2 cassette; A.V. Molofsky for providing Il7r<SUP>-/-</SUP>mice; J. Turnbaugh and the UCSF Gnotobiotic Core Facility for germfree mice; DRC NIH P30 DK63720 for gene targeting; A.B Molofsky and S. van Dyken for assistance with cell isolation; and D. Vaka for assistance with scRNA-seq data analysis. This work was supported by the NIH (grants R01AI026918, R01HL128903, and P01HL107202 to R.M.L. and grants F30AI122702 and T32GM007618 to J.L.), the Howard Hughes Medical Institute, the Australian NHMRC (grant APP1143020), and the Sandler Asthma Basic Research Center at UCSF. C.S. is supported by fellowships from the Swiss National Science Foundation (P2EZP3_162266; P300PA_171591). R.R.R.-G. is supported by grants from the Dermatology Foundation, the A.P. Giannini Foundation, and the Robert Wood Johnson Foundation.	Baglama J, 2005, SIAM J SCI COMPUT, V27, P19, DOI 10.1137/04060593X; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bando JK, 2013, J LEUKOCYTE BIOL, V94, P877, DOI 10.1189/jlb.0213084; Beaudin AE, 2016, BLOOD, V128, P2765, DOI 10.1182/blood-2016-10-697813; Beaudin AE, 2016, CELL STEM CELL, V19, P768, DOI 10.1016/j.stem.2016.08.013; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Ebbo M, 2017, NAT REV IMMUNOL, V17, P665, DOI 10.1038/nri.2017.86; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Ghaedi M, 2016, CELL REP, V15, P471, DOI 10.1016/j.celrep.2016.03.039; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gollwitzer ES, 2015, TRENDS IMMUNOL, V36, P684, DOI 10.1016/j.it.2015.09.009; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koga S, 2018, J EXP MED, V215, P1609, DOI 10.1084/jem.20172310; Kotas ME, 2018, IMMUNITY, V48, P1081, DOI 10.1016/j.immuni.2018.06.002; Lambrecht BN, 2017, NAT IMMUNOL, V18, P1076, DOI 10.1038/ni.3829; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; McGrath KE, 2015, SEMIN IMMUNOL, V27, P379, DOI 10.1016/j.smim.2016.03.013; Montecino-Rodriguez E, 2016, IMMUNITY, V45, P527, DOI 10.1016/j.immuni.2016.07.012; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Pawankar R, 2011, WAO WHITE BOOK ALLER; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Smith NL, 2018, CELL, V174, P117, DOI 10.1016/j.cell.2018.05.029; Steer CA, 2017, J ALLERGY CLIN IMMUN, V140, P593, DOI 10.1016/j.jaci.2016.12.984; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	63	120	121	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1425	+		10.1016/j.immuni.2019.04.019	http://dx.doi.org/10.1016/j.immuni.2019.04.019			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31128962	Bronze, Green Accepted			2022-12-18	WOS:000471876100014
J	O'Koren, EG; Yu, C; Klingeborn, M; Wong, AYW; Prigge, CL; Mathew, R; Kalnitsky, J; Msallam, RA; Silvin, A; Kay, JN; Rickman, CB; Arshavsky, VY; Ginhoux, F; Merad, M; Saban, DR				O'Koren, Emily G.; Yu, Chen; Klingeborn, Mikael; Wong, Alicia Y. W.; Prigge, Cameron L.; Mathew, Rose; Kalnitsky, Joan; Msallam, Rasha A.; Silvin, Aymeric; Kay, Jeremy N.; Rickman, Catherine Bowes; Arshavsky, Vadim Y.; Ginhoux, Florent; Merad, Miriam; Saban, Daniel R.			Microglial Function Is Distinct in Different Anatomical Locations during Retinal Homeostasis and Degeneration	IMMUNITY			English	Article							GENE-EXPRESSION SIGNATURE; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; ACTIVATED MICROGLIA; LANGERHANS CELLS; ADULT MICROGLIA; GANGLION-CELL; MOUSE; MAINTENANCE; REGION	Microglia from different nervous system regions are molecularly and anatomically distinct, but whether they also have different functions is unknown. We combined lineage tracing, single-cell transcriptomics, and electrophysiology of the mouse retina and showed that adult retinal microglia shared a common developmental lineage and were long-lived but resided in two distinct niches. Microglia in these niches differed in their interleukin-34 dependency and functional contribution to visual-information processing. During certain retinal-degeneration models, microglia from both pools relocated to the subretinal space, an inducible disease-associated niche that was poorly accessible to monocyte-derived cells. This microglial transition involved transcriptional reprogramming of microglia, characterized by reduced expression of homeostatic checkpoint genes and upregulation of injury-responsive genes. This transition was associated with protection of the retinal pigmented epithelium from damage caused by disease. Together, our data demonstrate that microglial function varies by retinal niche, thereby shedding light on the significance of microglia heterogeneity.	[O'Koren, Emily G.; Yu, Chen; Klingeborn, Mikael; Mathew, Rose; Kalnitsky, Joan; Kay, Jeremy N.; Rickman, Catherine Bowes; Arshavsky, Vadim Y.; Saban, Daniel R.] Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA; [Wong, Alicia Y. W.; Msallam, Rasha A.; Silvin, Aymeric; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Prigge, Cameron L.; Kay, Jeremy N.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Arshavsky, Vadim Y.] Duke Univ, Dept Pharmacol, Durham, NC 27710 USA; [Rickman, Catherine Bowes] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Saban, Daniel R.] Duke Univ, Dept Immunol, Durham, NC 27710 USA	Duke University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Duke University; Duke University; Duke University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Duke University	Saban, DR (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA.; Saban, DR (corresponding author), Duke Univ, Dept Immunol, Durham, NC 27710 USA.	daniel.saban@duke.edu	Klingeborn, Mikael/AAC-2471-2019; Yu, Chen/GPG-1530-2022	Klingeborn, Mikael/0000-0003-2907-0371; Yu, Chen/0000-0001-9651-9875; Wong, Alicia Yoke Wei/0000-0003-1169-7766; Bowes Rickman, Catherine/0000-0002-8555-9596	Bright Focus MDR [R01EY021798, P30EY005722, R01EY022959, R01EY026161]; Bright Focus PFA; Research to Prevent Blindness (Duke Eye Center); Singapore grant [NRF2016NRF-NRFI001-02]; SIgN core funding; NATIONAL EYE INSTITUTE [R01EY021798, R01EY024694, P30EY005722, R01EY026161, R01EY030611] Funding Source: NIH RePORTER	Bright Focus MDR(BrightFocus Foundation); Bright Focus PFA; Research to Prevent Blindness (Duke Eye Center); Singapore grant; SIgN core funding; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by Bright Focus MDR (D.R.S.), R01EY021798 (D.R.S.), P30EY005722 (Duke Eye Center), R01EY022959 (V.Y.A.), R01EY026161 (C.B.R.), Bright Focus PFA (M.K.), and Research to Prevent Blindness (Duke Eye Center). F.G. is an EMBO YIP awardee and is supported by SIgN core funding and a Singapore NRF2016NRF-NRFI001-02 grant. We would like to acknowledge the assistance of the Duke Molecular Physiology Institute Molecular Genomics core for the generation of data for the manuscript. We thank S. Finkelstein and E. Lobanova for provision of mice, P. Saloupis for help with OCT, and Y. Hao for TEM (Duke Eye Center). We thank S. Koh (Eroglu lab, Duke) for help with synapse quantification and B. Hogan (Duke) for gifting Rosa<SUP>R26R-fGFP</SUP> mice.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; Brown NL, 2001, DEVELOPMENT, V128, P2497; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Calippe B, 2017, IMMUNITY, V46, P261, DOI 10.1016/j.immuni.2017.01.006; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Danciger M, 2003, INVEST OPHTH VIS SCI, V44, P2442, DOI 10.1167/iovs.02-1252; De Biase LM, 2017, NEURON, V95, P341, DOI 10.1016/j.neuron.2017.06.020; De Haas AH, 2008, GLIA, V56, P888, DOI 10.1002/glia.20663; Diamond JS, 2017, ANNU REV VIS SCI, V3, P1, DOI 10.1146/annurev-vision-102016-061345; DICK AD, 1995, BRIT J OPHTHALMOL, V79, P834, DOI 10.1136/bjo.79.9.834; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Guziewicz KE, 2018, P NATL ACAD SCI USA, V115, pE2839, DOI 10.1073/pnas.1720662115; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Herrmann R, 2010, J NEUROSCI, V30, P3239, DOI 10.1523/JNEUROSCI.4775-09.2010; HOFFMAN AL, 1989, SURGERY, V106, P354; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Ippolito D.M., 2010, J VIS EXP, P2270; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jinno S, 2007, GLIA, V55, P1334, DOI 10.1002/glia.20552; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Koh S, 2018, J NEUROSCI, V38, P2923, DOI 10.1523/JNEUROSCI.1532-17.2018; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma WX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08702-7; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; McKay GJ, 2011, HUM MUTAT, V32, P1407, DOI 10.1002/humu.21577; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noell W K, 1966, Invest Ophthalmol, V5, P450; O'Koren EG, 2016, SCI REP-UK, V6, DOI 10.1038/srep20636; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reyes NJ, 2017, NAT REV IMMUNOL, V17, P322, DOI 10.1038/nri.2017.13; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scheetz TE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156001; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; THANOS S, 1992, BRAIN RES, V588, P21, DOI 10.1016/0006-8993(92)91340-K; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Toomey CB, 2015, P NATL ACAD SCI USA, V112, pE3040, DOI 10.1073/pnas.1424391112; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; VELA JM, 1995, J COMP NEUROL, V361, P602, DOI 10.1002/cne.903610405; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang X, 2016, J NEUROSCI, V36, P2827, DOI 10.1523/JNEUROSCI.3575-15.2016; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15711; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P971, DOI 10.1167/iovs.03-0301	71	120	123	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					723	+		10.1016/j.immuni.2019.02.007	http://dx.doi.org/10.1016/j.immuni.2019.02.007			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30850344	Green Accepted, Bronze			2022-12-18	WOS:000461660500021
J	Durek, P; Nordstroem, K; Gasparoni, G; Salhab, A; Kressler, C; De Almeida, M; Bassler, K; Ulas, T; Schmidt, F; Xiong, J; Glazar, P; Klironomos, F; Sinha, A; Kinkley, S; Yang, X; Arrigoni, L; Amirabad, AD; Ardakani, FB; Feuerbach, L; Gorka, O; Ebert, P; Mueller, F; Li, N; Frischbutter, S; Schlickeiser, S; Cendon, C; Froehler, S; Felder, B; Gasparoni, N; Imbusch, CD; Hutter, B; Zipprich, G; Tauchmann, Y; Reinke, S; Wassilew, G; Hoffmann, U; Richter, AS; Sieverling, L; Chang, HD; Syrbe, U; Kalus, U; Eils, J; Brors, B; Manke, T; Ruland, J; Lengauer, T; Rajewsky, N; Chen, W; Dong, J; Sawitzki, B; Chung, HR; Rosenstiel, P; Schulz, MH; Schultze, JL; Radbruch, A; Walter, J; Hamann, A; Polansky, JK				Durek, Pawel; Nordstroem, Karl; Gasparoni, Gilles; Salhab, Abdulrahman; Kressler, Christopher; De Almeida, Melanie; Bassler, Kevin; Ulas, Thomas; Schmidt, Florian; Xiong, Jieyi; Glazar, Petar; Klironomos, Filippos; Sinha, Anupam; Kinkley, Sarah; Yang, Xinyi; Arrigoni, Laura; Amirabad, Azim Dehghani; Ardakani, Fatemeh Behjati; Feuerbach, Lars; Gorka, Oliver; Ebert, Peter; Mueller, Fabian; Li, Na; Frischbutter, Stefan; Schlickeiser, Stephan; Cendon, Carla; Froehler, Sebastian; Felder, Baerbel; Gasparoni, Nina; Imbusch, Charles D.; Hutter, Barbara; Zipprich, Gideon; Tauchmann, Yvonne; Reinke, Simon; Wassilew, Georgi; Hoffmann, Ute; Richter, Andreas S.; Sieverling, Lina; Chang, Hyun-Dong; Syrbe, Uta; Kalus, Ulrich; Eils, Juergen; Brors, Benedikt; Manke, Thomas; Ruland, Juergen; Lengauer, Thomas; Rajewsky, Nikolaus; Chen, Wei; Dong, Jun; Sawitzki, Birgit; Chung, Ho-Ryun; Rosenstiel, Philip; Schulz, Marcel H.; Schultze, Joachim L.; Radbruch, Andreas; Walter, Joern; Hamann, Alf; Polansky, Julia K.		Deep Consortium	Epigenomic Profiling of Human CD4(+) T Cells Supports a Linear Differentiation Model and Highlights Molecular Regulators of Memory Development	IMMUNITY			English	Article							GLOBAL DNA METHYLATION; EPIGENETIC LANDSCAPE; GENE-EXPRESSION; CIRCULAR RNAS; BONE-MARROW; EFFECTOR; SUBSETS; SEQ; RESIDENT; REGIONS	The impact of epigenetics on the differentiation of memory T (Tmem) cells is poorly defined. We generated deep epigenomes comprising genome-wide profiles of DNA methylation, histone modifications, DNA accessibility, and coding and non-coding RNA expression in naive, central-, effector-, and terminally differentiated CD45RA(+) CD4(+) Tmem cells from blood and CD69(+) Tmem cells from bone marrow (BMTmem). We observed a progressive and proliferation-associated global loss of DNA methylation in heterochromatic parts of the genome during Tmem cell differentiation. Furthermore, distinct gradually changing signatures in the epigenome and the transcriptomesupported a linear model of memory development in circulating T cells, while tissue-resident BM-Tmembranched off with a unique epigenetic profile. Integrative analyses identified candidate master regulators of Tmem cell differentiation, including the transcription factor FOXP1. This study highlights the importance of epigenomic changes for Tmem cell biology and demonstrates the value of epigenetic data for the identification of lineage regulators.	[Durek, Pawel; Kressler, Christopher; De Almeida, Melanie; Frischbutter, Stefan; Hoffmann, Ute; Hamann, Alf; Polansky, Julia K.] German Rheumatism Res Ctr, Expt Rheumatol, D-10117 Berlin, Germany; [Nordstroem, Karl; Gasparoni, Gilles; Salhab, Abdulrahman; Gasparoni, Nina; Walter, Joern] Univ Saarland, Dept Genet, D-66123 Saarbrucken, Germany; [Bassler, Kevin; Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, Life & Med Sci Inst, Genom & Immunoregulat, D-53115 Bonn, Germany; [Schmidt, Florian; Amirabad, Azim Dehghani; Ardakani, Fatemeh Behjati; Ebert, Peter; Mueller, Fabian; Lengauer, Thomas; Schulz, Marcel H.] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, D-66123 Saarbrucken, Germany; [Schmidt, Florian; Amirabad, Azim Dehghani; Ardakani, Fatemeh Behjati; Schulz, Marcel H.] Univ Saarland, Excellence Cluster Multimodal Comp & Interact, D-66123 Saarbrucken, Germany; [Xiong, Jieyi; Froehler, Sebastian; Chen, Wei] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, D-13125 Berlin, Germany; [Glazar, Petar; Klironomos, Filippos; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Syst Biol Gene Regulatory Elements, D-13125 Berlin, Germany; [Sinha, Anupam; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Kinkley, Sarah; Yang, Xinyi; Li, Na; Chung, Ho-Ryun] Max Planck Inst Mol Genet, Otto Warburg Labs Epigenom, D-14195 Berlin, Germany; [Arrigoni, Laura; Richter, Andreas S.; Manke, Thomas] Max Planck Inst Immunobiol & Epigenet, D-78108 Freiburg, Germany; [Feuerbach, Lars; Imbusch, Charles D.; Hutter, Barbara; Sieverling, Lina; Brors, Benedikt] Deutsch Krebsforschungszentrum, Appl Bioinformat, D-59120 Heidelberg, Germany; [Gorka, Oliver; Ruland, Juergen] Tech Univ, Klinikum Rechts Isar, Inst Clin Chem & Pathobiochem, D-81675 Munich, Germany; [Schlickeiser, Stephan; Sawitzki, Birgit] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Cendon, Carla; Chang, Hyun-Dong; Dong, Jun; Radbruch, Andreas] German Rheumatism Res Ctr, Cell Biol, D-10117 Berlin, Germany; [Felder, Baerbel; Zipprich, Gideon; Eils, Juergen] Deutsch Krebsforschungszentrum, Data Management & Genom IT, D-69120 Heidelberg, Germany; [Tauchmann, Yvonne; Kalus, Ulrich] Charite, Inst Transfus Med, D-12203 Berlin, Germany; [Reinke, Simon] Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Wassilew, Georgi] Charite, Ctr Musculoskeletal Surg, D-10117 Berlin, Germany; [Syrbe, Uta] Charite, Med Klin Gastroenterol Infektiol & Rheumatol, D-12000 Berlin, Germany; [Ruland, Juergen] German Canc Consortium DKTK, D-59120 Heidelberg, Germany; [Ruland, Juergen] German Ctr Infect Res DZIF, Partner Site, D-81675 Munich, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Saarland University; University of Bonn; Max Planck Society; Saarland University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Kiel; Max Planck Society; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); German Center for Infection Research	Polansky, JK (corresponding author), German Rheumatism Res Ctr, Expt Rheumatol, D-10117 Berlin, Germany.	julia.polansky@drfz.de	Manke, Thomas/L-9075-2019; Frischbutter, Stefan/AAM-9487-2021; Walter, Jörn/AFN-6428-2022; Ruland, Jürgen/Q-6680-2018; Polansky-Biskup, Julia K./J-5937-2017; Gorka, Oliver/AAF-1633-2020; Feuerbach, Lars/AAT-1226-2021; Brors, Benedikt/E-5620-2013; Müller, Fabian/HGD-0719-2022; Sawitzki, Birgit S/S-2307-2016; Chang, Hyun-Dong/T-3697-2017; Schultze, Joachim L./ABA-8176-2020; Rosenstiel, Philip/A-5137-2009; Syrbe, Uta/T-7557-2017; Frohler, Sebastian/D-7555-2013	Frischbutter, Stefan/0000-0003-3971-7343; Walter, Jörn/0000-0003-0563-7417; Ruland, Jürgen/0000-0002-8381-3597; Polansky-Biskup, Julia K./0000-0003-4727-2540; Brors, Benedikt/0000-0001-5940-3101; Müller, Fabian/0000-0001-5809-2321; Chang, Hyun-Dong/0000-0002-7341-4533; Schultze, Joachim L./0000-0003-2812-9853; Rosenstiel, Philip/0000-0002-9692-8828; Schmidt, Florian/0000-0001-9222-6207; Reinke, Simon/0000-0002-3451-9383; Syrbe, Uta/0000-0001-8463-7890; Schulz, Marcel H./0000-0002-1252-3656; Kressler, Chritstopher/0000-0002-1111-0876; Kinkley, Sarah/0000-0003-4997-4749; de Almeida, Melanie/0000-0003-4871-2069; Schlickeiser, Stephan/0000-0003-3142-2890; Lengauer, Thomas/0000-0003-3801-2640; Frohler, Sebastian/0000-0001-8000-2927; Li, Na/0000-0001-6163-1648; Rajewsky, Nikolaus/0000-0002-4785-4332; Salhab, Abdulrahman/0000-0002-9649-6922; Sawitzki, Birgit/0000-0001-8166-8579; Richter, Andreas S./0000-0002-4166-0991; Nordstrom, Karl/0000-0001-6231-4417; Radbruch, Andreas/0000-0001-5753-0000; Gorka, Oliver/0000-0002-8245-3008; Kalus, Ulrich/0000-0001-9147-9851; Arrigoni, Laura/0000-0002-3626-4468; Ebert, Peter/0000-0001-7441-532X	EU FP7 [282510]; German Epigenome Programme (DEEP) of the Federal Ministry of Education and Research in Germany (BMBF); DFG [HA 1505/10-1, SFB650, SFB704]; ERC [322865]; EU FP7 "ONE Study";  [DFG-SFB650-TP1];  [ERC-2010-AdG_20100317];  [268987];  [1468]	EU FP7(European Commission); German Epigenome Programme (DEEP) of the Federal Ministry of Education and Research in Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); EU FP7 "ONE Study"; ; ; ; 	We thank Rene Maier for expert technical assistance, the FCCF of the DRFZ for expert cell sorting, staff from EURICE for project management, and Ulrike Biskup for help with figure layout. Selected data generated by the Blueprint Consortium (www.blueprint-epigenome.eu; EU FP7/2007-2013, grant agreement no. 282510 BLUEPRINT) were used. Funding is as follows: German Epigenome Programme (DEEP) of the Federal Ministry of Education and Research in Germany (BMBF), DFG HA 1505/10-1 to A.H., DFG-SFB650-TP1 to A.H., ERC grant 322865 to J.R., EU FP7 "ONE Study" to B.S., DFG SFB650 to B.S., DFG SFB704 to J.L.S., J.L.S. is a member of the Excellence Cluster Immunosensation, ERC-2010-AdG_20100317 Grant 268987 to A.R. and Priority Programme 1468 Immunobone to A.R.	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Arrigoni L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1495; Arsenio J, 2015, TRENDS IMMUNOL, V36, P670, DOI 10.1016/j.it.2015.09.004; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Carbone FR, 2013, CURR OPIN IMMUNOL, V25, P329, DOI 10.1016/j.coi.2013.05.007; Crompton JG, 2016, CELL MOL IMMUNOL, V13, P502, DOI 10.1038/cmi.2015.32; de Andres MC, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0748-5; Derhovanessian E, 2011, J GEN VIROL, V92, P2746, DOI 10.1099/vir.0.036004-0; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Flossdorf M, 2015, NAT IMMUNOL, V16, P891, DOI 10.1038/ni.3235; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gerlach UA, 2013, TRANSPLANTATION, V95, P1512, DOI 10.1097/TP.0b013e318290de18; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Hanieh H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/520763; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hashimoto S, 2013, J IMMUNOL, V190, P4076, DOI 10.4049/jimmunol.1202267; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Juhling F, 2016, GENOME RES, V26, P256, DOI 10.1101/gr.196394.115; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kinkley S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12514; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Komori HK, 2015, J IMMUNOL, V194, P1565, DOI 10.4049/jimmunol.1401162; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mammana A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0708-z; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Richard EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075175; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Sato S, 2014, ARTHRITIS RHEUMATOL, V66, P3436, DOI 10.1002/art.38818; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schmidt F., 2016, BIORXIV; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Urich MA, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.114; Wallner S, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0079-z; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wei HR, 2016, J IMMUNOL, V196, P3537, DOI 10.4049/jimmunol.1501896; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	61	120	123	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1148	1161		10.1016/j.immuni.2016.10.022	http://dx.doi.org/10.1016/j.immuni.2016.10.022			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851915	Green Submitted, Bronze			2022-12-18	WOS:000389473500023
J	Iborra, S; Martinez-Lopez, M; Khouili, SC; Enamorado, M; Cueto, FJ; Conde-Garrosa, R; del Fresno, C; Sancho, D				Iborra, Salvador; Martinez-Lopez, Maria; Khouili, Sofia C.; Enamorado, Michel; Cueto, Francisco J.; Conde-Garrosa, Ruth; del Fresno, Carlos; Sancho, David			Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1(+) Dendritic Cells	IMMUNITY			English	Article							CUTTING EDGE; NONLYMPHOID TISSUE; VIRUS-INFECTION; LOCAL ANTIGEN; RM CELLS; EFFECTOR; DIFFERENTIATION; RECEPTOR; IMMUNITY; PRECURSOR	Despite the crucial role of tissue-resident memory T (Trm) cells in protective immunity, their priming remains poorly understood. Here, we have shown differential priming requirements for Trm versus circulating memory CD8(+) T cells. In vaccinia cutaneous- infected mice, DNGR-1-mediated crosspresentation was required for optimal Trm cell priming but not for their skin differentiation or for circulating memory T cell generation. DNGR-1(+) dendritic cells (DCs) promoted T-bet transcription-factor induction and retention of CD8(+) T cells in the lymph nodes (LNs). Inhibition of LN egress enhanced Trm cell generation, whereas genetic or antibody blockade of DNGR-1 or specific signals provided during priming by DNGR-1(+) DCs, such as interleukin-12 (IL-12), IL-15, or CD24, impaired Trm cell priming. DNGR-1 also regulated Trm cell generation during influenza infection. Moreover, protective immunity depended on optimal Trm cell induction by DNGR-1(+) DCs. Our results reveal specific priming requirements for CD8(+) Trm cells during viral infection and vaccination.	[Iborra, Salvador; Martinez-Lopez, Maria; Khouili, Sofia C.; Enamorado, Michel; Cueto, Francisco J.; Conde-Garrosa, Ruth; del Fresno, Carlos; Sancho, David] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Melchor Fernandez Almagro 3, Madrid 28029, Spain; [Cueto, Francisco J.] Univ Autonoma Madrid, Fac Med, Dept Biochem, Calle Arzobispo Morcillo 4, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid	Iborra, S (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	siborra@cnic.es; dsancho@cnic.es	Iborra, Salvador/J-2863-2015; Del Fresno Sánchez, CArlos/AAY-1525-2021; Del Fresno, Carlos/ABD-7766-2020; Sancho, David/D-3433-2009; Cueto, Francisco J/AGN-4489-2022; Martinez Lopez, Maria/HGA-6834-2022	Iborra, Salvador/0000-0002-1607-1749; Del Fresno, Carlos/0000-0003-1771-7254; Sancho, David/0000-0003-2890-3984; Cueto, Francisco J/0000-0002-7457-9583; Enamorado Escalona, Neris Michel/0000-0001-7748-454X; Martinez Lopez, Maria/0000-0002-1995-0642	NIH Tetramer Core Facility [HHSN272201300006C]; CNIC; Spanish Ministry of Economy and Competitiveness (MINECO) [SAF-2013-42920R]; European Commission [635122-PROCROP H2020]; European Research Council [ERC-2010-StG 260414]; MINECO; Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO award) [SEV-2015-0505];  [SAF2015-74561-JIN]	NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNIC; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); MINECO(Spanish Government); Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO award)(Spanish Government); 	We are grateful to C. Reis e Sousa, E. Fernandez-Malave, M. del Val, J. Boettcher, M. Robinson, and members of the D.S. laboratory for discussions and critical reading of the manuscript. We thank the CNIC facilities, personnel, and S. Bartlett for editorial assistance. We acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for MHC-I tetramers. S. I. is funded by grant SAF2015-74561-JIN. Work in the D.S. laboratory is funded by the CNIC and grants from the Spanish Ministry of Economy and Competitiveness (MINECO, SAF-2013-42920R), the European Commission (635122-PROCROP H2020), and the European Research Council (ERC-2010-StG 260414). The CNIC is supported by the MINECO and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505).	Alexandre YO, 2016, J EXP MED, V213, P75, DOI 10.1084/jem.20142350; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Frost EL, 2015, J IMMUNOL, V195, P3520, DOI 10.4049/jimmunol.1501521; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Heipertz EL, 2014, J IMMUNOL, V193, P4169, DOI 10.4049/jimmunol.1302565; Henrickson SE, 2013, IMMUNITY, V39, P496, DOI 10.1016/j.immuni.2013.08.034; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Iborra S, 2013, J EXP MED, V210, P1463, DOI 10.1084/jem.20112495; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Khan TN, 2016, J EXP MED, V213, P951, DOI 10.1084/jem.20151855; Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004; Knudson KM, 2013, CELL REP, V4, P554, DOI 10.1016/j.celrep.2013.07.008; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Martinez-Lopez M, 2015, EUR J IMMUNOL, V45, P119, DOI 10.1002/eji.201444651; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Muzaki ARBM, 2016, MUCOSAL IMMUNOL, V9, P336, DOI 10.1038/mi.2015.64; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Seillet C, 2013, BLOOD, V121, P1574, DOI 10.1182/blood-2012-07-445650; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Sowell RT, 2014, J IMMUNOL, V193, P2067, DOI 10.4049/jimmunol.1400074; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Xu RH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000768; Yu CI, 2013, IMMUNITY, V38, P818, DOI 10.1016/j.immuni.2013.03.004	51	120	122	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					847	860		10.1016/j.immuni.2016.08.019	http://dx.doi.org/10.1016/j.immuni.2016.08.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27692611	Green Accepted, Bronze			2022-12-18	WOS:000389473200016
J	Gray, EE; Winship, D; Snyder, JM; Child, SJ; Geballe, AP; Stetson, DB				Gray, Elizabeth E.; Winship, Damion; Snyder, Jessica M.; Child, Stephanie J.; Geballe, Adam P.; Stetson, Daniel B.			The AIM2-like Receptors Are Dispensable for the Interferon Response to Intracellular DNA	IMMUNITY			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE SENSOR; AIM2 INFLAMMASOME; EXONUCLEASE TREX1; GENE; IFI16; CGAS; LUPUS; ACTIVATION; MUTATIONS	Detection of intracellular DNA triggers activation of the STING-dependent interferon-stimulatory DNA (ISD) pathway, which is essential for antiviral responses. Multiple DNA sensors have been proposed to activate this pathway, including AIM2-like receptors (ALRs). Whether the ALRs are essential for activation of this pathway remains unknown. To rigorously explore the function of ALRs, we generated mice lacking all 13 ALR genes. We found that ALRs are dispensable for the type I interferon (IFN) response to transfected DNA ligands, DNA virus infection, and lentivirus infection. We also found that ALRs do not contribute to autoimmune disease in the Trex1(-/-) mouse model of Aicardi-Goutieres Syndrome. Finally, CRISPR-mediated disruption of the human AIM2-like receptor IFI16 in primary fibroblasts revealed that IFI16 is not essential for the IFN response to human cytomegalovirus infection. Our findings indicate that ALRs are dispensable for the ISD response and suggest that alternative functions for these receptors should be explored.	[Gray, Elizabeth E.; Winship, Damion; Stetson, Daniel B.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Snyder, Jessica M.] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; [Child, Stephanie J.; Geballe, Adam P.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Child, Stephanie J.; Geballe, Adam P.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Child, Stephanie J.; Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Child, Stephanie J.; Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Stetson, DB (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	stetson@uw.edu	Geballe, Adam P/AAB-2737-2019	Geballe, Adam P/0000-0002-9279-6653; Child, Stephanie/0000-0002-1987-9540	NIH [AI113153, RO1AI027762]; Cancer Research Institute Irvington postdoctoral fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI113153, R01AI084914, R01AI026672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Irvington postdoctoral fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to the University of Washington Histology and Imaging Core and B. Johnson for histology preparation and members of the Stetson laboratory for helpful discussions. Wade Bresnahan kindly provided ADCREGFP, DUL83, and UL83stop virus strains. Denise Galloway kindly provided telomerase-immortalized human foreskin fibroblasts. Denise Monack kindly provided bone marrow from Aim2<SUP>-/-</SUP> mice generated in C57BL/6 ESCs. D.B.S. is a scholar of the Rita Allen Foundation and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease. This work was supported by grants from the NIH (AI113153 to D.B.S. and RO1AI027762 to A.P.G.). E.E.G. is supported by a Cancer Research Institute Irvington postdoctoral fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abate DA, 2004, J VIROL, V78, P10995, DOI 10.1128/JVI.78.20.10995-11006.2004; Browne EP, 2003, P NATL ACAD SCI USA, V100, P11439, DOI 10.1073/pnas.1534570100; Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cagliani R, 2014, GENOME BIOL EVOL, V6, P830, DOI 10.1093/gbe/evu066; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Corrales L., 2016, J IMMUNOL; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fernando MMA, 2011, ANN HUM GENET, V75, P383, DOI 10.1111/j.1469-1809.2011.00641.x; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Haywood MEK, 2004, J IMMUNOL, V173, P4277, DOI 10.4049/jimmunol.173.7.4277; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Jorgensen TN, 2010, J IMMUNOL, V184, P775, DOI 10.4049/jimmunol.0901322; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Li T, 2013, CELL HOST MICROBE, V14, P591, DOI 10.1016/j.chom.2013.10.007; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Orzalli MH, 2015, P NATL ACAD SCI USA, V112, pE1773, DOI 10.1073/pnas.1424637112; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Panchanathan R, 2010, J IMMUNOL, V185, P7385, DOI 10.4049/jimmunol.1002468; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Stavrou S, 2015, CELL HOST MICROBE, V17, P478, DOI 10.1016/j.chom.2015.02.021; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Storek KM, 2015, J IMMUNOL, V194, P3236, DOI 10.4049/jimmunol.1402764; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Taylor RT, 2006, J VIROL, V80, P920, DOI 10.1128/JVI.80.2.920-928.2006; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yin Q, 2013, CELL REP, V4, P327, DOI 10.1016/j.celrep.2013.06.024	55	120	124	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					255	266		10.1016/j.immuni.2016.06.015	http://dx.doi.org/10.1016/j.immuni.2016.06.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27496731	Green Accepted, Bronze			2022-12-18	WOS:000382267300009
J	Pikor, NB; Astarita, JL; Summers-Deluca, L; Galicia, G; Qu, J; Ward, LA; Armstrong, S; Dominguez, CX; Malhotra, D; Heiden, B; Kay, R; Castanov, V; Touil, H; Boon, L; O'Connor, P; Bar-Or, A; Prat, A; Ramaglia, V; Ludwin, S; Turley, SJ; Gommerman, JL				Pikor, Natalia B.; Astarita, Jillian L.; Summers-Deluca, Leslie; Galicia, Georgina; Qu, Joy; Ward, Lesley A.; Armstrong, Susan; Dominguez, Claudia X.; Malhotra, Deepali; Heiden, Brendan; Kay, Robert; Castanov, Valera; Touil, Hanane; Boon, Louis; O'Connor, Paul; Bar-Or, Amit; Prat, Alexandre; Ramaglia, Valeria; Ludwin, Samuel; Turley, Shannon J.; Gommerman, Jennifer L.			Integration of Th17-and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FIBROBLASTIC RETICULAR CELLS; MULTIPLE-SCLEROSIS; LYMPHOID FOLLICLES; DENDRITIC CELLS; B-CELLS; BETA; DISEASE; SYSTEM; DEMYELINATION	Tertiary lymphoid tissues (TLTs) have been observed in the meninges of multiple sclerosis (MS) patients, but the stromal cells and molecular signals that support TLTs remain unclear. Here, we show that T helper 17 (Th17) cells induced robust TLTs within the brain meninges that were associated with local demyelination during experimental autoimmune encephalitis (EAE). Th17-cell-induced TLTs were underpinned by a network of stromal cells producing extracellular matrix proteins and chemokines, enabling leukocytes to reside within, rather than simply transit through, the meninges. Within the CNS, interactions between lymphotoxin ab (LT alpha beta) on Th17 cells and LT beta R on meningeal radio-resistant cells were necessary for the propagation of de novo interleukin-17 responses, and activated T cells from MS patients expressed elevated levels of LTbR ligands. Therefore, input from both Th17 cells and the lymphotoxin pathway induce the formation of an immune-competent stromal cell niche in the meninges.	[Pikor, Natalia B.; Summers-Deluca, Leslie; Galicia, Georgina; Qu, Joy; Ward, Lesley A.; Armstrong, Susan; Kay, Robert; Castanov, Valera; Gommerman, Jennifer L.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Astarita, Jillian L.; Malhotra, Deepali; Heiden, Brendan; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol, Boston, MA 02115 USA; [Astarita, Jillian L.; Malhotra, Deepali; Heiden, Brendan; Turley, Shannon J.] Dana Farber Canc Inst, AIDS, Boston, MA 02115 USA; [Astarita, Jillian L.; Malhotra, Deepali; Heiden, Brendan; Turley, Shannon J.] Harvard Univ, Sch Med, Div Med Sci, Boston, MA 02115 USA; [Astarita, Jillian L.; Dominguez, Claudia X.; Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Touil, Hanane; Bar-Or, Amit] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Boon, Louis] EPIRUS Biopharmaceut Netherlands, NL-3584 CM Utrecht, Netherlands; [O'Connor, Paul] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [O'Connor, Paul] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Prat, Alexandre] CHU Montreal, Ctr Rech, Neuroimmunol Res Lab, Montreal, PQ H2L 4M1, Canada; [Ludwin, Samuel] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Ramaglia, Valeria] Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Noord Holland, Netherlands	University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Roche Holding; Genentech; McGill University; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Universite de Montreal; McMaster University; Queens University - Canada	Gommerman, JL (corresponding author), Univ Toronto, Dept Immunol, 100 Coll St, Toronto, ON M5S 1A8, Canada.	jen.gommerman@utoronto.ca	Boon, Laurence/HCI-3629-2022; Bar-Or, Amit/AIC-1416-2022; Kay, Robert/AAP-4670-2021	Castanov, Valera/0000-0003-0918-6414; Gommerman, Jennifer/0000-0003-4576-6168; Pikor, Natalia/0000-0002-6564-4232; Malhotra, Deepali/0000-0002-8215-7639; Touil, Hanane/0000-0002-9601-4364; Galicia, Georgina/0000-0003-4316-6986; Kay, Robert/0000-0002-0261-2321; Boon, Louis/0000-0002-0937-9171; Heiden, Brendan/0000-0002-0116-7377	MS Society of Canada (Operating Grant EGID) [1553]; Canadian Institutes of Health Research (MOG) [67157]; NIH [RO1 DK074500, PO1 AIO45757]; National Science Foundation; MS Society of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074500] Funding Source: NIH RePORTER	MS Society of Canada (Operating Grant EGID); Canadian Institutes of Health Research (MOG)(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); MS Society of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to acknowledge Biogen Idec for providing LT beta R-Ig, control antibodies, and BBF6 for this study, as well as Genentech Inc. for providing anti-IL-17A, anti-IL-17F, and anti-IL-22. We would also like to acknowledge Dr. Jeff Browning for helpful advice on the choice of control antibodies for i.c.v. treatments. This work was supported in part by the MS Society of Canada (Operating Grant EGID no. 1553 to J.L.G., Doctoral Studentships to N.P. and H.T., and Collaborative Research Grant to A.B.O., A.P., and J.L.G), the Canadian Institutes of Health Research (MOG no. 67157 to J.L.G.), the NIH (grants RO1 DK074500 and PO1 AIO45757 to S.J.T.), and the National Science Foundation (Graduate Research Fellowship to J.L.A.). S.J.T., J.L.A., and C.X.D. are employees of Genentech Inc., and V.R. is a cofounder of Regenesance BV.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Columba-Cabezas S, 2006, J NEUROIMMUNOL, V179, P76, DOI 10.1016/j.jneuroim.2006.06.015; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; deLuca LES, 2010, J IMMUNOL, V184, P3174, DOI 10.4049/jimmunol.0902881; deLuca LS, 2012, NAT REV IMMUNOL, V12, P339, DOI 10.1038/nri3193; Drayton DL, 2003, J EXP MED, V197, P1153, DOI 10.1084/jem.20021761; Fleige H, 2014, J EXP MED, V211, P643, DOI 10.1084/jem.20131737; Gommerman JL, 2003, J CLIN INVEST, V112, P755, DOI 10.1172/JCI200318648; Greter M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000109; Grogan JL, 2012, EUR J IMMUNOL, V42, P2255, DOI 10.1002/eji.201242656; Hu DS, 2015, IMMUNITY, V42, P1100, DOI 10.1016/j.immuni.2015.05.015; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Kuerten S, 2011, APMIS, V119, P336, DOI 10.1111/j.1600-0463.2011.02744.x; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lu TT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00047; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mead RJ, 2004, LAB INVEST, V84, P21, DOI 10.1038/labinvest.3700015; Mohan H, 2010, BRAIN PATHOL, V20, P966, DOI 10.1111/j.1750-3639.2010.00399.x; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; van Horssen J, 2005, J NEUROPATH EXP NEUR, V64, P722, DOI 10.1097/01.jnen.0000173894.09553.13; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	29	120	123	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1160	1173		10.1016/j.immuni.2015.11.010	http://dx.doi.org/10.1016/j.immuni.2015.11.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682987	Bronze			2022-12-18	WOS:000366846600019
J	Ladell, K; Hashimoto, M; Iglesias, MC; Wilmann, PG; McLaren, JE; Gras, S; Chikata, T; Kuse, N; Fastenackels, S; Gostick, E; Bridgeman, JS; Venturi, V; Arkoub, ZA; Agut, H; van Bockel, DJ; Almeida, JR; Douek, DC; Meyer, L; Venet, A; Takiguchi, M; Rossjohn, J; Price, DA; Appay, V				Ladell, Kristin; Hashimoto, Masao; Iglesias, Maria Candela; Wilmann, Pascal G.; McLaren, James E.; Gras, Stephanie; Chikata, Takayuki; Kuse, Nozomi; Fastenackels, Solene; Gostick, Emma; Bridgeman, John S.; Venturi, Vanessa; Arkoub, Zaina Ait; Agut, Henri; van Bockel, David J.; Almeida, Jorge R.; Douek, Daniel C.; Meyer, Laurence; Venet, Alain; Takiguchi, Masafumi; Rossjohn, Jamie; Price, David A.; Appay, Victor			A Molecular Basis for the Control of Preimmune Escape Variants by HIV-Specific CD8(+) T Cells	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I; LYMPHOCYTE ESCAPE; ANTIGEN RECOGNITION; INFECTION; RESPONSES; TYPE-1; GAG; DIVERSITY; REPLICATION	The capacity of the immune system to adapt to rapidly evolving viruses is a primary feature of effective immunity, yet its molecular basis is unclear. Here, we investigated protective HIV-1-specific CD8(+) T cell responses directed against the immunodominant p24 Gag-derived epitope KK10 (KRWIILGLNK(263-272)) presented by human leukocyte antigen (HLA)-B*2705. We found that cross-reactive CD8(+) T cell clonotypes were mobilized to counter the rapid emergence of HIV-1 variants that can directly affect T cell receptor (TCR) recognition. These newly recruited clonotypes expressed TCRs that engaged wild-type and mutant KK10 antigens with similar affinities and almost identical docking modes, thereby accounting for their antiviral efficacy in HLA-B*2705(+) individuals. A protective CD8(+) T cell repertoire therefore encompasses the capacity to control TCR-accessible mutations, ultimately driving the development of more complex viral escape variants that disrupt antigen presentation.	[Ladell, Kristin; McLaren, James E.; Gostick, Emma; Bridgeman, John S.; Rossjohn, Jamie; Price, David A.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Hashimoto, Masao; Chikata, Takayuki; Kuse, Nozomi; Takiguchi, Masafumi] Kumamoto Univ, Ctr AIDS Res, Kumamoto 8600811, Japan; [Iglesias, Maria Candela; Fastenackels, Solene; Almeida, Jorge R.; Appay, Victor] Univ Paris 06, Hop La Pitie Salpetriere, INSERM UMR S 945, F-75013 Paris, France; [Wilmann, Pascal G.; Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Venturi, Vanessa] Univ New S Wales, Ctr Vasc Res, Computat Biol Grp, Sydney, NSW 2052, Australia; [Arkoub, Zaina Ait; Agut, Henri] Univ Paris 06, Hop La Pitie Salpetriere, DETIV UPMC ER1, Virol Lab, F-75013 Paris, France; [van Bockel, David J.] St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [van Bockel, David J.] Univ New S Wales, Sydney, NSW 2010, Australia; [Almeida, Jorge R.; Douek, Daniel C.; Price, David A.] NIAID, Vaccine Res Ctr, Human Immunol Sect, NIH, Bethesda, MD 20892 USA; [Meyer, Laurence; Venet, Alain] Univ Paris 11, Hop Kremlin Bicetre, INSERM, F-94275 Le Kremlin Bicetre, France; [Appay, Victor] Grp Hosp Pitie Salpetriere, AP HP, Lab Immunol Cellulaire & Tissulaire, F-75013 Paris, France	Cardiff University; Kumamoto University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Monash University; University of New South Wales Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of New South Wales Sydney; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Appay, V (corresponding author), Univ Paris 06, Hop La Pitie Salpetriere, INSERM UMR S 945, F-75013 Paris, France.	victor.appay@upmc.fr	Appay, Victor/AAM-7701-2021; gras, stephanie/C-8307-2013; Takiguchi, Masafumi/E-7468-2013; Ladell, Kristin/K-2475-2013; Price, David A/C-7876-2013; Appay, Victor/M-4830-2017; Hashimoto, Masao/AAC-9225-2020; Rossjohn, Jamie/F-9032-2013; Ladell, Kristin/C-8301-2013	Price, David A/0000-0001-9416-2737; Hashimoto, Masao/0000-0002-7120-1390; Rossjohn, Jamie/0000-0002-2020-7522; Ladell, Kristin/0000-0002-9856-2938; gras, stephanie/0000-0001-7416-038X; Wilmann, Pascal/0000-0002-8376-5150; Ramos de Almeida, Jorge/0000-0002-5009-8478; Appay, Victor/0000-0001-5434-3963; Chikata, Takayuki/0000-0001-8907-1320; McLaren, James/0000-0002-7021-5934	ANR, Sidaction [ANR-09-JCJC-0114-01]; French ANRS; National Institutes of Health via the Intramural Program of the Vaccine Research Center (National Institute of Allergy and Infectious Diseases); Australian Research Council (ARC); Australian National Health and Medical Research Council (NHMRC); UK Biotechnology and Biological Sciences Research Council [BB/H001085/1]; Japanese Ministry of Health [18390141]; Global COE program ("Global Education and Research Center Aiming at the Control of AIDS'') of the Japanese Ministry of Education, Science, Sports, and Culture; Sidaction Fellowship; BBSRC [BB/H001085/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005066, ZIAAI005033] Funding Source: NIH RePORTER	ANR, Sidaction(French National Research Agency (ANR)); French ANRS(ANRSFrench National Research Agency (ANR)); National Institutes of Health via the Intramural Program of the Vaccine Research Center (National Institute of Allergy and Infectious Diseases); Australian Research Council (ARC)(Australian Research Council); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Japanese Ministry of Health; Global COE program ("Global Education and Research Center Aiming at the Control of AIDS'') of the Japanese Ministry of Education, Science, Sports, and Culture; Sidaction Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all study participants, the French Agence Nationale de la Recherche sur le SIDA (ANRS) Cohorts ALT and PRIMO groups, and the staff at the MX2 beamline (Australian synchrotron). We are grateful to C. Blanc for sorting viable infected cells at the Pitie-Salpetriere Flow Cytometry Platform. This work was supported by the ANR (project ANR-09-JCJC-0114-01), Sidaction, the French ANRS, the National Institutes of Health via the Intramural Program of the Vaccine Research Center (National Institute of Allergy and Infectious Diseases), the Australian Research Council (ARC), the Australian National Health and Medical Research Council (NHMRC), the UK Biotechnology and Biological Sciences Research Council (grant BB/H001085/1), the Japanese Ministry of Health (grant 18390141), and the Global COE program ("Global Education and Research Center Aiming at the Control of AIDS'') of the Japanese Ministry of Education, Science, Sports, and Culture. M. C. I. is supported by a Sidaction Fellowship. V. V. and S. G. are ARC Future Fellows. P. G. W. is an NHMRC CJ Martin Fellow. J.R. is an NHMRC Australia Fellow. D. A. P. is a Wellcome Trust Senior Investigator.	Akahoshi T, 2012, J VIROL, V86, P1971, DOI 10.1128/JVI.06470-11; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Ammaranond P, 2005, AIDS RES HUM RETROV, V21, P395, DOI 10.1089/aid.2005.21.395; Ammaranond P, 2011, J IMMUNOL, V186, P479, DOI 10.4049/jimmunol.0903227; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Dong T, 2011, BLOOD, V118, P98, DOI 10.1182/blood-2010-06-291963; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Lichterfeld M, 2007, J EXP MED, V204, P2813, DOI 10.1084/jem.20061865; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Pillay T, 2005, J VIROL, V79, P12100, DOI 10.1128/JVI.79.18.12100-12105.2005; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Quigley M. F., 2011, CURR PROTOC IMMUNOL, V10, P1033; Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; van Bockel DJ, 2011, J IMMUNOL, V186, P359, DOI 10.4049/jimmunol.1001807	48	120	124	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					425	436		10.1016/j.immuni.2012.11.021	http://dx.doi.org/10.1016/j.immuni.2012.11.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521884	Bronze			2022-12-18	WOS:000330941500009
J	King, CG; Koehli, S; Hausmann, B; Schmaler, M; Zehn, D; Palmer, E				King, Carolyn G.; Koehli, Sabrina; Hausmann, Barbara; Schmaler, Mathias; Zehn, Dietmar; Palmer, Ed			T Cell Affinity Regulates Asymmetric Division, Effector Cell Differentiation, and Tissue Pathology	IMMUNITY			English	Article							LYMPHOCYTE-RESPONSES; TRANSCRIPTION FACTOR; SELF-ANTIGENS; MEMORY; BET; AUTOIMMUNITY; INTEGRIN; CD8; TCR; PROLIFERATION	The strength of interactions between T cell receptors and the peptide-major histocompatibility complex (pMHC) directly modulates T cell fitness, clonal expansion, and acquisition of effector properties. Here we show that asymmetric T cell division is an important mechanistic link between increased signal strength, effector differentiation, and the ability to induce tissue pathology. Recognition of pMHC above a threshold affinity drove responding T cells into asymmetric cell division. The ensuing proximal daughters underwent extensive division and differentiated into short-lived effector cells expressing the integrin VLA-4, allowing the activated T cell to infiltrate and mediate destruction of peripheral target tissues. In contrast, T cells activated by below-threshold antigens underwent symmetric division, leading to abortive clonal expansion and failure to fully differentiate into tissue-infiltrating effector cells. Antigen affinity and asymmetric division are important factors that regulate fate specification in CD8(+) T cells and predict the potential of a self-reactive T cell to mediate tissue pathology.	[King, Carolyn G.; Koehli, Sabrina; Hausmann, Barbara; Palmer, Ed] Univ Basel Hosp, Dept Biomed, Lab Transplantat Immunol, CH-4031 Basel, Switzerland; [King, Carolyn G.; Koehli, Sabrina; Hausmann, Barbara; Palmer, Ed] Univ Basel Hosp, Dept Nephrol, Lab Transplantat Immunol, CH-4031 Basel, Switzerland; [Schmaler, Mathias] Univ Basel Hosp, Dept Biomed, Lab Immunoregulat, CH-4031 Basel, Switzerland; [Schmaler, Mathias] Univ Basel Hosp, Dept Nephrol, Lab Immunoregulat, CH-4031 Basel, Switzerland; Univ Basel, CH-4031 Basel, Switzerland; [Zehn, Dietmar] Swiss Vaccine Res Inst, CH-1066 Epalinges, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	King, CG (corresponding author), Univ Basel Hosp, Dept Biomed, Lab Transplantat Immunol, Hebelstr 20, CH-4031 Basel, Switzerland.	carolyn.king@unibas.ch; ed.palmer@unibas.ch		King, Carolyn G./0000-0001-6059-323X	EMBO, HSFP; Swiss Vaccine Research Institute [310030_130512/1]; Synergia [SNF]; Sybilla; EU FP7; TerraIncognita [ERC];  [310030B_133131/1]	EMBO, HSFP; Swiss Vaccine Research Institute; Synergia [SNF]; Sybilla; EU FP7(European Commission); TerraIncognita [ERC]; 	The authors thank L. Jeker, I. Luescher, D. Naeher, and E. Pearce for comments on the manuscript; R. Landmann for advice on culturing Listeria; E. Wagner and U. Schneider for animal husbandry; and E. Traunecker for cell sorting. The work was supported by post-doctoral grants to C.G.K. (EMBO, HSFP) and by research grants to D.Z. (310030_130512/1 [SNF]; support from Swiss Vaccine Research Institute) and to E.P. (310030B_133131/1 and Synergia [SNF], Sybilla, [EU FP7], and TerraIncognita [ERC]).	Behrens GMN, 2004, J IMMUNOL, V172, P5420, DOI 10.4049/jimmunol.172.9.5420; Beinke S, 2010, P NATL ACAD SCI USA, V107, P16234, DOI 10.1073/pnas.1011556107; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BURKLY LC, 1994, DIABETES, V43, P529, DOI 10.2337/diabetes.43.4.529; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; Hanninen A, 2007, AM J PATHOL, V170, P240, DOI 10.2353/ajpath.060142; Hernandez J, 2002, J EXP MED, V196, P323, DOI 10.1084/jem.20011612; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Juedes AE, 2004, J EXP MED, V199, P1153, DOI 10.1084/jem.20031873; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; MCKENZIE IFC, 1979, J EXP MED, V150, P1323, DOI 10.1084/jem.150.6.1323; Mueller KL, 2004, J IMMUNOL, V173, P2222, DOI 10.4049/jimmunol.173.4.2222; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Schubert DA, 2012, J EXP MED, V209, P335, DOI 10.1084/jem.20111485; Smith-Garvin JE, 2010, BLOOD, V116, P5548, DOI 10.1182/blood-2010-06-292748; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	37	120	122	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 19	2012	37	4					709	720		10.1016/j.immuni.2012.06.021	http://dx.doi.org/10.1016/j.immuni.2012.06.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23084359	Bronze, Green Accepted			2022-12-18	WOS:000310185400015
J	Moreau, HD; Lemaitre, F; Terriac, E; Azar, G; Piel, M; Lennon-Dumenil, AM; Bousso, P				Moreau, Helene D.; Lemaitre, Fabrice; Terriac, Emmanuel; Azar, Georges; Piel, Matthieu; Lennon-Dumenil, Ana-Maria; Bousso, Philippe			Dynamic In Situ Cytometry Uncovers T Cell Receptor Signaling during Immunological Synapses and Kinapses In Vivo	IMMUNITY			English	Article							DENDRITIC CELLS; LYMPH-NODES; ANTIGEN PRESENTATION; POSITIVE SELECTION; TCR; AFFINITY; ACTIVATION; MOTILITY; THRESHOLD; CHOREOGRAPHY	Upon antigen recognition, T cells form either static (synapses) or migratory (kinapses) contacts with antigen-presenting cells. Addressing whether synapses and kinapses result in distinct T cell receptor (TCR) signals has been hampered by the inability to simultaneously assess T cell phenotype and behavior. Here, we introduced dynamic in situ cytometry (DISC), a combination of intravital multiphoton imaging and flow cytometry-like phenotypic analysis. Taking advantage of CD62L shedding as a marker of early TCR signaling, we examined how T cells sense TCR ligands of varying affinities in vivo. We uncovered three modes of antigen recognition: synapses with the strongest TCR signals, kinapses with robust signaling, and kinapses with weak signaling. As illustrated here, the DISC approach should provide unique opportunities to link immune cell behavior to phenotype and function in vivo.	[Moreau, Helene D.; Lemaitre, Fabrice; Azar, Georges; Bousso, Philippe] Inst Pasteur, Dynam Immune Responses Unit, F-75015 Paris, France; [Moreau, Helene D.; Lemaitre, Fabrice; Azar, Georges; Bousso, Philippe] INSERM, U668, F-75015 Paris, France; [Moreau, Helene D.] Univ Paris Diderot, F-75015 Paris, France; [Terriac, Emmanuel; Piel, Matthieu] Inst Curie, CNRS, UMR 144, F-75005 Paris, France; [Lennon-Dumenil, Ana-Maria] Inst Curie, INSERM, U932, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Bousso, P (corresponding author), Inst Pasteur, Dynam Immune Responses Unit, F-75015 Paris, France.	philippe.bousso@pasteur.fr	BOUSSO, Philippe/M-6547-2014; Lennon-Dumenil, Ana-Maria/I-6716-2016	BOUSSO, Philippe/0000-0002-6362-561X; Moreau, Helene/0000-0001-5715-6864; Terriac, Emmanuel/0000-0002-8769-242X; Azar, Georges/0000-0001-7946-0146	Center for Human Immunology (CIH) at Institut Pasteur; Institut Pasteur; Inserm; Fondation pour la Recherche Medicale; ANR "PiriBio"; Fondation Innabiosante; European Research Council	Center for Human Immunology (CIH) at Institut Pasteur; Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR "PiriBio"(French National Research Agency (ANR)); Fondation Innabiosante; European Research Council(European Research Council (ERC)European Commission)	We thank S. Moreau for writing the DISCit software, J. Di Santo and A. Alcover for discussions, and M. Albert and members of the P.B. lab for helpful comments on the manuscript. We acknowledge The Center for Human Immunology (CIH) at Institut Pasteur for support in conducting this study, with specific recognition of V. Libri and M. Hasan for their contributions. This work is supported by Institut Pasteur, Inserm, Fondation pour la Recherche Medicale, ANR "PiriBio," Fondation Innabiosante, and the European Research Council Starting Grants "LymphocyteContact" (P.B.) and "Strapacemi" (A.-M.L.-D.).	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Azar GA, 2010, P NATL ACAD SCI USA, V107, P3675, DOI 10.1073/pnas.0905901107; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Chen JL, 2010, J IMMUNOL, V184, P1829, DOI 10.4049/jimmunol.0902103; Clark CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018916; Corse E, 2011, J IMMUNOL, V186, P5039, DOI 10.4049/jimmunol.1003650; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Friedman RS, 2010, J EXP MED, V207, P2733, DOI 10.1084/jem.20091201; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; Wang XCL, 2003, J IMMUNOL METHODS, V280, P25, DOI 10.1016/S0022-1759(03)00079-6; Wei SH, 2007, J IMMUNOL, V179, P1586, DOI 10.4049/jimmunol.179.3.1586; Wensveen FM, 2010, IMMUNITY, V32, P754, DOI 10.1016/j.immuni.2010.06.005; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	39	120	121	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 24	2012	37	2					351	363		10.1016/j.immuni.2012.05.014	http://dx.doi.org/10.1016/j.immuni.2012.05.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22683126	Bronze			2022-12-18	WOS:000308261800018
J	Roberts, NA; White, AJ; Jenkinson, WE; Turchinovich, G; Nakamura, K; Withers, DR; McConnell, FM; Desanti, GE; Benezech, C; Parnell, SM; Cunningham, AF; Paolino, M; Penninger, JM; Simon, AK; Nitta, T; Ohigashi, I; Takahama, Y; Caamano, JH; Hayday, AC; Lane, PJL; Jenkinson, EJ; Anderson, G				Roberts, Natalie A.; White, Andrea J.; Jenkinson, William E.; Turchinovich, Gleb; Nakamura, Kyoko; Withers, David R.; McConnell, Fiona M.; Desanti, Guillaume E.; Benezech, Cecile; Parnell, Sonia M.; Cunningham, Adam F.; Paolino, Magdalena; Penninger, Josef M.; Simon, Anna Katharina; Nitta, Takeshi; Ohigashi, Izumi; Takahama, Yousuke; Caamano, Jorge H.; Hayday, Adrian C.; Lane, Peter J. L.; Jenkinson, Eric J.; Anderson, Graham			Rank Signaling Links the Development of Invariant gamma delta T Cell Progenitors and Aire(+) Medullary Epithelium	IMMUNITY			English	Article							PROMISCUOUS GENE-EXPRESSION; DENDRITIC EPIDERMAL-CELLS; AUTOIMMUNE REGULATOR; SELF-TOLERANCE; THYMIC MEDULLA; NEGATIVE SELECTION; POSITIVE SELECTION; CD4(+) THYMOCYTES; INDUCER CELLS; ROR-GAMMA	The thymic medulla provides a specialized microenvironment for the negative selection of T cells, with the presence of autoimmune regulator (Aire)-expressing medullary thymic epithelial cells (mTECs) during the embryonic-neonatal period being both necessary and sufficient to establish long-lasting tolerance. Here we showed that emergence of the first cohorts of Aire(+) mTECs at this key developmental stage, prior to alpha beta T cell repertoire selection, was jointly directed by Rankl(+) lymphoid tissue inducer cells and invariant V gamma 5(+) dendritic epidermal T cell (DETC) progenitors that are the first thymocytes to express the products of gene rearrangement. In turn, generation of Aire(+) mTECs then fostered Skint-1-dependent, but Aire-independent, DETC progenitor maturation and the emergence of an invariant DETC repertoire. Hence, our data attributed a functional importance to the temporal development of V gamma 5(+) gamma delta T cells during thymus medulla formation for alpha beta T cell tolerance induction and demonstrated a Rank-mediated reciprocal link between DETC and Aire(+) mTEC maturation.	[Roberts, Natalie A.; White, Andrea J.; Jenkinson, William E.; Nakamura, Kyoko; Withers, David R.; McConnell, Fiona M.; Desanti, Guillaume E.; Benezech, Cecile; Parnell, Sonia M.; Cunningham, Adam F.; Caamano, Jorge H.; Lane, Peter J. L.; Jenkinson, Eric J.; Anderson, Graham] Univ Birmingham, MRC Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; [Turchinovich, Gleb; Hayday, Adrian C.] Canc Res UK, London Res Inst, London WC2A 3LY, England; [Turchinovich, Gleb; Hayday, Adrian C.] Guys Hosp, Univ London Kings Coll, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Paolino, Magdalena; Penninger, Josef M.] Austrian Acad Sci, Inst Biotechnol, IMBA, A-1030 Vienna, Austria; [Simon, Anna Katharina] Univ Oxford, Nuffield Dept Med, Human Immunol Unit, Oxford OX3 9DS, England; [Nitta, Takeshi; Ohigashi, Izumi; Takahama, Yousuke] Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan	University of Birmingham; Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Oxford; Tokushima University	Anderson, G (corresponding author), Univ Birmingham, MRC Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England.	g.anderson@bham.ac.uk	Withers, David/C-7055-2015; Takahama, Yousuke/A-5863-2010; Caamano, Jorge/I-6778-2012; Penninger, Josef M/I-6860-2013; Nakamura, Kyoko/B-4184-2013; Paolino, Magdalena/AAN-9417-2020; Desanti, Guillaume/ABA-6731-2020; Anderson, Graham/K-2634-2012; Caamano, Jorge/O-7530-2019	Withers, David/0000-0003-3757-7594; Takahama, Yousuke/0000-0002-4992-9174; Caamano, Jorge/0000-0003-3530-7056; Penninger, Josef M/0000-0002-8194-3777; Desanti, Guillaume/0000-0003-4902-1868; Caamano, Jorge/0000-0003-3530-7056; HAYDAY, ADRIAN/0000-0002-9495-5793; Jenkinson, William/0000-0003-3422-8372; anderson, graham/0000-0002-2917-4085; Paolino, Magdalena/0000-0001-9724-9029; Cunningham, Adam/0000-0003-0248-964X; Simon, Anna Katharina/0000-0002-4077-7995; Benezech, Cecile/0000-0002-2613-1418; /0000-0001-9113-6306	MRC; Wellcome Trust; BBSRC [BB/D018234/1] Funding Source: UKRI; MRC [G0401620, G1000213, G1001055, G9818340] Funding Source: UKRI; Cancer Research UK [19309] Funding Source: researchfish; Medical Research Council [MR/J006742/1, G1001055, G9818340, G1000213, G0401620, G0600698B] Funding Source: researchfish; Grants-in-Aid for Scientific Research [23659241, 24111004] Funding Source: KAKEN	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank R. Bird for assistance with cell sorting and BMSU staff for excellent animal husbandry. This work was supported by an MRC Programme grant to E.J.J., P.J.L.L., and G.A. and a Wellcome Trust Programme to P.J.L.L. and G.A.	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; FARR A, 1990, J IMMUNOL, V144, P492; Finke D, 2002, IMMUNITY, V17, P363, DOI 10.1016/S1074-7613(02)00395-3; Gabler J, 2007, EUR J IMMUNOL, V37, P3363, DOI 10.1002/eji.200737131; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gommeaux J, 2009, EUR J IMMUNOL, V39, P956, DOI 10.1002/eji.200839175; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Naspetti M, 1997, EUR J IMMUNOL, V27, P1392, DOI 10.1002/eji.1830270615; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Ripen AM, 2011, EUR J IMMUNOL, V41, P1278, DOI 10.1002/eji.201041375; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; SURH CD, 1992, J EXP MED, V176, P495, DOI 10.1084/jem.176.2.495; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Tuovinen H, 2009, CELL IMMUNOL, V257, P5, DOI 10.1016/j.cellimm.2009.01.012; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; White AJ, 2008, EUR J IMMUNOL, V38, P942, DOI 10.1002/eji.200738052; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Zhu MZ, 2008, IMMUNITY, V29, P386, DOI 10.1016/j.immuni.2008.09.001; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	62	120	121	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					427	437		10.1016/j.immuni.2012.01.016	http://dx.doi.org/10.1016/j.immuni.2012.01.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22425250	hybrid, Green Submitted, Green Published			2022-12-18	WOS:000302048400014
J	Sathaliyawala, T; O'Gorman, WE; Greter, M; Bogunovic, M; Konjufca, V; Hou, ZE; Nolan, GP; Miller, MJ; Merad, M; Reizis, B				Sathaliyawala, Taheri; O'Gorman, William E.; Greter, Melanie; Bogunovic, Milena; Konjufca, Vjollca; Hou, Z. Esther; Nolan, Garry P.; Miller, Mark J.; Merad, Miriam; Reizis, Boris			Mammalian Target of Rapamycin Controls Dendritic Cell Development Downstream of Flt3 Ligand Signaling	IMMUNITY			English	Article							PLASMACYTOID PREDENDRITIC CELLS; COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; IN-VIVO; BONE-MARROW; T-CELLS; LISTERIA-MONOCYTOGENES; INFLAMMATORY RESPONSE; CD8(+); MICE	Dendritic cells (DCs) comprise distinct functional subsets including CD8(-) and CD8(+) classical DCs (cDCs) and interferon-secreting plasmacytoid DCs (pDCs) The cytokine Flt3 ligand (Flt3L) controls the development of DCs and is particularly important for the pDC and CD8(+) cDC and their CD103(+) tissue counterparts We report that mammalian target of rapamycin (mTOR) inhibitor rapamycin impaired Flt3L-driven DC development in vitro, with the pDCs and CD8(+)-like cDCs most profoundly affected Conversely, deletion of the phosphoinositide 3-kinase (PI3K)-mTOR negative regulator Pten facilitated Flt3L-driven DC development in culture DC-specific Pten targeting in vivo caused the expansion of CD8(+) and CD103(+) cDC numbers, which was reversible by rapamycin The increased CD8(+) cDC numbers caused by Pten deletion correlated with increased susceptibility to the intracellular pathogen Listeria Thus, PI3K-mTOR signaling downstream of Flt3L controls DC development, and its restriction by Pten ensures optimal DC pool size and subset composition	[Sathaliyawala, Taheri; Hou, Z. Esther; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [O'Gorman, William E.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Greter, Melanie; Bogunovic, Milena; Merad, Miriam] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Greter, Melanie; Bogunovic, Milena; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Konjufca, Vjollca; Miller, Mark J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Columbia University; Stanford University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL)	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.		Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043; Miller, Mark/0000-0001-5676-389X; Reizis, Boris/0000-0003-1140-7853; Konjufca, Vjollca/0000-0002-7736-5097; Greter, Melanie/0000-0002-7220-5369	American Asthma Foundation; NIH [AI067804, AI072571, AI057229, HHSN272200700038C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085439, R01AI077600, U19AI057229, R21AI067804, R01AI072571, R37AI072571] Funding Source: NIH RePORTER	American Asthma Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A Ferrando T Diacovo and T Ludwig for animal strains N Serbina for LM OVA A Fay and J Dworkin for help with bacterial culture E Simonds for technical assistance and the Reizis lab members for help and discussions This work was supported by the SPAR American Asthma Foundation Award (B R) NIH grants AI067804 and AI072571 (B R) AI057229 and HHSN272200700038C (G P N) Technologies associated with phospho flow are licensed in part to BD Biosciences and G P N is a consultant for BD Biosciences a supplier of the reagents used in this report	Alaniz RC, 2004, J IMMUNOL, V172, P3725, DOI 10.4049/jimmunol.172.6.3725; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Aoshi T, 2009, EUR J IMMUNOL, V39, P417, DOI 10.1002/eji.200838718; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bedoui S, 2009, J IMMUNOL, V182, P4200, DOI 10.4049/jimmunol.0802286; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudani R, 2002, J IMMUNOL, V168, P5737, DOI 10.4049/jimmunol.168.11.5737; Eidenschenk C, 2010, P NATL ACAD SCI USA, V107, P9759, DOI 10.1073/pnas.1005186107; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mach N, 2000, CANCER RES, V60, P3239; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Mohi MG, 2004, P NATL ACAD SCI USA, V101, P3130, DOI 10.1073/pnas.0400063101; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; O'Keeffe M, 2002, BLOOD, V99, P2122, DOI 10.1182/blood.V99.6.2122; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tussiwand R, 2005, J IMMUNOL, V175, P3674, DOI 10.4049/jimmunol.175.6.3674; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vollstedt S, 2004, EUR J IMMUNOL, V34, P1849, DOI 10.1002/eji.200324443; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Winter C, 2007, J IMMUNOL, V179, P3099, DOI 10.4049/jimmunol.179.5.3099; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	49	120	120	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					597	606		10.1016/j.immuni.2010.09.012	http://dx.doi.org/10.1016/j.immuni.2010.09.012			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	20933441	Green Accepted, Bronze			2022-12-18	WOS:000284300200016
J	Kumanogoh, A; Shikina, T; Suzuki, K; Uematsu, S; Yukawa, K; Kashiwamura, SI; Tsutsui, H; Yamamoto, M; Takamatsu, H; Ko-Mitamura, EP; Takegahara, N; Marukawa, S; Ishida, I; Morishita, H; Prasad, DVR; Tamura, M; Mizui, M; Toyofuku, T; Akira, S; Takeda, K; Okabe, M; Kikutani, H				Kumanogoh, A; Shikina, T; Suzuki, K; Uematsu, S; Yukawa, K; Kashiwamura, SI; Tsutsui, H; Yamamoto, M; Takamatsu, H; Ko-Mitamura, EP; Takegahara, N; Marukawa, S; Ishida, I; Morishita, H; Prasad, DVR; Tamura, M; Mizui, M; Toyofuku, T; Akira, S; Takeda, K; Okabe, M; Kikutani, H			Nonredundant roles of Sema4A in the immune system: Defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice	IMMUNITY			English	Article							IV SEMAPHORIN CD100; TIM GENE FAMILY; DENDRITIC CELLS; TRANSCRIPTION FACTOR; B-CELL; RECEPTOR; BET; ACTIVATION; INDUCTION; DISEASE	The class IV semaphorin Sema4A provides a costimulatory signal to T cells. To investigate the possible developmental and regulatory roles of Sema4A in vivo, we generated Sema4A-deficient mice. Although Sema4A-deficient mice develop normally, DCs and T cells from knockout mice display poor allostimulatory activities and T helper cell (Th) differentiation, respectively. Interestingly, in addition to its expression on DCs, Sema4A is upregulated on Th1-differentiating cells, and it is necessary for in vitro Th1 differentiation and T-bet expression. Consequently, in vivo antigen-specific T cell priming and antibody responses against T cell-dependent antigens are impaired in the mutant mice. Additionally, Sema4A-deficient mice exhibit defective Th1 responses. Furthermore, reconstitution studies with antigen-pulsed DCs reveal that DC-derived Sema4A is important for T cell priming, while T cell-derived Sema4A is involved in developing Th1 responses. Collectively, these results indicate a nonredundant role of Sema4A not only in T cell priming, but also in the regulation of Th1/Th2 responses.	Osaka Univ, Dept Mol Immunol, Suita, Osaka 5650871, Japan; Osaka Univ, CREST Program, JST, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Host Def, Suita, Osaka 5650871, Japan; Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; Wakayama Med Coll, Dept Physiol 2, Wakayama 6410012, Japan; Hyogo Med Univ, Inst Adv Med Sci, Host Def Lab, Nishinomiya, Hyogo 6638501, Japan; Hyogo Med Univ, Inst Adv Med Sci, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan; Osaka Univ, Grad Sch Med, Dept Otolaryngol & Sensory Organ Surg E8, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan; Kyushu Univ, Med Inst Bioregulat, Devis Embry & Genet Engn, Higashi Ku, Fukuoka 8128582, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Osaka University; Wakayama Medical University; Hyogo College of Medicine; University of Hyogo; Hyogo College of Medicine; University of Hyogo; Osaka University; Osaka University; Kyushu University	Kikutani, H (corresponding author), Osaka Univ, Dept Mol Immunol, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	kikutani@ragtime.biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Kikutani, Hitoshi/C-9525-2009; Suzuki, Kazuhiro/B-3886-2012; Takeda, Kiyoshi/C-9331-2009; Mizui, Masayuki/AAD-1432-2019; Takegahara, Noriko/AAP-1694-2021; Kumanogoh, Atsushi/C-7354-2009; Okabe, Masaru/B-6917-2015	Mizui, Masayuki/0000-0003-2543-8108; Okabe, Masaru/0000-0002-0803-9044; Takeda, Kiyoshi/0000-0002-1778-6332; Tsutsui, Hiroko/0000-0001-7928-4875; Suzuki, Kazuhiro/0000-0002-9081-538X				Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Chae SC, 2003, BIOCHEM BIOPH RES CO, V312, P346, DOI 10.1016/j.bbrc.2003.10.125; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Hatton RD, 2003, SCIENCE, V302, P993, DOI 10.1126/science.1092040; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Kumanogoh A, 2003, J CELL SCI, V116, P3463, DOI 10.1242/jcs.00674; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; MacDonald AS, 2002, J IMMUNOL, V168, P537, DOI 10.4049/jimmunol.168.2.537; McIntire JJ, 2003, NATURE, V425, P576, DOI 10.1038/425576a; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	32	120	133	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					305	316		10.1016/j.immuni.2005.01.014	http://dx.doi.org/10.1016/j.immuni.2005.01.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780988	Bronze			2022-12-18	WOS:000228105700006
J	Depoil, D; Zaru, R; Guiraud, M; Chauveau, A; Harriague, J; Bismuth, G; Utzny, C; Muller, S; Valitutti, S				Depoil, D; Zaru, R; Guiraud, M; Chauveau, A; Harriague, J; Bismuth, G; Utzny, C; Muller, S; Valitutti, S			Immunological synapses are versatile structures enabling selective T cell polarization	IMMUNITY			English	Article							LYMPHOCYTE ACTIVATION; ANTIGEN PRESENTATION; DENDRITIC CELLS; CUTTING EDGE; RECEPTOR; COMPLEXES; CYTOSKELETON; SEGREGATION; LIGANDS; SURFACE	Helper T cells discriminate among different antigen-presenting cells to provide their help in a selective fashion. The molecular mechanisms leading to this exquisite selectivity are still elusive. Here, we demonstrate that immunological synapses are dynamic and adaptable structures allowing T cells to communicate with multiple cells. We show that T cells can form simultaneous immunological synapses with cells presenting different levels of antigenic ligands but eventually polarize toward the strongest stimulus. Remarkably, living T cells form discrete foci of signal transduction of different intensities during the interaction with different antigen-presenting cells and rapidly relocate TCR and Golgi apparatus toward the cell providing the strongest stimulus. Our results illustrate that, although T cell activation requires sustained signaling, T cells are capable of rapid synapse remodeling and swift polarization responses. The combination of sustained signaling with preferential and rapid polarization provides a mechanism for the high sensitivity and selectivity of T cell responses.	Inst Claude de Preval, INSERM, U563, F-31059 Toulouse, France; CNRS, UMR 8104, Inst Cochin, INSERM,U567, Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Valitutti, S (corresponding author), Inst Claude de Preval, INSERM, U563, F-31059 Toulouse, France.	svalitu@toulouse.inserm.fr	Valitutti, Salvatore/M-2999-2014	Valitutti, Salvatore/0000-0002-6432-4421; Zaru, Rossana/0000-0002-3358-4423; Harriague, Julie/0000-0001-6824-9169; Muller, Sabina/0000-0002-4580-2758				Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Favier B, 2001, INT IMMUNOL, V13, P1525, DOI 10.1093/intimm/13.12.1525; Gascoigne NRJ, 2004, CURR OPIN IMMUNOL, V16, P114, DOI 10.1016/j.coi.2003.11.008; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Hertz CJ, 2001, J IMMUNOL, V166, P2444, DOI 10.4049/jimmunol.166.4.2444; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; LANZAVECCHIA A, 1987, EUR J IMMUNOL, V17, P105, DOI 10.1002/eji.1830170118; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; ROTHSTEIN TL, 1978, J IMMUNOL, V121, P1652; Trautmann A, 2003, CURR OPIN IMMUNOL, V15, P249, DOI 10.1016/S0952-7915(03)00040-2; Valitutti S, 1996, EUR J IMMUNOL, V26, P2012, DOI 10.1002/eji.1830260907; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1; Zaru R, 2002, J IMMUNOL, V168, P4287, DOI 10.4049/jimmunol.168.9.4287	31	120	124	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					185	194		10.1016/j.immuni.2004.12.010	http://dx.doi.org/10.1016/j.immuni.2004.12.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723807	Bronze			2022-12-18	WOS:000227509600005
J	Nurieva, RI; Duong, J; Kishikawa, H; Dianzani, U; Rojo, JM; Ho, IC; Flavell, RA; Dong, C				Nurieva, RI; Duong, J; Kishikawa, H; Dianzani, U; Rojo, JM; Ho, IC; Flavell, RA; Dong, C			Transcriptional regulation of Th2 differentiation by inducible costimulator	IMMUNITY			English	Article							T-CELL ACTIVATION; IMMUNE-RESPONSES; MOLECULE ICOS; CUTTING EDGE; HISTONE ACETYLATION; GENE-EXPRESSION; CYTOKINE GENES; FACTOR GATA-3; C-MAF; IL-4	Helper T (Th) cell differentiation is accompanied by complex transcriptional changes. Although costimulatory receptors are important in Th differentiation, the underlying mechanisms are poorly understood. Here we examine the transcriptional mechanisms by which ICOS regulates Th2 differentiation and selective IL-4 expression by effector T cells. We found impaired expression of c-Maf transcription factor functionally associated with the IL-4 defect in ICOS-/- cells. c-Maf expression in effector cells was regulated by IL-4 levels during Th differentiation. ICOS costimulation potentiated the T cell receptor (TcR)-mediated initial IL-4 production, possibly through the enhancement of NFATc1 expression. These data indicate that ICOS, by enhancing TcR signals at an early stage of T cell activation, regulates IL-4 transcription and T cell function in effector cells.	Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; A Avogadro Univ Eastern Piedmont, Interdisciplinary Res Ctr Autoimmune Dis, I-28100 Novara, Italy; A Avogadro Univ Eastern Piedmont, Dept Med Sci, I-28100 Novara, Italy; CSIC, Ctr Invest Biol, Dept Immunol, E-28006 Madrid, Spain; Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Div Immunobiol, New Haven, CT 06520 USA	University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Yale University	Dong, C (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.		Dianzani, Umberto/K-1952-2016; dong, chen/B-3181-2009; Rojo, Jose/ABH-1189-2020	dong, chen/0000-0002-0084-9130; DIANZANI, Umberto/0000-0001-6723-3931; Rojo, Jose M./0000-0001-9032-0072				Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Buonfiglio D, 2000, EUR J IMMUNOL, V30, P3463, DOI 10.1002/1521-4141(2000012)30:12<3463::AID-IMMU3463>3.0.CO;2-5; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chow CW, 2000, MOL CELL BIOL, V20, P5227, DOI 10.1128/MCB.20.14.5227-5234.2000; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; DONG C, 2000, SCI STKE, pE1; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Glimcher LH, 2000, GENE DEV, V14, P1693; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Lee CY, 2001, J SCHED, V4, P3, DOI 10.1002/1099-1425(200101/02)4:1<3::AID-JOS57>3.0.CO;2-D; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Redoglia V, 1996, EUR J IMMUNOL, V26, P2781, DOI 10.1002/eji.1830261134; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	57	120	124	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2003	18	6					801	811		10.1016/S1074-7613(03)00144-4	http://dx.doi.org/10.1016/S1074-7613(03)00144-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818161	Green Submitted, Bronze			2022-12-18	WOS:000183767700010
J	York, IA; Mo, AXY; Lemerise, K; Zeng, WY; Shen, YL; Abraham, CR; Saric, T; Goldberg, AL; Rock, KL				York, IA; Mo, AXY; Lemerise, K; Zeng, WY; Shen, YL; Abraham, CR; Saric, T; Goldberg, AL; Rock, KL			The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; DISTINCT PROTEOLYTIC PROCESSES; MONOCLONAL-ANTIBODIES; T-CELLS; ENDOPLASMIC-RETICULUM; GENERATION; DEGRADATION; PROTEASOME; ENZYME; METALLOENDOPEPTIDASE	Most antigenic peptides presented on MHC class I molecules are generated by proteasomes during protein breakdown. It is unknown whether these peptides are protected from destruction by cytosolic peptidases. In cytosolic extracts, most antigenic peptides are degraded by the metalloendopeptidase, thimet oilgopeptidase (TOP). We therefore examined whether TOP destroys antigenic peptides in vivo. When TOP was overexpressed in cells, class I presentation of antigenic peptides was reduced. In contrast, TOP overexpression didn't reduce presentation of peptides generated in the endoplasmic reticulum or endosomes. Conversely, preventing TOP expression with siRNA enhanced presentation of antigenic peptides. TOP therefore plays an important role in vivo in degrading peptides released by proteasomes and is a significant factor limiting the extent of antigen presentation.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02155 USA; Boston Univ, Sch Med, Dept Biochem & Med, Boston, MA 02118 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Boston University	Rock, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	kenneth.rock@umassmed.edu	York, Ian/X-9351-2019; Saric, Tomo/B-3415-2015	York, Ian/0000-0002-3478-3344; Saric, Tomo/0000-0001-8344-1095; Abraham, Carmela/0000-0002-6649-1960				ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; Anton LC, 1997, J IMMUNOL, V158, P2535; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; BUCHLER M, 1994, EUR J BIOCHEM, V219, P627, DOI 10.1111/j.1432-1033.1994.tb19978.x; Camargo ACM, 1997, BIOCHEM J, V324, P517, DOI 10.1042/bj3240517; CARVALHO KM, 1981, BIOCHEMISTRY-US, V20, P7082, DOI 10.1021/bi00528a005; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; COLE GA, 1994, INT IMMUNOL, V6, P1767, DOI 10.1093/intimm/6.11.1767; Conn KJ, 1996, J NEUROCHEM, V66, P2011; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; DECKHUT AM, 1993, J IMMUNOL, V151, P2658; DIMENT S, 1990, J IMMUNOL, V145, P417; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Hirsch C, 2000, TRENDS CELL BIOL, V10, P268, DOI 10.1016/S0962-8924(00)01768-2; JONES B, 1981, NATURE, V292, P547, DOI 10.1038/292547a0; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; Mo XY, 1999, J IMMUNOL, V163, P5851; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; OZATO K, 1980, J IMMUNOL, V124, P533; PARHAM P, 1979, J IMMUNOL, V123, P342; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; PETERSON M, 1992, NATURE, V357, P596, DOI 10.1038/357596a0; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Portaro FCV, 1999, BIOCHEM BIOPH RES CO, V255, P596, DOI 10.1006/bbrc.1999.0251; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SHIMONKEVITZ R, 1983, J EXP MED, V158, P303, DOI 10.1084/jem.158.2.303; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; STAM NJ, 1986, J IMMUNOL, V137, P2299; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Townsend A, 1993, Semin Cell Biol, V4, P53, DOI 10.1006/scel.1993.1007; VIDARD L, 1991, J IMMUNOL, V147, P1786; VILLANUEVA MS, 1994, IMMUNITY, V1, P479, DOI 10.1016/1074-7613(94)90090-6; Vincent B, 1997, EUR J PHARMACOL, V334, P49, DOI 10.1016/S0014-2999(97)01209-0; Yamin R, 1999, J BIOL CHEM, V274, P18777, DOI 10.1074/jbc.274.26.18777; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	49	120	122	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					429	440		10.1016/S1074-7613(03)00058-X	http://dx.doi.org/10.1016/S1074-7613(03)00058-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648459	Bronze			2022-12-18	WOS:000181713700012
J	Manis, JP; Dudley, D; Kaylor, L; Alt, FW				Manis, JP; Dudley, D; Kaylor, L; Alt, FW			IgH class switch recombination to IgG1 in DNA-PKcs-deficient B cells	IMMUNITY			English	Article							CYTIDINE DEAMINASE AID; DOUBLE-STRAND BREAKS; V(D)J RECOMBINATION; SOMATIC HYPERMUTATION; CIRCULAR DNA; IMMUNOGLOBULIN GENES; EMBRYONIC LETHALITY; CATALYTIC SUBUNIT; MICE DEFICIENT; SCID MICE	To assess the role of the DNA-PKcs nonhomologous DNA end-joining (NHEJ) protein in Ig heavy chain class switch recombination (CSR), we assayed CSR ability of DNA-PKcs-deficient (DP-T) B cells generated via complementation of DP-T mice with Ig heavy chain and light chain knockin transgenes (DP-T/HC/LC mice). DP-T/HC/LC mice were severely deficient for all serum IgH isotypes except IgM and, unexpectedly, IgG1. Upon appropriate stimulation, DP-T/HC/LC B cells showed normal proliferation, germline CH gene transcription, and AID induction, indicating that DNA-PKcs deficiency did not affect cellular events upstream to CSR. Yet, in vitro activated DP-T/HC/LC B cells again underwent switching only to IgG1 and, like wild-type cells, frequently underwent CSR to gamma1 on both chromosomes. We conclude that DNA-PKcs is required for CSR to most C-H genes but that CSR to gamma1 occurs via a DNA-PKcs-independent mechanism.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 300 Longwood Ave, Boston, MA 02115 USA.				NIAID NIH HHS [AI 31541] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031541, U19AI031541] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ballantyne J, 1998, J IMMUNOL, V161, P1336; Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509; Bogue MA, 1998, P NATL ACAD SCI USA, V95, P15559, DOI 10.1073/pnas.95.26.15559; BOSMA GC, 1988, J EXP MED, V167, P1016, DOI 10.1084/jem.167.3.1016; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Bottaro A, 1998, INT IMMUNOL, V10, P799, DOI 10.1093/intimm/10.6.799; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CHANG Y, 1995, IMMUNITY, V2, P607, DOI 10.1016/1074-7613(95)90005-5; Chu WM, 2000, CELL, V103, P909, DOI 10.1016/S0092-8674(00)00194-X; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Cunningham K, 1998, INT IMMUNOL, V10, P527, DOI 10.1093/intimm/10.4.527; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Ehrenstein MR, 2001, P NATL ACAD SCI USA, V98, P14553, DOI 10.1073/pnas.241525998; Featherstone C, 1999, CURR BIOL, V9, pR759, DOI 10.1016/S0960-9822(00)80005-6; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gu YS, 2000, P NATL ACAD SCI USA, V97, P2668, DOI 10.1073/pnas.97.6.2668; Hempel WM, 1998, GENE DEV, V12, P2305, DOI 10.1101/gad.12.15.2305; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; Jacobs H, 2001, CURR OPIN IMMUNOL, V13, P208, DOI 10.1016/S0952-7915(00)00206-5; Kinoshita K, 1999, COLD SPRING HARB SYM, V64, P217, DOI 10.1101/sqb.1999.64.217; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Lin SC, 1996, MOL CELL BIOL, V16, P4591; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; LUNDGREN M, 1995, EUR J IMMUNOL, V25, P2042, DOI 10.1002/eji.1830250736; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; RADBRUCH A, 1986, P NATL ACAD SCI USA, V83, P3954, DOI 10.1073/pnas.83.11.3954; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Sekiguchi JM, 1999, COLD SPRING HARB SYM, V64, P169, DOI 10.1101/sqb.1999.64.169; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Storb U, 1996, CURR OPIN IMMUNOL, V8, P206, DOI 10.1016/S0952-7915(96)80059-8; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; WINTER E, 1987, EMBO J, V6, P1663, DOI 10.1002/j.1460-2075.1987.tb02415.x; Wuerffel RA, 1997, J IMMUNOL, V159, P4139	59	120	120	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2002	16	4					607	617		10.1016/S1074-7613(02)00306-0	http://dx.doi.org/10.1016/S1074-7613(02)00306-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970883	Bronze			2022-12-18	WOS:000175109600011
J	Boyington, JC; Riaz, AN; Patamawenu, A; Coligan, JE; Brooks, AG; Sun, PD				Boyington, JC; Riaz, AN; Patamawenu, A; Coligan, JE; Brooks, AG; Sun, PD			Structure of CD94 reveals a novel C-type lectin fold: Implications for the NK cell-associated CD94/NKG2 receptors	IMMUNITY			English	Article							MANNOSE-BINDING PROTEIN; NATURAL-KILLER-CELLS; HELICAL COILED-COIL; CRYSTAL-STRUCTURE; INHIBITORY RECEPTOR; RECOGNITION; DOMAIN; COMPLEX; MOLECULES	The crystal structure of the extracellular domain of CD94, a component of the CD94/NKG2 NK cell receptor, has been determined to 2.6 Angstrom resolution, revealing a unique variation of the C-type lectin fold. In this variation, the second cu helix, corresponding to residues 102-112, is replaced by a loop, the putative carbohydrate-binding site is significantly altered, and the Ca2+-binding site appears nonfunctional. This structure may serve as a prototype for other NK cell receptors such as Ly-49, NKR-P1, and CD69. The CD94 dimer observed in the crystal has an extensive hydrophobic interface that stabilizes the loop conformation of residues 102-112. The formation of this dimer reveals a putative ligand-binding region for HLA-E and suggests how NKG2 interacts with CD94.	NIAID, Struct Biol Sect, Off Sci Director, NIH, Rockville, MD 20852 USA; NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sun, PD (corresponding author), NIAID, Struct Biol Sect, Off Sci Director, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	sun@magenta.niaid.nih.gov		Brooks, Andrew/0000-0002-4085-9683	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000697, Z01AI000697] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARAMBURU J, 1990, J IMMUNOL, V144, P3238; Bertrand JA, 1996, EMBO J, V15, P2678, DOI 10.1002/j.1460-2075.1996.tb00628.x; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Cantoni C, 1998, EUR J IMMUNOL, V28, P327, DOI 10.1002/(SICI)1521-4141(199801)28:01<327::AID-IMMU327>3.0.CO;2-O; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; *CCP4, 1995, ACTA CRYSTALLOGR D, V50, P760; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DRICKAMER K, 1993, CURR OPIN STRUC BIOL, V3, P393, DOI 10.1016/S0959-440X(05)80112-5; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Gronwald W, 1998, BIOCHEMISTRY-US, V37, P4712, DOI 10.1021/bi972788c; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lazetic S, 1996, J IMMUNOL, V157, P4741; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1997, CURR OPIN IMMUNOL, V9, P344, DOI 10.1016/S0952-7915(97)80080-5; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mizuno H, 1997, NAT STRUCT BIOL, V4, P438, DOI 10.1038/nsb0697-438; Moretta A, 1997, CURR OPIN IMMUNOL, V9, P694, DOI 10.1016/S0952-7915(97)80051-9; Ng KKS, 1996, J BIOL CHEM, V271, P663, DOI 10.1074/jbc.271.2.663; Nielsen BB, 1997, FEBS LETT, V412, P388, DOI 10.1016/S0014-5793(97)00664-9; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pende D, 1998, EUR J IMMUNOL, V28, P2384, DOI 10.1002/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Smith KM, 1998, J IMMUNOL, V161, P7; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x	43	120	124	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1999	10	1					75	82		10.1016/S1074-7613(00)80008-4	http://dx.doi.org/10.1016/S1074-7613(00)80008-4			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023772	Bronze			2022-12-18	WOS:000078428700008
J	Mosyak, L; Zaller, DM; Wiley, DC				Mosyak, L; Zaller, DM; Wiley, DC			The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation	IMMUNITY			English	Article							INVARIANT CHAIN PEPTIDES; DR MOLECULES; CRYSTAL-STRUCTURE; PROCESSING MUTANT; LYSOSOMAL PH; BINDING; HLA-DR1; DISSOCIATION; EXPRESSION; ALPHA	The three-dimensional structure of the soluble ectodomain of HLA-DM has been determined to 2.5 Angstrom resolution by X-ray crystallography. HLA-DM has both peptide exchange activity and acts as a chaperone to peptide-free class II MHC molecules. As predicted, the structure is similar to that of classical class II MHC molecules except that the peptide-binding site is altered to an almost fully closed groove. An unusual cavity is found at the center of the region that binds peptides in class II MHC molecules, and a tryptophan-rich lateral surface is identified that is a candidate both for binding to HLA-DR, to effect catalysis, and to HLA-DO, an inhibitor.	Harvard Univ, Howard Hughes Med Inst, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA; Merck Res Labs, Dept Mol Immunol, Rahway, NJ 07065 USA	Harvard University; Howard Hughes Medical Institute; Merck & Company	Mosyak, L (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA.							BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Busch R, 1998, J IMMUNOL, V160, P734; Busch R, 1996, CURR OPIN IMMUNOL, V8, P51, DOI 10.1016/S0952-7915(96)80105-1; BUSCH R, 1998, IN PRESS J BIOL CHEM; BUUS S, 1988, SCIENCE, V242, P1045, DOI 10.1126/science.3194755; BUUS S, 1987, IMMUNOL REV, V98, P115, DOI 10.1111/j.1600-065X.1987.tb00522.x; CHO SG, 1991, NATURE, V353, P573, DOI 10.1038/353573a0; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1997, SCIENCE, V278, P106, DOI 10.1126/science.278.5335.106; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Douek DC, 1997, INT IMMUNOL, V9, P355, DOI 10.1093/intimm/9.3.355; FING SP, 1994, NATURE, V368, P554; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Guerra CB, 1998, J IMMUNOL, V160, P4289; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Liljedahl M, 1996, EMBO J, V15, P4817, DOI 10.1002/j.1460-2075.1996.tb00862.x; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; PARK SJ, 1995, P NATL ACAD SCI USA, V92, P11289, DOI 10.1073/pnas.92.24.11289; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; STRYER L, 1981, BIOCHEMISTRY-US, P220; TONNELLE C, 1985, EMBO J, V4, P2839, DOI 10.1002/j.1460-2075.1985.tb04012.x; TROWSDALE J, 1985, EMBO J, V4, P2231, DOI 10.1002/j.1460-2075.1985.tb03919.x; Ullrich HJ, 1997, P NATL ACAD SCI USA, V94, P13163, DOI 10.1073/pnas.94.24.13163; vanHam SM, 1997, CURR BIOL, V7, P950, DOI 10.1016/S0960-9822(06)00414-3; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; WATTS TH, 1986, P NATL ACAD SCI USA, V83, P9660, DOI 10.1073/pnas.83.24.9660; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; WEI YY, 1995, NAT STRUCT BIOL, V2, P218, DOI 10.1038/nsb0395-218; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	52	120	126	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1998	9	3					377	383		10.1016/S1074-7613(00)80620-2	http://dx.doi.org/10.1016/S1074-7613(00)80620-2			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768757	Bronze			2022-12-18	WOS:000076202300010
J	Logtenberg, MEW; Scheeren, FA; Schumacher, TN				Logtenberg, Meike E. W.; Scheeren, Ferenc A.; Schumacher, Ton N.			The CD47-SIRP alpha Immune Checkpoint	IMMUNITY			English	Review							SIGNAL-REGULATORY-PROTEIN; HEMATOPOIETIC STEM-CELLS; CD47 BLOCKADE; DOWN-REGULATION; TARGETING CD47; ALPHA; PHAGOCYTOSIS; EXPRESSION; CANCER; MACROPHAGES	The cytotoxic activity of myeloid cells is regulated by a balance of signals that are transmitted through inhibitory and activating receptors. The Cluster of Differentiation 47 (CD47) protein, expressed on both healthy and cancer cells, plays a pivotal role in this balance by delivering a "don't eat me signal'' upon binding to the Signal-regulatory protein alpha (SIRP alpha) receptor on myeloid cells. Here, we review the current understanding of the role of the CD47-SIRP alpha axis in physiological tissue homeostasis and as a promising therapeutic target in, among others, oncology, fibrotic diseases, atherosclerosis, and stem cell therapies. We discuss gaps in understanding and highlight where additional insight will be beneficial to allow optimal exploitation of this myeloid cell checkpoint as a target in human disease.	[Logtenberg, Meike E. W.; Schumacher, Ton N.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Scheeren, Ferenc A.] Leiden Univ, Dept Med Oncol, Med Ctr LUMC, Leiden, Netherlands; [Schumacher, Ton N.] Leiden Univ, Dept Immunohematol & Bloodtransfus, Med Ctr, Leiden, Netherlands	Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schumacher, TN (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.; Schumacher, TN (corresponding author), Leiden Univ, Dept Immunohematol & Bloodtransfus, Med Ctr, Leiden, Netherlands.	t.schumacher@nki.nl	Schumacher, Ton/Y-2432-2019	Schumacher, Ton/0000-0003-0517-8804; Logtenberg, Meike/0000-0002-8981-1189; Scheeren, Ferenc/0000-0002-8304-9023	ERC AdG SENSIT; Leiden University Medical Center fellowship; KWF [12629]	ERC AdG SENSIT; Leiden University Medical Center fellowship; KWF	The authors would like to thank L. Meyaard, K. Franke, A. van der Leun, and A. Sahillioglu for input and insightful discussions. This work was supported by ERC AdG SENSIT to T.N.S, Leiden University Medical Center fellowship to F.A.S., and KWF grant 12629 to F.A.S.	Adams S, 1998, J IMMUNOL, V161, P1853; Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Autio KA, 2020, CLIN CANCER RES, V26, P984, DOI 10.1158/1078-0432.CCR-19-1457; Barcellini W, 2015, TRANSFUS MED HEMOTH, V42, P287, DOI 10.1159/000439002; Barkal AA, 2019, NATURE, V572, P392, DOI 10.1038/s41586-019-1456-0; Barkal AA, 2018, NAT IMMUNOL, V19, P76, DOI 10.1038/s41590-017-0004-z; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Betancur PA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14802; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Brightwell RM, 2016, GYNECOL ONCOL, V143, P393, DOI 10.1016/j.ygyno.2016.08.325; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Buatois V, 2018, MOL CANCER THER, V17, P1739, DOI 10.1158/1535-7163.MCT-17-1095; CAMPBELL IG, 1992, CANCER RES, V52, P5416; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chao MP, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01380; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen J, 2017, NATURE, V544, P493, DOI 10.1038/nature22076; Chhabra A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aae0501; Deuse T, 2019, NAT BIOTECHNOL, V37, P252, DOI 10.1038/s41587-019-0016-3; Dheilly E, 2017, MOL THER, V25, P523, DOI 10.1016/j.ymthe.2016.11.006; Dong LW, 2008, MOL IMMUNOL, V45, P3025, DOI 10.1016/j.molimm.2008.03.012; Feng MY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05211-7; Fischer N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7113; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; George BM, 2019, CELL STEM CELL, V25, P185, DOI 10.1016/j.stem.2019.05.018; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Hatherley D, 2014, J BIOL CHEM, V289, P10024, DOI 10.1074/jbc.M114.550558; He Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08013-z; Ho CCM, 2015, J BIOL CHEM, V290, P12650, DOI 10.1074/jbc.M115.648220; Ichigotani Y, 2000, J HUM GENET, V45, P378, DOI 10.1007/s100380070013; Ingram JR, 2017, P NATL ACAD SCI USA, V114, P10184, DOI 10.1073/pnas.1710776114; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Johnson LDS, 2019, BLOOD ADV, V3, P1145, DOI 10.1182/bloodadvances.2018030577; Kasikara C, 2018, J CLIN INVEST, V128, P2713, DOI 10.1172/JCI97950; KAY MMB, 1984, P NATL ACAD SCI-BIOL, V81, P5753, DOI 10.1073/pnas.81.18.5753; Khandelwal S, 2007, TRANSFUSION, V47, P1725, DOI 10.1111/j.1537-2995.2007.01348.x; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kojima Y, 2016, NATURE, V536, P86, DOI 10.1038/nature18935; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Kuriyama T, 2012, BLOOD, V120, P4058, DOI 10.1182/blood-2012-02-408864; Lehrman EK, 2018, NEURON, V100, P120, DOI 10.1016/j.neuron.2018.09.017; Li Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14102-4; Liu F, 2017, ONCOTARGET, V8, P69477, DOI 10.18632/oncotarget.17704; Liu H., 2015, MOL CELLULAR PROTEOM; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Logtenberg MEW, 2019, NAT MED, V25, P612, DOI 10.1038/s41591-019-0356-z; Londino JD, 2015, J BIOL CHEM, V290, P31113, DOI 10.1074/jbc.M115.682914; Lutz HU, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00387; Ma LL, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-0571-2; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Mushegian A, 2002, PROTEINS, V47, P69, DOI 10.1002/prot.10073; Myers LM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08637-9; Oldenborg PA, 2002, BLOOD, V99, P3500, DOI 10.1182/blood.V99.10.3500; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Oldenborg Per-Arne, 2013, ISRN Hematol, V2013, P614619, DOI 10.1155/2013/614619; Olsson M, 2005, BLOOD, V105, P3577, DOI 10.1182/blood-2004-08-2980; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Petrova PS, 2017, CLIN CANCER RES, V23, P1068, DOI 10.1158/1078-0432.CCR-16-1700; Piccione EC, 2016, CLIN CANCER RES, V22, P5109, DOI 10.1158/1078-0432.CCR-15-2503; Piccione EC, 2015, MABS-AUSTIN, V7, P946, DOI 10.1080/19420862.2015.1062192; Ponce LP, 2017, ONCOTARGET, V8, P11284, DOI 10.18632/oncotarget.14500; REINHOLD MI, 1995, J CELL SCI, V108, P3419; Ring NG, 2017, P NATL ACAD SCI USA, V114, pE10578, DOI 10.1073/pnas.1710877114; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Sim J, 2019, MABS-AUSTIN, V11, P1036, DOI 10.1080/19420862.2019.1624123; Sockolosky JT, 2016, P NATL ACAD SCI USA, V113, pE2646, DOI 10.1073/pnas.1604268113; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Strauss L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay1863; Subramanian S, 2006, BLOOD CELL MOL DIS, V36, P364, DOI 10.1016/j.bcmd.2006.01.012; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Suzuki S, 2012, ONCOL REP, V28, P465, DOI 10.3892/or.2012.1831; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Toth AB, 2013, NAT NEUROSCI, V16, P1417, DOI 10.1038/nn.3516; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Voets E, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0772-0; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Wernig G, 2017, P NATL ACAD SCI USA, V114, P4757, DOI 10.1073/pnas.1621375114; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200; Yang SY, 2015, ONCOTARGET, V6, P43712, DOI 10.18632/oncotarget.6227; Zen K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3436; Zhang HM, 2015, P NATL ACAD SCI USA, V112, pE6215, DOI 10.1073/pnas.1520032112; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	96	119	122	13	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					742	752		10.1016/j.immuni.2020.04.011	http://dx.doi.org/10.1016/j.immuni.2020.04.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433947	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000535371100009
J	Daniels, BP; Kofman, SB; Smith, JR; Norris, GT; Snyder, AG; Kolb, JP; Gao, X; Locasale, JW; Martinez, J; Gale, M; Loo, YM; Oberst, A				Daniels, Brian P.; Kofman, Sigal B.; Smith, Julian R.; Norris, Geoffrey T.; Snyder, Annelise G.; Kolb, Joseph P.; Gao, Xia; Locasale, Jason W.; Martinez, Jennifer; Gale, Michael, Jr.; Loo, Yueh-Ming; Oberst, Andrew			The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons	IMMUNITY			English	Article							NILE-VIRUS-REPLICATION; INNATE IMMUNE-RESPONSE; ZIKA VIRUS; SUCCINATE-DEHYDROGENASE; PROGRAMMED NECROSIS; CELL-DEATH; ITACONATE; PATHOGENESIS; INFLAMMATION; NECROPTOSIS	As long-lived post-mitotic cells, neurons employ unique strategies to resist pathogen infection while preserving cellular function. Here, using a murine model of Zika virus (ZIKV) infection, we identified an innate immune pathway that restricts ZIKV replication in neurons and is required for survival upon ZIKV infection of the central nervous system (CNS). We found that neuronal ZIKV infection activated the nucleotide sensor ZBP1 and the kinases RIPK1 and RIPK3, core components of virus-induced necroptotic cell death signaling. However, activation of this pathway in ZIKV-infected neurons did not induce cell death. Rather, RIPK signaling restricted viral replication by altering cellular metabolism via upregulation of the enzyme IRG1 and production of the metabolite itaconate. Itaconate inhibited the activity of succinate dehydrogenase, generating a metabolic state in neurons that suppresses replication of viral genomes. These findings demonstrate an immuno-metabolic mechanism of viral restriction during neuroinvasive infection.	[Daniels, Brian P.; Kofman, Sigal B.; Smith, Julian R.; Norris, Geoffrey T.; Snyder, Annelise G.; Gale, Michael, Jr.; Loo, Yueh-Ming; Oberst, Andrew] Univ Washington, Dept Immunol, Seattle, WA 98109 USA; [Kolb, Joseph P.; Martinez, Jennifer] NIEHS, Immun Inflammat & Dis Lab, NIH, Res Triangle Pk, NC 27703 USA; [Gao, Xia; Locasale, Jason W.] Duke Univ, Dept Pharmacol & Canc Biol, Sch Med, Durham, NC 27710 USA; [Gale, Michael, Jr.; Loo, Yueh-Ming; Oberst, Andrew] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; University of Washington; University of Washington Seattle	Oberst, A (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98109 USA.; Oberst, A (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98109 USA.	oberst@uw.edu	Gao, Xia/CAF-4717-2022; Locasale, Jason W/ABE-6505-2020; Martinez, Jennifer/C-3740-2019	Gao, Xia/0000-0003-0979-9990; Locasale, Jason W/0000-0002-7766-3502; Martinez, Jennifer/0000-0002-3060-2518; Snyder, Annelise/0000-0002-3038-8099; Daniels, Brian/0000-0002-8473-0654; Loo, Yueh-Ming/0000-0001-6294-7273	NIH [R01 AI132595, R21 NS101542, U19 AI083019, F32 AI129254, T32 GM007270]; NIH Intramural Research Program [ZIA ES10328601]; National Science Foundation Graduate Research Fellowship [DGE-1256082]; Canadian Institutes of Health Research [146818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132595, U19AI083019, F32AI129254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES103286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS101542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Pooja Ralli-Jain and Tayla Olsen for technical assistance. We thank Kevin Gerrish and Rick Fannin in the Molecular Genomics Core at the National Institute of Environmental Health Sciences for microarray support, John Bertin (GlaxoSmithKline) for providing RIPK1 and RIPK3 inhibitors and Ripk1<SUP>KD/KD</SUP> mice used in this study, and Luke O'Neill (Trinity College, Dublin) for providing 4-octyl itaconate. This work was supported by NIH grants R01 AI132595 (AO), R21 NS101542 (AO), U19 AI083019 (MG), F32 AI129254 (BPD), T32 GM007270 (SBK and AGS), and the NIH Intramural Research Program ZIA ES10328601 (JM). A.G.S. was also supported by a National Science Foundation Graduate Research Fellowship (DGE-1256082). X.G. was supported by a fellowship from the Canadian Institutes of Health Research (reference number 146818).	Bambouskova M, 2018, NATURE, V556, P501, DOI 10.1038/s41586-018-0052-z; Brien J. D, 2013, CURRENT PROTOCOLS MI, V31, P1; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Costa F, 2018, LANCET INFECT DIS, V18, P236, DOI 10.1016/S1473-3099(17)30697-7; Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125; Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; da Cruz LCH, 2018, AM J NEURORADIOL, V39, P1967, DOI 10.3174/ajnr.A5649; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012; Kole AJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.220; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004; Nair S, 2018, J EXP MED, V215, P1035, DOI 10.1084/jem.20180118; Naujoks J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005408; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Orozco S, 2017, IMMUNOL REV, V277, P102, DOI 10.1111/imr.12536; Piret J, 2018, J GEN VIROL, V99, P209, DOI 10.1099/jgv.0.000992; Shen HY, 2017, CELL, V171, P771, DOI 10.1016/j.cell.2017.09.051; Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10; Tallam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149050; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; Williams JL, 2014, J EXP MED, V211, P791, DOI 10.1084/jem.20131224; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004	37	119	122	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					64	+		10.1016/j.immuni.2018.11.017	http://dx.doi.org/10.1016/j.immuni.2018.11.017			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30635240	Bronze, Green Accepted			2022-12-18	WOS:000455661600011
J	Suan, D; Krautler, NJ; Maag, JLV; Butt, D; Bourne, K; Hermes, JR; Avery, DT; Young, C; Statham, A; Elliott, M; Dinger, ME; Basten, A; Tangye, SG; Brink, R				Suan, Dan; Krautler, Nike J.; Maag, Jesper L. V.; Butt, Danyal; Bourne, Katherine; Hermes, Jana R.; Avery, Danielle T.; Young, Clara; Statham, Aaron; Elliott, Michael; Dinger, Marcel E.; Basten, Antony; Tangye, Stuart G.; Brink, Robert			CCR6 Defines Memory B Cell Precursors in Mouse and Human Germinal Centers, Revealing Light-Zone Location and Predominant Low Antigen Affinity	IMMUNITY			English	Article							PLASMA-CELLS; IMMUNOLOGICAL MEMORY; DIFFERENTIATION; EXPRESSION; SELECTION; LOCALIZATION; COMPARTMENT; DYNAMICS; SUBSETS; LIGAND	Memory B cells (MBCs) and plasma cells (PCs) constitute the two cellular outputs of germinal center (GC) responses that together facilitate long-term humoral immunity. Although expression of the transcription factor BLIMP-1 identifies cells undergoing PC differentiation, no such marker exists for cells committed to the MBC lineage. Here, we report that the chemokine receptor CCR6 uniquely marks MBC precursors in both mouse and human GCs. CCR6(+) GC B cells were highly enriched within the GC light zone (LZ), were the most quiescent of all GC B cells, exhibited a cell-surface phenotype and gene expression signature indicative of an MBC transition, and possessed the augmented response characteristics of MBCs. MBC precursors within the GC LZ predominantly possessed a low affinity for antigen but also included cells from within the high-affinity pool. These data indicate a fundamental dichotomy between the processes that drive MBC and PC differentiation during GC responses.	[Suan, Dan; Krautler, Nike J.; Butt, Danyal; Bourne, Katherine; Hermes, Jana R.; Avery, Danielle T.; Young, Clara; Basten, Antony; Tangye, Stuart G.; Brink, Robert] Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW 2010, Australia; [Suan, Dan] Univ Sydney, Westmead Clin Sch, Sydney, NSW 2145, Australia; [Krautler, Nike J.] ETH, Inst Microbiol, Zurich, Switzerland; [Maag, Jesper L. V.; Statham, Aaron; Dinger, Marcel E.] Garvan Inst Med Res, Genom & Epigenet Div, Darlinghurst, NSW 2010, Australia; [Elliott, Michael] Univ Sydney, Cent Clin Sch, Camperdown, NSW 2006, Australia; [Dinger, Marcel E.; Basten, Antony; Tangye, Stuart G.; Brink, Robert] UNSW Sydney, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia; [Maag, Jesper L. V.] NYU, Langone Med Ctr, Inst Syst Genet, New York, NY 10016 USA; [Butt, Danyal] Teva Pharmaceut, Biol Res & Dev, Macquarie Pk, NSW 2113, Australia	Garvan Institute of Medical Research; University of Sydney; Swiss Federal Institutes of Technology Domain; ETH Zurich; Garvan Institute of Medical Research; University of Sydney; University of New South Wales Sydney; New York University; NYU Langone Medical Center	Brink, R (corresponding author), Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW 2010, Australia.; Brink, R (corresponding author), UNSW Sydney, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia.	r.brink@garvan.org.au	Tangye, Stuart G/H-4023-2014; Dinger, Marcel/N-1398-2019; Brink, Robert/B-7910-2010	Tangye, Stuart G/0000-0002-5360-5180; Brink, Robert/0000-0002-9586-3655; Suan, Dan/0000-0001-5996-5120; Dinger, Marcel/0000-0003-4423-934X; Maag, Jesper/0000-0002-2578-8872	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank Rob Salomon and the Flow Cytometry Facility staff at the Garvan Institute for their assistance with cell sorting, and we thank Jenny Kingham and the staff at Australian BioResources for animal husbandry. This work was funded by the National Health and Medical Research Council of Australia through a program grant and research fellowships to S.G.T. and R.B. and a scholarship to D.S.	[Anonymous], 2013, VACCINES-BASEL; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Elgueta R, 2015, J IMMUNOL, V194, P505, DOI 10.4049/jimmunol.1401553; Gatto D, 2013, TRENDS IMMUNOL, V34, P336, DOI 10.1016/j.it.2013.01.007; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gatto D, 2010, J ALLERGY CLIN IMMUN, V126, P898, DOI 10.1016/j.jaci.2010.09.007; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; GRAY D, 1993, ANNU REV IMMUNOL, V11, P49, DOI 10.1146/annurev.immunol.11.1.49; Green JA, 2012, IMMUNOL REV, V247, P36, DOI 10.1111/j.1600-065X.2012.01114.x; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Huang CX, 2014, CELL REP, V8, P1497, DOI 10.1016/j.celrep.2014.07.059; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Krzysiek R, 2000, BLOOD, V96, P2338, DOI 10.1182/blood.V96.7.2338.h8002338_2338_2345; Kucharzik T, 2002, EUR J IMMUNOL, V32, P104, DOI 10.1002/1521-4141(200201)32:1<104::AID-IMMU104>3.0.CO;2-C; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Oliver AM, 1997, J IMMUNOL, V158, P1108; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Reimer D, 2017, IMMUNOL CELL BIOL, V95, P33, DOI 10.1038/icb.2016.68; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Tangye SG, 2012, ANN NY ACAD SCI, V1250, P1, DOI 10.1111/j.1749-6632.2011.06361.x; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Wiede F, 2013, IMMUNOL CELL BIOL, V91, P335, DOI 10.1038/icb.2013.14	40	119	119	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1142	+		10.1016/j.immuni.2017.11.022	http://dx.doi.org/10.1016/j.immuni.2017.11.022			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262350	Bronze			2022-12-18	WOS:000418486500017
J	Ichiyama, K; Gonzalez-Martin, A; Kim, BS; Jin, HY; Jin, W; Xu, W; Sabouri-Ghomi, M; Xu, SB; Zheng, P; Xiao, CC; Dong, C				Ichiyama, Kenji; Gonzalez-Martin, Alicia; Kim, Byung-Seok; Jin, Hyun Yong; Jin, Wei; Xu, Wei; Sabouri-Ghomi, Mohsen; Xu, Shunbin; Zheng, Pan; Xiao, Changchun; Dong, Chen			The MicroRNA-183-96-182 Cluster Promotes T Helper 17 Cell Pathogenicity by Negatively Regulating Transcription Factor Foxo1 Expression	IMMUNITY			English	Article							T(H)17 CELLS; TGF-BETA; GM-CSF; DIFFERENTIATION; INDUCTION; MICRORNAS; RECEPTOR; GENERATION; PREDICTION; IL-17	T helper 17 (Th17) cells are key players in autoimmune diseases. However, the roles of non-coding RNAs in Th17 cell development and function are largely unknown. We found that deletion of the endoribonuclease-encoding Dicer1 specifically in Th17 cells protected mice from experimental autoimmune encephalomyelitis. We found that the Dicer1-regulated microRNA (miR)-183-96-182 cluster (miR-183C) was highly expressed in Th17 cells and was induced by cytokine IL-6-STAT3 signaling. miR-183C expression enhanced pathogenic cytokine production from Th17 cells during their development and promoted autoimmunity. Mechanistically, miR-183C in Th17 cells directly repressed expression of the transcription factor Foxo1. Foxo1 negatively regulated the pathogenicity of Th17 cells in part by inhibiting expression of cytokine receptor IL-1R1. These findings indicate that the miR-183C drives Th17 pathogenicity in autoimmune diseases via inhibition of Foxo1 and present promising therapeutic targets.	[Ichiyama, Kenji; Zheng, Pan] Childrens Natl Med Ctr, Ctr Canc & Immunol Res, Washington, DC 20010 USA; [Gonzalez-Martin, Alicia; Jin, Hyun Yong; Sabouri-Ghomi, Mohsen; Xiao, Changchun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Kim, Byung-Seok] MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Xu, Shunbin] Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48201 USA; [Xu, Shunbin] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48202 USA; [Jin, Wei; Xu, Wei; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Jin, Wei; Xu, Wei; Dong, Chen] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Ichiyama, Kenji] Osaka Univ, Immunol Frontier Res Ctr, Expt Immunol Lab, Suita, Osaka 5650871, Japan	Children's National Health System; Scripps Research Institute; University of Texas System; UTMD Anderson Cancer Center; Wayne State University; Tsinghua University; Tsinghua University; Osaka University	Xiao, CC (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Dong, C (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.	cxiao@scripps.edu; chendong@tsinghua.edu.cn	dong, chen/B-3181-2009; Gonzalez-Martin, Alicia/B-1702-2017; Zheng, Pan/E-8691-2011	dong, chen/0000-0002-0084-9130; Gonzalez-Martin, Alicia/0000-0002-6179-089X; Zheng, Pan/0000-0003-2598-3544; Ichiyama, Kenji/0000-0002-3340-9799	NIH [AR050772, AI087634, AI089854]; PEW Charitable Trusts; Cancer Research Institute; Lupus Research Institute; JSPS; Mochida fellowships for research abroad; NATIONAL EYE INSTITUTE [R01EY026059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087634, R56AI110403, R01AI089854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PEW Charitable Trusts; Cancer Research Institute; Lupus Research Institute; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida fellowships for research abroad; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ron DePinho for Foxo1<SUP>f/f</SUP> mice and Yun-Cai Liu for providing the Foxo1 cDNA construct. Steven Head, Lana Schaffer, and Phillip Ordoukhanian at TSRI Next Generation Sequencing Core Facility for expert assistance. We also thank our colleagues for their help and suggestions. The work was supported in part by grants from the NIH (AR050772 to C.D., AI087634, and AI089854 to C.X.) and by grants from the PEW Charitable Trusts, Cancer Research Institute, and Lupus Research Institute to C.X. K.I. receives JSPS postdoctoral fellowships and Mochida fellowships for research abroad. C.D. is a Bayer Chair Professor at Tsinghua University. C.X. is a Pew Scholar in Biomedical Sciences.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurebayashi Y, 2013, GENES CELLS, V18, P247, DOI 10.1111/gtc.12039; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lukens JR, 2012, J IMMUNOL, V188, P3107, DOI 10.4049/jimmunol.1103308; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Wan Q, 2011, J EXP MED, V208, P1875, DOI 10.1084/jem.20102516; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200	43	119	122	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1284	1298		10.1016/j.immuni.2016.05.015	http://dx.doi.org/10.1016/j.immuni.2016.05.015			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332731	Green Accepted, Bronze			2022-12-18	WOS:000378341200009
J	Luo, BW; Gan, WT; Liu, ZW; Shen, ZG; Wang, JS; Shi, RC; Liu, YQ; Liu, Y; Jiang, M; Zhang, ZR; Wu, YZ				Luo, Bangwei; Gan, Woting; Liu, Zongwei; Shen, Zigang; Wang, Jinsong; Shi, Rongchen; Liu, Yuqi; Liu, Yu; Jiang, Man; Zhang, Zhiren; Wu, Yuzhang			Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; APOPTOTIC CELLS; SPHINGOSINE 1-PHOSPHATE; FIND-ME; ERYTHROPOIETIN; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; HYPOXIA; ACTIVATION; EXPRESSION	The failure of apoptotic cell clearance is linked to autoimmune diseases, nonresolving inflammation, and developmental abnormalities; however, pathways that regulate phagocytes for efficient apoptotic cell clearance remain poorly known. Apoptotic cells release find-me signals to recruit phagocytes to initiate their clearance. Here we found that find-me signal sphingosine 1-phosphate (S1P) activated macrophage erythropoietin (EPO) signaling promoted apoptotic cell clearance and immune tolerance. Dying cell-released S1P activated macrophage EPO signaling. Erythropoietin receptor (EPOR)-deficient macrophages exhibited impaired apoptotic cell phagocytosis. EPO enhanced apoptotic cell clearance through peroxisome proliferator activated receptor-g (PPAR gamma). Moreover, macrophage-specific Epor(-/-) mice developed lupus-like symptoms, and interference in EPO signaling ameliorated the disease progression in lupus-like mice. Thus, we have identified a pathway that regulates macrophages to clear dying cells, uncovered the priming function of find-me signal S1P, and found a role of the erythropoiesis regulator EPO in apoptotic cell disposal, with implications for harnessing dying cell clearance.	[Luo, Bangwei; Gan, Woting; Liu, Zongwei; Shen, Zigang; Wang, Jinsong; Shi, Rongchen; Liu, Yuqi; Liu, Yu; Jiang, Man; Zhang, Zhiren; Wu, Yuzhang] Third Mil Med Univ, Inst Immunol PLA, 30 Gaotanyan Main St, Chongqing 400038, Peoples R China	Army Medical University	Zhang, ZR; Wu, YZ (corresponding author), Third Mil Med Univ, Inst Immunol PLA, 30 Gaotanyan Main St, Chongqing 400038, Peoples R China.	zhangzhiren@yahoo.com; wuyuzhang@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835; Wu, Yuzhang/0000-0002-4049-0214	NNSC [81471570, 31170851]; Chongqing Basic Science and Advanced Technology Research [cstc2015jcyjB0134]	NNSC; Chongqing Basic Science and Advanced Technology Research	We thank H. Wu from University of California at Los Angeles for providing the Epor<SUP>loxp/loxp</SUP> mice. This work was supported by grants (81471570 and 31170851) from the NNSC (Z.Z.) and a grant (cstc2015jcyjB0134) from the Chongqing Basic Science and Advanced Technology Research (Z.Z.).	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Bijl M, 2006, ANN RHEUM DIS, V65, P57, DOI 10.1136/ard.2005.035733; Cummings RJ, 2002, J BIOL CHEM, V277, P30227, DOI 10.1074/jbc.M111078200; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Fadok VA, 1999, J MAMMARY GLAND BIOL, V4, P203, DOI 10.1023/A:1011384009787; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Grossi A, 1998, LEUKEMIA RES, V22, P145, DOI 10.1016/S0145-2126(97)00134-3; Gude DR, 2008, FASEB J, V22, P2629, DOI 10.1096/fj.08-107169; Herr B, 2009, BLOOD, V114, P2140, DOI 10.1182/blood-2009-01-201889; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Kono M, 2014, J CLIN INVEST, V124, P2076, DOI 10.1172/JCI71194; Lee HG, 2011, BIOMATERIALS, V32, P9197, DOI 10.1016/j.biomaterials.2011.08.059; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Luo BW, 2013, BBA-MOL BASIS DIS, V1832, P1260, DOI 10.1016/j.bbadis.2013.04.015; MacRedmond R, 2009, EUR RESPIR J, V33, P1403, DOI 10.1183/09031936.00084608; Michaud MD, 2009, ARTERIOSCL THROM VAS, V29, P902, DOI 10.1161/ATVBAHA.109.185280; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nairz M, 2012, MICROBES INFECT, V14, P238, DOI 10.1016/j.micinf.2011.10.005; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Park SJ, 2014, CELL SIGNAL, V26, P2249, DOI 10.1016/j.cellsig.2014.07.009; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Rivera-Gil P, 2010, CYTOSKELETON, V67, P773, DOI 10.1002/cm.20486; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Tas SW, 2006, ANN RHEUM DIS, V65, P216, DOI 10.1136/ard.2005.037143; Voulgarelis M, 2000, ANN RHEUM DIS, V59, P217, DOI 10.1136/ard.59.3.217; Watowich SS, 2011, J INVEST MED, V59, P1067, DOI 10.2310/JIM.0b013e31820fb28c; Weigert A, 2010, BLOOD, V115, P3531, DOI 10.1182/blood-2009-10-243444; Wen CL, 2012, PHYTOMEDICINE, V19, P424, DOI 10.1016/j.phymed.2011.11.003; Xin Q, 2015, J IMMUNOL, V194, P5437, DOI 10.4049/jimmunol.1403028; Yasuda Y, 2003, CARCINOGENESIS, V24, P1021, DOI 10.1093/carcin/bgg060	38	119	127	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					287	302		10.1016/j.immuni.2016.01.002	http://dx.doi.org/10.1016/j.immuni.2016.01.002			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26872696	Bronze			2022-12-18	WOS:000370294000012
J	Nabekura, T; Kanaya, M; Shibuya, A; Fu, G; Gascoigne, NRJ; Lanier, LL				Nabekura, Tsukasa; Kanaya, Minoru; Shibuya, Akira; Fu, Guo; Gascoigne, Nicholas R. J.; Lanier, Lewis L.			Costimulatory Molecule DNAM-1 Is Essential for Optimal Differentiation of Memory Natural Killer Cells during Mouse Cytomegalovirus Infection	IMMUNITY			English	Article							SRC-FAMILY KINASES; LIPID RAFT RECRUITMENT; MURINE CYTOMEGALOVIRUS; T-CELLS; POLIOVIRUS RECEPTOR; NK CELLS; ACTIVATING RECEPTORS; ADHESION MOLECULE; DENDRITIC CELLS; DOWN-REGULATION	Recent studies demonstrate that natural killer (NK) cells have adaptive immune features. Here, we investigated the role of the costimulatory molecule DNAM-1 in the differentiation of NK cells in a mouse model of cytomegalovirus (MCMV) infection. Antibody blockade of DNAM-1 suppressed the expansion of MCMV-specific Ly49H(+) cells during viral infection and inhibited the generation of memory NK cells. Similarly, DNAM-1-deficient (Cd226(-/-)) Ly49H(+) NK cells exhibited intrinsic defects in expansion and differentiation into memory cells. Src-family tyrosine kinase Fyn and serine-threonine protein kinase C isoform eta (PKC eta) signaling through DNAM-1 played distinct roles in the generation of MCMV-specific effector and memory NK cells. Thus, cooperative signaling through DNAM-1 and Ly49H are required for NK cell-mediated host defense against MCMV infection.	[Nabekura, Tsukasa; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Nabekura, Tsukasa; Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Kanaya, Minoru; Shibuya, Akira] Univ Tsukuba, Div Biomed Sci, Dept Immunol, Tsukuba, Ibaraki 3058575, Japan; [Fu, Guo; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Tsukuba; Scripps Research Institute	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014; Kanaya, Minoru/AAE-7446-2020	Lanier, Lewis L/0000-0003-1308-3952; Kanaya, Minoru/0000-0002-0035-8657	National Institutes of Health [AI068129, GM065230]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI088790, P30AI027763, R01AI068129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the L.L.L. laboratory for comments and discussions. We are grateful to A. Weiss for Fyn-deficient mice. The work was supported by National Institutes of Health grants AI068129 to L.L.L. and GM065230 to N.R.J.G. L.L.L. is an American Cancer Society Professor. The Uehara Memorial Foundation, the Natio Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, and Japan Society for the Promotion of Science support T.N.	Aoki J, 1997, EXP CELL RES, V235, P374, DOI 10.1006/excr.1997.3685; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; Cicin-Sain L, 2005, J VIROL, V79, P9492, DOI 10.1128/JVI.79.15.9492-9502.2005; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Fodil-Cornu N, 2008, J IMMUNOL, V181, P6394, DOI 10.4049/jimmunol.181.9.6394; Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Fu G, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002058; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Henry SC, 2000, J VIROL METHODS, V89, P61, DOI 10.1016/S0166-0934(00)00202-0; Hsu KM, 2009, J GEN VIROL, V90, P33, DOI 10.1099/vir.0.006668-0; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Kamran N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054406; Konig S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029672; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Lowin-Kropf B, 2002, EUR J IMMUNOL, V32, P773, DOI 10.1002/1521-4141(200203)32:3<773::AID-IMMU773>3.0.CO;2-U; Mason LH, 2006, J IMMUNOL, V176, P6615, DOI 10.4049/jimmunol.176.11.6615; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Nabekura T, 2006, MOL THER, V13, P301, DOI 10.1016/j.ymthe.2005.09.021; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Prod'homme V, 2010, J GEN VIROL, V91, P2034, DOI 10.1099/vir.0.021931-0; Ravens I, 2003, BIOCHEM BIOPH RES CO, V312, P1364, DOI 10.1016/j.bbrc.2003.11.067; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Schlub TE, 2011, J IMMUNOL, V187, P1385, DOI 10.4049/jimmunol.1100416; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya A, 1998, J IMMUNOL, V161, P1671; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shirakawa J, 2005, INT IMMUNOL, V17, P217, DOI 10.1093/intimm/dxh199; Shirakawa J, 2006, INT IMMUNOL, V18, P951, DOI 10.1093/intimm/dxl031; Sjolin H, 2002, J EXP MED, V195, P825, DOI 10.1084/jem.20011427; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Smith KM, 1998, J IMMUNOL, V161, P7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Sun JC, 2010, IMMUNOL REV, V236, P83, DOI 10.1111/j.1600-065X.2010.00900.x; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Tassi I, 2008, BLOOD, V112, P4109, DOI 10.1182/blood-2008-02-139527; Tomasec P, 2005, NAT IMMUNOL, V6, P181, DOI 10.1038/ni1156	56	119	134	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					225	234		10.1016/j.immuni.2013.12.011	http://dx.doi.org/10.1016/j.immuni.2013.12.011			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24440149	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000331637600010
J	Marichal, T; Starkl, P; Reber, LL; Kalesnikoff, J; Oettgen, HC; Tsai, M; Metz, M; Galli, SJ				Marichal, Thomas; Starkl, Philipp; Reber, Laurent L.; Kalesnikoff, Janet; Oettgen, Hans C.; Tsai, Mindy; Metz, Martin; Galli, Stephen J.			A Beneficial Role for Immunoglobulin E in Host Defense against Honeybee Venom	IMMUNITY			English	Article							MAST-CELL; BEE VENOM; IGE ANTIBODIES; IN-VIVO; MICE; ANAPHYLAXIS; ALLERGY; MOUSE; ASTHMA; SNAKE	Allergies are widely considered to be misdirected type 2 immune responses, in which immunoglobulin E (IgE) antibodies are produced against any of a broad range of seemingly harmless antigens. However, components of insect venoms also can sensitize individuals to develop severe IgE-associated allergic reactions, including fatal anaphylaxis, upon subsequent venom exposure. We found that mice injected with amounts of honeybee venom similar to that which could be delivered in one or two stings developed a specific type 2 immune response that increased their resistance to subsequent challenge with potentially lethal amounts of the venom. Our data indicate that IgE antibodies and the high affinity IgE receptor, Fc epsilon RI, were essential for such acquired resistance to honeybee venom. The evidence that IgE-dependent immune responses against venom can enhance survival in mice supports the hypothesis that IgE, which also contributes to allergic disorders, has an important function in protection of the host against noxious substances.	[Marichal, Thomas; Starkl, Philipp; Reber, Laurent L.; Kalesnikoff, Janet; Metz, Martin; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Oettgen, Hans C.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Metz, Martin] Charite, Allergie Ctr Charite, Dept Dermatol & Allergy, D-10117 Berlin, Germany	Stanford University; Stanford University; Harvard University; Boston Children's Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Metz, M (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	martin.metz@charite.de; sgalli@stanford.edu	Reber, Laurent L/K-4148-2014; Maurer, Marcus/ABG-2174-2020; Metz, Martin/M-5237-2013	Reber, Laurent L/0000-0003-3384-6769; Maurer, Marcus/0000-0002-4121-481X; Starkl, Philipp/0000-0001-7521-129X; Tsai, Mindy/0000-0002-8421-4721; Metz, Martin/0000-0002-4070-9976; Oettgen, Hans/0000-0003-1199-1391	Belgium American Educational Foundation; Marie Curie International Outgoing Fellowship for Career Development: European Union's Seventh Framework Programme [299954]; Max Kade Foundation; Austrian Academy of Sciences; Austrian Science Fund (FWF) [J3399-B21]; French "Fondation pour la Recherche Medicale FRM"; Lucile Packard Foundation for Children's Health; Stanford CTSA (National Institutes of Health) [UL1 RR025744]; Arthritis National Research Foundation [SPO106496]; German Research Foundation [DFG Me 2668/2-1]; National Institutes of Health [AI023990, CA072074, AI070813]; Austrian Science Fund (FWF) [J 3399] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023990, R01AI070813, R01AI023990] Funding Source: NIH RePORTER	Belgium American Educational Foundation; Marie Curie International Outgoing Fellowship for Career Development: European Union's Seventh Framework Programme; Max Kade Foundation; Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); French "Fondation pour la Recherche Medicale FRM"(Fondation pour la Recherche Medicale); Lucile Packard Foundation for Children's Health; Stanford CTSA (National Institutes of Health); Arthritis National Research Foundation(National Research Foundation of Korea); German Research Foundation(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Brit B. Turnbull for statistical advice, all members of the Galli laboratory for discussions, and Chen Liu and Mariola Liebersbach for technical assistance. T. M. is supported by a Belgium American Educational Foundation fellowship and a Marie Curie International Outgoing Fellowship for Career Development: European Union's Seventh Framework Programme (FP7-PEOPLE-2011-IOF), 299954; P. S. is supported by a Max Kade Fellowship of the Max Kade Foundation and the Austrian Academy of Sciences and a Schroedinger Fellowship of the Austrian Science Fund (FWF): J3399-B21; L. L. R. is supported by fellowships from the French "Fondation pour la Recherche Medicale FRM" and the Stanford Pediatric Research Fund of the Lucile Packard Foundation for Children's Health and the Stanford CTSA (National Institutes of Health grant UL1 RR025744) and by grant #SPO106496 from the Arthritis National Research Foundation. This work was supported by the German Research Foundation (grant DFG Me 2668/2-1, to M. M.) and by National Institutes of Health grants AI023990, CA072074, and AI070813 (to S.J.G.).	Akahoshi M, 2011, J CLIN INVEST, V121, P4180, DOI 10.1172/JCI46139; AMIRI P, 1994, J EXP MED, V180, P43, DOI 10.1084/jem.180.1.43; ANDO A, 1993, J CLIN INVEST, V92, P1639, DOI 10.1172/JCI116749; Annila I, 2000, CLIN EXP ALLERGY, V30, P1682, DOI 10.1046/j.1365-2222.2000.00885.x; Antonicelli L, 2002, CURR OPIN ALLERGY CL, V2, P341, DOI 10.1097/00130832-200208000-00008; Artis D, 2012, NATURE, V484, P458, DOI 10.1038/484458a; Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; CHARAVEJASARN CC, 1975, INT ARCH ALLER A IMM, V48, P691, DOI 10.1159/000231356; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Fitzsimmons CM, 2009, TRENDS PARASITOL, V25, P447, DOI 10.1016/j.pt.2009.07.004; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Haak-Frendscho M, 1998, IMMUNOLOGY, V94, P115; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Harrison RA, 2003, TOXICON, V41, P441, DOI 10.1016/S0041-0101(02)00360-4; HIGGINBOTHAM RD, 1971, J IMMUNOL, V106, P233; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; ISHIZAKA T, 1986, P NATL ACAD SCI USA, V83, P8323, DOI 10.1073/pnas.83.21.8323; JARISCH R, 1979, CLIN ALLERGY, V9, P535, DOI 10.1111/j.1365-2222.1979.tb02518.x; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; Mukherjee AK, 2000, TOXICON, V38, P163, DOI 10.1016/S0041-0101(99)00125-7; Muller UR, 2005, CURR OPIN ALLERGY CL, V5, P343; Oettgen HC, 1999, J CLIN INVEST, V104, P829, DOI 10.1172/JCI8205; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Ozdemir C, 2011, CLIN EXP ALLERGY, V41, P1226, DOI 10.1111/j.1365-2222.2011.03812.x; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pawankar R, 2012, CURR OPIN ALLERGY CL, V12, P39, DOI 10.1097/ACI.0b013e32834ec13b; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; Portier M.M., 1902, C R SOC BIOL, V54, P170; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; PROUVOSTDANON A, 1977, IMMUNOCHEMISTRY, V14, P81, DOI 10.1016/0019-2791(77)90284-1; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Reimers AR, 2000, CLIN EXP ALLERGY, V30, P276; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; SCHMIDT JO, 1995, TOXICON, V33, P917, DOI 10.1016/0041-0101(95)00011-A; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Simpson ID, 2007, WILD ENVIRON MED, V18, P2, DOI 10.1580/06-WEME-CO-023R1.1; Stetson DB, 2004, ADV IMMUNOL, V83, P163; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575	45	119	122	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					963	975		10.1016/j.immuni.2013.10.005	http://dx.doi.org/10.1016/j.immuni.2013.10.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24210352	Green Accepted, Bronze			2022-12-18	WOS:000330950600017
J	Kageyama, R; Cannons, JL; Zhao, F; Yusuf, I; Lao, C; Locci, M; Schwartzberg, PL; Crotty, S				Kageyama, Robin; Cannons, Jennifer L.; Zhao, Fang; Yusuf, Isharat; Lao, Christopher; Locci, Michela; Schwartzberg, Pamela L.; Crotty, Shane			The Receptor Ly108 Functions as a SAP Adaptor-Dependent On-Off Switch for T Cell Help to B Cells and NKT Cell Development	IMMUNITY			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; SLAM FAMILY RECEPTORS; NATURAL-KILLER-CELLS; PROTEIN-TYROSINE-PHOSPHATASE; MOLECULE-ASSOCIATED PROTEIN; HUMORAL IMMUNITY; CUTTING EDGE; IMMUNODEFICIENT MUTANT; GENETIC-EVIDENCE; NTB-A	Humans and mice deficient in the adaptor protein SAP (Sh2d1a) have a major defect in humoral immunity, resulting from a lack of T cell help for B cells. The role of SAP in this process is incompletely understood. We found that deletion of receptor Ly108 (Slamf6) in CD4(+) T cells reversed the Sh2d1a(-/-) phenotype, eliminating the SAP requirement for germinal centers. This potent negative signaling by Ly108 required immunotyrosine switch motifs (ITSMs) and SHP-1 recruitment, resulting in high amounts of SHP-1 at the T cell:B cell synapse, limiting T cell:B cell adhesion. Ly108-negative signaling was important not only in CD4(+) T cells; we found that NKT cell differentiation was substantially restored in Slamf6(-/-)Sh2d1a(-/-) mice. The ability of SAP to regulate both positive and negative signals in T cells can explain the severity of SAP deficiency and highlights the importance of SAP and SHP-1 competition for Ly108 ITSM binding as a rheostat for the magnitude of T cell help to B cells.	[Kageyama, Robin; Yusuf, Isharat; Lao, Christopher; Locci, Michela; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Cannons, Jennifer L.; Zhao, Fang; Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Zhao, Fang] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Crotty, Shane] Univ Calif San Diego, Dept Med, Sch Med, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of California System; University of California San Diego	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	shane@liai.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; Zhao, Fang/0000-0002-5059-0833	NIH; LIAI; NIH NHGRI; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LIAI; NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank I. Engel and M. Kronenberg for technical advice. Slamf6 mice were obtained through the NIH KOMP Repository program. This work was supported by NIH grants and LIAI institutional funds (S.C.) and the NIH NHGRI intramural program (P.L.S., J.L.C., F.Z.). F.Z. is a Scholar in the NIH-Oxford-Cambridge Scholars in Biomedical Research program.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benhnia MREI, 2009, J VIROL, V83, P12355, DOI 10.1128/JVI.01593-09; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bouchon A, 2001, J IMMUNOL, V167, P5517, DOI 10.4049/jimmunol.167.10.5517; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cao E, 2006, IMMUNITY, V25, P559, DOI 10.1016/j.immuni.2006.06.020; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chen G, 2005, J IMMUNOL, V175, P2212, DOI 10.4049/jimmunol.175.4.2212; Chen RY, 2006, MOL CELL BIOL, V26, P5559, DOI 10.1128/MCB.00357-06; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2006, BLOOD, V108, P3085, DOI 10.1182/blood-2006-04-018929; Crotty S, 2012, IMMUNOL REV, V247, P133, DOI 10.1111/j.1600-065X.2012.01117.x; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dutta M, 2012, J IMMUNOL, V188, P3031, DOI 10.4049/jimmunol.1103226; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Graham DB, 2006, J IMMUNOL, V176, P291, DOI 10.4049/jimmunol.176.1.291; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Iype T, 2010, J IMMUNOL, V185, P6115, DOI 10.4049/jimmunol.1000622; Jennings P, 2008, J AUTOIMMUN, V31, P345, DOI 10.1016/j.jaut.2008.08.002; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kamperschroer C, 2006, J IMMUNOL, V177, P5317, DOI 10.4049/jimmunol.177.8.5317; Keszei M, 2011, J EXP MED, V208, P811, DOI 10.1084/jem.20101653; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Ma CS, 2006, J CLIN INVEST, V116, P322, DOI 10.1172/JCI25720; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; Malbran A, 2004, BLOOD, V103, P1625, DOI 10.1182/blood-2003-07-2525; Mavaddat N, 2000, J BIOL CHEM, V275, P28100; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Nichols KE, 2001, NAT IMMUNOL, V2, P665, DOI 10.1038/90595; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Palendira U, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001187; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; SHULTZ LD, 1976, J IMMUNOL, V116, P936; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; Snow AL, 2009, J CLIN INVEST, V119, P2976, DOI 10.1172/JCI39518; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Veillette A, 2006, TRENDS IMMUNOL, V27, P228, DOI 10.1016/j.it.2006.03.003; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Veillette A, 2008, P NATL ACAD SCI USA, V105, P1273, DOI 10.1073/pnas.0710698105; Veillette A, 2009, IMMUNOL REV, V232, P229, DOI 10.1111/j.1600-065X.2009.00824.x; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Yan QR, 2007, P NATL ACAD SCI USA, V104, P10583, DOI 10.1073/pnas.0703893104; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200	86	119	121	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 29	2012	36	6					986	1002		10.1016/j.immuni.2012.05.016	http://dx.doi.org/10.1016/j.immuni.2012.05.016			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22683125	Green Accepted, Bronze			2022-12-18	WOS:000306097100016
J	Bettini, ML; Pan, F; Bettini, M; Finkelstein, D; Rehg, JE; Floess, S; Bell, BD; Ziegler, SF; Huehn, J; Pardoll, DM; Vignali, DAA				Bettini, Matthew L.; Pan, Fan; Bettini, Maria; Finkelstein, David; Rehg, Jerold E.; Floess, Stefan; Bell, Bryan D.; Ziegler, Steven F.; Huehn, Jochen; Pardoll, Drew M.; Vignali, Dario A. A.			Loss of Epigenetic Modification Driven by the Foxp3 Transcription Factor Leads to Regulatory T Cell Insufficiency	IMMUNITY			English	Article							HISTONE-DEACETYLASE INHIBITORS; INDEPENDENT REGULATION; TARGET GENES; UBIQUITIN; ACETYLTRANSFERASE; EXPRESSION; GENERATION; OCCUPANCY; INDUCTION; LIMITS	Regulatory T (Treg) cells, driven by the Foxp3 transcription factor, are responsible for limiting autoimmunity and chronic inflammation. We showed that a well-characterized Foxp3(gfp) reporter mouse, which expresses an N-terminal GFP-Foxp3 fusion protein, is a hypomorph that causes profoundly accelerated autoimmune diabetes on a NOD background. Although natural Treg cell development and in vitro function are not markedly altered in Foxp3(gfp) NOD and C57BL/6 mice, Treg cell function in inflammatory environments was perturbed and TGF-beta-induced Treg cell development was reduced. Foxp3(gfp) was unable to interact with the histone acetyltransferase Tip60, the histone deacetylase HDAC7, and the Ikaros family zinc finger 4, Eos, which led to reduced Foxp3 acetylation and enhanced K48-linked polyubiquitylation. Collectively this results in an altered transcriptional landscape and reduced Foxp3-mediated gene repression, notably at the hallmark IL-2 promoter. Loss of controlled Foxp3-driven epigenetic modification leads to Treg cell insufficiency that enables autoimmunity in susceptible environments.	[Bettini, Matthew L.; Bettini, Maria; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Pan, Fan; Pardoll, Drew M.] Johns Hopkins Univ, Sch Med, Immunol & Hematopoiesis Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Floess, Stefan; Huehn, Jochen] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Bell, Bryan D.; Ziegler, Steven F.] Benaroya Res Inst, Seattle, WA 98101 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Johns Hopkins University; Johns Hopkins Medicine; Helmholtz Association; Helmholtz-Center for Infection Research; Benaroya Research Institute	Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	vignali.lab@stjude.org	Rehg, Jerold E/N-8111-2018	Bettini, Maria/0000-0002-6415-7731	National Institutes of Health [AI039480, AI091977, DK089125]; Hartwell Postdoctoral Fellowship; JDRF [3-2009-594]; St. Jude National Cancer Institute Center [CA-21765]; American Lebanese Syrian Associated Charities; German Research Foundation (DFG) [SFB621, SFB738]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI039480, R01AI091977, R01AI039480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Postdoctoral Fellowship; JDRF(Juvenile Diabetes Research Foundation); St. Jude National Cancer Institute Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Rudensky and H. Chi for mice; M. Turnis for performing B16 injections; K. Vignali for technical assistance; M. Smeltzer for biostatistical support; K. Forbes, A. Castel law, and A. McKenna for maintenance, breeding, and genotyping of mouse colonies; R. Cross, G. Lennon, and S. Morgan for FACS; the staff of the Shared Animal Resource Center at St. Jude for animal husbandry; the Veterinary Pathology Core Laboratory at St. Jude for histology and immunohistochemistry support; and the Hartwell Center for Biotechnology and Bioinformatics at St. Jude for real-time PCR primer/probe synthesis. DNA methylation experiments were developed and performed by U. Baron and S. Olek at Epiontis GmbH. Supported by the National Institutes of Health (AI039480, AI091977, DK089125 to D.A.A.V.), a Hartwell Postdoctoral Fellowship (to M.L.B.), JDRF Postdoctoral Fellowship (3-2009-594 to M.B.), the St. Jude National Cancer Institute Center (CA-21765 to D.A.A.V. and J.E.R.), the American Lebanese Syrian Associated Charities (to D.A.A.V. and J.E.R.), and the German Research Foundation (DFG, SFB621 and SFB738 to J.H.).	Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Flick K, 2006, NAT CELL BIOL, V8, P509, DOI 10.1038/ncb1402; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Nagar M, 2008, INT IMMUNOL, V20, P1041, DOI 10.1093/intimm/dxn062; Ouni I, 2011, TRANSCR-AUSTIN, V2, P135, DOI 10.4161/trns.2.3.15903; Pan F, 2007, NATURE, V445, P433, DOI 10.1038/nature05476; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pillai MR, 2011, J IMMUNOL, V187, P4987, DOI 10.4049/jimmunol.1102173; Saouaf SJ, 2009, EXP MOL PATHOL, V87, P99, DOI 10.1016/j.yexmp.2009.06.003; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Thompson LJ, 2011, J IMMUNOL, V186, P4551, DOI 10.4049/jimmunol.1003573; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang LQ, 2009, IMMUNOL CELL BIOL, V87, P195, DOI 10.1038/icb.2008.106; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Workman CJ, 2011, METHODS MOL BIOL, V707, P119, DOI 10.1007/978-1-61737-979-6_9; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Xiao Y, 2010, CURR OPIN IMMUNOL, V22, P583, DOI 10.1016/j.coi.2010.08.013; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	49	119	125	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 25	2012	36	5					717	730		10.1016/j.immuni.2012.03.020	http://dx.doi.org/10.1016/j.immuni.2012.03.020			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22579476	Bronze, Green Accepted			2022-12-18	WOS:000304976000007
J	Elyaman, W; Bassil, R; Bradshaw, EM; Orent, W; Lahoud, Y; Zhu, B; Radtke, F; Yagita, H; Khoury, SJ				Elyaman, Wassim; Bassil, Ribal; Bradshaw, Elizabeth M.; Orent, William; Lahoud, Youmna; Zhu, Bing; Radtke, Freddy; Yagita, Hideo; Khoury, Samia J.			Notch Receptors and Smad3 Signaling Cooperate in the Induction of Interleukin-9-Producing T Cells	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TGF-BETA; IL-9 PRODUCTION; INTRACELLULAR DOMAIN; GATA3 EXPRESSION; MAST-CELLS; IN-VIVO; DIFFERENTIATION; ACTIVATION; EFFECTOR	Interleukin 9 (IL-9) is a pleiotropic cytokine that can regulate autoimmune responses by enhancing regulatory CD4(+)FoxP3(+) T regulatory (Treg) cell survival and T helper 17 (Th17) cell proliferation. Here, we analyzed the costimulatory requirements for the induction of Th9 cells, and demonstrated that Notch pathway cooperated with TGF-beta signaling to induce IL-9. Conditional ablation of Notch1 and Notch2 receptors inhibited the development of Th9 cells. Notch1 intracellular domain (NICD1) recruited Smad3, downstream of TGF-beta cytokine signaling, and together with recombining binding protein (RBP)-J kappa bound the II9 promoter and induced its transactivation. In experimental autoimmune encephalomyelitis (EAE), Jagged2 ligation regulated clinical disease in an IL-9-dependent fashion. Signaling through Jagged2 expanded Treg cells and suppressed EAE when administered before antigen immunization, but worsened EAE when administered concurrently with immunization by favoring Th17 cell expansion. We propose that Notch and Smad3 cooperate to induce IL-9 and participate in regulating the immune response.	[Elyaman, Wassim; Bassil, Ribal; Bradshaw, Elizabeth M.; Orent, William; Lahoud, Youmna; Zhu, Bing; Khoury, Samia J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Radtke, Freddy] Swiss Inst Expt Canc Res, Ecole Polytech Fed Lausanne, CH-1066 Epalinges, Switzerland; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Biomed Res Ctr, Tokyo 1138427, Japan; [Khoury, Samia J.] Amer Univ Beirut, Beirut 11072020, Lebanon	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Juntendo University; American University of Beirut	Khoury, SJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	skhoury@rics.bwh.harvard.edu	Radtke, Freddy/Q-3198-2017; Elyaman, Wassim/AAJ-1562-2021	Radtke, Freddy/0000-0003-4315-4045; khoury, samia/0000-0003-3198-6063; Lahoud, Youmna/0000-0002-5677-3665; Elyaman, Wassim/0000-0001-7238-374X	National Institutes of Health [R01AI067472, AI058680]; National Multiple Sclerosis Society [RG3666, PP1734]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI058680, R01AI058680, R01AI067472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Kennedy for mouse genotyping. We also thank M. Oukka for providing the FoxP3 reporter mice, W. Chen for critical reading of the manuscript, and J. van Snick for the generous gift of the anti-IL-9 antibody. This work is supported by research grants from the National Institutes of Health (R01AI067472, AI058680 to S.J.K.), and the National Multiple Sclerosis Society (RG3666 to S.J.K. and PP1734 to W.E.).	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038/nri2488; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bassil R, 2011, J IMMUNOL, V187, P2322, DOI 10.4049/jimmunol.1100725; Beriou G, 2010, J IMMUNOL, V185, P46, DOI 10.4049/jimmunol.1000356; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Elyaman W, 2007, J IMMUNOL, V179, P5990, DOI 10.4049/jimmunol.179.9.5990; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Feng LL, 2011, J CLIN IMMUNOL, V31, P1084, DOI 10.1007/s10875-011-9584-9; Fukushima A, 2008, IMMUNOL LETT, V121, P140, DOI 10.1016/j.imlet.2008.10.006; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kared H, 2006, IMMUNITY, V25, P823, DOI 10.1016/j.immuni.2006.09.008; Keir ME, 2005, IMMUNOL REV, V204, P128, DOI 10.1111/j.0105-2896.2005.00242.x; Kijima M, 2008, P NATL ACAD SCI USA, V105, P7010, DOI 10.1073/pnas.0709919105; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084/jem.20091442; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; RENAULD JC, 1994, ONCOGENE, V9, P1327; Richard M, 2000, P NATL ACAD SCI USA, V97, P767, DOI 10.1073/pnas.97.2.767; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Smith SE, 2011, CANCER IMMUNOL IMMUN, V60, P1775, DOI 10.1007/s00262-011-1075-6; Stassen M, 2007, MOL IMMUNOL, V44, P926, DOI 10.1016/j.molimm.2006.03.019; Stephens GL, 2011, EUR J IMMUNOL, V41, P952, DOI 10.1002/eji.201040879; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; UYTTENHOVE C, 1991, J EXP MED, V173, P519, DOI 10.1084/jem.173.2.519; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014	47	119	133	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 20	2012	36	4					623	634		10.1016/j.immuni.2012.01.020	http://dx.doi.org/10.1016/j.immuni.2012.01.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22503540	Green Accepted, Bronze			2022-12-18	WOS:000303223900014
J	Zhu, YW; Yao, S; Chen, LP				Zhu, Yuwen; Yao, Sheng; Chen, Lieping			Cell Surface Signaling Molecules in the Control of Immune Responses: A Tide Model	IMMUNITY			English	Review							PATTERN-RECOGNITION RECEPTORS; HERPESVIRUS ENTRY MEDIATOR; CD4(+) T-CELLS; NF-KAPPA-B; COSTIMULATORY MOLECULE; DENDRITIC CELLS; NK-CELLS; NONSELF DISCRIMINATION; IMMUNOLOGICAL SYNAPSE; SUPERFAMILY MEMBERS	A large numbers of cell surface signaling molecules (CSSMs) have been molecularly identified and functionally characterized in recent years and, via these studies, our knowledge in the control of immune response has increased exponentially. Two major lines of evidence emerge. First, the majority of immune cells rely on one or few CSSMs to deliver a primary triggering signal to sense their environment, leading to initiation of an immune response. Second, both costimulatory CSSMs that promote the response, and coinhibitory CSSMs that inhibit the response, are required to control direction and magnitude of a given immune response. With such tight feedback, immune responses are tuned and returned to baseline. These findings extend well beyond our previous observation in the requirement for lymphocyte activation and argue a revisit of the traditional "two-signal model" for activation and tolerance of lymphocytes. Here we propose a "tide" model to accommodate and interpret current experimental findings.	[Zhu, Yuwen; Yao, Sheng; Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Zhu, Yuwen; Yao, Sheng; Chen, Lieping] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06519 USA	Yale University; Yale University	Chen, LP (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06519 USA.	lieping.chen@yale.edu	zhu, yuwen/C-9010-2011	Chen, Lieping/0000-0002-6825-3069	National Institutes of Health [CA98731, CA106861, CA142779, AI72592, CA97085, CA85721]; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE [R01CA106861, R01CA085721, R01CA142779, R01CA098731, R01CA079915, R01CA097085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Cadugan for editing the manuscript. The study has been partially supported by National Institutes of Health grants CA98731, CA106861, CA142779, AI72592, CA97085, and CA85721 and the Melanoma Research Alliance.	Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bas A, 2011, P NATL ACAD SCI USA, V108, P4376, DOI 10.1073/pnas.1010647108; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; Clark GJ, 2009, IMMUNOBIOLOGY, V214, P730, DOI 10.1016/j.imbio.2009.06.004; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Duhen T, 2004, EUR J IMMUNOL, V34, P3534, DOI 10.1002/eji.200425598; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hashiguchi M, 2008, P NATL ACAD SCI USA, V105, P10495, DOI 10.1073/pnas.0802423105; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Hernandez-Caselles T, 2006, J LEUKOCYTE BIOL, V79, P46, DOI 10.1189/jlb.0205096; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; HUARD B, 1994, EUR J IMMUNOL, V24, P3216, DOI 10.1002/eji.1830241246; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kawasaki N, 2011, J INNATE IMMUN, V3, P411, DOI 10.1159/000322375; Kikuchi T, 2000, NAT MED, V6, P1154, DOI 10.1038/80498; KOBATA T, 1995, P NATL ACAD SCI USA, V92, P11249, DOI 10.1073/pnas.92.24.11249; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Minas K, 2006, CRIT REV IMMUNOL, V26, P213, DOI 10.1615/CritRevImmunol.v26.i3.20; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Nguyen T, 2006, J IMMUNOL, V176, P7354, DOI 10.4049/jimmunol.176.12.7354; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; O'Neill LAJ, 2007, CELL, V131, P1039, DOI 10.1016/j.cell.2007.11.032; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Smith IA, 2010, J IMMUNOL, V184, P3514, DOI 10.4049/jimmunol.0900416; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Stefferl A, 2000, J IMMUNOL, V165, P2859, DOI 10.4049/jimmunol.165.5.2859; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sugamura K, 2004, NAT REV IMMUNOL, V4, P420, DOI 10.1038/nri1371; Takeda K, 2000, J IMMUNOL, V164, P1741, DOI 10.4049/jimmunol.164.4.1741; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Takeuchi A, 2009, J IMMUNOL, V183, P4220, DOI 10.4049/jimmunol.0901248; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tsushima F, 2007, BLOOD, V110, P180, DOI 10.1182/blood-2006-11-060087; Uehara T, 2001, J CLIN INVEST, V108, P1041, DOI 10.1172/JCI200112195; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van den Heuvel MJ, 2011, TRENDS MOL MED, V17, P65, DOI 10.1016/j.molmed.2010.10.007; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Vinay DS, 2011, CELL MOL IMMUNOL, V8, P281, DOI 10.1038/cmi.2010.82; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; Wilcox RA, 2002, J IMMUNOL, V169, P4230, DOI 10.4049/jimmunol.169.8.4230; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698; Xu YH, 2007, BLOOD, V109, P4097, DOI 10.1182/blood-2006-09-047332; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; YAO S, 2011, IMMUNITY IN PRESS, V34, DOI DOI 10.1016/J.IMMUNI.2011.03.014; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zhang XY, 2010, J IMMUNOL, V184, P787, DOI 10.4049/jimmunol.0901619; ZHOU Z, 1994, IMMUNOL LETT, V41, P177, DOI 10.1016/0165-2478(94)90129-5; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	121	119	126	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 22	2011	34	4					466	478		10.1016/j.immuni.2011.04.008	http://dx.doi.org/10.1016/j.immuni.2011.04.008			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21511182	Green Accepted, Bronze			2022-12-18	WOS:000290367300007
J	Dustin, ML				Dustin, ML			Stop and go traffic to tune T cell responses	IMMUNITY			English	Review							IMMUNOLOGICAL SYNAPSE FORMATION; DENDRITIC CELLS; IN-VIVO; LYMPH-NODES; ANTIGEN PRESENTATION; CUTTING EDGE; CIRCULATING LYMPHOCYTES; 2-PHOTON MICROSCOPY; IMMUNE-RESPONSE; IL-2 PRODUCTION	Adaptive immune responses are initiated by interactions of T cells with antigen-presenting cells, but the basic nature of these interactions during an immune response in vivo has been a matter of speculation. While some in vitro systems provide evidence for stable interactions, referred to as immunological synapses, compelling evidence supports T cell activation through serial transient interactions. Deep tissue intravital and organ culture microscopy studies suggest that both modes of interaction are employed, but new issues have emerged. This review will discuss in vitro results that framed the hypotheses that are currently being tested in vivo. I present a model in which TCR stop signals compete with chemokine-mediated go signals to adjust the duration of immunological synapse formation and tune the immune response between tolerance and full activation.	NYU, Sch Med, Program Mol Pathogenesis, Skirball Inst Biomol Med, New York, NY 10021 USA; NYU, Sch Med, Dept Pathol, New York, NY 10021 USA	New York University; New York University	Dustin, ML (corresponding author), NYU, Sch Med, Program Mol Pathogenesis, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10021 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055037, R01AI055037] Funding Source: NIH RePORTER; NIAID NIH HHS [AI55037] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ardouin L, 2003, EUR J IMMUNOL, V33, P790, DOI 10.1002/eji.200323858; ARFORS KE, 1969, BIBL ANAT, P502; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Bromley SK, 2002, IMMUNOLOGY, V106, P289, DOI 10.1046/j.1365-2567.2002.01441.x; Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Dustin ML, 1996, J IMMUNOL, V157, P2014; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Dustin ML, 2001, TRENDS IMMUNOL, V22, P192, DOI 10.1016/S1471-4906(01)01872-5; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Ebnet K, 1996, ANNU REV IMMUNOL, V14, P155, DOI 10.1146/annurev.immunol.14.1.155; ERNOTO M, 2003, TRENDS IMMUNOL, V24, P364; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Hurez V, 2003, J EXP MED, V198, P123, DOI 10.1084/jem.20022230; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; INABA K, 1986, J EXP MED, V163, P247, DOI 10.1084/jem.163.2.247; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1987, J EXP MED, V165, P1565, DOI 10.1084/jem.165.6.1565; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LIPSKY PE, 1975, J EXP MED, V141, P138, DOI 10.1084/jem.141.1.138; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Pautler RG, 2003, CURR OPIN IMMUNOL, V15, P385, DOI 10.1016/S0952-7915(03)00073-6; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; Real E, 2004, J IMMUNOL, V173, P50, DOI 10.4049/jimmunol.173.1.50; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sumen C, 2004, J CELL BIOL, V166, P579, DOI 10.1083/jcb.200404059; SUNG KLP, 1986, SCIENCE, V234, P1405, DOI 10.1126/science.3491426; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Watson ARO, 2004, J IMMUNOL, V173, P33, DOI 10.4049/jimmunol.173.1.33; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Windon RG, 2000, VACCINE, V19, P572, DOI 10.1016/S0264-410X(00)00148-1; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	74	119	123	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2004	21	3					305	314		10.1016/j.immuni.2004.08.016	http://dx.doi.org/10.1016/j.immuni.2004.08.016			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357942	Bronze			2022-12-18	WOS:000224034900002
J	Miller, AT; Wilcox, HM; Lai, ZB; Berg, LJ				Miller, AT; Wilcox, HM; Lai, ZB; Berg, LJ			Signaling through ltk promotes T helper 2 differentiation via negative regulation of T-bet	IMMUNITY			English	Article							HELPER-CELL-DIFFERENTIATION; NONRECEPTOR TYROSINE KINASE; TEC FAMILY KINASES; TRANSCRIPTION FACTOR; AIRWAY INFLAMMATION; CYTOKINE EXPRESSION; ITK; ACTIVATION; GENE; PHOSPHORYLATION	The Tec family tyrosine kinase, Itk, is critical for PLC-gammal activation downstream of the TCR. Studies of Itk(-/-) mice have demonstrated a requirement for Itk in Th2 cytokine production and protective immunity to parasitic infections. Here we address the mechanism by which Itk regulates Th2 differentiation. We find that naive Itk(-/-) CD4(+) T cells respond normally to cytokine skewing signals and can differentiate efficiently into either Thl or Th2 lineage cells. In the absence of skewing cytokines, wild-type CD4(+) T cells stimulated with low-avidity ligands preferentially express GATA-3 mRNA and differentiate into Th2 cells. Under these same stimulation conditions, Itk(-/-) T cells produce large amounts of T-bet mRNA and differentiate into IFN-gamma-producing cells. Furthermore, Itk is upregulated during Th2 differentiation, while Rlk, a related Tec kinase, disappears rapidly from differentiating Th2 cells. Together, these findings provide a molecular explanation for the essential role of Itk in Th2 differentiation.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Berg, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, 55 Lake Ave N, Worcester, MA 01655 USA.	leslie.berg@umassmed.edu			NIAID NIH HHS [AI-07439, AI37584] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F35AI007439, R01AI037584] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Hartenstein B, 2002, EMBO J, V21, P6321, DOI 10.1093/emboj/cdf648; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; HU Q, 1995, J BIOL CHEM, V270, P1928, DOI 10.1074/jbc.270.4.1928; Ise W, 2002, J IMMUNOL, V168, P3242, DOI 10.4049/jimmunol.168.7.3242; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Kashiwakura J, 1999, J EXP MED, V190, P1147, DOI 10.1084/jem.190.8.1147; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; KOVAC Z, 1985, J IMMUNOL, V134, P3233; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Lucas JA, 2003, IMMUNOL REV, V191, P119, DOI 10.1034/j.1600-065X.2003.00029.x; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Matsumoto Y, 2002, INT ARCH ALLERGY IMM, V129, P327, DOI 10.1159/000067589; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; Miller AT, 2002, J IMMUNOL, V168, P2163, DOI 10.4049/jimmunol.168.5.2163; Miller AT, 2002, CURR OPIN IMMUNOL, V14, P331, DOI 10.1016/S0952-7915(02)00345-X; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Rodriguez-Palmero M, 1999, EUR J IMMUNOL, V29, P3914; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Schneider H, 2000, J BIOL CHEM, V275, P3835, DOI 10.1074/jbc.275.6.3835; Takeba Y, 2002, J IMMUNOL, V168, P2365, DOI 10.4049/jimmunol.168.5.2365; Veri MC, 2001, MOL CELL BIOL, V21, P6939, DOI 10.1128/MCB.21.20.6939-6950.2001; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200	38	119	128	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					67	80		10.1016/j.immuni.2004.06.009	http://dx.doi.org/10.1016/j.immuni.2004.06.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345221	Bronze			2022-12-18	WOS:000222975500009
J	Ashcroft, AJ; Cruickshank, SM; Croucher, PL; Perry, MJ; Rollinson, S; Lippitt, JM; Child, JA; Dunstan, C; Felsburg, PJ; Morgan, GJ; Carding, SR				Ashcroft, AJ; Cruickshank, SM; Croucher, PL; Perry, MJ; Rollinson, S; Lippitt, JM; Child, JA; Dunstan, C; Felsburg, PJ; Morgan, GJ; Carding, SR			Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; TNF FAMILY-MEMBER; KAPPA-B LIGAND; OSTEOCLAST FORMATION; RECEPTOR ACTIVATOR; LYMPHOCYTE DEVELOPMENT; POSTMENOPAUSAL WOMEN; RHEUMATOID-ARTHRITIS; SURVIVAL FACTOR; CROHNS-DISEASE	Autoimmune associated bone disease and intestinal inflammation are closely linked with deregulation and hyperactivation of autoreactive CD4 T cells. How these T cells are activated and mediate disease is not clear. Here we show that in the Interleukin 2-deficient mouse model of autoimmunity spontaneous osteopenia and colitis are caused by increased production of the ligand for receptor activator of NFkappaB (RANKL). RANKL acting via its receptor, receptor activator of NFkappaB (RANK), increases bone turnover and promotes intestinal dendritic cell (DC) survival in vivo. Modulation of RANKL-RANK interactions with exogenous recombinant osteoprotegerin (Fc-OPG) reverses skeletal abnormalities and reduces colitis by decreasing colonic DC numbers. This study identifies a common causal link between bone disease and intestinal inflammation and establishes the importance of DC in mediating colonic inflammation in vivo.	Univ Leeds, Sch Biochem & Mol Biol, Leeds, W Yorkshire, England; Univ Leeds, Acad Unit Haematol & Oncol, Sch Med, Leeds, W Yorkshire, England; Univ Sheffield, Sch Med, Div Clin Sci, Sheffield, S Yorkshire, England; Univ Bristol, Dept Anat, Bristol, Avon, England; Univ Sheffield, Dept Genom Med, Sheffield, S Yorkshire, England; Amgen Inc, Thousand Oaks, CA 91320 USA; Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA	University of Leeds; University of Leeds; University of Sheffield; University of Bristol; University of Sheffield; Amgen; University of Pennsylvania	Carding, SR (corresponding author), Univ Leeds, Sch Biochem & Mol Biol, Leeds, W Yorkshire, England.		Dunstan, Colin/G-6214-2013	Dunstan, Colin/0000-0001-7586-4071; Croucher, Peter/0000-0002-7102-2413; morgan, gareth/0000-0002-4271-6360; Carding, Simon/0000-0002-2383-9701; Cruickshank, Sheena/0000-0002-3047-5475	NCRR NIH HHS [RR12211] Funding Source: Medline; NIAID NIH HHS [AI41562] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P01RR012211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041562] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Atkins GJ, 2001, BONE, V28, P370, DOI 10.1016/S8756-3282(01)00404-5; Bekker PJ, 2001, J BONE MINER RES, V16, P348, DOI 10.1359/jbmr.2001.16.2.348; Bell SJ, 2001, J IMMUNOL, V166, P4958, DOI 10.4049/jimmunol.166.8.4958; Contractor NV, 1998, J IMMUNOL, V160, P385; Croucher PI, 2001, BLOOD, V98, P3534, DOI 10.1182/blood.V98.13.3534; de Jong DJ, 2002, AM J GASTROENTEROL, V97, P2011, DOI 10.1016/S0002-9270(02)04273-9; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; ESPINOZADELGADO I, 1995, J LEUKOCYTE BIOL, V57, P13, DOI 10.1002/jlb.57.1.13; Fickling WE, 2001, POSTGRAD MED J, V77, P33, DOI 10.1136/pmj.77.903.33; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; GOWEN M, 1986, J IMMUNOL, V136, P2478; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Honore P, 2000, NAT MED, V6, P521, DOI 10.1038/74999; Horwood NJ, 1999, BIOCHEM BIOPH RES CO, V265, P144, DOI 10.1006/bbrc.1999.1623; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Josien R, 1999, J IMMUNOL, V162, P2562; Kirchgatterer A, 2002, ACTA MED AUST, V29, P120, DOI 10.1046/j.1563-2571.2002.02018.x; Klaus J, 2002, GUT, V51, P654, DOI 10.1136/gut.51.5.654; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Krajina T, 2003, EUR J IMMUNOL, V33, P1073, DOI 10.1002/eji.200323518; KRAMER S, 1995, J EXP MED, V182, P1769, DOI 10.1084/jem.182.6.1769; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamb EJ, 2002, ALIMENT PHARM THER, V16, P1895, DOI 10.1046/j.1365-2036.2002.01363.x; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Morony S, 2001, CANCER RES, V61, P4432; Nosaka K, 2002, BLOOD, V99, P634, DOI 10.1182/blood.V99.2.634; Oelzner P, 1999, RHEUMATOLOGY, V38, P841, DOI 10.1093/rheumatology/38.9.841; Ogata Y, 1999, J IMMUNOL, V162, P2754; Reya T, 1998, BLOOD, V91, P2935, DOI 10.1182/blood.V91.8.2935.2935_2935_2947; RIES WL, 1989, J PERIODONTAL RES, V24, P242, DOI 10.1111/j.1600-0765.1989.tb01788.x; Rifas L, 2003, J CELL BIOCHEM, V88, P650, DOI 10.1002/jcb.10436; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Schierhorn M, 2002, NANO LETT, V2, P13, DOI 10.1021/nl015616g; SCHNEIDER GB, 1994, LYMPHOKINE CYTOK RES, V13, P335; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SCHUMMER B, 1998, BIOCHEMICA, V2, P31; SEYMOUR GJ, 1985, ARCH ORAL BIOL, V30, P481, DOI 10.1016/0003-9969(85)90094-9; Shipman CM, 2003, CANCER RES, V63, P912; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Udagawa N, 2002, ARTHRITIS RES, V4, P281, DOI 10.1186/ar431; Weitzmann MN, 2001, J BONE MINER RES, V16, P328, DOI 10.1359/jbmr.2001.16.2.328; Williamson E, 2002, J IMMUNOL, V169, P3606, DOI 10.4049/jimmunol.169.7.3606; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Yun TJ, 2001, J IMMUNOL, V166, P1482, DOI 10.4049/jimmunol.166.3.1482; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685; Zheng LX, 1998, J IMMUNOL, V160, P763	52	119	121	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2003	19	6					849	861		10.1016/S1074-7613(03)00326-1	http://dx.doi.org/10.1016/S1074-7613(03)00326-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670302	Bronze			2022-12-18	WOS:000187230700010
J	Hu-Li, J; Pannetier, C; Guo, LY; Lohning, M; Gu, H; Watson, C; Assenmacher, M; Radbruch, A; Paul, WE				Hu-Li, J; Pannetier, C; Guo, LY; Lohning, M; Gu, H; Watson, C; Assenmacher, M; Radbruch, A; Paul, WE			Regulation of expression of IL-4 alleles: Analysis using a chimeric GFP/IL-4 gene	IMMUNITY			English	Article							GERMINAL-CENTER FORMATION; T-CELL DIFFERENTIATION; CYTOKINE EXPRESSION; RECEPTOR; TH1; INACTIVATION; INFLAMMATION; ACTIVATION; EXCLUSION; MECHANISM	CD4 cells from mice heterozygous for an IL-4 and a GFP/IL-4 gene frequently express a single allele. Analysis of IL-4 or GFP production by cells from recently primed Th2 cells indicates that essentially all are competent to transcribe either allele but have a low probability of doing so. By contrast, long-term Th2 clones show distinct and heritable ratios in the proportion of cells that express IL-4 or GFP. We conclude that in the course of Th2 priming an early efficient event renders both alleles capable of being inefficiently transcribed; a second, less frequent event occurs that renders one allele more competent, accounting for the differential expression of IL-4 and GFP in different clones.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Deutsch Rheumaforschungszentrum, D-10117 Berlin, Germany; Miltenyi Biotec, D-51429 Bergisch Gladbach, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Deutsches Rheuma-Forschungszentrum (DRFZ); Miltenyi Biotec	Paul, WE (corresponding author), NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.		Löhning, Max/AAL-2967-2021	Löhning, Max/0000-0001-6382-7281; Radbruch, Andreas/0000-0001-5753-0000	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, Z01AI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Bergman Y, 1999, SEMIN IMMUNOL, V11, P319, DOI 10.1006/smim.1999.0188; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Brown KA, 1997, J NUCL CARDIOL, V4, P101; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; CORRY DB, 1994, J IMMUNOL, V153, P4142; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Draper N. R., 1981, APPL REGRESSION ANAL, P511; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Holgate ST, 1999, J ALLERGY CLIN IMMUN, V104, P1139, DOI 10.1016/S0091-6749(99)70005-9; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Lyon MF, 1999, CURR BIOL, V9, pR235, DOI 10.1016/S0960-9822(99)80151-1; MANZ R, 1995, P NATL ACAD SCI USA, V92, P1921, DOI 10.1073/pnas.92.6.1921; Mitsuyasu H, 1999, J IMMUNOL, V162, P1227; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	33	119	121	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2001	14	1					1	11		10.1016/S1074-7613(01)00084-X	http://dx.doi.org/10.1016/S1074-7613(01)00084-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	394FQ	11163225	Bronze			2022-12-18	WOS:000166513800001
J	Baker, BM; Gagnon, SJ; Biddison, WE; Wiley, DC				Baker, BM; Gagnon, SJ; Biddison, WE; Wiley, DC			Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: Implications for TCR signaling	IMMUNITY			English	Article							CAVITY-CREATING MUTATIONS; PEPTIDE-MHC COMPLEXES; MULTIVALENT STRUCTURE; DISSOCIATION RATE; RECEPTOR-BINDING; VIRUS TYPE-1; ALPHA-BETA; LIGANDS; RECOGNITION; HLA-A2	The structure of the A6 alpha beta TCR/HTLV-1 Tax-peptide/MHC I complex with proline 6 of Tax substituted with alanine (P6A), an antagonist, is nearly identical to the structure with wild-type Tax agonist. Neither the proline in the agonist nor the alanine in the antagonist is contacted by the alpha beta TCR. Here, we demonstrate that antagonist activity of P6A is associated with low affinity of the A6 alpha beta TCR for Tax-P6A/HLA-A2. We show that stepwise repair of a packing defect in the TCR/MHC interface using N-alkylated amino acids results in stepwise increases in TCR affinity and activity. Kinetic and thermodynamic measurements suggest that for some ligands the range of T cell outcomes does not correlate with either their alpha beta TCR affinity or the half-life of the alpha beta TCR/peptide/MHC complex.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Howard Hughes Med Inst, Cambridge, MA 02138 USA; NINDS, Mol Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wiley, DC (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dcwadmin@crystal.harvard.edu	Baker, Brian/B-4584-2009	Baker, Brian/0000-0002-0864-0964				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; BAKER BM, 2000, S QUANT BIOL, V64, P235; BECERRA SP, 1991, BIOCHEMISTRY-US, V30, P11707, DOI 10.1021/bi00114a015; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; DURCHSHLAG H, 1986, THERMODYNAMIC DATA B; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Hausmann S, 1999, J IMMUNOL, V162, P5389; HENNECKE J, 2000, IN PRESS EMBO J; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11259, DOI 10.1021/bi00093a001; JANEWAY CA, 1989, COLD SH Q B, V54, P657; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; Jose ES, 1998, EUR J IMMUNOL, V28, P12; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; Udaka K, 1996, J IMMUNOL, V157, P670; Utz U, 1996, J VIROL, V70, P843, DOI 10.1128/JVI.70.2.843-851.1996; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043	45	119	139	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2000	13	4					475	484		10.1016/S1074-7613(00)00047-9	http://dx.doi.org/10.1016/S1074-7613(00)00047-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070166	Bronze			2022-12-18	WOS:000090079100007
J	Legname, G; Seddon, B; Lovatt, M; Tomlinson, P; Sarner, N; Tolaini, M; Williams, K; Norton, T; Kioussis, D; Zamoyska, R				Legname, G; Seddon, B; Lovatt, M; Tomlinson, P; Sarner, N; Tolaini, M; Williams, K; Norton, T; Kioussis, D; Zamoyska, R			Inducible expression of a p56(Lck) transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes	IMMUNITY			English	Article							T-CELL DEVELOPMENT; GENE-EXPRESSION; MICE LACKING; TYROSINE PHOSPHORYLATION; MAMMALIAN-CELLS; ACTIVATION; SELECTION; RECEPTORS; SIGNALS; THYMUS	The T lymphocyte-specific protein tyrosine kinase p56(lck) (Lck) is an essential component of the TCR-mediated signal transduction complex. Lck knockout mice have reduced numbers of double-positive thymocytes and very few mature single-positive cells, particularly of the CD4 lineage. Here we demonstrate the ability of a tetracycline-based tissue-specific inducible Lck transgene to restore expansion of early thymocytes and maturation of single-positive cells in Lck(neg) mice upon induction with doxycycline. Restoration of Lck expression is particularly important for positive selection to the CD4(+) lineage but has a lesser impact on selection to the CD8(+) lineage, suggesting activation of Lck is an important component of the signals involved in lineage choice during thymic differentiation.	Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	MRC National Institute for Medical Research	Zamoyska, R (corresponding author), Natl Inst Med Res, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	rzamoys@nimr.mrc.ac.uk	Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393; Zamoyska, Rose/0000-0001-9816-2638; Seddon, Benedict/0000-0003-4352-3373				ANDERSON SJ, 1993, NATURE, V365, P552, DOI 10.1038/365552a0; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Basson MA, 1998, J EXP MED, V187, P1249; Bommhardt U, 1997, EUR J IMMUNOL, V27, P1152, DOI 10.1002/eji.1830270516; Bommhardt U, 1998, IMMUNOL REV, V165, P181, DOI 10.1111/j.1600-065X.1998.tb01239.x; CASABO LG, 1994, J IMMUNOL, V152, P397; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Haks MC, 1999, SEMIN IMMUNOL, V11, P23, DOI 10.1006/smim.1998.0153; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; LaFace DM, 1997, J IMMUNOL, V158, P2057; Levelt CN, 1995, IMMUNITY, V3, P667, DOI 10.1016/1074-7613(95)90056-X; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Molina TJ, 1998, J IMMUNOL, V160, P3828; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; PELCHENMATTHEWS A, 1989, EMBO J, V8, P3641, DOI 10.1002/j.1460-2075.1989.tb08538.x; PENIT C, 1989, J IMMUNOL, V142, P3369; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Sousa CRE, 1996, J EXP MED, V184, P149, DOI 10.1084/jem.184.1.149; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	36	119	120	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2000	12	5					537	546		10.1016/S1074-7613(00)80205-8	http://dx.doi.org/10.1016/S1074-7613(00)80205-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843386	Bronze			2022-12-18	WOS:000087356400009
J	Randall, TD; Heath, AW; Santos-Argumedo, L; Howard, MC; Weissman, IL; Lund, FE				Randall, TD; Heath, AW; Santos-Argumedo, L; Howard, MC; Weissman, IL; Lund, FE			Arrest of B lymphocyte terminal differentiation by CD40 signaling: Mechanism for lack of antibody-secreting cells in germinal centers	IMMUNITY			English	Article							HYPER-IGM SYNDROME; J-CHAIN GENE; CD40-DEFICIENT MICE; MESSENGER-RNAS; T-CELLS; LIGAND; ACTIVATION; PROLIFERATION; EXPRESSION; CYTOKINES	Despite extensive research, the role of CD40 signaling in B cell terminal differentiation remains controversial. Here we show that CD40 engagement arrests B cell differentiation prior to plasma cell formation. This arrest is manifested at a molecular level as a reduction in mRNA levels of secretory immunoglobulin gene products such as mu(s) and J chain as well as the loss of the transcriptional regulator BLIMP-1. Furthermore, the inhibition of B cell differentiation by CD40 engagement could not be overcome by either mitogens or cytokines, but could be reversed by antibodies that interfere with the CD40/gp39 interaction. These data suggest that secretory immunoglobulin is not produced by B cells that are actively engaged by gp39-expressing T cells.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA; Univ Sheffield, Sch Med, Dept Med Microbiol, Sheffield S10 2RX, S Yorkshire, England; Univ Sheffield, Sch Med, Sheffield Inst Vaccine Studies, Sheffield S10 2RX, S Yorkshire, England; CINVESTAV,IPN, Dept Cell Biol, Mexico City, DF, Mexico; Anergen, Redwood City, CA 94063 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Trudeau Institute; University of Sheffield; University of Sheffield; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Stanford University	Randall, TD (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.			Santos-Argumedo, Leopoldo/0000-0002-4772-0713				ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Arpin C, 1997, J EXP MED, V186, P931, DOI 10.1084/jem.186.6.931; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BJORCK P, 1993, IMMUNOLOGY, V78, P218; CALLAGHAN R, 1995, WESTERLY, V40, P11; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; DURANDY A, 1993, EUR J IMMUNOL, V23, P2294, DOI 10.1002/eji.1830230936; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; ERNST P, 1995, IMMUNITY, V2, P427, DOI 10.1016/1074-7613(95)90024-1; FAZEKAS S, 1980, J IMMUNOL METHODS, V35, P1; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; GAUCHAT JF, 1993, FEBS LETT, V315, P259, DOI 10.1016/0014-5793(93)81175-Y; GRABSTEIN KH, 1993, J IMMUNOL, V150, P3141; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; HAN SH, 1995, J IMMUNOL, V155, P556; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; HEATH AW, 1993, CELL IMMUNOL, V152, P468, DOI 10.1006/cimm.1993.1305; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Jacobson BA, 1997, IMMUNOL REV, V156, P103, DOI 10.1111/j.1600-065X.1997.tb00962.x; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KING LB, 1990, J IMMUNOL, V144, P3218; LAMSON G, 1984, J EXP MED, V160, P877, DOI 10.1084/jem.160.3.877; LANE P, 1995, EUR J IMMUNOL, V25, P1788, DOI 10.1002/eji.1830250646; LANE P, 1993, J EXP MED, V177, P1209, DOI 10.1084/jem.177.4.1209; LANSFORD RD, 1992, P NATL ACAD SCI USA, V89, P5966, DOI 10.1073/pnas.89.13.5966; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; MALISZEWSKI CR, 1993, EUR J IMMUNOL, V23, P1044, DOI 10.1002/eji.1830230510; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; RANDALL TD, 1992, J BIOL CHEM, V267, P18002; RANDALL TD, 1992, P NATL ACAD SCI USA, V89, P962, DOI 10.1073/pnas.89.3.962; RANDALL TD, 1993, MOL CELL BIOL, V13, P3929, DOI 10.1128/MCB.13.7.3929; RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; Silvy A, 1996, EUR J IMMUNOL, V26, P517, DOI 10.1002/eji.1830260303; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; SWAIN SL, 1988, J IMMUNOL, V140, P4224; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x; TUMER CA, 1994, CELL, V77, P297; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	47	119	122	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1998	8	6					733	742		10.1016/S1074-7613(00)80578-6	http://dx.doi.org/10.1016/S1074-7613(00)80578-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655487	Bronze			2022-12-18	WOS:000074396300009
J	FAHNESTOCK, ML; JOHNSON, JL; FELDMAN, RMR; NEVEU, JM; LANE, WS; BJORKMAN, PJ				FAHNESTOCK, ML; JOHNSON, JL; FELDMAN, RMR; NEVEU, JM; LANE, WS; BJORKMAN, PJ			THE MHC CLASS-I HOMOLOG ENCODED BY HUMAN CYTOMEGALOVIRUS BINDS ENDOGENOUS PEPTIDES	IMMUNITY			English	Article							FC RECEPTOR; HISTOCOMPATIBILITY ANTIGEN; VIRAL PEPTIDES; MOLECULES; EXPRESSION; COMPLEX; STABILITY; RECOGNITION; SEARCH; HLA-A2	The ability of a human cytomegalovirus-encoded homolog of MHC class I molecules to serve as a peptide receptor was investigated. Sequencing of peptide material eluted from the purified viral protein revealed a mixture of endogenous peptides with characteristics similar to those eluted from conventional class I molecules, that is, anchor residues, and a predominance of short peptides derived from cytoplasmic proteins. The possible function(s) of this viral MHC homolog are discussed in light of the finding that it binds endogenous peptides.	CALTECH,HOWARD HUGHES MED INST,PASADENA,CA 91125; CALTECH,DIV BIOL 15629,PASADENA,CA 91125; HARVARD UNIV,HARVARD MICROCHEM FACIL,CAMBRIDGE,MA 02138	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Harvard University								ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bebbington C. R., 1987, DNA CLONING PRACTICA, P163; BECK S, 1988, NATURE, V331, P269, DOI 10.1038/331269a0; BEERSMA MFC, 1993, J IMMUNOL, V151, P4455; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BROWNE H, 1992, J VIROL, V66, P6784, DOI 10.1128/JVI.66.11.6784-6787.1992; BROWNE H, 1990, NATURE, V347, P770, DOI 10.1038/347770a0; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; EVANS SV, 1993, J MOL GRAPHICS, V4, P134; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; FANNESTOCK ML, 1994, BIOCHEMISTRY-US, V33, P8149; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; HARLOW E, 1988, ANTIBODIES LABORATOR; JARDETZKY TS, 1991, NATURE, V353, P325; Kabat EA, 1991, SEQUENCES PROTEINS I; LANE WS, 1991, J PROTEIN CHEM, V10, P151, DOI 10.1007/BF01024778; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; MAUDSLEY DJ, 1991, IMMUNOL TODAY, V12, P429, DOI 10.1016/0167-5699(91)90013-J; PARHAM P, 1983, J BIOL CHEM, V258, P6179; RAGHAVAN M, 1993, BIOCHEMISTRY-US, V32, P8654, DOI 10.1021/bi00084a037; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; Sambrook J., 1989, MOL CLONING LAB MANU; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SCLAZO AA, 1992, J IMMUNOL, V149, P581; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; STERN LJ, 1994, STRUCTURE, V15, P245; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; URBAN RG, 1995, P NATL ACAD SCI USA, V91, P1534; VANBLEEK GM, 1990, NATURE, V348, P213	38	119	124	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					583	590		10.1016/1074-7613(95)90129-9	http://dx.doi.org/10.1016/1074-7613(95)90129-9			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584148	Bronze			2022-12-18	WOS:A1995TG28100006
J	CAI, YC; CEFAI, D; SCHNEIDER, H; RAAB, M; NABAVI, N; RUDD, CE				CAI, YC; CEFAI, D; SCHNEIDER, H; RAAB, M; NABAVI, N; RUDD, CE			SELECTIVE CD28PYMNM MUTATIONS IMPLICATE PHOSPHATIDYLINOSITOL 3-KINASE IN CD86-CD28-MEDIATED COSTIMULATION	IMMUNITY			English	Article							T-CELL ACTIVATION; LYMPHOCYTES-T; GROWTH-FACTOR; SH3 DOMAIN; CTLA-4; 3-KINASE; CD28; MOLECULES; RECEPTOR; ANTIGEN	CD28 costimulatory signals are required for lymphokine production and T cell proliferation. CD28 signaling recruits the intracellular proteins PI 3-kinase, ITK, and GRB-2/SOS. PI 3-kinase and GRB-2/SOS bind the CD28 cytoplasmic pYMNM motif via SH2 domains. We generated CD28 pYMNM mutants and found that Y-191 mutation (Y(191)CD28F) disrupted both PI 3-kinase and GRB-2 binding, while M(194) mutation (M(194)CD28C) disrupted only PI 3-kinase binding. Both mutants still bound ITK. We have assessed the ability of these selective mutants to support IL-2 production upon TCR zeta/ CD3 ligation in the presence of CHO-CD86 (B7-2) cells. Both Y(191)CD28F and M(194)CD28C mutants failed to generate IL-2. These data directly implicate PI 3-kinase in CD28-mediated costimulation leading to IL-2 secretion. Wortmannin, an inhibitor of PI 3-kinase, induced cell apoptosis and as such was unsuitable for use in this study.	HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; MED UNIV S CAROLINA,HOLLINGS CANC CTR,DEPT EXPTL ONCOL,CHARLESTON,SC 29425	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Medical University of South Carolina	CAI, YC (corresponding author), DANA FARBER CANC INST,DIV TUMOR IMMUNOL,44 BINNEY ST,BOSTON,MA 02115, USA.		Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019				ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BALDARI CT, 1993, J BIOL CHEM, V268, P2693; BASKAR S, 1993, P NATL ACAD SCI USA, V90, P5687, DOI 10.1073/pnas.90.12.5687; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; BOUSSIOTIS VA, 1993, P NATL ACAD SCI USA, V90, P11059, DOI 10.1073/pnas.90.23.11059; BOUSSIOTIS VA, 1994, SCIENCE, V299, P1039; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; CHEN CY, 1994, J IMMUNOL, V152, P4929; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; GABERT J, 1987, CELL, V60, P545; GILLIS S, 1978, J IMMUNOL, V120, P2027; GODFREY DI, 1994, J IMMUNOL, V152, P2105; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; GUERDER S, 1994, P NATL ACAD SCI USA, V91, P5138, DOI 10.1073/pnas.91.11.5138; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; HEYECK SD, 1993, P NATL ACAD SCI USA, V90, P669, DOI 10.1073/pnas.90.2.669; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; HUTCHCROFT JE, 1994, P NATL ACAD SCI USA, V91, P3260, DOI 10.1073/pnas.91.8.3260; JENKINS MK, 1988, J IMMUNOL, V140, P3324; JENKINS MK, 1993, CURR OPIN IMMUNOL, V5, P361, DOI 10.1016/0952-7915(93)90054-V; KOULOVA L, 1991, J EXP MED, V173, P759, DOI 10.1084/jem.173.3.759; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; LINSLEY PS, 1994, IMMUNITY, V7, P793; LU YL, 1995, EUR J IMMUNOL, V25, P533, DOI 10.1002/eji.1830250234; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; PARKER PJ, 1992, CELL GROWTH DIFFER, V3, P747; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; PRASAD KVS, 1993, MOL CELL BIOL, V13, P7708, DOI 10.1128/MCB.13.12.7708; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; RAAB M, 1994, MOL CELL BIOL, V14, P2862, DOI 10.1128/MCB.14.5.2862; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; RODRIGUEZVICIAN.P, 1994, NATURE, V370, P527; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; SCHNEIDER H, 1995, RES IMMUNOL, V146, P149, DOI 10.1016/0923-2494(96)80248-3; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; SJOLANDER A, 1991, P NATL ACAD SCI USA, V88, P7908, DOI 10.1073/pnas.88.18.7908; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; UCKER DS, 1989, J IMMUNOL, V143, P3461; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; VOGEL LB, 1993, MOL CELL BIOL, V13, P7408, DOI 10.1128/MCB.13.12.7408; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WARD SG, 1995, EUR J IMMUNOL, V25, P526, DOI 10.1002/eji.1830250233; YANO H, 1993, J BIOL CHEM, V268, P25846; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	76	119	122	0	6	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1995	3	4					417	426		10.1016/1074-7613(95)90171-X	http://dx.doi.org/10.1016/1074-7613(95)90171-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584133	Bronze			2022-12-18	WOS:A1995TB60800003
J	Califano, D; Cho, JJ; Uddin, MN; Lorentsen, KJ; Yang, Q; Bhandoola, A; Li, HM; Avram, D				Califano, Danielle; Cho, Jonathan J.; Uddin, Mohammad N.; Lorentsen, Kyle J.; Yang, Qi; Bhandoola, Avinash; Li, Hongmin; Avram, Dorina			Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells	IMMUNITY			English	Article							DOUBLE-POSITIVE THYMOCYTES; ROR-GAMMA-T; INTESTINAL INFLAMMATION; ALLERGIC INFLAMMATION; COMMENSAL BACTERIA; REGULATORY CELLS; FACTOR GATA3; LYMPHOCYTES; NOTCH; SPECIFICATION	Type 2 innate lymphoid cells (ILC2s) promote anti-helminth responses and contribute to allergies. Here, we report that Bcl11b, previously considered a T-cell-specific transcription factor, acted directly upstream of the key ILC2 transcription factor Gfi1 to maintain its expression in mature ILC2s. Consequently, Bcl11b(-/-) ILC2s downregulated Gata3 and downstream genes, including Il1rl1 (encoding IL-33 receptor), and upregulated Rorc and type 3 ILC (ILC3) genes. Additionally, independent of Gfi1, Bcl11b directly repressed expression of the gene encoding the ILC3 transcription factor Ahr, further contributing to silencing of ILC3 genes in ILC2s. Thus, Bcl11b(-/-) ILC2s lost their functions and gained ILC3 functions, and although they expanded in response to the protease allergen papain, they produced ILC3 but not ILC2 cytokines and caused increased airway infiltration of neutrophils instead of eosinophils. Our results demonstrate that Bcl11b is more than just a T-cell-only transcription factor and establish that Bcl11b sustains mature ILC2 genetic and functional programs and lineage fidelity.	[Califano, Danielle; Cho, Jonathan J.; Uddin, Mohammad N.; Lorentsen, Kyle J.; Avram, Dorina] Albany Med Ctr, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Cho, Jonathan J.; Uddin, Mohammad N.; Lorentsen, Kyle J.; Avram, Dorina] Univ Florida, Dept Med, Coll Med, Gainesville, FL 32610 USA; [Yang, Qi] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Bhandoola, Avinash] NCI, T Cell Biol & Dev Sect, Lab Genome Integr, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA	Albany Medical College; State University System of Florida; University of Florida; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University of New York (SUNY) System; Wadsworth Center	Avram, D (corresponding author), Albany Med Ctr, Ctr Immunol & Microbial Dis, 47 New Scotland Ave,MC 165, Albany, NY 12208 USA.	dorina.avram@medicine.ufl.edu	Li, Hongmin/ABI-2439-2020	Li, Hongmin/0000-0002-8684-5308; Cho, Jonathan/0000-0001-6280-9030	NIH [RO1AI067846, R21AI112492]; University of Florida startup funds; NATIONAL CANCER INSTITUTE [ZIABC011633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067846, R21AI131205, R21AI112492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We greatly acknowledge Drs. Kate MacNamara, Jon Harton, and Bill O'Connor (Albany Medical College) for valuable suggestions and exciting discussions. We further acknowledge Dr. Renjie Song (Wadsworth Center) for assistance with cell sorting. We greatly acknowledge Dr. Douglas Cohn, Ms. Victoria Boppert, and Ms. Hattie Wang for care of the mice. Financial support was provided by NIH grants RO1AI067846 and R21AI112492 and by University of Florida startup funds to Dorina Avram.	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Albu DI, 2011, P NATL ACAD SCI USA, V108, P6211, DOI 10.1073/pnas.1014304108; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Avram D, 2014, J IMMUNOL, V193, P2059, DOI 10.4049/jimmunol.1400930; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Califano D, 2014, J CLIN INVEST, V124, P174, DOI 10.1172/JCI70103; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Cismasiu VB, 2006, BLOOD, V108, P2695, DOI 10.1182/blood-2006-05-021790; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Del Real MM, 2013, DEVELOPMENT, V140, P1207, DOI 10.1242/dev.088559; Garcia-Ojeda ME, 2013, BLOOD, V121, P1749, DOI 10.1182/blood-2012-06-440065; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Uddin MN, 2014, J IMMUNOL, V192, P1946, DOI 10.4049/jimmunol.1301976; VanValkenburgh J, 2011, J EXP MED, V208, P2069, DOI 10.1084/jem.20102683; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Zhang SN, 2010, J EXP MED, V207, P1687, DOI 10.1084/jem.20092136	46	118	121	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					354	368		10.1016/j.immuni.2015.07.005	http://dx.doi.org/10.1016/j.immuni.2015.07.005			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26231117	Green Accepted, Bronze			2022-12-18	WOS:000360101200017
J	Hu, RZ; Kagele, DA; Huffaker, TB; Runtsch, MC; Alexander, M; Liu, J; Bake, E; Su, W; Williams, MA; Rao, DS; Moller, T; Garden, GA; Round, JL; O'Connell, RM				Hu, Ruozhen; Kagele, Dominique A.; Huffaker, Thomas B.; Runtsch, Marah C.; Alexander, Margaret; Liu, Jin; Bake, Erin; Su, Wei; Williams, Matthew A.; Rao, Dinesh S.; Moeller, Thomas; Garden, Gwenn A.; Round, June L.; O'Connell, Ryan M.			miR-155 Promotes T Follicular Helper Cell Accumulation during Chronic, Low-Grade Inflammation	IMMUNITY			English	Article							GERMINAL CENTER RESPONSE; MICRORNA-155; GENE; ACTIVATION; EXPRESSION; GENERATION; REGULATORS	Chronic inflammation is a contributing factor to most life-shortening human diseases. However, the molecular and cellular mechanisms that sustain chronic inflammatory responses remain poorly understood, making it difficult to treat this deleterious condition. Using a mouse model of age-dependent inflammation that results from a deficiency in miR-146a, we demonstrate that miR-155 contributed to the progressive inflammatory disease that emerged as Mir146a(-/-) mice grew older. Upon analyzing lymphocytes from inflamed versus healthy middle-aged mice, we found elevated numbers of T follicular helper (Tfh) cells, germinal center (GC) B cells, and autoantibodies, all occurring in a miR-155-dependent manner. Further, Cd4-cre Mir155(fl/fl) mice were generated and demonstrated that miR-155 functions in T cells, in addition to its established role in B cells, to promote humoral immunity in a variety of contexts. Taken together, our study discovers that miR-146a and miR-155 counterregulate Tfh cell development that drives aberrant GC reactions during chronic inflammation.	[Hu, Ruozhen; Kagele, Dominique A.; Huffaker, Thomas B.; Runtsch, Marah C.; Alexander, Margaret; Liu, Jin; Bake, Erin; Williams, Matthew A.; Round, June L.; O'Connell, Ryan M.] Univ Utah, Div Microbiol & Immunol, Dept Pathol, Salt Lake City, UT 84112 USA; [Su, Wei; Moeller, Thomas; Garden, Gwenn A.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	O'Connell, RM (corresponding author), Univ Utah, Div Microbiol & Immunol, Dept Pathol, 4280 JMRB,15 North Med Dr East, Salt Lake City, UT 84112 USA.	ryan.oconnell@path.utah.edu	Rao, Dinesh/AAE-9625-2019; Garden, Gwenn/CAF-9344-2022; Möller, Thomas/W-8974-2019; Rao, Dinesh/ABG-1257-2021	Rao, Dinesh/0000-0002-0794-9337; Williams, Matthew/0000-0002-4721-4482; Garden, Gwenn/0000-0002-8753-6515; Alexander, Margaret/0000-0003-2972-7521	NIH New Innovator Award [DP2GM111099-01]; NHLBI Pathway to Independence Award [R00HL102228-05]; American Cancer Society Research Scholar Grant; Edward Mallinckrodt Jr. Foundation; Pew Scholars Program; NSF CAREER award [IOS-1253278]; Packard Fellowship in Science and Engineering; NIAID [K22 AI95375, AI107090]; NIH [5T32DK007115-39, R03NS070141, R01CA166450-02]; NATIONAL CANCER INSTITUTE [K08CA133521, R01CA166450] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL102228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI107090, K22AI095375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM111099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS070141] Funding Source: NIH RePORTER	NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Pathway to Independence Award; American Cancer Society Research Scholar Grant(American Cancer Society); Edward Mallinckrodt Jr. Foundation; Pew Scholars Program; NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Packard Fellowship in Science and Engineering; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the University of Utah Gene Expression and Bioinformatics core facilities for help with RNA-seq and data analysis. We also thank the University of Utah Flow Cytometry core facility for assistance with cell sorting. This work was supported by the NIH New Innovator Award DP2GM111099-01 (R.M.O.), the NHLBI Pathway to Independence Award R00HL102228-05 (R.M.O.), an American Cancer Society Research Scholar Grant (R.M.O.), the Edward Mallinckrodt Jr. Foundation (J.L.R.), Pew Scholars Program (J.L.R.), NSF CAREER award IOS-1253278 (J.L.R.), Packard Fellowship in Science and Engineering (J.L.R.), NIAID K22 AI95375 (J.L.R.), NIAID AI107090 (J.L.R.), the NIH training grant 5T32DK007115-39 (D.A.K.), R03NS070141 (G.A.G. and T.M.) and R01CA166450-02 (D.S.R.).	Agrawal A, 2012, AGING-US, V4, P648, DOI 10.18632/aging.100490; Akbaraly TN, 2013, CAN MED ASSOC J, V185, pE763, DOI 10.1503/cmaj.122072; Moro-Garcia MA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00107; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Chen GB, 2010, J IMMUNOL, V185, P2350, DOI 10.4049/jimmunol.1000317; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Clark JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024504, 10.1371/journal.pone.0026885]; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Howcroft TK, 2013, AGING-US, V5, P84, DOI 10.18632/aging.100531; Hu RZ, 2013, J IMMUNOL, V190, P5972, DOI 10.4049/jimmunol.1300351; Huffaker TB, 2012, CELL REP, V2, P1697, DOI 10.1016/j.celrep.2012.10.025; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Linterman MA, 2014, IMMUNOL CELL BIOL, V92, P72, DOI 10.1038/icb.2013.77; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Malmhall C, 2014, J ALLERGY CLIN IMMUN, V133, P1429, DOI 10.1016/j.jaci.2013.11.008; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Nagele EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060726; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Paraboschi EM, 2011, INT J MOL SCI, V12, P8695, DOI 10.3390/ijms12128695; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yung RL, 2008, AUTOIMMUNITY, V41, P329, DOI 10.1080/08916930802024889; Zhao JL, 2013, ELIFE, V2, DOI 10.7554/eLife.00537; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	47	118	127	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					605	619		10.1016/j.immuni.2014.09.015	http://dx.doi.org/10.1016/j.immuni.2014.09.015			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367574	Green Accepted, Bronze			2022-12-18	WOS:000345504300014
J	Song, XY; Gao, HC; Lin, YY; Yao, YK; Zhu, S; Wang, JJ; Liu, Y; Yao, XM; Meng, GX; Shen, N; Shi, YF; Iwakura, Y; Qian, YC				Song, Xinyang; Gao, Hanchao; Lin, Yingying; Yao, Yikun; Zhu, Shu; Wang, Jingjing; Liu, Yan; Yao, Xiaomin; Meng, Guangxun; Shen, Nan; Shi, Yufang; Iwakura, Yoichiro; Qian, Youcun			Alterations in the Microbiota Drive Interleukin-17C Production from Intestinal Epithelial Cells to Promote Tumorigenesis	IMMUNITY			English	Article							COLITIS-ASSOCIATED CANCER; COLORECTAL-CANCER; AUTOIMMUNE-DISEASE; IMMUNE-SYSTEM; INFLAMMATION; RECEPTOR; NEOPLASIA; ACTIVATION; IL-17C; HOMEOSTASIS	Although the microbiota has been shown to drive production of interleukin-17A (IL-17A) from T helper 17 cells to promote cell proliferation and tumor growth in colorectal cancer, the molecular mechanisms for microbiota-mediated regulation of tumorigenesis are largely unknown. Here, we found that the innate-like cytokine IL-17C was upregulated in human colorectal cancers and in mouse intestinal tumor models. Alterations in the microbiota drove IL-17C upregulation specifically in intestinal epithelial cells (IECs) through Toll-like receptor (TLR)-MyD88-dependent signaling during intestinal tumorigenesis. Microbiota-driven IL-17C induced Bcl-2 and Bcl-x(L) expression in IECs in an autocrine manner to promote cell survival and tumorigenesis in both chemically induced and spontaneous intestinal tumor models. Thus, IL-17C promotes cancer development by increasing IEC survival, and the microbiota can mediate cancer pathogenesis through regulation of IL-17C.	[Song, Xinyang; Gao, Hanchao; Lin, Yingying; Yao, Yikun; Zhu, Shu; Wang, Jingjing; Liu, Yan; Shen, Nan; Shi, Yufang; Qian, Youcun] Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Song, Xinyang; Gao, Hanchao; Lin, Yingying; Yao, Yikun; Zhu, Shu; Wang, Jingjing; Liu, Yan; Shen, Nan; Shi, Yufang; Qian, Youcun] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Shen, Nan; Qian, Youcun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Shanghai Inst Rheumatol, Shanghai 200001, Peoples R China; [Yao, Xiaomin; Meng, Guangxun] Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China; [Yao, Xiaomin; Meng, Guangxun] Chinese Acad Sci, Shanghai 200025, Peoples R China; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 2780022, Japan	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Tokyo University of Science	Qian, YC (corresponding author), Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China.	ycqian@sibs.ac.cn	Iwakura, Yoichiro/E-5457-2011; Yao, Yikun/AAH-9197-2021; Yingying, Lin/AAS-1546-2021; Gao, Hanchao/AGW-6043-2022; Zhu, Shu/P-6163-2018; Shi, Yufang/AAE-4431-2020; Shen, Nan/AGK-6807-2022; Song, Xinyang/AAL-7495-2021	Iwakura, Yoichiro/0000-0002-9934-5775; Yingying, Lin/0000-0002-6935-5681; Zhu, Shu/0000-0002-8163-0869; Shi, Yufang/0000-0001-8964-319X; Song, Xinyang/0000-0002-3422-6927; Yao, Yikun/0000-0002-8890-2409; Shen, Nan/0000-0002-5875-4417	National Natural Science Foundation of China [81230075, 91029708, 30930084, 91329301]; 973 Program [2013CB944904, 2010CB529705]; Science and Technology Commission of Shanghai Municipality [13JC1408900]; Chinese Academy of Sciences [NNCAS-2012-9(A), KJZD-EW-L01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank ZymoGenetics for providing the Il17re-deficient mice. We also thank V. Dixit from Genentech for providing Asc-deficient mice. This work was supported by grants from the National Natural Science Foundation of China (81230075, 91029708, 30930084, and 91329301), the 973 Program (2013CB944904 and 2010CB529705), the Science and Technology Commission of Shanghai Municipality (13JC1408900), and the Chinese Academy of Sciences (NNCAS-2012-9(A) and KJZD-EW-L01).	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Chae WJ, 2011, BIOCHEM BIOPH RES CO, V414, P31, DOI 10.1016/j.bbrc.2011.09.016; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dove WF, 1997, CANCER RES, V57, P812; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hyun YS, 2012, CARCINOGENESIS, V33, P931, DOI 10.1093/carcin/bgs106; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Reynolds JM, 2012, J IMMUNOL, V189, P4226, DOI 10.4049/jimmunol.1103014; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Shi PQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001653; Song XY, 2013, CELL SIGNAL, V25, P2335, DOI 10.1016/j.cellsig.2013.07.021; Song XY, 2013, CYTOKINE, V62, P175, DOI 10.1016/j.cyto.2013.03.014; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	41	118	131	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					140	152		10.1016/j.immuni.2013.11.018	http://dx.doi.org/10.1016/j.immuni.2013.11.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24412611	Bronze			2022-12-18	WOS:000331476900016
J	Silva, EAC; Chan, PY; Joannas, L; Errasti, AE; Gagliani, N; Bosurgi, L; Jabbour, M; Perry, A; Smith-Chakmakova, F; Mucida, D; Cheroutre, H; Burstyn-Cohen, T; Leighton, JA; Lemke, G; Ghosh, S; Rothlin, CV				Silva, Eugenio A. Carrera; Chan, Pamela Y.; Joannas, Leonel; Errasti, Andrea E.; Gagliani, Nicola; Bosurgi, Lidia; Jabbour, Maurice; Perry, Anthony; Smith-Chakmakova, Faye; Mucida, Daniel; Cheroutre, Hilde; Burstyn-Cohen, Tal; Leighton, Jonathan A.; Lemke, Greg; Ghosh, Sourav; Rothlin, Carla V.			T Cell-Derived Protein S Engages TAM Receptor Signaling in Dendritic Cells to Control the Magnitude of the Immune Response	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; C4B-BINDING PROTEIN; LIGAND INTERACTION; ADAPTIVE IMMUNITY; APOPTOTIC CELLS; DEFICIENCY; PHOSPHATIDYLSERINE; PHAGOCYTOSIS; STIMULATION; REGULATORS	Dendritic cell (DC) activation is essential for the induction of immune defense against pathogens, yet needs to be tightly controlled to avoid chronic inflammation and exaggerated immune responses. Here, we identify a mechanism of immune homeostasis by which adaptive immunity, once triggered, tempers DC activation and prevents overreactive immune responses. T cells, once activated, produced Protein S (Pros1) that signaled through TAM receptor tyrosine kinases in DCs to limit the magnitude of DC activation. Genetic ablation of Pros1 in mouse T cells led to increased expression of costimulatory molecules and cytokines in DCs and enhanced immune responses to T cell-dependent antigens, as well as increased colitis. Additionally, PROS1 was expressed in activated human T cells, and its ability to regulate DC activation was conserved. Our results identify a heretofore unrecognized, homeostatic negative feedback mechanism at the interface of adaptive and innate immunity that maintains the physiological magnitude of the immune response.	[Silva, Eugenio A. Carrera; Chan, Pamela Y.; Joannas, Leonel; Errasti, Andrea E.; Gagliani, Nicola; Bosurgi, Lidia; Rothlin, Carla V.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Jabbour, Maurice; Ghosh, Sourav] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA; [Perry, Anthony] Banner MD Anderson Canc Ctr, Gilbert, AZ 85234 USA; [Smith-Chakmakova, Faye] St Josephs Hosp, Phoenix, AZ 85013 USA; [Mucida, Daniel; Cheroutre, Hilde] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Burstyn-Cohen, Tal; Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Leighton, Jonathan A.] Mayo Clin Arizona, Div Gastroenterol, Scottsdale, AZ 85259 USA	Yale University; University of Arizona; Banner Research; Banner Health; University of Texas System; UTMD Anderson Cancer Center; St. Joseph's Hospital and Medical Center; La Jolla Institute for Immunology; Salk Institute; Mayo Clinic; Mayo Clinic Phoenix	Ghosh, S (corresponding author), Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA.	sourav.ghosh@arizona.edu; carla.rothlin@yale.edu	Burstyn-Cohen, Tal/K-8846-2012	Burstyn-Cohen, Tal/0000-0002-2324-2921; Gagliani, Nicola/0000-0001-8514-1395; Rothlin, Carla V/0000-0002-5693-5572; Perry, Anthony/0000-0002-1162-4340; Mucida, Daniel/0000-0002-0000-0452; Carrera Silva, Eugenio Antonio/0000-0003-4428-8213; Errasti, Andrea/0000-0003-2384-775X; Bosurgi, Lidia/0000-0002-8775-4950; Ghosh, Sourav/0000-0001-5990-8708	National Institutes of Health [R01 AI077058, R01 AI089824, CA95060, T32 AI007019]; Crohn's and Colitis Foundation; American Heart Association; American Asthma Foundation; Lupus Research Institute; CONICET Postdoctoral Fellowship; Gershon-Trudeau Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [P50CA095060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050265, R01AI089824, T32AI007019, R01AI077058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; American Heart Association(American Heart Association); American Asthma Foundation; Lupus Research Institute; CONICET Postdoctoral Fellowship; Gershon-Trudeau Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Medzhitov for critical reading of this manuscript. We also thank S. Huber, A. Iwasaki, P. Kavathas, P. Lincona-Limon, S. Nish, D. Schenten and E. Zuniga for helpful suggestions and discussions. This research was supported by grants from the National Institutes of Health (R01 AI077058 to G. L., R01 AI089824 to C. V. R. and S. G., CA95060 to S. G., and T32 AI007019 to P.Y.C), by the Crohn's and Colitis Foundation (to C. V. R and S. G.), by the American Heart Association (C. V. R), American Asthma Foundation (C. V. R.), Lupus Research Institute (C. V. R), CONICET Postdoctoral Fellowship (A. E. E.), and a Gershon-Trudeau Postdoctoral Fellowship (E.A.C.S.).	AADLAND E, 1992, SCAND J GASTROENTERO, V27, P957, DOI 10.3109/00365529209000170; Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Dahlback B, 2007, THROMB HAEMOSTASIS, V98, P90, DOI 10.1160/TH07-04-0269; De Frutos PG, 2007, THROMB HAEMOSTASIS, V98, P543, DOI 10.1160/TH07-03-0199; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Gandrille S, 2000, THROMB HAEMOSTASIS, V84, P918; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Koutroubakis IE, 2000, AM J GASTROENTEROL, V95, P190, DOI 10.1111/j.1572-0241.2000.01683.x; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nyberg P, 1997, EUR J BIOCHEM, V246, P147, DOI 10.1111/j.1432-1033.1997.t01-2-00147.x; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Saller F, 2009, BLOOD, V114, P2307, DOI 10.1182/blood-2009-03-209031; Smiley ST, 1997, P NATL ACAD SCI USA, V94, P11484, DOI 10.1073/pnas.94.21.11484; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Suh CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3088; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580; Zezos P, 2007, HEPATO-GASTROENTEROL, V54, P1417	27	118	122	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					160	170		10.1016/j.immuni.2013.06.010	http://dx.doi.org/10.1016/j.immuni.2013.06.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23850380	Green Accepted, Bronze			2022-12-18	WOS:000330948300016
J	Wang, YG; Koroleva, EP; Kruglov, AA; Kuprash, DV; Nedospasov, SA; Fu, YX; Tumanov, AV				Wang, Yugang; Koroleva, Ekaterina P.; Kruglov, Andrei A.; Kuprash, Dmitry V.; Nedospasov, Sergei A.; Fu, Yang-Xin; Tumanov, Alexei V.			Lymphotoxin Beta Receptor Signaling in Intestinal Epithelial Cells Orchestrates Innate Immune Responses against Mucosal Bacterial Infection	IMMUNITY			English	Article							SECONDARY LYMPHOID-TISSUES; ROR-GAMMA-T; RODENTIUM-INDUCED COLITIS; SUPERFAMILY MEMBER LIGHT; CITROBACTER-RODENTIUM; INDUCER CELLS; B-CELLS; AUTOIMMUNE-DISEASE; ALPHA-BETA; EXPRESSION	Epithelial cells provide the first line of defense against mucosal pathogens; however, their coordination with innate and adaptive immune cells is not well understood. Using mice with conditional gene deficiencies, we found that lymphotoxin (LT) from innate cells expressing transcription factor ROR gamma t, but not from adaptive T and B cells, was essential for the control of mucosal C. rodentium infection. We demonstrate that the LT beta R signaling was required for the regulation of the early innate response against infection. Furthermore, we have revealed that LT beta R signals in gut epithelial cells and hematopoietic-derived cells coordinate to protect the host from infection. We further determined that LT beta R signaling in intestinal epithelial cells was required for recruitment of neutrophils to the infection site early during infection via production of CXCL1 and CXCL2 chemokines. These results support a model wherein LT from ROR gamma t(+) cells orchestrates the innate immune response against mucosal microbial infection.	[Wang, Yugang; Koroleva, Ekaterina P.; Fu, Yang-Xin; Tumanov, Alexei V.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kruglov, Andrei A.; Nedospasov, Sergei A.] DRFZ, German Rheumatism Res Ctr, D-10117 Berlin, Germany; [Kuprash, Dmitry V.; Nedospasov, Sergei A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia	University of Chicago; Deutsches Rheuma-Forschungszentrum (DRFZ); Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Fu, YX (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yfu@uchicago.edu; atumanov@bsd.uchicago.edu	Nedospasov, Sergei/J-5936-2013; Nedospasov, Sergei/Q-7319-2016; Nedospasov, Sergei/L-1990-2015; Kuprash, Dmitry/O-4899-2015; Tumanov, Alexei/AAR-1607-2021; Nedospasov, Sergei/C-3043-2018; Kruglov, Andrey/AAP-2023-2021; Kruglov, Andrey A/F-7543-2017	Kuprash, Dmitry/0000-0002-1488-4148; Tumanov, Alexei/0000-0001-6042-0152; Kruglov, Andrey A/0000-0002-4597-2087; fu, yang-xin/0000-0001-8441-6617	U.S. National Institutes of Health [AI062026, CA115540, DK58891]; Crohn's and Colitis Foundation (CCFA) [42672]; Digestive Disease Research Core Center of the University of Chicago [DK42086]; Deutsche Forschungsgemeinschaft [SFB633]; Russian Academy of Sciences; NATIONAL CANCER INSTITUTE [R01CA141975, R01CA115540, P01CA097296, R01CA134563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058897, R01DK058891, P30DK042086] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation (CCFA); Digestive Disease Research Core Center of the University of Chicago(University of Chicago); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Academy of Sciences(Russian Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was in part supported by U.S. National Institutes of Health grants AI062026, CA115540, and DK58891 to Y.X.F.; by Career Development Award from the Crohn's and Colitis Foundation (CCFA #42672), and by Digestive Disease Research Core Center of the University of Chicago DK42086 to A.V.T.; by SFB633 from Deutsche Forschungsgemeinschaft and by MCB Program of the Russian Academy of Sciences. We are grateful to C. Ware (La Jolla Institute for Allergy and Immunology, La Jolla, CA) for 3C8 LTI1R antibody and D. Littman for ROR gamma t-Cre mice. We thank N. Brown, B. Burnette, and E. Chang for critical reading of the manuscript.	Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Browning JL, 2002, J IMMUNOL, V168, P5079, DOI 10.4049/jimmunol.168.10.5079; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Junt T, 2006, EUR J IMMUNOL, V36, P2061, DOI 10.1002/eji.200626255; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; MacDonald TT, 2003, INT J MED MICROBIOL, V293, P87, DOI 10.1078/1438-4221-00247; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Ohtsuka Y, 2001, GUT, V49, P526, DOI 10.1136/gut.49.4.526; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Shakhov AN, 2000, J LEUKOCYTE BIOL, V68, P151; Spahn TW, 2004, GASTROENTEROLOGY, V127, P1463, DOI 10.1053/j.gastro.2004.08.022; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Summers-DeLuca LE, 2007, J EXP MED, V204, P1071, DOI 10.1084/jem.20061968; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tamada K, 2002, J IMMUNOL, V168, P4832, DOI 10.4049/jimmunol.168.10.4832; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Tumanov AV, 2002, IMMUNITY, V17, P239, DOI 10.1016/S1074-7613(02)00397-7; Uren TK, 2005, EUR J IMMUNOL, V35, P180, DOI 10.1002/eji.200425492; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Wang J, 2004, J CLIN INVEST, V113, P826, DOI 10.1172/JCI200420096; Wang YG, 2009, IMMUNOL REV, V229, P232, DOI 10.1111/j.1600-065X.2009.00762.x; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	45	118	122	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					403	413		10.1016/j.immuni.2010.02.011	http://dx.doi.org/10.1016/j.immuni.2010.02.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20226692	Green Accepted, Bronze			2022-12-18	WOS:000276125400013
J	Bertocci, B; De Smet, A; Berek, C; Weill, JC; Reynaud, CA				Bertocci, B; De Smet, A; Berek, C; Weill, JC; Reynaud, CA			Immunoglobulin kappa light chain gene rearrangement is impaired in mice deficient for DNA polymerase mu	IMMUNITY			English	Article							POL-MU; V(D)J RECOMBINATION; TRANSFERASE; ASSOCIATION; EXPRESSION; DIVERSITY; SEGMENTS; PROTEIN; KU; IV	DNA polymerase mu (pol mu) is a template-dependent polymerase closely related to the lymphoid-specific enzyme terminal deoxynucleotidyl transferase (TdT). We report here the phenotype of pol mu-deficient mice. Such animals display an abnormal B cell differentiation, with a specific alteration in the IgM(-) to IgM(+) transition in bone marrow. In all mice, Ig light chain gene rearrangement is impaired at the level of the Vkappa-Jkappa and Vlambda-Jlambda junctions, which show extensive nibbling of both coding extremities. These alterations lead to a profound defect in the peripheral B cell compartment which, although variable between animals, results in an average 40% reduction in the splenic B cell fraction. Pol mu, appears, therefore, as a key element contributing to the relative homogeneity in size of light chain CDR3 and taking part in Ig gene rearrangement at a stage where TdT is no longer expressed.	Fac Med Necker Enfacts Malades, Inst Natl Francais Rech Med U373, F-75730 Paris 15, France; Deutsch Rheumaforschungszentrum, D-10117 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ)	Weill, JC (corresponding author), Fac Med Necker Enfacts Malades, Inst Natl Francais Rech Med U373, 156 Rue Vaigirard, F-75730 Paris 15, France.	weill@necker.fr; reynaud@necker.fr	Bertocci, Barbara/L-9115-2018					ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bentolila LA, 1999, J IMMUNOL, V162, P2123; Bertocci B, 2002, J IMMUNOL, V168, P3702, DOI 10.4049/jimmunol.168.8.3702; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Cabaniols JP, 2001, J EXP MED, V194, P1385, DOI 10.1084/jem.194.9.1385; Cocea L, 1999, J EXP MED, V189, P1443, DOI 10.1084/jem.189.9.1443; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; Duvauchelle JB, 2002, NUCLEIC ACIDS RES, V30, P2061, DOI 10.1093/nar/30.9.2061; Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Havener JM, 2003, BIOCHEMISTRY-US, V42, P1777, DOI 10.1021/bi0270079; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Mahajan KN, 1999, P NATL ACAD SCI USA, V96, P13926, DOI 10.1073/pnas.96.24.13926; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; Purugganan MM, 2001, NUCLEIC ACIDS RES, V29, P1638, DOI 10.1093/nar/29.7.1638; RAMSDEN DA, 1995, GENE DEV, V9, P2409, DOI 10.1101/gad.9.19.2409; Reynaud CA, 2001, PHILOS T ROY SOC B, V356, P91, DOI 10.1098/rstb.2000.0753; Ruiz JF, 2001, PHILOS T R SOC B, V356, P99, DOI 10.1098/rstb.2000.0754; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Thai TH, 2002, NAT IMMUNOL, V3, P457, DOI 10.1038/ni788; TOMLINSON IM, 1995, EMBO J, V14, P4628, DOI 10.1002/j.1460-2075.1995.tb00142.x; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200; Zhang YB, 2001, MOL CELL BIOL, V21, P7995, DOI 10.1128/MCB.21.23.7995-8006.2001	39	118	119	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2003	19	2					203	211		10.1016/S1074-7613(03)00203-6	http://dx.doi.org/10.1016/S1074-7613(03)00203-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932354	Bronze			2022-12-18	WOS:000184929000008
J	Rabinowitz, JD; Vrljic, M; Kasson, PM; Liang, MN; Busch, R; Boniface, JJ; Davis, MM; McConnell, HM				Rabinowitz, JD; Vrljic, M; Kasson, PM; Liang, MN; Busch, R; Boniface, JJ; Davis, MM; McConnell, HM			Formation of a highly peptide-receptive state of class II MHC	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL RECOGNITION; HLA-DR MOLECULES; CHAIN-DERIVED PEPTIDE; INVARIANT-CHAIN; ANTIGEN PRESENTATION; PRESENTING CELLS; MICE LACKING; ACIDIC PH; BINDING	Peptide binding to class II MHC proteins occurs in acidic endosomal compartments following dissociation of class II-associated invariant chain peptide (CLIP). Based on peptide binding both to empty class II MHC and to molecules preloaded with peptides including CLIP, we find evidence for two isomeric forms of empty MHC. One (inactive) does not bind peptide. The other (active) binds peptide rapidly, with k(on) 1000-fold faster than previous estimates. The active isomer can be formed either by slow isomerization of the inactive molecule or by dissociation of a preformed peptide/MHC complex. In the absence of peptide, the active isomer is unstable, rapidly converting to the inactive isomer. These results demonstrate that fast peptide binding is an inherent property of one isomer of empty class II MHC. Dissociation of peptides such as CLIP yields this transient, peptide-receptive isomer.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	McConnell, HM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.		Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Kasson, Peter/0000-0002-3111-8103; Busch, Robert/0000-0002-4132-0751; Davis, Mark/0000-0001-6868-657X				BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Beeson C, 1996, J EXP MED, V184, P777, DOI 10.1084/jem.184.2.777; BEESON C, 1994, P NATL ACAD SCI USA, V91, P8842, DOI 10.1073/pnas.91.19.8842; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BONIFACE JJ, 1993, BIOCHEMISTRY-US, V32, P11761, DOI 10.1021/bi00095a003; BUUS S, 1988, SCIENCE, V242, P1045, DOI 10.1126/science.3194755; BUUS S, 1986, CELL, V47, P1071, DOI 10.1016/0092-8674(86)90822-6; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; FENG MHL, 1994, EUR J IMMUNOL, V24, P355, DOI 10.1002/eji.1830240213; FERSHT AR, 1985, ENZYME STRUCTURE MEC, P89; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; Goldberg JM, 1998, BIOCHEMISTRY-US, V37, P2546, DOI 10.1021/bi972402y; Harrison PM, 1997, CURR OPIN STRUC BIOL, V7, P53, DOI 10.1016/S0959-440X(97)80007-3; JENSEN PE, 1991, J EXP MED, V174, P1111, DOI 10.1084/jem.174.5.1111; JENSEN PE, 1990, J EXP MED, V171, P1779, DOI 10.1084/jem.171.5.1779; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; LEE C, 1995, P NATL ACAD SCI USA, V92, P8269, DOI 10.1073/pnas.92.18.8269; LIANG MN, 1995, INT IMMUNOL, V7, P1397, DOI 10.1093/intimm/7.9.1397; MCCONNELL HM, 1995, P NATL ACAD SCI USA, V92, P2750, DOI 10.1073/pnas.92.7.2750; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Rabinowitz JD, 1997, P NATL ACAD SCI USA, V94, P8702, DOI 10.1073/pnas.94.16.8702; REAY PA, 1994, J IMMUNOL, V152, P3946; REAY PA, 1992, EMBO J, V11, P2829, DOI 10.1002/j.1460-2075.1992.tb05350.x; Reich Z, 1997, P NATL ACAD SCI USA, V94, P2495, DOI 10.1073/pnas.94.6.2495; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROOF RW, 1990, P NATL ACAD SCI USA, V87, P1735, DOI 10.1073/pnas.87.5.1735; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; SADEGHNASSERI S, 1989, NATURE, V337, P274, DOI 10.1038/337274a0; SCHWARTZ RH, 1985, J IMMUNOL, V135, P2598; SETTE A, 1992, J IMMUNOL, V148, P844; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Springer S, 1998, BIOCHEMISTRY-US, V37, P3001, DOI 10.1021/bi9717441; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; TAMPE R, 1991, P NATL ACAD SCI USA, V88, P4661, DOI 10.1073/pnas.88.11.4661; Tompkins SM, 1996, J EXP MED, V183, P857, DOI 10.1084/jem.183.3.857; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; Wang ZL, 1996, BIOCHEMISTRY-US, V35, P16443, DOI 10.1021/bi961214p; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219; WITT SN, 1994, BIOCHEMISTRY-US, V33, P1861, DOI 10.1021/bi00173a032; WITT SN, 1993, ACCOUNTS CHEM RES, V26, P442, DOI 10.1021/ar00032a008; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	51	118	119	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					699	709		10.1016/S1074-7613(00)80667-6	http://dx.doi.org/10.1016/S1074-7613(00)80667-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846491	Bronze			2022-12-18	WOS:000077298300012
J	Tanchot, C; Guillaume, S; Delon, J; Bourgeois, C; Franzke, A; Sarukhan, A; Trautmann, A; Rocha, B				Tanchot, C; Guillaume, S; Delon, J; Bourgeois, C; Franzke, A; Sarukhan, A; Trautmann, A; Rocha, B			Modifications of CD8(+) T cell function during in vivo memory or tolerance induction	IMMUNITY			English	Article							TRANSGENIC MICE; IN-VIVO; SIGNALING PATHWAYS; VIRUS-INFECTION; LYMPHOCYTES-T; ANTIGEN; CALCIUM; ANERGY; INTERLEUKIN-10; CLONES	Naive monoclonal T cells specific for the male antigen can be stimulated in vivo to eliminate male cells and become memory cells or to permit survival of male cells and become tolerant. Memory cells responded to TCR ligation by cyclic oscillations of calcium levels and immediate secretion of very high levels of IL-2 and interferon-gamma. Tolerant cells did not proliferate in response to ionomycin and phorbol myristate acetate, failing to mobilize calcium to produce IL-2 or express IL-2R, but survived for long time periods in vivo and secreted IL-10. These results emphasize that tolerance is not an absence of all functional activity and may be associated with modifications of behavior conferring important regulatory functions on tolerant T cells.	Inst Necker, INSERM, U345, F-75730 Paris 15, France; Inst Necker, INSERM, U373, F-75730 Paris 15, France; CERVI, Lab Immunol Cellulaire, CNRS, URA 625, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Rocha, B (corresponding author), Inst Necker, INSERM, U345, 156 Rue Vaugirard, F-75730 Paris 15, France.	rocha@necker.fr	Bourgeois, Christine/L-5944-2018; Bourgeois, Christine/ABA-1432-2021	Bourgeois, Christine/0000-0003-1146-6087; Bourgeois, Christine/0000-0003-1146-6087; Delon, Jerome/0000-0003-0222-1192; Tanchot, Corinne/0000-0002-2913-1755; Sarukhan, Adelaida/0000-0003-3747-6304				BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; BECKER JC, 1994, INT IMMUNOL, V6, P1605, DOI 10.1093/intimm/6.10.1605; BECKER JC, 1995, P NATL ACAD SCI USA, V92, P2375, DOI 10.1073/pnas.92.6.2375; BHANDOOLA A, 1993, J IMMUNOL, V151, P2355; BLACKMAN MA, 1991, P NATL ACAD SCI USA, V88, P6682, DOI 10.1073/pnas.88.15.6682; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; Cauley LS, 1997, J EXP MED, V186, P71, DOI 10.1084/jem.186.1.71; DELASSUS S, 1994, J IMMUNOL, V152, P2411; DING L, 1993, J IMMUNOL, V151, P1224; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; Esser MT, 1996, J EXP MED, V183, P1697, DOI 10.1084/jem.183.4.1697; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; FREITAS AA, 1975, EUR J IMMUNOL, V5, P831, DOI 10.1002/eji.1830051207; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; FUJIHASHI K, 1993, J IMMUNOL METHODS, V160, P181, DOI 10.1016/0022-1759(93)90176-8; GAJEWSKI TF, 1990, J IMMUNOL, V144, P4110; GAJEWSKI TF, 1994, P NATL ACAD SCI USA, V91, P38, DOI 10.1073/pnas.91.1.38; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LAMB JR, 1983, J EXP MED, V157, P1434, DOI 10.1084/jem.157.5.1434; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; LASALLE JM, 1992, J EXP MED, V176, P177, DOI 10.1084/jem.176.1.177; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; Lowin B, 1996, INT IMMUNOL, V8, P57, DOI 10.1093/intimm/8.1.57; MACATONIA SE, 1993, J IMMUNOL, V150, P3755; MALEFYT RD, 1993, J IMMUNOL, V150, P4754; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Moutschen M, 1996, INT IMMUNOL, V8, P1715, DOI 10.1093/intimm/8.11.1715; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Putney JW, 1998, SCIENCE, V279, P191, DOI 10.1126/science.279.5348.191; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RAMMENSEE HG, 1989, EUR J IMMUNOL, V19, P643, DOI 10.1002/eji.1830190411; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; Renard V, 1996, EUR J IMMUNOL, V26, P2999, DOI 10.1002/eji.1830261227; ROCHA B, 1993, J EXP MED, V177, P1517, DOI 10.1084/jem.177.5.1517; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; ROCHA B, 1995, J EXP MED, V181, P993, DOI 10.1084/jem.181.3.993; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sundstedt A, 1997, J IMMUNOL, V158, P180; Sundstedt A, 1996, P NATL ACAD SCI USA, V93, P979, DOI 10.1073/pnas.93.3.979; TAGA K, 1993, BLOOD, V81, P2964; Tanchot C, 1997, J EXP MED, V186, P1099, DOI 10.1084/jem.186.7.1099; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; VIGNAUX F, 1995, J EXP MED, V181, P781, DOI 10.1084/jem.181.2.781; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0	56	118	119	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1998	8	5					581	590		10.1016/S1074-7613(00)80563-4	http://dx.doi.org/10.1016/S1074-7613(00)80563-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620679	Bronze			2022-12-18	WOS:000073885400006
J	Aifantis, I; Buer, J; vonBoehmer, H; Azogui, O				Aifantis, I; Buer, J; vonBoehmer, H; Azogui, O			Essential role of the pre-T cell receptor in allelic exclusion of the T cell receptor beta locus	IMMUNITY			English	Article							SURROGATE LIGHT-CHAIN; ALPHA-BETA; TCR-BETA; ANTIGEN RECEPTOR; TRANSGENIC MICE; B-CELLS; GENE; EXPRESSION; ORGANIZATION; REPERTOIRE	Following the recent realization that TCR beta transgenes can severely inhibit the rearrangement of endogenous V beta gene segments in the absence of pre-TCR alpha (pT alpha) chains, we tested whether the pre-TCR has an essential role in TCR beta allelic exclusion under more physiological conditions by analyzing TCR rearrangement in immature thymocytes by single-cell PCR. Our results in pTa(+) mice are consistent with an ordered model of TCR beta rearrangement beginning on one allele and continuing on the other only when the first attempt is unsuccessful. By contrast, a higher proportion of thymocytes from pTa(-/-) mice exhibited two productive TCR beta alleles. Thus, the pre-TOP-independent suppression of rearrangement by TCR beta transgenes represents a transgene artifact, whereas under physiological conditions the pre-TCR is essential for allelic exclusion.	INST NECKER,INSERM,F-75730 PARIS 15,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite				Buer, Jan/0000-0002-7602-1698				ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Arden Bernhard, 1995, Immunogenetics, V42, P501; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BROUNS GS, 1993, EUR J IMMUNOL, V23, P1088, DOI 10.1002/eji.1830230517; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; CLARK SP, 1984, NATURE, V311, P387, DOI 10.1038/311387a0; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GROETTRUP M, 1993, EUR J IMMUNOL, V23, P1393, DOI 10.1002/eji.1830230633; GROETTRUP M, 1992, EMBO J, V11, P2735, DOI 10.1002/j.1460-2075.1992.tb05339.x; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; Krotkova A, 1997, J EXP MED, V186, P767, DOI 10.1084/jem.186.5.767; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MELCHERS F, 1994, ANNU REV IMMUNOL, V12, P209, DOI 10.1146/annurev.immunol.12.1.209; NOMURA J, 1991, INT IMMUNOL, V3, P117, DOI 10.1093/intimm/3.2.117; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; STORB U, 1986, J EXP MED, V164, P627, DOI 10.1084/jem.164.2.627; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; WALLACE VA, 1995, EUR J IMMUNOL, V25, P1312, DOI 10.1002/eji.1830250527; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Xu Y, 1996, P NATL ACAD SCI USA, V93, P2169, DOI 10.1073/pnas.93.5.2169	34	118	119	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					601	607		10.1016/S1074-7613(00)80381-7	http://dx.doi.org/10.1016/S1074-7613(00)80381-7			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390684	Bronze			2022-12-18	WOS:A1997YH55400003
J	Beebe, AM; Mauze, S; Schork, NJ; Coffman, RL				Beebe, AM; Mauze, S; Schork, NJ; Coffman, RL			Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice	IMMUNITY			English	Article							CUTANEOUS LEISHMANIASIS; INTERFERON-GAMMA; MURINE LEISHMANIASIS; INFECTION; GENE; SUSCEPTIBILITY; RESOLUTION; TROPICA	Resistance or susceptibility of inbred mouse strains to the parasite Leishmania major correlates with CD4(+) T cell responses of the Th1 or Th2 subsets, respectively. To evaluate the genetic basis for this difference, resistant B10.D2 mice were backcrossed onto susceptible BALB/c mice for five generations with selection for resistance. Candidate resistance loci were identified by high frequency of heterozygosity in resistant N5 backcross mice. Loci on chromosomes 6, 7, 10, 11, 15, and 16 were associated with resistance, demonstrating the multigenic nature of this phenotype. The presence of all six loci was not necessary to confer resistance and no single locus was required. Rather, a variety of combinations of these loci may be capable of interacting to confer resistance.	DNAX RES INST MOL & CELLULAR BIOL INC,PALO ALTO,CA 94304; CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOSTAT & EPIDEMIOL,DEPT GENET,CLEVELAND,OH 44109; HARVARD UNIV,SCH PUBL HLTH,PROGRAM POPULAT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115; JACKSON LAB,BAR HARBOR,ME 04609	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Case Western Reserve University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Jackson Laboratory				Schork, Nicholas/0000-0003-0920-5013	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL054466, U10HL054466] Funding Source: NIH RePORTER; NCRR NIH HHS [NCRR 03655-11] Funding Source: Medline; NHLBI NIH HHS [NHLBI 54466-02] Funding Source: Medline; PHS HHS [NHKBI 54998-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bartlett MS, 1935, J GENET, V31, P327, DOI 10.1007/BF02982404; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; BLACKWELL JM, 1985, IMMUNOGENETICS, V21, P385, DOI 10.1007/BF00430803; BROWSTEIN DG, 1992, J VIROL, V66, P7073, DOI 10.1128/JVI.66.12.7073-7079.1992; CHATELAIN R, 1992, J IMMUNOL, V148, P1182; CHEN SZ, 1990, BIOTECHNIQUES, V8, P32; DETOLLA LJ, 1981, IMMUNOGENETICS, V14, P29, DOI 10.1007/BF00344297; Fisher R.A., 1965, THEORY INBREEDING, V2nd ed.; GIANNINI MSH, 1986, PARASITE IMMUNOL, V8, P31, DOI 10.1111/j.1365-3024.1986.tb00831.x; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; HOWARD JG, 1980, PARASITE IMMUNOL, V2, P303, DOI 10.1111/j.1365-3024.1980.tb00061.x; HOWARD JG, 1980, NATURE, V288, P161, DOI 10.1038/288161a0; KARLIN S, 1979, ADV APPL PROBAB, V11, P479, DOI 10.2307/1426950; Krishnan L, 1996, J IMMUNOL, V156, P644; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LIEW FY, 1993, ADV PARASIT, V32, P161, DOI 10.1016/S0065-308X(08)60208-0; MOCK B, 1993, EUR J IMMUNOGENET, V20, P335, DOI 10.1111/j.1744-313X.1993.tb00153.x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MURRAY HW, 1994, AM J MED, V97, P459, DOI 10.1016/0002-9343(94)90326-3; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; ROBERTS M, 1993, EUR J IMMUNOGENET, V20, P349, DOI 10.1111/j.1744-313X.1993.tb00154.x; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797	26	118	120	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					551	557		10.1016/S1074-7613(00)80343-X	http://dx.doi.org/10.1016/S1074-7613(00)80343-X			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175833	Bronze			2022-12-18	WOS:A1997XB81900006
J	Bleriot, C; Chakarov, S; Ginhoux, F				Bleriot, Camille; Chakarov, Svetoslav; Ginhoux, Florent			Determinants of Resident Tissue Macrophage Identity and Function	IMMUNITY			English	Review							MONOCYTE-DERIVED MACROPHAGES; YOLK-SAC; STEM-CELLS; ANALYSIS REVEALS; GENE-EXPRESSION; FETAL LIVER; ALVEOLAR MACROPHAGES; AORTIC ENDOTHELIUM; MICROGLIA DERIVE; ADULT MICROGLIA	Resident tissue macrophages (RTMs) have a broad spectrum of immune- and non-immune-related tissue-supporting activities. The roots of this heterogeneity and versatility are only beginning to be understood. Here, we propose a conceptual framework for considering the RTM heterogeneity that organizes the factors shaping RTM identity within four cardinal points: (1) ontogeny and the view that adult RTM populations comprise a defined mixture of cells that arise from either embryonic precursors or adult monocytes; (2) local factors unique to the niche of residence, evolving during development and aging; (3) inflammation status; and (4) the cumulative effect of time spent in a specific tissue that contributes to the resilient adaptation of macrophages to their dynamic environment. We review recent findings within this context and discuss the technological advances that are revolutionizing the study of macrophage biology.	[Bleriot, Camille; Chakarov, Svetoslav; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Biopolis, 8A Biomed Grove,Immunos Bldg 3-4, Singapore 138648, Singapore; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Ginhoux, Florent] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore 169856, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Sciences; Shanghai Jiao Tong University	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, Biopolis, 8A Biomed Grove,Immunos Bldg 3-4, Singapore 138648, Singapore.; Ginhoux, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.; Ginhoux, F (corresponding author), SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore 169856, Singapore.	florent_ginhoux@immunol.a-star.edu.sg		Chakarov, Svetoslav/0000-0002-0665-5417; BLERIOT, Camille/0000-0002-4298-2888				A-Gonzalez N, 2017, J EXP MED, V214, P1281, DOI 10.1084/jem.20161375; A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042; Aegerter H, 2020, NAT IMMUNOL, V21, P145, DOI 10.1038/s41590-019-0568-x; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Bain C.C., 2019, BIORXIV, DOI [10.1101/837336, DOI 10.1101/837336]; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Baranska A, 2018, J EXP MED, V215, P1115, DOI 10.1084/jem.20171608; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bernard Claude., 1885, LECONS PHENOMENES VI; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bian ZL, 2020, NATURE, V582, P571, DOI 10.1038/s41586-020-2316-7; BISTONI F, 1986, INFECT IMMUN, V51, P668, DOI 10.1128/IAI.51.2.668-674.1986; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bleriot C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02694; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Bottcher C, 2019, NAT NEUROSCI, V22, P78, DOI 10.1038/s41593-018-0290-2; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Browicz T., 1899, UEBER ZELLEN BLUTCAP, P6; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; CHEN BD, 1988, J IMMUNOL, V141, P139; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; Cohen SB, 2018, CELL HOST MICROBE, V24, P439, DOI 10.1016/j.chom.2018.08.001; Cronan MR, 2016, IMMUNITY, V45, P861, DOI 10.1016/j.immuni.2016.09.014; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; David BA, 2016, GASTROENTEROLOGY, V151, P1176, DOI 10.1053/j.gastro.2016.08.024; Dawson CA, 2020, NAT CELL BIOL, V22, P546, DOI 10.1038/s41556-020-0505-0; de Laval B, 2020, CELL STEM CELL, V26, P657, DOI 10.1016/j.stem.2020.01.017; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; Derecka M, 2020, NAT IMMUNOL, V21, P261, DOI 10.1038/s41590-020-0595-7; Di Paolo NC, 2013, CELL REP, V3, P1840, DOI 10.1016/j.celrep.2013.05.025; Drigo RAE, 2019, CELL METAB, V30, P343, DOI 10.1016/j.cmet.2019.05.010; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Eom DS, 2017, SCIENCE, V355, P1317, DOI 10.1126/science.aal2745; Fujiu K, 2017, NAT MED, V23, P611, DOI 10.1038/nm.4326; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Giladi A, 2018, CELL, V172, P14, DOI 10.1016/j.cell.2017.11.011; Ginhoux F, 2017, TRENDS IMMUNOL, V38, P693, DOI 10.1016/j.it.2017.05.009; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grindberg RV, 2013, P NATL ACAD SCI USA, V110, P19802, DOI 10.1073/pnas.1319700110; Guilliams M, 2020, IMMUNITY, V52, P434, DOI 10.1016/j.immuni.2020.02.015; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Haimon Z, 2018, NAT IMMUNOL, V19, P636, DOI 10.1038/s41590-018-0110-6; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hanamsagar R, 2017, GLIA, V65, P1504, DOI 10.1002/glia.23176; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hoyer FF, 2019, IMMUNITY, V51, P899, DOI 10.1016/j.immuni.2019.10.010; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Hume DA, 2019, TRENDS IMMUNOL, V40, P98, DOI 10.1016/j.it.2018.11.007; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jenkins SJ, 2014, TRENDS IMMUNOL, V35, P358, DOI 10.1016/j.it.2014.06.006; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kanitakis J, 2004, NEW ENGL J MED, V351, P2661, DOI 10.1056/NEJM200412163512523; Kanitakis J, 2011, EXP DERMATOL, V20, P145, DOI 10.1111/j.1600-0625.2010.01146.x; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Klimchenko O, 2011, BLOOD, V117, P3065, DOI 10.1182/blood-2010-07-295246; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Lai SM, 2018, CELL REP, V25, P3099, DOI 10.1016/j.celrep.2018.11.059; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.12.009, 10.1016/j.immuni.2018.06.008]; Link VM, 2018, CELL, V173, P1796, DOI 10.1016/j.cell.2018.04.018; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; MACKANESS GB, 1962, J EXP MED, V116, P381, DOI 10.1084/jem.116.3.381; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Metchnikoff E., 1883, BIOL ZBL, V3, P560; Metschnikoff E, 1891, Br Med J, V1, P213; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; MORRIS L, 1991, DEVELOPMENT, V112, P517; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Nahrendorf M, 2016, CIRC RES, V119, P414, DOI 10.1161/CIRCRESAHA.116.309194; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Naito M, 1996, J LEUKOCYTE BIOL, V59, P133, DOI 10.1002/jlb.59.2.133; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; NORTH RJ, 1969, J EXP MED, V130, P315, DOI 10.1084/jem.130.2.315; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Palis J, 1999, DEVELOPMENT, V126, P5073; Pandya H, 2017, NAT NEUROSCI, V20, P753, DOI 10.1038/nn.4534; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Pociask DA, 2017, AM J PATHOL, V187, P851, DOI 10.1016/j.ajpath.2016.12.012; Pucci F, 2016, SCIENCE, V352, P242, DOI 10.1126/science.aaf1328; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Reu P, 2017, CELL REP, V20, P779, DOI 10.1016/j.celrep.2017.07.004; Rieckmann JC, 2017, NAT IMMUNOL, V18, P583, DOI 10.1038/ni.3693; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Rojo R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11053-8; Rozenblatt-Rosen O, 2017, NATURE, V550, P451, DOI 10.1038/550451a; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; See P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02425; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Sierro F, 2017, IMMUNITY, V47, P374, DOI 10.1016/j.immuni.2017.07.018; Silvin A, 2018, GLIA, V66, P2045, DOI 10.1002/glia.23458; Stewart TA, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00250; Stremmel C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02492-2; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takata K, 2017, IMMUNITY, V47, P183, DOI 10.1016/j.immuni.2017.06.017; TARLING JD, 1982, CELL TISSUE KINET, V15, P577, DOI 10.1111/j.1365-2184.1982.tb01064.x; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; VANTWOUT JW, 1992, SCAND J IMMUNOL, V36, P713; von Kupffer K. W., 1876, ARCH MIKROSK ANAT, V12, P353, DOI DOI 10.1007/BF02933897; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Young MD, 2018, SCIENCE, V361, P594, DOI 10.1126/science.aat1699; Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	157	117	118	9	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					957	970		10.1016/j.immuni.2020.05.014	http://dx.doi.org/10.1016/j.immuni.2020.05.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32553181	Bronze			2022-12-18	WOS:000541890000011
J	Hammond, TR; Marsh, SE; Stevens, B				Hammond, Timothy R.; Marsh, Samuel E.; Stevens, Beth			Immune Signaling in Neurodegeneration	IMMUNITY			English	Review							GENOME-WIDE ASSOCIATION; CENTRAL-NERVOUS-SYSTEM; MYELOID CELLS 2; FRONTOTEMPORAL LOBAR DEGENERATION; TRANSGENIC MOUSE MODEL; FLUID SOLUBLE TREM2; GROWTH-FACTOR-BETA; ANTI-A-BETA; ALZHEIMERS-DISEASE; AMYLOID-BETA	Neurodegenerative diseases of the central nervous system progressively rob patients of their memory, motor function, and ability to perform daily tasks. Advances in genetics and animal models are beginning to unearth an unexpected role of the immune system in disease onset and pathogenesis; however, the role of cytokines, growth factors, and other immune signaling pathways in disease pathogenesis is still being examined. Here we review recent genetic risk and genome-wide association studies and emerging mechanisms for three key immune pathways implicated in disease, the growth factor TGF-beta, the complement cascade, and the extracellular receptor TREM2. These immune signaling pathways are important under both healthy and neurodegenerative conditions, and recent work has highlighted new functional aspects of their signaling. Finally, we assess future directions for immune-related research in neurodegeneration and potential avenues for immune-related therapies.	[Hammond, Timothy R.; Marsh, Samuel E.; Stevens, Beth] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Hammond, Timothy R.; Marsh, Samuel E.; Stevens, Beth] Harvard Med Sch, Boston, MA 02115 USA; [Hammond, Timothy R.; Marsh, Samuel E.; Stevens, Beth] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Stevens, Beth] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Stevens, B (corresponding author), Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.; Stevens, B (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Stevens, B (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Stevens, B (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	beth.stevens@childrens.harvard.edu		Marsh, Samuel/0000-0002-3012-6945	Cure Alzheimer's Fund; NIH/NIA [1RF1AG051496]; NICHD [U54HD090255]; Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH112491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG051496] Funding Source: NIH RePORTER	Cure Alzheimer's Fund; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by: Cure Alzheimer's Fund (B.S.), NIH/NIA 1RF1AG051496 (B.S.), and NICHD U54HD090255 (B.S.). We wish to thank Christina Usher for her helpful feedback and editing. We also wish to thank the authors of the following papers for their commitment to open science for their creation of a series of excellent online databases which were extremely helpful in examination of immune cell enrichment for disease associated genes/loci: http://dropviz.crg/(Saunders et al., 2018), http://micmgliasinglecell.ccm/(Hammond et al., 2019), http://brainmaseq.org/(Bennett et al., 2016; Zhang et al., 2014, 2016), http://www.immgen.org (Immunological Genome Project; Heng et al., 2008), https://gtexportal.org/home/index.html (Gene-Tissue Expression Project; GTEx Consortium, 2013). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The data used in reference to tissue gene -expression enrichment in this manuscript were obtained from: GTEx Gene Expression Portal on 02/05/19 https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000424.v7.p2.	Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042; Afagh A, 1996, EXP NEUROL, V138, P22, DOI 10.1006/exnr.1996.0043; Alzheimer A, 1911, EIGENARTIGE KRANKHEI; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Baird JK, 2019, PARKINSONISM RELAT D, V60, P25, DOI 10.1016/j.parkreldis.2018.10.029; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Baruch K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8967; Bemiller SM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0216-6; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Billingsley KJ, 2018, CELL TISSUE RES, V373, P9, DOI 10.1007/s00441-018-2817-y; Bobela Wojciech, 2014, Curr Protoc Mouse Biol, V4, P121, DOI 10.1002/9780470942390.mo140092; Bond AM, 2012, DEV NEUROBIOL, V72, P1068, DOI 10.1002/dneu.22022; Bonham LW, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0339-y; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brinkman-Vand der Linden ECM, 2003, MOL CELL BIOL, V23, P4199, DOI 10.1128/MCB.23.12.4199-4206.2003; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Broce I, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002487; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Brys M., 2018, 70 ANN M AM AC NEUR; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Caraci F, 2008, NEUROBIOL DIS, V30, P234, DOI 10.1016/j.nbd.2008.01.007; Carmona S, 2018, LANCET NEUROL, V17, P721, DOI 10.1016/S1474-4422(18)30232-1; Castellani RJ, 2011, J NEURAL TRANSM, V118, P23, DOI 10.1007/s00702-010-0485-5; Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Chan G, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000090; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; CHAO CC, 1994, CLIN DIAGN LAB IMMUN, V1, P109, DOI 10.1128/CDLI.1.1.109-110.1994; Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116549; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Chong JR, 2017, J ALZHEIMERS DIS, V56, P157, DOI 10.3233/JAD-160781; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Das P, 2003, J NEUROSCI, V23, P8532; DAVIES P, 1976, LANCET, V2, P1403; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Dawson TM, 2018, NAT NEUROSCI, V21, P1370, DOI 10.1038/s41593-018-0236-8; Dejanovic B, 2018, NEURON, V100, P1322, DOI 10.1016/j.neuron.2018.10.014; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; Depboylu C, 2011, J NEUROIMMUNOL, V236, P39, DOI 10.1016/j.jneuroim.2011.05.006; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; DeVos SL, 2018, BRAIN, V141, P2194, DOI 10.1093/brain/awy117; Dias JM, 2014, NEURON, V84, P927, DOI 10.1016/j.neuron.2014.10.033; Dickson DW, 2018, NEUROLOGY, V91, pE1182, DOI 10.1212/WNL.0000000000006212; Diniz LP, 2017, J NEUROSCI, V37, P6797, DOI 10.1523/JNEUROSCI.3351-16.2017; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Dzamko N, 2015, NEUROSCIENCE, V302, P89, DOI 10.1016/j.neuroscience.2014.10.028; Farfel JM, 2016, NEUROLOGY, V87, P489, DOI 10.1212/WNL.0000000000002909; Ferrari R, 2014, LANCET NEUROL, V13, P686, DOI 10.1016/S1474-4422(14)70065-1; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Fu HJ, 2017, NEURON, V93, P533, DOI 10.1016/j.neuron.2016.12.023; Gagliano SA, 2016, ANN CLIN TRANSL NEUR, V3, P924, DOI 10.1002/acn3.369; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Giraldo M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.02.016; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Glebov K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0479-9; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goetz CG, 2008, ANN NEUROL, V64, pS81, DOI 10.1002/ana.21455; Gotz J, 2018, NAT REV NEUROSCI, V19, P583, DOI 10.1038/s41583-018-0054-8; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Guerreiro R, 2018, LANCET NEUROL, V17, P64, DOI 10.1016/S1474-4422(17)30400-3; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hammond TR, 2018, ANNU REV CELL DEV BI, V34, P523, DOI 10.1146/annurev-cellbio-100616-060509; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HANSEN L, 1990, NEUROLOGY, V40, P1; Hartl D, 2020, MOL PSYCHIATR, V25, P629, DOI 10.1038/s41380-018-0091-8; Hasegawa H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4917; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hinz FI, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023705; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holmans P, 2013, HUM MOL GENET, V22, P1039, DOI 10.1093/hmg/dds492; Holtzman DM, 2004, J MOL NEUROSCI, V23, P247, DOI 10.1385/JMN:23:3:247; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang KL, 2017, NAT NEUROSCI, V20, P1052, DOI 10.1038/nn.4587; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; JIANG HX, 1994, J IMMUNOL, V152, P5050; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Johansson JU, 2018, ALZHEIMERS DEMENT, V14, P1438, DOI 10.1016/j.jalz.2018.04.003; Jones L, 2015, ALZHEIMERS DEMENT, V11, P658, DOI 10.1016/j.jalz.2014.05.1757; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kelly A, 2017, ADV IMMUNOL, V134, P137, DOI 10.1016/bs.ai.2017.01.001; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Kober DL, 2017, J MOL BIOL, V429, P1607, DOI 10.1016/j.jmb.2017.04.004; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Koenigsknecht-Talboo J, 2008, J NEUROSCI, V28, P14156, DOI 10.1523/JNEUROSCI.4147-08.2008; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Lalli MA, 2015, MOL PSYCHIATR, V20, P1294, DOI 10.1038/mp.2015.131; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee SH, 2016, CELL REP, V16, P1690, DOI 10.1016/j.celrep.2016.06.099; Lee Y., 2012, COLD SPRING HARB PER, V2, P1; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lewy F. H., 1923, ZUGLEICH SYSTEMATISC; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; Liang YJ, 2007, BRAIN RES, V1178, P132, DOI 10.1016/j.brainres.2007.08.033; Liao F, 2018, J CLIN INVEST, V128, P2144, DOI 10.1172/JCI96429; Lill CM, 2015, ALZHEIMERS DEMENT, V11, P1407, DOI 10.1016/j.jalz.2014.12.009; Linnartz Bettina, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/587463; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu EC, 2015, NEUROLOGY, V85, P692, DOI 10.1212/WNL.0000000000001877; Loeffler DA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-29; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Magdalinou N, 2014, J NEUROL NEUROSUR PS, V85, P1065, DOI 10.1136/jnnp-2013-307539; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; Mancuso R., 2019, BIORXIV, DOI [10.1101/562561, DOI 10.1101/562561]; Marioni RE, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0150-6; Marsh SE, 2016, P NATL ACAD SCI USA, V113, pE1316, DOI 10.1073/pnas.1525466113; Marsh SE, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt109; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; Meyer AS, 2015, CELL SYST, V1, P25, DOI 10.1016/j.cels.2015.06.002; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Milber JM, 2012, NEUROLOGY, V79, P2307, DOI 10.1212/WNL.0b013e318278fe32; Mishra A, 2017, BRAIN, V140, P1437, DOI 10.1093/brain/awx066; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; MOGI M, 1995, NEUROSCI LETT, V193, P129, DOI 10.1016/0304-3940(95)11686-Q; Molinuevo JL, 2018, ACTA NEUROPATHOL, V136, P821, DOI 10.1007/s00401-018-1932-x; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Mosley RL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009381; Moustafa AA, 2016, NEUROSCI BIOBEHAV R, V68, P727, DOI 10.1016/j.neubiorev.2016.07.010; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Naj AC, 2014, JAMA NEUROL, V71, P1394, DOI 10.1001/jamaneurol.2014.1491; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Notter T, 2018, MOL PSYCHIATR, V23, P323, DOI 10.1038/mp.2016.248; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Orme T, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0874-y; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Outeiro TF, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0306-8; Palazuelos J, 2014, J NEUROSCI, V34, P7917, DOI 10.1523/JNEUROSCI.0363-14.2014; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; Pankiewicz JE, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0156-1; Parhizkar S, 2019, NAT NEUROSCI, V22, P191, DOI 10.1038/s41593-018-0296-9; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Piccio L, 2016, ACTA NEUROPATHOL, V131, P925, DOI 10.1007/s00401-016-1533-5; Pottier C, 2019, ACTA NEUROPATHOL, V137, P879, DOI 10.1007/s00401-019-01962-9; Qin Y, 2018, CELL, V174, P156, DOI 10.1016/j.cell.2018.05.027; Qureshi Irfan A, 2018, Alzheimers Dement (N Y), V4, P746, DOI 10.1016/j.trci.2018.10.007; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ransohoff RM, 2018, J EXP MED, V215, P2955, DOI 10.1084/jem.20182042; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Reichwald J, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-35; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Saul A, 2013, NEUROBIOL AGING, V34, P2564, DOI 10.1016/j.neurobiolaging.2013.05.003; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Sayed F. A., 2018, P NATL ACAD SCI USA; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schenk DB, 2017, MOVEMENT DISORD, V32, P211, DOI 10.1002/mds.26878; Schlepckow K, 2017, EMBO MOL MED, V9, P1356, DOI 10.15252/emmm.201707672; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Song WM, 2018, ADV IMMUNOL, V139, P1, DOI 10.1016/bs.ai.2018.04.002; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Sosna J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0244-x; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stipursky J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00393; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Suarez-Calvet M, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-018-0301-5; Suarez-Calvet M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1767; Sulzer D, 2017, NATURE, V546, P656, DOI 10.1038/nature22815; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Tesseur I, 2017, J NEUROSCI, V37, P4584, DOI 10.1523/JNEUROSCI.2952-16.2017; Thornton P, 2017, EMBO MOL MED, V9, P1366, DOI 10.15252/emmm.201707673; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Tsuang D, 2013, JAMA NEUROL, V70, P223, DOI 10.1001/jamaneurol.2013.600; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; Ulrich JD, 2018, J EXP MED, V215, P1047, DOI 10.1084/jem.20171265; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Visanji NP, 2016, TRENDS NEUROSCI, V39, P750, DOI 10.1016/j.tins.2016.09.003; Walker Z, 2015, LANCET, V386, P1683, DOI 10.1016/S0140-6736(15)00462-6; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Weihofen A, 2019, NEUROBIOL DIS, V124, P276, DOI 10.1016/j.nbd.2018.10.016; Wong K, 2017, NAT IMMUNOL, V18, P633, DOI 10.1038/ni.3743; Woollacott IOC, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0405-8; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Xiang XY, 2016, EMBO MOL MED, V8, P992, DOI 10.15252/emmm.201606370; YAMADA T, 1992, ACTA NEUROPATHOL, V84, P100, DOI 10.1007/BF00427222; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0; Yeh FL, 2017, TRENDS MOL MED, V23, P512, DOI 10.1016/j.molmed.2017.03.008; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yin CJ, 2019, NAT MED, V25, P496, DOI 10.1038/s41591-018-0336-8; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94; Zetterberg H, 2019, NEUROPATH APPL NEURO, V45, P81, DOI 10.1111/nan.12530; Zetterberg H, 2004, NEUROSCI LETT, V367, P194, DOI 10.1016/j.neulet.2004.06.001; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zhong L, 2017, J EXP MED, V214, P597, DOI 10.1084/jem.20160844; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	280	117	122	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					955	974		10.1016/j.immuni.2019.03.016	http://dx.doi.org/10.1016/j.immuni.2019.03.016			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995509	Green Accepted, Bronze			2022-12-18	WOS:000464660800013
J	Kishore, M; Cheung, KCP; Fu, HM; Bonacina, F; Wang, GS; Coe, D; Ward, EJ; Colamatteo, A; Jangani, M; Baragetti, A; Matarese, G; Smith, DM; Haas, R; Mauro, C; Wraith, DC; Okkenhaug, K; Catapano, AL; De Rosa, V; Norata, GD; Marelli-Berg, FM				Kishore, Madhav; Cheung, Kenneth C. P.; Fu, Hongmei; Bonacina, Fabrizia; Wang, Guosu; Coe, David; Ward, Eleanor J.; Colamatteo, Alessandra; Jangani, Maryam; Baragetti, Andrea; Matarese, Giuseppe; Smith, David M.; Haas, Robert; Mauro, Claudio; Wraith, David C.; Okkenhaug, Klaus; Catapano, Alberico L.; De Rosa, Veronica; Norata, Giuseppe D.; Marelli-Berg, Federica M.			Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis	IMMUNITY			English	Article							GENERAL-POPULATION; SIGNALING PATHWAY; MAMMALIAN TARGET; CD28; CTLA-4; ACTIVATION; RECEPTOR; DIFFERENTIATION; METABOLISM; EXPRESSION	Migration of activated regulatory T (Treg) cells to inflamed tissue is crucial for their immune-modulatory function. While metabolic reprogramming during Treg cell differentiation has been extensively studied, the bioenergetics of Treg cell trafficking remains undefined. We have investigated the metabolic demands of migrating Treg cells in vitro and in vivo. We show that glycolysis was instrumental for their migration and was initiated by pro-migratory stimuli via a PI3K-mTORC2-mediated pathway culminating in induction of the enzyme glucokinase (GCK). Subsequently, GCK promoted cytoskeletal rearrangements by associating with actin. Treg cells lacking this pathway were functionally suppressive but failed to migrate to skin allografts and inhibit rejection. Similarly, human carriers of a loss-of-function GCK regulatory protein gene-leading to increased GCK activity-had reduced numbers of circulating Treg cells. These cells displayed enhanced migratory activity but similar suppressive function, while conventional T cells were unaffected. Thus, GCK-dependent glycolysis regulates Treg cell migration.	[Kishore, Madhav; Cheung, Kenneth C. P.; Fu, Hongmei; Wang, Guosu; Coe, David; Ward, Eleanor J.; Jangani, Maryam; Haas, Robert; Mauro, Claudio; Marelli-Berg, Federica M.] Queen Mary Univ London, William Harvey Res Inst, London EC1M 6BQ, England; [Bonacina, Fabrizia; Baragetti, Andrea; Catapano, Alberico L.; Norata, Giuseppe D.] Univ Milan, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy; [Colamatteo, Alessandra; Matarese, Giuseppe; De Rosa, Veronica] CNR, IEOS, I-80131 Naples, Italy; [Matarese, Giuseppe] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [Smith, David M.] AstraZeneca, Discovery Sci Innovat Med & Early Dev Biotech Uni, Cambridge CB4 0WG, Cambs, England; [Wraith, David C.] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England; [Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Catapano, Alberico L.] IRCCS Multimed Hosp, I-20138 Milan, Italy; [Norata, Giuseppe D.] Curtin Univ, Sch Biomed Sci, Curtin Hlth Innovat Res Inst, Perth, WA 6102, Australia	University of London; Queen Mary University London; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; AstraZeneca; University of Birmingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Curtin University	Marelli-Berg, FM (corresponding author), Queen Mary Univ London, William Harvey Res Inst, London EC1M 6BQ, England.	f.marelli-berg@qmul.ac.uk	, ken/Q-7665-2018; Okkenhaug, Klaus/H-3154-2019; Cheung, Kenneth Chat Pan/AAD-3351-2020; Catapano, alberico/AAC-2827-2019; Norata, Giuseppe Danilo/AAC-2863-2019; Mauro, Claudio/AAN-1848-2021; Bonacina, Fabrizia/AAC-3359-2022; Matarese, Giuseppe/AAO-4077-2021	, ken/0000-0002-7783-1780; Okkenhaug, Klaus/0000-0002-9432-4051; Cheung, Kenneth Chat Pan/0000-0002-7783-1780; Catapano, alberico/0000-0002-7593-2094; Mauro, Claudio/0000-0002-3736-0099; Bonacina, Fabrizia/0000-0002-2611-1177; Matarese, Giuseppe/0000-0001-9429-0616; Haas, Robert/0000-0003-4826-2379; Norata, Giuseppe Danilo/0000-0002-6081-1257; Smith, David/0000-0001-6831-280X; Wraith, David/0000-0003-2147-5614; Coe, David/0000-0001-8167-600X	British Heart Foundation [CH/15/2/32064, RG/14/2/30616]; Barts Charity [MGU0377]; Fondazione Italiana Sclerosi Multipla [2016/R/18]; Associazione Italiana per la Ricerca sul Cancro-Cariplo Transforming IDEas in Oncological Research (TRIDEO) [17447]; Fondazione Cariplo [2016-0852]; Ministero della Salute [GR-2011-02346974]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0428, BBS/E/B/000C0409, BBS/E/B/000C0427, BBS/E/B/000C0407] Funding Source: researchfish; British Heart Foundation [FS/11/64/28945, FS/12/38/29640, PG/15/105/31906] Funding Source: researchfish; Medical Research Council [1263270] Funding Source: researchfish; BBSRC [BBS/E/B/000C0428, BBS/E/B/000C0427, BBS/E/B/000C0407, BBS/E/B/000C0409] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Barts Charity; Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Associazione Italiana per la Ricerca sul Cancro-Cariplo Transforming IDEas in Oncological Research (TRIDEO)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); Ministero della Salute(Ministry of Health, Italy); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Fulvio D'Acquisto for helpful discussions. F.M.M.-B. is supported by the British Heart Foundation grants CH/15/2/32064 and RG/14/2/30616 and by the Barts Charity grant MGU0377, G.M. is supported by the Fondazione Italiana Sclerosi Multipla (grant no. 2016/R/18), V.D.R. is supported by the Associazione Italiana per la Ricerca sul Cancro-Cariplo Transforming IDEas in Oncological Research (TRIDEO) (grant no. 17447), and G.D.N. is supported by Fondazione Cariplo 2016-0852 and Ministero della Salute GR-2011-02346974. D.M.S. is employed by and holds shares in AstraZeneca Plc.	Baragetti A, 2015, J INTERN MED, V277, P478, DOI 10.1111/joim.12282; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Bernstein BW, 2003, J NEUROSCI, V23, P1; BOSCA L, 1988, EUR J BIOCHEM, V175, P317, DOI 10.1111/j.1432-1033.1988.tb14199.x; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; CLARKE FM, 1975, BIOCHIM BIOPHYS ACTA, V381, P37, DOI 10.1016/0304-4165(75)90187-7; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fu HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4436; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Haas R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002202; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jain N, 2013, NAT MED, V19, P1632, DOI 10.1038/nm.3393; Jarmin SJ, 2008, J CLIN INVEST, V118, P1154, DOI 10.1172/JCI33267; Jung JH, 2002, J BIOL CHEM, V277, P48931, DOI 10.1074/jbc.M208806200; Lenzen S, 2014, J BIOL CHEM, V289, P12189, DOI 10.1074/jbc.R114.557314; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; MARJANOVIC S, 1990, BIOCHIM BIOPHYS ACTA, V1087, P1, DOI 10.1016/0167-4781(90)90113-G; Masui K, 2014, TRENDS ENDOCRIN MET, V25, P364, DOI 10.1016/j.tem.2014.04.002; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mirenda V, 2007, BLOOD, V109, P2968, DOI 10.1182/blood-2006-10-050724; Muller N, 2008, J CLIN INVEST, V118, P1405, DOI 10.1172/JCI32698; Murata T, 1997, FEBS LETT, V406, P109, DOI 10.1016/S0014-5793(97)00253-6; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Norata GD, 2006, STROKE, V37, P1558, DOI 10.1161/01.STR.0000221803.16897.22; Norata GD, 2009, NUTR METAB CARDIOVAS, V19, P129, DOI 10.1016/j.numecd.2008.03.004; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Waring MJ, 2012, MEDCHEMCOMM, V3, P1077, DOI 10.1039/c2md20077e; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510	51	117	126	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					875	+		10.1016/j.immuni.2017.10.017	http://dx.doi.org/10.1016/j.immuni.2017.10.017			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166588	Green Published, hybrid			2022-12-18	WOS:000416483700012
J	Mamantopoulos, M; Ronchi, F; Van Hauwermeiren, F; Vieira-Silva, S; Yilmaz, B; Martens, L; Saeys, Y; Drexler, SK; Yazdi, AS; Raes, J; Lamkanfi, M; McCoy, KD; Wullaert, A				Mamantopoulos, Michail; Ronchi, Francesca; Van Hauwermeiren, Filip; Vieira-Silva, Sara; Yilmaz, Bahtiyar; Martens, Liesbet; Saeys, Yvan; Drexler, Stefan K.; Yazdi, Amir S.; Raes, Jeroen; Lamkanfi, Mohamed; McCoy, Kathy D.; Wullaert, Andy			Nlrp6-and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition	IMMUNITY			English	Article							WIDE ASSOCIATION; INNATE IMMUNITY; RECEPTOR; COLITIS; PRIMERS; GENOME	The gut microbiota regulate susceptibility to multiple human diseases. The Nlrp6-ASC inflammasome is widely regarded as a hallmark host innate immune axis that shapes the gut microbiota composition. This notion stems from studies reporting dysbiosis in mice lacking these inflammasome components when compared with non-littermate wild-type animals. Here, we describe microbial analyses in inflammasome-deficient mice while minimizing non-genetic confounders using littermate-controlled Nlrp6-deficient mice and ex-germ-free littermate-controlled ASC-deficient mice that were all allowed to shape their gut microbiota naturally after birth. Careful microbial phylogenetic analyses of these cohorts failed to reveal regulation of the gut microbiota composition by the Nlrp6- and ASC-dependent inflammasomes. Our results obtained in two geographically separated animal facilities dismiss a generalizable impact of Nlrp6- and ASC-dependent inflammasomes on the composition of the commensal gut microbiota and highlight the necessity for littermate-controlled experimental design in assessing the influence of host immunity on gut microbial ecology.	[Yilmaz, Bahtiyar; Martens, Liesbet; Drexler, Stefan K.; Raes, Jeroen; McCoy, Kathy D.; Wullaert, Andy] Univ Ghent, Dept Internal Med, Ghent, Belgium; [Van Hauwermeiren, Filip; Yilmaz, Bahtiyar; Yazdi, Amir S.] VIB UGent Ctr Inflammat Res, VIB, Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	McCoy, KD; Wullaert, A (corresponding author), Univ Ghent, Dept Internal Med, Ghent, Belgium.	kathy.mccoy@ucalgary.ca; andy.wullaert@ugent.be	McCoy, Kathy/ABD-5814-2021; Wullaert, Andy/D-2975-2018; raes, jeroen/D-7835-2018; Wullaert, Andy/R-1924-2019; Saeys, Yvan/C-1311-2009; Yilmaz, Bahtiyar/U-6646-2019; Vieira-Silva, Sara/ABE-1247-2021	Wullaert, Andy/0000-0001-5012-654X; raes, jeroen/0000-0002-1337-041X; Wullaert, Andy/0000-0001-5012-654X; Saeys, Yvan/0000-0002-0415-1506; Vieira-Silva, Sara/0000-0002-4616-7602; Ronchi, Francesca/0000-0002-2035-6528; Martens, Liesbet/0000-0001-9180-7456; Yilmaz, Bahtiyar/0000-0003-1888-9226	SNSF [SNSF310030_134902]; European Research Council (FP/ERC) [281785]; Marie Heim-Vogtlin fellowship from SNSF [PMPDP3_145453]; ECCO grant; Odysseus grant from the Fund for Scientific Research-Flanders [G.0C49.13N]; Ghent University Concerted Research Actions [BOF14/GOA/013]; European Research Council [281600, 683144]; Baillet Latour Medical Research Grant	SNSF(Swiss National Science Foundation (SNSF)); European Research Council (FP/ERC); Marie Heim-Vogtlin fellowship from SNSF; ECCO grant; Odysseus grant from the Fund for Scientific Research-Flanders(FWO); Ghent University Concerted Research Actions; European Research Council(European Research Council (ERC)European Commission); Baillet Latour Medical Research Grant	K.D.M. was supported by a grant from the SNSF (SNSF310030_134902) and the European Research Council (FP/2007-2013/ERC grant Agreement no 281785). F.R. was supported by a Marie Heim-Vogtlin fellowship from SNSF (PMPDP3_145453) and an ECCO grant. A.W. was supported by the Odysseus grant G.0C49.13N from the Fund for Scientific Research-Flanders. F.V.H. and A.W. are post-doctoral fellows with the Fund for Scientific Research-Flanders in the M.L. laboratory. Work in the M.L. laboratory is further supported by Ghent University Concerted Research Actions grant BOF14/GOA/013, European Research Council grants 281600 and 683144, and a Baillet Latour Medical Research Grant. We are grateful for excellent technical support by Maarten Verdonckt (Ghent University).	Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Drexler SK, 2012, P NATL ACAD SCI USA, V109, P18384, DOI 10.1073/pnas.1209171109; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; Malik A, 2016, J CLIN INVEST, V126, P4469, DOI 10.1172/JCI88625; Martin M, 2011, EMBNET J, V17; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rausch P, 2016, INT J MED MICROBIOL, V306, P343, DOI 10.1016/j.ijmm.2016.03.004; Robertson SJ, 2013, GUT MICROBES, V4, P222, DOI 10.4161/gmic.24373; Rogers GB, 2014, SCI REP-UK, V4, DOI 10.1038/srep05437; Stappenbeck TS, 2016, NATURE, V534, P191, DOI 10.1038/nature18285; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Turpin W, 2016, NAT GENET, V48, P1413, DOI 10.1038/ng.3693; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Wang J, 2016, NAT GENET, V48, P1396, DOI 10.1038/ng.3695; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whiteley AS, 2012, J MICROBIOL METH, V91, P80, DOI 10.1016/j.mimet.2012.07.008; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	38	117	122	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					339	+		10.1016/j.immuni.2017.07.011	http://dx.doi.org/10.1016/j.immuni.2017.07.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28801232	Bronze			2022-12-18	WOS:000407788300018
J	Andrabi, R; Voss, JE; Liang, CH; Briney, B; Mccoy, LE; Wu, CY; Wong, CH; Poignard, P; Burton, DR				Andrabi, Raiees; Voss, James E.; Liang, Chi-Hui; Briney, Bryan; Mccoy, Laura E.; Wu, Chung-Yi; Wong, Chi-Huey; Poignard, Pascal; Burton, Dennis R.			Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design	IMMUNITY			English	Article							STRUCTURAL BASIS; V1/V2 DOMAIN; RECOGNITION; EPITOPE; GP120; MATURATION; REVEAL; TRIMER; PG16; PG9	Broadly neutralizing antibodies (bnAbs) directed to the V2 apex of the HIV envelope (Env) trimer isolated from individual HIV-infected donors potently neutralize diverse HIV strains, but strategies for designing immunogens to elicit bnAbs have not been identified. Here, we compared four prototypes (PG9, CH01, PGT145, and CAP256.VRC26.09) of V2 apex bnAbs and showed that all recognized a core epitope of basic V2 residues and the glycan-N160. Two prototype bnAbs were derived from VH-germlines that were 99% identical and used a common germline D-gene encoded YYD-motif to interact with the V2-epitope. We identified isolates that were neutralized by inferred germline (iGL) versions of three of the prototype bnAbs. Soluble Env derived from one of these isolates was shown to form a well-ordered Env trimer that could serve as an immunogen to initiate a V2-apex bnAb response. These studies illustrate a strategy to transition from panels of bnAbs to vaccine candidates.	[Andrabi, Raiees; Voss, James E.; Liang, Chi-Hui; Briney, Bryan; Mccoy, Laura E.; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Andrabi, Raiees; Voss, James E.; Liang, Chi-Hui; Briney, Bryan; Mccoy, Laura E.; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Andrabi, Raiees; Voss, James E.; Liang, Chi-Hui; Briney, Bryan; Mccoy, Laura E.; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Burton, Dennis R.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02114 USA; [Burton, Dennis R.] Harvard Univ, Boston, MA 02114 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Academia Sinica - Taiwan; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	burton@scripps.edu	poignard, pascal/N-6678-2013; Wu, Chung-Yi/K-8334-2018; poignard, pascal/AAB-4613-2020	Poignard, Pascal/0000-0002-0021-7192; McCoy, Laura/0000-0001-9503-7946	International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium (NAC) [SFP2120/2121]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [UM1AI100663]; Bill and Melinda Gates Foundation Collaboration; American people through USAID; James and Jessie Minor Chair in Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244, UM1AI100663] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium (NAC); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); Bill and Melinda Gates Foundation Collaboration; American people through USAID(United States Agency for International Development (USAID)); James and Jessie Minor Chair in Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank, John Mascola, Michel Nussenzweig, James Robinson, Miroslaw K. Gorny, and Susan Zolla-Pazner for providing antibodies directly or through the IAVI Neutralizing Antibody Consortium (Scripps) or NIH AIDS Research and Reference Reagent Program (ARRRP). This work was supported by the International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium (NAC) Grant SFP2120/2121 (to D.R.B.) and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) Grant UM1AI100663 (to D.R.B.). This study was made possible by the generous support of the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) and the American people through USAID. D.R.B. acknowledges the support of the James and Jessie Minor Chair in Immunology. We thank Christina Corbaci for her help in the preparation of figures.	Barbian HJ, 2015, MBIO, V6, DOI 10.1128/mBio.00296-15; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Braibant M, 2013, AIDS, V27, P1239, DOI 10.1097/QAD.0b013e32835ecb42; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore PL, 2013, J VIROL, V87, P4882, DOI 10.1128/JVI.03424-12; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang S, 2015, CELL, V160, P785, DOI 10.1016/j.cell.2015.01.027; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	38	117	121	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					959	973		10.1016/j.immuni.2015.10.014	http://dx.doi.org/10.1016/j.immuni.2015.10.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588781	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000366846000016
J	Proietti, M; Cornacchione, V; Jost, TR; Romagnani, A; Faliti, CE; Perruzza, L; Rigoni, R; Radaelli, E; Caprioli, F; Preziuso, S; Brannetti, B; Thelen, M; McCoy, KD; Slack, E; Traggiai, E; Grassi, F				Proietti, Michele; Cornacchione, Vanessa; Jost, Tanja Rezzonico; Romagnani, Andrea; Faliti, Caterina Elisa; Perruzza, Lisa; Rigoni, Rosita; Radaelli, Enrico; Caprioli, Flavio; Preziuso, Silvia; Brannetti, Barbara; Thelen, Marcus; McCoy, Kathy D.; Slack, Emma; Traggiai, Elisabetta; Grassi, Fabio			ATP-Gated Ionotropic P2X7 Receptor Controls Follicular T Helper Cell Numbers in Peyer's Patches to Promote Host-Microbiota Mutualism	IMMUNITY			English	Article							CLASS SWITCH RECOMBINATION; IMMUNE-RESPONSES; COMMENSAL BACTERIA; CHEMOKINE RECEPTOR; GUT HOMEOSTASIS; CECAL LIGATION; RETINOIC ACID; IGA; INDUCTION; DEATH	Microbial colonization of the gut induces the development of gut-associated lymphoid tissue (GALT). The molecular mechanisms that regulate GALT function and result in gut-commensal homeostasis are poorly defined. T follicular helper (Tfh) cells in Peyer's patches (PPs) promote high-affinity IgA responses. Here we found that the ATP-gated ionotropic P2X7 receptor controls Tfh cell numbers in PPs. Lack of P2X7 in Tfh cells enhanced germinal center reactions and high-affinity IgA secretion and binding to commensals. The ensuing depletion of mucosal bacteria resulted in reduced systemic translocation of microbial components, lowering B1 cell stimulation and serum IgM concentrations. Mice lacking P2X7 had increased susceptibility to polymicrobial sepsis, which was rescued by Tfh cell depletion or administration of purified IgM. Thus, regulation of Tfh cells by P2X7 activity is important for mucosal colonization, which in turn results in IgM serum concentrations necessary to protect the host from bacteremia.	[Proietti, Michele; Cornacchione, Vanessa; Jost, Tanja Rezzonico; Romagnani, Andrea; Faliti, Caterina Elisa; Perruzza, Lisa; Rigoni, Rosita; Thelen, Marcus; Grassi, Fabio] Biomed Res Inst, CH-6500 Bellinzona, Switzerland; [Cornacchione, Vanessa; Brannetti, Barbara; Traggiai, Elisabetta] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Romagnani, Andrea; Faliti, Caterina Elisa; Perruzza, Lisa] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3012 Bern, Switzerland; [Radaelli, Enrico] Fdn Filarete, I-20139 Milan, Italy; [Caprioli, Flavio] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy; [Caprioli, Flavio] Osped Policlin Milano, Fdn IRCCS Ca Granda, Unit Gastroenterol 2, I-20122 Milan, Italy; [Preziuso, Silvia] Univ Camerino, Dept Vet Med Sci, I-62024 Matelica, Italy; [McCoy, Kathy D.] Univ Bern, UVCM, Maurice Muller Labs, CH-3010 Bern, Switzerland; [Slack, Emma] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Grassi, Fabio] Univ Milan, Dept Med Biotechnol & Translat Med, I-20133 Milan, Italy	Universita della Svizzera Italiana; Novartis; University of Bern; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Luigi Sacco Hospital; University of Camerino; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Milan	Grassi, F (corresponding author), Biomed Res Inst, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	fabio.grassi@irb.usi.ch	McCoy, Kathy/ABD-5814-2021; Slack, Emma/B-1612-2016; Slack, Emma/AAD-5837-2019; Caprioli, Flavio/AAB-5176-2019; Rigoni, Rosita/J-3151-2018	Slack, Emma/0000-0002-2473-1145; Slack, Emma/0000-0002-2473-1145; Caprioli, Flavio/0000-0002-8077-8175; Faliti, Katia/0000-0003-0487-1914; , Barbara/0000-0001-9436-0362; GRASSI, FABIO/0000-0003-3348-1712; Rigoni, Rosita/0000-0002-2419-7907	Swiss National Science Foundation [310030-140963, CRSII2-127547]; Fondazione Cariplo [2012-0519]; Nano-Tera project [20NA21-128841]; Fondazione Ticinese per la Ricerca sul Cancro; Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; Converge Biotech	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondazione Cariplo(Fondazione Cariplo); Nano-Tera project; Fondazione Ticinese per la Ricerca sul Cancro; Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; Converge Biotech	We thank D. Jarrossay and E. Montani (Institute for Research in Biomedicine) for cell sorting and help with confocal microscopy, M. Francolini (Fondazione Filarete, Milan, Italy) for SEM, and J. Hastewell (Novartis Institute for Biomedical Research, Cambridge, MA) for comments on the manuscript. The work was supported by grant 310030-140963 and Sinergia CRSII2-127547 of the Swiss National Science Foundation, grant 2012-0519 of Fondazione Cariplo, Nano-Tera project 20NA21-128841, Fondazione Ticinese per la Ricerca sul Cancro, Fondazione per la Ricerca sulla Trasfusione e sui Trapianti, and Converge Biotech.	Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; BOYD JM, 1995, ONCOGENE, V11, P1921; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iyer SS, 2013, EUR J IMMUNOL, V43, P3219, DOI 10.1002/eji.201343469; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; McLay J, 2002, J IMMUNOL, V168, P3437, DOI 10.4049/jimmunol.168.7.3437; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Sait LC, 2007, INT IMMUNOL, V19, P257, DOI 10.1093/intimm/dxl142; Schena F, 2013, CELL REP, V3, P1824, DOI 10.1016/j.celrep.2013.05.022; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Slack E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00100; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Taylor SRJ, 2008, J IMMUNOL, V180, P300, DOI 10.4049/jimmunol.180.1.300; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	63	117	118	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					789	801		10.1016/j.immuni.2014.10.010	http://dx.doi.org/10.1016/j.immuni.2014.10.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25464855	Bronze			2022-12-18	WOS:000345504900015
J	Li, SL; Miao, TZ; Sebastian, M; Bhullar, P; Ghaffari, E; Liu, MY; Symonds, ALJ; Wang, P				Li, Suling; Miao, Tizong; Sebastian, Meera; Bhullar, Punamdip; Ghaffari, Emma; Liu, Mengya; Symonds, Alistair L. J.; Wang, Ping			The Transcription Factors Egr2 and Egr3 Are Essential for the Control of Inflammation and Antigen-Induced Proliferation of B and T Cells	IMMUNITY			English	Article							FACTOR BATF CONTROLS; NEGATIVE REGULATOR; INDUCTION; EXPRESSION; ACTIVATOR; AP-1; DIFFERENTIATION; REQUIREMENT; SUPPRESSORS; HOMEOSTASIS	Lymphocytes provide optimal responses against pathogens with minimal inflammatory pathology. However, the intrinsic mechanisms regulating these responses are unknown. Here, we report that deletion of both transcription factors Egr2 and Egr3 in lymphocytes resulted in a lethal autoimmune syndrome with excessive serum proinflammatory cytokines but also impaired antigen receptor-induced proliferation of B and T cells. Egr2- and Egr3-defective B and T cells had hyperactive signal transducer and activator of transcription-1 (STAT1) and STAT3 while antigen receptor-induced activation of transcription factor AP-1 was severely impaired. We discovered that Egr2 and/or Egr3 directly induced expression of suppressor of cytokine signaling-1 (SOCS1) and SOCS3, inhibitors of STAT1 and STAT3, and also blocked the function of Batf, an AP-1 inhibitor, in B and T cells. Thus, Egr2 and Egr3 regulate B and T cell function in adaptive immune responses and homeostasis by promoting antigen receptor signaling and controlling inflammation.	[Miao, Tizong; Sebastian, Meera; Symonds, Alistair L. J.; Wang, Ping] Barts & London Queen Marys Sch Med & Dent, BICMS, London E1 2AD, England; [Li, Suling; Bhullar, Punamdip; Ghaffari, Emma; Liu, Mengya] Brunel Univ, Uxbridge UB8 3PH, Middx, England	University of London; Queen Mary University London; Brunel University	Wang, P (corresponding author), Barts & London Queen Marys Sch Med & Dent, BICMS, 4 Newark St, London E1 2AD, England.	p.wang@qmul.ac.uk		Wang, Ping/0000-0001-8992-1233; Symonds, Alistair/0000-0002-9461-0816	Arthritis Research UK; Versus Arthritis [18724] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	We thank J. Milbrandt for providing Egr3<SUP>-/-</SUP> mice, G. Warnes for cell sorting, and J. Walker for animal experiments. This work was supported by Arthritis Research UK.	Anderson P, 2003, INT IMMUNOL, V15, P1309, DOI 10.1093/intimm/dxg130; Anderson PO, 2006, EUR J IMMUNOL, V36, P1374, DOI 10.1002/eji.200635883; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chong MMW, 2005, BLOOD, V106, P1668, DOI 10.1182/blood-2004-08-3049; Crispin JC, 2011, P NATL ACAD SCI USA, V108, P12443, DOI 10.1073/pnas.1103915108; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Davey GM, 2005, J EXP MED, V202, P1099, DOI 10.1084/jem.20050003; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Guinea-Viniegra J, 2009, GENE DEV, V23, P2663, DOI 10.1101/gad.543109; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jenks SA, 2009, AUTOIMMUN REV, V8, P209, DOI 10.1016/j.autrev.2008.07.047; King CG, 2008, J IMMUNOL, V180, P34, DOI 10.4049/jimmunol.180.1.34; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Li S, 2011, PLOS ONE, V14; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Meixner A, 2008, NAT CELL BIOL, V10, P1003, DOI 10.1038/ncb1761; Myouzen K, 2010, HUM MOL GENET, V19, P2313, DOI 10.1093/hmg/ddq092; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Pflegerl P, 2009, P NATL ACAD SCI USA, V106, P20423, DOI 10.1073/pnas.0910371106; Pospisil V, 2011, EMBO J, V30, P4450, DOI 10.1038/emboj.2011.317; Puga I, 2008, IMMUNITY, V29, P193, DOI 10.1016/j.immuni.2008.06.010; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Rauen T, 2011, J BIOL CHEM, V286, P32366, DOI 10.1074/jbc.M111.245811; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sela U, 2008, J IMMUNOL, V180, P1584, DOI 10.4049/jimmunol.180.3.1584; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	48	117	118	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 19	2012	37	4					685	696		10.1016/j.immuni.2012.08.001	http://dx.doi.org/10.1016/j.immuni.2012.08.001			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23021953	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000310185400013
J	Vardhana, S; Choudhuri, K; Varma, R; Dustin, ML				Vardhana, Santosha; Choudhuri, Kaushik; Varma, Rajat; Dustin, Michael L.			Essential Role of Ubiquitin and TSG101 Protein in Formation and Function of the Central Supramolecular Activation Cluster	IMMUNITY			English	Article							T-CELL-ACTIVATION; KINASE-C-THETA; MULTIVESICULAR BODY FORMATION; IMMUNOLOGICAL SYNAPSE; EARLY ENDOSOMES; DOWN-MODULATION; PKC-THETA; RECEPTOR MICROCLUSTERS; ESCRT MACHINERY; DISTINCT ROLES	Agonist MHC-peptide complexes in the immunological synapse (IS) signal through T cell receptor (TCR) microclusters (MCs) that converge into a central supramolecular activation cluster (cSMAC). The determinants and function of the cSMAC remain unknown. We demonstrate an essential role for ubiquitin (Ub) and TSG101, but less so for HRS, in signal processing events at the cSMAC. Using siRNA in primary T cells, we show that Ub recognition by TSG101 is required for cSMAC formation, TCR MC signal termination, TCR downregulation, and segregation of TCR-MHC-peptide from PKC-0-enriched signaling complexes. Weak agonist MHC-peptide induced CD80-dependent TCR MCs that dissociated in the center of the IS without recruiting TSG101. These results support TSG101-dependent recognition of CD80-independent TCR MCs as a molecular checkpoint for TCR downregulation.	[Vardhana, Santosha; Choudhuri, Kaushik; Varma, Rajat; Dustin, Michael L.] NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med,Program, New York, NY 10016 USA; [Vardhana, Santosha; Choudhuri, Kaushik; Varma, Rajat; Dustin, Michael L.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University	Dustin, ML (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med,Program, 540 1st Ave, New York, NY 10016 USA.		Dustin, Michael/AAM-4611-2020; Varma, Rajat/I-1209-2012	Varma, Rajat/0000-0001-5131-0402; Choudhuri, Kaushik/0000-0002-3911-027X; Vardhana, Santosha/0000-0002-3100-1298; Dustin, Michael/0000-0003-4983-6389	NIH [T32 GM07308, R01 AI043542, PN2 EY016586]; Cancer Research Institute; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001027, R01AI043542, R37AI043542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W Sundquist for human TSG101 expression plasmids. U Unge-wickell for the clathrin light chain-GFP fusion expression plasmid, and J Gruenberg for the anti-LBPA monoclonal antibody This work was supported by NIH grant T32 GM07308 (S V). a Cancer Research Institute Fellowship (K C). and NIH grants R01 AI043542 and PN2 EY016586 (M L D)	Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Brignatz C, 2005, BBA-MOL CELL RES, V1746, P108, DOI 10.1016/j.bbamcr.2005.08.009; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 2002, ARTHRITIS RES THER, V4, pS119, DOI 10.1186/ar559; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Itoh Y, 1999, J IMMUNOL, V162, P2073; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Krogsgaard M, 2003, SEMIN IMMUNOL, V15, P307, DOI 10.1016/j.smim.2003.09.002; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Monjas A, 2004, J BIOL CHEM, V279, P55376, DOI 10.1074/jbc.M409342200; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Pan S, 2006, J BIOL CHEM, V281, P34640, DOI 10.1074/jbc.M602263200; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, J CELL SCI, V114, P2255; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Truschel ST, 2009, TRAFFIC, V10, P1318, DOI 10.1111/j.1600-0854.2009.00955.x; Tseng SY, 2008, J IMMUNOL, V181, P4852, DOI 10.4049/jimmunol.181.7.4852; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Welsch S, 2006, TRAFFIC, V7, P1551, DOI 10.1111/j.1600-0854.2006.00489.x; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Wouters FS, 1998, EMBO J, V17, P7179, DOI 10.1093/emboj/17.24.7179; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011	58	117	117	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					531	540		10.1016/j.immuni.2010.04.005	http://dx.doi.org/10.1016/j.immuni.2010.04.005			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20399684	Green Accepted, Bronze			2022-12-18	WOS:000277171900012
J	Chtanova, T; Han, SJ; Schaeffer, M; van Dooren, GG; Herzmark, P; Striepen, B; Robey, EA				Chtanova, Tatyana; Han, Seong-Ji; Schaeffer, Marie; van Dooren, Giel G.; Herzmark, Paul; Striepen, Boris; Robey, Ellen A.			Dynamics of T Cell, Antigen-Presenting Cell, and Pathogen Interactions during Recall Responses in the Lymph Node	IMMUNITY			English	Article							TOXOPLASMA-GONDII INFECTION; IN-VIVO; SUBCAPSULAR SINUS; B-CELLS; PARASITOPHOROUS VACUOLE; MEDIATED-IMMUNITY; DENDRITIC CELLS; MICE; NEUTROPHILS; MACROPHAGE	Memory T cells circulate through lymph nodes where they are poised to respond rapidly upon re-exposure to a pathogen; however, the dynamics of memory T cell, antigen-p resenting cell, and pathogen interactions during recall responses are largely unknown. We used a mouse model of infection with the intracellular protozoan parasite, Toxoplasma gondii, in conjunction with two-photon microscopy, to address this question. After challenge, memory T cells migrated more rapidly than naive T cells, relocalized toward the subcapsular sinus (SCS) near invaded macrophages, and engaged in prolonged interactions with infected cells. Parasite invasion of T cells occurred by direct transfer of the parasite from the target cell into the T cell and corresponded to an antigen-specific increase in the rate of T cell invasion. Our results provide insight into cellular interactions during recall responses and suggest a mechanism of pathogen subversion of the immune response.	[Chtanova, Tatyana; Han, Seong-Ji; Schaeffer, Marie; Herzmark, Paul; Robey, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [van Dooren, Giel G.] Univ Georgia, Ctr Trop & Emerging Global Dis, Paul D Coverdell Ctr, Athens, GA 30602 USA; [van Dooren, Giel G.; Striepen, Boris] Univ Georgia, Dept Cellular Biol, Paul D Coverdell Ctr, Athens, GA 30602 USA	University of California System; University of California Berkeley; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Robey, EA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	erobey@berkeley.edu	van Dooren, Giel G/A-8896-2012; Schaeffer, Marie/C-9815-2019	van Dooren, Giel G/0000-0003-2455-9821; Schaeffer, Marie/0000-0002-2063-5324; Striepen, Boris/0000-0002-7426-432X; Chtanova, Tatyana/0000-0003-3419-4483	NIH; Human Frontier Science Program Fellowship; C.J. Martin Overseas Fellowship [400489]; Australian National Health and Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065537, P01AI065831, R01AI093132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Fellowship(Human Frontier Science Program); C.J. Martin Overseas Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank E. Ladi for help with motility calculations, Z. Bomzon for help with density calculations, K. Garapaty for help with Matlab, S. Chan for technical assistance, H. Aaron for help with confocal microscopy, H. Nolla and A. Valeros (LIC Berkeley CRL flow cytometry facility) and J. Nelson (CTEGID Flow Cytometry Facility) for help with flow cytometry, and N. Blanchard, P. Bousso, and members of the Robey lab for useful suggestions and proofreading of the manuscript. This work was funded by the NIH (B.S. and E.A.R.), Human Frontier Science Program Fellowship (T.C.), and C.J. Martin Overseas Fellowship (400489) from the Australian National Health and Medical Research Council (G.G.v.D.).	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; BROWN CR, 1990, J IMMUNOL, V145, P3438; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; Denkers EY, 2004, INT J PARASITOL, V34, P411, DOI 10.1016/j.ijpara.2003.11.001; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dzierszinski FS, 2008, PARASITE IMMUNOL, V30, P235, DOI 10.1111/j.1365-3024.2007.01016.x; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; FOSSUM S, 1980, SCAND J IMMUNOL, V12, P433, DOI 10.1111/j.1365-3083.1980.tb00087.x; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; Goldszmid RS, 2009, J EXP MED, V206, P399, DOI 10.1084/jem.20082108; Gubbels MJ, 2005, INFECT IMMUN, V73, P703, DOI 10.1128/IAI.73.2.703-711.2005; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kasper L, 2004, INT J PARASITOL, V34, P401, DOI 10.1016/j.ijpara.2003.11.023; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Kwok LY, 2003, J IMMUNOL, V170, P1949, DOI 10.4049/jimmunol.170.4.1949; Labruyere E, 1999, MOL BIOCHEM PARASIT, V102, P311, DOI 10.1016/S0166-6851(99)00092-4; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lieberman Linda A, 2002, Int Rev Immunol, V21, P373, DOI 10.1080/08830180213281; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Persson EK, 2007, J IMMUNOL, V179, P8357, DOI 10.4049/jimmunol.179.12.8357; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Plattner F, 2008, ANNU REV MICROBIOL, V62, P471, DOI 10.1146/annurev.micro.62.081307.162802; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schaeffer M, 2009, J IMMUNOL, V182, P6379, DOI 10.4049/jimmunol.0804307; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; SUZUKI Y, 1988, J IMMUNOL, V140, P3943; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288	53	117	121	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					342	355		10.1016/j.immuni.2009.06.023	http://dx.doi.org/10.1016/j.immuni.2009.06.023			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19699173	Green Accepted, Bronze			2022-12-18	WOS:000269338600019
J	Martinoli, C; Chiavelli, A; Rescigno, M				Martinoli, Chiara; Chiavelli, Andrea; Rescigno, Maria			Entry route of Salmonella typhimurium directs the type of induced immune response	IMMUNITY			English	Article							INTESTINAL DENDRITIC CELLS; CLASS SWITCH RECOMBINATION; GUT EPITHELIAL MONOLAYERS; B-CELLS; PEYERS-PATCHES; SECRETORY ANTIBODIES; COMMENSAL BACTERIA; FUSION PROTEINS; LAMINA PROPRIA; ORAL CHALLENGE	Secretory immunoglobulin A (SIgA) represents a first line of defense against mucosal pathogens by limiting their entrance. By using different strains of Salmonella typhimurium that target the two mechanisms of bacterial entry (microfold cell [M cell]- or dendritic cell-mediated), we demonstrated here that the distribution of bacteria after oral infection directed the type of induced immune response. M cell-penetrating invasive, but not noninvasive, S. typhimurium was found in large numbers in Peyer's patches (PPs), leading to the activation of immune cells and the release of fecal IgA. In contrast, both strains of bacteria were equally capable of reaching the mesenteric lymph node and the spleen and inducing IgG responses. These data suggest that PPs are absolutely required for the initiation of an IgA response to Salmonella, whereas they are dispensable for a systemic response. This compartmentalization could allow the fast generation of both mucosal and systemic acquired immunity to pathogens.	[Martinoli, Chiara; Chiavelli, Andrea; Rescigno, Maria] European Inst Oncol, Dept Expt Oncol, I-20124 Brescia, Italy	IRCCS European Institute of Oncology (IEO)	Rescigno, M (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20124 Brescia, Italy.	maria.rescigno@ifom-ieo-campus.it	Rescigno, Maria/J-9704-2012	Rescigno, Maria/0000-0002-6464-509X; martinoli, chiara/0000-0002-8173-5046				Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Bergqvist P, 2006, J IMMUNOL, V177, P7772, DOI 10.4049/jimmunol.177.11.7772; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; CEBRA JJ, 1991, IMMUNOL RES, V10, P393, DOI 10.1007/BF02919728; CEBRA JJ, 1994, HDB MUCOSAL IMMUNOLO; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Cornelis P, 1996, BIO-TECHNOL, V14, P203, DOI 10.1038/nbt0296-203; Cote-Sierra J, 1998, GENE, V221, P25, DOI 10.1016/S0378-1119(98)00437-5; DeRosier DJ, 1998, CELL, V93, P17, DOI 10.1016/S0092-8674(00)81141-1; Everest P, 1999, INFECT IMMUN, V67, P2815, DOI 10.1128/IAI.67.6.2815-2821.1999; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; GOTS RE, 1974, J INFECT DIS, V130, P280, DOI 10.1093/infdis/130.3.280; GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011; HAYAKAWA K, 1988, ANNU REV IMMUNOL, V6, P197, DOI 10.1146/annurev.iy.06.040188.001213; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mantis NJ, 2002, J IMMUNOL, V169, P1844, DOI 10.4049/jimmunol.169.4.1844; Marchetti M, 2004, MICROBES INFECT, V6, P521, DOI 10.1016/j.micinf.2004.02.009; Mastroeni P, 2004, MICROBES INFECT, V6, P398, DOI 10.1016/j.micinf.2003.12.009; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Penheiter KL, 1997, MOL MICROBIOL, V24, P697, DOI 10.1046/j.1365-2958.1997.3741745.x; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rey J, 2004, J IMMUNOL, V172, P3026, DOI 10.4049/jimmunol.172.5.3026; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Schulte R, 1998, MED MICROBIOL IMMUN, V187, P53, DOI 10.1007/s004300050074; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434	45	117	122	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC	2007	27	6					975	984		10.1016/j.immuni.2007.10.011	http://dx.doi.org/10.1016/j.immuni.2007.10.011			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18083577	Bronze			2022-12-18	WOS:000251907300016
J	Siggs, OM; Miosge, LA; Yates, AL; Kucharska, EM; Sheahan, D; Brdicka, T; Weiss, A; Liston, A; Goodnow, CC				Siggs, Owen M.; Miosge, Lisa A.; Yates, Adele L.; Kucharska, Edyta M.; Sheahan, Daniel; Brdicka, Tomas; Weiss, Arthur; Liston, Adrian; Goodnow, Christopher C.			Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions	IMMUNITY			English	Article							LYMPHOID TYROSINE PHOSPHATASE; AUTOIMMUNE ARTHRITIS; GENETIC ASSOCIATION; NEGATIVE SELECTION; THYMIC SELECTION; ADAPTER PROTEIN; MUTATION; POLYMORPHISM; INDUCTION; PTPN22	Null mutations that cripple T cell receptor (TCR) signaling explain rare primary immunodeficiencies, but it is not understood why more common polymorphisms that lead to subtle TCR signaling defects are paradoxically associated with autoimmunity. Here we analyzed how a series of Zap70 variants with step-wise decreases in TCR signaling impacted upon opposing TCR functions of immunity and tolerance. One Zap70 variant, murdock, moderately decreased TCR signaling and thymic selection without compromising immunological tolerance, whereas a more severe Zap70 defect, mrtless, abolished thymic-positive selection and led to immunodeficiency. Signaling capacities between these two thresholds disproportionately compromised negative selection and Foxp3(+) regulatory T cell formation, creating a cellular imbalance between immunogenic and tolerogenic functions that resulted in the excessive production of autoantibodies and immunoglobulin E (IgE). The pleictropic functions of ZAP-70 and their differential response to graded variation provide a paradigm for understanding the complex outcomes of human genetic variation.	[Siggs, Owen M.; Miosge, Lisa A.; Yates, Adele L.; Kucharska, Edyta M.; Sheahan, Daniel; Liston, Adrian; Goodnow, Christopher C.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Siggs, Owen M.; Miosge, Lisa A.; Yates, Adele L.; Kucharska, Edyta M.; Sheahan, Daniel; Liston, Adrian; Goodnow, Christopher C.] Australian Natl Univ, Australian Phenom Facil, Canberra, ACT 2601, Australia; [Brdicka, Tomas; Weiss, Arthur] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Brdicka, Tomas; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Australian National University; John Curtin School of Medical Research; Australian National University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Liston, A (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	liston@u.washington.edu; chris.goodnow@anu.edu.au	Goodnow, Christopher C/V-8108-2018; Liston, Adrian/G-8606-2013; Brdicka, Tomas/G-6205-2014	Goodnow, Christopher C/0000-0001-5296-6155; Liston, Adrian/0000-0002-6272-4085; Brdicka, Tomas/0000-0002-1560-4398; Siggs, Owen/0000-0003-2840-4851; Miosge, Lisa/0000-0001-8317-3377	NIAID NIH HHS [R01 AI52127, U19 AI100627, R01 AI052127, R01 AI052127-05] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, R01AI052127] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; Arkwright PD, 2002, BLOOD, V99, P2694, DOI 10.1182/blood.V99.8.2694; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Baccala R, 2005, TRENDS IMMUNOL, V26, P5, DOI 10.1016/j.it.2004.11.006; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Caserta S, 2007, TRENDS IMMUNOL, V28, P245, DOI 10.1016/j.it.2007.04.006; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Dai KZ, 2001, GENES IMMUN, V2, P263, DOI 10.1038/sj.gene.6363774; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FINK PJ, 1994, J IMMUNOL, V152, P4270; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Khiong K, 2007, J CLIN INVEST, V117, P1270, DOI 10.1172/JCI30513; Kobayashi K, 2006, INFLAMM RES, V55, P335, DOI 10.1007/s00011-006-5208-x; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lesage S, 2002, J EXP MED, V196, P1175, DOI 10.1084/jem.20020735; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Marrella V, 2007, J CLIN INVEST, V117, P1260, DOI 10.1172/JCI30928; Marti F, 2006, J EXP MED, V203, P281, DOI 10.1084/jem.20051637; Miosge LA, 2002, J EXP MED, V196, P1113, DOI 10.1084/jem.20020959; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sakaguchi S, 2005, CURR OPIN IMMUNOL, V17, P589, DOI 10.1016/j.coi.2005.09.017; Smerdel A, 2004, GENES IMMUN, V5, P310, DOI 10.1038/sj.gene.6364093; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Sosinowski T, 2001, IMMUNITY, V15, P457, DOI 10.1016/S1074-7613(01)00195-9; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Wiest DL, 1997, IMMUNITY, V6, P663, DOI 10.1016/S1074-7613(00)80442-2; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	49	117	117	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					912	926		10.1016/j.immuni.2007.11.013	http://dx.doi.org/10.1016/j.immuni.2007.11.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18093540	Green Accepted, Bronze			2022-12-18	WOS:000251907300011
J	van Dommelen, SLH; Sumaria, N; Schreiber, RD; Scalzo, AA; Smyth, MJ; Degli-Esposti, MA				van Dommelen, Serani L. H.; Sumaria, Nital; Schreiber, Robert D.; Scalzo, Anthony A.; Smyth, Mark J.; Degli-Esposti, Mariapia A.			Perforin and granzymes have distinct roles in defensive immunity and immunopathology	IMMUNITY			English	Article							MURINE CYTOMEGALOVIRUS-INFECTION; NATURAL-KILLER-CELLS; CD8(+) T-CELLS; FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; EPSTEIN-BARR-VIRUS; MEDIATED CYTOTOXICITY; INTERFERON-GAMMA; DENDRITIC CELLS; DEFICIENT MICE; MONOCLONAL-ANTIBODIES	Successful control of viral infection requires the host to eliminate the infecting pathogen without causing overt immunopathology. Here we showed that perforin (Prf1) and granzymes (Gzms) have distinct roles in defensive immunity and immunopathology in a well-established model of viral infection. Both Prf1 and Gzms drastically affected the outcome of murine cytomegalovirus (MCMV) infection. Viral titres increased markedly in both Prf1(-/-) and Gzma(-/-)Gzmb(-/-) mice, but Gzma(-/-)Gzmb(-/-) mice recovered and survived infection, whereas Prf1(-/-) mice did not. Indeed, infected Prf1-deficient hosts developed a fatal hemophagocytic lympholhistiocytosis (HLH)-like syndrome. This distinction in outcome depended on accumulation of mononuclear cells and T cells in infected Prf1(-/-) mice. Importantly, blocking experiments that clearly identified tumor necrosis factor-alpha (TNF-alpha) as the principal contributor to the lethality observed in infected Prf1(-/-) mice provided support for the clinical potential of such an approach in HLH patients whose disease is triggered by viral infection.	Univ Western Australia, Ctr Ophthalmol & Visual Sci, Immunol & Virol Program, Nedlands, WA 6009, Australia; Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA 6009, Australia; Washington Univ, Sch Med, Dept Pathol & Immunol, Ctr Immunol, St Louis, MO 63110 USA; Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Immunol Program, Melbourne, Vic 3002, Australia	University of Western Australia; Lions Eye Institute; University of Western Australia; Washington University (WUSTL); Peter Maccallum Cancer Center	Degli-Esposti, MA (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Immunol & Virol Program, Nedlands, WA 6009, Australia.	mariapia@cyllene.uwa.edu.au	Degli-Esposti, Mariapia/H-9073-2014; Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013; Degli-Esposti, Mariapia/E-9529-2013; Smyth, Mark J/H-8709-2014	Schreiber, Robert D/0000-0001-6311-0432; Smyth, Mark J/0000-0001-7098-7240; Degli-Esposti, Mariapia/0000-0002-7808-5935; Schreiber, Robert/0000-0003-1590-2341	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Badovinac VP, 2003, IMMUNITY, V18, P463, DOI 10.1016/S1074-7613(03)00079-7; Badovinac VP, 2000, J IMMUNOL METHODS, V238, P107, DOI 10.1016/S0022-1759(00)00153-8; BASILE GD, 2001, CURR OPIN IMMUNOL, V13, P549; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Binder D, 1998, J EXP MED, V187, P1903, DOI 10.1084/jem.187.11.1903; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BRAUTIGAM AR, 1979, J GEN VIROL, V44, P349, DOI 10.1099/0022-1317-44-2-349; CHISARI FV, 1995, SPRINGER SEMIN IMMUN, V17, P261, DOI 10.1007/BF00196169; CLINE MJ, 1994, BLOOD, V84, P2840; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Egeler RM, 1996, J PEDIAT HEMATOL ONC, V18, P340, DOI 10.1097/00043426-199611000-00002; Ericson KG, 2001, AM J HUM GENET, V68, P590, DOI 10.1086/318796; Feldmann J, 2002, BRIT J HAEMATOL, V117, P965, DOI 10.1046/j.1365-2141.2002.03534.x; Hanson LK, 1999, J VIROL, V73, P5970, DOI 10.1128/JVI.73.7.5970-5980.1999; HENTER JI, 1991, BLOOD, V78, P2918, DOI 10.1182/blood.V78.11.2918.2918; Henzan T, 2006, AM J HEMATOL, V81, P59, DOI 10.1002/ajh.20462; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hoang MP, 1998, HUM PATHOL, V29, P1074, DOI 10.1016/S0046-8177(98)90416-6; HommelBerrey GA, 1997, CELL IMMUNOL, V180, P1, DOI 10.1006/cimm.1997.1173; Imashuku S, 2005, EUR J PEDIATR, V164, P315, DOI 10.1007/s00431-005-1636-9; IMASHUKU S, 1994, BRIT J HAEMATOL, V88, P656, DOI 10.1111/j.1365-2141.1994.tb05095.x; Jahn G, 1999, INTERVIROLOGY, V42, P365, DOI 10.1159/000053973; Johnson H, 2003, BLOOD, V101, P3093, DOI 10.1182/blood-2002-08-2485; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kagi D, 1999, EUR J IMMUNOL, V29, P3262, DOI 10.1002/(SICI)1521-4141(199910)29:10<3262::AID-IMMU3262>3.0.CO;2-A; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; KOSZINOWSKI UH, 1991, CURR OPIN IMMUNOL, V3, P471, DOI 10.1016/0952-7915(91)90005-L; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Loh J, 2005, J VIROL, V79, P661, DOI 10.1128/JVI.79.1.661-667.2005; LOWIN B, 1994, P NATL ACAD SCI USA, V91, P11571, DOI 10.1073/pnas.91.24.11571; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Malipiero U, 1997, EUR J IMMUNOL, V27, P3151, DOI 10.1002/eji.1830271211; Marcenaro E, 2005, AUTOIMMUN REV, V4, P520, DOI 10.1016/j.autrev.2005.04.015; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Mullbacher A, 1999, J VIROL, V73, P1665; OHGA S, 1993, AM J PEDIAT HEMATOL, V15, P291; Orange JS, 1997, J VIROL, V71, P9248, DOI 10.1128/JVI.71.12.9248-9258.1997; Orange JS, 1996, J IMMUNOL, V156, P4746; Pao LI, 2005, J IMMUNOL, V175, P3235, DOI 10.4049/jimmunol.175.5.3235; Peng SL, 1998, J IMMUNOL, V160, P652; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Raja SM, 2003, CURR OPIN IMMUNOL, V15, P528, DOI 10.1016/S0952-7915(03)00111-0; Regner M, 2004, IMMUNOL CELL BIOL, V82, P161, DOI 10.1046/j.0818-9641.2004.01225.x; Riera L, 2000, EUR J IMMUNOL, V30, P1350, DOI 10.1002/(SICI)1521-4141(200005)30:5<1350::AID-IMMU1350>3.0.CO;2-J; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Schneider EM, 2002, BLOOD, V100, P2891, DOI 10.1182/blood-2001-12-0260; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Smyth MJ, 2001, J LEUKOCYTE BIOL, V70, P18; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Trapani JA, 2000, CURR OPIN IMMUNOL, V12, P323, DOI 10.1016/S0952-7915(00)00094-7; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Trgovcich J, 2000, ARCH VIROL, V145, P2601, DOI 10.1007/s007050070010; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; Waterhouse NJ, 2006, J CELL BIOL, V173, P133, DOI 10.1083/jcb.200510072; WATSON HG, 1994, BRIT J HAEMATOL, V86, P213, DOI 10.1111/j.1365-2141.1994.tb03282.x; Zinkernagel RM, 1999, IMMUNOL REV, V168, P305, DOI 10.1111/j.1600-065X.1999.tb01300.x	65	117	117	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2006	25	5					835	848		10.1016/j.immuni.2006.09.010	http://dx.doi.org/10.1016/j.immuni.2006.09.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17088087	Bronze			2022-12-18	WOS:000242063100015
J	Ikawa, T; Kawamoto, H; Wright, LYT; Murre, C				Ikawa, T; Kawamoto, H; Wright, LYT; Murre, C			Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent	IMMUNITY			English	Article							IMMUNOGLOBULIN GENE REARRANGEMENT; LOOP-HELIX PROTEINS; IN-VIVO; TARGET GENES; E2A; TRANSCRIPTION; LINEAGE; IDENTIFICATION; EBF; DIFFERENTIATION	E2A proteins are essential for the development of B cells beyond the progenitor cell stage. Here we have isolated E2A-deficient bone marrow-derived cells that have the ability to grow long-term in vitro and coexpress, at low levels, regulators of different hematopoietic cell lineages. When transferred into lethally irradiated hosts, E2A-deficient hematopoietic progenitor cells reconstitute the T, NK, myeloid, dendritic, and erythroid lineages but fail to develop into mature B lineage cells. Enforced expression of E47 in E2A-deficient hematopoietic progenitor cells directly activates the transcription of a subset of B lineage-specific genes, including lambda5, mb-1, and Pax5. In contrast, E47 inhibits the expression of regulators of other hematopoietic lineages, including TCF-1 and GATA-1. These observations indicate that E2A-deficient hematopoietic progenitor cells remain pluripotent after long-term culture in vitro and that E2A proteins play a critical role in B cell commitment.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Kyoto Univ, Fac Med, Riken Res Ctr Allergy & Immunol, Lab Lymphocyte Dev,Sakyo Ku, Kyoto 6068507, Japan	University of California System; University of California San Diego; Kyoto University; RIKEN	Murre, C (corresponding author), Univ Calif San Diego, Div Biol Sci, 0377, La Jolla, CA 92093 USA.	murre@biomail.ucsd.edu						Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; Goebel P, 2001, J EXP MED, V194, P645, DOI 10.1084/jem.194.5.645; Greenbaum S, 2002, P NATL ACAD SCI USA, V99, P15030, DOI 10.1073/pnas.232299999; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Osmond DG, 1998, IMMUNOL TODAY, V19, P65, DOI 10.1016/S0167-5699(97)01203-6; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; Schaniel C, 2002, BLOOD, V99, P2760, DOI 10.1182/blood.V99.8.2760; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Warren LA, 2003, CURR OPIN IMMUNOL, V15, P166, DOI 10.1016/S0952-7915(03)00011-6; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	49	117	118	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2004	20	3					349	360		10.1016/S1074-7613(04)00049-4	http://dx.doi.org/10.1016/S1074-7613(04)00049-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030778	Bronze			2022-12-18	WOS:000221442600012
J	Papathanasiou, P; Perkins, AC; Cobb, BS; Ferrini, R; Sridharan, R; Hoyne, GF; Nelms, KA; Smale, ST; Goodnow, CC				Papathanasiou, P; Perkins, AC; Cobb, BS; Ferrini, R; Sridharan, R; Hoyne, GF; Nelms, KA; Smale, ST; Goodnow, CC			Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor	IMMUNITY			English	Article							DNA-BINDING PROTEINS; MURINE BONE-MARROW; ENU MUTAGENESIS; GENOME-WIDE; CENTROMERIC HETEROCHROMATIN; CELL COMMITMENT; FACTOR GATA-1; MUTANT MICE; C-KIT; GENE	A central issue in understanding the hematolymphoid system is the generation of appropriate mutant alleles in mice to reveal the function of regulatory genes. Here we describe a mouse strain, Plastic, with a point mutation in a zinc finger of Ikaros that disrupts DNA binding but preserves efficient assembly of the full-length protein into higher order complexes. Ikaros(Plastic) homozygosity is embryonically lethal with severe defects in terminal erythrocyte and granulocyte differentiation, excessive macrophage formation, and blocked lymphopoiesis, while heterozygotes display a partial block in lymphocyte differentiation. The contrast with more circumscribed effects of Ikaros alleles that ablate the full-length protein highlights the importance in mammals of generating recessive niche-filling alleles that inactivate function without creating a void in multi-molecular assemblies.	Australian Natl Univ, John Curtin Sch Med Res, Australian Canc Res Fdn, Genet Lab, Canberra, ACT 2601, Australia; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia; Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Phenomix Corp, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Monash University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Australian Canc Res Fdn, Genet Lab, Canberra, ACT 2601, Australia.	chris.goodnow@anu.edu.au	Hoyne, Gerard/M-5406-2013; Perkins, Andrew C/M-3216-2014; Goodnow, Christopher C/V-8108-2018; Perkins, Andrew/AAJ-9696-2020; Perkins, Andrew/X-4180-2019	Hoyne, Gerard/0000-0002-7370-9139; Perkins, Andrew C/0000-0003-3644-7093; Goodnow, Christopher C/0000-0001-5296-6155; Perkins, Andrew/0000-0003-3644-7093				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Dumortier A, 2003, BLOOD, V101, P2219, DOI 10.1182/blood-2002-05-1336; ERNST P, 1993, MOL CELL BIOL, V13, P2982, DOI 10.1128/MCB.13.5.2982; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Hardy RR, 2000, IMMUNOL REV, V175, P23, DOI 10.1111/j.1600-065X.2000.imr017517.x; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Honma Y, 1999, FEBS LETT, V447, P76, DOI 10.1016/S0014-5793(99)00265-3; *JACKS LAB, 2002, MOUS GEN DAT; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; Lopez RA, 2002, P NATL ACAD SCI USA, V99, P602, DOI 10.1073/pnas.022412699; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Miosge LA, 2002, J EXP MED, V196, P1113, DOI 10.1084/jem.20020959; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; OGAWA M, 1993, DEVELOPMENT, V117, P1089; Perdomo J, 2000, J BIOL CHEM, V275, P38347, DOI 10.1074/jbc.M005457200; PERKINS AC, 1995, NATURE, V375, P318; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; RUSSELL ES, 1965, FED PROC, V24, P240; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183	56	117	119	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL	2003	19	1					131	144		10.1016/S1074-7613(03)00168-7	http://dx.doi.org/10.1016/S1074-7613(03)00168-7			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871645	Bronze			2022-12-18	WOS:000184260400014
J	Naitza, S; Rosse, C; Kappler, C; Georgel, P; Belvin, M; Gubb, D; Camonis, J; Hoffmann, JA; Reichhart, JM				Naitza, S; Rosse, C; Kappler, C; Georgel, P; Belvin, M; Gubb, D; Camonis, J; Hoffmann, JA; Reichhart, JM			The Drosophila immune defense against gram-negative infection requires the death protein dFADD	IMMUNITY			English	Article							NF-KAPPA-B; PEPTIDOGLYCAN RECOGNITION PROTEINS; CASPASE DREDD; HOST-DEFENSE; CELL-DEATH; ACTIVATION; APOPTOSIS; DOMAIN; TOLL; FADD/MORT1	Drosophila responds to Gram-negative infections by mounting an immune response that depends on components of the IMD pathway. We recently showed that imd encodes a protein with a death domain with high similarity to that of mammalian RIP. Using a two-hybrid screen in yeast, we have isolated the death protein dFADD as a molecule that associates with IMD. Our data show that loss of dFADD function renders flies highly susceptible to Gram-negative infections without affecting resistance to Gram-positive bacteria. By genetic analysis we show that dFADD acts downstream of IMD in the pathway that controls inducibility of the antibacterial peptide genes.	CNRS, UPR 9022, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; INSERM, U528, Inst Curie, F-75248 Paris 05, France; Exelixis Inc, San Francisco, CA 94083 USA; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Exelixis, Inc.; University of Cambridge	Naitza, S (corresponding author), CNRS, UPR 9022, Inst Biol Mol & Cellulaire, 15 Rue Rene Descartes, F-67084 Strasbourg, France.		georgel, philippe/P-5676-2016; Naitza, Silvia/D-5620-2017; NAITZA, SILVIA/AAB-8775-2022; Rosse, Carine/L-4775-2017; Gubb, David/F-9793-2011	georgel, philippe/0000-0001-6853-7080; NAITZA, SILVIA/0000-0002-0108-757X; 	NIAID NIH HHS [1P01 AI44220] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bannerman DD, 2002, J CLIN INVEST, V109, P419, DOI 10.1172/JCI14774; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Chen P, 1998, DEV BIOL, V201, P202, DOI 10.1006/dbio.1998.9000; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Hu SM, 2000, J BIOL CHEM, V275, P30761, DOI 10.1074/jbc.C000341200; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Reichhart JM, 2002, GENESIS, V34, P160, DOI 10.1002/gene.10122; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Schaub FJ, 2000, NAT MED, V6, P790, DOI 10.1038/77521; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Strasser A, 1999, INT J BIOCHEM CELL B, V31, P533, DOI 10.1016/S1357-2725(99)00003-5; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	41	117	127	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2002	17	5					575	581		10.1016/S1074-7613(02)00454-5	http://dx.doi.org/10.1016/S1074-7613(02)00454-5			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433364	Bronze			2022-12-18	WOS:000179335100004
J	Anton, IM; de la Fuente, MA; Sims, TN; Freeman, S; Ramesh, N; Hartwig, JH; Dustin, ML; Geha, RS				Anton, IM; de la Fuente, MA; Sims, TN; Freeman, S; Ramesh, N; Hartwig, JH; Dustin, ML; Geha, RS			WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation	IMMUNITY			English	Article							WISKOTT-ALDRICH-SYNDROME; SYNDROME PROTEIN; ANTIGEN RECEPTOR; N-WASP; DEPOLYMERIZING PROTEIN; IMMUNOLOGICAL SYNAPSE; SIGNAL-TRANSDUCTION; TYROSINE KINASES; ARP2/3 COMPLEX; POLYMERIZATION	WIP stabilizes actin filaments and is important for filopodium formation. To define the role of WIP in immunity, we generated WIP-deficient mice. WIP-/- mice have normal lymphocyte development, but their T cells fail to proliferate, secrete IL-2, increase their F-actin content, polarize and extend protrusions following T cell receptor ligation, and are deficient in conjugate formation with superantigen-presenting B cells and anti-CD3 bilayers. In contrast, WIP-deficient B lymphocytes have enhanced proliferation and CD69 expression following B cell receptor ligation and mount normal antibody responses to T-independent antigens. Both WIP-deficient T and B cells show a profound defect in their subcortical actin filament networks. These results suggest that WIP is important for immunologic synapse formation and T cell activation.	Childrens Hosp, Div Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Expt Med, Boston, MA 02115 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; New York University	Geha, RS (corresponding author), Childrens Hosp, Div Immunol, 300 Longwood Ave, Boston, MA 02115 USA.		Dustin, Michael/AAM-4611-2020; Anton, Ines M/G-6090-2015; de la Fuente, Miguel A/C-7478-2013	Anton, Ines M/0000-0002-2935-5919; de la Fuente, Miguel A/0000-0003-4619-8756; Dustin, Michael/0000-0003-4983-6389	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL059561] Funding Source: Medline; PHS HHS [59561] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; BRAUN J, 1982, J IMMUNOL, V128, P1198; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Cheng PC, 2001, J IMMUNOL, V166, P3693, DOI 10.4049/jimmunol.166.6.3693; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Gallego MD, 1997, BLOOD, V90, P3089, DOI 10.1182/blood.V90.8.3089; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hollander GA, 1996, P NATL ACAD SCI USA, V93, P4994, DOI 10.1073/pnas.93.10.4994; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Jugloff LS, 1997, J IMMUNOL, V159, P1096; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Klasen S, 1998, INT IMMUNOL, V10, P481, DOI 10.1093/intimm/10.4.481; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Kurosaki T, 2000, IMMUNOL REV, V176, P19; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; MOLINA IJ, 1993, J IMMUNOL, V151, P4383; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; PARSEY MV, 1993, J IMMUNOL, V151, P1881; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; PHATAK PD, 1994, J CELL PHYSIOL, V159, P365, DOI 10.1002/jcp.1041590220; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; RISSO A, 1989, EUR J IMMUNOL, V19, P323, DOI 10.1002/eji.1830190216; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; ROTHSTEIN TL, 1985, J IMMUNOL, V135, P106; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; Rudd CE, 1996, IMMUNITY, V4, P527, DOI 10.1016/S1074-7613(00)80479-3; Savoy DN, 2000, J IMMUNOL, V164, P2866, DOI 10.4049/jimmunol.164.6.2866; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Silvin C, 2001, J BIOL CHEM, V276, P21450, DOI 10.1074/jbc.M010729200; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P10844, DOI 10.1073/pnas.94.20.10844; Vaduva G, 1999, J BIOL CHEM, V274, P17103, DOI 10.1074/jbc.274.24.17103; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Wulfing C, 2000, P NATL ACAD SCI USA, V97, P10150, DOI 10.1073/pnas.97.18.10150; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329	49	117	121	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2002	16	2					193	204		10.1016/S1074-7613(02)00268-6	http://dx.doi.org/10.1016/S1074-7613(02)00268-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869681	Bronze, Green Published			2022-12-18	WOS:000174039600004
J	Chuvpilo, S; Zimmer, M; Kerstan, A; Glockner, J; Avots, A; Escher, C; Fischer, C; Inashkina, I; Jankevics, E; Berberich-Siebelt, F; Schmitt, E; Serfling, E				Chuvpilo, S; Zimmer, M; Kerstan, A; Glockner, J; Avots, A; Escher, C; Fischer, C; Inashkina, I; Jankevics, E; Berberich-Siebelt, F; Schmitt, E; Serfling, E			Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells	IMMUNITY			English	Article							SECRETORY POLY(A) SITE; PRE-MESSENGER-RNA; TRANSCRIPTION FACTORS; INTERLEUKIN-2 PROMOTER; DOWNSTREAM ELEMENTS; BINDING-SITES; GENE FAMILY; EXPRESSION; ACTIVATION; SELECTION	The transcription factor NF-ATc is synthesized in three prominent isoforms. These differ in the length of their C terminal peptides and mode of synthesis. Due to a switch from the use of a 3' polyA site to a more proximal polyA site, NF-ATc expression switches from the synthesis of the two longer isoforms in naive T cells to that of short isoform A in T effector cells. The relative low binding affinity of cleavage stimulation factor CstF-64 to the proximal polyA site seems to contribute to its neglect in naive T cells. These alternative polyadenylation events ensure the rapid accumulation of high concentrations of NF-ATc necessary to exceed critical threshold levels of NF-ATc for gene induction in effector T cells.	Univ Wurzburg, Inst Pathol, Dept Mol Pathol, D-97080 Wurzburg, Germany; Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany; Univ Mainz, Inst Immunol, D-55101 Mainz, Germany; Latvian State Univ, Biomed Res & Study Ctr, LV-1067 Riga, Latvia	University of Wurzburg; University of Wurzburg; Johannes Gutenberg University of Mainz; Latvian Biomedical Research & Study Centre; University of Latvia	Chuvpilo, S (corresponding author), Univ Wurzburg, Inst Pathol, Dept Mol Pathol, D-97080 Wurzburg, Germany.		Serfling, Edgar/X-7212-2019; Brunner, Cornelia/L-1291-2013; Inashkina, Inna/AAH-9955-2021; Chuvpilo, Sergey/AAD-3144-2019; Brunner, Cornelia/H-8893-2018	Brunner, Cornelia/0000-0002-6456-5508; Inashkina, Inna/0000-0002-7560-797X				AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Driever W., 1992, TRANSCRIPTIONAL REGU, P1221; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li-Weber M, 1998, J IMMUNOL, V161, P1380; Luo C, 1996, MOL CELL BIOL, V16, P3955; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; MCDEVITT MA, 1986, EMBO J, V5, P2907, DOI 10.1002/j.1460-2075.1986.tb04586.x; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Park JC, 1996, J BIOL CHEM, V271, P20914, DOI 10.1074/jbc.271.34.20914; PFEUFFER I, 1994, J IMMUNOL, V153, P5572; Phillips C, 1997, NUCLEIC ACIDS RES, V25, P2344, DOI 10.1093/nar/25.12.2344; Phillips C, 1996, EUR J IMMUNOL, V26, P3144, DOI 10.1002/eji.1830261247; RACKWITZ HR, 1985, GENE, V40, P259, DOI 10.1016/0378-1119(85)90048-4; RANDAK C, 1990, EMBO J, V9, P2529, DOI 10.1002/j.1460-2075.1990.tb07433.x; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; SCHMITT E, 1994, EUR J IMMUNOL, V24, P343, DOI 10.1002/eji.1830240211; Schuh K, 1997, IMMUNOL LETT, V57, P171, DOI 10.1016/S0165-2478(97)00068-0; Schuh K, 1998, EUR J IMMUNOL, V28, P2456, DOI 10.1002/(SICI)1521-4141(199808)28:08<2456::AID-IMMU2456>3.0.CO;2-9; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; THOMPSON CB, 1992, MOL CELL BIOL, V12, P1043, DOI 10.1128/MCB.12.3.1043; Wolfe SA, 1997, NATURE, V385, P172, DOI 10.1038/385172a0; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1	41	117	123	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					261	269		10.1016/S1074-7613(00)80026-6	http://dx.doi.org/10.1016/S1074-7613(00)80026-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072078	Bronze			2022-12-18	WOS:000078972200013
J	Glithero, A; Tormo, J; Haurum, JS; Arsequell, G; Valencia, G; Edwards, J; Springer, S; Townsend, A; Pao, YL; Wormald, M; Dwek, RA; Jones, EY; Elliott, T				Glithero, A; Tormo, J; Haurum, JS; Arsequell, G; Valencia, G; Edwards, J; Springer, S; Townsend, A; Pao, YL; Wormald, M; Dwek, RA; Jones, EY; Elliott, T			Crystal structures of two H-2D(b)/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity	IMMUNITY			English	Article							CYTOTOXIC LYMPHOCYTES-T; VIRAL PEPTIDES; CELL RECEPTOR; CARBOHYDRATE; RECOGNITION; PROTEIN; GLYCOSYLATION; BINDING; OLIGOSACCHARIDE; SPECIFICITY	Two synthetic O-GlcNAc-bearing peptides that elicit H-2D(b)-restricted glycopeptide-specific cytotoxic T cells (CTL) have been shown to display nonreciprocal patterns of cross-reactivity. Here, we present the crystal structures of the H-2D(b) glycopeptide complexes to 2.85 Angstrom resolution or better. In both cases, the glycan is solvent exposed and available for direct recognition by the T cell receptor (TCR). We have modeled the complex formed between the MHC-glycopeptide complexes and their respective TCRs, showing that a single saccharide residue can be accommodated in the standard TCR-MHC geometry. The models also reveal a possible molecular basis for the observed crossreactivity patterns of the CTL clones, which appear to be influenced by the length of the CDR3 loop and the nature of the immunizing ligand.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Univ Oxford, Mol Biophys Lab, Oxford OX1 3QU, England; Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England; John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; CSIC, Cid, Unit Glycoconjugate Chem, E-08034 Barcelona, Spain	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Danish Cancer Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC)	Elliott, T (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.	tim.elliott@ndm.ox.ac.uk	Jones, Yvonne/N-8111-2019; Wormald, Mark R/G-2785-2011; Arsequell, Gemma/ABG-7934-2020; Jones, Yvonne/J-2293-2016; Springer, Sebastian/AAJ-7036-2021	Jones, Yvonne/0000-0002-3834-1893; Wormald, Mark R/0000-0002-4853-2773; Jones, Yvonne/0000-0002-3834-1893; Springer, Sebastian/0000-0002-5527-6149; Townsend, Alain/0000-0002-3702-0107; ARSEQUELL, GEMMA/0000-0002-7009-3738	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AbdelMotal UM, 1996, EUR J IMMUNOL, V26, P544, DOI 10.1002/eji.1830260307; Bevan MJ, 1997, IMMUNITY, V7, P175, DOI 10.1016/S1074-7613(00)80520-8; Brock R, 1996, P NATL ACAD SCI USA, V93, P13108, DOI 10.1073/pnas.93.23.13108; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X; DECK B, 1995, J IMMUNOL, V155, P1074; DUDLER T, 1995, EUR J IMMUNOL, V25, P538, DOI 10.1002/eji.1830250235; ELLIOTT TJ, 1990, P NATL ACAD SCI USA, V87, P5213, DOI 10.1073/pnas.87.13.5213; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FIELDER M, 1995, FEBS LETT, V369, P243, DOI 10.1016/0014-5793(95)00760-7; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GARBOCZI DN, 1994, J MOL BIOL, V239, P581, DOI 10.1006/jmbi.1994.1398; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HAMMERLING GJ, 1979, IMMUNOGENETICS, V8, P433, DOI 10.1007/BF01561454; HARDING CV, 1993, J IMMUNOL, V151, P2419; HARLOS K, 1992, J APPL CRYSTALLOGR, V25, P536, DOI 10.1107/S0021889892002656; Hart GW, 1996, GLYCOBIOLOGY, V6, P711, DOI 10.1093/glycob/6.7.711; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; HAURUM JS, 1994, J EXP MED, V180, P739, DOI 10.1084/jem.180.2.739; Haurum JS, 1995, EUR J IMMUNOL, V25, P3270, DOI 10.1002/eji.1830251211; HAURUM JS, 1996, THESIS U OXFORD OXFO; Jensen T, 1997, J IMMUNOL, V158, P3769; JONES TA, 1985, METHOD ENZYMOL, V115, P157; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAST WM, 1991, P NATL ACAD SCI USA, V88, P2283, DOI 10.1073/pnas.88.6.2283; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MICHAELSSON E, 1994, J EXP MED, V180, P745, DOI 10.1084/jem.180.2.745; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; QUIOCHO FA, 1998, ANNU REV BIOCHEM, V55, P287; Rigney E, 1998, J BIOL CHEM, V273, P14200, DOI 10.1074/jbc.273.23.14200; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; SINHA AA, 1990, SCIENCE, V248, P1380, DOI 10.1126/science.1972595; Smith KJ, 1996, IMMUNITY, V4, P215, DOI 10.1016/S1074-7613(00)80430-6; Springer S, 1998, BIOCHEMISTRY-US, V37, P3001, DOI 10.1021/bi9717441; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; ZHAO XJ, 1995, J EXP MED, V182, P67, DOI 10.1084/jem.182.1.67	49	117	120	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1999	10	1					63	74		10.1016/S1074-7613(00)80007-2	http://dx.doi.org/10.1016/S1074-7613(00)80007-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023771	Bronze			2022-12-18	WOS:000078428700007
J	Subbarao, K; Mahanty, S				Subbarao, Kanta; Mahanty, Siddhartha			Respiratory Virus Infections: Understanding COVID-19	IMMUNITY			English	Editorial Material								Respiratory viruses affect us throughout our lives, from infancy to old age, causing illnesses ranging from a common cold to severe pneumonia. They belong to several virus families, and although many features of infection with these diverse viruses are shared, some have unique characteristics. Here we explain what happens when we are infected by respiratory viruses, including SARS-CoV-2, which causes COVID-19.	[Subbarao, Kanta] Univ Melbourne, Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3000, Australia; [Subbarao, Kanta] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Mahanty, Siddhartha] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Med, Melbourne, Vic 3000, Australia	University of Melbourne; World Health Organization; University of Melbourne; University of Melbourne	Subbarao, K (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3000, Australia.; Subbarao, K (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.	kanta.subbarao@influenzacentre.org			Australian Government Department of Health	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health.	Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Vardhana SA, 2020, J EXP MED, V217, DOI 10.1084/jem.20200678; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	16	116	116	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					905	909		10.1016/j.immuni.2020.05.004	http://dx.doi.org/10.1016/j.immuni.2020.05.004			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32497522	Green Published, Bronze			2022-12-18	WOS:000541890000008
J	Mrdjen, D; Pavlovic, A; Hartmann, FJ; Schreiner, B; Utz, SG; Leung, BP; Lelios, I; Heppner, FL; Kipnis, J; Merkler, D; Greter, M; Becher, B				Mrdjen, Dunja; Pavlovic, Anto; Hartmann, Felix J.; Schreiner, Bettina; Utz, Sebastian G.; Leung, Brian P.; Lelios, Iva; Heppner, Frank L.; Kipnis, Jonathan; Merkler, Doron; Greter, Melanie; Becher, Burkhard			High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease (vol 48, pg 380, 2018)	IMMUNITY			English	Correction												becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020; Kipnis, Jonathan/AGG-9735-2022; Merkler, Doron/N-9157-2016; Heppner, Frank/ABH-8393-2020	Becher, Burkhard/0000-0002-1541-7867; Kipnis, Jonathan/0000-0002-3714-517X; Merkler, Doron/0000-0002-0247-2007; Heppner, Frank/0000-0001-9816-8917; Mrdjen, Dunja/0000-0001-9269-2806; Greter, Melanie/0000-0002-7220-5369				Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011	1	116	120	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					599	599		10.1016/j.immuni.2018.02.014	http://dx.doi.org/10.1016/j.immuni.2018.02.014			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562204	Bronze, Green Accepted			2022-12-18	WOS:000427916900018
J	Wang, Y; Bi, YJ; Chen, X; Li, CX; Li, Y; Zhang, ZG; Wang, J; Lu, Y; Yu, Q; Su, HL; Yang, H; Liu, GW				Wang, Yu; Bi, Yujing; Chen, Xi; Li, Chunxiao; Li, Yan; Zhang, Zhengguo; Wang, Jian; Lu, Yun; Yu, Qing; Su, Huilin; Yang, Hui; Liu, Guangwei			Histone Deacetylase SIRT1 Negatively Regulates the Differentiation of Interleukin-9-Producing CD4(+) T Cells	IMMUNITY			English	Article							IL-9 PRODUCTION; REG CELLS; TGF-BETA; INFLAMMATION; METABOLISM; MTOR; RESPONSES; HYPOXIA; GAMMA; FATE	Distinct metabolic programs support the differentiation of CD4(+) T cells into separate functional subsets. In this study, we investigated metabolic mechanisms underlying the differentiation of IL-9-producing CD4(+) T cells (Th9) in allergic airway inflammation and cancerous tumors. We found that histone deacetylase SIRT1 negatively regulated Th9 cell differentiation. A deficiency of SIRT1 induced by either conditional deletion in mouse CD4(+) T cells or the use of small interfering RNA (siRNA) in mouse or human T cells increased IL-9 production, whereas ectopic SIRT1 expression inhibited it. Notably, SIRT1 inhibited Th9 cell differentiation that regulated anti-tumor immunity and allergic pulmonary inflammation. Glycolytic activation through them TOR-hypoxia- inducible factor-1 alpha (HIF1 alpha) was required for the differentiation of Th9 cells that conferred protection against tumors and is involved in allergic airway inflammation. Our results define the essential features of SIRT1-mTOR-HIF1 alpha signaling-coupled glycolytic pathway in inducing Th9 cell differentiation, with implications for metabolic reprogramming as an immunotherapeutic approach.	[Wang, Yu; Chen, Xi; Li, Chunxiao; Li, Yan; Zhang, Zhengguo; Wang, Jian; Lu, Yun; Yu, Qing; Su, Huilin; Liu, Guangwei] Beijing Normal Univ, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol, Minist Educ,Coll Life Sci, Beijing 100875, Peoples R China; [Wang, Yu; Chen, Xi; Li, Chunxiao; Li, Yan; Zhang, Zhengguo; Wang, Jian; Lu, Yun; Su, Huilin; Yang, Hui; Liu, Guangwei] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China; [Bi, Yujing] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China	Beijing Normal University; Fudan University; Beijing Institute of Microbiology & Epidemiology	Liu, GW (corresponding author), Beijing Normal Univ, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol, Minist Educ,Coll Life Sci, Beijing 100875, Peoples R China.; Liu, GW (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China.	liugw@bnu.edu.cn	Li, Chunxiao/N-3084-2019	Li, Chunxiao/0000-0002-1805-140X; Su, Huilin/0000-0002-5694-5535; Liu, Guangwei/0000-0002-6008-2891	National Natural Science Foundation for General Programs of China [31171407, 81273201]; Key Basic Research Project of the Science and Technology Commission of Shanghai Municipality [12JC1400900]; Innovation Program of Shanghai Municipal Education Commission [14ZZ009]	National Natural Science Foundation for General Programs of China(National Natural Science Foundation of China (NSFC)); Key Basic Research Project of the Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	The authors' research is supported by grants from the National Natural Science Foundation for General Programs of China (31171407 and 81273201 to G.L.), Key Basic Research Project of the Science and Technology Commission of Shanghai Municipality (12JC1400900 to G.L.), and Innovation Program of Shanghai Municipal Education Commission (14ZZ009 to G.L.).	Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Kim IK, 2015, NAT MED, V21, P1010, DOI 10.1038/nm.3922; Legutko A, 2011, J IMMUNOL, V187, P4517, DOI 10.4049/jimmunol.1101493; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liu GW, 2015, P NATL ACAD SCI USA, V112, pE957, DOI 10.1073/pnas.1420419112; Liu GW, 2014, CANCER RES, V74, P727, DOI 10.1158/0008-5472.CAN-13-2584; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Man K, 2015, NAT REV IMMUNOL, V15, P574, DOI 10.1038/nri3874; Nakatsukasa H, 2015, NAT IMMUNOL, V16, P1077, DOI 10.1038/ni.3252; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Yang Hui, 2015, Critical Reviews in Oncogenesis, V20, P49; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003	25	116	129	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1337	1349		10.1016/j.immuni.2016.05.009	http://dx.doi.org/10.1016/j.immuni.2016.05.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27317260	Bronze			2022-12-18	WOS:000378341200013
J	Liu, C; Wu, CA; Yang, QF; Gao, J; Li, L; Yang, DQ; Luo, LF				Liu, Chi; Wu, Chuan; Yang, Qifen; Gao, Jing; Li, Li; Yang, Deqin; Luo, Lingfei			Macrophages Mediate the Repair of Brain Vascular Rupture through Direct Physical Adhesion and Mechanical Traction	IMMUNITY			English	Article							BLOOD-VESSEL FORMATION; CEREBRAL MICROBLEEDS; ENDOTHELIAL-CELLS; MYOSIN-II; IN-VIVO; STROKE; ZEBRAFISH; REGENERATION; MICROGLIA; FILOPODIA	Hemorrhagic stroke and brain microbleeds are caused by cerebrovascular ruptures. Fast repair of such ruptures is the most promising therapeutic approach. Due to a lack of high-resolution in vivo real-time studies, the dynamic cellular events involved in cerebrovascular repair remain unknown. Here, we have developed a cerebrovascular rupture system in zebrafish by using multi-photon laser, which generates a lesion with two endothelial ends. In vivo time-lapse imaging showed that a macrophage arrived at the lesion and extended filopodia or lamellipodia to physically adhere to both endothelial ends. This macrophage generated mechanical traction forces to pull the endothelial ends and facilitate their ligation, thus mediating the repair of the rupture. Both depolymerization of microfilaments and inhibition of phosphatidylinositide 3-kinase or Rac1 activity disrupted macrophage-endothelial adhesion and impaired cerebrovascular repair. Our study reveals a hitherto unexpected role for macrophages in mediating repair of cerebrovascular ruptures through direct physical adhesion and mechanical traction.	[Liu, Chi; Wu, Chuan; Yang, Qifen; Li, Li; Luo, Lingfei] Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Lab Mol Dev Biol,Sch Life Sci, Chongqing 400715, Peoples R China; [Gao, Jing; Yang, Deqin] Chongqing Med Univ, Dept Endodont & Operat Dent, Chongqing Key Lab Oral Dis & Biomed Sci, Affiliated Hosp Stomatol, Chongqing, Peoples R China	Southwest University - China; Chongqing Medical University	Luo, LF (corresponding author), Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Lab Mol Dev Biol,Sch Life Sci, Chongqing 400715, Peoples R China.; Yang, DQ (corresponding author), Chongqing Med Univ, Dept Endodont & Operat Dent, Chongqing Key Lab Oral Dis & Biomed Sci, Affiliated Hosp Stomatol, Chongqing, Peoples R China.	yangdeqin@gmail.com; lluo@swu.edu.cn		Liu, Chi/0000-0003-2057-9649; Yang, Deqin/0000-0002-2579-8384	National Key Basic Research Program of China [2015CB942800]; National Natural Science Foundation of China [91539201, 31330051, 31130038, 31371473, 31571508]; 111 Program [B14037]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Program(Ministry of Education, China - 111 Project)	We thank Didier Y. Stainier, Markus Affolter, Arndt F. Siekmann, Jiulin Du, and Niels Galjart for fish lines, antibodies, and plasmids and we thank Annoroad Gene Technology for the help on RNA sequencing and analysis. This work was supported by the National Key Basic Research Program of China (2015CB942800), the National Natural Science Foundation of China (91539201, 31330051, 31130038, 31371473, 31571508), and the 111 Program (B14037).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bohgaki M, 2007, INT J HEMATOL, V86, P42, DOI 10.1532/IJH97.06217; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Bussmann J, 2011, DEVELOPMENT, V138, P1717, DOI 10.1242/dev.059881; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Chen Q, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001374; Chiba T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/759103; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Fisher M, 2010, STROKE, V41, P2782, DOI 10.1161/STROKEAHA.110.593657; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Glod J, 2006, BLOOD, V107, P940, DOI 10.1182/blood-2004-11-4403; Gregoire SM, 2012, CEREBROVASC DIS, V33, P430, DOI 10.1159/000336237; He JB, 2014, GASTROENTEROLOGY, V146, P789, DOI 10.1053/j.gastro.2013.11.045; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Liman TG, 2012, CEREBROVASC DIS, V33, P492, DOI 10.1159/000337155; Liu XL, 2009, J CELL BIOL, V184, P805, DOI 10.1083/jcb.200806074; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2013, STROKE, V44, pS90, DOI 10.1161/STROKEAHA.112.679621; Phng LK, 2013, DEVELOPMENT, V140, P4031, DOI 10.1242/dev.097352; Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rossi F, 2015, CELL REP, V11, P1008, DOI 10.1016/j.celrep.2015.04.028; Ruegg C, 2002, NEWS PHYSIOL SCI, V17, P213, DOI 10.1152/nips.01389.2002; Rymo SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015846; Sanchez-Moreno C, 2004, STROKE, V35, P163, DOI 10.1161/01.STR.0000105391.62306.2E; Sasaki Y, 2003, GLIA, V44, P242, DOI 10.1002/glia.10293; Schmidt T, 2010, NATURE, V465, P697, DOI 10.1038/465697a; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Stepanova T, 2003, J NEUROSCI, V23, P2655; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wittmann T, 2001, J CELL SCI, V114, P3795; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015	53	116	118	3	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1162	1176		10.1016/j.immuni.2016.03.008	http://dx.doi.org/10.1016/j.immuni.2016.03.008			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27156384	Bronze			2022-12-18	WOS:000376478500020
J	Yang, JY; Kim, MS; Kim, E; Cheon, JH; Lee, YS; Kim, Y; Lee, SH; Seo, SU; Shin, SH; Choi, SS; Kim, B; Chang, SY; Ko, HJ; Bae, JW; Kweon, MN				Yang, Jin-Young; Kim, Min-Soo; Kim, Eugene; Cheon, Jae Hee; Lee, Yong-Soo; Kim, Yeji; Lee, Su-Hyun; Seo, Sang-Uk; Shin, Seung-Ho; Choi, Sun Shim; Kim, Bumseok; Chang, Sun-Young; Ko, Hyun-Jeong; Bae, Jin-Woo; Kweon, Mi-Na			Enteric Viruses Ameliorate Gut Inflammation via Toll-like Receptor 3 and Toll-like Receptor 7-Mediated Interferon-beta Production	IMMUNITY			English	Article							INDUCED ACUTE COLITIS; DOUBLE-STRANDED-RNA; DAY-CARE-CENTER; BOWEL-DISEASE; CROHNS-DISEASE; ROTAVIRUS INFECTION; COMMENSAL BACTERIA; IMMUNE-RESPONSE; HUMAN FECES; RIG-I	Metagenomic studies show that diverse resident viruses inhabit the healthy gut; however, little is known about the role of these viruses in the maintenance of gut homeostasis. We found that mice treated with antiviral cocktail displayed more severe dextran sulfate sodium (DSS)-induced colitis compared with untreated mice. DSS-induced colitis was associated with altered enteric viral abundance and composition. When wild-type mice were reconstituted with Toll-like receptor 3 (TLR3) or TLR7 agonists or inactivated rotavirus, colitis symptoms were significantly ameliorated. Mice deficient in both TLR3 and TLR7 were more susceptible to DSS-induced experimental colitis. In humans, combined TLR3 and TLR7 genetic variations significantly influenced the severity of ulcerative colitis. Plasmacytoid dendritic cells isolated from inflamed mouse colon produced interferon-beta in a TLR3 and TLR7-dependent manner. These results imply that recognition of resident viruses by TLR3 and TLR7 is required for protective immunity during gut inflammation.	[Yang, Jin-Young; Kim, Eugene; Lee, Yong-Soo; Kim, Yeji; Lee, Su-Hyun; Kweon, Mi-Na] Univ Ulsan, Dept Convergence Med, Mucosal Immunol Lab, Coll Med,Asan Med Ctr, Seoul 05505, South Korea; [Kim, Min-Soo; Bae, Jin-Woo] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 02447, South Korea; [Kim, Min-Soo; Bae, Jin-Woo] Kyung Hee Univ, Dept Biol, Seoul 02447, South Korea; [Cheon, Jae Hee] Yonsei Univ, Dept Internal Med, Coll Med, Seoul 03722L, South Korea; [Cheon, Jae Hee] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul 03722L, South Korea; [Seo, Sang-Uk] Seoul Natl Univ, Wide River Inst Immunol, Dept Med, Coll Med, Seoul 03080, South Korea; [Shin, Seung-Ho; Choi, Sun Shim] Kangwon Natl Univ, Dept Med Biotechnol, Coll Biomed Sci, Chunchon 24341, South Korea; [Kim, Bumseok] Chonbuk Natl Univ, Coll Vet Med, Lab Pathol, Plus Program BK21, Iksan 54596, South Korea; [Chang, Sun-Young] Ajou Univ, Coll Pharm, Microbiol Lab, Suwon 16499, South Korea; [Ko, Hyun-Jeong] Kangwon Natl Univ, Coll Pharm, Lab Microbiol & Immunol, Chunchon 24341, South Korea	University of Ulsan; Kyung Hee University; Kyung Hee University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Kangwon National University; Jeonbuk National University; Ajou University; Kangwon National University	Kweon, MN (corresponding author), Univ Ulsan, Dept Convergence Med, Mucosal Immunol Lab, Coll Med,Asan Med Ctr, Seoul 05505, South Korea.; Bae, JW (corresponding author), Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 02447, South Korea.; Bae, JW (corresponding author), Kyung Hee Univ, Dept Biol, Seoul 02447, South Korea.	baejw@khu.ac.kr; mnkweon@amc.seoul.kr	Cheon, Jae Hee/B-4523-2015; Bae, Jin-Woo/S-1955-2017	Cheon, Jae Hee/0000-0002-2282-8904; Ko, Hyun-Jeong/0000-0002-3844-928X; Bae, Jin-Woo/0000-0001-6433-5270; Kim, Yeji/0000-0002-9869-9301; Kim, Min-Soo/0000-0002-7184-4396	Korean Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [HI12C06870000, A120770, A120176, HI13C0016]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2010-0029133, 2011-0028854, 2012-0000805, 2013R1A2A2A01067123, 2015M3C9A2054299]	Korean Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP)	This work was supported by the Korean Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea HI12C06870000 (A120770 and A120176) and HI13C0016, and the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (2010-0029133, 2011-0028854, 2012-0000805, 2013R1A2A2A01067123, and 2015M3C9A2054299).	Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Berry D, 2012, ISME J, V6, P2091, DOI 10.1038/ismej.2012.39; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; BURNS JW, 1995, VIROLOGY, V207, P143, DOI 10.1006/viro.1995.1060; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; FIELD HJ, 1981, J GEN VIROL, V56, P259, DOI 10.1099/0022-1317-56-2-259; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; GROHMANN G, 1991, J CLIN MICROBIOL, V29, P544, DOI 10.1128/JCM.29.3.544-550.1991; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kandiel A, 2006, AM J GASTROENTEROL, V101, P2857, DOI 10.1111/j.1572-0241.2006.00869.x; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kim B, 2008, VACCINE, V26, P5601, DOI 10.1016/j.vaccine.2008.07.099; Kim MS, 2013, ENV MICROBIOL REP, V5, P765, DOI 10.1111/1758-2229.12079; Kim MS, 2011, APPL ENVIRON MICROB, V77, P8062, DOI 10.1128/AEM.06331-11; Lazarevic Vladimir, 2012, J Clin Bioinforma, V2, P4, DOI 10.1186/2043-9113-2-4; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lepage P, 2008, GUT, V57, DOI 10.1136/gut.2007.134668; Li XD, 2011, P NATL ACAD SCI USA, V108, P17390, DOI 10.1073/pnas.1107114108; MATSON DO, 1990, PEDIATR INFECT DIS J, V9, P190, DOI 10.1097/00006454-199003000-00009; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Morrey JD, 1999, ANTIVIR RES, V42, P97, DOI 10.1016/S0166-3542(99)00009-1; Nakanishi Y, 2015, MUCOSAL IMMUNOL, V8, P152, DOI 10.1038/mi.2014.53; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Parry GCN, 1997, J IMMUNOL, V159, P5450; Perez-Brocal V, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.9; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Sainathan SK, 2012, INFLAMM BOWEL DIS, V18, P955, DOI 10.1002/ibd.21867; Schunter MO, 2007, J CROHNS COLITIS, V1, P41, DOI 10.1016/j.crohns.2007.06.004; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Vijay-Kumar M, 2007, INFLAMM BOWEL DIS, V13, P856, DOI 10.1002/ibd.20142; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wagner J, 2013, INFLAMM BOWEL DIS, V19, P1598, DOI 10.1097/MIB.0b013e318292477c; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zoetendal EG, 2006, NAT PROTOC, V1, P870, DOI 10.1038/nprot.2006.142	55	116	126	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					889	900		10.1016/j.immuni.2016.03.009	http://dx.doi.org/10.1016/j.immuni.2016.03.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27084119	Bronze			2022-12-18	WOS:000374444300019
J	Worthington, JJ; Kelly, A; Smedley, C; Bauche, D; Campbell, S; Marie, JC; Travis, MA				Worthington, John J.; Kelly, Aoife; Smedley, Catherine; Bauche, David; Campbell, Simon; Marie, Julien C.; Travis, Mark A.			Integrin alpha v beta 8-Mediated TGF-beta Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; IMMUNE PATHOLOGY; TGF-BETA-1; EXPRESSION; TOLERANCE; HOMEOSTASIS; GENERATION; INDUCTION; COLITIS; DISEASE	Regulatory T (Treg) cells play a pivotal role in suppressing self-harmful T cell responses, but how Treg cells mediate suppression to maintain immune homeostasis and limit responses during inflammation is unclear. Here we show that effector Treg cells express high amounts of the integrin alpha v beta 8, which enables them to activate latent transforming growth factor-beta (TGF-beta). Treg-cell-specific deletion of integrin alpha v beta 8 did not result in a spontaneous inflammatory phenotype, suggesting that this pathway is not important in Treg-cell-mediated maintenance of immune homeostasis. However, Treg cells lacking expression of integrin avb8 were unable to suppress pathogenic T cell responses during active inflammation. Thus, our results identify a mechanism by which Treg cells suppress exuberant immune responses, highlighting a key role for effector Treg-cell-mediated activation of latent TGF-beta in suppression of self-harmful T cell responses during active inflammation.	[Worthington, John J.; Kelly, Aoife; Smedley, Catherine; Travis, Mark A.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England; [Worthington, John J.; Kelly, Aoife; Smedley, Catherine; Travis, Mark A.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9NT, Lancs, England; [Worthington, John J.; Kelly, Aoife; Smedley, Catherine; Travis, Mark A.] Univ Manchester, Fac Life Sci, Manchester Immunol Grp, Manchester M13 9NT, Lancs, England; [Bauche, David; Marie, Julien C.] CNRS, Ctr Leon Berard, CRCL, Immunol Virol & Inflammat Dept,Inserm,UMR 1052,52, F-69373 Lyon 08, France; [Bauche, David; Marie, Julien C.] Univ Lyon 1, F-69000 Lyon, France; [Bauche, David; Marie, Julien C.] Labex DEVweCAN, F-69008 Lyon, France; [Bauche, David; Marie, Julien C.] German Canc Res Ctr, DKFZ, TGFss & Immunoevas Grp, D-69120 Heidelberg, Germany; [Campbell, Simon] Cent Manchester Univ, Hosp NHS Fdn Trust, Manchester Royal Infirm, Gastroenterol Unit, Manchester M13 PWL, Lancs, England	University of Manchester; University of Manchester; University of Manchester; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Helmholtz Association; German Cancer Research Center (DKFZ)	Worthington, JJ (corresponding author), Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England.	john.j.worthington@manchester.ac.uk; mark.travis@manchester.ac.uk	Marie, Julien/I-5084-2016; bauche, david/M-2409-2019; Travis, Mark/E-9643-2015	Marie, Julien/0000-0001-6713-7923; Worthington, John Joseph/0000-0002-1429-5669; Kelly, Aoife/0000-0002-8101-3422; Travis, Mark/0000-0002-8485-2272	Wellcome Trust [097820/Z/11/B, 088785/Z/09/Z]; MRC [MR/M00242X/1]; Manchester Collaborative Centre for Inflammation Research grant; Ligue contre le cancer comite du rhone; ANR investissement d'avenir [ANR-10-LABX-61]; DEVweCAN; Medical Research Council [MR/M00242X/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Manchester Collaborative Centre for Inflammation Research grant; Ligue contre le cancer comite du rhone(Ligue nationale contre le cancer); ANR investissement d'avenir(French National Research Agency (ANR)); DEVweCAN; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Dr. Kevin Couper, Prof. Richard Grencis (University of Manchester), and Prof. Dean Sheppard (UCSF) for critical reading of the manuscript, Dr. Mark Wilson (MRC NIMR) for provision of reagents, and Mike Jackson and Dr. Gareth Howell from the Faculty of Life Sciences/Manchester Collaborative Centre for Inflammation Research flow cytometry facilities for help with cell sorting. We also thank all staff in the University of Manchester Biological Services Unit for help with animal work. This work was supported by a Wellcome Trust Stepping Stones Fellowship (097820/Z/11/B to J.J.W.), by an MRC grant (MR/M00242X/1), and by a Manchester Collaborative Centre for Inflammation Research grant (to M.A.T.). The Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, is supported by core funding from the Wellcome Trust (088785/Z/09/Z). J.C.M. was supported by Ligue contre le cancer comite du rhone and ANR investissement d'avenir ANR-10-LABX-61. D.B. was supported by DEVweCAN and J.C.M. is a Helmholtz association investigator.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Afzali B, 2013, EUR J IMMUNOL, V43, P2043, DOI 10.1002/eji.201243296; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Edwards JP, 2014, J IMMUNOL, V193, P2843, DOI 10.4049/jimmunol.1401102; Edwards JP, 2013, J IMMUNOL, V190, P5506, DOI 10.4049/jimmunol.1300199; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Konkel JE, 2014, P NATL ACAD SCI USA, V111, pE465, DOI 10.1073/pnas.1320319111; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liu HY, 2003, J IMMUNOL, V171, P5012, DOI 10.4049/jimmunol.171.10.5012; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maloy KJ, 2005, IMMUNOL LETT, V97, P189, DOI 10.1016/j.imlet.2005.01.004; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tang Q, 2013, COLD SPRING HARB PER, V3; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Workman CJ, 2011, METHODS MOL BIOL, V707, P119, DOI 10.1007/978-1-61737-979-6_9; Worthington JJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003675; Worthington JJ, 2011, GASTROENTEROLOGY, V141, P1802, DOI 10.1053/j.gastro.2011.06.057; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Zhang XM, 2006, INT IMMUNOL, V18, P495, DOI 10.1093/intimm/dxh390; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	42	116	122	4	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					903	915		10.1016/j.immuni.2015.04.012	http://dx.doi.org/10.1016/j.immuni.2015.04.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25979421	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-18	WOS:000354827400016
J	Martinez-Martin, N; Fernandez-Arenas, E; Cemerski, S; Delgado, P; Turner, M; Heuser, J; Irvine, DJ; Huang, B; Bustelo, XR; Shaw, A; Alarcon, B				Martinez-Martin, Nuria; Fernandez-Arenas, Elena; Cemerski, Saso; Delgado, Pilar; Turner, Martin; Heuser, John; Irvine, Darrell J.; Huang, Bonnie; Bustelo, Xose R.; Shaw, Andrey; Alarcon, Balbino			T Cell Receptor Internalization from the Immunological Synapse Is Mediated by TC21 and RhoG GTPase-Dependent Phagocytosis	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; DOWN-REGULATION; INTERCELLULAR TRANSFER; MOLECULAR-MECHANISMS; TRANSGENIC MICE; ACTIVATION; PROTEIN; COMPLEXES; MHC; TRANSFORMATION	The immunological synapse (IS) serves a dual role for sustained T cell receptor (TCR) signaling and for TCR downregulation. TC21 (Rras2) is a RRas subfamily GTPase that constitutively associates with the TCR and is implicated in tonic TCR signaling by activating phosphatidylinositol 3-kinase. In this study, we demonstrate that TC21 both cotranslocates with the TCR to the IS and is necessary for TCR internalization from the IS through a mechanism dependent on RhoG, a small GTPase previously associated with phagocytosis. Indeed, we found that the TCR triggers T cells to phagocytose 1-6 mu m beads through a TC21- and RhoG-dependent pathway. We further show that TC21 and RhoG are necessary for the TCR-promoted uptake of major histocompatibility complex (MHC) from antigen-presenting cells. Therefore, TC21 and RhoG dependence underlie the existence of a common phagocytic mechanism that drives TCR internalization from the IS together with its peptide-MHC ligand.	[Martinez-Martin, Nuria; Fernandez-Arenas, Elena; Delgado, Pilar; Alarcon, Balbino] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Cemerski, Saso; Shaw, Andrey] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Heuser, John] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; [Turner, Martin] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Irvine, Darrell J.; Huang, Bonnie] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Bustelo, Xose R.] Univ Salamanca, Ctr Invest Canc, Canc Res Ctr CSIC, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Washington University (WUSTL); Washington University (WUSTL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Massachusetts Institute of Technology (MIT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Alarcon, B (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain.	balarcon@cbm.uam.es	Martinez-Martin, Nuria/A-9160-2017; Bustelo, Xose R./A-9526-2010; Turner, Martin/N-9976-2014; Alarcon, Balbino/N-9648-2016; Delgado, Pilar/F-3365-2016; Bustelo, Xose R./AAD-2081-2022	Martinez-Martin, Nuria/0000-0003-2309-8920; Bustelo, Xose R./0000-0001-9398-6072; Turner, Martin/0000-0002-3801-9896; Alarcon, Balbino/0000-0001-7820-1070; Delgado, Pilar/0000-0002-8431-8002; Bustelo, Xose R./0000-0001-9398-6072	CICYT [SAF2006-01391, SAF2010-14912]; Comunidad de Madrid [SAL-0159/2006]; RETICS [RD06/0020/1002, RD06/0020/0001]; EU; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer; MRC [G0601618] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI057966] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C206, BBS/E/B/0000C207, BBS/E/B/00001207] Funding Source: researchfish; Medical Research Council [G0601618] Funding Source: researchfish	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Comunidad de Madrid(Comunidad de Madrid); RETICS; EU(European Commission); Fundacion Cientifica de la Asociacion Espanola Contra el Cancer; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank M. Davis, E. Palmer, R. Samaniego, and M. Zerial for kindly providing us with reagents and F. Niedergang, K. Okkenhaug, and M. Sefton for critical reading of the manuscript. We are also indebted to C. Prieto, V. Blanco, T. Gomez, and the Confocal Microscopy Unit for their expert technical assistance. This work was supported by grants SAF2006-01391 and SAF2010-14912 from CICYT, SAL-0159/2006 from the Comunidad de Madrid, RD06/0020/1002 and RD06/0020/0001 from RETICS, and FP7/2007-2013 from the EU and from Fundacion Cientifica de la Asociacion Espanola Contra el Cancer. Institutional support from the Fundacion Ramon Areces to the CBMSO is also acknowledged.	Ahmed KA, 2008, CELL MOL IMMUNOL, V5, P261, DOI 10.1038/cmi.2008.32; Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; Andre P, 1997, J IMMUNOL, V159, P5253; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Balagopalan L, 2009, IMMUNOL REV, V232, P84, DOI 10.1111/j.1600-065X.2009.00840.x; Batista A, 2004, J IMMUNOL, V172, P6709, DOI 10.4049/jimmunol.172.11.6709; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; CHAN AML, 1994, P NATL ACAD SCI USA, V91, P7558, DOI 10.1073/pnas.91.16.7558; Clark GJ, 1996, ONCOGENE, V12, P169; Cox D, 2001, SEMIN IMMUNOL, V13, P339, DOI 10.1006/smim.2001.0330; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Daubeuf S, 2006, NAT PROTOC, V1, P2536, DOI 10.1038/nprot.2006.400; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Delgado P, 2009, NAT IMMUNOL, V10, P880, DOI 10.1038/ni.1749; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Dragone LL, 2009, IMMUNOL REV, V232, P218, DOI 10.1111/j.1600-065X.2009.00827.x; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Gerisch G, 2009, CELL ADHES MIGR, V3, P373, DOI 10.4161/cam.3.4.9708; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; GRAHAM SM, 1994, MOL CELL BIOL, V14, P4108, DOI 10.1128/MCB.14.6.4108; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Henson PM, 2005, CURR BIOL, V15, pR29, DOI 10.1016/j.cub.2004.12.017; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Monjas A, 2004, J BIOL CHEM, V279, P55376, DOI 10.1074/jbc.M409342200; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Murphy GA, 2002, J BIOL CHEM, V277, P9966, DOI 10.1074/jbc.M109059200; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Niedergang F, 1997, J IMMUNOL, V159, P1703; Prieto-Sanchez RM, 2006, ONCOGENE, V25, P2961, DOI 10.1038/sj.onc.1209333; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rong R, 2002, ONCOGENE, V21, P1062, DOI 10.1038/sj.onc.1205154; Rosario M, 2001, MOL CELL BIOL, V21, P3750, DOI 10.1128/MCB.21.11.3750-3762.2001; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; SANJOSE E, 2000, IMMUNOL REV, V221, P90; Sharma R, 2005, ONCOLOGY-BASEL, V69, P10, DOI 10.1159/000087283; Singleton K, 2006, J IMMUNOL, V177, P4402, DOI 10.4049/jimmunol.177.7.4402; Smyth LA, 2007, AM J TRANSPLANT, V7, P1442, DOI 10.1111/j.1600-6143.2007.01816.x; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Umeshappa CS, 2009, J IMMUNOL, V182, P193, DOI 10.4049/jimmunol.182.1.193; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; Vigorito E, 2004, MOL CELL BIOL, V24, P719, DOI 10.1128/MCB.24.2.719-729.2004; von Essen M, 2006, J IMMUNOL, V176, P7502, DOI 10.4049/jimmunol.176.12.7502; Wetzel SA, 2006, CRIT REV IMMUNOL, V26, P1; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; Yokosuka T, 2010, CURR TOP MICROBIOL, V340, P81, DOI 10.1007/978-3-642-03858-7_5; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	55	116	118	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 26	2011	35	2					208	222		10.1016/j.immuni.2011.06.003	http://dx.doi.org/10.1016/j.immuni.2011.06.003			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21820331	Bronze, Green Accepted			2022-12-18	WOS:000294387900011
J	Ma, G; Pan, PY; Eisenstein, S; Divino, CM; Lowell, CA; Takai, T; Chen, SH				Ma, Ge; Pan, Ping-Ying; Eisenstein, Samuel; Divino, Celia M.; Lowell, Clifford A.; Takai, Toshiyuki; Chen, Shu-Hsia			Paired Immunoglobin-like Receptor-B Regulates the Suppressive Function and Fate of Myeloid-Derived Suppressor Cells	IMMUNITY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; MHC CLASS-I; IMMUNE SUPPRESSION; BEARING HOST; KAPPA-B; ACTIVATION; POLARIZATION; TOLERANCE; MICE; CANCER	Myeloid-derived suppressor cells (MDSCs) bear characteristics of precursors for both M1 and M2 macrophages. The molecular mechanism underlying the differentiation into M1 and M2 macrophages and the relationship of this differentiation to antitumor responses remains largely undefined. Herein, we investigate the potential function of paired immunoglobulin-like receptor B (PIR-B), also known as leukocyte immunoglobulin-like receptor subfamily B member 3 (LILRB3) in MDSC differentiation, and its role in tumor-induced immunity. Our studies indicated that MDSCs genetically ablated for PIR-B (Lilrb3(-/-)) underwent a specific transition to M1-like cells when entering the periphery from bone marrow, resulting in decreased suppressive function, regulatory T cell activation activity, primary tumor growth, and lung metastases. Activation of Toll-like receptor (TLR), signal transducers, and activators of transcription 1 (STAT1), and nuclear factor-kappa B (NF-kappa B) signaling in Lilrb3(-/-) MDSC promoted the acquisition of M1 phenotype. Inhibition of the PIR-B signaling pathway promoted MDSC differentiation into M1 macrophages.	[Ma, Ge; Pan, Ping-Ying; Chen, Shu-Hsia] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Eisenstein, Samuel; Divino, Celia M.; Chen, Shu-Hsia] Mt Sinai Sch Med, Dept Surg, New York, NY 10029 USA; [Chen, Shu-Hsia] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Chen, Shu-Hsia] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Chen, Shu-Hsia] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; Tohoku University	Chen, SH (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, 1425 Madison Ave,Room 13-02, New York, NY 10029 USA.	shu-hsia.chen@mssm.edu	Eisenstein, Samuel/L-6221-2019		National Cancer Institute; Black Family Stem Cell Foundation; Pfizer; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA140243, R01CA070337, R01CA109322, R01CA127483] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22659057] Funding Source: KAKEN	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Black Family Stem Cell Foundation; Pfizer(Pfizer); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Meseck for her kind editing of this manuscript and H.-M. Hu provided the OVA-LLC cell line. The work was supported in part by grants from the National Cancer Institute, Black Family Stem Cell Foundation, and Pfizer research fund to S.-H.C. and grant support from the Susan G. Komen Breast Cancer Foundation to P.-Y.P.	Blanchette J, 2009, IMMUNOLOGY, V127, P123, DOI 10.1111/j.1365-2567.2008.02929.x; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Chen BC, 2001, BRIT J PHARMACOL, V134, P1055, DOI 10.1038/sj.bjp.0704334; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Dong F, 2001, J IMMUNOL, V167, P6447, DOI 10.4049/jimmunol.167.11.6447; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guruvayoorappan C, 2008, INTEGR CANCER THER, V7, P90, DOI 10.1177/1534735408319060; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Kodumudi KN, 2010, CLIN CANCER RES, V16, P4583, DOI 10.1158/1078-0432.CCR-10-0733; Kubagawa H, 1999, J EXP MED, V189, P309, DOI 10.1084/jem.189.2.309; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mantovani A, 2009, BLOOD, V114, P3135, DOI 10.1182/blood-2009-07-231795; Mantovani A, 2009, HUM IMMUNOL, V70, P325, DOI 10.1016/j.humimm.2009.02.008; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Nakata K, 2011, MOL IMMUNOL, V48, P472, DOI 10.1016/j.molimm.2010.10.001; Nakayama M, 2007, J IMMUNOL, V178, P4250, DOI 10.4049/jimmunol.178.7.4250; Otsuji M, 1996, P NATL ACAD SCI USA, V93, P13119, DOI 10.1073/pnas.93.23.13119; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Pan PY, 2010, CANCER RES, V70, P99, DOI 10.1158/0008-5472.CAN-09-1882; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sinha P, 2005, CANCER IMMUNOL IMMUN, V54, P1137, DOI 10.1007/s00262-005-0703-4; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Taylor LS, 1999, BLOOD, V94, P1790, DOI 10.1182/blood.V94.5.1790.417k16_1790_1796; Tun T, 2003, TISSUE ANTIGENS, V61, P220, DOI 10.1034/j.1399-0039.2003.00042.x; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Vlad G, 2010, INT REV IMMUNOL, V29, P119, DOI 10.3109/08830180903281185; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	45	116	125	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					385	395		10.1016/j.immuni.2011.02.004	http://dx.doi.org/10.1016/j.immuni.2011.02.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21376641	Green Accepted, Bronze			2022-12-18	WOS:000289014500014
J	Huang, HN; Jeon, MS; Liao, LJ; Yang, C; Elly, C; Yates, JR; Liu, YC				Huang, Haining; Jeon, Myung-shin; Liao, Lujian; Yang, Chun; Elly, Chris; Yates, John R., III; Liu, Yun-Cai			K33-Linked Polyubiquitination of T Cell Receptor-zeta Regulates Proteolysis-Independent T Cell Signaling	IMMUNITY			English	Article							E3 UBIQUITIN LIGASE; CBL-B; PROTEASOMAL DEGRADATION; AIRWAY INFLAMMATION; NEGATIVE REGULATION; DOWN-REGULATION; TCR-ZETA; C-CBL; ITCH; ACTIVATION	Tagging the cell surface receptor with ubiquitin is believed to provide a signal for the endocytic pathway. E3 ubiquitin ligases such as Cbl-b and Itch have been implicated in T cell activation and tolerance induction. However, the underlying mechanisms remain unclear. We describe that in mice deficient in the E3 ubiquitin ligases Cbl-b and Itch, T cell activation was augmented, accompanied by spontaneous autoimmunity. The double-mutant T cells exhibited increased phosphorylation of the T cell receptor-zeta (TCR-zeta) chain, whereas the endocytosis and stability of the TCR complex were not affected. TCR-zeta was polyubiquitinated via a K33-linkage, which affected its phosphorylation and association with the zeta chain-associated protein kinase Zap-70. The juxtamembrane K54 residue in TCR-zeta was identified to be a primary ubiquitin conjugation site, whose mutation increased its phosphorylation and association of TCR-zeta and Zap-70. Thus, the present study reveals unconventional K33-linked polyubiquitination in nonproteolytic regulation of cell-surface-receptor-mediated signal transduction.	[Huang, Haining; Jeon, Myung-shin; Yang, Chun; Elly, Chris; Liu, Yun-Cai] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Liao, Lujian; Yates, John R., III] Scripps Res Inst, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Scripps Research Institute	Liu, YC (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA.	yuncail@liai.org	Liao, Lujian/G-5976-2010	LIU, YUN-CAI/0000-0002-0996-7109	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062969, R01AI078272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank former and current lab members Y. Bai, K. Cooper, D. Demydenko, J. Feng, Y. Harada, K. Iwanami, W. Piao, Y. Shao, A. Teng, K. Venuprasad, and W. Zhang for assistance. This work is supported by grants from National Institutes of Health to Y.-C.L.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; D'Oro U, 2002, J IMMUNOL, V169, P6269, DOI 10.4049/jimmunol.169.11.6269; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Venuprasad K, 2006, J CLIN INVEST, V116, P1117, DOI 10.1172/JCI26858; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang BL, 2008, NAT IMMUNOL, V9, P1356, DOI 10.1038/ni.1670; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	39	116	122	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					60	70		10.1016/j.immuni.2010.07.002	http://dx.doi.org/10.1016/j.immuni.2010.07.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20637659	Bronze, Green Accepted			2022-12-18	WOS:000280418100010
J	Stelekati, E; Bahri, R; D'Orlando, O; Orinska, Z; Mittrucker, HW; Langenhaun, R; Glatzel, M; Bollinger, A; Paus, R; Bulfone-Paus, S				Stelekati, Erietta; Bahri, Rajia; D'Orlando, Orietta; Orinska, Zane; Mittruecker, Hans-Willi; Langenhaun, Rabea; Glatzel, Markus; Bollinger, Annalena; Paus, Ralf; Bulfone-Paus, Silvia			Mast Cell-Mediated Antigen Presentation Regulates CD8(+) T Cell Effector Functions	IMMUNITY			English	Article							GENE-EXPRESSION PROFILES; CENTRAL-NERVOUS-SYSTEM; DENDRITIC CELLS; SEVERE DISEASE; MURINE MODEL; LYMPH-NODES; ITO CELLS; IN-VITRO; ACTIVATION; RESPONSES	The characteristics, importance, and molecular requirements for interactions between mast cells (MCs) and CD8(+) T cells have not been elucidated. Here, we demonstrated that MCs induced antigenspecific CD8(+) T cell activation and proliferation. This process required direct cell contact and MHC class I-dependent antigen cross-presentation by MCs and induced the secretion of interleukin-2, interferon-gamma, and macrophage inflammatory protein-1 alpha by CD8(+) T cells. MCs regulated antigen-specific CD8(+) T cell cytotoxicity by increasing granzyme B expression and by promoting CD8(+) T cell degranulation. Because MCs also upregulated their expression of costimulatory molecules (4-1 BB) and released osteopontin upon direct T cell contact, MC-T cell interactions probably are bidirectional. In vivo, adoptive transfer of antigen-pulsed MCs induced MHC class I-dependent, antigen-specific CD8(+) T cell proliferation, and MCs regulated CD8(+) T cell-specific priming in experimental autoimmune encephalomyelitis. Thus, MCs are important players in antigen-specific regulation of CD8(+) T cells.	[Stelekati, Erietta; Bahri, Rajia; D'Orlando, Orietta; Orinska, Zane; Langenhaun, Rabea; Bollinger, Annalena; Bulfone-Paus, Silvia] Res Ctr, Dept Immunol & Cell Biol, D-23845 Borstel, Germany; [Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, D-20246 Hamburg, Germany; [Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Paus, Ralf] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester, Lancs, England	Forschungszentrum Borstel; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Manchester	Bulfone-Paus, S (corresponding author), Res Ctr, Dept Immunol & Cell Biol, D-23845 Borstel, Germany.	sbulfone@fz-borstel.de	Bahri, Rajia/ABE-1725-2021; Glatzel, Markus/G-3356-2011; Paus, Ralf/F-6243-2011; Glatzel, Markus/V-8844-2019	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817	Deutsche Forschungsgerneinschaft (DFG) [SFB/TR 22, A14]	Deutsche Forschungsgerneinschaft (DFG)(German Research Foundation (DFG))	We thank M-L. Helms, G. Rode, and K. Westphal for excellent technical support, F. Mirghomizadeh for help with primer design, F. Winau for providing the B2m<SUP>-/-</SUP> mice, and H. Shen for providing recombinant L. monocytogenes-OVA. This work was funded in part by grants from the Deutsche Forschungsgerneinschaft (DFG) to S.B.P. (SFB/TR 22, A14).	Andersen MH, 2006, J INVEST DERMATOL, V126, P32, DOI 10.1038/sj.jid.5700001; BANOVAC K, 1989, IMMUNOL INVEST, V18, P901, DOI 10.3109/08820138909050768; Bennett JL, 2009, J IMMUNOL, V182, P5507, DOI 10.4049/jimmunol.0801485; Bernhard H, 2000, IMMUNOBIOLOGY, V201, P568, DOI 10.1016/S0171-2985(00)80075-3; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; Burkett MW, 2005, J IMMUNOTHER, V28, P396, DOI 10.1097/01.cji.0000165357.11548.6d; Caron G, 2001, J IMMUNOL, V166, P6000, DOI 10.4049/jimmunol.166.10.6000; Dabak DO, 2004, ANAT HISTOL EMBRYOL, V33, P5, DOI 10.1111/j.1439-0264.2004.00500.x; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; FOX CC, 1994, CELL IMMUNOL, V158, P253, DOI 10.1006/cimm.1994.1272; FRANDJI P, 1993, J IMMUNOL, V151, P6318; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Gekara NO, 2008, CELL MICROBIOL, V10, P225, DOI 10.1111/j.1462-5822.2007.01033.x; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; Gregory GD, 2005, EUR J IMMUNOL, V35, P3478, DOI 10.1002/eji.200535271; Gregory Gregory D, 2006, Methods Mol Biol, V315, P35; Heib V, 2007, BLOOD, V110, P946, DOI 10.1182/blood-2006-07-036889; Heine H, 2007, J ENDOTOXIN RES, V13, P126, DOI 10.1177/0968051907079122; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huff Thomas F., 1997, P1393; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; HURTADO JC, 1995, J IMMUNOL, V155, P3360; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; Kellner A, 2009, ANN NEUROL, V65, P24, DOI 10.1002/ana.21475; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Malaviya R, 1996, J IMMUNOL, V156, P1490; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; Nagasaka A, 2008, EUR J IMMUNOL, V38, P489, DOI 10.1002/eji.200737057; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Nakae S, 2005, P NATL ACAD SCI USA, V102, P6467, DOI 10.1073/pnas.0501912102; Nishimoto H, 2005, BLOOD, V106, P4241, DOI 10.1182/blood-2005-04-1358; Okumura S, 2003, BLOOD, V102, P2547, DOI 10.1182/blood-2002-12-3929; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; Poncet P, 1999, J LEUKOCYTE BIOL, V66, P105, DOI 10.1002/jlb.66.1.105; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Ruckert R, 2003, EUR J IMMUNOL, V33, P3493, DOI 10.1002/eji.200324545; Rumsaeng V, 1997, J IMMUNOL, V159, P2904; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Skokos D, 2003, J IMMUNOL, V170, P3037, DOI 10.4049/jimmunol.170.6.3037; Stelekati E, 2007, IMMUNOBIOLOGY, V212, P505, DOI 10.1016/j.imbio.2007.03.012; SU MWC, 1993, J IMMUNOL, V151, P658; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Sundstrom JB, 2007, BLOOD, V109, P5293, DOI 10.1182/blood-2006-11-058438; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; Tkaczyk C, 2000, J ALLERGY CLIN IMMUN, V105, P134, DOI 10.1016/S0091-6749(00)90188-X; Unanue ER, 2007, IMMUNITY, V26, P9, DOI 10.1016/j.immuni.2007.01.001; Wang HW, 1998, J CLIN INVEST, V102, P1617, DOI 10.1172/JCI3704; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; WONG GHW, 1982, P NATL ACAD SCI-BIOL, V79, P6989, DOI 10.1073/pnas.79.22.6989; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	61	116	119	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					665	676		10.1016/j.immuni.2009.08.022	http://dx.doi.org/10.1016/j.immuni.2009.08.022			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19818652	Bronze			2022-12-18	WOS:000271403900017
J	Zhu, JW; Brdicka, T; Katsumoto, TR; Lin, J; Weiss, A				Zhu, Jing W.; Brdicka, Tomas; Katsumoto, Tamiko R.; Lin, Joseph; Weiss, Arthur			Structurally distinct Phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; LYN-DEFICIENT MICE; LYMPHOCYTE DEVELOPMENT; AUTOIMMUNE-DISEASE; ANTIGEN RECEPTOR; BREAST-CANCER; GROWTH; DEP-1; PTPRJ; GENE	The receptor-type protein tyrosine phosphatase (RPTP) CD148 is thought to have an inhibitory function in signaling and proliferation in nonhematopoietic cells. However, its role in the immune system has not been thoroughly studied. Our analysis of CD148 loss-of-function mice showed that CD148 has a positive regulatory function in B cells and macrophages, similar to the role of CD45 as a positive regulator of Src family kinases (SFKs). Analysis of CD148 and CD45 doubly deficient B cells and macrophages revealed hyperphosphorylation of the C-terminal inhibitory tyrosine of SFKs accompanied by substantial alterations in B and myeloid lineage development and defective immunoreceptor signaling. Because these findings suggest the C-terminal tyrosine of SFKs is a common substrate for both CD148 and CD45 phosphatases and imply a level of redundancy not previously appreciated, a reassessment of the function of CD45 in the B and myeloid lineages based on prior data from the CD45-deficient mouse is warranted.	[Zhu, Jing W.; Brdicka, Tomas; Katsumoto, Tamiko R.; Weiss, Arthur] Univ Calif San Francisco, Rosalind Russel Med Res Ctr Arthritis, Howard Hughes Med Inst, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Rosalind Russel Med Res Ctr Arthritis, Howard Hughes Med Inst, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu	Brdicka, Tomas/G-6205-2014; Katsumoto, Tamiko/V-4086-2019	Brdicka, Tomas/0000-0002-1560-4398; Katsumoto, Tamiko/0000-0002-7978-0315	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066120] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI066120-03, R01 AI066120, AI 066120] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Benatar T, 1996, J EXP MED, V183, P329, DOI 10.1084/jem.183.1.329; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Harder KW, 2001, IMMUNITY, V15, P603, DOI 10.1016/S1074-7613(01)00208-4; Hardy RR, 2000, IMMUNOL REV, V175, P23, DOI 10.1111/j.1600-065X.2000.imr017517.x; Hermiston ML, 2005, IMMUNITY, V23, P635, DOI 10.1016/j.immuni.2005.11.001; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Huntington ND, 2006, NAT IMMUNOL, V7, P190, DOI 10.1038/ni1292; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jandt E, 2003, ONCOGENE, V22, P4175, DOI 10.1038/sj.onc.1206652; Keane MM, 1996, CANCER RES, V56, P4236; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Kong YY, 1995, EUR J IMMUNOL, V25, P3431, DOI 10.1002/eji.1830251234; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Kung C, 2000, NAT MED, V6, P343; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Lesueur F, 2005, HUM MOL GENET, V14, P2349, DOI 10.1093/hmg/ddi237; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; MARTH JD, 1986, P NATL ACAD SCI USA, V83, P7400, DOI 10.1073/pnas.83.19.7400; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; Ruivenkamp C, 2003, ONCOGENE, V22, P3472, DOI 10.1038/sj.onc.1206246; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Trapasso F, 2004, CARCINOGENESIS, V25, P2107, DOI 10.1093/carcin/bgh224; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Trapasso F, 2006, DNA CELL BIOL, V25, P376, DOI 10.1089/dna.2006.25.376; Yanagi S, 1996, J BIOL CHEM, V271, P30487, DOI 10.1074/jbc.271.48.30487	44	116	119	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2008	28	2					183	196		10.1016/j.immuni.2007.11.024	http://dx.doi.org/10.1016/j.immuni.2007.11.024			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18249142	Green Accepted, Bronze			2022-12-18	WOS:000253275000009
J	Gangadharan, D; Lambolez, F; Attinger, A; Wang-Zhu, Y; Sullivan, BA; Cheroutre, H				Gangadharan, Denise; Lambolez, Florence; Attinger, Antoine; Wang-Zhu, Yiran; Sullivan, Barbara A.; Cheroutre, Hilde			Identification of pre- and postselection TCR alpha beta(+) intraepithelial lymphocyte precursors in the thymus	IMMUNITY			English	Article							T-CELL-RECEPTOR; BETA-CHAIN EXPRESSION; ALPHA-BETA; NEGATIVE SELECTION; GAMMA-DELTA; DIFFERENTIATION; CD8-ALPHA-ALPHA; THYMOCYTES; GUT; ANTIGEN	The immune system preserves and makes use of autoreactive lymphocytes with specialized functions. Here we showed that one of these populations, CD8 alpha alpha+TCR alpha beta(+) intestinal intraepithelial lymphocytes (IELs), arose from a unique subset of double-positive thymocytes. This subset of cells was precommitted to preferentially give rise to CD8 alpha alpha+TCR alpha beta(+) IELs, but they required exposure to self-agonist peptides. The agonist-selected TCR alpha beta(+) thymocytes are CD4 and CD8 double-negative, and their final maturation, including the induction of CD8 alpha alpha expression, appeared to occur only after thymus export in the IL-15-rich environment of the gut. These developmental steps, including precommitment of immature thymocytes, TCR-mediated agonist selection, and postthymic differentiation promoted by cytokines, define a unique pathway for the generation of CD8 alpha alpha a(+)TCR alpha beta(+) IEL.	La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	hilde@liai.org		Sullivan, Barbara/0000-0003-0969-6131	NIDDK NIH HHS [DK 54451] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK054451, R01DK054451] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aifantis I, 2006, J EXP MED, V203, P1543, DOI 10.1084/jem.20051711; Attinger A, 2005, J IMMUNOL, V174, P3501, DOI 10.4049/jimmunol.174.6.3501; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Baldwin TA, 2004, J IMMUNOL, V173, P6515, DOI 10.4049/jimmunol.173.11.6515; Barnden MJ, 1997, CELL IMMUNOL, V175, P111, DOI 10.1006/cimm.1996.1054; Bendelac A, 2004, NAT IMMUNOL, V5, P557, DOI 10.1038/ni0604-557; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Chidgey A, 1997, INT IMMUNOL, V9, P1527, DOI 10.1093/intimm/9.10.1527; Cruz D, 1998, J EXP MED, V188, P255, DOI 10.1084/jem.188.2.255; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Gangadharan D, 2004, CURR OPIN IMMUNOL, V16, P264, DOI 10.1016/j.coi.2004.03.015; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; Guy-Grand D, 2001, EUR J IMMUNOL, V31, P2593, DOI 10.1002/1521-4141(200109)31:9<2593::AID-IMMU2593>3.0.CO;2-X; HANKE T, 1994, J EXP MED, V180, P1629, DOI 10.1084/jem.180.5.1629; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kennedy P, 2000, LAT TRADE, V8, P15; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Mintern JD, 2004, J IMMUNOL, V172, P699, DOI 10.4049/jimmunol.172.1.699; Mixter PF, 1999, J IMMUNOL, V162, P5747; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; PARK JH, 1993, J EXP MED, V177, P541, DOI 10.1084/jem.177.2.541; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; Priatel JJ, 2001, J IMMUNOL, V167, P6188, DOI 10.4049/jimmunol.167.11.6188; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Vasseur F, 2001, EUR J IMMUNOL, V31, P3038, DOI 10.1002/1521-4141(2001010)31:10<3038::AID-IMMU3038>3.0.CO;2-3; WU L, 1990, INT IMMUNOL, V2, P51, DOI 10.1093/intimm/2.1.51; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Yu QS, 2006, J IMMUNOL, V176, P6180, DOI 10.4049/jimmunol.176.10.6180	46	116	118	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2006	25	4					631	641		10.1016/j.immuni.2006.08.018	http://dx.doi.org/10.1016/j.immuni.2006.08.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17045820	Bronze			2022-12-18	WOS:000241481500014
J	Chapman, TL; Heikema, AP; West, AP; Bjorkman, PJ				Chapman, TL; Heikema, AP; West, AP; Bjorkman, PJ			Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; FC-RECEPTOR; HLA-C; GROWTH-HORMONE; AMINO-ACID; MOLECULES; AFFINITY; COMPLEX; REVEAL; DESIGN	LIR-1 is an inhibitory receptor that recognizes class I MHC molecules and the human cytomegalovirus class I homolog UL18. Here, we report the 2.1 A resolution crystal structure of the ligand binding portion of LIR-1 (domains 1 and 2 [D1D2]) and localize the binding region for UL18. LIR-1 D1D2 is composed of two immunoglobulin-like domains arranged at an acute angle to form a bent structure resembling the structures of natural killer inhibitory receptors (KIRs). The LIR-1 binding site comprises a portion of D1 distant from the interdomain hinge region that constitutes the KIR binding site, consistent with differences in LIR-1 and KIR recognition properties and functions.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Bjorkman, PJ (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	bjorkman@caltech.edu						ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BECK S, 1988, NATURE, V331, P269, DOI 10.1038/331269a0; Biassoni R, 1997, EUR J IMMUNOL, V27, P3095, DOI 10.1002/eji.1830271203; Borges L, 1997, J IMMUNOL, V159, P5192; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Colonna M, 1998, J IMMUNOL, V160, P3096; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; HUBER AH, 1994, NEURON, V12, P717, DOI 10.1016/0896-6273(94)90326-3; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Vaughn DE, 1997, BIOCHEMISTRY-US, V36, P9374, DOI 10.1021/bi970841r; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wines BD, 1999, J IMMUNOL, V162, P2146; Winter CC, 1997, J IMMUNOL, V158, P4026; Winter CC, 1998, J IMMUNOL, V161, P571	40	116	123	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2000	13	5					727	736		10.1016/S1074-7613(00)00071-6	http://dx.doi.org/10.1016/S1074-7613(00)00071-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114384	Bronze			2022-12-18	WOS:000165598500014
J	Nguyen, LT; Duncan, GS; Mirtsos, C; Ng, M; Speiser, DE; Shahinian, A; Marino, MW; Mak, TW; Ohashi, PS; Yeh, WC				Nguyen, LT; Duncan, GS; Mirtsos, C; Ng, M; Speiser, DE; Shahinian, A; Marino, MW; Mak, TW; Ohashi, PS; Yeh, WC			TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses	IMMUNITY			English	Article							NECROSIS-FACTOR RECEPTOR; NF-KAPPA-B; CELL-DEATH; INSULIN-RECEPTOR; CD40; ACTIVATION; LIGAND; FAMILY; DOMAIN; PROTEINS	Tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) can interact with various members of the TNF receptor family. Previously, we reported that TRAF2-deficient mice die prematurely and have elevated serum TNF levels. In this study, we demonstrate that TRAF2-deficient macrophages produce increased amounts of nitric oxide (NO) and TNF in response to TNF stimulation. Furthermore, we could enhance the survival of TRAF2-deficient mice by eliminating either TNF or TNFR1. Using these double-knockout mice, we show that in the absence of TRAF2, the T helper-dependent antibody response, CD40-mediated proliferation, and NF-kappa B activation are defective. These data demonstrate two important roles of TRAF2, one as a negative regulator of certain TNFR1 signals and the other as a positive mediator of CD40 signaling.	Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; CHU Vaudois, Div Clin Oncoimmunol, Ludwig Inst Canc Res, Lausanne Branch, CH-1011 Lausanne, Switzerland; Mem Sloan Kettering Canc Ctr, New York Branch, Ludwig Inst Canc Res, New York, NY 10021 USA; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; University of Toronto	Yeh, WC (corresponding author), Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada.		Duncan, Gordon/AIE-7011-2022; Speiser, Daniel E./F-2173-2013	Ohashi, Pamela S./0000-0003-2915-9317				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Argiles JM, 1997, FASEB J, V11, P743, DOI 10.1096/fasebj.11.10.9271359; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Endres R, 1997, IMMUNITY, V7, P419, DOI 10.1016/S1074-7613(00)80363-5; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Laman JD, 1996, CRIT REV IMMUNOL, V16, P59, DOI 10.1615/CritRevImmunol.v16.i1.40; Lee HH, 1999, P NATL ACAD SCI USA, V96, P1421, DOI 10.1073/pnas.96.4.1421; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MCCAREN LC, 1959, J EXP MED, V109, P475; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; NUSSLER AK, 1993, J LEUKOCYTE BIOL, V54, P171, DOI 10.1002/jlb.54.2.171; Oxenius A, 1996, J EXP MED, V183, P2209, DOI 10.1084/jem.183.5.2209; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; ROOST HP, 1990, EUR J IMMUNOL, V20, P2647; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; RUDDLE NH, 1992, CURR OPIN IMMUNOL, V4, P327, DOI 10.1016/0952-7915(92)90084-R; SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q; SCOTT DW, 1970, CLIN EXP IMMUNOL, V6, P313; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tewari M, 1996, CURR OPIN GENET DEV, V6, P39, DOI 10.1016/S0959-437X(96)90008-8; Tsukamoto N, 1999, P NATL ACAD SCI USA, V96, P1234, DOI 10.1073/pnas.96.4.1234; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; ZINKERNAGEL RM, 1990, NATURE, V345, P68, DOI 10.1038/345068a0	51	116	117	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1999	11	3					379	389		10.1016/S1074-7613(00)80113-2	http://dx.doi.org/10.1016/S1074-7613(00)80113-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514016	Bronze			2022-12-18	WOS:000082918500013
J	Sogn, JA				Sogn, JA			Tumor immunology: The glass is half full	IMMUNITY			English	Review							SIGNAL-TRANSDUCTION MOLECULES; CYTOTOXIC T-LYMPHOCYTES; ANTIGENIC CANCER-CELLS; BEARING MICE; IMMUNE-RESPONSE; TRANSGENIC MICE; SOLID TUMORS; FAS-LIGAND; IN-VIVO; LYMPHOMA		NCI, Div Canc Biol, Canc Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sogn, JA (corresponding author), NCI, Div Canc Biol, Canc Immunol Branch, NIH, Bethesda, MD 20892 USA.							Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Arai H, 1997, P NATL ACAD SCI USA, V94, P13862, DOI 10.1073/pnas.94.25.13862; Armstrong TD, 1998, CANCER IMMUNOL IMMUN, V46, P70, DOI 10.1007/s002620050463; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett AJ, 1997, STEM CELLS, V15, P248, DOI 10.1002/stem.150248; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Boon T, 1997, CURR OPIN IMMUNOL, V9, P681, DOI 10.1016/S0952-7915(97)80049-0; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Cheever MA, 1997, IMMUNOL REV, V157, P177, DOI 10.1111/j.1600-065X.1997.tb00982.x; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Chouaib S, 1997, IMMUNOL TODAY, V18, P493, DOI 10.1016/S0167-5699(97)01115-8; CIERICI M, 1998, J NATL CANCER I, V90, P261; Colombo MP, 1997, CANCER METAST REV, V16, P421, DOI 10.1023/A:1005980418533; Correa MR, 1997, J IMMUNOL, V158, P5292; Dimitriadou V, 1997, ANTICANCER RES, V17, P1541; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; Faure F, 1998, CRIT REV IMMUNOL, V18, P77, DOI 10.1615/CritRevImmunol.v18.i1-2.90; Fenton RG, 1997, J NATL CANCER I, V89, P272, DOI 10.1093/jnci/89.4.272; FRANCO JL, 1995, CANCER RES, V55, P3840; Fuchs E J, 1996, Semin Immunol, V8, P271, DOI 10.1006/smim.1996.0035; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Green DR, 1997, P NATL ACAD SCI USA, V94, P5986, DOI 10.1073/pnas.94.12.5986; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; HARA I, 1995, J EXP MED, V182, P1609, DOI 10.1084/jem.182.5.1609; Hellstrom I, 1998, CRIT REV IMMUNOL, V18, P1; Hsu FJ, 1997, BLOOD, V89, P3129, DOI 10.1182/blood.V89.9.3129; Huang AYC, 1996, J EXP MED, V183, P769, DOI 10.1084/jem.183.3.769; Kaminski MS, 1996, J CLIN ONCOL, V14, P1974, DOI 10.1200/JCO.1996.14.7.1974; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kirsch I R, 1997, Semin Immunol, V9, P207, DOI 10.1006/smim.1997.0071; KLEIN G, 1975, HARVEY LECT, V69, P71; Kolb Hans-Jochem, 1997, Current Opinion in Oncology, V9, P139; Kolenko V, 1997, J IMMUNOL, V159, P3057; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; Lala PK, 1998, CANCER METAST REV, V17, P1, DOI 10.1023/A:1005963400984; Levey DL, 1996, IMMUNOL TODAY, V17, P365, DOI 10.1016/0167-5699(96)10013-X; Ling WJ, 1998, BLOOD, V92, P1334, DOI 10.1182/blood.V92.4.1334.416k25_1334_1341; Liu B, 1996, J IMMUNOL, V156, P1117; Liu SY, 1997, HEMATOL ONCOL CLIN N, V11, P987, DOI 10.1016/S0889-8588(05)70475-5; Maloney DG, 1997, BLOOD, V90, P2188; Marchand M, 1995, INT J CANCER, V63, P883, DOI 10.1002/ijc.2910630622; Maric M, 1998, CANCER RES, V58, P3376; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Melero I, 1997, LIFE SCI, V60, P2035, DOI 10.1016/S0024-3205(96)00686-8; MIESCHER S, 1986, J IMMUNOL, V136, P1899; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; Morgan DJ, 1998, J IMMUNOL, V160, P643; Musiani P, 1997, IMMUNOL TODAY, V18, P32, DOI 10.1016/S0167-5699(97)80012-6; Nieland JD, 1998, J IMMUNOTHER, V21, P317, DOI 10.1097/00002371-199807000-00009; Onrust SV, 1996, J CLIN INVEST, V97, P54, DOI 10.1172/JCI118406; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; PENNINGER JM, 1995, NATURE, V375, P241, DOI 10.1038/375241a0; Petersson M, 1998, J IMMUNOL, V161, P2099; RATLIFF TL, 1992, EUR UROL, V21, P17; Reichert TE, 1998, J IMMUNOTHER, V21, P295, DOI 10.1097/00002371-199807000-00007; Riethmuller G, 1998, J CLIN ONCOL, V16, P1788, DOI 10.1200/JCO.1998.16.5.1788; Schuler G, 1997, J EXP MED, V186, P1183, DOI 10.1084/jem.186.8.1183; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; SINGH S, 1992, J EXP MED, V175, P139, DOI 10.1084/jem.175.1.139; Speiser DE, 1998, CELL MOL LIFE SCI, V54, P263, DOI 10.1007/s000180050148; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Toes REM, 1996, J IMMUNOL, V156, P3911; Umansky V, 1996, J MOL MED-JMM, V74, P353, DOI 10.1007/BF00210630; UYTTENHOVE C, 1983, J EXP MED, V157, P1040, DOI 10.1084/jem.157.3.1040; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; Vierboom MPM, 1997, J EXP MED, V186, P695, DOI 10.1084/jem.186.5.695; Wick M, 1997, J EXP MED, V186, P229, DOI 10.1084/jem.186.2.229; WIEDENFELD EA, 1994, CANCER RES, V54, P1175; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Xiang R, 1998, CANCER RES, V58, P3918; Yee C, 1997, CURR OPIN IMMUNOL, V9, P702, DOI 10.1016/S0952-7915(97)80052-0	73	116	123	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					757	763		10.1016/S1074-7613(00)80641-X	http://dx.doi.org/10.1016/S1074-7613(00)80641-X			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881966	Bronze			2022-12-18	WOS:000077836600001
J	SMITH, KGC; WEISS, U; RAJEWSKY, K; NOSSAL, GJV; TARLINTON, DM				SMITH, KGC; WEISS, U; RAJEWSKY, K; NOSSAL, GJV; TARLINTON, DM			BCL-2 INCREASES MEMORY B-CELL RECRUITMENT BUT DOES NOT PERTURB SELECTION IN GERMINAL-CENTERS	IMMUNITY			English	Article							PRIMARY IMMUNE-RESPONSE; MOLECULAR CHARACTERIZATION; PRIMARY IMMUNIZATION; AFFINITY MATURATION; ANTIBODY-RESPONSES; TRANSGENIC MICE; DEATH; ANTIGEN; APOPTOSIS; PROTEIN	To address the role of apoptosis in the humoral immune response, we have examined a well-characterized T cell-dependent B cell response in mice expressing transgenic Bcl-2 in their B lymphocytes. The selection of somatic mutants and the appearance of high affinity antibodies was not affected by constitutive Bcl-2 expression. Such expression did, however, disproportionately increase the antigen-specific memory B cell pool, suggesting that the final size of the memory compartment may be regulated by an apoptotic process, which, in turn, can be influenced by Bcl-2. In addition, transgenic mice showed prolonged survival of foci of early antibody-producing cells, suggesting their removal is mediated by apoptosis that can be blocked by Bcl-2.	UNIV COLOGNE,INST GENET,D-50931 COLOGNE 41,GERMANY	University of Cologne	SMITH, KGC (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,MELBOURNE,VIC 3050,AUSTRALIA.			Tarlinton, David/0000-0001-9928-686X; Smith, Kenneth/0000-0003-3829-4326; Rajewsky, Klaus/0000-0002-6633-6370	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI003958] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 03958] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; BACHMANN MF, 1994, EUR J IMMUNOL, V24, P2567, DOI 10.1002/eji.1830241046; BEREK C, 1993, IMMUNOL TODAY, V14, P400, DOI 10.1016/0167-5699(93)90143-9; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; HERZENBERG LA, 1980, J EXP MED, V151, P1071, DOI 10.1084/jem.151.5.1071; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; Hockenbery D M, 1992, Semin Immunol, V4, P413; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Kabat EA, 1991, SEQUENCES PROTEINS I; KINCADE PW, 1981, J IMMUNOL METHODS, V42, P17, DOI 10.1016/0022-1759(81)90220-9; KORSMEYER SJ, 1992, IMMUNOL TODAY, V13, P285, DOI 10.1016/0167-5699(92)90037-8; KRAMMER PH, 1994, CURR OPIN IMMUNOL, V6, P279, DOI 10.1016/0952-7915(94)90102-3; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; LINTON PJ, 1989, CELL, V59, P1049, DOI 10.1016/0092-8674(89)90761-7; LIU YJ, 1991, EUR J IMMUNOL, V21, P1905, DOI 10.1002/eji.1830210819; MACLENNAN ICM, 1992, IMMUNOL REV, V126, P143, DOI 10.1111/j.1600-065X.1992.tb00635.x; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MCDONNELL TJ, 1990, MOL CELL BIOL, V10, P1901, DOI 10.1128/MCB.10.5.1901; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MCHEYZERWILLIAM.MG, 1993, J EXP MED, V178, P295; MCHEYZERWILLIAM.MG, 1991, NATURE, V350, P502; MERINO R, 1994, EMBO J, V13, P683, DOI 10.1002/j.1460-2075.1994.tb06307.x; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; NISITANI S, 1993, J EXP MED, V178, P1247, DOI 10.1084/jem.178.4.1247; NUNEZ G, 1991, NATURE, V353, P71, DOI 10.1038/353071a0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; PEZZELLA F, 1990, AM J PATHOL, V137, P225; PULENDRAN B, 1994, P NATL ACAD SCI USA, V91, P2639, DOI 10.1073/pnas.91.7.2639; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SIEGEL RM, 1992, P NATL ACAD SCI USA, V89, P7003, DOI 10.1073/pnas.89.15.7003; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, P NATL ACAD SCI USA, V91, P1376, DOI 10.1073/pnas.91.4.1376; TAO W, 1994, J EXP MED, V179, P145, DOI 10.1084/jem.179.1.145; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681	50	116	116	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1994	1	9					803	813		10.1016/S1074-7613(94)80022-7	http://dx.doi.org/10.1016/S1074-7613(94)80022-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX648	7895168				2022-12-18	WOS:A1994PX64800010
J	Lauterbach, MA; Hanke, JE; Serefidou, M; Mangan, MSJ; Kolbe, CC; Hess, T; Rothe, M; Kaiser, R; Hoss, F; Gehlen, J; Engels, G; Kreutzenbeck, M; Schmidt, SV; Christ, A; Imhof, A; Hiller, K; Latz, E				Lauterbach, Mario A.; Hanke, Jasmin E.; Serefidou, Magdalini; Mangan, Matthew S. J.; Kolbe, Carl-Christian; Hess, Timo; Rothe, Maximilian; Kaiser, Romina; Hoss, Florian; Gehlen, Jan; Engels, Gudrun; Kreutzenbeck, Maike; Schmidt, Susanne V.; Christ, Anette; Imhof, Axel; Hiller, Karsten; Latz, Eicke			Toll-like Receptor Signaling Rewires Macrophage Metabolism and Promotes Histone Acetylation via ATP-Citrate Lyase	IMMUNITY			English	Article							GENE-EXPRESSION; SUCCINATE-DEHYDROGENASE; CELLULAR-METABOLISM; CHROMATIN; IMMUNITY; TRANSCRIPTION; INNATE; PHOSPHORYLATION; ACTIVATION; INHIBITION	Toll-like receptor (TLR) activation induces inflammatory responses in macrophages by activating temporally defined transcriptional cascades. Whether concurrent changes in the cellular metabolism that occur upon TLR activation influence the quality of the transcriptional responses remains unknown. Here, we investigated how macrophages adopt their metabolism early after activation to regulate TLR-inducible gene induction. Shortly after TLR4 activation, macrophages increased glycolysis and tricarboxylic acid (TCA) cycle volume. Metabolic tracing studies revealed that TLR signaling redirected metabolic fluxes to generate acetyl-Coenzyme A (CoA) from glucose resulting in augmented histone acetylation. Signaling through the adaptor proteins MyD88 and TRIF resulted in activation of ATP-citrate lyase, which in turn facilitated the induction of distinct LPS-inducible gene sets. We postulate that metabolic licensing of histone acetylation provides another layer of control that serves to fine-tune transcriptional responses downstream of TLR activation. Our work highlights the potential of targeting the metabolic-epigenetic axis in inflammatory settings.	[Lauterbach, Mario A.; Mangan, Matthew S. J.; Kolbe, Carl-Christian; Rothe, Maximilian; Kaiser, Romina; Hoss, Florian; Engels, Gudrun; Kreutzenbeck, Maike; Schmidt, Susanne V.; Christ, Anette; Latz, Eicke] Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Hanke, Jasmin E.; Hiller, Karsten] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Integrated Ctr Syst Biol BRICS, Dept Bioinformat & Biochem, Braunschweig, Germany; [Serefidou, Magdalini; Imhof, Axel] Ludwig Maximilians Univ Munchen, Fac Med, BioMed Ctr, Inst Mol Biol, Grosshadernerstr 9, D-82152 Martinsried, Germany; [Mangan, Matthew S. J.; Kaiser, Romina; Latz, Eicke] German Ctr Neurodegenerat Dis, D-53127 Bonn, Germany; [Hess, Timo; Gehlen, Jan] Univ Marburg, Ctr Human Genet, Marburg, Germany; [Hess, Timo; Gehlen, Jan] Univ Bonn, Inst Human Genet, Bonn, Germany; [Christ, Anette; Latz, Eicke] UMass Med Sch, Dept Infect Dis & Immunol, Worcester, MA 01605 USA; [Imhof, Axel] Ludwig Maximilians Univ Munchen, Fac Med, BioMed Ctr, Prot Anal Unit, Grosshadernerstr 9, D-82152 Martinsried, Germany; [Hiller, Karsten] Helmholtz Ctr Infect Res, Computat Biol Infect Res, Braunschweig, Germany; [Latz, Eicke] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway	University of Bonn; Braunschweig University of Technology; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Philipps University Marburg; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; University of Munich; Helmholtz Association; Helmholtz-Center for Infection Research; Norwegian University of Science & Technology (NTNU)	Latz, E (corresponding author), Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, D-53127 Bonn, Germany.; Latz, E (corresponding author), German Ctr Neurodegenerat Dis, D-53127 Bonn, Germany.; Latz, E (corresponding author), UMass Med Sch, Dept Infect Dis & Immunol, Worcester, MA 01605 USA.; Latz, E (corresponding author), Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway.	eicke.latz@uni-bonn.de	Imhof, Axel/AAU-5313-2021; Schmidt, Susanne/AAU-6827-2021; Latz, Eicke/H-3951-2014	Imhof, Axel/0000-0003-2993-8249; Hiller, Karsten/0000-0001-9322-5820; Hoss, Florian/0000-0002-9231-5848; Hess, Timo/0000-0003-2778-4274; Latz, Eicke/0000-0003-1488-5666	Deutsche Forschungsgesellschaft [DFG SFB 645, DFG SFB 670, DFG SFB 1123, TRR 83, TRR 57, EXC2151 - 390873048]; NIH [1R01HL112661]; Federal State of Lower Saxony, Niedersachsisches Vorab CDInfect project; University of Bonn (BONFOR grant) [2018-2-02]; European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant) [675610]; ERC Consolidator grant (InflammAct)	Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Federal State of Lower Saxony, Niedersachsisches Vorab CDInfect project; University of Bonn (BONFOR grant); European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant); ERC Consolidator grant (InflammAct)	We thank E. Pearce and A. Cameron at Max Planck Institute of Immunobiology and Epigenetics in Freiburg for their advice and discussion. RNA sequencing was performed at the NGS core facility University Hospitals Bonn, and we thank Kerstin Ludwig and Andre Heimbach for support. W. Barchet and P. Muller are thanked for providing TRIF-deficient mice. Funding was provided by grants from the Deutsche Forschungsgesellschaft (DFG SFBs 645, 670, 1123; TRRs 83, 57 and under Germany's Excellence Strategy - EXC2151 - 390873048), a grant from NIH (1R01HL112661), the Federal State of Lower Saxony, Niedersachsisches Vorab CDInfect project, the University of Bonn (BONFOR grant 2018-2-02), the European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant agreement no. 675610), and an ERC Consolidator grant (InflammAct).	Andrews S., 2010, FASTQC QUALITY CONTR; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cameron AM, 2019, NAT IMMUNOL, V20, P420, DOI 10.1038/s41590-019-0336-y; CHESTIER A, 1979, P NATL ACAD SCI USA, V76, P46, DOI 10.1073/pnas.76.1.46; Conaway EA, 2017, J IMMUNOL, V198, P2906, DOI 10.4049/jimmunol.1601781; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Fan J, 2015, ACS CHEM BIOL, V10, P95, DOI 10.1021/cb500846u; Feller C, 2015, MOL CELL, V57, P559, DOI 10.1016/j.molcel.2014.12.008; Ference BA, 2019, NEW ENGL J MED, V380, P1033, DOI 10.1056/NEJMoa1806747; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Infantino V, 2013, BIOCHEM BIOPH RES CO, V440, P105, DOI 10.1016/j.bbrc.2013.09.037; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jung J, 2019, NAT CELL BIOL, V21, P85, DOI 10.1038/s41556-018-0217-x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Langston PK, 2019, NAT IMMUNOL, V20, P1186, DOI 10.1038/s41590-019-0453-7; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liaudet L, 2002, AM J RESP CRIT CARE, V165, P372, DOI 10.1164/ajrccm.165.3.2106050; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Meiser J, 2016, J BIOL CHEM, V291, P3932, DOI 10.1074/jbc.M115.676817; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3; Nonnenmacher Y, 2018, CELL MOL LIFE SCI, V75, P2093, DOI 10.1007/s00018-018-2784-1; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Peleg S, 2016, TRENDS BIOCHEM SCI, V41, P700, DOI 10.1016/j.tibs.2016.05.008; Pfleger J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.202; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Potapova IA, 2000, BIOCHEMISTRY-US, V39, P1169, DOI 10.1021/bi992159y; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Ronowska A, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00169; Sapcariu SC, 2014, METHODSX, V1, P74, DOI 10.1016/j.mex.2014.07.002; Schmidt FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121971; Sheikh BN, 2019, NAT REV GENET, V20, P7, DOI 10.1038/s41576-018-0072-4; Stutz A, 2017, J EXP MED, V214, P1725, DOI 10.1084/jem.20160933; Suarez-Alvarez K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/967067; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tong AJ, 2016, CELL, V165, P165, DOI 10.1016/j.cell.2016.01.020; van Galen P, 2016, MOL CELL, V61, P170, DOI 10.1016/j.molcel.2015.11.003; Volker-Albert Moritz Carl, 2018, Curr Protoc Protein Sci, V92, pe54, DOI 10.1002/cpps.54; Vysochan A, 2017, P NATL ACAD SCI USA, V114, pE1528, DOI 10.1073/pnas.1614268114; Wegner M, 2008, CYTOKINE, V42, P312, DOI 10.1016/j.cyto.2008.02.014; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Williams NC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00141; Winkler G, 1998, DIABETOLOGIA, V41, P488, DOI 10.1007/s001250050935; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06	63	115	117	4	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					997	+		10.1016/j.immuni.2019.11.009	http://dx.doi.org/10.1016/j.immuni.2019.11.009			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31851905	Bronze			2022-12-18	WOS:000503162900008
J	Zhao, F; Xiao, C; Evans, KS; Theivanthiran, T; DeVito, N; Holtzhausen, A; Liu, J; Liu, XJ; Boczkowski, D; Nair, S; Locasale, JW; Hanks, BA				Zhao, Fei; Xiao, Christine; Evans, Kathy S.; Theivanthiran, Tbalamayooran; DeVito, Nicholas; Holtzhausen, Alisha; Liu, Juan; Liu, Xiaojing; Boczkowski, David; Nair, Smita; Locasale, Jason W.; Hanks, Brent A.			Paracrine Wnt5a-beta-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization	IMMUNITY			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; BETA-CATENIN; PHENOTYPE; ACID; ACTIVATION; INHIBITION; EXPRESSION; TOLERANCE; RESPONSES; PATHWAY	Despite recent advances, many cancers remain refractory to available immunotherapeutic strategies. Emerging evidence indicates that the tolerization of local dendritic cells (DCs) within the tumor micro-environment promotes immune evasion. Here, we have described a mechanism by which melanomas establish a site of immune privilege via a paracrine Wnt5a-beta-catenin-peroxisome proliferator-activated receptor-gamma (PPAR-gamma) signaling pathway that drives fatty acid oxidation (FAO) in DCs by upregulating the expression of the carnitine palmitoyltransferase-1A (CPT1A) fatty acid transporter. This FAO shift increased the protoporphyrin IX prosthetic group of indoleamine 2,3-dioxgenase-1 (IDO) while suppressing interleukin(IL)-6 and IL-12 cytokine expression, culminating in enhanced IDO activity and the generation of regulatory T cells. We demonstrated that blockade of this pathway augmented anti-melanoma immunity, enhanced the activity of anti-PD-1 antibody immunotherapy, and suppressed disease progression in a transgenic melanoma model. This work implicates a role for tumor-mediated metabolic reprogramming of local DCs in immune evasion and immunotherapy resistance.	[Zhao, Fei; Xiao, Christine; Evans, Kathy S.; Theivanthiran, Tbalamayooran; DeVito, Nicholas; Hanks, Brent A.] Duke Canc Inst, Div Med Oncol, Dept Med, Durham, NC 27710 USA; [Boczkowski, David; Nair, Smita] Duke Canc Inst, Div Surg Sci, Dept Surg, Durham, NC 27710 USA; [Liu, Juan; Liu, Xiaojing; Locasale, Jason W.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Holtzhausen, Alisha] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hanks, BA (corresponding author), Duke Canc Inst, Div Med Oncol, Dept Med, Durham, NC 27710 USA.	brent.hanks@duke.edu	Locasale, Jason W/ABE-6505-2020; Hanks, Brent A./V-3835-2019; Zhao, Fei/D-1857-2014; Nair, Smita/GYR-2993-2022; Holtzhausen, Alisha/AAR-3606-2021; DeVito, Nicholas/M-6810-2016	Locasale, Jason W/0000-0002-7766-3502; Hanks, Brent A./0000-0002-2803-3272; Zhao, Fei/0000-0002-2149-1457; Nair, Smita/0000-0001-5615-7056; Holtzhausen, Alisha/0000-0003-3604-7401; Liu, Xiaojing/0000-0002-4231-6017; DeVito, Nicholas/0000-0001-7537-8647	Duke Cancer Institute; National Cancer Institute of the National Institutes of Health [1K08CA191063-01A1]; NATIONAL CANCER INSTITUTE [K08CA191063, R00CA168997] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018164] Funding Source: NIH RePORTER	Duke Cancer Institute; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Dr. Ciriana Orabona (University of Perugia) for assistance with the kynurenine HPLC assay and Dr. Jeff Rathmell (Vanderbilt University) for his assistance with the preparation of the manuscript. B.A.H. is supported by start-up funding from the Duke Cancer Institute and the National Cancer Institute of the National Institutes of Health (1K08CA191063-01A1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; COLLIER GR, 1993, HORM METAB RES, V25, P9, DOI 10.1055/s-2007-1002035; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Hanks BA, 2013, J CLIN INVEST, V123, P3925, DOI 10.1172/JCI65745; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Holtzhausen A, 2015, CANCER IMMUNOL RES, V3, P1082, DOI 10.1158/2326-6066.CIR-14-0167; Hossain F, 2015, CANCER IMMUNOL RES, V3, P1236, DOI 10.1158/2326-6066.CIR-15-0036; Hryhorenko EA, 1998, PHOTOCHEM PHOTOBIOL, V67, P565, DOI 10.1562/0031-8655(1998)067<0565:COEPII>2.3.CO;2; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Luke JJ, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3004; Malinarich F, 2015, J IMMUNOL, V194, P5174, DOI 10.4049/jimmunol.1303316; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Mullard A., 2015, NAT REV DRUG DISCOV, V14, P373; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Nair S., 2012, CURRENT PROTOCOLS IM; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Oderup C, 2013, J IMMUNOL, V190, P6126, DOI 10.4049/jimmunol.1203002; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; PESCE MA, 1975, CLIN CHEM, V21, P1932; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shen ZH, 1997, J IMMUNOL, V158, P2723; Sherwood V, 2014, CARCINOGENESIS, V35, P784, DOI 10.1093/carcin/bgt390; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Sweis RF, 2016, CANCER IMMUNOL RES, V4, P563, DOI 10.1158/2326-6066.CIR-15-0274; Thomas SR, 2001, J IMMUNOL, V166, P6332, DOI 10.4049/jimmunol.166.10.6332; Wheatcraft DRA, 2014, JOVE-J VIS EXP, DOI 10.3791/52313; Zhao FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099657; Zhao F, 2015, J APPL TOXICOL, V35, P945, DOI 10.1002/jat.3094	45	115	120	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					147	+		10.1016/j.immuni.2017.12.004	http://dx.doi.org/10.1016/j.immuni.2017.12.004			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343435	Green Accepted, Bronze			2022-12-18	WOS:000422751600017
J	Phan, AT; Doedens, AL; Palazon, A; Tyrakis, PA; Cheung, KP; Johnson, RS; Goldrath, AW				Phan, Anthony T.; Doedens, Andrew L.; Palazon, Asis; Tyrakis, Petros A.; Cheung, Kitty P.; Johnson, Randall S.; Goldrath, Ananda W.			Constitutive Glycolytic Metabolism Supports CD8(+) T Cell Effector Memory Differentiation during Viral Infection	IMMUNITY			English	Article							HYPOXIA-INDUCIBLE FACTORS; RESPONSES; PROMOTES; FOXO1; EXPRESSION; IMMUNITY; ADAPTATION; ACTIVATION; FACTOR-1; ANTIGEN	Extensive metabolic changes accompany T cell activation, including a switch to glycolytic energy production and increased biosynthesis. Recent studies suggest that subsequent return to reliance on oxidative phosphorylation and increasing spare respiratory capacity are essential for the differentiation of memory CD8(+) T cells. In contrast, we found that constitutive glycolytic metabolism and suppression of oxidative phosphorylation in CD8(+) T cells, achieved by conditional deletion of hypoxia-inducible factor regulator Vhl, accelerated CD8(+) memory cell differentiation during viral infection. Despite sustained glycolysis, CD8(+) memory cells emerged that upregulated key memory-associated cytokine receptors and transcription factors and showed a heightened response to secondary challenge. In addition, increased glycolysis not only permitted memory formation, but it also favored the formation of long-lived effector-memory CD8(+) T cells. These data redefine the role of cellular metabolism in memory cell differentiation, showing that reliance on glycolytic metabolism does not hinder formation of a protective memory population.	[Phan, Anthony T.; Doedens, Andrew L.; Cheung, Kitty P.; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Palazon, Asis; Tyrakis, Petros A.; Johnson, Randall S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2, England; [Johnson, Randall S.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	University of California System; University of California San Diego; University of Cambridge; Karolinska Institutet	Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	agoldrath@ucsd.edu	Johnson, Randall/AAM-1189-2021; Palazon, Asis/ABI-1748-2020	Johnson, Randall/0000-0002-4084-6639; Palazon, Asis/0000-0002-7172-7229; Tyrakis, Petros Andreas/0000-0003-3281-2153; Goldrath, Ananda/0000-0002-5900-508X; Phan, Anthony/0000-0003-2935-6070; Doedens, Andrew/0000-0003-2461-3496	UCSD NIH Cell and Molecular Genetics Training Grant [5T32GM007240-36]; US NIH; NIH [A1096852, A1072117]; Leukemia and Lymphoma Society; Pew Scholars Fund; UCSD CancerBiology Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072117, R01AI096852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	UCSD NIH Cell and Molecular Genetics Training Grant; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Pew Scholars Fund; UCSD CancerBiology Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding of this work provided by UCSD NIH Cell and Molecular Genetics Training Grant (5T32GM007240-36) for A.T.P., the US NIH and UCSD CancerBiology Fund for A.L.D., the NIH (A1096852, A1072117), the Leukemia and Lymphoma Society, and Pew Scholars Fund for A.W.G. We thank J.J. Milner, J.T. Chang, S. Hedrick, and Goldrath lab members for critical discussions and review of the manuscript; B. Yu for assistance with bioinformatics analysis and critical discussions; and J.V. Nguyen and K.T. Brannan for technical assistance.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chaoul N, 2015, CANCER RES, V75, P3279, DOI 10.1158/0008-5472.CAN-15-0454; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Kucejova B, 2011, MOL CANCER RES, V9, P1255, DOI 10.1158/1541-7786.MCR-11-0302; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Okoye I, 2015, SCIENCE, V348, P995, DOI 10.1126/science.aaa7516; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Pearce E. L., 2013, SCIENCE, V342; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Phan AT, 2015, MOL IMMUNOL, V68, P527, DOI 10.1016/j.molimm.2015.08.004; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shrestha S, 2014, P NATL ACAD SCI USA, V111, P14858, DOI 10.1073/pnas.1404264111; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725	42	115	120	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1024	1037		10.1016/j.immuni.2016.10.017	http://dx.doi.org/10.1016/j.immuni.2016.10.017			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27836431	Green Accepted, Bronze			2022-12-18	WOS:000389473500014
J	Ballesteros-Tato, A; Randall, TD; Lund, FE; Spolski, R; Leonard, WJ; Leon, B				Ballesteros-Tato, Andre; Randall, Troy D.; Lund, Frances E.; Spolski, Rosanne; Leonard, Warren J.; Leon, Beatriz			T Follicular Helper Cell Plasticity Shapes Pathogenic T Helper 2 Cell-Mediated Immunity to Inhaled House Dust Mite	IMMUNITY			English	Article							DENDRITIC CELLS; B-CELLS; TYPE-2 IMMUNITY; IN-VIVO; DIFFERENTIATION; INDUCTION; ALLERGEN; ANTIGEN; ASTHMA; INFLAMMATION	Exposure to environmental antigens, such as house dust mite (HDM), often leads to T helper 2 (Th2) cell-driven allergic responses. However, the mechanisms underlying the development of these responses are incompletely understood. We found that the initial exposure to HDM did not lead to Th2 cell development but instead promoted the formation of interleukin-4 (IL-4)-committed T follicular helper (Tfh) cells. Following challenge exposure to HDM, Tfh cells differentiated into IL-4 and IL-13 double-producing Th2 cells that accumulated in the lung and recruited eosinophils. B cells were required to expand IL-4-committed Tfh cells during the sensitization phase, but did not directly contribute to disease. Impairment of Tfh cell responses during the sensitization phase or Tfh cell depletion prevented Th2 cell-mediated responses following challenge. Thus, our data demonstrate that Tfh cells are precursors of HDM-specific Th2 cells and reveal an unexpected role of B cells and Tfh cells in the pathogenesis of allergic asthma.	[Ballesteros-Tato, Andre; Randall, Troy D.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Lund, Frances E.; Leon, Beatriz] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Spolski, Rosanne; Leonard, Warren J.] NHLBI, Lab Mol Immunol, Bldg 10, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Leon, B (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	bleon@uab.edu	Leonard, Warren/AAA-1397-2022	Ballesteros-Tato, Andre/0000-0002-4833-593X	National Institutes of Health [1R01 AI116584, 1R01 AI110480, 1R01 AI104725, U19 AI109962]; Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; UAB; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104725, P30AI027767, R01AI110480, R01AI116584, U19AI109962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UAB; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors would like to thank Uma Mudunuru and Thomas S. Simpler for animal husbandry. This work was supported by UAB and National Institutes of Health grants 1R01 AI116584 to B.L., 1R01 AI110480 to A.B.-T., 1R01 AI104725 to F.E.L., and U19 AI109962 to T.D.R. and Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH.	Ballesteros-Tato A, 2014, IMMUNOL CELL BIOL, V92, P22, DOI 10.1038/icb.2013.62; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Coquet JM, 2015, IMMUNITY, V43, P318, DOI 10.1016/j.immuni.2015.07.015; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gelfand EW, 2004, J IMMUNOL, V173, P1298, DOI 10.4049/jimmunol.173.2.1298; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Lambrecht BN, 2013, EUR J IMMUNOL, V43, P3125, DOI 10.1002/eji.201343730; Lane P, 2000, J EXP MED, V191, P201, DOI 10.1084/jem.191.2.201; Leon B, 2014, J IMMUNOL, V193, P1531, DOI 10.4049/jimmunol.1400149; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Lindell DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003129; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; van Helden MJ, 2013, CURR OPIN IMMUNOL, V25, P745, DOI 10.1016/j.coi.2013.10.002; Wang L, 2011, P NATL ACAD SCI USA, V108, P9542, DOI 10.1073/pnas.1018182108	30	115	118	2	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					259	273		10.1016/j.immuni.2015.11.017	http://dx.doi.org/10.1016/j.immuni.2015.11.017			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26825674	Bronze, Green Accepted			2022-12-18	WOS:000370294000010
J	Cronk, JC; Derecki, NC; Ji, E; Xu, Y; Lampano, AE; Smirnov, I; Baker, W; Norris, GT; Marin, I; Coddington, N; Wolf, Y; Turner, SD; Aderem, A; Klibanov, AL; Harris, TH; Jung, S; Litvak, V; Kipnis, J				Cronk, James C.; Derecki, Noel C.; Ji, Emily; Xu, Yang; Lampano, Aaron E.; Smirnov, Igor; Baker, Wendy; Norris, Geoffrey T.; Marin, Ioana; Coddington, Nathan; Wolf, Yochai; Turner, Stephen D.; Aderem, Alan; Klibanov, Alexander L.; Harris, Tajie H.; Jung, Steffen; Litvak, Vladimir; Kipnis, Jonathan			Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli	IMMUNITY			English	Article							TISSUE-RESIDENT MACROPHAGES; RETT-SYNDROME; MOUSE MODEL; MECP2; MONOCYTES; CELLS; MATURATION; MUTATIONS; SYMPTOMS; PATHWAYS	Mutations in MECP2, encoding the epigenetic regulator methyl-CpG-binding protein 2, are the predominant cause of Rett syndrome, a disease characterized by both neurological symptoms and systemic abnormalities. Microglial dysfunction is thought to contribute to disease pathogenesis, and here we found microglia become activated and subsequently lost with disease progression in Mecp2-null mice. Mecp2 was found to be expressed in peripheral macrophage and monocyte populations, several of which also became depleted in Mecp2-null mice. RNA-seq revealed increased expression of glucocorticoid- and hypoxia-induced transcripts in Mecp2-deficient microglia and peritoneal macrophages. Furthermore, Mecp2 was found to regulate inflammatory gene transcription in response to TNF stimulation. Postnatal re-expression of Mecp2 using Cx3cr1(creER) increased the lifespan of otherwise Mecp2-null mice. These data suggest that Mecp2 regulates microglia and macrophage responsiveness to environmental stimuli to promote homeostasis. Dysfunction of tissue-resident macrophages might contribute to the systemic pathologies observed in Rett syndrome.	[Cronk, James C.; Derecki, Noel C.; Ji, Emily; Smirnov, Igor; Baker, Wendy; Norris, Geoffrey T.; Marin, Ioana; Coddington, Nathan; Harris, Tajie H.; Kipnis, Jonathan] Univ Virginia, Sch Med, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA; [Cronk, James C.; Derecki, Noel C.; Ji, Emily; Smirnov, Igor; Baker, Wendy; Norris, Geoffrey T.; Marin, Ioana; Coddington, Nathan; Harris, Tajie H.; Kipnis, Jonathan] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; [Cronk, James C.; Derecki, Noel C.; Norris, Geoffrey T.; Marin, Ioana; Harris, Tajie H.; Kipnis, Jonathan] Univ Virginia, Sch Med, Grad Program Neurosci, Charlottesville, VA 22908 USA; [Cronk, James C.; Kipnis, Jonathan] Univ Virginia, Sch Med, Med Scientist Training Program, Charlottesville, VA 22908 USA; [Klibanov, Alexander L.] Univ Virginia, Sch Med, Dept Internal Med, Cardiovasc Res Ctr,Cardiovasc Div, Charlottesville, VA 22908 USA; [Turner, Stephen D.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Klibanov, Alexander L.] Univ Virginia, Sch Med, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Litvak, Vladimir] Univ Massachusetts, Dept Microbiol & Physiol Syst, Sch Med, Worcester, MA 01655 USA; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Massachusetts System; University of Massachusetts Worcester; Weizmann Institute of Science; Center for Infectious Disease Research	Litvak, V (corresponding author), Univ Massachusetts, Dept Microbiol & Physiol Syst, Sch Med, Worcester, MA 01655 USA.	vladimir.litvak@umassmed.edu; kipnis@virginia.edu	Turner, Stephen/GXM-4654-2022; Jung, Steffen/K-1409-2012; Kipnis, Jonathan/AGG-9735-2022	Jung, Steffen/0000-0003-4290-5716; Kipnis, Jonathan/0000-0002-3714-517X; Wolf, Yochai/0000-0003-0270-2025; Turner, Stephen/0000-0001-9140-9028; Harris, Tajie/0000-0002-1355-2109	Hartwell Foundation; National Institute of Allergy and Infectious Diseases [1F30AI109984]; National Institutes of Neurological Disorders and Stroke [NS081026]; Simons Foundation Autism Research Initiative; Rett Syndrome Research Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, F30AI109984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081026] Funding Source: NIH RePORTER	Hartwell Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation Autism Research Initiative; Rett Syndrome Research Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Shirley Smith for editorial assistance and Dr. Alex Koeppel (Bioinformatics Core, School of Medicine, University of Virginia) for his initial analysis of RNA-seq data. We thank Dr. Arthur Mercurio and Bryan Pursell (Department of Molecular, Cell and Cancer Biology, UMass Medical School) for their help with hypoxia experiments. We thank the members of the Kipnis laboratory, as well as the members of the Center for Brain Immunology and Glia (BIG) for their valuable comments during multiple discussions of this work. N.C.D. was supported by Hartwell Foundation post-doctoral fellowship. J.C.C. was supported by an award from the National Institute of Allergy and Infectious Diseases 1F30AI109984. This work was primarily supported by a grant from the National Institutes of Neurological Disorders and Stroke NS081026 (J.K.), the Simons Foundation Autism Research Initiative (J.K.), and from the Rett Syndrome Research Trust (J.K.).	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011; Braun S, 2012, HUM MOL GENET, V21, P1673, DOI 10.1093/hmg/ddr602; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Dunn HG, 2001, CAN J NEUROL SCI, V28, P16; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gow DJ, 2010, J LEUKOCYTE BIOL, V88, P475, DOI 10.1189/jlb.0310158; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Khwaja OS, 2014, P NATL ACAD SCI USA, V111, P4596, DOI 10.1073/pnas.1311141111; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Koelsch KA, 2013, J AUTOIMMUN, V41, P168, DOI 10.1016/j.jaut.2012.12.012; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Nguyen MVC, 2013, J NEUROSCI, V33, P18764, DOI 10.1523/JNEUROSCI.2657-13.2013; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Urdinguio RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003669; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wheeler MA, 2014, NEURON, V82, P587, DOI 10.1016/j.neuron.2014.04.009; Yasui DH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-3; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001	44	115	121	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					679	691		10.1016/j.immuni.2015.03.013	http://dx.doi.org/10.1016/j.immuni.2015.03.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902482	Bronze, Green Accepted			2022-12-18	WOS:000353347500014
J	Zhang, YB; Lu, Y; Ma, L; Cao, XD; Xiao, J; Chen, JX; Jiao, SZ; Gao, YZ; Liu, C; Duan, ZJ; Li, DS; He, YL; Wei, B; Wang, HY				Zhang, Yanbo; Lu, Yao; Ma, Li; Cao, Xudong; Xiao, Jun; Chen, Jiexia; Jiao, Shaozhuo; Gao, Yunzhen; Liu, Chang; Duan, Zhaojun; Li, Dangsheng; He, Yulong; Wei, Bin; Wang, Hongyan			Activation of Vascular Endothelial Growth Factor Receptor-3 in Macrophages Restrains TLR4-NF-kappa B Signaling and Protects against Endotoxin Shock	IMMUNITY			English	Article							PHOSPHOINOSITIDE 3-KINASE P110-DELTA; NEGATIVE REGULATION; LYMPHATIC VESSELS; FOXP3 EXPRESSION; SEVERE SEPSIS; CUTTING EDGE; CELLS; LYMPHANGIOGENESIS; ANGIOGENESIS; VEGF	Toll-like receptors (TLRs) are critical in mediating innate immune responses against infections. However, uncontrolled TLR-triggered inflammation is associated with endotoxin shock. To better understand the homeostatic mechanisms induced by TLR4 signaling, we screened a group of key cytokines, chemokines, growth factors, and their receptors for bacteria-or LPS-induced expression. The surface vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C were upregulated in macrophages. VEGFR-3 ligation by VEGF-C significantly attenuated proinflammatory cytokine production. Notably, ablation of the ligand-binding domain or tyrosine kinase activity of VEGFR-3 rendered mice more sensitive to septic shock. VEGFR-3 restrained TLR4-NF-kappa B activation by regulating the PI3-kinase-Akt signaling pathway and SOCS1 expression. Aside from targeting lymphatic vessels, we suggest a key role of VEGFR-3 on macrophages to prevent infections that is complicated with lymphoedema. Thus, VEGFR-3-VEGF-C signaling represents a "self-control" mechanism during antibacterial innate immunity.	[Zhang, Yanbo; Lu, Yao; Ma, Li; Xiao, Jun; Jiao, Shaozhuo; Gao, Yunzhen; Liu, Chang; Wei, Bin; Wang, Hongyan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Cao, Xudong; He, Yulong] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China; [Chen, Jiexia] Anhui Med Univ, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China; [Duan, Zhaojun] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Li, Dangsheng] Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wang, Hongyan] Chinese Acad Sci, Shanghai Clin Ctr, Xu Hui Cent Hosp, Canc Res Ctr, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Soochow University - China; Anhui Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wei, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.	binweiwhy@gmail.com; hongyanwang@sibcb.ac.cn	Zhang, Yanbo/B-3047-2011; , 肖俊/AAO-9118-2020	Zhang, Yanbo/0000-0002-6201-7970; HE, YULONG/0000-0002-0099-3749; Jiao, Shaozhuo/0000-0003-1514-7200	Ministry of Science and Technology of China [2012CB910800]; National Natural Science Foundation of China [31070778, 31370859, 31300723, 30671038]; Shanghai Pujiang Program [11PJ1410700]; Instrument Developing Project of the Chinese Academy of Sciences [YZ201339]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Instrument Developing Project of the Chinese Academy of Sciences; Priority Academic Program Development of Jiangsu Higher Education Institutions	We are grateful to S. Sun (MD Anderson Cancer Center) and D. Altmann (Imperial College London) for critical reading of the manuscript. We thank Q. Leng, (SIBS, CAS) for helping with animal infection studies. B. Sun and B. Ge (SIBS, CAS), Z. Yang (Nanjing University), X. Cao (SMMU, Shanghai), and X. Zhang (Lehigh University) for providing reagents. This work was supported by the Ministry of Science and Technology of China (2012CB910800), National Natural Science Foundation of China (31070778; 31370859; 31300723; 30671038), Shanghai Pujiang Program (11PJ1410700), Instrument Developing Project of the Chinese Academy of Sciences (YZ201339), and Priority Academic Program Development of Jiangsu Higher Education Institutions for Y.H.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Burke JE, 2011, STRUCTURE, V19, P1127, DOI 10.1016/j.str.2011.06.003; Ding A., 2006, TRENDS IMMUNOL, V7, P375; Dixelius J, 2003, J BIOL CHEM, V278, P40973, DOI 10.1074/jbc.M304499200; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Evel-Kabler K, 2006, J CLIN INVEST, V116, P90, DOI 10.1172/JCI26169; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Harrison C, 2010, NAT REV DRUG DISCOV, V9, P360, DOI 10.1038/nrd3162; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Karkkainen MJ, 2000, ONCOGENE, V19, P5598, DOI 10.1038/sj.onc.1203855; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Keck S, 2010, J IMMUNOL, V184, P5809, DOI 10.4049/jimmunol.0901423; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kirkin V, 2004, INT J CANCER, V112, P986, DOI 10.1002/ijc.20509; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kukk E, 1996, DEVELOPMENT, V122, P3829; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Tidswell M, 2010, CRIT CARE MED, V38, P72, DOI 10.1097/CCM.0b013e3181b07b78; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Williams DL, 2003, CRIT CARE MED, V31, P1808, DOI 10.1097/01.CCM.0000069343.27691.F3; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Zhang LQ, 2010, CELL RES, V20, P1319, DOI 10.1038/cr.2010.116	50	115	124	2	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					501	514		10.1016/j.immuni.2014.01.013	http://dx.doi.org/10.1016/j.immuni.2014.01.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24656836	Bronze			2022-12-18	WOS:000334849400009
J	Moseman, EA; Iannacone, M; Bosurgi, L; Tonti, E; Chevrier, N; Tumanov, A; Fu, YX; Hacohen, N; von Andrian, UH				Moseman, E. Ashley; Iannacone, Matteo; Bosurgi, Lidia; Tonti, Elena; Chevrier, Nicolas; Tumanov, Alexei; Fu, Yang-Xin; Hacohen, Nir; von Andrian, Ulrich H.			B Cell Maintenance of Subcapsular Sinus Macrophages Protects against a Fatal Viral Infection Independent of Adaptive Immunity	IMMUNITY			English	Article							SIMULIUM-VITTATUM DIPTERA; BETA LT-BETA; LYMPH-NODE; VIRUS GLYCOPROTEIN; T-CELLS; ANTIBODY-RESPONSES; LYMPHOTOXIN; MICE; ANTIGEN; TRANSMISSION	Neutralizing antibodies have been thought to be required for protection against acutely cytopathic viruses, such as the neurotropic vesicular stomatitis virus (VSV). Utilizing mice that possess B cells but lack antibodies, we show here that survival upon subcutaneous (s.c.) VSV challenge was independent of neutralizing antibody production or cell-mediated adaptive immunity. However, B cells were absolutely required to provide lymphotoxin (LT) alpha 1 beta 2, which maintained a protective subcapsular sinus (SCS) macrophage phenotype within virus draining lymph nodes (LNs). Macrophages within the SCS of B cell-deficient LNs, or of mice that lack LT alpha 1 beta 2 selectively in B cells, displayed an aberrant phenotype, failed to replicate VSV, and therefore did not produce type I interferons, which were required to prevent fatal VSV invasion of intranodal nerves. Thus, although B cells are essential for survival during VSV infection, their contribution involves the provision of innate differentiation and maintenance signals to macrophages, rather than adaptive immune mechanisms.	[Moseman, E. Ashley; Iannacone, Matteo; Bosurgi, Lidia; Tonti, Elena; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & lmmunobiol, Immune Dis Inst, Boston, MA 02115 USA; [Moseman, E. Ashley; Iannacone, Matteo; Bosurgi, Lidia; Tonti, Elena; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & lmmunobiol, Div Immunol, Boston, MA 02115 USA; [Iannacone, Matteo; Tonti, Elena] Ist Sci San Raffaele, Div Immunol Infect Dis & Transplantat, I-20132 Milan, Italy; [Bosurgi, Lidia] Univ Vita Salute San Raffaele, Milan, Italy; [Chevrier, Nicolas; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Chevrier, Nicolas; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Tumanov, Alexei] Trudeau Inst, Saranac Lake, NY 12983 USA; [Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Trudeau Institute; University of Chicago	Iannacone, M (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & lmmunobiol, Immune Dis Inst, Boston, MA 02115 USA.	matteo.iannacone@hsr.it; uva@hms.harvard.edu	Tumanov, Alexei/AAR-1607-2021; von Andrian, Ulrich H/A-5775-2008; Iannacone, Matteo/I-8507-2018	Tumanov, Alexei/0000-0001-6042-0152; Iannacone, Matteo/0000-0002-9370-2671; Bosurgi, Lidia/0000-0002-8775-4950; Tonti, Elena/0000-0001-5002-7613; fu, yang-xin/0000-0001-8441-6617	National Institutes of Health (NIH) [AI069259, AI072252, AI078897, 5T32-HL07623-20]; Giovanni Armenise-Harvard Foundation; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI069259, R01AI072252, P01AI078897] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giovanni Armenise-Harvard Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Cheng and M. Flynn for technical support; M. Perdue for secretarial assistance; K. Rajewsky for providing D<INF>H</INF>LMP2A mice; L. Martinez-Pomares for CR-Fc; S. Whelan for VSV and VSVeGFP; N. van Rooijen for clodronate liposomes; J. Browning for LT beta R-Ig; L.G. Guidotti for helpful advice; and the members of the U.H.v.A. laboratory for helpful discussion. This work was supported by the National Institutes of Health (NIH) grants AI069259, AI072252, and AI078897 (to U.H.v.A.), the Giovanni Armenise-Harvard Foundation (to M.I.), and a NIH T32 Training Grant in Hematology 5T32-HL07623-20 (to E.A.M.).	Agyekum S, 2003, J PATHOL, V199, P115, DOI 10.1002/path.1249; [Anonymous], 1988, LANCET, V1, P917; Bach P, 2007, J IMMUNOL, V178, P5839, DOI 10.4049/jimmunol.178.9.5839; BACHMANN MF, 1994, EUR J IMMUNOL, V24, P2567, DOI 10.1002/eji.1830241046; Bachmann MF, 1997, SCIENCE, V276, P2024, DOI 10.1126/science.276.5321.2024; Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Benedict CA, 2001, IMMUNITY, V15, P617, DOI 10.1016/S1074-7613(01)00222-9; Berger DP, 1999, VIROLOGY, V260, P136, DOI 10.1006/viro.1999.9811; Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; CHARAN S, 1986, J IMMUNOL, V136, P3057; Ciavarra RP, 2005, VIROLOGY, V342, P177, DOI 10.1016/j.virol.2005.07.031; DELEMARRE FGA, 1990, J LEUKOCYTE BIOL, V47, P251, DOI 10.1002/jlb.47.3.251; DELEMARRE FGA, 1990, IMMUNOBIOLOGY, V182, P70, DOI 10.1016/S0171-2985(11)80584-X; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Fava RA, 2003, J IMMUNOL, V171, P115, DOI 10.4049/jimmunol.171.1.115; FOSSUM S, 1980, SCAND J IMMUNOL, V12, P433, DOI 10.1111/j.1365-3083.1980.tb00087.x; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; GOBET R, 1988, EXP CELL BIOL, V56, P175; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Junt T, 2006, EUR J IMMUNOL, V36, P2061, DOI 10.1002/eji.200626255; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kundig TM, 1996, P NATL ACAD SCI USA, V93, P9716, DOI 10.1073/pnas.93.18.9716; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Mead DG, 1999, J MED ENTOMOL, V36, P410, DOI 10.1093/jmedent/36.4.410; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; MILLET I, 1994, J IMMUNOL, V152, P4336; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; SAINTEMARIE G, 1985, CELL TISSUE RES, V239, P31, DOI 10.1007/BF00214899; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; Shi ZC, 2011, J BIOL CHEM, V286, P4517, DOI 10.1074/jbc.M110.159590; Smith PF, 2009, J MED ENTOMOL, V46, P1537, DOI 10.1603/033.046.0643; Spahn TW, 2005, INFECT IMMUN, V73, P7077, DOI 10.1128/IAI.73.11.7077-7088.2005; STEINHOFF U, 1995, J VIROL, V69, P2153, DOI 10.1128/JVI.69.4.2153-2158.1995; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757; Trottier MD, 2005, VIROLOGY, V333, P215, DOI 10.1016/j.virol.2005.01.009; Tumanov AV, 2002, IMMUNITY, V17, P239, DOI 10.1016/S1074-7613(02)00397-7; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Yu P, 2002, J IMMUNOL, V168, P5117, DOI 10.4049/jimmunol.168.10.5117; ZINKERNAGEL RM, 1978, EXP CELL BIOL, V46, P53	56	115	116	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 23	2012	36	3					415	426		10.1016/j.immuni.2012.01.013	http://dx.doi.org/10.1016/j.immuni.2012.01.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22386268	Bronze, Green Accepted			2022-12-18	WOS:000302048400013
J	Yuseff, MI; Reversat, A; Lankar, D; Diaz, J; Fanget, I; Pierobon, P; Randrian, V; Larochette, N; Vascotto, F; Desdouets, C; Jauffred, B; Bellaiche, Y; Gasman, S; Darchen, F; Desnos, C; Lennon-Dumenil, AM				Yuseff, Maria-Isabel; Reversat, Anne; Lankar, Danielle; Diaz, Jheimmy; Fanget, Isabelle; Pierobon, Paolo; Randrian, Violaine; Larochette, Nathanael; Vascotto, Fulvia; Desdouets, Chantal; Jauffred, Bertrand; Bellaiche, Yohanns; Gasman, Stephane; Darchen, Francois; Desnos, Claire; Lennon-Dumenil, Ana-Maria			Polarized Secretion of Lysosomes at the B Cell Synapse Couples Antigen Extraction to Processing and Presentation	IMMUNITY			English	Article							IMMUNOLOGICAL-SYNAPSE; SUBCAPSULAR SINUS; MTOC POLARIZATION; RECEPTOR; ACTIVATION; PROTEINS; MYOSIN; TRAFFICKING; INITIATION; DYNAMICS	Engagement of the B cell receptor (BCR) by surface-tethered antigens (Ag) leads to formation of a synapse that promotes Ag uptake for presentation onto major histocompatibility complex class II (MHCII) molecules. We have highlighted the membrane trafficking events and associated molecular mechanisms involved in Ag extraction and processing at the B cell synapse. MHCII-containing lysosomes are recruited to the synapse where they locally undergo exocytosis, allowing synapse acidification and the extracellular release of hydrolases that promote the extraction of the immobilized Ag. Lysosome recruitment and secretion results from the polarization of the microtubule-organizing center (MTOC), which relies on the cell division cycle (Cdc42)-downstream effector, atypical protein kinase C (aPKC zeta). aPKC zeta is phosphorylated upon BCR engagement, associates to lysosomal vesicles, and is required for their polarized secretion at the B cell synapse. Regulation of B lymphocyte polarity therefore emerges as a central mechanism that couples Ag extraction to Ag processing and presentation.	[Yuseff, Maria-Isabel; Reversat, Anne; Lankar, Danielle; Diaz, Jheimmy; Pierobon, Paolo; Randrian, Violaine; Vascotto, Fulvia; Lennon-Dumenil, Ana-Maria] Inst Curie, INSERM, U932, F-75005 Paris, France; [Fanget, Isabelle; Larochette, Nathanael; Darchen, Francois; Desnos, Claire] Univ Paris 05, CNRS, UMR8192, F-75006 Paris, France; [Desdouets, Chantal] Univ Paris 05, CNRS, UMR8104, Inst Cochin, F-75014 Paris, France; [Jauffred, Bertrand; Bellaiche, Yohanns] Inst Curie, INSERM, U934, CNRS,UMR3215, F-75005 Paris, France; [Gasman, Stephane] Univ Strasbourg, CNRS, UPR3212, Inst Neurosci Cellulaires & Integrat, F-67084 Strasbourg, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Yuseff, MI (corresponding author), Inst Curie, INSERM, U932, 12 Rue Lhomond, F-75005 Paris, France.	maria-isabel.yuseff@curie.fr; ana-maria.lennon@curie.fr	Diaz, Jheimmy/AAF-6886-2019; Lennon-Dumenil, Ana-Maria/I-6716-2016; Gasman, Stephane/D-5113-2017; Pierobon, Paolo/G-7395-2014; stéphane, gasman/Q-1145-2019; Desdouets, Chantal/M-3430-2017; LAROCHETTE, Nathanael/R-4298-2017	Gasman, Stephane/0000-0001-8415-1276; stéphane, gasman/0000-0001-8415-1276; LAROCHETTE, Nathanael/0000-0002-7936-678X; Vascotto, Fulvia/0000-0002-9839-3484; Reversat, Anne/0000-0003-0666-8928	Fondation pour la Recherche Medicale [DPT20081214431]; Agence Nationale pour la Recherche [ANR-06-BLAN-0211-02, ANR-06-JCJC-0054]; City of Paris; European Research Council [209718, 243103]; Ministere Francais de la Recherche; Curie Institute; Inserm	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche(French National Research Agency (ANR)); City of Paris(Region Ile-de-France); European Research Council(European Research Council (ERC)European Commission); Ministere Francais de la Recherche(Ministry of Research, France); Curie Institute; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The authors thank H. Ploegh for providing I-A<SUP>b</SUP>beta-GFP genetically targeted mice as well as S. Amigorena, C. Hivroz, and G. Dumenil for critical reading of the manuscript. The authors greatly acknowledge the Nikon Imaging Centre at Institut Curie-CNRS, especially V. Fraisier, V. Calco (CNRS, UPR3212, INCI, Strasbourg, France), O. Leroy, and O. Renaud for technical assistance, G. Raposo for support with electron microscopy experiments, the Institut Curie animal facility, R. Basto and V. Marthiens (UMR144, Institut Curie, Paris, France) for PLK4 constructs and discussion, and M. Piel and M. Heuze for their precious help with image analysis. A.R. especially thanks F.-X. Gobert for technical support, notably in lentiviral production. M.-I.Y. especially thanks A. Sanchez-Squella for help with statistical analysis. M.-I.Y. had been supported by fellowships from the Curie Institute, Inserm and Fondation pour la Recherche Medicale. A.R. and B.J. were supported by fellowships from the Ministere Francais de la Recherche. This work was funded by grants from the Fondation pour la Recherche Medicale (help for platform creation, DPT20081214431), the Agence Nationale pour la Recherche to F.D. (ANR-06-BLAN-0211-02) and A.-M.L.-D. (ANR-06-JCJC-0054), the Young Investigator Program from the City of Paris to A.-M.L.-D., and the European Research Council to Y.B. (CePoDro 209718) and A.-M.L.-D. (Strapacemi 243103).	Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Boulanger J, 2010, IEEE T MED IMAGING, V29, P442, DOI 10.1109/TMI.2009.2033991; Brezski RJ, 2007, J IMMUNOL, V179, P4464, DOI 10.4049/jimmunol.179.7.4464; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Haka AS, 2009, MOL BIOL CELL, V20, P4932, DOI 10.1091/mbc.E09-07-0559; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; KUPFER A, 1987, J EXP MED, V165, P1565, DOI 10.1084/jem.165.6.1565; Lankar D, 2002, J EXP MED, V195, P461, DOI 10.1084/jem.20011543; Le Roux D, 2007, MOL BIOL CELL, V18, P3451, DOI 10.1091/mbc.E06-12-1114; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; Martin-Cofreces NB, 2008, J CELL BIOL, V182, P951, DOI 10.1083/jcb.200801014; Milasta S, 2005, BIOCHEM J, V387, P573, DOI 10.1042/BJ20041745; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; Moss CX, 2007, EMBO J, V26, P2137, DOI 10.1038/sj.emboj.7601660; Onabajo OO, 2008, J IMMUNOL, V180, P6685, DOI 10.4049/jimmunol.180.10.6685; Pulecio J, 2010, J EXP MED, V207, P2719, DOI 10.1084/jem.20100007; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Tolar P, 2008, IMMUNOL REV, V221, P64, DOI 10.1111/j.1600-065X.2008.00583.x; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Wubbolts R, 1999, J CELL SCI, V112, P785	44	115	117	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 23	2011	35	3					361	374		10.1016/j.immuni.2011.07.008	http://dx.doi.org/10.1016/j.immuni.2011.07.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21820334	Bronze			2022-12-18	WOS:000295748100008
J	Chen, Y; Haines, CJ; Gutcher, I; Hochweller, K; Blumenschein, WM; McClanahan, T; Hammerling, G; Li, MO; Cua, DJ; McGeachy, MJ				Chen, Yi; Haines, Christopher J.; Gutcher, Ilona; Hochweller, Kristin; Blumenschein, Wendy M.; McClanahan, Terrill; Haemmerling, Guenter; Li, Ming O.; Cua, Daniel J.; McGeachy, Mandy J.			Foxp3(+) Regulatory T Cells Promote T Helper 17 Cell Development In Vivo through Regulation of Interleukin-2	IMMUNITY			English	Article							TGF-BETA; TH17 CELLS; IFN-GAMMA; DIFFERENTIATION; INDUCTION; T(H)17; IL-2; INFLAMMATION; HOMEOSTASIS; EXPRESSION	T helper 17 (Th17) cell development is driven by cytokines including transforming growth factor-beta (TGF-beta), interleukin-6 (IL-6), IL-1, and IL-23. Regulatory T (Treg) cells can provide the TGF-beta in vitro, but their role in vivo remains unclear, particularly because Treg Th17 cell-associated autoimmunity. We used mice expressing Diphtheria toxin receptor under control of the Foxp3 promoter to deplete Foxp3(+) Treg cells in adult mice during in vivo Th17 cell priming. Treg cell depletion resulted in a reduced frequency of antigen-specific IL-17 producers in draining lymph nodes and blood, correlating with reduced inflammatory skin responses. In contrast, Treg cells did not promote IL-17 secretion after initial activation stages. Treg cell production of TGF-beta was not required for Th17 cell promotion, and neither was suppression of Th1 cell-associated cytokines. Rather, regulation of IL-2 availability and resultant signaling through CD25 by Treg cells was found to play an important role.	[Chen, Yi; Haines, Christopher J.; Blumenschein, Wendy M.; McClanahan, Terrill; Cua, Daniel J.; McGeachy, Mandy J.] Merck Res Labs, Palo Alto, CA 94304 USA; [Gutcher, Ilona; Li, Ming O.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Hochweller, Kristin; Haemmerling, Guenter] German Canc Res Ctr, Div Mol Immunol, D-69120 Heidelberg, Germany	Merck & Company; Memorial Sloan Kettering Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ)	McGeachy, MJ (corresponding author), Merck Res Labs, 901 Calif Ave, Palo Alto, CA 94304 USA.	mandy.mcgeachy@merck.com		Altan-Bonnet, Gregoire/0000-0002-7283-3162; li, ming/0000-0002-1383-0535	National Research Fund, Luxembourg; European Commission; Rita Allen Foundation; National Institute of Arthritis, Musculoskeletal and Skin Diseases [KO1 AR053595, RO1 AR060723]; Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053595, R01AR060723] Funding Source: NIH RePORTER	National Research Fund, Luxembourg(Luxembourg National Research Fund); European Commission(European CommissionEuropean Commission Joint Research Centre); Rita Allen Foundation; National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	I.G. is funded by the National Research Fund, Luxembourg, and cofunded under the Marie Curie actions of the European Commission (fp7-cofund). M.O.L. is funded by grants from the Rita Allen Foundation, the National Institute of Arthritis, Musculoskeletal and Skin Diseases (KO1 AR053595 and RO1 AR060723), and the Arthritis Foundation. Y.C., C.J.H., W.M.B., T.M., D.J.C., and M.J.M. are employees of Merck.	Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Park IK, 2005, J IMMUNOL, V175, P5666, DOI 10.4049/jimmunol.175.9.5666; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Suffner J, 2010, J IMMUNOL, V184, P1810, DOI 10.4049/jimmunol.0902420; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	41	115	122	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					409	421		10.1016/j.immuni.2011.02.011	http://dx.doi.org/10.1016/j.immuni.2011.02.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435588	Bronze			2022-12-18	WOS:000289014500016
J	Han, JH; Akira, S; Calame, K; Beutler, B; Selsing, E; Imanishi-Kari, T				Han, Jin-Hwan; Akira, Shizuo; Calame, Kathryn; Beutler, Bruce; Selsing, Erik; Imanishi-Kari, Thereza			Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and toll-like receptors	IMMUNITY			English	Article							INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN REPERTOIRE; AFFINITY MATURATION; V(D)J RECOMBINATION; SIGNALING PATHWAY; GERMINAL-CENTERS; PLASMA-CELLS; MU-CHAIN; EXPRESSION; GENE	Activation-induced cytidine deaminase (AID) is required for immunoglobulin (1g) gene class switch recombination (CSR), somatic hypermutation (SHM), and somatic hyperconversion. In general, high AID expression is found in mature B cells that are responding to antigens. However, AID expression and SHM have also been detected in developing B cells from transgenic mice that have a limited Ig repertoire. Here we demonstrate that AID expression, ongoing CSR, and active SHM occur in developing B cells from wild-type mice. Further, our results suggest that somatic variants arising from developing B cells in the bone marrow further diversify in the spleen of unimmunized mice. AID expression in developing B cells is T cell independent but involves engagement of B cell receptors and Toll-like receptors. Early AID expression can increase the preimmune repertoire of developing B cells, may provide an innate population of IgG- and IgAexpressing cells, and could be involved in receptor editing of self-reactive immature B cells.	Sackler Sch Grad Biomed Sci, Program Immunol, Boston, MA 02111 USA; Sackler Sch Grad Biomed Sci, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan; Columbia Univ, Coll Phys & Surg, Dept Microbiol & Biochem & Mol Biophys, New York, NY 10032 USA; Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Tufts University; Columbia University; Scripps Research Institute; Scripps Research Institute	Imanishi-Kari, T (corresponding author), Sackler Sch Grad Biomed Sci, Program Immunol, Boston, MA 02111 USA.	thereza.imanishi-kari@tufts.edu	Akira, Shizuo/C-3134-2009		NIAID NIH HHS [R01 AI024465, R01AI43576, R01 AI045104-05, R01 AI045104, R01AI45104, R01AI24465] Funding Source: Medline; NIGMS NIH HHS [R01GM060031] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043576, R01AI045104, R01AI024465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060031] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Brekke KM, 2004, IMMUNOGENETICS, V56, P490, DOI 10.1007/s00251-004-0659-0; BURROWS PD, 1981, P NATL ACAD SCI-BIOL, V78, P564, DOI 10.1073/pnas.78.1.564; Cooper MD, 2002, IMMUNOL REV, V185, P175, DOI 10.1034/j.1600-065X.2002.18515.x; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; DEPINHO R, 1984, MOL CELL BIOL, V4, P2905, DOI 10.1128/MCB.4.12.2905; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; GONZALEZFERNANDEZ A, 1993, P NATL ACAD SCI USA, V90, P9862, DOI 10.1073/pnas.90.21.9862; Gourzi P, 2006, IMMUNITY, V24, P779, DOI 10.1016/j.immuni.2006.03.021; Hasan M, 2002, EUR J IMMUNOL, V32, P3463, DOI 10.1002/1521-4141(200212)32:12<3463::AID-IMMU3463>3.0.CO;2-B; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HONJO T, 1981, IMMUNOL REV, V59, P33, DOI 10.1111/j.1600-065X.1981.tb00455.x; KALLED SL, 1990, J EXP MED, V172, P559, DOI 10.1084/jem.172.2.559; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kato J, 1998, J IMMUNOL, V160, P4788; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KELSOE G, 1995, IMMUNOL TODAY, V16, P324, DOI 10.1016/0167-5699(95)80146-4; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6; MCKEARN JP, 1984, J IMMUNOL, V132, P332; Monson NL, 2001, CLIN IMMUNOL, V100, P71, DOI 10.1006/clim.2001.5049; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Orinska Z, 2002, EUR J IMMUNOL, V32, P3472, DOI 10.1002/1521-4141(200212)32:12<3472::AID-IMMU3472>3.0.CO;2-F; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Seagal J, 2003, J EXP MED, V198, P1609, DOI 10.1084/jem.20030357; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; SUGIYAMA H, 1986, J IMMUNOL, V136, P3092; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Thiebe R, 1999, EUR J IMMUNOL, V29, P2072, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2072::AID-IMMU2072&gt;3.0.CO;2-E; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; Wang Y, 2000, EUR J IMMUNOL, V30, P2226, DOI 10.1002/1521-4141(2000)30:8<2226::AID-IMMU2226>3.0.CO;2-5; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	53	115	118	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2007	27	1					64	75		10.1016/j.immuni.2007.05.018	http://dx.doi.org/10.1016/j.immuni.2007.05.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17658280	Green Accepted, Bronze			2022-12-18	WOS:000248398100009
J	Shimaoka, M; Salas, A; Yang, W; Weitz-Schmidt, G; Springer, TA				Shimaoka, M; Salas, A; Yang, W; Weitz-Schmidt, G; Springer, TA			Small molecule integrin antagonists that bind to the beta(2) subunit I-like domain and activate signals in one direction and block them in the other	IMMUNITY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; EXTRACELLULAR SEGMENT; ADHESION RECEPTORS; CRYSTAL-STRUCTURE; DISULFIDE BOND; HIGH-AFFINITY; LFA-1; CONFORMATION; INHIBITION; ICAM-1	Leukocyte integrins contain an inserted (I) domain in their alpha subunits and an I-like domain in their beta(2) subunit, which directly bind ligand and regulate ligand binding, respectively. We describe a novel mechanistic class of integrin inhibitors that bind to the metal ion-dependent adhesion site of the beta(2) I-like domain and prevent its interaction with and activation of the alpha(L) I domain. The inhibitors do not bind to the alpha(L) I domain but stabilize alpha/beta subunit association and can show selectivity for alpha(L)beta(2) compared to alpha(M)beta(2). The inhibitors reveal a crucial intersection for relaying conformational signals within integrin extracellular domains. While blocking signals in one direction to the I domain, the antagonists induce the active conformation of the I-like domain and stalk domains, and thus transmit conformational signals in the other direction toward the transmembrane domains.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Anesthesia & Pathol, Boston, MA 02115 USA; Novartis Pharma AG, Preclin Res, CH-4002 Basel, Switzerland	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Novartis	Shimaoka, M (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.		Yang, Wei/U-6557-2017; Salas, Azucena/AAN-7035-2020	Salas, Azucena/0000-0003-4572-2907; Yang, Wei/0000-0002-7634-6601	NATIONAL CANCER INSTITUTE [R37CA031798, R01CA031798] Funding Source: NIH RePORTER; NCI NIH HHS [CA31798] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; ANDERSON DC, 1989, METABOLIC BASIS INHE, P2751; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; BURDICK DJ, 1999, Patent No. 9949856; BURDICK DJ, 2001, Patent No. 02059114; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; DUSTIN ML, 1992, J IMMUNOL, V148, P2654; FOTOUHI N, 1999, Patent No. 0021920; FOTOUHI N, 2001, Patent No. 0158853; Gadek TR, 2002, SCIENCE, V295, P1086, DOI 10.1126/science.295.5557.1086; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Gottlieb AB, 2002, CLIN IMMUNOL, V105, P105, DOI 10.1006/clim.2002.5289; Gottlieb AB, 2002, ARCH DERMATOL, V138, P591, DOI 10.1001/archderm.138.5.591; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grassberger M, 1999, BRIT J DERMATOL, V141, P264; HARLAN JM, 1992, ADHESION ITS ROLE IN, P117; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Huang CC, 2000, J BIOL CHEM, V275, P21514, DOI 10.1074/jbc.M002286200; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Jackson DY, 2002, CURR PHARM DESIGN, V8, P1229, DOI 10.2174/1381612023394737; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Last-Barney K, 2001, J AM CHEM SOC, V123, P5643, DOI 10.1021/ja0104249; LEE JC, 1995, STRUCT ENG MECH, V3, P1; Leitinger B, 2000, MOL BIOL CELL, V11, P677, DOI 10.1091/mbc.11.2.677; Liu G, 2001, J MED CHEM, V44, P1202, DOI 10.1021/jm000503f; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; Lu CF, 1997, J IMMUNOL, V159, P268; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; MARTIN S, 1993, J VIROL, V67, P3561, DOI 10.1128/JVI.67.6.3561-3568.1993; Nicolls MR, 2002, J IMMUNOL, V169, P4831, DOI 10.4049/jimmunol.169.9.4831; Peter K, 2001, THROMB RES, V103, pS21, DOI 10.1016/S0049-3848(01)00300-0; PETRUZZELLI L, 1995, J IMMUNOL, V155, P854; Poston RS, 2000, TRANSPLANTATION, V69, P2005, DOI 10.1097/00007890-200005270-00006; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; Sarnacki S, 2000, GUT, V47, P97, DOI 10.1136/gut.47.1.97; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Springer TA, 2002, CURR OPIN STRUC BIOL, V12, P802, DOI 10.1016/S0959-440X(02)00384-6; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Thibault G, 2000, MOL PHARMACOL, V58, P1137, DOI 10.1124/mol.58.5.1137; VANKOOYK Y, 1991, J CELL BIOL, V112, P345, DOI 10.1083/jcb.112.2.345; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Welzenbach K, 2002, J BIOL CHEM, V277, P10590, DOI 10.1074/jbc.M110521200; Woska JR, 2001, J LEUKOCYTE BIOL, V70, P329; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yalamanchili P, 2000, J BIOL CHEM, V275, P21877, DOI 10.1074/jbc.M908868199; Zang Q, 2000, J BIOL CHEM, V275, P22202, DOI 10.1074/jbc.M002883200; Zolotarjova NI, 2001, J BIOL CHEM, V276, P17063, DOI 10.1074/jbc.M009627200	57	115	126	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2003	19	3					391	402		10.1016/S1074-7613(03)00238-3	http://dx.doi.org/10.1016/S1074-7613(03)00238-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499114	Bronze			2022-12-18	WOS:000185499800010
J	Hsu, LY; Lauring, J; Liang, HE; Greenbaum, S; Cado, D; Zhuang, Y; Schlissel, MS				Hsu, LY; Lauring, J; Liang, HE; Greenbaum, S; Cado, D; Zhuang, Y; Schlissel, MS			A conserved transcriptional enhancer regulates RAG gene expression in developing B cells	IMMUNITY			English	Article							V(D)J RECOMBINATION; CHROMATIN STRUCTURE; BONE-MARROW; ELEMENTS 5'; PROMOTER; RECEPTOR; TOLERANCE; DIVERSIFICATION; IDENTIFICATION; SELECTION	Although expression of the RAG1 and RAG2 genes is essential for lymphocyte development, the mechanisms responsible for the lymphoid- and developmental stage-specific regulation of these genes are poorly understood. We have identified a novel, evolutionarily conserved transcriptional enhancer in the RAG locus, called Erag, which was essential for the expression of a chromosomal reporter gene driven by either RAG promoter. Targeted deletion of Erag in the mouse germline results in a partial block in B cell development associated with deficient V(D)J recombination, whereas T cell development appears unaffected. We found that E2A transcription factors bind to Erag in vivo and can transactivate Erag-dependent reporter constructs in cotransfected cell lines. These findings lead us to conclude that RAG transcription is regulated by distinct elements in developing B and T cells and that Erag is required for optimal levels of RAG expression in early B cell precursors but not in T cells.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA; Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21205 USA; Duke Univ, Med Ctr, Durham, NC 27710 USA	University of California System; University of California Berkeley; Johns Hopkins University; Duke University	Schlissel, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.			zhuang, yuan/0000-0002-2964-3654; Lauring, Josh/0000-0002-4312-704X	NCI NIH HHS [CA72433] Funding Source: Medline; NHLBI NIH HHS [R01 HL48702] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072433] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRANDLE D, 1992, P NATL ACAD SCI USA, V89, P9529, DOI 10.1073/pnas.89.20.9529; Brown ST, 1997, J IMMUNOL, V158, P5071; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Fuller K, 1997, MOL IMMUNOL, V34, P939, DOI 10.1016/S0161-5890(97)00000-X; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Greenbaum S, 2002, P NATL ACAD SCI USA, V99, P15030, DOI 10.1073/pnas.232299999; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Kurioka H, 1996, MOL IMMUNOL, V33, P1059, DOI 10.1016/S0161-5890(96)00062-4; Lauring J, 1999, MOL CELL BIOL, V19, P2601; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Monroe RJ, 1999, P NATL ACAD SCI USA, V96, P12713, DOI 10.1073/pnas.96.22.12713; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Radic MZ, 1996, IMMUNITY, V5, P505, DOI 10.1016/S1074-7613(00)80266-6; ROLINK A, 1993, J EXP MED, V178, P1263, DOI 10.1084/jem.178.4.1263; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Schlissel MS, 1998, MOL CELL BIOL, V18, P2029, DOI 10.1128/MCB.18.4.2029; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; Wang QF, 2000, MOL CELL BIOL, V20, P9203, DOI 10.1128/MCB.20.24.9203-9211.2000; Wei XC, 2002, J IMMUNOL, V169, P873, DOI 10.4049/jimmunol.169.2.873; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Xiong N, 2002, IMMUNITY, V16, P453, DOI 10.1016/S1074-7613(02)00285-6; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080; Zarrin AA, 1997, J IMMUNOL, V159, P4382	33	115	117	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2003	19	1					105	117		10.1016/S1074-7613(03)00181-X	http://dx.doi.org/10.1016/S1074-7613(03)00181-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871643	Bronze			2022-12-18	WOS:000184260400012
J	Morrison, TE; Mauser, A; Wong, A; Ting, JPY; Kenney, SC				Morrison, TE; Mauser, A; Wong, A; Ting, JPY; Kenney, SC			Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein	IMMUNITY			English	Article							MURINE CYTOMEGALOVIRUS-INFECTION; INTERFERON REGULATORY FACTOR; CLASS-II TRANSACTIVATOR; BINDING PROTEIN; BZLF1 PROTEIN; DNA-BINDING; TRANSCRIPTION FACTOR; ANTIGEN PRESENTATION; DIMERIZATION DOMAIN; ZTA TRANSACTIVATOR	Viruses have evolved elaborate mechanisms to target many aspects of the host's immune response. The cytokine IFN-gamma plays a central role in resistance of the host to infection via direct antiviral effects as well as modulation of the immune response. In this study, we demonstrate that the Epstein-Barr virus (EBV) immediate-early protein, BZLF1, inhibits the IFN-gamma signaling pathway. BZLF1 decreases the ability of IFN-gamma to activate a variety of important downstream target genes, such as IRF-1, p48, and CIITA, and prevents IFN-gamma -induced class II MHC surface expression. Additionally, BZLF1 inhibits IFN-gamma -induced STAT1 tyrosine phosphorylation and nuclear translocation. Finally, we demonstrate that BZLF1 decreases expression of the IFN-gamma receptor, suggesting a mechanism by which EBV may escape antiviral immune responses during primary infection.	Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kenney, SC (corresponding author), Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA.				NATIONAL CANCER INSTITUTE [R01CA066519, P01CA019014, R01CA058853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007419] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA19014, 2-R01-CA58853, 2-R01-CA66519] Funding Source: Medline; NIAID NIH HHS [T32-AI07419] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abendroth A, 2000, J VIROL, V74, P1900, DOI 10.1128/JVI.74.4.1900-1907.2000; Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; ANDERSON S, 1994, DR DOBBS J, V19, P16; ASKOVIC S, 1997, J VIROL, V73, P10458; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; BOULEY DM, 1995, J IMMUNOL, V155, P3964; Cantin E, 1999, J VIROL, V73, P5196, DOI 10.1128/JVI.73.6.5196-5200.1999; Cayrol C, 1996, EMBO J, V15, P2748, DOI 10.1002/j.1460-2075.1996.tb00635.x; CAYROL C, 1995, J VIROL, V69, P4206, DOI 10.1128/JVI.69.7.4206-4212.1995; CHANG YN, 1990, J VIROL, V64, P3358, DOI 10.1128/JVI.64.7.3358-3369.1990; Chen HL, 1999, P NATL ACAD SCI USA, V96, P9339, DOI 10.1073/pnas.96.16.9339; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Cohen JI, 1999, CURR OPIN IMMUNOL, V11, P365, DOI 10.1016/S0952-7915(99)80062-4; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; COUNTRYMAN J, 1985, P NATL ACAD SCI USA, V82, P4085, DOI 10.1073/pnas.82.12.4085; COX M, 1985, J VIROL, V64, P313; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; FARRELL PJ, 1989, EMBO J, V8, P127, DOI 10.1002/j.1460-2075.1989.tb03356.x; FIXMAN ED, 1995, J VIROL, V69, P2998, DOI 10.1128/JVI.69.5.2998-3006.1995; FIXMAN ED, 1992, J VIROL, V66, P5030, DOI 10.1128/JVI.66.8.5030-5039.1992; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; FLEMINGTON EK, 1992, J VIROL, V66, P922, DOI 10.1128/JVI.66.2.922-929.1992; FURNARI FB, 1994, J VIROL, V68, P1827, DOI 10.1128/JVI.68.3.1827-1836.1994; Gao SJ, 1997, ONCOGENE, V15, P1979, DOI 10.1038/sj.onc.1201571; GIOT JF, 1991, NUCLEIC ACIDS RES, V19, P1251, DOI 10.1093/nar/19.6.1251; GRIBAUDO G, 1993, VIROLOGY, V197, P303, DOI 10.1006/viro.1993.1591; GUTSCH D, 1994, MOL CELL BIOL, V14, P139; HARDWICK JM, 1988, J VIROL, V62, P2274, DOI 10.1128/JVI.62.7.2274-2284.1988; HARDWICK JM, 1992, J VIROL, V66, P5500, DOI 10.1128/JVI.66.9.5500-5508.1992; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Heise MT, 1998, J EXP MED, V187, P1037, DOI 10.1084/jem.187.7.1037; HOLLEYGUTHRIE EA, 1990, J VIROL, V64, P3753, DOI 10.1128/JVI.64.8.3753-3759.1990; HORNEF MW, 1995, CLIN DIAGN LAB IMMUN, V2, P209, DOI 10.1128/CDLI.2.2.209-213.1995; KENNEY S, 1989, J VIROL, V63, P3878, DOI 10.1128/JVI.63.9.3878-3883.1989; Kieff E., 1996, FIELDS VIROLOGY, P2343; KOUZARIDES T, 1991, ONCOGENE, V6, P195; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; Li MT, 1998, J VIROL, V72, P5433, DOI 10.1128/JVI.72.7.5433-5440.1998; LI QX, 1992, NATURE, V356, P347, DOI 10.1038/356347a0; LIEBERMAN PM, 1989, J VIROL, V63, P3040, DOI 10.1128/JVI.63.7.3040-3050.1989; LINDE A, 1992, J INFECT DIS, V165, P994, DOI 10.1093/infdis/165.6.994; LUCIN P, 1994, J GEN VIROL, V75, P101, DOI 10.1099/0022-1317-75-1-101; Miller DM, 1998, J EXP MED, V187, P675, DOI 10.1084/jem.187.5.675; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; ORANGE JS, 1995, J EXP MED, V182, P1045, DOI 10.1084/jem.182.4.1045; PACKHAM G, 1990, J VIROL, V64, P2110, DOI 10.1128/JVI.64.5.2110-2116.1990; POBER JS, 1983, NATURE, V305, P726, DOI 10.1038/305726a0; Presti RM, 1998, J EXP MED, V188, P577, DOI 10.1084/jem.188.3.577; QUINLIVAN EB, 1993, NUCLEIC ACIDS RES, V21, P1999, DOI 10.1093/nar/21.8.1999; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; ROONEY CM, 1989, J VIROL, V63, P3109, DOI 10.1128/JVI.63.7.3109-3116.1989; Sarisky RT, 1996, J VIROL, V70, P8340, DOI 10.1128/JVI.70.12.8340-8347.1996; SCHEPERS A, 1993, EMBO J, V12, P3921, DOI 10.1002/j.1460-2075.1993.tb06070.x; SEDMAK DD, 1994, AM J PATHOL, V144, P683; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; Spriggs MK, 1996, J VIROL, V70, P5557, DOI 10.1128/JVI.70.8.5557-5563.1996; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Strockbine LD, 1998, J VIROL, V72, P4015, DOI 10.1128/JVI.72.5.4015-4021.1998; TAKADA K, 1986, J VIROL, V57, P1016, DOI 10.1128/JVI.57.3.1016-1022.1986; TOMKINSON BE, 1987, J IMMUNOL, V139, P3802; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; URIER G, 1989, EMBO J, V8, P1447, DOI 10.1002/j.1460-2075.1989.tb03527.x; Westphal EM, 1999, CANCER RES, V59, P1485; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194; ZHANG Q, 1994, MOL CELL BIOL, V14, P1929, DOI 10.1128/MCB.14.3.1929; Zimring JC, 1998, J VIROL, V72, P701, DOI 10.1128/JVI.72.1.701-707.1998	75	115	122	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					787	799		10.1016/S1074-7613(01)00226-6	http://dx.doi.org/10.1016/S1074-7613(01)00226-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728340	Bronze, Green Published			2022-12-18	WOS:000172528200011
J	Benschop, RJ; Aviszus, K; Zhang, XH; Manser, T; Cambier, JC; Wysocki, LJ				Benschop, RJ; Aviszus, K; Zhang, XH; Manser, T; Cambier, JC; Wysocki, LJ			Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive	IMMUNITY			English	Article							REACTIVE LYMPHOCYTES-B; NON-AUTOIMMUNE MICE; HEAVY-CHAIN; ANTIGEN-RECEPTOR; SIGNAL-TRANSDUCTION; DNA; TOLERANCE; EXPRESSION; ANTIBODY; DELETION	Available evidence indicates that B cell tolerance is attained by receptor editing, anergy, or clonal deletion. Here, we describe a p-azophenylarsonate (Ars)-specific immunoglobulin transgenic mouse in which B coils become anergic as a consequence of cross-reaction with autoantigen in the bone marrow. Developing bone marrow B cells show no evidence of receptor editing but transiently upregulate activation markers and appear to undergo accelerated development. Mature B cells are present in normal numbers but are refractory to BCR-mediated induction of calcium mobilization, tyrosine phosphorylation, and antibody responses. Activation marker expression and acquisition of the anergic phenotype is prevented in bone marrow cultures by monovalent hapten. In this model, it appears that induction of anergy in B cells can be prevented by monovalent hapten competing with autoantigen for the binding site.	Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Sch Med, Denver, CO 80206 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Kimmel Canc Inst, Philadelphia, PA 19107 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Jefferson University	Cambier, JC (corresponding author), Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA.			Cambier, John/0000-0002-7803-242X	NIAID NIH HHS [P1AI22295, AI20519] Funding Source: Medline; NIA NIH HHS [AG13983] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI020519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013983] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Brauweiler A, 2000, J EXP MED, V191, P1545, DOI 10.1084/jem.191.9.1545; CAMBIER JC, 1976, J EXP MED, V144, P293, DOI 10.1084/jem.144.1.293; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; CHEN C, 1994, J IMMUNOL, V152, P1970; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; Cook MC, 1998, EUR J IMMUNOL, V28, P2549, DOI 10.1002/(SICI)1521-4141(199808)28:08<2549::AID-IMMU2549>3.0.CO;2-O; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841; DURDIK J, 1989, P NATL ACAD SCI USA, V86, P2346, DOI 10.1073/pnas.86.7.2346; Eivazova ER, 2000, ARTHRITIS RHEUM-US, V43, P429, DOI 10.1002/1529-0131(200002)43:2<429::AID-ANR25>3.0.CO;2-N; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; ERIS JM, 1994, P NATL ACAD SCI USA, V91, P4392, DOI 10.1073/pnas.91.10.4392; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; KUETTNER MG, 1972, J EXP MED, V135, P579, DOI 10.1084/jem.135.3.579; LEO O, 1985, J IMMUNOL, V134, P1734; Liu AH, 1996, J EXP MED, V183, P2053, DOI 10.1084/jem.183.5.2053; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; Manser T, 1998, IMMUNOL REV, V162, P183, DOI 10.1111/j.1600-065X.1998.tb01441.x; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Melamed D, 1997, J IMMUNOL, V159, P1233; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; METCALF ES, 1976, J EXP MED, V143, P1327, DOI 10.1084/jem.143.6.1327; Nemazee D, 2000, CURR TOP MICROBIOL, V245, P57; Nemazee D, 2000, Adv Immunol, V74, P89; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Noorchashm H, 1999, INT IMMUNOL, V11, P765, DOI 10.1093/intimm/11.5.765; NORVELL A, 1995, J IMMUNOL, V154, P4404; PIKE BL, 1982, P NATL ACAD SCI-BIOL, V79, P2013, DOI 10.1073/pnas.79.6.2013; Retter MW, 1996, J IMMUNOL, V156, P1296; Roark JH, 1997, INT IMMUNOL, V9, P1615, DOI 10.1093/intimm/9.11.1615; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Santulli-Marotto S, 1998, IMMUNITY, V8, P209, DOI 10.1016/S1074-7613(00)80473-2; SHARON J, 1989, J IMMUNOL, V142, P596; SHARON J, 1990, P NATL ACAD SCI USA, V87, P4814, DOI 10.1073/pnas.87.12.4814; SIEKEVITZ M, 1983, EUR J IMMUNOL, V13, P123, DOI 10.1002/eji.1830130207; Takeda I, 1999, J AUTOIMMUN, V13, P423, DOI 10.1006/jaut.1999.0330; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Wysocki LJ, 1998, CURR TOP MICROBIOL, V229, P105; WYSOCKI LJ, 1981, EUR J IMMUNOL, V11, P832, DOI 10.1002/eji.1830111016	54	115	117	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2001	14	1					33	43		10.1016/S1074-7613(01)00087-5	http://dx.doi.org/10.1016/S1074-7613(01)00087-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	394FQ	11163228	Bronze			2022-12-18	WOS:000166513800004
J	Marie, JC; Kehren, J; Trescol-Biemont, MC; Evlashev, A; Valentin, H; Walzer, T; Tedone, R; Loveland, B; Nicolas, JF; Rabourdin-Combe, C; Horvat, B				Marie, JC; Kehren, J; Trescol-Biemont, MC; Evlashev, A; Valentin, H; Walzer, T; Tedone, R; Loveland, B; Nicolas, JF; Rabourdin-Combe, C; Horvat, B			Mechanism of measles virus-induced suppression of inflammatory immune responses	IMMUNITY			English	Article							CELL-MEDIATED-IMMUNITY; CD4(+) T-CELLS; INDUCED IMMUNOSUPPRESSION; CONTACT HYPERSENSITIVITY; DENDRITIC CELLS; IN-VIVO; INFECTION; RECEPTOR; ANTIBODIES; INDUCTION	Measles virus (MV) causes profound immunosuppression, resulting in high infant mortality. The mechanisms are poorly understood, largely due to the lack of a suitable animal model. Here, we report that particular MV proteins, in the absence of MV replication, could generate a systemic immunosuppression in mice through two pathways: (1) via MV-nucleoprotein and its receptor Fc gammaR on dendritic cells; and (2) via virus envelope glycoproteins and the MV-hemagglutinin cellular receptor, CD46. The effects comprise reduced hypersensitivity responses associated with impaired function of dendritic cells, decreased production of IL-12, and the loss of antigen-specific T cell proliferation. These results introduce a novel model for testing the immunosuppressive potential of anti-measles vaccines and reveal a specific mechanism of MV-induced modulation of inflammatory reactions.	CERVI Immunobiol Fondamentale & Clin, INSERM, U503, F-69365 Lyon, France; Austin Res Inst, Heidelberg, Vic 3084, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); Austin Research Institute	Horvat, B (corresponding author), CERVI Immunobiol Fondamentale & Clin, INSERM, U503, F-69365 Lyon, France.		Walzer, Thierry/L-9418-2014; Valentin, Helene/AAA-4265-2020; Marie, Julien/I-5084-2016; Horvat, Branka/M-3504-2014	Walzer, Thierry/0000-0002-0857-8179; Horvat, Branka/0000-0003-0578-7765; NICOLAS, JEAN FRANCOIS/0000-0003-4204-803X; Marie, Julien/0000-0001-6713-7923				Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Auwaerter PG, 1999, J INFECT DIS, V180, P950, DOI 10.1086/314993; BECKFORD AP, 1985, S AFR MED J, V68, P858; BELLINI WJ, 1994, J INFECT DIS, V170, pS15, DOI 10.1093/infdis/170.Supplement_1.S15; BLUMBERG RW, 1947, AM J DIS CHILD, V63, P151; BONER AL, 1985, ANN ALLERGY, V55, P605; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; ESOLEN LM, 1993, J INFECT DIS, V168, P47, DOI 10.1093/infdis/168.1.47; Fehr T, 1998, NAT MED, V4, P945, DOI 10.1038/nm0898-945; FIREMAN P, 1969, PEDIATRICS, V43, P264; Frankel SS, 1996, SCIENCE, V272, P115, DOI 10.1126/science.272.5258.115; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; GALAMA JMD, 1980, CELL IMMUNOL, V50, P405, DOI 10.1016/0008-8749(80)90294-4; GARENNE M, 1991, LANCET, V338, P903, DOI 10.1016/0140-6736(91)91771-L; GIRAUDON P, 1981, J GEN VIROL, V54, P325, DOI 10.1099/0022-1317-54-2-325; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; GRAVES M, 1984, J VIROL, V49, P409, DOI 10.1128/JVI.49.2.409-412.1984; GRIFFIN DE, 1994, J INFECT DIS S1, V170, P24; Grosjean I, 1997, J EXP MED, V186, P801, DOI 10.1084/jem.186.6.801; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; HIRSCH RL, 1984, CLIN IMMUNOL IMMUNOP, V31, P1, DOI 10.1016/0090-1229(84)90184-3; Horvat B, 1996, J VIROL, V70, P6673, DOI 10.1128/JVI.70.10.6673-6681.1996; Hussey GD, 1996, J INFECT DIS, V173, P1320, DOI 10.1093/infdis/173.6.1320; HUTCHINS G, 1947, AM J DIS CHILD, V73, P242; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; LIBEAU G, 1994, VET REC, V134, P300, DOI 10.1136/vr.134.12.300; LIN CY, 1986, PEDIATR RES, V20, P685, DOI 10.1203/00006450-198607000-00022; Manchester M, 2000, J VIROL, V74, P3967, DOI 10.1128/JVI.74.9.3967-3974.2000; MULLER G, 1995, J IMMUNOL, V155, P4661; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Niewiesk S, 1997, J VIROL, V71, P7214, DOI 10.1128/JVI.71.10.7214-7219.1997; NORRBY E, 1975, J INFECT DIS, V132, P262, DOI 10.1093/infdis/132.3.262; Oldstone MBA, 1999, CELL, V98, P629, DOI 10.1016/S0092-8674(00)80050-1; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Ravanel K, 1997, J EXP MED, V186, P269, DOI 10.1084/jem.186.2.269; Schlender J, 1996, P NATL ACAD SCI USA, V93, P13194, DOI 10.1073/pnas.93.23.13194; Schnorr JJ, 1997, P NATL ACAD SCI USA, V94, P5326, DOI 10.1073/pnas.94.10.5326; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Spielhofer P, 1998, J VIROL, V72, P2150, DOI 10.1128/JVI.72.3.2150-2159.1998; Sun XM, 1998, VIROLOGY, V246, P24, DOI 10.1006/viro.1998.9186; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; TAMASHIRO VG, 1987, PEDIATR INFECT DIS J, V6, P451, DOI 10.1097/00006454-198705000-00007; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Thorley BR, 1997, EUR J IMMUNOL, V27, P726, DOI 10.1002/eji.1830270322; Tishon A, 1996, NAT MED, V2, P1250, DOI 10.1038/nm1196-1250; VONPIRQUET C, 1908, DEUT MED WOCHENSCHR, V30, P1297	52	115	120	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2001	14	1					69	79		10.1016/S1074-7613(01)00090-5	http://dx.doi.org/10.1016/S1074-7613(01)00090-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	394FQ	11163231	Bronze			2022-12-18	WOS:000166513800007
J	Vezys, V; Olson, S; Lefrancois, L				Vezys, V; Olson, S; Lefrancois, L			Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction	IMMUNITY			English	Article							INFLAMMATORY BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; INTRAEPITHELIAL LYMPHOCYTES; TRANSGENIC MICE; IN-VIVO; DEPENDENT CYTOTOXICITY; NEGATIVE SELECTION; IMMUNE-SYSTEM; RECEPTOR; ACTIVATION	Reactivity to intestinal epithelium-specific antigen was studied by transgenic expression of cytosolic ovalbumin controlled by an enterocyte-specific promoter. Transferred OVA-specific CD8 cells (OT-I) preferentially expanded in mucosal lymphoid tissues and the epithelium but failed to cause tissue damage. In contrast, concomitant VSV-ova infection induced OT-I-mediated epithelial cell destruction that correlated with antigen density. OT-I cells retained in the epithelium exhibited high levels of lytic activity but were unable to produce cytokines. The mice were systemically tolerant to OVA since endogenous CD8 cells were nonresponsive to VSV-ova infection. Thus, intestinal antigen gained access to peripheral tissues via absorption from effete epithelial cells. This system demonstrated a requirement for inflammation to drive pathogenic autoreactivity against enterocytes and identified pathways of intestine-specific immunoregulation.	Univ Connecticut, Ctr Hlth, Dept Med, Div Rheumat Dis, Farmington, CT 06030 USA	University of Connecticut	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Div Rheumat Dis, Farmington, CT 06030 USA.	liefranc@neuron.uchc.edu	Vezys, Vaiva/N-3144-2013; Eckhardt, Erik/G-1567-2010	Vezys, Vaiva/0000-0002-2520-809X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041576, T32AI007080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057932] Funding Source: NIH RePORTER; NIAID NIH HHS [AI41576, T32-AI07080] Funding Source: Medline; NIDDK NIH HHS [DK57932] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; CARBONE FR, 1989, J EXP MED, V169, P603, DOI 10.1084/jem.169.3.603; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; GREEN RP, 1992, DNA CELL BIOL, V11, P31, DOI 10.1089/dna.1992.11.31; Guy-Grand D, 1998, EUR J IMMUNOL, V28, P730, DOI 10.1002/(SICI)1521-4141(199802)28:02<730::AID-IMMU730>3.0.CO;2-U; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; HULEATT JW, 1995, J IMMUNOL, V154, P5684; JAMES SP, 1990, J IMMUNOL, V144, P1251; Kagi D, 1995, EUR J IMMUNOL, V25, P3256, DOI 10.1002/eji.1830251209; Kagi D, 1996, J EXP MED, V183, P2143, DOI 10.1084/jem.183.5.2143; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Kim SK, 1997, J IMMUNOL, V159, P4295; Krakauer T., 1999, FUNDAMENTAL IMMUNOLO, P775; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Laky K, 1997, J IMMUNOL, V158, P1417; LI Y, 1995, J EXP MED, V182, P1079, DOI 10.1084/jem.182.4.1079; Lundqvist C, 1996, J IMMUNOL, V157, P1926; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; OTTEN GR, 1991, SCIENCE, V251, P1228, DOI 10.1126/science.1900952; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; POTTEN CS, 1988, J CELL SCI, P45; PROBERT L, 1995, EUR J IMMUNOL, V25, P1794, DOI 10.1002/eji.1830250647; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rutgeerts P, 1998, DIGESTION, V59, P453, DOI 10.1159/000007523; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Steinhoff U, 1999, IMMUNITY, V11, P349, DOI 10.1016/S1074-7613(00)80110-7; STROBER W, 1993, CELL, V75, P203, DOI 10.1016/0092-8674(93)80062-J; SWEETSER DA, 1988, P NATL ACAD SCI USA, V85, P9611, DOI 10.1073/pnas.85.24.9611; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Van Parijs L, 1998, SCIENCE, V280, P243; VANBLEEK GM, 1990, NATURE, V348, P213; vonHerrath MG, 1997, J EXP MED, V185, P531, DOI 10.1084/jem.185.3.531; Wack A, 1997, EUR J IMMUNOL, V27, P577, DOI 10.1002/eji.1830270302; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	52	115	119	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2000	12	5					505	514		10.1016/S1074-7613(00)80202-2	http://dx.doi.org/10.1016/S1074-7613(00)80202-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843383	Bronze			2022-12-18	WOS:000087356400006
J	Cho, BK; Palliser, D; Guillen, E; Wisniewski, J; Young, RA; Chen, JZ; Eisen, HN				Cho, BK; Palliser, D; Guillen, E; Wisniewski, J; Young, RA; Chen, JZ; Eisen, HN			A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; PRESENTATION PATHWAY; DENDRITIC CELLS; PEPTIDE; MICE; HELPER; EXPRESSION; DELIVERY; RECEPTOR	A 65 kDa mycobacterial heat shock protein (hsp65), fused to a polypeptide that contains an octapeptide (SIYRYYGL) agonist for a particular T cell receptor (2C TCR), stimulated C57BL/6 mice as well as CD4-deficient mice to produce CD8(+) cytolytic T lymphocytes (CTL) to the fusion partner's octapeptide. This and other hsp65 fusion proteins but not native hsp65 itself stimulated dendritic cells in vitro and in vivo to upregulate the levels of MHC (class I and II) and costimulatory (B7.2) molecules. The results suggest a mechanism for the general finding that hsp fusion proteins, having fusion partners of widely differing lengths and sequences, elicit CD8 CTL to peptides from the fusion partners without requiring exogenous adjuvents or the participation of CD4(+) T cells.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Stressgen Biotechnol Inc, Victoria, BC VB2 4B9, Canada	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Eisen, HN (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NATIONAL CANCER INSTITUTE [P30CA014051, R01CA060686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007463] Funding Source: NIH RePORTER; NCI NIH HHS [CA-14051, CA-60686] Funding Source: Medline; NIAID NIH HHS [5T32-AI-07463] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anthony LSD, 1999, VACCINE, V17, P373, DOI 10.1016/S0264-410X(98)00199-6; Ballard JD, 1996, P NATL ACAD SCI USA, V93, P12531, DOI 10.1073/pnas.93.22.12531; BARRIOS C, 1992, EUR J IMMUNOL, V22, P1365, DOI 10.1002/eji.1830220606; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Carbonetti NH, 1999, INFECT IMMUN, V67, P602, DOI 10.1128/IAI.67.2.602-607.1999; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Demangel C, 1999, EUR J IMMUNOL, V29, P1972, DOI 10.1002/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1; DiRosa F, 1996, J EXP MED, V183, P2153, DOI 10.1084/jem.183.5.2153; EISENLOHR LC, 1992, J EXP MED, V175, P481, DOI 10.1084/jem.175.2.481; FALK K, 1992, EUR J IMMUNOL, V22, P1323, DOI 10.1002/eji.1830220530; Goletz TJ, 1997, P NATL ACAD SCI USA, V94, P12059, DOI 10.1073/pnas.94.22.12059; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Henderson RA, 1997, J IMMUNOL, V159, P635; Huang Q, 2000, J EXP MED, V191, P403, DOI 10.1084/jem.191.2.403; Konecny P, 1999, EUR J IMMUNOL, V29, P1803, DOI 10.1002/(SICI)1521-4141(199906)29:06&lt;1803::AID-IMMU1803&gt;3.0.CO;2-F; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; Manning TC, 1997, J IMMUNOL, V159, P4665; Nair S, 1999, J IMMUNOL, V162, P6426; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Rescigno M, 1998, P NATL ACAD SCI USA, V95, P5229, DOI 10.1073/pnas.95.9.5229; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rock KL, 1996, J IMMUNOL, V156, P3721; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; SRIVASTAVA PK, 1993, ADV CANCER RES, V62, P153, DOI 10.1016/S0065-230X(08)60318-8; Stevenson PG, 1998, P NATL ACAD SCI USA, V95, P15565, DOI 10.1073/pnas.95.26.15565; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Suzue K, 1997, P NATL ACAD SCI USA, V94, P13146, DOI 10.1073/pnas.94.24.13146; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Udaka K, 1996, J IMMUNOL, V157, P670; WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	38	115	135	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2000	12	3					263	272		10.1016/S1074-7613(00)80179-X	http://dx.doi.org/10.1016/S1074-7613(00)80179-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755613	Bronze			2022-12-18	WOS:000086292100004
J	Teitelbaum, R; Schubert, W; Gunther, L; Kress, Y; Macaluso, F; Pollard, JW; McMurray, DN; Bloom, BR				Teitelbaum, R; Schubert, W; Gunther, L; Kress, Y; Macaluso, F; Pollard, JW; McMurray, DN; Bloom, BR			The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis	IMMUNITY			English	Article							INTESTINAL M-CELLS; OSTEOPETROTIC OP/OP MOUSE; OP OP MOUSE; LYMPHOID-TISSUE; ADHESION MOLECULE-1; DENDRITIC CELLS; PEYERS-PATCHES; T-CELLS; HOST; MACROPHAGES	M. tuberculosis accesses the terminal lung and is phagocytosed by alveolar macrophages. Utilizing a mouse intratracheal challenge model, we demonstrate that M. tuberculosis rapidly enters through M cells as well. From there, bacilli are deposited within associated intraepithelial leukocytes and subsequently conveyed to the draining lymph nodes early after infection. Osteopetrotic (Csfm(op)/Csfm(op)) mice, null mutants for macrophage colony-stimulating factor, possess diminished numbers of circulating monocytes and tissue macrophages. Csfm(op)/Csfm(op) mice were highly susceptible to challenge with M. tuberculosis. In contrast to controls, tubercle bacilli were not conveyed to draining lymph nodes early after infection but were instead retained within the mucosa. These results indicate that M cells represent an alternate portal of entry for M. tuberculosis, which may contribute to the rapid development of protective lung immune responses.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Analyt Imaging Facil, Bronx, NY 10461 USA; Texas A&M Univ, Hlth Sci Ctr, Dept Med Microbiol & Immunol, College Stn, TX 77843 USA	Harvard University; Harvard T.H. Chan School of Public Health; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bloom, BR (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.				NIAID NIH HHS [AI02545, AI07118] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAN CH, 1993, GASTROENTEROLOGY, V104, P698, DOI 10.1016/0016-5085(93)91004-2; BEINENSTOCK J, 1976, LAB INVEST, V35, P343; BEINENSTOCK J, 1973, LAB INVEST, V28, P693; CALMETTE A, 1933, ANN ACAD MED, V110, P203; CATTORETTI G, 1992, J PATHOL, V168, P357, DOI 10.1002/path.1711680404; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; DAMLE NK, 1992, J IMMUNOL, V148, P1985; FINZI G, 1993, HISTOCHEMISTRY, V99, P201, DOI 10.1007/BF00269138; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; FUJIMURA Y, 1986, Gastroenterologia Japonica, V21, P325; Fujimura Yoshinori, 1992, Journal of Clinical Electron Microscopy, V25, P35; GONG JL, 1992, J EXP MED, V175, P797, DOI 10.1084/jem.175.3.797; GREGSON RL, 1979, BRIT J EXP PATHOL, V60, P471; GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011; HATCH TF, 1942, PUBLICATION AM ASS A, V17, P102; HENDERSON HJ, 1963, J IMMUNOL, V90, P553; INMAN LR, 1983, J CLIN INVEST, V71, P1, DOI 10.1172/JCI110737; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; KOHBATA S, 1986, MICROBIOL IMMUNOL, V30, P1225, DOI 10.1111/j.1348-0421.1986.tb03055.x; LURIE MB, 1955, AM REV TUBERC PULM, V72, P297; McMurray David N., 1994, P135; MORIN MJ, 1994, J EXP MED, V180, P1523, DOI 10.1084/jem.180.4.1523; NAGAISHI C, 1972, FUNCTIONAL ANATOMY H, P102; NETTER FH, 1992, CIBA COLLECTION MED, V7, P32; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; OWEN RL, 1986, J INFECT DIS, V153, P1108, DOI 10.1093/infdis/153.6.1108; PAPPO J, 1989, CLIN EXP IMMUNOL, V76, P144; POLLARD JW, 1991, DEV BIOL, V148, P273, DOI 10.1016/0012-1606(91)90336-2; Pollard JW., 1996, ADV D BIOCH, V4, P153; RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069; SEMNANI RT, 1994, J EXP MED, V180, P2125, DOI 10.1084/jem.180.6.2125; SICINSKI P, 1990, GASTROENTEROLOGY, V98, P56, DOI 10.1016/0016-5085(90)91290-M; SMINIA T, 1989, CRIT REV IMMUNOL, V9, P119; SMITH DW, 1970, AM REV RESPIR DIS, V102, P937; TENNERRACZ K, 1979, LAB INVEST, V41, P106; UEKI T, 1995, ACTA MED OKAYAMA, V49, P145; VANSEVENTER GA, 1992, J IMMUNOL, V149, P3872; WASSEF JS, 1989, INFECT IMMUN, V57, P858, DOI 10.1128/IAI.57.3.858-863.1989; WELLS WF, 1947, AM J HYG, V47, P11; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; WIKTORJEDRZEJCZAK W, 1992, EXP HEMATOL, V20, P1004; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; WOLF JL, 1981, SCIENCE, V212, P471, DOI 10.1126/science.6259737	46	115	118	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1999	10	6					641	650		10.1016/S1074-7613(00)80063-1	http://dx.doi.org/10.1016/S1074-7613(00)80063-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403639	Bronze			2022-12-18	WOS:000081209600002
J	NOVAK, TJ; FARBER, D; LEITENBERG, D; HONG, SC; JOHNSON, P; BOTTOMLY, K				NOVAK, TJ; FARBER, D; LEITENBERG, D; HONG, SC; JOHNSON, P; BOTTOMLY, K			ISOFORMS OF THE TRANSMEMBRANE TYROSINE PHOSPHATASE CD45 DIFFERENTIALLY AFFECT T-CELL RECOGNITION	IMMUNITY			English	Article							HUMAN LYMPHOCYTES-T; LEUKOCYTE-COMMON ANTIGEN; ALTERNATIVELY SPLICED EXONS; PROTEIN-KINASE P56LCK; CLASS-II MHC; SIGNAL TRANSDUCTION; PHOSPHOTYROSINE PHOSPHATASE; MONOCLONAL-ANTIBODY; SRC FAMILY; FUNCTIONAL COMPLEX	Activation of T cells has been shown to require CD45. CD45 is expressed on T cells as distinct isoforms and these isoforms are expressed differentially on subsets of CD4 T cells. We have generated T cell lines expressing a T cell receptor (TCR) of known specificity, with or without CD4, and examined the effect of different CD45 isoforms on stimulation through the antigen receptor. We find that isoforms differ in their ability to participate in antigen recognition, with the null isoform that is predominantly found on memory CD4 T cells being the most effective. The ability of the CD45 ectodomain to differentially affect sensitivity to specific ligands represents a novel way of regulating the efficacy of signaling through a receptor without altering its specificity. It may play a crucial role both in immunological memory and during intrathymic maturation of T cells.	YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06510; UNIV BRITISH COLUMBIA,DEPT MICROBIOL & IMMUNOL,VANCOUVER V6T 1Z3,BC,CANADA	Yale University; University of British Columbia	NOVAK, TJ (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510, USA.		Johnson, Pauline/G-9659-2019	Johnson, Pauline/0000-0001-7367-4653; Leitenberg, David/0000-0002-0622-9522; Farber, Donna/0000-0001-8236-9183				ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; AKBAR AN, 1988, J IMMUNOL, V140, P2171; ALTEVOGT P, 1990, INT IMMUNOL, V2, P353, DOI 10.1093/intimm/2.4.353; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BIRKELAND ML, 1989, P NATL ACAD SCI USA, V86, P6734, DOI 10.1073/pnas.86.17.6734; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; BYRNE JA, 1988, J IMMUNOL, V141, P3249; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; DELALUNA S, 1988, GENE, V62, P121; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; DIANZANI U, 1992, EUR J IMMUNOL, V22, P365, DOI 10.1002/eji.1830220212; DIANZANI U, 1990, EUR J IMMUNOL, V20, P2249, DOI 10.1002/eji.1830201014; DIANZANI U, 1992, INT IMMUNOL, V4, P995, DOI 10.1093/intimm/4.9.995; ENGEL P, 1993, J IMMUNOL, V150, P4719; FUJII Y, 1992, EUR J IMMUNOL, V22, P1843, DOI 10.1002/eji.1830220725; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; GUTTINGER M, 1992, INT IMMUNOL, V4, P1325, DOI 10.1093/intimm/4.11.1325; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; HATHCOCK KS, 1992, J IMMUNOL, V148, P19; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; HORGAN KJ, 1990, EUR J IMMUNOL, V20, P1111, DOI 10.1002/eji.1830200525; HOVIS RR, 1993, SCIENCE, V260, P544, DOI 10.1126/science.8475387; HSI ED, 1989, J BIOL CHEM, V264, P10836; HUNTER T, 1989, CELL, V58, P1013, DOI 10.1016/0092-8674(89)90496-0; HYMAN R, 1981, IMMUNOGENETICS, V12, P511, DOI 10.1007/BF01561692; ISAKOV N, 1993, MOL IMMUNOL, V30, P197, DOI 10.1016/0161-5890(93)90092-P; JANEWAY CA, 1987, J MOL CELL IMMUNOL, V3, P121; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; JOHNSON P, 1989, J EXP MED, V169, P1179, DOI 10.1084/jem.169.3.1179; JUNE CH, 1990, J IMMUNOL, V144, P1591; KAYE J, 1984, J EXP MED, V159, P1397, DOI 10.1084/jem.159.5.1397; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KORETZKY GA, 1992, J IMMUNOL, V149, P1138; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; LEFRANCOIS L, 1987, J IMMUNOL, V139, P3718; LUQMAN M, 1991, EUR J IMMUNOL, V21, P17, DOI 10.1002/eji.1830210104; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; MERKENSCHLAGER M, 1991, INT IMMUNOL, V3, P1, DOI 10.1093/intimm/3.1.1; MITTLER RS, 1991, J IMMUNOL, V147, P3434; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; MUSTELIN T, 1990, ONCOGENE, V5, P809; NAKAGAWA TY, 1991, EUR J IMMUNOL, V21, P2851, DOI 10.1002/eji.1830211129; OROURKE AM, 1988, J BIOL CHEM, V263, P18594; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; PEYRON JF, 1991, INT IMMUNOL, V3, P1357, DOI 10.1093/intimm/3.12.1357; PILARSKI LM, 1989, IMMUNOL LETT, V21, P187, DOI 10.1016/0165-2478(89)90103-X; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; PORTOLES P, 1989, J MOL CELL IMMUNOL, V4, P129; PORTOLES P, 1990, J IMMUNOL METHODS, V129, P105, DOI 10.1016/0022-1759(90)90426-V; PORTOLES P, 1989, J IMMUNOL, V142, P4169; PORTOLES P, 1989, EUR J IMMUNOL, V19, P83, DOI 10.1002/eji.1830190114; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SAMELSON LD, 1991, CURRENT PROTOCOLS IM; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; SANDERS ME, 1988, IMMUNOL TODAY, V9, P195, DOI 10.1016/0167-5699(88)91212-1; SANDERS ME, 1989, EUR J IMMUNOL, V19, P803, DOI 10.1002/eji.1830190504; SANDERS ME, 1988, J IMMUNOL, V140, P1401; SCHRAVEN B, 1991, EUR J IMMUNOL, V21, P2469, DOI 10.1002/eji.1830211025; SCHRAVEN B, 1990, NATURE, V345, P71, DOI 10.1038/345071a0; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; SPRINGER T, 1978, EUR J IMMUNOL, V8, P539, DOI 10.1002/eji.1830080802; STAMENKOVIC I, 1991, CELL, V66, P1133, DOI 10.1016/0092-8674(91)90036-X; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; SUSSMAN JJ, 1988, NATURE, V334, P625, DOI 10.1038/334625a0; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TORIMOTO Y, 1991, J IMMUNOL, V147, P2514; VANDENELSEN P, 1985, NATURE, V314, P542, DOI 10.1038/314542a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VOLAREVIC S, 1993, SCIENCE, V260, P541, DOI 10.1126/science.8475386; VOLAREVIC S, 1990, P NATL ACAD SCI USA, V87, P7085, DOI 10.1073/pnas.87.18.7085; VOLAREVIC S, 1992, J EXP MED, V176, P835, DOI 10.1084/jem.176.3.835; WALLACE VA, 1992, J EXP MED, V176, P1657, DOI 10.1084/jem.176.6.1657; WEAVER CT, 1991, MOL CELL BIOL, V11, P4415, DOI 10.1128/MCB.11.9.4415; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WEISSMAN AM, 1988, SCIENCE, V239, P1018, DOI 10.1126/science.3278377	88	115	117	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1994	1	2					109	119		10.1016/1074-7613(94)90104-X	http://dx.doi.org/10.1016/1074-7613(94)90104-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK162	7889403				2022-12-18	WOS:A1994PK16200003
J	Zhang, XW; Bai, XC; Chen, ZJJ				Zhang, Xuewu; Bai, Xiao-chen; Chen, Zhijian J.			Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway	IMMUNITY			English	Review							CYCLIC GMP-AMP; DI-GMP; DNA SENSOR; CRYSTAL-STRUCTURES; BYSTANDER CELLS; MOLECULAR-BASIS; IKK-BETA; ACTIVATION; REVEALS; RECOGNITION	Besides its role as the blueprint of life, DNA can also alert the cell to the presence of microbial pathogens as well as damaged or malignant cells. A major sensor of DNA that triggers the innate immune response is cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) (cGAMP) synthase (cGAS), which produces the second messenger cGAMP. cGAMP activates stimulator of interferon genes (STING), which activates a signaling cascade leading to the production of type I interferons and other immune mediators. Recent research has demonstrated an expanding role of the cGAS-cGAMP-STING pathway in many physiological and pathological processes, including host defense against microbial infections, anti-tumor immunity, cellular senescence, autophagy, and autoimmune and inflammatory diseases. Biochemical and structural studies have elucidated the mechanism of signal transduction in the cGAS pathway at the atomic resolution. This review focuses on the structural and mechanistic insights into the roles of cGAS and STING in immunity and diseases revealed by these recent studies.	[Zhang, Xuewu] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Zhang, Xuewu; Bai, Xiao-chen] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Bai, Xiao-chen] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Ctr Inflammat Res, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, XW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.; Zhang, XW; Bai, XC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Bai, XC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Inflammat Res, Dallas, TX 75390 USA.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	xuewu.zhang@utsouthwestern.edu; xiaochen.bai@utsouthwestern.edu; zhijian.chen@utsouthwestern.edu	Bai, Xiao-chen/HGV-1244-2022	Bai, Xiao-chen/0000-0002-4234-5686	National Institutes of Health [U54CA244719, R35GM130289, R01GM136976]; Welch Foundation [I-1389, I-1702, I-1944]; Cancer Prevention and Research Institute of Texas [RP180725, RP16082]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas	Work in our laboratories has been supported by grants from the National Institutes of Health (U54CA244719 to Z.J.C., R35GM130289 to X.Z., and R01GM136976 to X.-c.B.), the Welch Foundation (I-1389 to Z.J.C., I-1702 to X.Z., and I-1944 to X.-c.B.), and the Cancer Prevention and Research Institute of Texas (RP180725 to Z.J.C. and RP16082 to X.-c.B.). Z.J.C. is an investigator of the Howard Hughes Medical Institute.	Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; An J, 2017, ARTHRITIS RHEUMATOL, V69, P800, DOI 10.1002/art.40002; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chin KH, 2013, ACTA CRYSTALLOGR D, V69, P352, DOI 10.1107/S0907444912047269; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Cong XY, 2019, J BIOL CHEM, V294, P11420, DOI [10.1074/jbc.RA119.007367, 10.1074/jbc.ra119.007367]; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005; Crow YJ, 2010, EUR J IMMUNOL, V40, P2376, DOI 10.1002/eji.201040829; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Ergun SL, 2019, CELL, V178, P290, DOI 10.1016/j.cell.2019.05.036; Ernst AM, 2018, DEV CELL, V47, P479, DOI 10.1016/j.devcel.2018.10.024; Flood BA, 2019, IMMUNOL REV, V290, P24, DOI 10.1111/imr.12765; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Heinz LX, 2020, NATURE, V581, P316, DOI 10.1038/s41586-020-2282-0; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kato K, 2015, STRUCTURE, V23, P843, DOI 10.1016/j.str.2015.01.023; Kato K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076983; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Kranzusch PJ, 2014, CELL, V158, P1011, DOI 10.1016/j.cell.2014.07.028; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lohofener J, 2015, STRUCTURE, V23, P851, DOI 10.1016/j.str.2015.03.012; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Luecke S, 2017, EMBO REP, V18, P1707, DOI 10.15252/embr.201744017; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; Melki I, 2017, J ALLERGY CLIN IMMUN, V140, P543, DOI 10.1016/j.jaci.2016.10.031; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Ramanjulu JM, 2018, NATURE, V564, P439, DOI 10.1038/s41586-018-0705-y; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Seo GJ, 2015, CELL REP, V13, P440, DOI 10.1016/j.celrep.2015.09.007; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shi HP, 2015, P NATL ACAD SCI USA, V112, P8947, DOI 10.1073/pnas.1507317112; Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Skopelja-Gardner S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64865-w; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Song B., 2020, MOL CELL PROTEOMICS; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tao JL, 2017, J IMMUNOL, V198, P3627, DOI 10.4049/jimmunol.1601909; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Volkman HE, 2019, ELIFE, V8, DOI 10.7554/eLife.47491; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Xie W, 2019, P NATL ACAD SCI USA, V116, P11946, DOI 10.1073/pnas.1905013116; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhao BY, 2019, NATURE, V569, P718, DOI 10.1038/s41586-019-1228-x; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong L, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0162-2; Zhou C, 2020, IMMUNITY, V52, P767, DOI 10.1016/j.immuni.2020.03.016; Zhou W, 2018, CELL, V174, P300, DOI 10.1016/j.cell.2018.06.026; Zhou Y, 2020, IMMUNITY, V52, P357, DOI 10.1016/j.immuni.2020.01.014; Zhu DY, 2014, MOL CELL, V55, P931, DOI 10.1016/j.molcel.2014.08.001; Zierhut C, 2019, CELL, V178, P302, DOI 10.1016/j.cell.2019.05.035	104	114	121	16	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					43	53		10.1016/j.immuni.2020.05.013	http://dx.doi.org/10.1016/j.immuni.2020.05.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32668227	Bronze			2022-12-18	WOS:000551116800009
J	Braza, MS; van Leent, MMT; Lameijer, M; Sanchez-Gaytan, BL; Arts, RJW; Perez-Medina, C; Conde, P; Garcia, MR; Gonzalez-Perez, M; Brahmachary, M; Fay, F; Kluza, E; Kossatz, S; Dress, RJ; Salem, F; Rialdi, A; Reiner, T; Boros, P; Strijkers, GJ; Calcagno, CC; Ginhoux, F; Marazzi, I; Lutgens, E; Nicolaes, GAF; Weber, C; Swirski, FK; Nahrendorf, M; Fisher, EA; Duivenvoorden, R; Fayad, ZA; Netea, MG; Mulder, WJM; Ochando, J				Braza, Mounia S.; van Leent, Mandy M. T.; Lameijer, Marnix; Sanchez-Gaytan, Brenda L.; Arts, Rob J. W.; Perez-Medina, Carlos; Conde, Patricia; Garcia, Mercedes R.; Gonzalez-Perez, Maria; Brahmachary, Manisha; Fay, Francois; Kluza, Ewelina; Kossatz, Susanne; Dress, Regine J.; Salem, Fadi; Rialdi, Alexander; Reiner, Thomas; Boros, Peter; Strijkers, Gustav J.; Calcagno, Claudia C.; Ginhoux, Florent; Marazzi, Ivan; Lutgens, Esther; Nicolaes, Gerry A. F.; Weber, Christian; Swirski, Filip K.; Nahrendorf, Matthias; Fisher, Edward A.; Duivenvoorden, Raphael; Fayad, Zahi A.; Netea, Mihai G.; Mulder, Willem J. M.; Ochando, Jordi			Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance	IMMUNITY			English	Article							RENAL-ALLOGRAFT SURVIVAL; DENDRITIC CELLS; MACROPHAGES; RECOGNITION; ACTIVATION; MONOCYTES; VIMENTIN; IMMUNITY	Inducing graft acceptance without chronic immunosuppression remains an elusive goal in organ transplantation. Using an experimental transplantation mouse model, we demonstrate that local macrophage activation through dectin-1 and toll-like receptor 4 (TLR4) drives trained immunity-associated cytokine production during allograft rejection. We conducted nanoimmunotherapeutic studies and found that a short-term mTOR-specific high-density lipoprotein (HDL) nanobiologic treatment (mTORi-HDL) averted macrophage aerobic glycolysis and the epigenetic modifications underlying inflammatory cytokine production. The resulting regulatory macrophages prevented alloreactive CD8(+) T cell-mediated immunity and promoted tolerogenic CD4(+) regulatory T (Treg) cell expansion. To enhance therapeutic efficacy, we complemented the mTORi-HDL treatment with a CD40-TRAF6-specific nanobiologic (TRAF6i-HDL) that inhibits co-stimulation. This synergistic nanoimmunotherapy resulted in indefinite allograft survival. Together, we show that HDL-based nanoimmunotherapy can be employed to control macrophage function in vivo. Our strategy, focused on preventing inflammatory innate immune responses, provides a framework for developing targeted therapies that promote immunological tolerance.	[Braza, Mounia S.; van Leent, Mandy M. T.; Sanchez-Gaytan, Brenda L.; Perez-Medina, Carlos; Fay, Francois; Strijkers, Gustav J.; Calcagno, Claudia C.; Duivenvoorden, Raphael; Fayad, Zahi A.; Mulder, Willem J. M.] Icahn Sch Med Mt Sinai, Dept Radiol, Translat & Mol Imaging Inst, New York, NY 10029 USA; [Braza, Mounia S.; Brahmachary, Manisha; Boros, Peter; Mulder, Willem J. M.; Ochando, Jordi] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Lameijer, Marnix; Kluza, Ewelina; Lutgens, Esther; Mulder, Willem J. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands; [Arts, Rob J. W.; Netea, Mihai G.] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands; [Arts, Rob J. W.; Netea, Mihai G.] Radboud Univ Nijmegen, Radboud Ctr Infect Dis, Med Ctr, Nijmegen, Netherlands; [Conde, Patricia; Garcia, Mercedes R.; Gonzalez-Perez, Maria; Ochando, Jordi] Inst Salud Carlos III, Transplant Immunol Unit, Natl Ctr Microbiol, Madrid, Spain; [Kossatz, Susanne; Reiner, Thomas] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Dress, Regine J.; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Salem, Fadi] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Rialdi, Alexander; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Reiner, Thomas] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Strijkers, Gustav J.] Acad Med Ctr, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [Lutgens, Esther] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Munich, Germany; [Nicolaes, Gerry A. F.; Weber, Christian] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Swirski, Filip K.; Nahrendorf, Matthias] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Swirski, Filip K.; Nahrendorf, Matthias] Harvard Med Sch, Boston, MA USA; [Fisher, Edward A.] NYU, Sch Med, Dept Med Cardiol, New York, NY USA; [Duivenvoorden, Raphael] Acad Med Ctr, Dept Nephrol, Amsterdam, Netherlands; [Duivenvoorden, Raphael] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Netea, Mihai G.] Univ Bonn, Dept Genom & Immunoregulat, Life & Med Sci Inst LIMES, Bonn, Germany; [Mulder, Willem J. M.] Eindhoven Univ Technol, Dept Biomed Engn, Lab Chem Biol, Eindhoven, Netherlands; [Mulder, Willem J. M.] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Memorial Sloan Kettering Cancer Center; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University; University of Amsterdam; Academic Medical Center Amsterdam; University of Munich; Maastricht University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; New York University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Bonn; Eindhoven University of Technology; Eindhoven University of Technology	Mulder, WJM (corresponding author), Icahn Sch Med Mt Sinai, Dept Radiol, Translat & Mol Imaging Inst, New York, NY 10029 USA.; Mulder, WJM; Ochando, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Mulder, WJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands.; Ochando, J (corresponding author), Inst Salud Carlos III, Transplant Immunol Unit, Natl Ctr Microbiol, Madrid, Spain.; Mulder, WJM (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Lab Chem Biol, Eindhoven, Netherlands.; Mulder, WJM (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands.	willem.mulder@mssm.edu; jordi.ochando@mssm.edu	Braza, MS/AAB-3679-2019; Netea, Mihai/N-5155-2014; Duivenvoorden, Raphaël/B-5154-2019; Mulder, Willem J.M./B-7232-2009; Weber, Christian/AAW-2153-2020; Fisher, Edward/ABE-7469-2020; ROMAN, paTRICIA CONDE-SAN/AAA-7525-2020; Swirski, Filip/AAF-1340-2019; Fayad, Zahi/Z-3272-2019; Salem, Fadi/AAP-9399-2020; Ochando, jordi/ABE-2358-2020; Sanchez-Gaytan, Brenda L/B-2333-2013; Arts, Rob JW/P-8678-2015; Perez-Medina, Carlos/B-2336-2018; Nicolaes, Gerry/A-8421-2016	Duivenvoorden, Raphaël/0000-0003-1446-8336; Mulder, Willem J.M./0000-0001-8665-3878; Weber, Christian/0000-0003-4610-8714; Fayad, Zahi/0000-0002-3439-7347; Salem, Fadi/0000-0002-2603-2778; Ochando, jordi/0000-0001-7037-1681; Arts, Rob JW/0000-0002-6649-7190; Perez-Medina, Carlos/0000-0002-6011-0629; fay, francois/0000-0001-7405-5600; van Leent, Mandy/0000-0002-9747-1022; Fisher, Edward/0000-0001-9802-143X; Gonzalez Perez, Maria/0000-0003-0838-4734; Nicolaes, Gerry/0000-0002-2482-0412; Dress, Regine J./0000-0001-8785-5471; Swirski, Filip/0000-0002-3163-9152; Kossatz, Susanne/0000-0002-1908-1782; Reiner, Thomas/0000-0002-7819-5480; Strijkers, Gustav/0000-0001-6700-5058	National Institutes of Health [R01 HL118440, R01 HL125703, P01 HL131478, R01 AI139623, R01 EB009638, EB009638, R01 HL144072]; NIH Program of Excellence in Nanotechnology (PEN) Award [HHSN368201000045C, K25 EB016673, P30 CA008748]; Harold S. Geneen Charitable Trust; Netherlands Organisation for Scientific Research (NWO) grant ZonMW Veni [016156059]; ZonMW Vidi [91713324]; ZonMW Vici [91818622]; Spanish Ministry of Science [SAF2016-80031-R]; Comunidad de Madrid [B2017/BMD-3731]; American Heart Association [16SDG27250090]; ERC Consolidator Grant [310372]; Spinoza prize of the Netherlands Organisation for Scientific Research; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125703, R01HL144072, P01HL131478, R01HL118440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI139623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K25EB016673, R01EB009638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Program of Excellence in Nanotechnology (PEN) Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold S. Geneen Charitable Trust; Netherlands Organisation for Scientific Research (NWO) grant ZonMW Veni; ZonMW Vidi(Netherlands Organization for Health Research and Development); ZonMW Vici; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); American Heart Association(American Heart Association); ERC Consolidator Grant(European Research Council (ERC)); Spinoza prize of the Netherlands Organisation for Scientific Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank James Hutchinson (University Hospital Regensburg) and Heth Turn-quist (University of Pittsburgh) for critical review of the manuscript. We thank the technical contributions of the flow cytometry and microsurgery shared resource facilities at Mount Sinai. We also acknowledge Marcy Kuenzel and Sridar Chittur at the University of Albany Center for Functional Genomics microarray core facility for their assistance in generating the microarray data. This work was supported by National Institutes of Health grants R01 HL118440, R01 HL125703, and P01 HL131478 (all to W.J.M.M.), R01 AI139623 (to J.O.), R01 EB009638 and EB009638 (to Z.A.F.), and R01 HL144072 (to W.J.M. M. and Z.A.F.); NIH Program of Excellence in Nanotechnology (PEN) Award (HHSN368201000045C to Z.A.F.), K25 EB016673 (T.R.), and P30 CA008748, as well as the Harold S. Geneen Charitable Trust Award (Z.A.F.), the Netherlands Organisation for Scientific Research (NWO) grant ZonMW Veni 016156059 (R.D.), ZonMW Vidi 91713324 (W.J.M. M.), ZonMW Vici 91818622 (W.J.M. M.), the Spanish Ministry of Science grant SAF2016-80031-R (J.O.), and the Comunidad de Madrid grant B2017/BMD-3731 (J.O.). C.C. is supported by a Scientist Development Grant from the American Heart Association (16SDG27250090). M.G.N. is supported by an ERC Consolidator Grant (#310372) and a Spinoza prize of the Netherlands Organisation for Scientific Research. We thank Kaley Joyes for editing the manuscript.	Azimzadeh AM, 2005, AM J TRANSPLANT, V5, P2349, DOI 10.1111/j.1600-6143.2005.01022.x; Braza MS, 2018, AM J TRANSPLANT, V18, P1247, DOI 10.1111/ajt.14645; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Conde P, 2015, IMMUNITY, V42, P1143, DOI 10.1016/j.immuni.2015.05.009; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Dai HH, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6202; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; Duivenvoorden R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4065; Gardiner KM, 2016, ANN TRANSPL, V21; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; HANCOCK WW, 1983, TRANSPLANTATION, V35, P458, DOI 10.1097/00007890-198305000-00013; Huang Y, 2007, AM J TRANSPLANT, V7, P799, DOI 10.1111/j.1600-6143.2007.01734.x; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lakkis FG, 2018, AM J TRANSPLANT, V18, P289, DOI 10.1111/ajt.14436; Lameijer M, 2018, NAT BIOMED ENG, V2, P279, DOI 10.1038/s41551-018-0221-2; Lien YHH, 2016, AM J MED, V129, P568, DOI 10.1016/j.amjmed.2015.11.034; Liu WT, 2012, J IMMUNOL, V188, P2703, DOI 10.4049/jimmunol.1102997; Mantovani A, 2014, CURR OPIN PHARMACOL, V17, P38, DOI 10.1016/j.coph.2014.07.004; Martinez FO, 2015, EXPERT REV CLIN IMMU, V11, P5, DOI 10.1586/1744666X.2015.985658; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; MILLER JF, 1961, LANCET, V2, P748; Mulder WJM, 2018, ACCOUNTS CHEM RES, V51, P127, DOI 10.1021/acs.accounts.7b00339; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Netea MG, 2017, CELL HOST MICROBE, V21, P297, DOI 10.1016/j.chom.2017.02.003; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Oberbarnscheidt MH, 2014, J CLIN INVEST, V124, P3579, DOI 10.1172/JCI74370; Ochando J, 2017, JOVE-J VIS EXP, DOI 10.3791/54242; Page EK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00198; PANTELOURIS EM, 1971, IMMUNOLOGY, V20, P247; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Perez-Medina C, 2015, J NUCL MED, V56, P1272, DOI 10.2967/jnumed.115.158956; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Shen H, 2009, J AM SOC NEPHROL, V20, P1032, DOI 10.1681/ASN.2008070778; Tang J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400223; Thiagarajan PS, 2013, CARDIOVASC RES, V99, P494, DOI 10.1093/cvr/cvt117; Turnquist HR, 2007, J IMMUNOL, V178, P7018, DOI 10.4049/jimmunol.178.11.7018; Weinstein SL, 2000, J LEUKOCYTE BIOL, V67, P405, DOI 10.1002/jlb.67.3.405; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967; Zarzycka B, 2015, J CHEM INF MODEL, V55, P294, DOI 10.1021/ci500631e; Zecher D, 2009, J IMMUNOL, V183, P7810, DOI 10.4049/jimmunol.0902194; Zhuang Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12623	44	114	120	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					819	+		10.1016/j.immuni.2018.09.008	http://dx.doi.org/10.1016/j.immuni.2018.09.008			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30413362	Bronze, Green Accepted, Green Submitted, Green Published			2022-12-18	WOS:000450752200009
J	Kumari, S; Bonnet, MC; Ulvmar, MH; Wolk, K; Karagianni, N; Witte, E; Uthoff-Hachenberg, C; Renauld, JC; Kollias, G; Toftgard, R; Sabat, R; Pasparakis, M; Haase, I				Kumari, Snehlata; Bonnet, Marion C.; Ulvmar, Maria H.; Wolk, Kerstin; Karagianni, Niki; Witte, Ellen; Uthoff-Hachenberg, Claudia; Renauld, Jean-Christophe; Kollias, George; Toftgard, Rune; Sabat, Robert; Pasparakis, Manolis; Haase, Ingo			Tumor Necrosis Factor Receptor Signaling in Keratinocytes Triggers Interleukin-24-Dependent Psoriasis-like Skin Inflammation in Mice	IMMUNITY			English	Article							MOUSE MODEL; IN-VIVO; INTERLEUKIN (IL)-19; INNATE IMMUNITY; CELL-DEATH; DISEASE; IL-22; TNF; ACTIVATION; PROTEIN	Psoriasis is a common chronic inflammatory skin disease with a prevalence of about 2% in the Caucasian population. Tumor necrosis factor (TNF) plays an essential role in the pathogenesis of psoriasis, but its mechanism of action remains poorly understood. Here we report that the development of psoriasis-like skin inflammation in mice with epidermis-specific inhibition of the transcription factor NF-kappa B was triggered by TNF receptor 1 (TNFR1)-dependent upregulation of interleukin-24 (IL-24) and activation of signal transducer and activator of transcription 3 (STAT3) signaling in keratinocytes. IL-24 was strongly expressed in human psoriatic epidermis, and pharmacological inhibition of NF-kappa B increased IL-24 expression in TNF-stimulated human primary keratinocytes, suggesting that this mechanism is relevant for human psoriasis. Therefore, our results expand current views on psoriasis pathogenesis by revealing a new keratinocyte-intrinsic mechanism that links TNFR1, NF-kappa B, ERK, IL-24, IL-22R1, and STAT3 signaling to disease initiation.	[Kumari, Snehlata; Haase, Ingo] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Kumari, Snehlata; Bonnet, Marion C.; Uthoff-Hachenberg, Claudia; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50674 Cologne, Germany; [Kumari, Snehlata; Bonnet, Marion C.; Uthoff-Hachenberg, Claudia; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Ulvmar, Maria H.; Toftgard, Rune] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Wolk, Kerstin; Witte, Ellen; Sabat, Robert] Univ Hosp Charite, Campus Charite Mitte, Interdisciplinary Grp Mol Immunopathol, D-10117 Berlin, Germany; [Witte, Ellen; Sabat, Robert] Univ Hosp Charite, Psoriasis Res & Treatment Ctr, D-10117 Berlin, Germany; [Kollias, George] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari 16672, Greece; [Karagianni, Niki] Biomedcode Hellas SA, Vari 16672, Greece; [Renauld, Jean-Christophe] Ludwig Inst Canc Res Ltd, B-1200 Brussels, Belgium; [Renauld, Jean-Christophe] Catholic Univ Louvain, Expt Med Unit, B-1200 Brussels, Belgium	University of Cologne; University of Cologne; University of Cologne; Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Alexander Fleming Biomedical Sciences Research Center; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Pasparakis, M (corresponding author), Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Zulpicher Str 47a, D-50674 Cologne, Germany.	pasparakis@uni-koeln.de; ingo.haase@uni-koeln.de	Kollias, George/A-7079-2012; Ulvmar, Maria/AAS-2245-2020; Pasparakis, Manolis/N-4350-2019; Bonnet, Marion C/C-5612-2014; Wolk, Kerstin/O-1205-2013; Kumari, Snehlata/ABA-5739-2020; Pasparakis, Manolis/H-9292-2017; Renauld, Jean-Christophe/B-7268-2012	Kollias, George/0000-0003-1867-3150; Ulvmar, Maria/0000-0002-9050-0978; Pasparakis, Manolis/0000-0002-9870-0966; Bonnet, Marion C/0000-0002-7559-2413; Kumari, Snehlata/0000-0002-4971-3162; Pasparakis, Manolis/0000-0002-9870-0966; Wolk, Kerstin/0000-0002-7689-4130; Renauld, Jean-Christophe/0000-0003-1736-2131	IMI project BTCure [115142]; Swedish Cancer Society; DFG [SFB829, SFB670, SA1868/2-1]; EC [223404, 223151]; ERC [2012-ADG_20120314]	IMI project BTCure; Swedish Cancer Society(Swedish Cancer Society); DFG(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); ERC(European Research Council (ERC)European Commission)	We thank J. Pfeiffer, E. Mahlberg, D. Beier, J. Buchholz, B. Hulser, B. Wolff, R. Pofahl, and B. Herzberg for excellent technical support. We acknowledge support by the following grant funding bodies: IMI project BTCure (Grant 115142) (to G. K.), the Swedish Cancer Society (to R. T.), the DFG (SFB829 to M. P. and I. H., SFB670 to M. P., and SA1868/2-1 to R. S.), EC FP7 grants 223404 (Master-switch) and 223151 (InflaCare) (to M. P. and G. K.), and the ERC (2012-ADG_20120314) to M. P. G. K. is a founder, shareholder, and member of the scientific advisory board, and N.K. is an employee of Biomedcode Hellas SA.	Apostolaki M, 2010, CURR DIR AUTOIMMUN, V11, P1, DOI 10.1159/000289195; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Conti P, 2003, IMMUNOL LETT, V88, P171, DOI 10.1016/S0165-2478(03)00087-7; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Haase I, 2001, J CLIN INVEST, V108, P527, DOI 10.1172/JCI200112153; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; He M, 2010, J IMMUNOL, V184, P1793, DOI 10.4049/jimmunol.0901829; Hobbs RM, 2003, J BIOL CHEM, V278, P19798, DOI 10.1074/jbc.M300513200; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Leng RX, 2011, EXPERT OPIN THER TAR, V15, P119, DOI 10.1517/14728222.2011.534461; Lind MH, 2004, P NATL ACAD SCI USA, V101, P4972, DOI 10.1073/pnas.0307106101; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nickoloff BJ, 2000, EXP DERMATOL, V9, P359, DOI 10.1034/j.1600-0625.2000.009005359.x; Nickoloff BJ, 1999, AM J PATHOL, V155, P145, DOI 10.1016/S0002-9440(10)65109-7; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rebholz B, 2007, IMMUNITY, V27, P296, DOI 10.1016/j.immuni.2007.05.024; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; Van Hauwermeiren F, 2013, J CLIN INVEST, V123, P2590, DOI 10.1172/JCI65624; van Hogerlinden M, 1999, CANCER RES, V59, P3299; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; Walczak H, 2011, IMMUNOL REV, V244, P9, DOI 10.1111/j.1600-065X.2011.01066.x; Wang F, 2012, BRIT J DERMATOL, V167, P92, DOI 10.1111/j.1365-2133.2012.10961.x; Weiss B, 2004, GENES IMMUN, V5, P330, DOI 10.1038/sj.gene.6364104; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2011, J IMMUNOL, V186, P1228, DOI 10.4049/jimmunol.0903907; Wolk K, 2009, EUR J IMMUNOL, V39, P3570, DOI 10.1002/eji.200939687; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Yang BX, 2011, MOL CANCER THER, V10, P615, DOI 10.1158/1535-7163.MCT-10-0863; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	46	114	115	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					899	911		10.1016/j.immuni.2013.10.009	http://dx.doi.org/10.1016/j.immuni.2013.10.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24211183	Bronze, Green Accepted			2022-12-18	WOS:000330950600012
J	Kim, MV; Ouyang, W; Liao, W; Zhang, MQ; Li, MO				Kim, Myoungjoo V.; Ouyang, Weiming; Liao, Will; Zhang, Michael Q.; Li, Ming O.			The Transcription Factor Foxo1 Controls Central-Memory CD8(+) T Cell Responses to Infection	IMMUNITY			English	Article							INTERLEUKIN-7 RECEPTOR; IN-VIVO; EFFECTOR; DIFFERENTIATION; GENERATION; SUBSETS; NAIVE; HOMEOSTASIS; SURVIVAL; IMMUNITY	Memory T cells protect hosts from pathogen reinfection, but how these cells emerge from a pool of antigen-experienced T cells is unclear. Here, we show that mice lacking the transcription factor Foxo1 in activated CD8(+) T cells have defective secondary, but not primary, responses to Listeria monocytogenes infection. Compared to short-lived effector T cells, memory-precursor T cells expressed higher amounts of Foxo1, which promoted their generation and maintenance. Chromatin immunoprecipitation sequencing revealed the transcription factor Tcf7 and the chemokine receptor Ccr7 as Foxo1-bound target genes, which have critical functions in central-memory T cell differentiation and trafficking. These findings demonstrate that Foxo1 is selectively incorporated into the genetic program that regulates memory CD8(+) T cell responses to infection.	[Kim, Myoungjoo V.; Ouyang, Weiming; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Kim, Myoungjoo V.; Li, Ming O.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA; [Liao, Will] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Liao, Will] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Zhang, Michael Q.] Tsinghua Univ, TNLIST, Bioinformat Div, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Dallas; Tsinghua University	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	lim@mskcc.org		li, ming/0000-0002-1383-0535	Starr Cancer Consortium [13-A123]; Rita Allen Foundation; NBRPC [2012CB316503]; NIH [HG001696]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER	Starr Cancer Consortium; Rita Allen Foundation; NBRPC(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. Jacob for the Gzmb-cre mouse strain and E. Pamer and I. Leiner for the LM-OVA bacterium strain. This work was supported by the Starr Cancer Consortium (13-A123 to M.O.L. and M.Q.Z.), the Rita Allen Foundation (M.O.L.), the NBRPC (2012CB316503 to M.Q.Z), and the NIH (HG001696 to M.Q.Z.).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Bevan MJ, 2011, NAT IMMUNOL, V12, P463, DOI 10.1038/ni.2041; Bupp MRG, 2009, EUR J IMMUNOL, V39, P2991, DOI 10.1002/eji.200939427; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Sullivan JA, 2012, J VIROL, V86, P9025, DOI 10.1128/JVI.00942-12; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zhang N, 2012, NAT IMMUNOL, V13, P667, DOI 10.1038/ni.2319; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	49	114	116	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					286	297		10.1016/j.immuni.2013.07.013	http://dx.doi.org/10.1016/j.immuni.2013.07.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23932570	Green Accepted, Bronze			2022-12-18	WOS:000330948800011
J	Garg, S; Sharma, M; Ung, C; Tuli, A; Barral, DC; Hava, DL; Veerapen, N; Besra, GS; Hacohen, N; Brenner, MB				Garg, Salil; Sharma, Mahak; Ung, Cindy; Tuli, Amit; Barral, Duarte C.; Hava, David L.; Veerapen, Natacha; Besra, Gurdyal S.; Hacohen, Nir; Brenner, Michael B.			Lysosomal Trafficking, Antigen Presentation, and Microbial Killing Are Controlled by the Arf-like GTPase Arl8b	IMMUNITY			English	Article							T-CELL DEVELOPMENT; CD1D; EXPRESSION; RAB; LOCALIZATION; MOLECULES; PATHWAYS; REVEALS; EVASION; PROTEIN	Antigen presentation and microbial killing are critical arms of host defense that depend upon cargo trafficking into lysosomes. Yet, the molecular regulators of traffic into lysosomes are only partly understood. Here, using a lysosome-dependent immunological screen of a trafficking shRNA library, we identified the Art-like GTPase Arl8b as a critical regulator of cargo delivery to lysosomes. Homotypic fusion and vacuole protein sorting (HOPS) complex members were identified as effectors of Arl8b and were dependent on Arl8b for recruitment to lysosomes, suggesting that Arl8b-HOPS plays a general role in directing traffic to lysosomes. Moreover, the formation of CD1 antigen-presenting complexes in lysosomes, their delivery to the plasma membrane, and phagosome-lysosome fusion were all markedly impaired in Arl8b silenced cells resulting in corresponding defects in T cell activation and microbial killing. Together, these results define Arl8b as a key regulator of lysosomal cellular and immunological functions.	[Sharma, Mahak; Ung, Cindy; Tuli, Amit; Barral, Duarte C.; Hava, David L.; Brenner, Michael B.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Garg, Salil] Harvard Div Med Sci, Grad Program Immunol, Boston, MA 02115 USA; [Garg, Salil] Harvard MIT MD PhD Program, Boston, MA 02115 USA; [Veerapen, Natacha; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA	Harvard University; Brigham & Women's Hospital; University of Birmingham; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Brenner, MB (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA.	mbrenner@rics.bwh.harvard.edu	Sharma, Mahak/AAE-9071-2019; Barral, Duarte/E-7548-2013; Garg, Salil/GXH-2201-2022	Sharma, Mahak/0000-0002-4117-4790; Barral, Duarte/0000-0001-8867-2407; Garg, Salil/0000-0002-7198-1833; Tuli, Amit/0000-0001-5476-4127; Besra, Gurdyal/0000-0002-5605-0395	Medical Council; Wellcome Trust [084923/B/08/7]; NIH [AI028973, AI063428]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028973, R01AI063428, R56AI063428, R37AI028973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; MRC [G0400421] Funding Source: UKRI; Medical Research Council [G0400421] Funding Source: researchfish	Medical Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to acknowledge S. Silver and G. Cowley of the Broad Institute RNAi Platform. We would like to acknowledge S. Porcelli (Albert Einstein) for the gift of L363 antibody and V. Hsu for helpful discussions regarding trafficking. We would like to thank J. Neefjes (Netherlands Cancer Institute), J.W. Harper (Harvard University), V. Faundez (Emory University), R.C. Piper (University of Iowa), and A. Edinger (University of California Irvine) for their general gifts of molecular constructs. S.G. would also like to thank A. Sant (University of Rochester) for helpful discussions and previous mentorship. M.S. would like to thank S. Caplan and N. Naslavsky (University of Nebraska) for their mentorship and gifts of molecular constructs. G.B. acknowledges support from J. Badrick, the Medical Council, and The Wellcome Trust (084923/B/08/7). N.H. is a recipient of the NIH Director's New Innovator Award. This work was primarily funded by NIH grants AI028973 and AI063428 to M.B.	Bagshaw RD, 2006, BIOCHEM BIOPH RES CO, V344, P1186, DOI 10.1016/j.bbrc.2006.03.221; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Cernadas M, 2003, J IMMUNOL, V171, P4149, DOI 10.4049/jimmunol.171.8.4149; Chen N, 2006, EUR J IMMUNOL, V36, P278, DOI 10.1002/eji.200535487; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Hava DL, 2008, P NATL ACAD SCI USA, V105, P11281, DOI 10.1073/pnas.0804681105; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Nakae I, 2010, MOL BIOL CELL, V21, P2434, DOI 10.1091/mbc.E09-12-1010; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Okai T, 2004, J CELL SCI, V117, P4705, DOI 10.1242/jcs.01347; Paul P, 2011, CELL, V145, P268, DOI 10.1016/j.cell.2011.03.023; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Ramachandra L, 2009, CURR OPIN IMMUNOL, V21, P98, DOI 10.1016/j.coi.2009.01.001; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Veerapen N, 2009, BIOORG MED CHEM LETT, V19, P4288, DOI 10.1016/j.bmcl.2009.05.095; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Yuan WM, 2006, NAT IMMUNOL, V7, P835, DOI 10.1038/ni1364; Zhang M, 2009, BIOSCIENCE REP, V29, P193, DOI 10.1042/BSR20090032	30	114	115	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 26	2011	35	2					182	193		10.1016/j.immuni.2011.06.009	http://dx.doi.org/10.1016/j.immuni.2011.06.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21802320	Green Published, hybrid			2022-12-18	WOS:000294387900009
J	Saleh, M; Elson, CO				Saleh, Maya; Elson, Charles O.			Experimental Inflammatory Bowel Disease: Insights into the Host-Microbiota Dialog	IMMUNITY			English	Review							REGULATORY T-CELLS; GENOME-WIDE ASSOCIATION; ACTIVE CROHNS-DISEASE; ULCERATIVE-COLITIS; DENDRITIC CELLS; GUT MICROBIOTA; CUTTING EDGE; COLORECTAL-CANCER; BET DEFICIENCY; MICE DEFICIENT	Inflammatory bowel disease appears to result from an abnormal host immune response to the intestinal microbiota. Experimental models have allowed the dissection of the complex dialog between the host and its microbiota. Through genetic manipulation of the host genome the immune compartments, cells, molecules, and genes that are critical for maintenance of intestinal homeostasis are being identified. Genetic association studies in humans have identified over 100 susceptibility loci. Although there is remarkable coherence between the experimental model and the human genetic data, a full understanding of the mechanisms involved in genetic susceptibility to IBD and of gene-gene and gene-environmental interactions will require a "next generation" of experimental models.	[Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada; [Elson, Charles O.] Univ Alabama Birmingham, Dept Med, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA	McGill University; University of Alabama System; University of Alabama Birmingham	Saleh, M (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada.	maya.saleh@mcgill.ca; coelson@uab.edu		Saleh, Maya/0000-0003-1538-9146	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI056542, U19 AI056542-05] Funding Source: Medline; NIDDK NIH HHS [P01 DK071176, P01 DK071176-06] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bamias G, 2005, GASTROENTEROLOGY, V128, P654, DOI 10.1053/j.gastro.2004.11.053; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Beckwith J, 2005, GASTROENTEROLOGY, V129, P1473, DOI 10.1053/j.gastro.2005.07.057; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Bristol IJ, 2000, INFLAMM BOWEL DIS, V6, P290, DOI 10.1002/ibd.3780060407; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butler M, 2007, J CROHNS COLITIS, V1, P106, DOI 10.1016/j.crohns.2007.08.006; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Campbell BJ, 2001, GLYCOCONJUGATE J, V18, P851, DOI 10.1023/A:1022240107040; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Denning TL, 2005, J IMMUNOL, V174, P7487, DOI 10.4049/jimmunol.174.12.7487; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Elson CO, 2009, INFLAMM BOWEL DIS, P25; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hand T, 2010, CURR OPIN IMMUNOL, V22, P63, DOI 10.1016/j.coi.2010.01.008; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Holmen N, 2006, INFLAMM BOWEL DIS, V12, P447, DOI 10.1097/00054725-200606000-00003; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mizoguchi A, 2000, GASTROENTEROLOGY, V119, P983, DOI 10.1053/gast.2000.18153; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Nguyen DD, 2007, GASTROENTEROLOGY, V133, P1188, DOI 10.1053/j.gastro.2007.07.010; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Panwala CM, 1998, J IMMUNOL, V161, P5733; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2009, IMMUNITY, V31, P454, DOI 10.1016/j.immuni.2009.08.015; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Shanahan F, 2009, CURR OPIN GASTROEN, V25, P301, DOI 10.1097/MOG.0b013e32832b12ef; Shen C, 2008, INFLAMM BOWEL DIS, V14, P1641, DOI 10.1002/ibd.20645; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Takahashi I, 1997, GASTROENTEROLOGY, V112, P1876, DOI 10.1053/gast.1997.v112.pm9178680; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Van Assche G, 2009, CURR OPIN GASTROEN, V25, P323, DOI 10.1097/MOG.0b013e32832c073a; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Weinstock JV, 2009, INFLAMM BOWEL DIS, V15, P128, DOI 10.1002/ibd.20633; Westbrook AM, 2009, CELL CYCLE, V8, P2482, DOI 10.4161/cc.8.16.9274; Wirtz S, 1999, J IMMUNOL, V162, P1884; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Wohlfert E, 2010, MUCOSAL IMMUNOL, V3, P213, DOI 10.1038/mi.2010.11; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yu RY, 2010, J IMMUNOL, V185, P7302, DOI 10.4049/jimmunol.1002410; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	113	114	118	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					293	302		10.1016/j.immuni.2011.03.008	http://dx.doi.org/10.1016/j.immuni.2011.03.008			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435584	Bronze, Green Accepted			2022-12-18	WOS:000289014500006
J	Belver, L; de Yebenes, VG; Ramiro, AR				Belver, Laura; de Yebenes, Virginia G.; Ramiro, Almudena R.			MicroRNAs Prevent the Generation of Autoreactive Antibodies	IMMUNITY			English	Article							BRUTONS TYROSINE KINASE; REACTIVE B-LYMPHOCYTES; MARGINAL-ZONE; CELL DEVELOPMENT; TRANSGENIC MICE; ACTIVATION; EXPRESS; POLYREACTIVITY; TOLERANCE; SELECTION	MicroRNAs have been shown to be critical for a number of aspects of immune system regulation and function. Here, we have examined the role of microRNAs in terminal B cell differentiation by analyzing Cd19-Cre(ki/+) Dicer1(fl/fl) mice. We found that in the absence of Dicer, the transitional and marginal zone (MZ) B cell compartments were overrepresented and follicular (FO) B cell generation was impaired. microRNA analysis revealed that miR185, a microRNA overexpressed in FO cells, dampened B cell receptor (BCR) signaling through Bruton tyrosine kinase downregulation. Dicer-deficient B cells had a skewed BCR repertoire with hallmarks of autoreactivity, which correlated with high titers of autoreactive antibodies in serum and autoimmune features in females. Together, our results reveal a crucial role for microRNAs in late B cell differentiation and in the establishment of B cell tolerance.	[Belver, Laura; de Yebenes, Virginia G.; Ramiro, Almudena R.] Spanish Natl Canc Res Ctr CNIO, DNA Hypermutat & Canc Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Ramiro, AR (corresponding author), Spanish Natl Canc Res Ctr CNIO, DNA Hypermutat & Canc Grp, Madrid 28029, Spain.	aramiro@cnio.es	Belver, Laura/AAH-2177-2019; Belver, Laura/AAC-1621-2021; de Yébenes, Virginia/F-3156-2016; Ramiro, Almudena R/H-6037-2015	Belver, Laura/0000-0001-7493-7072; de Yébenes, Virginia/0000-0002-3785-5868; Ramiro, Almudena R/0000-0002-7539-3844	Spanish National Cancer Research Center (CNIO); Ministerio de Ciencia e Innovacion [SAF2007-63130]; Comunidad Autonoma de Madrid (DIFHEMAT-CM); European Research Council [BCLYM-207844]; CNIO	Spanish National Cancer Research Center (CNIO); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid (DIFHEMAT-CM)(Comunidad de Madrid); European Research Council(European Research Council (ERC)European Commission); CNIO	We would like to thank C.J. Tabin and K. Rajewsky for kindly providing us with Dicer1<SUP>fl/fl</SUP> and Cd19-Cre<SUP>Ki/+</SUP> mice, respectively, V. Barreto, O. Fernandez-Capetillo, I. Moreno de Alboran, and T. Wossning for critical reading of the manuscript, and J.M. Ligos, S. Minguet, D.G. Pisano, G. Gomez, D. Megias, O. Dominguez, D. Martinez, M. Canamero, and C. Velasco for technical advice. L.B. is supported by the Spanish National Cancer Research Center (CNIO), V.G.Y. is a Ramon y Cajal Investigator (Ministerio de Ciencia e Innovacion), and A.R.R. is funded by CNIO. This work was funded by grants from Ministerio de Ciencia e Innovacion (SAF2007-63130), Comunidad Autonoma de Madrid (DIFHEMAT-CM), and European Research Council Starting Grant program (BCLYM-207844).	Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; CROUZIER R, 1995, J IMMUNOL, V154, P4526; Dammers PM, 2000, J IMMUNOL, V165, P6156, DOI 10.4049/jimmunol.165.11.6156; de Yebenes VG, 2008, J EXP MED, V205, P2199, DOI 10.1084/jem.20080579; Dingjan GM, 1998, EMBO J, V17, P5309, DOI 10.1093/emboj/17.18.5309; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grimaldi C, 2005, J IMMUNOL, V174, P1775, DOI 10.4049/jimmunol.174.4.1775; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Halcomb KE, 2008, MOL IMMUNOL, V46, P233, DOI 10.1016/j.molimm.2008.08.278; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; Maas A, 1999, J IMMUNOL, V162, P6526; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Martinez J, 2007, GENE DEV, V21, P1983, DOI 10.1101/gad.1591407; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Satterthwaite AB, 1997, P NATL ACAD SCI USA, V94, P13152, DOI 10.1073/pnas.94.24.13152; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Su TT, 2004, IMMUNOL REV, V197, P161, DOI 10.1111/j.0105-2896.2004.0102.x; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027	39	114	116	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					713	722		10.1016/j.immuni.2010.11.010	http://dx.doi.org/10.1016/j.immuni.2010.11.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21093320	Green Accepted, Bronze			2022-12-18	WOS:000286082600010
J	Jenkins, MR; Tsun, A; Stinchcombe, JC; Griffiths, GM				Jenkins, Misty R.; Tsun, Andy; Stinchcombe, Jane C.; Griffiths, Gillian M.			The Strength of T Cell Receptor Signal Controls the Polarization of Cytotoxic Machinery to the Immunological Synapse	IMMUNITY			English	Article							MICROTUBULE-ORGANIZING CENTER; ALTERED PEPTIDE LIGANDS; SECRETORY LYSOSOMES; POSITIVE SELECTION; ANTIGEN RECEPTOR; ACTIVATION; TCR; CTL; PHOSPHORYLATION; CYTOSKELETON	Killing by cytotoxic T lymphocytes (CTLs) is mediated by the secretion of lytic granules. The centrosome plays a key role in granule delivery, polarizing to the central supramolecular activation complex (cSMAC) within the immunological synapse upon T cell receptor (TCR) activation. Although stronger TCR signals lead to increased target cell death than do weaker signals, it is not known how the strength of TCR signal controls polarization of the centrosome and lytic granules. By using TCR transgenic OT-I CTLs, we showed that both high- and low-avidity interactions led to centrosome polarization to the cSMAC. However, only high-avidity interactions, which induced a higher threshold of intracellular signaling, gave rise to granule recruitment to the polarized centrosome at the synapse. By controlling centrosome and granule polarization independently, the centrosome is able to respond rapidly to weak signals so that CTLs are poised and ready for the trigger for granule delivery.	[Jenkins, Misty R.; Tsun, Andy; Stinchcombe, Jane C.; Griffiths, Gillian M.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Griffiths, GM (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, POB 139,Hills Rd, Cambridge CB2 0XY, England.	gg305@cam.ac.uk		Griffiths, Gillian/0000-0003-0434-5842; stinchcombe, jane/0000-0003-1459-9299	Australian National Health and Medical Research Council Fellowship; Wellcome Trust	Australian National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Rose Zamoyska, Adrian Hayday, Doug Fearon, and Jim Kaufman for excellent questions and discussions; Doug Fearon and James Thaventhiran for OT-I spleens; David Clayton for statistical analysis; and Matthew Gratian, Mark Bowen, and Nick Bright for assistance with imaging. M.R.J. is supported by an Australian National Health and Medical Research Council Fellowship. This research was funded by a Wellcome Trust Principal Research Fellowship to G. M.G.	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Boerth NJ, 2000, J BIOL CHEM, V275, P5143, DOI 10.1074/jbc.275.7.5143; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Giurisato E, 2009, MOL CELL BIOL, V29, P1554, DOI 10.1128/MCB.01421-08; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Koniaras C, 1999, IMMUNOL CELL BIOL, V77, P318, DOI 10.1046/j.1440-1711.1999.00828.x; Konig R, 2002, CURR OPIN IMMUNOL, V14, P75, DOI 10.1016/S0952-7915(01)00300-4; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1985, J MOL CELL IMMUNOL, V2, P37; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Ma JSY, 2008, J IMMUNOL, V181, P4716, DOI 10.4049/jimmunol.181.7.4716; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Poenie M, 2004, CURR OPIN IMMUNOL, V16, P428, DOI 10.1016/j.coi.2004.05.016; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Robertson LK, 2005, J IMMUNOL, V175, P8138, DOI 10.4049/jimmunol.175.12.8138; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015	38	114	119	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					621	631		10.1016/j.immuni.2009.08.024	http://dx.doi.org/10.1016/j.immuni.2009.08.024			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19833087	Green Published, hybrid			2022-12-18	WOS:000271403900013
J	Linterman, MA; Rigby, RJ; Wong, R; Silva, D; Withers, D; Anderson, G; Verma, NK; Brink, R; Hutloff, A; Goodnow, CC; Vinuesa, CG				Linterman, Michelle A.; Rigby, Robert J.; Wong, Raphael; Silva, Diego; Withers, David; Anderson, Graham; Verma, Naresh K.; Brink, Robert; Hutloff, Andreas; Goodnow, Chris C.; Vinuesa, Carola G.			Roquin Differentiates the Specialized Functions of Duplicated T Cell Costimulatory Receptor Genes Cd28 and Icos	IMMUNITY			English	Article							CXC CHEMOKINE RECEPTOR-5; B-CELLS; SALMONELLA-TYPHIMURIUM; CD28-DEFICIENT MICE; UBIQUITIN LIGASE; GERMINAL-CENTERS; CUTTING EDGE; PLASMA-CELL; IN-VIVO; RESPONSES	During evolutionary adaptation in the immune system, host defense is traded off against autoreactivity. Signals through the costimulatory receptor CD28 enable T cells to respond specifically to pathogens, whereas those through the related costimulatory receptor, ICOS, which arose by gene duplication, are critical for affinity maturation and memory antibody responses. ICOS ligand, unlike the pathogen-inducible CD28 ligands, is widely and constitutively expressed in the immune system. Here, we show that crosstalk between these two pathways provides a mechanism for obviating the normal T cell dependence on CD28. Several CD28-mediated responses-generation of follicular helper T cells, germinal center formation, T helper 1 cell-dependent extrafollicular antibody responses to Salmonella and bacterial clearance, and regulatory T cell homeostasis-became independent of CD28 and dependent on ICOS when the E3 ubiquitin ligase Roquin was mutated. Mechanisms to functionally compartmentalize ICOS and CD28 signals are thus critical for two-signal control of normal immune reactions.	[Linterman, Michelle A.; Rigby, Robert J.; Wong, Raphael; Silva, Diego; Goodnow, Chris C.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia; [Goodnow, Chris C.] Australian Phen Facil, Canberra, ACT 2601, Australia; [Withers, David; Anderson, Graham] Univ Birmingham, MRC Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; [Verma, Naresh K.] Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 2601, Australia; [Brink, Robert] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Hutloff, Andreas] Robert Koch Inst, D-13353 Berlin, Germany	Australian National University; John Curtin School of Medical Research; University of Birmingham; Australian National University; Garvan Institute of Medical Research; Robert Koch Institute	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia.	carola.vinuesa@anu.edu.au	Goodnow, Christopher C/V-8108-2018; Linterman, Michelle/AAN-4210-2021; Verma, Naresh/C-9161-2009; Withers, David/C-7055-2015; Hutloff, Andreas/D-1781-2014; Silva, Diego/GRF-5446-2022; Brink, Robert/B-7910-2010; Vinuesa, Carola G/B-1108-2010	Goodnow, Christopher C/0000-0001-5296-6155; Linterman, Michelle/0000-0001-6047-1996; Verma, Naresh/0000-0001-8109-2215; Withers, David/0000-0003-3757-7594; Hutloff, Andreas/0000-0002-0572-8151; Brink, Robert/0000-0002-9586-3655; Vinuesa, Carola G/0000-0001-9799-0298; anderson, graham/0000-0002-2917-4085; Rigby, Robert/0000-0003-3853-1707	Viertel Senior Medical Research Fellowship; National Health and Medical Research Council [316956, 427620]; Juvenile Diabetes Research Foundation [1-2006-96]	Viertel Senior Medical Research Fellowship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was funded by a Viertel Senior Medical Research Fellowship, National Health and Medical Research Council grants 316956 and 427620 to C.G.V. and C.C.G., and Juvenile Diabetes Research Foundation grant 1-2006-96 to C.G.V. and D.S. We thank M. Cook and A. Liston for critical review of the manuscript and helpful discussions.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Beier KC, 2000, EUR J IMMUNOL, V30, P3707, DOI 10.1002/1521-4141(200012)30:12<3707::AID-IMMU3707>3.0.CO;2-Q; Bernard D, 2007, DEV COMP IMMUNOL, V31, P255, DOI 10.1016/j.dci.2006.06.003; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3; Burmeister Y, 2008, J IMMUNOL, V180, P774, DOI 10.4049/jimmunol.180.2.774; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; GROSS JA, 1992, J IMMUNOL, V149, P380; Harada Y, 2003, J EXP MED, V197, P257, DOI 10.1084/jem.20021305; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hess J, 1996, J IMMUNOL, V156, P3321; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hsu E, 1998, IMMUNOL REV, V162, P25, DOI 10.1111/j.1600-065X.1998.tb01426.x; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; LAFFERTY KJ, 1980, IMMUNOL REV, V51, P279, DOI 10.1111/j.1600-065X.1980.tb00325.x; Li WS, 2007, DEV CELL, V12, P235, DOI 10.1016/j.devcel.2006.12.002; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Ling V, 2000, J IMMUNOL, V164, P1653, DOI 10.4049/jimmunol.164.4.1653; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McSorley SJ, 2000, INFECT IMMUN, V68, P3344, DOI 10.1128/IAI.68.6.3344-3348.2000; Mittrucker HW, 1999, J IMMUNOL, V163, P6769; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Riley JL, 2001, J IMMUNOL, V166, P4943, DOI 10.4049/jimmunol.166.8.4943; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; SEGALL T, 1991, J VET MED B, V38, P142, DOI 10.1111/j.1439-0450.1991.tb00857.x; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Suh WK, 2004, J IMMUNOL, V172, P5917, DOI 10.4049/jimmunol.172.10.5917; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tan AHM, 2006, J BIOL CHEM, V281, P28666, DOI 10.1074/jbc.M604081200; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vos Q, 2000, IMMUNOL REV, V176, P154; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Walker LSK, 2003, J IMMUNOL, V170, P91, DOI 10.4049/jimmunol.170.1.91; Watanabe R, 2006, J IMMUNOL, V177, P1085, DOI 10.4049/jimmunol.177.2.1085; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	59	114	117	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					228	241		10.1016/j.immuni.2008.12.015	http://dx.doi.org/10.1016/j.immuni.2008.12.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19217324	Bronze			2022-12-18	WOS:000263710500010
J	Kiel, MJ; Morrison, SJ				Kiel, Mark J.; Morrison, Sean J.			Maintaining hematopoietic stem cells in the vascular niche	IMMUNITY			English	Editorial Material							ENGRAFTMENT; MICE		Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stem Cell Biol, Life Sci Inst, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kiel, MJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.		Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329				Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	10	114	118	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					862	864		10.1016/j.immuni.2006.11.005	http://dx.doi.org/10.1016/j.immuni.2006.11.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174928	Bronze			2022-12-18	WOS:000243087500004
J	Lee, KN; Kang, HS; Jeon, JH; Kim, EM; Yoon, SR; Song, H; Lyu, CY; Piao, ZH; Kim, SU; Han, YH; Song, SS; Lee, YH; Song, KS; Kim, YM; Yu, DY; Choi, I				Lee, KN; Kang, HS; Jeon, JH; Kim, EM; Yoon, SR; Song, H; Lyu, CY; Piao, ZH; Kim, SU; Han, YH; Song, SS; Lee, YH; Song, KS; Kim, YM; Yu, DY; Choi, I			VDUP1 is required for the development of natural killer cells	IMMUNITY			English	Article							UP-REGULATED PROTEIN-1; RECEPTOR-BETA-CHAIN; T-CELL; INTRAEPITHELIAL LYMPHOCYTES; NK CELLS; THIOREDOXIN FUNCTION; EXPRESSION; MICE; D-3; DIFFERENTIATION	Vitamin D-3 upregulated protein 1 (VDUP1) is a stress-response gene that is upregulated by 1,25(OH)(2)D-3 in tumor cells. The in vivo roles of VDUP1 were investigated by producing mice lacking VDUP1 (VDUP1(-/-) mice). VDUP1(-/-) mice showed minimal changes in the development of T and B cells, but there was a profound reduction in the numbers of natural killer (NK) cells. As well, these mice showed decreased NK activity. In the VDUP1(-/-) mice, the expression of CD122 was reduced, demonstrating that VDUP1 is required for CD122 expression and NK maturation. In addition, severe lymphoid hyperplasia in the small intestine was observed in VDUP1(-/-) mice. Taken together, these results suggest that VDUP1 is a critical factor for the development and function of NK cells in vivo.	Korea Res Inst Biosci & Biotechnol, Immunol Lab, Taejon 305333, South Korea; Chonnam Natl Univ, Sch Biol Sci & Technol, Biotechnol Res Inst, Kwangju 500757, South Korea; Korea Res Inst Biosci & Biotechnol, Lab Dev & Differentiat, Taejon 305333, South Korea; Chungnam Natl Univ, Coll Med, Dept Anat, Taejon 301131, South Korea; Chungnam Natl Univ, Coll Med, Dept Pathol, Taejon 301131, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chonnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Chungnam National University	Yu, DY (corresponding author), Korea Res Inst Biosci & Biotechnol, Immunol Lab, Taejon 305333, South Korea.	dyyu10@kribb.re.kr; ipchoi@kribb.re.kr						ALTMANN GG, 1990, INT J CANCER, V46, P965; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Balogh G, 1999, EXP MOL PATHOL, V67, P63, DOI 10.1006/exmp.1999.2264; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P267, DOI 10.1016/S0167-5699(99)01468-1; Brandtzaeg P, 2001, NAT IMMUNOL, V2, P1093, DOI 10.1038/ni1201-1093; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; DANGEAC AD, 1991, J CELL PHYSIOL, V147, P460, DOI 10.1002/jcp.1041470312; Douagi I, 2002, SEMIN IMMUNOL, V14, P361, DOI 10.1016/S1044532302000702; FUJIHASHI K, 1990, J IMMUNOL, V145, P2010; Geldhof AB, 2002, BLOOD, V100, P4049, DOI 10.1182/blood-2001-11-0106; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Iizuka K, 1999, P NATL ACAD SCI USA, V96, P6336, DOI 10.1073/pnas.96.11.6336; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; JORDAN SC, 1989, MOL IMMUNOL, V26, P979, DOI 10.1016/0161-5890(89)90116-8; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Junn E, 2000, J IMMUNOL, V165, P2190, DOI 10.4049/jimmunol.165.4.2190; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kelly JM, 2002, NAT IMMUNOL, V3, P83, DOI 10.1038/ni746; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; LEU RW, 1985, CANCER RES, V45, P3282; Lian RH, 2002, SEMIN IMMUNOL, V14, P453, DOI 10.1016/S1044532302000805; Lin JX, 1997, MOL CELL BIOL, V17, P3714, DOI 10.1128/MCB.17.7.3714; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Mariani E, 1999, CLIN EXP IMMUNOL, V116, P19; Mellqvist UH, 2000, BLOOD, V96, P1961, DOI 10.1182/blood.V96.5.1961.h8001961_1961_1968; MICKEL RA, 1988, CANCER RES, V48, P5017; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; Nakamura K, 1998, CANCER BIOTHER RADIO, V13, P275, DOI 10.1089/cbr.1998.13.275; Nishinaka Y, 2004, CANCER RES, V64, P1287, DOI 10.1158/0008-5472.CAN-03-0908; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Porter BO, 1999, J IMMUNOL, V163, P5906; Raulet DH, 1999, CURR OPIN IMMUNOL, V11, P129, DOI 10.1016/S0952-7915(99)80023-5; RIGBY WFC, 1985, J IMMUNOL, V135, P2279; SCHATTNER A, 1984, ARTHRITIS RHEUM, V27, P1072, DOI 10.1002/art.1780270924; Song H, 2003, IMMUNOL LETT, V86, P235, DOI 10.1016/S0165-2478(03)00024-5; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Verlinden L, 1997, J STEROID BIOCHEM, V60, P87, DOI 10.1016/S0960-0760(96)00174-4; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Williams NS, 1999, J IMMUNOL, V163, P2648; Wong JC, 2002, ONCOGENE, V21, P2009, DOI 10.1038/sj.onc.1205262	49	114	121	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					195	208		10.1016/j.immuni.2004.12.012	http://dx.doi.org/10.1016/j.immuni.2004.12.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723808	Bronze			2022-12-18	WOS:000227509600006
J	Hokama, A; Mizoguchi, E; Sugimoto, K; Shimomura, Y; Tanaka, Y; Yoshida, M; Rietdijk, ST; de Jong, YP; Snapper, SB; Terhorst, C; Blumberg, RS; Mizoguchi, A				Hokama, A; Mizoguchi, E; Sugimoto, K; Shimomura, Y; Tanaka, Y; Yoshida, M; Rietdijk, ST; de Jong, YP; Snapper, SB; Terhorst, C; Blumberg, RS; Mizoguchi, A			Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation	IMMUNITY			English	Article							KINASE-C-THETA; EXPERIMENTAL COLITIS; BOWEL-DISEASE; IMMUNOLOGICAL SYNAPSE; INTERFERON-GAMMA; ACTIVATION; BINDING; INTERLEUKIN-6; MODELS; GLYCOSYLATION	Inflammatory bowel disease is an immune-mediated intestinal inflammatory condition that is associated with an increase in autoantibodies that bind to epithelial cells. However, it is unknown whether the epithelial cell-derived products that are recognized by such autoantibodies are involved in the pathogenic process. Through a combined antigen-screening approach utilizing humoral and cellular immune responses, we identify herein an epithelial lectin, galectin-4, that specifically stimulates IL-6 production by CD4(+) T cells. Interestingly, the reactivity of CD4(+) T cells to galectin-4 is precisely elicited under intestinal inflammatory conditions. The galectin-4-mediated production of IL-6 is MHC class II independent and induced by PKCtheta-associated pathway through the immunological synapse. The galectin-4-mediated stimulation of CD4(+) T cells is shown to exacerbate chronic colitis and delay the recovery from acute intestinal injury. These studies identify the presence of an immunogenic, endogenous lectin in the intestine and dissect the biological role of lectin/CD4(+) T cell interactions under inflammatory conditions.	Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Study Inflammat Bowel Dis, Boston, MA 02114 USA; Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA USA; Harvard Univ, Sch Med, Dept Pathol & Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Mizoguchi, A (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	amizoguchi@partners.org	, Hokama/AAE-1946-2021; Rietdijk, Svend/AAH-7519-2021	, Hokama/0000-0002-8310-9989; 	NIDDK NIH HHS [R01 DK44319, R01 DK53056, DK43351C11, K08DK64289, R01 DK064351, R01 DK57362] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, K08DK064289, R01DK064351, R01DK044319, R01DK053056] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arendt CW, 2002, CURR OPIN IMMUNOL, V14, P323, DOI 10.1016/S0952-7915(02)00346-1; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Baum LG, 2002, IMMUNITY, V16, P5, DOI 10.1016/S1074-7613(02)00265-0; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bhan AK, 1999, IMMUNOL REV, V169, P195, DOI 10.1111/j.1600-065X.1999.tb01316.x; Braccia A, 2003, J BIOL CHEM, V278, P15679, DOI 10.1074/jbc.M211228200; Burack WR, 2002, J IMMUNOL, V169, P2837, DOI 10.4049/jimmunol.169.6.2837; Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Drakesmith H, 1998, P NATL ACAD SCI USA, V95, P14903, DOI 10.1073/pnas.95.25.14903; Dupre L, 2002, IMMUNITY, V17, P157, DOI 10.1016/S1074-7613(02)00360-6; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Gitt MA, 1998, J BIOL CHEM, V273, P2954, DOI 10.1074/jbc.273.5.2954; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Ideo H, 2002, GLYCOBIOLOGY, V12, P199, DOI 10.1093/glycob/12.3.199; Iijima H, 1999, J EXP MED, V190, P607, DOI 10.1084/jem.190.5.607; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Mizoguchi A, 1996, J EXP MED, V183, P847, DOI 10.1084/jem.183.3.847; Mizoguchi A, 1999, GASTROENTEROLOGY, V116, P320, DOI 10.1016/S0016-5085(99)70128-9; Mizoguchi E, 2003, GASTROENTEROLOGY, V125, P148, DOI 10.1016/S0016-5085(03)00665-6; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; Mizoguchi E, 1997, LAB INVEST, V76, P385; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1; Simpson SJ, 1998, J EXP MED, V187, P1225, DOI 10.1084/jem.187.8.1225; STARNES HF, 1990, J IMMUNOL, V145, P4185; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Targan SR, 1998, GASTROENTEROLOGY, V114, P1099, DOI 10.1016/S0016-5085(98)70331-2; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; WILLIAMA KL, 2002, GASTROENTEROLOGY, V120, P925; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	63	114	118	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2004	20	6					681	693		10.1016/j.immuni.2004.05.009	http://dx.doi.org/10.1016/j.immuni.2004.05.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189734	Bronze			2022-12-18	WOS:000222205300005
J	Haas, KM; Hasegawa, M; Steeber, DA; Poe, JC; Zabel, MD; Bock, CB; Karp, DR; Briles, DE; Weis, JH; Tedder, TF				Haas, KM; Hasegawa, M; Steeber, DA; Poe, JC; Zabel, MD; Bock, CB; Karp, DR; Briles, DE; Weis, JH; Tedder, TF			Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses	IMMUNITY			English	Article							SPLENIC MARGINAL ZONE; FOLLICULAR DENDRITIC CELLS; B-CELLS; PNEUMOCOCCAL POLYSACCHARIDES; SUBCLASS RESTRICTION; AFFINITY MATURATION; MICE DEFICIENT; CR2(-/-) MICE; LYMPHOCYTES-B; ANTIGENS	The CD21/35 receptor provides an important link between innate and adaptive immunity. Its importance during protective immune responses to encapsulated extracellular bacteria was assessed using a new line of mice completely deficient in CD21/35 expression (CD21/35(-/-)). CD21/35 expression was essential for the rapid trapping of C3dg-antigen complexes by B cells in vivo, especially in splenic marginal zones. Despite normal B cell development in CD21/35(-/-) mice, T cell-independent and -dependent antibody responses to low-dose antigens were significantly decreased, with a striking impairment in IgG3 responses. Accordingly, CD21/35(-/-) mice were more susceptible to acute lethal Streptococcus pneumoniae infection. Thus, CD21/35 expression is critical for early protective antibody responses to lethal pathogens that rapidly multiply and quickly overwhelm the immune system.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Alabama, Dept Cell & Mol Biol, Birmingham, AL 35294 USA	Duke University; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.			Poe, Jonathan/0000-0002-7789-1564	NATIONAL CANCER INSTITUTE [R55CA054464, R01CA054464, R01CA081776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024158] Funding Source: NIH RePORTER; NCI NIH HHS [CA81776, CA54464] Funding Source: Medline; NIAID NIH HHS [AI24158] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; BITTERSUERMANN D, 1989, CURR TOP MICROBIOL I, V153, P223; Botto M, 1993, Int Rev Immunol, V10, P37, DOI 10.3109/08830189309051170; BRILES DE, 1986, CURR TOP MICROBIOL, V124, P21; BROWN EJ, 1981, J IMMUNOL, V126, P2230; BURMAN LA, 1985, REV INFECT DIS, V7, P133; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Chen ZB, 2000, J IMMUNOL, V164, P4522, DOI 10.4049/jimmunol.164.9.4522; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Fang YF, 1998, J IMMUNOL, V160, P5273; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Fischer MB, 1996, J IMMUNOL, V157, P549; GREENSPAN NS, 1993, SPRINGER SEMIN IMMUN, V15, P275; GRIFFIOEN AW, 1991, INFECT IMMUN, V59, P1839, DOI 10.1128/IAI.59.5.1839-1845.1991; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; Hasegawa M, 2001, J IMMUNOL, V167, P3190, DOI 10.4049/jimmunol.167.6.3190; HEBELL T, 1991, SCIENCE, V254, P102, DOI 10.1126/science.1718035; Henson SE, 2001, J IMMUNOL METHODS, V258, P97, DOI 10.1016/S0022-1759(01)00471-9; HEYMAN B, 1990, J EXP MED, V172, P665, DOI 10.1084/jem.172.2.665; KINOSHITA T, 1988, J IMMUNOL, V140, P3066; Kuijpers T W, 1992, Allergol Immunopathol (Madr), V20, P28; Llopis MJP, 1996, J ALLERGY CLIN IMMUN, V97, P1015, DOI 10.1016/S0091-6749(96)80078-9; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; McLay J, 2002, J IMMUNOL, V168, P3437, DOI 10.4049/jimmunol.168.7.3437; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MORI H, 1989, INT J IMMUNOPHARMACO, V11, P597, DOI 10.1016/0192-0561(89)90144-6; Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165; Oliver AM, 1999, J IMMUNOL, V162, P7198; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; PERLMUTTER RM, 1978, J IMMUNOL, V121, P566; Poe J C, 2001, Int Rev Immunol, V20, P739, DOI 10.3109/08830180109045588; PRYJMA J, 1974, NATURE, V252, P505, DOI 10.1038/252505a0; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Sato S, 1996, J IMMUNOL, V157, P4371; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SHACKELFORD PG, 1988, J IMMUNOL, V140, P3200; Test ST, 2001, INFECT IMMUN, V69, P3031, DOI 10.1128/IAI.69.5.3031-3040.2001; THORNTON BP, 1994, J IMMUNOL, V152, P1727; THYPHRONITIS G, 1991, J IMMUNOL, V147, P224; TIMENS W, 1989, J IMMUNOL, V143, P3200; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WINKELSTEIN JA, 1981, REV INFECT DIS, V3, P289; Wu XB, 2000, J IMMUNOL, V165, P3119, DOI 10.4049/jimmunol.165.6.3119	47	114	118	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					713	723		10.1016/S1074-7613(02)00483-1	http://dx.doi.org/10.1016/S1074-7613(02)00483-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479818	Bronze			2022-12-18	WOS:000179985500004
J	Zal, T; Zal, MA; Gascoigne, NRJ				Zal, T; Zal, MA; Gascoigne, NRJ			Inhibition of T cell receptor-coreceptor interactions by antagonist ligands visualized by live FRET imaging of the T-hybridoma immunological synapse	IMMUNITY			English	Article							RESONANCE ENERGY-TRANSFER; GREEN FLUORESCENT PROTEIN; PHYSICAL ASSOCIATION; CD4; ANTIGEN; COMPLEX; RECOGNITION; ACTIVATION; SURFACE; EFFICIENCY	The diverse effects of TCR agonists and antagonists on T cell activation are believed to be modified by the differential recruitment of CD4 or CD8 coreceptors to the TCR-MHCp complex. We used three-dimensional live cell imaging of fluorescence resonance energy transfer (FRET) between CD3zeta and CD4 fused to variants of the green fluorescent protein to investigate TCR-CD4 interactions during T cell activation, We demonstrate that recognition of agonist MHCp complexes triggers intermolecular interaction between CD4 and TCR, detectable across the T-hybridoma-APC contact area. This interaction is blocked by the presence of antagonist ligands without decreasing the recruitment of and CD4 or preventing their partial colocalization in the immunological synapse.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Gascoigne, NRJ (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Zal, Tomasz/0000-0002-3469-4261	NIDA NIH HHS [R03 DA 14036] Funding Source: Medline; NIDDK NIH HHS [R21 DK 61329] Funding Source: Medline; NIGMS NIH HHS [R01 GM 48002, R01 GM 39476] Funding Source: Medline; NIMH NIH HHS [P30 MH 62261] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK061329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048002, R01GM039476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA014036] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDERSON P, 1988, J IMMUNOL, V140, P1732; BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; GASCOIGNE NRJ, 2001, EXP REV MOL MED 0212; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; Huang J, 2000, EUR J IMMUNOL, V30, P50, DOI 10.1002/1521-4141(200001)30:1<50::AID-IMMU50>3.3.CO;2-9; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KINCH MS, 1993, J IMMUNOL, V151, P4552; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1987, P NATL ACAD SCI USA, V84, P5888, DOI 10.1073/pnas.84.16.5888; Lim GEK, 1998, EUR J IMMUNOL, V28, P745, DOI 10.1002/(SICI)1521-4141(199802)28:02<745::AID-IMMU745>3.0.CO;2-6; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MAZEROLLES F, 1990, EUR J IMMUNOL, V20, P637, DOI 10.1002/eji.1830200326; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; MITTLER RS, 1989, P NATL ACAD SCI USA, V86, P8531, DOI 10.1073/pnas.86.21.8531; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; ROJO JM, 1989, P NATL ACAD SCI USA, V86, P3311, DOI 10.1073/pnas.86.9.3311; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; TRON L, 1984, BIOPHYS J, V45, P939, DOI 10.1016/S0006-3495(84)84240-X; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vignali DAA, 1996, J EXP MED, V183, P2097, DOI 10.1084/jem.183.5.2097; Volkmann A, 1998, J EXP MED, V188, P1083, DOI 10.1084/jem.188.6.1083; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; YOUWAN DC, 1997, BIOTECHNOL; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8	33	114	115	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2002	16	4					521	534		10.1016/S1074-7613(02)00301-1	http://dx.doi.org/10.1016/S1074-7613(02)00301-1			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970876	Bronze			2022-12-18	WOS:000175109600004
J	Hippen, KL; Buhl, AM; DAmbrosio, D; Nakamura, K; Persin, C; Cambier, JC				Hippen, KL; Buhl, AM; DAmbrosio, D; Nakamura, K; Persin, C; Cambier, JC			Fc gamma RIIB1 inhibition of BCR-mediated phosphoinositide hydrolysis and Ca2+ mobilization is integrated by CD19 dephosphorylation	IMMUNITY			English	Article							SIGNAL-TRANSDUCTION MOLECULE; TYROSINE ACTIVATION MOTIF; B-LYMPHOCYTE DEVELOPMENT; CELL ANTIGEN RECEPTOR; FC-GAMMA RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; IG-ALPHA; CYTOPLASMIC DOMAIN; CROSS-LINKING; SH2 DOMAINS	The B cell receptor for immunoglobulin G, Fc gamma RIIB1, is a potent transducer of signals that block antigen-induced B cell activation. Coligation of Fc gamma RIIB1 with B lymphocyte antigen receptors (BCR) causes premature termination of phosphoinositide hydrolysis and Ca2+ mobilization and inhibits proliferation. This inhibitory signal is mediated in part by phosphorylation of Fc gamma RIIB1 and recruitment of phosphatases; however, the molecular target(s) of effecters is unknown. Here we report that Fc gamma RIIB1 inhibition of BCR signaling is mediated in part by selective dephosphorylation of CD19, a BCR accessory molecule and coreceptor. CD19 dephosphorylation leads to failed CD19 association with phosphatidylinositol 3-kinase, and this in turn leads to termination of inositol-1,4,5-trisphosphate production, intracellular Ca2+ release, and Ca2+ influx. The results define a molecular circuit by which Fc gamma RIIB signals block phosphoinositide hydrolysis.	UNIV COLORADO,HLTH SCI CTR,NATL JEWISH MED & RES CTR,DEPT PEDIAT,DIV BASIC SCI,DENVER,CO 80206	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver				Cambier, John/0000-0002-7803-242X				AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; Ashman RF, 1996, J IMMUNOL, V157, P5; BIJSTERBOSCH MK, 1985, J EXP MED, V162, P1825, DOI 10.1084/jem.162.6.1825; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; CAMBIER J, 1988, P NATL ACAD SCI USA, V85, P6493, DOI 10.1073/pnas.85.17.6493; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Chacko GW, 1996, J IMMUNOL, V157, P2234; CHALUPNY NJ, 1993, EMBO J, V12, P2691, DOI 10.1002/j.1460-2075.1993.tb05930.x; CHAN PL, 1971, IMMUNOLOGY, V21, P967; CHOQUET D, 1993, J CELL BIOL, V121, P355, DOI 10.1083/jcb.121.2.355; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; COUTURE C, 1994, MOL CELL BIOL, V14, P5249, DOI 10.1128/MCB.14.8.5249; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; DAmbrosio D, 1996, IMMUNOL LETT, V54, P77, DOI 10.1016/S0165-2478(96)02653-3; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; FLASWINKEL H, 1994, EMBO J, V13, P83, DOI 10.1002/j.1460-2075.1994.tb06237.x; FONG DC, 1996, IMMUNOL LETT, V54, P124; FRIDMAN WH, 1992, IMMUNOL REV, V125, P49, DOI 10.1111/j.1600-065X.1992.tb00625.x; FUKAZAWA T, 1995, J BIOL CHEM, V270, P20177, DOI 10.1074/jbc.270.34.20177; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; JONES B, 1986, J IMMUNOL, V136, P348; JUSTEMENT LB, 1989, J IMMUNOL, V143, P881; Kiener PA, 1997, J BIOL CHEM, V272, P3838, DOI 10.1074/jbc.272.6.3838; KIM KJ, 1979, J IMMUNOL, V122, P549; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Musci MA, 1997, J IMMUNOL, V158, P1565; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; OKADA T, 1994, J BIOL CHEM, V269, P3568; Olcese L, 1996, J IMMUNOL, V156, P4531; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; ONO M, 1997, IN PRESS CELL; PHILLIPS NE, 1983, J IMMUNOL, V130, P602; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SILLMAN AL, 1995, J BIOL CHEM, V270, P11806, DOI 10.1074/jbc.270.20.11806; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; VELY F, 1997, IN PRESS EUR J IMMUN; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WENG WK, 1994, J BIOL CHEM, V269, P32514; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WILSON HA, 1987, J IMMUNOL, V138, P1712; YANO H, 1993, J BIOL CHEM, V268, P25846; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884	53	114	114	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					49	58		10.1016/S1074-7613(00)80509-9	http://dx.doi.org/10.1016/S1074-7613(00)80509-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252119	Bronze			2022-12-18	WOS:A1997XN69300005
J	Shu, T; Ning, WS; Wu, D; Xu, JQ; Han, QQ; Huang, MH; Zou, XJ; Yang, QY; Yuan, Y; Bie, YY; Pan, SW; Mu, JF; Han, Y; Yang, XB; Zhou, H; Li, RT; Ren, YJ; Chen, X; Yao, SL; Qiu, Y; Zhang, DY; Xue, Y; Shang, Y; Zhou, X				Shu, Ting; Ning, Wanshan; Wu, Di; Xu, Jiqian; Han, Qiangqiang; Huang, Muhan; Zou, Xiaojing; Yang, Qingyu; Yuan, Yang; Bie, Yuanyuan; Pan, Shangwen; Mu, Jingfang; Han, Yang; Yang, Xiaobo; Zhou, Hong; Li, Ruiting; Ren, Yujie; Chen, Xi; Yao, Shanglong; Qiu, Yang; Zhang, Ding-Yu; Xue, Yu; Shang, You; Zhou, Xi			Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19	IMMUNITY			English	Article							L-PLASTIN; FETUIN-B; PROTEIN; FRACTIONATION; DISEASE; MICE	The coronavirus disease 2019 (COVID-19) pandemic is a global public health crisis. However, little is known about the pathogenesis and biomarkers of COVID-19. Here, we profiled host responses to COVID-19 by performing plasma proteomics of a cohort of COVID-19 patients, including non-survivors and survivors recovered from mild or severe symptoms, and uncovered numerous COVID-19-associated alterations of plasma proteins. We developed a machine-learning-based pipeline to identify 11 proteins as biomarkers and a set of biomarker combinations, which were validated by an independent cohort and accurately distinguished and predicted COVID-19 outcomes. Some of the biomarkers were further validated by enzyme-linked immunosorbent assay (ELISA) using a larger cohort. These markedly altered proteins, including the biomarkers, mediate pathophysiological pathways, such as immune or inflammatory responses, platelet degranulation and coagulation, and metabolism, that likely contribute to the pathogenesis. Our findings provide valuable knowledge about COVID-19 biomarkers and shed light on the pathogenesis and potential therapeutic targets of COVID-19.	[Shu, Ting; Yang, Qingyu; Yuan, Yang; Han, Yang; Zhou, Hong; Zhang, Ding-Yu] Wuhan Jinyintan Hosp, Wuhan Inst Virol, Joint Lab Infect Dis & Hlth, Wuhan 430023, Hubei, Peoples R China; [Shu, Ting; Yang, Qingyu; Yuan, Yang; Han, Yang; Zhou, Hong; Zhang, Ding-Yu] Wuhan Jinyintan Hosp, Wuhan 430023, Hubei, Peoples R China; [Shu, Ting; Wu, Di; Huang, Muhan; Yang, Qingyu; Bie, Yuanyuan; Mu, Jingfang; Han, Yang; Ren, Yujie; Qiu, Yang; Zhou, Xi] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China; [Shu, Ting; Yang, Qingyu; Yuan, Yang; Han, Yang; Zhou, Hong; Qiu, Yang; Zhang, Ding-Yu; Zhou, Xi] Wuhan Jinyintan Hosp, Ctr Translat Med, Wuhan 430023, Hubei, Peoples R China; [Ning, Wanshan; Xue, Yu] Huazhong Univ Sci & Technol HUST, Coll Life Sci & Technol, Ctr Artificial Intelligence Biol, Hubei Bioinformat & Mol Imaging Key Lab,MOE Key L, Wuhan 430074, Hubei, Peoples R China; [Wu, Di; Huang, Muhan; Mu, Jingfang; Ren, Yujie; Qiu, Yang; Zhou, Xi] Chinese Acad Sci, Wuhan Inst Virol, Joint Lab Infect Dis & Hlth, Wuhan 430023, Hubei, Peoples R China; [Wu, Di; Huang, Muhan; Mu, Jingfang; Ren, Yujie; Qiu, Yang; Zhou, Xi] Chinese Acad Sci, Wuhan Jinyintan Hosp, Wuhan 430023, Hubei, Peoples R China; [Xu, Jiqian; Zou, Xiaojing; Pan, Shangwen; Yang, Xiaobo; Li, Ruiting; Shang, You] HUST, Tongji Med Coll, Union Hosp, Dept Crit Care Med, Wuhan 430030, Hubei, Peoples R China; [Han, Qiangqiang; Chen, Xi] SpecAlly Life Technol Co Ltd, Wuhan 430075, Hubei, Peoples R China; [Bie, Yuanyuan; Qiu, Yang; Zhou, Xi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yao, Shanglong; Shang, You] HUST, Tongji Med Coll, Union Hosp, Inst Anesthesiol & Crit Care Med, Wuhan 430030, Hubei, Peoples R China; [Yao, Shanglong; Shang, You] Clin Res Ctr Anesthesiol Hubei Prov, Wuhan 430030, Peoples R China; [Zhang, Ding-Yu; Shang, You] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan 430071, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Wuhan Jinyintan Hospital; Wuhan Jinyintan Hospital; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Wuhan Jinyintan Hospital; Huazhong University of Science & Technology; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; Wuhan Jinyintan Hospital; Huazhong University of Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Huazhong University of Science & Technology; Chinese Academy of Sciences	Zhang, DY (corresponding author), Wuhan Jinyintan Hosp, Wuhan Inst Virol, Joint Lab Infect Dis & Hlth, Wuhan 430023, Hubei, Peoples R China.; Zhang, DY (corresponding author), Wuhan Jinyintan Hosp, Wuhan 430023, Hubei, Peoples R China.; Qiu, Y; Zhou, X (corresponding author), Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China.; Qiu, Y; Zhang, DY; Zhou, X (corresponding author), Wuhan Jinyintan Hosp, Ctr Translat Med, Wuhan 430023, Hubei, Peoples R China.; Xue, Y (corresponding author), Huazhong Univ Sci & Technol HUST, Coll Life Sci & Technol, Ctr Artificial Intelligence Biol, Hubei Bioinformat & Mol Imaging Key Lab,MOE Key L, Wuhan 430074, Hubei, Peoples R China.; Qiu, Y; Zhou, X (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Joint Lab Infect Dis & Hlth, Wuhan 430023, Hubei, Peoples R China.; Qiu, Y; Zhou, X (corresponding author), Chinese Acad Sci, Wuhan Jinyintan Hosp, Wuhan 430023, Hubei, Peoples R China.; Shang, Y (corresponding author), HUST, Tongji Med Coll, Union Hosp, Dept Crit Care Med, Wuhan 430030, Hubei, Peoples R China.; Qiu, Y; Zhou, X (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Shang, Y (corresponding author), HUST, Tongji Med Coll, Union Hosp, Inst Anesthesiol & Crit Care Med, Wuhan 430030, Hubei, Peoples R China.; Shang, Y (corresponding author), Clin Res Ctr Anesthesiol Hubei Prov, Wuhan 430030, Peoples R China.; Zhang, DY; Shang, Y (corresponding author), Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan 430071, Hubei, Peoples R China.	yangqiu@wh.lov.cn; zhangdy@hotmail.com; xueyu@hust.edu.cn; you_shanghust@163.com; zhouxi@wh.iov.cn	Yang, Heroine/GRY-2630-2022; Xue, Yu/G-5929-2011	Xue, Yu/0000-0002-9403-6869; Qiu, Yang/0000-0001-5152-1242; shang, you/0000-0003-4097-6131; Ning, Wanshan/0000-0002-1410-7891; Li, Ruiting/0000-0001-8041-1050; Zhou, Xi/0000-0002-3846-5079	Strategic Priority Research Program of CAS [XDB29010300]; National Science and Technology Major Project [2020ZX09201-001, 2018ZX10101004]; National Natural Science Foundation of China [81873964, 81971818, 81772047, 31930021, 31970633, 34671360, 82002155, 32000131, 31670161]; CAS Youth Innovation Promotion Association [2020332]; program for HUST Academic Frontier Youth Team; Clinical Research Center for Anesthesiology of Hubei Province [2019ACA167]	Strategic Priority Research Program of CAS; National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Youth Innovation Promotion Association; program for HUST Academic Frontier Youth Team; Clinical Research Center for Anesthesiology of Hubei Province	We thank the patients and the nurses and clinical staff who are providing care for these patients. We also thank many staffmembers at Wuhan Jinyintan Hospital and SpecAlly Life Technology Co., Ltd. for their contributions and assistance in this study and Dr. Zhimei Ma for technical support. We thank Mr. An Wang and other members of Zhou group for their assistance. We sincerely pay tribute to our colleagues who have strived in the forefront of treating COVID-19 patients and are studying this coronavirus inWuhan and around the world. This work was supported by the Strategic Priority Research Program of CAS (XDB29010300 to X. Zhou.), the National Science and Technology Major Project (2020ZX09201-001 to D.-Y.Z. and 2018ZX10101004 to X. Zhou.), National Natural Science Foundation of China (81873964 to Y.Q.; 81971818 and 81772047 to Y.S.; 31930021, 31970633, and 34671360 to Y.X.; 82002155 to T.S.; 32000131 to D.W.; and 31670161 to X. Zhou.), grant from the CAS Youth Innovation Promotion Association (2020332 to Y.Q.), the program for HUST Academic Frontier Youth Team (Y.X.), and grant from Clinical Research Center for Anesthesiology of Hubei Province (2019ACA167).	[Anonymous], LANCET, DOI DOI 10.1016/S0140-6736(20)30211-7; Baneres-Roquet F, 2009, ANTIMICROB AGENTS CH, V53, P1528, DOI 10.1128/AAC.00971-08; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Batth TS, 2014, J PROTEOME RES, V13, P6176, DOI 10.1021/pr500893m; Bengtsson AA, 2012, ARTHRITIS RHEUM-US, V64, P1579, DOI 10.1002/art.33493; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Calderone A, 2013, NAT METHODS, V10, P690, DOI 10.1038/nmeth.2561; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Ceciliani F, 2019, CURR PROTEIN PEPT SC, V20, P505, DOI 10.2174/1389203720666190405101138; Choi JW, 2012, CELL PHYSIOL BIOCHEM, V30, P295, DOI 10.1159/000339065; CICHY J, 1995, J CLIN INVEST, V95, P2729, DOI 10.1172/JCI117975; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Deady LE, 2014, INFECT IMMUN, V82, P1982, DOI 10.1128/IAI.01199-13; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gu X., 2020, LANCET, V395, P506, DOI [10.1016/S0140-6736(20)30183-5, DOI 10.1016/S0140-6736(20)30183-5]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hassan MI, 2008, MOL CANCER RES, V6, P892, DOI 10.1158/1541-7786.MCR-07-2195; Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karmilin K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37024-5; Kotlyar M, 2019, NUCLEIC ACIDS RES, V47, pD581, DOI 10.1093/nar/gky1037; Lachmann PJ, 2019, IMMUNOBIOLOGY, V224, P511, DOI 10.1016/j.imbio.2019.05.003; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; Li TB, 2017, NAT METHODS, V14, P61, DOI 10.1038/nmeth.4083; Liu MJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00062; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Luo ZM, 2015, J PHYSIOL BIOCHEM, V71, P329, DOI 10.1007/s13105-015-0389-9; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Martinelli AEM, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0888-0; Meex RC, 2015, CELL METAB, V22, P1078, DOI 10.1016/j.cmet.2015.09.023; Miao M, 2019, VIROL SIN, V34, P549, DOI 10.1007/s12250-019-00131-2; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; National Health Commission, 2020, PROT PREV CONTR COVI; Ning WS, 2021, BRIEF BIOINFORM, V22, P1836, DOI 10.1093/bib/bbaa038; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Regn M, 2016, J MOL CELL CARDIOL, V99, P57, DOI 10.1016/j.yjmcc.2016.08.010; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Todd EM, 2016, BLOOD, V128, P2785, DOI 10.1182/blood-2016-03-705962; Tyagi Ethika, 2013, Int J Alzheimers Dis, V2013, P606083, DOI 10.1155/2013/606083; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Venancio TM, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1784014; Wang D, 2020, J AEROSPACE ENG, V33, DOI 10.1061/(ASCE)AS.1943-5525.0001149; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; WHO, 2020, 128 WHO; Wu D, 2020, NATL SCI REV, V7, P1157, DOI 10.1093/nsr/nwaa086; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3; Xu JQ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03098-9; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yang XB, 2020, J THROMB HAEMOST, V18, P1469, DOI 10.1111/jth.14848; Yaprak E, 2018, J DENT SCI, V13, P386, DOI 10.1016/j.jds.2018.08.004; Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1; Zhang Y, 2020, VIROL SIN, V35, P143, DOI 10.1007/s12250-019-00157-6; Zhou, NATURE, V579, P270; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	64	113	117	16	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					1108	+		10.1016/j.immuni.2020.10.008	http://dx.doi.org/10.1016/j.immuni.2020.10.008			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33128875	Bronze, Green Published			2022-12-18	WOS:000599348200019
J	Johnson, JL; Georgakilas, G; Petrovic, J; Kurachi, M; Cai, S; Harly, C; Pear, WS; Bhandoola, A; Wherry, EJ; Vahedi, G				Johnson, John L.; Georgakilas, Georgios; Petrovic, Jelena; Kurachi, Makoto; Cai, Stanley; Harly, Christelle; Pear, Warren S.; Bhandoola, Avinash; Wherry, E. John; Vahedi, Golnaz			Lineage-Determining Transcription Factor TCF-1 Initiates the Epigenetic Identity of T Cells	IMMUNITY			English	Article							GENE-EXPRESSION; CHROMATIN; OCCUPANCY; SPECIFICATION; ACCESSIBILITY; LANDSCAPE; STABILITY; ENHANCER; BINDING	T cell development is orchestrated by transcription factors that regulate the expression of genes initially buried within inaccessible chromatin, but the transcription factors that establish the regulatory landscape of the T cell lineage remain unknown. Profiling chromatin accessibility at eight stages of T cell development revealed the selective enrichment of TCF-1 at genomic regions that became accessible at the earliest stages of development. TCF-1 was further required for the accessibility of these regulatory elements and at the single-cell level, it dictated a coordinate opening of chromatin in T cells. TCF-1 expression in fibroblasts generated de novo chromatin accessibility even at chromatin regions with repressive marks, inducing the expression of T cell-restricted genes. These results indicate that a mechanism by which TCF-1 controls T cell fate is through its widespread ability to target silent chromatin and establish the epigenetic identity of T cells.	[Johnson, John L.; Georgakilas, Georgios; Cai, Stanley; Vahedi, Golnaz] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Johnson, John L.; Georgakilas, Georgios; Petrovic, Jelena; Kurachi, Makoto; Cai, Stanley; Pear, Warren S.; Wherry, E. John; Vahedi, Golnaz] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Johnson, John L.; Georgakilas, Georgios; Cai, Stanley; Vahedi, Golnaz] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA; [Petrovic, Jelena; Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kurachi, Makoto; Wherry, E. John] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Harly, Christelle; Bhandoola, Avinash] NCI, NIH, Bethesda, MD 20184 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Vahedi, G (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA.	vahedi@pennmedicine.upenn.edu	Wherry, John/ABI-1280-2020; Georgakilas, Georgios/W-5874-2019	Harly, Christelle/0000-0002-8045-9166; Georgakilas, Georgios/0000-0003-1160-5753	NIH [K22AI112570, R01AI047833, P01CA119070, AI105343, AI082630, AI112521, AI115712, AI117718, AI108545, AI117950]; Sloan Foundation; National Psoriasis Foundation; LLS Fellow Award; Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE [ZIABC011633, P01CA119070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI115712, R01AI047833, U19AI082630, R01AI105343, R21AI117718, U19AI117950, K22AI112570, P01AI108545, P01AI112521] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation(Alfred P. Sloan Foundation); National Psoriasis Foundation; LLS Fellow Award; Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the NGS sequencing facilities at Penn's School of Medicine and Vet School. We are grateful to Drs. Shelley Berger, Kenneth Zaret, Douglas Epstein, Klaus Kaestner, R. Babak Faryabi, Jorge Henao-Mejia, Maria Fasolino, and Naomi Goldman for critically reading this manuscript. We thank members of the Vahedi, Wherry, and Faryabi labs particularly Aaron Chen, Gregory Schwartz, and Yeqiao Zhou. We thank Stephanie Sansbury for initial RNA-seq library and Junko Kurachi for designing and validating the constructs. This study is funded by NIH K22AI112570, Sloan Foundation, and National Psoriasis Foundation to G.V., LLS Fellow Award to J.P., and NIH R01AI047833 and P01CA119070 to W.S.P., and NIH AI105343, AI082630, AI112521, AI115712, AI117718, AI108545, AI117950, and funding from the Parker Institute for Cancer Immunotherapy to E.J.W.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Boller S, 2016, IMMUNITY, V44, P527, DOI 10.1016/j.immuni.2016.02.021; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Chung H. R, 2016, NORMR NORMALIZATION; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Di Stefano B, 2014, NATURE, V506, P235, DOI 10.1038/nature12885; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dose M, 2014, P NATL ACAD SCI USA, V111, P391, DOI 10.1073/pnas.1315752111; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gray SM, 2017, IMMUNITY, V46, P596, DOI 10.1016/j.immuni.2017.03.012; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lepoivre C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-914; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Li Q., 2011, MEASURING REPRODUCIB, P1752; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; Mudge JM, 2015, MAMM GENOME, V26, P366, DOI 10.1007/s00335-015-9583-x; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Oestreich KJ, 2012, CURR TOP MICROBIOL, V356, P145, DOI 10.1007/82_2011_141; Osipovich O, 2010, SEMIN IMMUNOL, V22, P313, DOI 10.1016/j.smim.2010.07.001; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Team RC, 2016, R LANG ENV STAT COMP; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wohrle S, 2007, MOL CELL BIOL, V27, P8164, DOI 10.1128/MCB.00555-07; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	57	113	113	5	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					243	+		10.1016/j.immuni.2018.01.012	http://dx.doi.org/10.1016/j.immuni.2018.01.012			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466756	Green Accepted, Bronze			2022-12-18	WOS:000425507800011
J	Paules, CI; Marston, HD; Eisinger, RW; Baltimore, D; Fauci, AS				Paules, Catharine I.; Marston, Hilary D.; Eisinger, Robert W.; Baltimore, David; Fauci, Anthony S.			The Pathway to a Universal Influenza Vaccine	IMMUNITY			English	News Item								Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.	[Paules, Catharine I.; Marston, Hilary D.; Eisinger, Robert W.; Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA; [Baltimore, David] CALTECH, Pasadena, CA 91125 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); California Institute of Technology	Fauci, AS (corresponding author), NIAID, NIH, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov		Paules, Catharine/0000-0002-9064-6678				[Anonymous], 2014, INFL VIR INF HUM; CDC, 2016, PAND INFL PAST PAND; CDC, 2017, SEAS INFL VACC EFF 2; Francis T., 1960, P AM PHILOS SOC, V104, P7; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; WHO, 2008, INFLUENZA; Zheng M, 2014, INFECTION, V42, P251, DOI 10.1007/s15010-013-0546-4	7	113	117	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					599	603		10.1016/j.immuni.2017.09.007	http://dx.doi.org/10.1016/j.immuni.2017.09.007			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045889	Bronze			2022-12-18	WOS:000413091600001
J	Coquet, JM; Schuijs, MJ; Smyth, MJ; Deswarte, K; Beyaert, R; Braun, H; Boon, L; Hedestam, GBK; Nutt, SL; Hammad, H; Lambrecht, BN				Coquet, Jonathan M.; Schuijs, Martijn J.; Smyth, Mark J.; Deswarte, Kim; Beyaert, Rudi; Braun, Harald; Boon, Louis; Hedestam, Gunilla B. Karlsson; Nutt, Steven L.; Hammad, Hamida; Lambrecht, Bart N.			Interleukin-21-Producing CD4(+) T Cells Promote Type 2 Immunity to House Dust Mites	IMMUNITY			English	Article							FOLLICULAR-HELPER-CELLS; INNATE LYMPHOID-CELLS; ALLERGIC LUNG INFLAMMATION; TH2 EFFECTOR FUNCTION; B-CELLS; IN-VIVO; CYTOKINE PRODUCTION; HELMINTH INFECTION; DENDRITIC CELLS; RECEPTOR	Asthma is a T helper 2 (Th2)-cell-mediated disease; however, recent findings implicate Th17 and innate lymphoid cells also in regulating airway inflammation. Herein, we have demonstrated profound interleukin-21 (IL-21) production after house dust mite (HDM)-driven asthma by using T cell receptor (TCR) transgenic mice reactive to Dermatophagoides pteronyssinus 1 and an IL-21GFP reporter mouse. IL-21-producing cells in the mediastinal lymph node (mLN) bore characteristics of T follicular helper (Tfh) cells, whereas IL-21(+) cells in the lung did not express CXCR5 (a chemokine receptor expressed by Tfh cells) and were distinct from effector Th2 or Th17 cells. Il21r(-/-) mice developed reduced type 2 responses and the IL-21 receptor (IL-21R) enhanced Th2 cell function in a cell-intrinsic manner. Finally, administration of recombinant IL-21 and IL-25 synergistically promoted airway eosinophilia primarily via effects on CD4(+) lymphocytes. This highlights an important Th2-cell-amplifying function of IL-21-producing CD4(+) T cells in allergic airway inflammation.	[Coquet, Jonathan M.; Schuijs, Martijn J.; Deswarte, Kim; Beyaert, Rudi; Braun, Harald; Hammad, Hamida; Lambrecht, Bart N.] Univ Ghent, VIB Inflammat Res Ctr IRC, Ghent, Belgium; [Coquet, Jonathan M.; Hedestam, Gunilla B. Karlsson] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, S-17177 Stockholm, Sweden; [Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld 4006, Australia; [Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld 4006, Australia; [Beyaert, Rudi; Braun, Harald] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Boon, Louis] Bioceros, NL-3584 CM Utrecht, Netherlands; [Nutt, Steven L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3010, Australia; [Nutt, Steven L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Hammad, Hamida; Lambrecht, Bart N.] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium; [Lambrecht, Bart N.] ErasmusMC, Dept Pulm Med, NL-3015 CD Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Karolinska Institutet; QIMR Berghofer Medical Research Institute; University of Queensland; Ghent University; Walter & Eliza Hall Institute; University of Melbourne; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Coquet, JM (corresponding author), Univ Ghent, VIB Inflammat Res Ctr IRC, Zwijnaarde 9052B, Ghent, Belgium.	jonathan.coquet@ki.se	Hammad, Hamida/J-9391-2015; Beyaert, Rudi/B-2589-2009; Smyth, Mark J/H-8709-2014; Boon, Laurence/HCI-3629-2022; Nutt, Stephen L/C-9256-2013; Lambrecht, Bart N/K-2484-2014; Coquet, Jonathan M/A-5551-2015; Hedestam, Gunilla Karlsson/AAN-9616-2021	Hammad, Hamida/0000-0003-3762-8603; Smyth, Mark J/0000-0001-7098-7240; Nutt, Stephen L/0000-0002-0020-6637; Lambrecht, Bart N/0000-0003-4376-6834; Coquet, Jonathan M/0000-0002-5967-4857; Beyaert, Rudi/0000-0002-5704-582X; Braun, Harald/0000-0002-3491-9504; Boon, Louis/0000-0002-0937-9171; Deswarte, Kim/0000-0002-9761-6973	"Mechanisms for the Development of Allergy (MeDALL)," a Seventh Framework Program (FP7) of the European Union; National Health and Medical Research Council of Australia [1054925]; ERC consolidator grant; University of Gent GROUP-ID MRP grant; Swedish Research Council Young Investigator Grant; FWO grants	"Mechanisms for the Development of Allergy (MeDALL)," a Seventh Framework Program (FP7) of the European Union; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); ERC consolidator grant(European Research Council (ERC)); University of Gent GROUP-ID MRP grant; Swedish Research Council Young Investigator Grant; FWO grants(FWO)	Research was funded by the project, "Mechanisms for the Development of Allergy (MeDALL),'' a Seventh Framework Program (FP7) of the European Union (2011-2014). S.L.N. is supported by the National Health and Medical Research Council of Australia (1054925). B.N.L. was supported by an ERC consolidator grant and a University of Gent GROUP-ID MRP grant. B.N.L., H.H., and R.B. are supported by several FWO grants. J.M.C. is supported by a Swedish Research Council Young Investigator Grant.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Birrell MA, 2010, EUR RESPIR J, V36, P1220, DOI 10.1183/09031936.00069110; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Coquet JM, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.7; Dullaers M, 2012, J ALLERGY CLIN IMMUN, V129, P635, DOI 10.1016/j.jaci.2011.10.029; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harada M, 2006, J EXP MED, V203, P2929, DOI 10.1084/jem.20062206; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Johansson-Lindbom B, 2003, J IMMUNOL, V171, P1657, DOI 10.4049/jimmunol.171.4.1657; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; King IL, 2010, J IMMUNOL, V185, P6138, DOI 10.4049/jimmunol.1001703; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu B, 2015, J IMMUNOL, V194, P3583, DOI 10.4049/jimmunol.1400951; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Meisel C, 2001, J IMMUNOL, V166, P3143, DOI 10.4049/jimmunol.166.5.3143; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Ruedl C, 2000, EUR J IMMUNOL, V30, P2056, DOI 10.1002/1521-4141(200007)30:7<2056::AID-IMMU2056>3.0.CO;2-S; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	56	113	115	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					318	330		10.1016/j.immuni.2015.07.015	http://dx.doi.org/10.1016/j.immuni.2015.07.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26287681	Bronze			2022-12-18	WOS:000360101200014
J	Griseri, T; Arnold, IC; Pearson, C; Krausgruber, T; Schiering, C; Franchini, F; Schulthess, J; McKenzie, BS; Crocker, PR; Powrie, F				Griseri, Thibault; Arnold, Isabelle C.; Pearson, Claire; Krausgruber, Thomas; Schiering, Chris; Franchini, Fanny; Schulthess, Julie; McKenzie, Brent S.; Crocker, Paul R.; Powrie, Fiona			Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; GM-CSF; AIRWAY INFLAMMATION; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; CROHNS-DISEASE; BONE-MARROW; SIGLEC-F; CELLS; HOMEOSTASIS	The role of intestinal eosinophils in immune homeostasis is enigmatic and the molecular signals that drive them from protective to tissue damaging are unknown. Most commonly associated with Th2 cell-mediated diseases, we describe a role for eosinophils as crucial effectors of the interleukin-23 (IL-23)-granulocyte macrophage colony-stimulating factor (GM-CSF) axis in colitis. Chronic intestinal inflammation was characterized by increased bone marrow eosinopoiesis and accumulation of activated intestinal eosinophils. IL-5 blockade or eosinophil depletion ameliorated colitis, implicating eosinophils in disease pathogenesis. GM-CSF was a potent activator of eosinophil effector functions and intestinal accumulation, and GM-CSF blockade inhibited chronic colitis. By contrast neutrophil accumulation was GM-CSF independent and dispensable for colitis. In addition to TNF secretion, release of eosinophil peroxidase promoted colitis identifying direct tissue-toxic mechanisms. Thus, eosinophils are key perpetrators of chronic inflammation and tissue damage in IL-23-mediated immune diseases and it suggests the GM-CSF-eosinophil axis as an attractive therapeutic target.	[Griseri, Thibault; Arnold, Isabelle C.; Pearson, Claire; Krausgruber, Thomas; Franchini, Fanny; Schulthess, Julie; Powrie, Fiona] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Griseri, Thibault; Arnold, Isabelle C.; Pearson, Claire; Krausgruber, Thomas; Schiering, Chris; Franchini, Fanny; Schulthess, Julie; Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Expt Med Div,Translat Gastroenterol Unit, Oxford OX3 9DU, England; [McKenzie, Brent S.] Univ Melbourne, CSL Ltd, Res Dept, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Schiering, Chris] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland	University of Oxford; University of Oxford; CSL; University of Melbourne; University of Dundee	Powrie, F (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England.	fiona.powrie@kennedy.ox.ac.uk	Krausgruber, Thomas/H-8490-2018	Krausgruber, Thomas/0000-0002-1374-0329; Arnold, Isabelle C./0000-0001-8679-9666; Franchini, Fanny/0000-0002-4522-3385; Schiering, Chris/0000-0001-7902-6024	Wellcome Trust; Senior Investigator Award; Wellcome Trust Senior Fellowship; Fondation Louis-Jeantet; Kennedy Trust for Rheumatology Research; Career Development Fellowship from Arthritis Research UK; Wellcome Trust [095688/Z/11/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Senior Investigator Award; Wellcome Trust Senior Fellowship(Wellcome Trust); Fondation Louis-Jeantet; Kennedy Trust for Rheumatology Research; Career Development Fellowship from Arthritis Research UK; Wellcome Trust(Wellcome TrustEuropean Commission)	We thank H. Ferry for assistance with cell sorting, R. Stillion for histology, and the staff of our animal facility. We thank J.J. Lee (Mayo Clinic) for providing the EPO ELISA. This work was supported by grants from the Wellcome Trust to T.G., I.C.A., C.P., T.K., and C.S. (Four-Year PhD Programme), F.P. (Senior Investigator Award), and P.R.C. (Wellcome Trust Senior Fellowship). F.P. was also supported by the Fondation Louis-Jeantet and T.G. by the Kennedy Trust for Rheumatology Research and by a Career Development Fellowship from Arthritis Research UK. B.S.M. was employed by CSL Ltd and is currently employed by Genentech.	Ahrens R, 2008, J IMMUNOL, V181, P7390, DOI 10.4049/jimmunol.181.10.7390; Bischoff SC, 1997, DIGEST DIS SCI, V42, P394, DOI 10.1023/A:1018886423475; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chin AC, 2006, ANN NY ACAD SCI, V1072, P276, DOI 10.1196/annals.1326.018; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Dyer KD, 2011, J IMMUNOL METHODS, V369, P91, DOI 10.1016/j.jim.2011.04.009; Egea L, 2013, J IMMUNOL, V190, P1702, DOI 10.4049/jimmunol.1202368; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Feng YH, 2012, J ZHEJIANG UNIV-SC B, V13, P386, DOI 10.1631/jzus.B1100218; Forbes E, 2004, J IMMUNOL, V172, P5664, DOI 10.4049/jimmunol.172.9.5664; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Garcia NV, 2011, J IMMUNOL, V187, P2268, DOI 10.4049/jimmunol.1101008; Geering B, 2013, TRENDS IMMUNOL, V34, P398, DOI 10.1016/j.it.2013.04.002; Gleich GJ, 2013, ALLERGY, V68, P829, DOI 10.1111/all.12169; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Hirata Y, 2010, CELL HOST MICROBE, V7, P151, DOI 10.1016/j.chom.2010.01.006; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ina K, 1999, J GASTROEN HEPATOL, V14, P46, DOI 10.1046/j.1440-1746.1999.01807.x; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Kita H, 2011, IMMUNOL REV, V242, P161, DOI 10.1111/j.1600-065X.2011.01026.x; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Ledford JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032436; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Masterson JC, 2014, GUT, V63, P43, DOI 10.1136/gutjnl-2012-303631; Minar P, 2014, INFLAMM BOWEL DIS, V20, P1037, DOI 10.1097/MIB.0000000000000049; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mowat AM, 2011, J INNATE IMMUN, V3, P550, DOI 10.1159/000329099; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Noguchi M, 2001, DIGESTION, V63, P32, DOI 10.1159/000051908; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Ohnmacht C, 2007, J IMMUNOL, V179, P4766, DOI 10.4049/jimmunol.179.7.4766; Pazdrak K, 2011, J IMMUNOL, V186, P6485, DOI 10.4049/jimmunol.1001868; Peng J, 2010, CELL RES, V20, P62, DOI 10.1038/cr.2009.128; Plager DA, 2009, J IMMUNOL, V183, P4013, DOI 10.4049/jimmunol.0900055; Rose CE, 2010, CELL MOL IMMUNOL, V7, P361, DOI 10.1038/cmi.2010.31; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Roth L, 2012, INFLAMM BOWEL DIS, V18, P1333, DOI 10.1002/ibd.22973; Saitoh O, 1999, AM J GASTROENTEROL, V94, P3513, DOI 10.1111/j.1572-0241.1999.01640.x; Stolarski B, 2010, J IMMUNOL, V185, P3472, DOI 10.4049/jimmunol.1000730; TAKANASKI S, 1994, J EXP MED, V180, P711, DOI 10.1084/jem.180.2.711; TOMONAGA M, 1986, BLOOD, V67, P31; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Yang YJ, 2011, AM J PATHOL, V179, P1199, DOI 10.1016/j.ajpath.2011.05.022; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zimmermann N, 2008, ALLERGY, V63, P1156, DOI 10.1111/j.1398-9995.2008.01709.x; Zorzi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054562	50	113	113	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					187	199		10.1016/j.immuni.2015.07.008	http://dx.doi.org/10.1016/j.immuni.2015.07.008			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26200014	Green Published, hybrid			2022-12-18	WOS:000360101100020
J	Cadwell, K				Cadwell, Ken			The Virome in Host Health and Disease	IMMUNITY			English	Review							MURINE NOROVIRUS INFECTION; AUTOPHAGY GENE ATG16L1; STRANDED-DNA VIRUSES; ROTAVIRUS INFECTION; VIRAL-INFECTION; METAGENOMIC ANALYSIS; IMMUNE-RESPONSES; FECAL MICROBIOTA; ENTERIC VIRUS; MOUSE	The mammalian virome includes diverse commensal and pathogenic viruses that evoke a broad range of immune responses from the host. Sustained viral immunomodulation is implicated in a variety of inflammatory diseases, but also confers unexpected benefits to the host. These outcomes of viral infections are often dependent on host genotype. Moreover, it is becoming clear that the virome is part of a dynamic network of microorganisms that inhabit the body. Therefore, viruses can be viewed as a component of the microbiome, and interactions with commensal bacteria and other microbial agents influence their behavior. This piece is a review of our current understanding of how the virome, together with other components of the microbiome, affects the function of the host immune system to regulate health and disease.	NYU, Sch Med, Dept Microbiol, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA	New York University	Cadwell, K (corresponding author), NYU, Sch Med, Dept Microbiol, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA.	ken.cadwell@med.nyu.edu		Cadwell, Ken/0000-0002-5860-0661	NIH grant [R01 DK093668]; American Heart Association grant [12GRNT12030041]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093668] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	K.C. is supported by NIH grant R01 DK093668 and American Heart Association grant 12GRNT12030041. The author would like to thank P'ng Loke, Elisabeth Kernbauer, Jessica Pane, Timothy Nice, Tiffany Reese, and Namiko Abe for helpful comments on the manuscript. Special thanks to This Week in Virology (TWiV) for reminding us that biology makes the most sense when you include viruses in the discussion.	Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Bartlett NW, 2009, CURR OPIN ALLERGY CL, V9, P395, DOI 10.1097/ACI.0b013e32833066fa; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Bernardin F, 2010, TRANSFUSION, V50, P2474, DOI 10.1111/j.1537-2995.2010.02699.x; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Busca A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-22; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Culley FJ, 2006, J VIROL, V80, P4521, DOI 10.1128/JVI.80.9.4521-4527.2006; Draborg AH, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/535738; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Frazer IH, 2011, ANNU REV IMMUNOL, V29, P111, DOI 10.1146/annurev-immunol-031210-101308; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Graham KL, 2008, J VIROL, V82, P6139, DOI 10.1128/JVI.00597-08; Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hickman D, 2014, MBIO, V5, DOI 10.1128/mBio.01032-13; Honeyman MC, 2000, DIABETES, V49, P1319, DOI 10.2337/diabetes.49.8.1319; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kim MS, 2011, APPL ENVIRON MICROB, V77, P8062, DOI 10.1128/AEM.06331-11; Kim YG, 2011, CELL HOST MICROBE, V9, P496, DOI 10.1016/j.chom.2011.05.006; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Larson JD, 2012, P NATL ACAD SCI USA, V109, pE1092, DOI 10.1073/pnas.1203019109; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; MacDuff DA, 2015, ELIFE, V4, DOI 10.7554/eLife.04494; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Matthews PC, 2014, J CLIN VIROL, V61, P20, DOI 10.1016/j.jcv.2014.05.018; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nelson AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048224; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Notkins A L, 1979, Adv Exp Med Biol, V119, P137; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Pamer EG, 2014, MUCOSAL IMMUNOL, V7, P210, DOI 10.1038/mi.2013.117; Pane JA, 2013, DIABETOLOGIA, V56, P573, DOI 10.1007/s00125-012-2798-4; Pane JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003998; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; Ramanan D, 2014, IMMUNITY, V41, P311, DOI 10.1016/j.immuni.2014.06.015; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Roossinck MJ, 2011, NAT REV MICROBIOL, V9, P99, DOI 10.1038/nrmicro2491; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Stauffer Y, 2001, IMMUNITY, V15, P591, DOI 10.1016/S1074-7613(01)00212-6; Sun LL, 2015, CELL HOST MICROBE, V17, P85, DOI 10.1016/j.chom.2014.11.004; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tauriainen S, 2011, SEMIN IMMUNOPATHOL, V33, P45, DOI 10.1007/s00281-010-0207-y; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Tomov VT, 2013, J VIROL, V87, P7015, DOI 10.1128/JVI.03389-12; Torgbor C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004170; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wolff MJ, 2012, TRENDS PARASITOL, V28, P187, DOI 10.1016/j.pt.2012.02.008; Wylie KM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0071-7; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Zeng M, 2014, SCIENCE, V346, P1486, DOI 10.1126/science.346.6216.1486; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	95	113	121	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					805	813		10.1016/j.immuni.2015.05.003	http://dx.doi.org/10.1016/j.immuni.2015.05.003			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992857	Green Accepted, Bronze			2022-12-18	WOS:000354827400008
J	Teichmann, LL; Schenten, D; Medzhitov, R; Kashgarian, M; Shlomchik, MJ				Teichmann, Lino L.; Schenten, Dominik; Medzhitov, Ruslan; Kashgarian, Michael; Shlomchik, Mark J.			Signals via the Adaptor MyD88 in B Cells and DCs Make Distinct and Synergistic Contributions to Immune Activation and Tissue Damage in Lupus	IMMUNITY			English	Article							DENDRITIC CELLS; T-CELLS; AUTOANTIBODY PRODUCTION; AUTOIMMUNE-DISEASE; INTERFERON-ALPHA; MURINE MODEL; IFN-GAMMA; ERYTHEMATOSUS; INDUCTION; HOMEOSTASIS	Detection of self nucleic acids by Toll-like receptors (TLR) preciptates autoimmune diseases, including systemic lupus erythematosus (SLE). It remains unknown how TLR signals in specific cell types contribute to distinct manifestations of SLE. Here, we demonstrate that formation of anti-nuclear antibodies in MRL. Fas(lpr) mice entirely depends on the TLR signaling adaptor MyD88 in B cells. Further, MyD88 deficiency in B cells ameliorated nephritis, including antibody-independent interstitial T cell infiltrates, suggesting that nucleic acid-specific B cells activate nephrotoxic T cells. Surprisingly, MyD88 deletion in dendritic cells (DCs) did not affect nephritis, despite the importance of DCs in renal inflammation. In contrast, MyD88 in DCs was critical for dermatitis, revealing a separate pathogenetic mechanism. DC-expressed MyD88 promoted interferon-alpha production by plasmacytoid DCs, which was associated with Death domain-associated protein 6 upregulation and B lymphopenia. Our findings thus reveal unique immunopathological consequences of MyD88 signaling in B cells and DCs in lupus.	[Teichmann, Lino L.; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06519 USA; [Schenten, Dominik; Medzhitov, Ruslan; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Kashgarian, Michael] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06519 USA; [Teichmann, Lino L.] Univ Hosp Bonn, Dept Hematol Oncol, D-53127 Bonn, Germany	Yale University; Yale University; Yale University; University of Bonn	Shlomchik, MJ (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06519 USA.	mark.shlomchik@yale.edu	Teichmann, Lino/GQA-4636-2022; Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Teichmann, Lino/0000-0001-9489-7282	National Institutes of Health [R01-AR044077, P01-AR050256]; Deutsche Forschungsgemeinschaft; Howard Hughes Medical Institute; Cancer Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044077, P30AR053495, P01AR050256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Yale Animal Resources Center for outstanding animal husbandry. Supported by National Institutes of Health grant R01-AR044077 and P01-AR050256 (M.J.S.), Deutsche Forschungsgemeinschaft (fellowship to L. L. T.), Howard Hughes Medical Institute (R. M.), and Cancer Research Institute (fellowship to D. S.). We thank K. Nickerson, A. Campbell, and A. Marshak-Rothstein for critical reading of the manuscript.	Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chan O, 1998, J IMMUNOL, V160, P51; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Divekar AA, 2011, J IMMUNOL, V186, P924, DOI 10.4049/jimmunol.1002218; Gongora R, 2001, IMMUNITY, V14, P727, DOI 10.1016/S1074-7613(01)00152-2; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; JABS DA, 1992, CELL IMMUNOL, V141, P496, DOI 10.1016/0008-8749(92)90166-M; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lovgren T, 2006, ARTHRITIS RHEUM-US, V54, P1917, DOI 10.1002/art.21893; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Ng WL, 2006, QJM-INT J MED, V99, P37, DOI 10.1093/qjmed/hci155; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Rodriguez-Pinto D, 2005, EUR J IMMUNOL, V35, P1097, DOI 10.1002/eji.200425732; Ronnblom L, 2011, SEMIN IMMUNOL, V23, P113, DOI 10.1016/j.smim.2011.01.009; Schwarting A, 1998, J IMMUNOL, V161, P494; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Sweet RA, 2011, P NATL ACAD SCI USA, V108, P7932, DOI 10.1073/pnas.1018571108; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457	36	113	118	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					528	540		10.1016/j.immuni.2012.11.017	http://dx.doi.org/10.1016/j.immuni.2012.11.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23499488	Green Accepted, Bronze			2022-12-18	WOS:000330941500017
J	Chan, CY; St John, AL; Abraham, SN				Chan, Cheryl Y.; St John, Ashley L.; Abraham, Soman N.			Mast Cell Interleukin-10 Drives Localized Tolerance in Chronic Bladder Infection	IMMUNITY			English	Article							URINARY-TRACT-INFECTION; UROPATHOGENIC ESCHERICHIA-COLI; SERUM-ANTIBODY LEVELS; BACTERIAL CLEARANCE; IMMUNE-RESPONSE; IL-10; HETEROGENEITY; INDUCTION; VIRULENCE	The lower urinary tract's virtually inevitable exposure to external microbial pathogens warrants efficient tissue-specialized defenses to maintain sterility. The observation that the bladder can become chronically infected in combination with clinical observations that antibody responses after bladder infections are not detectable suggest defects in the formation of adaptive immunity and immunological memory. We have identified a broadly immunosuppressive transcriptional program specific to the bladder, but not the kidney, during infection of the urinary tract that is dependent on tissue-resident mast cells (MCs). This involves localized production of interleukin-10 and results in suppressed humoral and cell-mediated responses and bacterial persistence. Therefore, in addition to the previously described role of MCs orchestrating the early innate immunity during bladder infection, they subsequently play a tissue-specific immunosuppressive role. These findings may explain the prevalent recurrence of bladder infections and suggest the bladder as a site exhibiting an intrinsic degree of MC-maintained immune privilege.	[Chan, Cheryl Y.; St John, Ashley L.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [St John, Ashley L.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore 169857, Singapore	Duke University; Duke University; Duke University; National University of Singapore	Abraham, SN (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	soman.abraham@duke.edu	StJohn, Ashley/AAE-4378-2021	StJohn, Ashley/0000-0001-5098-1044	US National Institutes of Health [R01 A135678, R01 DK077159, R01 A150021, R37 DK50814, R21 A1056101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI074751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101456, R56DK095198, R37DK050814, R01DK077159] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. Seed, H. Staats, M. Kuehn, and L. Hale for discussions and J. Wright for the use of equipment. E. coli J96 was a gift from S. Normark (Umea University). Special thanks to A. Roers (University of Technology, Dresden) for Mcpt5-Cre<SUP>+/+</SUP> Il10<SUP>fl/fl</SUP> mice and T. Haering for assisting with animal import. We also thank Z. Swan for acquiring the image in Figure 1B and W. X. G. Ang for critical manuscript reading. This work was supported by US National Institutes of Health grants R01 A135678, R01 DK077159, R01 A150021, R37 DK50814, and R21 A1056101.	Abraham SN, 1998, SEMIN IMMUNOL, V10, P373, DOI 10.1006/smim.1998.0140; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Belkaid Y, 2010, NAT IMMUNOL, V11, P1077, DOI 10.1038/ni1210-1077; BIENENSTOCK J, 1985, INT ARCH ALLER A IMM, V77, P126, DOI 10.1159/000233766; Carrington LM, 2006, INVEST OPHTH VIS SCI, V47, P1886, DOI 10.1167/iovs.05-0635; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; ENK AH, 1993, J IMMUNOL, V151, P2390; Fihn SD, 2003, NEW ENGL J MED, V349, P259, DOI 10.1056/NEJMcp030027; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Foxman B, 2002, AM J MED, V113, p5S; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; HAGBERG L, 1981, INFECT IMMUN, V31, P564, DOI 10.1128/IAI.31.2.564-570.1981; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Kobayashi T, 2000, J IMMUNOL, V164, P3855, DOI 10.4049/jimmunol.164.7.3855; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Malaviya R, 2004, IMMUNOL LETT, V91, P103, DOI 10.1016/j.imlet.2003.10.005; Malaviya R, 1999, P NATL ACAD SCI USA, V96, P8110, DOI 10.1073/pnas.96.14.8110; Malisan F, 1996, J EXP MED, V183, P937, DOI 10.1084/jem.183.3.937; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Norman MU, 2008, AM J PATHOL, V172, P1638, DOI 10.2353/ajpath.2008.070559; NORMARK S, 1983, INFECT IMMUN, V41, P942, DOI 10.1128/IAI.41.3.942-949.1983; PERCIVAL A, 1964, LANCET, V2, P1027; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rao KN, 2008, ANN NY ACAD SCI, V1143, P83, DOI 10.1196/annals.1443.023; RATNER JJ, 1981, J INFECT DIS, V143, P404, DOI 10.1093/infdis/143.3.404; RENE P, 1982, INFECT IMMUN, V37, P749, DOI 10.1128/IAI.37.2.749-754.1982; SANFORD BA, 1978, J CLIN MICROBIOL, V8, P575; Sawa T, 1997, J IMMUNOL, V159, P2858; Shelburne CP, 2009, CELL HOST MICROBE, V6, P331, DOI 10.1016/j.chom.2009.09.004; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; STAMM WE, 1983, AM J MED, V75, P53, DOI 10.1016/0002-9343(83)90073-6; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinbrink K, 1999, BLOOD, V93, P1634, DOI 10.1182/blood.V93.5.1634.405k11_1634_1642; Thumbikat P, 2006, J IMMUNOL, V176, P3080, DOI 10.4049/jimmunol.176.5.3080; Vanderford DA, 2010, EXP DERMATOL, V19, P518, DOI 10.1111/j.1600-0625.2009.01032.x; Waldmann H, 2006, NATURE, V442, P987, DOI 10.1038/nature05165; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; WINBERG J, 1963, Br Med J, V2, P524	54	113	114	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					349	359		10.1016/j.immuni.2012.10.019	http://dx.doi.org/10.1016/j.immuni.2012.10.019			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23415912	Bronze, Green Accepted			2022-12-18	WOS:000330940800016
J	O'Neill, SK; Getahun, A; Gauld, SB; Merrell, KT; Tamir, I; Smith, MJ; Dal Porto, JM; Li, QZ; Cambier, JC				O'Neill, Shannon K.; Getahun, Andrew; Gauld, Stephen B.; Merrell, Kevin T.; Tamir, Idan; Smith, Mia J.; Dal Porto, Joseph M.; Li, Quan-Zhen; Cambier, John C.			Monophosphorylation of CD79a and CD79b ITAM Motifs Initiates a SHIP-1 Phosphatase-Mediated Inhibitory Signaling Cascade Required for B Cell Anergy	IMMUNITY			English	Article							FC-GAMMA-RIIB; ANTIGEN RECEPTOR; NEGATIVE REGULATION; DEFICIENT MICE; TYROSINE PHOSPHORYLATION; AUTOIMMUNE-DISEASE; KINASE ACTIVATION; SH2 DOMAINS; LIFE-SPAN; LYMPHOCYTES	Anergic B cells are characterized by impaired signaling and activation after aggregation of their antigen receptors (BCR). The molecular basis of this impairment is not understood. In studies reported here, Src homology-2 (SH2)-containing inositol 5-phosphatase SHIP-1 and its adaptor Dok-1 were found to be constitutively phosphorylated in anergic B cells, and activation of this inhibitory circuit was dependent on Src-family kinase activity and consequent to biased BCR immunoreceptor tyrosine-based activation motif (ITAM) monophosphorylation. B cell-targeted deletion of SHIP-1 caused severe lupus-like disease. Moreover, absence of SHIP-1 in B cells led to loss of anergy as indicated by restoration of BCR signaling, loss of anergic surface phenotype, and production of autoantibodies. Thus, chronic BCR signals maintain anergy in part via ITAM monophosphorylation-directed activation of an inhibitory signaling circuit involving SHIP-1 and Dok-1.	[O'Neill, Shannon K.; Getahun, Andrew; Gauld, Stephen B.; Merrell, Kevin T.; Tamir, Idan; Smith, Mia J.; Dal Porto, Joseph M.; Cambier, John C.] Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO 80206 USA; [O'Neill, Shannon K.; Getahun, Andrew; Gauld, Stephen B.; Merrell, Kevin T.; Tamir, Idan; Smith, Mia J.; Dal Porto, Joseph M.; Cambier, John C.] Natl Jewish Hlth, Denver, CO 80206 USA; [Li, Quan-Zhen] Univ Texas SW Med Ctr Dallas, Dept Immunol & Internal Med, Dallas, TX 75390 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cambier, JC (corresponding author), Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO 80206 USA.	cambierj@njhealth.org		Cambier, John/0000-0002-7803-242X	National Institutes of Health [AI022295, AI077597, AG013989]; Arthritis Foundation; Swedish Research Council; Swedish Society for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI077597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Burke for technical assistance; L. Wysocki for reagents; M. Reth, J. Ravetch, and S. Bolland for mice; and T. Packard for invaluable technical assistance with Adobe Illustrator and help with editing the figures. This study was supported by National Institutes of Health grants AI022295, AI077597, AG013989 (J.C.C.), an Arthritis Foundation postdoctoral fellowship (S.K.O.), the Swedish Research Council, and the Swedish Society for Medical Research (A.G.). J.C.C. is an Ida and Cecil Green Distinguished Professor.	Adachi T, 2007, BIOCHEM BIOPH RES CO, V364, P111, DOI 10.1016/j.bbrc.2007.09.100; Auborn KJ, 2003, J NUTR, V133, P3610, DOI 10.1093/jn/133.11.3610; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Blasioli Julie, 2002, Curr Dir Autoimmun, V5, P151; Blery M, 2006, J EXP MED, V203, P1773, DOI 10.1084/jem.20060552; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Borrero M, 2002, J IMMUNOL, V168, P13, DOI 10.4049/jimmunol.168.1.13; Browne CD, 2009, IMMUNITY, V31, P749, DOI 10.1016/j.immuni.2009.08.026; Buhl AM, 1999, J IMMUNOL, V162, P4438; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; Ferry H, 2005, EUR J IMMUNOL, V35, P3655, DOI 10.1002/eji.200535247; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRUPP SA, 1993, J BIOL CHEM, V268, P25776; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Healy JI, 1998, CIBA F SYMP, V215, P137; Heizmann B, 2010, P NATL ACAD SCI USA, V107, P18563, DOI 10.1073/pnas.1009048107; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Inabe K, 2002, BLOOD, V99, P584, DOI 10.1182/blood.V99.2.584; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Kersh EN, 1999, J EXP MED, V190, P1627, DOI 10.1084/jem.190.11.1627; Kimura T, 1997, J BIOL CHEM, V272, P13991, DOI 10.1074/jbc.272.21.13991; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Li DHH, 2008, ARTHRITIS RHEUM-US, V58, P3192, DOI 10.1002/art.23812; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Liu Y, 2007, J LEUKOCYTE BIOL, V82, P742, DOI 10.1189/jlb.1206736; Malbec O, 1998, J IMMUNOL, V160, P1647; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Maxwell MJ, 2011, J IMMUNOL, V186, P7164, DOI 10.4049/jimmunol.1004185; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Moody JL, 2003, GENES IMMUN, V4, P60, DOI 10.1038/sj.gene.6363903; Noorchashm H, 1999, INT IMMUNOL, V11, P765, DOI 10.1093/intimm/11.5.765; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Pao LI, 1998, J IMMUNOL, V160, P3305; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Robson JD, 2004, MOL CELL BIOL, V24, P2332, DOI 10.1128/MCB.24.6.2332-2343.2004; SHULTZ LD, 1984, AM J PATHOL, V116, P179; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; Vilen BJ, 2002, J IMMUNOL, V168, P4344, DOI 10.4049/jimmunol.168.9.4344; Vilen BJ, 1997, J IMMUNOL, V159, P231; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WIENANDS J, 1995, INT IMMUNOL, V7, P1701, DOI 10.1093/intimm/7.11.1701; Yarkoni Y, 2011, MOL IMMUNOL, V48, P1851, DOI 10.1016/j.molimm.2011.05.006; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Zhang ZS, 2003, J BIOL CHEM, V278, P4668, DOI 10.1074/jbc.M210028200; Zhao MM, 2001, J EXP MED, V194, P265, DOI 10.1084/jem.194.3.265	61	113	118	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					746	756		10.1016/j.immuni.2011.10.011	http://dx.doi.org/10.1016/j.immuni.2011.10.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22078222	Green Accepted, Bronze			2022-12-18	WOS:000297390800014
J	West, EE; Youngblood, B; Tan, WG; Jin, HT; Araki, K; Alexe, G; Konieczny, BT; Calpe, S; Freeman, GJ; Terhorst, C; Haining, WN; Ahmed, R				West, Erin E.; Youngblood, Ben; Tan, Wendy G.; Jin, Hyun-Tak; Araki, Koichi; Alexe, Gabriela; Konieczny, Bogumila T.; Calpe, Silvia; Freeman, Gordon J.; Terhorst, Cox; Haining, W. Nicholas; Ahmed, Rafi			Tight Regulation of Memory CD8(+) T Cells Limits Their Effectiveness during Sustained High Viral Load	IMMUNITY			English	Article							NK-ASSOCIATED RECEPTORS; PROTECTIVE IMMUNITY; NAIVE RATHER; IN-VIVO; INFECTION; PERSISTENCE; EXHAUSTION; EXPRESSION; VIRUS; IMMUNOSUPPRESSION	To design successful vaccines for chronic diseases, an understanding of memory CD8(+) T cell responses to persistent antigen restimulation is critical. However, most studies comparing memory and naive cell responses have been performed only in rapidly cleared acute infections. Herein, by comparing the responses of memory and naive CD8(+) T cells to acute and chronic lymphocytic choriomeningitis virus infection, we show that memory cells dominated over naive cells and were protective when present in sufficient numbers to quickly reduce infection. In contrast, when infection was not rapidly reduced, because of high antigen load or persistence, memory cells were quickly lost, unlike naive cells. This loss of memory cells was due to a block in sustaining cell proliferation, selective regulation by the inhibitory receptor 2B4, and increased reliance on CD4(+) T cell help. Thus, emphasizing the importance of designing vaccines that elicit effective CD4(+) T cell help and rapidly control infection.	[West, Erin E.; Youngblood, Ben; Tan, Wendy G.; Jin, Hyun-Tak; Araki, Koichi; Konieczny, Bogumila T.; Ahmed, Rafi] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [West, Erin E.; Youngblood, Ben; Tan, Wendy G.; Jin, Hyun-Tak; Araki, Koichi; Konieczny, Bogumila T.; Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Freeman, Gordon J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Alexe, Gabriela] Broad Inst, Cambridge, MA 02142 USA; [Calpe, Silvia; Terhorst, Cox] Harvard Univ, Sch Med, Div Immunol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Haining, W. Nicholas] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA	Emory University; Emory University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Ahmed, R (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	rahmed@emory.edu	Freeman, Gordon/AAC-5380-2019; Youngblood, Benjamin/N-2508-2018	Freeman, Gordon/0000-0002-7210-5616; Youngblood, Benjamin/0000-0002-1261-9957; Araki, Koichi/0000-0003-3478-6315	National Institutes of Health (NIH) [R01 AI030048]; American Cancer Society (ACS) [PF-09-134-01-MPC]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Karaffa and S. Durham for FACS sorting at the Emory University School of Medicine Flow Cytometry Core Facility, and we thank the members of the R.A. lab for helpful discussions. We also thank R. Akondy for initial help with the microarray analysis. This work was supported by the National Institutes of Health (NIH) grant R01 AI030048 (to R.A.) and the American Cancer Society (ACS) postdoctoral fellowship PF-09-134-01-MPC (to B.Y.).	Ahlers JD, 2010, BLOOD, V115, P1678, DOI 10.1182/blood-2009-06-227546; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Badovinac VP, 2003, J IMMUNOL, V170, P4933, DOI 10.4049/jimmunol.170.10.4933; Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casado JG, 2005, CANCER IMMUNOL IMMUN, V54, P1162, DOI 10.1007/s00262-005-0682-5; Chlewicki LK, 2008, J IMMUNOL, V180, P8159, DOI 10.4049/jimmunol.180.12.8159; DiSpirito JR, 2010, CELL RES, V20, P13, DOI 10.1038/cr.2009.140; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; Enose-Akahata Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000682; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Northrop JK, 2004, CURR OPIN IMMUNOL, V16, P451, DOI 10.1016/j.coi.2004.05.004; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rey J, 2006, EUR J IMMUNOL, V36, P2359, DOI 10.1002/eji.200635935; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarazona R, 2002, AIDS, V16, P197, DOI 10.1097/00002030-200201250-00008; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Wang NH, 2010, J IMMUNOL, V185, P5683, DOI 10.4049/jimmunol.1001974; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams MA, 2006, IMMUNOL REV, V211, P146, DOI 10.1111/j.0105-2896.2006.00389.x	54	113	117	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 26	2011	35	2					285	298		10.1016/j.immuni.2011.05.017	http://dx.doi.org/10.1016/j.immuni.2011.05.017			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21856186	Green Accepted, Bronze			2022-12-18	WOS:000294387900017
J	Bougneres, L; Helft, J; Tiwari, S; Vargas, P; Chang, BHJ; Chan, L; Campisi, L; Lauvau, G; Hugues, S; Kumar, P; Kamphorst, AO; Dumenil, AML; Nussenzweig, M; MacMicking, JD; Amigorena, S; Guermonprez, P				Bougneres, Laurence; Helft, Julie; Tiwari, Sangeeta; Vargas, Pablo; Chang, Benny Hung-Junn; Chan, Lawrence; Campisi, Laura; Lauvau, Gregoire; Hugues, Stephanie; Kumar, Pradeep; Kamphorst, Alice O.; Dumenil, Ana-Maria Lennon; Nussenzweig, Michel; MacMicking, John D.; Amigorena, Sebastian; Guermonprez, Pierre			A Role for Lipid Bodies in the Cross-presentation of Phagocytosed Antigens by MHC Class I in Dendritic Cells	IMMUNITY			English	Article							DIFFERENTIATION-RELATED PROTEIN; INDUCIBLY EXPRESSED GTPASE; ENDOPLASMIC-RETICULUM; EXOGENOUS ANTIGENS; MICE LACKING; GAMMA; DROPLETS; CD8(+); COMPARTMENT; ACTIVATION	Dendritic cells (DCs) have the striking ability to cross-present exogenous antigens in association with major histocompatibility complex (MHC) class I to CD8(+) T cells. However, the intracellular pathways underlying cross-presentation remain ill defined. Current models involve cytosolic proteolysis of antigens by the proteasome and peptide import into endoplasmic reticulum (ER) or phagosomal lumen by the transporters associated with antigen processing (TAP1 and TAP2). Here, we show that DCs expressed an ER-resident 47 kDa immune-related GTPase, Igtp (Irgm3). Igtp resides on ER and lipid body (LB) membranes where it binds the LB coat component ADFP. Inactivation of genes encoding for either Igtp or ADFP led to defects in LB formation in DCs and severely impaired cross-presentation of phagocytosed antigens to CD8(+) T cells but not antigen presentation to CD4(+) T cells. We thus define a new role for LB organelles in regulating cross-presentation of exogenous antigens to CD8(+) T lymphocytes in DCs.	[Bougneres, Laurence; Helft, Julie; Vargas, Pablo; Hugues, Stephanie; Dumenil, Ana-Maria Lennon; Amigorena, Sebastian; Guermonprez, Pierre] Inst Curie, INSERM, U653, Sect Rech, F-75248 Paris 05, France; [Tiwari, Sangeeta; Kumar, Pradeep; MacMicking, John D.] Yale Univ, Sch Med, Boyer Ctr Mol Med, New Haven, CT 06510 USA; [Chang, Benny Hung-Junn; Chan, Lawrence] Baylor Coll Med, Houston, TX 77030 USA; [Campisi, Laura; Lauvau, Gregoire] Inst Pharmacol Mol & Cellulaire, INSERM, U924, F-06560 Valbonne, France; [Kamphorst, Alice O.; Nussenzweig, Michel; Guermonprez, Pierre] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Yale University; Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Rockefeller University	Guermonprez, P (corresponding author), Inst Curie, INSERM, U653, Sect Rech, 26 Rue Ulm, F-75248 Paris 05, France.	pguermonpr@mail.rockefeller.edu	Helft, Julie/ABE-6179-2020; Lennon-Dumenil, Ana-Maria/I-6716-2016; Campisi, Laura/AAL-2064-2021; Guermonprez, Pierre/ABE-7718-2020; Vargas, Pablo/L-9858-2017; Tiwari, Sangeeta/GWV-0350-2022; Nussenzweig, Michel/AAE-7292-2019; VARGAS, Pablo/HHM-4543-2022; tiwari, sangeeta/T-5810-2019	Helft, Julie/0000-0002-2733-1972; Campisi, Laura/0000-0003-4173-4521; Guermonprez, Pierre/0000-0001-5621-2262; Vargas, Pablo/0000-0002-6475-494X; VARGAS, Pablo/0000-0002-6475-494X; hugues, stephanie/0000-0002-1031-5909; Kamphorst, Alice/0000-0002-9230-9501; Amigorena, Sebastian/0000-0001-8583-8416	Association pour la Recherche sur le Cancer; Curie Institute; INSERM; National Institutes of Health (NIH) [HL 51586, R01 AI068041-01A1]; Burroughs Wellcome Fund Award; Searle Foundation [05-F-114]; Cancer Research Institute; W.W. Winchester Foundation; Centre National de la Recherche Scientifique; Agence Nationale pour la Recherche; Rockefeller University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573, R01AI068041] Funding Source: NIH RePORTER	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Curie Institute; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Award(Burroughs Wellcome Fund); Searle Foundation; Cancer Research Institute; W.W. Winchester Foundation; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Rockefeller University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank G. Taylor, H. Shen, Z. Maciorowski, C. Guerin, I. Grandjean, A. Boissonnas, L. Saveanu, A. Savina, W. Faigle, D. Loew, B. Lombard, C.L. Trubert, M. Merad, and S. Davis for reagents, helpful discussions, or critical reading of the manuscript. L.B. was supported by the Association pour la Recherche sur le Cancer, the Curie Institute, and INSERM. L.C. was supported by the National Institutes of Health (NIH) Grant HL 51586. J.D.M. was supported by the NIH National Institute of Allergy and Infectious Diseases (R01 AI068041-01A1), the Burroughs Wellcome Fund Award, the Searle Foundation (05-F-114), Cancer Research Institute, and the W.W. Winchester Foundation. P.G. was supported by the Centre National de la Recherche Scientifique, the Agence Nationale pour la Recherche, and the Rockefeller University.	Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Fujimoto T, 2006, AUTOPHAGY, V2, P299, DOI 10.4161/auto.2904; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hotta C, 2006, IMMUNOLOGY, V117, P97, DOI 10.1111/j.1365-2567.2005.02270.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Maroof A, 2005, IMMUNOLOGY, V115, P473, DOI 10.1111/j.1365-2567.2005.02181.x; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Tabata N, 1997, PHYTOCHEMISTRY, V46, P683, DOI 10.1016/S0031-9422(97)00157-X; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y	49	113	113	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					232	244		10.1016/j.immuni.2009.06.022	http://dx.doi.org/10.1016/j.immuni.2009.06.022			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19699172	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000269338600010
J	Yasuda, T; Sanjo, H; Pages, G; Kawano, Y; Karasuyama, H; Pouyssegur, J; Ogata, M; Kurosaki, T				Yasuda, Tomoharu; Sanjo, Hideki; Pages, Gilles; Kawano, Yohei; Karasuyama, Hajime; Pouyssegur, Jacques; Ogata, Masato; Kurosaki, Tomohiro			Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASES; ALLELIC EXCLUSION; NUR77 EXPRESSION; DEFICIENT MICE; G1 PHASE; C-MYC; DIFFERENTIATION; ACTIVATION; GENE; PHOSPHORYLATION	The pre-B cell receptor (pre-BCR) plays a crucial role in the development of immature B cells. Although certain aspects of proximal pre-BCR signaling have been studied, the intermediate signal transducers and the distal transcription modulators are poorly characterized. Here, we demonstrate that deletion of both Erk1 and Erk2 kinases was associated with defective pre-BCR-mediated cell expansion as well as a block in the transition of pro-B to pre-B cells. Phosphorylation of transcription factors Elk1 and CREB was mediated by Erk, and a dominant-negative mutation in the Erk-mediated phosphorylation sites of Elk1 or CREB suppressed pre-BCR-mediated cell expansion as well as expression of genes including Myc, which is involved in the cell-cycle progression. Together, our results identify a crucial role for Erk kinases in regulating B cell development by initiating transcriptional regulatory network and thereby pre-BCR-mediated cell expansion.	[Yasuda, Tomoharu; Sanjo, Hideki; Kurosaki, Tomohiro] RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Tsurumi Ku, Kanagawa 2300045, Japan; [Pages, Gilles; Pouyssegur, Jacques] Ctr Antoine Lacassagne, CNRS, Inst Signaling Dev Biol & Canc Res, UMR 6543, F-06189 Nice, France; [Kawano, Yohei; Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch, Dept Immune Regulat, Bunkyo Ku, Tokyo 1138519, Japan; [Ogata, Masato] Mie Univ, Sch Med, Dept Biochem, Tsu, Mie 5148507, Japan	RIKEN; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Tokyo Medical & Dental University (TMDU); Mie University	Kurosaki, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Tsurumi Ku, Kanagawa 2300045, Japan.	kurosaki@rcai.riken.jp	Kawano, Yohei/V-1335-2018; Pages, Gilles/N-7135-2017; Karasuyama, Hajime/A-7966-2011; Yasuda, Tomoharu/J-5102-2019; Kurosaki, Tomohiro/D-1306-2009	Karasuyama, Hajime/0000-0003-0689-0836; Kurosaki, Tomohiro/0000-0002-6352-304X; Kawano, Yohei/0000-0001-7181-2282; Yasuda, Tomoharu/0000-0001-9997-6852				Bell SE, 2004, EUR J IMMUNOL, V34, P2237, DOI 10.1002/eji.200425054; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cesari F, 2004, MOL CELL BIOL, V24, P294, DOI 10.1128/MCB.24.1.294-305.2004; Chen HC, 2006, J IMMUNOL, V176, P2208, DOI 10.4049/jimmunol.176.4.2208; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; Craxton A, 2005, J EXP MED, V202, P1363, DOI 10.1084/jem.20051283; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grumont RJ, 2002, MOL CELL, V10, P1283, DOI 10.1016/S1097-2765(02)00779-7; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Kawano Y, 2006, J IMMUNOL, V177, P2242, DOI 10.4049/jimmunol.177.4.2242; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Middendorp S, 2002, J IMMUNOL, V168, P2695, DOI 10.4049/jimmunol.168.6.2695; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Schweighoffer E, 2003, IMMUNITY, V18, P523, DOI 10.1016/S1074-7613(03)00082-7; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Su YW, 2003, IMMUNITY, V19, P295, DOI 10.1016/S1074-7613(03)00202-4; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; Wen RR, 2004, EMBO J, V23, P4007, DOI 10.1038/sj.emboj.7600405; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yang BS, 1996, MOL CELL BIOL, V16, P538; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang CY, 2002, J BIOL CHEM, V277, P48359, DOI 10.1074/jbc.M209329200; Zhao GH, 2005, EXP CELL RES, V305, P312, DOI 10.1016/j.yexcr.2004.12.030	52	113	116	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2008	28	4					499	508		10.1016/j.immuni.2008.02.015	http://dx.doi.org/10.1016/j.immuni.2008.02.015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18356083	Bronze			2022-12-18	WOS:000254939400011
J	Santiago, C; Ballesteros, A; Tami, C; Martinez-Munoz, L; Kaplan, GG; Casasnovas, JM				Santiago, Cesar; Ballesteros, Angela; Tami, Cecilia; Martinez-Munoz, Laura; Kaplan, Gerardo G.; Casasnovas, Jose M.			Structures of T cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family	IMMUNITY			English	Article							HEPATITIS-A-VIRUS; MONKEY KIDNEY-CELLS; CRYSTAL-STRUCTURE; ADHESION MOLECULE; SOLUBLE FORM; DOMAIN; IDENTIFICATION; ACTIVATION; IG	The T cell immunoglobulin mucin (TIM) receptors are involved in the regulation of immune responses, autoimmunity, and allergy. Structures of the N-terminal ligand binding domain of the murine mTIM-1 and mTIM-2 receptors revealed an immunoglobulin (Ig) fold, with four Cys residues bridging a distinctive CC' loop to the GFC beta-sheet. The structures showed two ligand-recognition modes in the TIM family. The mTIM-1 structure identified a homophilic TIM-TIM adhesion interaction, whereas the mTIM-2 domain formed a dimer that prevented homophilic binding. Biochemical, mutational, and cell adhesion analyses confirmed the divergent ligand-binding modes revealed by the structures. Structural features characteristic of mTIM-1 appear conserved in human TIM-1, which also mediated homophilic interactions. The extracellular mucin domain enhanced binding through the Ig domain, modulating TIM receptor functions. These results explain the divergent immune functions described for the murine receptors and the role of TIM-1 as a cell adhesion receptor in renal regeneration and cancer.	CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); US Food & Drug Administration (FDA)	Casasnovas, JM (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus Univ Autonoma, E-28049 Madrid, Spain.	jcasasnovas@cnb.uam.es	Santiago, César/K-4240-2014; Martínez-Muñoz, Laura/C-2719-2017; Casasnovas, Jose M/L-6299-2014	Santiago, César/0000-0002-5149-1722; Martínez-Muñoz, Laura/0000-0003-3098-279X; Casasnovas, Jose M/0000-0002-2873-6410; kaplan, gerardo/0000-0003-3303-7259; Ballesteros Morcillo, Angela/0000-0001-5796-6875	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054456] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI54456, P01 AI054456] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chakravarti S, 2005, J EXP MED, V202, P437, DOI 10.1084/jem.20050308; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102; Feigelstock D, 1998, J VIROL, V72, P6621, DOI 10.1128/JVI.72.8.6621-6628.1998; Feigelstock D, 1998, J VIROL, V72, P6218, DOI 10.1128/JVI.72.7.6218-6222.1998; Han Won K, 2004, Curr Opin Crit Care, V10, P476, DOI 10.1097/01.ccx.0000145095.90327.f2; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; McIntire JJ, 2003, NATURE, V425, P576, DOI 10.1038/425576a; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Mesri M, 2006, INT IMMUNOL, V18, P473, DOI 10.1093/intimm/dxh388; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; MILLER E, 1995, HARVARD ED LETT, V11, P1; Rennert PD, 2006, J IMMUNOL, V177, P4311, DOI 10.4049/jimmunol.177.7.4311; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Silberstein E, 2003, J VIROL, V77, P8765, DOI 10.1128/JVI.77.16.8765-8774.2003; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Thompson P, 1998, J VIROL, V72, P3751, DOI 10.1128/JVI.72.5.3751-3761.1998; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Vila MR, 2004, KIDNEY INT, V65, P1761, DOI 10.1111/j.1523-1755.2004.00601.x; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wang JH, 1998, IMMUNOL REV, V163, P197, DOI 10.1111/j.1600-065X.1998.tb01198.x	32	113	132	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2007	26	3					299	310		10.1016/j.immuni.2007.01.014	http://dx.doi.org/10.1016/j.immuni.2007.01.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17363299	Green Published, Bronze			2022-12-18	WOS:000245228100007
J	Cairo, CW; Mirchev, R; Golan, DE				Cairo, Christopher W.; Mirchev, Rossen; Golan, David E.			Cytoskeletal regulation couples LFA-1 conformational changes to receptor lateral mobility and clustering	IMMUNITY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; SINGLE-PARTICLE TRACKING; T-CELL ADHESION; I-DOMAIN; SIGNAL-TRANSDUCTION; AVIDITY REGULATION; LYMPHOCYTE ARREST; INTEGRIN AVIDITY; TERMINAL REGION; HIGH-AFFINITY	The alpha(L)beta(2) integrin (leukocyte function-associated antigen-1 [LFA-1]) is regulated to engage and maintain T cell adhesion. Conformational changes in the receptor are associated with changes in receptor-ligand affinity and are necessary for firm adhesion. Less well understood is the relationship between receptor conformation and the regulation of its lateral mobility. We have used fluorescence photobleaching recovery and single-particle tracking to measure the lateral mobility of specific conformations of LFA-1. These measurements show that different receptor conformations have distinct diffusion profiles and that these profiles vary according to the activation state of the cell. Notably, a high-affinity conformation of LFA-1 is mobile on resting cells but immobile on phorbol-12-myristate-13-acetate-activated cells. This activation-induced immobilization is prevented by a calpain inhibitor and by an allosteric LFA-1 inhibitor. Our results suggest that current models of LFA-1 regulation are incomplete and that LFA-1 confinement by cytoskeletal attachment regulates cell adhesion both negatively and positively.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Golan, DE (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA.	dgolan@hms.harvard.edu	Cairo, Christopher W/B-5355-2009	Cairo, Christopher W/0000-0003-3363-8708	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032854, U54HL070819, T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067292] Funding Source: NIH RePORTER; NHLBI NIH HHS [U54HL070819, T32 HL07623, R37HL032854] Funding Source: Medline; NIGMS NIH HHS [F32 GM067292] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beals CR, 2001, J IMMUNOL, V167, P6113, DOI 10.4049/jimmunol.167.11.6113; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Drbal K, 2001, IMMUNOBIOLOGY, V203, P687, DOI 10.1016/S0171-2985(01)80017-6; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gaborski T, 2005, BIOPHYS J, V88, p588A; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Gestwicki JE, 2002, J AM CHEM SOC, V124, P14922, DOI 10.1021/ja027184x; Jin TQ, 2002, J BIOL CHEM, V277, P32963, DOI 10.1074/jbc.M201525200; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Liu SC, 2000, J CELL SCI, V113, P3563; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200; Mirchev R, 2001, BLOOD CELL MOL DIS, V27, P143, DOI 10.1006/bcmd.2000.0367; Peters IM, 1999, CYTOMETRY, V36, P189, DOI 10.1002/(SICI)1097-0320(19990701)36:3<189::AID-CYTO7>3.0.CO;2-3; Porter JC, 2002, J IMMUNOL, V168, P6330, DOI 10.4049/jimmunol.168.12.6330; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P1694, DOI 10.1074/jbc.272.3.1694; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Sheather SJ, 2004, STAT SCI, V19, P588, DOI 10.1214/088342304000000297; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Sigal A, 2000, J IMMUNOL, V165, P442, DOI 10.4049/jimmunol.165.1.442; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tan SM, 2001, J BIOL CHEM, V276, P36370, DOI 10.1074/jbc.M102392200; Tanaka Y, 1999, LEUKEMIA LYMPHOMA, V36, P15, DOI 10.3109/10428199909145945; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Weitz-Schmidt G, 2004, J BIOL CHEM, V279, P46764, DOI 10.1074/jbc.M407951200; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Welzenbach K, 2002, J BIOL CHEM, V277, P10590, DOI 10.1074/jbc.M110521200	45	113	114	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2006	25	2					297	308		10.1016/j.immuni.2006.06.012	http://dx.doi.org/10.1016/j.immuni.2006.06.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16901728	Bronze, Green Submitted			2022-12-18	WOS:000240047500015
J	Fernandez, MI; Pedron, T; Tournebize, R; Olivo-Marin, JC; Sansonetti, PJ; Phalipon, A				Fernandez, MI; Pedron, T; Tournebize, R; Olivo-Marin, JC; Sansonetti, PJ; Phalipon, A			Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells	IMMUNITY			English	Article							INVASIVE SHIGELLA-FLEXNERI; MUCOSAL IGA RESPONSES; CANINE KIDNEY-CELLS; NF-KAPPA-B; SECRETORY COMPONENT; SALMONELLA-TYPHIMURIUM; MONOCLONAL-ANTIBODIES; CONJUGATE VACCINES; GOLGI-APPARATUS; IMMUNE-SYSTEM	Intestinal epithelial cells (IEC) play a central role in innate and acquired mucosal immunity. They ensure early signaling to trigger an inflammatory response against pathogens. Moreover, IEC mediate transcytosis of dimeric IgA (dlgA), through the polymeric-immunoglobulin receptor (plgR), to provide secretory IgA, the major protective Ig in mucosal secretions. Using an in vitro model of polarized IEC, we describe an additional anti-inflammatory mechanism of dlgA-mediated protection against intracellular bacterial components involved in the proinflammatory activation of IEC. Specific dlgA colocalizes to lipopolysaccharide (LPS) in the apical recycling endosome compartment, preventing LPS-induced NF-kappaB translocation and subsequent proinflammatory response. Thus, intracellular neutralization by dlgA limits the acute local inflammation induced by proinflammatory pathogen-associated molecular patterns such as LPS.	Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75015 Paris, France; Inst Pasteur, Unite Anal Images Quantitat, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fernandez, MI (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, 28 Rue Dr Roux, F-75015 Paris, France.		Tournebize, Regis/K-7847-2018; Olivo-Marin, Jean-Christophe/K-4428-2015	Tournebize, Regis/0000-0003-3718-3130; Olivo-Marin, Jean-Christophe/0000-0001-6796-0696				ANAND BS, 1986, GASTROENTEROLOGY, V90, P654, DOI 10.1016/0016-5085(86)91120-0; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; BARROSO M, 1994, J CELL BIOL, V124, P83, DOI 10.1083/jcb.124.1.83; Beatty WL, 1997, INFECT IMMUN, V65, P4395, DOI 10.1128/IAI.65.11.4395-4404.1997; Beatty WL, 1999, J CELL BIOL, V145, P689, DOI 10.1083/jcb.145.4.689; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; BJERKE K, 1988, CLIN EXP IMMUNOL, V71, P502; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Bowman EP, 2002, J EXP MED, V195, P269, DOI 10.1084/jem.20010670; BRANDTZAEG P, 1992, ANN NY ACAD SCI, V664, P157, DOI 10.1111/j.1749-6632.1992.tb39758.x; Brandtzaeg P, 1996, BAILLIERE CLIN RHEUM, V10, P1; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Christ AD, 1997, SPRINGER SEMIN IMMUN, V18, P449, DOI 10.1007/BF00824052; Corthesy B, 1999, CURR TOP MICROBIOL, V236, P93; Corthesy B, 1996, J BIOL CHEM, V271, P33670, DOI 10.1074/jbc.271.52.33670; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; Detmers PA, 1996, J IMMUNOL, V157, P5589; DYER RB, 1993, INFECT IMMUN, V61, P4427, DOI 10.1128/IAI.61.10.4427-4433.1993; Fujioka H, 1998, J EXP MED, V188, P1223, DOI 10.1084/jem.188.7.1223; GarciadelPortillo F, 1997, INFECT IMMUN, V65, P24, DOI 10.1128/IAI.65.1.24-34.1997; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; HANSEN SH, 1995, J BIOL CHEM, V270, P28425; Hayashi M, 1997, IMMUNOLOGY, V92, P220, DOI 10.1046/j.1365-2567.1997.00341.x; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Hocini H, 1999, J INFECT DIS, V179, pS448, DOI 10.1086/314802; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8791; KEREN DF, 1982, J IMMUNOL, V128, P475; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; KRAMER DR, 1995, J IMMUNOL, V154, P2051; KVALE D, 1988, J IMMUNOL, V140, P3086; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; LEVINE B, 1991, SCIENCE, V254, P856, DOI 10.1126/science.1658936; Loman S, 1997, AM J PHYSIOL-LUNG C, V272, pL951, DOI 10.1152/ajplung.1997.272.5.L951; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2001, MICROBES INFECT, V3, P1021, DOI 10.1016/S1286-4579(01)01460-5; MATHAN MM, 1986, AM J PATHOL, V123, P25; MAZANEC MB, 1992, P NATL ACAD SCI USA, V89, P6901, DOI 10.1073/pnas.89.15.6901; MAZANEC MB, 1995, J VIROL, V69, P1339, DOI 10.1128/JVI.69.2.1339-1343.1995; MAZANEC MB, 1993, IMMUNOL TODAY, V14, P430, DOI 10.1016/0167-5699(93)90245-G; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Orzech E, 2000, J BIOL CHEM, V275, P15207, DOI 10.1074/jbc.275.20.15207; Passwell JH, 2001, INFECT IMMUN, V69, P1351, DOI 10.1128/IAI.69.3.1351-1357.2001; Phalipon A, 1999, CURR TOP MICROBIOL, V236, P163; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; PHALIPON A, 1995, J EXP MED, V182, P769, DOI 10.1084/jem.182.3.769; Phillips C, 2000, CANCER PRACT, V8, P165, DOI 10.1046/j.1523-5394.2000.84009.x; Raqib R, 1996, EUR J IMMUNOL, V26, P1130, DOI 10.1002/eji.1830260526; RAQIB R, 1995, INFECT IMMUN, V63, P289, DOI 10.1128/IAI.63.1.289-296.1995; Robinson JK, 2001, J IMMUNOL, V166, P3688, DOI 10.4049/jimmunol.166.6.3688; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Schwartz-Cornil I, 2002, J VIROL, V76, P8110, DOI 10.1128/JVI.76.16.8110-8117.2002; SONG WX, 1994, J BIOL CHEM, V269, P29474; TAYLOR DN, 1993, INFECT IMMUN, V61, P3678, DOI 10.1128/IAI.61.9.3678-3687.1993; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Zar J.H, 1999, BIOSTAT ANAL, V4th	66	113	126	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2003	18	6					739	749		10.1016/S1074-7613(03)00122-5	http://dx.doi.org/10.1016/S1074-7613(03)00122-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818156	Bronze			2022-12-18	WOS:000183767700005
J	Turner, SJ; Diaz, G; Cross, R; Doherty, PC				Turner, SJ; Diaz, G; Cross, R; Doherty, PC			Analysis of clonotype distribution and persistence for an influenza virus-specific CD8(+) T cell response	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RECEPTOR BETA-CHAIN; IN-VIVO; VIRAL-INFECTION; TCR REPERTOIRES; ALPHA-BETA; A VIRUS; BACTERIAL-INFECTION; SENDAI-VIRUS; LYMPH-NODE	The spectrum of TCR Vbeta usage is compared for primary and recall CD8(+)D(b)PA(224)(+) T cell responses in mice with influenza pneumonia. Single-cell RT-PCR established that the same clonotypes were present in the lymphoid tissue and in the virus-infected lung. Longitudinal analysis indicated that the memory TCR repertoire reflects the primary response, with no decrease in diversity prior to (or after) secondary challenge. The re-engagement of memory T cells looked to be stochastic in this localized, transient infection. Analysis of clonotypes from the blood, spleen, regional lymph nodes, bone marrow, lung, and liver over a 200 day interval showed no evidence of selective localization or loss. The long-term distribution of memory T cells seemed to be essentially random.	St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Doherty, PC (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale, Memphis, TN 38105 USA.	peter.doherty@stjude.org	Turner, Stephen/GXM-4654-2022; Doherty, Peter Charles/C-4185-2013	Turner, Stephen/0000-0002-1002-0000; Doherty, Peter Charles/0000-0002-5028-3489	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029579, R01AI029579] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NIAID NIH HHS [AI29579] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AEBISCHER T, 1990, EUR J IMMUNOL, V20, P523, DOI 10.1002/eji.1830200310; ALLAN W, 1990, J IMMUNOL, V144, P3980; Annels NE, 2000, J IMMUNOL, V165, P4831, DOI 10.4049/jimmunol.165.9.4831; Arden Bernhard, 1995, Immunogenetics, V42, P501; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Belz GT, 2000, J IMMUNOL, V165, P2404, DOI 10.4049/jimmunol.165.5.2404; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Blattman JN, 2000, J IMMUNOL, V165, P6081, DOI 10.4049/jimmunol.165.11.6081; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Brander C, 1999, J IMMUNOL, V162, P4796; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; Chen ZW, 2001, J IMMUNOL, V166, P4525, DOI 10.4049/jimmunol.166.7.4525; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; CIBOTTI R, 1994, J EXP MED, V180, P861, DOI 10.1084/jem.180.3.861; COSE SC, 1995, J VIROL, V69, P5849, DOI 10.1128/JVI.69.9.5849-5852.1995; DAVIS MM, 1999, FUNDAMENTAL IMMUNOLO, P341; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123; EICHELBERGER MC, 1991, J GEN VIROL, V72, P1695, DOI 10.1099/0022-1317-72-7-1695; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Flynn KJ, 1999, P NATL ACAD SCI USA, V96, P8597, DOI 10.1073/pnas.96.15.8597; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0; HAMILTONEASTON A, 1995, J VIROL, V69, P6359, DOI 10.1128/JVI.69.10.6359-6366.1995; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Huleatt JW, 2001, J IMMUNOL, V166, P4065, DOI 10.4049/jimmunol.166.6.4065; Islam SA, 2001, J VIROL, V75, P4907, DOI 10.1128/JVI.75.10.4907-4911.2001; IWAMOTO A, 1987, J EXP MED, V165, P591, DOI 10.1084/jem.165.3.591; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Lin MY, 1998, J EXP MED, V188, P1993, DOI 10.1084/jem.188.11.1993; LONE YC, 1994, CR ACAD SCI III-VIE, V317, P645; Malherbe L, 2000, IMMUNITY, V13, P771, DOI 10.1016/S1074-7613(00)00075-3; MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Maryanski JL, 1996, IMMUNITY, V4, P47, DOI 10.1016/S1074-7613(00)80297-6; Maryanski JL, 2001, IMMUNOL RES, V23, P75, DOI 10.1385/IR:23:1:75; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; McWilliam AS, 1997, J VIROL, V71, P226, DOI 10.1128/JVI.71.1.226-236.1997; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Naumov YN, 1998, J IMMUNOL, V160, P2842; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; ROTT R, 1995, AM J RESP CRIT CARE, V152, pS16, DOI 10.1164/ajrccm/152.4_Pt_2.S16; SAITO H, 1984, NATURE, V309, P757, DOI 10.1038/309757a0; Sourdive DJD, 1998, J EXP MED, V188, P71, DOI 10.1084/jem.188.1.71; Stevenson PG, 1999, P NATL ACAD SCI USA, V96, P9281, DOI 10.1073/pnas.96.16.9281; TABI Z, 1988, CELL IMMUNOL, V113, P268, DOI 10.1016/0008-8749(88)90026-3; TRIPP RA, 1995, J IMMUNOL, V154, P6013; Turner SJ, 2001, J IMMUNOL, V167, P2753, DOI 10.4049/jimmunol.167.5.2753; Turner SJ, 1997, J IMMUNOL, V159, P2312; Usherwood EJ, 1999, J IMMUNOL, V162, P3350; WALKER JA, 1992, VIROLOGY, V190, P278, DOI 10.1016/0042-6822(92)91214-F; Walker PR, 1996, INT IMMUNOL, V8, P1131, DOI 10.1093/intimm/8.7.1131; Wallace ME, 2000, IMMUNITY, V12, P547, DOI 10.1016/S1074-7613(00)80206-X; Wang FM, 1998, P NATL ACAD SCI USA, V95, P5217, DOI 10.1073/pnas.95.9.5217; YANAGI Y, 1990, J VIROL, V64, P5919, DOI 10.1128/JVI.64.12.5919-5926.1990	62	113	117	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2003	18	4					549	559		10.1016/S1074-7613(03)00087-6	http://dx.doi.org/10.1016/S1074-7613(03)00087-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705857	Bronze			2022-12-18	WOS:000182353900010
J	Laichalk, LL; Hochberg, D; Babcock, GJ; Freeman, RB; Thorley-Lawson, DA				Laichalk, LL; Hochberg, D; Babcock, GJ; Freeman, RB; Thorley-Lawson, DA			The dispersal of mucosal memory B cells: Evidence from persistent EBV infection	IMMUNITY			English	Article							EPSTEIN-BARR-VIRUS; VARIABLE REGION GENES; HUMAN PALATINE TONSIL; PERIPHERAL-BLOOD; IN-VIVO; LYMPHOID-TISSUE; T-CELLS; LYMPHOCYTES; MODEL; IDENTIFICATION	We have used latent infection with the human herpesvirus Epstein-Barr virus to track the dispersal of memory B cells from the mucosal lymphoid tissue of Waldeyer's ring (tonsils/adenoids). EBV is evenly distributed between the memory compartments of Waldeyer's ring and the peripheral blood. However, it has an approximately 20-fold higher preference for Waldeyer's ring over the spleen or mesenteric lymph nodes. These observations are consistent with a model whereby the virus preferentially establishes persistent infection within memory B cells from Waldeyer's ring. The virus then colonizes the entire peripheral lymphoid system, at a low level, by trafficking with these memory B cells as they circulate through the body and back to Waldeyer's ring. This pathway may reflect that of normal memory B cells derived from nasopharyngeal and other mucosal lymph nodes.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Div Transplant Surg, Boston, MA 02111 USA	Tufts University; Tufts Medical Center	Thorley-Lawson, DA (corresponding author), Tufts Univ, Sch Med, Dept Pathol, 136 Harrison Ave, Boston, MA 02111 USA.	david.thorley-lawson@tufts.edu			NATIONAL CANCER INSTITUTE [R01CA065883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018757] Funding Source: NIH RePORTER; NCI NIH HHS [CA 65883] Funding Source: Medline; NIAID NIH HHS [AI 18757] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; AMAN P, 1984, J EXP MED, V159, P208, DOI 10.1084/jem.159.1.208; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Babcock GJ, 2000, P NATL ACAD SCI USA, V97, P12250, DOI 10.1073/pnas.200366597; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Babcock GJ, 1999, J EXP MED, V190, P567, DOI 10.1084/jem.190.4.567; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; CHEN F, 1995, J VIROL, V69, P3752, DOI 10.1128/JVI.69.6.3752-3758.1995; Dono M, 1996, EUR J IMMUNOL, V26, P2043, DOI 10.1002/eji.1830260912; Dono M, 1996, EUR J IMMUNOL, V26, P2035, DOI 10.1002/eji.1830260911; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; FEFALCO J, 2001, SCIENCE, V291, P2608; GRAY D, 1982, EUR J IMMUNOL, V12, P564, DOI 10.1002/eji.1830120707; Hayes DP, 1999, J CLIN PATHOL-MOL PA, V52, P97, DOI 10.1136/mp.52.2.97; HOWARD JC, 1972, J EXP MED, V135, P200, DOI 10.1084/jem.135.2.200; Joseph AM, 2000, J IMMUNOL, V165, P2975, DOI 10.4049/jimmunol.165.6.2975; Joseph AM, 2000, J VIROL, V74, P9964, DOI 10.1128/JVI.74.21.9964-9971.2000; Khan G, 1996, IMMUNITY, V5, P173, DOI 10.1016/S1074-7613(00)80493-8; Khanna R, 1999, IMMUNOL REV, V170, P49, DOI 10.1111/j.1600-065X.1999.tb01328.x; KLEIN U, 1994, J EXP MED, V180, P1383, DOI 10.1084/jem.180.4.1383; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kurth J, 2000, IMMUNITY, V13, P485, DOI 10.1016/S1074-7613(00)00048-0; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; LIU YJ, 1995, IMMUNITY, V2, P239, DOI 10.1016/1074-7613(95)90048-9; MacLennan ICM, 1998, CURR OPIN IMMUNOL, V10, P220, DOI 10.1016/S0952-7915(98)80252-5; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; NIEUWENHUIS P, 1976, CELL IMMUNOL, V23, P254, DOI 10.1016/0008-8749(76)90191-X; NILSSON K, 1971, INT J CANCER, V8, P432, DOI 10.1002/ijc.2910080311; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; QU LR, 1992, J VIROL, V66, P3715, DOI 10.1128/JVI.66.6.3715-3724.1992; SPENCER J, 1985, CLIN EXP IMMUNOL, V62, P607; Spencer J, 1998, IMMUNOL TODAY, V19, P421, DOI 10.1016/S0167-5699(98)01308-5; STEIN H, 1980, J HISTOCHEM CYTOCHEM, V28, P746, DOI 10.1177/28.8.7003001; Tan LC, 1999, J IMMUNOL, V162, P1827; Thorley-Lawson DA, 1999, LIFE SCI, V65, P1433, DOI 10.1016/S0024-3205(99)00214-3; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; THORLEYLAWSON DA, 1985, J EXP MED, V162, P45, DOI 10.1084/jem.162.1.45; TIERNEY RJ, 1994, J VIROL, V68, P7374, DOI 10.1128/JVI.68.11.7374-7385.1994	41	113	117	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2002	16	5					745	754		10.1016/S1074-7613(02)00318-7	http://dx.doi.org/10.1016/S1074-7613(02)00318-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049725	Bronze			2022-12-18	WOS:000175820400012
J	Jacinto, E; Werlen, G; Karin, M				Jacinto, E; Werlen, G; Karin, M			Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASES; CELL ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; TRANSCRIPTIONAL ACTIVITY; NUCLEAR FACTOR; MICE LACKING; C-FOS; EXPRESSION; PATHWAYS; PHOSPHORYLATION	The MAP kinase (MAPK) JNK but not ERK is synergistically activated during costimulation of T cells. We examined how protein tyrosine kinases (PTKs) and GTPases differentially regulate JNK and ERK in T cells. While PTKs are not selective, small GTPases display distinct MAPK-activating functions. Whereas Ras activates ERK, Rac activates JNK. Rac cooperates with a Syk-generated signal to enhance JNK activation and appears to be at a nodal point for pathways emanating from CD28, calcineurin, and protein kinase C. AP-1-and NF-AT-dependent reporters are stimulated by Rac and Syk and are dependent on JNK. Unlike Syk, the PTK Lck activates JNK but does not cooperate with Pac, resulting in weak AP-1 and NF-AT activation. Therefore, signals generated by PTKs are functionally distinct and need to be integrated to induce transcriptional responses.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu		Jacinto, Estela/0000-0001-7118-1759	NATIONAL CANCER INSTITUTE [P01CA050528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES004151, R01ES004151] Funding Source: NIH RePORTER; NCI NIH HHS [CA50528] Funding Source: Medline; NIEHS NIH HHS [ES04151] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Cantrell DA, 1996, CANCER SURV, V27, P165; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; COOKE M P, 1989, New Biologist, V1, P66; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; COUTURE C, 1994, MOL CELL BIOL, V14, P5249, DOI 10.1128/MCB.14.8.5249; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; DeSilva DR, 1996, J EXP MED, V183, P2017, DOI 10.1084/jem.183.5.2017; FARGNOLI J, 1995, J BIOL CHEM, V270, P26533, DOI 10.1074/jbc.270.44.26533; Faris M, 1996, J BIOL CHEM, V271, P27366, DOI 10.1074/jbc.271.44.27366; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; Law CL, 1996, MOL CELL BIOL, V16, P1305; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Marais R, 1996, CANCER SURV, V27, P101; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Mondino A, 1996, J IMMUNOL, V157, P2048; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; QUILL H, 1992, J IMMUNOL, V149, P2887; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; SCHREIBER SL, 1992, CELL, V70, P365, DOI 10.1016/0092-8674(92)90158-9; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; THORNE M, 1995, J EXP MED, V181, P1997; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Williams S, 1997, EUR J BIOCHEM, V245, P84, DOI 10.1111/j.1432-1033.1997.00084.x; WRIGHT DD, 1994, MOL CELL BIOL, V14, P2429, DOI 10.1128/MCB.14.4.2429	57	113	114	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1998	8	1					31	41		10.1016/S1074-7613(00)80456-2	http://dx.doi.org/10.1016/S1074-7613(00)80456-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462509	Bronze			2022-12-18	WOS:000071765700004
J	White, LC; Wright, KL; Felix, NJ; Ruffner, H; Reis, LFL; Pine, R; Ting, JPY				White, LC; Wright, KL; Felix, NJ; Ruffner, H; Reis, LFL; Pine, R; Ting, JPY			Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8(+) T cells in IRF-1(-/-) mice	IMMUNITY			English	Review							CLASS-I MOLECULES; INTERFERON-INDUCIBLE GENES; TRANSCRIPTION FACTOR IRF-1; ANTIGEN PRESENTATION; IFN-BETA; POSITIVE SELECTION; GAMMA-INTERFERON; FUNCTIONAL DIVERSITY; PEPTIDASE ACTIVITIES; GROWTH-INHIBITION	The TAP1 and LMP2 genes are central for class I MHC function and share a common promoter. Here, we analyze the molecular mechanism of IFN gamma up-regulation of TAP1 and LMP2. In vivo footprinting indicates IFN gamma up-regulates protein-DNA contacts at an IRF-E that is essential for the up-regulation of TAP1 and LMP2 by IFN gamma. Gel shift analysis indicates that this site binds IRF-1. The expression of TAP1 and LMP2 are both greatly reduced in IRF-1-deficient mice. Surface class I MHC as well as CD8(+) T cells are reduced in IRF-1(-/-) mice. The role of IRF-1 in the regulation of TAP1 and LMP2 suggests a mechanism for the antiviral properties of IRF-1 and the unexpected deficiency of CD8(+) T cells observed in IRF-1(-/-) mice.	SALK INST BIOL STUDIES,GENET LAB,SAN DIEGO,CA 92186; PUBL HLTH RES INST,NEW YORK,NY 10016; UNIV FED MINAS GERAIS,DEPT MICROBIOL,BR-31270901 BELO HORIZONT,MG,BRAZIL	Salk Institute; Universidade Federal de Minas Gerais	White, LC (corresponding author), UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27599, USA.		Reis, Luiz F. L./C-4556-2013	Reis, Luiz/0000-0002-4040-2456	NIAID NIH HHS [AI29564] Funding Source: Medline; CSR NIH HHS [RG1785] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029564, R56AI029564, R37AI029564] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CSR NIH HHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABDOLLAHI A, 1991, CELL GROWTH DIFFER, V2, P401; AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; AKIYAMA K, 1994, FEBS LETT, V343, P85, DOI 10.1016/0014-5793(94)80612-8; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; ASHTONRICKARDT PG, 1993, THYMUS, V22, P111; BECK S, 1992, J MOL BIOL, V228, P433, DOI 10.1016/0022-2836(92)90832-5; BELICH MP, 1995, MOL BIOL REP, V21, P53, DOI 10.1007/BF00990971; BLANAR MA, 1989, EMBO J, V8, P1139, DOI 10.1002/j.1460-2075.1989.tb03484.x; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIKEN V, 1995, MOL CELL BIOL, V15, P975; CERUNDOLO V, 1995, EUR J IMMUNOL, V25, P554, DOI 10.1002/eji.1830250238; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DAY PM, 1995, IMMUNITY, V2, P137, DOI 10.1016/S1074-7613(95)80014-X; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; EHRLICH RE, 1995, IMMUNOL RES, V14, P77, DOI 10.1007/BF02918170; Falk K, 1993, Semin Immunol, V5, P81, DOI 10.1006/smim.1993.1012; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; FRUH K, 1994, EMBO J, V13, P3236, DOI 10.1002/j.1460-2075.1994.tb06625.x; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HARROCH S, 1994, EMBO J, V13, P1942, DOI 10.1002/j.1460-2075.1994.tb06463.x; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; HUGO P, 1993, IMMUNOL REV, V135, P133, DOI 10.1111/j.1600-065X.1993.tb00647.x; KAMIJO R, 1993, J EXP MED, V178, P1435, DOI 10.1084/jem.178.4.1435; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; KERR IM, 1992, J INTERFERON RES, V12, P237, DOI 10.1089/jir.1992.12.237; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; KIRCHHOFF S, 1993, NUCLEIC ACIDS RES, V21, P2881, DOI 10.1093/nar/21.12.2881; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; LIM SP, 1994, IMMUNOGENETICS, V39, P168; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0; MACDONALD NJ, 1990, CELL, V60, P767, DOI 10.1016/0092-8674(90)90091-R; MACHOLD RP, 1995, J EXP MED, V181, P1111, DOI 10.1084/jem.181.3.1111; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; MURRAY HW, 1994, AM J MED, V97, P459, DOI 10.1016/0002-9343(94)90326-3; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; NIEDERMANN G, 1995, IMMUNITY, V2, P289, DOI 10.1016/1074-7613(95)90053-5; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; PARRINGTON J, 1993, EUR J BIOCHEM, V214, P617, DOI 10.1111/j.1432-1033.1993.tb17961.x; PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992; PINE R, 1990, MOL CELL BIOL, V10, P2448, DOI 10.1128/MCB.10.6.2448; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; RUFFNER H, 1993, P NATL ACAD SCI USA, V90, P11503, DOI 10.1073/pnas.90.24.11503; Sambrook J, 1989, MOL CLONING LAB MANU; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SCHWARTZ RH, 1989, CELL, V57, P1073, DOI 10.1016/0092-8674(89)90044-5; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; STARK GR, 1992, J INTERFERON RES, V12, P147, DOI 10.1089/jir.1992.12.147; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; TANAKA K, 1994, J LEUKOCYTE BIOL, V56, P571, DOI 10.1002/jlb.56.5.571; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; van Bleek G M, 1992, Trends Cell Biol, V2, P202, DOI 10.1016/0962-8924(92)90247-K; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; VILCEK J, 1994, INT ARCH ALLERGY IMM, V104, P311; VONBOEHMER H, 1993, IMMUNOL REV, V135, P67; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; WRIGHT KL, 1995, J EXP MED, V181, P1459, DOI 10.1084/jem.181.4.1459; YANG Y, 1992, J BIOL CHEM, V267, P11669; YEHUDAR RR, 1994, J EXP MED, V180, P477; YEWDELL J, 1994, J IMMUNOL, V152, P1163; YULEE LY, 1990, MOL CELL BIOL, V10, P3087, DOI 10.1128/MCB.10.6.3087; ZHOU XZ, 1994, EUR J IMMUNOL, V24, P1863, DOI 10.1002/eji.1830240822; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X	101	113	115	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1996	5	4					365	376		10.1016/S1074-7613(00)80262-9	http://dx.doi.org/10.1016/S1074-7613(00)80262-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VP444	8885869	Bronze			2022-12-18	WOS:A1996VP44400008
J	Morioka, S; Maueroder, C; Ravichandran, KS				Morioka, Sho; Maueroder, Christian; Ravichandran, Kodi S.			Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology	IMMUNITY			English	Review							DENSITY-LIPOPROTEIN RECEPTOR; GLYCATION END-PRODUCTS; APOPTOTIC CELL CLEARANCE; PANNEXIN 1 CHANNELS; ALPHA-V INTEGRINS; FIND-ME SIGNAL; EARLY ATHEROSCLEROSIS; CONTINUED CLEARANCE; TYROSINE KINASES; EPITHELIAL-CELLS	Nearly every tissue in the body undergoes routine turnover of cells as part of normal healthy living. The majority of these cells undergoing turnover die via apoptosis, and then are rapidly removed by phagocytes by the process of efferocytosis that is anti-inflammatory. However, a number of pathologies have recently been linked to defective clearance of apoptotic cells. Perturbed clearance arises for many reasons, including overwhelming of the clearance machinery, disruptions at different stages of efferocytosis, and responses of phagocytes during efferocytosis, all of which can alter the homeostatic tissue environment. This review covers linkages of molecules involved in the different phases of efferocytosis to disease pathologies that can arise due to their loss or altered function.	[Morioka, Sho; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Morioka, Sho; Ravichandran, Kodi S.] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Morioka, Sho; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Maueroder, Christian; Ravichandran, Kodi S.] Univ Ghent, VIB UGent Ctr Inflammat Res, Techologiepk Zwijnaarde, Ghent, Belgium; [Maueroder, Christian; Ravichandran, Kodi S.] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	University of Virginia; University of Virginia; University of Virginia; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Ravichandran, KS (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA.; Ravichandran, KS (corresponding author), Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA.; Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.; Ravichandran, KS (corresponding author), Univ Ghent, VIB UGent Ctr Inflammat Res, Techologiepk Zwijnaarde, Ghent, Belgium.; Ravichandran, KS (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	ravi@virginia.edu	; Maueroder, Christian/H-7412-2016	Ravichandran, Kodi/0000-0001-9049-1410; Maueroder, Christian/0000-0002-7563-883X; Morioka, Sho/0000-0002-1153-4919	National Institutes of Health NIGMS [GM064709]; NHLBI [P01HL120840]; Odysseus Award from the FWO (Belgium); Mishima-Kaiun Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; German Research Foundation (DFG) [MA 7770/1-1]; EOS-DECODE award from the FWO (Belgium); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI136073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064709, R35GM122542] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Odysseus Award from the FWO (Belgium); Mishima-Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; German Research Foundation (DFG)(German Research Foundation (DFG)); EOS-DECODE award from the FWO (Belgium)(FWO); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants to K.S.R. from the National Institutes of Health NIGMS (GM064709), NHLBI (P01HL120840), an Odysseus Award from the FWO (Belgium), and the EOS-DECODE award from the FWO (Belgium). S.M. is supported by grants from the Mishima-Kaiun Memorial Foundation and The Kanae Foundation for the Promotion of Medical Science. C.M. is supported by a postdoctoral research fellowship from the German Research Foundation (DFG) (MA 7770/1-1).	Abreu JRF, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2900; Acharya M, 2010, J CLIN INVEST, V120, P4445, DOI 10.1172/JCI43796; Ait-Oufella H, 2007, CIRCULATION, V115, P2168, DOI 10.1161/CIRCULATIONAHA.106.662080; Akhtar N, 2016, DEV CELL, V38, P522, DOI 10.1016/j.devcel.2016.08.005; Akitake-Kawano R, 2013, CARCINOGENESIS, V34, P1567, DOI 10.1093/carcin/bgt069; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Bhatia VK, 2007, AM J PATHOL, V170, P416, DOI 10.2353/ajpath.2007.060406; Billaud M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005824; Bischoff ED, 2010, J LIPID RES, V51, P900, DOI [10.1194/jlr.M900096-JLR200, 10.1194/jlr.M900096]; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Borisenko GG, 2004, CELL DEATH DIFFER, V11, P943, DOI 10.1038/sj.cdd.4401421; Bossi F, 2014, P NATL ACAD SCI USA, V111, P4209, DOI 10.1073/pnas.1311968111; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Bosurgi L, 2013, P NATL ACAD SCI USA, V110, P13091, DOI 10.1073/pnas.1302507110; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520; Cai L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036785; Cao WM, 2004, J MOL ENDOCRINOL, V32, P497, DOI 10.1677/jme.0.0320497; Casanova-Acebes M, 2018, J EXP MED, V215, P2778, DOI 10.1084/jem.20181468; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Christiansen-Weber TA, 2000, AM J PATHOL, V157, P1017, DOI 10.1016/S0002-9440(10)64614-7; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1; Cummings RJ, 2016, NATURE, V539, P565, DOI 10.1038/nature20138; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dogusan Z, 2004, J IMMUNOL, V172, P4717, DOI 10.4049/jimmunol.172.8.4717; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Elliott MR, 2016, DEV CELL, V38, P147, DOI 10.1016/j.devcel.2016.06.029; Elliott MR, 2010, ANN NY ACAD SCI, V1209, P30, DOI 10.1111/j.1749-6632.2010.05764.x; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Englert JM, 2011, INT J CLIN EXP PATHO, V4, P241; Felton JM, 2018, J ALLERGY CLIN IMMUN, V142, P1884, DOI 10.1016/j.jaci.2018.01.029; Flannagan RS, 2014, MOL BIOL CELL, V25, P1511, DOI 10.1091/mbc.E13-04-0212; Fond AM, 2015, J CLIN INVEST, V125, P2748, DOI 10.1172/JCI80300; Frasch SC, 2016, J IMMUNOL, V197, P1425, DOI 10.4049/jimmunol.1600264; Freemerman AJ, 2019, J IMMUNOL, V202, P1265, DOI 10.4049/jimmunol.1800002; Good ME, 2018, CIRC RES, V122, P606, DOI 10.1161/CIRCRESAHA.117.312380; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Haka AS, 2016, J LIPID RES, V57, P980, DOI 10.1194/jlr.M064089; Han CZ, 2016, NATURE, V539, P570, DOI 10.1038/nature20141; Hathaway CK, 2016, P NATL ACAD SCI USA, V113, P2218, DOI 10.1073/pnas.1600511113; He M, 2007, AM J PHYSIOL-LUNG C, V293, pL1427, DOI 10.1152/ajplung.00075.2007; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; Heideveld E, 2017, IMMUNOBIOLOGY, V222, P814, DOI 10.1016/j.imbio.2016.11.007; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hernandez JB, 2010, CURR OPIN CELL BIOL, V22, P865, DOI 10.1016/j.ceb.2010.08.003; Higgins JM, 2015, CLIN LAB MED, V35, P43, DOI 10.1016/j.cll.2014.10.002; Hildeman D, 2007, CURR OPIN IMMUNOL, V19, P516, DOI 10.1016/j.coi.2007.05.005; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Huang QC, 2008, RHEUMATOL INT, V28, P697, DOI 10.1007/s00296-008-0534-7; Jeon JY, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4563; Ji HF, 2014, HEPATOLOGY, V60, P2052, DOI 10.1002/hep.27334; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Ke FFS, 2018, CELL, V173, P1217, DOI 10.1016/j.cell.2018.04.036; Kojima Y, 2017, CIRCULATION, V135, P476, DOI 10.1161/CIRCULATIONAHA.116.025684; Kojima Y, 2016, NATURE, V536, P86, DOI 10.1038/nature18935; Kolb JP, 2017, TRENDS IMMUNOL, V38, P705, DOI 10.1016/j.it.2017.06.009; Kristiansen M, 2014, CELL DEATH DIFFER, V21, P1025, DOI 10.1038/cdd.2014.47; Kusunoki R, 2015, J GASTROENTEROL, V50, P862, DOI 10.1007/s00535-014-1036-x; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Lee CS, 2016, IMMUNITY, V44, P807, DOI 10.1016/j.immuni.2016.02.005; Lee J, 2019, CELL DEATH DIFFER, V26, P1646, DOI 10.1038/s41418-018-0238-9; Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Llacuna L, 2010, HEPATOLOGY, V52, P1371, DOI 10.1002/hep.23833; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; Luo BW, 2016, IMMUNITY, V44, P287, DOI 10.1016/j.immuni.2016.01.002; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Mazaheri F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5046; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; McCarty JH, 2008, AM J PATHOL, V172, P1740, DOI 10.2353/ajpath.2008.070700; Medina CB, 2016, CELL DEATH DIFFER, V23, P979, DOI 10.1038/cdd.2016.13; Merezhinskaya N, 2000, MUSCLE NERVE, V23, P90, DOI 10.1002/(SICI)1097-4598(200001)23:1<90::AID-MUS12>3.0.CO;2-M; Mihaly SR, 2014, CELL DEATH DIFFER, V21, P1667, DOI 10.1038/cdd.2014.123; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Miyanishi M, 2012, INT IMMUNOL, V24, P551, DOI 10.1093/intimm/dxs064; Moffatt OD, 1999, J IMMUNOL, V162, P6800; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Morioka S, 2018, NATURE, V563, P714, DOI 10.1038/s41586-018-0735-5; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Parks BW, 2013, J LIPID RES, V54, P1114, DOI 10.1194/jlr.M035352; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Penberthy KK, 2018, TRENDS CELL BIOL, V28, P317, DOI 10.1016/j.tcb.2018.01.004; Penberthy KK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15191-1; Peng YF, 2011, J CLIN INVEST, V121, P2221, DOI 10.1172/JCI43254; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Poon IKH, 2014, NATURE, V507, P329, DOI 10.1038/nature13147; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Proto JD, 2018, IMMUNITY, V49, P666, DOI 10.1016/j.immuni.2018.07.015; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010; Stanford JC, 2014, J CLIN INVEST, V124, P4737, DOI 10.1172/JCI76375; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Tian LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4146; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Vasheghani F, 2013, AM J PATHOL, V182, P1099, DOI 10.1016/j.ajpath.2012.12.012; Veillette A, 2018, TRENDS IMMUNOL, V39, P173, DOI 10.1016/j.it.2017.12.005; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wang Y, 2017, CELL, V171, P331, DOI 10.1016/j.cell.2017.08.041; Weaver JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42550; Weinger JG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-49; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Yamaguchi H, 2014, ELIFE, V3, DOI 10.7554/eLife.02172; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Yancey PG, 2011, CIRCULATION, V124, P454, DOI 10.1161/CIRCULATIONAHA.111.032268; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Yang HX, 2014, INVEST OPHTH VIS SCI, V55, P2795, DOI 10.1167/iovs.13-13323; Yoon KW, 2015, SCIENCE, V349, DOI 10.1126/science.1261669; Youssef LA, 2018, BLOOD, V131, P2581, DOI 10.1182/blood-2017-12-822619; Zhu D, 2015, J CLIN INVEST, V125, P1497, DOI 10.1172/JCI74603; 2010, ALLERGY, V65, P1545, DOI DOI 10.1111/J.1398-9995.2010.02426.X; 2014, CLIN CANCER RES, V20, P6452, DOI DOI 10.1158/1078-0432.CCR-14-1236; 2017, J EXP MED, V214, P1281, DOI DOI 10.1084/JEM.20161375; 2014, NAT IMMUNOL, V15, P920, DOI DOI 10.1038/NI.2986	157	112	116	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1149	1162		10.1016/j.immuni.2019.04.018	http://dx.doi.org/10.1016/j.immuni.2019.04.018			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	31117011	Green Accepted, Bronze			2022-12-18	WOS:000468429500008
J	Schappe, MS; Szteyn, K; Stremska, ME; Mendu, SK; Downs, TK; Seegren, PV; Mahoney, MA; Dixit, S; Krupa, JK; Stipes, EJ; Rogers, JS; Adamson, SE; Leitinger, N; Desai, BN				Schappe, Michael S.; Szteyn, Kalina; Stremska, Marta E.; Mendu, Suresh K.; Downs, Taylor K.; Seegren, Philip V.; Mahoney, Michelle A.; Dixit, Sumeet; Krupa, Julia K.; Stipes, Eric J.; Rogers, Jason S.; Adamson, Samantha E.; Leitinger, Norbert; Desai, Bimal N.			Chanzyme TRPM7 Mediates the Ca2+ Influx Essential for Lipopolysaccharide-Induced Toll-Like Receptor 4 Endocytosis and Macrophage Activation	IMMUNITY			English	Article							NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; PERITONEAL-MACROPHAGES; INTRACELLULAR CALCIUM; TRANSCRIPTION FACTORS; POTENTIAL CHANNELS; NLRP3 INFLAMMASOME; SIGNALING PATHWAY; ADAPTIVE IMMUNITY; DENDRITIC CELLS	Toll-like receptors (TLRs) sense pathogen-associated molecular patterns to activate the production of inflammatory mediators. TLR4 recognizes lipopolysaccharide (LPS) and drives the secretion of inflammatory cytokines, often contributing to sepsis. We report that transient receptor potential melastatin-like 7 (TRPM7), a non-selective but Ca2+-conducting ion channel, mediates the cytosolic Ca2+ elevations essential for LPS-induced macrophage activation. LPS triggered TRPM7-dependent Ca2+ elevations essential for TLR4 endocytosis and the subsequent activation of the transcription factor IRF3. In a parallel pathway, the Ca2+ signaling initiated by TRPM7 was also essential for the nuclear translocation of NFkB. Consequently, TRPM7-deficient macrophages exhibited major deficits in the LPS-induced transcriptional programs in that they failed to produce IL-1b and other key pro-inflammatory cytokines. In accord with these defects, mice with myeloid-specific deletion of Trpm7 are protected from LPS-induced peritonitis. Our study highlights the importance of Ca2+ signaling in macrophage activation and identifies the ion channel TRPM7 as a central component of TLR4 signaling.	[Schappe, Michael S.; Szteyn, Kalina; Stremska, Marta E.; Mendu, Suresh K.; Downs, Taylor K.; Seegren, Philip V.; Mahoney, Michelle A.; Dixit, Sumeet; Krupa, Julia K.; Stipes, Eric J.; Rogers, Jason S.; Adamson, Samantha E.; Leitinger, Norbert; Desai, Bimal N.] Univ Virginia, Pharmacol Dept, Jordan Hall,1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA; [Leitinger, Norbert; Desai, Bimal N.] Univ Virginia, Carter Immunol Ctr, 345 Crispell Dr MR-6, Charlottesville, VA 22908 USA; [Leitinger, Norbert; Desai, Bimal N.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, 415 Lane Rd, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Desai, BN (corresponding author), Univ Virginia, Pharmacol Dept, Jordan Hall,1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.; Desai, BN (corresponding author), Univ Virginia, Carter Immunol Ctr, 345 Crispell Dr MR-6, Charlottesville, VA 22908 USA.; Desai, BN (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, 415 Lane Rd, Charlottesville, VA 22908 USA.	bdesai@virginia.edu		Seegren, Philip/0000-0002-7153-4670	NIH [GM108989, 5T32GM007055-41]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108989, T32GM007055, T32GM007267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Desai and Leitinger laboratories, Prof. J. Casanova (UVA), and Prof. S. Ewald (UVA) for their helpful insights and discussions. We thank the following core facilities for their technical resources and support: UVA Flow Cytometry Core, Carter Immunology Center Flow Cytometry Core, and the UVA Cardiovascular Research Center Microscopy Facility. We are also grateful for the funding that supported this work: grants GM108989 (B.N.D.) and 5T32GM007055-41 (M.S.S.) from the NIH.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Desai BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00580; Desai BN, 2012, DEV CELL, V22, P1149, DOI 10.1016/j.devcel.2012.04.006; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Helmchen Fritjof, 2011, Cold Spring Harb Protoc, V2011, P923, DOI 10.1101/pdb.top120; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kadl A, 2007, SHOCK, V28, P582, DOI 10.1097/shk.0b013e31804d41dd; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Krapivinsky G, 2014, CELL, V157, P1061, DOI 10.1016/j.cell.2014.03.046; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; Lemonnier L, 2004, FEBS LETT, V556, P121, DOI 10.1016/S0014-5793(03)01387-5; LETARI O, 1991, J IMMUNOL, V147, P980; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Liu XH, 2016, J BIOL CHEM, V291, P8440, DOI 10.1074/jbc.M115.713008; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Qin X, 2013, BRIT J PHARMACOL, V168, P1294, DOI 10.1111/bph.12012; Rada B, 2014, INFLAMM RES, V63, P821, DOI 10.1007/s00011-014-0756-y; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rosadini CV, 2017, CURR OPIN IMMUNOL, V44, P14, DOI 10.1016/j.coi.2016.10.005; Santoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00034; Schilling T, 2014, J CELL SCI, V127, P4561, DOI 10.1242/jcs.151068; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Vaeth M, 2015, J IMMUNOL, V195, P1202, DOI 10.4049/jimmunol.1403013; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	62	112	116	4	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					59	+		10.1016/j.immuni.2017.11.026	http://dx.doi.org/10.1016/j.immuni.2017.11.026			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343440	Bronze, Green Accepted			2022-12-18	WOS:000422751600011
J	Swamy, M; Beck-Garcia, K; Beck-Garcia, E; Hartl, FA; Morath, A; Yousefi, OS; Dopfer, EP; Molnar, E; Schulze, AK; Blanco, R; Borroto, A; Martin-Blanco, N; Alarcon, B; Hofer, T; Minguet, S; Schamel, WWA				Swamy, Mahima; Beck-Garcia, Katharina; Beck-Garcia, Esmeralda; Hartl, Frederike A.; Morath, Anna; Yousefi, O. Sascha; Dopfer, Elaine Pashupati; Molnar, Eszter; Schulze, Anna K.; Blanco, Raquel; Borroto, Aldo; Martin-Blanco, Nadia; Alarcon, Balbino; Hoefer, Thomas; Minguet, Susana; Schamel, Wolfgang W. A.			A Cholesterol-Based Allostery Model of T Cell Receptor Phosphorylation	IMMUNITY			English	Article							INDUCED CONFORMATIONAL-CHANGE; LIPID RAFTS; ACTIVATION; LIGAND; TCR; CD3-EPSILON; ANTIGEN; RECOGNITION; LYMPHOCYTES; RECRUITMENT	Signaling through the T cell receptor (TCR) controls adaptive immune responses. Antigen binding to TCR alpha beta transmits signals through the plasma membrane to induce phosphorylation of the CD3 cytoplasmic tails by incompletely understood mechanisms. Here we show that cholesterol bound to the TCR beta transmembrane region keeps the TCR in a resting, inactive conformation that cannot be phosphorylated by active kinases. Only TCRs that spontaneously detached from cholesterol could switch to the active conformation (termed primed TCRs) and then be phosphorylated. Indeed, by modulating cholesterol binding genetically or enzymatically, we could switch the TCR between the resting and primed states. The active conformation was stabilized by binding to peptide-MHC, which thus controlled TCR signaling. These data are explained by a model of reciprocal allosteric regulation of TCR phosphorylation by cholesterol and ligand binding. Our results provide both a molecular mechanism and a conceptual framework for how lipid-receptor interactions regulate signal transduction.	[Swamy, Mahima; Beck-Garcia, Katharina; Beck-Garcia, Esmeralda; Hartl, Frederike A.; Morath, Anna; Yousefi, O. Sascha; Molnar, Eszter; Minguet, Susana; Schamel, Wolfgang W. A.] Univ Freiburg, Fac Biol, BIOSS Ctr Biol Signalling Studies, Dept Immunol, D-79104 Freiburg, Germany; [Swamy, Mahima; Beck-Garcia, Katharina; Beck-Garcia, Esmeralda; Hartl, Frederike A.; Morath, Anna; Yousefi, O. Sascha; Molnar, Eszter; Minguet, Susana; Schamel, Wolfgang W. A.] Univ Freiburg, Univ Clin Freiburg, CCI, D-79104 Freiburg, Germany; [Swamy, Mahima; Beck-Garcia, Katharina; Beck-Garcia, Esmeralda; Hartl, Frederike A.; Morath, Anna; Yousefi, O. Sascha; Molnar, Eszter; Minguet, Susana; Schamel, Wolfgang W. A.] Univ Freiburg, Fac Med, D-79104 Freiburg, Germany; [Swamy, Mahima; Beck-Garcia, Katharina; Beck-Garcia, Esmeralda; Dopfer, Elaine Pashupati; Minguet, Susana; Schamel, Wolfgang W. A.] Max Planck Inst Immunbiol & Epigenet, D-79108 Freiburg, Germany; [Swamy, Mahima] Univ Dundee, Div Cell Signalling & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Beck-Garcia, Katharina; Morath, Anna; Yousefi, O. Sascha] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Beck-Garcia, Esmeralda] Int Max Planck Res Sch Mol & Cellular Biol, D-79108 Freiburg, Germany; [Schulze, Anna K.; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany; [Schulze, Anna K.; Hoefer, Thomas] Heidelberg Univ, BioQuant Ctr, D-69120 Heidelberg, Germany; [Blanco, Raquel; Borroto, Aldo; Martin-Blanco, Nadia] Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; University of Dundee; University of Freiburg; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Schamel, WWA (corresponding author), Univ Freiburg, Fac Biol, BIOSS Ctr Biol Signalling Studies, Dept Immunol, D-79104 Freiburg, Germany.; Schamel, WWA (corresponding author), Univ Freiburg, Univ Clin Freiburg, CCI, D-79104 Freiburg, Germany.; Schamel, WWA (corresponding author), Univ Freiburg, Fac Med, D-79104 Freiburg, Germany.; Schamel, WWA (corresponding author), Max Planck Inst Immunbiol & Epigenet, D-79108 Freiburg, Germany.	wolfgang.schamel@biologie.uni-freiburg.de	Höfer, Thomas/G-5665-2013; Alarcon, Balbino/N-9648-2016; Swamy, Mahima/J-7046-2019; Blanco, Raquel/M-4290-2015	Höfer, Thomas/0000-0003-3560-8780; Alarcon, Balbino/0000-0001-7820-1070; Swamy, Mahima/0000-0003-3977-3425; Blanco, Raquel/0000-0001-5477-5379; Yousefi, Omid Sascha/0000-0001-5304-729X; Minguet, Susana/0000-0001-8211-5538	EU; ERC [334763]; Deutsche Forschungsgemeinschaft (DFG) [EXC294, EXC81, GSC-4, SCHA 976/2-1]	EU(European Commission); ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank K. Fehrenbach for technical assistance, P. Nielsen for reading the manuscript, I. Luscher, E. Palmer and C. Thiele for providing reagents, and U. Coskun and A. Czogalla for discussions. This work was funded by the EU through grant FP7/2007-2013 (SYBILLA, B.A., T.H., and W.W.S.) and ERC 2013 Advanced Grant 334763 (NOVARIPP, B.A.) and the Deutsche Forschungsgemeinschaft (DFG) through EXC294 (Center for Biological Signalling Studies, BIOSS, and W.W.S.), EXC81 (CellNetworks, T.H.), GSC-4 (Spemann Graduate School, K.B.G., O.S.Y., and A.M.) and grant SCHA 976/2-1 (W.W.S.).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Beck-Garcia E, 2013, ANAL BIOCHEM, V436, P75, DOI 10.1016/j.ab.2013.01.026; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Borroto A, 2013, J IMMUNOL, V190, P1103, DOI 10.4049/jimmunol.1202055; Brumeanu TD, 2007, MOL IMMUNOL, V44, P530, DOI 10.1016/j.molimm.2006.02.008; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; de la Cruz J, 2011, J IMMUNOL, V186, P2282, DOI 10.4049/jimmunol.1003225; Deswal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022928; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Falck E, 2004, BIOPHYS J, V87, P1076, DOI 10.1529/biophysj.104.041368; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gimpl G, 2007, BIOSCIENCE REP, V27, P335, DOI 10.1007/s10540-007-9060-1; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Lee MS, 2015, IMMUNITY, V43, P227, DOI 10.1016/j.immuni.2015.06.018; Martinez-Martin N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000402; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Minguet S, 2008, TRENDS BIOCHEM SCI, V33, P51, DOI 10.1016/j.tibs.2007.10.008; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Molnar E, 2012, J BIOL CHEM, V287, P42664, DOI 10.1074/jbc.M112.386045; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; Petersen TR, 2004, INT IMMUNOL, V16, P889, DOI 10.1093/intimm/dxh098; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Risueno RM, 2005, BLOOD, V106, P601, DOI 10.1182/blood-2004-12-4763; Risueno RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001747; Rouquette-Jazdanian AK, 2006, CELL SIGNAL, V18, P105, DOI 10.1016/j.cellsig.2005.03.024; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Steinberg M, 2004, BLOOD, V104, P760, DOI 10.1182/blood-2003-12-4314; Tani-ichi S, 2005, INT IMMUNOL, V17, P749, DOI 10.1093/intimm/dxh257; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412	51	112	114	2	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1091	1101		10.1016/j.immuni.2016.04.011	http://dx.doi.org/10.1016/j.immuni.2016.04.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192576	Green Submitted, Bronze			2022-12-18	WOS:000376478500014
J	O'Neill, LAJ				O'Neill, Luke A. J.			A Broken Krebs Cycle in Macrophages	IMMUNITY			English	Editorial Material							INFLAMMATION; METABOLISM		Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986	7	112	113	4	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					393	394		10.1016/j.immuni.2015.02.017	http://dx.doi.org/10.1016/j.immuni.2015.02.017			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786167	Bronze			2022-12-18	WOS:000351301900001
J	Montaldo, E; Teixeira-Alves, LG; Glatzer, T; Durek, P; Stervbo, U; Hamann, W; Babic, M; Paclik, D; Stolzel, K; Grone, J; Lozza, L; Juelke, K; Matzmohr, N; Loiacono, F; Petronelli, F; Huntington, ND; Moretta, L; Mingari, MC; Romagnani, C				Montaldo, Elisa; Teixeira-Alves, Luiz Gustavo; Glatzer, Timor; Durek, Pawel; Stervbo, Ulrik; Hamann, Wiebke; Babic, Marina; Paclik, Daniela; Stoelzel, Katharina; Groene, Joern; Lozza, Laura; Juelke, Kerstin; Matzmohr, Nadine; Loiacono, Fabrizio; Petronelli, Francesca; Huntington, Nicholas David; Moretta, Lorenzo; Mingari, Maria Cristina; Romagnani, Chiara			Human ROR gamma t(+)CD34(+) Cells Are Lineage-Specified Progenitors of Group 3 ROR gamma t(+) Innate Lymphoid Cells	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; TISSUE-INDUCER CELLS; MURINE BONE-MARROW; HELPER 17 CELLS; ACTIVATING RECEPTOR; SELECTIVELY EXPRESS; SURFACE-MOLECULE; NKP46(+) CELLS	Group 3 innate lymphoid cells (ILC3s) are defined by the expression of the transcription factor ROR gamma t, which is selectively required for their development. The lineage-specified progenitors of ILC3s and their site of development after birth remain undefined. Here we identified a population of human CD34(+) hematopoietic progenitor cells (HPCs) that express RORgt and share a distinct transcriptional signature with ILC3s. ROR gamma t(+)CD34(+) HPCs were located in tonsils and intestinal lamina propria (LP) and selectively differentiated toward ILC3s. In contrast, ROR gamma t(-)CD34(+) HPCs could differentiate to become either ILC3s or natural killer (NK) cells, with differentiation toward ILC3 lineage determined by stem cell factor (SCF) and aryl hydrocarbon receptor (AhR) signaling. Thus, we demonstrate that in humans ROR gamma t(+)CD34(+) cells are lineage-specified progenitors of IL-22(+) ILC3s and propose that tonsils and intestinal LP, which are enriched both in committed precursors and mature ILC3s, might represent preferential sites of ILC3 lineage differentiation.	[Montaldo, Elisa; Mingari, Maria Cristina] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Montaldo, Elisa; Mingari, Maria Cristina] IRCCS AOU San Martino IST, UOC Immunol, I-16132 Genoa, Italy; [Teixeira-Alves, Luiz Gustavo; Glatzer, Timor; Hamann, Wiebke; Babic, Marina; Paclik, Daniela; Juelke, Kerstin; Romagnani, Chiara] Leibniz Gemeinschaft, Deutsch Rheuma Forschungszentrum DRFZ Berlin, D-10117 Berlin, Germany; [Babic, Marina] Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka 51000, Croatia; [Stoelzel, Katharina] Charite, HNO Klin, D-10117 Berlin, Germany; [Groene, Joern] Charite, Klin Allgemein Gefass & Thoraxchirurg, D-12203 Berlin, Germany; [Lozza, Laura] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; [Juelke, Kerstin; Matzmohr, Nadine] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Loiacono, Fabrizio; Petronelli, Francesca; Moretta, Lorenzo] Giannina Gaslini Inst, I-16147 Genoa, Italy; [Huntington, Nicholas David] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Dept Med Biol, Parkville, Vic 3052, Australia	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Rijeka; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Melbourne; Walter & Eliza Hall Institute	Romagnani, C (corresponding author), Leibniz Gemeinschaft, Deutsch Rheuma Forschungszentrum DRFZ Berlin, Charitepl 1, D-10117 Berlin, Germany.	romagnani@drfz.de	Romagnani, Chiara/E-4708-2016; Stervbo, Ulrik/AAV-1561-2020; Babic Cac, Marina/AFO-1124-2022; Moretta, Lorenzo/AAA-7239-2020; Montaldo, Elisa/AAB-9353-2022; Huntington, NICHOLAS/AAV-4704-2020; Cac, Marina Babic/ABH-3595-2020; Montaldo, Elisa/AAN-1889-2020; Mingari, Maria Cristina/AAB-1315-2019	Romagnani, Chiara/0000-0002-5167-7463; Stervbo, Ulrik/0000-0002-2831-8868; Moretta, Lorenzo/0000-0003-4658-1747; Huntington, NICHOLAS/0000-0002-5267-7211; Montaldo, Elisa/0000-0001-9293-0683; Julke, Kerstin/0000-0002-3910-817X; LOIACONO, FABRIZIO/0000-0001-9370-8910	Deutsche Forschungsgemeinschaft (DFG) [SFB 633, SFB 650]; AIRC [10225, 9962]; MIUR [2009T4TC33_004]; Leibniz Association (International Leibniz Research Cluster "ImmunoMemory''); EFIS-IL fellowship; FIRC fellowship	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR)); Leibniz Association (International Leibniz Research Cluster "ImmunoMemory''); EFIS-IL fellowship; FIRC fellowship(Fondazione AIRC per la ricerca sul cancro)	We thank Toralf Kaiser and Jenny Kirsch (FCCF) for cell sorting; Silvia Ruberg, Michail Knauel, and Jutta Kollet from Miltenyi Genomic Services and Bioinformatics Department; and Monica Killig, Merlin Luetke-Eversloh, Quirin Hammer, Jens Geginat, Francesco Annunziato, and Chiara Vitale for critical reading of the manuscript and discussion. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB 633 and SFB 650 (to C.R.); by AIRC (no 10225 and no 9962 to L.M.); by MIUR (no MIUR-PRIN2009 2009T4TC33_004 to M.C.M.); and by the Leibniz Association (International Leibniz Research Cluster "ImmunoMemory''). E.M. was supported by EFIS-IL and FIRC fellowships.	Ahn YO, 2013, BLOOD, V121, P2234, DOI 10.1182/blood-2012-07-440099; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Chappaz S, 2010, J IMMUNOL, V185, P3514, DOI 10.4049/jimmunol.1000665; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Cherrier M, 2012, CURR OPIN IMMUNOL, V24, P178, DOI 10.1016/j.coi.2012.02.003; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Hughes T, 2014, CELL REP, V8, P150, DOI 10.1016/j.celrep.2014.05.042; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; MILLER JS, 1994, BLOOD, V83, P2594; Montaldo E, 2012, BLOOD, V119, P3987, DOI 10.1182/blood-2011-09-379693; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Santarlasci V, 2012, IMMUNITY, V36, P201, DOI 10.1016/j.immuni.2011.12.013; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; Tang Q, 2011, BLOOD, V117, P4052, DOI 10.1182/blood-2010-09-303081; Toren A, 2005, STEM CELLS, V23, P1142, DOI 10.1634/stemcells.2004-0317; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	54	112	116	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					988	1000		10.1016/j.immuni.2014.11.010	http://dx.doi.org/10.1016/j.immuni.2014.11.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25500367	Bronze			2022-12-18	WOS:000346654100016
J	Shafiani, S; Dinh, C; Ertelt, JM; Moguche, AO; Siddiqui, I; Smigiel, KS; Sharma, P; Campbell, DJ; Way, SS; Urdahl, KB				Shafiani, Shahin; Dinh, Crystal; Ertelt, James M.; Moguche, Albanus O.; Siddiqui, Imran; Smigiel, Kate S.; Sharma, Pawan; Campbell, Daniel J.; Way, Sing Sing; Urdahl, Kevin B.			Pathogen-Specific Treg Cells Expand Early during Mycobacterium tuberculosis Infection but Are Later Eliminated in Response to Interleukin-12	IMMUNITY			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; VIRAL-INFECTION; CUTTING EDGE; IFN-GAMMA; ANTIGEN; BET; TOLERANCE; MEMORY; SELF	Thymically derived Foxp(3+) regulatory T (Treg) cells have a propensity to recognize self-peptide: MHC complexes, but their ability to respond to epitopedefined foreign antigens during infectious challenge has not been demonstrated. Here we show that pulmonary infection with Mycobacterium tuberculosis (Mtb), but not Listeria monocytogenes (Lm), induced robust lymph node expansion of a highly activated population of pathogen-specific Treg cells from the pre-existing pool of thymically derived Treg cells. These antigen-specific Treg cells peaked in numbers 3 weeks after infection but subsequently underwent selective elimination driven, in part, by interleukin-12-induced intrinsic expression of the Th1-cell-promoting transcription factor T-bet. Thus, the initial Mtb-induced inflammatory response promotes pathogen- specific Treg cell proliferation, but these cells are actively culled later, probably to prevent suppression during later stages of infection. These findings have important implications for the prevention and treatment of tuberculosis and other chronic diseases in which antigen-specific Treg cells restrict immunity.	[Shafiani, Shahin; Dinh, Crystal; Moguche, Albanus O.; Siddiqui, Imran; Urdahl, Kevin B.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Ertelt, James M.; Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Moguche, Albanus O.; Smigiel, Kate S.; Campbell, Daniel J.; Urdahl, Kevin B.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Siddiqui, Imran; Sharma, Pawan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Smigiel, Kate S.; Campbell, Daniel J.] Benaroya Res Inst, Program Immunol, Seattle, WA 98103 USA	Center for Infectious Disease Research; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Washington; University of Washington Seattle; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Benaroya Research Institute	Urdahl, KB (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	kevin.urdahl@seattlebiomed.org	Siddiqui, Imran/K-5000-2012; Sharma, Pawan/F-7806-2010	Siddiqui, Imran/0000-0002-6792-8730; Sharma, Pawan/0000-0002-2525-5451; Way, Sing Sing/0000-0001-8948-1952; Urdahl, Kevin/0000-0003-0088-1066	National Institutes of Health [R01AI076327]; Paul G. Allen Family Foundation; NIH [R01AI087830, R01AI085130]; Burroughs Wellcome Fund Infectious Disease Program; Fogarty International Center [D43TW000924];  [R01AI100934]; FOGARTY INTERNATIONAL CENTER [D43TW000924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100934, R01AI087830, R01AI085130, R01AI076327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul G. Allen Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Infectious Disease Program; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Stohr for technical assistance; M. Jenkins, M. Pepper, and H. Chu for technical advice regarding tetramer staining; M. Jenkins, R. Larson, J. Lund, and L. Ramakrishnan for comments on the manuscript. This work was funded by grants to K. B. U. (National Institutes of Health R01AI076327 and from the Paul G. Allen Family Foundation), to S. S. W. (NIH R01AI087830 and R01AI100934 and the Burroughs Wellcome Fund Infectious Disease Program), and to D. J. C. (NIH R01AI085130). I. S. was supported by Award Number D43TW000924 from the Fogarty International Center.	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Betts RJ, 2012, J VIROL, V86, P2817, DOI 10.1128/JVI.05685-11; Byrne WL, 2011, CANCER RES, V71, P6915, DOI 10.1158/0008-5472.CAN-11-1156; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; DiPaolo RJ, 2009, EUR J IMMUNOL, V39, P234, DOI 10.1002/eji.200838772; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Johanns TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001043; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Orr MT, 2007, J IMMUNOL, V178, P4731, DOI 10.4049/jimmunol.178.8.4731; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Rudd BD, 2011, P NATL ACAD SCI USA, V108, P13694, DOI 10.1073/pnas.1107594108; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Urdahl KB, 2003, J IMMUNOL, V170, P1987, DOI 10.4049/jimmunol.170.4.1987; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Winslow GM, 2003, J IMMUNOL, V170, P2046, DOI 10.4049/jimmunol.170.4.2046; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547; Zhao JX, 2011, J EXP MED, V208, P1571, DOI 10.1084/jem.20110236; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	50	112	117	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1261	1270		10.1016/j.immuni.2013.06.003	http://dx.doi.org/10.1016/j.immuni.2013.06.003			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23791647	Green Accepted, Bronze			2022-12-18	WOS:000330947500020
J	Sonda, N; Simonato, F; Peranzoni, E; Cali, B; Bortoluzzi, S; Bisognin, A; Wang, E; Marincola, FM; Naldini, L; Gentner, B; Trautwein, C; Sackett, SD; Zanovello, P; Molon, B; Bronte, V				Sonda, Nada; Simonato, Francesca; Peranzoni, Elisa; Cali, Bianca; Bortoluzzi, Stefania; Bisognin, Andrea; Wang, Ena; Marincola, Francesco M.; Naldini, Luigi; Gentner, Bernhard; Trautwein, Christian; Sackett, Sara Dutton; Zanovello, Paola; Molon, Barbara; Bronte, Vincenzo			miR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELL-DIFFERENTIATION; SUPPRESSOR-CELLS; PANCREATIC-CANCER; T-CELLS; GM-CSF; MYELOID CELLS; MICRORNAS; BETA; PROGRESSION	Tumor progression is accompanied by an altered myelopoiesis causing the accumulation of immunosuppressive cells. Here, we showed that miR-142-3p downregulation promoted macrophage differentiation and determined the acquisition of their immunosuppressive function in tumor. Tumorreleased cytokines signaling through gp130, the common subunit of the interleukin-6 cytokine receptor family, induced the LAP* isoform of C/EBP beta transcription factor, promoting macrophage generation. miR-142-3p downregulated gp130 by canonical binding to its messenger RNA (mRNA) 3' UTR and repressed C/EBP beta LAP* by noncanonical binding to its 5' mRNA coding sequence. Enforced miR expression impaired macrophage differentiation both in vitro and in vivo. Mice constitutively expressing miR-142-3p in the bone marrow showed a marked increase in survival following immunotherapy with tumor-specific T lymphocytes. By modulating a specific miR in bone marrow precursors, we thus demonstrated the feasibility of altering tumor-induced macrophage differentiation as a potent tool to improve the efficacy of cancer immunotherapy.	[Sonda, Nada; Simonato, Francesca; Cali, Bianca; Zanovello, Paola] Univ Padua, Dept Surg Oncol & Gastroenterol, Oncol & Immunol Sect, I-35128 Padua, Italy; [Sonda, Nada; Peranzoni, Elisa; Zanovello, Paola; Molon, Barbara] IRCCS, Ist Oncol Veneto, I-35128 Padua, Italy; [Molon, Barbara] Venetian Inst Mol Med, I-35129 Padua, Italy; [Bortoluzzi, Stefania; Bisognin, Andrea] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Wang, Ena; Marincola, Francesco M.] NIH, Dept Transfus Med, Infect Dis & Immunogenet Sect, Ctr Clin, Bethesda, MD 20892 USA; [Wang, Ena; Marincola, Francesco M.] NIH, Ctr Human Immunol, Bethesda, MD 20892 USA; [Marincola, Francesco M.] Sidra Med & Res Ctr, Doha, Qatar; [Naldini, Luigi; Gentner, Bernhard] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; [Naldini, Luigi; Gentner, Bernhard] Ist Sci San Raffaele, Div Regenerat Med Gene Therapy & Stem Cells, I-20132 Milan, Italy; [Naldini, Luigi; Gentner, Bernhard] Univ Vita Salute San Raffaele, Sch Med, I-20132 Milan, Italy; [Trautwein, Christian; Sackett, Sara Dutton] RWTH Univ Hosp, Dept Med 3, D-52074 Aachen, Germany; [Bronte, Vincenzo] Univ Verona, Verona Univ Hosp, I-37134 Verona, Italy; [Bronte, Vincenzo] Univ Verona, Dept Pathol, Immunol Sect, I-37134 Verona, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Veneto Institute Molecular Medicine; University of Padua; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; Sidra Medical & Research Center; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; RWTH Aachen University; RWTH Aachen University Hospital; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Bronte, V (corresponding author), Univ Verona, Verona Univ Hosp, I-37134 Verona, Italy.	vincenzo.bronte@univr.it	Bronte, Vincenzo/K-7902-2016; Bortoluzzi, Stefania/G-8211-2011; Peranzoni, Elisa/ABA-8091-2020; Bisognin, Andrea/J-3619-2013	Bronte, Vincenzo/0000-0002-3741-5141; Bortoluzzi, Stefania/0000-0001-8240-3070; Peranzoni, Elisa/0000-0002-2077-2409; NALDINI, Luigi/0000-0002-7835-527X; Zanovello, Paola/0000-0002-9996-2669; Cali, Bianca/0000-0002-9090-9992; Gentner, Bernhard/0000-0001-6024-4718; Bisognin, Andrea/0000-0002-9114-1508	Italian Ministry of Education, University and Research [RBAP11T3WB_003, 2009NREAT2_003]; Italian Association for Cancer Research (AIRC) [IG10400, 12182, AGIMM 100005, 6599]; AIRC-Cariparo; BMBF [01KU1214B]; OBIHEP [360365]; Fondazione Telethon Funding Source: Custom	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC-Cariparo(Fondazione AIRC per la ricerca sul cancro); BMBF(Federal Ministry of Education & Research (BMBF)); OBIHEP; Fondazione Telethon(Fondazione Telethon)	We thank Maurizio Buggio, Serena Zilio, and Stefano Ugel for help with the in vivo experiments and Andrea Predonzani for the generation of plasmids. This work was supported by grants from the Italian Ministry of Education, University and Research (FIRB project RBAP11T3WB_003 and MIUR project 2009NREAT2_003), Italian Association for Cancer Research (AIRC, Grants IG10400, 12182, AGIMM 100005, and 6599), and AIRC-Cariparo, Regional Grant 2008. The work of C.T. was supported by the BMBF 01KU1214B (OBIHEP 360365).	Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bronte V, 1999, J IMMUNOL, V162, P5728; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Eruslanov E, 2010, J LEUKOCYTE BIOL, V88, P839, DOI 10.1189/jlb.1209821; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gade P, 2008, MOL CELL BIOL, V28, P2528, DOI 10.1128/MCB.00784-07; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Gutsch R, 2011, J BIOL CHEM, V286, P22716, DOI 10.1074/jbc.M110.152538; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Liu QF, 2011, INT J CANCER, V129, P2662, DOI 10.1002/ijc.25921; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Munera V, 2010, ANN SURG, V251, P120, DOI 10.1097/SLA.0b013e3181bfda1c; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nefedova Y, 2005, CANCER RES, V65, P9525, DOI 10.1158/0008-5472.CAN-05-0529; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Schmeier S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-595; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Sonda N, 2011, CURR OPIN IMMUNOL, V23, P279, DOI 10.1016/j.coi.2010.12.006; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Torroella-Kouri M, 2009, CANCER RES, V69, P4800, DOI 10.1158/0008-5472.CAN-08-3427; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Ugel S, 2010, BLOOD, V115, P1374, DOI 10.1182/blood-2009-07-233270; Viola A., 2012, MOL BIOL REP, V39, P2713; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630; Zhang MM, 2011, J IMMUNOL, V186, P4716, DOI 10.4049/jimmunol.1002989; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	56	112	118	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1236	1249		10.1016/j.immuni.2013.06.004	http://dx.doi.org/10.1016/j.immuni.2013.06.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23809164	Bronze, Green Submitted			2022-12-18	WOS:000330947500018
J	Vijayanand, P; Seumois, G; Simpson, LJ; Abdul-Wajid, S; Baumjohann, D; Panduro, M; Huang, XZ; Interlandi, J; Djuretic, VM; Brown, DR; Sharpe, AH; Rao, A; Ansel, KM				Vijayanand, Pandurangan; Seumois, Gregory; Simpson, Laura J.; Abdul-Wajid, Sarah; Baumjohann, Dirk; Panduro, Marisella; Huang, Xiaozhu; Interlandi, Jeneen; Djuretic, Vane M.; Brown, Daniel R.; Sharpe, Arlene H.; Rao, Anjana; Ansel, K. Mark			Interleukin-4 Production by Follicular Helper T Cells Requires the Conserved Il4 Enhancer Hypersensitivity Site V	IMMUNITY			English	Article							TYPE-2 IMMUNITY; GENE-EXPRESSION; IL-4 PRODUCTION; COORDINATE REGULATOR; CYTOKINE PRODUCTION; HELMINTH INFECTION; ALLERGIC DISEASES; GATA3 EXPRESSION; MAST-CELLS; TH2 CELLS	Follicular helper T cells (Tfh cells) are the major producers of interleukin-4 (IL-4) in secondary lymphoid organs where humoral immune responses develop. Il4 regulation in Tfh cells appears distinct from the classical T helper 2 (Th2) cell pathway, but the underlying molecular mechanisms remain largely unknown. We found that hypersensitivity site V (HS V; also known as CNS2), a 3' enhancer in the Il4 locus, is essential for IL-4 production by Tfh cells. Mice lacking HS V display marked defects in type 2 humoral immune responses, as evidenced by abrogated IgE and sharply reduced IgG1 production in vivo. In contrast, effector Th2 cells that are involved in tissue responses were far less dependent on HS V. HS V facilitated removal of repressive chromatin marks during Th2 and Tfh cell differentiation and increased accessibility of the Il4 promoter. Thus, Tfh and Th2 cells utilize distinct but overlapping molecular mechanisms to regulate Il4, a finding with important implications for understanding the molecular basis of allergic diseases.	[Simpson, Laura J.; Abdul-Wajid, Sarah; Baumjohann, Dirk; Panduro, Marisella; Ansel, K. Mark] Univ Calif San Francisco, Dept Microbiol & Immunol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care, San Francisco, CA 94143 USA; [Vijayanand, Pandurangan; Seumois, Gregory; Rao, Anjana] La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA; [Vijayanand, Pandurangan; Seumois, Gregory] Southampton Gen Hosp, Sir Henry Wellcome Labs, Southampton NIHR Resp Biomed Res Unit, Div Infect Inflammat & Immun,Sch Med, Southampton SO16 6YD, Hants, England; [Vijayanand, Pandurangan; Seumois, Gregory] Univ Southampton, Southampton SO16 6YD, Hants, England; [Interlandi, Jeneen; Djuretic, Vane M.; Rao, Anjana] Harvard Univ, Sch Med, Immune Dis Inst, Dept Pathol, Boston, MA 02115 USA; [Interlandi, Jeneen; Djuretic, Vane M.; Rao, Anjana] Harvard Univ, Sch Med, Program Cellular & Mol Med, Boston, MA 02115 USA; [Brown, Daniel R.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Brown, Daniel R.; Sharpe, Arlene H.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; La Jolla Institute for Immunology; University of Southampton; University of Southampton; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Ansel, KM (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA.	mark.ansel@ucsf.edu	Baumjohann, Dirk/C-9047-2009	Baumjohann, Dirk/0000-0001-8385-8288; Seumois, Gregory/0000-0002-8164-6852; Abdul-Wajid, Sarah/0000-0002-6000-7226	Burroughs Wellcome Fund; GSK National Clinician Scientist Fellowship Award; Peel Travel Fellowship Award in United Kingdom; NIH [AI40127, AI44432]; American Asthma Foundation; National Science Foundation; Swiss National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040127, R01AI044432] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); GSK National Clinician Scientist Fellowship Award; Peel Travel Fellowship Award in United Kingdom; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank L. Du, L. Smith, E. Yanni, Z. Yang, Y. Soo Choi, and J. Yang for expert technical assistance and M. Kubo and S. Crotty for advice and critical reading of the manuscript. This project was funded by the Burroughs Wellcome Fund (to K.M.A.), GSK National Clinician Scientist Fellowship Award and Peel Travel Fellowship Award in United Kingdom (to P.V.), NIH grants AI40127 and AI44432, and an award from the American Asthma Foundation (to A.R.). L.J.S. is a National Science Foundation Graduate Research Fellow. D.B. is the recipient of a Swiss National Science Foundation Postdoctoral Fellowship. P.V., G.S., K.M.A., and A.R. conceived the work, designed, performed and analyzed experiments, and wrote the paper; L.J.S., S.A.-W., J.I., I.M.D., and D.R.B. assisted in some of the experiments under the supervision of P.V., G.S., K.M.A., A.R., and A.H.S.; and X.H. performed some of the experiments with the model of allergic airway disease.	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kay AB, 2001, NEW ENGL J MED, V344, P109, DOI 10.1056/NEJM200101113440206; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Koh BH, 2010, P NATL ACAD SCI USA, V107, P10614, DOI 10.1073/pnas.1005383107; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Levine SJ, 2010, ANN INTERN MED, V152, P232, DOI 10.7326/0003-4819-152-4-201002160-00008; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sofi MH, 2011, J IMMUNOL, V186, P2792, DOI 10.4049/jimmunol.1003353; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	56	112	113	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					175	187		10.1016/j.immuni.2011.12.014	http://dx.doi.org/10.1016/j.immuni.2011.12.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22326582	Green Accepted, Bronze			2022-12-18	WOS:000300812400007
J	Malynn, BA; Ma, A				Malynn, Barbara A.; Ma, Averil			Ubiquitin Makes Its Mark on Immune Regulation	IMMUNITY			English	Review							NF-KAPPA-B; TOLL-LIKE RECEPTOR; UNANCHORED POLYUBIQUITIN CHAINS; T-CELL TOLERANCE; TNF-ALPHA; PROTEIN UBIQUITINATION; NEGATIVE REGULATOR; CONJUGATING ENZYME; EDITING ENZYME; CUTTING EDGE	Ubiquitination, the covalent attachment of ubiquitin molecules to proteins, is emerging as a widely utilized mechanism for rapidly regulating cell signaling. Recent studies indicate that ubiquitination plays potent roles in regulating a variety of signals in both innate and adaptive immune cells. Here, we will review recent studies of ubiquitin ligases, ubiquitin chain linkages, and ubiquitin binding proteins that highlight the diversity and specificity of ubiquitin dependent functions in immune cells. We will also review studies that shed light on how ubiquitination signals are integrated in cell-type-specific fashion to regulate the immune system in vivo.	[Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, Program Biomed Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, Program Biomed Sci, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu			National Institutes of Health; Kenneth Rainin Foundation; Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kenneth Rainin Foundation; Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work from our laboratory is supported by the National Institutes of Health, the Kenneth Rainin Foundation, and the Alliance for Lupus Research.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Carter RS, 2005, J BIOL CHEM, V280, P43272, DOI 10.1074/jbc.M508656200; Cejas PJ, 2010, BLOOD, V115, P4750, DOI 10.1182/blood-2009-09-242768; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen DJ, 2009, ANTI-CANCER DRUG, V20, P646, DOI 10.1097/CAD.0b013e32832ced78; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Christensen DE, 2009, FEBS J, V276, P5381, DOI 10.1111/j.1742-4658.2009.07249.x; Chu Y., 2010, BLOOD; Conze DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000518; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fushman D, 2010, J MOL BIOL, V395, P803, DOI 10.1016/j.jmb.2009.10.039; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Ha Hyunil, 2009, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109ds87; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; King CG, 2008, J IMMUNOL, V180, P34, DOI 10.4049/jimmunol.180.1.34; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004736; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Lin AE, 2007, CURR OPIN IMMUNOL, V19, P665, DOI 10.1016/j.coi.2007.10.002; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2008, EUR J IMMUNOL, V38, P2219, DOI 10.1002/eji.200738113; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Scheper J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011403; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Spallek T, 2009, CELL MICROBIOL, V11, P1425, DOI 10.1111/j.1462-5822.2009.01346.x; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Venuprasad K, 2010, CANCER RES, V70, P3009, DOI 10.1158/0008-5472.CAN-09-4076; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Wada K, 2009, J BIOCHEM, V146, P821, DOI 10.1093/jb/mvp127; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang HP, 2010, EMBO J, V29, P1285, DOI 10.1038/emboj.2010.10; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273; Zucchelli S, 2010, HUM MOL GENET, V19, P3759, DOI 10.1093/hmg/ddq290	99	112	125	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 22	2010	33	6					843	852		10.1016/j.immuni.2010.12.007	http://dx.doi.org/10.1016/j.immuni.2010.12.007			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21168777	Bronze, Green Accepted			2022-12-18	WOS:000286293900006
J	Wang, L; Gordon, RA; Huynh, L; Su, XD; Min, KHP; Han, JH; Arthur, JS; Kalliolias, GD; Ivashkiv, LB				Wang, Lu; Gordon, Rachael A.; Huynh, Linda; Su, Xiaodi; Min, Kyung-Hyun Park; Han, Jiahuai; Arthur, J. Simon; Kalliolias, George D.; Ivashkiv, Lionel B.			Indirect Inhibition of Toll-like Receptor and Type I Interferon Responses by ITAM-Coupled Receptors and Integrins	IMMUNITY			English	Article							CROSS-REGULATION; CELL-RECEPTOR; INFLAMMATION; INDUCTION; SUPPRESSES; CYTOKINE; DECTIN-1; PATHWAY; TRANSCRIPTION; MACROPHAGES	An important function of immunoreceptor tyrosine-based activation motif (ITAM)-coupled receptors is cross-regulation of heterologous receptor signaling, but mechanisms of cross-inhibition are poorly understood. We show that high-avidity ligation of ITAM-coupled beta 2 integnns and Fc gamma Rs in macrophages inhibited type I interferon receptor and Toll-like receptor (TLR) signaling and induced expression of interleukin-10 (IL-10); signaling inhibitors SOCS3, ABIN-3, and A20; and repressors of cytokine gene transcription STAT3 and Hes1. Induction of inhibitors was dependent on a pathway composed of signaling molecules DAP12, Syk, and Pyk2 that coupled to downstream kinases p38 and MSKs and required integration of IL-10-dependent and -independent signals. ITAM-induced inhibitors abrogated TLR responses by cooperatively targeting distinct steps in TLR signaling. Inhibitory signaling was suppressed by IFN-gamma and attenuated in inflammatory arthritis synovial macrophages. These results provide an indirect mechanism of cross-inhibition of TLRs and delineate a signaling pathway important for deactivation of macrophages.	[Wang, Lu; Gordon, Rachael A.; Huynh, Linda; Su, Xiaodi; Min, Kyung-Hyun Park; Kalliolias, George D.; Ivashkiv, Lionel B.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Huynh, Linda; Su, Xiaodi; Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA; [Han, Jiahuai] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Arthur, J. Simon] Univ Dundee, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Scripps Research Institute; University of Dundee	Ivashkiv, LB (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.		Arthur, J. Simon/B-8058-2010; Kalliolias, George D./H-3136-2019; Han, J/G-4671-2010	Arthur, J. Simon/0000-0002-8135-1958; Kalliolias, George D./0000-0002-4427-8245; Gordon, Rachael/0000-0001-6598-0546	NIH [T32 AR07517]; Kirkland Center for Lupus Research; Arthritis Foundation; MRC [MC_U127081014] Funding Source: UKRI; Medical Research Council [MC_U127081014] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059636, R01AI068896, R01AI046712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046713, T32AR007517] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirkland Center for Lupus Research; Arthritis Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank V Tybulewicz (National Institute for Medical Research, London, UK) for providing Syk-deficient mice and X Hu for critically reviewing the manuscript We thank M Hong and M Otsuka for assistance with obtaining p38 alpha-deficient macrophages and A Ding for providing MyD88- and Trif-deficient mice We thank the Hospital for Special Surgery rheumatologists for providing synovial specimens This work was supported by grants from the NIH to L B I and the Kirkland Center for Lupus Research LW was supported by a training grant from the NIH (T32 AR07517) K H -P M is supported by a grant from the Arthritis Foundation LW designed and performed most of the experiments and wrote the manuscript, R A G performed the experiments with arthritic macrophages, L H, X.S, and K H -P M contributed to experiments with IFNs, J H and J S C A provided mice and cells. G D K oversaw the arthritic macrophage experiments, and L B I conceptualized the project, designed and supervised research, and wrote the manuscript	Abram C.L., 2007, SCI STKE, V2007, pre2; Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Adams RA, 2007, CURR MED CHEM, V14, P2925, DOI 10.2174/092986707782360015; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; Borde M, 2006, IMMUNOL REV, V210, P105, DOI 10.1111/j.0105-2896.2006.00370.x; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cappiello MG, 2001, J IMMUNOL, V166, P4498, DOI 10.4049/jimmunol.166.7.4498; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; HAMERMAN JA, 2006, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3202006RE1; Hammerberg C, 1998, J EXP MED, V187, P1133, DOI 10.1084/jem.187.7.1133; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Ivashkiv LB, 2003, ARTHRITIS RHEUM, V48, P2092, DOI 10.1002/art.11095; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kanamaru Y, 2008, J IMMUNOL, V180, P2669, DOI 10.4049/jimmunol.180.4.2669; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leon F, 2006, J IMMUNOL, V177, P6974, DOI 10.4049/jimmunol.177.10.6974; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Park-Min KH, 2007, IMMUNITY, V26, P67, DOI 10.1016/j.immuni.2006.11.010; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; Swiecki MK, 2007, EUR J IMMUNOL, V37, P3327, DOI 10.1002/eji.200737944; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Weaver BK, 2007, MOL CELL BIOL, V27, P4603, DOI 10.1128/MCB.00223-07; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	51	112	112	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					518	530		10.1016/j.immuni.2010.03.014	http://dx.doi.org/10.1016/j.immuni.2010.03.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20362473	Green Accepted, Bronze			2022-12-18	WOS:000277171900011
J	Baaten, BJG; Li, CR; Deiro, MF; Lin, MM; Linton, PJ; Bradley, LM				Baaten, Bas J. G.; Li, Cheng-Rui; Deiro, Mia F.; Lin, Melissa M.; Linton, Phyllis J.; Bradley, Linda M.			CD44 Regulates Survival and Memory Development in Th1 Cells	IMMUNITY			English	Article							SIGNALING COMPLEX; T-CELLS; CASPASE-8 CLEAVAGE; DENDRITIC CELLS; UP-REGULATION; B-CELLS; ACTIVATION; DEATH; HYALURONAN; APOPTOSIS	Optimal immunity to microorganisms depends upon the regulated death of clonally expanded effector cells and the survival of a cohort of cells that become memory cells. After activation of naive T cells, CD44, a widely expressed receptor for extracellular matrix components, is upregulated. High expression of CD44 remains on memory cells and despite its wide usage as a "memory marker," its function is unknown. Here we report that CD44 was essential for the generation of memory T helper 1 (Th1) cells by promoting effector cell survival. This dependency was not found in Th2, Th17, or CD8(+) T cells despite similar expression of CD44 and the absence of splice variants in all subsets. CD44 limited Fas-mediated death in Th1 cells and its ligation engaged the phosphoinositide 3-kinase-Akt kinase signaling pathway that regulates cell survival. The difference in CD44-regulated apoptosis resistance in T cell subpopulations has important implications in a broad spectrum of diseases.	[Baaten, Bas J. G.; Li, Cheng-Rui; Deiro, Mia F.; Lin, Melissa M.; Linton, Phyllis J.; Bradley, Linda M.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Bradley, LM (corresponding author), Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.	lbradley@burnham.org			NIH [AI061615, AI046530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046530, R01AI061615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG025805] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank R. Padrick, K. Falls, and T. Brondstetter for technical assistance, C. Torres for multicolor flow cytometry, and E. Virts for advice on the RT-PCR for CD44 variants. This work was supported by grants from NIH (AI061615 and AI046530) to L.M.B.	BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; CAMP RL, 1991, J CELL BIOL, V115, P1283, DOI 10.1083/jcb.115.5.1283; Chapman TJ, 2005, VIROLOGY, V340, P296, DOI 10.1016/j.virol.2005.06.023; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; Do Y, 2004, J IMMUNOTHER, V27, P1, DOI 10.1097/00002371-200401000-00001; Foger N, 2000, EUR J IMMUNOL, V30, P2888; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Harbertson J, 2002, J IMMUNOL, V168, P1095, DOI 10.4049/jimmunol.168.3.1095; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Hauptschein RS, 2005, CANCER RES, V65, P1887, DOI 10.1158/0008-5472.CAN-04-3571; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lee JL, 2008, MOL CELL BIOL, V28, P5710, DOI 10.1128/MCB.00186-08; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Marhaba R, 2003, J LEUKOCYTE BIOL, V74, P135, DOI 10.1189/jlb.1202615; Marhaba R, 2006, EUR J IMMUNOL, V36, P3017, DOI 10.1002/eji.200636158; McKallip RJ, 2002, INT IMMUNOL, V14, P1015, DOI 10.1093/intimm/dxf068; MCLELLAN AD, 1995, J IMMUNOL METHODS, V184, P81, DOI 10.1016/0022-1759(95)00077-N; Mielgo A, 2006, CELL DEATH DIFFER, V13, P465, DOI 10.1038/sj.cdd.4401763; Mummert ME, 2002, J IMMUNOL, V169, P4322, DOI 10.4049/jimmunol.169.8.4322; Nakano K, 2007, APOPTOSIS, V12, P45, DOI 10.1007/s10495-006-0488-8; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Naor D, 2007, ANN NY ACAD SCI, V1110, P233, DOI 10.1196/annals.1423.025; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Rozsnyay Z, 1999, IMMUNOL LETT, V68, P101, DOI 10.1016/S0165-2478(99)00037-1; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Varadhachary AS, 2001, J IMMUNOL, V166, P6564, DOI 10.4049/jimmunol.166.11.6564; Varadhachary AS, 1999, J IMMUNOL, V163, P4772; WITTIG BM, 2000, J EXP MED, V178, P497; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; ZHENG Z, 1995, J CELL BIOL, V130, P485, DOI 10.1083/jcb.130.2.485	46	112	112	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 29	2010	32	1					104	115		10.1016/j.immuni.2009.10.011	http://dx.doi.org/10.1016/j.immuni.2009.10.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20079666	Green Accepted, Bronze			2022-12-18	WOS:000274119900015
J	Nguyen, K; Sylvain, NR; Bunnell, SC				Nguyen, Ken; Sylvain, Nicholas R.; Bunnell, Stephen C.			T cell costimulation via the integrin VLA-4 inhibits the actin-dependent centralization of signaling microclusters containing the adaptor SLP-76	IMMUNITY			English	Article							FC-EPSILON-RI; RECEPTOR MICROCLUSTERS; IMMUNOLOGICAL SYNAPSE; ACTIVATION; MEMBRANE; CYTOSKELETON; LYMPHOCYTES; COMPLEX; PROTEIN; VCAM-1	Antigen-dependent T cell activation drives the formation of signaling microclusters containing the adaptor SLP-76. Costimulatory integrins regulate SLP-76 phosphorylation and could influence SLP-76 microclusters in the integrin-rich periphery of the immune synapse. We report that costimulation by the integrin VLA-4 (alpha 4 beta 1) required SLP-76 domains implicated in microcluster assembly. Pro-adhesive ligands; enlarged the contact and increased the number of SLP-76 microclusters regardless of their costimulatory potential. Costimulatory VLA-4 ligands also prevented the centralization of SLP-76, promoted microcluster persistence, prolonged lateral interactions between SLP-76 and its upstream kinase, ZAP-70, and retained SLP-76 in tyrosine-phosphorylated peripheral structures. SLP-76 centralization was driven by dynamic actin polymerization and was correlated with inward actin flows. VLA-4 ligation retarded these flows, even in the absence of SLP-76. These data suggest a widely applicable model of costimulation, in which integrins promote sustained signaling by attenuating cytoskeletal movements that drive the centralization and inactivation of SLP-76 microclusters.	[Nguyen, Ken; Sylvain, Nicholas R.; Bunnell, Stephen C.] Tufts Univ, Sch Med, Program Immunol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Bunnell, Stephen C.] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA	Tufts University; Tufts University	Bunnell, SC (corresponding author), Tufts Univ, Sch Med, Program Immunol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA.	stephen.bunnell@tufts.edu		Bunnell, Stephen/0000-0001-6887-0828				Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Bell MP, 2001, NAT MED, V7, P1155, DOI 10.1038/nm1001-1155; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; BUNNELL SC, 2003, SCI STKE, pPL8; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Doucey MA, 2003, J BIOL CHEM, V278, P26983, DOI 10.1074/jbc.M302709200; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Fierro NA, 2006, J IMMUNOL, V176, P7346, DOI 10.4049/jimmunol.176.12.7346; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jakus Z, 2007, TRENDS CELL BIOL, V17, P493, DOI 10.1016/j.tcb.2007.09.001; Kamiguchi K, 1999, J IMMUNOL, V163, P563; Kitazawa H, 1997, J IMMUNOL, V159, P2259; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lim YC, 2000, MICROCIRCULATION, V7, P201, DOI 10.1038/sj.mn.7300103; Luckashenak N, 2007, FRONT BIOSCI-LANDMRK, V12, P419, DOI 10.2741/2072; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Paessens LC, 2008, MOL IMMUNOL, V45, P42, DOI 10.1016/j.molimm.2007.05.016; SALOMON DR, 1994, J EXP MED, V179, P1573, DOI 10.1084/jem.179.5.1573; Sedwick CE, 2004, MOL IMMUNOL, V41, P675, DOI 10.1016/j.molimm.2004.01.007; Singer AL, 2004, J BIOL CHEM, V279, P15481, DOI 10.1074/jbc.M313339200; Sixt M, 2006, CURR OPIN CELL BIOL, V18, P482, DOI 10.1016/j.ceb.2006.08.007; Tong JK, 2004, J EXP MED, V199, P1277, DOI 10.1084/jem.20021602; Tseng SY, 2005, J IMMUNOL, V175, P7829, DOI 10.4049/jimmunol.175.12.7829; Udagawa T, 1996, J IMMUNOL, V157, P1965; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	42	112	112	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					810	821		10.1016/j.immuni.2008.04.019	http://dx.doi.org/10.1016/j.immuni.2008.04.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549800	Bronze			2022-12-18	WOS:000256760200012
J	Lim, JH; Stirling, B; Derry, J; Koga, T; Jono, H; Woo, CH; Xu, H; Bourne, P; Ha, UH; Ishinaga, H; Xu, HD; Andalibi, A; Feng, XH; Zhu, HG; Huang, YX; Zhang, WH; Weng, XH; Yan, C; Yin, Z; Briles, DE; Davis, RJ; Flavell, RA; Li, JD				Lim, Jae Hyang; Stirling, Brigid; Derry, Jonathan; Koga, Tomoaki; Jono, Hirofumi; Woo, Chang-Hoon; Xu, Haodong; Bourne, Patricia; Ha, Un-Hwan; Ishinaga, Hajime; Xu, Haidong; Andalibi, Ali; Feng, Xin-Hua; Zhu, Hongguang; Huang, Yuxian; Zhang, Wenhong; Weng, Xinhua; Yan, Chen; Yin, Zhinan; Briles, David E.; Davis, Roger J.; Flavell, Richard A.; Li, Jian-Dong			Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections	IMMUNITY			English	Article							NF-KAPPA-B; ACTIVATOR INHIBITOR TYPE-1; MUC5AC MUCIN TRANSCRIPTION; PLASMINOGEN-ACTIVATOR; DEUBIQUITINATING ENZYME; NEGATIVE REGULATOR; EXPRESSION; PNEUMOLYSIN; IDENTIFICATION; PATHOGENESIS	Streptococcus pneumoniae (S. pneumoniae) causes high early mortality in pneumococcal pneumonia, which is characterized by acute lung injury (ALI). The molecular mechanisms underlying ALI and the high early mortality remain unknown. Despite recent studies that identify deubiquitinating enzyme cylindromatosis (CYLD) as a key regulator for T cell development, tumor cell proliferation, and NF-kappa B transcription factor signaling, its role in regulating bacteria-induced lethality, however, is unknown. Here, we showed that CYLD deficiency protected mice from S. pneumoniae pneumolysin (PLY)-induced ALI and lethality. CYLD was highly induced by PLY, and it inhibited MKK3-p38 kinase-dependent expression of plasminogen activator inhibitor-1 (PAI-1) in lung, thereby potentiating ALI and mortality. Thus, CYLD is detrimental for host survival, thereby indicating a mechanism underlying the high early mortality of pneumococcal pneumonia.	Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Cardiovasc Res Inst, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; Amgen Inc, Seattle, WA 98101 USA; Univ So Calif, House Ear Inst, Gonda Dept Mol & Cellular Biol, Los Angeles, CA 90057 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai Med Coll, Shanghai 200433, Peoples R China; Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; Yale Univ, Sch Med, Dept Med, Rheumatol Sect, New Haven, CT 06520 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	University of Rochester; University of Rochester; University of Rochester; Amgen; House Research Institute; University of Southern California; Baylor College of Medicine; Baylor College of Medicine; Fudan University; Fudan University; Yale University; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Yale University; Howard Hughes Medical Institute; Yale University	Li, JD (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	jian-dong_li@urmc.rochester.edu	Ha, Un-Hwan/ABH-8017-2020; 吴, 晶/D-3782-2013	Lim, Jae Hyang/0000-0003-0972-9271; Li, Jian-Dong/0000-0002-5593-050X; Ha, Un-Hwan/0000-0001-9182-7000; Davis, Roger/0000-0002-0130-1652; Yan, Chen/0000-0002-1397-6358	NHLBI NIH HHS [HL077789] Funding Source: Medline; NIAID NIH HHS [R01AI56219] Funding Source: Medline; NIAMS NIH HHS [K01 AR 02188] Funding Source: Medline; NIDCD NIH HHS [DC005843, DC004562] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR002188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC005843] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Berry CN, 1998, BRIT J PHARMACOL, V125, P29, DOI 10.1038/sj.bjp.0702030; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brandenburg JA, 2000, J GEN INTERN MED, V15, P638, DOI 10.1046/j.1525-1497.2000.04429.x; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; CHAPMAN HA, 1990, J IMMUNOL, V145, P3398; Cockeran R, 2002, CURR OPIN INFECT DIS, V15, P235, DOI 10.1097/00001432-200206000-00004; DECLERCK PJ, 1992, J BIOL CHEM, V267, P11693; Grigoryev DN, 2004, CRIT CARE, V8, P440, DOI 10.1186/cc2901; Happel KI, 2004, AM J MED SCI, V328, P230, DOI 10.1097/00000441-200410000-00006; HASLETON PS, 1996, SPENCERS PATHOL LUNG; Hollingshead SK, 2001, CURR OPIN MICROBIOL, V4, P71, DOI 10.1016/S1369-5274(00)00167-3; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kietzmann T, 2003, THROMB HAEMOSTASIS, V89, P666; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lagoa CE, 2005, HEPATOLOGY, V42, P390, DOI 10.1002/hep.20797; Loeschcke H, 1931, BEITR PATHOL ANAT AL, V86, P201; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Maus UA, 2004, J IMMUNOL, V173, P1307, DOI 10.4049/jimmunol.173.2.1307; Norata GD, 2004, BRIT J HAEMATOL, V127, P97, DOI 10.1111/j.1365-2141.2004.05163.x; OLMAN MA, 1995, J CLIN INVEST, V96, P1621, DOI 10.1172/JCI118201; Prabhakaran P, 2003, AM J PHYSIOL-LUNG C, V285, pL20, DOI 10.1152/ajplung.00312.2002; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Renckens R, 2007, BLOOD, V109, P1593, DOI 10.1182/blood-2006-05-025197; Rijneveld AW, 2003, BLOOD, V102, P934, DOI 10.1182/blood-2003-01-0227; Roca C, 2003, CANCER RES, V63, P1500; RUBINS JB, 1993, INFECT IMMUN, V61, P1352, DOI 10.1128/IAI.61.4.1352-1358.1993; Schwarz M A, 2001, Paediatr Respir Rev, V2, P3, DOI 10.1053/prrv.2000.0095; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; SUFFREDINI AF, 1989, NEW ENGL J MED, V320, P1165, DOI 10.1056/NEJM198905043201802; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; TUOMANEN EI, 1995, NEW ENGL J MED, V332, P1280, DOI 10.1056/NEJM199505113321907; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200; Ware Lorraine B., 2005, Keio Journal of Medicine, V54, P142, DOI 10.2302/kjm.54.142; Wood WB, 1941, J EXP MED, V73, P201, DOI 10.1084/jem.73.2.201; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	39	112	117	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					349	360		10.1016/j.immuni.2007.07.011	http://dx.doi.org/10.1016/j.immuni.2007.07.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723219	Bronze			2022-12-18	WOS:000249056300019
J	Kuwata, H; Matsumoto, M; Atarashi, K; Morishita, H; Hirotani, T; Koga, R; Takeda, K				Kuwata, H; Matsumoto, M; Atarashi, K; Morishita, H; Hirotani, T; Koga, R; Takeda, K			I kappa BNS inhibits induction of a subset of toll-like receptor-dependent genes and limits inflammation	IMMUNITY			English	Article							INDUCIBLE NUCLEAR-PROTEIN; NEGATIVE REGULATION; CHRONIC ENTEROCOLITIS; IMMUNE-RESPONSES; MYD88-DEFICIENT MICE; INNATE IMMUNITY; B ACTIVATION; MACROPHAGES; REGULATOR; ENDOTOXIN	Toll-like receptor (TLR)-mediated immune responses are downregulated by several mechanisms that affect signaling pathways. However, it remains elusive how TLR-mediated gene expression is differentially modulated. Here, we show that I kappa BNS, a TLR-inducible nuclear I kappa B protein, negatively regulates induction of a subset of TLR-dependent genes through inhibition of NF-kappa B activity. I kappa BNS-deficient macrophages and dendritic cells show increased TLR-mediated expression of genes such as IL-6 and IL-12p40, which are induced late after TLR stimulation. In contrast, I kappa BNS-deficient cells showed normal induction of genes that are induced early or induced via IRF-3 activation. LPS stimulation of I kappa BNS-deficient macrophages prolonged NF-kappa B activity at the specific promoters, indicating that I kappa BNS mediates termination of NF-kappa B activity at selective gene promoters. Moreover, I kappa BNS-deficient mice are highly susceptible to LPS-induced endotoxin shock and intestinal inflammation. Thus, I kappa BNS regulates inflammatory responses by inhibiting the induction of a subset of TLR-dependent genes through modulation of NF-kappa B activity.	Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Higashi Ku, Fukuoka 8128582, Japan; Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan	Kyushu University; Osaka University	Takeda, K (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ktakeda@bioreg.kyushu-u.ac.jp	Kuwata, Hiro/N-2023-2019; Atarashi, Koji/I-5363-2014; Takeda, Kiyoshi/C-9331-2009	Kuwata, Hiro/0000-0002-5023-1777; Atarashi, Koji/0000-0001-5422-0736; Morishita, Hideaki/0000-0003-0860-8371; Takeda, Kiyoshi/0000-0002-1778-6332				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738	44	112	118	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2006	24	1					41	51		10.1016/j.immuni.2005.11.004	http://dx.doi.org/10.1016/j.immuni.2005.11.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413922	Bronze			2022-12-18	WOS:000234850200009
J	Roth, C; Carlyle, JR; Takizawa, H; Raulet, DH				Roth, C; Carlyle, JR; Takizawa, H; Raulet, DH			Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; MOUSE BONE-MARROW; STEM-CELLS; COMPLEX; EXPRESSION; DIFFERENTIATION; SPECIFICITY; PROGENITORS; RECOGNITION; PRECURSORS	We report an in vitro stroma-dependent system for the clonal growth and differentiation of natural killer (NK) cells from lymphoid-restricted bone marrow progenitors or bone marrow NK1.1(+) cells. Strikingly, the potential to initiate expression of specific Ly49 receptors becomes increasingly restricted as NK cells develop. Moreover, when NK cells express a Ly49 receptor specific for stromal cell class I MHC, they are less likely to initiate expression of another Ly49 receptor in the clonal culture system. The results indicate multiple roles for stromal cells in NK cell development, in supporting clonal growth, in initiation of Ly49 receptor expression, and in formation of the NK cell receptor repertoire.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@uclink4.berkeley.edu	Carlyle, James R/A-1224-2008	Raulet, David/0000-0002-1257-8649; Carlyle, James/0000-0002-3579-0300				ANTICA M, 1994, BLOOD, V84, P111; Brennan J, 1996, J EXP MED, V184, P2085, DOI 10.1084/jem.184.6.2085; Brown MG, 1997, GENOMICS, V42, P16, DOI 10.1006/geno.1997.4721; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; Delfino DV, 1996, BLOOD, V87, P2394, DOI 10.1182/blood.V87.6.2394.bloodjournal8762394; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; Dorfman JR, 1998, J EXP MED, V187, P609, DOI 10.1084/jem.187.4.609; HACKETT J, 1986, J IMMUNOL, V136, P3124; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Held W, 1997, J EXP MED, V185, P2079, DOI 10.1084/jem.185.12.2079; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; Jaleco AC, 1997, J IMMUNOL, V159, P694; KODAMA H, 1994, EXP HEMATOL, V22, P979; Kuboto A, 1999, J IMMUNOL, V163, P212; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; MASON LH, 1995, J EXP MED, V182, P293, DOI 10.1084/jem.182.2.293; McQueen KL, 1998, IMMUNOGENETICS, V48, P174, DOI 10.1007/s002510050421; Mingari MC, 1997, EUR J IMMUNOL, V27, P1374, DOI 10.1002/eji.1830270612; Raulet DH, 1999, CURR OPIN IMMUNOL, V11, P129, DOI 10.1016/S0952-7915(99)80023-5; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; SENTMAN CL, 1989, J EXP MED, V170, P191, DOI 10.1084/jem.170.1.191; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VANDENBRINK MRM, 1990, J EXP MED, V172, P303, DOI 10.1084/jem.172.1.303; Williams NS, 1999, J IMMUNOL, V163, P2648; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081	31	112	113	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2000	13	1					143	153		10.1016/S1074-7613(00)00015-7	http://dx.doi.org/10.1016/S1074-7613(00)00015-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933402	Bronze			2022-12-18	WOS:000088463600014
J	Haks, MC; Krimpenfort, P; van den Brakel, JHN; Kruisbeek, AM				Haks, MC; Krimpenfort, P; van den Brakel, JHN; Kruisbeek, AM			Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells	IMMUNITY			English	Article							RECEPTOR-BETA-CHAIN; EARLY THYMIC SELECTION; TUMOR-SUPPRESSOR P53; DEVELOPMENT IN-VIVO; THYMOCYTE DEVELOPMENT; ALPHA-BETA; ALLELIC EXCLUSION; GENE REARRANGEMENT; MICE LACKING; LYMPHOCYTE DEVELOPMENT	Signaling through the pre-TCR is essential for early T cell development and is severely impaired in mice lacking the CD3 gamma chain of the pre-TCR. We here address the molecular mechanisms underlying this defect. Impaired pre-TCR signaling is shown to be associated with a profound increase in the number of apoptotic CD4(-)CD8(-) (DN) thymocytes. introduction of p53 deficiency into CD3 gamma-deficient mice completely reverses the cell survival defect in CD3 gamma-deficient DN thymocytes and rescues the block in pre-T cell differentiation. In addition, the CD4(+)CD8(+) (DP) compartment is expanded to its normal size. These findings suggest that the pre-TCR regulates progression through the DNA-damage checkpoint of the DN to DP transition by inactivating p53.	Antoni Van Leeuwenhoek Huis, Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; Antoni Van Leeuwenhoek Huis, Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Kruisbeek, AM (corresponding author), Antoni Van Leeuwenhoek Huis, Netherlands Canc Inst, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	akru@nki.nl						ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; ABRAHAM KM, 1991, J EXP MED, V173, P1421, DOI 10.1084/jem.173.6.1421; Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; Almog N, 1997, BBA-REV CANCER, V1333, pF1, DOI 10.1016/S0304-419X(97)00012-7; ANDERSON SJ, 1993, NATURE, V365, P552, DOI 10.1038/365552a0; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Ardouin L, 1998, J EXP MED, V187, P105, DOI 10.1084/jem.187.1.105; Berger MA, 1997, J EXP MED, V186, P1461, DOI 10.1084/jem.186.9.1461; Bogue MA, 1996, GENE DEV, V10, P553, DOI 10.1101/gad.10.5.553; Borst J, 1996, CURR OPIN IMMUNOL, V8, P181, DOI 10.1016/S0952-7915(96)80056-2; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; Eichmann K, 1998, Dev Immunol, V6, P19, DOI 10.1155/1998/25758; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fehling HJ, 1997, IMMUNITY, V6, P703, DOI 10.1016/S1074-7613(00)80446-X; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Haks MC, 1999, SEMIN IMMUNOL, V11, P23, DOI 10.1006/smim.1998.0153; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; HARPER JW, 1993, CELL, V75, P805; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; HOUGH MR, 1994, J EXP MED, V179, P177, DOI 10.1084/jem.179.1.177; HUNTER T, 1993, CELL, V75, P839, DOI 10.1016/0092-8674(93)90528-X; Jacks T, 1996, J CANCER RES CLIN, V122, P319, DOI 10.1007/BF01220798; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KORSMEYER SJ, 1992, IMMUNOL TODAY, V13, P285, DOI 10.1016/0167-5699(92)90037-8; Krotkova A, 1997, J EXP MED, V186, P767, DOI 10.1084/jem.186.5.767; Levelt CN, 1995, IMMUNITY, V3, P667, DOI 10.1016/1074-7613(95)90056-X; LEVELT CN, 1995, IMMUNITY, V3, P215, DOI 10.1016/1074-7613(95)90091-8; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Malissen B, 1996, CURR OPIN IMMUNOL, V8, P383, DOI 10.1016/S0952-7915(96)80129-4; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; PENIT C, 1995, J IMMUNOL, V154, P5103; PURDIE CA, 1994, ONCOGENE, V9, P603; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; TISTY TD, 1992, CELL, V70, P923; Tybulewicz VLJ, 1998, CURR OPIN CELL BIOL, V10, P195, DOI 10.1016/S0955-0674(98)80142-7; VANOERS NSC, 1995, J EXP MED, V182, P1585, DOI 10.1084/jem.182.5.1585; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; WALLACE VA, 1995, EUR J IMMUNOL, V25, P1312, DOI 10.1002/eji.1830250527; Wang BP, 1998, J EXP MED, V188, P1375, DOI 10.1084/jem.188.7.1375; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Wu G, 1996, INT IMMUNOL, V8, P1159, DOI 10.1093/intimm/8.7.1159; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	78	112	112	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1999	11	1					91	101		10.1016/S1074-7613(00)80084-9	http://dx.doi.org/10.1016/S1074-7613(00)80084-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435582	Bronze			2022-12-18	WOS:000081671300009
J	Speir, JA; Abdel-Motal, UM; Jondal, M; Wilson, IA				Speir, JA; Abdel-Motal, UM; Jondal, M; Wilson, IA			Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL	IMMUNITY			English	Article							T-CELL RECOGNITION; DIFFERENT PEPTIDES; VIRAL PEPTIDES; ANTIGEN; COMPLEX; MOLECULES; PROTEINS; BINDING; REFINEMENT; RESOLUTION	T cell receptor (TCR) recognition of nonpeptidic and modified peptide antigens has been recently uncovered but is still poorly understood. Immunization with an H-2K(b)-restricted glycopeptide RGY8-6H-Gal(2) generates a population of cytotoxic T cells that express both alpha/beta TCR, specific for glycopeptide, and gamma/delta TCR, specific for the disaccharide, even on glycolipids, The crystal structure of K-b/RGY8-6H-Gal(2) now demonstrates that the peptide and H-2K(b) structures are unaffected by the peptide glycosylation, but the central region of the putative TCR binding site is dominated by the extensive exposure of the tethered carbohydrate. These features of the K-b/RGY8-6H-Gal(2) structure are consistent with the individual ligand binding preferences identified for the alpha/beta and gamma/delta TCRs and thus explain the generation of a carbohydrate-specific T cell response.	Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Karolinska Inst, Microbiol & Tumorbiol Ctr, S-17177 Stockholm, Sweden	Scripps Research Institute; Scripps Research Institute; Karolinska Institutet	Speir, JA (corresponding author), Scripps Res Inst, Dept Biol Mol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R37AI042266] Funding Source: NIH RePORTER; NCI NIH HHS [CA58896] Funding Source: Medline; NIAID NIH HHS [AI42266] Funding Source: Medline; NIMH NIH HHS [MH19185] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AbdelMotal UM, 1996, EUR J IMMUNOL, V26, P544, DOI 10.1002/eji.1830260307; AbdelMotal UM, 1995, J IMMUNOL METHODS, V188, P21, DOI 10.1016/0022-1759(96)82888-2; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Boismenu R, 1997, CURR OPIN IMMUNOL, V9, P57, DOI 10.1016/S0952-7915(97)80159-8; Broddefalk J, 1998, J AM CHEM SOC, V120, P7676, DOI 10.1021/ja980489k; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Carbone FR, 1997, GLYCOBIOLOGY, V7, P725, DOI 10.1093/glycob/7.6.725-d; Chesnut R W, 1995, Pharm Biotechnol, V6, P847; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Davis CA, 1995, SURF COAT TECH, V76, P316, DOI 10.1016/0257-8972(95)02553-7; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Eisen HN, 1996, ADV PROTEIN CHEM, V49, P1, DOI 10.1016/S0065-3233(08)60487-8; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; GalliStampino L, 1997, CANCER RES, V57, P3214; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hakomori S., 1989, GANGLIOSIDES CANC, P57; HANSEN JES, 1990, J VIROL, V64, P2833, DOI 10.1128/JVI.64.6.2833-2840.1990; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; HAURUM JS, 1994, J EXP MED, V180, P739, DOI 10.1084/jem.180.2.739; HOCHGESCHWENDER U, 1987, NATURE, V326, P307, DOI 10.1038/326307a0; HOLMES EH, 1987, J BIOL CHEM, V262, P15649; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; ISHIOKA GY, 1992, J IMMUNOL, V148, P2446; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Kihlberg J, 1997, CURR MED CHEM, V4, P85; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KLEYWEGT GJ, 1995, ESF CCP4 NEWSLETT, V31, P45; Kohler J, 1997, J IMMUNOL, V158, P591; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; LANZAVECCHIA A, 1993, SCIENCE, V260, P937, DOI 10.1126/science.8493532; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MARTIN S, 1992, J IMMUNOL, V149, P2569; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCREE DE, 1993, PRACTICAL PROTEIN CR, P225; Melian A, 1996, CURR OPIN IMMUNOL, V8, P82, DOI 10.1016/S0952-7915(96)80109-9; MOTAL UMA, 1993, EUR J IMMUNOL, V23, P3224, DOI 10.1002/eji.1830231227; NORES GA, 1987, J IMMUNOL, V139, P3171; NUDELMAN E, 1983, SCIENCE, V220, P509, DOI 10.1126/science.6836295; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porcelli SA, 1996, CURR OPIN IMMUNOL, V8, P510, DOI 10.1016/S0952-7915(96)80039-2; Porcelli SA, 1998, IMMUNOL TODAY, V19, P362, DOI 10.1016/S0167-5699(98)01289-4; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; SCHUMACHER TNM, 1991, NATURE, V350, P703, DOI 10.1038/350703a0; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Smith KJ, 1996, IMMUNITY, V4, P215, DOI 10.1016/S1074-7613(00)80430-6; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; SMITH TJ, 1995, J MOL GRAPHICS, V13, P122, DOI 10.1016/0263-7855(94)00019-O; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; STURA EA, 1992, J MOL BIOL, V228, P975, DOI 10.1016/0022-2836(92)90881-J; SVENSSON G, 1986, CARBOHYD RES, V146, P29, DOI 10.1016/0008-6215(86)85021-2; VANBLEEK GM, 1990, NATURE, V348, P213; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wilson IA, 1997, CURR OPIN STRUC BIOL, V7, P839, DOI 10.1016/S0959-440X(97)80156-X; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; ZHOU XZ, 1992, J IMMUNOL METHODS, V153, P193, DOI 10.1016/0022-1759(92)90322-K	73	112	115	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1999	10	1					51	61		10.1016/S1074-7613(00)80006-0	http://dx.doi.org/10.1016/S1074-7613(00)80006-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023770	Bronze			2022-12-18	WOS:000078428700006
J	Tourne, S; Miyazaki, T; Oxenius, A; Klein, L; Fehr, T; Kyewski, B; Benoist, C; Mathis, D				Tourne, S; Miyazaki, T; Oxenius, A; Klein, L; Fehr, T; Kyewski, B; Benoist, C; Mathis, D			Selection of a broad repertoire of CB4(+) T cells in H-2Ma(0/0) mice	IMMUNITY			English	Article							MHC CLASS-II; SHOCK SYNDROME TOXIN-1; POSITIVE SELECTION; TRANSGENIC MICE; ANTIGEN PRESENTATION; THYMOCYTE SELECTION; SINGLE PEPTIDE; RECEPTOR; BINDING; RECOGNITION	According to past reports, H-2Ma(0/0) mice express a single major histocompatiblity complex class II molecule, A(b), heavily loaded with a single peptide derived from the invariant chain, CLIP. Despite the highly restricted diversity of the class Il:peptide complexes expressed on thymic stromal cells in the mutant animals, a large and diverse population of CD4(+) T cells is positively selected. However, two important issues remained unresolved and al are addressed here: Just how preponderant is CLIP occupancy of the class II molecules from H-2M(0/0) mice? How extensive and functionally competent is the CD4+ population selected in the mutant animals? Our results argue that a single class il:peptide complex can select a very broad, though not complete, repertoire of CD4+ T cells.	UNIV STRASBOURG 1,INST GENET & BIOL MOL & CELLULAIRE,CNRS,INSERM,F-67404 ILLKIRCH GRAFFENS,FRANCE; UNIV ZURICH HOSP,INST PATHOL,CH-8091 ZURICH,SWITZERLAND; GERMAN CANC RES CTR,DIV CELLULAR IMMUNOL,TUMOR IMMUNOL PROGRAM,D-69120 HEIDELBERG,GERMANY	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Zurich; University Zurich Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)			Oxenius, Annette/G-7794-2015; Klein, Ludger/G-8785-2011	Klein, Ludger/0000-0003-2054-071X				ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Battegay M, 1996, CELL IMMUNOL, V167, P115, DOI 10.1006/cimm.1996.0014; Benoist C, 1997, CURR OPIN IMMUNOL, V9, P245, DOI 10.1016/S0952-7915(97)80143-4; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; DOFFINGER R, 1997, IN PRESS MOL IMMUNOL; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Guery JC, 1996, J EXP MED, V183, P751, DOI 10.1084/jem.183.3.751; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; IGNATOWICZ L, 1995, J IMMUNOL, V154, P3852; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; KAYE J, 1992, J IMMUNOL, V148, P3342; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Klein TC, 1995, EUR J IMMUNOL, V25, P3489, DOI 10.1002/eji.1830251242; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; LEMEUR M, 1985, NATURE, V316, P38, DOI 10.1038/316038a0; LUCAS B, 1996, CURR BIOL, V7, P783; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; Oxenius A, 1996, J EXP MED, V183, P2209, DOI 10.1084/jem.183.5.2209; OXENIUS A, 1997, IN PRESS J IMMUNOL; Pawlowski TJ, 1996, EUR J IMMUNOL, V26, P851, DOI 10.1002/eji.1830260419; ROOST HP, 1990, EUR J IMMUNOL, V20, P2547, DOI 10.1002/eji.1830201204; SCOTT DW, 1970, CLIN EXP IMMUNOL, V6, P13; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; THIBODEAU J, 1994, SCIENCE, V266, P1874, DOI 10.1126/science.7997881; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; VONBONIN A, 1995, EUR J IMMUNOL, V25, P2894, DOI 10.1002/eji.1830251028; Wen R, 1996, J EXP MED, V183, P1083, DOI 10.1084/jem.183.3.1083; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	37	112	112	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					187	195		10.1016/S1074-7613(00)80522-1	http://dx.doi.org/10.1016/S1074-7613(00)80522-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285404	Bronze			2022-12-18	WOS:A1997XT49200003
J	VENKATARAMAN, L; FRANCIS, DA; WANG, ZH; LIU, JL; ROTHSTEIN, TL; SEN, R				VENKATARAMAN, L; FRANCIS, DA; WANG, ZH; LIU, JL; ROTHSTEIN, TL; SEN, R			CYCLOSPORINE-A SENSITIVE INDUCTION OF NF-AT IN MURINE B-CELLS	IMMUNITY			English	Article							SURFACE IG RECEPTOR; KINASE-C ACTIVATION; T-CELLS; KAPPA-B; INTERLEUKIN-2 PROMOTER; NUCLEAR FACTOR; ANTIGEN RECEPTOR; LYMPHOCYTES-T; CROSS-LINKING; EXPRESSION	Primary B cells are Induced to proliferate by crosslinking surface immunoglobulin or by its pharmacological equivalent, phorbol ester and calcium ionophore. However, nuclear responses that have been studied in activated B cells are typically inducible with phorbol esters alone. We show that a factor, indistinguishable from the nuclear factor of activated T cells (NF-AT), is induced in B cells in response to anti-immunoglobulin signals or the combined action of phorbol ester and ionomycin, but not in response to either reagent alone. The signals necessary for NF-AT induction in B cells, therefore, closely parallel those required to induce B cell proliferation. Transfection analysis shows that B cell NF-AT is a transcriptional activator. Furthermore, NF-AT induction In splenic cells is suppressed by cyclosporin A, suggesting a mechanism by which immunosuppressive agents act on the B cell compartment. We propose that NF-AT should be considered more generally as a nuclear factor of activated lymphoid cells.	BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254; BOSTON UNIV,MED CTR,DEPT PATHOL,BOSTON,MA 02118; BOSTON UNIV,MED CTR,DEPT MICROBIOL,BOSTON,MA 02118; BOSTON UNIV,MED CTR,DEPT MED,BOSTON,MA 02118	Brandeis University; Boston University; Boston University; Boston University	VENKATARAMAN, L (corresponding author), BRANDEIS UNIV,ROSENSTIEL RES CTR,WALTHAM,MA 02254, USA.		Liu, Jialing/A-8627-2012	Liu, Jialing/0000-0003-4420-4382	NIGMS NIH HHS [GM-00563] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANERJI SS, 1991, MOL CELL BIOL, V11, P4074, DOI 10.1128/MCB.11.8.4074; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; CHILES TC, 1992, J IMMUNOL, V149, P825; CHILES TC, 1991, J IMMUNOL, V146, P1730; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GRANELLIPIPERNO A, 1990, J EXP MED, V172, P1869, DOI 10.1084/jem.172.6.1869; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; JAIN J, 1992, J IMMUNOL, V148, P1240; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAMIESON C, 1991, J IMMUNOL, V147, P416; KLAUS G, 1988, TRANSPLANTATION, V46, P115; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; LALMANACHGIRARD AC, 1993, J EXP MED, V177, P1215, DOI 10.1084/jem.177.4.1215; LIU JL, 1991, J IMMUNOL, V146, P1685; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; MAUXION F, 1991, P NATL ACAD SCI USA, V88, P2141, DOI 10.1073/pnas.88.6.2141; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MIZUGUCHI J, 1987, J IMMUNOL, V139, P1054; NELSEN B, 1990, MOL CELL BIOL, V10, P3145, DOI 10.1128/MCB.10.6.3145; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; RAO A, 1991, CRIT REV IMMUNOL, V10, P495; ROONEY JW, 1991, EUR J IMMUNOL, V21, P2993, DOI 10.1002/eji.1830211214; SEYFERT VL, 1990, J IMMUNOL, V145, P3647; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SIEBENLIST U, 1986, MOL CELL BIOL, V6, P3042, DOI 10.1128/MCB.6.9.3042; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; WICKER LS, 1990, EUR J IMMUNOL, V20, P2277, DOI 10.1002/eji.1830201017; XIE HJ, 1993, J IMMUNOL, V151, P880; Xie W.Q., 1991, BIOTECHNIQUES, V11, P326; YASEEN NR, 1993, J BIOL CHEM, V268, P14285	37	112	112	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1994	1	3					189	196		10.1016/1074-7613(94)90097-3	http://dx.doi.org/10.1016/1074-7613(94)90097-3			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK165	7889407				2022-12-18	WOS:A1994PK16500003
J	Zhou, Y; Fei, MJ; Zhang, G; Liang, WC; Lin, WY; Wu, Y; Piskol, R; Ridgway, J; McNamara, E; Huang, HC; Zhang, J; Oh, J; Patel, JM; Jakubiak, D; Lau, J; Blackwood, B; Bravo, DD; Shi, YC; Wang, JY; Hu, HM; Lee, WP; Jesudason, R; Sangaraju, D; Modrusan, Z; Anderson, KR; Warming, S; Roose-Girma, M; Yan, M				Zhou, Yi; Fei, Mingjian; Zhang, Gu; Liang, Wei-Ching; Lin, Weiyu; Wu, Yan; Piskol, Robert; Ridgway, John; McNamara, Erin; Huang, Haochu; Zhang, Juan; Oh, Jaehak; Patel, Jaina M.; Jakubiak, Diana; Lau, Jeff; Blackwood, Beth; Bravo, Daniel D.; Shi, Yongchang; Wang, Jianyong; Hu, Hong-Ming; Lee, Wyne P.; Jesudason, Rajiv; Sangaraju, Dewakar; Modrusan, Zora; Anderson, Keith R.; Warming, Soren; Roose-Girma, Merone; Yan, Minhong			Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP	IMMUNITY			English	Article							IMMUNE CHECKPOINT BLOCKADE; CYCLIC GMP-AMP; DENDRITIC CELLS; I INTERFERON; CANCER-IMMUNOTHERAPY; TYROSINE KINASES; APOPTOTIC CELLS; DNA; CLEARANCE; RESPONSES	Clearance of apoptotic cells by macrophages prevents excessive inflammation and supports immune tolerance. Here, we examined the effect of blocking apoptotic cell clearance on anti-tumor immune response. We generated an antibody that selectively inhibited efferocytosis by phagocytic receptor MerTK. Blockade of MerTK resulted in accumulation of apoptotic cells within tumors and triggered a type I interferon response. Treatment of tumor-bearing mice with anti-MerTK antibody stimulated T cell activation and synergized with anti-PD-1 or anti PD-L1 therapy. The anti-tumor effect induced by anti-MerTK treatment was lost in Sting(gt/gt) mice, but not in Cgas(-/-) mice. Abolishing cGAMP production in Cgas(-/-) tumor cells, depletion of extracellular ATP, or inactivation of the ATP-gated P2X7R channel also compromised the effects of MerTK blockade. Mechanistically, extracellular ATP acted via P2X7R to enhance the transport of extracellular cGAMP into macrophages and subsequent STING activation. Thus, MerTK blockade increases tumor immunogenicity and potentiates anti-tumor immunity, which has implications for cancer immunotherapy.	[Zhou, Yi; Fei, Mingjian; Zhang, Gu; Liang, Wei-Ching; Lin, Weiyu; Wu, Yan; Piskol, Robert; Ridgway, John; McNamara, Erin; Huang, Haochu; Zhang, Juan; Oh, Jaehak; Jakubiak, Diana; Lau, Jeff; Blackwood, Beth; Bravo, Daniel D.; Shi, Yongchang; Wang, Jianyong; Lee, Wyne P.; Jesudason, Rajiv; Sangaraju, Dewakar; Modrusan, Zora; Anderson, Keith R.; Warming, Soren; Roose-Girma, Merone; Yan, Minhong] Genentech Inc, San Francisco, CA 94080 USA; [Patel, Jaina M.; Hu, Hong-Ming] Earle A Chiles Res Inst, Canc Immunobiol Lab, Portland, OR USA	Roche Holding; Genentech	Yan, M (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	minhong@gene.com	Warming, Soren/ABD-5729-2021; Zhou, Yi/AAK-2579-2021	bravo, daniel/0000-0003-1872-6929; Zhou, Yi/0000-0002-1926-5290	Genentech Inc., United States	Genentech Inc., United States	We thank M. Wang, R. Corpuz, and I. Lehoux for protein production and purification; E. Wonder, M. Long, and W. Ortiz for animal husbandry; K. Hotzel and F. Peale for pathology support; K. Totpal for cell bank assistance; B. Alicke and B. Forrest for statistical analysis support; and members of the Microinjection, Genetic Analysis, Microscopy, and FACS laboratories for technical assistance. Funding source: Genentech Inc., United States.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ahn J, 2018, CANCER CELL, V33, P862, DOI 10.1016/j.ccell.2018.03.027; Akalu YT, 2017, IMMUNOL REV, V276, P165, DOI 10.1111/imr.12522; Anderson KR, 2018, NAT METHODS, V15, P512, DOI 10.1038/s41592-018-0011-5; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Benechet AP, 2019, NATURE, V574, P200, DOI 10.1038/s41586-019-1620-6; Bernhard CA, 2015, P NATL ACAD SCI USA, V112, P5461, DOI 10.1073/pnas.1423356112; Bezu L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00187; Broz ML, 2014, CANCER CELL, V26, P938, DOI 10.1016/j.ccell.2014.11.010; Buchbinder EI, 2016, AM J CLIN ONCOL-CANC, V39, P98, DOI 10.1097/COC.0000000000000239; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Cook RS, 2013, J CLIN INVEST, V123, P3231, DOI 10.1172/JCI67655; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Crittenden MR, 2016, ONCOTARGET, V7, P78653, DOI 10.18632/oncotarget.11823; Daemen A, 2018, CELL METAB, V28, P383, DOI 10.1016/j.cmet.2018.06.003; Demaria O, 2015, P NATL ACAD SCI USA, V112, P15408, DOI 10.1073/pnas.1512832112; Dempke WCM, 2017, EUR J CANCER, V74, P55, DOI 10.1016/j.ejca.2017.01.001; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Di Virgilio F, 2018, NAT REV CANCER, V18, P601, DOI 10.1038/s41568-018-0037-0; Di Virgilio F, 2018, TRENDS CELL BIOL, V28, P392, DOI 10.1016/j.tcb.2018.01.005; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Dull Angie B, 2018, Oncotarget, V9, P17104, DOI 10.18632/oncotarget.24936; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Galon J, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1029-z; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jonsson KL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14391; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lo M, 2017, J BIOL CHEM, V292, P3900, DOI 10.1074/jbc.M116.767749; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; Minn AJ, 2016, CELL, V165, P272, DOI 10.1016/j.cell.2016.03.031; Moserle L, 2008, CANCER RES, V68, P5658, DOI 10.1158/0008-5472.CAN-07-6341; Muraoka D, 2019, J CLIN INVEST, V129, P1278, DOI 10.1172/JCI97642; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Riley JS, 2018, EMBO J, V37, DOI 10.15252/embj.201899238; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sanchez-Paulete AR, 2016, CANCER DISCOV, V6, P71, DOI 10.1158/2159-8290.CD-15-0510; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Savio LEB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00052; Schadt L, 2019, CELL REP, V29, P1236, DOI 10.1016/j.celrep.2019.09.065; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seeber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086184; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Stanford JC, 2014, J CLIN INVEST, V124, P4737, DOI 10.1172/JCI76375; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Weir GM, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0169-2; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wood S.N, 2017, GEN ADDITIVE MODELS, Vsecond; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xia TL, 2016, CANCER RES, V76, P6747, DOI 10.1158/0008-5472.CAN-16-1404; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Xu MM, 2017, IMMUNITY, V47, P363, DOI 10.1016/j.immuni.2017.07.016; Yaari G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt660; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yang JC, 2000, J IMMUNOTHER, V23, P177, DOI 10.1097/00002371-200003000-00001; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	98	111	114	11	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					357	+		10.1016/j.immuni.2020.01.014	http://dx.doi.org/10.1016/j.immuni.2020.01.014			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32049051	Bronze			2022-12-18	WOS:000515082000016
J	Kashiwagi, I; Morita, R; Schichita, T; Komai, K; Saeki, K; Matsumoto, M; Takeda, K; Nomura, M; Hayashi, A; Kanai, T; Yoshimura, A				Kashiwagi, Ikkou; Morita, Rimpei; Schichita, Takashi; Komai, Kyoko; Saeki, Keita; Matsumoto, Makoto; Takeda, Kiyoshi; Nomura, Masatoshi; Hayashi, Atsushi; Kanai, Takanori; Yoshimura, Akihiko			Smad2 and Smad3 Inversely Regulate TGF-beta Autoinduction in Clostridium butyricum-Activated Dendritic Cells	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; T-CELLS; COMMENSAL; TRANSCRIPTION; SUPPRESSION; INDUCTION; DIFFERENTIATION; COACTIVATORS; MACROPHAGES; DISRUPTION	Colonizationwith a mixture of Clostridium species has been shown to induce accumulation of induced regulatory T (iTreg) cells in the colon. Transforming growth factor-beta (TGF-beta) is an essential factor for iTreg cell induction; however, the relationship between Clostridium species and TGF-beta remains to be clarified. Here we demonstrated that a gram-positive probiotic bacterial strain, Clostridium butyricum(C. butyricum), promoted iTreg cell generation in the intestine through induction of TGF-beta 1 from lamina propria dendritic cells (LPDCs). C. butyricum-mediated TGF-beta 1 induction was mainly Toll-like receptor 2 (TLR2) dependent, and the ERK-AP-1 kinase pathway played an important role. In addition, the autocrine TGF-beta-Smad3 transcription factor signal was necessary for robust TGF-beta expression in DCs, whereas Smad2 negatively regulated TGF-beta expression. Smad2-deficient DCs expressed higher concentrations of TGF-beta and were tolerogenic for colitismodels. This study reveals a novel mechanism of TGF-beta induction by Clostridia through a cooperation between TLR2-AP-1 and TGF-beta-Smad signaling pathways.	[Kashiwagi, Ikkou; Morita, Rimpei; Schichita, Takashi; Komai, Kyoko; Saeki, Keita; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Internal Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Kashiwagi, Ikkou; Morita, Rimpei; Schichita, Takashi; Komai, Kyoko; Saeki, Keita; Hayashi, Atsushi; Kanai, Takanori; Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Tokyo 1020076, Japan; [Schichita, Takashi] PRESTO Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Matsumoto, Makoto] Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan; [Takeda, Kiyoshi] Osaka Univ, Dept Microbiol & Immunol, Grad Sch Med, WPI Immunol Frontier Res Ctr,Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Nomura, Masatoshi] Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Hayashi, Atsushi; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1608582, Japan; [Hayashi, Atsushi] Miyarisan Pharmaceut Co Ltd, Res Lab, Tokyo 1140016, Japan	Keio University; Japan Science & Technology Agency (JST); Hyogo College of Medicine; Osaka University; Kyushu University; Keio University	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013	KASHIWAGI, IKKOH/0000-0001-5386-5719	Miyarisan Pharmaceutical Co., Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan; SENSHIN Research Foundation; Kanae Foundation for the Promotion of Medical Science; Mochida Memorial Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP) [22-4]	Miyarisan Pharmaceutical Co., Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SENSHIN Research Foundation; Kanae Foundation for the Promotion of Medical Science; Mochida Memorial Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP)	A.H. is supported by Miyarisan Pharmaceutical Co., Ltd. We thank M. Asakawa, S. Tsuruta, and R. Komine for technical assistance. This work was supported by special grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Intramural Research Grant (22-4) for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP), the SENSHIN Research Foundation, the Kanae Foundation for the Promotion of Medical Science, the Mochida Memorial Foundation, the Uehara Memorial Foundation, and the Takeda Science Foundation.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Hayashi A, 2013, CELL HOST MICROBE, V13, P711, DOI 10.1016/j.chom.2013.05.013; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; Lyons A, 2010, CLIN EXP ALLERGY, V40, P811, DOI 10.1111/j.1365-2222.2009.03437.x; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsumura Y, 2007, J IMMUNOL, V179, P2170, DOI 10.4049/jimmunol.179.4.2170; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Presser LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056367; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Ruane DT, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00025; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Sato R, 1997, MICROBIOL IMMUNOL, V41, P665, DOI 10.1111/j.1348-0421.1997.tb01909.x; Seki H, 2003, PEDIATR INT, V45, P86, DOI 10.1046/j.1442-200X.2003.01671.x; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Sugiyama Y, 2012, INT IMMUNOL, V24, P253, DOI 10.1093/intimm/dxr126; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tamiya T, 2013, J IMMUNOL, V191, P2360, DOI 10.4049/jimmunol.1301276; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wakabayashi Y, 2011, J BIOL CHEM, V286, P35456, DOI 10.1074/jbc.M111.236794; Worthington JJ, 2011, GASTROENTEROLOGY, V141, P1802, DOI 10.1053/j.gastro.2011.06.057; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822	43	111	118	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					65	79		10.1016/j.immuni.2015.06.010	http://dx.doi.org/10.1016/j.immuni.2015.06.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26141582	Bronze			2022-12-18	WOS:000360101100011
J	Bailis, W; Yashiro-Ohtani, Y; Fang, TC; Hatton, RD; Weaver, CT; Artis, D; Pear, WS				Bailis, Will; Yashiro-Ohtani, Yumi; Fang, Terry C.; Hatton, Robin D.; Weaver, Casey T.; Artis, David; Pear, Warren S.			Notch Simultaneously Orchestrates Multiple Helper T Cell Programs Independently of Cytokine Signals	IMMUNITY			English	Article							IFNG GENE-EXPRESSION; HELMINTH INFECTION; CRITICAL REGULATOR; GATA3 EXPRESSION; INTERFERON-GAMMA; TRICHURIS-MURIS; DIFFERENTIATION; IMMUNITY; TRANSCRIPTION; INFLAMMATION	Two models are proposed to explain Notch function during helper T (Th) cell differentiation. One argues that Notch instructs one Th cell fate over the other, whereas the other posits that Notch function is dictated by cytokines. Here we provide a detailed mechanistic study investigating the role of Notch in orchestrating Th cell differentiation. Notch neither instructed Th cell differentiation nor did cytokines direct Notch activity, but instead, Notch simultaneously regulated the Th1, Th2, and Th17 cell genetic programs independently of cytokine signals. In addition to regulating these programs in both polarized and nonpolarized Th cells, we identified Ifng as a direct Notch target. Notch bound the Ifng CNS-22 enhancer, where it synergized with Tbet at the promoter. Thus, Notch acts as an unbiased amplifier of Th cell differentiation. Our data provide a paradigm for Notch in hematopoiesis, with Notch simultaneously orchestrating multiple lineage programs, rather than restricting alternate outcomes.	[Bailis, Will; Yashiro-Ohtani, Yumi; Fang, Terry C.; Pear, Warren S.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Bailis, Will; Yashiro-Ohtani, Yumi; Artis, David; Pear, Warren S.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Hatton, Robin D.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35233 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham	Pear, WS (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	wpear@mail.med.upenn.edu		Hatton, Robin/0000-0002-4797-9899; Artis, David/0000-0002-1753-4100; Weaver, Casey/0000-0002-2180-1793	Cancer Research Institute [T32HD007516, 1F31CA165813]; NIH [R01AI047833, RO1AI061570, R01AI077574]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016520, F31CA165813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061570, R01AI077574, R01AI047833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Avinash Bhandoola and John Wherry for providing advice and/or reagents. The following cores at the University of Pennsylvania contributed to this study: mouse husbandry (ULAR), the Abramson Cancer Center Flow Cytometry Core (P30-CA016520), the AFCRI Cores, the Matthew J. Ryan Veterinary Hospital Pathology Laboratory, and the NIH/NIDDK P30 Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306). This work was supported by T32HD007516 and 1F31CA165813 predoctoral fellowships to W. B., a predoctoral fellowship from the Cancer Research Institute to T. C. F., and grants from the NIH to W. S. P. (R01AI047833), D. A. (RO1AI061570), and R. D. H. and C. T. W. (R01AI077574). D. A. is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038/nri2488; Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Auderset F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002560; Balasubramani A, 2010, IMMUNITY, V33, P35, DOI 10.1016/j.immuni.2010.07.004; Blackwell NM, 2001, INFECT IMMUN, V69, P3860, DOI 10.1128/IAI.69.6.3860-3868.2001; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Coghill JM, 2011, BLOOD, V117, P3268, DOI 10.1182/blood-2010-12-290403; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Helbig C, 2012, P NATL ACAD SCI USA, V109, P9041, DOI 10.1073/pnas.1206044109; Keerthivasan S, 2011, J IMMUNOL, V187, P692, DOI 10.4049/jimmunol.1003658; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kubo M, 2007, IMMUNITY, V27, P3, DOI 10.1016/j.immuni.2007.07.005; Le Friec G, 2012, NAT IMMUNOL, V13, P1213, DOI 10.1038/ni.2454; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Tong YK, 2005, P NATL ACAD SCI USA, V102, P2034, DOI 10.1073/pnas.0409510102; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zhang Y, 2011, BLOOD, V117, P299, DOI 10.1182/blood-2010-03-271940	39	111	116	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					148	159		10.1016/j.immuni.2013.07.006	http://dx.doi.org/10.1016/j.immuni.2013.07.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890069	Green Accepted, Bronze			2022-12-18	WOS:000330948300015
J	Malhotra, N; Narayan, K; Cho, OH; Sylvia, KE; Yin, C; Melichar, H; Rashighi, M; Lefebvre, V; Harris, JE; Berg, LJ; Kang, J				Malhotra, Nidhi; Narayan, Kavitha; Cho, Ok Hyun; Sylvia, Katelyn E.; Yin, Catherine; Melichar, Heather; Rashighi, Mehdi; Lefebvre, Veronique; Harris, John E.; Berg, Leslie J.; Kang, Joonsoo		Immunol Genome Project Consortium	A Network of High-Mobility Group Box Transcription Factors Programs Innate Interleukin-17 Production	IMMUNITY			English	Article							DELTA-T-CELLS; ROR-GAMMA-T; LYMPHOID-CELLS; INTERFERON-GAMMA; IN-VIVO; THYMOCYTE DIFFERENTIATION; PROINFLAMMATORY IL-17(+); COLON-CARCINOMA; NKP46(+) CELLS; EXPRESSION	How innate lymphoid cells (ILCs) in the thymus and gut become specialized effectors is unclear. The prototypic innate-like gamma delta T cells (T gamma delta 17) are a major source of interleukin-17 (IL-17). We demonstrate that T gamma delta 17 cells are programmed by a gene regulatory network consisting of a quartet of high-mobility group (HMG) box transcription factors, SOX4, SOX13, TCF1, and LEF1, and not by conventional TCR signaling. SOX4 and SOX13 directly regulated the two requisite T gamma delta 17 cell-specific genes, Rorc and Blk, whereas TCF1 and LEF1 countered the SOX proteins and induced genes of alternate effector subsets. The T cell lineage specification factor TCF1 was also indispensable for the generation of IL-22 producing gut NKp46(+) ILCs and restrained cytokine production by lymphoid tissue inducer-like effectors. These results indicate that similar gene network architecture programs innate sources of IL-17, independent of anatomical origins.	[Malhotra, Nidhi; Narayan, Kavitha; Cho, Ok Hyun; Sylvia, Katelyn E.; Yin, Catherine; Melichar, Heather; Berg, Leslie J.; Kang, Joonsoo] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Rashighi, Mehdi; Harris, John E.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA; [Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Lefebvre, Veronique] Cleveland Clin, Orthopaed & Rheumatol Ctr, Cleveland, OH 44195 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Kang, J (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	joonsoo.kang@umassmed.edu	Gautier, Emmanuel L./E-2259-2017; Heng, Tracy/AAR-5712-2021; Heng, Tracy/B-9847-2015; Rashighi, Mehdi/T-6185-2019	Gautier, Emmanuel L./0000-0003-2976-7566; Heng, Tracy/0000-0003-4147-8986; Heng, Tracy/0000-0003-4147-8986; Rashighi, Mehdi/0000-0002-9170-5887; Gazit, Roi/0000-0002-0548-2147; kang, joonsoo/0000-0001-8419-7995	eBioscience; Affymetrix; Expression Analysis; NIH/NCI [CA100382]; NIH/NIAID [AI084987, AI072073]; NIH/NIAMS [AR54153]; NATIONAL CANCER INSTITUTE [R01CA100382] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101301, T32AI007349, R01AI084987, R24AI072073, R01AI101048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR061437, R01AR054153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	eBioscience; Affymetrix; Expression Analysis; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Bix and E. Huseby for comments on the manuscript, the ImmGen core team (M. Painter, J. Ericson, S. Davis) for help with data generation and processing, eBioscience, Affymetrix, and Expression Analysis for support of the ImmGen Project, and H. Birchmeier and H. Clevers for mice. This work was supported by NIH/NCI CA100382 to J. K., NIH/NIAID AI084987 to L. J. B., AI072073 to ImmGen, and NIH/NIAMS AR54153 to V. L. Immunological Genome Project Consortium authors are as follows: E. L. Gautier, C. Jakubzick, G. J. Randolph, J. A. Best, J. Knell, A. Goldrath, J. Miller, B. Brown, M. Merad, V. Jojic, D. Koller, N. Cohen, P. Brennan, M. Brenner, T. Shay, A. Regev, A. Fletcher, K. Elpek, A. Bellemare-Pelletier, D. Malhotra, S. Turley, R. Jianu, D. Laidlaw, J. Collins, N. Malhotra, K. Sylvia, J. Kang, R. Gazit, B. Garrison, D. J. Rossi, F. Kim, T. N. Rao, A. Wagers, S. A. Shinton, R. R. Hardy, P. Monach, N. A. Bezman, J. C. Sun, C. C. Kim, L. L. Lanier, T. Heng, T. Kreslavsky, M. Painter, J. Ericson, S. Davis, D. Mathis, C. Benoist.	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Driskell RR, 2007, DEV BIOL, V305, P90, DOI 10.1016/j.ydbio.2007.01.038; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Huang ZF, 2006, J IMMUNOL, V176, P4880, DOI 10.4049/jimmunol.176.8.4880; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Malhotra N, 2010, J BIOL CHEM, V285, P29044, DOI 10.1074/jbc.C110.156745; Marfil V, 2010, J BIOL CHEM, V285, P5726, DOI 10.1074/jbc.M109.046649; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Penzo-Mendez A, 2007, GENESIS, V45, P776, DOI 10.1002/dvg.20358; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Powolny-Budnicka I, 2011, IMMUNITY, V34, P364, DOI 10.1016/j.immuni.2011.02.019; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Yu Q, 2011, J IMMUNOL, V186, P3946, DOI 10.4049/jimmunol.1003497; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	52	111	114	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					681	693		10.1016/j.immuni.2013.01.010	http://dx.doi.org/10.1016/j.immuni.2013.01.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23562159	Green Accepted, Bronze			2022-12-18	WOS:000330942100011
J	Yarovinsky, F; Kanzler, H; Hieny, S; Coffman, RL; Sher, A				Yarovinsky, Felix; Kanzler, Holger; Hieny, Sara; Coffman, Robert L.; Sher, Alan			Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4(+) T cell response	IMMUNITY			English	Article							DENDRITIC CELLS; TOXOPLASMA-GONDII; IN-VIVO; BACTERIAL FLAGELLIN; IMMUNE-RESPONSE; LYMPHOCYTES-T; ANTIGEN; MICE; ADAPTER; IDENTIFICATION	Although Toll-like Receptors (TLRs) play a major function in innate recognition of pathogens, their role in antigen processing and presentation in vivo is poorly understood. Here we establish that Toxoplasma gondii profilin, a TLR11 ligand present in the parasite, is an immunodominant antigen in the CD4(+) T cell response to the pathogen. The immunogenicity of profilin was entirely dependent on both TLR11 recognition and signaling through the adaptor myelold differentiation factor 88 (MyD88). Selective responsiveness to this parasite protein was regulated at the level of antigen presentation by dendritic cells (DC) and required both TLR signaling and major histocompatibility complex (MHC) class II recognition acting in cis. These findings support a major influence of TLR recognition in antigen presentation by DC in vivo and establish a mechanism by which TLR ligand association regulates the immunogenicity of microbial antigens.	NIAID, Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; Dynavax Technol Corp Berkeley, Berkeley, CA 94710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yarovinsky, F (corresponding author), NIAID, Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	fyarovinsky@niaid.nih.gov		Yarovinsky, Felix/0000-0001-5825-8002	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000579, ZIAAI000579] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; ARAUJO FG, 1991, INFECT IMMUN, V59, P1614, DOI 10.1128/IAI.59.5.1614-1619.1991; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509, DOI 10.1038/75365; Cookson BT, 1997, J IMMUNOL, V158, P4310; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; Ghielmetti M, 2005, IMMUNOBIOLOGY, V210, P211, DOI 10.1016/j.imbio.2005.05.015; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayashi Mieko, 2003, Nucleic Acids Res Suppl, P323; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Shirota H, 2001, J IMMUNOL, V167, P66, DOI 10.4049/jimmunol.167.1.66; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; SUZUKI Y, 1988, J IMMUNOL, V140, P3943; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2006, INT J PARASITOL, V36, P255, DOI 10.1016/j.ijpara.2005.12.003	36	111	121	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2006	25	4					655	664		10.1016/j.immuni.2006.07.015	http://dx.doi.org/10.1016/j.immuni.2006.07.015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17000122	Bronze			2022-12-18	WOS:000241481500016
